Brn3c O +
null O +
mutant O +
mice O +
show O +
long O -
- O -
term O -
, O +
incomplete O +
retention O +
of O +
some O +
afferent O +
inner O +
ear O +
innervation O +
Abstract O +
Background O +
Ears O +
of O +
Brn3c O +
null O +
mutants O +
develop O +
immature O +
hair O +
cells O -
, O +
identifiable O +
only O +
by O +
certain O +
molecular O +
markers O -
, O +
and O +
undergo O +
apoptosis O +
in O +
neonates O -
. O +

This O +
partial O +
development O +
of O +
hair O +
cells O +
could O +
lead O +
to O +
enough O +
neurotrophin O +
expression O +
to O +
sustain O +
sensory O +
neurons O +
through O +
embryonic O +
development O -
. O +

We O +
have O +
therefore O +
investigated O +
in O +
these O +
mutants O +
the O +
patterns O +
of O +
innervation O +
and O +
of O +
expression O +
of O +
known O +
neurotrophins O -
. O +

Results O +
At O +
birth O +
there O +
is O +
a O +
limited O +
expression O +
of O +
BDNF O +
and O +
NT-3 O +
in O +
the O +
mutant O +
sensory O +
epithelia O +
and O +
DiI B-Chemical +
tracing O +
shows O +
no O +
specific O +
reduction O +
of O +
afferents O +
or O +
efferents O +
that O +
resembles O +
neurotrophin O +
null O +
mutations O -
. O +

At O +
postnatal O +
day O +
7 O -
/ O -
8 O +
( O -
P7 O -
/ O -
8 O -
) O -
, O +
innervation O +
is O +
severely O +
reduced O +
both O +
qualitatively O +
and O +
quantitatively O -
. O +

1 O -
% O +
of O +
myosin O +
VIIa O -
- O -
positive O +
immature O +
hair O +
cells O +
are O +
present O +
in O +
the O +
mutant O +
cochlea O -
, O +
concentrated O +
in O +
the O +
base O -
. O +

Around O +
20 O -
% O +
of O +
immature O +
hair O +
cells O +
exist O +
in O +
the O +
mutant O +
vestibular O +
sensory O +
epithelia O -
. O +

Despite O +
more O +
severe O +
loss O +
of O +
hair O +
cells O +
( O -
1 O -
% O +
compared O +
to O +
20 O -
% O -
) O -
, O +
the O +
cochlea O +
retains O +
many O +
more O +
sensory O +
neurons O +
( O -
46 O -
% O +
compared O +
to O +
15 O -
% O -
) O +
than O +
vestibular O +
epithelia O -
. O +

Even O +
6 O +
months O +
old O +
mutant O +
mice O +
have O +
some O +
fibers O +
to O +
all O +
vestibular O +
sensory O +
epithelia O +
and O +
many O +
more O +
to O +
the O +
cochlear O +
apex O +
which O +
lacks O +
MyoVIIa O +
positive O +
hair O +
cells O -
. O +

Topologically O +
organized O +
central O +
cochlea O +
projections O +
exist O +
at O +
least O +
until O +
P8 O -
, O +
suggesting O +
that O +
functional O +
hair O +
cells O +
are O +
not O +
required O +
to O +
establish O +
such O +
projections O -
. O +

Conclusion O +
The O +
limited O +
expression O +
of O +
neurotrophins O +
in O +
the O +
cochlea O +
of O +
Brn3c O +
null O +
mice O +
suffices O +
to O +
support O +
many O +
sensory O +
neurons O -
, O +
particularly O +
in O +
the O +
cochlea O -
, O +
until O +
birth O -
. O +

The O +
molecular O +
nature O +
of O +
the O +
long O +
term O +
survival O +
of O +
apical O +
spiral O +
neurons O +
remains O +
unclear O -
. O +

Keywords O -
: O +
ear O +
development O -
, O +
POU O +
factors O +
and O +
hair O +
cells O -
, O +
afferent O +
ear O +
innervation O -
, O +
efferent O +
ear O +
innervation O +

Background O +
Brn3c O +
is O +
a O +
POU O +
domain O +
factor O +
that O +
is O +
crucial O +
for O +
inner O +
ear O +
hair O +
cell O +
development O -
. O +

Targeted O +
null O +
Brn3c O +
mutants O +
have O +
no O +
mature O +
hair O +
cells O +
[ O -
1,2 O -
] O -
. O +

Close O +
examination O +
has O +
revealed O +
that O +
some O +
' O -
immature O -
' O +
hair O +
cells O +
form O +
in O +
Brn3c O +
null O +
mutants O +
and O +
express O +
cellular O +
markers O +
such O +
as O +
Myosin O +
VI O +
and O +
VIIa O -
, O +
calretinin O +
and O +
parvalbumin O +
[ O -
3 O -
] O -
. O +

Furthermore O -
, O +
these O +
immature O +
hair O +
cells O +
of O +
Brn3c O +
null O +
mutants O +
undergo O +
apoptosis O +
in O +
neonates O +
[ O -
3 O -
] O -
. O +

Consistent O +
with O +
an O +
apparent O +
absence O +
of O +
mature O +
hair O +
cells O -
, O +
initial O +
work O +
suggested O +
that O +
all O +
vestibular O +
and O +
most O +
spiral O +
ganglion O +
cells O +
are O +
lost O +
by O +
postnatal O +
day O +
14 O +
( O -
P14 O -
; O +
[ O -
1 O -
] O -
) O -
. O +

However O -
, O +
more O +
detailed O +
quantification O +
by O +
others O +
[ O -
3 O -
] O +
reported O +
that O +
at O +
P4 O +
about O +
77 O -
% O +
of O +
vestibular O +
neurons O +
and O +
only O +
29 O -
% O +
of O +
spiral O +
neurons O +
are O +
lost O -
. O +

It O +
was O +
suggested O +
that O +
there O +
is O +
possibly O +
a O +
complete O +
loss O +
in O +
adults O +
[ O -
3 O -
] O -
. O +

Other O +
than O +
these O +
preliminary O +
statements O -
, O +
no O +
data O +
exists O +
concerning O +
the O +
detailed O +
pattern O +
of O +
loss O +
of O +
innervation O +
in O +
Brn3c O +
null O +
mutants O -
. O +

The O +
initial O +
development O +
and O +
partial O +
differentiation O +
of O +
hair O +
cells O +
in O +
Brn3c O +
mutants O +
could O +
possibly O +
lead O +
to O +
some O +
neurotrophin O +
expression O +
in O +
these O +
cells O +
to O +
sustain O +
sensory O +
neurons O +
through O +
embryonic O +
development O +
and O +
beyond O -
. O +

Data O +
on O +
various O +
single O +
and O +
compound O +
neurotrophin O +
null O +
mutants O +
have O +
shown O +
that O +
the O +
loss O +
of O +
a O +
specific O +
neurotrophin O +
leads O +
to O +
topologically O +
restricted O +
loss O +
of O +
sensory O +
neurons O +
in O +
the O +
embryonic O +
ear O +
[ O -
4,5 O -
] O -
. O +

Such O +
selective O +
loss O +
in O +
Brn3c O +
null O +
mutants O +
would O +
therefore O +
indicate O +
reduction O +
of O +
a O +
specific O +
neurotrophin O +
in O +
immature O +
hair O +
cells O -
. O +

Moreover O -
, O +
recent O +
work O +
shows O +
that O +
in O +
embryos O +
NT-3 O +
is O +
primarily O +
expressed O +
in O +
supporting O +
cells O -
, O +
moving O +
only O +
around O +
birth O +
into O +
hair O +
cells O +
[ O -
6,7 O -
] O -
. O +

In O +
fact O -
, O +
the O +
selective O +
loss O +
of O +
vestibular O +
as O +
compared O +
to O +
cochlear O +
sensory O +
neurons O +
( O -
77 O -
% O +
versus O +
29 O -
% O -
; O +
[ O -
3 O -
] O -
) O +
suggests O +
that O +
NT-3 O +
expression O +
may O +
be O +
less O +
downregulated O +
in O +
Brn3c O +
null O +
mutants O +
than O +
BDNF O +
[ O -
6,8,9 O -
] O -
, O +
provided O +
that O +
at O +
least O +
some O +
differentiation O +
of O +
supporting O +
cells O +
takes O +
place O -
. O +

In O +
the O +
ear O +
[ O -
4 O -
] O +
as O +
well O +
as O +
elsewhere O +
[ O -
10 O -
] O +
neurotrophins O +
are O +
progressively O +
downregulated O +
in O +
postnatal O +
mammals O +
and O +
possibly O +
replaced O +
by O +
other O +
factors O +
[ O -
11 O -
] O -
. O +

We O +
have O +
investigated O +
in O +
detail O +
the O +
pattern O +
of O +
innervation O +
in O +
the O +
Brn3c O +
mutants O -
, O +
as O +
well O +
as O +
the O +
expression O +
of O +
NT-3 O +
and O +
BDNF O -
. O +

We O +
want O +
to O +
evaluate O +
a O +
possible O +
correlation O +
between O +
the O +
topology O +
of O +
sensory O +
neuron O +
loss O +
and O +
absence O +
of O +
a O +
specific O +
neurotrophin O +
or O +
topological O +
loss O +
of O +
hair O +
cells O +
at O +
birth O +
and O +
in O +
older O +
animals O -
. O +

This O +
information O +
could O +
be O +
important O +
for O +
an O +
in O -
- O -
depth O +
evaluation O +
of O +
the O +
human O +
deafness O +
related O +
to O +
the O +
Pou4f3 O +
gene O -
, O +
DFNA15 O +
[ O -
12 O -
] O -
. O +

We O +
report O +
here O +
long O +
term O +
retention O +
of O +
cochlear O +
sensory O +
neurons O +
for O +
at O +
least O +
6 O +
months O -
, O +
in O +
particular O +
in O +
the O +
cochlear O +
apex O -
, O +
in O +
Brn3c O +
null O +
mutant O +
mice O -
. O +

This O +
retention O +
of O +
afferents O +
and O +
efferents O +
is O +
unrelated O +
to O +
hair O +
cell O +
differentiation O +
as O +
not O +
even O +
immature O +
hair O +
cells O +
can O +
be O +
detected O +
at O +
early O +
postnatal O +
stages O +
with O +
MyoVII O +
immunocytochemistry O +
in O +
this O +
part O +
of O +
the O +
cochlea O -
. O +

This O +
retention O +
of O +
apical O +
spiral O +
neurons O +
is O +
also O +
largely O +
unrelated O +
to O +
neurotrophins O +
which O +
are O +
known O +
to O +
be O +
reduced O +
in O +
their O +
expression O +
in O +
neonatal O +
rodents O +
[ O -
4 O -
] O -
. O +

Results O +
To O +
appreciate O +
the O +
effects O +
of O +
the O +
Brn3c O +
null O +
mutation O +
on O +
the O +
pattern O +
of O +
the O +
inner O +
ear O +
innervation O -
, O +
we O +
first O +
want O +
to O +
present O +
the O +
effects O +
of O +
BDNF O +
and O +
NT-3 O +
null O +
mutations O +
at O +
birth O +
[ O -
6,13,14 O -
] O -
. O +

Null O +
mutants O +
of O +
BDNF O +
or O +
its O +
receptor O +
trkB O +
lose O +
all O +
innervation O +
to O +
the O +
semicircular O +
canals O +
and O +
have O +
a O +
reduced O +
innervation O +
to O +
the O +
utricle O -
, O +
saccule O +
and O +
apical O +
turn O +
of O +
the O +
cochlea O -
. O +

In O +
contrast O -
, O +
null O +
mutations O +
of O +
either O +
NT-3 O +
or O +
its O +
receptor O +
trkC O +
result O +
in O +
loss O +
of O +
spiral O +
neurons O +
in O +
the O +
basal O +
turn O +
with O +
formation O +
of O +
an O +
inner O +
spiral O +
bundle O +
of O +
afferents O +
extending O +
to O +
the O +
basal O +
tip O -
. O +

Our O +
null O +
hypothesis O +
for O +
this O +
study O +
would O +
be O +
that O +
Brn3c O +
null O +
mice O +
show O +
severe O +
compromised O +
production O +
of O +
these O +
neurotrophins O +
and O +
should O +
therefore O +
show O +
a O +
comparable O +
pattern O +
of O +
nerve O +
fiber O +
loss O -
. O +

Brn3c O +
null O +
mutants O +
at O +
birth O +
( O -
P0 O -
) O +
Vestibular O +
ganglia O +
are O +
smaller O +
in O +
Brn3c O +
null O +
mutants O +
( O -
Fig. O +
1b O -
) O +
than O +
in O +
control O +
littermates O +
( O -
Fig. O +
1a O -
) O -
, O +
but O +
larger O +
than O +
in O +
BDNF O +
or O +
trkB O +
null O +
mutants O +
of O +
the O +
same O +
age O +
[ O -
13,15 O -
] O -
. O +

The O +
reduction O +
in O +
apparent O +
size O +
of O +
the O +
vestibular O +
ganglia O +
is O +
in O +
agreement O +
with O +
quantitative O +
data O +
published O +
previously O +
[ O -
3,13 O -
] O -
. O +

These O +
data O +
suggest O +
a O +
loss O +
of O +
80–85 O -
% O +
of O +
vestibular O +
sensory O +
neurons O +
in O +
BDNF O +
and O +
trkB O +
null O +
mutants O +
[ O -
13 O -
] O +
and O +
of O +
77 O -
% O +
of O +
vestibular O +
sensory O +
neurons O +
in O +
P4 O +
Brn3c O +
null O +
mutants O +
[ O -
3 O -
] O -
. O +

Thus O -
, O +
the O +
size O +
reduction O +
in O +
the O +
vestibular O +
sensory O +
ganglion O +
could O +
be O +
compatible O +
with O +
a O +
loss O +
of O +
BDNF O +
production O +
in O +
the O +
immature O +
hair O +
cells O -
. O +

Figure O +
1 O +
Size O +
variations O +
of O +
vestibular O +
ganglia O +
in O +
control O +
and O +
mutant O +
littermates O +
labeled O +
with O +
DiI. B-Chemical +
In O +
newborn O +
animals O -
, O +
the O +
vestibular O +
ganglion O +
shows O +
a O +
dramatic O +
reduction O +
in O +
Brn3c O +
null O +
mutants O +
( O -
b O -
) O +
compared O +
to O +
control O +
littermates O +
( O -
a O -
) O -
. O +

Abbreviations O +
for O +
this O +
and O +
other O +
figures O -
: O +
AC O -
, O +
anterior O +
crista O -
; O +
ggl O -
, O +
ganglion O -
; O +
c O -
, O +
spiral O +
capillary O -
; O +
Genic O -
. O +

ggl O -
. O -
, O +
geniculate O +
ganglion O -
; O +
GER O -
, O +
greater O +
epithelial O +
ridge O -
; O +
HC O -
, O +
horizontal O +
crista O -
; O +
HaC O -
, O +
vestibular O +
hair O +
cell O -
; O +
IHC O -
, O +
inner O +
hair O +
cell O -
; O +
iHC O -
, O +
immature O +
hair O +
cell O -
; O +
IGSB O -
, O +
intraganglionic O +
spiral O +
bundle O -
; O +
OHC O -
, O +
outer O +
hair O +
cell O -
; O +
PC O -
, O +
posterior O +
crista O -
; O +
S O -
, O +
saccule O -
; O +
SG O -
, O +
spiral O +
ganglion O -
; O +
TM O -
, O +
tectorial O +
membrane O -
; O +
U O -
, O +
utricle O -
; O +
VCN O -
, O +
ventral O +
cochlear O +
nucleus O -
; O +
VG O -
, O +
vestibular O +
ganglion O -
. O +

Bar O +
indicates O +
1000 O +
μm O -
. O +

However O -
, O +
the O +
Brn3c O +
null O +
mutants O +
show O +
only O +
a O +
reduced O +
density O +
of O +
afferent O +
and O +
efferent O +
fibers O +
to O +
all O +
vestibular O +
sensory O +
epithelia O -
. O +

There O +
is O +
no O +
specific O +
loss O +
of O +
all O +
afferent O +
and O +
efferent O +
innervation O +
to O +
the O +
canal O +
crista O +
( O -
Fig. O +
2a O -
) O -
, O +
a O +
hallmark O +
of O +
both O +
BDNF O +
and O +
trkB O +
null O +
mutations O +
[ O -
13,15 O -
] O -
. O +

In O +
fact O -
, O +
the O +
reduction O +
of O +
fibers O +
seems O +
to O +
be O +
rather O +
uniform O +
throughout O +
a O +
given O +
sensory O +
epithelium O +
with O +
the O +
crista O +
innervation O +
being O +
qualitatively O +
no O +
more O +
reduced O +
than O +
the O +
innervation O +
of O +
the O +
utricle O +
and O +
saccule O -
. O +

No O +
loss O +
in O +
specific O +
areas O -
, O +
comparable O +
to O +
that O +
in O +
BDNF O +
null O +
mutant O +
mice O -
, O +
is O +
apparent O +
in O +
the O +
saccule O +
or O +
utricle O +
of O +
Brn3c O +
null O +
mice O -
. O +

Similar O +
patterns O +
of O +
innervation O +
are O +
obtained O +
using O +
acteylated O +
tubulin O +
immunocytochemistry O +
( O -
Fig. O +
2b O -
) O -
. O +

Figure O +
2 O +
Innervation O +
of O +
Brn3c O +
null O +
and O +
control O +
ears O +
are O +
shown O +
for O +
newborn O +
mice O -
. O +

There O +
is O +
no O +
specific O +
loss O +
of O +
fibers O +
to O +
any O +
vestibular O +
endorgan O -
, O +
as O +
visualized O +
by O +
DiI B-Chemical +
labeling O +
( O -
a O -
) O +
or O +
acetylated O +
tubulin O +
immunoreactivity O +
( O -
b O -
) O -
. O +

No O +
major O +
differences O +
in O +
pattern O +
of O +
projection O +
through O +
radial O +
fibers O +
are O +
found O +
in O +
the O +
cochlea O +
of O +
Brn3c O +
null O +
mutants O +
( O -
d O -
, O -
f O -
) O +
as O +
compared O +
to O +
control O +
littermates O +
( O -
c O -
) O -
. O +

Note O -
, O +
however O -
, O +
the O +
lack O +
of O +
orderly O +
fiber O +
outgrowth O +
to O +
the O +
outer O +
hair O +
cells O +
( O -
c O -
, O +
d O -
) O -
. O +

Efferent O +
fibers O +
to O +
the O +
ear O +
show O +
a O +
well O +
developed O +
intraganglionic O +
spiral O +
bundle O +
( O -
IGSB O -
) O +
with O +
no O +
detectable O +
differences O +
compared O +
to O +
controls O +
( O -
e O -
) O -
. O +

Bar O +
indicates O +
100 O +
μm O -
. O +

Consistent O +
with O +
the O +
finding O +
of O +
Xiang O +
et O +
al. O +
[ O -
3 O -
] O +
of O +
only O +
a O +
29 O -
% O +
loss O +
of O +
spiral O +
sensory O +
neurons O +
at O +
P4 O -
, O +
our O +
data O +
show O +
little O +
difference O +
in O +
the O +
pattern O +
of O +
innervation O +
of O +
the O +
cochlea O +
in O +
P0 O +
Brn3c O +
null O +
mutants O +
( O -
Fig. O +
2c,2d O -
) O -
. O +

No O +
selective O +
loss O +
of O +
spiral O +
neurons O +
is O +
observed O +
in O +
Brn3c O +
null O +
mutants O +
in O +
the O +
basal O +
turn O -
, O +
a O +
feature O +
of O +
either O +
NT-3 O +
or O +
trkC O +
loss O +
[ O -
6,9,14 O -
] O -
. O +

Likewise O -
, O +
the O +
innervation O +
of O +
the O +
apex O +
( O -
Fig. O +
2f O -
) O +
shows O +
no O +
detectable O +
abnormality O +
in O +
overall O +
pattern O +
of O +
innervation O +
compared O +
to O +
control O +
animals O +
( O -
data O +
not O +
shown O -
) O -
, O +
an O +
indication O +
that O +
BDNF O +
could O +
be O +
expressed O +
in O +
the O +
apex O +
[ O -
6 O -
] O -
. O +

In O +
addition O -
, O +
the O +
pattern O +
of O +
efferent O +
innervation O +
shows O +
no O +
deviation O +
from O +
normal O +
either O +
( O -
Fig. O +
2e O -
) O -
, O +
whereas O +
they O +
show O +
the O +
same O +
pattern O +
of O +
loss O +
as O +
afferent O +
fibers O +
in O +
neurotrophin O +
null O +
mutants O +
[ O -
16 O -
] O -
. O +

These O +
data O +
suggest O +
that O +
the O +
spiral O +
sensory O +
neurons O +
develop O +
qualitatively O +
normal O +
at O +
least O +
until O +
P0 O +
and O +
therefore O +
allow O +
normal O +
pathfinding O +
of O +
efferents O -
. O +

Most O +
interestingly O -
, O +
there O +
is O +
no O +
increase O +
in O +
radial O +
fiber O +
spacing O +
in O +
the O +
apex O -
, O +
a O +
specific O +
problem O +
of O +
BDNF O +
null O +
mutants O +
[ O -
6,13 O -
] O -
. O +

However O -
, O +
there O +
is O +
one O +
qualitative O +
difference O +
not O +
recognized O +
in O +
any O +
single O +
neurotrophin O +
null O +
mutant O -
. O +

Afferents O +
reach O +
all O +
three O +
rows O +
of O +
outer O +
hair O +
cells O +
in O +
the O +
basal O +
turn O +
of O +
control O +
wildtype O +
littermates O +
( O -
Fig. O +
2c O -
) O -
, O +
but O +
both O +
afferent O +
and O +
efferent O +
outgrowth O +
is O +
disorganized O +
to O +
outer O +
hair O +
cells O +
in O +
Brn3c O +
null O +
mutants O +
( O -
Fig. O +
2d O -
) O +
and O +
does O +
not O +
show O +
any O +
clear O +
organization O +
into O +
three O +
distinct O +
longitudinal O +
fiber O +
bundles O +
paralleling O +
the O +
three O +
rows O +
in O +
the O +
outer O +
hair O +
cell O +
region O -
. O +

These O +
data O +
suggest O +
that O +
fiber O +
organization O +
in O +
the O +
outer O +
hair O +
cell O +
region O +
is O +
partly O +
disrupted O +
in O +
Brn3c O +
null O +
mutant O -
. O +

Brn3c O +
null O +
mutants O +
at O +
P7 O -
/ O -
8 O +
Reduction O +
of O +
vestibular O +
innervation O +
is O +
more O +
pronounced O +
than O +
at O +
P0 O -
. O +

Loss O +
of O +
afferents O +
and O -
, O +
even O +
more O +
clearly O +
of O +
efferents O -
, O +
is O +
most O +
pronounced O +
in O +
the O +
utricle O +
( O -
Fig. O +
3a,3b O -
) O +
and O +
saccule O +
( O -
data O +
not O +
shown O -
) O -
. O +

In O +
contrast O -
, O +
the O +
innervation O +
to O +
the O +
canal O +
cristae O -
, O +
while O +
reduced O -
, O +
has O +
changed O +
little O +
from O +
P0 O -
. O +

In O +
particular O +
the O +
horizontal O +
canal O +
receives O +
a O +
rather O +
dense O +
afferent O +
and O +
efferent O +
innervation O +
in O +
Brn3c O +
null O +
mutants O -
. O +

Figure O +
3 O +
Reduction O +
of O +
innervation O +
of O +
the O +
ear O +
is O +
shown O +
in O +
8-day O +
old O +
mice O -
. O +

While O +
all O +
vestibular O +
sensory O +
epithelia O +
retain O +
some O +
afferent O +
( O -
a O -
) O +
and O +
efferent O +
( O -
b O -
) O +
innervation O -
, O +
there O +
is O +
a O +
more O +
pronounced O +
reduction O -
, O +
in O +
particular O +
of O +
efferent O +
fibers O -
, O +
to O +
the O +
utricle O +
( O -
a O -
, O -
b O -
) O +
as O +
compared O +
to O +
the O +
canals O -
. O +

In O +
the O +
cochlea O +
there O +
is O +
an O +
increased O +
spacing O +
between O +
radial O +
fiber O +
bundles O +
in O +
the O +
basal O +
turn O +
( O -
c O -
, O -
e O -
) O -
. O +

No O +
afferents O +
can O +
be O +
traced O +
to O +
the O +
three O +
outer O +
spiral O +
bundles O +
along O +
outer O +
hair O +
cells O +
of O +
mutant O +
littermates O +
( O -
c O -
, O +
e O -
) O -
. O +

The O +
apex O +
shows O +
little O +
change O -
, O +
except O +
for O +
the O +
absence O +
of O +
fibers O +
to O +
the O +
area O +
of O +
outer O +
hair O +
cells O +
and O +
the O +
formation O +
of O +
inner O +
spiral O +
bundles O +
passing O +
along O +
the O +
few O +
immature O +
hair O +
cells O +
( O -
d O -
, O -
f O -
, O -
g O -
) O -
. O +

The O +
pattern O +
obtained O +
with O +
DiI B-Chemical +
tracing O +
is O +
identical O +
to O +
that O +
obtained O +
by O +
acetylated O +
tubulin O +
immunoreactivity O +
( O -
f O -
, O -
g O -
) O -
. O +

Bar O +
indicates O +
1000 O +
μm O +
in O +
a O -
, O +
100 O +
μm O +
in O +
b O -
- O -
g O -
. O +

The O +
cochlea O +
at O +
P8 O +
shows O +
more O +
qualitative O +
deviations O +
from O +
the O +
normal O +
pattern O +
of O +
innervation O -
. O +

For O +
example O -
, O +
all O +
three O +
rows O +
of O +
outer O +
hair O +
cells O +
now O +
receive O +
both O +
afferent O +
and O +
efferent O +
innervation O +
in O +
the O +
base O +
of O +
control O +
littermates O +
( O -
Fig. O +
3c O -
) O -
. O +

However O -
, O +
no O +
fibers O +
extend O +
to O +
the O +
outer O +
hair O +
cell O +
region O +
in O +
Brn3c O +
null O +
mutants O +
( O -
Figs. O +
3d,3e,3f O -
) O -
. O +

In O +
control O +
animals O +
there O +
is O +
dense O +
innervation O +
of O +
inner O +
hair O +
cells O -
, O +
whereas O +
Brn3c O +
null O +
mutants O +
show O +
a O +
curious O +
aggregation O +
of O +
fibers O +
near O +
focal O +
spots O +
around O +
the O +
habenula O +
perforata O -
. O +

The O +
apex O +
shows O +
less O +
pronounced O +
deviations O +
from O +
normal O +
( O -
Fig. O +
3f,3 O -
g O -
) O -
. O +

However O -
, O +
as O +
in O +
the O +
base O -
, O +
afferents O +
and O +
efferents O +
extend O +
sparingly O +
to O +
the O +
outer O +
hair O +
cell O +
region O -
. O +

There O +
is O +
formation O +
of O +
an O +
inner O +
spiral O +
bundle O +
communicating O +
both O +
afferents O +
and O +
efferents O +
between O +
the O +
focal O +
points O +
where O +
fibers O +
appear O +
to O +
pass O +
through O +
the O +
habenula O +
perforata O +
( O -
Fig. O +
3f,3 O -
g O -
) O -
. O +

As O +
in O +
newborn O +
animals O -
, O +
efferent O +
fibers O +
closely O +
follow O +
the O +
pattern O +
of O +
innervation O +
displayed O +
by O +
afferents O +
( O -
data O +
not O +
shown O -
) O -
. O +

The O +
limited O +
qualitative O +
effect O +
of O +
Brn3c O +
null O +
mutations O +
on O +
fiber O +
loss O +
is O +
particularly O +
obvious O +
in O +
the O +
P8 O +
Brn3c O +
null O +
mutant O +
apical O +
turn O +
( O -
Fig. O +
3 O -
g O -
) O -
. O +

Immunocytochemical O +
and O +
histochemcial O +
data O +
show O +
the O +
presence O +
of O +
only O +
a O +
few O +
immature O +
hair O +
cells O +
in O +
the O +
cochlea O +
( O -
Fig. O +
4 O -
) O -
, O +
which O +
amounted O +
to O +
about O +
1 O -
% O +
( O -
Table O +
1 O -
) O -
. O +

Not O +
a O +
single O +
immature O +
hair O +
cell O +
forms O +
in O +
the O +
apex O +
of O +
the O +
cochlea O -
. O +

In O +
contrast O -
, O +
more O +
immature O +
hair O +
cells O +
are O +
found O +
in O +
the O +
appropriate O +
position O +
of O +
hair O +
cells O +
in O +
the O +
vestibular O +
endorgans O +
( O -
Table O +
1 O -
) O -
. O +

In O +
fact O -
, O +
the O +
vestibular O +
end O +
organs O +
show O +
no O +
overt O +
morphological O +
defect O +
other O +
than O +
the O +
reduced O +
presence O +
of O +
these O +
immature O +
hair O +
cells O -
. O +

Nerve O +
fibers O +
can O +
be O +
traced O +
into O +
the O +
sensory O +
epithelium O +
of O +
P0 O +
and O +
P8 O +
Brn3c O +
null O +
mutants O +
past O +
the O +
habenula O +
perforata O +
and O +
there O +
is O +
a O +
normal O +
location O +
of O +
spiral O +
sensory O +
neurons O +
in O +
Rosenthal O -
's O +
canal O +
in O +
the O +
apex O +
of O +
P8 O +
Brn3c O +
null O +
mutants O +
( O -
Fig. O +
3d,3 O -
g O -
) O -
. O +

The O +
cochlea O +
shows O +
other O +
defects O +
as O +
well O -
. O +

For O +
example O -
, O +
the O +
spiral O +
capillary O +
is O +
not O +
found O +
underneath O +
the O +
organ O +
of O +
Corti O +
but O +
in O +
the O +
spiral O +
limbus O +
nearby O +
( O -
Fig. O +
4 O -
) O -
. O +

The O +
lack O +
of O +
immature O +
hair O +
cells O +
seems O +
to O +
affect O +
also O +
the O +
formation O +
of O +
pillar O +
cells O +
( O -
undifferentiated O +
almost O +
throughout O +
the O +
cochlea O -
; O +
Fig. O +
4 O -
) O +
and O +
Deiters O -
' O +
cells O +
( O -
not O +
recognizable O +
based O +
on O +
their O +
morphology O -
) O -
, O +
a O +
suggestion O +
consistent O +
with O +
recent O +
molecular O +
data O +
on O +
the O +
interaction O +
of O +
hair O +
cells O +
and O +
supporting O +
cells O +
[ O -
17,18 O -
] O -
. O +

Figure O +
4 O +
The O +
distribution O +
of O +
hair O +
cells O +
as O +
identified O +
with O +
MyoVII O +
immunocytochemistry O +
is O +
shown O +
for O +
7-day O +
old O +
whole O +
mounted O +
cochlea O +
( O -
a O -
- O -
d O -
) O +
and O +
the O +
appearance O +
of O +
cytological O +
differentiation O +
is O +
shown O +
as O +
revealed O +
with O +
epoxy O +
resin O +
sections O +
in O +
7-day O +
old O +
( O -
e O -
- O -
g O -
) O +
and O +
6-month O +
old O +
( O -
h O -
) O +
control O +
( O -
a O -
, O -
c O -
, O -
e O -
) O +
and O +
Brn3c O +
mutant O +
cochleae O +
( O -
b O -
, O -
d O -
, O -
f O -
- O -
h O -
) O -
. O +

Note O +
the O +
uniform O +
staining O +
with O +
this O +
antibody O +
of O +
all O +
three O +
rows O +
of O +
outer O +
hair O +
cells O +
( O -
OHC O -
) O +
and O +
the O +
single O +
row O +
of O +
inner O +
hair O +
cells O +
( O -
IHC O -
) O +
in O +
the O +
wildtype O +
( O -
a O -
, O -
c O -
) O -
. O +

In O +
contrast O -
, O +
only O +
few O +
immature O +
hair O +
cells O +
( O -
iHC O -
) O +
are O +
found O +
in O +
the O +
basal O +
turn O +
of O +
the O +
mutant O +
littermate O +
( O -
b O -
) O +
and O +
only O +
an O +
occasional O +
cell O +
is O +
MyoVII O +
immunopositive O +
in O +
the O +
middle O +
turn O +
( O -
d O -
) O -
. O +

No O +
MyoVII O +
positive O +
immature O +
hair O +
cells O +
exist O +
in O +
the O +
apex O -
. O +

Sections O +
show O +
the O +
degree O +
of O +
differentiation O +
of O +
hair O +
cells O +
and O +
their O +
innervating O +
fibers O +
stained O +
with O +
tubulin O +
immunocytochemistry O +
( O -
arrow O -
; O +
e O -
- O -
h O -
) O -
. O +

Note O +
the O +
presence O +
of O +
a O +
spiral O +
capillary O +
( O -
C O -
) O +
under O +
the O +
tunnel O +
of O +
Corti O +
separating O +
the O +
inner O +
and O +
outer O +
hair O +
cells O +
in O +
the O +
P7 O +
wildtype O +
( O -
e O -
) O -
. O +

In O +
contrast O -
, O +
no O +
such O +
capillary O +
is O +
present O +
underneath O +
the O +
organ O +
of O +
Corti O +
in O +
mutants O +
( O -
f O -
- O -
h O -
) O +
and O +
no O +
tunnel O +
of O +
Corti O +
is O +
found O +
either O -
. O +

A O +
tectorial O +
membrane O +
forms O +
( O -
TM O -
) O +
but O +
otherwise O +
there O +
is O +
little O +
cyotological O +
differentiation O -
. O +

Note O +
that O +
tubulin O -
- O -
positive O +
fibers O +
can O +
be O +
traced O +
to O +
the O +
immature O +
cells O +
until O +
6 O +
months O +
( O -
h O -
) O -
. O +

Bar O +
in O +
c O +
indicates O +
100 O +
μm O -
. O +

Table O +
1 O +
Numbers O +
of O +
hair O +
cells O +
and O +
sensory O +
neurons O +
in O +
P7 O +
wildtype O +
and O +
Brn3c O +
mutant O +
littermates O +
Differences O +
between O +
wildtype O +
and O +
mutants O +
are O +
all O +
highly O +
significant O -
. O +

Comparison O +
of O +
numbers O +
of O +
immature O +
hair O +
cells O +
in O +
the O +
vestibular O +
and O +
cochlear O +
areas O +
( O -
Fig. O +
4 O -
) O +
with O +
the O +
numbers O +
of O +
surviving O +
vestibular O +
and O +
cochlear O +
sensory O +
neurons O +
does O +
not O +
show O +
any O +
correlation O +
( O -
Table O +
1 O -
; O +
Fig. O +
5 O -
) O -
. O +

Only O +
a O +
few O +
undifferentiated O +
hair O +
cells O +
were O +
detected O +
by O +
MyoVIIa O +
immunostaining O +
and O +
only O +
in O +
the O +
basal O +
region O +
of O +
the O +
cochlea O -
. O +

And O +
yet O +
only O +
about O +
50 O -
% O +
of O +
cochlear O +
sensory O +
neurons O +
are O +
lost O +
overall O +
with O +
a O +
less O +
severe O +
loss O +
in O +
the O +
apex O +
in O +
which O +
we O +
could O +
not O +
detect O +
any O +
immature O +
hair O +
cells O +
with O +
MyoVIIa O +
immunocytochemistry O -
. O +

This O +
does O +
not O +
exclude O +
the O +
possibility O +
that O +
even O +
less O +
differentiated O +
hair O +
cells O +
may O +
form O +
in O +
the O +
apex O -
. O +

Figure O +
5 O +
This O +
graph O +
shows O +
the O +
reduction O +
in O +
sensory O +
neurons O +
( O -
top O -
) O +
and O +
in O +
hair O +
cells O +
( O -
bottom O -
) O +
between O +
7-day O +
old O +
wildtype O +
and O +
Brn3c O +
null O +
mutant O +
littermates O -
. O +

Note O +
the O +
sharp O +
reduction O +
to O +
1 O -
% O +
in O +
the O +
cochlear O +
immature O +
hair O +
cells O +
( O -
bottom O -
) O +
whereas O +
spiral O +
sensory O +
neurons O +
( O -
SG O -
) O +
are O +
only O +
reduced O +
by O +
50 O -
% O +
( O -
top O -
) O -
. O +

In O +
contrast O -
, O +
20 O -
% O +
immature O +
hair O +
cells O +
could O +
be O +
identified O +
in O +
vestibular O +
sensory O +
epithelia O +
( O -
saccule O +
has O +
been O +
selected O -
; O +
bottom O -
) O +
whereas O +
only O +
around O +
15 O -
% O +
of O +
the O +
vestibular O +
sensory O +
neurons O +
survive O +
to O +
this O +
age O +
( O -
VG O -
; O +
top O -
) O -
. O +

For O +
details O +
on O +
the O +
data O +
see O +
Table O +
1 O -
. O +

The O +
central O +
projection O +
of O +
DiI B-Chemical +
and O +
DiA B-Chemical +
traces O +
fibers O +
to O +
the O +
cochlear O +
nuclei O +
( O -
Fig. O +
6 O -
) O +
where O +
they O +
show O +
a O +
clear O +
segregation O +
of O +
apical O +
turn O +
afferents O +
( O -
Fig. O +
6 O -
, O +
green O -
) O +
and O +
basal O +
turn O +
afferents O +
( O -
Fig. O +
6 O -
, O +
red O -
) O +
in O +
both O +
the O +
entering O +
cochlear O +
nerve O +
( O -
Fig. O +
6a O -
) O +
and O +
the O +
ventral O +
cochlear O +
nucleus O +
( O -
VCN O -
) O +
( O -
Fig. O +
6b O -
) O -
. O +

Qualitative O +
comparable O +
central O +
projections O +
are O +
found O +
in O +
wildtype O +
control O +
littermates O +
( O -
data O +
not O +
shown O -
) O +
and O +
suggest O +
that O +
the O +
central O +
projection O +
to O +
cochlear O +
nuclei O +
is O +
at O +
least O +
until O +
P8 O +
in O +
mice O +
not O +
critically O +
dependent O +
on O +
auditory O +
information O +
or O +
other O +
hair O +
cell O -
- O -
mediated O +
influences O -
, O +
in O +
agreement O +
with O +
recent O +
suggestions O +
[ O -
5,19 O -
] O -
. O +

Figure O +
6 O +
These O +
confocal O +
images O +
show O +
the O +
projection O +
pattern O +
of O +
a O +
P8 O +
Brn3c O +
null O +
mutant O +
mouse O -
. O +

DiI B-Chemical +
( O -
red O -
) O +
was O +
inserted O +
into O +
the O +
basal O +
turn O -
, O +
DiA B-Chemical +
( O -
green O -
) O +
was O +
inserted O +
into O +
the O +
apical O +
turn O -
. O +

Note O +
that O +
the O +
fibers O +
run O +
in O +
discrete O +
bundles O +
inside O +
the O +
cochlear O +
nerve O +
( O -
a O -
) O -
, O +
spiral O +
around O +
each O +
other O +
near O +
the O +
root O +
and O +
project O +
to O +
distinct O +
medial O +
and O +
lateral O +
divisions O +
of O +
the O +
ventral O +
cochlear O +
nucleus O +
( O -
b O -
) O -
. O +

These O +
data O +
suggest O +
that O +
a O +
crude O +
cochleotopic O +
projection O +
can O +
form O +
independently O +
of O +
any O +
signaling O +
from O +
the O +
immature O +
hair O +
cells O +
of O +
the O +
cochlea O -
. O +

Arrow O +
indicates O +
the O +
efferent O +
bundle O +
as O +
it O +
leaves O +
the O +
afferent O +
fiber O +
tract O -
. O +

Bar O +
indicates O +
100 O +
μm O -
. O +

6 O +
months O +
Brn3c O +
null O +
mutants O +
Very O +
few O +
fibers O +
( O -
both O +
afferent O +
and O +
efferent O -
) O +
to O +
the O +
vestibular O +
epithelia O +
remain O +
( O -
Fig. O +
7a O -
) O -
, O +
thus O +
displaying O +
a O +
further O +
reduction O +
of O +
the O +
pattern O +
of O +
innervation O +
found O +
in O +
P8 O +
Brn3c O +
null O +
mutants O -
. O +

Notably O -
, O +
there O +
are O +
still O +
a O +
number O +
of O +
fibers O +
extending O +
from O +
the O +
very O +
few O +
vestibular O +
sensory O +
neurons O +
to O +
the O +
canal O +
epithelia O -
, O +
in O +
particular O +
the O +
horizontal O +
canal O +
( O -
Fig. O +
7a,7b O -
) O -
. O +

Only O +
very O +
few O +
fibers O +
extend O +
to O +
the O +
utricle O +
and O +
saccule O +
with O +
the O +
reduction O +
of O +
efferents O +
to O +
these O +
epithelia O +
being O +
almost O +
complete O +
( O -
Fig. O +
7a O +
and O +
data O +
not O +
shown O -
) O -
. O +

Comparable O +
to O +
control O +
mice O -
, O +
there O +
is O +
some O +
transcellular O +
labeling O +
with O +
DiI B-Chemical +
to O +
cells O +
apparently O +
contacted O +
by O +
the O +
afferent O +
fibers O +
in O +
the O +
Brn3c O +
null O +
mutant O +
utricle O +
( O -
Fig. O +
7b O -
) O -
. O +

However O -
, O +
these O +
cells O +
could O +
not O +
be O +
clearly O +
identified O +
as O +
immature O +
hair O +
cells O +
based O +
on O +
their O +
morphology O -
. O +

Figure O +
7 O +
The O +
innervation O +
of O +
sensory O +
epithelia O +
is O +
shown O +
in O +
6-month O +
old O +
Brn3c O +
null O +
mutant O +
mice O -
. O +

Compared O +
to O +
P8 O +
animals O +
there O +
is O +
a O +
further O +
reduction O +
of O +
fiber O +
density O +
to O +
vestibular O +
sensory O +
epithelia O -
, O +
but O +
fibers O +
can O +
be O +
traced O +
to O +
all O +
sensory O +
epithelia O +
( O -
a O -
, O -
b O -
) O -
. O +

Transcellular O +
labeling O +
with O +
DiI B-Chemical +
( O -
b O -
) O +
suggest O +
contacts O +
between O +
these O +
afferents O +
and O +
immature O +
hair O +
cells O -
. O +

The O +
cochlea O +
shows O +
a O +
much O +
reduced O +
density O +
of O +
radial O +
bundles O -
, O +
even O +
in O +
the O +
apex O +
( O -
c O -
, O -
d O -
) O -
. O +

However O -
, O +
spiral O +
sensory O +
neurons O +
are O +
present O +
in O +
Rosenthal O -
's O +
canal O +
( O -
c O -
, O -
d O -
) O +
and O +
fibers O +
extend O +
to O +
the O +
organ O +
of O +
Corti O +
where O +
they O +
form O +
longitudinal O +
tracts O +
in O +
the O +
immature O +
epithelium O -
. O +

Bar O +
indicates O +
100 O +
μm O -
. O +

The O +
cochlea O -
, O +
most O +
prominently O +
the O +
apex O -
, O +
receives O +
many O +
afferent O +
fibers O -
, O +
which O +
form O +
an O +
interrupted O +
inner O +
spiral O +
bundle O +
( O -
Fig. O +
7c O -
) O -
. O +

Some O +
of O +
the O +
radial O +
fiber O +
bundles O +
are O +
myelinated O +
( O -
Fig. O +
7d O -
) O -
. O +

Only O +
an O +
occasional O +
fiber O +
extends O +
beyond O +
the O +
inner O +
spiral O +
bundle O +
into O +
the O +
area O +
of O +
the O +
outer O +
hair O +
cells O +
( O -
Fig. O +
7d O -
) O -
. O +

Even O +
at O +
this O +
late O +
stage O +
in O +
maturation O +
there O +
are O +
still O +
numerous O +
spiral O +
neurons O +
present O +
in O +
the O +
apex O +
( O -
Fig. O +
7c,7d O -
) O -
. O +

In O +
summary O -
, O +
these O +
tracing O +
data O +
suggest O +
that O +
mature O +
hair O +
cells O +
are O +
not O +
necessary O +
to O +
direct O +
fiber O +
outgrowth O +
and O +
to O +
maintain O +
some O +
fibers O +
at O +
least O +
up O +
to O +
6 O +
months O +
in O +
the O +
apex O +
of O +
the O +
cochlea O -
. O +

Importantly O -
, O +
the O +
spatio O -
- O -
temporal O +
loss O +
of O +
innervation O +
does O +
not O +
follow O +
the O +
pattern O +
of O +
loss O +
known O +
from O +
neurotrophin O +
and O +
neurotrophin O +
receptor O +
null O +
mutations O +
as O +
it O +
starts O +
in O +
Brn3c O +
mutant O +
mice O +
after O +
birth O -
. O +

In O +
situ O +
hybridization O +
confirms O +
neonatal O +
neurotrophin O +
expression O +
We O +
processed O +
four O +
ears O +
of O +
P0 O +
and O +
P8 O +
Brn3c O +
null O +
and O +
control O +
littermates O +
for O +
expression O +
of O +
BDNF O +
and O +
NT-3 O +
using O +
the O +
riboprobes O +
previously O +
described O +
[ O -
7 O -
] O -
. O +

We O +
did O +
not O +
analyze O +
neurotrophin O +
expression O +
in O +
6-month O +
old O +
animals O +
as O +
neurotrophins O +
are O +
downregulated O +
in O +
neonates O +
[ O -
20 O -
] O +
and O +
no O +
expression O +
can O +
be O +
found O +
even O +
in O +
normal O +
animals O +
[ O -
4 O -
] O -
. O +

In O +
the O +
canal O +
cristae O +
we O +
expected O -
, O +
and O +
found O -
, O +
only O +
a O +
BDNF O +
signal O -
. O +

This O +
signal O +
was O +
very O +
strong O +
over O +
hair O +
cells O +
of O +
the O +
P0 O +
control O +
animals O +
( O -
Fig. O +
8b O -
) O -
. O +

In O +
contrast O -
, O +
only O +
a O +
faint O +
signal O +
was O +
detected O +
in O +
the O +
Brn3c O +
null O +
mutant O +
( O -
Fig. O +
8a O -
) O +
and O +
the O +
few O +
silver O +
grains O +
were O +
located O +
predominantly O +
over O +
the O +
area O +
of O +
the O +
immature O +
hair O +
cells O -
. O +

The O +
BDNF O +
signal O +
in O +
the O +
utricle O +
was O +
clearly O +
centered O +
on O +
the O +
hair O +
cells O +
in O +
the O +
control O +
animal O +
but O +
some O +
aggregation O +
of O +
silver O +
grains O +
appeared O +
also O +
in O +
the O +
Brn3c O +
null O +
mutants O +
( O -
data O +
not O +
shown O -
) O -
. O +

Figure O +
8 O +
The O +
expression O +
of O +
BDNF O +
and O +
NT-3 O +
mRNA O +
is O +
shown O +
in O +
the O +
P0 O +
vestibular O +
sensory O +
epithelia O -
. O +

Silver O +
grains O +
are O +
false O +
colored O +
as O +
red O +
to O +
enhance O +
visibility O +
against O +
the O +
grey O +
Nissl O -
- O -
stained O +
background O -
. O +

Canal O +
cristae O +
contain O +
only O +
BDNF O +
( O -
a O -
, O -
b O -
) O -
, O +
but O +
gravistatic O +
endorgans O -
, O +
such O +
as O +
saccule O +
and O +
utricle O -
, O +
contain O +
both O +
BDNF O +
and O +
NT-3 O +
( O -
c O -
- O -
f O -
) O -
. O +

Note O +
the O +
prominent O +
BDNF O +
expression O +
in O +
the O +
hair O +
cell O +
region O +
( O -
HaC O -
) O +
of O +
control O +
canal O +
( O -
b O -
) O +
and O +
saccule O +
( O -
d O -
) O +
and O +
low O +
levels O +
of O +
expression O +
in O +
the O +
Brn3c O +
null O +
mice O +
( O -
a O -
, O -
c O -
) O +
over O +
immature O +
hair O +
cells O +
( O -
iHC O -
) O -
. O +

The O +
NT-3 O +
expression O +
is O +
much O +
more O +
diffuse O +
in O +
both O +
control O +
and O +
Brn3c O +
mutant O +
littermates O -
. O +

Bar O +
indicates O +
100 O +
μm O -
. O +

In O +
the O +
saccule O -
, O +
we O +
directly O +
compared O +
the O +
BDNF O +
( O -
Fig. O +
8c,8d O -
) O +
and O +
NT-3 O +
signal O +
( O -
Fig. O +
8e,8f O -
) O +
of O +
the O +
Brn3c O +
null O +
mutant O +
( O -
Fig. O +
8c,8e O -
) O +
and O +
control O +
littermates O +
( O -
Fig. O +
8d,8f O -
) O -
. O +

A O +
strong O +
BDNF O +
signal O +
was O +
found O +
over O +
the O +
hair O +
cells O +
of O +
control O +
animals O +
and O +
an O +
occasional O +
immature O +
hair O +
cell O +
also O +
showed O +
a O +
BDNF O +
signal O +
in O +
the O +
Brn3c O +
null O +
mutants O -
. O +

The O +
NT-3 O +
signal O +
was O +
more O +
diffuse O +
in O +
both O +
the O +
control O +
and O +
the O +
Brn3c O +
null O +
littermates O +
but O +
showed O +
some O +
slightly O +
above O +
background O +
signal O +
in O +
the O +
area O +
of O +
the O +
sensory O +
epithelium O +
even O +
in O +
the O +
Brn3c O +
null O +
mutant O -
. O +

In O +
the O +
cochlea O -
, O +
the O +
BDNF O +
signal O +
was O +
very O +
weak O +
in O +
the O +
base O +
in O +
both O +
the O +
control O +
( O -
Fig. O +
9b O -
) O +
and O +
the O +
Brn3c O +
null O +
littermates O +
( O -
Fig. O +
9a O -
) O -
. O +

However O -
, O +
there O +
was O +
a O +
surprisingly O +
strong O +
NT-3 O +
signal O +
over O +
the O +
organ O +
of O +
Corti O +
in O +
the O +
apex O +
of O +
Brn3c O +
null O +
littermates O +
( O -
Fig. O +
9c O -
) O +
that O +
closely O +
matched O +
the O +
signal O +
found O +
in O +
the O +
control O +
littermates O +
( O -
Fig. O +
9d O -
) O -
. O +

The O +
NT-3 O +
signal O +
in O +
the O +
area O +
of O +
the O +
cochlea O +
that O +
corresponds O +
to O +
the O +
IHC O -
's O +
persisted O +
at O +
least O +
until O +
P8 O +
in O +
the O +
apex O +
of O +
Brn3c O +
null O +
mice O +
( O -
Fig. O +
9e,9f O -
) O -
. O +

Figure O +
9 O +
BDNF O +
and O +
NT-3 O +
mRNA O +
expression O +
is O +
shown O +
in O +
the O +
cochlea O +
of O +
P0 O +
( O -
a O -
- O -
d O -
) O +
and O +
P8 O +
( O -
e O -
, O -
f O -
) O +

Brn3c O +
null O +
and O +
control O +
littermates O -
. O +

Note O +
the O +
limited O +
expression O +
of O +
BDNF O +
in O +
the O +
basal O +
turn O +
of O +
both O +
wildtype O +
and O +
mutant O +
littermates O +
( O -
a O -
, O -
b O -
) O +
and O +
the O +
much O +
stronger O +
expression O +
of O +
NT-3 O +
in O +
the O +
apex O +
over O +
the O +
region O +
of O +
the O +
inner O +
hair O +
cells O +
in O +
both O +
wildtype O +
and O +
control O +
littermates O +
( O -
c O -
, O -
d O -
) O -
. O +

NT-3 O +
expression O +
persists O +
at O +
least O +
until O +
P8 O +
in O +
the O +
apex O +
of O +
Brn3c O +
null O +
mice O +
in O +
an O +
area O +
that O +
topologically O +
compares O +
to O +
the O +
inner O +
hair O +
cells O +
of O +
control O +
animals O +
( O -
e O -
, O -
f O -
, O +
arrows O -
) O -
. O +

Bar O +
indicates O +
100 O +
μm O -
. O +

Discussion O +
We O +
will O +
explore O +
five O +
points O +
in O +
this O +
discussion O -
: O +
How O +
the O +
limited O +
expression O +
of O +
neurotrophins O +
relates O +
to O +
the O +
apparent O +
survival O +
of O +
primary O +
neurons O +
until O +
P8 O -
; O +
how O +
the O +
known O +
absence O +
of O +
apical O +
hair O +
cells O +
and O +
of O +
classical O +
neurotrophins O +
can O +
be O +
related O +
to O +
the O +
presence O +
of O +
large O +
numbers O +
of O +
apical O +
turn O +
spiral O +
neurons O -
; O +
how O +
absence O +
of O +
differentiated O +
hair O +
cells O +
affects O +
afferent O +
and O +
efferent O +
targeting O -
; O +
and O +
how O +
these O +
data O +
possibly O +
relate O +
to O +
other O +
mutant O +
animals O +
and O +
to O +
children O +
born O +
with O +
profound O +
hearing O +
loss O -
. O +

Immature O +
hair O +
cells O +
and O +
limited O +
expression O +
of O +
neurotrophins O +
rescue O +
afferent O +
projection O +
until O +
P8 O +
The O +
neurotrophins O +
have O +
long O +
been O +
implicated O +
as O +
the O +
mediators O +
for O +
target O +
mediated O +
cell O +
death O -
. O +

In O +
essence O -
, O +
this O +
theory O +
of O +
regulation O +
of O +
neuronal O +
connections O +
via O +
neurotrophic O +
support O +
implies O +
that O +
only O +
limited O +
quantities O +
of O +
neurotrophins O +
are O +
released O +
by O +
the O +
target O +
tissue O +
to O +
support O +
only O +
properly O +
connected O +
sensory O +
neurons O +
by O +
providing O +
only O +
these O +
with O +
a O +
critical O +
amount O +
of O +
neurotrophins O +
[ O -
21 O -
] O -
. O +

Past O +
experiments O -
, O +
which O +
eliminated O +
one O +
or O +
more O +
neurotrophins O +
entirely O -
, O +
only O +
partially O +
tested O +
the O +
basic O +
assumption O +
of O +
this O +
theory O +
in O +
vivo O -
. O +

For O +
example O -
, O +
in O +
BDNF O +
heterozygotic O +
animals O +
there O +
is O +
a O +
small O +
decrease O +
in O +
the O +
number O +
of O +
sensory O +
neurons O +
in O +
the O +
ear O +
[ O -
13 O -
] O +
but O +
no O +
change O +
in O +
the O +
overall O +
pattern O +
of O +
innervation O -
. O +

Moreover O -
, O +
all O +
of O +
the O +
neurotrophin O -
/ O -
neurotrophin O +
receptor O +
null O +
mutants O +
studied O +
to O +
date O +
eliminate O +
expression O +
in O +
both O +
the O +
peripheral O +
target O +
and O +
the O +
brain O +
simultaneously O +
and O +
achieve O +
their O +
effects O +
in O +
late O +
embryos O -
. O +

In O +
contrast O -
, O +
Brn3c O +
is O +
barely O +
expressed O +
during O +
embryogenesis O +
in O +
the O +
CNS O +
[ O -
22 O -
] O +
thus O +
arguing O +
that O +
the O +
survival O +
of O +
ear O +
primary O +
neurons O +
depends O +
crucially O +
on O +
the O +
periphery O -
. O +

We O +
suggest O +
that O +
limited O +
expression O +
of O +
neurotrophins O +
in O +
the O +
immature O +
target O +
leads O +
to O +
retention O +
of O +
primary O +
neurons O +
and O +
their O +
afferent O +
fibers O +
in O +
newborn O +
and O +
early O +
postnatal O +
Brn3c O +
null O +
mice O -
. O +

In O +
agreement O +
with O +
this O +
suggestion O -
, O +
our O +
in O +
situ O +
data O +
show O +
a O +
severe O +
reduction O +
in O +
expression O +
of O +
BDNF O +
( O -
Figs. O +
8 O -
, O +
9 O -
) O -
. O +

Despite O +
this O +
reduction O -
, O +
some O -
, O +
apparently O +
biologically O +
significant O +
low O +
levels O +
of O +
neurotrophins O +
are O +
apparently O +
expressed O +
in O +
all O +
sensory O +
epithelia O +
in O +
embryonic O +
Brn3c O +
null O +
mutants O -
. O +

It O +
appears O +
that O +
even O +
these O +
low O +
levels O +
of O +
neurotrophins O +
in O +
the O +
vestibular O +
sensory O +
epithelia O +
can O +
sustain O +
normal O +
fiber O +
outgrowth O +
and O +
a O +
limited O +
maintenance O +
until O +
P0 O -
. O +

The O +
comparatively O +
high O +
level O +
of O +
NT-3 O +
expression O +
in O +
Brn3c O +
null O +
mutant O +
cochlea O -
, O +
which O +
has O +
been O +
shown O +
to O +
be O +
the O +
neurotrophin O +
most O +
prominently O +
supporting O +
spiral O +
sensory O +
neurons O +
[ O -
6,9,14 O -
] O -
, O +
is O +
in O +
agreement O +
with O +
the O +
normal O +
development O +
of O +
cochlear O +
innervation O +
in O +
newborn O +
Brn3c O +
null O +
mutants O -
. O +

Since O +
BDNF O +
appears O +
to O +
be O +
exclusively O +
produced O +
by O +
hair O +
cells O +
[ O -
6,7,20 O -
] O -
, O +
the O +
lack O +
of O +
terminal O +
differentiation O +
of O +
hair O +
cells O +
appears O +
to O +
be O +
accompanied O +
by O +
only O +
limited O +
expression O +
of O +
BDNF O -
, O +
as O +
is O +
the O +
case O +
in O +
the O +
canal O +
cristae O +
( O -
Fig. O +
8) O -
. O +

Past O +
research O +
has O +
shown O +
that O +
in O +
BDNF O +
and O +
trkB O +
null O +
mutants O +
this O +
innervation O +
to O +
canal O +
cristae O +
is O +
lost O +
before O +
birth O +
[ O -
6,13 O -
] O -
. O +

That O +
even O +
these O +
low O +
levels O +
of O +
expression O +
are O +
significant O +
is O +
clear O +
from O +
the O +
fact O +
that O +
all O +
canal O +
sensory O +
epithelia O +
receive O +
an O +
innervation O +
by O +
both O +
afferents O +
and O +
efferents O +
at O +
birth O +
and O +
later O +
( O -
Figs. O +
2 O -
, O +
3 O -
) O -
. O +

The O +
situation O +
in O +
the O +
utricle O -
, O +
saccule O +
and O +
cochlea O +
is O +
less O +
clear O +
as O +
both O +
BDNF O +
and O +
NT-3 O +
are O +
expressed O +
[ O -
6,7 O -
] O -
. O +

In O +
fact O -
, O +
it O +
appears O +
that O +
the O +
levels O +
of O +
NT-3 O +
expression O +
hardly O +
differ O +
from O +
those O +
in O +
control O +
littermates O +
( O -
Figs. O +
8 O -
, O +
9 O -
) O -
. O +

The O +
latter O +
is O +
particularly O +
obvious O +
in O +
the O +
apex O +
of O +
the O +
cochlea O -
. O +

In O +
fact O -
, O +
in O +
the O +
cochlea O +
of O +
embryos O +
and O +
neonates O +
as O +
well O +
as O +
in O +
the O +
saccule O +
and O +
utricle O +
of O +
embryos O -
, O +
NT-3 O +
is O +
predominantly O +
expressed O +
in O +
supporting O +
cells O +
[ O -
6 O -
] O -
. O +

This O +
expression O +
of O +
NT-3 O +
in O +
supporting O +
cells O +
in O +
embryos O +
and O +
neonates O +
may O +
even O +
preserve O +
in O +
Brn3c O +
null O +
mutants O +
the O +
numerous O +
spiral O +
sensory O +
neurons O +
in O +
the O +
apex O +
of O +
8-day O +
old O +
animals O +
( O -
Figs. O +
3 O -
, O +
4 O -
) O -
. O +

Long O +
term O +
survival O +
of O +
apical O +
sensory O +
neurons O +
is O +
unrelated O +
to O +
differentiated O +
hair O +
cells O +
and O +
likely O +
is O +
independent O +
of O +
neurotrophins O +
Past O +
work O +
has O +
shown O +
that O +
BDNF O +
and O +
NT-3 O +
appear O +
to O +
shift O +
in O +
their O +
expression O +
into O +
inner O +
hair O +
cells O +
around O +
birth O +
or O +
are O +
lost O +
in O +
the O +
ear O +
and O +
other O +
parts O +
of O +
the O +
nervous O +
system O +
[ O -
6,10,20,23 O -
] O -
. O +

It O +
has O +
been O +
suggested O +
that O +
other O +
neurotrophins O +
may O +
come O +
into O +
play O +
in O +
the O +
ear O +
[ O -
11 O -
] O -
. O +

However O -
, O +
the O +
apex O +
of O +
Brn3c O +
null O +
mutants O -
, O +
which O +
retains O +
most O +
of O +
the O +
spiral O +
neuron O +
afferents O +
at O +
6-month O -
, O +
shows O +
no O +
formation O +
of O +
mature O +
hair O +
cells O +
at O +
any O +
time O +
surveyed O +
here O +
( O -
P0 O -
, O +
P8 O -
, O +
P10 O -
) O -
. O +

Thus O +
the O +
factor O -
( O -
s O -
) O +
can O -
not O +
be O +
released O +
by O +
differentiated O +
hair O +
cells O +
but O +
there O +
is O +
an O +
unexplored O +
possibility O +
of O +
generalized O +
expression O +
of O +
neurotrophins O +
at O +
low O +
levels O +
in O +
the O +
undifferentiated O +
epithelia O -
. O +

However O -
, O +
known O +
neurotrophins O +
are O +
largely O +
absent O +
in O +
the O +
adult O +
cochleae O +
[ O -
4 O -
] O +
and O +
significant O +
amounts O +
of O +
neurotrophin O +
expression O +
appear O +
to O +
develop O +
only O +
in O +
postnatal O +
animals O +
in O +
the O +
CNS O +
[ O -
24 O -
] O -
. O +

Such O +
expression O +
in O +
the O +
CNS O +
could O +
possibly O +
offset O +
to O +
some O +
extent O +
the O +
peripheral O +
loss O +
of O +
neutrophins O +
in O +
targeted O +
null O +
mutants O -
. O +

This O +
would O +
work O +
only O +
in O +
cases O +
in O +
which O +
the O +
loss O +
of O +
primary O +
neurons O +
would O +
not O +
already O +
be O +
completed O +
long O +
before O +
birth O +
as O +
is O +
the O +
case O +
in O +
the O +
ear O +
[ O -
6,13 O -
] O -
. O +

It O +
therefore O +
remains O +
unclear O +
what O +
supports O +
the O +
many O +
afferents O +
in O +
the O +
apex O +
of O +
the O +
Brn3c O +
null O +
mutants O +
until O +
6 O +
months O +
of O +
age O +
or O +
longer O -
, O +
unknown O +
peripheral O +
neurotrophic O +
substances O +
or O +
neurotrophic O +
support O +
provided O +
by O +
the O +
CNS O -
. O +

Comparable O +
long O +
term O +
retention O +
of O +
apical O +
spiral O +
sensory O +
neurons O +
was O +
described O +
for O +
the O +
deaf O +
white O +
cat O +
[ O -
25 O -
] O +
and O +
may O +
also O +
be O +
the O +
case O +
in O +
humans O +
with O +
congenital O +
deafness O -
. O +

Growth O +
of O +
fibers O +
to O +
the O +
cochlea O +
does O +
not O +
require O +
mature O +
hair O +
cells O +
Formation O +
of O +
radial O +
fibers O +
that O +
bring O +
peripheral O +
processes O +
of O +
spiral O +
neurons O +
to O +
the O +
organ O +
of O +
Corti O +
seems O +
to O +
be O +
rather O +
normal O -
, O +
even O +
in O +
the O +
apex O +
of O +
the O +
cochlea O +
which O +
does O +
not O +
even O +
develop O +
immature O +
hair O +
cells O +
recognizable O +
by O +
Myo O +
VIIa O -
. O +

This O +
does O +
not O +
preclude O +
that O +
even O +
less O +
differentiated O +
hair O +
cell O +
precursors O +
may O +
form O +
in O +
the O +
apex O +
or O +
that O +
those O +
precursors O +
have O +
died O +
before O +
birth O -
. O +

Interestingly O -
, O +
the O +
growth O +
to O +
outer O +
hair O +
cells O +
is O +
most O +
affected O +
in O +
Brn3c O +
null O +
mutant O +
cochleae O -
. O +

Instead O +
of O +
extending O +
radially O +
through O +
the O +
tunnel O +
of O +
Corti O +
to O +
outer O +
hair O +
cells O -
, O +
afferents O +
appear O +
to O +
stall O +
and O +
extend O +
in O +
longitudinal O +
directions O +
as O +
inner O +
spiral O +
bundles O +
( O -
Figs. O +
3 O -
, O +
7 O -
) O -
. O +

It O +
has O +
been O +
shown O +
that O +
the O +
differentiation O +
of O +
pillar O +
cells O +
depends O +
on O +
activation O +
of O +
Fgfr3 O +
[ O -
26 O -
] O +
by O +
FGF O -
's O -
, O +
probably O +
Fgf8 O -
, O +
a O +
factor O +
produced O +
by O +
developing O +
and O +
mature O +
inner O +
hair O +
cells O +
[ O -
18,27 O -
] O -
. O +

The O +
formation O +
of O +
supporting O +
cells O +
also O +
appears O +
to O +
depend O +
on O +
the O +
proper O +
expression O +
of O +
various O +
bHLH O +
factors O +
such O +
as O +
He O -
s O +
1 O +
and O +
5 O +
which O +
appear O +
to O +
be O +
regulated O +
by O +
the O +
Notch O +
signaling O +
pathway O +
[ O -
17,28,29 O -
] O -
. O +

It O +
is O +
possible O +
that O +
the O +
apparent O +
inability O +
of O +
fibers O +
to O +
extend O +
along O +
outer O +
hair O +
cells O +
is O +
related O +
to O +
the O +
lack O +
of O +
differentiation O +
of O +
supporting O +
cells O +
in O +
the O +
absence O +
of O +
mature O +
hair O +
cells O -
. O +

Probing O +
for O +
the O +
proper O +
expression O +
of O +
supporting O +
cell O +
specific O +
markers O +
in O +
Brn3c O +
null O +
mutants O +
is O +
necessary O +
to O +
further O +
evaluate O +
these O +
suggestions O -
. O +

Previous O +
work O +
has O +
suggested O +
that O +
efferent O +
fibers O -
, O +
derived O +
from O +
facial O +
branchial O +
motoneurons O -
, O +
follow O +
afferents O +
and O +
for O +
that O +
reason O +
reflect O +
in O +
detail O +
all O +
connectional O +
deviations O +
of O +
afferents O +
[ O -
16,30 O -
- O -
32 O -
] O -
. O +

Our O +
data O +
agree O +
with O +
this O +
scenario O +
but O +
extend O +
it O -
. O +

Specifically O -
, O +
efferent O +
fibers O +
may O +
suffer O +
the O +
same O +
loss O +
of O +
their O +
molecularly O +
unknown O +
neurotrophic O +
support O +
as O +
do O +
afferents O +
and O +
therefore O +
show O +
the O +
same O +
spatio O -
- O -
temporal O +
profile O +
of O +
loss O +
( O -
Fig. O +
3 O -
) O -
. O +

Alternatively O -
, O +
efferent O +
fibers O +
can O +
sustain O +
established O +
connections O +
only O +
as O +
long O +
as O +
afferent O +
fibers O +
are O +
present O -
. O +

More O +
information O +
on O +
the O +
actual O +
molecular O +
support O +
of O +
efferent O +
fibers O +
in O +
the O +
ear O +
is O +
needed O +
before O +
those O +
two O +
possibilities O +
can O +
be O +
distinguished O -
. O +

The O +
onset O +
of O +
cochleotopic O +
projections O +
has O +
been O +
investigated O +
in O +
detail O +
in O +
only O +
very O +
few O +
mammals O +
[ O -
19 O -
] O -
. O +

These O +
data O +
suggest O +
that O +
a O +
cochleotopic O +
projection O +
develops O +
before O +
onset O +
of O +
hearing O -
. O +

Our O +
data O +
show O +
that O +
at O +
least O +
a O +
cochleotopic O +
projection O +
in O +
the O +
cochlear O +
nerve O +
and O +
the O +
cochlear O +
nuclei O +
develops O +
even O +
in O +
Brn O +
3c O +
null O +
mutants O +
( O -
Fig. O +
6 O -
) O -
. O +

Those O +
data O +
are O +
also O +
consistent O +
with O +
the O +
formation O +
of O +
a O +
crude O +
cochleotopic O +
projection O +
in O +
NT-3 O +
null O +
mutants O +
[ O -
6,14 O -
] O -
. O +

Those O +
mutants O +
have O +
a O +
much O +
more O +
severely O +
reduced O +
density O +
of O +
innervation O +
in O +
the O +
developing O +
cochlea O +
[ O -
6,14 O -
] O +
than O +
the O +
reduction O +
we O +
found O +
in O +
Brn3c O +
null O +
mutants O +
at O +
P0 O -
. O +

In O +
this O +
context O -
, O +
it O +
would O +
be O +
interesting O +
to O +
see O +
whether O +
the O +
recently O +
generated O +
transgenic O +
mouse O +
in O +
which O +
BDNF O +
is O +
expressed O +
under O +
NT-3 O +
promoter O +
control O +
[ O -
33 O -
] O +
could O +
actually O +
perform O +
an O +
even O +
more O +
pronounced O +
rescue O +
in O +
a O +
Brn3c O +
null O +
mutant O +
background O -
. O +

Relevance O +
of O +
our O +
findings O +
to O +
other O +
mutations O +
with O +
hair O +
cell O +
loss O +
Vahava O +
et O +
al. O +
[ O -
12 O -
] O +
and O +
Frydman O +
et O +
al. O +
[ O -
34 O -
] O +
have O +
demonstrated O +
that O +
mutation O +
in O +
a O +
single O +
human O +
allele O +
of O +
Pou4f3 O +
( O -
Brn3c O -
) O +
results O +
in O +
a O +
late O +
onset O +
of O +
high O +
frequency O +
hearing O +
loss O -
. O +

Thus O +
far O +
no O +
data O +
are O +
available O +
that O +
correlate O +
the O +
late O +
onset O +
of O +
hearing O +
loss O +
with O +
morphological O +
defects O +
in O +
the O +
cochlea O -
. O +

In O +
fact O -
, O +
an O +
investigation O +
of O +
Brn3c O +
heterozygotic O +
mice O +
showed O +
no O +
additional O +
effect O +
on O +
hearing O +
loss O +
due O +
to O +
haploinsufficiency O +
in O +
these O +
mice O +
[ O -
35 O -
] O -
. O +

Our O +
data O +
on O +
Brn3c O +
null O +
mouse O +
mutants O +
nevertheless O +
suggest O +
that O +
the O +
high O +
to O +
low O +
frequency O +
progressive O +
hearing O +
loss O +
in O +
humans O +
may O +
correlate O +
with O +
the O +
unknown O +
factor O -
( O -
s O -
) O +
that O +
mediate O +
apical O +
spiral O +
neuron O +
survival O +
into O +
adulthood O -
. O +

Quantitative O +
data O +
on O +
human O +
Pou4f3 O +
cochleae O +
is O +
needed O +
to O +
verify O +
that O +
spiral O +
neuron O +
loss O +
is O +
more O +
pronounced O +
in O +
the O +
basal O -
, O +
high O +
frequency O +
area O +
of O +
these O +
hearing O -
- O -
deficient O +
patients O -
. O +

Similar O +
data O +
are O +
also O +
needed O +
for O +
other O +
congenitally O +
deaf O +
children O +
[ O -
36 O -
] O +
and O +
in O +
the O +
deaf O +
white O +
cat O +
[ O -
25 O -
] O -
. O +

Further O +
work O +
on O +
the O +
recently O +
available O +
mutant O +
mice O +
with O +
specific O +
absence O +
of O +
all O +
hair O +
cells O +
[ O -
37 O -
] O -
, O +
outer O +
hair O +
cells O +
in O +
the O +
base O +
[ O -
38 O -
] O +
or O +
apex O +
[ O -
39 O -
] O +
could O +
further O +
help O +
to O +
clarify O +
the O +
role O +
of O +
hair O +
cells O +
in O +
forming O +
and O +
maintaining O +
afferent O +
and O +
efferent O +
innervation O +
in O +
these O +
model O +
mice O -
. O +

Conclusion O +

The O +
progressive O +
loss O +
of O +
afferent O +
and O +
efferent O +
innervation O +
in O +
Brn3c O +
null O +
mutants O +
shows O +
neither O +
in O +
spatial O +
nor O +
in O +
temporal O +
pattern O +
a O +
resemblance O +
to O +
losses O +
reported O +
in O +
simple O +
BDNF O +
or O +
NT-3 O +
null O +
mutations O +
[ O -
6 O -
] O -
. O +

Null O +
mutants O +
of O +
ear O +
specific O +
neurotrophins O +
have O +
completed O +
the O +
loss O +
of O +
sensory O +
neurons O +
before O +
birth O -
. O +

In O +
contrast O -
, O +
our O +
results O +
suggest O +
a O +
slow O +
loss O +
of O +
afferent O +
and O +
efferent O +
innervation O +
between O +
P0 O +
and O +
at O +
least O +
6 O +
months O -
. O +

This O +
late O +
sensory O +
neuron O +
loss O +
is O +
likely O +
not O +
related O +
to O +
known O +
neurotrophin O +
signaling O +
which O +
becomes O +
reduced O +
in O +
neonatal O +
wildtype O +
animals O -
. O +

Other O +
factors O -
, O +
such O +
as O +
GDNF O +
[ O -
11,40 O -
] O +
need O +
to O +
be O +
investigated O +
in O +
their O +
expression O +
in O +
these O +
mutants O +
and O +
their O +
functional O +
role O +
needs O +
to O +
be O +
assessed O -
, O +
in O +
particular O +
in O +
the O +
cochlear O +
apex O -
. O +

The O +
long O +
term O +
retention O +
of O +
afferents O +
in O +
the O +
cochlear O +
apex O +
in O +
the O +
absence O +
of O +
any O +
apparent O +
differentiation O +
of O +
hair O +
cells O +
raises O +
hopes O +
for O +
cochlear O +
implants O +
in O +
deaf O -
- O -
born O +
children O -
. O +

Similar O +
long O +
term O +
retention O +
of O +
apical O +
afferents O +
exists O +
in O +
the O +
deaf O +
white O +
cat O +
[ O -
25 O -
] O +
and O +
should O +
be O +
explored O +
in O +
other O +
model O +
systems O +
with O +
embryonic O +
and O +
neonatal O +
hair O +
cell O +
loss O +
[ O -
37,38 O -
] O -
. O +

Methods O +
Breeding O +
and O +
genotyping O +
Brn3c O +
mice O +
were O +
bred O +
as O +
previously O +
described O +
[ O -
22 O -
] O -
. O +

Mice O +
were O +
genotyped O +
and O +
Brn3c O +
null O +
mutants O +
were O +
raised O +
to O +
a O +
specific O +
age O +
( O -
P0 O -
, O +
N O +
= O +
8 O -
; O +
P7 O -
, O +
N O +
= O +
6 O -
; O +
P8 O -
, O +
N O +
= O +
6 O -
; O +
6 O +
months O +
old O -
, O +
N O +
= O +
2 O -
) O -
. O +

The O +
animals O +
were O +
deeply O +
anesthetized O +
with O +
pentobarbital B-Chemical +
and O +
transcardially O +
perfused O +
with O +
4 O -
% O +
paraformaldehyde O +
in O +
0.1 O +
M O +
phosphate O +
buffer O +
( O -
pH O +
7.4 O -
) O -
. O +

Ears O +
were O +
postfixed O +
in O +
the O +
same O +
fixative B-Chemical +
for O +
at O +
least O +
one O +
day O +
prior O +
to O +
dissection O -
. O +

Tracing O +
of O +
nerve O +
fibers O +
DiI B-Chemical +
tracing O +
from O +
the O +
brainstem O +
was O +
performed O +
as O +
previously O +
described O +
[ O -
41 O -
] O -
. O +

Small O +
filter O +
stripes O +
soaked O +
with O +
saturated O +
DiI B-Chemical +
were O +
implanted O +
into O +
the O +
efferent O +
fiber O +
bundle O +
near O +
the O +
floor O +
plate O +
or O +
into O +
the O +
ascending O +
or O +
descending O +
afferents O +
in O +
the O +
alar O +
plate O +
[ O -
42 O -
] O -
. O +

After O +
appropriate O +
diffusion O +
time O +
of O +
the O +
dye B-Chemical -
, O +
the O +
ears O +
were O +
dissected O +
and O +
mounted O +
flat O +
for O +
visualization O +
in O +
an O +
epifluorescent O +
microscope O -
. O +

Images O +
were O +
taken O +
on O +
black O +
and O +
white O +
film O +
or O +
acquired O +
with O +
a O +
cooled O +
CCD O +
camera O +
and O +
processed O +
using O +
ImagePro O +
software O +
( O -
Media O +
Cybernetics O -
) O -
. O +

Ears O +
were O +
subsequently O +
reacted O +
for O +
acetylated O +
tubulin O +
to O +
reveal O +
the O +
pattern O +
of O +
innervation O +
in O +
addition O +
to O +
the O +
DiI B-Chemical +
tracing O +
with O +
a O +
different O +
technique O +
as O +
previously O +
described O +
[ O -
14 O -
] O -
. O +

Briefly O -
, O +
dissected O +
ears O +
were O +
incubated O +
with O +
1:500 O +
anti O -
- O -
acetylated O +
tubulin O +
antibodies O +
( O -
Sigma O -
, O +
St. O +
Louis O -
) O +
followed O +
by O +
secondary O +
antibodies O +
conjugated O +
to O +
HRP O -
. O +

Dissected O +
inner O +
ears O +
were O +
reacted O +
with O +
DAB O +
and O +
H2O2 B-Chemical +
for O +
HRP O +
distribution O +
and O +
subsequently O +
viewed O +
as O +
whole O +
mounts O -
. O +

After O +
photographing O +
as O +
whole O +
mounts O -
, O +
the O +
ears O +
were O +
embedded O +
in O +
epoxy O +
resin O +
and O +
sectioned O +
to O +
reveal O +
the O +
distribution O +
of O +
fibers O +
inside O +
the O +
sensory O +
epithelia O +
in O +
more O +
detail O -
. O +

Cochleotopic O +
projection O +
was O +
evaluated O +
by O +
inserting O +
DiI B-Chemical +
soaked O +
filter O +
strips O +
into O +
the O +
base O +
and O +
DiA B-Chemical +
soaked O +
filter O +
strips O +
into O +
the O +
apical O +
turn O +
of O +
2 O +
P0 O +
and O +
4 O +
P8 O +
Brn3c O +
null O +
mutants O +
and O +
a O +
similar O +
number O +
of O +
wildtype O +
littermates O -
. O +

After O +
appropriate O +
diffusion O +
time O +
[ O -
43 O -
] O -
, O +
the O +
brains O +
with O +
the O +
attached O +
cochlear O +
nerve O +
were O +
embedded O +
in O +
gelatin B-Chemical -
, O +
hardened O +
in O +
4 O -
% O +
PFA O +
over O +
night O -
, O +
sectioned O +
coronally O +
on O +
a O +
vibratome O +
( O -
100 O +
μm O +
thickness O -
) O +
and O +
viewed O +
with O +
a O +
Biorad O +
Radiance O +
2000 O +
confocal O +
system O +
attached O +
to O +
a O +
Nikon O +
Eclipse O +
800 O +
microscope O -
. O +

Image O +
stacks O +
were O +
collapsed O +
to O +
view O +
the O +
entire O +
projection O +
in O +
one O +
section O +
in O +
one O +
focal O +
plane O -
. O +

In O +
situ O +
hybridization O +
Four O +
ears O +
each O +
of O +
Brn3c O +
null O +
mutants O +
( O -
P0 O +
and O +
P8 O -
) O +
and O +
control O +
littermates O +
were O +
embedded O +
in O +
paraffin O -
, O +
sectioned O +
and O +
probed O +
for O +
the O +
presence O +
of O +
BDNF O +
and O +
NT-3 O +
mRNA O +
using O +
the O +
in O +
situ O +
technique O +
previously O +
described O +
[ O -
7 O -
] O -
. O +

Sections O +
were O +
lightly O +
counterstained O +
and O +
viewed O +
with O +
bright O +
and O +
dark O +
field O +
microscopy O -
. O +

Images O +
were O +
acquired O +
with O +
a O +
CCD O +
camera O +
and O +
displayed O +
as O +
false O +
color O +
images O +
as O +
previously O +
described O +
[ O -
18 O -
] O -
. O +

Immunocytochemistry O +
of O +
hair O +
cells O +
and O +
quantification O +
of O +
hair O +
cells O +
and O +
neurons O +
Immunostaining O +
of O +
P7 O +
cochlear O +
whole O +
mounts O +
using O +
the O +
hair O +
cell O +
specific O -
- O -
myosin O +
VII O +
( O -
MyoVIIa O -
) O +
antibody O +
was O +
performed O +
as O +
previously O +
described O +
[ O -
2 O -
] O -
. O +

Images O +
of O +
labeled O +
organs O +
of O +
Corti O +
were O +
then O +
acquired O +
using O +
a O +
SPOT O +
digital O +
camera O +
( O -
Diagnostic O +
Instruments O +
Inc. O -
) O +
and O +
the O +
number O +
of O +
hair O +
cells O +
was O +
scored O +
from O +
acquired O +
images O -
. O +

To O +
determine O +
the O +
number O +
of O +
hair O +
cells O +
or O +
neurons O +
in O +
vestibular O +
endorgans O +
or O +
sensory O +
ganglia O -
, O +
serial O +
sections O +
were O +
stained O +
with O +
Cresyl B-Chemical +
Violet I-Chemical +
and O +
images O +
were O +
similarly O +
acquired O +
and O +
scored O -
. O +

Every O +
other O +
section O +
was O +
scored O +
for O +
each O +
sensory O +
epithelium O +
and O +
every O +
forth O +
section O +
was O +
scored O +
for O +
each O +
ganglion O -
. O +

Only O +
neurons O +
or O +
cells O +
with O +
a O +
clear O +
nucleus O +
and O +
nucleoli O +
were O +
counted O +
and O +
4–6 O +
samples O +
were O +
counted O +
for O +
each O +
epithelium O +
and O +
ganglion O -
. O +

All O +
data O +
were O +
tested O +
for O +
significance O +
using O +
two O -
- O -
sample O +
Student O -
's O +
t O -
- O -
test O +
with O +
unequal O +
variances O -
. O +

Authors O -
' O +
contributions O +
MX O +
generated O +
the O +
null O +
mutation O -
, O +
bred O +
all O +
the O +
mice O +
used O +
for O +
this O +
study O +
and O +
generated O +
the O +
statistical O +
data O +
and O +
the O +
immunocytochemical O +
data O +
with O +
MyoVII O -
, O +
AM O +
conducted O +
the O +
tract O +
tracing O +
studies O +
of O +
cochlear O +
afferents O +
and O +
helped O +
with O +
the O +
histological O +
analysis O +
and O +
assembly O +
of O +
image O +
plates O -
, O +
UP O +
carried O +
out O +
the O +
in O +
situ O +
hybridization O +
for O +
neurotrophins O +
and O +
assembled O +
the O +
plates O +
for O +
these O +
data O -
, O +
BF O +
wrote O +
the O +
manuscript O -
, O +
carried O +
out O +
most O +
of O +
the O +
neuronal O +
tracing O +
and O +
immunocytochemistry O +
for O +
acetylated O +
tubulin O +
and O +
data O +
presentation O -
. O +

All O +
authors O +
read O +
and O +
approved O +
the O +
final O +
manuscript O -
. O +

Acknowledgements O +
Supported O +
by O +
the O +
National O +
Eye O +
Institute O +
( O -
EY12020 O -
, O +
MX O -
) O -
, O +
the O +
March O +
of O +
Dimes O +
Birth O +
Defects O +
Foundation O +
( O -
MX O -
) O -
, O +
the O +
Egyptian O +
Government O +
( O -
AM O -
) O -
, O +
the O +
Juselius O +
Foundation O +
( O -
UP O -
) O -
, O +
the O +
NIDCD O +
( O -
2 O +
P01 O +
DC00215 O -
, O +
BF O -
; O +
DC04594 O -
, O +
M.X. O -
) O -
, O +
the O +
Taub O +
foundation O +
( O -
BF O -
) O +
and O +
NASA O +
( O -
01-OBPR-06 O -
; O +
BF O -
) O -
. O +

Structure O -
- O -
function O +
evolution O +
of O +
the O +
Transforming O +
acidic B-Chemical +
coiled O +
coil O +
genes O +
revealed O +
by O +
analysis O +
of O +
phylogenetically O +
diverse O +
organisms O +
Abstract O +
Background O +
Examination O +
of O +
ancient O +
gene O +
families O +
can O +
provide O +
an O +
insight O +
into O +
how O +
the O +
evolution O +
of O +
gene O +
structure O +
can O +
relate O +
to O +
function O -
. O +

Functional O +
homologs O +
of O +
the O +
evolutionarily O +
conserved O +
transforming O +
acidic B-Chemical +
coiled O +
coil O +
( O -
TACC O -
) O +
gene O +
family O +
are O +
present O +
in O +
organisms O +
from O +
yeast O +
to O +
man O -
. O +

However O -
, O +
correlations O +
between O +
functional O +
interactions O +
and O +
the O +
evolution O +
of O +
these O +
proteins O +
have O +
yet O +
to O +
be O +
determined O -
. O +

Results O +
We O +
have O +
performed O +
an O +
extensive O +
database O +
analysis O +
to O +
determine O +
the O +
genomic O +
and O +
cDNA O +
sequences O +
of O +
the O +
TACCs O +
from O +
phylogenetically O +
diverse O +
organisms O -
. O +

This O +
analysis O +
has O +
determined O +
the O +
phylogenetic O +
relationship O +
of O +
the O +
TACC O +
proteins O +
to O +
other O +
coiled O +
coil O +
proteins O -
, O +
the O +
resolution O +
of O +
the O +
placement O +
of O +
the O +
rabbit O +
TACC4 O +
as O +
the O +
orthologue O +
of O +
human O +
TACC3 O -
, O +
and O +
RHAMM O +
as O +
a O +
distinct O +
family O +
of O +
coiled O +
coil O +
proteins O -
. O +

We O +
have O +
also O +
extended O +
the O +
analysis O +
of O +
the O +
TACCs O +
to O +
the O +
interaction O +
databases O +
of O +
C. O +
elegans O +
and O +
D. O +
melanogaster O +
to O +
identify O +
potentially O +
novel O +
TACC O +
interactions O -
. O +

The O +
validity O +
of O +
this O +
modeling O +
was O +
confirmed O +
independently O +
by O +
the O +
demonstration O +
of O +
direct O +
binding O +
of O +
human O +
TACC2 O +
to O +
the O +
nuclear O +
hormone O +
receptor O +
RXRβ O -
. O +

Conclusion O +
The O +
data O +
so O +
far O +
suggest O +
that O +
the O +
ancestral O +
TACC O +
protein O +
played O +
a O +
role O +
in O +
centrosomal O -
/ O -
mitotic O +
spindle O +
dynamics O -
. O +

TACC O +
proteins O +
were O +
then O +
recruited O +
to O +
complexes O +
involved O +
in O +
protein O +
translation O -
, O +
RNA O +
processing O +
and O +
transcription O +
by O +
interactions O +
with O +
specific O +
bridging O +
proteins O -
. O +

However O -
, O +
during O +
evolution O -
, O +
the O +
TACC O +
proteins O +
have O +
now O +
acquired O +
the O +
ability O +
to O +
directly O +
interact O +
with O +
components O +
of O +
these O +
complexes O +
( O -
such O +
as O +
the O +
LSm O +
proteins O -
, O +
nuclear O +
hormone O +
receptors O -
, O +
GAS41 O -
, O +
and O +
transcription O +
factors O -
) O -
. O +

This O +
suggests O +
that O +
the O +
function O +
of O +
the O +
TACC O +
proteins O +
may O +
have O +
evolved O +
from O +
performing O +
assembly O +
or O +
coordination O +
functions O +
in O +
the O +
centrosome O +
to O +
include O +
a O +
more O +
intimate O +
role O +
in O +
the O +
functional O +
evolution O +
of O +
chromatin O +
remodeling O -
, O +
transcriptional O +
and O +
posttranscriptional O +
complexes O +
in O +
the O +
cell O -
. O +

Background O +
The O +
evolution O +
of O +
complex O +
organisms O +
has O +
been O +
associated O +
with O +
the O +
generation O +
of O +
gene O +
families O +
by O +
the O +
continual O +
duplication O +
of O +
an O +
initial O +
relatively O +
small O +
set O +
of O +
ancestral O +
genes O -
. O +

Through O +
this O +
process O -
, O +
followed O +
by O +
subsequent O +
mutation O -
, O +
reduplication O +
and O +
exon O +
shuffling O +
between O +
gene O +
families O -
, O +
genes O +
have O +
evolved O +
both O +
discrete O -
, O +
and O +
partially O +
redundant O +
functions O +
with O +
their O +
related O +
family O +
members O -
. O +

With O +
the O +
completion O +
of O +
the O +
genome O +
sequencing O +
projects O +
of O +
human O -
, O +
mouse O -
, O +
rat O -
, O +
fruit O +
fly O +
and O +
nematodes O -
, O +
we O +
are O +
now O +
in O +
a O +
position O +
to O +
ask O +
fundamental O +
questions O +
in O +
regard O +
to O +
how O +
genes O +
interact O +
in O +
the O +
context O +
of O +
the O +
whole O +
organism O -
. O +

Thus O -
, O +
with O +
the O +
appropriate O +
application O +
of O +
bioinformatics O -
, O +
it O +
is O +
now O +
possible O +
to O +
trace O +
the O +
lineage O +
of O +
particular O +
genes O +
and O +
gene O +
families O -
, O +
with O +
related O +
gene O +
families O +
in O +
other O +
organisms O -
. O +

Furthermore O -
, O +
with O +
the O +
growing O +
amount O +
of O +
large O -
- O -
scale O +
proteomic O +
and O +
genomic O +
data O +
becoming O +
publicly O +
available O -
, O +
this O +
analysis O +
can O +
now O +
be O +
extended O +
to O +
reveal O +
the O +
complex O +
interplay O +
between O +
evolution O +
of O +
gene O +
structure O +
and O +
protein O +
function O -
. O +

The O +
first O +
Transforming O +
acidic B-Chemical +
coiled O +
coil O +
gene O -
, O +
TACC1 O -
, O +
was O +
identified O +
during O +
the O +
development O +
of O +
an O +
expression O +
map O +
of O +
the O +
proximal O +
short O +
arm O +
of O +
human O +
chromosome O +
8 O +
[ O -
1 O -
] O -
. O +

Two O +
additional O +
TACC O +
family O +
members O +
were O +
subsequently O +
identified O +
and O +
mapped O +
to O +
paralogous O +
chromosomal O +
regions O +
on O +
human O +
chromosomes O +
4p16 O +
and O +
10q26 O -
, O +
physically O +
close O +
to O +
members O +
of O +
the O +
FGFR O +
gene O +
family O +
[ O -
1 O -
- O -
3 O -
] O -
. O +

This O +
mapping O +
data O -
, O +
together O +
with O +
identification O +
of O +
a O +
single O +
TACC O +
gene O +
in O +
the O +
protostomes O +
Caenorhabitis O +
elegans O -
, O +
and O +
Drosophila O +
melanogaster O +
[ O -
4 O -
- O -
6 O -
] O -
, O +
led O +
to O +
the O +
speculation O +
that O +
the O +
ancestral O +
FGFR O +
and O +
TACC O +
genes O +
were O +
located O +
physically O +
close O +
to O +
each O +
other O -
. O +

Thus O -
, O +
during O +
the O +
evolution O +
of O +
vertebrates O -
, O +
subsequent O +
successive O +
duplications O +
of O +
the O +
ancestral O +
gene O +
cluster O +
have O +
given O +
rise O +
to O +
three O +
TACC O +
family O +
members O +
located O +
close O +
to O +
FGFR O +
genes O +
in O +
humans O -
. O +

In O +
accordance O +
with O +
the O +
proposed O +
quadruplication O +
of O +
the O +
vertebrate O +
genome O +
during O +
evolution O -
, O +
there O +
is O +
a O +
fourth O +
FGFR O +
family O +
member O +
in O +
vertebrates O -
, O +
raising O +
the O +
question O +
of O +
whether O +
a O +
fourth O +
TACC O +
gene O +
is O +
associated O +
with O +
FGFR4 O +
in O +
vertebrate O +
genomes O -
. O +

To O +
date O -
, O +
only O +
three O +
active O +
TACC O +
genes O +
have O +
been O +
cloned O +
in O +
humans O +
[ O -
1 O -
- O -
3 O -
] O -
, O +
one O +
in O +
each O +
of O +
mouse O +
[ O -
7 O -
] O -
, O +
Xenopus O +
laevis O +
[ O -
8 O -
] O -
, O +
D. O +
melanogaster O +
[ O -
4 O -
] O -
, O +
and O +
C. O +
elegans O +
[ O -
5,6 O -
] O -
. O +

Although O +
two O +
additional O +
new O +
candidate O +
TACC O +
family O +
members O -
, O +
Oryctolagus O +
cuniculus O +
TACC4 O +
[ O -
9 O -
] O +
and O +
human O +
RHAMM O +
[ O -
10 O -
] O +
have O +
been O +
proposed O -
, O +
their O +
true O +
identity O +
and O +
placement O +
in O +
the O +
evolution O +
of O +
the O +
TACC O +
family O +
is O +
under O +
debate O -
. O +

Thus O -
, O +
the O +
identification O +
and O +
functional O +
characterization O +
of O +
new O +
members O +
of O +
the O +
TACC O +
family O +
in O +
other O +
organisms O -
, O +
alternatively O +
spliced O +
isoforms O +
of O +
each O +
TACC O +
and O +
comparison O +
of O +
the O +
phylogenetic O +
relationship O +
of O +
these O +
genes O +
relative O +
to O +
other O +
members O +
of O +
the O +
coiled O +
coil O +
superfamily O +
will O +
resolve O +
this O +
issue O +
and O +
provide O +
clues O +
to O +
the O +
evolution O +
of O +
TACC O +
function O -
. O +

Results O +
and O +
Discussion O +
In O +
silico O +
identification O +
of O +
TACC O +
family O +
members O +
from O +
vertebrate O +
and O +
invertebrate O +
lineages O +
Sequence O +
similarity O +
searches O +
of O +
the O +
publicly O +
available O +
genome O +
databases O +
with O +
the O +
BLAST O +
and O +
TBLAST O +
programs O +
were O +
performed O +
to O +
identify O +
TACC O +
and O +
RHAMM O +
orthologues O -
, O +
and O +
other O +
members O +
of O +
the O +
coiled O +
coil O +
superfamily O +
in O +
a O +
diverse O +
set O +
of O +
species O +
( O -
Fig. O +
1 O -
) O -
. O +

This O +
identified O +
the O +
complete O +
sequence O +
of O +
the O +
TACC O +
genes O +
in O +
representatives O +
of O +
five O +
major O +
phylogenetically O +
distinct O +
clades O -
. O +

Where O +
possible O -
, O +
the O +
construction O +
of O +
the O +
TACC O +
sequences O +
from O +
these O +
organisms O +
was O +
also O +
confirmed O +
by O +
the O +
analysis O +
of O +
the O +
cDNA O +
databases O -
. O +

Several O +
partial O +
sequences O +
in O +
other O +
vertebrate O +
species O -
, O +
the O +
echinodermate O +
Strongylocentrotus O +
purpuratus O +
and O +
the O +
protostome O +
insect O +
Anopheles O +
gambiae O +
were O +
also O +
identified O -
, O +
suggesting O +
an O +
ancient O +
conservation O +
of O +
the O +
TACC O +
genes O +
in O +
metazoan O +
lineages O -
. O +

However O -
, O +
due O +
to O +
the O +
relative O +
infancy O +
of O +
the O +
cDNA O -
/ O -
genome O +
projects O +
for O +
these O +
latter O +
organisms O -
, O +
complete O +
characterization O +
of O +
these O +
TACC O +
genes O +
could O +
not O +
be O +
undertaken O -
. O +

No O +
conclusion O +
could O +
be O +
made O +
about O +
the O +
existence O +
of O +
TACC O -
- O -
like O +
sequence O +
in O +
non O -
- O -
bilaterian O +
metazoans O -
, O +
such O +
as O +
Cnidaria O +
or O +
Porifera O -
, O +
due O +
to O +
the O +
paucity O +
of O +
sequence O +
information O +
for O +
these O +
organisms O -
, O +
and O +
additional O +
definitive O +
sequences O +
with O +
a O +
defined O +
TACC O +
domain O +
could O +
not O +
be O +
found O +
in O +
other O +
non O -
- O -
metazoan O +
organisms O -
. O +

Figure O +
1 O +
Phylogenetic O +
analysis O +
of O +
the O +
TACC O +
family O +
members O +
compared O +
to O +
other O +
coiled O +
coil O +
proteins O -
. O +

The O +
phylogenetic O +
tree O +
was O +
constructed O +
as O +
described O +
in O +
the O +
Methods O +
section O -
. O +

The O +
TACC O +
family O +
defines O +
a O +
separate O +
subfamily O +
of O +
coiled O +
coil O +
containing O +
proteins O -
, O +
distinct O +
from O +
other O +
coiled O +
coil O +
families O +
such O +
as O +
the O +
keratins O -
, O +
RHAMM O +
and O +
tropomyosins O -
. O +

Note O +
that O +
the O +
RHAMM O +
proteins O +
form O +
a O +
separate O +
branch O +
more O +
closely O +
related O +
to O +
the O +
tropomyosins O +
and O +
kinesin O +
like O +
proteins O +
( O -
KLP O -
) O -
, O +
than O +
the O +
TACC O +
proteins O -
. O +

At O +
the O +
base O +
of O +
the O +
chordate O +
branch O +
of O +
life O -
, O +
a O +
single O +
TACC O +
gene O +
was O +
identified O +
in O +
the O +
genome O +
of O +
the O +
urochordate O +
Ciona O +
intestinalis O +
[ O -
11 O -
] O -
, O +
and O +
a O +
partial O +
TACC O +
sequence O +
from O +
an O +
analysis O +
of O +
the O +
Halocynthia O +
rortezi O +
EST O +
database O +
[ O -
12 O -
] O -
. O +

This O +
confirms O +
the O +
original O +
assumption O +
that O +
a O +
single O +
TACC O +
gene O +
was O +
present O +
in O +
the O +
chordate O +
ancestor O -
. O +

The O +
next O +
major O +
event O +
in O +
the O +
evolution O +
of O +
the O +
chordate O +
genome O +
has O +
been O +
suggested O +
to O +
have O +
occurred O +
687 O +
± O +
155.7 O +
million O +
years O +
ago O +
( O -
MYA O -
) O -
, O +
with O +
the O +
first O +
duplication O +
of O +
the O +
chordate O +
genome O -
, O +
and O +
a O +
second O +
duplication O +
occurring O +
shortly O +
thereafter O -
. O +

Thus O -
, O +
if O +
the O +
TACC O +
genes O +
were O +
duplicated O +
at O +
both O +
events O -
, O +
we O +
would O +
expect O +
to O +
identify O +
four O +
TACC O +
genes O +
in O +
the O +
most O +
" O -
primitive O -
" O +
compact O +
vertebrate O +
genome O +
sequenced O +
to O +
date O -
, O +
the O +
pufferfish O +
Takifugu O +
rubripes O -
, O +
with O +
three O +
genes O +
corresponding O +
to O +
the O +
human O +
TACC1 O -
- O -
3 O -
, O +
and O -
, O +
in O +
keeping O +
with O +
the O +
proposed O +
model O +
for O +
genomic O +
duplication O +
of O +
the O +
chromosomal O +
loci O +
for O +
the O +
TACC O +
genes O +
( O -
discussed O +
below O -
) O -
, O +
a O +
possible O +
fourth O +
gene O +
deriving O +
from O +
the O +
TACC3 O +
ancestor O -
. O +

Indeed O -
, O +
four O +
TACC O +
genes O +
were O +
identified O +
in O +
T. O +
rubripes O -
. O +

Of O +
these O -
, O +
two O +
genes O +
corresponded O +
to O +
the O +
T. O +
rubripes O +
orthologues O +
of O +
human O +
TACC2 O +
and O +
TACC3 O -
. O +

However O -
, O +
the O +
other O +
two O +
genes O -
, O +
trTACC1A O +
and O +
trTACC1B O +
are O +
clearly O +
most O +
related O +
to O +
TACC1 O +
( O -
Fig. O +
1 O -
) O -
. O +

Although O +
trTACC1A O +
is O +
highly O +
homologous O +
to O +
trTACC1B O -
, O +
the O +
latter O +
encodes O +
a O +
significantly O +
smaller O +
predicted O +
protein O -
. O +

The O +
trTACC1B O +
gene O +
is O +
encoded O +
by O +
15 O +
exons O +
over O +
approximately O +
7 O +
kb O +
of O +
the O +
Takifugu O +
Scaffold O +
191 O +
( O -
see O +
below O -
) O -
. O +

A O +
search O +
of O +
this O +
region O +
using O +
the O +
trTACC1A O +
sequence O +
and O +
gene O +
prediction O +
software O +
has O +
so O +
far O +
failed O +
to O +
identify O +
additional O +
exons O +
of O +
trTACC1B O -
. O +

However O -
, O +
given O +
the O +
intron O -
/ O -
exon O +
structure O +
of O +
this O +
apparently O +
complete O +
gene O -
, O +
it O +
appears O +
likely O +
that O +
trTACC1B O +
is O +
active O +
in O +
the O +
pufferfish O -
, O +
and O +
presumably O +
fulfils O +
either O +
a O +
temporal O -
- O -
spatial O +
specific O +
function O +
within O +
the O +
organism O -
, O +
or O +
a O +
distinct O +
function O +
from O +
the O +
larger O +
trTACC1A O +
product O +
within O +
the O +
cell O -
. O +

Thus O -
, O +
based O +
upon O +
the O +
surrounding O +
chromosomal O +
loci O +
( O -
see O +
below O -
) O -
, O +
the O +
trTACC1A O +
and O +
trTACC1B O +
genes O +
appear O +
to O +
have O +
arisen O +
from O +
the O +
duplication O +
of O +
the O +
chromosomal O +
segment O +
containing O +
the O +
teleost O +
TACC1 O +
ancestor O -
, O +
during O +
the O +
additional O +
partial O +
genomic O +
duplication O +
that O +
occurred O +
in O +
the O +
teleost O +
lineage O -
. O +

Therefore O -
, O +
this O +
analysis O +
of O +
T. O +
rubripes O +
does O +
not O +
support O +
the O +
hypothesis O +
that O +
the O +
region O +
surrounding O +
the O +
TACC3 O +
ancestor O +
was O +
included O +
in O +
the O +
second O +
round O +
of O +
vertebrate O +
genomic O +
duplication O -
. O +

Examination O +
of O +
higher O +
vertebrates O +
led O +
to O +
the O +
identification O +
of O +
splice O +
variants O +
of O +
TACC1 O +
and O +
TACC2 O +
in O +
Mus O +
musculus O -
, O +
and O +
the O +
assembly O +
of O +
the O +
previously O +
unidentified O +
orthologues O +
of O +
TACC1 O -
- O -
3 O +
from O +
Rattus O +
norvegus O -
. O +

In O +
addition O -
, O +
the O +
TACC1X O +
sequence O +
was O +
found O +
on O +
mouse O +
chromosome O +
X. O +
This O +
gene O +
is O +
clearly O +
related O +
to O +
the O +
mouse O +
TACC1 O -
, O +
however O -
, O +
further O +
examination O +
revealed O +
a O +
mouse O +
B1 O +
repeat O +
distributed O +
over O +
the O +
length O +
of O +
the O +
proposed O +
intron O -
. O +

In O +
addition O -
, O +
no O +
expression O +
of O +
TACC1X O +
was O +
detected O +
in O +
mouse O +
RNA O +
by O +
rt O -
- O -
PCR O +
analysis O +
( O -
data O +
not O +
shown O -
) O -
, O +
suggesting O +
that O +
this O +
sequence O +
is O +
a O +
processed O +
pseudogene O -
. O +

Similarly O -
, O +
TACC1 O +
pseudogenes O +
also O +
exist O +
spread O +
over O +
22 O +
kb O +
of O +
the O +
centromeric O +
region O +
of O +
human O +
chromosome O +
10 O +
and O -
, O +
in O +
8q21 O -
, O +
a O +
shorter O +
region O +
86 O -
% O +
identical O +
to O +
the O +
final O +
359 O +
bp O +
of O +
the O +
TACC1 O +
3 O -
' O +
untranslated O +
region O -
. O +

No O +
pseudogenes O +
corresponding O +
to O +
TACC2 O +
or O +
TACC3 O +
were O +
identified O +
in O +
any O +
mammalian O +
species O -
. O +

Characterization O +
of O +
vertebrate O +
TACC3 O +
orthologues O +
Based O +
upon O +
current O +
functional O +
analysis O -
, O +
the O +
characterization O +
of O +
TACC3 O +
orthologues O +
is O +
likely O +
to O +
be O +
pivotal O +
to O +
understanding O +
the O +
sequence O +
and O +
functional O +
evolution O +
of O +
the O +
TACC O +
gene O +
family O -
. O +

As O +
indicated O +
below O -
, O +
the O +
chromosomal O +
region O +
containing O +
the O +
TACC O +
gene O +
precursors O +
was O +
duplicated O +
twice O +
during O +
vertebrate O +
evolution O -
. O +

Although O +
the O +
analysis O +
of O +
T. O +
rubripes O -
, O +
rodents O +
and O +
humans O +
so O +
far O +
suggests O +
that O +
the O +
vertebrate O +
TACC3 O +
precursor O +
was O +
not O +
included O +
in O +
the O +
second O +
round O +
of O +
genomic O +
duplication O -
, O +
it O +
could O +
not O +
be O +
excluded O +
that O +
a O +
TACC4 O +
gene O +
may O +
have O +
been O +
lost O +
during O +
the O +
evolution O +
of O +
these O +
lineages O -
. O +

The O +
cloning O +
of O +
a O +
new O +
member O +
of O +
the O +
TACC O +
family O +
in O +
Oryctolagus O +
cuniculus O +
has O +
added O +
to O +
this O +
controversy O +
[ O -
9 O -
] O -
. O +

Designated O +
TACC4 O -
, O +
the O +
1.5 O +
kb O +
cDNA O +
was O +
highly O +
related O -
, O +
but O +
proposed O +
to O +
be O +
distinct O +
from O +
TACC3 O -
. O +

However O -
, O +
Northern O +
blot O +
data O +
suggested O +
that O +
this O +
gene O +
produces O +
a O +
single O +
2.3 O +
kb O +
transcript O +
[ O -
9 O -
] O -
, O +
indicating O +
that O +
the O +
cloned O +
cDNA O +
was O +
incomplete O -
. O +

The O +
degree O +
of O +
similarity O +
to O +
the O +
published O +
sequence O +
of O +
human O +
and O +
mouse O +
TACC3 O +
suggested O +
to O +
us O +
that O +
TACC4 O +
actually O +
represents O +
a O +
partial O +
rabbit O +
TACC3 O +
cDNA O -
. O +

To O +
test O +
this O +
hypothesis O -
, O +
we O +
set O +
out O +
to O +
clone O +
the O +
complete O +
rabbit O +
TACC3 O +
sequence O -
, O +
based O +
upon O +
the O +
known O +
features O +
of O +
human O +
and O +
mouse O +
TACC3 O -
. O +

We O +
have O +
previously O +
noted O +
that O +
the O +
N O -
- O -
terminal O +
and O +
C O -
- O -
terminal O +
regions O +
of O +
the O +
human O +
and O +
mouse O +
TACC3 O +
proteins O +
are O +
highly O +
conserved O +
( O -
[ O -
2 O -
] O -
, O +
see O +
below O -
) O -
. O +

Therefore O -
, O +
based O +
upon O +
the O +
sequence O +
identity O +
between O +
these O +
genes O -
, O +
we O +
designed O +
a O +
consensus O +
oligonucleotide O +
primer O -
, O +
T3con2 O -
, O +
that O +
would O +
be O +
suitable O +
for O +
the O +
identification O +
of O +
the O +
region O +
containing O +
the O +
initiator O +
methionine O +
of O +
the O +
TACC3 O +
cDNAs O +
from O +
primates O +
and O +
rodents O -
. O +

Using O +
this O +
primer O -
, O +
in O +
combination O +
with O +
the O +
TACC4-specific O +
RACE O +
primer O +
( O -
RACE2 O -
) O -
, O +
initially O +
used O +
by O +
Steadman O +
et O +
al O +
[ O -
9 O -
] O -
, O +
we O +
isolated O +
a O +
1.5 O +
kb O +
PCR O +
product O +
from O +
rabbit O +
brain O +
cDNA O +
by O +
rt O -
- O -
PCR O -
. O +

In O +
combination O +
with O +
3'RACE O -
, O +
this O +
generated O +
a O +
consensus O +
cDNA O +
of O +
2283 O +
bp O +
which O +
corresponds O +
to O +
the O +
transcript O +
size O +
of O +
2.3 O +
kb O +
detected O +
by O +
the O +
" O -
TACC4 O -
" O +
sequence O +
reported O +
in O +
Figure O +
4 O +
of O +
Steadman O +
et O +
al O +
[ O -
9 O -
] O -
. O +

Thus O -
, O +
while O +
it O +
remains O +
possible O +
that O +
the O +
" O -
TACC4 O -
" O +
sequence O +
is O +
an O +
alternative O +
splice O +
product O -
, O +
or O +
is O +
the O +
product O +
of O +
reduplication O +
of O +
the O +
TACC3 O +
gene O +
( O -
events O +
that O +
would O +
be O +
specific O +
to O +
the O +
rabbit O -
) O -
, O +
the O +
only O +
transcript O +
detected O +
in O +
rabbit O +
RNA O +
corresponds O +
to O +
the O +
predicted O +
transcript O +
size O +
of O +
the O +
TACC3 O +
sequence O +
that O +
we O +
have O +
identified O +
here O -
. O +

Furthermore O -
, O +
the O +
string O +
of O +
nucleotides O +
found O +
at O +
the O +
5 O -
' O +
end O +
of O +
the O +
" O -
TACC4 O -
" O +
sequence O +
is O +
also O +
found O +
at O +
the O +
5 O -
' O +
ends O +
of O +
a O +
number O +
of O +
cDNA O +
sequences O +
( O -
e.g. O +
U82468 O -
, O +
NM_023500 O -
) O -
, O +
that O +
were O +
isolated O +
by O +
5'RACE O -
, O +
suggesting O +
that O +
they O +
may O +
correspond O +
to O +
an O +
artefact O +
of O +
the O +
5'RACE O +
methodology O +
used O +
in O +
their O +
construction O -
. O +

The O +
rabbit O +
" O -
TACC4 O -
" O +
and O +
the O +
rabbit O +
TACC3 O +
sequence O +
that O +
we O +
have O +
isolated O +
are O +
also O +
found O +
on O +
the O +
same O +
branch O +
of O +
the O +
TACC O +
phylogenetic O +
tree O +
with O +
the O +
other O +
TACC3 O +
orthologues O -
, O +
including O +
maskin O +
( O -
Xenopus O +
laevis O -
) O -
, O +
and O +
the O +
newly O +
identified O +
TACC3 O +
sequences O +
in O +
Rattus O +
norvegus O -
, O +
Gallus O +
gallus O -
, O +
Silurana O +
tropicalis O -
, O +
Danio O +
rerio O +
and O +
T. O +
rubripes O -
, O +
reported O +
in O +
this O +
manuscript O +
( O -
Fig. O +
1 O -
) O -
. O +

Thus O -
, O +
it O +
is O +
not O +
in O +
a O +
separate O +
branch O +
that O +
may O +
be O +
expected O +
if O +
the O +
sequence O +
was O +
a O +
distinct O +
TACC O +
family O +
member O -
. O +

Placement O +
of O +
the O +
RHAMM O +
gene O +
in O +
the O +
phylogeny O +
of O +
the O +
coiled O +
coil O +
gene O +
family O +
Human O +
RHAMM O +
has O +
also O +
been O +
proposed O +
to O +
be O +
the O +
missing O +
fourth O +
member O +
of O +
the O +
TACC O +
family O +
[ O -
10 O -
] O -
. O +

Evidence O +
used O +
in O +
support O +
of O +
this O +
claim O +
included O +
its O +
chromosomal O +
location O +
on O +
5q32 O +
in O +
humans O +
( O -
discussed O +
below O -
) O -
, O +
its O +
sequence O +
similarity O +
in O +
its O +
coiled O +
coil O +
domain O +
to O +
the O +
TACC O +
domain O +
and O +
the O +
subcellular O +
localization O +
of O +
the O +
RHAMM O +
protein O +
in O +
the O +
centrosome O -
. O +

However O -
, O +
if O +
RHAMM O +
were O +
a O +
bona O +
fide O +
TACC O +
family O +
member O -
, O +
then O +
we O +
would O +
predict O +
its O +
evolution O +
would O +
be O +
similar O +
to O +
those O +
of O +
other O +
TACC O +
family O +
members O -
, O +
and O +
fit O +
with O +
the O +
proposed O +
evolution O +
of O +
the O +
vertebrate O +
genome O -
. O +

Thus O -
, O +
we O +
set O +
out O +
to O +
identify O +
RHAMM O +
orthologues O +
and O +
related O +
genes O +
in O +
metazoans O -
, O +
so O +
that O +
a O +
more O +
complete O +
phylogeny O +
of O +
the O +
coiled O +
coil O +
super O +
family O +
could O +
be O +
generated O -
. O +

We O +
identified O +
a O +
single O +
RHAMM O +
gene O +
in O +
all O +
deuterostomes O +
for O +
which O +
cDNA O +
and/or O +
genomic O +
sequence O +
was O +
available O -
, O +
including O +
C. O +
intestinalis O -
. O +

No O +
RHAMM O +
gene O +
was O +
identified O +
in O +
insects O +
or O +
nematodes O -
. O +

This O +
indicates O +
that O +
the O +
RHAMM O -
/ O -
TACC O +
genes O +
diverged O +
after O +
the O +
protostome O -
/ O -
deuterostome O +
split O +
833–933 O +
MYA O -
, O +
but O +
prior O +
to O +
the O +
echinodermata O -
/ O -
urochordate O +
divergence O +
( O -
> O -
750 O +
MYA O -
) O -
. O +

Significantly O -
, O +
sequence O +
and O +
phylogenetic O +
analysis O +
of O +
coiled O +
coil O +
proteins O +
( O -
Fig. O +
1 O -
) O +
clearly O +
shows O +
that O +
RHAMM O +
does O +
not O +
contain O +
a O +
TACC O +
domain O +
and O +
instead O +
forms O +
a O +
distinct O +
family O +
of O +
proteins O +
in O +
the O +
coiled O +
coil O +
superfamily O -
, O +
and O +
is O +
not O +
a O +
direct O +
descendant O +
of O +
the O +
ancestral O +
TACC O +
gene O -
. O +

Evolution O +
of O +
the O +
chromosomal O +
segments O +
containing O +
the O +
TACC O +
genes O +
The O +
phylogenetic O +
tree O +
of O +
the O +
FGFR O +
genes O +
closely O +
resembles O +
that O +
of O +
the O +
vertebrate O +
TACC1 O -
- O -
3 O +
genes O -
. O +

Recently O -
, O +
detailed O +
analyses O +
of O +
the O +
chromosomal O +
regions O +
containing O +
the O +
FGFR O +
gene O +
family O +
in O +
humans O -
, O +
mouse O +
and O +
the O +
arthopod O +
D. O +
melanogaster O +
have O +
revealed O +
the O +
conservation O +
of O +
paralogous O +
chromosomal O +
segments O +
between O +
these O +
organisms O +
( O -
Fig. O +
2 O -
, O +
[ O -
13 O -
] O -
, O +
Table O +
1 O +
[ O -
see O +
Additional O +
file O +
1 O -
] O -
) O -
. O +

This O +
has O +
provided O +
further O +
support O +
that O +
an O +
ancient O +
chromosomal O +
segment O +
was O +
duplicated O +
twice O +
during O +
vertebrate O +
evolution O -
, O +
with O +
the O +
first O +
duplication O +
that O +
gave O +
rise O +
to O +
the O +
human O +
chromosome O +
4p16 O -
/ O -
5q32-ter O +
and O +
human O +
chromosome O +
8p O -
/ O -
10q23-ter O +
ancestors O +
occurring O +
in O +
the O +
early O +
stages O +
after O +
the O +
invertebrate O +
divergence O -
. O +

This O +
suggests O +
that O +
the O +
ancestral O +
FGFR O -
- O -
TACC O +
gene O +
pair O +
most O +
probably O +
arose O +
prior O +
to O +
the O +
initial O +
duplication O +
and O +
subsequent O +
divergence O +
of O +
these O +
paralogous O +
chromosomal O +
segments O -
, O +
estimated O +
to O +
have O +
occurred O +
687 O +
± O +
155.7 O +
MYA O -
. O +

This O +
has O +
raised O +
the O +
suggestion O +
that O +
a O +
fourth O +
TACC O +
gene O +
in O +
vertebrates O +
would O +
reside O +
in O +
the O +
same O +
chromosomal O +
region O +
as O +
FGFR4 O -
. O +

Indeed O +
this O +
hypothesis O +
has O +
been O +
used O +
in O +
support O +
for O +
the O +
RHAMM O +
gene O +
as O +
a O +
member O +
of O +
the O +
TACC O +
family O +
[ O -
10 O -
] O -
. O +

Human O +
RHAMM O +
maps O +
to O +
chromosome O +
5q32 O +
in O +
a O +
region O +
bounded O +
by O +
GPX3 O +
and O +
NKX2E O -
. O +

These O +
loci O +
separate O +
two O +
clusters O +
of O +
genes O +
on O +
human O +
chromosome O +
5 O +
that O +
are O +
paralogous O +
with O +
4p16 O -
. O +

Interestingly O -
, O +
these O +
three O +
clusters O +
are O +
located O +
on O +
different O +
chromosomes O +
in O +
mouse O +
and O +
rat O +
( O -
Fig. O +
2 O -
) O -
, O +
further O +
suggesting O +
that O +
this O +
cluster O +
of O +
genes O +
was O +
transposed O +
into O +
this O +
region O +
after O +
the O +
primate O -
/ O -
rodent O +
divergence O -
. O +

Figure O +
2 O +
Linear O +
organization O +
of O +
gene O +
clusters O +
centering O +
upon O +
the O +
chromosomal O +
loci O +
of O +
the O +
FGFR O +
genes O +
in O +
humans O -
. O +

Paralogous O +
genes O +
present O +
in O +
at O +
least O +
two O +
of O +
the O +
four O +
loci O +
are O +
shown O -
, O +
with O +
the O +
exception O +
of O +
the O +
region O +
between O +
GPX3 O +
and O +
NKX2E O +
on O +
chromosome O +
5 O -
, O +
which O +
appears O +
to O +
represent O +
a O +
series O +
of O +
intervening O +
genes O +
inserted O +
after O +
duplication O +
of O +
the O +
4p16 O -
/ O -
5q32 O -
- O -
35 O +
clusters O -
, O +
and O +
genes O +
mentioned O +
in O +
Fig. O +
3 O -
. O +

Corresponding O +
syntenic O +
mouse O +
chromosomal O +
regions O +
( O -
mm O -
* O -
) O +
are O +
indicated O -
. O +

Takifugu O +
rubripes O +
scaffolds O +
are O +
shown O +
( O -
TR O -
* O -
) O +
that O +
contain O +
more O +
than O +
one O +
homologous O +
gene O +
from O +
these O +
clusters O -
. O +

Further O +
details O +
on O +
the O +
location O +
of O +
paralogous O +
genes O +
can O +
be O +
found O +
in O +
[ O -
see O +
Additional O +
file O +
1 O -
] O -
. O +

Because O +
the O +
conservation O +
of O +
gene O +
order O +
can O +
also O +
provide O +
clues O +
to O +
the O +
evolution O +
of O +
gene O +
regulation O -
, O +
we O +
next O +
attempted O +
to O +
trace O +
the O +
evolution O +
of O +
these O +
paralogous O +
segments O +
by O +
examining O +
the O +
genome O +
of O +
the O +
tunicate O +
C. O +
intestinalis O +
[ O -
11 O -
] O +
and O +
the O +
most O +
" O -
primitive O -
" O +
compact O +
vertebrate O +
genome O +
sequenced O +
to O +
date O -
, O +
T. O +
rubripes O +
[ O -
14 O -
] O -
. O +

Although O +
not O +
fully O +
assembled O -
, O +
examination O +
of O +
the O +
genome O +
of O +
T. O +
rubripes O +
confirmed O +
the O +
presence O +
of O +
chromosomal O +
segments O +
paralogous O +
to O +
those O +
found O +
in O +
higher O +
vertebrates O +
( O -
Fig. O +
2 O -
) O -
. O +

For O +
instance O -
, O +
the O +
orthologues O +
of O +
GPRK2L O +
and O +
RGS12 O +
are O +
found O +
on O +
T. O +
rubripes O +
scaffold O +
290 O +
( O -
emb|CAAB01000290.1 O -
) O -
, O +
and O +
within O +
300 O +
kb O +
of O +
each O +
other O +
in O +
human O +
4p16 O -
. O +

The O +
T. O +
rubripes O +
orthologues O +
of O +
FGFR3 O -
, O +
LETM1 O +
and O +
WHSC1 O +
are O +
located O +
on O +
the O +
same O +
166 O +
kb O +
genomic O +
scaffold O +
251 O +
( O -
emb|CAAB01000166.1 O -
) O -
. O +

Significantly O -
, O +
the O +
three O +
human O +
orthologues O +
of O +
these O +
genes O +
are O +
also O +
located O +
within O +
300 O +
kb O +
of O +
each O +
other O +
on O +
4p16 O -
. O +

Furthermore O -
, O +
TACC3 O +
and O +
FGFRL O +
map O +
to O +
the O +
overlapping O +
scaffolds O +
1184 O -
/ O -
4669 O +
( O -
emb|CAAB01004668 O -
) O -
. O +

Similarly O -
, O +
elements O +
of O +
these O +
gene O +
clusters O -
, O +
extending O +
from O +
HMP19 O +
to O +
GPRK6 O +
in O +
human O +
chromosome O +
5q34-ter O +
are O +
also O +
found O +
in O +
the O +
pufferfish O -
, O +
with O +
the O +
T. O +
rubripes O +
orthologues O +
of O +
NSD1 O -
, O +
FGFR4 O +
and O +
a O +
RAB O -
- O -
like O +
gene O +
mapping O +
on O +
scaffold O +
407 O +
( O -
emb|CAAB01000407 O -
) O -
. O +

However O -
, O +
there O +
is O +
no O +
evidence O +
for O +
a O +
gene O +
corresponding O +
to O +
a O +
TACC4 O +
gene O +
in O +
any O +
of O +
these O +
clusters O -
. O +

As O +
noted O +
above O -
, O +
phylogenetic O +
analysis O +
of O +
the O +
TACC O +
sequences O +
indicate O +
that O +
there O +
are O +
two O +
TACC1 O +
related O +
genes O +
in O +
the O +
pufferfish O -
. O +

trTACC1B O +
is O +
located O +
on O +
the O +
180 O +
kb O +
scaffold O +
191 O +
( O -
emb|CAAB01000191.1 O -
) O -
, O +
which O +
also O +
contains O +
the O +
orthologues O +
of O +
several O +
genes O +
located O +
in O +
human O +
chromosome O +
8p21 O -
- O -
11 O -
. O +

Thus O -
, O +
this O +
scaffold O +
represents O +
the O +
more O +
" O -
developed O -
" O +
TACC1 O +
chromosomal O +
segment O +
that O +
is O +
evident O +
in O +
higher O +
vertebrates O -
. O +

On O +
the O +
other O +
hand O -
, O +
the O +
trTACC1A O +
gene O +
is O +
located O +
in O +
the O +
396 O +
kb O +
scaffold O +
12 O +
( O -
emb|CAAB010012.1 O -
) O -
. O +

This O +
scaffold O +
also O +
contains O +
the O +
T. O +
rubripes O +
orthologues O +
of O +
MSX1 O -
, O +
STX18 O -
, O +
D4S234E O +
and O +
the O +
predicted O +
gene O +
LOC118711 O -
, O +
in O +
addition O +
to O +
sequences O +
with O +
homology O +
to O +
LOXL O -
, O +
EVC O -
, O +
LOC159291 O -
, O +
and O +
the O +
LDB O +
family O -
. O +

Thus O -
, O +
scaffold O +
12 O +
contains O +
genes O +
found O +
in O +
the O +
regions O +
of O +
human O +
chromosome O +
4 O +
and O +
10 O +
that O +
also O +
contain O +
the O +
loci O +
for O +
TACC3 O +
and O +
TACC2 O -
, O +
respectively O -
, O +
and O +
may O +
therefore O +
more O +
closely O +
resemble O +
the O +
genomic O +
organization O +
resulting O +
from O +
the O +
initial O +
duplication O +
of O +
the O +
ancestral O +
paralogous O +
chromosomal O +
segment O -
. O +

Conserved O +
paralogous O +
clusters O +
may O +
result O +
from O +
the O +
initial O +
clustering O +
of O +
the O +
genes O +
in O +
a O +
relatively O +
small O +
ancestral O +
genomic O +
contig O -
. O +

Some O +
evidence O +
for O +
the O +
existence O +
of O +
" O -
protoclusters O -
" O +
that O +
could O +
correspond O +
to O +
the O +
paralogous O +
chromosomal O +
segments O +
noted O +
in O +
higher O +
vertebrates O +
is O +
present O +
in O +
the O +
genome O +
of O +
the O +
urochordate O +
C. O +
intestinalis O +
[ O -
11 O -
] O -
. O +

For O +
instance O -
, O +
the O +
orthologues O +
of O +
FGFR O -
, O +
and O +
WHSC1 O -
, O +
carboxypeptidase O +
Z O +
and O +
FLJ25359 O +
cluster O +
within O +
an O +
85 O +
kb O +
region O +
of O +
the O +
C. O +
intestinalis O +
genome O +
and O +
the O +
human O +
orthologues O +
are O +
still O +
maintained O +
in O +
paralogous O +
segments O +
of O +
4p16 O -
, O +
8p O +
and O +
10q O +
( O -
Fig. O +
3 O -
, O +
[ O -
see O +
Additional O +
file O +
1 O -
] O -
) O -
. O +

However O -
, O +
it O +
should O +
be O +
noted O +
that O +
no O +
clusters O +
of O +
genes O +
from O +
the O +
vertebrate O +
paralogous O +
segments O +
are O +
locate O +
close O +
to O +
the O +
TACC O +
or O +
RHAMM O +
genes O +
of O +
C. O +
intestinalis O -
, O +
indicating O +
that O +
the O +
formation O +
of O +
the O +
much O +
larger O +
paralogous O +
segments O +
encompassing O +
the O +
FGFR O -
- O -
TACC O +
genes O +
formed O +
later O +
in O +
evolutionary O +
time O -
, O +
or O +
conversely O +
have O +
been O +
subject O +
to O +
extensive O +
rearrangement O +
in O +
tunicates O -
. O +

In O +
combination O +
with O +
the O +
examination O +
of O +
the O +
T. O +
rubripes O +
genome O -
, O +
this O +
also O +
provides O +
additional O +
evidence O +
that O +
either O +
the O +
second O +
round O +
of O +
duplication O +
of O +
the O +
chromosomal O +
segment O +
that O +
contained O +
the O +
FGFR3 O -
/ O -
4 O +
ancestor O +
did O +
not O +
include O +
a O +
TACC O +
gene O -
, O +
or O +
that O +
such O +
a O +
gene O +
was O +
lost O +
very O +
early O +
in O +
vertebrate O +
evolution O -
, O +
prior O +
to O +
the O +
divergence O +
of O +
the O +
Gnanthostome O +
lineages O -
. O +

However O -
, O +
the O +
final O +
resolution O +
of O +
the O +
initial O +
evolution O +
of O +
these O +
paralogous O +
segment O +
will O +
await O +
the O +
sequencing O +
of O +
the O +
amphioxus O +
and O +
lamprey O +
genomes O -
, O +
which O +
only O +
have O +
one O +
FGFR O +
gene O -
, O +
and O +
therefore O +
should O +
only O +
contain O +
one O +
copy O +
of O +
the O +
other O +
corresponding O +
genes O +
in O +
this O +
conserved O +
segment O -
. O +

Figure O +
3 O +
Formation O +
of O +
protoclusters O +
in O +
Takifugu O +
rubripes O +
and O +
Ciona O +
intestinalis O -
: O +
( O -
A O -
) O -
: O +
Structure O +
of O +
the O +
genomic O +
scaffolds O +
containing O +
the O +
Takifugu O +
rubripes O +
trTACC1A O +
and O +
trTACC1B O +
genes O -
. O +

Scaffold O +
12 O -
, O +
the O +
site O +
for O +
the O +
trTACC1A O +
gene O +
contains O +
genes O +
found O +
with O +
either O +
homologues O +
or O +
orthologues O +
on O +
the O +
distal O +
long O +
arm O +
of O +
human O +
chromosome O +
10 O +
and O +
4p16 O -
. O +

This O +
scaffold O -
, O +
therefore O -
, O +
has O +
some O +
of O +
the O +
characteristics O +
of O +
the O +
predicted O +
immediate O +
ancestor O +
of O +
the O +
TACC1 O -
/ O -
TACC2 O +
chromosomal O +
segment O -
. O +

trTACC1B O +
is O +
found O +
on O +
scaffold O +
191 O -
, O +
which O +
contains O +
orthologues O +
of O +
genes O +
found O +
in O +
the O +
proximal O +
short O +
arm O +
of O +
human O +
chromosome O +
8 O -
. O +
( O -
B O -
) O -
: O +
Ciona O +
intestinalis O +
clusters O +
containing O +
genes O +
found O +
in O +
paralogous O +
segments O +
on O +
human O +
8 O -
, O +
4p16 O -
, O +
10q O +
and O +
5q O -
. O +

Figure O +
4 O +
Genomic O +
structure O +
of O +
the O +
TACC O +
genes O -
. O +

Conserved O +
regions O +
known O +
to O +
bind O +
protein O +
factors O +
in O +
all O +
human O +
TACC O +
proteins O +
are O +
shown O -
. O +

The O +
SDP O +
repeat O +
of O +
human O +
TACC1 O -
- O -
3 O +
is O +
known O +
to O +
bind O +
GAS41 O +
( O -
[ O -
3,15 O -
] O +
and O +
data O +
not O +
shown O -
) O -
. O +

The O +
TACC O +
domain O +
binds O +
ch O -
- O -
TOG O +
and O +
members O +
of O +
the O +
Aurora O +
kinases O +
in O +
all O +
species O +
examined O +
to O +
date O -
. O +

This O +
motif O +
is O +
characteristically O +
encoded O +
by O +
the O +
3 O -
' O +
exons O +
of O +
the O +
TACC O +
genes O -
. O +

The O +
size O +
of O +
the O +
largest O +
isoform O +
for O +
each O +
gene O +
is O +
shown O -
. O +

Comparative O +
genomic O +
structure O +
of O +
the O +
TACC O +
family O +
The O +
genomic O +
DNA O +
sequences O +
corresponding O +
to O +
the O +
orthologous O +
TACC O +
genes O +
of O +
human O -
, O +
mouse O -
, O +
rat O -
, O +
pufferfish O -
, O +
C. O +
intestinalis O -
, O +
D. O +
melanogaster O +
and O +
C. O +
elegans O +
were O +
extracted O +
and O +
analyzed O +
by O +
Genescan O +
and O +
BLAST O +
to O +
determine O +
the O +
genomic O +
structure O +
of O +
each O +
TACC O +
gene O -
. O +

In O +
some O +
cases O -
, O +
for O +
rat O +
and O +
pufferfish O -
, O +
exons O +
were O +
added O +
or O +
modified O +
based O +
on O +
the O +
best O +
similarity O +
of O +
translated O +
peptides O +
to O +
the O +
corresponding O +
mouse O +
and O +
human O +
proteins O -
. O +

For O +
regions O +
with O +
low O +
sequence O +
similarity O +
in O +
T. O +
rubripes O -
, O +
genomic O +
sequences O +
from O +
the O +
fresh O +
water B-Chemical +
pufferfish O -
, O +
Tetraodon O +
nigroviridis O +
were O +
used O +
as O +
additional O +
means O +
to O +
verify O +
the O +
predicted O +
exons O -
. O +

The O +
general O +
structure O +
of O +
the O +
TACC O +
genes O +
and O +
proteins O +
is O +
depicted O +
in O +
Fig. O +
4 O -
. O +

The O +
main O +
conserved O +
feature O +
of O +
the O +
TACC O +
family O -
, O +
the O +
TACC O +
domain O -
, O +
is O +
located O +
at O +
the O +
carboxy O +
terminus O +
of O +
the O +
protein O -
. O +

In O +
the O +
case O +
of O +
the O +
C. O +
elegans O +
TAC O +
protein O -
, O +
this O +
structure O +
comprises O +
the O +
majority O +
of O +
the O +
protein O +
and O +
is O +
encoded O +
by O +
two O +
of O +
the O +
three O +
exons O +
of O +
the O +
gene O -
. O +

In O +
the O +
higher O +
organisms O -
, O +
D. O +
melanogaster O -
, O +
and O +
the O +
deuterostomes O +
C. O +
intestinalis O +
to O +
human O -
, O +
this O +
feature O +
is O +
also O +
encoded O +
by O +
the O +
final O +
exons O +
of O +
the O +
gene O +
( O -
five O +
in O +
D. O +
melanogaster O -
, O +
seven O +
in O +
the O +
deuterostome O +
genes O -
) O -
. O +

Outside O +
of O +
the O +
TACC O +
domain O -
, O +
however O -
, O +
TACC O +
family O +
members O +
show O +
relatively O +
little O +
homology O -
. O +

It O +
is O +
interesting O +
that O +
each O +
TACC O +
gene O +
contains O +
one O +
large O +
exon O -
, O +
which O +
shows O +
considerable O +
variability O +
between O +
TACC O +
orthologues O -
, O +
and O +
constitutes O +
the O +
main O +
difference O +
between O +
the O +
TACC3 O +
genes O +
in O +
the O +
vertebrates O +
( O -
see O +
below O -
) O -
. O +

In O +
deuterostomes O -
, O +
this O +
exon O +
contains O +
the O +
SDP O +
repeat O +
( O -
or O +
in O +
the O +
case O +
of O +
the O +
murine O +
TACC3 O -
's O -
, O +
a O +
rodent O -
- O -
specific O +
24 O +
amino O +
acid O +
repeat O -
) O -
, O +
which O +
is O +
responsible O +
for O +
the O +
binding O +
of O +
the O +
SWI O -
/ O -
SNF O +
chromatin O +
remodeling O +
complex O +
component O +
GAS41 O +
[ O -
15,16 O -
] O -
. O +

Of O +
the O +
vertebrate O +
TACC O +
proteins O -
, O +
the O +
TACC3 O +
orthologues O +
show O +
the O +
greatest O +
variability O +
in O +
size O +
and O +
sequence O -
, O +
ranging O +
in O +
size O +
from O +
599 O +
amino O +
acids O +
for O +
the O +
rat O +
TACC3 O +
protein O -
, O +
to O +
942 O +
amino O +
acids O +
in O +
the O +
Danio O +
rerio O +
protein O -
. O +

The O +
reasons O +
for O +
these O +
differences O +
are O +
apparent O +
from O +
the O +
genomic O +
structure O +
of O +
the O +
TACC3 O +
orthologues O -
. O +

TACC3 O +
can O +
be O +
divided O +
into O +
three O +
sections O -
: O +
a O +
conserved O +
N O -
- O -
terminal O +
region O +
( O -
CNTR O -
) O +
of O +
108 O +
amino O +
acids O -
, O +
encoded O +
by O +
exons O +
2 O +
and O +
3 O +
in O +
each O +
vertebrate O +
TACC3 O +
gene O -
, O +
the O +
conserved O +
TACC O +
domain O +
distributed O +
over O +
the O +
final O +
seven O +
exons O -
, O +
and O +
a O +
highly O +
variable O +
central O +
region O -
. O +

The O +
lack O +
of O +
conservation O +
in O +
both O +
size O +
and O +
sequence O +
of O +
the O +
central O +
portion O +
of O +
the O +
TACC3 O +
proteins O +
of O +
human O +
and O +
mouse O +
has O +
been O +
previously O +
noted O -
, O +
and O +
accounts O +
for O +
the O +
major O +
difference O +
between O +
these O +
two O +
orthologues O +
[ O -
2 O -
] O -
. O +

The O +
majority O +
of O +
this O +
central O +
portion O -
, O +
which O +
contains O +
the O +
SDP O +
repeat O +
motifs O -
, O +
is O +
encoded O +
by O +
one O +
exon O +
in O +
human O +
and O +
the O +
pufferfish O +
( O -
emb|CAAB01001184 O -
) O -
. O +

In O +
rodents O -
, O +
however O -
, O +
this O +
region O +
is O +
almost O +
entirely O +
composed O +
of O +
seven O +
24 O +
amino O +
acid O +
repeats O -
, O +
which O +
are O +
located O +
in O +
a O +
single O +
exon O +
of O +
the O +
mouse O +
and O +
rat O +
TACC3 O +
genes O -
. O +

It O +
has O +
been O +
previously O +
reported O +
that O +
there O +
are O +
four O +
mouse O +
TACC3 O +
splice O +
variants O +
that O +
differ O +
in O +
the O +
number O +
of O +
these O +
repeats O +
[ O -
2,7,17 O -
] O -
. O +

As O +
these O +
repeats O +
are O +
present O +
in O +
a O +
single O +
exon O -
, O +
it O +
appears O +
likely O +
that O +
these O +
different O +
sequences O +
may O +
be O +
the O +
result O +
of O +
the O +
DNA O +
polymerases O +
used O +
in O +
the O +
cDNA O +
synthesis O +
and/or O +
PCR O +
reaction O +
stuttering O +
through O +
the O +
repeat O +
motif O -
. O +

The O +
correct O +
sequence O -
, O +
reported O +
by O +
Sadek O +
et O +
al O +
[ O -
7 O -
] O -
, O +
is O +
the O +
one O +
used O +
throughout O +
the O +
entirety O +
of O +
this O +
manuscript O -
. O +

These O +
repeats O +
are O +
not O +
evident O +
in O +
the O +
rabbit O +
protein O -
, O +
or O +
any O +
other O +
TACC O +
protein O -
, O +
and O +
may O +
indicate O +
that O +
the O +
rodent O +
TACC3 O +
has O +
evolved O +
distinct O +
functions O -
, O +
as O +
has O +
already O +
been O +
noted O +
for O +
the O +
amphibian O +
Xenopus O +
TACC3 O -
, O +
maskin O +
[ O -
8 O -
] O -
. O +

Alternative O +
splicing O +
in O +
vertebrate O +
TACC O +
genes O +
Whereas O +
exon O +
shuffling O +
can O +
drive O +
the O +
functional O +
diversification O +
of O +
gene O +
families O +
over O +
evolutionary O +
time O -
, O +
the O +
temporal O +
and/or O +
tissue O +
specific O +
alternative O +
splicing O +
of O +
a O +
gene O +
can O +
give O +
rise O +
to O +
functional O +
diversification O +
of O +
a O +
single O +
gene O +
during O +
the O +
development O +
of O +
an O +
organism O -
. O +

Although O +
no O +
alternative O +
splicing O +
of O +
TACC3 O +
has O +
been O +
clearly O +
documented O -
, O +
both O +
temporal O +
and O +
tissue O +
specific O +
splicing O +
is O +
observed O +
in O +
the O +
TACC1 O +
and O +
TACC2 O +
genes O -
. O +

In O +
the O +
case O +
of O +
TACC2 O -
, O +
an O +
additional O +
large O +
( O -
5 O +
kb O -
) O +
exon O +
accounts O +
for O +
the O +
main O +
difference O +
between O +
the O +
major O +
splice O +
variants O +
of O +
the O +
vertebrate O +
TACC2 O +
genes O +
[ O -
3 O -
] O -
. O +

The O +
alternative O +
splicing O +
of O +
this O +
exon O +
suggests O +
a O +
major O +
functional O +
difference O +
between O +
the O +
two O +
TACC2 O +
isoforms O -
, O +
TACC2s O +
and O +
TACC2l O +
[ O -
3 O -
] O -
, O +
as O +
well O +
as O +
a O +
significant O +
difference O +
between O +
TACC2 O +
and O +
its O +
closest O +
TACC O +
family O +
relative O -
, O +
TACC1 O -
. O +

However O -
, O +
the O +
function O +
of O +
this O +
region O +
of O +
the O +
TACC2l O +
isoform O +
is O +
current O +
unknown O -
. O +

Alternative O +
splicing O -
, O +
together O +
with O +
differential O +
promoter O +
usage O +
has O +
already O +
been O +
noted O +
for O +
the O +
human O +
TACC1 O +
gene O +
[ O -
18,19 O -
] O -
. O +

In O +
addition O -
, O +
as O +
shown O +
in O +
Fig. O +
5 O -
, O +
we O +
have O +
identified O +
additional O +
TACC1 O +
isoforms O +
that O +
result O +
from O +
alternative O +
splicing O +
of O +
exons O +
1b-4a O -
. O +

The O +
functions O +
of O +
these O +
different O +
isoforms O +
are O +
unknown O -
, O +
however O +
the O +
region O +
deleted O +
from O +
the O +
shorter O +
variants O +
can O +
include O +
the O +
binding O +
site O +
for O +
LSm7 O +
[ O -
20 O -
] O +
( O -
variants O +
C O -
, O +
D O -
, O +
F O -
- O -
I O -
) O -
, O +
and/or O +
the O +
nuclear O +
localization O +
signals O +
and O +
binding O +
site O +
for O +
GAS41 O +
[ O -
15 O -
] O +
and O +
PCTAIRE2BP O +
[ O -
20 O -
] O +
( O -
isoforms O +
B O -
- O -
D O -
, O +
S O -
) O -
. O +

One O +
of O +
these O +
isoforms O -
, O +
TACC1S O +
is O +
localized O +
exclusively O +
to O +
the O +
cytoplasm O +
[ O -
19 O -
] O -
, O +
suggesting O +
that O +
the O +
shorter O +
isoforms O +
would O +
not O +
be O +
able O +
to O +
interact O +
with O +
elements O +
of O +
the O +
chomatin O +
remodeling O +
and/or O +
RNA O +
processing O +
machinery O +
in O +
the O +
nucleus O -
. O +

Thus O -
, O +
changes O +
in O +
the O +
complement O +
of O +
TACC1 O +
isoforms O +
in O +
the O +
cell O +
may O +
result O +
in O +
alterations O +
in O +
cellular O +
RNA O +
metabolism O +
at O +
multiple O +
levels O -
, O +
and O +
may O +
account O +
for O +
the O +
observation O +
that O +
TACC1D O +
and O +
TACC1F O +
isoforms O +
are O +
associated O +
with O +
tumorigenic O +
changes O +
in O +
gastric O +
mucosa O +
[ O -
18 O -
] O -
. O +

Figure O +
5 O +
Alternative O +
splicing O +
of O +
the O +
human O +
TACC1 O +
gene O -
. O +

( O -
A O -
) O -
: O +
Seven O +
splice O +
variants O +
have O +
been O +
identified O +
for O +
human O +
TACC1 O +
( O -
A O -
- O -
F O +
and O +
S O -
) O -
. O +

We O +
have O +
also O +
identified O +
additional O +
splice O +
variants O +
( O -
G O -
- O -
I O -
) O +
from O +
database O +
analysis O +
and O +
rt O -
- O -
PCR O +
analysis O +
of O +
human O +
brain O +
RNA O -
. O +

( O -
B O -
) O -
: O +
Alternative O +
splicing O +
of O +
TACC1 O +
in O +
the O +
human O +
brain O -
. O +

rt O -
- O -
PCR O +
analysis O +
confirms O +
splicing O +
of O +
the O +
untranslated O +
exon O +
1a O +
to O +
exon O +
1 O -
, O +
with O +
retention O +
of O +
the O +
originally O +
defined O +
start O +
methionine O +
( O -
GB O -
: O -
NP_006274 O -
) O +
( O -
Variant O +
A O -
* O -
, O +
lanes O +
1 O +
and O +
3 O -
) O -
. O +

Exon O +
1a O +
also O +
splices O +
to O +
exon O +
2 O -
, O +
removing O +
the O +
L O -
- O -
Sm7 O +
binding O +
motif O +
( O -
variant O +
I O -
, O +
lanes O +
3,12 O +
and O +
13 O -
) O -
. O +

Variants O +
that O +
functionally O +
delete O +
exons O +
2 O +
and/or O +
3 O -
, O +
such O +
as O +
variant O +
C O +
( O -
lane O +
15 O -
) O +
also O +
remove O +
the O +
predicted O +
nuclear O +
localization O +
signals O -
, O +
and O +
the O +
binding O +
domains O +
for O +
GAS41 O +
and O +
PCTAIRE2BP O -
. O +

These O +
variants O +
would O +
retain O +
the O +
TACC O +
domain O -
, O +
and O +
therefore O +
the O +
potential O +
to O +
bind O +
to O +
ch O -
- O -
TOG O +
and O +
Aurora O +
A O +
kinase O +
in O +
the O +
centrosome O -
. O +

Lane O +
1 O -
: O +
EF O -
/ O -
X1R O -
, O +
Lane O +
2 O -
: O +
EF O -
/ O -
BX647R O -
, O +
Lane O +
3 O -
: O +
EF O -
/ O -
6SPR O -
, O +
Lane O +
4 O -
: O +
EF O -
/ O -
1DR O -
, O +
Lane O +
5 O -
, O +
EF O -
/ O -
128R O -
, O +
Lane O +
6 O +
X3F O -
/ O -
X1R O -
, O +
Lane O +
7 O -
: O +
X3F O -
/ O -
BX647R O -
, O +
Lane O +
8 O -
: O +
X3F O -
/ O -
6SPR O -
, O +
Lane O +
9 O -
: O +
X3F O -
/ O -
1DR O -
, O +
Lane O +
10 O -
, O +
X3F O -
/ O -
128R O -
, O +
Lane O +
11 O -
: O +
1DF O -
/ O -
X1R O -
, O +
Lane O +
12 O -
: O +
1DF O -
/ O -
BX647R O -
, O +
Lane O +
13 O -
: O +
1DF O -
/ O -
6SPR O -
, O +
Lane O +
14 O -
: O +
1DF O -
/ O -
1DR O -
, O +
Lane O +
15 O -
: O +
1DF O -
/ O -
128R O -
, O +
Lane O +
16 O -
: O +
Biorad O +
1 O +
kb+ O +
Size O +
ladder O -
. O +

In O +
silico O +
modeling O +
of O +
the O +
evolution O +
of O +
TACC O +
protein O +
function O +
The O +
protein O +
and O +
genomic O +
structure O +
of O +
the O +
present O +
day O +
TACC O +
family O +
members O +
suggests O +
that O +
the O +
function O +
of O +
the O +
ancestral O +
TACC O +
protein O +
was O +
mediated O +
solely O +
through O +
the O +
interactions O +
of O +
the O +
conserved O +
TACC O +
domain O -
. O +

Using O +
an O +
in O +
silico O +
protein O -
- O -
protein O +
interaction O +
model O +
based O +
upon O +
known O +
mitotic O +
spindle O +
and O +
centrosomal O +
components O -
, O +
we O +
have O +
previously O +
predicted O +
a O +
number O +
of O +
additional O +
interactions O +
that O +
could O +
be O +
conserved O +
between O +
a O +
functional O +
TACC O +
homologue O +
in O +
yeast O -
, O +
spc-72 O -
, O +
and O +
one O +
or O +
more O +
human O +
TACC O +
proteins O +
[ O -
21 O -
] O -
. O +

Thus O -
, O +
it O +
is O +
known O +
that O +
all O +
the O +
TACC O +
proteins O +
examined O +
to O +
date O +
interact O -
, O +
via O +
the O +
TACC O +
domain O -
, O +
with O +
the O +
microtubule O -
/ O -
centrosomal O +
proteins O +
of O +
the O +
stu2 O -
/ O -
msps O -
/ O -
ch O -
- O -
TOG O +
family O +
[ O -
5,6,22 O -
- O -
24 O -
] O -
, O +
and O +
with O +
the O +
Aurora O +
kinases O +
[ O -
20,21,25 O -
] O -
. O +

These O +
interactions O +
are O +
required O +
for O +
the O +
accumulation O +
of O +
the O +
D O -
- O -
TACC O -
, O +
spc72 O -
, O +
ceTAC1 O +
and O +
TACC3 O +
proteins O +
to O +
the O +
centrosome O +
[ O -
5,6,22 O -
- O -
24 O -
] O -
. O +

Hence O -
, O +
this O +
functional O +
interaction O +
with O +
the O +
centrosome O +
and O +
mitotic O +
spindle O +
is O +
likely O +
to O +
represent O +
the O +
ancient O -
, O +
conserved O +
function O +
of O +
the O +
TACC O +
family O -
. O +

However O -
, O +
it O +
is O +
apparent O +
that O +
the O +
human O +
TACC O +
proteins O +
also O +
differ O +
in O +
their O +
ability O +
to O +
interact O +
with O +
the O +
Aurora O +
kinases O -
. O +

For O +
instance O -
, O +
TACC1 O +
and O +
TACC3 O +
interact O +
with O +
Aurora O +
A O +
kinase O -
, O +
whereas O +
TACC2 O +
interacts O +
with O +
Aurora O +
C O +
kinase O +
[ O -
21 O -
] O -
, O +
suggesting O +
a O +
degree O +
of O +
functional O +
specialization O +
in O +
the O +
derivatives O +
of O +
the O +
ancestral O +
chordate O +
TACC O -
, O +
after O +
the O +
radiation O +
of O +
the O +
vertebrate O +
TACC O +
genes O -
. O +

The O +
localization O +
of O +
the O +
vertebrate O +
TACC O +
proteins O +
in O +
the O +
interphase O +
nucleus O +
[ O -
15,26,27 O -
] O +
suggests O +
that O +
they O +
have O +
additional O +
functions O +
outside O +
their O +
ancient O +
role O +
in O +
the O +
centrosome O +
and O +
microtubule O +
dynamics O -
. O +

Thus O -
, O +
it O +
seems O +
likely O +
that O +
TACC O +
family O +
members O +
in O +
protostomes O +
and O +
deuterostomes O +
have O +
integrated O +
new O +
unique O +
functions O +
as O +
the O +
evolving O +
TACC O +
genes O +
acquired O +
additional O +
exons O -
. O +

The O +
results O +
of O +
the O +
pilot O +
large O -
- O -
scale O +
proteomic O +
analysis O +
in O +
C. O +
elegans O +
and O +
D. O +
melanogaster O +
provide O +
further O +
suggestive O +
evidence O +
to O +
this O +
functional O +
evolution O -
. O +

Yeast O +
two O +
hybrid O +
analysis O +
indicates O +
that O +
ceTAC O +
directly O +
binds O +
to O +
C. O +
elegans O +
lin15A O -
, O +
lin36 O +
and O +
lin37 O +
[ O -
28 O -
] O -
. O +

These O +
proteins O +
bridge O +
ceTAC O +
to O +
other O +
elements O +
of O +
the O +
cytoskeleton O +
and O +
microtubule O +
network O -
, O +
as O +
well O +
as O +
to O +
components O +
of O +
the O +
ribosome O -
, O +
the O +
histone B-Chemical +
deacetylase O +
chromatin O +
remodeling O +
machinery O +
such O +
as O +
egr-1 O +
and O +
lin-53 O +
( O -
the O +
C. O +
elegans O +
homologues O +
of O +
the O +
human O +
MTA-1 O +
and O +
RbAP48 O -
) O -
, O +
and O +
to O +
transcription O +
factors O +
such O +
as O +
the O +
PAL1 O +
homeobox O +
and O +
the O +
nuclear O +
hormone O +
receptor O +
nhr-86 O +
[ O -
28 O -
] O +
( O -
Fig. O +
6A O -
) O -
. O +

Similarly O -
, O +
large O +
scale O +
proteomics O +
[ O -
29 O -
] O +
has O +
shown O +
that O +
Drosophila O +
TACC O +
interacts O +
with O +
two O +
proteins O -
, O +
the O +
RNA O +
binding O +
protein O +
TBPH O +
and O +
CG14540 O +
( O -
Fig. O +
6B O -
) O -
, O +
and O +
thus O +
indirectly O +
with O +
the O +
Drosophila O +
SWI O -
/ O -
SNF O +
chromatin O +
remodeling O +
complex O +
and O +
DNA O +
damage O +
repair O +
machinery O -
. O +

Significantly O -
, O +
the O +
ceTAC O +
protein O +
has O +
also O +
recently O +
been O +
implicated O +
in O +
DNA O +
repair O +
through O +
its O +
direct O +
interaction O +
with O +
the O +
C. O +
elegans O +
BARD1 O +
orthologue O +
[ O -
30 O -
] O -
. O +

It O +
should O +
be O +
noted O +
that O +
a O +
number O +
of O +
interactions O +
with O +
the O +
TACC O +
proteins O +
from O +
these O +
organisms O +
have O +
probably O +
been O +
missed O +
by O +
these O +
large O +
scale O +
methods O -
, O +
including O +
the O +
well O +
documented O +
direct O +
interactions O +
with O +
the O +
aurora O +
kinases O +
and O +
the O +
stu2 O -
/ O -
msps O -
/ O -
ch O -
- O -
TOG O +
family O -
. O +

Figure O +
6 O +
Functional O +
evolution O +
of O +
the O +
TACC O +
proteins O +
modeled O +
in O +
C. O +
elegans O +
and O +
D. O +
melanogaster O -
. O +

( O -
A O -
) O -
. O +

C. O +
elegans O +
interaction O +
map O +
shows O +
empirically O +
defined O +
interactions O +
of O +
ceTAC O -
, O +
and O +
extrapolated O +
interactions O +
defined O +
by O +
[ O -
28 O -
] O -
. O +

( O -
B O -
) O -
: O +
Using O +
the O +
BIND O +
database O +
[ O -
29 O -
] O -
, O +
DTACC O +
directly O +
binds O +
to O +
TBPH O +
and O +
CG14540 O -
, O +
and O +
thus O +
indirectly O +
to O +
chromatin O +
remodeling O +
complexes O +
( O -
SWI O -
/ O -
SNF O +
and O +
histone B-Chemical +
acetyltransferases O -
) O -
, O +
DNA O +
damage O +
repair O +
machinery O +
( O -
via O +
RAD23 O -
) O -
, O +
and O +
RNA O +
splicing O -
, O +
transport O +
and O +
translational O +
machinery O -
. O +

( O -
C O -
) O -
: O +
Predicted O +
interaction O +
map O +
for O +
vertebrate O +
TACCs O -
, O +
based O +
upon O +
ceTAC O -
, O +
suggests O +
an O +
indirect O +
interaction O +
with O +
the O +
nuclear O +
hormone O +
receptor O +
RXRβ O -
. O +

It O +
is O +
also O +
of O +
interest O +
that O +
this O +
predicts O +
a O +
functional O +
interaction O +
with O +
the O +
LDB O +
family O -
, O +
members O +
of O +
which O +
are O +
also O +
found O +
in O +
TACC O +
containing O +
paralogous O +
segments O +
noted O +
in O +
Figs O +
2 O -
, O +
3 O +
and O +
Additional O +
file O +
1 O -
. O +

( O -
D O -
) O -
: O +
Predicted O +
TACC O +
interaction O +
map O +
based O +
upon O +
DTACC O -
. O +

( O -
E O -
) O -
: O +
Vertebrate O +
TACC O +
interactions O +
identified O +
to O +
date O -
. O +
? O +
denotes O +
uncertainty O +
over O +
the O +
identity O +
of O +
a O +
functional O +
vertebrate O +
homologue O -
. O +

In O +
C O -
, O +
D O +
and O +
E O -
, O +
' O -
* O -
' O +
denotes O +
one O +
or O +
more O +
members O +
of O +
the O +
TACC O +
or O +
Aurora O +
kinase O +
family O -
. O +

Because O +
of O +
the O +
evolutionary O +
conservation O +
of O +
the O +
TACC O +
domain O -
, O +
we O +
would O +
predict O +
that O +
some O +
of O +
the O +
functional O +
interactions O +
seen O +
in O +
C. O +
elegans O +
and O +
D. O +
melanogaster O +
would O +
be O +
observed O +
in O +
higher O +
animals O -
. O +

Phylogenetic O +
profiling O +
from O +
these O +
interaction O +
maps O +
suggests O +
two O +
similar O +
sets O +
of O +
predicted O +
interactions O +
for O +
vertebrate O +
TACCs O +
( O -
Fig. O +
6C O +
and O +
6D O -
) O -
. O +

Strikingly O -
, O +
however O -
, O +
the O +
C. O +
elegans O +
specific O +
proteins O +
lin15A O -
, O +
lin36 O +
and O +
lin37 O +
do O +
not O +
have O +
readily O +
discernible O +
homologues O +
in O +
vertebrates O +
or O +
Drosophila O -
, O +
although O +
the O +
presence O +
of O +
a O +
zinc O +
finger O +
domain O +
in O +
lin36 O +
may O +
suggest O +
that O +
this O +
protein O +
is O +
involved O +
directly O +
in O +
transcription O +
or O +
perform O +
an O +
adaptor O +
role O +
similar O +
to O +
LIM O +
containing O +
proteins O -
. O +

For O +
the O +
DTACC O +
interacting O +
proteins O -
, O +
TBPH O +
corresponds O +
to O +
TDP43 O -
, O +
a O +
protein O +
implicated O +
in O +
transcriptional O +
regulation O +
and O +
splicing O +
[ O -
31,32 O -
] O -
. O +

However O -
, O +
the O +
assignment O +
of O +
the O +
human O +
homologue O +
of O +
CG14540 O +
is O +
less O +
clear O -
, O +
with O +
the O +
closest O +
matches O +
in O +
the O +
human O +
databases O +
corresponding O +
to O +
glutamine O +
rich O +
transcription O +
factors O +
such O +
as O +
CREB O +
and O +
the O +
G O -
- O -
box O +
binding O +
factor O -
. O +

Comparison O +
of O +
modeled O +
with O +
experimentally O +
defined O +
interactions O +
of O +
the O +
vertebrate O +
TACC O +
proteins O +
The O +
interaction O +
data O +
for O +
the O +
vertebrate O +
TACCs O +
is O +
relatively O +
limited O -
; O +
however O -
, O +
interaction O +
networks O +
are O +
now O +
beginning O +
to O +
emerge O -
. O +

The O +
results O +
of O +
our O +
functional O +
analysis O -
, O +
as O +
well O +
as O +
other O +
published O +
data O +
clearly O +
indicate O +
that O +
the O +
vertebrate O +
TACCs O +
interact O +
with O +
proteins O +
that O +
can O +
be O +
divided O +
into O +
two O +
broad O +
categories O -
: O +
1 O -
) O +
proteins O +
with O +
roles O +
in O +
centrosome O -
/ O -
mitotic O +
spindle O +
dynamics O -
, O +
and O +
2 O -
) O +
proteins O +
involved O +
in O +
gene O +
regulation O -
, O +
either O +
at O +
the O +
level O +
of O +
transcription O -
, O +
or O +
subsequent O +
RNA O +
processing O +
and O +
translation O +
[ O -
3,5 O -
- O -
7,15,19 O -
- O -
21,24,25,33,34 O -
] O -
. O +

Many O +
of O +
these O +
proteins O +
do O +
not O +
appear O +
to O +
interact O +
directly O +
with O +
the O +
protostome O +
TACCs O -
, O +
but O +
would O +
be O +
expected O +
to O +
be O +
in O +
the O +
same O +
protein O +
complex O +
( O -
Fig. O +
6C,6D O -
) O -
. O +

Significant O +
analysis O +
of O +
the O +
association O +
of O +
the O +
TACCs O +
with O +
the O +
centrosome O +
and O +
the O +
dynamics O +
of O +
mitotic O +
spindle O +
assembly O +
from O +
yeast O +
to O +
humans O +
has O +
been O +
published O +
[ O -
5,6,21 O -
- O -
24 O -
] O -
. O +

From O +
this O +
analysis O -
, O +
it O +
seems O +
likely O +
that O +
the O +
vertebrate O +
TACC3 O +
protein O +
has O +
retained O +
this O +
direct O +
ancestral O +
function O -
, O +
based O +
upon O +
its O +
location O +
in O +
these O +
structures O +
during O +
mitosis O +
[ O -
27 O -
] O -
, O +
its O +
strong O +
interaction O +
with O +
Aurora O +
Kinase O +
A O -
, O +
and O +
the O +
observation O +
that O +
it O +
is O +
the O +
only O +
human O +
TACC O +
protein O +
phosphorylated O +
by O +
this O +
enzyme O +
[ O -
21 O -
] O -
. O +

However O -
, O +
the O +
variability O +
of O +
the O +
central O +
domain O +
of O +
the O +
vertebrate O +
orthologues O -
, O +
suggests O +
that O +
TACC3 O +
may O +
also O +
have O +
acquired O +
additional O -
, O +
and O +
in O +
some O +
instances O -
, O +
species O -
- O -
specific O +
functions O -
. O +

For O +
instance O -
, O +
in O +
X. O +
laevis O -
, O +
the O +
maskin O +
protein O +
has O +
acquired O +
a O +
binding O +
site O +
for O +
the O +
eIF4E O +
protein O -
, O +
and O +
thus O +
a O +
function O +
in O +
the O +
coordinated O +
control O +
of O +
polyadenylation O +
and O +
translation O +
in O +
the O +
Xenopus O +
oocyte O +
[ O -
8,35 O -
] O -
. O +

A O +
recent O +
study O +
has O +
suggested O +
that O +
this O +
function O +
may O +
be O +
unique O +
to O +
maskin O -
: O +
although O +
it O +
is O +
unclear O +
whether O +
the O +
other O +
vertebrate O +
TACC3 O +
proteins O +
interact O +
with O +
the O +
eIF4E O -
/ O -
CPEB O +
complex O -
, O +
the O +
human O +
TACC1A O +
isoform O +
is O +
unable O +
to O +
interact O +
with O +
the O +
eIF4E O -
/ O -
CPEB O +
complex O -
. O +

Instead O -
, O +
some O +
TACC1 O +
isoforms O +
have O +
evolved O +
a O +
related O -
, O +
but O +
distinct O +
function O +
by O +
directly O +
interacting O +
with O +
elements O +
of O +
the O +
RNA O +
splicing O +
and O +
transport O +
machinery O +
[ O -
19 O -
] O -
. O +

To O +
further O +
characterize O +
the O +
evolving O +
functions O +
of O +
the O +
TACC O +
proteins O -
, O +
we O +
have O +
used O +
an O +
unbiased O +
yeast O +
two O +
hybrid O +
screening O +
method O +
to O +
identify O +
proteins O +
that O +
bind O +
to O +
the O +
human O +
TACC O +
proteins O +
[ O -
3,34 O -
] O -
. O +

In O +
a O +
screen O +
of O +
a O +
MATCHMAKER O +
fetal O +
brain O +
library O +
( O -
BD O +
Biosciences O +
Clontech O -
) O -
, O +
in O +
addition O +
to O +
isolating O +
the O +
histone B-Chemical +
acetyltransferase O +
hGCN5L2 O +
[ O -
34 O -
] O -
, O +
we O +
also O +
identified O +
the O +
β3 O +
isoform O +
of O +
retinoid B-Chemical -
- O -
X O +
receptor O +
β O +
as O +
a O +
protein O +
that O +
interacts O +
with O +
the O +
TACC O +
domain O +
of O +
TACC2 O -
. O +

As O +
shown O +
in O +
Fig. O +
7 O -
, O +
this O +
interaction O +
is O +
confirmed O +
in O +
vitro O +
by O +
GST O -
- O -
pull O +
down O +
analysis O -
. O +

Significantly O -
, O +
RXRβ O +
is O +
a O +
close O +
family O +
relative O +
of O +
the O +
nuclear O +
hormone O +
receptor O -
, O +
nhr-86 O -
, O +
from O +
C. O +
elegans O -
, O +
which O +
interacts O +
with O +
the O +
ceTAC O +
binding O +
protein O +
lin36 O +
( O -
Fig. O +
6A O -
) O -
. O +

This O +
suggests O +
that O +
while O +
protostome O +
TACCs O +
may O +
require O +
additional O +
protein O +
factors O +
to O +
interact O +
with O +
such O +
components O -
, O +
the O +
TACCs O +
in O +
higher O +
organisms O +
may O +
have O +
evolved O +
the O +
ability O +
to O +
directly O +
interact O +
with O +
some O +
of O +
the O +
proteins O +
in O +
the O +
predicted O +
interaction O +
map O +
( O -
Fig. O +
6E O -
) O -
. O +

Indeed O -
, O +
this O +
appears O +
to O +
be O +
directly O +
linked O +
to O +
the O +
acquisition O +
of O +
new O +
domains O +
and O +
duplication O +
of O +
the O +
chordate O +
TACC O +
precursor O -
. O +

In O +
fact O -
, O +
the O +
first O +
identified O +
function O +
of O +
a O +
vertebrate O +
TACC O +
protein O +
was O +
as O +
a O +
transcriptional O +
coactivator O +
acting O +
through O +
a O +
direct O +
interaction O +
with O +
the O +
ARNT O +
transcription O +
factor O +
[ O -
7 O -
] O -
. O +

It O +
is O +
also O +
intriguing O +
that O +
the O +
deuterostome O +
specific O +
SDP O +
repeat O +
interacts O +
with O +
GAS41 O -
, O +
a O +
component O -
/ O -
accessory O +
factor O +
of O +
the O +
human O +
SWI O -
/ O -
SNF O +
chromatin O +
remodeling O +
complex O +
[ O -
3,15 O -
] O -
. O +

Although O +
there O +
is O +
a O +
D. O +
melanogaster O +
homologue O +
of O +
GAS41 O -
, O +
dmGAS41 O -
, O +
the O +
large O +
scale O +
proteomic O +
interaction O +
database O +
does O +
not O +
indicate O +
a O +
direct O +
interaction O +
of O +
dmGAS41 O +
with O +
DTACC O -
. O +

This O +
may O +
be O +
due O +
to O +
the O +
lack O +
of O +
the O +
SDP O +
repeat O +
region O +
in O +
the O +
Drosophila O +
TACC O +
protein O -
. O +

This O +
further O +
suggests O +
that O +
the O +
vertebrate O +
TACCs O +
have O +
gained O +
the O +
specific O +
ability O +
to O +
direct O +
interact O +
with O +
transcriptional O +
regulatory O +
complexes O -
, O +
and O +
that O +
bridging O +
protein O -
( O -
s O -
) O +
are O +
no O +
longer O +
required O -
. O +

Thus O -
, O +
where O +
the O +
ceTAC O +
protein O +
is O +
only O +
composed O +
of O +
the O +
TACC O +
domain O -
, O +
the O +
significantly O +
larger O +
TACC O +
family O +
members O +
in O +
higher O +
protostomes O +
and O +
deuterostomes O +
may O +
have O +
integrated O +
one O +
or O +
more O +
functions O +
of O +
the O +
bridging O +
protein O +
( O -
in O +
this O +
case O +
lin15A O -
, O +
lin36 O +
or O +
lin37 O -
) O -
. O +

This O +
may O +
also O +
explain O +
the O +
absence O +
of O +
lin15A O -
, O +
lin36 O +
and O +
lin37 O +
homologues O +
in O +
higher O +
organisms O -
, O +
as O +
they O +
were O +
no O +
longer O +
under O +
selective O +
evolutionary O +
pressure O +
to O +
remain O +
within O +
the O +
complex O -
, O +
and O +
thus O +
lost O +
in O +
the O +
evolving O +
genome O -
. O +

Figure O +
7 O +
In O +
vitro O +
interaction O +
of O +
RXRβ3 O +
and O +
TACC2s O -
. O +

Top O +
panel O -
: O +
Autoradiograph O +
of O +
12 O -
% O +
SDS B-Chemical +
polyacrylamide O +
gel O +
with O +
in O +
vitro O +
translated O +
RXRβ3 O +
construct O +
pulled O +
down O +
with O +
GST O -
- O -
TACC2 O +
( O -
Lane O +
1 O -
) O +
or O +
GST O +
( O -
Lane O +
2 O -
) O -
; O +
Lane O +
3 O -
: O +
5 O -
% O +
input O +
of O +
in O +
vitro O +
translated O +
RXR O -
- O -
β O +
protein O -
. O +

Bottom O +
two O +
panels O +
represent O +
Coomassie O +
blue O +
stained O +
gels O +
of O +
pull O +
down O +
experiment O +
showing O +
loading O +
of O +
GST O -
- O -
TACC2 O +
and O +
GST O -
. O +

Conclusion O +
Proposed O +
functional O +
evolution O +
of O +
the O +
TACC O +
family O +
Examination O +
of O +
the O +
evolution O +
of O +
ancient O +
gene O +
families O +
provides O +
an O +
insight O +
into O +
how O +
gene O +
structure O +
relates O +
to O +
function O -
. O +

We O +
have O +
presented O +
above O -
, O +
a O +
detailed O +
examination O +
of O +
one O +
such O +
gene O +
family O -
. O +

The O +
data O +
so O +
far O +
suggest O +
that O +
the O +
functional O +
TACC O +
homologue O +
in O +
yeast O +
( O -
spc72 O -
) O +
has O +
a O +
specific O +
role O +
in O +
centrosomal O -
/ O -
mitotic O +
spindle O +
dynamics O +
[ O -
21,22 O -
] O -
. O +

This O +
ancient O +
TACC O +
function O +
is O +
conserved O +
throughout O +
evolution O +
in O +
both O +
protostomes O +
and O +
deuterostomes O -
. O +

In O +
addition O -
, O +
the O +
TACC O +
proteins O +
of O +
lower O +
organisms O +
appear O +
to O +
interact O +
with O +
bridging O +
proteins O +
that O +
are O +
components O +
of O +
several O +
different O +
protein O +
complexes O +
involved O +
in O +
DNA O +
damage O +
repair O -
, O +
protein O +
translation O -
, O +
RNA O +
processing O +
and O +
transcription O -
. O +

However O -
, O +
over O +
the O +
process O +
of O +
evolutionary O +
time O -
, O +
with O +
the O +
acquisition O +
of O +
new O +
domains O +
and O +
duplication O +
of O +
the O +
chordate O +
TACC O +
precursor O -
, O +
the O +
chordate O +
TACC O +
proteins O +
have O +
acquired O +
the O +
ability O +
to O +
directly O +
interact O +
with O +
some O +
of O +
the O +
other O +
components O +
of O +
these O +
complexes O +
( O -
such O +
as O +
the O +
LSm O +
proteins O -
, O +
nuclear O +
hormone O +
receptors O -
, O +
GAS41 O -
, O +
accessory O +
proteins O +
and O +
transcription O +
factors O -
) O -
, O +
and O +
thus O +
evolved O +
additional O +
functions O +
within O +
these O +
complexes O -
. O +

Indeed O -
, O +
the O +
first O +
assigned O +
function O +
of O +
a O +
vertebrate O +
TACC O +
protein O -
, O +
mouse O +
TACC3 O -
, O +
was O +
as O +
a O +
transcriptional O +
coactivator O +
of O +
the O +
ARNT O +
mediated O +
transcriptional O +
response O +
to O +
hypoxia O +
and O +
polyaromatic B-Chemical +
hydrocarbons I-Chemical +
[ O -
7 O -
] O -
. O +

Mouse O +
TACC3 O +
has O +
also O +
been O +
reported O +
to O +
interact O +
with O +
the O +
transcription O +
factor O +
STAT5 O +
[ O -
33 O -
] O -
. O +

Recently O -
, O +
we O +
have O +
demonstrated O +
that O +
TACC2 O +
and O +
TACC3 O +
can O +
bind O +
to O +
nuclear O +
histone B-Chemical +
acetyltransferases O +
[ O -
34 O -
] O -
, O +
further O +
confirming O +
a O +
more O +
direct O +
role O +
for O +
the O +
TACC O +
proteins O +
in O +
transcriptional O +
and O +
chromatin O +
remodeling O +
events O -
. O +

Interestingly O +
although O +
all O +
human O +
TACC O +
proteins O +
can O +
directly O +
interact O +
with O +
the O +
histone B-Chemical +
acetyltransferase O +
pCAF O +
in O +
vitro O -
, O +
the O +
TACC1 O +
isoforms O +
expressed O +
in O +
human O +
breast O +
cancer O +
cells O +
do O +
not O +
interact O +
with O +
this O +
histone B-Chemical +
acetylase O +
[ O -
34 O -
] O -
. O +

This O +
may O +
be O +
attributable O +
to O +
the O +
proposed O +
function O +
of O +
the O +
Exon O +
1 O +
containing O +
TACC1 O +
variants O +
in O +
RNA O +
processing O -
, O +
via O +
the O +
interaction O +
with O +
LSm-7 O +
and O +
SmG O +
[ O -
19 O -
] O -
. O +

Thus O -
, O +
alternative O +
splicing O +
of O +
the O +
TACC1 O +
gene O +
adds O +
further O +
diversity O +
to O +
TACC1 O +
function O -
, O +
as O +
the O +
deletion O +
of O +
specific O +
exons O +
and O +
their O +
associated O +
binding O +
domains O +
will O +
change O +
the O +
potential O +
protein O +
complexes O +
with O +
which O +
they O +
can O +
associate O -
, O +
either O +
directly O -
, O +
or O +
by O +
redirecting O +
the O +
splice O +
variants O +
to O +
different O +
subcellular O +
compartments O -
. O +

With O +
the O +
duplication O +
of O +
the O +
TACC1 O -
/ O -
TACC2 O +
ancestor O -
, O +
it O +
is O +
apparent O +
that O +
an O +
even O +
greater O +
functional O +
diversity O +
may O +
have O +
been O +
introduced O +
into O +
the O +
TACC O +
family O -
. O +

The O +
TACC2 O +
protein O +
retains O +
the O +
ability O +
of O +
TACC3 O +
to O +
interact O +
with O +
GAS41 O -
, O +
INI1 O -
, O +
histone B-Chemical +
acetyltransferases O +
and O +
transcription O +
factors O +
( O -
in O +
this O +
case O -
, O +
RXRβ O -
) O +
( O -
Fig. O +
7 O -
) O +
[ O -
3,34 O -
] O -
. O +

However O -
, O +
the O +
tissue O +
specific O +
splicing O +
of O +
the O +
5 O +
kb O +
exon O +
in O +
the O +
TACC2l O +
isoform O +
[ O -
3 O -
] O +
indicates O +
that O +
this O +
protein O +
has O +
several O +
temporal O +
and O +
tissue O +
specific O +
functions O +
yet O +
to O +
be O +
identified O -
. O +

Methods O +
Compilation O +
and O +
assembly O +
of O +
previously O +
uncharacterized O +
TACC O +
cDNAs O +
and O +
genes O +
Corresponding O +
orthologous O +
sequences O +
for O +
TACC O -
, O +
RHAMM O -
, O +
KLP O -
, O +
KIF O -
, O +
TPM O +
and O +
keratins O +
families O +
were O +
identified O +
initially O +
using O +
the O +
TBLASTN O +
program O +
[ O -
36 O -
] O +
to O +
search O +
the O +
published O +
genomic O +
and O +
cDNA O +
databases O -
. O +

For O +
Takifugu O +
rubripes O -
, O +
gene O +
predictions O +
were O +
produced O +
by O +
the O +
Ensembl O +
automated O +
pipeline O +
[ O -
37 O -
] O +
and O +
the O +
JGI O +
blast O +
server O +
. O +

DNA O +
sequences O +
covering O +
the O +
homology O +
regions O +
were O +
extracted O +
and O +
analyzed O +
by O +
Genscan O +
to O +
obtain O +
potential O +
exons O -
. O +

In O +
some O +
cases O -
, O +
exons O +
were O +
added O +
or O +
modified O +
based O +
on O +
the O +
best O +
similarity O +
of O +
translated O +
peptides O +
to O +
the O +
corresponding O +
mouse O +
and O +
human O +
proteins O -
. O +

For O +
regions O +
with O +
low O +
sequence O +
similarity O -
, O +
genomic O +
sequences O +
from O +
the O +
fresh O +
water B-Chemical +
pufferfish O -
, O +
Tetraodon O +
nigroviridis O +
were O +
used O +
as O +
additional O +
means O +
to O +
verify O +
the O +
predicted O +
exons O -
. O +

Due O +
to O +
the O +
variability O +
of O +
the O +
central O +
region O +
of O +
vertebrate O +
TACC3 O +
cDNAs O +
( O -
see O +
text O -
) O -
, O +
to O +
further O +
confirm O +
prediction O +
of O +
the O +
Takifugu O +
rubripes O +
TACC3 O -
, O +
full O +
length O +
cDNAs O +
corresponding O +
to O +
the O +
Danio O +
rerio O +
TACC3 O +
( O -
IMAGE O +
clones O +
2639991 O -
, O +
2640369 O +
and O +
3724452 O -
) O +
were O +
also O +
obtained O +
from O +
A.T.C.C. O +
and O +
fully O +
sequenced O -
. O +

Potential O +
paralogous O +
chromosomal O +
segments O +
and O +
scaffold O +
were O +
identified O +
by O +
searching O +
the O +
public O +
databases O +
deposited O +
at O +
NCBI O +
and O +
at O +
the O +
Human O +
Genome O +
Mapping O +
Project O -
, O +
Cambridge O +
UK O -
. O +

Cloning O +
of O +
vertebrate O +
TACC O +
cDNAs O +
The O +
rabbit O +
TACC3 O +
was O +
cloned O +
by O +
rt O -
- O -
PCR O +
using O +
the O +
" O -
TACC4 O -
" O +
specific O +
primer O +
T4RACE2 O +
[ O -
9 O -
] O +
( O -
5'-cccgaactgctccaggtaatcgatctc-3 O -
' O -
) O +
and O +
a O +
consensus O +
primer O -
, O +
T3con2 O -
, O +
designed O +
to O +
the O +
region O +
encompassing O +
the O +
vertebrate O +
TACC3 O +
initiator O +
methionine O +
( O -
5'-tatgagtctgcaggtcttaaacgac-3 O -
' O -
) O -
. O +

For O +
cloning O +
the O +
mouse O +
Tacc1X O +
cDNA O -
, O +
the O +
primers O +
used O +
were O +
based O +
upon O +
the O +
genomic O +
sequence O +
reported O -
, O +
and O +
the O +
sequence O +
of O +
the O +
IMAGE O +
cDNA O +
clone O +
4933429K08 O -
: O +
T1XF O +
( O -
5'-ccatgttcagtcattggcaggtc-3 O -
' O -
) O -
, O +
T1XF2 O +
( O -
5'-ctgcagaaccaacagttcaag-3 O -
' O -
) O -
, O +
T1XR1 O +
( O -
5'-agatctgtgacatcacagctc-3 O -
' O -
) O -
, O +
T1XR2 O +
( O -
5'-ctcgagtcagttagtcttatccagctt-3 O -
' O -
) O -
, O +
BB617F O +
( O -
5'-accaccaacttgagtacctg-3 O -
' O -
) O +
and O +
BB617R O +
( O -
5'-gtatcttgaactgttggttctg-3 O -
' O -
) O -
. O +

For O +
analysis O +
of O +
TACC1 O +
splice O +
variants O -
, O +
the O +
forward O +
primers O +
used O +
were O +
located O +
in O +
exon O +
1b O -
: O +
EF O +
( O -
5'-gagagatgcgaaatcagcg-3 O -
' O -
) O -
, O +
Exon O +
1d O -
: O +
X3F O +
( O -
5'-agtcaaagaaggcatctgcag-3 O -
' O -
) O -
, O +
Exon O +
1a O -
: O +
1DF O +
( O -
5'-ccaagttctgcgccatggg-3 O -
' O -
) O -
. O +

The O +
reverse O +
primers O +
used O +
were O -
: O +
Exon O +
1 O -
: O +
X1R O +
( O -
5'-ggatttggtctcggcttgcgaatc-3 O -
' O -
) O -
, O +
Exon O +
2 O -
: O +
BX647R O +
( O -
5'-cttgtgattcttggcttttgg-3 O -
' O -
) O -
, O +
Exon O +
3 O -
: O +
6SPR O +
( O -
5'-gtcatcgcctcgtcctggagggc-3 O -
' O -
) O -
, O +
Exon O +
4a O -
: O +
1DR O +
( O -
5'-aatttcacttgttcagtagtc-3 O -
' O -
) O -
, O +
Exon O +
5 O -
: O +
128R O +
( O -
5'-cctgcttctgaggatgaaaacgc-3 O -
' O -
) O -
. O +

Rabbit O +
brain O +
poly O +
A+ O +
mRNA O -
, O +
mouse O +
testis O +
and O +
human O +
brain O +
total O +
RNA O +
were O +
obtained O +
from O +
BD O +
Bioscience O +
Clontech O +
( O -
Palo O +
Alto O -
, O +
CA O -
, O +
U.S.A. O -
) O -
. O +

Reverse O +
transcription O +
and O +
PCR O +
was O +
performed O +
as O +
previously O +
described O -
, O +
using O +
either O +
1 O +
μg O +
of O +
total O +
RNA O +
or O +
50 O +
ng O +
of O +
poly O +
A+ O +
mRNA O +
as O +
template O +
for O +
first O +
strand O +
cDNA O +
synthesis O -
. O +

PCR O +
products O +
were O +
cloned O +
into O +
pCR2.1 O +
( O -
Invitrogen O -
, O +
Carlsbad O +
CA O -
, O +
U.S.A. O -
) O +
and O +
transformed O +
into O +
InvαF O -
' O +
competent O +
cells O -
. O +

Plasmid O +
inserts O +
were O +
sequenced O +
by O +
the O +
Roswell O +
Park O +
Cancer O +
Institute O +
Biopolymer B-Chemical +
Core O +
Facility O -
. O +

Deposition O +
of O +
nucleotide O +
sequences O +
Sequences O +
from O +
this O +
article O +
have O +
been O +
deposited O +
in O +
the O +
GenBank O +
database O +
with O +
the O +
following O +
accession O +
numbers O -
: O +
Homo O +
sapiens O +
TACC1 O +
short O +
isoform O +
S O +
( O -
AY177411 O -
) O -
, O +
Mus O +
musculus O +
TACC1 O +
short O +
isoform O +
S O +
( O -
AY177412 O -
) O -
, O +
Mus O +
musculus O +
TACC1 O +
long O +
isoform O +
A O +
( O -
AY177413 O -
) O -
, O +
Mus O +
musculus O +
TACC2s O +
( O -
AY177410 O -
) O -
, O +
Oryctolagus O +
cuniculus O +
TACC3 O +
( O -
AY161270 O -
) O -
, O +
Danio O +
rerio O +
TACC3 O +
( O -
AY170618 O -
) O -
. O +

Annotations O +
submitted O +
to O +
the O +
Third O +
party O +
annotation O +
database O +
at O +
NCBI O +
are O +
as O +
follows O -
: O +
Rattus O +
norvegus O +
TACC1 O +
long O +
isoform O +
A O +
( O -
BK001653 O -
) O -
, O +
Takifugu O +
rubripes O +
TACC1A O +
( O -
BK000666 O -
/ O -
BK000667 O -
) O -
, O +
Takifugu O +
rubripes O +
TACC1B O +
( O -
BK000664 O -
) O -
, O +
Mus O +
musculus O +
TACC2l O +
( O -
BK001495 O -
) O -
, O +
Rattus O +
norvegus O +
TACC2l O +
( O -
BK001658 O -
) O -
, O +
Rattus O +
norvegus O +
TACC2s O +
( O -
BK001657 O -
) O -
, O +
Takifugu O +
rubripes O +
TACC2l O +
( O -
BK000690 O -
) O -
, O +
Rattus O +
norvegus O +
TACC3 O +
( O -
BK001491 O -
) O -
, O +
Gallus O +
gallus O +
TACC3 O +
( O -
BK001482 O -
) O -
, O +
Silurana O +
tropicalis O +
TACC3 O +
( O -
BK001481 O -
) O -
,Takifugu O +
rubripes O +
TACC3 O +
( O -
BK000649 O -
) O -
, O +
Takifugu O +
rubripes O +
RHAMM O +
( O -
BK000676 O -
) O -
, O +
Ciona O +
intestinalis O +
RHAMM O +
( O -
BK001479 O -
) O -
, O +
Takifugu O +
rubripes O +
Keratin O +
( O -
BK000677 O -
) O -
, O +
Takifugu O +
rubripes O +
TPM1 O +
( O -
BAC10576 O -
) O -
, O +
Ciona O +
intestinalis O +
Kif3b O +
( O -
BK001492 O -
) O -
, O +
Ciona O +
intestinalis O +
klp2 O +
( O -
BK001493 O -
) O -
. O +

Phylogenetic O +
analysis O +
In O +
order O +
to O +
examine O +
evolutionary O +
relationships O +
of O +
proteins O +
containing O +
coiled O +
coil O +
domains O -
, O +
protein O +
sequences O +
representing O +
the O +
major O +
members O +
of O +
this O +
super O +
family O -
, O +
including O +
TACC O -
, O +
RHAMM O -
, O +
KLP O -
, O +
keratin O +
and O +
tropomyosin O +
from O +
available O +
vertebrates O +
and O +
their O +
recognizable O +
orthologues O +
from O +
the O +
urochordate O +
Ciona O +
intestinalis O -
, O +
Drosophila O +
melanogaster O -
, O +
C. O +
elegans O +
and O +
Saccharomyces O +
cerevisiae O +
were O +
either O +
directly O +
retrieved O +
from O +
NCBI O +
sequence O +
databases O -
, O +
newly O +
predicted O +
or O +
isolated O +
( O -
see O +
above O -
) O -
. O +

Species O +
abbreviations O +
are O +
as O +
follows O -
: O +
hs O +
( O -
Homo O +
sapiens O -
) O -
, O +
mm O +
( O -
Mus O +
musculus O -
) O -
, O +
rn O +
( O -
Rattus O +
norvegus O -
) O -
, O +
oc O +
( O -
Oryctolagus O +
cuniculus O -
) O -
, O +
gg O +
( O -
Gallus O +
gallus O -
) O -
, O +
xl O +
( O -
Xenopus O +
laevis O -
) O -
, O +
st O +
( O -
Silurana O +
tropicalis O -
) O -
, O +
tr O +
( O -
Takifugu O +
rubripes O -
) O -
, O +
dr O +
( O -
Danio O +
rerio O -
) O -
, O +
ci O +
( O -
Ciona O +
intestinalis O -
) O -
, O +
dm O +
( O -
D. O +
melanogaster O -
) O -
, O +
ce O +
( O -
C. O +
elegans O -
) O -
, O +
sc O +
( O -
Saccharomyces O +
cerevisiae O -
) O -
. O +

The O +
sequences O +
identified O +
above O +
and O +
the O +
following O +
protein O +
or O +
predicted O +
translations O +
were O +
used O +
for O +
phylogenetic O +
analysis O -
: O +
hsTACC1A O +
( O -
NP_006274 O -
) O -
, O +
hsTACC2l O +
( O -
AAO62630 O -
) O +
hsTACC2s O +
( O -
AAO62629 O -
) O -
, O +
hsTACC3 O +
( O -
NP_006333 O -
) O -
, O +
mmTACC3 O +
( O -
Q9JJ11 O -
) O -
, O +
xlMaskin O +
( O -
Q9PTG8 O -
) O -
, O +
dmTACC O +
( O -
AAF52099 O -
) O -
, O +
ceTAC1 O +
( O -
NP_497059 O -
) O -
, O +
scSPC72 O +
( O -
NP_009352 O -
) O -
, O +
hsRHAMM O +
( O -
NP_036616 O -
) O -
, O +
mmRHAMM O +
( O -
NP_038580 O -
) O -
, O +
rnRHAMM O +
( O -
NP_037096 O -
) O -
, O +
drRHAMM O +
( O -
AAQ97980 O -
) O -
, O +
hsKeratin O +
( O -
CAB76828 O -
) O -
, O +
mmKeratin O +
( O -
A61368 O -
) O -
, O +
rnKeratin O +
( O -
XP_235679 O -
) O -
, O +
hsTPM1 O +
( O -
NP_000357 O -
) O -
, O +
mmTPM1 O +
( O -
NP_077745 O -
) O -
, O +
rnTPM1 O +
( O -
NP_62004 O -
, O +
drTPM1 O +
( O -
NP_571180 O -
) O +
dmTPM1 O +
( O -
P06754 O -
) O -
, O +
ceTPM O +
( O -
NP_493540 O -
) O +
scTPM1 O +
( O -
P17536 O -
) O -
, O +
hsKLP2 O +
( O -
BAB03309 O -
) O -
, O +
rnKIF15 O +
( O -
AAP44513 O -
) O -
, O +
xlKLP2 O +
( O -
CAA08879 O -
) O -
, O +
dmKLP2 O +
( O -
NP_476818 O -
) O -
, O +
ceKLP18 O +
( O -
AA034669 O -
) O -
, O +
hsKIF3A O +
( O -
Q9Y496 O -
) O -
, O +
mmKIF3A O +
( O -
NP_032469 O -
) O -
, O +
rnKIF3A O +
( O -
XP_340797 O -
) O -
, O +
xlKIF3A O +
( O -
CAA08879 O -
) O -
, O +
ceKLP11 O +
( O -
NP_741473 O -
) O -
, O +
ciKIF3 O +
( O -
ci0100148992 O -
) O -
, O +
hsKIF3B O +
( O -
NP_004789 O -
) O -
, O +
mmKIF3B O +
( O -
NP_004789 O -
) O -
, O +
rnKIF3B O +
( O -
XP_215883 O -
) O -
, O +
dmKIF3B O +
( O -
NP_524029 O -
) O -
, O +
hsKIF3C O +
( O -
NP_002245 O -
) O -
, O +
mmKIF3C O +
( O -
NP_032471 O -
) O -
, O +
rnKIF3C O +
( O -
NP_445938 O -
) O -
, O +
dmKIF3C O +
( O -
NP_651939 O -
) O -
. O +

These O +
protein O +
sequences O +
were O +
initially O +
aligned O +
with O +
CLUSTAL O +
X O +
[ O -
38 O -
] O -
. O +

Minor O +
adjustments O +
to O +
certain O +
regions O +
of O +
the O +
alignment O +
for O +
optimization O +
purposes O +
were O +
made O +
based O +
on O +
pairwise O +
alignments O -
, O +
the O +
output O +
saved O +
in O +
PHYLIP O +
format O -
, O +
after O +
which O -
, O +
the O +
distances O +
between O +
proteins O +
were O +
calculated O +
using O +
Poisson O +
correction O +
and O +
the O +
Unrooted O +
trees O +
were O +
inferred O +
with O +
the O +
NJ O +
method O +
and O +
then O +
displayed O +
using O +
TreeView O +
[ O -
39 O -
] O -
. O +

Bootstrap O +
values O +
above O +
700 O +
for O +
1000 O +
trials O +
are O +
shown O +
at O +
the O +
node O -
. O +

To O +
validate O +
the O +
tree O -
, O +
the O +
same O +
sequence O +
set O +
was O +
analyzed O +
with O +
tools O +
in O +
the O +
PHYLIP O +
package O +
[ O -
40 O -
] O -
, O +
using O +
PRODIST O +
followed O +
by O +
FITCH O +
or O +
NEIGNBOR O +
and O +
tree O +
displaying O +
using O +
TreeView O -
. O +

This O +
additional O +
method O +
produced O +
trees O +
with O +
essentially O +
the O +
same O +
topology O +
( O -
data O +
not O +
shown O -
) O -
. O +

In O +
vitro O +
interaction O +
of O +
TACC2 O +
and O +
RXRβ3 O +
The O +
TACC2 O +
cDNA O +
was O +
cloned O +
into O +
GST O +
fusion O +
vector O +
pGEX5X2 O +
( O -
Amersham O +
Biosciences O -
, O +
Piscataway O -
, O +
NJ O -
, O +
USA O -
) O -
. O +

GST O +
and O +
GST O -
- O -
TACC2 O +
proteins O +
were O +
expressed O +
in O +
E. O +
coli O +
BL21 O -
( O -
DE3 O -
) O +
plys O +
" O -
S O -
" O +
with O +
1 O +
mM O +
IPTG B-Chemical +
at O +
37 O -
° O -
C O +
shaker O +
for O +
2 O +
hrs O -
. O +

Cells O +
( O -
50 O +
ml O -
) O +
were O +
harvested O +
and O +
resuspended O +
in O +
5 O +
ml O +
of O +
20 O +
mM O +
Tris B-Chemical -
- O -
HCl B-Chemical +
pH.8.0 O -
, O +
200 O +
mM O +
NaCl B-Chemical -
, O +
1 O +
mM O +
EDTA O +
pH8.0 O -
, O +
Protease O +
inhibitor O +
set O +
III O +
( O -
Calbiochem O -
) O -
. O +

The O +
cells O +
were O +
lysed O +
by O +
sonication O +
and O +
lysate O +
cleared O +
by O +
centrifugation O +
at O +
7500 O +
rpm O +
at O +
4 O -
° O -
C O +
for O +
15 O +
min O -
. O +

The O +
cleared O +
lysate O +
was O +
immobilized O +
on O +
glutathione B-Chemical +
sepharose O +
beads O +
in O +
3 O +
ml O +
of O +
20 O +
mM O +
Tris B-Chemical -
- O -
HCl B-Chemical +
pH.8.0 O -
, O +
200 O +
mM O +
NaCl B-Chemical -
, O +
1 O +
mM O +
EDTA O +
pH8.0 O -
) O -
. O +

RXRβ3 O +
cDNA O +
was O +
cloned O +
into O +
pET O +
28C O -
( O -
+ O -
) O +
( O -
Invitrogen O -
, O +
Carlsbad O -
, O +
CA O -
, O +
USA O -
) O +
and O +
protein O +
synthesized O +
by O +
TNT O +
quick O +
coupled O +
transcription O -
/ O -
translation O +
system O +
kit O +
( O -
Promega O -
) O +
and O +
radiolabeled O +
with O +
35S B-Chemical +
methionine O +
according O +
to O +
manufacturer O -
's O +
instructions O -
. O +

100 O +
μl O +
of O +
in O +
vitro O +
translated O +
RXRβ3 O +
protein O +
in O +
1 O +
ml O +
of O +
20 O +
mM O +
Tris B-Chemical -
- O -
HCl B-Chemical +
pH.8.0 O -
, O +
200 O +
mM O +
NaCl B-Chemical -
, O +
1 O +
mM O +
EDTA O +
pH8.0 O +
was O +
incubated O +
at O +
4 O -
° O -
C O +
with O +
immobilized O +
GST O -
- O -
TACC2 O +
or O +
GST O +
for O +
90 O +
min O -
. O +

Unbound O +
RXRβ3 O +
was O +
removed O +
by O +
washing O +
three O +
times O +
with O +
20 O +
mM O +
Tris B-Chemical -
- O -
HCl B-Chemical +
pH.8.0 O -
, O +
200 O +
mM O +
NaCl B-Chemical -
, O +
1 O +
mM O +
EDTA O +
pH8.0 O -
. O +

Bound O +
proteins O +
were O +
eluted O +
from O +
the O +
beads O +
at O +
room O +
temperature O +
for O +
10 O +
min O +
in O +
elution O +
buffer O +
( O -
100 O +
mM O +
Tris B-Chemical +
HCl B-Chemical -
, O +
pH8.0 O -
, O +
20 O +
mM O +
reduced O +
glutathione B-Chemical -
) O -
. O +

The O +
proteins O +
were O +
analyzed O +
on O +
12 O -
% O +
SDS B-Chemical +
polyacrylamide O +
gels O -
. O +

Coomassie O +
blue O +
staining O +
verified O +
equal O +
loading O +
of O +
GST O +
fusion O +
protein O -
. O +

Dried O +
gels O +
were O +
autoradiographed O -
. O +

Authors O -
' O +
contributions O +
I.H.S O +
performed O +
most O +
of O +
the O +
sequence O +
analysis O +
and O +
drafted O +
the O +
assembly O +
of O +
the O +
TACC O -
, O +
KLP O -
, O +
KIF O +
and O +
RHAMM O +
sequences O -
. O +

I.H.S. O +
performed O +
the O +
cDNA O +
isolation O +
of O +
the O +
rabbit O +
TACC3 O +
cDNA O -
. O +

AK O +
identified O +
potential O +
TACC1 O +
splice O +
variants O -
, O +
and O +
the O +
interaction O +
between O +
RXRβ3 O +
and O +
TACC2 O -
. O +

A.M. O +
characterized O +
mouse O +
TACC O +
orthologues O -
. O +

P.L. O +
performed O +
the O +
identification O +
and O +
assembly O +
of O +
T. O +
rubripes O +
gene O +
sequences O -
, O +
and O +
the O +
phylogenetic O +
analysis O -
. O +

I.H.S. O +
conceived O +
and O +
designed O +
the O +
project O +
and O +
drafted O +
the O +
complete O +
manuscript O -
. O +

Supplementary O +
Material O +
Additional O +
file O +
1 O +
Location O +
of O +
paralogous O +
genes O +
found O +
on O +
human O +
4p16 O -
, O +
5q31-ter O -
, O +
10q23-ter O -
, O +
8p O +
and O +
chromosome O +
2 O -
. O +

Positions O +
of O +
genes O +
are O +
given O +
in O +
Mb O +
from O +
the O +
telomere O +
of O +
the O +
short O +
arm O +
of O +
the O +
chromosome O -
. O +

Blue O +
highlighted O +
genes O +
( O -
five O +
copies O -
) O +
are O +
found O +
in O +
all O +
four O +
paralogous O +
segments O -
, O +
and O +
the O +
partially O +
duplicated O +
segment O +
on O +
chromosome O +
2 O -
. O +

Green O +
highlighted O +
genes O +
are O +
found O +
in O +
either O +
all O +
four O +
paralogous O +
segments O -
, O +
or O +
three O +
of O +
the O +
segments O +
and O +
the O +
partially O +
duplicated O +
region O +
on O +
chromosome O +
2 O -
. O +

Pink O +
highlighted O +
genes O +
have O +
paralogues O +
in O +
three O +
of O +
the O +
segments O -
, O +
suggesting O +
either O +
loss O +
of O +
the O +
fourth O +
copy O +
or O +
exclusion O +
of O +
one O +
paralogue O +
from O +
the O +
second O +
round O +
of O +
duplication O -
. O +

Black O +
highlighted O +
genes O +
( O -
two O +
paralogues O -
) O +
are O +
found O +
in O +
only O +
one O +
of O +
the O +
derivatives O +
of O +
the O +
second O +
round O +
of O +
genome O +
duplication O -
, O +
suggesting O +
complete O +
exclusion O +
of O +
both O +
copies O +
from O +
the O +
second O +
round O +
of O +
duplication O -
. O +

Purple O +
highlighted O +
genes O +
( O -
two O +
paralogues O -
) O +
were O +
duplicated O +
at O +
the O +
second O +
round O +
of O +
genome O +
duplication O -
, O +
or O +
from O +
interchromosomal O +
recombination O +
between O +
paralogous O +
clusters O -
. O +

Click O +
here O +
for O +
file O +

Acknowledgements O +
We O +
wish O +
to O +
thank O +
Dr. O +
Sei O -
- O -
ichi O +
Matsui O +
for O +
his O +
assistance O +
and O +
input O +
in O +
the O +
preparation O +
of O +
this O +
manuscript O -
. O +

This O +
work O +
was O +
supported O +
in O +
part O +
by O +
developmental O +
funds O +
support O +
from O +
the O +
Roswell O +
Park O +
Cancer O +
Institute O -
, O +
and O +
Core O +
grant O +
2P30CA016056 O -
- O -
27 O +
from O +
the O +
National O +
Cancer O +
Institute O -
. O +

The O +
Zebrafish O +
moonshine O +
Gene O +
Encodes O +
Transcriptional O +
Intermediary O +
Factor O +
1γ O -
, O +
an O +
Essential O +
Regulator O +
of O +
Hematopoiesis O +
Abstract O +
Hematopoiesis O +
is O +
precisely O +
orchestrated O +
by O +
lineage O -
- O -
specific O +
DNA O -
- O -
binding O +
proteins O +
that O +
regulate O +
transcription O +
in O +
concert O +
with O +
coactivators O +
and O +
corepressors O -
. O +

Mutations O +
in O +
the O +
zebrafish O +
moonshine O +
( O -
mon O -
) O +
gene O +
specifically O +
disrupt O +
both O +
embryonic O +
and O +
adult O +
hematopoiesis O -
, O +
resulting O +
in O +
severe O +
red O +
blood O +
cell O +
aplasia O -
. O +

We O +
report O +
that O +
mon O +
encodes O +
the O +
zebrafish O +
ortholog O +
of O +
mammalian O +
transcriptional O +
intermediary O +
factor O +
1γ O +
( O -
TIF1γ O -
) O +
( O -
or O +
TRIM33 O -
) O -
, O +
a O +
member O +
of O +
the O +
TIF1 O +
family O +
of O +
coactivators O +
and O +
corepressors O -
. O +

During O +
development O -
, O +
hematopoietic O +
progenitor O +
cells O +
in O +
mon O +
mutants O +
fail O +
to O +
express O +
normal O +
levels O +
of O +
hematopoietic O +
transcription O +
factors O -
, O +
including O +
gata1 O -
, O +
and O +
undergo O +
apoptosis O -
. O +

Three O +
different O +
mon O +
mutant O +
alleles O +
each O +
encode O +
premature O +
stop O +
codons O -
, O +
and O +
enforced O +
expression O +
of O +
wild O -
- O -
type O +
tif1γ O +
mRNA O +
rescues O +
embryonic O +
hematopoiesis O +
in O +
homozygous O +
mon O +
mutants O -
. O +

Surprisingly O -
, O +
a O +
high O +
level O +
of O +
zygotic O +
tif1γ O +
mRNA O +
expression O +
delineates O +
ventral O +
mesoderm O +
during O +
hematopoietic O +
stem O +
cell O +
and O +
progenitor O +
formation O +
prior O +
to O +
gata1 O +
expression O -
. O +

Transplantation O +
studies O +
reveal O +
that O +
tif1γ O +
functions O +
in O +
a O +
cell O -
- O -
autonomous O +
manner O +
during O +
the O +
differentiation O +
of O +
erythroid O +
precursors O -
. O +

Studies O +
in O +
murine O +
erythroid O +
cell O +
lines O +
demonstrate O +
that O +
Tif1γ O +
protein O +
is O +
localized O +
within O +
novel O +
nuclear O +
foci O -
, O +
and O +
expression O +
decreases O +
during O +
erythroid O +
cell O +
maturation O -
. O +

Our O +
results O +
establish O +
a O +
major O +
role O +
for O +
this O +
transcriptional O +
intermediary O +
factor O +
in O +
the O +
differentiation O +
of O +
hematopoietic O +
cells O +
in O +
vertebrates O -
. O +

Introduction O +
Hematopoiesis O +
involves O +
the O +
coordinated O +
processes O +
of O +
cell O +
proliferation O +
and O +
differentiation O +
of O +
a O +
relatively O +
small O +
number O +
of O +
progenitor O +
cells O +
into O +
billions O +
of O +
circulating O +
red O +
and O +
white O +
blood O +
cells O +
( O -
Thisse O +
and O +
Zon O +
2002 O -
) O -
. O +

Hematopoiesis O +
in O +
vertebrates O -
, O +
from O +
zebrafish O +
to O +
humans O -
, O +
is O +
an O +
evolutionarily O +
conserved O +
program O +
that O +
produces O +
two O +
waves O +
of O +
stem O +
or O +
progenitor O +
cells O +
that O +
differ O +
both O +
in O +
their O +
embryonic O +
origins O +
and O +
in O +
the O +
lineages O +
of O +
differentiated O +
blood O +
cells O +
produced O +
( O -
Palis O +
and O +
Yoder O +
2001 O -
; O +
Orkin O +
and O +
Zon O +
2002 O -
; O +
Galloway O +
and O +
Zon O +
2003 O -
) O -
. O +

The O +
first O -
, O +
or O +
primitive O -
, O +
wave O +
of O +
hematopoiesis O +
originates O +
from O +
ventral O +
mesoderm O +
and O +
gives O +
rise O +
to O +
progenitor O +
cells O +
that O +
differentiate O +
in O +
embryonic O +
blood O +
islands O -
. O +

The O +
primitive O +
wave O +
of O +
hematopoiesis O +
produces O +
a O +
burst O +
of O +
embryonic O +
erythrocytes O +
and O +
macrophages O -
. O +

The O +
second O -
, O +
or O +
definitive O -
, O +
wave O +
of O +
hematopoiesis O +
arises O +
from O +
self O -
- O -
renewing O +
stem O +
cells O +
that O +
develop O +
primarily O +
in O +
the O +
intraembryonic O +
aorta O -
– O -
gonad O -
– O -
mesonephros O +
region O -
. O +

These O +
definitive O +
hematopoietic O +
stem O +
cells O +
seed O +
the O +
later O +
developing O +
marrow O +
spaces O -
, O +
to O +
produce O +
all O +
lineages O +
of O +
adult O +
blood O +
cells O -
, O +
including O +
definitive O +
erythrocytes O -
, O +
myeloid O +
cells O -
, O +
and O +
lymphocytes O -
. O +

We O +
have O +
undertaken O +
a O +
genetic O +
approach O +
to O +
characterize O +
genes O +
that O +
control O +
hematopoiesis O +
using O +
the O +
zebrafish O +
as O +
a O +
model O +
system O +
( O -
Thisse O +
and O +
Zon O +
2002 O -
) O -
. O +

As O +
part O +
of O +
a O +
large O -
- O -
scale O +
forward O +
genetic O +
screen O -
, O +
we O +
previously O +
identified O +
bloodless O +
zebrafish O +
mutants O +
that O +
failed O +
to O +
express O +
the O +
erythroid O +
transcription O +
factor O +
gata1 O +
normally O +
in O +
embryonic O +
hematopoietic O +
precursors O +
( O -
Ransom O +
et O +
al. O +
1996 O -
) O -
. O +

We O +
named O +
one O +
of O +
these O +
zebrafish O +
genes O +
moonshine O +
( O -
mon O -
) O -
, O +
and O +
another O +
group O +
named O +
a O +
noncomplementing O +
allele O +
vampire O +
( O -
Weinstein O +
et O +
al. O +
1996 O -
) O -
. O +

Here O -
, O +
we O +
have O +
determined O +
that O +
mutations O +
in O +
the O +
mon O +
gene O +
cause O +
a O +
disruption O +
in O +
both O +
primitive O +
embryonic O +
and O +
definitive O +
adult O +
hematopoiesis O -
, O +
resulting O +
in O +
a O +
severe O +
loss O +
of O +
erythroid O +
cells O -
. O +

Erythroid O +
progenitor O +
cells O +
in O +
mon O +
mutants O +
are O +
initially O +
present O -
, O +
but O +
fail O +
to O +
express O +
normal O +
levels O +
of O +
hematopoietic O +
transcription O +
factors O +
and O +
undergo O +
apoptosis O -
. O +

Positional O +
cloning O +
identifies O +
the O +
mon O +
gene O +
as O +
the O +
zebrafish O +
ortholog O +
of O +
mammalian O +
transcriptional O +
intermediary O +
factor O +
1γ O +
( O -
TIF1γ O -
) O -
, O +
a O +
member O +
of O +
the O +
TIF1 O +
family O +
of O +
transcriptional O +
coactivators O +
and O +
corepressors O +
( O -
Le O +
Douarin O +
et O +
al. O +
1995 O -
; O +
Friedman O +
et O +
al. O +
1996 O -
; O +
Kim O +
et O +
al. O +
1996 O -
; O +
Venturini O +
et O +
al. O +
1999 O -
; O +
Peng O +
et O +
al. O +
2002 O -
) O -
. O +

The O +
three O +
members O +
of O +
the O +
vertebrate O +
TIF1 O +
family O +
( O -
α O -
, O +
β O -
, O +
and O +
γ O -
) O +
are O +
large O +
nuclear O +
proteins O +
that O +
each O +
contain O +
an O +
N O -
- O -
terminal O +
RBCC O +
or O +
TRIM O +
domain O +
( O -
Reymond O +
et O +
al. O +
2001 O -
) O +
composed O +
of O +
a O +
RING O +
finger O -
, O +
two O +
B O -
- O -
boxes O -
, O +
and O +
a O +
coiled O -
- O -
coil O +
domain O -
. O +

TIF1 O +
family O +
members O +
also O +
contain O +
a O +
C O -
- O -
terminal O +
plant O +
homeodomain O +
finger O +
and O +
bromodomain O +
that O +
are O +
characteristic O +
of O +
chromatin O +
remodeling O +
factors O -
. O +

TIF1α O +
has O +
been O +
shown O +
to O +
associate O +
with O +
a O +
variety O +
of O +
ligand O -
- O -
bound O +
nuclear O +
hormone O +
receptors O +
( O -
Le O +
Douarin O +
et O +
al. O +
1995 O -
) O +
and O +
function O +
as O +
a O +
coactivator O +
for O +
retinoic B-Chemical +
acid I-Chemical +
receptors O +
( O -
Zhong O +
et O +
al.1999 O -
) O -
. O +

TIF1β O +
has O +
been O +
shown O +
to O +
act O +
as O +
a O +
corepressor O +
for O +
the O +
large O +
family O +
of O +
Krüppel O -
- O -
associated O +
box O +
( O -
KRAB O -
) O +
domain O +
zinc O -
- O -
finger O +
transcription O +
factors O +
( O -
Friedman O +
et O +
al. O +
1996 O -
; O +
Abrink O +
et O +
al. O +
2001 O -
) O -
. O +

In O +
contrast O -
, O +
TIF1γ O +
does O +
not O +
associate O +
directly O +
with O +
either O +
nuclear O +
receptors O +
or O +
KRAB O +
domains O +
that O +
bind O +
to O +
the O +
other O +
TIF1 O +
family O +
members O +
( O -
Venturini O +
et O +
al. O +
1999 O -
; O +
Abrink O +
et O +
al. O +
2001 O -
) O -
. O +

Biochemical O +
studies O +
also O +
demonstrate O +
that O +
TIF1γ O +
forms O +
both O +
homo O -
- O -
oligomers O +
and O +
hetero O -
- O -
oligomers O +
with O +
TIF1α O +
but O +
not O +
with O +
TIF1β O +
( O -
Peng O +
et O +
al. O +
2002 O -
) O -
. O +

The O +
murine O +
Tif1α O +
and O +
Tif1γ O +
genes O +
have O +
not O +
yet O +
been O +
subjected O +
to O +
gene O +
targeting O +
experiments O -
, O +
whereas O +
analysis O +
of O +
mouse O +
mutants O +
demonstrates O +
that O +
Tif1β O +
is O +
required O +
for O +
postimplantation O +
embryogenesis O +
and O +
mesoderm O +
induction O +
in O +
particular O +
( O -
Cammas O +
et O +
al. O +
2000 O -
) O -
. O +

Taken O +
together O -
, O +
these O +
studies O +
suggest O +
that O +
a O +
major O +
function O +
of O +
TIF1 O +
family O +
members O +
is O +
to O +
link O +
DNA O -
- O -
binding O +
proteins O +
with O +
other O +
coactivators O +
or O +
corepressors O +
during O +
development O -
. O +

Our O +
studies O +
establish O +
that O +
tif1γ O +
functions O +
as O +
an O +
essential O +
regulator O +
of O +
embryonic O +
and O +
adult O +
hematopoiesis O +
in O +
vertebrates O -
. O +

Cell O +
transplantation O +
studies O +
demonstrate O +
that O +
tif1γ O +
acts O +
in O +
a O +
cell O -
- O -
autonomous O +
manner O +
during O +
embryonic O +
hematopoiesis O -
. O +

The O +
tif1γ O +
gene O +
is O +
expressed O +
specifically O +
in O +
ventral O +
mesoderm O +
and O +
hematopoietic O +
progenitors O -
, O +
then O +
downregulated O +
as O +
erythroid O +
maturation O +
occurs O -
. O +

Tif1γ O +
protein O +
localizes O +
to O +
a O +
novel O +
class O +
of O +
nuclear O +
bodies O +
in O +
both O +
primary O +
mouse O +
embryo O +
fibroblasts O +
and O +
erythroleukemia O +
cell O +
lines O -
. O +

Taken O +
together O -
, O +
our O +
studies O +
demonstrate O +
that O +
Tif1γ O +
is O +
required O +
for O +
normal O +
erythroid O +
cell O +
development O +
and O +
survival O -
. O +

Results O +
The O +
Zebrafish O +
mon O +
Gene O +
Is O +
Essential O +
for O +
Both O +
Primitive O +
and O +
Definitive O +
Erythropoiesis O +
In O +
order O +
to O +
determine O +
when O +
the O +
mon O +
gene O +
is O +
required O +
in O +
development O -
, O +
we O +
first O +
examined O +
hematopoietic O +
gene O +
expression O +
and O +
apoptosis O +
in O +
zebrafish O +
homozygous O +
mon O +
mutant O +
embryos O -
. O +

During O +
embryogenesis O -
, O +
homozygous O +
zebrafish O +
mon O +
mutants O +
have O +
no O +
red O +
blood O +
cells O +
( O -
RBCs O -
) O +
visible O +
in O +
circulation O +
( O -
Ransom O +
et O +
al. O +
1996 O -
; O +
Weinstein O +
et O +
al. O +
1996 O -
) O -
. O +

The O +
mon O +
mutants O +
initiate O +
expression O +
of O +
gata1 O +
in O +
hematopoietic O +
cells O +
around O +
the O +
five O -
- O -
somite O +
stage O -
, O +
similar O +
to O +
wild O -
- O -
type O +
embryos O +
( O -
data O +
not O +
shown O -
) O -
; O +
however O -
, O +
based O +
on O +
TUNEL O +
staining O -
, O +
the O +
differentiating O +
erythroid O +
cells O +
undergo O +
programmed O +
cell O +
death O +
from O +
the O +
12-somite O +
stage O +
to O +
22 O +
h O +
postfertilization O +
( O -
hpf O -
) O +
( O -
Figure O +
1A O +
and O +
1B O -
, O +
arrows O -
) O -
. O +

At O +
12 O +
somites O -
, O +
gata1 O +
expression O +
is O +
only O +
slightly O +
reduced O -
. O +

By O +
18–22 O +
hpf O -
, O +
hematopoietic O -
- O -
specific O +
markers O +
such O +
as O +
gata1 O -
, O +
scl O -
, O +
gata2 O -
, O +
and O +
ikaros O +
are O +
not O +
detected O +
in O +
the O +
embryonic O +
blood O +
island O +
( O -
Figure O +
1A O +
and O +
1B O -
; O +
unpublished O +
data O -
) O -
. O +

The O +
hematopoietic O +
cells O +
are O +
thus O +
correctly O +
specified O +
early O +
during O +
the O +
development O +
of O +
mon O +
mutant O +
embryos O -
, O +
but O +
these O +
precursors O +
undergo O +
cell O +
death O -
. O +

Based O +
on O +
expression O +
of O +
c O -
- O -
myb O +
and O +
rag1 O +
( O -
Figure O +
1B O -
, O +
arrows O -
) O -
, O +
mon O +
mutants O +
have O +
normal O +
myeloid O +
and O +
lymphoid O +
development O -
, O +
respectively O -
. O +

In O +
addition O +
to O +
the O +
deficit O +
of O +
RBCs O +
in O +
mon O +
mutants O -
, O +
there O +
is O +
a O +
prominent O +
loss O +
of O +
fin O -
- O -
fold O +
and O +
tail O +
mesenchyme O +
( O -
Ransom O +
et O +
al. O +
1996 O -
) O -
. O +

TUNEL O +
staining O +
of O +
mon O +
mutants O +
demonstrates O +
extensive O +
apoptosis O +
of O +
mesenchymal O +
cells O +
in O +
the O +
trunk O +
and O +
tail O +
bud O +
regions O +
( O -
Figure O +
1A O +
and O +
1B O -
, O +
arrows O -
) O -
. O +

The O +
mon O +
gene O +
is O +
thus O +
required O +
for O +
normal O +
development O +
and O +
survival O +
of O +
both O +
committed O +
erythroid O +
progenitor O +
cells O +
and O +
posterior O +
mesenchymal O +
cells O -
. O +

We O +
next O +
examined O +
definitive O +
hematopoiesis O +
in O +
rare O +
surviving O +
homozygous O +
adult O +
zebrafish O +
mon O +
mutants O -
. O +

Mutations O +
in O +
mon O +
are O +
generally O +
lethal O +
by O +
10 O +
to O +
14 O +
d O +
of O +
development O +
( O -
Ransom O +
et O +
al. O +
1996 O -
) O -
, O +
although O +
rare O +
mon O +
homozygous O +
mutants O +
( O -
approximately O +
1 O +
in O +
500 O +
bloodless O +
embryos O -
) O +
of O +
all O +
tested O +
alleles O +
survive O +
to O +
adulthood O -
. O +

Adult O +
mon O +
mutants O +
show O +
cardiac O +
hypertrophy O -
, O +
presumably O +
due O +
to O +
the O +
severe O +
anemia O +
leading O +
to O +
a O +
high O +
output O +
state O +
( O -
Figure O +
2 O -
) O -
. O +

In O +
wild O -
- O -
type O +
zebrafish O -
, O +
the O +
adult O +
site O +
of O +
hematopoiesis O +
is O +
the O +
kidney O +
( O -
Al O +
Adhami O +
and O +
Kunz O +
1977 O -
) O -
, O +
which O +
contains O +
erythroid O -
, O +
lymphoid O -
, O +
and O +
myeloid O +
populations O +
at O +
various O +
stages O +
of O +
differentiation O +
( O -
Bennett O +
et O +
al. O +
2001 O -
) O -
. O +

In O +
mon O +
homozygous O +
mutants O -
, O +
there O +
is O +
a O +
severe O +
block O +
in O +
maturation O +
at O +
the O +
proerythroblast O +
stage O +
( O -
Figure O +
2 O -
) O -
, O +
whereas O +
the O +
differentiation O +
of O +
myeloid O +
cells O +
is O +
normal O +
( O -
unpublished O +
data O -
) O -
. O +

This O +
demonstrates O +
that O +
the O +
mon O +
gene O +
product O +
acts O +
during O +
both O +
primitive O +
and O +
definitive O +
erythropoiesis O -
. O +

Positional O +
Cloning O +
Identifies O +
mon O +
as O +
the O +
Zebrafish O +
Ortholog O +
of O +
Mammalian O +
TIF1γ O +
We O +
identified O +
the O +
mon O +
gene O +
by O +
positional O +
cloning O +
using O +
a O +
panel O +
of O +
2,200 O +
diploid O +
mutants O +
collected O +
from O +
Tübingen O +
background O +
( O -
TU O -
) O -
/ O -
WIK O +
strain O +
hybrid O +
parents O +
carrying O +
the O +
montg234 O +
allele O -
. O +

The O +
mon O +
mutant O +
gene O +
was O +
positioned O +
on O +
Chromosome O +
8 O +
between O +
microsatellite O +
markers O +
z987 O +
and O +
z11001 O +
( O -
Figure O +
3A O -
) O +
( O -
Knapik O +
et O +
al. O +
1998 O -
) O -
. O +

For O +
positional O +
cloning O +
purposes O -
, O +
over O +
12,000 O +
polymorphic O +
markers O +
were O +
screened O +
using O +
amplified O +
fragment O +
length O +
polymorphism O +
( O -
AFLP O -
) O +
( O -
Ransom O +
and O +
Zon O +
1999 O -
) O -
, O +
and O +
36 O +
markers O +
within O +
the O +
interval O +
were O +
isolated O -
. O +

One O +
of O +
these O -
, O +
MA3 O -
, O +
was O +
found O +
to O +
be O +
0.3 O +
cM O +
from O +
the O +
gene O +
( O -
Figure O +
3A O -
) O +
and O +
was O +
utilized O +
as O +
the O +
starting O +
point O +
of O +
a O +
chromosomal O +
walk O -
. O +

A O +
critical O +
P1 O +
bacterial O +
artificial O +
chromosome O +
clone O +
( O -
PAC O -
) O -
, O +
107N19 O -
, O +
was O +
obtained O +
that O +
spanned O +
the O +
genetic O +
interval O -
. O +

Two O +
simple O +
sequence O +
conformation O +
polymorphism O +
( O -
SSCP O -
) O +
markers O +
found O +
on O +
this O +
PAC O +
clone O +
flank O +
the O +
critical O +
genetic O +
interval O -
. O +

The O +
marker O +
80M12-T7 O +
maps O +
two O +
recombinants O +
out O +
of O +
4,400 O +
meioses O +
telomeric O +
of O +
the O +
mutation O -
, O +
and O +
the O +
marker O +
157J23-T7 O +
maps O +
one O +
recombinant O +
centromic O +
of O +
the O +
mutation O +
( O -
Figure O +
3A O -
) O -
. O +

The O +
end O +
sequences O +
and O +
SSCP O +
markers O +
of O +
PAC O +
107N19 O +
are O +
found O +
in O +
the O +
zebrafish O +
genomic O +
sequence O +
contig O +
ctg23107 O +
( O -
http://www.ensembl.org/Danio_rerio/ O -
) O +
containing O +
a O +
predicted O +
zebrafish O +
TIF1 O +
family O +
gene O -
. O +

This O +
PAC O +
was O +
hybridized O +
to O +
a O +
kidney O +
cDNA O +
library O -
, O +
resulting O +
in O +
the O +
isolation O +
of O +
four O +
clones O +
that O +
represented O +
the O +
same O +
gene O -
. O +

The O +
mon O +
gene O +
encodes O +
a O +
member O +
of O +
the O +
TIF1 O +
family O +
of O +
transcriptional O +
cofactors B-Chemical +
( O -
Figure O +
3B O +
and O +
3C O -
) O -
. O +

The O +
coding O +
sequence O +
of O +
mon O +
is O +
most O +
similar O +
to O +
human O +
TIFγ O +
( O -
Le O +
Douarin O +
et O +
al. O +
1995 O -
; O +
Friedman O +
et O +
al. O +
1996 O -
; O +
Venturini O +
et O +
al. O +
1999 O -
) O -
, O +
and O +
the O +
locations O +
of O +
exon O +
boundaries O +
are O +
conserved O +
between O +
the O +
zebrafish O +
and O +
human O +
genes O +
( O -
unpublished O +
data O -
) O -
. O +

The O +
mon O +
locus O +
on O +
zebrafish O +
Chromosome O +
8 O +
is O +
also O +
predicted O +
to O +
be O +
syntenic O +
to O +
the O +
region O +
of O +
human O +
Chromosome O +
1p O +
that O +
contains O +
the O +
TIF1γ O +
gene O +
based O +
on O +
the O +
conserved O +
locations O +
of O +
12 O +
other O +
orthologous O +
gene O +
pairs O -
, O +
including O +
NRAS O -
, O +
mapped O +
to O +
these O +
regions O +
in O +
human O +
and O +
zebrafish O +
( O -
Barbazuk O +
et O +
al. O +
2000 O -
) O -
. O +

Therefore O -
, O +
based O +
on O +
sequence O +
similarity O +
and O +
chromosomal O +
location O -
, O +
the O +
zebrafish O +
mon O +
gene O +
is O +
the O +
likely O +
ortholog O +
of O +
the O +
human O +
TIF1γ O +
gene O -
. O +

We O +
have O +
identified O +
ethyl B-Chemical -
- I-Chemical -
nitrosourea I-Chemical +
( O -
ENU B-Chemical -
) O -
-induced O +
point O +
mutations O +
in O +
three O +
alleles O +
of O +
mon O +
( O -
Figure O +
3C O +
and O +
3D O -
) O -
, O +
each O +
of O +
which O +
generates O +
a O +
premature O +
stop O +
codon O -
. O +

The O +
montb222b O +
and O +
montg234 O +
alleles O +
have O +
a O +
severe O +
phenotype O +
with O +
no O +
circulating O +
blood O +
cells O -
. O +

In O +
contrast O -
, O +
the O +
monm262 O +
allele O +
has O +
10–100 O +
circulating O +
blood O +
cells O +
by O +
48 O +
hpf O -
, O +
in O +
comparison O +
to O +
the O +
approximately O +
3,000 O +
RBCs O +
in O +
the O +
circulation O +
of O +
wild O -
- O -
type O +
or O +
heterozygous O +
embryos O +
at O +
the O +
same O +
time O +
point O -
. O +

The O +
monm262 O +
allele O +
was O +
found O +
to O +
encode O +
a O +
premature O +
stop O +
codon O +
at O +
position O +
E40 O -
, O +
which O +
would O +
encode O +
a O +
putative O +
protein O +
of O +
only O +
40 O +
amino O +
acids O -
. O +

Although O +
this O +
mutation O +
would O +
be O +
expected O +
to O +
lead O +
to O +
a O +
complete O +
loss O +
of O +
mon O +
gene O +
product O -
, O +
another O +
methionine O +
is O +
found O +
downstream O +
at O +
amino O +
acid O +
position O +
104 O -
. O +

In O +
vitro O +
translation O +
experiments O +
in O +
reticulocyte O +
lysates O +
demonstrate O +
reinitiation O +
of O +
translation O +
from O +
this O +
methionine O +
( O -
unpublished O +
data O -
) O -
. O +

Therefore O -
, O +
the O +
hypomorphic O +
larval O +
phenotype O +
of O +
the O +
monm262 O +
allele O +
is O +
likely O +
due O +
to O +
partial O +
loss O +
of O +
mon O +
function O +
or O +
expression O -
. O +

The O +
presence O +
of O +
mutations O +
in O +
each O +
of O +
the O +
mon O +
alleles O +
indicates O +
that O +
defective O +
Tif1γ O +
function O +
is O +
the O +
cause O +
of O +
the O +
mon O +
phenotype O -
. O +

In O +
order O +
to O +
determine O +
whether O +
tif1γ O +
is O +
expressed O +
in O +
hematopoietic O +
mesoderm O -
, O +
we O +
next O +
examined O +
zebrafish O +
embryos O +
by O +
whole O -
- O -
mount O +
in O +
situ O +
hybridization O +
( O -
Figure O +
4A O -
) O -
. O +

tif1γ O +
mRNA O +
is O +
expressed O +
maternally O +
and O +
is O +
found O +
throughout O +
the O +
embryo O +
during O +
blastula O +
stages O -
. O +

During O +
gastrulation O +
and O +
epiboly O +
stages O -
, O +
zygotic O +
expression O +
of O +
mon O +
is O +
highest O +
in O +
the O +
mesendoderm O +
of O +
the O +
germ O +
ring O -
. O +

At O +
tail O +
bud O +
and O +
early O +
somite O +
stages O +
a O +
high O +
level O +
of O +
tif1γ O +
expression O +
delineates O +
a O +
horseshoe O -
- O -
shaped O +
population O +
of O +
ventral O -
/ O -
lateral O +
mesoderm O +
that O +
will O +
give O +
rise O +
to O +
blood O +
and O +
also O +
expresses O +
stem O +
cell O +
leukemiahematopoietic O +
transcription O +
factor O +
( O -
scl O -
) O +
( O -
Liao O +
et O +
al. O +
1997 O -
) O -
. O +

This O +
group O +
of O +
cells O +
continues O +
to O +
express O +
tif1γ O +
and O +
scl O +
while O +
it O +
converges O +
and O +
forms O +
the O +
embryonic O +
blood O +
island O +
( O -
Detrich O +
et O +
al. O +
1995 O -
) O -
. O +

The O +
tif1γ O +
gene O +
is O +
also O +
highly O +
expressed O +
in O +
the O +
central O +
nervous O +
system O +
as O +
well O +
as O +
the O +
mesenchyme O +
of O +
the O +
trunk O +
and O +
tail O -
. O +

Homozygous O +
montg234 O +
mutants O +
have O +
a O +
greatly O +
reduced O +
amount O +
of O +
tif1γ O +
mRNA O +
in O +
all O +
tissues O +
consistent O +
with O +
nonsense O -
- O -
mediated O +
message B-Chemical +
decay O -
. O +

Thus O -
, O +
zebrafish O +
tif1γ O +
is O +
specifically O +
expressed O +
in O +
ventral O +
mesoderm O +
and O +
putative O +
hemangioblasts O +
prior O +
to O +
and O +
during O +
the O +
embryonic O +
stages O +
when O +
hematopoietic O +
progenitors O +
are O +
undergoing O +
apoptosis O +
in O +
mon O +
mutants O -
. O +

We O +
also O +
compared O +
the O +
expression O +
of O +
zebrafish O +
mon O +
to O +
mouse O +
Tif1γ O +
( O -
Figure O +
4A O +
and O +
4B O -
) O -
. O +

Mouse O +
Tif1γ O +
is O +
highly O +
expressed O +
in O +
erythroid O +
blood O +
islands O +
of O +
the O +
yolk O +
sac O -
, O +
and O +
it O +
is O +
subsequently O +
expressed O +
in O +
the O +
fetal O +
liver O +
at O +
a O +
high O +
level O -
, O +
and O +
in O +
other O +
tissues O -
, O +
including O +
the O +
central O +
nervous O +
system O -
. O +

Taken O +
together O +
these O +
results O +
strongly O +
suggest O +
that O +
zebrafish O +
mon O +
and O +
mouse O +
Tif1γ O +
are O +
orthologs O +
that O +
function O +
during O +
hematopoiesis O -
. O +

Given O +
that O +
mammalian O +
TIF1γ O +
has O +
been O +
shown O +
to O +
form O +
hetero O -
- O -
oligomers O +
with O +
Tif1α O +
( O -
Peng O +
et O +
al. O +
2002 O -
) O -
, O +
we O +
searched O +
for O +
additional O +
TIF1 O +
family O +
members O +
in O +
zebrafish O +
to O +
compare O +
with O +
tif1γ O -
. O +

Using O +
zebrafish O +
expressed O +
sequence O +
tag O +
( O -
EST O -
) O +
sequences O -
, O +
we O +
designed O +
primers O +
to O +
RT O -
- O -
PCR O +
amplify O +
a O +
TIF1-related O +
cDNA O +
from O +
embryonic O +
10-hpf O +
and O +
24-hpf O +
RNA O -
. O +

This O +
cDNA O +
encodes O +
a O +
predicted O +
zebrafish O +
ortholog O +
of O +
human O +
TIF1α O +
based O +
on O +
predicted O +
amino O +
acid O +
sequences O +
( O -
see O +
Figure O +
3B O -
) O -
. O +

In O +
addition O -
, O +
zebrafish O +
tif1α O +
ESTs O +
map O +
to O +
LG4 O +
in O +
a O +
region O +
predicted O +
to O +
be O +
syntenic O +
to O +
the O +
region O +
of O +
human O +
Chromosome O +
7 O +
that O +
contains O +
the O +
TIF1α O +
gene O +
based O +
on O +
the O +
conserved O +
locations O +
of O +
eight O +
other O +
orthologous O +
gene O +
pairs O -
, O +
including O +
SEMA3A O -
, O +
mapped O +
to O +
these O +
regions O +
in O +
human O +
and O +
zebrafish O +
( O -
Barbazuk O +
et O +
al. O +
2000 O -
) O -
. O +

We O +
next O +
compared O +
the O +
embryonic O +
expression O +
pattern O +
of O +
tif1α O +
mRNA O +
to O +
tif1γ O +
by O +
in O +
situ O +
hybridization O -
. O +

Like O +
mammalian O +
TIF1α O +
( O -
Le O +
Douarin O +
et O +
al. O +
1995 O -
; O +
Niederreither O +
et O +
al. O +
1999 O -
) O -
, O +
the O +
predicted O +
zebrafish O +
tif1γ O +
gene O +
is O +
broadly O +
expressed O +
( O -
see O +
Figure O +
4A O -
) O -
. O +

At O +
five O +
somites O -
, O +
zebrafish O +
tif1α O +
does O +
not O +
display O +
the O +
relatively O +
high O +
expression O +
in O +
the O +
horseshoe O -
- O -
shaped O +
region O +
of O +
hematopoietic O +
mesoderm O +
seen O +
with O +
tif1γ O -
. O +

At O +
later O +
stages O -
, O +
tif1α O +
is O +
evenly O +
expressed O +
throughout O +
most O +
of O +
the O +
embryo O -
, O +
including O +
the O +
developing O +
blood O +
islands O -
. O +

Therefore O -
, O +
tif1α O +
is O +
coexpressed O +
in O +
the O +
same O +
cells O +
with O +
tif1γ O +
and O +
may O +
therefore O +
be O +
available O +
to O +
form O +
hetero O -
- O -
oligomers O +
in O +
vivo O -
. O +

Forced O +
Expression O +
of O +
tif1γ O +
Rescues O +
Hematopoiesis O +
in O +
mon O +
Mutants O +
To O +
further O +
confirm O +
that O +
a O +
mutation O +
in O +
the O +
zebrafish O +
tif1γ O +
gene O +
is O +
responsible O +
for O +
the O +
mon O +
mutant O +
phenotype O +
we O +
performed O +
embryo O +
rescue O +
experiments O +
( O -
Figure O +
5A O -
; O +
Table O +
1 O -
) O -
. O +

Microinjection O +
of O +
synthetic O +
wild O -
- O -
type O +
mon O +
mRNA O +
at O +
the O +
one O -
- O -
cell O +
stage O +
rescues O +
the O +
formation O +
of O +
embryonic O +
erythrocytes O +
in O +
genotyped O +
mutant O +
embryos O +
without O +
causing O +
obvious O +
defects O +
in O +
embryonic O +
patterning O +
or O +
organogenesis O -
. O +

At O +
4 O +
d O +
of O +
development O -
, O +
70 O -
% O +
( O -
n O +
= O +
10 O -
) O +
of O +
montg234 O +
mutants O +
show O +
significant O +
( O -
greater O +
than O +
200 O +
cells O +
in O +
comparison O +
to O +
a O +
wild O -
- O -
type O +
estimate O +
of O +
3,000 O +
cells O -
) O +
rescue O +
of O +
circulating O +
hemoglobinized O +
RBCs O +
in O +
comparison O +
to O +
control O +
sibling O +
mutants O +
( O -
n O +
= O +
75 O -
) O -
. O +

Based O +
on O +
the O +
correction O +
of O +
the O +
jagged O +
fin O -
- O -
fold O +
phenotype O +
( O -
Ransom O +
et O +
al. O +
1996 O -
) O -
, O +
the O +
mesenchymal O +
cells O +
are O +
rescued O +
to O +
a O +
similar O +
extent O +
as O +
the O +
anemia O +
( O -
unpublished O +
data O -
) O -
. O +

Overexpression O +
of O +
mon O +
did O +
not O +
result O +
in O +
expanded O +
blood O +
cell O +
numbers O +
in O +
wild O -
- O -
type O +
embryos O +
and O +
was O +
not O +
toxic O +
at O +
doses O +
that O +
rescue O +
the O +
phenotype O +
of O +
mon O +
mutants O +
( O -
unpublished O +
data O -
) O -
. O +

Since O +
there O +
were O +
no O +
expanded O +
or O +
ectopic O +
blood O +
populations O +
in O +
the O +
embryos O -
, O +
these O +
rescue O +
experiments O +
suggest O +
that O +
mon O +
functions O +
as O +
a O +
permissive O +
factor O +
required O +
for O +
hematopoiesis O -
. O +

Marrow O +
Transplantation O +
Rescues O +
Erythropoiesis O +
in O +
mon O +
Mutants O +
The O +
high O +
levels O +
of O +
tif1γ O +
expression O +
in O +
erythroid O +
cells O +
suggest O +
that O +
it O +
functions O +
as O +
a O +
cell O -
- O -
autonomous O +
regulator O +
of O +
gene O +
expression O +
in O +
hematopoietic O +
cells O -
. O +

In O +
order O +
to O +
test O +
this O +
hypothesis O -
, O +
we O +
transplanted O +
wild O -
- O -
type O +
adult O +
zebrafish O +
kidney O +
marrow O +
cells O +
carrying O +
a O +
gata1 O -
: O -
green O +
fluorescent O +
protein O +
( O -
GFP O -
) O +
transgene O +
into O +
48-hpf O +
mon O +
mutant O +
embryos O +
( O -
Figure O +
5B O -
; O +
Table O +
2 O -
) O -
. O +

The O +
gata1 O -
: O -
GFP O +
transgene O +
makes O +
use O +
of O +
the O +
gata1 O +
promoter O +
to O +
drive O +
GFP O +
expression O +
and O +
can O +
thus O +
be O +
used O +
to O +
mark O +
donor O -
- O -
derived O +
erythroid O +
cells O +
( O -
Long O +
et O +
al. O +
1997 O -
) O -
. O +

Untransplanted O +
mutant O +
embryos O +
have O +
no O +
embryonic O +
blood O +
cells O +
in O +
circulation O -
. O +

Following O +
transplantation O -
, O +
mutant O +
host O +
embryos O +
were O +
observed O +
daily O +
for O +
2 O +
wk O -
. O +

Of O +
191 O +
mutant O +
embryos O +
injected O -
, O +
129 O +
( O -
68 O -
% O -
) O +
showed O +
GFP+ O +
cells O +
in O +
circulation O +
2 O +
d O +
later O -
. O +

Many O +
recipients O +
showed O +
robust O +
increases O +
in O +
donor O -
- O -
derived O +
cells O +
over O +
the O +
observation O +
period O -
. O +

Of O +
81 O +
recipients O +
initially O +
scored O +
as O +
having O +
less O +
than O +
ten O +
GFP+ O +
cells O +
at O +
day O +
2 O +
posttransplant O -
, O +
13 O +
( O -
16 O -
% O -
) O +
of O +
these O +
demonstrated O +
a O +
marked O +
increase O +
in O +
erythroid O +
cells O +
with O +
100–1,000 O +
GFP+ O +
cells O +
in O +
circulation O +
6 O +
d O +
later O -
. O +

By O +
day O +
10 O -
, O +
these O +
transplanted O +
embryos O +
showed O +
approximately O +
3,000 O +
cells O +
in O +
circulation O -
, O +
similar O +
to O +
the O +
number O +
of O +
blood O +
cells O +
in O +
normal O +
embryos O -
. O +

Despite O +
robust O +
reconstitution O +
of O +
blood O +
cells O -
, O +
mutant O +
recipients O +
did O +
not O +
inflate O +
their O +
swim O +
bladders O +
and O +
thus O +
failed O +
to O +
survive O +
longer O +
than O +
nontransplanted O +
sibling O +
controls O -
, O +
all O +
dying O +
by O +
3 O +
wk O +
of O +
age O -
. O +

In O +
contrast O -
, O +
13 O -
/ O -
35 O +
( O -
37 O -
% O -
) O +
heterozygous O +
montg234 O +
transplants O +
survived O +
to O +
early O +
adulthood O -
. O +

Similar O +
transplants O +
of O +
wild O -
- O -
type O +
cells O +
can O +
fully O +
rescue O +
vlad O +
tepes O +
( O -
gata1 O -
) O +
mutants O +
( O -
Traver O +
et O +
al. O +
2003 O -
) O -
. O +

Therefore O -
, O +
the O +
results O +
of O +
cell O +
transplantations O +
suggests O +
that O +
tif1γ O +
plays O +
a O +
cell O -
- O -
autonomous O +
role O +
in O +
erythroid O +
cells O -
, O +
and O +
its O +
role O +
in O +
nonhematopoietic O +
tissues O -
, O +
such O +
as O +
trunk O +
mesenchyme O +
or O +
the O +
nervous O +
system O -
, O +
is O +
also O +
required O +
for O +
embryo O +
survival O -
. O +

Tif1γ O +
in O +
Punctate O +
Nuclear O +
Foci O +
Is O +
Developmentally O +
Regulated O +
In O +
order O +
to O +
examine O +
the O +
subcellular O +
distribution O +
of O +
Tif1γ O +
protein O -
, O +
we O +
generated O +
an O +
affinity O -
- O -
purified O +
rabbit O +
polyclonal O +
antiserum O +
directed O +
against O +
the O +
C O -
- O -
terminal O +
15 O +
amino O +
acids O +
conserved O +
in O +
human O +
TIF1γ O +
and O +
mouse O +
Tif1γ O -
. O +

Immunofluorescence O +
of O +
mouse O +
embryo O +
fibroblast O +
nuclei O +
with O +
the O +
anti O -
- O -
Tif1γ O +
antiserum O +
demonstrates O +
that O +
Tif1γ O +
is O +
localized O +
in O +
small O +
nuclear O +
foci O +
( O -
Figure O +
6A O -
) O -
. O +

The O +
localization O +
of O +
Tif1γ O +
protein O +
appears O +
different O +
from O +
the O +
more O +
diffuse O +
nuclear O +
patterns O +
typically O +
seen O +
in O +
studies O +
of O +
Tif1α O +
( O -
Remboutsika O +
et O +
al. O +
2002 O -
) O +
or O +
TIF1β O +
( O -
Cammas O +
et O +
al. O +
2002 O -
) O -
. O +

A O +
recent O +
report O +
demonstrates O +
that O +
TIF1β O +
associates O +
with O +
heterochromatin O -
- O -
containing O +
foci O +
after O +
retinoic B-Chemical +
acid I-Chemical +
treatment O +
or O +
serum O +
starvation O +
( O -
Cammas O +
et O +
al. O +
2002 O -
) O -
. O +

Thus O -
, O +
localization O +
or O +
expression O +
of O +
the O +
TIF1 O +
proteins O +
may O +
be O +
regulated O +
during O +
distinct O +
developmental O +
processes O +
or O +
by O +
environmental O +
cues O -
. O +

The O +
nuclear O +
foci O +
that O +
contain O +
Tif1γ O +
do O +
not O +
colocalize O +
with O +
two O +
markers O +
of O +
heterochromatin O -
, O +
HP1α O +
protein O +
and O +
DAPI B-Chemical +
staining O +
of O +
DNA O +
( O -
Figure O +
6A O -
) O -
. O +

Furthermore O -
, O +
Tif1γ O +
does O +
not O +
colocalize O +
with O +
promyelocytic O +
leukemia O +
gene O +
product O +
( O -
PML O -
) O +
nuclear O +
bodies O -
, O +
DNA O +
repair O +
complexes O +
that O +
contain O +
Mre11 O -
, O +
or O +
transcriptional O +
complexes O +
containing O +
TFII O -
- O -
B O +
( O -
unpublished O +
data O -
) O -
. O +

We O +
next O +
examined O +
the O +
expression O +
of O +
Tif1γ O +
protein O +
during O +
the O +
differentiation O +
of O +
G1E O +
cells O -
, O +
a O +
murine O +
erythroleukemia O +
cell O +
line O +
that O +
can O +
terminally O +
differentiate O +
into O +
erythrocytes O +
when O +
a O +
Gata1 O -
: O -
estrogen B-Chemical +
receptor O +
fusion O +
protein O +
is O +
stabilized O +
in O +
response O +
to O +
estrogen B-Chemical +
exposure O +
( O -
Weiss O +
et O +
al. O +
1997 O -
) O -
. O +

Western O +
blot O +
analysis O +
demonstrated O +
that O +
Tif1γ O +
protein O +
expression O +
decreases O +
with O +
terminal O +
erythroid O +
differentiation O +
( O -
Figure O +
6B O -
) O -
. O +

Consistent O +
with O +
this O +
finding O -
, O +
after O +
24 O +
hpf O -
, O +
zebrafish O +
mon O +
mRNA O +
expression O +
falls O +
during O +
the O +
terminal O +
maturation O +
of O +
the O +
primitive O +
erythroid O +
cells O +
( O -
unpublished O +
data O -
) O -
. O +

In O +
two O +
different O +
murine O +
erythroleukemia O +
cell O +
lines O +
( O -
MEL O +
and O +
G1E O -
) O -
, O +
Tif1γ O +
is O +
also O +
expressed O +
in O +
nuclear O +
foci O -
, O +
and O +
even O +
though O +
the O +
overall O +
Tif1γ O +
protein O +
level O +
is O +
reduced O -
, O +
this O +
nuclear O +
foci O +
localization O +
does O +
not O +
change O +
with O +
differentiation O +
( O -
unpublished O +
data O -
) O -
. O +

This O +
provides O +
further O +
support O +
for O +
the O +
hypothesis O +
that O +
Tif1γ O +
acts O +
within O +
novel O +
nuclear O +
foci O -
, O +
during O +
erythroid O +
differentiation O -
. O +

Discussion O +
The O +
zebrafish O +
is O +
an O +
excellent O +
model O +
system O +
to O +
elucidate O +
the O +
molecular O +
machinery O +
controlling O +
gene O +
expression O +
during O +
hematopoiesis O +
( O -
Thisse O +
and O +
Zon O +
2002 O -
; O +
Galloway O +
and O +
Zon O +
2003 O -
) O -
. O +

As O +
part O +
of O +
a O +
large O -
- O -
scale O +
forward O +
genetic O +
screen O -
, O +
we O +
originally O +
identified O +
a O +
complementation O +
group O +
of O +
independent O +
mutant O +
alleles O +
in O +
the O +
zebrafish O +
gene O +
that O +
we O +
named O +
moonshine O +
( O -
Ransom O +
et O +
al. O +
1996 O -
) O -
. O +

Positional O +
cloning O +
was O +
used O +
to O +
identify O +
the O +
mon O +
gene O -
, O +
establishing O +
a O +
critical O +
role O +
for O +
a O +
transcriptional O +
intermediary O +
factor O -
, O +
Tif1γ O -
, O +
during O +
hematopoietic O +
development O -
. O +

The O +
mon O +
Gene O +
Encodes O +
the O +
Zebrafish O +
Ortholog O +
of O +
Mammalian O +
TIF1γ O +

Our O +
results O +
strongly O +
support O +
the O +
conclusion O +
that O +
we O +
have O +
positionally O +
cloned O +
the O +
zebrafish O +
mon O +
gene O +
correctly O -
, O +
and O +
it O +
is O +
the O +
ortholog O +
of O +
mammalian O +
Tif1γ O -
. O +

Tif1γ O +
is O +
present O +
in O +
the O +
critical O +
genetic O +
interval O +
encompassing O +
a O +
single O +
approximately O +
50-kb O +
PAC O +
clone O +
defined O +
by O +
linkage O +
analysis O +
( O -
see O +
Figure O +
3 O -
) O -
. O +

Sequence O +
analysis O +
indicates O +
that O +
zebrafish O +
tif1γ O +
is O +
most O +
similar O +
in O +
predicted O +
amino O +
acid O +
sequence O +
and O +
intron O -
/ O -
exon O +
structure O +
compared O +
to O +
the O +
predicted O +
orthologous O +
human O +
and O +
mouse O +
genes O -
. O +

Zebrafish O +
tif1γ O +
is O +
located O +
in O +
a O +
region O +
of O +
zebrafish O +
Chromosome O +
8 O +
syntenic O +
to O +
the O +
region O +
of O +
human O +
Chromosome O +
1 O +
containing O +
TIF1γ O -
. O +

We O +
identified O +
point O +
mutations O +
in O +
tif1γ O +
from O +
three O +
different O +
alleles O +
of O +
mon O +
that O +
each O +
result O +
in O +
premature O +
stop O +
codons O +
and O +
mRNA O +
decay O -
. O +

In O +
addition O -
, O +
tif1γ O -
/ O -
Tif1γ O +
is O +
highly O +
expressed O +
in O +
hematopoietic O +
cells O +
throughout O +
embryogenesis O +
in O +
both O +
zebrafish O +
and O +
mouse O +
( O -
see O +
Figure O +
4 O -
) O -
. O +

And O +
as O +
predicted O -
, O +
forced O +
expression O +
of O +
wild O -
- O -
type O +
tif1γ O +
mRNA O +
efficiently O +
rescues O +
hematopoiesis O +
in O +
mon O +
mutants O +
and O +
does O +
not O +
perturb O +
hematopoiesis O +
in O +
wild O -
- O -
type O +
embryos O +
( O -
see O +
Figure O +
5 O -
) O -
. O +

We O +
have O +
also O +
cloned O +
the O +
predicted O +
zebrafish O +
ortholog O +
of O +
tif1α O -
, O +
which O +
is O +
more O +
uniformly O +
expressed O +
in O +
zebrafish O +
embryos O +
like O +
mammalian O +
TIF1α O +
( O -
Le O +
Douarin O +
et O +
al. O +
1995 O -
; O +
Niederreither O +
et O +
al. O +
1999 O -
) O +
( O -
see O +
Figures O +
3A O +
and O +
4A O -
) O +
and O +
may O +
therefore O +
be O +
available O +
to O +
form O +
hetero O -
- O -
oligomers O +
with O +
Tif1γ O +
protein O +
in O +
developing O +
hematopoietic O +
cells O -
. O +

Comparing O +
available O +
zebrafish O +
and O +
mammalian O +
TIF1-predicted O +
amino O +
acid O +
sequences O -
, O +
it O +
appears O +
that O +
the O +
Tif1γ O +
orthologs O +
are O +
the O +
most O +
highly O +
conserved O +
family O +
members O +
while O +
the O +
Tif1α O +
sequences O +
are O +
relatively O +
more O +
divergent O -
. O +

We O +
have O +
not O +
found O +
a O +
Tif1β O +
ortholog O -
, O +
thus O +
far O -
, O +
in O +
the O +
zebrafish O +
or O +
fugu O +
genome O +
or O +
EST O +
sequences O -
. O +

It O +
is O +
possible O +
that O +
Tif1β O -
, O +
like O +
the O +
KRAB O +
domain O +
transcription O +
factors O +
it O +
binds O +
to O -
, O +
may O +
be O +
present O +
only O +
in O +
tetrapods O +
( O -
Urrutia O +
2003 O -
) O -
. O +

However O -
, O +
more O +
complete O +
genome O +
sequences O +
will O +
be O +
needed O +
to O +
confirm O +
this O +
hypothesis O -
. O +

Based O +
on O +
our O +
analysis O +
of O +
zebrafish O +
mon O +
mutants O -
, O +
it O +
is O +
reasonable O +
to O +
predict O +
that O +
Tif1γ O -
, O +
the O +
most O +
evolutionarily O +
conserved O +
TIF1 O +
family O +
member O -
, O +
plays O +
a O +
similarly O +
essential O +
role O +
in O +
human O +
and O +
mouse O +
hematopoiesis O -
. O +

Mutations O +
in O +
tif1γ O +
Cause O +
Apoptosis O +
of O +
Erythroid O +
Progenitors O +
Our O +
examination O +
of O +
hematopoietic O +
gene O +
expression O -
, O +
apoptosis O -
, O +
and O +
marrow O +
histology O +
in O +
mon O +
mutants O +
demonstrates O +
that O +
early O +
erythroid O +
progenitors O +
are O +
formed O +
in O +
homozygous O +
mutants O -
, O +
but O +
they O +
fail O +
to O +
properly O +
differentiate O +
and O +
instead O +
undergo O +
programmed O +
cell O +
death O +
( O -
see O +
Figure O +
1 O -
) O -
. O +

The O +
expression O +
of O +
gata1 O +
appears O +
to O +
initiate O +
normally O +
in O +
the O +
committed O +
erythroid O +
cells O +
of O +
mon O +
mutants O -
. O +

However O -
, O +
the O +
cells O +
are O +
abnormal O +
prior O +
to O +
the O +
complete O +
loss O +
of O +
gata1 O +
expression O -
. O +

TUNEL O -
- O -
positive O +
apoptotic O +
cells O +
are O +
abundant O +
by O +
the O +
12-somite O +
stage O +
of O +
development O -
, O +
and O +
by O +
22 O +
hpf O +
all O +
hematopoietic O +
gene O +
expression O +
is O +
extinguished O -
. O +

The O +
expression O +
of O +
marker O +
genes O -
, O +
including O +
scl O +
and O +
gata2 O -
, O +
characteristic O +
of O +
hematopoietic O +
stem O +
cells O +
and O +
primitive O +
hematopoietic O +
progenitors O -
, O +
are O +
also O +
not O +
detected O +
in O +
the O +
embryonic O +
blood O +
islands O +
of O +
mutants O +
at O +
22 O +
hpf O -
. O +

This O +
indicates O +
that O +
the O +
mutant O +
hematopoietic O +
cells O +
are O +
not O +
blocked O +
prior O +
to O +
commitment O +
to O +
the O +
erythroid O +
lineage O -
, O +
but O +
instead O +
develop O +
as O +
abnormal O +
erythroid O +
cells O +
and O +
undergo O +
apoptosis O -
, O +
similar O +
to O +
gata1-deficient O +
erythroid O +
cells O +
( O -
Fujiwara O +
et O +
al. O +
1996 O -
; O +
Lyons O +
et O +
al. O +
2002 O -
) O -
. O +

Defective O +
erythropoiesis O +
and O +
severe O +
anemia O +
were O +
also O +
observed O +
in O +
rare O +
surviving O +
homozygous O +
mutant O +
mon O +
adults O -
, O +
demonstrating O +
that O +
tif1γ O +
is O +
also O +
required O +
in O +
definitive O +
hematopoiesis O +
( O -
see O +
Figure O +
2 O -
) O -
. O +

The O +
zygotic O +
phenotypes O +
of O +
mon O +
mutants O +
may O +
not O +
reveal O +
the O +
function O +
of O +
maternally O +
inherited O +
Tif1γ O -
. O +

Maternally O +
expressed O +
zebrafish O +
Tif1γ O +
may O +
play O +
roles O +
in O +
hematopoiesis O +
or O +
other O +
aspects O +
of O +
organogenesis O +
that O +
are O +
not O +
detectable O +
due O +
to O +
the O +
presence O +
of O +
wild O -
- O -
type O +
mRNA O +
in O +
eggs O +
laid O +
by O +
heterozygous O +
mothers O -
. O +

Analysis O +
of O +
the O +
offspring O +
of O +
homozygous O +
mon O +
mutant O +
female O +
zebrafish O +
will O +
aid O +
in O +
defining O +
the O +
function O +
of O +
this O +
maternal O +
mRNA O -
. O +

The O +
present O +
analysis O +
of O +
zygotic O +
mon O +
mutants O +
provides O +
data O +
that O +
are O +
consistent O +
with O +
the O +
conclusion O +
that O +
tif1γ O +
is O +
essential O +
for O +
erythropoiesis O +
but O +
do O +
not O +
rule O +
out O +
essential O +
functions O +
in O +
other O +
hematopoietic O +
lineages O -
. O +

The O +
hematopoietic O +
phenotype O +
of O +
mon O +
mutants O +
resembles O +
the O +
loss O +
of O +
erythroid O +
cells O +
seen O +
in O +
both O +
mouse O +
Gata1 O +
knockout O +
embryos O +
and O +
zebrafish O +
vlad O +
tepes O +
( O -
gata1 O -
) O +
mutant O +
embryos O +
( O -
Fujiwara O +
et O +
al. O +
1996 O -
; O +
Lyons O +
et O +
al. O +
2002 O -
) O -
. O +

In O +
an O +
effort O +
to O +
determine O +
if O +
there O +
is O +
a O +
genetic O +
relationship O +
between O +
mon O +
and O +
gata1 O -
, O +
we O +
tested O +
their O +
ability O +
to O +
rescue O +
erythropoiesis O -
. O +

Both O +
injection O +
of O +
gata1 O +
mRNA O +
into O +
mon O +
homozygous O +
mutant O +
embryos O +
and O +
injection O +
of O +
tif1γ O +
mRNA O +
into O +
gata1 O +
knock O -
- O -
down O +
embryos O +
failed O +
to O +
rescue O +
hematopoiesis O +
( O -
unpublished O +
data O -
) O -
. O +

We O +
also O +
tested O +
for O +
a O +
direct O +
interaction O +
between O +
Tif1γ O +
and O +
Gata1 O +
proteins O +
by O +
coimmunoprecipitation O +
and O +
yeast O +
two O -
- O -
hybrid O +
assays O +
and O +
found O +
no O +
association O +
( O -
unpublished O +
data O -
) O -
. O +

Although O +
the O +
mutations O +
in O +
each O +
of O +
these O +
genes O +
arrest O +
cells O +
at O +
a O +
similar O +
stage O +
of O +
development O -
, O +
our O +
results O +
suggest O +
that O +
gata1 O +
and O +
tif1γ O +
act O +
independently O -
. O +

This O +
does O +
not O +
rule O +
out O +
the O +
possibility O +
that O +
parallel O +
genetic O +
pathways O +
involving O +
gata1 O +
and O +
tif1γ O -
, O +
operating O +
together O -
, O +
regulate O +
gene O +
transcription O +
within O +
blood O +
cells O -
. O +

The O +
Role O +
of O +
Tif1γ O +
in O +
Primitive O +
and O +
Definitive O +
Erythropoiesis O +
Taken O +
together O -
, O +
our O +
data O +
suggest O +
that O +
tif1γ O +
is O +
required O +
as O +
a O +
permissive O +
cofactor B-Chemical +
for O +
the O +
erythroid O +
lineage O -
- O -
specific O +
control O +
of O +
hematopoietic O +
gene O +
expression O -
. O +

We O +
reasonably O +
predict O +
that O +
Tif1γ O +
protein O +
functions O +
as O +
a O +
transcriptional O +
intermediary O +
factor O +
in O +
hematopoietic O +
progenitor O +
cells O +
given O +
that O +
both O +
TIF1α O +
( O -
Zhong O +
et O +
al. O +
1999 O -
) O +
and O +
TIF1β O +
( O -
Friedman O +
et O +
al. O +
1996 O -
; O +
Abrink O +
et O +
al. O +
2001 O -
) O +
have O +
been O +
shown O +
to O +
act O +
as O +
intermediary O +
factors O +
that O +
positively O +
or O +
negatively O +
regulate O +
gene O +
transcription O -
. O +

These O +
studies O +
indicate O +
that O +
TIF1α O +
and O +
TIF1β O +
act O +
as O +
scaffolds O +
that O +
link O +
different O +
classes O +
of O +
DNA O -
- O -
binding O +
proteins O +
and O +
chromatin O -
- O -
associated O +
proteins O +
into O +
larger O +
regulatory O +
complexes O -
. O +

Tif1γ O +
is O +
detected O +
within O +
nuclear O +
foci O +
( O -
see O +
Figure O +
6 O -
) O -
, O +
which O -
, O +
based O +
on O +
our O +
analysis O -
, O +
do O +
not O +
appear O +
to O +
correspond O +
to O +
several O +
types O +
of O +
previously O +
described O +
nuclear O +
bodies O -
, O +
including O +
PML O +
bodies O -
. O +

Localization O +
of O +
Tif1γ O +
to O +
these O +
nuclear O +
bodies O +
may O +
be O +
regulated O +
by O +
posttranslational O +
modification O +
such O +
as O +
SUMO O +
modification O +
that O +
is O +
required O +
for O +
PML O +
to O +
form O +
PML O +
nuclear O +
domains O +
( O -
Zhong O +
et O +
al. O +
2000a O -
, O +
2000b O -
; O +
Best O +
et O +
al. O +
2002 O -
) O -
. O +

These O +
foci O +
may O +
serve O +
as O +
assembly O +
points O +
where O +
Tif1γ O +
forms O +
multisubunit O +
complexes O +
with O +
DNA O -
- O -
binding O +
transcription O +
factors O +
and O +
their O +
other O +
essential O +
coactivators O +
or O +
corepressors O -
, O +
during O +
the O +
early O +
stages O +
of O +
erythroid O +
differentiation O -
. O +

It O +
will O +
be O +
important O +
to O +
determine O +
the O +
identity O +
of O +
Tif1γ O -
- O -
interacting O +
proteins O +
in O +
nuclear O +
foci O +
and O +
establish O +
how O +
they O +
function O +
with O +
Tif1γ O +
to O +
regulate O +
blood O +
cell O +
development O -
. O +

Materials O +
and O +
Methods O +
Zebrafish O +
and O +
mouse O +
strains O +
and O +
studies O +
Zebrafish O +
were O +
maintained O +
and O +
staged O +
as O +
described O +
( O -
Westerfield O +
1998 O -
) O -
. O +

The O +
alleles O +
montb222b O +
and O +
montg234 O +
were O +
generated O +
in O +
a O +
large O -
- O -
scale O +
screen O +
for O +
ENU B-Chemical -
- O -
induced O +
mutations O +
( O -
Ransom O +
et O +
al. O +
1996 O -
) O +
on O +
the O +
TU O -
, O +
whereas O +
the O +
monm262 O +
allele O +
was O +
derived O +
on O +
the O +
AB O +
strain O +
and O +
was O +
originally O +
called O +
vampire O +
( O -
Weinstein O +
et O +
al. O +
1996 O -
) O -
. O +

Mapping O +
strains O +
were O +
constructed O +
by O +
mating O +
to O +
WIK O +
or O +
SJD O +
polymorphic O +
strains O -
. O +

Linkage O +
analysis O +
was O +
performed O +
on O +
haploid O +
or O +
diploid O +
embryos O +
obtained O +
from O +
TU O -
/ O -
SJD O +
or O +
TU O -
/ O -
WIK O +
hybrids O -
. O +

In O +
situ O +
hybridization O +
and O +
stainings O +
of O +
embryos O +
were O +
done O +
as O +
described O +
( O -
Thompson O +
et O +
al. O +
1998 O -
; O +
Liao O +
et O +
al. O +
2002 O -
) O -
. O +

In O +
situ O +
hybridization O +
of O +
mouse O +
embryos O +
was O +
performed O +
as O +
described O +
( O -
Kingsley O +
et O +
al. O +
2001 O -
) O -
. O +

Genomic O +
DNA O +
isolation O -
, O +
genotyping O -
, O +
AFLP O +
analysis O -
, O +
and O +
chromosomal O +
walking O +
were O +
each O +
performed O +
as O +
previously O +
described O +
( O -
Brownlie O +
et O +
al. O +
1998 O -
; O +
Ransom O +
and O +
Zon O +
1999 O -
) O -
. O +

A O +
complete O +
list O +
of O +
primers O +
for O +
genetic O +
mapping O -
, O +
RT O -
- O -
PCR O -
, O +
and O +
sequencing O +
of O +
mon O +
are O +
available O +
on O +
request O -
. O +

mRNA O +
expression O +
constructs O -
, O +
morpholinos O -
, O +
and O +
microinjection O +
The O +
full O -
- O -
length O +
mon O +
cDNA O +
was O +
subcloned O +
into O +
EcoRI O +
and O +
XhoI O +
sites O +
in O +
the O +
pCS2 O -
+ O +
vector O -
. O +

Synthetic O +
mRNA O +
was O +
transcribed O +
in O +
vitro O -
, O +
and O +
microinjection O +
was O +
performed O +
essentially O +
as O +
described O +
( O -
Liao O +
et O +
al. O +
2002 O -
) O -
. O +

Cell O +
transplantation O +
Whole O +
kidney O +
marrow O +
cells O +
were O +
isolated O +
from O +
adult O +
gata1 O -
: O -
EGFP O +
transgenic O +
donors O -
, O +
resuspended O +
in O +
0.9X O +
phosphate O -
- O -
buffered O +
saline O +
+ O +
5 O -
% O +
fetal O +
bovine O +
serum O -
, O +
and O +
injected O +
into O +
the O +
sinus O +
venosus O +
of O +
2-d O -
- O -
old O +
montg234 O +
− O -
/ O -
− O +
and O +
control O +
embryos O -
. O +

Between O +
102 O +
and O +
103 O +
kidney O +
marrow O +
cells O +
were O +
injected O +
per O +
embryo O -
. O +

Individual O +
transplanted O +
embryos O +
were O +
anesthetized O +
and O +
visualized O +
daily O +
under O +
an O +
inverted O +
fluorescent O +
microscope O +
( O -
DM O -
- O -
IRE2 O -
; O +
Leica O -
, O +
Wetzlar O -
, O +
Germany O -
) O +
for O +
GFP+ O +
cells O +
over O +
a O +
span O +
of O +
12 O +
d. O +
On O +
day O +
13 O +
posttransplant O -
, O +
all O +
surviving O +
larvae O +
( O -
12 O -
/ O -
129 O -
; O +
9 O -
% O -
) O +
were O +
placed O +
in O +
tanks O +
and O +
monitored O +
for O +
survival O -
. O +

Antibodies O -
, O +
immunostaining O -
, O +
and O +
immunoblots O +
Antisera O +
against O +
the O +
human O +
C O -
- O -
terminal O +
TIF1γ O +
sequence O +
RRKRLKSDERPVHIK O +
was O +
generated O +
in O +
rabbits O +
( O -
Genemed O +
Synthesis O -
, O +
South O +
San O +
Francisco O -
, O +
California O -
, O +
United O +
States O -
) O +
and O +
affinity O +
purified O -
. O +

Mouse O +
embryonic O +
fibroblasts O +
grown O +
on O +
coverslips O +
were O +
immunostained O +
with O +
HP1α O +
( O -
Chemicon O -
, O +
Temecula O -
, O +
California O -
, O +
United O +
States O -
) O +
and O +
Tif1γ O +
antisera O +
simultaneously O -
. O +

In O +
brief O -
, O +
cells O +
were O +
fixed O +
in O +
4 O -
% O +
paraformaldehyde O +
for O +
5 O +
min O -
, O +
washed O +
with O +
phosphate O -
- O -
buffered O +
saline O -
, O +
and O +
blocked O +
with O +
5 O -
% O +
serum O +
( O -
PBST O -
) O +
for O +
30 O +
min O -
. O +

After O +
incubation O +
with O +
the O +
primary O +
antibodies O +
( O -
PBST O -
, O +
60 O +
min O -
) O +
cells O +
were O +
washed O +
three O +
times O +
with O +
PBST O +
and O +
incubated O +
with O +
secondary O +
antibodies O +
( O -
Jackson O +
Laboratory O -
, O +
Bar O +
Harbor O -
, O +
Maine O -
, O +
United O +
States O -
) O +
followed O +
by O +
three O +
washes O +
in O +
PBST O -
. O +

Cells O +
were O +
embedded O +
with O +
Vectashield O -
/ O -
DAPI B-Chemical +
and O +
analyzed O +
using O +
an O +
Axioplan O +
2 O +
microscope O +
( O -
Zeiss O -
, O +
Jena O -
, O +
Germany O -
) O -
. O +

Digital O +
images O +
were O +
processed O +
using O +
the O +
Volocity O +
1.0 O +
software O +
( O -
Improvision O -
, O +
Lexington O -
, O +
Massachusetts O -
, O +
United O +
States O -
) O -
. O +

G1E O +
cell O +
differentiation O +
experiments O +
were O +
performed O +
essentially O +
as O +
described O +
( O -
Weiss O +
et O +
al. O +
1997 O -
) O -
. O +

Supporting O +
Information O +
Transplantation O +
of O +
wild O -
- O -
type O +
zebrafish O +
marrow O +
cells O +
carrying O +
a O +
gata1 O -
: O -
GFP O +
transgene O +
into O +
2-d O -
- O -
old O +
embryos O +
reconstitutes O +
erythropoiesis O -
, O +
but O +
not O +
viability O -
, O +
in O +
montg234 O +
homozygous O +
mutants O -
. O +

Movies O +
of O +
live O +
embryos O +
at O +
day O +
3 O +
posttransplant O +
highlight O +
less O +
than O +
100 O +
GFP+ O +
RBCs O +
in O +
circulation O -
. O +

Transplanted O +
cells O +
were O +
observed O +
to O +
proliferate O -
, O +
resulting O +
in O +
thousands O +
of O +
donor O -
- O -
derived O +
erythrocytes O +
7 O +
d O +
later O -
. O +

Movies O +
present O +
GFP O -
- O -
fluorescent O +
images O +
of O +
live O +
zebrafish O +
larvae O -
. O +

Video O +
S1 O +
Untransplanted O +
Control O +
montg234 O +
Homozygous O +
Mutants O +
Had O +
No O +
Fluorescent O +
Cells O +
in O +
Circulation O +
at O +
3 O +
Days O +
of O +
Development O +
( O -
13.7 O +
MB O +
MOV O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Video O +
S2 O +
One O +
Day O +
after O +
Transplantation O -
, O +
Less O +
Than O +
100 O +
GFP+ O +
Erythrocytes O +
Were O +
Visible O +
in O +
the O +
Circulation O +
of O +
Three O +
montg234 O +
Homozygous O +
Mutants O +
( O -
11.3 O +
MB O +
MOV O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Video O +
S3 O +
Untransplanted O +
Control O +
montg234 O +
Homozygous O +
Mutants O +
Had O +
No O +
Fluorescent O +
Cells O +
in O +
Circulation O +
at O +
9 O +
Days O +
of O +
Development O +
( O -
7.9 O +
MB O +
MOV O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Video O +
S4 O +
Seven O +
Days O +
after O +
Transplantation O -
, O +
Thousands O +
of O +
Donor O -
- O -
Derived O +
Erythrocytes O +
Were O +
Visible O +
in O +
the O +
Circulation O +
of O +
a O +
Representative O +
montg234 O +
Homozygous O +
Mutant O +
( O -
11.2 O +
MB O +
MOV O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Accession O +
Numbers O +
The O +
GenBank O +
( O -
http://www.ncbi.nlm.nih.gov/Genbank O -
) O +
accession O +
numbers O +
for O +
the O +
genes O +
and O +
gene O +
products O +
discussed O +
in O +
this O +
paper O +
are O +
fly O +
bonus O +
( O -
AAF19646 O -
) O -
, O +
human O +
TIF1α O +
( O -
015164 O -
) O -
, O +
human O +
TIF1β O +
( O -
Q13263 O -
) O -
, O +
human O +
TIFγ O +
( O -
Q9UPN9 O -
) O -
, O +
human O +
TIF1γ O +
( O -
Q9UPN9 O -
) O -
, O +
mon O +
( O -
AY59853 O -
) O -
, O +
mouse O +
Tif1α O +
( O -
Q64127 O -
) O -
, O +
mouse O +
Tif1β O +
( O -
AAH58391 O -
) O -
, O +
and O +
mouse O +
Tif1γ O +
( O -
NP444400 O -
) O -
. O +

The O +
cDNA O +
sequences O +
of O +
zebrafish O +
mon O -
/ O -
tif1γ O +
and O +
tif1α O +
have O +
been O +
deposited O +
in O +
GenBank O +
under O +
the O +
accession O +
numbers O +
AY598453 O +
and O +
AY598454 O -
, O +
respectively O -
. O +

Acknowledgements O +
We O +
thank O +
A. O +
Davidson O -
, O +
J. O +
Amatruda O -
, O +
and O +
J. O +
Christian O +
for O +
critical O +
review O +
of O +
this O +
manuscript O -
; O +
J. O +
Postlethwait O +
and O +
W. O +
Talbot O +
for O +
helpful O +
discussions O +
and O +
experimental O +
advice O -
; O +
B. O +
Weinstein O +
for O +
the O +
gift O +
of O +
the O +
m262 O +
allele O +
of O +
mon O -
; O +
and O +
D. O +
Giarla O +
for O +
administrative O +
assistance O -
. O +

DGR O +
was O +
funded O +
by O +
the O +
American O +
Cancer O +
Society O +
and O +
an O +
award O +
to O +
Oregon O +
Health O +
and O +
Science O +
University O +
by O +
the O +
Howard O +
Hughes O +
Medical O +
Institute O +
( O -
HHMI O -
) O +
Biomedical O +
Research O +
Support O +
Program O +
for O +
Medical O +
Schools O -
. O +

LIZ O +
and O +
SHO O +
are O +
investigators O +
of O +
the O +
HHMI O -
. O +

This O +
work O +
was O +
supported O +
by O +
grants O +
from O +
the O +
National O +
Institutes O +
of O +
Health O -
. O +

Abbreviations O +
AFLP O +
- O +
amplified O +
fragment O +
length O +
polymorphism O +
ENU B-Chemical +
- O +
ethyl B-Chemical -
- I-Chemical -
nitrosourea I-Chemical +
EST O +
- O +
expressed O +
sequence O +
tag O +
GFP O +
- O +
green O +
fluorescent O +
protein O +
hpf O +
- O +
hours O +
postfertilization O +
KRAB O +
- O +
Krüppel O -
- O -
associated O +
box O +
mon O +
- O +
moonshine O -
; O +
PAC O +
PML O +
- O +
promyelocytic O +
leukemia O +
gene O +
product O +
RBCs O +
- O +
red O +
blood O +
cells O +
scl O +
- O +
stem O +
cell O +
leukemia O -
; O +
SSCP O +
TIF O +
- O +
transcriptional O +
intermediary O +
factor O +
TU O +
- O +
Tübingen O +
background O +
Figures O +
and O +
Tables O +
Figure O +
1 O +
Zebrafish O +
mon O +
Mutants O +
Have O +
Severe O +
Defects O +
in O +
Primitive O +
Hematopoiesis O +
( O -
A O -
) O +
Whole O -
- O -
mount O +
TUNEL O +
assays O +
reveal O +
that O +
ventral O -
- O -
posterior O +
mesodermal O +
cells O +
undergo O +
apoptosis O +
in O +
homozygous O +
montg234 O +
mutant O +
embryos O -
. O +

Whole O -
- O -
mount O +
in O +
situ O +
hybridization O +
of O +
gata1 O +
detected O +
at O +
the O +
12- O +
and O +
18-somite O +
stage O +
in O +
genotyped O +
embryos O -
. O +

Posterior O +
views O -
, O +
anterior O +
to O +
the O +
left O -
. O +

( O -
B O -
) O +
Extensive O +
apoptosis O +
is O +
visible O +
in O +
the O +
trunk O +
and O +
tail O +
( O -
arrowhead O -
) O +
and O +
also O +
in O +
hematopoietic O +
cells O +
of O +
the O +
embryonic O +
blood O +
island O +
at O +
22 O +
h O +
of O +
development O +
( O -
arrow O -
) O -
. O +

Whole O -
- O -
mount O +
in O +
situ O +
hybridization O +
at O +
22 O +
hpf O +
including O +
scl O -
, O +
gata2 O -
, O +
gata1 O -
, O +
ikaros O -
, O +
and O +
myb O +
in O +
montg234 O +
mutants O -
. O +

Expression O +
of O +
myb O +
is O +
greatly O +
reduced O +
in O +
the O +
blood O +
islands O +
because O +
of O +
a O +
loss O +
of O +
erythroid O +
cells O -
, O +
but O +
embryonic O +
macrophages O +
are O +
still O +
present O +
( O -
arrows O -
) O -
. O +

The O +
expression O +
of O +
rag1 O +
in O +
thymic O +
T O -
- O -
cells O +
appears O +
normal O +
in O +
mon O +
mutants O +
at O +
5 O +
d O +
postfertilization O +
( O -
arrow O +
heads O -
) O -
. O +

Lateral O +
views O +
of O +
22 O +
hpf O +
and O +
5-d O -
- O -
old O +
embryos O -
. O +

Figure O +
2 O +
Zebrafish O +
mon O +
Mutants O +
Also O +
Have O +
Severe O +
Defects O +
in O +
Definitive O +
Hematopoiesis O +
Adult O +
phenotype O +
of O +
wild O -
- O -
type O +
and O +
mon O +
mutants O -
. O +

A O +
rare O +
surviving O +
montb222 O +
homozygous O +
adult O +
shows O +
significant O +
cardiomegaly O +
in O +
comparison O +
to O +
a O +
wild O -
- O -
type O +
age O -
- O -
matched O +
control O -
. O +

Wright O -
– O -
Giemsa O +
stained O +
marrow O +
of O +
wild O -
- O -
type O +
adult O +
in O +
comparison O +
to O +
a O +
homozygous O +
mutant O -
. O +

Note O +
the O +
dramatic O +
reduction O +
of O +
terminally O +
differentiated O +
erythroid O +
cells O +
and O +
the O +
presence O +
of O +
abnormally O +
large O +
megaloblastic O +
proerythroblasts O +
in O +
the O +
montb222 O +
mutant O +
marrow O -
. O +

Figure O +
3 O +
Positional O +
Cloning O +
Identifies O +
the O +
mon O +
Gene O +
as O +
Zebrafish O +
tif1γ O +
( O -
A O -
) O +
Physical O +
map O +
of O +
the O +
mon O +
locus O +
on O +
zebrafish O +
Chromosome O +
8 O -
. O +

Microsatellite O +
markers O +
z987 O +
and O +
z11001 O +
were O +
used O +
to O +
initially O +
identify O +
recombinants O +
in O +
a O +
panel O +
of O +
2,200 O +
diploid O +
montg234 O +
homozygous O +
mutants O -
. O +

The O +
AFLP O +
marker O +
MA3 O +
was O +
used O +
to O +
initiate O +
a O +
chromosomal O +
walk O +
in O +
PAC O +
libraries O -
. O +

The O +
critical O +
PACS O +
that O +
were O +
isolated O +
to O +
encompass O +
the O +
mon O +
locus O +
are O +
indicated O +
by O +
numbers O +
above O +
bar O -
. O +

The O +
PAC O +
107N19 O +
defines O +
the O +
critical O +
interval O +
for O +
the O +
mon O +
gene O -
. O +

This O +
PAC O +
was O +
used O +
as O +
a O +
probe O +
to O +
screen O +
cDNA O +
libraries O +
and O +
to O +
identify O +
zebrafish O +
tif1γ O +
cDNAs O -
. O +

Numbers O +
below O +
the O +
bar O +
indicate O +
the O +
number O +
of O +
recombinants O +
identified O +
by O +
SSCP O +
analysis O -
. O +

( O -
B O -
) O +
Clustal O -
- O -
W O -
– O -
generated O +
phylogentic O +
tree O +
of O +
zebrafish O +
( O -
Danio O +
rerio O +
[ O -
Dr O -
] O -
) O +

Tif1γ O +
and O +
Tif1α O +
peptide O +
sequences O +
in O +
comparison O +
to O +
TIF1 O +
family O +
members O -
: O +
human O +
( O -
Hs O -
) O +
TIF1α O -
, O +
TIF1β O -
, O +
and O +
TIF1γ O -
; O +
mouse O +
( O -
Mm O -
) O +
Tif1α O -
, O +
Tif1β O -
, O +
and O +
Tif1γ O -
; O -
; O +
and O +
fly O +
( O -
Dm O -
) O +
bonus O -
. O +

( O -
C O -
) O +
Diagrams O +
illustrating O +
the O +
structure O +
of O +
the O +
Tif1γ O -
- O -
predicted O +
peptide O +
and O +
the O +
three O +
identified O +
point O +
mutants O -
. O +

RING O +
finger O +
( O -
RING O -
) O -
, O +
B O -
- O -
boxes O +
( O -
B1 O +
and O +
B2 O -
) O -
, O +
plant O +
homeodomain O +
finger O +
( O -
PHD O -
) O +
and O +
bromodomain O +
( O -
BROMO O -
) O -
. O +

Numbers O +
below O +
the O +
first O +
diagram O +
indicate O +
the O +
percent O +
identity O +
shared O +
between O +
each O +
of O +
these O +
domains O +
in O +
zebrafish O +
and O +
human O +
TIF1γ O -
. O +

The O +
predicted O +
truncated O +
proteins O +
are O +
indicated O -
. O +

( O -
D O -
) O +
DNA O +
sequence O +
chromatograms O +
showing O +
the O +
three O +
ENU B-Chemical -
- O -
induced O +
point O +
mutants O +
in O +
comparison O +
to O +
wild O -
- O -
type O +
control O +
sequences O +
Figure O +
4 O +
The O +
mon O -
/ O -
tif1γ O +
Gene O +
Is O +
Highly O +
Expressed O +
in O +
Hematopoietic O +
Mesoderm O +
( O -
A O -
) O +
In O +
situ O +
hybridization O +
of O +
zebrafish O +
embryos O +
demonstrating O +
the O +
embryonic O +
expression O +
of O +
tif1γ O -
. O +

tif1γ O +
is O +
initially O +
expressed O +
as O +
a O +
maternal O +
mRNA O -
. O +

Increased O +
expression O +
of O +
tif1γ O +
in O +
ventral O -
- O -
lateral O +
mesoderm O +
begins O +
between O +
the O +
one- O +
to O +
three O -
- O -
somite O +
stages O +
and O +
increases O +
through O +
early O +
development O -
. O +

By O +
five O +
somites O -
, O +
tif1γ O +
is O +
strongly O +
expressed O +
in O +
lateral O +
stripes O +
of O +
mesoderm O +
that O +
also O +
express O +
scl O -
. O +

At O +
22 O +
hpf O +
tif1γ O +
is O +
expressed O +
broadly O +
in O +
the O +
brain O -
, O +
spinal O +
cord O -
, O +
trunk O -
, O +
and O +
tail O +
mesenchyme O -
, O +
but O +
is O +
at O +
much O +
higher O +
levels O +
in O +
hematopoietic O +
cells O +
of O +
the O +
blood O +
island O -
. O +

Zebrafish O +
tif1α O +
is O +
also O +
broadly O +
expressed O +
but O +
relatively O +
more O +
uniform O +
in O +
most O +
tissues O -
, O +
in O +
comparison O +
to O +
tif1γ O -
. O +

Tif1α O +
is O +
weakly O +
expressed O +
at O +
early O +
somite O +
stages O +
in O +
hematopoietic O +
mesoderm O +
and O +
uniformly O +
expressed O +
at O +
22 O +
hpf O -
, O +
including O +
expression O +
in O +
the O +
blood O +
islands O -
. O +

Expression O +
of O +
scl O +
at O +
five O +
somites O +
and O +
22 O +
hpf O +
highlights O +
the O +
embryonic O +
blood O +
island O +
in O +
comparison O +
to O +
tif1γ O +
expression O -
. O +

( O -
B O -
) O +
In O +
situ O +
hybridization O +
of O +
mouse O +
embryos O +
detects O +
broad O +
expression O +
of O +
Tif1γ O +
at O +
embryonic O +
day O +
8.5 O +
including O +
the O +
yolk O +
sac O +
blood O +
islands O +
( O -
arrow O -
) O -
. O +

AT O +
embryonic O +
day O +
12.5 O -
, O +
there O +
is O +
high O +
level O +
expression O +
in O +
the O +
fetal O +
liver O +
( O -
arrow O -
) O +
and O +
broad O +
expression O +
in O +
the O +
embryonic O +
brain O -
, O +
spinal O +
chord O -
, O +
gut O -
, O +
and O +
muscle O -
. O +

Figure O +
5 O +
Overexpression O +
of O +
Wild O -
- O -
Type O +
tif1γ O +
mRNA O +
or O +
Marrow O +
Transplantation O +
Rescues O +
Embryonic O +
Hematopoiesis O +
in O +
mon O +
Mutants O +
( O -
A O -
) O +
montg234 O +
mutants O +
are O +
rescued O +
by O +
injection O +
of O +
mRNA O -
- O -
encoding O +
wild O -
- O -
type O +
Tif1γ O +
protein O -
. O +

At O +
4 O +
d O +
of O +
development O -
, O +
large O +
numbers O +
of O +
RBCs O +
are O +
visible O +
in O +
the O +
circulation O +
of O +
wild O -
- O -
type O +
zebrafish O -
, O +
shown O +
here O +
by O +
o B-Chemical -
- I-Chemical -
dianisidine I-Chemical +
staining O +
of O +
hemoglobin O -
. O +

Uninjected O +
monttg234 O +
homozygous O +
mutants O +
are O +
completely O +
bloodless O -
. O +

Injection O +
of O +
100 O +
pg O +
of O +
wild O -
- O -
type O +
tif1γ O +
mRNA O +
rescues O +
erythropoiesis O +
in O +
mutant O +
embryos O -
. O +

o B-Chemical -
- I-Chemical -
dianisidine I-Chemical -
- O -
stained O +
larvae O +
are O +
shown O +
in O +
ventral O +
views O +
to O +
highlight O +
blood O +
in O +
vessels O -
. O +

( O -
B O -
) O +
Transplantation O +
of O +
wild O -
- O -
type O +
zebrafish O +
marrow O +
cells O +
carrying O +
a O +
gata1 O -
: O -
GFP O +
transgene O +
into O +
2-d O -
- O -
old O +
embryos O +
reconstitutes O +
erythropoiesis O -
, O +
but O +
not O +
viability O -
, O +
in O +
montg234 O +
homozygous O +
mutants O -
. O +

Still O +
frames O +
from O +
movies O +
of O +
live O +
embryos O +
at O +
day O +
3 O +
posttransplant O +
highlight O +
less O +
than O +
100 O +
GFP+ O +
RBCs O +
in O +
circulation O +
( O -
top O -
) O -
. O +

Transplanted O +
cells O +
were O +
observed O +
to O +
proliferate O +
resulting O +
in O +
thousands O +
of O +
donor O -
- O -
derived O +
erythrocytes O +
7 O +
d O +
later O +
( O -
bottom O -
) O -
. O +

Arrows O +
indicate O +
the O +
hearts O +
of O +
control O +
and O +
transplanted O +
zebrafish O -
. O +

See O +
Videos O +
S1–S4 O -
. O +

Figure O +
6 O +
Mammalian O +
Tif1γ O +
Protein O +
Localizes O +
to O +
Nuclear O +
Bodies O +
Distinct O +
from O +
Heterochromatin O +
( O -
A O -
) O +
Deconvolved O +
immunofluorescence O +
images O +
of O +
a O +
mouse O +
embryonic O +
fibroblast O +
cell O +
nucleus O +
stained O +
with O +
an O +
anti O -
- O -
Tif1γ O +
antibody O +
and O +
stained O +
with O +
a O +
monoclonal O +
antibody O +
directed O +
against O +
HP1α O -
. O +

This O +
is O +
also O +
compared O +
to O +
DAPI B-Chemical +
staining O -
. O +

The O +
merged O +
images O +
of O +
the O +
nucleus O +
show O +
that O +
Tif1γ O +
does O +
not O +
colocalize O +
with O +
the O +
HP1α O +
or O +
DAPI B-Chemical +
staining O +
of O +
heterochromatin O +
while O +
HP1α O +
and O +
DAPI B-Chemical +
staining O +
overlap O -
. O +

( O -
B O -
) O +
G1ER O +
mouse O +
erythroleukemia O +
cells O +
express O +
high O +
levels O +
of O +
Tif1γ O +
protein O +
as O +
detected O +
by O +
Western O +
blot O +
analysis O -
. O +

Expression O +
of O +
Tif1γ O +
decreases O +
during O +
Gata1-dependent O +
erythroid O +
maturation O +
induced O +
by O +
β B-Chemical -
- I-Chemical -
estradiol I-Chemical +
treatment O +
to O +
induce O +
a O +
Gata1–ER O +
fusion O +
protein O -
. O +

Table O +
1 O +
Overexpression O +
of O +
tif1γ O +
mRNA O +
Rescues O +
mon O +
Mutants O -
: O +
Hematopoietic O +
Phenotypes O +
Synthetic O +
tif1γ O +
mRNA O +
( O -
100 O +
pg O -
) O +
was O +
injected O +
at O +
the O +
one O -
- O -
cell O +
stage O +
into O +
embryos O +
of O +
the O +
indicated O +
genotypes O -
. O +

For O +
the O +
mon O +
embryos O -
, O +
circulating O +
cells O +
where O +
counted O +
each O +
day O +
through O +
4 O +
d O -
, O +
when O +
the O +
embryos O +
were O +
fixed O +
and O +
stained O +
with O +
o B-Chemical -
- I-Chemical -
dianisidine I-Chemical +
to O +
detect O +
hemoglobin O +
in O +
mature O +
RBCs O -
. O +

Normal O +
embryos O +
contain O +
approximately O +
3,000 O +
circulating O +
cells O +
at O +
these O +
time O +
points O -
. O +

Results O +
are O +
given O +
as O +
number O +
of O +
embryos O +
with O +
the O +
indicated O +
phenotype O -
. O +

Numbers O +
in O +
parentheses O +
represent O +
percentage O +
of O +
total O +
embryos O +
analyzed O +
Table O +
2 O +
Marrow O +
Transplantation O +
Rescues O +
Hematopoiesis O +
But O +
Not O +
Survival O +
in O +
mon O +
Mutants O -
: O +
Embryos O +
with O +
Transplanted O +
Erythroid O +
Cells O +
Between O +
100 O +
and O +
1,000 O +
kidney O +
marrow O +
cells O +
from O +
adult O +
gata1 O -
: O -
EGFP O +
transgenic O +
donors O +
were O +
injected O +
per O +
zebrafish O +
embryo O +
at O +
48 O +
hpf O -
. O +

Individual O +
transplanted O +
embryos O +
were O +
anesthetized O +
and O +
visualized O +
for O +
GFP+ O +
erythroid O +
cells O -
. O +

By O +
10 O +
d O +
posttransplantation O +
the O +
indicated O +
number O +
of O +
embryos O +
had O +
an O +
estimated O +
100 O +
to O +
3,000 O +
GFP+ O +
cells O +
in O +
circulation O -
. O +

At O +
3 O +
mo O +
the O +
indicated O +
number O +
of O +
fish O +
were O +
alive O -
. O +

The O +
relative O +
percentage O +
of O +
embryos O +
is O +
shown O +
in O +
parentheses O +
Footnotes O +
Conflicts O +
of O +
interest O -
. O +

The O +
authors O +
have O +
declared O +
that O +
no O +
conflicts O +
of O +
interest O +
exist O -
. O +

Author O +
contributions O -
. O +

DGR O -
, O +
NB O -
, O +
KN O -
, O +
DT O -
, O +
CB O -
, O +
NST O -
, O +
YZ O -
, O +
JP O -
, O +
SHO O -
, O +
and O +
LIZ O +
conceived O +
and O +
designed O +
the O +
experiments O -
. O +

DGR O -
, O +
NB O -
, O +
KN O -
, O +
DT O -
, O +
CB O -
, O +
NST O -
, O +
NPL O -
, O +
WJS O -
, O +
CAL O -
, O +
CH O -
, O +
BAB O -
, O +
and O +
PDK O +
performed O +
the O +
experiments O -
. O +

DGR O -
, O +
NB O -
, O +
KN O -
, O +
DT O -
, O +
CB O -
, O +
NST O -
, O +
NPL O -
, O +
YZ O -
, O +
JP O -
, O +
SHO O -
, O +
and O +
LIZ O +
analyzed O +
the O +
data O -
. O +

DGR O -
, O +
NB O -
, O +
KN O -
, O +
DT O -
, O +
NST O -
, O +
YZ O -
, O +
BAB O -
, O +
SL O -
, O +
and O +
JP O +
contributed O +
reagents B-Chemical -
/ O -
materials O -
/ O -
analysis O +
tools O -
. O +

DGR O -
, O +
NB O -
, O +
KN O -
, O +
DT O -
, O +
and O +
LIZ O +
wrote O +
the O +
paper O -
. O +

Academic O +
Editor O -
: O +

William O +
Talbot O -
, O +
Stanford O +
University O +
¤Current O +
address O -
: O +
Department O +
of O +
Cell O +
and O +
Developmental O +
Biology O -
, O +
Oregon O +
Health O +
and O +
Science O +
University O -
, O +
Portland O -
, O +
Oregon O -
, O +
United O +
States O +
of O +
America O +
Citation O -
: O +
Ransom O +
DG O -
, O +
Bahary O +
N O -
, O +
Niss O +
K O -
, O +
Traver O +
D O -
, O +
Burns O +
C O -
, O +
et O +
al. O +
( O -
2004 O -
) O +

The O +
zebrafish O +
moonshine O +
gene O +
encodes O +
transcriptional O +
intermediary O +
factor O +
1γ O -
, O +
an O +
essential O +
regulator O +
of O +
hematopoiesis O -
. O +

PLoS O +
Biol O +
2 O -
( O -
8 O -
) O -
: O +
e237 O -
. O +

Spontaneous O +
Autoimmunity O +
in O +
129 O +
and O +
C57BL O -
/ O -
6 O +
Mice O -
— O -
Implications O +
for O +
Autoimmunity O +
Described O +
in O +
Gene O -
- O -
Targeted O +
Mice O +
Abstract O +
Systemic O +
lupus O +
erythematosus O +
( O -
SLE O -
) O +
is O +
a O +
multisystem O +
autoimmune O +
disorder O +
in O +
which O +
complex O +
genetic O +
factors O +
play O +
an O +
important O +
role O -
. O +

Several O +
strains O +
of O +
gene O -
- O -
targeted O +
mice O +
have O +
been O +
reported O +
to O +
develop O +
SLE O -
, O +
implicating O +
the O +
null O +
genes O +
in O +
the O +
causation O +
of O +
disease O -
. O +

However O -
, O +
hybrid O +
strains O +
between O +
129 O +
and O +
C57BL O -
/ O -
6 O +
mice O -
, O +
widely O +
used O +
in O +
the O +
generation O +
of O +
gene O -
- O -
targeted O +
mice O -
, O +
develop O +
spontaneous O +
autoimmunity O -
. O +

Furthermore O -
, O +
the O +
genetic O +
background O +
markedly O +
influences O +
the O +
autoimmune O +
phenotype O +
of O +
SLE O +
in O +
gene O -
- O -
targeted O +
mice O -
. O +

This O +
suggests O +
an O +
important O +
role O +
in O +
the O +
expression O +
of O +
autoimmunity O +
of O +
as O -
- O -
yet O -
- O -
uncharacterised O +
background O +
genes O +
originating O +
from O +
these O +
parental O +
mouse O +
strains O -
. O +

Using O +
genome O -
- O -
wide O +
linkage O +
analysis O -
, O +
we O +
identified O +
several O +
susceptibility O +
loci O -
, O +
derived O +
from O +
129 O +
and O +
C57BL O -
/ O -
6 O +
mice O -
, O +
mapped O +
in O +
the O +
lupus O -
- O -
prone O +
hybrid O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O +
model O -
. O +

By O +
creating O +
a O +
C57BL O -
/ O -
6 O +
congenic O +
strain O +
carrying O +
a O +
129-derived O +
Chromosome O +
1 O +
segment O -
, O +
we O +
found O +
that O +
this O +
129 O +
interval O +
was O +
sufficient O +
to O +
mediate O +
the O +
loss O +
of O +
tolerance O +
to O +
nuclear O +
antigens B-Chemical -
, O +
which O +
had O +
previously O +
been O +
attributed O +
to O +
a O +
disrupted O +
gene O -
. O +

These O +
results O +
demonstrate O +
important O +
epistatic O +
modifiers O +
of O +
autoimmunity O +
in O +
129 O +
and O +
C57BL O -
/ O -
6 O +
mouse O +
strains O -
, O +
widely O +
used O +
in O +
gene O +
targeting O -
. O +

These O +
background O +
gene O +
influences O +
may O +
account O +
for O +
some O -
, O +
or O +
even O +
all O -
, O +
of O +
the O +
autoimmune O +
traits O +
described O +
in O +
some O +
gene O -
- O -
targeted O +
models O +
of O +
SLE O -
. O +

Introduction O +
Systemic O +
lupus O +
erythematosus O +
( O -
SLE O -
) O +
is O +
a O +
chronic O +
autoimmune O +
disease O +
characterised O +
by O +
the O +
production O +
of O +
autoantibodies O +
( O -
auto O -
- O -
Abs O -
) O +
against O +
a O +
wide O +
spectrum O +
of O +
self O -
- O -
antigens B-Chemical -
, O +
mainly O +
from O +
subcellular O +
compartments O -
, O +
especially O +
the O +
cell O +
nucleus O -
. O +

Genetic O +
predisposition O +
is O +
an O +
important O +
contributor O +
to O +
susceptibility O +
to O +
SLE O +
in O +
both O +
humans O +
and O +
animals O +
( O -
Vyse O +
and O +
Todd O +
1996 O -
; O +
Harley O +
et O +
al. O +
1998 O -
; O +
Theofilopoulos O +
and O +
Kono O +
1999 O -
; O +
Wakeland O +
et O +
al. O +
2001 O -
) O -
. O +

Genes O +
in O +
multiple O +
pathways O +
participate O +
in O +
mediating O +
disease O +
pathogenesis O -
, O +
and O +
epistatic O +
interactions O +
amongst O +
these O +
genes O +
influence O +
the O +
expression O +
of O +
disease O -
. O +

In O +
this O +
context O -
, O +
both O +
genetic O +
linkage O +
studies O +
in O +
spontaneous O +
lupus O -
- O -
prone O +
models O +
and O +
synthetic O +
murine O +
models O +
of O +
autoimmunity O +
generated O +
by O +
targeted O +
disruption O +
of O +
specific O +
genes O +
modulating O +
the O +
immune O +
system O +
have O +
widely O +
been O +
used O +
to O +
investigate O +
the O +
complexity O +
of O +
SLE O -
. O +

The O +
best O -
- O -
studied O +
strains O +
of O +
mice O +
that O +
spontaneously O +
develop O +
a O +
lupus O -
- O -
like O +
pathology O +
are O +
the O +
New O +
Zealand O +
Black O -
/ O -
New O +
Zealand O +
White O +
hybrid O +
strain O +
( O -
NZB O -
/ O -
WF1 O -
) O -
; O +
the O +
MRL O -
/ O -
Mp O +
lpr O -
/ O -
lpr O +
strain O -
, O +
which O +
carries O +
the O +
lpr O +
mutation O +
of O +
the O +
FAS O +
receptor O +
gene O -
; O +
and O +
the O +
BXSB O +
strain O -
, O +
which O +
carries O +
the O +
Y O +
chromosome O +
autoimmune O +
accelerator O +
( O -
Yaa O -
) O +
gene O +
( O -
Theofilopoulos O +
and O +
Dixon O +
1985 O -
) O -
. O +

Extensive O +
genetic O +
mapping O +
studies O +
in O +
all O +
three O +
strains O +
have O +
identified O +
multiple O +
intervals O +
associated O +
with O +
disease O +
susceptibility O -
. O +

Interestingly O -
, O +
the O +
majority O +
of O +
the O +
intervals O +
detected O +
are O +
strain O -
- O -
specific O -
, O +
confirming O +
the O +
genetic O +
complexity O +
of O +
the O +
disease O +
and O +
indicating O +
the O +
presence O +
of O +
extensive O +
heterogeneity O +
in O +
the O +
genes O +
contributing O +
to O +
the O +
pathogenesis O +
of O +
the O +
disease O -
. O +

However O -
, O +
some O +
susceptibility O +
loci O +
have O +
been O +
mapped O +
to O +
similar O +
chromosome O +
locations O +
in O +
different O +
strains O -
, O +
suggesting O +
that O +
at O +
least O +
some O +
susceptibility O +
may O +
be O +
shared O +
amongst O +
lupus O -
- O -
prone O +
strains O -
. O +

Amongst O +
these O +
shared O +
susceptibility O +
loci O -
, O +
the O +
most O +
striking O +
are O +
loci O +
on O +
distal O +
Chromosome O +
1 O -
, O +
for O +
which O +
important O +
contributing O +
genes O +
have O +
been O +
found O +
in O +
New O +
Zealand O +
and O +
BXSB O +
models O +
( O -
Theofilopoulos O +
and O +
Kono O +
1999 O -
; O +
Wakeland O +
et O +
al. O +
2001 O -
) O -
. O +

Although O +
considerable O +
efforts O +
have O +
been O +
made O +
to O +
identify O +
the O +
genes O +
responsible O +
for O +
the O +
development O +
of O +
the O +
disease O -
, O +
with O +
the O +
exception O +
of O +
the O +
lpr O +
mutation O -
, O +
none O +
of O +
the O +
genetic O +
contributions O +
to O +
disease O +
in O +
the O +
three O +
well O -
- O -
documented O +
murine O +
SLE O +
strains O +
have O +
yet O +
been O +
fully O +
resolved O +
at O +
the O +
molecular O +
or O +
protein O +
level O -
. O +

Thus O -
, O +
targeted O +
genetic O +
disruption O +
of O +
candidate O +
genes O +
encoding O +
proteins O +
of O +
the O +
immune O +
system O +
has O +
been O +
extensively O +
used O +
to O +
examine O +
their O +
role O +
in O +
immune O +
regulation O -
. O +

However O -
, O +
the O +
most O +
surprising O +
result O +
of O +
this O +
powerful O +
approach O +
has O +
been O +
the O +
high O +
frequency O +
with O +
which O +
such O +
mutations O +
have O +
been O +
associated O +
with O +
an O +
autoimmune O +
phenotype O -
. O +

In O +
this O +
regard O -
, O +
it O +
is O +
of O +
note O +
that O +
hybrid O +
strains O +
between O +
129 O +
and O +
C57BL O -
/ O -
6 O +
mice O -
, O +
widely O +
used O +
in O +
the O +
generation O +
of O +
gene O -
- O -
targeted O +
mice O -
, O +
are O +
spontaneously O +
predisposed O +
to O +
development O +
of O +
humoral O +
autoimmunity O +
with O +
low O +
levels O +
of O +
glomerulonephritis O +
( O -
Obata O +
et O +
al. O +
1979 O -
; O +
Botto O +
et O +
al. O +
1998 O -
; O +
Bickerstaff O +
et O +
al. O +
1999 O -
; O +
Santiago O -
- O -
Raber O +
et O +
al. O +
2001 O -
) O -
. O +

Furthermore O -
, O +
the O +
genetic O +
background O +
markedly O +
influences O +
the O +
autoimmune O +
phenotype O +
in O +
gene O -
- O -
targeted O +
mice O +
( O -
Bolland O +
and O +
Ravetch O +
2000 O -
; O +
Santiago O -
- O -
Raber O +
et O +
al. O +
2001 O -
; O +
Mitchell O +
et O +
al. O +
2002 O -
) O -
. O +

These O +
observations O +
led O +
to O +
the O +
hypothesis O +
that O +
the O +
autoimmune O +
phenotype O +
described O +
in O +
some O +
gene O -
- O -
targeted O +
mice O +
might O +
be O +
due O +
primarily O +
to O +
combinations O +
of O +
as O -
- O -
yet O -
- O -
uncharacterised O +
background O +
genes O -
, O +
originating O +
from O +
129 O +
and O +
C57BL O -
/ O -
6 O +
mice O +
strains O -
, O +
interacting O +
or O +
not O +
with O +
the O +
mutated O +
allele O -
. O +

To O +
test O +
this O -
, O +
we O +
conducted O +
a O +
genome O -
- O -
wide O +
scan O +
analysis O +
of O +
two O +
large O +
cohorts O +
of O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
mice O -
, O +
one O +
of O +
which O +
carried O +
a O +
mutation O +
in O +
the O +
serum O +
amyloid B-Chemical +
P O +
component O +
gene O +
( O -
Apcs O -
) O -
. O +

The O +
Apcs O -
- O -
deficient O +
mice O +
( O -
Apcs− O -
/ O -
− O -
) O +
were O +
chosen O +
as O +
an O +
example O +
of O +
a O +
gene O -
- O -
targeted O +
strain O +
previously O +
reported O +
to O +
develop O +
a O +
lupus O -
- O -
like O +
disease O +
on O +
the O +
hybrid O +
genetic O +
background O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
; O +
autoimmunity O +
in O +
Apcs− O -
/ O -
− O +
mice O +
persists O +
even O +
after O +
backcrossing O +
the O +
mutated O +
gene O +
onto O +
C57BL O -
/ O -
6 O +
( O -
Bickerstaff O +
et O +
al. O +
1999 O -
) O -
. O +

We O +
chose O +
this O +
targeted O +
gene O +
in O +
particular O +
to O +
study O +
since O +
the O +
Apcs O +
gene O +
is O +
located O +
on O +
Chromosome O +
1 O -
, O +
approximately O +
94 O +
cM O +
from O +
the O +
centromere O -
, O +
within O +
a O +
region O +
where O +
several O +
lupus O -
- O -
susceptibility O +
loci O -
, O +
designated O +
Sle1 O +
( O -
Morel O +
et O +
al. O +
2001 O -
) O -
, O +
Nba2 O +
( O -
Drake O +
et O +
al. O +
1995 O -
; O +
Vyse O +
et O +
al. O +
1997 O -
) O -
, O +
and O +
Bxs3 O +
( O -
Hogarth O +
et O +
al. O +
1998 O -
; O +
Haywood O +
et O +
al. O +
2000 O -
) O -
, O +
have O +
been O +
mapped O +
in O +
NZW O -
, O +
NZB O -
, O +
and O +
BXSB O +
lupus O -
- O -
prone O +
strains O -
, O +
respectively O -
. O +

This O +
region O +
contains O +
several O +
genes O -
, O +
including O +
those O +
encoding O +
FcγRII O -
, O +
the O +
complement O +
receptor O +
CR1 O -
/ O -
2 O +
( O -
CD35 O -
/ O -
CD21 O -
) O -
, O +
and O +
the O +
decay O -
- O -
accelerating O +
factor O +
CD55 O +
( O -
Prodeus O +
et O +
al. O +
1998 O -
; O +
Bolland O +
and O +
Ravetch O +
2000 O -
; O +
Miwa O +
et O +
al. O +
2002 O -
; O +
Wu O +
et O +
al. O +
2002 O -
) O -
, O +
which O +
have O +
each O +
been O +
implicated O +
in O +
the O +
causation O +
of O +
SLE O +
when O +
inactivated O +
by O +
gene O -
- O -
targeting O +
in O +
129 O +
embryonic O +
stem O +
cells O -
. O +

Here O +
we O +
show O +
that O +
there O +
are O +
multiple O +
genetic O +
loci O -
, O +
derived O +
from O +
both O +
129 O +
and O +
C57BL O -
/ O -
6 O +
mice O -
, O +
contributing O +
to O +
autoimmunity O -
. O +

Furthermore O -
, O +
a O +
129-derived O +
interval O +
on O +
distal O +
Chromosome O +
1 O -
, O +
when O +
transferred O +
onto O +
the O +
C57BL O -
/ O -
6 O +
genome O -
, O +
a O +
combination O +
commonly O +
created O +
by O +
backcrossing O +
onto O +
C57BL O -
/ O -
6 O +
a O +
gene O +
that O +
has O +
been O +
inactivated O +
in O +
129 O +
embryonic O +
stem O +
cells O -
, O +
was O +
sufficient O +
to O +
cause O +
humoral O +
autoimmunity O +
in O +
its O +
own O +
right O -
, O +
irrespective O +
of O +
the O +
presence O +
of O +
the O +
mutated O +
Apcs O +
gene O -
. O +

These O +
results O +
demonstrate O +
important O +
epistatic O +
interactions O +
between O +
genes O +
from O +
129 O +
and O +
C57BL O -
/ O -
6 O +
genomes O +
on O +
the O +
development O +
of O +
autoimmunity O +
and O +
illustrate O +
the O +
important O +
effects O +
of O +
background O +
genes O +
in O +
the O +
analysis O +
and O +
interpretation O +
of O +
autoimmune O +
phenotypes O +
associated O +
with O +
targeted O +
genetic O +
disruptions O -
. O +

Results O +
Disease O +
Traits O +
in O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
and O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs− O -
/ O -
− O +
Mice O +
To O +
investigate O +
the O +
genetic O +
basis O +
of O +
the O +
lupus O -
- O -
like O +
disease O +
observed O +
in O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O +
hybrid O +
mice O -
, O +
we O +
generated O +
two O +
large O +
cohorts O +
of O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
animals O -
, O +
one O +
carrying O +
a O +
mutation O +
in O +
the O +
Apcs O +
gene O -
, O +
and O +
monitored O +
them O +
for O +
1 O +
y O +
under O +
identical O +
environmental O +
conditions O -
. O +

Since O +
female O +
mice O +
in O +
the O +
original O +
reports O +
showed O +
a O +
higher O +
penetrance O +
of O +
disease O -
, O +
the O +
present O +
study O +
was O +
conducted O +
only O +
on O +
female O +
mice O -
. O +

The O +
results O +
of O +
the O +
phenotypic O +
analysis O +
at O +
1 O +
y O +
of O +
age O +
are O +
summarised O +
in O +
Tables O +
1 O +
and O +
2 O -
. O +

As O +
previously O +
reported O +
( O -
Botto O +
et O +
al. O +
1998 O -
) O -
, O +
the O +
wild O -
- O -
type O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
mice O +
developed O +
lupus O +
traits O +
with O +
elevated O +
levels O +
of O +
auto O -
- O -
Abs O -
, O +
starting O +
from O +
6 O +
mo O +
of O +
age O +
( O -
data O +
not O +
shown O -
) O -
, O +
and O +
histological O +
evidence O +
of O +
proliferative O +
glomerulonephritis O -
. O +

In O +
agreement O +
with O +
our O +
previous O +
observations O +
( O -
Bickerstaff O +
et O +
al. O +
1999 O -
) O -
, O +
the O +
titres O +
of O +
anti O -
- O -
nuclear O +
Abs O +
( O -
ANAs O -
) O +
and O +
anti O -
- O -
chromatin O +
Ab O +
were O +
considerably O +
greater O +
in O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs− O -
/ O -
− O +
mice O +
compared O +
with O +
the O +
strain O -
- O -
matched O +
controls O -
. O +

However O -
, O +
in O +
contrast O +
to O +
our O +
original O +
findings O -
, O +
the O +
levels O +
of O +
the O +
other O +
two O +
disease O +
serological O +
markers O +
analysed O +
( O -
anti O -
- O -
single O -
- O -
stranded O +
DNA O +
[ O -
ssDNA O -
] O +
and O +
anti O -
- O -
double O -
- O -
stranded O +
DNA O +
[ O -
dsDNA O -
] O +
Abs O -
) O +
and O +
the O +
severity O +
of O +
the O +
renal O +
pathology O +
were O +
not O +
different O +
between O +
the O +
two O +
experimental O +
groups O -
. O +

In O +
view O +
of O +
the O +
possibility O +
of O +
an O +
association O +
between O +
the O +
fixed O +
129-derived O +
segment O +
flanking O +
the O +
mutated O +
Apcs O +
gene O +
and O +
the O +
autoimmune O +
traits O +
observed O -
, O +
the O +
genome O -
- O -
wide O +
linkage O +
analysis O +
of O +
the O +
two O +
experimental O +
cohorts O +
was O +
carried O +
out O +
separately O -
. O +

Mapping O +
of O +
Loci O +
Predisposing O +
to O +
Lupus O +
in O +
the O +
Hybrid O +
Strain O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O +
Mice O +
were O +
genotyped O +
with O +
143 O +
microsatellite O +
markers O +
distributed O +
throughout O +
the O +
autosomes O +
such O +
that O +
98 O -
% O +
of O +
the O +
genes O +
were O +
within O +
20 O +
cM O +
of O +
an O +
informative O +
marker O -
. O +

A O +
summary O +
of O +
the O +
genome O -
- O -
wide O +
linkage O +
analysis O +
for O +
each O +
of O +
the O +
disease O +
traits O +
measured O +
is O +
shown O +
in O +
Table O +
3 O -
. O +

The O +
areas O +
of O +
linkage O +
were O +
defined O +
according O +
to O +
the O +
parental O +
origin O -
, O +
129 O +
or O +
C57BL O -
/ O -
6 O -
. O +

Only O +
linkages O +
identified O +
in O +
both O +
experimental O +
groups O +
are O +
reported O +
in O +
Table O +
3 O -
, O +
with O +
the O +
exception O +
of O +
the O +
Chromosome O +
1 O +
distal O +
segment O -
, O +
where O +
the O +
linkage O +
analysis O +
could O +
not O +
be O +
applied O +
to O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs− O -
/ O -
− O +
mice O +
as O +
this O +
region O +
was O +
of O +
fixed O +
129 O +
origin O -
. O +

Chromosomes O +
where O +
linkages O +
were O +
present O +
only O +
in O +
one O +
of O +
the O +
two O +
cohorts O +
are O +
shown O +
in O +
Figures O +
1–3 O -
. O +

The O +
quantitative O +
trait O +
linkage O +
( O -
QTL O -
) O +
analysis O +
identified O +
several O +
intervals O +
on O +
Chromosome O +
1 O +
with O +
linkage O +
to O +
disease O +
serological O +
markers O -
, O +
and O +
these O +
regions O +
were O +
all O +
derived O +
from O +
the O +
129 O +
mouse O +
strain O +
( O -
see O +
Table O +
3 O -
; O +
Figures O +
4 O +
and O +
5 O -
) O -
. O +

Interestingly O -
, O +
whilst O +
ANA O +
and O +
anti O -
- O -
chromatin O +
Ab O +
levels O +
showed O +
suggestive O +
or O +
significant O +
linkages O +
only O +
to O +
the O +
telomeric O +
region O +
of O +
Chromosome O +
1 O -
, O +
with O +
an O +
estimated O +
peak O +
occurring O +
at O +
a O +
position O +
approximately O +
90 O +
cM O +
near O +
the O +
Apcs O +
gene O -
, O +
anti O -
- O -
dsDNA O +
or O +
anti O -
- O -
ssDNA O +
Ab O +
production O +
was O +
also O +
linked O +
to O +
other O +
segments O +
on O +
Chromosome O +
1 O -
, O +
indicating O +
a O +
more O +
complex O +
genetic O +
contribution O +
from O +
the O +
129 O +
mouse O +
strain O -
. O +

Guided O +
by O +
these O +
observations O -
, O +
we O +
investigated O +
whether O +
the O +
increased O +
levels O +
of O +
ANA O +
and O +
anti O -
- O -
chromatin O +
Ab O +
observed O +
in O +
the O +
Apcs− O -
/ O -
− O +
mice O +
were O +
caused O +
by O +
a O +
gene O -
( O -
s O -
) O +
within O +
the O +
fixed O +
129 O +
region O +
surrounding O +
the O +
mutated O +
Apcs O +
gene O -
, O +
rather O +
than O +
caused O +
by O +
the O +
mutated O +
Apcs O +
gene O +
itself O -
. O +

We O +
compared O +
the O +
levels O +
of O +
these O +
auto O -
- O -
Abs O +
between O +
all O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs− O -
/ O -
− O +
mice O +
and O +
a O +
group O +
of O +
33 O +
wild O -
- O -
type O +
mice O +
that O +
were O +
selected O +
for O +
being O +
homozygous O +
129 O +
in O +
the O +
region O +
of O +
Chromosome O +
1 O +
between O +
microsatellites O +
D1Mit105 O +
and O +
D1Mit O +
223 O +
( O -
80–106 O +
cM O -
) O +
( O -
Figure O +
6A–6D O -
) O -
. O +

In O +
contrast O +
to O +
the O +
results O +
reported O +
in O +
Table O +
1 O -
, O +
this O +
comparison O +
showed O +
no O +
significant O +
differences O +
between O +
the O +
two O +
experimental O +
groups O -
. O +

This O +
result O +
demonstrates O +
that O -
, O +
most O +
likely O -
, O +
the O +
129-derived O +
region O +
and O +
not O +
the O +
lack O +
of O +
Apcs O +
was O +
mediating O +
the O +
production O +
of O +
ANA O +
and O +
anti O -
- O -
chromatin O +
Ab O -
. O +

Consistent O +
with O +
this O +
explanation O -
, O +
we O +
found O +
that O +
the O +
129 O +
mice O +
have O +
significantly O +
higher O +
levels O +
of O +
Apcs O +
in O +
circulation O +
compared O +
with O +
the O +
C57BL O -
/ O -
6 O +
mice O +
( O -
median O -
, O +
83 O +
mg O -
/ O -
l O -
; O +
range O -
, O +
25–208 O -
; O +
n O +
= O +
16 O +
versus O +
median O -
, O +
5 O +
mg O -
/ O -
l O -
; O +
range O -
, O +
4–9 O -
; O +
n O +
= O +
10 O -
, O +
respectively O -
; O +
p O +
< O +
0.0001 O -
) O -
. O +

The O +
C57BL O -
/ O -
6 O +
strain O +
has O +
previously O +
been O +
reported O +
to O +
be O +
one O +
of O +
the O +
murine O +
strains O +
defined O +
as O +
low O +
Apcs O +
producers O +
( O -
Pepys O +
et O +
al. O +
1979 O -
; O +
Baltz O +
et O +
al. O +
1980 O -
) O -
. O +

In O +
addition O -
, O +
sequence O +
analysis O +
of O +
the O +
entire O +
Apcs O +
coding O +
region O +
in O +
both O +
strains O +
failed O +
to O +
identify O +
any O +
coding O +
sequence O +
polymorphisms O +
in O +
the O +
Apcs O +
gene O +
( O -
data O +
not O +
shown O -
) O -
, O +
indicating O +
that O +
a O +
structural O +
variant O +
of O +
the O +
protein O +
is O +
unlikely O +
to O +
be O +
the O +
explanation O +
for O +
our O +
findings O -
. O +

This O +
is O +
consistent O +
with O +
a O +
previous O +
report O +
by O +
Drake O +
et O +
al. O +
( O -
1996 O -
) O +
that O +
showed O +
no O +
Apcs O +
coding O +
sequence O +
differences O +
amongst O +
several O +
autoimmune O +
and O +
nonautoimmune O +
murine O +
strains O -
. O +

In O +
addition O +
to O +
the O +
129-derived O +
segments O -
, O +
in O +
both O +
cohorts O +
the O +
C57BL O -
/ O -
6 O +
strain O +
contributed O +
to O +
the O +
autoimmune O +
traits O +
with O +
one O +
major O +
susceptibility O +
locus O +
on O +
Chromosome O +
3 O -
. O +

A O +
genomic O +
region O +
between O +
D3Mit40 O +
and O +
D3Mit13 O -
, O +
with O +
an O +
estimated O +
peak O +
at O +
position O +
approximately O +
51 O +
cM O -
, O +
showed O +
a O +
significant O +
linkage O +
to O +
ANA O +
production O +
and O +
weaker O +
linkages O +
to O +
anti O -
- O -
ssDNA O +
and O +
anti O -
- O -
chromatin O +
production O +
( O -
see O +
Table O +
3 O -
; O +
Figure O +
7 O -
) O -
. O +

The O +
high O +
frequency O +
of O +
autoimmune O +
phenotype O +
in O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O +
hybrid O +
genetic O +
background O +
and O +
its O +
absence O +
in O +
either O +
of O +
the O +
inbred O +
parental O +
strains O +
imply O +
that O +
there O +
are O +
essential O +
interactions O +
between O +
129- O +
and O +
C57BL O -
/ O -
6-derived O +
alleles O +
for O +
the O +
expression O +
of O +
autoimmunity O -
. O +

We O +
investigated O +
further O +
the O +
effects O +
of O +
genes O +
from O +
the O +
C57BL O -
/ O -
6 O +
background O +
by O +
repeating O +
the O +
linkage O +
analysis O +
in O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
mice O -
, O +
whilst O +
controlling O +
for O +
the O +
very O +
strong O +
129 O +
effect O +
on O +
distal O +
Chromosome O +
1 O -
, O +
as O +
previously O +
described O +
( O -
Zeng O +
1994 O -
) O -
. O +

The O +
results O +
of O +
this O +
analysis O +
showed O +
that O +
the O +
statistical O +
support O +
for O +
the O +
linkage O +
of O +
the O +
C57BL O -
/ O -
6 O +
locus O +
on O +
Chromosome O +
3 O +
for O +
ANA O +
increased O +
from O +
logarithm O +
of O +
odds O +
( O -
LOD O -
) O +
5.4 O +
to O +
LOD O +
6.4 O -
. O +

In O +
contrast O +
to O +
these O +
strong O +
associations O +
with O +
disease O +
serological O +
markers O -
, O +
the O +
QTL O +
analysis O +
identified O +
only O +
two O +
potential O +
linkages O +
to O +
glomerulonephritis O -
: O +
one O +
in O +
the O +
wild O -
- O -
type O +
mice O +
on O +
Chromosome O +
7 O +
across O +
a O +
10 O +
cM O +
region O +
between O +
D7Mit246 O +
( O -
15 O +
cM O -
) O +
and O +
D7Mit145 O +
( O -
26.5 O +
cM O -
) O +
of O +
129 O +
origin O +
( O -
LOD O +
2.86 O -
, O +
p O +
= O +
0.0013 O -
) O -
, O +
and O +
one O +
on O +
Chromosome O +
17 O +
between O +
D17Mit100 O +
( O -
11.7 O +
cM O -
) O +
and O +
D17Mit216 O +
( O -
29.4 O +
cM O -
) O +
from O +
the O +
C57BL O -
/ O -
6 O +
strain O +
( O -
LOD O +
1.3 O -
, O +
p O +
= O +
0.049 O +
and O +
LOD O +
1.67 O -
, O +
p O +
= O +
0.021 O +
in O +
the O +
wild O -
- O -
type O +
and O +
Apcs− O -
/ O -
− O +
mice O -
, O +
respectively O -
) O -
. O +

Histological O +
evidence O +
of O +
glomerulonephritis O +
was O +
only O +
found O +
in O +
approximately O +
20 O -
% O +
of O +
the O +
mice O +
in O +
each O +
cohort O -
, O +
which O +
reduces O +
the O +
power O +
of O +
the O +
QTL O +
analysis O +
for O +
this O +
disease O +
trait O -
. O +

Production O +
of O +
a O +
C57BL O -
/ O -
6.129 O +
Chromosome O +
1 O +
Congenic O +
Line O +
and O +
Its O +
Phenotypic O +
Analysis O +
We O +
generated O +
a O +
C57BL O -
/ O -
6 O +
congenic O +
line O +
carrying O +
the O +
telomeric O +
region O +
of O +
Chromosome O +
1 O +
from O +
the O +
129 O +
mouse O +
strain O -
, O +
in O +
order O +
to O +
dissect O +
the O +
complex O +
polygenic O +
disease O +
phenotype O +
of O +
the O +
( O -
C57BL O -
/ O -
6 O +
× O +
129 O -
/ O -
Sv O -
) O -
F2 O +
hybrid O +
strain O +
into O +
its O +
individual O +
genetic O +
components O -
. O +

The O +
129 O +
interval O +
was O +
backcrossed O +
seven O +
times O +
onto O +
C57BL O -
/ O -
6 O -
, O +
and O +
at O +
each O +
generation O +
the O +
presence O +
or O +
absence O +
of O +
the O +
Chromosome O +
1 O +
interval O +
was O +
determined O +
with O +
several O +
microsatellite O +
markers O -
. O +

Each O +
backcrossed O +
generation O +
was O +
screened O +
with O +
more O +
than O +
three O +
markers O +
per O +
chromosome O +
to O +
facilitate O +
the O +
removal O +
of O +
unselected O +
129 O +
genomic O +
regions O -
. O +

At O +
the O +
end O +
of O +
the O +
backcrossing O -
, O +
the O +
129-derived O +
Chromosome O +
1 O +
interval O +
in O +
the O +
congenic O +
mice O +
extended O +
from O +
microsatellite O +
marker O +
D1Mit105 O +
to O +
D1Mit223 O +
( O -
80–106 O +
cM O -
) O -
, O +
which O +
encompasses O +
the O +
most O +
important O +
129 O +
interval O +
identified O +
by O +
the O +
linkage O +
studies O +
in O +
the O +
( O -
C57BL O -
/ O -
6 O +
× O +
129 O -
/ O -
Sv O -
) O -
F2 O +
mice O -
. O +

Female O +
Chromosome O +
1 O +
congenic O +
mice O +
( O -
C57BL O -
/ O -
6.129 O -
[ O -
D1Mit105–223 O -
] O -
) O -
, O +
together O +
with O +
sex O -
- O -
matched O +
Apcs− O -
/ O -
− O +
mice O +
backcrossed O +
onto O +
C57BL O -
/ O -
6 O +
for O +
ten O +
generations O +
( O -
C57BL O -
/ O -
6.Apcs− O -
/ O -
− O -
) O +
and O +
C57BL O -
/ O -
6 O +
controls O -
, O +
were O +
monitored O +
for O +
the O +
presence O +
of O +
lupus O -
. O +

In O +
the O +
C57BL O -
/ O -
6.Apcs− O -
/ O -
− O +
mice O -
, O +
the O +
129 O +
genome O +
around O +
the O +
Apcs O +
locus O +
was O +
mapped O +
as O +
a O +
stretch O +
of O +
approximately O +
17 O +
cM O -
, O +
positioned O +
from O +
87.9 O +
cM O +
( O -
D1Mit15 O -
) O +
to O +
105 O +
cM O +
( O -
D1Mit17 O -
) O -
. O +

Thus O -
, O +
the O +
congenic O +
line O +
carried O +
a O +
similar O +
129 O +
region O +
( O -
80–106 O +
cM O -
) O +
to O +
the O +
one O +
present O +
in O +
the O +
C57BL O -
/ O -
6.Apcs− O -
/ O -
− O +
mice O +
( O -
87.9–105 O +
cM O -
) O -
. O +

At O +
1 O +
y O +
of O +
age O -
, O +
all O +
animals O +
were O +
sacrificed O -
, O +
the O +
auto O -
- O -
Abs O +
assessed O -
, O +
and O +
the O +
renal O +
histology O +
examined O -
. O +

The O +
results O +
of O +
this O +
analysis O +
are O +
shown O +
in O +
Figure O +
8 O -
. O +

As O +
previously O +
reported O +
( O -
Bickerstaff O +
et O +
al. O +
1999 O -
) O -
, O +
the O +
levels O +
of O +
auto O -
- O -
Abs O +
were O +
markedly O +
increased O +
in O +
the O +
C57BL O -
/ O -
6.Apcs− O -
/ O -
− O +
compared O +
to O +
the O +
wild O -
- O -
type O +
C57BL O -
/ O -
6 O +
controls O -
. O +

However O -
, O +
the O +
C57BL O -
/ O -
6.129 O -
( O -
D1Mit105–223 O -
) O +
animals O +
also O +
expressed O +
high O +
levels O +
of O +
auto O -
- O -
Abs O -
, O +
and O +
these O +
titres O +
were O +
not O +
different O +
from O +
those O +
detected O +
in O +
the O +
matched O +
congenic O +
mice O +
containing O +
a O +
null O +
mutation O +
of O +
the O +
Apcs O +
gene O -
. O +

These O +
results O +
clearly O +
demonstrated O +
that O +
epistatic O +
interactions O +
between O +
129 O +
loci O +
on O +
Chromosome O +
1 O +
and O +
C57BL O -
/ O -
6 O +
genes O +
were O +
sufficient O +
to O +
mediate O +
the O +
loss O +
of O +
tolerance O +
to O +
nuclear O +
autoantigens O -
. O +

However O -
, O +
in O +
contrast O +
to O +
the O +
serological O +
data O -
, O +
the O +
histological O +
assessment O +
of O +
the O +
kidneys O +
showed O +
evidence O +
of O +
markedly O +
increased O +
glomerulonephritis O +
in O +
the O +
C57BL O -
/ O -
6.Apcs− O -
/ O -
− O +
compared O +
to O +
both O +
control O +
groups O +
( O -
Figure O +
9 O -
) O -
, O +
suggesting O +
that O +
the O +
lack O +
of O +
Apcs O -
, O +
when O +
combined O +
with O +
other O +
C57BL O -
/ O -
6 O +
susceptibility O +
alleles O -
, O +
can O +
induce O +
the O +
development O +
of O +
severe O +
renal O +
damage O -
. O +

Discussion O +
There O +
is O +
accumulating O +
evidence O +
that O +
background O +
genes O +
may O +
influence O +
the O +
expression O +
of O +
autoimmunity O +
in O +
gene O -
- O -
targeted O +
mice O -
. O +

Here O +
we O +
report O +
what O +
is O +
to O +
our O +
knowledge O +
the O +
first O +
systematic O +
study O +
that O +
has O +
examined O +
this O +
in O +
the O +
129 O +
and O +
C57BL O -
/ O -
6 O +
mouse O +
strains O -
, O +
widely O +
used O +
for O +
gene O +
targeting O -
. O +

Our O +
results O +
demonstrate O +
interacting O +
loci O +
between O +
129 O +
and O +
C57BL O -
/ O -
6 O +
mice O +
that O +
can O +
cause O +
the O +
expression O +
of O +
a O +
powerful O +
autoimmune O +
phenotype O +
in O +
these O +
animals O -
, O +
in O +
the O +
absence O +
of O +
any O +
gene O -
- O -
targeted O +
mutations O -
. O +

We O +
also O +
developed O +
a O +
congenic O +
mouse O +
strain O +
bearing O +
a O +
portion O +
of O +
129 O +
Chromosome O +
1 O +
on O +
a O +
C57BL O -
/ O -
6 O +
background O +
and O +
showed O +
that O +
this O +
wild O -
- O -
type O +
congenic O +
line O +
expressed O +
striking O +
anti O -
- O -
nuclear O +
autoimmunity O -
. O +

By O +
comparing O +
this O +
Chromosome O +
1 O +
congenic O +
strain O +
with O +
matched O +
congenic O +
mice O +
lacking O +
the O +
Apcs O +
gene O -
, O +
we O +
demonstrated O +
that O +
serum O +
amyloid B-Chemical +
P O +
component O +
deficiency O +
influences O +
the O +
severity O +
of O +
glomerulonephritis O -
, O +
but O +
is O +
not O +
the O +
prime O +
mover O +
in O +
the O +
induction O +
of O +
anti O -
- O -
nuclear O +
autoimmunity O -
, O +
contrary O +
to O +
our O +
own O +
original O +
interpretation O +
of O +
our O +
data O +
( O -
Bickerstaff O +
et O +
al. O +
1999 O -
) O -
. O +

The O +
same O +
consideration O +
applies O +
to O +
other O +
genes O +
located O +
in O +
the O +
same O +
Chromosome O +
1 O +
region O +
that O +
have O +
been O +
implicated O +
in O +
the O +
development O +
of O +
SLE O +
when O +
inactivated O +
by O +
gene O -
- O -
targeting O +
in O +
129 O +
embryonic O +
stem O +
cells O +
and O +
then O +
backcrossed O +
onto O +
a O +
pure O +
genetic O +
background O +
( O -
Bolland O +
and O +
Ravetch O +
2000 O -
; O +
Miwa O +
et O +
al. O +
2002 O -
; O +
Wu O +
et O +
al. O +
2002 O -
) O -
. O +

For O +
each O -
, O +
there O +
has O +
to O +
be O +
a O +
question O +
as O +
to O +
whether O +
the O +
anti O -
- O -
nuclear O +
autoimmunity O +
is O +
due O +
to O +
the O +
gene O -
- O -
targeted O +
mutant O +
gene O +
or O +
to O +
the O +
normal O +
129 O +
genes O +
expressed O +
in O +
the O +
same O +
region O +
as O +
the O +
targeted O +
gene O -
. O +

The O +
influence O +
of O +
background O +
genes O +
on O +
the O +
development O +
of O +
spontaneous O +
autoimmune O +
disease O +
is O +
well O +
known O -
, O +
especially O +
with O +
respect O +
to O +
the O +
lpr O +
and O +
Yaa O +
disease O -
- O -
susceptibility O +
genes O -
. O +

In O +
MRL O -
/ O -
Mp O +
mice O -
, O +
the O +
presence O +
of O +
the O +
lpr O +
gene O +
accelerates O +
the O +
development O +
of O +
high O +
level O +
and O +
broad O -
- O -
spectrum O +
auto O -
- O -
Ab O +
production O +
and O +
lethal O +
glomerulonephritis O -
, O +
in O +
addition O +
to O +
marked O +
lymphoproliferative O +
disease O -
. O +

In O +
contrast O -
, O +
homozygosity O +
of O +
the O +
lpr O +
gene O +
in O +
other O +
strains O +
such O +
as O +
C57BL O -
/ O -
6 O -
, O +
AKR O -
, O +
LG O -
/ O -
J O -
, O +
and O +
C3H O +
leads O +
only O +
to O +
auto O -
- O -
Ab O +
production O +
( O -
Izui O +
et O +
al. O +
1984 O -
) O -
. O +

Similarly O -
, O +
the O +
Y O -
- O -
chromosome O -
- O -
linked O +
Yaa O +
gene O +
in O +
BXSB O +
and O +
MRL O -
/ O -
Mp O +
males O +
enhances O +
the O +
rapid O +
development O +
of O +
auto O -
- O -
Abs O +
and O +
glomerulonephritis O +
( O -
Izui O +
et O +
al. O +
1988 O -
; O +
Merino O +
et O +
al. O +
1989 O -
) O -
. O +

However O -
, O +
in O +
the O +
C57BL O -
/ O -
6 O +
background O -
, O +
the O +
Yaa O +
gene O +
does O +
not O +
lead O +
to O +
an O +
autoimmune O +
phenotype O +
( O -
Izui O +
et O +
al. O +
1988 O -
) O -
. O +

Not O +
surprisingly O -
, O +
important O +
effects O +
of O +
the O +
genetic O +
background O +
on O +
the O +
expression O +
of O +
autoimmunity O +
have O +
also O +
been O +
reported O +
in O +
gene O -
- O -
targeted O +
mice O +
( O -
Bolland O +
and O +
Ravetch O +
2000 O -
; O +
Santiago O -
- O -
Raber O +
et O +
al. O +
2001 O -
; O +
Mitchell O +
et O +
al. O +
2002 O -
) O -
. O +

Thus O -
, O +
SLE O +
exists O +
as O +
a O +
complex O -
- O -
trait O +
disorder O +
in O +
which O +
specific O +
combinations O +
of O +
susceptibility O +
alleles O +
are O +
required O +
for O +
the O +
expression O +
of O +
the O +
full O +
phenotype O -
. O +

Through O +
the O +
use O +
of O +
microsatellite O +
marker O +
maps O -
, O +
the O +
identification O +
of O +
murine O +
SLE O +
susceptibility O +
intervals O +
in O +
experimental O +
crosses O +
has O +
been O +
made O +
possible O -
. O +

These O +
mapping O +
studies O +
have O +
shown O +
that O +
the O +
disease O +
expression O +
in O +
relation O +
to O +
the O +
inheritance O +
of O +
the O +
different O +
alleles O +
followed O +
a O +
threshold O +
liability O +
pattern O +
in O +
which O +
a O +
positive O +
phenotype O +
depended O +
upon O +
the O +
presence O +
of O +
multiple O +
discrete O +
susceptibility O +
loci O +
with O +
no O +
single O +
locus O +
being O +
a O +
prerequisite O +
factor O -
. O +

We O +
have O +
employed O +
the O +
same O +
approach O +
to O +
analyse O +
the O +
genetic O +
basis O +
of O +
disease O +
inheritance O +
in O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O +
hybrid O +
strain O -
, O +
the O +
most O +
common O +
genetic O +
background O +
in O +
gene O -
- O -
targeted O +
mice O -
. O +

Although O +
spontaneous O +
autoimmunity O +
has O +
not O +
been O +
documented O +
in O +
either O +
of O +
the O +
pure O +
129 O +
or O +
C57BL O -
/ O -
6 O +
strains O -
, O +
a O +
spontaneous O +
lupus O -
- O -
like O +
phenotype O +
has O +
been O +
described O +
in O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O +
hybrid O +
strains O +
( O -
Obata O +
et O +
al. O +
1979 O -
; O +
Botto O +
et O +
al. O +
1998 O -
; O +
Bickerstaff O +
et O +
al. O +
1999 O -
; O +
Santiago O -
- O -
Raber O +
et O +
al. O +
2001 O -
) O -
, O +
suggesting O +
that O +
the O +
predisposition O +
in O +
these O +
hybrid O +
mice O +
may O +
arise O +
as O +
a O +
result O +
of O +
the O +
interaction O +
between O +
specific O +
combinations O +
of O +
alleles O +
inherited O +
from O +
both O +
the O +
129 O +
and O +
C57BL O -
/ O -
6 O +
parental O +
strains O -
. O +

This O +
was O +
confirmed O +
by O +
the O +
mapping O +
study O +
reported O +
here O -
. O +

We O +
showed O +
that O +
there O +
are O +
multiple O +
genetic O +
loci O +
contributing O +
to O +
the O +
disease O +
and O +
these O +
are O +
derived O +
from O +
both O +
129 O +
and O +
C57BL O -
/ O -
6 O +
mice O -
. O +

We O +
demonstrated O +
that O +
a O +
129-derived O +
segment O +
of O +
Chromosome O +
1 O +
was O +
strongly O +
linked O +
to O +
the O +
expression O +
of O +
auto O -
- O -
Abs O -
. O +

This O +
region O +
is O +
probably O +
capable O +
of O +
causing O +
the O +
initiation O +
of O +
a O +
humoral O +
autoimmune O +
response O +
to O +
nuclear O +
antigens B-Chemical -
; O +
however O -
, O +
this O +
response O +
does O +
not O +
occur O +
in O +
the O +
absence O +
of O +
C57BL O -
/ O -
6 O +
genes O -
. O +

In O +
support O +
of O +
this O -
, O +
we O +
identified O +
a O +
C57BL O -
/ O -
6 O +
segment O +
on O +
Chromosome O +
3 O -
, O +
which O +
may O +
interact O +
with O +
the O +
129 O +
genes O +
on O +
Chromosome O +
1 O +
to O +
mediate O +
the O +
loss O +
of O +
tolerance O -
. O +

Interestingly O -
, O +
although O +
the O +
C57BL O -
/ O -
6 O +
SLE O -
- O -
susceptibility O +
region O +
on O +
Chromosome O +
3 O +
is O +
novel O -
, O +
disease O -
- O -
modifying O +
alleles O +
derived O +
from O +
C57BL O -
/ O -
10 O +
and O +
C57BL O -
/ O -
6 O +
strains O +
have O +
been O +
mapped O +
to O +
a O +
portion O +
of O +
Chromosome O +
3 O +
close O +
to O +
the O +
region O +
identified O +
in O +
this O +
study O +
( O -
Morel O +
et O +
al. O +
1999 O -
; O +
Haywood O +
et O +
al. O +
2000 O -
) O -
. O +

Furthermore O -
, O +
the O +
region O +
on O +
Chromosome O +
7 O +
associated O +
with O +
the O +
development O +
of O +
lupus O +
nephritis O +
has O +
been O +
linked O +
to O +
the O +
same O +
trait O +
in O +
other O +
murine O +
models O +
of O +
SLE O +
( O -
Santiago O +
et O +
al. O +
1998 O -
; O +
Morel O +
et O +
al. O +
1999 O -
; O +
Xie O +
et O +
al. O +
2002 O -
) O -
, O +
suggesting O +
the O +
possibility O +
of O +
shared O +
susceptibility O +
loci O -
. O +

Taken O +
together O +
our O +
results O +
suggest O +
a O +
complex O +
genetic O +
contribution O +
from O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O +
hybrid O +
background O +
genome O -
, O +
with O +
both O +
enhancing O +
as O +
well O +
as O +
inhibitory O +
loci O +
from O +
the O +
129 O +
mouse O -
, O +
in O +
addition O +
to O +
genes O +
promoting O +
autoimmunity O +
from O +
the O +
C57BL O -
/ O -
6 O +
mice O -
. O +

The O +
impact O +
that O +
these O +
interacting O +
loci O +
may O +
have O +
on O +
the O +
lupus O -
- O -
like O +
disease O +
present O +
in O +
several O +
gene O -
- O -
targeted O +
animals O +
was O +
further O +
assessed O +
by O +
comparing O +
Apcs− O -
/ O -
− O +
mice O +
with O +
Chromosome O +
1 O +
genetically O +
matched O +
controls O -
. O +

In O +
the O +
context O +
of O +
SLE O +
susceptibility O -
, O +
one O +
of O +
the O +
most O +
consistently O +
mapped O +
non O -
- O -
MHC O +
regions O +
of O +
the O +
mouse O +
genome O +
is O +
the O +
telomeric O +
Chromosome O +
1 O +
segment O -
, O +
where O +
several O +
disease O +
loci O -
, O +
designated O +
Sle1 O +
( O -
Morel O +
et O +
al. O +
2001 O -
) O -
, O +
Nba2 O +
( O -
Drake O +
et O +
al. O +
1995 O -
; O +
Rozzo O +
et O +
al. O +
1996 O -
; O +
Vyse O +
et O +
al. O +
1997 O -
) O -
, O +
and O +
Bxs3 O +
( O -
Hogarth O +
et O +
al. O +
1998 O -
) O -
, O +
have O +
been O +
mapped O +
in O +
lupus O -
- O -
prone O +
strains O -
. O +

Moreover O -
, O +
this O +
region O +
of O +
mouse O +
Chromosome O +
1 O +
is O +
orthologous O +
to O +
a O +
region O +
on O +
human O +
Chromosome O +
1q22–1q25 O -
, O +
which O +
has O +
also O +
been O +
linked O +
with O +
human O +
SLE O +
( O -
Moser O +
et O +
al. O +
1998 O -
) O -
. O +

The O +
Apcs O +
gene O +
is O +
one O +
of O +
the O +
candidate O +
genes O +
known O +
to O +
lie O +
within O +
this O +
region O -
. O +

The O +
human O +
serum O +
amyloid B-Chemical +
P O +
component O +
binds O +
avidly O +
to O +
DNA O -
, O +
chromatin O -
, O +
and O +
apoptotic O +
cells O +
in O +
physiological O +
conditions O +
in O +
vitro O +
( O -
Pepys O +
1974 O -
; O +
Pepys O +
and O +
Butler O +
1987 O -
; O +
Butler O +
et O +
al. O +
1990 O -
) O +
and O +
also O +
to O +
exposed O +
chromatin O +
and O +
apoptotic O +
cells O +
in O +
vivo O +
( O -
Hintner O +
et O +
al. O +
1988 O -
; O +
Breathnach O +
et O +
al. O +
1989 O -
; O +
Familian O +
et O +
al. O +
2001 O -
) O -
. O +

We O +
have O +
previously O +
reported O +
that O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
.Apcs− O -
/ O -
− O +
mice O +
spontaneously O +
produce O +
a O +
wide O +
range O +
of O +
ANAs O +
and O +
develop O +
significant O +
immune O +
complex O +
glomerulonephritis O +
( O -
Bickerstaff O +
et O +
al. O +
1999 O -
) O -
. O +

On O +
the O +
basis O +
of O +
these O +
observations O -
, O +
it O +
was O +
postulated O +
that O +
Apcs O -
, O +
by O +
altering O +
the O +
clearance O +
of O +
chromatin O -
, O +
contributes O +
to O +
the O +
pathogenesis O +
of O +
SLE O -
. O +

However O -
, O +
in O +
this O +
study O +
we O +
found O +
that O +
only O +
ANA O +
and O +
anti O -
- O -
chromatin O +
Ab O +
levels O +
were O +
significantly O +
increased O +
in O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs− O -
/ O -
− O +
mice O -
. O +

A O +
possible O +
explanation O +
for O +
this O +
discrepancy O +
may O +
lie O +
in O +
the O +
fact O +
that O +
the O +
Apcs− O -
/ O -
− O +
mice O +
analysed O +
in O +
the O +
original O +
study O +
were O +
generated O +
from O +
a O +
limited O +
number O +
of O +
founders O +
and O +
that O +
this O +
may O +
have O +
caused O +
a O +
nonrandom O +
inheritance O +
of O +
the O +
loci O +
from O +
the O +
parental O +
strains O -
. O +

Furthermore O -
, O +
the O +
whole O -
- O -
genome O +
analysis O +
identified O +
the O +
129 O +
region O +
surrounding O +
the O +
Apcs O +
gene O +
as O +
the O +
main O +
locus O +
contributing O +
to O +
the O +
development O +
of O +
ANA O +
and O +
anti O -
- O -
chromatin O +
Ab O -
. O +

In O +
agreement O +
with O +
this O -
, O +
when O +
we O +
carried O +
out O +
a O +
selective O +
comparison O +
between O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs− O -
/ O -
− O +
mice O +
and O +
Chromosome O +
1 O +
genetically O +
matched O +
controls O -
, O +
we O +
failed O +
to O +
detect O +
any O +
significant O +
difference O +
in O +
the O +
levels O +
of O +
these O +
two O +
auto O -
- O -
Abs O -
. O +

These O +
findings O -
, O +
taken O +
together O -
, O +
indicated O +
that O +
the O +
phenotype O +
associated O +
with O +
Apcs O +
deficiency O +
was O +
caused O +
by O +
the O +
presence O +
of O +
unaltered O +
129 O +
genes O +
from O +
the O +
telomeric O +
region O +
of O +
Chromosome O +
1 O +
operating O +
in O +
the O +
C57BL O -
/ O -
6 O +
genomic O +
background O -
. O +

Strong O +
supportive O +
evidence O +
for O +
this O +
was O +
provided O +
by O +
the O +
analysis O +
of O +
the O +
C57BL O -
/ O -
6 O +
mice O +
congenic O +
for O +
this O +
129 O +
region O -
. O +

The O +
generation O +
and O +
analysis O +
of O +
congenic O +
strains O +
have O +
successfully O +
been O +
used O +
to O +
dissect O +
the O +
contribution O +
of O +
individual O +
susceptibility O +
alleles O +
to O +
a O +
multigenic O +
trait O +
such O +
as O +
SLE O -
. O +

We O +
adopted O +
the O +
same O +
strategy O +
to O +
investigate O +
the O +
relative O +
contribution O +
of O +
the O +
129 O +
Chromosome O +
1 O +
segment O +
and O +
the O +
Apcs O +
gene O +
to O +
each O +
disease O +
trait O -
. O +

Using O +
this O +
approach O -
, O +
we O +
demonstrated O +
that O +
the O +
129 O +
interval O +
on O +
distal O +
Chromosome O +
1 O -
, O +
when O +
transferred O +
onto O +
the O +
C57BL O -
/ O -
6 O +
genome O -
, O +
a O +
combination O +
commonly O +
created O +
by O +
backcrossing O +
onto O +
C57BL O -
/ O -
6 O +
a O +
mutated O +
gene O +
located O +
in O +
that O +
chromosomal O +
region O -
, O +
was O +
sufficient O +
to O +
mediate O +
the O +
production O +
of O +
auto O -
- O -
Abs O -
. O +

In O +
this O +
context O -
, O +
it O +
is O +
of O +
note O +
that O +
several O +
strains O +
of O +
mice O +
with O +
targeted O +
mutations O +
of O +
genes O +
encoded O +
in O +
this O +
region O +
have O +
been O +
reported O +
to O +
express O +
a O +
lupus O -
- O -
like O +
illness O -
, O +
including O +
mice O +
lacking O +
FcγRIIB O +
( O -
Bolland O +
and O +
Ravetch O +
2000 O -
) O -
, O +
complement O +
receptors O +
( O -
CR1 O -
/ O -
2 O -
) O +
( O -
Prodeus O +
et O +
al. O +
1998 O -
; O +
Wu O +
et O +
al. O +
2002 O -
) O -
, O +
and O +
decay O -
- O -
accelerating O +
factor O +
( O -
CD55 O -
) O +
( O -
Miwa O +
et O +
al. O +
2002 O -
) O -
. O +

In O +
each O +
case O -
, O +
the O +
autoimmune O +
phenotype O +
was O +
described O +
in O +
mice O +
in O +
which O +
the O +
null O +
mutation O +
was O +
generated O +
in O +
129 O +
embryonic O +
stem O +
cells O +
and O +
then O +
backcrossed O +
to O +
the O +
C57BL O -
/ O -
6 O +
or O +
another O +
genetic O +
background O -
. O +

Thus O -
, O +
in O +
view O +
of O +
our O +
findings O -
, O +
one O +
may O +
postulate O +
that O +
in O +
each O +
of O +
these O +
murine O +
models O +
of O +
SLE O -
, O +
the O +
effects O +
of O +
the O +
targeted O +
null O +
gene O +
were O +
irrelevant O -
. O +

Similar O +
conclusions O +
may O +
apply O +
to O +
other O +
gene O -
- O -
targeted O +
animals O +
carrying O +
mutations O +
of O +
genes O +
mapped O +
in O +
the O +
129-derived O +
susceptibility O +
allele O +
on O +
Chromosome O +
7 O +
( O -
O'Keefe O +
et O +
al. O +
1996 O -
, O +
1999 O -
) O -
. O +

The O +
expression O +
of O +
anti O -
- O -
nuclear O +
autoimmunity O +
was O +
identical O +
comparing O +
the O +
congenic O +
with O +
the O +
Apcs− O -
/ O -
− O +
mice O -
. O +

The O +
only O +
difference O +
in O +
phenotype O +
between O +
these O +
mice O +
was O +
in O +
the O +
expression O +
of O +
glomerulonephritis O -
, O +
which O +
was O +
more O +
pronounced O +
in O +
the O +
Apcs− O -
/ O -
− O +
mice O +
compared O +
with O +
the O +
congenic O +
mice O -
. O +

Although O +
these O +
findings O +
demonstrate O +
that O +
Apcs O +
is O +
not O +
implicated O +
in O +
the O +
processing O +
of O +
autoantigens O -
, O +
as O +
it O +
had O +
previously O +
been O +
suggested O -
, O +
they O +
indicate O +
that O +
Apcs O +
might O +
still O +
play O +
an O +
important O +
protective O +
role O +
in O +
lupus O +
nephritis O -
. O +

In O +
support O +
of O +
this O -
, O +
the O +
expression O +
of O +
the O +
human O +
C O -
- O -
reactive O +
protein O -
, O +
an O +
acute O -
- O -
phase O +
protein O +
closely O +
related O +
to O +
Apcs O -
, O +
has O +
been O +
shown O +
to O +
delay O +
the O +
onset O +
and O +
severity O +
of O +
lupus O +
nephritis O +
in O +
the O +
NZB O -
/ O -
W O +
strain O +
by O +
preventing O +
the O +
deposition O +
of O +
immune O +
complexes O +
in O +
the O +
renal O +
cortex O +
( O -
Szalai O +
et O +
al. O +
2003 O -
) O -
. O +

Consistent O +
with O +
this O -
, O +
a O +
polymorphism O +
associated O +
with O +
reduced O +
basal O +
level O +
of O +
C O -
- O -
reactive O +
protein O +
has O +
been O +
reported O +
to O +
be O +
linked O +
to O +
SLE O +
in O +
humans O +
( O -
Russell O +
et O +
al. O +
2004 O -
) O -
. O +

However O -
, O +
as O +
the O +
congenic O +
mice O +
and O +
the O +
Apcs− O -
/ O -
− O +
mice O +
carried O +
similar O +
but O +
not O +
identical O +
129 O +
regions O +
on O +
Chromosome O +
1 O -
, O +
an O +
alternative O +
explanation O +
for O +
our O +
findings O +
may O +
still O +
lay O +
in O +
the O +
numerous O +
and O +
complex O +
synergistic O +
and O +
counteractive O +
interactions O +
between O +
129 O +
and O +
C57BL O -
/ O -
6 O +
genes O +
involved O +
in O +
self O -
- O -
tolerance O +
and O +
end O +
organ O +
damage O -
. O +

Thus O -
, O +
whilst O +
the O +
lack O +
of O +
lupus O +
nephritis O +
in O +
the O +
congenic O +
mice O +
is O +
consistent O +
with O +
the O +
need O +
for O +
multiple O +
susceptibility O +
genes O +
for O +
the O +
full O +
expression O +
of O +
lupus O -
, O +
further O +
studies O +
will O +
be O +
required O +
to O +
fully O +
elucidate O +
the O +
role O +
of O +
Apcs O +
in O +
the O +
pathogenesis O +
of O +
renal O +
damage O -
. O +

In O +
summary O -
, O +
our O +
findings O +
demonstrate O +
the O +
impact O +
of O +
epistatic O +
interactions O +
between O +
129 O +
and O +
C57BL O -
/ O -
6 O +
genomes O +
on O +
the O +
development O +
of O +
SLE O +
and O +
illustrate O +
how O +
these O +
background O +
gene O +
effects O +
may O +
lead O +
to O +
incorrect O +
interpretations O +
when O +
analysing O +
the O +
autoimmune O +
phenotype O +
of O +
specific O +
genetic O +
disruptions O -
. O +

Materials O +
and O +
Methods O +
Mice O -
. O +

All O +
the O +
mice O +
were O +
females O -
. O +

Wild O -
- O -
type O +
C57BL O -
/ O -
6 O +
and O +
129 O -
/ O -
Sv O +
( O -
129S6 O -
, O +
according O +
to O +
the O +
revised O +
nomenclature O -
) O +
were O +
bred O +
and O +
maintained O +
in O +
the O +
animal O +
care O +
facility O +
at O +
Imperial O +
College O -
, O +
London O -
, O +
United O +
Kingdom O -
. O +

( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F1 O +
mice O +
were O +
generated O +
by O +
intercrossing O +
the O +
two O +
wild O -
- O -
type O +
strains O +
and O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
mice O +
by O +
interbreeding O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F1 O +
mice O -
. O +

The O +
Apcs− O -
/ O -
−mice O +
were O +
generated O +
as O +
previously O +
reported O +
( O -
Botto O +
et O +
al. O +
1997 O -
) O -
, O +
and O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs− O -
/ O -
− O +
mice O +
were O +
generated O +
by O +
intercrossing O +
Apcs− O -
/ O -
− O +
mice O +
on O +
the O +
129 O +
genetic O +
background O +
with O +
Apcs− O -
/ O -
− O +
animals O +
backcrossed O +
onto O +
C57BL O -
/ O -
6 O +
for O +
ten O +
generations O -
. O +

A O +
total O +
of O +
141 O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
and O +
158 O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs− O -
/ O -
− O +
female O +
mice O +
were O +
produced O +
and O +
monitored O +
for O +
1 O +
y. O +
Wild O -
- O -
type O +
congenic O +
C57BL O -
/ O -
6.129 O -
( O -
D1Mit105–223 O -
) O +
mice O +
were O +
generated O +
by O +
backcrossing O +
the O +
129 O +
interval O +
between O +
microsatellites O +
D1Mit105 O +
and O +
D1Mit223 O +
( O -
80 O +
cM O +
to O +
106 O +
cM O -
) O +
onto O +
the O +
C57BL O -
/ O -
6 O +
strain O -
. O +

Inherited O +
129 O +
regions O +
were O +
mapped O +
with O +
microsatellite O +
markers O +
polymorphic O +
between O +
129 O +
and O +
C57BL O -
/ O -
6 O +
mice O +
( O -
see O +
below O -
) O -
. O +

After O +
seven O +
generations O +
of O +
backcrossing O -
, O +
siblings O +
were O +
intercrossed O +
to O +
generate O +
C57BL O -
/ O -
6.129 O -
( O -
D1Mit105–223 O -
) O +
congenic O +
mice O +
homozygous O +
for O +
the O +
129 O +
Chromosome O +
1 O +
interval O -
. O +

Inside O +
129 O +
markers O +
at O +
positions O +
81.6 O +
cM O +
( O -
D1Mit159 O -
) O +
and O +
105 O +
cM O +
( O -
D1Mit17 O -
) O -
, O +
respectively O -
, O +
and O +
an O +
outside O +
C57BL O -
/ O -
6 O +
marker O +
at O +
position O +
74.3cM O +
( O -
D1Mit159 O -
) O +
were O +
used O +
to O +
further O +
define O +
the O +
interval O -
. O +

In O +
the O +
C57BL O -
/ O -
6.Apcs− O -
/ O -
− O +
mice O +
( O -
backcrossed O +
onto O +
C57BL O -
/ O -
6 O +
for O +
ten O +
generations O -
) O -
, O +
the O +
129 O +
genome O +
around O +
the O +
Apcs O +
locus O +
was O +
mapped O +
as O +
a O +
segment O +
from O +
87.9 O +
cM O +
( O -
D1Mit15 O -
) O +
to O +
105 O +
cM O +
( O -
D1Mit17 O -
) O -
. O +

In O +
this O +
analysis O -
, O +
the O +
inside O +
129 O +
markers O +
were O +
at O +
positions O +
93 O +
cM O +
( O -
D1Mit36 O -
) O +
and O +
99.7 O +
cM O +
( O -
D1Mit115 O -
) O +
and O +
the O +
outside O +
C57BL O -
/ O -
6 O +
markers O +
at O +
positions O +
81.6 O +
cM O +
( O -
D1Mit159 O -
) O +
and O +
106 O +
cM O +
( O -
D1Mit223 O -
) O -
. O +

Along O +
with O +
28 O +
C57BL O -
/ O -
6.Apcs− O -
/ O -
−mice O +
and O +
30 O +
C57BL O -
/ O -
6 O +
wild O -
- O -
type O +
animals O -
, O +
26 O +
C57BL O -
/ O -
6.129 O -
( O -
D1Mit105–223 O -
) O +
female O +
mice O +
− O -
/ O -
−were O +
followed O +
up O +
to O +
1 O +
y O +
of O +
age O -
. O +

Animals O +
were O +
maintained O +
in O +
specific O +
pathogen O -
- O -
free O +
conditions O -
. O +

All O +
animal O +
procedures O +
were O +
in O +
accordance O +
with O +
institutional O +
guidelines O -
. O +

Serological O +
analyses O -
. O +

Sera O -
, O +
collected O +
at O +
6 O +
and O +
12 O +
mo O +
of O +
age O -
, O +
were O +
assayed O +
for O +
the O +
presence O +
of O +
auto O -
- O -
Abs O -
. O +

Levels O +
of O +
IgG O +
ANA O +
were O +
sought O +
by O +
indirect O +
immunofluorescence O +
using O +
Hep-2 O +
cells O -
, O +
and O +
anti O -
- O -
dsDNA O +
Abs O +
were O +
detected O +
by O +
indirect O +
immunofluorescence O +
on O +
Crithidia O +
luciliae O +
as O +
previously O +
described O +
( O -
Mitchell O +
et O +
al. O +
2002 O -
) O -
. O +

Serum O +
samples O +
were O +
screened O +
at O +
a O +
1:80 O +
( O -
ANA O -
) O +
or O +
1:20 O +
( O -
anti O -
- O -
dsDNA O -
) O +
dilution O +
and O +
the O +
positive O +
samples O +
titrated O +
to O +
endpoint O -
. O +

Abs O +
to O +
ssDNA O +
and O +
anti O -
- O -
chromatin O +
were O +
measured O +
by O +
ELISA O -
, O +
as O +
previously O +
described O +
( O -
Mitchell O +
et O +
al. O +
2002 O -
) O -
. O +

Samples O +
were O +
screened O +
at O +
a O +
1:100 O +
dilution O -
, O +
and O +
the O +
results O +
were O +
expressed O +
in O +
arbitrary O +
ELISA O +
units O +
( O -
AEUs O -
) O +
relative O +
to O +
a O +
standard O +
positive O +
sample O +
( O -
derived O +
from O +
an O +
MRL O -
/ O -
Mp.lpr O -
/ O -
lpr O +
mouse O -
) O -
, O +
which O +
was O +
assigned O +
a O +
value O +
of O +
100 O -
. O +

For O +
interplate O +
comparison O -
, O +
serial O +
dilutions O +
of O +
a O +
positive O +
control O +
serum O +
sample O +
were O +
included O +
on O +
each O +
plate O -
. O +

Apcs O +
levels O +
were O +
assessed O +
by O +
ELISA O +
using O +
sheep O +
anti O -
- O -
mouse O +
Apcs O +
and O +
rabbit O +
anti O -
- O -
mouse O +
Apcs O +
Abs O +
( O -
Calbiochem O -
, O +
Nottigham O -
, O +
United O +
Kingdom O -
) O -
. O +

Samples O +
were O +
screened O +
at O +
a O +
1:3,000 O +
dilution O -
, O +
and O +
the O +
results O +
were O +
expressed O +
in O +
milligrams O +
per O +
liters O -
, O +
referring O +
to O +
a O +
standard O +
curve O +
derived O +
from O +
an O +
acute O -
- O -
phase O +
serum O +
with O +
a O +
known O +
concentration O +
of O +
Apcs O +
( O -
Calbiochem O -
) O -
. O +

Apcs− O -
/ O -
− O +
mouse O +
serum O +
was O +
included O +
as O +
a O +
negative O +
control O -
. O +

Histological O +
analysis O -
. O +

All O +
the O +
mice O -
, O +
except O +
the O +
few O +
that O +
died O +
before O +
the O +
end O +
of O +
the O +
experiment O -
, O +
were O +
sacrificed O +
at O +
1 O +
y O +
of O +
age O -
, O +
and O +
kidney O +
portions O +
were O +
fixed O +
in O +
Bouin O -
's O +
solution B-Chemical +
and O +
paraffin O +
embedded O -
, O +
and O +
sections O +
were O +
stained O +
with O +
periodic B-Chemical +
acid I-Chemical -
– O -
Schiff O +
reagent B-Chemical -
. O +

Glomerular O +
histology O +
was O +
graded O +
in O +
a O +
blinded O +
fashion O +
as O +
follows O -
: O +
grade O +
0 O -
, O +
normal O -
; O +
grade O +
1 O -
, O +
hypercellularity O +
involving O +
greater O +
than O +
50 O -
% O +
of O +
the O +
glomerular O +
tuft O +
in O +
25%–50 O -
% O +
of O +
glomeruli O -
; O +
grade O +
2 O -
, O +
hypercellularity O +
involving O +
greater O +
than O +
50 O -
% O +
of O +
the O +
glomerular O +
tuft O +
in O +
50%–75 O -
% O +
of O +
glomeruli O -
; O +
grade O +
3 O -
, O +
glomerular O +
hypercellularity O +
in O +
greater O +
than O +
75 O -
% O +
of O +
glomeruli O +
or O +
crescents O +
in O +
greater O +
than O +
25 O -
% O +
of O +
glomeruli O -
. O +

Statistical O +
analysis O +
Non O -
- O -
parametric O +
data O +
are O +
expressed O +
as O +
median O +
with O +
range O +
of O +
values O +
in O +
parentheses O -
. O +

All O +
statistics O +
were O +
calculated O +
using O +
GraphPad O +
PrismTM O +
version O +
3.0 O +
for O +
Windows O +
( O -
GraphPad O +
Software O -
, O +
San O +
Diego O -
, O +
California O -
, O +
United O +
States O -
) O -
. O +

Non O -
- O -
parametric O +
tests O +
were O +
applied O +
throughout O -
, O +
with O +
differences O +
being O +
considered O +
significant O +
for O +
p O +
values O +
< O +
0.05 O -
. O +

The O +
Mann O -
– O -
Whitney O +
test O +
was O +
used O +
for O +
comparison O +
of O +
two O +
groups O -
, O +
whilst O +
for O +
analysis O +
of O +
three O +
groups O +
the O +
Kruskal O -
– O -
Wallis O +
test O +
with O +
Dunn O -
's O +
multiple O +
comparison O +
test O +
was O +
used O -
. O +

Genotypic O +
analysis O +
Genotyping O +
was O +
carried O +
out O +
by O +
PCR O +
of O +
genomic O +
DNA O +
using O +
143 O +
polymorphic O +
markers O +
( O -
list O +
available O +
on O +
request O -
) O +
distributed O +
throughout O +
all O +
19 O +
autosomes O -
. O +

PCRs O +
were O +
performed O +
using O +
standard O +
reagents B-Chemical +
containing O +
1.5 O +
mM O +
MgCl2 B-Chemical +
and O +
0.4 O +
μM O +
primers O -
. O +

Microsatellite O +
markers O +
were O +
screened O +
for O +
size O +
polymorphisms O +
between O +
129 O +
and O +
C57BL O -
/ O -
6 O +
mice O -
. O +

Only O +
primers O +
with O +
differences O +
detectable O +
on O +
ethidium B-Chemical +
bromide I-Chemical -
- O -
stained O +
agarose B-Chemical +
gels O +
or O +
on O +
SDS B-Chemical -
- O -
polyacrylamide O +
gels O +
were O +
used O -
. O +

Linkage O +
analysis O +
The O +
QTL O +
program O +
MAPMANAGER.QTL O +
( O -
ftp://mcbio.med.buffalo.edu/pub/MapMgr/ O -
) O +
was O +
used O -
, O +
and O +
the O +
two O +
experimental O +
groups O +
were O +
examined O +
independently O -
. O +

Only O +
data O +
from O +
mice O +
at O +
12 O +
mo O +
of O +
age O +
were O +
analysed O -
. O +

Log O +
transformations O +
of O +
auto O -
- O -
Abs O +
levels O +
resulted O +
in O +
more O +
normalised O +
distribution O +
and O +
were O +
used O +
in O +
QTL O +
mapping O -
. O +

LOD O +
thresholds O +
for O +
suggestive O +
and O +
significant O +
linkages O +
were O +
determined O +
by O +
using O +
a O +
cohort- O +
and O +
trait O -
- O -
specific O +
permutation O +
test O +
( O -
1,000 O +
permutations O -
) O -
. O +

The O +
average O +
threshold O +
for O +
suggestive O -
, O +
significant O -
, O +
and O +
highly O +
significant O +
linkages O +
were O +
LOD O +
≥ O +
2.1 O +
( O -
p O +
≤ O +
7.8 O +
× O +
10−3 O -
) O -
, O +
LOD O +
≥ O +
3.6 O +
( O -
p O +
≤ O +
2.4 O +
× O +
10−4 O -
) O -
, O +
and O +
LOD O +
≥ O +
5 O +
( O -
p O +
≤ O +
1 O +
× O +
10−5 O -
) O -
, O +
respectively O +
( O -
Manly O +
and O +
Olson O +
1999 O -
) O -
. O +

Supporting O +
Information O +
Accession O +
Numbers O +
The O +
LocusLink O +
( O -
http://www.ncbi.nlm.nih.gov/LocusLink/ O -
) O +
ID O +
numbers O +
for O +
the O +
genes O +
and O +
gene O +
products O +
discussed O +
in O +
this O +
paper O +
are O +
Apcs O +
( O -
LocusLink O +
ID O +
20219 O -
) O -
, O +
CD35 O -
/ O -
CD21 O +
( O -
LocusLink O +
ID O +
12902 O -
) O -
, O +
CD55 O +
( O -
LocusLink O +
ID O +
13136 O -
) O -
, O +
the O +
FAS O +
receptor O +
gene O +
( O -
LocusLink O +
ID O +
14102 O -
) O -
, O +
and O +
FcγRII O +
( O -
LocusLink O +
ID O +
14130 O -
) O -
. O +

Acknowledgements O +
We O +
are O +
grateful O +
to O +
M. O +
Lewis O +
for O +
the O +
processing O +
of O +
the O +
samples O +
for O +
histology O +
and O +
to O +
F. O +
Reid O +
and O +
D. O +
Mitchell O +
for O +
their O +
help O -
. O +

We O +
thank O +
all O +
of O +
the O +
staff O +
in O +
the O +
animal O +
facility O +
for O +
their O +
technical O +
assistance O -
. O +

This O +
work O +
was O +
supported O +
by O +
the O +
Wellcome O +
Trust O +
( O -
grant O +
number O +
061438 O -
) O -
. O +

JCH O +
was O +
a O +
recipient O +
of O +
a O +
fellowship O +
from O +
the O +
National O +
Institute O +
of O +
Health O -
, O +
Spain O +
( O -
BEFI O +
99 O -
/ O -
9212 O -
) O -
. O +

Abbreviations O +
Ab O +
- O +
antibody O +
ANA O +
- O +
anti O -
- O -
nuclear O +
antibody O +
AEU O +
- O +
arbitrary O +
ELISA O +
unit O +
Apcs− O -
/ O -
− O +
- O +
Apcs O -
- O -
deficient O +
mice O +
Apcs O +
- O +
serum O +
amyloid B-Chemical +
P O +
component O +
gene O +
dsDNA O +
- O +
double O -
- O -
stranded O +
DNA O +
LOD O +
- O +
logarithm O +
of O +
odds O +
QTL O +
- O +
quantitative O +
trait O +
linkage O +
SLE O +
- O +
systemic O +
lupus O +
erythematosus O +
ssDNA O +
- O +
anti O -
- O -
single O -
- O -
stranded O +
DNA O +
Figures O +
and O +
Tables O +
Figure O +
1 O +
Linkage O +
of O +
Chromosome O +
2 O +
with O +
ANA O +
and O +
Anti O -
- O -
Chromatin O +
Abs O +
in O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs− O -
/ O -
− O +
Mice O +
These O +
associations O +
were O +
not O +
detected O +
in O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
animals O -
. O +

Centimorgan O +
positions O +
were O +
deduced O +
by O +
interval O +
mapping O -
, O +
anchoring O +
marker O +
locations O +
to O +
data O +
from O +
http://www.informatics.jax.org O -
. O +

Dotted O +
lines O +
and O +
the O +
dashed O +
line O +
indicate O +
the O +
threshold O +
over O +
which O +
linkages O +
were O +
considered O +
suggestive O +
or O +
significant O -
, O +
respectively O -
, O +
as O +
defined O +
in O +
Materials O +
and O +
Methods O -
. O +

Figure O +
3 O +
Linkage O +
of O +
Chromosome O +
4 O +
with O +
Anti O -
- O -
dsDNA O +
Abs O +

The O +
estimated O +
peak O +
in O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
mice O +
was O +
at O +
position O +
51.3 O +
cM O -
, O +
whilst O +
in O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs− O -
/ O -
−animals O +
it O +
was O +
was O +
at O +
position O +
71 O +
cM O -
, O +
indicating O +
that O +
most O +
likely O +
these O +
were O +
two O +
independent O +
loci O -
. O +

Centimorgan O +
positions O +
were O +
deduced O +
by O +
interval O +
mapping O -
, O +
anchoring O +
marker O +
locations O +
to O +
data O +
from O +
http://www.informatics.jax.org O -
. O +

Dotted O +
lines O +
the O +
indicate O +
threshold O +
over O +
which O +
linkage O +
was O +
considered O +
suggestive O -
, O +
as O +
defined O +
in O +
Materials O +
and O +
Methods O -
. O +

Figure O +
4 O +
Interval O +
Mapping O +
Scans O +
Showing O +
QTL O +
on O +
Chromosome O +
1 O +
with O +
Anti O -
- O -
dsDNA O +
and O +
Anti O -
- O -
ssDNA O +
Abs O +
Centimorgan O +
positions O +
were O +
deduced O +
by O +
interval O +
mapping O -
, O +
anchoring O +
marker O +
locations O +
to O +
data O +
from O +
http://www.informatics.jax.org O -
. O +

Dotted O +
lines O +
indicate O +
the O +
threshold O +
over O +
which O +
linkage O +
was O +
considered O +
suggestive O -
, O +
dashed O +
lines O +
indicate O +
the O +
threshold O +
over O +
which O +
linkage O +
was O +
considered O +
significant O -
, O +
and O +
dotted O -
/ O -
dashed O +
lines O +
indicate O +
highly O +
significant O +
linkage O -
, O +
as O +
defined O +
in O +
Materials O +
and O +
Methods O -
. O +

See O +
Table O +
3 O +
for O +
additional O +
details O -
. O +

Figure O +
5 O +
Interval O +
Mapping O +
Scans O +
Showing O +
QTL O +
on O +
Chromosome O +
1 O +
with O +
ANA O +
and O +
Anti O -
- O -
Chromatin O +
Abs O +
Centimorgan O +
positions O +
were O +
deduced O +
by O +
interval O +
mapping O -
, O +
anchoring O +
marker O +
locations O +
to O +
data O +
from O +
http://www.informatics.jax.org O -
. O +

Dotted O +
lines O +
indicate O +
the O +
threshold O +
over O +
which O +
linkage O +
was O +
considered O +
suggestive O -
, O +
and O +
dashed O +
lines O +
indicate O +
the O +
threshold O +
over O +
which O +
linkage O +
was O +
considered O +
significant O -
, O +
as O +
defined O +
in O +
Materials O +
and O +
Methods O -
. O +

See O +
Table O +
3 O +
for O +
additional O +
details O -
. O +

Figure O +
6 O +
Auto O -
- O -
Ab O +
Profiles O +
( O -
A O -
) O +
ANA O +
titres O +
in O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs− O -
/ O -
− O +
mice O +
and O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
at O +
1 O +
y O +
of O +
age O -
. O +

A O +
small O +
circle O +
represents O +
one O +
mouse O -
; O +
a O +
large O +
circle O -
, O +
a O +
variable O +
number O +
of O +
animals O -
, O +
as O +
indicated O +
in O +
parentheses O -
. O +

Serum O +
samples O +
were O +
titrated O +
to O +
endpoint O -
. O +

( O -
B O -
) O +
ANA O +
titres O +
in O +
the O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs O +
− O -
/ O -
− O +
mice O +
and O +
a O +
selected O +
number O +
of O +
wild O -
- O -
type O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
animals O +
carrying O +
the O +
Chromosome O +
1 O +
region O +
between O +
D1Mit105 O +
and O +
D1Mit223 O +
( O -
80–106 O +
cM O -
) O +
of O +
129 O +
origin O -
. O +

The O +
symbols O +
are O +
as O +
in O +
( O -
A O -
) O -
. O +

( O -
C O +
and O +
D O -
) O +
Anti O -
- O -
chromatin O +
Ab O +
levels O +
expressed O +
in O +
AEUs O +
related O +
to O +
a O +
standard O +
positive O +
sample O -
, O +
which O +
was O +
assigned O +
a O +
value O +
of O +
100 O +
AEU O -
. O +

The O +
comparison O +
is O +
between O +
the O +
same O +
groups O +
of O +
mice O +
as O +
in O +
( O -
A O -
) O +
and O +
( O -
B O -
) O -
, O +
respectively O -
. O +

The O +
symbols O +
are O +
as O +
in O +
( O -
A O -
) O -
. O +

Figure O +
7 O +
Interval O +
Mapping O +
Scans O +
Showing O +
QTL O +
on O +
Chromosome O +
3 O +
with O +
ANA O -
, O +
Anti O -
- O -
Chromatin O -
, O +
and O +
Anti O -
- O -
ssDNA O +
Abs O +
See O +
Table O +
3 O +
for O +
additional O +
details O -
. O +

Centimorgan O +
positions O +
were O +
deduced O +
by O +
interval O +
mapping O -
, O +
anchoring O +
marker O +
locations O +
to O +
data O +
from O +
http://www.informatics.jax.org O -
. O +

Dotted O +
lines O +
indicate O +
the O +
threshold O +
over O +
which O +
linkage O +
was O +
considered O +
suggestive O -
, O +
the O +
dashed O +
line O +
indicate O +
the O +
threshold O +
over O +
which O +
linkage O +
was O +
considered O +
significant O -
, O +
and O +
dotted O -
/ O -
dashed O +
lines O +
indicate O +
highly O +
significant O +
linkage O -
, O +
as O +
defined O +
in O +
Materials O +
and O +
Methods O -
. O +

Figure O +
8 O +
Auto O -
- O -
Ab O +
Profiles O +
( O -
A O -
) O +
ANA O +
titres O +
in O +
C57BL O -
/ O -
6 O +
mice O -
, O +
C57BL O -
/ O -
6.Apcs O +
− O -
/ O -
− O +
mice O -
, O +
and O +
C57BL O -
/ O -
6.129 O -
( O -
D1Mit105–223 O -
) O +
congenic O +
mice O +
at O +
1 O +
y O +
of O +
age O -
. O +

Small O +
symbols O +
represent O +
one O +
mouse O -
; O +
large O +
symbols O -
, O +
a O +
variable O +
number O +
of O +
animals O +
as O +
indicated O +
in O +
parentheses O -
. O +

Serum O +
sample O +
were O +
titrated O +
to O +
endpoint O -
. O +

( O -
B O +
and O +
C O -
) O +
Anti O -
- O -
ssDNA O +
( O -
B O -
) O +
and O +
anti O -
- O -
chromatin O +
( O -
C O -
) O +
Ab O +
levels O +
in O +
the O +
same O +
cohorts O +
of O +
mice O +
as O +
in O +
( O -
A O -
) O -
. O +

The O +
Ab O +
levels O +
are O +
expressed O +
in O +
AEUs O +
related O +
to O +
a O +
standard O +
positive O +
sample O -
, O +
which O +
was O +
assigned O +
a O +
value O +
of O +
100 O +
AEU O -
. O +

( O -
D O -
) O +
Anti O -
- O -
dsDNA O +
Ab O +
levels O -
. O +

Serum O +
samples O +
were O +
screened O +
at O +
1:20 O -
. O +

Samples O +
that O +
were O +
positive O +
were O +
titrated O +
to O +
endpoint O -
. O +

The O +
symbols O +
are O +
as O +
in O +
( O -
A O -
) O -
. O +

Figure O +
9 O +
Renal O +
Histological O +
Assessment O +
C57BL O -
/ O -
6 O +
mice O -
, O +
C57BL O -
/ O -
6.Apcs− O -
/ O -
− O +
mice O -
, O +
and O +
C57BL O -
/ O -
6.129 O -
( O -
D1Mit105–223 O -
) O +
congenic O +
mice O +
were O +
sacrificed O +
at O +
1 O +
y O +
of O +
age O +
to O +
obtain O +
age O -
- O -
matched O +
autopsy O +
specimens O -
. O +

Bouin O -
's O +
fixed O +
kidney O +
sections O +
were O +
scored O +
blinded O +
for O +
glomerulonephritis O -
. O +

Glomerulonephritis O +
was O +
graded O +
on O +
a O +
0–3 O +
scale O +
( O -
see O +
Materials O +
and O +
Methods O +
for O +
details O -
) O -
. O +

Figure O +
2 O +
Linkage O +
of O +
Chromosome O +
8 O +
with O +
Anti O -
- O -
Chromatin O +
and O +
Anti O -
- O -
dsDNA O +
Abs O +
in O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
Mice O +
These O +
linkages O +
were O +
not O +
detected O +
in O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2.Apcs− O -
/ O -
− O +
animals O -
. O +

Centimorgan O +
positions O +
were O +
deduced O +
by O +
interval O +
mapping O -
, O +
anchoring O +
marker O +
locations O +
to O +
data O +
from O +
http://www.informatics.jax.org O -
. O +

Dotted O +
lines O +
indicate O +
the O +
threshold O +
over O +
which O +
linkage O +
was O +
considered O +
suggestive O -
, O +
as O +
defined O +
in O +
Materials O +
and O +
Methods O -
. O +

Table O +
1 O +
Spontaneous O +
Auto O -
- O -
Abs O +
in O +
Apcs− O -
/ O -
− O +
and O +
Wild O -
- O -
Type O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
Female O +
Mice O +
Significant O +
differences O +
between O +
Apcs− O -
/ O -
− O +
and O +
wild O -
- O -
type O +
controls O +
by O +
Mann O -
– O -
Whitney O +
U O +
test O -
. O +

The O +
numbers O +
tested O +
for O +
different O +
phenotypes O +
are O +
not O +
equal O +
due O +
to O +
the O +
limited O +
amount O +
of O +
serum O +
or O +
death O +
of O +
the O +
mice O +
before O +
the O +
end O +
of O +
the O +
experiment O -
. O +

NS O -
, O +
not O +
significant O +
Table O +
2 O +
Histological O +
Assessment O +
of O +
Kidney O +
Sections O +
in O +
Apcs− O -
/ O -
− O +
and O +
Wild O -
- O -
Type O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
Female O +
Mice O +
The O +
renal O +
sections O +
were O +
scored O +
on O +
a O +
0–3 O +
scale O +
on O +
the O +
intensity O +
and O +
extent O +
of O +
the O +
histopathological O +
changes O +
as O +
described O +
in O +
Materials O +
and O +
Methods O -
. O +

The O +
difference O +
between O +
the O +
two O +
experimental O +
groups O +
was O +
not O +
significant O +
Table O +
3 O +
Summary O +
of O +
Genome O -
- O -
Wide O +
Linkage O +
Analysis O +
in O +
Apcs− O -
/ O -
− O +
and O +
Wild O -
- O -
Type O +
( O -
129 O +
× O +
C57BL O -
/ O -
6 O -
) O -
F2 O +
Female O +
Mice O +
a O +
Suggestive O +
linkage O +
b O +
Significant O +
linkage O +
c O +
Highly O +
significant O +
linkage O +
as O +
defined O +
in O +
the O +
material O +
and O +
method O +
section O +
Chr O -
, O +
Chromosome O -
; O +
Est O -
. O +

Peak O -
, O +
Estimated O +
Peak O -
; O +
LOD O -
, O +
logarithm O +
of O +
odds O -
; O +
N O -
/ O -
A O -
, O +
not O +
applicable O +
Chromosomes O +
where O +
linkages O +
were O +
not O +
present O +
in O +
both O +
experimental O +
groups O +
are O +
not O +
illustrated O -
. O +

See O +
Materials O +
and O +
Methods O +
for O +
details O -
. O +

The O +
oligonucleotide O +
sequences O +
and O +
approximate O +
positions O +
of O +
the O +
microsatellite O +
markers O +
used O +
were O +
taken O +
from O +
the O +
Mouse O +
Genome O +
Database O -
, O +
Mouse O +
Genome O +
Informatics O -
, O +
Jackson O +
Laboratory O -
, O +
Bar O +
Harbor O -
, O +
Maine O -
, O +
United O +
States O +
( O -
http://www.informatics.jax.org O -
) O +
Footnotes O +
Conflicts O +
of O +
interest O -
. O +

The O +
authors O +
have O +
declared O +
that O +
no O +
conflicts O +
of O +
interest O +
exist O -
. O +

Author O +
contributions O -
. O +

MJW O -
, O +
TJV O -
, O +
and O +
MB O +
conceived O +
and O +
designed O +
the O +
experiments O -
. O +

AEB O -
, O +
KLR O -
, O +
JW O -
, O +
JC O -
- O -
H O -
, O +
and O +
RJR O +
performed O +
the O +
experiments O -
. O +

AEB O -
, O +
KLR O -
, O +
RJR O -
, O +
and O +
HTC O +
analyzed O +
the O +
data O -
. O +

MB O +
wrote O +
the O +
paper O -
. O +

Academic O +
Editor O -
: O +
David O +
Nemazee O -
, O +
Scripps O +
Research O +
Institute O +
¤ O +
Current O +
address O -
: O +

The O +
Wellcome O +
Trust O -
, O +
London O -
, O +
United O +
Kingdom O +
Citation O -
: O +
Bygrave O +
AE O -
, O +
Rose O +
KL O -
, O +
Cortes O -
- O -
Hernandez O +
J O -
, O +
Warren O +
J O -
, O +
Rigby O +
RJ O -
, O +
et O +
al. O +
( O -
2004 O -
) O +
Spontaneous O +
autoimmunity O +
in O +
129 O +
and O +
C57BL O -
/ O -
6 O +
mice O -
— O -
Implications O +
for O +
autoimmunity O +
described O +
in O +
gene O -
- O -
targeted O +
mice O -
. O +

PLoS O +
Biol O +
2 O -
( O -
8 O -
) O -
: O +
e243 O -
. O +

Regulation O +
of O +
Muscle O +
Fiber O +
Type O +
and O +
Running O +
Endurance O +
by O +
PPARδ O +
Abstract O +
Endurance O +
exercise O +
training O +
can O +
promote O +
an O +
adaptive O +
muscle O +
fiber O +
transformation O +
and O +
an O +
increase O +
of O +
mitochondrial O +
biogenesis O +
by O +
triggering O +
scripted O +
changes O +
in O +
gene O +
expression O -
. O +

However O -
, O +
no O +
transcription O +
factor O +
has O +
yet O +
been O +
identified O +
that O +
can O +
direct O +
this O +
process O -
. O +

We O +
describe O +
the O +
engineering O +
of O +
a O +
mouse O +
capable O +
of O +
continuous O +
running O +
of O +
up O +
to O +
twice O +
the O +
distance O +
of O +
a O +
wild O -
- O -
type O +
littermate O -
. O +

This O +
was O +
achieved O +
by O +
targeted O +
expression O +
of O +
an O +
activated O +
form O +
of O +
peroxisome O +
proliferator O -
- O -
activated O +
receptor O +
δ O +
( O -
PPARδ O -
) O +
in O +
skeletal O +
muscle O -
, O +
which O +
induces O +
a O +
switch O +
to O +
form O +
increased O +
numbers O +
of O +
type O +
I O +
muscle O +
fibers O -
. O +

Treatment O +
of O +
wild O -
- O -
type O +
mice O +
with O +
PPARδ B-Chemical +
agonist I-Chemical +
elicits O +
a O +
similar O +
type O +
I O +
fiber O +
gene O +
expression O +
profile O +
in O +
muscle O -
. O +

Moreover O -
, O +
these O +
genetically O +
generated O +
fibers O +
confer O +
resistance O +
to O +
obesity O +
with O +
improved O +
metabolic O +
profiles O -
, O +
even O +
in O +
the O +
absence O +
of O +
exercise O -
. O +

These O +
results O +
demonstrate O +
that O +
complex O +
physiologic O +
properties O +
such O +
as O +
fatigue O -
, O +
endurance O -
, O +
and O +
running O +
capacity O +
can O +
be O +
molecularly O +
analyzed O +
and O +
manipulated O -
. O +

Introduction O +
Skeletal O +
muscle O +
fibers O +
are O +
generally O +
classified O +
as O +
type O +
I O +
( O -
oxidative O -
/ O -
slow O -
) O +
or O +
type O +
II O +
( O -
glycolytic O -
/ O -
fast O -
) O +
fibers O -
. O +

They O +
display O +
marked O +
differences O +
in O +
respect O +
to O +
contraction O -
, O +
metabolism O -
, O +
and O +
susceptibility O +
to O +
fatigue O -
. O +

Type O +
I O +
fibers O +
are O +
mitochondria O -
- O -
rich O +
and O +
mainly O +
use O +
oxidative O +
metabolism O +
for O +
energy O +
production O -
, O +
which O +
provides O +
a O +
stable O +
and O +
long O -
- O -
lasting O +
supply O +
of O +
ATP O -
, O +
and O +
thus O +
are O +
fatigue O -
- O -
resistant O -
. O +

Type O +
II O +
fibers O +
comprise O +
three O +
subtypes O -
, O +
IIa O -
, O +
IIx O -
, O +
and O +
IIb O -
. O +

Type O +
IIb O +
fibers O +
have O +
the O +
lowest O +
levels O +
of O +
mitochondrial O +
content O +
and O +
oxidative O +
enzymes O -
, O +
rely O +
on O +
glycolytic O +
metabolism O +
as O +
a O +
major O +
energy O +
source O -
, O +
and O +
are O +
susceptible O +
to O +
fatigue O -
, O +
while O +
the O +
oxidative O +
and O +
contraction O +
functions O +
of O +
type O +
IIa O +
and O +
IIx O +
lie O +
between O +
type O +
I O +
and O +
IIb O +
( O -
Booth O +
and O +
Thomason O +
1991 O -
; O +
Berchtold O +
et O +
al. O +
2000 O -
; O +
Olson O +
and O +
Williams O +
2000 O -
) O -
. O +

Adult O +
skeletal O +
muscle O +
shows O +
plasticity O +
and O +
can O +
undergo O +
conversion O +
between O +
different O +
fiber O +
types O +
in O +
response O +
to O +
exercise O +
training O +
or O +
modulation O +
of O +
motoneuron O +
activity O +
( O -
Booth O +
and O +
Thomason O +
1991 O -
, O +
Jarvis O +
et O +
al. O +
1996 O -
; O +
Pette O +
1998 O -
; O +
Olson O +
and O +
Williams O +
2000 O -
; O +
Hood O +
2001 O -
) O -
. O +

This O +
conversion O +
of O +
muscle O +
fiber O +
from O +
type O +
IIb O +
to O +
type O +
IIa O +
and O +
type O +
I O +
is O +
likely O +
to O +
be O +
mediated O +
by O +
a O +
calcium O +
signaling O +
pathway O +
that O +
involves O +
calcineurin O -
, O +
calmodulin O -
- O -
dependent O +
kinase O -
, O +
and O +
the O +
transcriptional O +
cofactor B-Chemical +
Peroxisome O +
proliferator O -
- O -
activated O +
receptor O -
- O -
gamma O +
coactivator O +
1α O +
( O -
PGC-1α O -
) O +
( O -
Naya O +
et O +
al. O +
2000 O -
; O +
Olson O +
and O +
Williams O +
2000 O -
; O +
Lin O +
et O +
al. O +
2002 O -
; O +
Wu O +
et O +
al. O +
2002 O -
) O -
. O +

However O -
, O +
the O +
targeted O +
transcriptional O +
factors O +
directly O +
responsible O +
for O +
reprogramming O +
the O +
fiber O -
- O -
specific O +
contractile O +
and O +
metabolic O +
genes O +
remain O +
to O +
be O +
identified O -
. O +

Muscle O +
fiber O +
specification O +
appears O +
to O +
be O +
associated O +
with O +
obesity O +
and O +
diabetes O -
. O +

For O +
instance O -
, O +
rodents O +
that O +
gain O +
the O +
most O +
weight O +
on O +
high O -
- O -
fat O +
diets O +
possess O +
fewer O +
type O +
I O +
fibers O +
( O -
Abou O +
et O +
al. O +
1992 O -
) O -
. O +

In O +
obese O +
patients O -
, O +
skeletal O +
muscle O +
has O +
been O +
observed O +
to O +
have O +
reduced O +
oxidative O +
capacity O -
, O +
increased O +
glycolytic O +
capacity O -
, O +
and O +
a O +
decreased O +
percentage O +
of O +
type O +
I O +
fibers O +
( O -
Hickey O +
et O +
al. O +
1995 O -
; O +
Tanner O +
et O +
al. O +
2002 O -
) O -
. O +

Similar O +
observations O +
have O +
been O +
made O +
in O +
type O +
2 O +
diabetic O +
patients O +
( O -
Lillioja O +
et O +
al. O +
1987 O -
; O +
Hickey O +
et O +
al. O +
1995 O -
) O -
. O +

Recently O -
, O +
it O +
has O +
been O +
shown O +
that O +
increasing O +
oxidative O +
fibers O +
can O +
lead O +
to O +
improved O +
insulin O +
action O +
and O +
reduced O +
adipocyte O +
size O +
( O -
Luquet O +
et O +
al. O +
2003 O -
; O +
Ryder O +
et O +
al. O +
2003 O -
) O -
. O +

We O +
have O +
previously O +
established O +
that O +
peroxisome O +
proliferator O -
- O -
activated O +
receptor O +
( O -
PPAR O -
) O +
δ O +
is O +
a O +
major O +
transcriptional O +
regulator O +
of O +
fat O +
burning O +
in O +
adipose O +
tissue O +
through O +
activation O +
of O +
enzymes O +
associated O +
with O +
long B-Chemical -
- I-Chemical -
chain I-Chemical +
fatty I-Chemical -
- I-Chemical -
acid I-Chemical +
β O -
- O -
oxidation O +
( O -
Wang O +
et O +
al. O +
2003 O -
) O -
. O +

Although O +
PPARδ O +
is O +
the O +
predominant O +
PPAR O +
isoform O +
present O +
in O +
skeletal O +
muscle O -
, O +
its O +
in O +
vivo O +
function O +
has O +
not O +
been O +
determined O -
. O +

Our O +
current O +
study O +
uncovers O +
PPARδ O +
as O +
the O +
first O +
transcription O +
factor O +
able O +
to O +
drive O +
the O +
formation O +
of O +
functional O +
type O +
I O +
muscle O +
fibers O -
, O +
whose O +
activation O +
entrains O +
complex O +
pathways O +
both O +
enhancing O +
physical O +
performance O +
and O +
creating O +
a O +
state O +
of O +
obesity O +
resistance O -
. O +

Results O +
Activation O +
of O +
PPARδ O +
Leads O +
to O +
Muscle O +
Fiber O +
Transformation O +
A O +
role O +
of O +
PPARδ O +
in O +
muscle O +
fiber O +
was O +
suggested O +
by O +
its O +
enhanced O +
expression O -
— O -
at O +
levels O +
10-fold O +
and O +
50-fold O +
greater O +
than O +
PPARα O +
and O +
γ O +
isoforms O -
, O +
respectively O +
( O -
unpublished O +
data O -
) O -
. O +

An O +
examination O +
of O +
PPARδ O +
in O +
different O +
muscle O +
fibers O +
reveals O +
a O +
significantly O +
higher O +
level O +
in O +
type O +
I O +
muscle O +
( O -
soleus O -
) O +
relative O +
to O +
type O +
II O -
– O -
rich O +
muscle O +
( O -
extensor O +
digitorum O +
longus O -
) O +
or O +
type O +
I O +
and O +
type O +
II O +
mixed O +
muscle O +
( O -
gastrocnemius O -
) O +
( O -
Figure O +
1A O -
) O -
; O +
this O +
expression O +
pattern O +
closely O +
resembles O +
that O +
of O +
PGC-1α O +
( O -
Lin O +
et O +
al. O +
2002 O -
) O -
. O +

A O +
similar O +
pattern O +
but O +
with O +
more O +
pronounced O +
differences O +
was O +
found O +
at O +
the O +
protein O +
level O +
( O -
Figure O +
1B O -
) O -
. O +

To O +
directly O +
assess O +
the O +
role O +
of O +
activation O +
of O +
PPARδ O +
in O +
control O +
of O +
muscle O +
fiber O +
plasticity O +
and O +
mitochondrial O +
biogenesis O -
, O +
we O +
generated O +
mice O +
expressing O +
a O +
transgene O +
in O +
which O +
the O +
78-amino O -
- O -
acid O +
VP16 O +
activation O +
domain O +
was O +
fused O +
to O +
the O +
N O -
- O -
terminus O +
of O +
full O -
- O -
length O +
PPARδ O -
, O +
under O +
control O +
of O +
the O +
2.2-kb O +
human O +
α O -
- O -
skeletal O +
actin O +
promoter O -
. O +

In O +
agreement O +
with O +
the O +
previous O +
characterization O +
of O +
this O +
promoter O +
( O -
Brennan O +
and O +
Hardeman O +
1993 O -
; O +
Clapham O +
et O +
al. O +
2000 O -
) O -
, O +
the O +
VP16-PPARδ O +
transgene O +
was O +
selectively O +
expressed O +
in O +
skeletal O +
muscle O -
, O +
with O +
10-fold O +
less O +
in O +
the O +
heart O +
( O -
Figure O +
1C O -
) O -
. O +

Among O +
different O +
types O +
of O +
muscle O +
fibers O -
, O +
the O +
levels O +
of O +
VP16-PPARδ O +
expression O +
appeared O +
to O +
be O +
similar O +
( O -
unpublished O +
data O -
) O -
. O +

As O +
shown O +
in O +
Figure O +
1D O +
for O +
gastrocnemius O +
muscle O -
, O +
VP16-PPARδ O +
fusion O +
protein O +
was O +
produced O +
at O +
a O +
level O +
similar O +
to O +
that O +
of O +
endogenous O +
PPARδ O +
in O +
wild O -
- O -
type O +
littermates O -
. O +

Interestingly O -
, O +
the O +
level O +
of O +
endogenous O +
muscle O +
PPARδ O +
protein O +
in O +
the O +
transgenic O +
mice O +
was O +
much O +
higher O +
than O +
in O +
the O +
control O +
littermates O -
. O +

The O +
substantial O +
increase O +
of O +
endogenous O +
PPARδ O +
may O +
have O +
been O +
caused O +
by O +
a O +
switch O +
to O +
type O +
I O +
fiber O +
( O -
see O +
below O -
) O -
, O +
which O +
intrinsically O +
expresses O +
higher O +
levels O +
of O +
PPARδ O +
( O -
Figure O +
1A O +
and O +
1B O -
) O -
. O +

Type O +
I O +
muscle O +
can O +
be O +
readily O +
distinguished O +
from O +
type O +
II O +
or O +
mixed O +
muscle O +
by O +
its O +
red O +
color O -
, O +
because O +
of O +
its O +
high O +
concentration O +
of O +
myoglobin O -
, O +
a O +
protein O +
typically O +
expressed O +
in O +
oxidative O +
muscle O +
fibers O -
. O +

We O +
found O +
that O +
muscles O +
in O +
the O +
transgenic O +
mice O +
appeared O +
redder O +
( O -
Figure O +
2A O -
) O -
, O +
which O +
is O +
particularly O +
evident O +
in O +
the O +
mixed O +
type O +
I O -
/ O -
II O +
fibers O +
of O +
the O +
hindlimb O +
( O -
Figure O +
2B O -
) O -
. O +

Indeed O -
, O +
metachromatic O +
staining O +
revealed O +
a O +
substantial O +
muscle O +
fiber O +
transformation O +
( O -
Figure O +
2C O -
) O -
. O +

In O +
gastrocnemius O +
muscle O -
, O +
we O +
estimated O +
that O +
there O +
was O +
a O +
2-fold O +
increase O +
of O +
type O +
I O +
fibers O -
. O +

A O +
diagnostic O +
component O +
of O +
oxidative O +
fibers O +
is O +
their O +
high O +
myoglobin O +
and O +
mitochondrial O +
content O -
, O +
which O +
is O +
supported O +
by O +
the O +
mRNA O +
analysis O +
shown O +
in O +
Figure O +
3A O -
. O +

In O +
addition O +
to O +
myoglobin O -
, O +
mitochondrial O +
components O +
for O +
electron B-Chemical +
transfer O +
( O -
cytochrome B-Chemical +
c I-Chemical +
and O +
cytochrome B-Chemical +
c I-Chemical +
oxidase O +
[ O -
COX O -
] O +
II O +
and O +
IV O -
) O +
and O +
fatty B-Chemical -
- I-Chemical -
acid I-Chemical +
β O -
- O -
oxidation O +
enzymes O +
were O +
elevated O +
( O -
Figure O +
3A O -
; O +
unpublished O +
data O -
) O -
. O +

These O +
effects O +
appear O +
to O +
be O +
direct O +
consequences O +
of O +
PPARδ O +
activation O -
, O +
as O +
levels O +
of O +
PGC-1α O -
, O +
a O +
coactivator O +
involved O +
in O +
muscle O +
fiber O +
switch O +
and O +
mitochondrial O +
biogenesis O +
( O -
Wu O +
et O +
al. O +
1999 O -
; O +
Lehman O +
et O +
al. O +
2000 O -
; O +
Lin O +
et O +
al. O +
2002 O -
) O -
, O +
remained O +
unchanged O -
. O +

Southern O +
blot O +
analysis O +
detected O +
a O +
substantially O +
higher O +
copy O +
number O +
of O +
the O +
mitochondrial O +
genome O -
– O -
encoded O +
COXII O +
DNA O +
in O +
the O +
transgenic O +
mice O +
( O -
Figure O +
3B O -
) O -
. O +

Mitochondrial O +
DNA O +
was O +
increased O +
2.3-fold O +
in O +
gastrocnemius O +
muscle O +
of O +
the O +
transgenic O +
mice O +
( O -
Figure O +
3C O -
) O -
. O +

These O +
results O +
reveal O +
a O +
marked O +
stimulation O +
of O +
mitochondrial O +
biogenesis O +
and O +
further O +
support O +
the O +
idea O +
that O +
there O +
is O +
a O +
muscle O +
fiber O +
switch O -
. O +

This O +
conclusion O +
was O +
also O +
confirmed O +
by O +
Western O +
blot O +
analysis O -
. O +

As O +
shown O +
in O +
Figure O +
3D O -
, O +
the O +
characteristic O +
type O +
I O +
fiber O +
proteins O -
, O +
such O +
as O +
myoglobin O +
and O +
cytochrome B-Chemical +
c B-Chemical +
and O +
b B-Chemical -
, O +
were O +
significantly O +
increased O -
. O +

More O +
importantly O -
, O +
the O +
specialized O +
contraction O +
protein O +
troponin O +
I O +
( O -
slow O -
) O +
of O +
type O +
I O +
fiber O +
was O +
robustly O +
induced O -
; O +
this O +
was O +
accompanied O +
by O +
a O +
marked O +
reduction O +
of O +
the O +
specialized O +
contraction O +
protein O +
troponin O +
I O +
( O -
fast O -
) O +
of O +
type O +
II O +
fiber O -
, O +
indicating O +
a O +
high O +
degree O +
of O +
fiber O +
transformation O -
. O +

We O +
next O +
examined O +
whether O +
acute O +
activation O +
of O +
endogenous O +
PPARδ O +
would O +
induce O +
similar O +
target O +
genes O -
. O +

In O +
agreement O +
with O +
the O +
chronic O +
effects O +
in O +
the O +
transgenic O +
mice O -
, O +
we O +
found O +
that O -
, O +
after O +
treatment O +
of O +
wild O -
- O -
type O +
C57B6J O +
mice O +
with O +
the O +
PPARδ O -
- O -
specific O +
agonist O +
GW501516 B-Chemical +
for O +
only O +
10 O +
d O -
, O +
genes O +
for O +
slow O +
fiber O +
contractile O +
proteins O -
, O +
mitochondrial O +
biogenesis O -
, O +
and O +
β O -
- O -
oxidation O +
were O +
all O +
upregulated O +
( O -
Figure O +
3E O -
) O -
. O +

This O +
indicates O +
that O +
rapid O -
, O +
systematic O -
, O +
and O +
coordinated O +
changes O +
of O +
muscle O +
fiber O +
properties O +
toward O +
type O +
I O +
can O +
be O +
achieved O +
by O +
activation O +
of O +
the O +
endogenous O +
PPARδ O +
pathway O -
. O +

Muscle O +
Fiber O +
Switch O +
by O +
PPARδ O +
Protects O +
Against O +
Obesity O +
A O +
number O +
of O +
previous O +
studies O +
have O +
shown O +
that O +
obese O +
individuals O +
have O +
fewer O +
oxidative O +
fibers O -
, O +
implying O +
that O +
the O +
presence O +
of O +
oxidative O +
fibers O +
alone O +
may O +
play O +
a O +
part O +
in O +
obesity O +
resistance O -
. O +

To O +
test O +
this O +
possibility O -
, O +
we O +
fed O +
the O +
transgenic O +
mice O +
and O +
their O +
wild O -
- O -
type O +
littermates O +
with O +
a O +
high O -
- O -
fat O +
diet O +
for O +
97 O +
d. O +
Although O +
the O +
initial O +
body O +
weights O +
of O +
the O +
two O +
groups O +
were O +
very O +
similar O -
, O +
the O +
transgenic O +
mice O +
had O +
gained O +
less O +
than O +
50 O -
% O +
at O +
day O +
47 O -
, O +
and O +
only O +
one O -
- O -
third O +
at O +
day O +
97 O -
, O +
of O +
the O +
weight O +
gained O +
by O +
the O +
wild O -
- O -
type O +
animals O +
( O -
Figure O +
4A O -
) O -
. O +

The O +
transgenic O +
mice O +
displayed O +
significantly O +
higher O +
oxygen O +
consumption O +
on O +
the O +
high O -
- O -
fat O +
diet O +
than O +
the O +
control O +
littermates O +
( O -
unpublished O +
data O -
) O -
. O +

By O +
the O +
end O +
of O +
this O +
experiment O -
, O +
the O +
control O +
littermates O +
became O +
obese O -
, O +
whereas O +
the O +
transgenic O +
mice O +
still O +
maintained O +
a O +
normal O +
body O +
weight O +
and O +
fat O +
mass O +
composition O +
( O -
Figure O +
4A O -
) O -
. O +

A O +
histological O +
analysis O +
of O +
inguinal O +
fat O +
pad O +
revealed O +
a O +
much O +
smaller O +
cell O +
size O +
in O +
the O +
transgenic O +
mice O +
( O -
Figure O +
4B O -
) O -
, O +
due O +
to O +
the O +
increased O +
muscle O +
oxidative O +
capacity O -
. O +

While O +
there O +
was O +
no O +
significant O +
difference O +
in O +
intramuscular O +
glycogen B-Chemical +
content O -
, O +
the O +
triglyceride B-Chemical +
content O +
was O +
much O +
less O +
in O +
the O +
transgenic O +
mice O +
( O -
Figure O +
4C O +
and O +
4D O -
) O -
, O +
which O +
may O +
explain O +
their O +
improved O +
glucose B-Chemical +
tolerance O +
( O -
Figure O +
4E O -
) O -
. O +

We O +
also O +
placed O +
wild O -
- O -
type O +
C57BJ6 O +
mice O +
on O +
the O +
high O -
- O -
fat O +
diet O +
and O +
treated O +
them O +
with O +
either O +
vehicle O +
or O +
the O +
PPARδ B-Chemical +
agonist I-Chemical +
GW501516 B-Chemical +
for O +
2 O +
mo O -
. O +

GW501516 B-Chemical +
produced O +
a O +
sustained O +
induction O +
of O +
genes O +
for O +
type O +
I O +
muscle O +
fibers O -
; O +
this O -
, O +
at O +
least O +
in O +
part O -
, O +
resulted O +
in O +
an O +
only O +
30 O -
% O +
gain O +
in O +
body O +
weight O -
, O +
a O +
dramatically O +
reduced O +
fat O +
mass O +
accumulation O -
, O +
and O +
improved O +
glucose B-Chemical +
tolerance O -
, O +
compared O +
to O +
the O +
vehicle O -
- O -
treated O +
group O +
( O -
Figure O +
5 O -
) O -
. O +

Thus O -
, O +
muscle O +
fiber O +
conversion O +
by O +
stimulation O +
with O +
the O +
PPARδ B-Chemical +
agonist I-Chemical +
or O +
the O +
activated O +
transgene O +
has O +
a O +
protective O +
role O +
against O +
obesity O -
. O +

Activation O +
of O +
PPARδ O +
Enhances O +
Physical O +
Performance O +
Muscle O +
oxidative O +
capacity O +
is O +
a O +
crucial O +
factor O +
for O +
determining O +
endurance O +
and O +
fatigue O -
. O +

Indeed O -
, O +
type O +
I O +
fibers O +
adaptively O +
generated O +
through O +
exercise O +
training O +
are O +
considered O +
to O +
be O +
fatigue O +
resistant O -
. O +

However O -
, O +
whether O +
the O +
type O +
I O +
fibers O +
generated O +
molecularly O +
via O +
PPARδ O +
expression O +
can O +
contribute O +
to O +
enhanced O +
performance O +
in O +
the O +
absence O +
of O +
previous O +
training O +
is O +
unclear O -
. O +

In O +
fact O -
, O +
the O +
consequence O +
of O +
genetically O +
induced O +
fiber O +
switch O +
on O +
running O +
capacity O +
has O +
to O +
our O +
knowledge O +
never O +
been O +
evaluated O -
. O +

We O +
thus O +
compared O +
exercise O +
performance O +
between O +
untrained O -
, O +
body O -
- O -
weight O -
- O -
matched O +
transgenic O +
and O +
wild O -
- O -
type O +
littermates O -
. O +

Mice O +
were O +
run O +
on O +
oxygen O -
- O -
infused O -
, O +
enclosed O +
treadmills O +
until O +
exhaustion O -
. O +

Strikingly O -
, O +
the O +
running O +
time O +
and O +
distance O +
the O +
transgenic O +
mice O +
were O +
able O +
to O +
sustain O +
were O +
increased O +
by O +
67 O -
% O +
and O +
92 O -
% O -
, O +
respectively O +
( O -
Figure O +
6A O -
; O +
also O +
see O +
Videos O +
S1 O +
and O +
S2 O -
) O -
. O +

The O +
transgenic O +
mice O +
ran O +
about O +
1 O +
h O +
longer O +
than O +
the O +
controls O -
, O +
which O +
translates O +
to O +
nearly O +
a O +
kilometer O +
further O -
. O +

No O +
significant O +
differences O +
in O +
muscle O +
mass O +
( O -
unpublished O +
data O -
) O +
and O +
daily O +
activity O +
( O -
total O +
counts O +
of O +
activity O +
per O +
hour O -
: O +
1618 O +
± O +
209 O +
for O +
transgenic O +
versus O +
1987 O +
± O +
301 O +
for O +
wild O -
- O -
type O -
, O +
p O +
> O +
0.35 O -
, O +
n O +
= O +
4 O -
) O +
were O +
observed O +
between O +
the O +
transgenic O +
and O +
control O +
mice O -
. O +

Thus O -
, O +
the O +
remarkable O +
increase O +
in O +
endurance O +
is O +
the O +
physiologic O +
manifestation O +
of O +
muscle O +
fiber O +
transformation O -
. O +

This O +
suggests O +
that O +
genetically O +
directed O +
muscle O +
fiber O +
switch O +
is O +
physiologically O +
and O +
functionally O +
relevant O -
. O +

In O +
addition O -
, O +
we O +
looked O +
at O +
what O +
effect O +
the O +
absence O +
of O +
PPARδ O +
function O +
has O +
on O +
exercise O +
endurance O -
. O +

In O +
the O +
treadmill O +
test O -
, O +
the O +
PPARδ O -
- O -
null O +
mice O +
could O +
sustain O +
only O +
38 O -
% O +
of O +
the O +
running O +
time O +
and O +
34 O -
% O +
of O +
the O +
distance O +
of O +
their O +
age- O +
and O +
weight O -
- O -
matched O +
wild O -
- O -
type O +
counterparts O +
( O -
Figure O +
6B O -
) O -
. O +

These O +
results O +
further O +
support O +
a O +
role O +
for O +
PPARδ O +
in O +
enhancement O +
of O +
physical O +
performance O -
. O +

Discussion O +
Our O +
data O +
reveal O +
that O +
a O +
PPARδ O -
- O -
mediated O +
transcriptional O +
pathway O +
can O +
regulate O +
muscle O +
fiber O +
specification O -
, O +
enabling O +
the O +
generation O +
of O +
a O +
strain O +
of O +
mice O +
with O +
a O +
" O -
long O -
- O -
distance O +
running O -
" O +
phenotype O -
. O +

We O +
show O +
that O +
targeted O +
expression O +
of O +
an O +
activated O +
form O +
of O +
PPARδ O +
produces O +
profound O +
and O +
coordinated O +
increases O +
in O +
oxidation O +
enzymes O -
, O +
mitochondrial O +
biogenesis O -
, O +
and O +
production O +
of O +
specialized O +
type O +
I O +
fiber O +
contractile O +
proteins O -
— O -
the O +
three O +
hallmarks O +
for O +
muscle O +
fiber O +
type O +
switching O +
( O -
Figure O +
6C O -
) O -
. O +

While O +
induction O +
of O +
muscle O +
oxidation O +
enzymes O +
by O +
PPARδ O +
has O +
been O +
seen O +
both O +
in O +
vivo O +
and O +
in O +
vitro O +
( O -
Muoio O +
et O +
al. O +
2002 O -
; O +
Dressel O +
et O +
al. O +
2003 O -
; O +
Luquet O +
et O +
al. O +
2003 O -
; O +
Tanaka O +
et O +
al. O +
2003 O -
; O +
Wang O +
et O +
al. O +
2003 O -
) O -
, O +
its O +
effects O +
shown O +
here O +
on O +
muscle O +
fiber O +
switching O +
are O +
unexpected O -
. O +

These O +
progressive O +
changes O +
in O +
oxidative O +
capacity O +
in O +
conjunction O +
with O +
eventual O +
changes O +
in O +
type O +
I O +
muscle O +
fiber O +
lead O +
to O +
a O +
dramatically O +
improved O +
exercise O +
profile O +
and O +
protection O +
against O +
obesity O -
. O +

This O +
does O +
not O +
solely O +
depend O +
on O +
achieving O +
a O +
directed O +
muscle O +
fiber O +
type O +
switch O +
but O +
also O +
requires O +
all O +
the O +
associated O +
changes O +
in O +
neural O +
innervation O -
, O +
motor O +
neuron O +
function O -
, O +
and O +
peripheral O +
metabolic O +
adaptation O +
to O +
enable O +
a O +
new O +
integrated O +
physiological O +
response O -
. O +

Accordingly O -
, O +
activation O +
of O +
muscle O +
PPARδ O +
essentially O +
recapitulates O +
the O +
effects O +
of O +
exercise O +
training O +
even O +
in O +
the O +
absence O +
of O +
training O +
itself O -
. O +

To O +
our O +
knowledge O -
, O +
this O +
has O +
not O +
been O +
directly O +
described O +
for O +
any O +
other O +
transcriptional O +
factor O -
. O +

The O +
muscle O +
phenotypes O +
described O +
here O +
are O +
remarkably O +
similar O +
to O +
those O +
of O +
transgenic O +
mice O +
expressing O +
either O +
calcineurin O -
, O +
calmodulin O -
- O -
dependent O +
kinase O -
, O +
or O +
PGC-1α O +
( O -
Naya O +
et O +
al. O +
2000 O -
; O +
Lin O +
et O +
al. O +
2002 O -
; O +
Wu O +
et O +
al. O +
2002 O -
) O -
, O +
indicating O +
that O +
PPARδ O +
could O +
be O +
one O +
of O +
the O +
hypothetical O +
downstream O +
transcription O +
factors O +
of O +
these O +
pathways O -
. O +

It O +
is O +
important O +
to O +
note O +
that O -
, O +
from O +
our O +
ligand O +
and O +
gain O -
- O -
of O -
- O -
function O +
transgenic O +
studies O -
, O +
PPARδ O +
needs O +
to O +
be O +
activated O +
in O +
order O +
to O +
direct O +
the O +
muscle O +
fiber O +
switch O -
. O +

Indeed O -
, O +
in O +
a O +
recent O +
report O +
by O +
Luquet O +
et O +
al. O +
( O -
2003 O -
) O -
, O +
simple O +
overexpression O +
of O +
wild O -
- O -
type O +
PPARδ O +
in O +
muscle O +
was O +
found O +
not O +
to O +
be O +
sufficient O +
to O +
promote O +
a O +
fiber O +
switch O +
or O +
obesity O +
resistance O -
, O +
although O +
certain O +
oxidation O +
enzymes O +
were O +
increased O -
. O +

This O +
supports O +
the O +
model O +
in O +
Figure O +
6C O +
that O +
the O +
activating O +
signal O +
or O +
ligand O -
, O +
but O +
not O +
the O +
receptor O -
, O +
is O +
limiting O -
. O +

Thus O -
, O +
PPARδ O +
activation O -
, O +
rather O +
than O +
merely O +
an O +
increase O +
of O +
PPARδ O +
levels O -
, O +
is O +
an O +
essential O +
element O +
for O +
fiber O +
switching O +
and O +
its O +
associated O +
functional O +
manifestations O -
. O +

How O +
might O +
endogenous O +
PPARδ O +
become O +
activated O +
naturally O +
by O +
exercise O +
training O -
? O +

First O -
, O +
it O +
is O +
possible O +
that O +
exercise O +
generates O +
or O +
increases O +
endogenous O +
ligands O +
for O +
PPARδ O +
as O +
tissues O +
are O +
undergoing O +
substantial O +
increases O +
in O +
fatty B-Chemical -
- I-Chemical -
acid I-Chemical +
internalization O +
and O +
burning O -
. O +

Fatty B-Chemical +
acids I-Chemical +
and O +
their O +
metabolites B-Chemical +
can O +
activate O +
PPARδ O -
. O +

A O +
second O +
model O +
is O +
that O +
exercise O +
may O +
induce O +
expression O +
of O +
PGC-1α O +
( O -
Goto O +
et O +
al. O +
2000 O -
) O +
and O +
thereby O +
activate O +
PPARδ O -
. O +

This O +
is O +
consistent O +
with O +
previous O +
work O +
in O +
which O +
we O +
have O +
shown O +
that O +
PGC-1α O +
physically O +
associates O +
with O +
PPARδ O +
in O +
muscle O +
tissue O +
and O +
can O +
powerfully O +
activate O +
it O +
even O +
in O +
the O +
absence O +
of O +
ligands O +
( O -
Wang O +
et O +
al. O +
2003 O -
) O -
. O +

Alternatively O -
, O +
PPARδ O +
may O +
be O +
activated O +
by O +
a O +
distal O +
upstream O +
signaling O +
component O +
such O +
as O +
a O +
kinase O +
cascade O -
. O +

Further O +
dissecting O +
the O +
interactions O +
between O +
PPARδ O +
and O +
its O +
regulatory O +
components O +
will O +
be O +
necessary O +
to O +
fully O +
understand O +
the O +
molecular O +
basis O +
of O +
muscle O +
fiber O +
determination O +
pertinent O +
to O +
exercise O +
training O -
. O +

Skeletal O +
muscle O +
is O +
a O +
major O +
site O +
to O +
regulate O +
whole O -
- O -
body O +
fatty B-Chemical -
- I-Chemical -
acid I-Chemical +
and O +
glucose B-Chemical +
metabolism O -
. O +

We O +
show O +
that O +
mice O +
with O +
increased O +
oxidative O +
fibers O +
are O +
resistant O +
to O +
high O -
- O -
fat O -
- O -
induced O +
obesity O +
and O +
glucose B-Chemical +
intolerance O -
. O +

Moreover O -
, O +
ligand O +
studies O +
provide O +
compelling O +
evidence O +
that O +
activation O +
of O +
endogenous O +
PPARδ O +
can O +
produce O +
similar O +
effects O -
. O +

Might O +
PPARδ O +
have O +
any O +
beneficial O +
effects O +
on O +
glucose B-Chemical +
metabolism O +
in O +
the O +
lean O +
condition O -
? O +

This O +
has O +
not O +
been O +
explored O -
; O +
however O -
, O +
insulin O +
resistance O +
in O +
the O +
elderly O +
is O +
confined O +
mostly O +
to O +
skeletal O +
muscle O +
and O +
may O +
be O +
due O +
to O +
reduction O +
of O +
mitochondrial O +
number O +
and/or O +
function O +
( O -
Petersen O +
et O +
al. O +
2003 O -
) O -
. O +

The O +
ability O +
of O +
PPARδ O +
to O +
stimulate O +
mitochondrial O +
biogenesis O +
and O +
oxidative O +
function O +
suggests O +
that O +
PPARδ O +
could O +
be O +
important O +
for O +
control O +
of O +
insulin O +
resistance O +
during O +
normal O +
aging O -
. O +

Together O -
, O +
these O +
data O +
indicate O +
that O +
PPARδ O +
and O +
its O +
ligands O +
comprise O +
a O +
key O +
molecular O +
switch O +
to O +
regulate O +
muscle O +
fiber O +
specification O -
, O +
obesity O +
resistance O -
, O +
insulin O +
sensitivity O -
, O +
and O -
, O +
most O +
surprisingly O -
, O +
physical O +
endurance O -
. O +

This O +
work O +
demonstrates O +
that O +
complex O +
physiologic O +
properties O +
such O +
as O +
fatigue O -
, O +
endurance O -
, O +
and O +
running O +
capacity O +
can O +
be O +
genetically O +
manipulated O -
. O +

Materials O +
and O +
Methods O +
Animals O -
. O +

The O +
transactivation O +
domain O +
( O -
78 O +
amino O +
acid O +
residues O -
, O +
corresponding O +
to O +
residues O +
413–490 O -
) O +
of O +
VP16 O +
was O +
fused O +
in O +
frame O +
with O +
the O +
N O -
- O -
terminus O +
of O +
mouse O +
PPARδ O -
. O +

The O +
VP16-PPARδ O +
fusion O +
cDNA O +
was O +
placed O +
downstream O +
of O +
the O +
human O +
α O -
- O -
skeletal O +
actin O +
promoter O +
( O -
Brennan O +
and O +
Hardeman O +
1993 O -
) O -
, O +
and O +
upstream O +
of O +
the O +
SV40 O +
intron O -
/ O -
poly O -
( O -
A O -
) O +
sequence O -
. O +

The O +
transgene O +
was O +
purified O +
and O +
injected O +
into O +
C57BL O -
/ O -
6J O +
× O +
CBA O +
F1 O +
zygotes O -
. O +

Transgenic O +
mice O +
were O +
backcrossed O +
with O +
C57BL O -
/ O -
6J O +
for O +
two O +
generations O -
. O +

Wild O -
- O -
type O +
littermates O +
were O +
used O +
as O +
controls O +
throughout O +
the O +
study O -
. O +

On O +
normal O +
chow B-Chemical +
diet O -
, O +
the O +
transgenic O +
mice O +
and O +
control O +
littermates O +
used O +
here O +
had O +
similar O +
body O +
weights O -
. O +

PPARδ O -
- O -
null O +
mice O +
were O +
previously O +
generated O +
( O -
Barak O +
et O +
al. O +
2002 O -
) O -
. O +

Mice O +
were O +
fed O +
either O +
a O +
standard O +
chow B-Chemical +
with O +
4 O -
% O +
( O -
w O -
/ O -
w O -
) O +
fat O +
content O +
( O -
Harlan O +
Teklad O -
, O +
Harlan O -
, O +
Indianapolis O -
, O +
Indiana O -
, O +
United O +
States O -
) O +
or O +
a O +
high O -
- O -
fat O +
diet O +
containing O +
35 O -
% O +
( O -
w O -
/ O -
w O -
) O +
fat O +
content O +
( O -
product O +
F3282 O -
, O +
Bioserv O -
, O +
Frenchtown O -
, O +
New O +
Jersey O -
, O +
United O +
States O -
) O +
as O +
indicated O -
. O +

For O +
ligand O +
experiments O -
, O +
we O +
synthesized O +
the O +
GW501516 B-Chemical +
compound B-Chemical +
and O +
mice O +
were O +
orally O +
gavaged O +
daily O +
( O -
10 O +
mg O -
/ O -
kg O +
or O +
vehicle O +
alone O -
) O -
. O +

Gene O +
expression O +
analysis O +
and O +
physiological O +
studies O +
Mouse O +
EST O +
clones O +
were O +
obtained O +
from O +
ATCC O +
( O -
Manassas O -
, O +
Virginia O -
, O +
United O +
States O -
) O -
, O +
verified O +
by O +
sequencing O -
, O +
and O +
used O +
as O +
Northern O +
probes O -
. O +

Antibodies O +
were O +
obtained O +
from O +
Santa O +
Cruz O +
Biotechnology O +
( O -
Santa O +
Cruz O -
, O +
California O -
, O +
United O +
States O -
) O -
. O +

Total O +
muscle O +
protein O +
extracts O +
( O -
Lin O +
et O +
al. O +
2002 O -
) O +
and O +
nuclear O +
proteins O +
( O -
Wang O +
et O +
al. O +
2003 O -
) O +
were O +
prepared O +
as O +
described O -
. O +

Prior O +
to O +
the O +
exercise O +
performance O +
test O -
, O +
the O +
mice O +
were O +
accustomed O +
to O +
the O +
treadmill O +
( O -
Columbus O +
Instruments O -
, O +
Columbus O -
, O +
Ohio O -
, O +
United O +
States O -
) O +
with O +
a O +
5-min O +
run O +
at O +
7 O +
m O -
/ O -
min O +
once O +
per O +
day O +
for O +
2 O +
d. O +
The O +
exercise O +
test O +
regimen O +
was O +
10 O +
m O -
/ O -
min O +
for O +
the O +
first O +
60 O +
min O -
, O +
followed O +
by O +
1 O +
m O -
/ O -
min O +
increment O +
increases O +
at O +
15-min O +
intervals O -
. O +

Exhaustion O +
was O +
defined O +
when O +
mice O +
were O +
unable O +
to O +
avoid O +
repetitive O +
electrical O +
shocks O -
. O +

Muscle O +
fiber O +
typing O +
and O +
mitochondrial O +
DNA O +
isolation O +
Muscle O +
fiber O +
typing O +
was O +
essentially O +
performed O +
using O +
metachromatic O +
dye B-Chemical -
– O -
ATPase O +
methods O +
as O +
described O +
( O -
Ogilvie O +
and O +
Feeback O +
1990 O -
) O -
. O +

Muscle O +
mitochondria O +
were O +
isolated O +
( O -
Scholte O +
et O +
al. O +
1997 O -
) O -
. O +

Mitochondrial O +
DNA O +
was O +
prepared O +
and O +
analyzed O +
on O +
1 O -
% O +
agarose B-Chemical +
gel O -
. O +

Statistical O +
analysis O +
Number O +
of O +
mice O +
for O +
each O +
group O +
used O +
in O +
experiments O +
is O +
indicated O +
in O +
figure O +
legends O -
. O +

Values O +
are O +
presented O +
as O +
mean O +
± O +
SEM O -
. O +

A O +
two O -
- O -
tailed O +
Student O -
's O +
t O +
test O +
was O +
used O +
to O +
calculate O +
p O -
- O -
values O -
. O +

Supporting O +
Information O +
Video O +
S1 O +
Beginning O +
of O +
Running O +
Test O +
This O +
video O +
shows O +
the O +
exercise O +
performance O +
of O +
a O +
representative O +
of O +
the O +
transgenic O +
mice O +
( O -
right O +
chamber O -
) O +
and O +
a O +
representative O +
of O +
wild O -
- O -
type O +
control O +
littermates O +
( O -
left O +
chamber O -
) O +
on O +
the O +
treadmill O +
15 O +
min O +
into O +
the O +
exercise O +
challenge O -
. O +

( O -
52.4 O +
MB O +
MOV O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Video O +
S2 O +
Running O +
Test O +
90 O +
Min O +
Later O +

This O +
video O +
shows O +
the O +
exercise O +
performance O +
of O +
a O +
representative O +
of O +
the O +
transgenic O +
mice O +
( O -
right O +
chamber O -
) O +
and O +
a O +
representative O +
of O +
wild O -
- O -
type O +
control O +
littermates O +
( O -
left O +
chamber O -
) O +
on O +
the O +
treadmill O +
90 O +
min O +
into O +
the O +
exercise O +
challenge O -
. O +

( O -
41.7 O +
MB O +
MOV O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Acknowledgements O +
We O +
thank O +
Dr. O +
M. O +
Downes O +
for O +
providing O +
the O +
α O -
- O -
skeletal O +
actin O +
promoter O -
; O +
Dr. O +
G. O +
D. O +
Barish O +
for O +
comments O +
on O +
the O +
manuscript O -
; O +
M.A. O +
Lawrence O +
for O +
histology O -
; O +
Dr. O +
S. O +
Pfaff O +
for O +
the O +
use O +
of O +
microscopes O +
and O +
photographic O +
equipment O -
; O +
M. O +
Lieberman O +
and O +
K.L. O +
Schnoeker O +
for O +
photography O -
; O +
J.M. O +
Shelton O +
for O +
advice O +
on O +
fiber O +
staining O -
; O +
and O +
E. O +
Stevens O +
and O +
E. O +
Ong O +
for O +
administrative O +
assistance O -
. O +

YXW O +
was O +
supported O +
by O +
a O +
postdoctoral O +
fellowship O +
from O +
California O +
Tobacco O -
- O -
Related O +
Disease O +
Research O +
Program O -
. O +

JH O +
was O +
supported O +
by O +
the O +
BK21 O +
program O -
, O +
Ministry O +
of O +
Education O -
, O +
Korea O -
. O +

HK O +
was O +
supported O +
by O +
grant O +
M1–0311 O -
- O -
00–0145 O +
from O +
the O +
Molecular O +
and O +
Cellular O +
BioDiscovery O +
Research O +
Program O -
, O +
Ministry O +
of O +
Science O +
and O +
Technology O -
, O +
Korea O -
. O +

RME O +
is O +
an O +
Investigator O +
of O +
the O +
Howard O +
Hughes O +
Medical O +
Institute O +
at O +
the O +
Salk O +
Institute O +
for O +
Biological O +
Studies O +
and O +
March O +
of O +
Dimes O +
Chair O +
in O +
Molecular O +
and O +
Developmental O +
Biology O -
. O +

This O +
work O +
was O +
supported O +
by O +
the O +
Howard O +
Hughes O +
Medical O +
Institute O +
and O +
the O +
Hillblom O +
Foundation O -
. O +

Abbreviations O +
COX O +
- O +
cytochrome B-Chemical +
c I-Chemical +
oxidase O +
mCPT1 O +
- O +
muscle O +
carnitine B-Chemical +
palmitoyltransferase-1 O +
PGC-1α O +
- O +
Peroxisome O +
proliferator O -
- O -
activated O +
receptor O -
- O -
gamma O +
coactivator O +
1α O +
PPAR O +
- O +
peroxisome O +
proliferator O -
- O -
activated O +
receptor O +
UCP O +
- O +
uncoupling O +
protein O +
Figures O +
and O +
Tables O +
Figure O +
1 O +
Expression O +
of O +
Endogenous O +
PPARδ O +
and O +
VP16-PPARδ O +
Transgene O +
in O +
Muscle O +
( O -
A O -
) O +
Pooled O +
RNA O +
isolated O +
from O +
various O +
muscles O +
of O +
five O +
wild O -
- O -
type O +
male O +
C57B6 O +
mice O +
was O +
hybridized O +
with O +
indicated O +
probes O -
. O +

EDL O -
, O +
extensor O +
digitorum O +
longus O -
; O +
Gastro O -
, O +
gastrocnemius O -
. O +

( O -
B O -
) O +
Pooled O +
nuclear O +
proteins O +
( O -
15 O +
μg O -
/ O -
lane O -
) O +
isolated O +
from O +
muscles O +
of O +
five O +
wild O -
- O -
type O +
male O +
C57B6 O +
were O +
probed O +
with O +
anti O -
- O -
PPARδ O +
antibody O -
. O +

RNA O +
polymerase O +
II O +
( O -
Pol O +
II O -
) O +
is O +
shown O +
as O +
a O +
loading O +
control O -
. O +

( O -
C O -
) O +
Expression O +
of O +
the O +
VP16-PPARδ O +
transgene O +
in O +
various O +
tissues O -
. O +

10 O +
μg O +
of O +
total O +
RNA O +
from O +
each O +
tissue O +
was O +
hybridized O +
with O +
a O +
VP16 O +
cDNA O +
probe O -
. O +

Gastrocnemius O +
muscle O +
was O +
used O +
here O -
. O +

( O -
D O -
) O +
Nuclear O +
proteins O +
( O -
15 O +
μg O -
/ O -
lane O -
) O +
isolated O +
from O +
gastrocnemius O +
muscle O +
of O +
the O +
transgenic O +
mice O +
( O -
TG O -
) O +
and O +
the O +
wild O -
- O -
type O +
littermates O +
( O -
WT O -
) O +
were O +
probed O +
with O +
indicated O +
antibodies O -
. O +

The O +
upper O -
, O +
nonspecific O +
band O +
that O +
cross O -
- O -
reacted O +
with O +
the O +
anti O -
- O -
PPARδ O +
antibody O +
serves O +
a O +
loading O +
control O -
. O +

Figure O +
2 O +
Increased O +
Oxidative O +
Type O +
I O +
Fibers O +
in O +
the O +
Transgenic O +
Mice O +
( O -
A O +
and O +
B O -
) O +
Muscles O +
in O +
transgenic O +
mice O +
( O -
TG O -
) O +
are O +
redder O +
than O +
those O +
in O +
wild O -
- O -
type O +
mice O +
( O -
WT O -
) O -
. O +

( O -
C O -
) O +
Metachromatic O +
staining O +
of O +
the O +
type O +
II O +
plantaris O +
muscle O -
. O +

Type O +
I O +
fibers O +
are O +
stained O +
dark O +
blue O -
. O +

Figure O +
3 O +
Activation O +
of O +
PPARδ O +
Induces O +
Genes O +
Typical O +
for O +
Type O +
I O +
Fibers O +
and O +
Promotes O +
Mitochondrial O +
Biogenesis O +
( O -
A O -
) O +
Total O +
RNA O +
( O -
10 O +
μg O -
/ O -
lane O -
) O +
prepared O +
from O +
gastrocnemius O +
muscle O +
of O +
transgenic O +
( O -
TG O -
) O +
and O +
wild O -
- O -
type O +
( O -
WT O -
) O +
littermates O +
was O +
probed O +
with O +
indicated O +
probes O -
. O +

The O +
fold O +
increase O +
of O +
induction O +
of O +
each O +
gene O +
is O +
shown O -
. O +

( O -
B O -
) O +
Total O +
genomic O +
DNA O +
( O -
10 O +
μg O -
/ O -
lane O -
) O +
prepared O +
from O +
gastrocnemius O +
muscle O +
was O +
digested O +
with O +
Nco1 O +
and O +
subjected O +
to O +
Southern O +
analysis O +
with O +
COXII O +
( O -
mitochondrial O +
genome O -
– O -
encoded O -
) O +
and O +
MCIP1 O +
( O -
nuclear O +
genome O -
– O -
encoded O -
) O +
DNA O +
probes O -
. O +

( O -
C O -
) O +
Equal O +
amounts O +
of O +
gastrocnemius O +
muscle O +
were O +
collected O +
from O +
both O +
transgenic O +
mice O +
and O +
control O +
littermates O -
. O +

Total O +
mitochondrial O +
DNA O +
was O +
isolated O +
and O +
separated O +
on O +
1 O -
% O +
agarose B-Chemical +
gel O -
. O +

The O +
relative O +
abundance O +
of O +
mitochondrial O +
DNA O +
in O +
transgenic O +
and O +
wild O -
- O -
type O +
mice O +
is O +
presented O -
. O +

( O -
D O -
) O +
Western O +
blot O +
analysis O +
of O +
muscle O +
fiber O +
markers O +
and O +
mitochondrial O +
components O -
. O +

Each O +
lane O +
was O +
loaded O +
with O +
80 O +
μg O +
of O +
total O +
gastrocnemius O +
muscle O +
extracts O -
. O +

( O -
E O -
) O +
Wild O -
- O -
type O +
C57B6 O +
mice O +
were O +
treated O +
with O +
vehicle O +
or O +
PPARδ B-Chemical +
agonist I-Chemical +
GW501516 B-Chemical +
for O +
10 O +
d. O +
Total O +
RNA O +
( O -
10 O +
μg O -
/ O -
lane O -
) O +
prepared O +
from O +
the O +
gastrocnemius O +
muscle O +
was O +
probed O +
with O +
indicated O +
probes O -
. O +

Figure O +
4 O +
Resistance O +
to O +
High O -
- O -
Fat O -
- O -
Induced O +
Obesity O +
in O +
the O +
Transgenic O +
Mice O +
( O -
A O -
) O +
Seven O -
- O -
week O -
- O -
old O +
transgenic O +
( O -
TG O -
) O +
and O +
wild O -
- O -
type O +
( O -
WT O -
) O +
littermates O +
( O -
n O +
= O +
5–6 O +
for O +
each O +
group O -
) O +
were O +
fed O +
with O +
a O +
high O -
- O -
fat O +
diet O +
for O +
97 O +
d. O +
Left O +
panel O +
shows O +
net O +
body O +
weight O +
gain O -
, O +
which O +
was O +
calculated O +
for O +
individual O +
mice O +
and O +
then O +
averaged O -
. O +

Right O +
panel O +
shows O +
the O +
body O +
weights O +
before O +
( O -
Day O +
0 O -
) O +
and O +
after O +
( O -
Day O +
97 O -
) O +
high O -
- O -
fat O +
feeding O -
. O +

( O -
B O -
) O +
Histology O +
of O +
inguinal O +
fat O +
pad O +
in O +
the O +
transgenic O +
and O +
wild O -
- O -
type O +
littermates O +
under O +
a O +
high O -
- O -
fat O +
diet O +
for O +
2 O +
mo O -
. O +

( O -
C O +
and O +
D O -
) O +
Intramuscular O +
glycogen B-Chemical +
content O +
( O -
C O -
) O +
and O +
triglyceride B-Chemical +
content O +
( O -
D O -
) O +
of O +
mice O +
in O +
( O -
A O -
) O +
after O +
high O -
- O -
fat O +
feeding O +
( O -
n O +
= O +
6 O -
) O -
. O +

( O -
E O -
) O +
Glucose B-Chemical +
tolerance O +
test O -
. O +

Mice O +
in O +
( O -
A O -
) O +
after O +
high O -
- O -
fat O +
feeding O +
were O +
fasted O +
for O +
6 O +
h O +
and O +
then O +
injected O +
with O +
glucose B-Chemical +
at O +
a O +
concentration O +
of O +
1g O -
/ O -
kg O +
body O +
weight O -
. O +

Then O +
blood O +
glucose B-Chemical +
levels O +
were O +
measured O +
periodically O +
over O +
2 O +
h O +
( O -
n O +
= O +
6 O -
) O -
. O +

Figure O +
5 O +
PPARδ B-Chemical +
Agonists I-Chemical +
Counteract O +
Obesity O +
Induced O +
by O +
High O -
- O -
Fat O +
Diet O +
( O -
A O -
) O +
Eleven O -
- O -
week O -
- O -
old O +
wild O -
- O -
type O +
C57B6 O +
mice O +
were O +
fed O +
a O +
high O -
- O -
fat O +
diet O +
in O +
combination O +
with O +
vehicle O +
or O +
GW501516 B-Chemical +
for O +
57 O +
d. O +
Total O +
RNA O +
( O -
10 O +
μg O -
/ O -
lane O -
) O +
prepared O +
from O +
the O +
gastrocnemius O +
muscle O +
was O +
probed O +
with O +
indicated O +
probes O -
. O +

( O -
B O -
) O +
Net O +
body O +
weight O +
gain O +
for O +
mice O +
in O +
( O -
A O -
) O +
after O +
treatment O +
was O +
calculated O +
for O +
individual O +
mice O +
and O +
averaged O -
. O +

Initial O +
body O +
weights O +
were O +
28.54 O +
± O +
1.04 O +
g O +
for O +
vehicle O +
group O +
( O -
n O +
= O +
5 O -
) O +
and O +
28.86 O +
± O +
0.80 O +
g O +
for O +
GW501516 B-Chemical +
group O +
( O -
n O +
= O +
5 O -
) O -
. O +

( O -
C O -
) O +
Various O +
tissue O +
weights O +
for O +
mice O +
in O +
( O -
A O -
) O +
after O +
treatment O -
. O +

ifat O -
, O +
inguinal O +
fat O -
; O +
rdfat O -
, O +
reproductive O +
fat O -
; O +
retrofat O -
, O +
retroperitoneal O +
fat O -
. O +

( O -
D O -
) O +
Glucose B-Chemical +
tolerance O +
test O -
. O +

Mice O +
in O +
( O -
A O -
) O +
after O +
treatment O +
were O +
fasted O +
for O +
6 O +
h O +
and O +
then O +
injected O +
with O +
glucose B-Chemical +
at O +
a O +
concentration O +
of O +
1g O -
/ O -
kg O +
body O +
weight O -
. O +

Blood O +
glucose B-Chemical +
levels O +
were O +
then O +
measured O +
periodically O +
over O +
2 O +
h. O +
Figure O +
6 O +
PPARδ O +
Regulates O +
Exercise O +
Endurance O +
( O -
A O -
) O +
Enhanced O +
exercise O +
performance O +
in O +
the O +
transgenic O +
mice O -
. O +

Fourteen O -
- O -
week O -
- O -
old O +
male O +
transgenic O +
and O +
wild O -
- O -
type O +
littermates O +
with O +
similar O +
body O +
weights O +
( O -
n O +
= O +
4 O +
for O +
each O +
group O -
) O +
were O +
subjected O +
to O +
a O +
forced O +
treadmill O +
exercise O +
test O -
. O +

( O -
B O -
) O +
Compromised O +
exercise O +
performance O +
in O +
PPARδ O -
- O -
null O +
mice O -
. O +

Two O -
- O -
month O -
- O -
old O +
male O +
PPARδ O -
- O -
null O +
mice O +
and O +
wild O -
- O -
type O +
controls O +
with O +
similar O +
body O +
weights O +
( O -
n O +
= O +
6 O +
for O +
each O +
group O -
) O +
were O +
subjected O +
to O +
a O +
forced O +
treadmill O +
exercise O +
test O -
. O +

( O -
C O -
) O +
Functions O +
of O +
PPARδ O +
in O +
skeletal O +
muscle O -
. O +

Footnotes O +
Conflicts O +
of O +
interest O -
. O +

The O +
authors O +
have O +
declared O +
that O +
no O +
conflicts O +
of O +
interest O +
exist O -
. O +

Author O +
contributions O -
. O +

YXW O +
and O +
RME O +
conceived O +
and O +
designed O +
the O +
experiments O -
. O +

YXW O -
, O +
CLZ O -
, O +
RTY O -
, O +
MCN O -
, O +
and O +
CRBO O +
performed O +
the O +
experiments O -
. O +

YXW O -
, O +
CLZ O -
, O +
and O +
RME O +
analyzed O +
the O +
data O -
. O +

HKC O -
, O +
JH O -
, O +
and O +
HK O +
contributed O +
reagents B-Chemical -
/ O -
materials O -
/ O -
analysis O +
tools O -
. O +

YXW O +
and O +
RME O +
wrote O +
the O +
paper O -
. O +

Academic O +
Editor O -
: O +

Steve O +
O'Rahilly O -
, O +
University O +
of O +
Cambridge O +
Citation O -
: O +
Wang O +
YX O -
, O +
Zhang O +
CL O -
, O +
Yu O +
RT O -
, O +
Cho O +
HK O -
, O +
Nelson O +
MC O -
, O +
et O +
al. O +
( O -
2004 O -
) O +
Regulation O +
of O +
muscle O +
fiber O +
type O +
and O +
running O +
endurance O +
by O +
PPARδ O -
. O +

PLoS O +
Biol O +
2 O -
( O -
10 O -
) O -
: O +
e294 O -
. O +

A O +
Chemoattractant O +
Role O +
for O +
NT-3 O +
in O +
Proprioceptive O +
Axon O +
Guidance O +
Abstract O +
Neurotrophin-3 O +
( O -
NT-3 O -
) O +
is O +
required O +
for O +
proprioceptive O +
neuron O +
survival O -
. O +

Deletion O +
of O +
the O +
proapoptotic O +
gene O +
Bax O +
in O +
NT-3 O +
knockout O +
mice O +
rescues O +
these O +
neurons O +
and O +
allows O +
for O +
examination O +
of O +
their O +
axon O +
growth O +
in O +
the O +
absence O +
of O +
NT-3 O +
signaling O -
. O +

TrkC O -
- O -
positive O +
peripheral O +
and O +
central O +
axons O +
from O +
dorsal O +
root O +
ganglia O +
follow O +
proper O +
trajectories O +
and O +
arrive O +
in O +
close O +
proximity O +
to O +
their O +
targets O +
but O +
fail O +
to O +
innervate O +
them O -
. O +

Peripherally O -
, O +
muscle O +
spindles O +
are O +
absent O +
and O +
TrkC O -
- O -
positive O +
axons O +
do O +
not O +
enter O +
their O +
target O +
muscles O -
. O +

Centrally O -
, O +
proprioceptive O +
axons O +
branch O +
in O +
ectopic O +
regions O +
of O +
the O +
spinal O +
cord O -
, O +
even O +
crossing O +
the O +
midline O -
. O +

In O +
vitro O +
assays O +
reveal O +
chemoattractant O +
effects O +
of O +
NT-3 O +
on O +
dorsal O +
root O +
ganglion O +
axons O -
. O +

Our O +
results O +
show O +
that O +
survival O +
factor O +
NT-3 O +
acts O +
as O +
a O +
short O -
- O -
distance O +
axon O +
guidance O +
molecule B-Chemical +
for O +
muscle O +
sensory O +
afferents O +
as O +
they O +
approach O +
their O +
proper O +
targets O -
. O +

Introduction O +
Neurotrophin-3 O +
( O -
NT-3 O -
) O +
is O +
a O +
key O +
requirement O +
for O +
the O +
development O +
of O +
proprioceptive O +
inputs O +
to O +
motor O +
neurons O +
( O -
Chen O +
and O +
Frank O +
1999 O -
; O +
Chen O +
et O +
al. O +
2003 O -
) O -
. O +

Mice O +
deficient O +
in O +
NT-3 O -
, O +
its O +
tyrosine O +
kinase O +
receptor O -
, O +
TrkC O -
, O +
or O +
in O +
TrkC O -
- O -
positive O +
neuron O -
- O -
specific O +
transcription O +
factor O +
Runx3 O +
display O +
severe O +
ataxia O +
associated O +
with O +
the O +
absence O +
of O +
muscle O +
spindles O -
, O +
and O +
loss O +
of O +
proprioceptive O +
neurons O +
in O +
dorsal O +
root O +
ganglia O +
( O -
DRGs O -
) O +
or O +
their O +
axons O +
( O -
Ernfors O +
et O +
al. O +
1994 O -
; O +
Klein O +
et O +
al. O +
1994 O -
; O +
Tessarollo O +
et O +
al. O +
1994 O -
; O +
Fariñas O +
et O +
al. O +
1996 O -
; O +
Liebl O +
et O +
al. O +
1997 O -
; O +
Inoue O +
et O +
al. O +
2002 O -
; O +
Levanon O +
et O +
al. O +
2002 O -
) O -
. O +

NT-3 O +
is O +
expressed O +
in O +
the O +
ventral O +
spinal O +
cord O -
, O +
in O +
the O +
developing O +
limb O +
buds O -
, O +
and O +
in O +
intrafusal O +
bag O +
fibers O +
of O +
muscle O +
spindles O +
later O +
in O +
development O +
( O -
Copray O +
and O +
Brouwer O +
1994 O -
; O +
Fariñas O +
et O +
al. O +
1996 O -
; O +
Tojo O +
et O +
al. O +
1996 O -
) O -
. O +

When O +
sensory O +
axons O +
contact O +
developing O +
myotubes O -
, O +
they O +
induce O +
muscle O +
spindle O +
differentiation O -
, O +
forming O +
ring O -
- O -
like O +
spiral O +
nerve O +
endings O +
around O +
them O -
. O +

In O +
the O +
chicken O +
embryo O -
, O +
limb O +
ablations O +
or O +
anti O -
- O -
NT-3 O +
antibody O +
injections O +
into O +
limb O +
buds O +
lead O +
to O +
elimination O +
of O +
TrkC O -
- O -
positive O +
neurons O +
and O +
decreased O +
innervation O +
of O +
motor O +
neurons O +
( O -
Oakley O +
et O +
al. O +
1995 O -
, O +
1997 O -
) O -
. O +

Is O +
NT-3 O +
only O +
a O +
chemotrophic O +
survival O +
factor O +
for O +
muscle O +
sensory O +
afferents O -
, O +
or O +
does O +
it O +
have O +
additional O +
roles O +
in O +
the O +
development O +
of O +
the O +
proprioceptors O +
and O +
the O +
establishment O +
of O +
the O +
monosynaptic O +
reflex O +
arc O -
? O +

Here O +
we O +
provide O +
evidence O +
that O +
NT-3 O +
acts O +
as O +
a O +
chemoattractant O +
for O +
sensory O +
axons O +
during O +
the O +
final O +
phase O +
of O +
their O +
target O -
- O -
directed O +
pathfinding O -
. O +

Results O +
TrkC O -
- O -
Positive O +
DRG O +
Neurons O +
Are O +
Rescued O +
in O +
Bax O -
/ O -
NT-3 O +
Double O +
Knockout O +
Mice O +
Mice O +
lacking O +
proapoptotic O +
protein O +
Bax O +
allow O +
for O +
distinguishing O +
survival O +
effects O +
of O +
neurotrophins O +
from O +
other O +
effects O -
. O +

Bax O -
- O -
deficient O +
sensory O +
neurons O +
no O +
longer O +
require O +
neurotrophins O +
for O +
survival O +
( O -
White O +
et O +
al. O +
1998 O -
; O +
Patel O +
et O +
al. O +
2000 O -
) O -
, O +
thus O +
they O +
can O +
be O +
used O +
to O +
examine O +
axonal O +
effects O -
. O +

We O +
bred O +
NT-3 O +
heterozygote O +
and O +
Bax O +
knockout O +
( O -
KO O -
) O +
mice O +
to O +
obtain O +
mice O +
with O +
double O +
KO O +
of O +
both O +
NT-3 O +
and O +
Bax O +
genes O -
, O +
and O +
examined O +
proprioceptive O +
axonal O +
projections O -
. O +

All O +
NT-3 O +
and O +
double O +
KOs O +
died O +
within O +
48 O +
h O +
after O +
birth O +
( O -
Tessarollo O +
et O +
al. O +
1994 O -
) O -
. O +

We O +
performed O +
TrkA O -
/ O -
TrkC O +
double O +
immunohistochemistry O +
( O -
Huang O +
et O +
al. O +
1999 O -
) O -
, O +
enabling O +
detection O +
of O +
both O +
proteins O +
in O +
the O +
same O +
sample O -
. O +

TrkC O -
- O -
positive O +
cells O +
( O -
Figure O +
1A O -
) O +
and O +
fibers O +
( O -
Figure O +
1E O -
) O +
were O +
absent O +
in O +
NT-3 O +
KOs O +
at O +
embryonic O +
day O +
( O -
E O -
) O +
15 O -
. O +

Two O +
subsets O +
of O +
DRG O +
cells O +
expressing O +
either O +
TrkA O +
or O +
TrkC O +
were O +
detected O +
in O +
double O +
KOs O -
, O +
similar O +
to O +
wild O -
- O -
type O +
( O -
WT O -
) O +
or O +
Bax O +
KO O +
animals O -
. O +

Surprisingly O -
, O +
at O +
postnatal O +
day O +
( O -
P O -
) O +
0 O -
, O +
a O +
few O +
cells O +
expressed O +
TrkC O +
even O +
in O +
NT-3 O +
KO O +
animals O +
in O +
the O +
Bax+ O -
/ O -
+ O +
genetic O +
background O -
, O +
and O +
some O +
cells O +
co O -
- O -
expressed O +
TrkA O +
and O +
TrkC O -
, O +
regardless O +
of O +
the O +
genotype O +
( O -
Figure O +
1B O -
) O -
. O +

In O +
order O +
to O +
quantify O +
our O +
results O -
, O +
we O +
analyzed O +
the O +
ratio O +
of O +
TrkA O +
and O +
TrkC O +
immunopositive O +
cells O +
from O +
four O +
different O +
DRGs O +
of O +
animals O +
of O +
different O +
genotypes O -
. O +

At O +
all O +
ages O +
studied O -
, O +
Bax O -
/ O -
NT-3 O +
double O +
null O +
DRGs O +
had O +
TrkA O -
/ O -
TrkC O +
ratios O +
similar O +
to O +
those O +
of O +
Bax O +
null O +
DRGs O -
, O +
and O +
higher O +
than O +
those O +
of O +
NT-3 O +
null O +
DRGs O +
( O -
Figure O +
1D O -
) O -
. O +

TrkC O -
- O -
positive O +
neurons O +
rescued O +
by O +
Bax O +
deletion O -
, O +
however O -
, O +
failed O +
to O +
differentiate O +
properly O -
, O +
as O +
evidenced O +
by O +
the O +
lack O +
of O +
expression O +
of O +
the O +
proprioceptive O +
molecular O +
marker O +
Parvalbumin O +
( O -
PV O -
) O +
( O -
Figure O +
1C O -
) O -
. O +

NT-3 O +
Is O +
Necessary O +
for O +
Proper O +
Innervation O +
of O +
Motor O +
Neurons O +
TrkA O -
/ O -
TrkC O -
- O -
positive O +
fibers O +
in O +
the O +
spinal O +
cord O +
could O +
be O +
detected O +
at O +
E15 O +
( O -
Figure O +
1E O -
) O -
. O +

TrkA O -
- O -
positive O +
fibers O +
were O +
restricted O +
to O +
and O +
terminated O +
in O +
the O +
dorsolateral O +
spinal O +
cord O -
, O +
whereas O +
TrkC O -
- O -
positive O +
fibers O +
entered O +
the O +
cord O +
dorsomedially O -
, O +
and O +
descended O +
into O +
the O +
ventral O +
horns O +
in O +
WT O +
( O -
Ozaki O +
and O +
Snider O +
1997 O -
) O +
and O +
Bax O +
KO O +
embryos O -
. O +

There O +
was O +
no O +
detectable O +
TrkC O +
expression O +
in O +
NT-3 O +
KO O +
spinal O +
cord O -
, O +
indicating O +
complete O +
absence O +
of O +
proprioceptive O +
fibers O -
. O +

In O +
double O +
KO O +
spinal O +
cord O -
, O +
TrkC O -
- O -
positive O +
fibers O +
entered O +
the O +
dorsal O +
spinal O +
cord O +
and O +
descended O +
medially O +
in O +
a O +
manner O +
similar O +
to O +
that O +
seen O +
in O +
WT O +
or O +
Bax O +
KO O +
cases O -
. O +

However O -
, O +
it O +
was O +
not O +
possible O +
to O +
follow O +
TrkC O +
immunolabeled O +
fibers O +
all O +
the O +
way O +
to O +
their O +
terminal O +
zones O +
in O +
any O +
of O +
the O +
cases O -
. O +

Next O +
we O +
examined O +
the O +
central O +
projections O +
of O +
DRG O +
axons O +
with O +
the O +
lipophilic O +
tracer B-Chemical +
DiI B-Chemical +
at O +
P0 O -
. O +

In O +
WT O +
and O +
Bax O +
KO O +
pups O -
, O +
proprioceptive O +
afferents O +
entered O +
the O +
dorsal O +
spinal O +
cord O +
and O +
followed O +
a O +
medial O +
course O +
towards O +
the O +
ventral O +
horn O -
. O +

They O +
then O +
turned O +
laterally O +
towards O +
motor O +
neurons O +
in O +
the O +
lateral O +
motor O +
column O -
, O +
where O +
they O +
branched O +
and O +
terminated O +
( O -
Figure O +
2A O -
) O -
. O +

DiI B-Chemical +
labeling O +
was O +
confined O +
to O +
dorsal O +
spinal O +
cord O +
in O +
NT-3 O +
KOs O +
( O -
Figure O +
2A O -
) O -
, O +
as O +
reported O +
earlier O -
, O +
consistent O +
with O +
a O +
complete O +
absence O +
of O +
proprioceptive O +
innervation O +
( O -
Ernfors O +
et O +
al. O +
1994 O -
; O +
Tessarollo O +
et O +
al. O +
1994 O -
) O -
. O +

In O +
double O +
KOs O -
, O +
proprioceptive O +
afferents O +
initially O +
followed O +
a O +
trajectory O +
similar O +
to O +
that O +
of O +
WT O +
counterparts O -
, O +
but O +
most O +
of O +
them O +
failed O +
to O +
project O +
all O +
the O +
way O +
to O +
the O +
ventral O +
cord O +
and O +
into O +
the O +
lateral O +
motor O +
column O -
. O +

Instead O -
, O +
they O +
arborized O +
near O +
the O +
ventral O +
midline O -
; O +
some O +
crossed O +
the O +
midline O +
and O +
extended O +
into O +
the O +
contralateral O +
ventral O +
cord O +
( O -
Figure O +
2A O +
and O +
2C O -
) O -
. O +

In O +
order O +
to O +
distinguish O +
between O +
a O +
role O +
for O +
NT-3 O +
in O +
initiation O +
of O +
motor O +
neuron O +
innervation O +
and O +
a O +
role O +
for O +
maintenance O -
, O +
we O +
repeated O +
the O +
DiI B-Chemical +
labeling O +
at O +
E17 O -
. O +

Innervation O +
patterns O +
of O +
E17 O +
spinal O +
cords O +
( O -
Figure O +
3 O -
) O +
were O +
similar O +
to O +
those O +
at O +
P0 O +
( O -
Figure O +
2 O -
) O -
. O +

Dorsal O +
horns O +
of O +
all O +
genotypes O +
were O +
filled O +
with O +
DiI B-Chemical -
- O -
labeled O +
fibers O +
corresponding O +
to O +
nerve O +
growth O +
factor O -
– O -
dependent O +
nociceptive O +
axons O -
. O +

In O +
WT O +
and O +
Bax O +
KO O +
embryos O -
, O +
proprioceptive O +
fibers O +
extended O +
towards O +
ventral O +
horn O +
motor O +
neurons O +
( O -
Figure O +
3A O +
and O +
3B O -
) O -
, O +
whereas O +
the O +
ventral O +
horns O +
of O +
the O +
NT-3 O +
KO O +
embryos O +
were O +
devoid O +
of O +
innervation O +
( O -
Figure O +
3C O -
) O -
. O +

In O +
the O +
Bax O -
/ O -
NT-3 O +
double O +
KOs O -
, O +
DiI B-Chemical -
- O -
labeled O +
fibers O +
entered O +
the O +
ventral O +
spinal O +
cord O -
, O +
but O +
extended O +
towards O +
the O +
midline O +
instead O +
of O +
the O +
ventral O +
horn O +
( O -
Figure O +
3D O -
) O -
, O +
in O +
a O +
pattern O +
similar O +
to O +
that O +
observed O +
at O +
P0 O -
. O +

Our O +
data O +
point O +
to O +
a O +
complete O +
absence O +
of O +
proprioceptive O +
innervation O +
of O +
the O +
ventral O +
horn O +
of O +
the O +
Bax O -
/ O -
NT-3 O +
null O +
spinal O +
cord O +
throughout O +
the O +
developmental O +
stages O +
investigated O -
. O +

As O +
the O +
sensory O +
axons O +
never O +
reach O +
motor O +
neuron O +
dendrites O +
in O +
the O +
ventral O +
horn O +
( O -
Figure O +
S1 O -
) O -
, O +
the O +
stretch O +
reflex O +
arc O +
circuit O +
is O +
not O +
established O -
. O +

The O +
failure O +
to O +
initiate O +
contact O +
between O +
sensory O +
axons O +
and O +
motor O +
neurons O +
in O +
the O +
absence O +
of O +
NT-3 O +
suggests O +
a O +
requirement O +
for O +
NT-3 O +
for O +
proper O +
axon O +
targeting O +
in O +
addition O +
to O +
a O +
role O +
in O +
sensory O +
axon O +
maintenance O -
. O +

NT-3 O +
Is O +
Required O +
for O +
Proper O +
Peripheral O +
Innervation O +
In O +
order O +
to O +
study O +
peripheral O +
innervation O +
in O +
double O +
KO O +
animals O -
, O +
we O +
investigated O +
spindle O +
development O +
in O +
the O +
gastrocnemius O +
muscle O -
. O +

Muscle O +
spindles O +
could O +
be O +
identified O +
easily O +
in O +
P0 O +
WT O +
and O +
Bax O +
KO O +
animals O +
by O +
their O +
characteristic O +
morphology O +
( O -
Figure O +
4A O +
and O +
4B O -
) O -
. O +

Proprioceptive O +
fibers O +
labeled O +
with O +
neurofilament O -
- O -
M O +
( O -
NF O -
- O -
M O -
) O +
antibody O +
formed O +
ring O -
- O -
like O +
spiral O +
endings O +
wrapped O +
around O +
intrafusal O +
bag O +
fibers O +
labeled O +
with O +
S46 O +
antibody O -
, O +
specific O +
for O +
slow O +
developmental O +
myosin O +
heavy O +
chain O +
protein O +
( O -
Miller O +
et O +
al. O +
1985 O -
) O -
. O +

As O +
reported O +
earlier O -
, O +
there O +
were O +
no O +
muscle O +
spindles O +
in O +
NT-3 O +
KO O +
animals O +
( O -
Ernfors O +
et O +
al. O +
1994 O -
) O -
. O +

On O +
the O +
other O +
hand O -
, O +
Bax O +
KO O +
animals O +
had O +
more O +
spindles O +
than O +
WT O -
, O +
and O +
spindles O +
were O +
in O +
clusters O +
similar O +
to O +
animals O +
over O -
- O -
expressing O +
NT-3 O +
in O +
the O +
muscle O +
( O -
Wright O +
et O +
al. O +
1997 O -
) O -
. O +

Although O +
NT-3-dependent O +
cells O +
were O +
rescued O -
, O +
no O +
muscle O +
spindles O +
were O +
detected O +
in O +
the O +
limbs O +
of O +
double O +
KOs O +
( O -
Figure O +
4A O +
and O +
4B O -
) O -
. O +

Muscle O +
spindles O +
could O +
be O +
observed O +
with O +
TrkC O +
antibody O +
in O +
WT O +
and O +
Bax O +
KO O +
animals O -
, O +
but O +
not O +
in O +
NT-3 O +
or O +
double O +
KOs O +
( O -
Figure O +
4E O -
) O -
. O +

In O +
both O +
NT-3 O +
and O +
double O +
KO O +
animals O -
, O +
NF O -
- O -
M O -
- O -
labeled O +
fibers O +
could O +
be O +
detected O +
in O +
muscles O -
, O +
thus O +
the O +
muscles O +
of O +
these O +
animals O +
were O +
not O +
completely O +
devoid O +
of O +
nerve O +
fibers O -
. O +

Since O +
there O +
were O +
no O +
TrkC O -
- O -
positive O +
fibers O +
in O +
these O +
muscles O -
, O +
we O +
think O +
that O +
these O +
NF O -
- O -
M O -
- O -
labeled O +
fibers O +
correspond O +
to O +
motor O +
axons O -
. O +

Absence O +
of O +
muscle O +
spindles O +
might O +
be O +
due O +
to O +
a O +
failure O +
in O +
initiation O +
of O +
differentiation O +
by O +
proprioceptive O +
axons O -
, O +
or O +
a O +
failure O +
of O +
maturation O +
and O +
maintenance O +
in O +
the O +
absence O +
of O +
NT-3 O -
. O +

To O +
distinguish O +
between O +
these O +
two O +
possibilities O -
, O +
we O +
investigated O +
muscle O +
spindle O +
development O +
at O +
E15 O +
and O +
E17 O +
with O +
S46 O -
/ O -
NF O -
- O -
M O +
immunostaining O +
as O +
well O +
as O +
DiI B-Chemical +
labeling O -
. O +

No O +
structures O +
with O +
the O +
characteristic O +
muscle O +
spindle O +
shape O +
could O +
be O +
detected O +
in O +
any O +
of O +
the O +
genotypes O +
at O +
E15 O +
( O -
Figure O +
S2 O -
) O -
. O +

However O -
, O +
numerous O +
developing O +
spindles O +
could O +
be O +
identified O +
at O +
E17 O +
in O +
WT O +
and O +
Bax O +
KOs O -
, O +
but O +
not O +
in O +
NT-3 O +
KO O +
embryos O +
( O -
Figure O +
4C O -
) O -
. O +

Bax O -
/ O -
NT-3 O +
double O +
null O +
muscles O +
were O +
devoid O +
of O +
spindles O +
( O -
Figure O +
4C O -
) O -
, O +
except O +
for O +
one O +
spindle O -
- O -
like O +
structure O +
observed O +
in O +
one O +
leg O +
of O +
an O +
embryo O +
( O -
Figure O +
4C O -
, O +
inset O -
, O +
denoted O +
by O +
the O +
asterisk O -
) O -
. O +

DiI B-Chemical +
labeling O +
through O +
the O +
DRGs O +
at O +
E17 O +
yielded O +
similar O +
results O -
, O +
with O +
muscle O +
spindles O +
identified O +
in O +
parallel O +
sections O +
in O +
WT O +
and O +
Bax O +
null O +
muscles O +
( O -
Figure O +
4D O -
) O -
, O +
but O +
not O +
in O +
NT-3 O +
or O +
double O +
KO O +
animals O -
. O +

Although O +
DiI B-Chemical -
- O -
labeled O +
fibers O +
could O +
be O +
detected O +
in O +
double O +
null O +
muscles O -
, O +
they O +
never O +
formed O +
ring O -
- O -
like O +
structures O +
characteristic O +
of O +
muscle O +
spindles O -
. O +

We O +
also O +
examined O +
TrkA O -
/ O -
TrkC O +
expression O +
at O +
P0 O +
in O +
the O +
tibial O +
nerve O -
, O +
which O +
carries O +
sensory O +
fibers O +
to O +
the O +
gastrocnemius O +
muscle O +
as O +
well O +
as O +
the O +
skin O +
of O +
the O +
lower O +
leg O -
. O +

In O +
NT-3 O +
KOs O -
, O +
TrkA O -
- O -
positive O +
axons O +
could O +
be O +
seen O +
in O +
the O +
tibial O +
nerve O +
but O +
there O +
were O +
no O +
TrkC O -
- O -
positive O +
axons O -
; O +
in O +
contrast O -
, O +
TrkA- O +
and O +
TrkC O -
- O -
labeled O +
axons O +
are O +
both O +
present O +
in O +
WT O -
, O +
Bax O +
KO O -
, O +
and O +
double O +
KO O +
animals O +
( O -
Figure O +
4F O -
) O -
. O +

These O +
results O +
suggest O +
that O +
although O +
proprioceptive O +
axons O +
follow O +
proper O +
trajectories O +
in O +
distal O +
peripheral O +
nerves O -
, O +
they O +
fail O +
to O +
innervate O +
their O +
target O +
muscles O +
in O +
the O +
absence O +
of O +
NT-3 O -
. O +

NT-3 O +
Is O +
a O +
Chemoattractant O +
for O +
DRG O +
Axons O +
In O +
Vitro O +
To O +
test O +
the O +
hypothesis O +
that O +
NT-3 O +
acts O +
as O +
a O +
chemoattractant O +
for O +
sensory O +
axons O -
, O +
we O +
performed O +
a O +
series O +
of O +
in O +
vitro O +
assays O -
. O +

Proprioceptive O +
axons O +
in O +
mice O +
enter O +
the O +
gray O +
matter O +
in O +
the O +
spinal O +
cord O +
and O +
advance O +
ventrally O +
parallel O +
to O +
the O +
midline O +
by O +
E13 O +
and O +
reach O +
the O +
motor O +
neurons O +
by O +
E15 O +
( O -
Ozaki O +
and O +
Snider O +
1994 O -
) O -
. O +

We O +
co O -
- O -
cultured O +
collagen O -
- O -
embedded O +
E13 O +
WT O +
DRG O +
explants O +
with O +
NT-3-soaked O +
sepharose O +
beads O +
( O -
n O +
= O +
26 O -
) O -
. O +

Control O +
cultures O +
were O +
set O +
up O +
using O +
bovine O +
serum O +
albumin O +
( O -
BSA O -
) O -
– O +
or O +
phosphate O +
buffer O +
saline O +
( O -
PBS O -
) O -
–soaked O +
beads O +
( O -
n O +
= O +
12 O -
) O -
. O +

DRG O +
axons O +
began O +
extending O +
towards O +
the O +
localized O +
NT-3 O +
source O +
by O +
the O +
end O +
of O +
the O +
first O +
day O +
and O +
consistently O +
displayed O +
a O +
strong O +
chemoattraction O +
by O +
3 O +
d O +
in O +
vitro O -
, O +
whereas O +
they O +
did O +
not O +
show O +
such O +
preference O +
for O +
BSA O -
- O -
loaded O +
control O +
beads O +
( O -
Figure O +
5A O +
and O +
5B O -
) O -
. O +

This O +
attraction O +
was O +
not O +
due O +
to O +
survival O +
support O +
of O +
NT-3 O +
because O +
Bax O +
null O +
ganglia O +
displayed O +
the O +
same O +
chemoattraction O +
( O -
Figure O +
5C O -
; O +
n O +
= O +
16 O -
) O -
. O +

NT-3 O +
may O +
act O +
through O +
either O +
TrkC O -
, O +
or O +
the O +
p75NTR O -
. O +

We O +
repeated O +
the O +
co O -
- O -
culture O +
experiments O +
with O +
DRG O +
explants O +
derived O +
from O +
p75NTR O +
KO O +
mice O +
( O -
n O +
= O +
18 O -
) O -
. O +

Axons O +
of O +
these O +
ganglia O +
also O +
showed O +
strong O +
chemoattraction O +
towards O +
the O +
NT-3 O +
beads O +
( O -
Figure O +
5D O -
) O -
. O +

Finally O -
, O +
we O +
used O +
diffusible O +
TrkC O +
receptors O +
conjugated O +
to O +
IgG O +
constant O +
regions O +
( O -
TrkC O -
- O -
Fc O -
) O +
added O +
to O +
the O +
medium O +
( O -
n O +
= O +
6 O -
) O +
to O +
deplete O +
soluble O +
NT-3 O +
from O +
the O +
collagen O +
gels O +
( O -
Figure O +
5E O -
) O -
. O +

In O +
the O +
presence O +
of O +
TrkC O -
- O -
Fc O +
the O +
chemoattraction O +
was O +
completely O +
blocked O -
, O +
demonstrating O +
that O +
the O +
effect O +
we O +
see O +
is O +
specific O +
for O +
NT-3 O -
. O +

In O +
order O +
to O +
investigate O +
the O +
active O +
range O +
of O +
our O +
beads O -
, O +
we O +
have O +
repeated O +
the O +
cultures O +
with O +
WT O +
E13 O +
DRGs O +
by O +
placing O +
the O +
beads O +
at O +
increasing O +
distances O +
from O +
the O +
ganglia O +
( O -
n O +
= O +
4 O +
each O -
) O +
( O -
Figure O +
5F O -
) O -
. O +

There O +
was O +
still O +
preferred O +
growth O +
towards O +
the O +
bead O +
at O +
1,200μm O -
, O +
the O +
longest O +
distance O +
studied O -
, O +
although O +
the O +
number O +
of O +
axons O +
and O +
the O +
extent O +
of O +
growth O +
were O +
not O +
as O +
robust O -
. O +

Next O -
, O +
we O +
set O +
up O +
E13 O +
DRG O +
spinal O +
cord O +
explant O +
cultures O +
using O +
NT-3-loaded O +
beads O +
placed O +
at O +
the O +
midline O +
at O +
mid O -
- O -
spinal O +
cord O +
level O +
as O +
an O +
ectopic O +
NT-3 O +
source O +
( O -
n O +
= O +
15 O -
) O -
. O +

Control O +
cultures O +
were O +
set O +
using O +
PBS O -
- O -
loaded O +
beads O +
( O -
n O +
= O +
6 O -
) O -
. O +

DiI B-Chemical +
labeling O +
through O +
the O +
DRGs O +
revealed O +
numerous O +
fibers O +
entering O +
the O +
spinal O +
cord O +
at O +
ectopic O +
regions O +
and O +
growing O +
towards O +
the O +
NT-3 O +
beads O +
( O -
Figure O +
6A O -
) O -
, O +
surrounding O +
the O +
beads O +
and O +
forming O +
bundles O +
around O +
them O +
( O -
Figure O +
6C–6E O -
) O -
. O +

In O +
control O +
cultures O -
, O +
all O +
labeled O +
fibers O +
were O +
directed O +
towards O +
the O +
dorsal O +
spinal O +
cord O +
and O +
terminated O +
there O -
, O +
where O +
they O +
normally O +
enter O +
the O +
gray O +
matter O +
at O +
E13 O +
( O -
Figure O +
6B O -
) O -
. O +

No O +
axons O +
were O +
observed O +
around O +
the O +
PBS O -
- O -
loaded O +
control O +
beads O +
( O -
Figure O +
6F O -
) O -
. O +

Axons O +
that O +
normally O +
enter O +
the O +
gray O +
matter O +
through O +
dorsal O +
spinal O +
cord O +
grow O +
towards O +
the O +
midline O +
when O +
presented O +
with O +
a O +
localized O +
NT-3 O +
source O -
, O +
and O +
new O +
axon O +
growth O +
towards O +
the O +
NT-3 O +
bead O +
is O +
initiated O +
from O +
DRGs O -
, O +
entering O +
the O +
spinal O +
cord O +
at O +
ectopic O +
loci O +
at O +
lateral O +
mid O -
- O -
spinal O +
cord O +
( O -
Figure O +
6 O -
G O -
) O -
. O +

NT-3 O +
is O +
therefore O +
capable O +
of O +
acting O +
as O +
a O +
chemoattractant O +
for O +
DRG O +
axons O -
. O +

Discussion O +
Relatively O +
few O +
studies O +
have O +
implicated O +
NT-3 O +
as O +
a O +
chemoattractant O +
agent O +
for O +
sensory O +
and O +
motor O +
axons O -
. O +

Previously O +
noted O +
chemoattractant O +
action O +
of O +
the O +
embryonic O +
mouse O +
maxillary O +
process O +
on O +
trigeminal O +
ganglion O +
neurons O +
( O -
Lumsden O +
and O +
Davies O +
1986 O -
) O +
is O +
now O +
attributed O +
to O +
NT-3 O +
and O +
brain O -
- O -
derived O +
neurotrophic O +
factor O +
( O -
BDNF O -
) O +
( O -
O'Connor O +
et O +
al. O +
1999 O -
) O -
. O +

Recently O -
, O +
Tucker O +
et O +
al. O +
( O -
2001 O -
) O +
showed O +
that O +
developing O +
sensory O +
and O +
motor O +
axons O +
in O +
limb O +
slice O +
cultures O +
preferentially O +
grow O +
towards O +
neurotrophin O -
- O -
soaked O +
beads O +
instead O +
of O +
following O +
their O +
normal O +
trajectories O -
. O +

Conversely O -
, O +
beads O +
soaked O +
with O +
neurotrophin O +
function O -
- O -
blocking O +
antibodies O +
led O +
to O +
reduction O +
of O +
sensory O +
and O +
motor O +
axon O +
growth O +
towards O +
the O +
limb O -
. O +

In O +
transgenic O +
mice O -
, O +
which O +
over O -
- O -
express O +
NT-3 O +
under O +
the O +
nestin O +
promoter O +
in O +
the O +
central O +
nervous O +
system O -
, O +
the O +
course O +
of O +
the O +
proprioceptive O +
afferents O +
are O +
altered O +
and O +
directed O +
towards O +
the O +
regions O +
with O +
high O +
levels O +
of O +
ectopic O +
NT-3 O +
expression O +
in O +
the O +
spinal O +
cord O +
( O -
Ringstedt O +
et O +
al. O +
1997 O -
) O -
. O +

Ringstedt O +
et O +
al. O +
considered O +
the O +
possibility O +
that O +
NT-3 O +
may O +
play O +
a O +
chemoattractant O +
role O +
during O +
the O +
innervation O +
of O +
ventral O +
horns O +
by O +
proprioceptive O +
afferents O -
. O +

However O -
, O +
earlier O +
findings O +
of O +
normal O +
proprioceptive O +
afferent O +
trajectories O +
in O +
chicken O +
embryos O +
despite O +
injection O +
of O +
function O -
- O -
blocking O +
NT-3 O +
antibody O +
into O +
the O +
spinal O +
cord O +
( O -
Oakley O +
et O +
al. O +
1995 O -
) O +
led O +
them O +
to O +
discount O +
this O +
possibility O -
. O +

In O +
that O +
study O -
, O +
though O -
, O +
assays O +
on O +
the O +
effectiveness O +
of O +
antibody O +
perturbation O +
on O +
NT-3-dependent O +
cell O +
survival O +
showed O +
that O +
effectiveness O +
was O +
significant O +
( O -
approximately O +
90 O -
% O -
) O +
but O +
not O +
complete O +
( O -
Oakley O +
et O +
al. O +
1995 O -
) O -
. O +

Ringstedt O +
et O +
al. O +
( O -
1997 O -
) O +
argue O +
that O +
while O +
central O +
sensory O +
axons O +
may O +
still O +
navigate O +
properly O +
in O +
the O +
absence O +
of O +
NT-3 O -
, O +
ectopic O +
expression O +
of O +
NT-3 O +
disrupts O +
their O +
targeting O -
. O +

Recently O -
, O +
another O +
member O +
of O +
the O +
neurotrophin O +
family O -
, O +
BDNF O -
, O +
has O +
been O +
suggested O +
to O +
act O +
as O +
a O +
chemoattractant O +
for O +
sensory O +
axons O +
innervating O +
ear O +
( O -
Tessarollo O +
et O +
al. O +
2004 O -
) O -
. O +

In O +
a O +
gene O +
replacement O +
strategy O +
in O +
which O +
BDNF O +
expression O +
was O +
driven O +
by O +
the O +
NT-3 O +
promoter O -
, O +
vestibular O +
axons O +
rerouted O +
towards O +
ectopic O +
sources O +
of O +
BDNF O +
in O +
the O +
cochlea O +
that O +
normally O +
expressed O +
NT-3 O +
and O +
were O +
not O +
innervated O +
by O +
these O +
axons O -
. O +

Ectopic O +
NT-3 O +
supplied O +
using O +
osmotic O +
pumps O +
and O +
adenovirus O -
- O -
mediated O +
expression O +
induce O +
sensory O +
axon O +
growth O +
during O +
regeneration O +
( O -
Zhang O +
et O +
al. O +
1998 O -
, O +
Bradbury O +
et O +
al. O +
1999 O -
, O +
Oudega O +
et O +
al. O +
1999 O -
, O +
Ramer O +
et O +
al. O +
2002 O -
) O -
, O +
and O +
induce O +
axonal O +
plasticity O +
of O +
corticospinal O +
axons O +
in O +
injured O +
adult O +
spinal O +
cord O +
( O -
Zhou O +
et O +
al. O +
2003 O -
) O -
, O +
where O +
the O +
sprouting O +
axons O +
from O +
the O +
intact O +
site O +
cross O +
the O +
midline O +
towards O +
the O +
NT-3 O +
source O +
on O +
the O +
lesion O +
side O +
of O +
the O +
spinal O +
cord O -
. O +

Our O +
present O +
results O +
are O +
in O +
agreement O +
with O +
these O +
observations O -
, O +
and O +
provide O +
further O +
evidence O +
that O +
NT-3 O +
acts O +
as O +
a O +
chemoattractant O +
for O +
sensory O +
afferents O -
. O +

Previously O -
, O +
normal O +
motor O +
neuron O +
innervation O +
was O +
rescued O +
in O +
NT-3 O +
KO O +
animals O +
by O +
over O -
- O -
expressing O +
NT-3 O +
selectively O +
in O +
their O +
muscles O +
( O -
Wright O +
et O +
al. O +
1997 O -
) O -
. O +

It O +
appears O +
that O +
peripheral O +
NT-3 O +
alone O +
is O +
sufficient O +
for O +
rescuing O +
proprioceptive O +
neurons O +
in O +
NT-3 O +
KO O +
animals O +
and O +
proper O +
axonal O +
pathfinding O +
in O +
the O +
spinal O +
cord O -
. O +

However O -
, O +
it O +
is O +
unclear O +
whether O +
NT-3 O +
is O +
absent O +
from O +
the O +
ventral O +
spinal O +
cords O +
of O +
these O +
animals O -
. O +

The O +
possibility O +
has O +
been O +
raised O +
that O +
motor O +
neurons O +
may O +
retrogradely O +
transport O +
NT-3 O +
in O +
muscle O +
to O +
the O +
spinal O +
cord O +
( O -
Chen O +
and O +
Frank O +
1999 O -
) O -
. O +

Assays O +
to O +
determine O +
whether O +
any O +
NT-3 O +
is O +
present O +
in O +
the O +
ventral O +
horns O +
of O +
these O +
mice O +
would O +
be O +
informative O -
. O +

Recently O -
, O +
Patel O +
et O +
al. O +
( O -
2003 O -
) O +
reported O +
their O +
observations O +
on O +
Bax O -
/ O -
NT-3 O +
double O +
KO O +
mice O +
they O +
bred O -
. O +

Their O +
results O +
are O +
significantly O +
different O +
from O +
ours O -
. O +

They O +
see O +
no O +
proprioceptive O +
afferents O +
in O +
the O +
periphery O +
of O +
the O +
double O +
knockouts O +
and O +
note O +
that O +
central O +
proprioceptive O +
afferents O +
terminate O +
in O +
the O +
intermediate O +
spinal O +
cord O +
without O +
extending O +
ventrally O -
. O +

Their O +
observations O +
are O +
based O +
on O +
PV O +
immunostaining O +
and O +
DiI B-Chemical +
labeling O +
of O +
the O +
peripheral O +
nerves O -
. O +

We O +
noted O +
that O +
PV O +
immunolabeling O +
is O +
diminished O +
in O +
our O +
Bax O -
/ O -
NT-3 O +
double O +
KOs O -
. O +

In O +
various O +
manipulations O +
of O +
the O +
neurotrophins O +
it O +
has O +
been O +
noted O +
that O +
molecular O +
markers O +
for O +
proprioceptive O +
axons O +
such O +
as O +
PV O +
or O +
calcitonin O +
gene O -
- O -
related O +
peptide O +
for O +
nerve O +
growth O +
factor O -
– O -
responsive O +
axons O +
are O +
compromised O +
( O -
Ringstedt O +
et O +
al. O +
1997 O -
; O +
Patel O +
et O +
al. O +
2000 O -
) O -
, O +
thus O +
PV O +
immunostaining O +
in O +
Bax O -
/ O -
NT-3 O +
double O +
KOs O +
can O -
not O +
reveal O +
the O +
extent O +
of O +
proprioceptive O +
axons O +
in O +
the O +
periphery O -
. O +

Seventy O -
- O -
three O +
percent O +
of O +
retrogradely O +
labeled O +
gastrocnemius O +
muscle O +
afferents O +
were O +
reported O +
to O +
be O +
expressing O +
TrkC O +
RNA O +
in O +
the O +
adult O +
rat O +
DRG O -
, O +
although O +
some O +
of O +
these O +
( O -
about O +
10 O -
% O -
) O +
may O +
represent O +
cutaneous O +
innervation O +
( O -
McMahon O +
et O +
al. O +
1994 O -
) O -
. O +

Presently O -
, O +
it O +
is O +
not O +
clear O +
whether O +
TrkC O +
protein O +
is O +
also O +
made O +
by O +
cutaneous O +
afferents O +
and O +
if O +
so O +
at O +
what O +
stage O +
in O +
development O +
this O +
receptor O +
is O +
expressed O +
by O +
cutaneous O +
axons O -
. O +

Based O +
on O +
the O +
available O +
evidence O +
showing O +
that O +
all O +
proprioceptive O +
neurons O +
are O +
eliminated O +
in O +
NT-3 O +
or O +
TrkC O +
null O +
mice O -
, O +
we O +
think O +
that O +
TrkC O +
staining O +
in O +
the O +
tibial O +
nerve O +
mostly O +
represents O +
proprioceptive O +
axons O +
in O +
the O +
vicinity O +
of O +
their O +
peripheral O +
target O -
. O +

Altogether O -
, O +
our O +
findings O +
suggest O +
a O +
role O +
for O +
NT-3 O +
in O +
initiation O +
of O +
muscle O +
innervation O +
and O +
spindle O +
differentiation O +
by O +
the O +
proprioceptive O +
axons O -
. O +

Patel O +
et O +
al. O +
( O -
2003 O -
) O +
examined O +
DiI B-Chemical -
- O -
labeled O +
central O +
DRG O +
axons O +
in O +
the O +
spinal O +
cord O +
of O +
three O +
E17 O +
and O +
two O +
P0 O +
cases O -
, O +
and O +
report O +
that O +
central O +
proprioceptive O +
axons O +
stop O +
in O +
the O +
intermediate O +
laminae O -
, O +
never O +
entering O +
the O +
ventral O +
cord O -
. O +

We O +
have O +
examined O +
nine O +
Bax O -
/ O -
NT-3 O +
double O +
KO O +
cases O -
, O +
and O +
often O +
incomplete O +
DiI B-Chemical +
labeling O +
gives O +
the O +
impression O +
that O +
there O +
are O +
no O +
axons O +
reaching O +
the O +
ventral O +
spinal O +
cord O -
. O +

We O +
have O +
also O +
seen O +
cases O +
similar O +
to O +
theirs O +
( O -
n O +
= O +
4 O -
) O -
, O +
but O +
at O +
higher O +
magnification O +
these O +
axons O +
did O +
not O +
have O +
terminal O +
boutons O +
and O +
were O +
not O +
completely O +
labeled O -
. O +

However O -
, O +
with O +
complete O +
fills O +
( O -
n O +
= O +
5 O -
) O -
, O +
it O +
was O +
possible O +
to O +
trace O +
these O +
axons O +
into O +
the O +
ventral O +
midline O +
and O +
across O +
to O +
the O +
contralateral O +
side O -
, O +
and O +
visualize O +
terminal O +
boutons O +
at O +
their O +
tips O +
( O -
see O +
Figure O +
3C O -
) O -
. O +

Previously O -
, O +
Arber O +
et O +
al. O +
( O -
2000 O -
) O +
reported O +
that O +
members O +
of O +
the O +
Ets O +
family O +
of O +
transcription O +
factors O -
, O +
Er81 O +
and O +
Pea3 O -
, O +
are O +
expressed O +
by O +
DRG O +
neurons O +
as O +
well O +
as O +
motor O +
neurons O +
and O +
their O +
target O +
muscle O +
fibers O -
. O +

They O +
found O +
that O +
in O +
the O +
spinal O +
cord O +
of O +
Er81 O +
KO O +
mice O -
, O +
ventral O +
projections O +
of O +
proprioceptive O +
axons O +
were O +
mostly O +
absent O -
, O +
and O +
very O +
few O +
axons O +
made O +
it O +
to O +
the O +
ventral O +
cord O -
. O +

Patel O +
et O +
al. O +
( O -
2003 O -
) O +
note O +
that O +
the O +
phenotype O +
they O +
observed O +
in O +
their O +
Bax O -
/ O -
NT-3 O +
double O +
KO O +
mice O +
is O +
quite O +
similar O +
to O +
that O +
of O +
Er81 O +
KO O +
mice O -
. O +

They O +
provide O +
evidence O +
that O +
NT-3 O +
induces O +
Er81 O +
expression O +
in O +
DRG O +
explants O +
in O +
vitro O -
. O +

Patel O +
et O +
al. O +
( O -
2003 O -
) O +
report O +
that O +
Er81 O +
mRNA O +
expression O +
is O +
diminished O +
( O -
but O +
not O +
abolished O -
) O +
in O +
both O +
NT-3 O +
KO O +
and O +
Bax O -
/ O -
NT-3 O +
double O +
KO O +
mice O -
, O +
while O +
their O +
immunohistochemistry O +
shows O +
much O +
less O +
protein O +
expression O +
in O +
the O +
double O +
KO O +
mice O -
. O +

It O +
is O +
highly O +
possible O +
that O +
a O +
small O +
but O +
considerable O +
number O +
of O +
DRG O +
cells O +
express O +
the O +
transcription O +
factor O +
Er81 O +
and O +
that O +
their O +
axons O +
grow O +
beyond O +
the O +
intermediate O +
levels O +
of O +
the O +
spinal O +
cord O +
in O +
Bax O -
/ O -
NT-3 O +
double O +
KO O +
mice O -
. O +

While O +
the O +
phenotype O +
of O +
Er81 O +
KO O +
mice O +
is O +
quite O +
dramatic O -
, O +
and O +
most O +
proprioceptive O +
axons O +
stop O +
within O +
the O +
intermediate O +
spinal O +
cord O -
, O +
it O +
is O +
important O +
to O +
note O +
that O +
a O +
few O +
axons O +
still O +
find O +
their O +
way O +
to O +
the O +
ventral O +
spinal O +
cord O +
and O +
target O +
properly O +
to O +
the O +
motor O +
neurons O +
( O -
Arber O +
et O +
al. O +
2000 O -
) O -
. O +

Patel O +
et O +
al. O +
( O -
2003 O -
) O +
also O +
present O +
observations O +
from O +
islet2DTA O +
mice O -
, O +
which O +
lack O +
a O +
significant O +
portion O +
of O +
the O +
motor O +
neurons O +
in O +
the O +
ventral O +
cord O -
. O +

In O +
these O +
mice O +
PV O +
immunostaining O +
shows O +
axons O +
in O +
the O +
ventral O +
horns O -
. O +

Patel O +
et O +
al. O +
argue O +
that O +
since O +
motor O +
neurons O +
are O +
absent O +
in O +
these O +
mice O -
, O +
NT-3 O +
secreted O +
by O +
them O +
could O +
not O +
be O +
a O +
signal O +
for O +
proprioceptive O +
axons O +
to O +
enter O +
the O +
lateral O +
motor O +
columns O -
. O +

However O -
, O +
there O +
is O +
no O +
evidence O +
showing O +
that O +
NT-3 O +
mRNA O +
or O +
protein O +
expressed O +
in O +
the O +
ventral O +
spinal O +
cord O +
is O +
exclusively O +
from O +
motor O +
neurons O -
, O +
and O +
there O +
are O +
no O +
available O +
data O +
indicating O +
that O +
in O +
islet2DTA O +
mice O -
, O +
NT-3 O +
expression O +
in O +
the O +
ventral O +
spinal O +
cord O +
is O +
abolished O +
( O -
Yang O +
et O +
al. O +
2001 O -
; O +
Pun O +
et O +
al. O +
2002 O -
) O -
. O +

Studies O +
in O +
embryonic O +
mice O +
reported O +
NT-3 O +
mRNA O +
in O +
the O +
ventral O +
horns O +
of O +
the O +
spinal O +
cord O -
, O +
but O +
it O +
is O +
not O +
definitive O +
that O +
both O +
mRNA O +
and O +
protein O +
are O +
expressed O +
solely O +
by O +
motor O +
neurons O -
. O +

In O +
the O +
adult O +
spinal O +
cord O -
, O +
while O +
motor O +
neurons O +
express O +
high O +
levels O +
of O +
NT-3 O -
, O +
other O +
cells O -
, O +
including O +
glia O -
, O +
also O +
express O +
it O +
( O -
Zhou O +
and O +
Rush O +
1994 O -
; O +
Dreyfus O +
et O +
al. O +
1999 O -
; O +
Buck O +
et O +
al. O +
2000 O -
) O -
. O +

Our O +
present O +
results O -
, O +
along O +
with O +
those O +
from O +
transgenic O +
mice O +
with O +
NT-3 O +
over O -
- O -
expression O +
in O +
ectopic O +
regions O +
of O +
the O +
spinal O +
cord O +
( O -
Ringstedt O +
et O +
al. O +
1997 O -
) O -
, O +
argue O +
for O +
a O +
role O +
of O +
NT-3 O +
in O +
chemoattractant O +
axon O +
guidance O +
of O +
proprioceptive O +
axons O +
in O +
the O +
spinal O +
cord O -
. O +

Finally O -
, O +
in O +
culture O +
assays O -
, O +
we O +
see O +
a O +
strong O +
chemoattraction O +
of O +
DRG O +
neurons O +
to O +
localized O +
sources O +
of O +
NT-3 O -
. O +

This O +
response O +
is O +
seen O +
in O +
WT O -
, O +
Bax O +
null O +
and O +
in O +
p75 O +
null O +
DRG O +
explants O -
, O +
and O +
in O +
the O +
absence O +
of O +
any O +
other O +
neurotrophins O +
or O +
target O -
- O -
derived O +
axon O +
guidance O +
molecules B-Chemical -
. O +

Furthermore O -
, O +
in O +
vitro O -
, O +
sensory O +
axon O +
response O +
to O +
NT-3 O +
does O +
not O +
appear O +
to O +
be O +
dose O -
- O -
dependent O +
( O -
Ringstedt O +
et O +
al. O +
1997 O -
; O +
Tucker O +
et O +
al. O +
2001 O -
) O -
. O +

NT-3 O +
is O +
capable O +
of O +
attracting O +
axons O +
along O +
distances O +
of O +
up O +
to O +
1 O +
mm O +
in O +
collagen O +
gel O +
matrix O -
, O +
covering O +
the O +
physiological O +
range O +
it O +
needs O +
to O +
attract O +
axons O +
during O +
development O -
. O +

Previous O +
studies O +
with O +
exogenous O +
or O +
local O +
applications O +
of O +
NT-3 O +
to O +
developing O +
primary O +
sensory O +
axons O +
have O +
indicated O +
that O +
this O +
neurotrophin O +
can O +
attract O +
and O +
induce O +
axonal O +
branching O +
( O -
Ulupınar O +
et O +
al. O +
2000 O -
; O +
Özdinler O +
and O +
Erzurumlu O +
2001 O -
, O +
Özdinler O +
et O +
al. O +
2004 O -
) O -
. O +

Along O +
the O +
monosynaptic O +
stretch O +
reflex O +
pathway O -
, O +
only O +
Wnt-3 O +
has O +
been O +
implicated O +
as O +
an O +
axon O +
arborization O +
factor O +
in O +
the O +
spinal O +
cord O +
( O -
Krylova O +
et O +
al. O +
2002 O -
) O -
. O +

Another O +
molecule B-Chemical -
, O +
Slit2 O -
, O +
expressed O +
in O +
the O +
midline O +
and O +
by O +
motor O +
neurons O +
( O -
Wang O +
et O +
al. O +
1999 O -
) O +
is O +
capable O +
of O +
inducing O +
axonal O +
branching O +
( O -
Nguyen O +
Ba O -
- O -
Charvet O +
et O +
al. O +
2001 O -
; O +
Özdinler O +
and O +
Erzurumlu O +
2002 O -
) O -
. O +

DRG O +
neurons O +
express O +
Robo O +
receptors O -
, O +
which O +
bind O +
to O +
Slits O -
, O +
and O +
proprioceptive O +
axons O +
are O +
therefore O +
capable O +
of O +
responding O +
to O +
Slit O +
signals O +
( O -
Wang O +
et O +
al. O +
1999 O -
) O -
. O +

Slit2 O +
does O +
not O +
cause O +
repulsion O +
of O +
NT-3-responsive O +
DRG O +
axons O +
in O +
vitro O +
( O -
Nguyen O +
Ba O -
- O -
Charvet O +
et O +
al. O +
2001 O -
) O -
, O +
but O +
causes O +
ectopic O +
branching O +
and O +
arborization O +
of O +
trigeminal O +
axons O +
in O +
the O +
brainstem O +
( O -
Özdinler O +
and O +
Erzurumlu O +
2002 O -
) O -
. O +

Thus O -
, O +
Slit2 O +
might O +
also O +
be O +
involved O +
in O +
terminal O +
branching O +
of O +
propioceptive O +
axons O +
in O +
the O +
ventral O +
cord O +
and O +
in O +
the O +
midline O +
branching O +
observed O +
in O +
our O +
double O +
KOs O -
. O +

Lack O +
of O +
PV O +
expression O +
in O +
Bax O -
/ O -
NT-3 O +
KO O +
mice O +
suggests O +
that O +
PV O +
expression O +
might O +
be O +
responsible O +
for O +
proper O +
axon O +
targeting O +
and O +
muscle O +
spindle O +
differentiation O -
. O +

Presently O +
we O +
can O -
not O +
completely O +
rule O +
out O +
this O +
possibility O -
. O +

However O -
, O +
no O +
defects O +
in O +
axon O +
pathfinding O +
along O +
the O +
monosynaptic O +
reflex O +
arc O +
or O +
in O +
muscle O +
spindle O +
differentiation O +
have O +
been O +
noted O +
in O +
PV O +
KO O +
mice O -
, O +
which O +
develop O +
normally O +
and O +
show O +
no O +
apparent O +
changes O +
in O +
their O +
behavior O +
or O +
physical O +
activity O +
( O -
Schwaller O +
et O +
al. O +
1999 O -
) O -
. O +

These O +
observations O +
suggest O +
that O +
axonal O +
targeting O +
defects O +
in O +
Bax O -
/ O -
NT-3 O +
double O +
KO O +
mice O +
can O -
not O +
be O +
simply O +
due O +
to O +
lack O +
of O +
PV O +
expression O +
in O +
proprioceptive O +
cells O -
. O +

Our O +
present O +
results O +
suggest O +
that O +
NT-3 O +
acts O +
as O +
a O +
short O -
- O -
range O +
axon O +
guidance O +
cue O +
for O +
proprioceptive O +
axons O +
centrally O +
and O +
peripherally O -
, O +
as O +
they O +
navigate O +
to O +
their O +
targets O +
using O +
other O +
axon O +
guidance O +
cues O -
. O +

In O +
its O +
absence O -
, O +
these O +
axons O +
terminate O +
in O +
inappropriate O +
loci O -
. O +

However O -
, O +
NT-3 O +
may O +
not O +
be O +
the O +
only O +
molecule B-Chemical +
that O +
plays O +
a O +
role O +
in O +
targeting O +
and O +
terminal O +
branching O +
of O +
sensory O +
axons O +
in O +
the O +
ventral O +
spinal O +
cord O -
. O +

NT-3 O +
most O +
likely O +
acts O +
cooperatively O +
with O +
other O +
axon O +
guidance O +
molecules B-Chemical +
or O +
by O +
regulating O +
expression O +
of O +
yet O +
to O +
be O +
identified O +
proprioceptive O +
neuron O -
- O -
specific O +
receptors O -
/ O -
ligands O +
for O +
numerous O +
axon O +
guidance O +
cues O -
. O +

Materials O +
and O +
Methods O +
Generation O +
of O +
double O +
KOs O -
. O +

We O +
crossed O +
Bax O +
KO O +
females O +
on O +
a O +
C57BL O -
/ O -
6 O +
background O +
( O -
Jackson O +
Laboratory O -
, O +
Bar O +
Harbor O -
, O +
Maine O -
, O +
United O +
States O -
) O +
to O +
NT-3 O +
heterozygote O +
males O +
on O +
a O +
129 O +
Sv O +
background O +
to O +
generate O +
double O +
heterozygote O +
animals O -
. O +

Progeny O +
was O +
genotyped O +
with O +
PCR O -
, O +
and O +
animals O +
heterozygous O +
for O +
both O +
genes O +
were O +
bred O +
to O +
obtain O +
the O +
double O +
KOs O -
. O +

Primers O +
used O +
for O +
the O +
Bax O +
locus O +
were O +
R661 O -
, O +
GTT O +
GAC O +
CAG O +
AGT O +
GGC O +
GTA O +
GG O -
; O +
R662 O -
, O +
CCG O +
CTT O +
CCA O +
TTG O +
CTC O +
AGC O +
GG O -
; O +
and O +
R663 O -
, O +
GAG O +
CTG O +
ATC O +
AGA O +
ACC O +
ATC O +
ATG O -
. O +

Primers O +
used O +
for O +
the O +
NT-3 O +
locus O +
were O +
NT3A O -
, O +
CGT O +
GGT O +
GAG O +
GTT O +
CTA O +
TTG O +
GCT O +
AC O -
; O +
NT3B O -
, O +
CAG O +
AGC O +
ACC O +
CTG O +
CCC O +
AAA O +
GCA O +
GAG O -
; O +
NT3R O -
, O +
CCT O +
TGA O +
CAA O +
TAC O +
TGA O +
ATG O +
CC O -
; O +
and O +
NEOF O -
, O +
GGG O +
AAC O +
TTC O +
CTG O +
ACT O +
AGG O -
. O +

WT O -
, O +
Bax O +
KO O -
, O +
and O +
NT-3 O +
KO O +
littermates O +
were O +
used O +
as O +
controls O -
. O +

A O +
total O +
of O +
11 O +
Bax O -
/ O -
NT-3 O +
double O +
KO O +
mice O +
were O +
analyzed O -
, O +
of O +
these O +
nine O +
were O +
P0 O +
pups O -
. O +

The O +
p75 O +
colony O +
on O +
a O +
129 O +
S1 O +
background O +
was O +
received O +
from O +
Jackson O +
Laboratory O -
. O +

We O +
used O +
tail O +
DNA O +
to O +
genotype O +
animals O +
using O +
the O +
primers O +
IMR0013 O -
, O +
CTT O +
GGG O +
TGG O +
AGA O +
GGC O +
TAT O +
TC O -
; O +
IMR0014 O -
, O +
AGG O +
TGA O +
GAT O +
GAC O +
AGG O +
AGA O +
TC O +
( O -
generic O +
neo O +
primers O -
) O -
; O +
IMR0710 O -
, O +
TGT O +
TAC O +
GTT O +
CTC O +
TGA O +
CGT O +
GGT O +
GAG O -
; O +
and O +
IMR0711 O -
, O +
TCA O +
GCC O +
CAG O +
GGT O +
GTG O +
CAC O +
TC O +
( O -
p75 O +
locus O -
) O -
. O +

For O +
embryonic O +
experiments O -
, O +
day O +
of O +
plug O +
positivity O +
was O +
considered O +
E0 O -
. O +

All O +
of O +
the O +
protocols O +
used O +
in O +
this O +
study O +
were O +
approved O +
by O +
the O +
Louisiana O +
State O +
University O +
Health O +
Sciences O +
Center O +
Institutional O +
Animal O +
Care O +
and O +
Use O +
Committee O +
and O +
conformed O +
to O +
the O +
National O +
Institutes O +
of O +
Health O +
guidelines O +
for O +
use O +
of O +
experimental O +
animals O -
. O +

TrkA O -
/ O -
TrkC O +
immunohistochemistry O -
. O +

Frozen O +
spinal O +
cord O +
sections O +
( O -
10 O +
μm O +
thick O -
) O +
were O +
blocked O +
and O +
incubated O +
in O +
a O +
cocktail B-Chemical +
of O +
rabbit O +
anti O -
- O -
TrkA O +
and O +
goat O +
anti O -
- O -
TrkC O +
antibodies O +
( O -
gift O +
of O +
Dr. O +
Reichardt O -
; O +
Huang O +
et O +
al. O +
1999 O -
) O -
, O +
followed O +
by O +
a O +
cocktail B-Chemical +
of O +
CY3 B-Chemical +
conjugated O +
donkey O +
anti O -
- O -
rabbit O +
and O +
FITC B-Chemical +
conjugated O +
donkey O +
anti O -
- O -
goat O +
antibodies O +
( O -
Chemicon O -
, O +
Temecula O -
, O +
California O -
, O +
United O +
States O -
) O +
in O +
the O +
presence O +
of O +
0.3 O -
% O +
TritonX-100 B-Chemical +
and O +
10 O -
% O +
normal O +
donkey O +
serum O -
. O +

For O +
PV O +
immunohistochemistry O -
, O +
sections O +
were O +
reacted O +
with O +
monoclonal O +
mouse O +
anti O -
- O -
PV O +
antibody O +
( O -
Sigma O -
, O +
St. O +
Louis O -
, O +
Missouri O -
, O +
United O +
States O -
) O -
, O +
and O +
developed O +
by O +
Vector O +
fluorescein B-Chemical +
mouse O +
on O +
mouse O +
kit O +
( O -
Vector O +
Laboratories O -
, O +
Burlingame O -
, O +
California O -
, O +
United O +
States O -
) O -
. O +

For O +
quantification O +
purposes O -
, O +
TrkA- O +
and O +
TrkC O -
- O -
labeled O +
cells O +
from O +
four O +
different O +
DRGs O +
of O +
each O +
genotype O +
and O +
age O +
studied O +
were O +
counted O -
, O +
and O +
ratios O +
plotted O -
. O +

Muscle O +
spindle O +
detection O -
. O +

Gastrocnemius O +
muscle O +
was O +
dissected O +
out O +
in O +
P0 O +
pups O +
and O +
sectioned O +
longitudinally O -
, O +
or O -
, O +
in O +
some O +
cases O -
, O +
the O +
whole O +
leg O +
at O +
the O +
level O +
of O +
gastrocnemius O +
muscle O +
with O +
tibial O +
nerve O +
was O +
sectioned O +
in O +
cross O +
section O -
. O +

Sections O +
were O +
incubated O +
with O +
monoclonal O +
S46 O +
antibody O +
( O -
gift O +
of O +
Dr. O +
Stockdale O -
) O +
reactive O +
to O +
the O +
spindle O -
- O -
specific O +
slow O -
- O -
tonic O +
myosin O +
heavy O +
chain O +
isoform O +
and O +
developed O +
by O +
Vector O +
mouse O +
on O +
mouse O +
kit O +
as O +
described O +
above O -
, O +
followed O +
by O +
rabbit O +
anti O -
- O -
NF O -
- O -
M O +
antibody O +
( O -
Chemicon O -
) O +
and O +
CY3 B-Chemical +
conjugated O +
goat O +
anti O -
- O -
rabbit O +
antibody O +
( O -
Chemicon O -
) O +
in O +
a O +
sequential O +
double O -
- O -
labeling O +
protocol O -
. O +

In O +
another O +
method O -
, O +
DiI B-Chemical +
crystals O +
were O +
placed O +
in O +
DRGs O +
of O +
E17 O +
embryos O +
from O +
different O +
genotypes O +
( O -
n O +
= O +
2 O -
) O -
, O +
and O +
the O +
gastrocnemius O +
muscle O +
was O +
isolated O +
and O +
sectioned O +
into O +
40-μm O -
- O -
thick O +
slices O +
on O +
a O +
vibratome O -
. O +

DiI B-Chemical +
labeling O -
. O +

Spinal O +
cords O +
were O +
dissected O +
out O +
with O +
the O +
DRGs O +
attached O -
, O +
motor O +
root O +
was O +
cut O +
to O +
prevent O +
backfilling O +
of O +
motor O +
neurons O -
, O +
and O +
crystals O +
of O +
1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine B-Chemical +
perchlorate I-Chemical +
( O -
DiI B-Chemical -
; O +
Molecular O +
Probes O -
, O +
Eugene O -
, O +
Oregon O -
, O +
United O +
States O -
) O +
were O +
inserted O +
in O +
DRGs O -
. O +

Labeled O +
spinal O +
cords O +
were O +
incubated O +
at O +
37 O +
° O -
C O +
for O +
8 O +
d O +
and O +
sectioned O +
on O +
a O +
vibrotome O +
at O +
100 O +
μm O -
. O +

Sections O +
were O +
observed O +
under O +
the O +
fluorescent O +
microscope O +
and O +
photographed O -
, O +
and O +
images O +
were O +
transferred O +
to O +
Adobe O +
Photoshop O -
, O +
inverted O -
, O +
and O +
adjusted O +
for O +
brightness O +
and O +
contrast O -
. O +

Photoconverted O +
in O +
0.15 O -
% O +
DAB O +
( O -
3,3′-diaminobenzidine O -
; O +
Sigma O -
) O +
in O +
0.1 O -
M O +
Tris B-Chemical +
buffer O +
( O -
pH O +
8.2 O -
) O -
. O +

In O +
vitro O +
co O -
- O -
culture O +
assay O -
. O +

DRG O +
explants O +
were O +
derived O +
from O +
Swiss O +
Webster O -
, O +
Bax O +
null O -
, O +
and O +
p75 O +
null O +
mouse O +
embryos O +
( O -
E13 O -
) O -
. O +

For O +
collagen O +
matrix O +
assays O -
, O +
DRGs O +
were O +
dissected O +
out O +
under O +
a O +
stereomicroscope O +
using O +
tungsten O +
needles O -
. O +

Collagen O +
matrix O +
was O +
prepared O +
with O +
430 O +
μl O +
of O +
collagen O +
( O -
3 O +
mg O -
/ O -
ml O +
dissolved O +
in O +
0.1 O -
M O +
acetic B-Chemical +
acid I-Chemical -
, O +
Sigma O -
) O -
, O +
50 O +
μl O +
of O +
10X O +
DMEM O +
medium O -
, O +
and O +
2.5 O +
μl O +
of O +
0.8 O +
M O +
NaCa2 O -
, O +
and O +
the O +
pH O +
was O +
adjusted O +
to O +
7.5 O -
. O +

Individual O +
ganglion O +
explants O +
were O +
placed O +
in O +
24-well O +
plates O +
and O +
covered O +
with O +
freshly O +
prepared O +
collagen O -
. O +

Sepharose O +
beads O +
with O +
an O +
average O +
diameter O +
of O +
150 O +
μm O +
were O +
used O -
. O +

Beads O +
were O +
washed O +
twice O +
with O +
PBS O -
, O +
air O +
dried O -
, O +
and O +
loaded O +
with O +
10 O -
, O +
20 O -
, O +
50 O -
, O +
or O +
100 O +
ng O -
/ O -
μl O +
NT-3 O +
( O -
Collaborative O +
Research O -
, O +
Chemicon O -
) O +
at O +
4 O +
° O -
C O +
overnight O +
with O +
constant O +
shaking O -
. O +

For O +
negative O +
control O -
, O +
beads O +
were O +
loaded O +
with O +
BSA O +
( O -
10–100 O +
ng O -
/ O -
μl O -
) O +
or O +
PBS O -
. O +

Either O +
a O +
single O +
neurotrophin O -
- O -
loaded O +
bead O +
or O +
a O +
single O +
BSA O +
( O -
or O +
PBS O -
) O -
–loaded O +
bead O +
was O +
implanted O +
about O +
200–1,200 O +
μm O +
away O +
from O +
the O +
ganglion O +
explant O -
. O +

Collagen O -
- O -
embedded O +
cultures O +
were O +
then O +
placed O +
at O +
33 O +
° O -
C O +
for O +
15 O +
min O +
for O +
the O +
matrix O +
to O +
harden O -
. O +

Serum O -
- O -
free O +
culture O +
medium O +
was O +
then O +
added O +
to O +
each O +
well O -
. O +

In O +
cultures O +
with O +
WT O +
DRG O +
and O +
control O +
beads O -
, O +
10 O -
% O +
serum O +
was O +
added O +
to O +
ensure O +
viability O +
of O +
the O +
explants O -
. O +

TrkC O -
- O -
Fc O +
( O -
Regeneron O +
Pharmaceuticals B-Chemical -
, O +
Tarrytown O -
, O +
New O +
York O -
, O +
United O +
States O -
) O +
was O +
added O +
( O -
20 O +
μg O -
/ O -
ml O -
) O +
into O +
the O +
culture O +
medium O -
. O +

Explant O +
co O -
- O -
cultures O +
Spinal O +
cords O +
with O +
attached O +
DRGs O +
were O +
dissected O +
out O +
from O +
Swiss O +
Webster O +
mouse O +
embryos O +
at O +
E13 O -
, O +
and O +
sectioned O +
into O +
300-μm O -
- O -
thick O +
slices O -
. O +

Tissue O +
slices O +
were O +
placed O +
on O +
Millicell O +
Tissue O +
Culture O +
Inserts O +
( O -
Millipore O -
, O +
Billrica O -
, O +
Massachusetts O -
, O +
United O +
States O -
) O -
. O +

NT-3-loaded O +
( O -
n O +
= O +
15 O -
) O +
or O +
PBS O -
- O -
loaded O +
( O -
n O +
= O +
6 O -
) O +
sepharose O +
beads O +
were O +
prepared O +
as O +
described O +
above O -
, O +
and O +
placed O +
in O +
the O +
midline O +
at O +
mid O -
- O -
spinal O +
cord O +
level O -
. O +

Inserts O +
were O +
placed O +
in O +
six O -
- O -
well O +
plates O +
with O +
serum O -
- O -
free O +
medium O +
at O +
the O +
bottom O +
of O +
the O +
wells O -
, O +
and O +
kept O +
at O +
33 O +
° O -
C O +
for O +
3 O +
d O +
in O +
the O +
presence O +
of O +
5 O -
% O +
CO2 B-Chemical -
. O +

Cultures O +
were O +
then O +
fixed O +
with O +
4 O -
% O +
paraformaldehyde O +
in O +
PBS O -
, O +
and O +
small O +
crystals O +
of O +
DiI B-Chemical +
were O +
placed O +
into O +
the O +
DRGs O -
. O +

Samples O +
were O +
incubated O +
in O +
a O +
37- O -
° O -
C O +
incubator O -
, O +
allowing O +
the O +
dye B-Chemical +
to O +
diffuse O -
, O +
and O +
photographed O +
under O +
a O +
Nikon O +
( O -
Tokyo O -
, O +
Japan O -
) O +
inverted O +
epifluoresence O +
microscope O -
. O +

Supporting O +
Information O +
Figure O +
S1 O +
Motor O +
Neuron O +
Innervation O +
Initiated O +
in O +
WT O +
E17 O +
Embryos O +
Can O -
not O +
Be O +
Detected O +
in O +
Bax O -
/ O -
NT-3 O +
Double O +
KOs O +
In O +
some O +
of O +
the O +
samples O -
, O +
motor O +
neurons O +
were O +
labeled O +
by O +
backfilling O +
through O +
the O +
ventral O +
root O +
in O +
addition O +
to O +
the O +
sensory O +
axons O +
labeled O +
through O +
the O +
DRGs O -
. O +

( O -
A O -
) O +
WT O +
embryo O +
showing O +
proprioceptive O +
axons O +
contacting O +
motor O +
neuron O +
dendrites O +
in O +
the O +
ventral O +
horn O -
, O +
forming O +
synapses O -
. O +

( O -
B O -
) O +
Bax O -
/ O -
NT-3 O +
double O +
null O +
spinal O +
cord O -
. O +

Although O +
labeled O +
fibers O +
enter O +
the O +
ventral O +
spinal O +
cord O -
, O +
they O +
extend O +
towards O +
the O +
midline O +
instead O +
of O +
the O +
ventral O +
horn O +
and O +
never O +
contact O +
the O +
motor O +
neuron O +
dendrites O -
. O +

( O -
C O -
) O +
High O -
- O -
power O +
image O +
of O +
the O +
inset O +
in O +
( O -
A O -
) O -
. O +

Arrows O +
point O +
to O +
the O +
proprioceptive O +
fibers O +
contacting O +
motor O +
neurons O +
( O -
asterisk O -
) O -
. O +

( O -
D O -
) O +
High O -
- O -
power O +
image O +
of O +
the O +
inset O +
in O +
( O -
B O -
) O -
. O +

Notice O +
that O +
there O +
are O +
no O +
sensory O +
axons O +
contacting O +
labeled O +
motor O +
neurons O +
( O -
asterisk O -
) O -
. O +

Scale O +
bar O -
: O +
100 O +
μm O +
( O -
A O +
and O +
B O -
) O -
, O +
50 O +
μm O +
( O -
C O +
and O +
D O -
) O -
. O +

( O -
24 O +
MB O +
TIF O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S2 O +
S46 O -
/ O -
NF O -
- O -
M O +
Immunohistochemistry O +
at O +
E15 O +
Gastrocnemius O +
Muscle O +
Although O +
numerous O +
muscle O +
and O +
nerve O +
fibers O +
were O +
labeled O -
, O +
no O +
muscle O +
spindles O +
could O +
be O +
identified O +
because O +
the O +
characteristic O +
morphology O +
of O +
sensory O +
nerve O +
ending O +
wrapped O +
around O +
muscle O +
bag O +
fiber O +
had O +
not O +
begun O +
to O +
develop O +
in O +
any O +
of O +
the O +
genotypes O +
yet O -
. O +

Scale O +
bar O -
: O +
25 O +
μm O -
. O +

( O -
13 O +
MB O +
TIF O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Acknowledgements O +
We O +
thank O +
L. O +
Tessarollo O +
for O +
providing O +
NT-3 O +
KO O +
animals O -
, O +
L. O +
Reichardt O +
for O +
TrkA O +
and O +
TrkC O +
antibodies O -
, O +
F. O +
Stockdale O +
for O +
the O +
S46 O +
antibody O -
, O +
K. O +
Muneoka O +
for O +
sepharose O +
beads O -
, O +
and O +
B. O +
King O +
for O +
maintenance O +
of O +
animals O +
used O +
in O +
this O +
study O -
. O +

We O +
particularly O +
thank O +
E. O +
Frank O +
for O +
many O +
helpful O +
comments O +
and O +
discussions O +
about O +
this O +
study O +
and O +
for O +
sharing O +
unpublished O +
data O +
from O +
his O +
laboratory O -
. O +

Supported O +
by O +
National O +
Institutes O +
of O +
Health O -
/ O -
National O +
Institute O +
of O +
Dental O +
and O +
Craniofacial O +
Research O +
grant O +
P01 O +
DE07734 O -
. O +

Abbreviations O +
BDNF O +
- O +
brain O -
- O -
derived O +
neurotrophic O +
factor O +
BSA O +
- O +
bovine O +
serum O +
albumin O +
DRG O +
- O +
dorsal O +
root O +
ganglion O +
E O +
- O +
embryonic O +
day O +
KO O +
- O +
knockout O +
NF O -
- O -
M O +
- O +
neurofilament O -
- O -
M O +
NT-3 O +
- O +
neurotrophin-3 O +
P O +
- O +
postnatal O +
day O +
PBS O +
- O +
phosphate O +
buffer O +
saline O +
PV O +
- O +
parvalbumin O +
TrkC O -
- O -
Fc O +
- O +
diffusible O +
TrkC O +
receptors O +
conjugated O +
to O +
IgG O +
constant O +
regions O +
WT O +
- O +
wild O -
- O -
type O +
Figures O +
and O +
Tables O +
Figure O +
1 O +
TrkA O -
/ O -
TrkC O +
and O +
PV O +
Immunohistochemistry O +
in O +
DRG O +
and O +
Spinal O +
Cord O +
Red O +
represents O +
TrkA O -
, O +
green O +
represents O +
TrkC O +
( O -
and O +
PV O +
in O +
[ O -
C O -
] O -
) O -
, O +
and O +
yellow O +
represents O +
co O -
- O -
expression O -
. O +

( O -
A O -
) O +
TrkA O -
/ O -
TrkC O +
immunostaining O +
in O +
E15 O +
DRG O -
. O +

TrkC O -
- O -
positive O +
neurons O +
normally O +
eliminated O +
in O +
NT-3 O +
KOs O +
are O +
rescued O +
in O +
double O +
KOs O -
. O +

( O -
B O -
) O +
TrkA O -
/ O -
TrkC O +
immunostaining O +
at O +
P0 O +
in O +
DRG O -
. O +

( O -
C O -
) O +
PV O +
immunostaining O +
in O +
P0 O +
DRG O -
. O +

Rescued O +
TrkC O -
- O -
positive O +
cells O +
fail O +
to O +
express O +
PV O -
. O +

( O -
D O -
) O +
Ratio O +
of O +
TrkA O -
- O -
immunopositive O +
cells O +
to O +
TrkC O -
- O -
immunopositive O +
cells O +
in O +
E15 O +
and O +
P0 O +
DRGs O -
. O +

Data O +
are O +
presented O +
as O +
percentage O +
of O +
cells O +
with O +
standard O +
deviation O -
. O +

Double O +
KOs O +
always O +
had O +
similar O +
ratios O +
to O +
Bax O +
KOs O -
, O +
and O +
NT-3 O +
KOs O +
had O +
the O +
least O +
amount O +
of O +
TrkC O -
- O -
positive O +
cells O -
, O +
if O +
any O -
. O +

( O -
E O -
) O +
TrkA O -
/ O -
TrkC O +
immunostaining O +
in O +
E15 O +
spinal O +
cord O -
. O +

Arrow O +
points O +
to O +
group O +
Ia O +
fibers O -
. O +

Dorsal O +
is O +
up O -
. O +

Scale O +
bar O -
: O +
50 O +
μm O +
( O -
A O -
– O -
C O -
) O -
, O +
1 O +
mm O +
( O -
E O -
) O -
. O +

Figure O +
2 O +
Axonal O +
Projections O +
in O +
the O +
Spinal O +
Cord O +
after O +
DiI B-Chemical +
Labeling O +
of O +
DRG O +
at O +
P0 O +
( O -
A O -
) O +
Rescued O +
DRG O +
proprioceptive O +
neurons O +
fail O +
to O +
properly O +
innervate O +
motor O +
neurons O +
in O +
double O +
KOs O -
. O +

Instead O -
, O +
some O +
axons O +
are O +
directed O +
towards O +
the O +
ventral O +
midline O -
; O +
they O +
cross O +
the O +
midline O +
and O +
branch O -
. O +

( O -
B O -
) O +
Schematic O +
drawing O +
of O +
the O +
monosynaptic O +
reflex O +
arc O +
as O +
it O +
normally O +
develops O -
. O +

Small O +
black O +
dots O +
represent O +
NT-3 O +
released O +
centrally O +
by O +
the O +
motor O +
neurons O +
and O +
peripherally O +
by O +
the O +
muscle O +
spindles O -
. O +

( O -
C O -
) O +
High O -
- O -
power O +
magnification O +
of O +
the O +
inset O +
in O +
( O -
A O -
) O -
. O +

Arrow O +
points O +
to O +
the O +
midline O -
, O +
and O +
arrowheads O +
point O +
to O +
synaptic O +
bouton O -
- O -
like O +
structures O -
. O +

Scale O +
bar O -
: O +
1 O +
mm O +
( O -
A O -
) O -
, O +
400 O +
μm O +
( O -
C O -
) O -
. O +

Figure O +
3 O +
Sensory O +
Axons O +
Labeled O +
with O +
DiI B-Chemical +
through O +
the O +
DRG O +
at O +
E17 O +
( O -
A O -
) O +
DiI B-Chemical -
- O -
labeled O +
fibers O +
in O +
WT O +
spinal O +
cord O -
. O +

Notice O +
proprioceptive O +
axons O +
extending O +
towards O +
the O +
motor O +
neurons O +
located O +
in O +
the O +
ventral O +
horn O +
of O +
the O +
spinal O +
cord O +
in O +
cross O +
section O -
. O +

( O -
B O -
) O +
Bax O +
null O +
spinal O +
cord O -
. O +

( O -
C O -
) O +
NT-3 O +
null O +
spinal O +
cord O -
. O +

Stained O +
fibers O +
are O +
restricted O +
to O +
the O +
nociceptive O +
axons O +
in O +
the O +
dorsal O +
horn O -
, O +
as O +
evidenced O +
by O +
the O +
complete O +
absence O +
of O +
labeling O +
in O +
the O +
ventral O +
spinal O +
cord O -
. O +

( O -
D O -
) O +
Bax O -
/ O -
NT-3 O +
double O +
null O +
spinal O +
cord O -
. O +

Although O +
fibers O +
extend O +
into O +
the O +
ventral O +
spinal O +
cord O -
, O +
they O +
never O +
grow O +
towards O +
the O +
motor O +
neurons O -
, O +
but O +
are O +
directed O +
towards O +
the O +
midline O +
instead O -
. O +

Scale O +
bar O -
: O +
100 O +
μm O -
. O +

Figure O +
4 O +
Muscle O +
Spindles O +
in O +
Gastrocnemius O +
Muscle O +
and O +
TrkA O -
/ O -
TrkC O +
Staining O +
in O +
the O +
Tibial O +
Nerve O +
at O +
P0 O +
( O -
A O -
) O +
NF O -
- O -
M O +
( O -
red O -
) O +
and O +
S46 O +
( O -
green O -
) O +
immunostaining O +
in O +
cross O +
section O +
of O +
gastrocnemius O +
muscle O +
at O +
P0 O -
. O +

There O +
are O +
no O +
muscle O +
spindles O +
detected O +
in O +
double O +
KOs O -
. O +

( O -
B O -
) O +
NF O -
- O -
M O +
( O -
red O -
) O +
and O +
S46 O +
( O -
green O -
) O +
immunostaining O +
in O +
parallel O +
sections O +
of O +
gastrocnemius O +
muscle O +
at O +
P0 O -
. O +

( O -
C O -
) O +
NF O -
- O -
M O +
( O -
red O -
) O +
and O +
S46 O +
( O -
green O -
) O +
immunostaining O +
in O +
parallel O +
sections O +
of O +
gastrocnemius O +
muscle O +
at O +
E17 O -
. O +

Double O +
null O +
muscles O +
are O +
mostly O +
devoid O +
of O +
muscle O +
spindles O -
, O +
except O +
for O +
one O +
spindle O -
- O -
like O +
structure O +
detected O +
( O -
shown O +
in O +
inset O -
, O +
denoted O +
by O +
the O +
asterisk O -
) O -
. O +

( O -
D O -
) O +
Muscle O +
spindles O +
detected O +
by O +
DiI B-Chemical +
labeling O +
through O +
the O +
DRG O -
. O +

Gastrocnemius O +
muscle O +
is O +
sectioned O +
at O +
40 O +
μm O +
thickness O +
in O +
parallel O +
plane O +
to O +
the O +
muscle O +
fibers O -
. O +

( O -
E O -
) O +
Muscle O +
spindles O +
detected O +
by O +
TrkC O +
staining O +
in O +
cross O +
section O +
of O +
gastrocnemius O +
muscle O +
at O +
P0 O -
. O +

( O -
F O -
) O +
TrkA O +
( O -
red O -
) O +
and O +
TrkC O +
( O -
green O -
) O +
immunostaining O +
in O +
the O +
tibial O +
nerve O +
cross O +
section O +
at O +
P0 O -
. O +

TrkC O -
- O -
positive O +
fibers O +
are O +
missing O +
in O +
NT-3 O +
KOs O -
. O +

Red O -
- O -
green O +
overlap O +
( O -
yellow O -
) O +
is O +
due O +
to O +
the O +
thickness O +
of O +
the O +
section O +
and O +
overlapping O +
of O +
red- O +
and O +
green O -
- O -
labeled O +
( O -
TrkA O +
and O +
TrkC O -
) O +
fibers O +
present O +
at O +
different O +
focal O +
depths O -
, O +
rather O +
than O +
co O -
- O -
localization O -
. O +

Arrows O +
indicate O +
muscle O +
spindles O -
. O +

Scale O +
bar O -
: O +
50 O +
μm O +
( O -
A O -
, O +
B O -
, O +
D O -
) O -
, O +
25 O +
μm O +
( O -
C O -
, O +
E O -
) O -
, O +
75 O +
μm O +
( O -
F O -
) O -
. O +

Figure O +
5 O +
Chemoattraction O +
of O +
E13 O +
DRG O +
Axons O +
to O +
Local O +
NT-3 O +
Observed O +
by O +
In O +
Vitro O +
Co O -
- O -
Culture O +
Assays O +
( O -
A O -
) O +
WT O +
DRG O +
with O +
NT-3-loaded O +
bead O -
. O +

( O -
B O -
) O +
WT O +
DRG O +
with O +
BSA O -
- O -
loaded O +
bead O -
. O +

( O -
C O -
) O +
Bax O +
null O +
DRG O +
with O +
NT-3-loaded O +
bead O -
. O +

( O -
D O -
) O +
p75 O +
null O +
DRG O +
with O +
NT-3-loaded O +
bead O -
. O +

( O -
E O -
) O +
WT O +
DRG O +
with O +
NT-3-loaded O +
bead O +
and O +
TrkC O -
- O -
Fc O +
in O +
the O +
medium O -
. O +

( O -
F O -
) O +
WT O +
DRG O +
with O +
NT-3 O +
loaded O +
beads O +
placed O +
at O +
increasing O +
distances O +
away O +
from O +
the O +
ganglia O +
( O -
range O -
, O +
500–1,200 O +
μm O -
) O -
. O +

Scale O +
bar O -
: O +
150 O +
μm O +
( O -
A O -
– O -
E O -
) O -
, O +
350 O +
μm O +
( O -
F O -
) O -
. O +

Figure O +
6 O +
Chemoattraction O +
Towards O +
NT-3 O +
Beads O +
Placed O +
in O +
E13 O +
Spinal O +
Cord O +
DRG O +
Explant O +
Co O -
- O -
Cultures O +
( O -
A O -
) O +
NT-3 O +
bead O +
placed O +
in O +
the O +
midline O +
of O +
E13 O +
WT O +
spinal O +
cord O -
. O +

Notice O +
axons O +
labeled O +
through O +
the O +
DRGs O +
( O -
circled O +
with O +
black O +
dashed O +
lines O -
) O +
growing O +
towards O +
the O +
bead O +
( O -
circled O +
with O +
white O +
dashed O +
lines O -
) O +
enter O +
the O +
spinal O +
cord O +
at O +
ectopic O +
loci O +
instead O +
of O +
dorsal O +
spinal O +
cord O -
. O +

( O -
B O -
) O +
PBS O -
- O -
loaded O +
bead O +
in O +
E13 O +
spinal O +
cord O -
. O +

All O +
labeled O +
axons O +
extend O +
along O +
the O +
dorsal O +
spinal O +
cord O -
, O +
where O +
they O +
terminate O -
. O +

( O -
C O -
) O +
High O -
- O -
power O +
image O +
of O +
the O +
bead O +
in O +
( O -
A O -
) O -
. O +

Notice O +
labeled O +
axons O +
surrounding O +
the O +
bead O -
. O +

( O -
D O -
) O +
High O -
- O -
power O +
image O +
of O +
an O +
NT-3-loaded O +
bead O -
. O +

Notice O +
axons O +
bundled O +
around O +
the O +
bead O -
. O +

( O -
E O -
) O +
High O -
- O -
power O +
image O +
of O +
an O +
NT-3-loaded O +
bead O -
. O +

Notice O +
the O +
axons O +
approaching O +
the O +
bead O +
via O +
the O +
dorsal O +
spinal O +
cord O -
. O +

( O -
F O -
) O +
High O -
- O -
power O +
image O +
of O +
a O +
PBS O -
- O -
loaded O +
bead O -
. O +

No O +
labeled O +
fibers O +
were O +
observed O +
around O +
control O +
beads O -
. O +

( O -
G O -
) O +
Summary O +
of O +
our O +
observations O +
from O +
E13 O +
spinal O +
cord O +
DRG O +
organotypic O +
cultures O -
. O +

In O +
control O +
cultures O +
fibers O +
extend O +
along O +
the O +
dorsal O +
spinal O +
cord O -
, O +
where O +
they O +
normally O +
enter O +
the O +
gray O +
matter O +
at O +
E13 O -
. O +

In O +
the O +
presence O +
of O +
an O +
ectopic O +
NT-3 O +
source O +
localized O +
at O +
the O +
midline O -
, O +
these O +
axons O +
grow O +
towards O +
the O +
NT-3 O +
bead O -
. O +

NT-3 O +
also O +
initiates O +
axon O +
growth O +
from O +
the O +
DRGs O -
, O +
entering O +
the O +
spinal O +
cord O +
at O +
ectopic O +
lateral O +
loci O -
, O +
growing O +
towards O +
the O +
bead O -
, O +
surrounding O +
the O +
bead O -
, O +
forming O +
nerve O +
bundles O -
, O +
and O +
branching O +
around O +
it O -
. O +

Scale O +
bar O -
, O +
175 O +
μm O +
( O -
A O +
and O +
B O -
) O -
, O +
100 O +
μm O +
( O -
C O -
– O -
F O -
) O -
. O +

Footnotes O +
Conflicts O +
of O +
interest O -
. O +

The O +
authors O +
have O +
declared O +
that O +
no O +
conflicts O +
of O +
interest O +
exist O -
. O +

Author O +
contributions O -
. O +

BG O +
and O +
RE O +
conceived O +
and O +
designed O +
the O +
experiments O -
. O +

BG O -
, O +
AEM O -
, O +
and O +
PHO O +
performed O +
the O +
experiments O -
. O +

BG O -
, O +
PHO O -
, O +
and O +
RE O +
analyzed O +
the O +
data O -
. O +

BG O +
and O +
RE O +
wrote O +
the O +
paper O -
. O +

Academic O +
Editor O -
: O +
Joshua O +
R. O +
Sanes O -
, O +
Harvard O +
University O +
¤Current O +
address O -
: O +
Massachusetts O +
General O +
Hospital O -
, O +
Harvard O +
Medical O +
School O +
Center O +
for O +
Nervous O +
System O +
Repair O -
, O +
Boston O -
, O +
Massachusetts O -
, O +
United O +
States O +
of O +
America O +
Citation O -
: O +
Genç O +
B O -
, O +
Özdinler O +
PH O -
, O +
Mendoza O +
AE O -
, O +
Erzurumlu O +
RS O +
( O -
2004 O -
) O +
A O +
chemoattractant O +
role O +
for O +
NT-3 O +
in O +
proprioceptive O +
axon O +
guidance O -
. O +

PLoS O +
Biol O +
2 O -
( O -
12 O -
) O -
: O +
e403 O -
. O +

Membrane O +
trafficking O +
and O +
mitochondrial O +
abnormalities O +
precede O +
subunit O +
c O +
deposition O +
in O +
a O +
cerebellar O +
cell O +
model O +
of O +
juvenile O +
neuronal O +
ceroid O +
lipofuscinosis O +
Abstract O +
Background O +
JNCL O +
is O +
a O +
recessively O +
inherited O -
, O +
childhood O -
- O -
onset O +
neurodegenerative O +
disease O +
most O -
- O -
commonly O +
caused O +
by O +
a O +
~1 O +
kb O +
CLN3 O +
mutation O -
. O +

The O +
resulting O +
loss O +
of O +
battenin O +
activity O +
leads O +
to O +
deposition O +
of O +
mitochondrial O +
ATP O +
synthase O -
, O +
subunit O +
c O +
and O +
a O +
specific O +
loss O +
of O +
CNS O +
neurons O -
. O +

We O +
previously O +
generated O +
Cln3Δex7 O -
/ O -
8 O +
knock O -
- O -
in O +
mice O -
, O +
which O +
replicate O +
the O +
common O +
JNCL O +
mutation O -
, O +
express O +
mutant O +
battenin O +
and O +
display O +
JNCL O -
- O -
like O +
pathology O -
. O +

Results O +
To O +
elucidate O +
the O +
consequences O +
of O +
the O +
common O +
JNCL O +
mutation O +
in O +
neuronal O +
cells O -
, O +
we O +
used O +
P4 O +
knock O -
- O -
in O +
mouse O +
cerebella O +
to O +
establish O +
conditionally O +
immortalized O +
CbCln3 O +
wild O -
- O -
type O -
, O +
heterozygous O -
, O +
and O +
homozygous O +
neuronal O +
precursor O +
cell O +
lines O -
, O +
which O +
can O +
be O +
differentiated O +
into O +
MAP-2 O +
and O +
NeuN O -
- O -
positive O -
, O +
neuron O -
- O -
like O +
cells O -
. O +

Homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
precursor O +
cells O +
express O +
low O +
levels O +
of O +
mutant O +
battenin O +
and O -
, O +
when O +
aged O +
at O +
confluency O -
, O +
accumulate O +
ATPase O +
subunit O +
c. O +
Recessive O +
phenotypes O +
are O +
also O +
observed O +
at O +
sub O -
- O -
confluent O +
growth O -
; O +
cathepsin O +
D O +
transport O +
and O +
processing O +
are O +
altered O -
, O +
although O +
enzyme O +
activity O +
is O +
not O +
significantly O +
affected O -
, O +
lysosomal O +
size O +
and O +
distribution O +
are O +
altered O -
, O +
and O +
endocytosis O +
is O +
reduced O -
. O +

In O +
addition O -
, O +
mitochondria O +
are O +
abnormally O +
elongated O -
, O +
cellular O +
ATP O +
levels O +
are O +
decreased O -
, O +
and O +
survival O +
following O +
oxidative O +
stress O +
is O +
reduced O -
. O +

Conclusions O +
These O +
findings O +
reveal O +
that O +
battenin O +
is O +
required O +
for O +
intracellular O +
membrane O +
trafficking O +
and O +
mitochondrial O +
function O -
. O +

Moreover O -
, O +
these O +
deficiencies O +
are O +
likely O +
to O +
be O +
early O +
events O +
in O +
the O +
JNCL O +
disease O +
process O +
and O +
may O +
particularly O +
impact O +
neuronal O +
survival O -
. O +

Background O +
Juvenile O +
neuronal O +
ceroid O +
lipofuscinosis O +
( O -
JNCL O -
) O -
, O +
or O +
Batten O +
disease O -
, O +
is O +
a O +
recessively O +
inherited O +
childhood O -
- O -
onset O +
neurodegenerative O +
disorder O +
characterized O +
by O +
progressive O +
blindness O -
, O +
seizures O -
, O +
motor O +
and O +
cognitive O +
decline O -
, O +
and O +
early O +
death O +
[ O -
1 O -
] O -
. O +

The O +
primary O +
genetic O +
defect O +
( O -
> O -
80 O -
% O +
disease O +
chromosomes O -
) O +
leading O +
to O +
JNCL O +
is O +
a O +
1.02 O +
kb O +
genomic O +
DNA O +
deletion O +
in O +
the O +
CLN3 O +
gene O -
, O +
which O +
eliminates O +
exons O +
7 O +
and O +
8 O +
and O +
surrounding O +
intronic O +
DNA O -
, O +
predicting O +
a O +
non O -
- O -
functional O +
protein O +
product O +
[ O -
2 O -
] O -
. O +

The O +
pathological O +
hallmark O +
of O +
JNCL O +
is O +
autofluorescent O +
ceroid O +
lipofuscin O +
deposits O +
within O +
autolysosomes O +
that O +
are O +
enriched O +
in O +
subunit O +
c O +
of O +
the O +
mitochondrial O +
ATP O +
synthase O +
complex O +
[ O -
3 O -
- O -
5 O -
] O -
. O +

Remarkably O -
, O +
these O +
deposits O +
are O +
not O +
only O +
found O +
in O +
CNS O +
neurons O +
but O +
are O +
also O +
abundant O +
in O +
non O -
- O -
neuronal O +
cells O +
outside O +
of O +
the O +
nervous O +
system O -
. O +

The O +
relationship O +
of O +
subunit O +
c O +
deposits O +
to O +
the O +
JNCL O +
disease O +
process O -
, O +
and O +
the O +
underlying O +
reason O +
for O +
the O +
neuronal O +
specificity O +
of O +
the O +
disease O +
remain O +
poorly O +
understood O -
. O +

The O +
CLN3-encoded O +
protein O +
( O -
battenin O -
, O +
also O +
called O +
CLN3 O +
or O +
cln3 O +
p O -
) O +
is O +
a O +
highly O +
conserved O -
, O +
ubiquitously O +
expressed O -
, O +
multi O -
- O -
pass O +
membrane O +
protein O +
[ O -
6 O -
] O +
that O +
localizes O +
to O +
the O +
lysosome O +
and O +
other O +
vesicular O +
compartments O +
[ O -
7 O -
- O -
9 O -
] O -
. O +

Battenin O +
function O +
remains O +
to O +
be O +
elucidated O -
, O +
although O +
studies O +
of O +
btn1 O -
, O +
the O +
yeast O +
CLN3 O +
ortholog O -
, O +
have O +
implicated O +
battenin O +
in O +
lysosomal O +
pH O +
homeostasis O +
and O +
amino O +
acid O +
transport O +
[ O -
10,11 O -
] O -
. O +

To O +
explore O +
JNCL O +
pathogenesis O +
and O +
battenin O +
function O -
, O +
we O +
previously O +
generated O +
a O +
genetically O +
precise O +
JNCL O +
mouse O +
model O -
. O +

Cln3Δex7 O -
/ O -
8 O +
knock O -
- O -
in O +
mice O +
harbor O +
the O +
~1 O +
kb O +
common O +
JNCL O +
mutation O +
and O +
express O +
a O +
non O -
- O -
truncated O +
mutant O +
battenin O +
isoform O +
that O +
is O +
detectable O +
with O +
antibodies O +
recognizing O +
C O -
- O -
terminal O +
epitopes O -
. O +

Homozygous O +
Cln3Δex7 O -
/ O -
8 O +
knock O -
- O -
in O +
mice O +
exhibit O +
a O +
progressive O +
JNCL O -
- O -
like O +
disease O -
, O +
with O +
perinatal O +
onset O +
of O +
subunit O +
c O +
deposition O +
in O +
many O +
cell O +
types O +
and O +
later O +
onset O +
of O +
neuronal O +
dysfunction O +
and O +
behavioral O +
deficits O +
[ O -
12 O -
] O -
. O +

These O +
findings O +
suggest O +
that O +
the O +
major O +
JNCL O +
defect O +
leads O +
to O +
abnormal O +
turnover O +
of O +
mitochondrial O +
subunit O +
c O -
, O +
in O +
a O +
manner O +
that O +
selectively O +
compromises O +
CNS O +
neurons O -
. O +

Currently O -
, O +
there O +
is O +
no O +
suitable O +
neuronal O +
cell O +
system O +
to O +
investigate O +
the O +
impact O +
of O +
the O +
common O +
JNCL O +
mutation O +
on O +
biological O +
processes O -
. O +

Therefore O -
, O +
we O +
have O +
established O +
cerebellar O +
neuronal O +
precursor O +
cell O +
lines O +
from O +
Cln3Δex7 O -
/ O -
8 O +
knock O -
- O -
in O +
mice O -
. O +

Homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
exhibit O +
pathological O +
hallmarks O +
of O +
the O +
disease O -
, O +
and O +
a O +
survey O +
of O +
membrane O +
organelles O +
revealed O +
membrane O +
trafficking O +
defects O +
and O +
mitochondrial O +
dysfunction O +
in O +
homozygous O +
mutant O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
. O +

Results O +
Generation O +
of O +
a O +
genetically O +
precise O +
cerebellar O +
JNCL O +
cell O +
model O +
To O +
generate O +
a O +
precise O +
genetic O -
, O +
neuron O -
- O -
derived O +
JNCL O +
cell O +
culture O +
system O -
, O +
we O +
immortalized O +
granule O +
neurons O +
cultured O +
from O +
postnatal O +
day O +
4 O +
( O -
P4 O -
) O +
cerebella O +
of O +
homozygous O +
and O +
heterozygous O +
Cln3Δex7 O -
/ O -
8 O +
knock O -
- O -
in O +
mice O -
, O +
and O +
wild O -
- O -
type O +
littermates O -
. O +

Primary O +
cell O +
cultures O +
enriched O +
for O +
granule O +
neurons O +
were O +
transduced O +
with O +
retroviral O +
vector O +
bearing O +
a O +
selection O +
cassette O +
and O +
temperature O -
- O -
sensitive O +
tsA58 O +
SV40 O +
large O +
T O +
antigen B-Chemical -
. O +

Growth O +
in O +
G418 B-Chemical +
containing O +
medium O +
at O +
the O +
permissive O +
temperature O +
( O -
33 O -
° O -
C O -
) O +
allowed O +
for O +
selection O +
and O +
isolation O +
of O +
multiple O +
clonal O +
nestin O -
- O -
positive O +
( O -
Fig. O +
1a O -
) O -
, O +
and O +
GFAP O -
- O -
negative O +
( O -
Fig. O +
1b O -
) O -
, O +
cell O +
lines O +
for O +
each O +
genotype O -
. O +

No O +
genotype O +
specific O +
differences O +
were O +
observed O +
in O +
cellular O +
morphology O +
or O +
doubling O +
time O +
( O -
~46 O +
hours O -
) O +
( O -
data O +
not O +
shown O -
) O -
. O +

As O +
expected O -
, O +
SV40 O +
large O +
T O +
antigen B-Chemical +
expression O +
was O +
rapidly O +
lost O +
and O +
cell O +
division O +
ceased O +
when O +
cells O +
were O +
shifted O +
to O +
the O +
non O -
- O -
permissive O +
temperature O +
( O -
39 O -
° O -
C O -
) O +
( O -
data O +
not O +
shown O -
) O -
. O +

Upon O +
addition O +
of O +
neuronal O +
differentiation O +
cocktail B-Chemical -
, O +
precursor O +
cells O +
became O +
neuron O -
- O -
like O +
in O +
morphology O +
and O +
exhibited O +
decreased O +
nestin O +
expression O +
( O -
data O +
not O +
shown O -
) O +
and O +
increased O +
MAP2 O +
and O +
NeuN O +
expression O +
( O -
Fig. O +
1c,1d O -
) O -
, O +
but O +
not O +
expression O +
of O +
the O +
Purkinje O +
marker O -
, O +
calbindin O +
( O -
Fig. O +
1e O -
) O -
. O +

Figure O +
1 O +
Neuronal O +
marker O +
expression O +
in O +
CbCln3+ O -
/ O -
+ O +
cells O +
Characterization O +
of O +
CbCln3+ O -
/ O -
+ O +
cells O +
by O +
immunofluorescence O +
with O +
marker O +
antibodies O +
is O +
shown O -
. O +

CbCln3+ O -
/ O -
+ O +
precursors O +
exhibit O +
nestin O +
expression O +
( O -
a O -
) O +
but O +
not O +
GFAP O +
expression O +
( O -
b O -
) O -
, O +
consistent O +
with O +
a O +
neuronal O +
precursor O +
identity O -
. O +

Upon O +
stimulation O +
with O +
a O +
differentiation O +
cocktail B-Chemical +
( O -
see O +
Methods O -
) O -
, O +
CbCln3+ O -
/ O -
+ O +
cells O +
achieved O +
neuron O -
- O -
like O +
morphology O -
, O +
with O +
rounded O +
cell O +
bodies O +
and O +
extension O +
of O +
processes O -
, O +
and O +
MAP2 O +
( O -
c O -
) O +
and O +
NeuN O +
( O -
d O -
) O +
expression O +
was O +
increased O -
. O +

CbCln3+ O -
/ O -
+ O +
cells O +
are O +
negative O +
for O +
the O +
Purkinje O +
neuron O +
marker O +
calbindin O +
( O -
e O -
) O -
. O +

CbCln3+ O -
/ O -
Δex7 O -
/ O -
8 O +
and O +
CbCln3Δex7 O -
/ O -
8 O -
/ O -
Δex7 O -
/ O -
8 O +
cell O +
lines O +
exhibited O +
identical O +
marker O +
immunofluorescence O +
results O -
. O +

a O -
, O +
b O -
) O +
20 O +
× O +
magnification O -
; O +
c O -
, O +
d O -
, O +
e O -
) O +
40 O +
× O +
magnification O -
. O +

Homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
express O +
mutant O +
battenin O +
and O +
display O +
JNCL O -
- O -
like O +
pathology O +
Homozygous O +
Cb O +
Cln3Δex7 O -
/ O -
8 O +
cells O +
were O +
first O +
examined O +
for O +
JNCL O -
- O -
like O +
characteristics O -
. O +

Homozygous O +
Cln3Δex7 O -
/ O -
8 O +
knock O -
- O -
in O +
mice O +
express O +
multiple O +
Cln3 O +
mRNA O +
splice O +
variants O +
and O +
mutant O +
battenin O +
protein O +
that O +
is O +
detectable O +
by O +
batp1 O +
antibody O +
recognizing O +
C O -
- O -
terminal O +
epitopes O +
[ O -
12 O -
] O -
. O +

To O +
assess O +
this O +
molecular O +
phenotype O +
in O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
, O +
RT O -
- O -
PCR O +
and O +
anti O -
- O -
battenin O +
( O -
batp1 O -
) O +
immunostaining O +
were O +
performed O -
. O +

As O +
shown O +
in O +
Figure O +
2 O -
, O +
Cln3 O +
mRNA O +
isoforms O +
in O +
wild O -
- O -
type O +
and O +
homozygous O +
cells O +
were O +
similar O +
to O +
those O +
observed O +
in O +
total O +
RNA O +
isolated O +
from O +
wild O -
- O -
type O +
or O +
homozygous O +
Cln3Δex7 O -
/ O -
8 O +
knock O -
- O -
in O +
brain O -
, O +
respectively O +
( O -
Fig. O +
2 O -
) O -
. O +

In O +
addition O -
, O +
batp1 O +
immunostaining O +
detected O +
mutant O +
battenin O +
product O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
, O +
in O +
a O +
similar O +
albeit O +
reduced O +
cytoplasmic O -
, O +
vesicular O +
staining O +
pattern O +
as O +
that O +
seen O +
in O +
wild O -
- O -
type O +
cells O -
. O +

Batp1 O +
signal O +
exhibited O +
some O +
overlap O +
with O +
the O +
lysosomal O +
marker O -
, O +
Lamp1 O -
, O +
but O +
had O +
more O +
significant O +
overlap O +
with O +
early O +
endosome O +
antigen B-Chemical +
1 O +
( O -
EEA1 O -
) O +
and O +
the O +
late O +
endosomal O +
marker O -
, O +
Rab7 O +
( O -
Fig. O +
3 O -
) O -
. O +

Only O +
limited O +
overlap O +
was O +
observed O +
with O +
recycling O +
endosomes O -
, O +
as O +
determined O +
by O +
transferrin O +
receptor O +
co O -
- O -
staining O +
( O -
data O +
not O +
shown O -
) O -
. O +

Intriguingly O -
, O +
Lamp1 O +
and O +
EEA1 O +
immunocytochemical O +
distribution O +
were O +
altered O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
, O +
with O +
less O +
perinuclear O +
clustering O +
than O +
in O +
wild O -
- O -
type O +
cells O -
, O +
and O +
Rab7 O +
staining O +
was O +
frequently O +
less O +
intense O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
( O -
Fig. O +
3 O -
) O -
. O +

Heterozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
contained O +
a O +
mixture B-Chemical +
of O +
Cln3 O +
mRNA O +
products O +
from O +
both O +
the O +
wild O -
- O -
type O +
allele O +
and O +
the O +
mutant O +
allele O -
, O +
and O +
batp1 O +
signal O +
was O +
similar O +
to O +
that O +
seen O +
in O +
wild O -
- O -
type O +
cells O +
( O -
data O +
not O +
shown O -
) O -
. O +

Figure O +
2 O +
RT O -
- O -
PCR O +
of O +
Cln3 O +
mRNA O +
in O +
wild O -
- O -
type O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
Cln3 O +
Exon1-forward O -
, O +
Exon O +
15-reverse O +
RT O -
- O -
PCR O +
products O +
are O +
shown O -
, O +
from O +
total O +
wild O -
- O -
type O +
( O -
+ O -
/+ O -
) O +
or O +
homozygous O +
mutant O +
( O -
Δex7 O -
/ O -
8 O -
/ O -
Δex7 O -
/ O -
8 O -
) O +
brain O +
and O +
cell O +
line O +
RNA O -
. O +

Brain O +
and O +
cell O +
line O +
RT O -
- O -
PCR O +
reaction O +
products O +
had O +
identical O +
band O +
patterns O +
on O +
ethidium B-Chemical -
- I-Chemical -
bromide I-Chemical +
stained O +
agarose B-Chemical +
gels O -
. O +

Wild O -
- O -
type O +
RT O -
- O -
PCR O +
product O +
was O +
a O +
single O +
~1.6 O +
kb O +
band O +
and O +
mutant O +
products O +
were O +
~1.6 O -
, O +
~1.5 O -
, O +
~1.4 O -
, O +
~1.35 O -
, O +
and O +
~1.3 O +
kb O -
, O +
representing O +
multiple O +
mutant O +
splice O +
variants O -
. O +

Figure O +
3 O +
Battenin O +
and O +
lysosomal O +
and O +
endosomal O +
marker O +
co O -
- O -
staining O +
in O +
wild O -
- O -
type O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cerebellar O +
precursor O +
cells O +
Batp1 O +
immunostaining O +
of O +
wild O -
- O -
type O +
( O -
CbCln3+ O -
/ O -
+ O -
) O +
and O +
homozygous O +
mutant O +
( O -
CbCln3Δex7 O -
/ O -
8 O -
/ O -
Δex7 O -
/ O -
8 O -
) O +
cerebellar O +
precursor O +
cells O +
is O +
shown O -
, O +
with O +
co O -
- O -
staining O +
for O +
lysosomes O +
( O -
Lamp O +
1 O -
) O -
, O +
early O +
endosomes O +
( O -
EEA1 O -
) O -
, O +
and O +
late O +
endosomes O +
( O -
Rab7 O -
) O -
. O +

Significant O +
overlap O +
of O +
Batp1 O +
signal O +
( O -
red O -
) O +
with O +
EEA1 O +
( O -
green O -
, O +
middle O +
panels O -
) O +
and O +
Rab7 O +
( O -
green O -
, O +
bottom O +
panels O -
) O +
can O +
be O +
seen O +
as O +
yellow O +
when O +
the O +
two O +
channels O +
are O +
merged O +
( O -
Merge O -
) O -
. O +

The O +
degree O +
of O +
Batp1 O +
overlap O +
is O +
greatest O +
with O +
Rab7 O -
. O +

Only O +
limited O +
overlap O +
between O +
Batp1 O +
( O -
red O -
) O +
and O +
Lamp O +
1 O +
( O -
green O -
, O +
top O +
panels O -
) O +
can O +
be O +
seen O -
. O +

Batp1 O +
signal O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
is O +
significantly O +
reduced O -
, O +
but O +
significant O +
overlap O +
with O +
EEA1 O +
and O +
Rab7 O -
, O +
and O +
very O +
little O +
Lamp O +
1 O +
overlap O -
, O +
can O +
be O +
seen O +
as O +
yellow O +
in O +
the O +
respective O +
merged O +
panels O -
. O +

Notably O -
, O +
Lamp O +
1 O +
and O +
EEA1 O +
localization O +
appear O +
altered O -
, O +
and O +
Rab7 O +
staining O +
was O +
frequently O +
less O +
intense O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
. O +

Wild O -
- O -
type O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
confocal O +
images O +
were O +
captured O +
with O +
identical O +
exposure O +
settings O -
. O +

60 O +
× O +
magnification O -
. O +

During O +
sub O -
- O -
confluent O +
growth O +
conditions O -
, O +
neither O +
wild O -
- O -
type O +
nor O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
displayed O +
autofluorescence O +
or O +
subunit O +
c O +
inclusion O +
formation O +
( O -
data O +
not O +
shown O -
) O -
. O +

However O -
, O +
when O +
cells O +
were O +
aged O +
at O +
confluency O +
( O -
3 O -
+ O +
days O +
post O -
- O -
confluency O -
) O -
, O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cellular O +
subunit O +
c O +
levels O +
were O +
elevated O +
beyond O +
normal O +
wild O -
- O -
type O +
levels O +
by O +
immunostaining O +
( O -
Fig. O +
4a O -
) O +
and O +
immunoblot O +
analysis O +
( O -
Fig. O +
4b O -
) O -
. O +

Autofluorescent O +
signal O +
sometimes O +
overlapped O +
with O +
subunit O +
c O +
signal O -
, O +
but O +
also O +
was O +
elevated O +
more O +
diffusely O +
( O -
Fig. O +
4a O -
) O -
. O +

Moreover O -
, O +
although O +
multilamellar O +
" O -
fingerprint O -
" O +
profiles O +
were O +
not O +
detected O -
, O +
confluency O -
- O -
aged O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
displayed O +
numerous O +
ultrastructural O +
abnormalities O +
including O +
electron B-Chemical +
dense O +
inclusions O +
characteristic O +
of O +
lipofuscin O +
and O +
large O +
autophagosomes O +
that O +
contained O +
dense O +
core O +
structures O -
, O +
degenerating O +
mitochondria O -
, O +
and O +
many O +
smaller O +
vesicles O +
( O -
Fig. O +
4c O -
) O -
. O +

Inclusion O +
bodies O +
and O +
autophagosomes O +
were O +
infrequently O +
observed O +
in O +
confluency O -
- O -
aged O +
wild O -
- O -
type O +
cultures O +
( O -
data O +
not O +
shown O -
) O -
. O +

Figure O +
4 O +
Subunit O +
c O +
accumulation O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cerebellar O +
precursor O +
cells O +
a. O +
Subunit O +
c O +
immunostaining O +
and O +
autofluorescence O +
of O +
7-day O +
confluency O -
- O -
aged O +
wild O -
- O -
type O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
is O +
shown O -
. O +

Wild O -
- O -
type O +
cultures O +
( O -
CbCln3+ O -
/ O -
+ O -
) O +
exhibited O +
limited O +
subunit O +
c O +
immunostaining O +
and O +
autofluorescence O -
. O +

However O -
, O +
CbCln3Δex7 O -
/ O -
8 O -
/ O -
Δex7 O -
/ O -
8 O +
cells O +
contained O +
numerous O +
subunit O +
c O +
puncta O -
. O +

Autofluorescence O +
( O -
7 O +
days O +
AF O -
) O +
was O +
also O +
significantly O +
elevated O +
( O -
right O +
panels O -
) O -
, O +
although O +
limited O +
overlap O +
with O +
subunit O +
c O +
puncta O +
was O +
observed O +
( O -
arrows O -
) O -
. O +

40 O +
× O +
magnification O -
. O +

b. O +
Immunoblot O +
analysis O +
of O +
subunit O +
c O +
protein O +
at O +
sub O -
- O -
confluency O +
or O +
7-day O +
confluency O +
incubation O +
is O +
shown O -
. O +

Total O +
protein O +
extracts O +
from O +
sub O -
- O -
confluency O +
wild O -
- O -
type O +
( O -
+ O -
/+ O -
) O +
and O +
homozygous O +
mutant O +
( O -
Δex7 O -
/ O -
8 O -
/ O -
Δex7 O -
/ O -
8 O -
) O +
cultures O +
contained O +
approximately O +
equal O +
levels O +
of O +
subunit O +
c O +
protein O +
( O -
α O -
- O -
sub O +
c O -
) O -
. O +

7-day O +
confluency O +
extract O +
from O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
( O -
Δex7 O -
/ O -
8 O -
/ O -
Δex7 O -
/ O -
8 O -
) O +
had O +
elevated O +
levels O +
of O +
subunit O +
c O +
protein O +
( O -
~1.5X O -
) O -
, O +
relative O +
to O +
wild O -
- O -
type O +
extract O +
( O -
+ O -
/+ O -
) O -
. O +

Protein O +
levels O +
were O +
normalized O +
to O +
cytochrome B-Chemical +
c I-Chemical +
oxidase O +
subunit O +
IV O +
( O -
α O -
- O -
cox4 O -
) O -
. O +

c. O +
TEM O +
analysis O +
of O +
inclusions O +
in O +
7-day O +
confluency O -
- O -
aged O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
is O +
shown O -
. O +

A O +
large O +
autophagosome O +
contained O +
by O +
double O +
membrane O +
( O -
arrows O -
) O +
is O +
filled O +
with O +
degenerating O +
mitochondria O +
( O -
Md O -
) O -
, O +
electron B-Chemical +
dense O +
cores O +
( O -
left O +
and O +
right O +
of O +
* O -
) O +
and O +
other O +
smaller O +
vesicular O +
structures O -
. O +

A O +
large O +
electron B-Chemical -
- O -
dense O +
inclusion O -
, O +
with O +
a O +
lipofuscin O +
( O -
Ln O -
) O +
appearance O -
, O +
is O +
also O +
present O -
. O +

M O -
, O +
mitochondria O -
. O +

10,000 O +
× O +
magnification O -
. O +

Homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
and O +
Cln3Δex7 O -
/ O -
8 O +
knock O -
- O -
in O +
mice O +
process O +
cathepsin O +
D O +
abnormally O +
We O +
next O +
investigated O +
the O +
basis O +
for O +
subunit O +
c O +
accumulation O -
, O +
testing O +
the O +
hypothesis O +
that O +
cathepsin O +
D O +
is O +
abnormal O +
since O +
it O +
is O +
required O +
for O +
ATP O +
synthase O +
subunit O +
c O +
degradation O +
in O +
the O +
lysosome O +
[ O -
13 O -
] O -
. O +

We O +
first O +
tested O +
cathepsin O +
D O +
transport O +
and O +
processing O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
and O +
Cln3Δex7 O -
/ O -
8 O +
mice O +
using O +
anti O -
- O -
cathepsin O +
D O +
antibody O +
that O +
recognizes O +
unprocessed O +
and O +
processed O +
cathepsin O +
D O +
isoforms O -
. O +

Immunostaining O +
of O +
wild O -
- O -
type O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
revealed O +
a O +
perinuclear O +
and O +
punctate O +
vesicular O +
cathepsin O +
D O +
distribution O -
, O +
consistent O +
with O +
its O +
transport O +
and O +
processing O +
through O +
the O +
secretory O +
pathway O +
and O +
delivery O +
to O +
the O +
lysosome O +
( O -
Fig. O +
5a O -
) O -
. O +

However O -
, O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
, O +
cathepsin O +
D O +
distribution O +
was O +
less O +
vesicular O +
and O +
more O +
perinuclear O -
- O -
clustered O +
than O +
in O +
wild O -
- O -
type O +
cells O -
. O +

Immunoblots O +
of O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cell O +
and O +
Cln3Δex7 O -
/ O -
8 O +
tissue O +
extracts O +
also O +
showed O +
altered O +
relative O +
levels O +
of O +
cathepsin O +
D O +
isoforms O +
( O -
Fig. O +
5b O -
) O -
. O +

Cathepsin O +
D O +
isoforms O -
, O +
identified O +
by O +
relative O +
molecular O +
weights O -
, O +
represent O +
the O +
~45 O +
kDa O +
precursor O -
, O +
the O +
~43 O +
kDa O +
intermediate O +
single O +
chain O +
form O +
of O +
the O +
enzyme O -
, O +
and O +
the O +
31 O +
kDa O +
heavy O +
chain O +
of O +
the O +
double O -
- O -
chain O +
form O +
of O +
the O +
mature O +
enzyme O +
[ O -
14 O -
] O -
. O +

In O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cell O +
and O +
Cln3Δex7 O -
/ O -
8 O +
tissue O +
extracts O -
, O +
the O +
precursor O +
and O +
heavy O +
chains O +
were O +
reduced O -
, O +
and O +
the O +
single O +
chain O +
was O +
slightly O +
elevated O +
compared O +
to O +
wild O -
- O -
type O +
extracts O -
. O +

The O +
cellular O +
growth O +
media O +
did O +
not O +
contain O +
altered O +
levels O +
of O +
cathepsin O +
D O -
, O +
indicating O +
enzyme O +
secretion O +
was O +
not O +
affected O -
. O +

Heterozygous O +
Cln3Δex7 O -
/ O -
8 O +
mice O +
and O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
were O +
indistinguishable O +
from O +
wild O -
- O -
type O -
, O +
as O +
expected O +
for O +
a O +
recessive O +
disease O +
phenotype O +
( O -
data O +
not O +
shown O -
) O -
. O +

Figure O +
5 O +
Cathepsin O +
D O +
localization O +
and O +
processing O +
in O +
wild O -
- O -
type O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
a. O +
Immunostaining O +
of O +
wild O -
- O -
type O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
precursor O +
cells O +
with O +
anti O -
- O -
cathepsin O +
D O +
antibody O -
, O +
recognizing O +
unprocessed O +
and O +
processed O +
forms O +
of O +
cathepsin O +
D O +
protein O +
is O +
shown O -
. O +

CbCln3+ O -
/ O -
+ O +
cells O +
( O -
left O +
panel O -
) O +
exhibited O +
a O +
perinuclear O +
and O +
cytoplasmic O +
punctate O +
signal O -
. O +

Cathepsin O +
D O +
signal O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
( O -
right O +
panel O -
) O +
was O +
more O +
often O +
perinuclear O -
, O +
with O +
less O +
cytoplasmic O +
punctate O +
signal O -
, O +
compared O +
to O +
wild O -
- O -
type O +
CbCln3+ O -
/ O -
+ O +
cells O -
. O +

40 O +
× O +
magnification O -
. O +

b. O +
α O -
- O -
Cathepsin O +
D O -
- O -
probed O +
immunoblots O +
of O +
total O +
wild O -
- O -
type O +
versus O +
homozygous O +
Cln3Δex7 O -
/ O -
8 O +
knock O -
- O -
in O +
tissue O +
or O +
CbCln3Δex7 O -
/ O -
8 O +
cellular O +
extracts O +
are O +
shown O -
. O +

The O +
~45 O +
kDa O +
cathepsin O +
D O +
band O -
, O +
representing O +
precursor O -
, O +
was O +
the O +
predominant O +
band O +
in O +
wild O -
- O -
type O +
( O -
wt O -
) O +
tissue O +
and O +
cellular O +
extracts O -
, O +
with O +
lower O +
levels O +
of O +
mature O +
enzyme O +
( O -
single O +
chain O -
, O +
~43 O +
kDa O -
, O +
and O +
heavy O +
chain O -
, O +
~31 O +
kDa O -
) O -
. O +

Conversely O -
, O +
homozygous O +
Cln3Δex7 O -
/ O -
8 O +
and O +
CbCln3Δex7 O -
/ O -
8 O +
mutant O +
( O -
m O -
) O +
extracts O +
exhibited O +
reduced O +
levels O +
of O +
precursor O +
and O +
heavy O +
chain O +
of O +
the O +
double O -
- O -
chain O +
form O +
of O +
the O +
enzyme O -
, O +
with O +
elevated O +
levels O +
of O +
single O -
- O -
chain O +
mature O +
enzyme O -
. O +

The O +
impact O +
of O +
the O +
altered O +
cathepsin O +
D O +
processing O +
on O +
enzymatic O +
activity O +
was O +
next O +
tested O +
to O +
determine O +
if O +
altered O +
enzymatic O +
activity O +
accounts O +
for O +
inefficient O +
subunit O +
c O +
turnover O -
. O +

In O +
a O +
fluorogenic B-Chemical +
in O +
vitro O +
assay O -
, O +
cathepsin O +
D O +
activity O +
in O +
total O +
cellular O +
extracts O +
was O +
not O +
significantly O +
altered O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
( O -
376 O +
± O +
89 O +
RFU O -
/ O -
μg O +
total O +
protein O -
) O -
, O +
versus O +
wild O -
- O -
type O +
cells O +
( O -
324 O +
± O +
58 O +
RFU O -
/ O -
μg O +
total O +
protein O -
) O -
, O +
although O +
a O +
consistent O +
trend O +
towards O +
increased O +
enzymatic O +
activity O +
in O +
mutant O +
cells O +
was O +
observed O -
. O +

Thus O -
, O +
cathepsin O +
D O +
transport O +
and O +
processing O +
are O +
disrupted O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
in O +
a O +
manner O +
such O +
that O +
enzymatic O +
activity O +
appears O +
to O +
be O +
relatively O +
unaffected O -
. O +

Homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
show O +
abnormal O +
membrane O +
organelles O +
The O +
abnormal O +
transport O +
and O +
processing O +
of O +
cathepsin O +
D O +
suggested O +
membrane O +
trafficking O +
disruptions O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
; O +
therefore O -
, O +
we O +
surveyed O +
the O +
subcellular O +
distribution O +
and O +
morphology O +
of O +
membrane O +
organelles O -
. O +

Components O +
of O +
the O +
secretory O +
pathway O -
, O +
including O +
the O +
ER O -
, O +
cis O -
- O -
Golgi O -
, O +
and O +
trans O -
- O -
Golgi O -
, O +
did O +
not O +
appear O +
altered O +
from O +
wild O -
- O -
type O +
appearance O +
when O +
labeled O +
with O +
the O +
respective O +
markers O -
, O +
protein B-Chemical +
disulfide I-Chemical +
isomerase O +
( O -
PDI O -
) O -
, O +
GM130 O -
, O +
and O +
VVL O +
( O -
data O +
not O +
shown O -
) O -
. O +

By O +
contrast O -
, O +
the O +
lysosomal O +
markers O -
, O +
Lysotracker O +
and O +
Lamp O +
2 O +
had O +
significantly O +
altered O +
signal O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
, O +
versus O +
wild O -
- O -
type O +
cells O -
. O +

Wild O -
- O -
type O +
cells O +
exhibited O +
brightly O +
stained O +
lysosomes O +
that O +
were O +
large O +
and O +
clustered O +
in O +
the O +
perinuclear O +
region O +
whereas O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
lysosomes O +
were O +
lightly O +
stained O -
, O +
smaller O +
vesicles O +
that O +
were O +
more O +
diffusely O +
scattered O +
in O +
the O +
cytoplasm O +
of O +
the O +
cell O +
( O -
Fig. O +
6 O -
) O -
. O +

Lamp O +
1 O +
distribution O +
was O +
also O +
altered O -
, O +
as O +
previously O +
noted O +
( O -
Fig. O +
3 O -
) O -
. O +

However O -
, O +
Lamp O +
1 O +
and O +
Lamp O +
2 O +
total O +
protein O +
levels O +
were O +
similar O +
in O +
wild O -
- O -
type O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
by O +
immunoblot O +
analysis O -
, O +
indicating O +
the O +
altered O +
signal O +
likely O +
reflects O +
dispersed O +
lysosomes O +
or O +
altered O +
localization O +
and/or O +
epitope O +
availability O +
( O -
data O +
not O +
shown O -
) O -
. O +

It O +
is O +
noteworthy O +
that O +
Lysotracker O +
dye B-Chemical -
, O +
which O +
selectively O +
accumulates O +
in O +
acidic B-Chemical +
compartments O -
, O +
exhibited O +
the O +
most O +
marked O +
reduction O +
in O +
lysosomal O +
labeling O -
. O +

This O +
observation O +
may O +
reflect O +
altered O +
lysosomal O +
pH O -
, O +
an O +
established O +
finding O +
in O +
JNCL O +
[ O -
10,15 O -
] O -
. O +

Figure O +
6 O +
Lysotracker O +
and O +
Lamp O +
2 O +
labeling O +
of O +
wild O -
- O -
type O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
lysosomes O +
Lysosomal O +
labeling O +
of O +
wild O -
- O -
type O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
precursor O +
cells O +
with O +
lysotracker O +
and O +
Lamp O +
2 O +
antibody O +
is O +
shown O -
. O +

Lysotracker O +
dye B-Chemical +
( O -
top O +
panels O -
) O +
labeled O +
large O -
, O +
perinuclear O -
- O -
clustered O +
lysosomes O +
and O +
scattered O +
lysosomes O +
in O +
the O +
periphery O +
of O +
wild O -
- O -
type O +
cells O +
( O -
CbCln3+ O -
/ O -
+ O -
) O -
. O +

Lysotracker O +
stain O +
was O +
dramatically O +
reduced O +
in O +
homozygous O +
mutant O +
cells O +
( O -
CbCln3Δex7 O -
/ O -
8 O -
/ O -
Δex7 O -
/ O -
8 O -
) O -
, O +
with O +
smaller O +
labeled O +
vesicles O +
and O +
less O +
apparent O +
perinuclear O +
clustering O -
. O +

Lamp O +
2 O +
( O -
bottom O +
panels O -
) O +
immunostaining O +
also O +
showed O +
reduced O +
signal O +
intensity O +
with O +
less O +
perinuclear O +
clustering O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
, O +
although O +
the O +
effect O +
was O +
somewhat O +
less O +
dramatic O +
than O +
that O +
observed O +
with O +
Lysotracker O +
dye B-Chemical -
. O +

Wild O -
- O -
type O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
confocal O +
images O +
were O +
captured O +
with O +
identical O +
exposure O +
settings O -
. O +

60 O +
× O +
magnification O -
. O +

Consistent O +
with O +
the O +
altered O +
early O +
endosome O +
marker O +
( O -
EEA1 O -
) O +
signal O +
observed O +
by O +
immunostaining O +
( O -
Fig. O +
3 O -
) O -
, O +
fluid O -
- O -
phase O +
endocytosis O +
was O +
also O +
altered O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
, O +
as O +
measured O +
by O +
dextran B-Chemical -
- O -
FITC B-Chemical +
uptake O +
( O -
Fig. O +
7 O -
) O -
. O +

Following O +
a O +
15-minute O +
incubation O +
in O +
media O +
containing O +
dextran B-Chemical -
- O -
FITC B-Chemical -
, O +
wild O -
- O -
type O +
and O +
heterozygote O +
cells O +
displayed O +
brightly O +
stained O -
, O +
large O +
endocytic O +
vesicles O +
that O +
were O +
clustered O +
in O +
the O +
perinuclear O +
region O -
. O +

However O -
, O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
were O +
less O +
brightly O +
stained O +
with O +
most O +
dextran B-Chemical -
- O -
FITC B-Chemical +
signal O +
localizing O +
to O +
smaller O +
vesicles O +
scattered O +
throughout O +
the O +
cytoplasm O +
of O +
the O +
cell O -
. O +

Figure O +
7 O +
Endocytosis O +
in O +
wild O -
- O -
type O -
, O +
heterozygous O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
Dextran B-Chemical -
- O -
FITC B-Chemical +
uptake O +
in O +
wild O -
- O -
type O -
, O +
heterozygous O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
precursor O +
cells O +
is O +
shown O -
. O +

In O +
wild O -
- O -
type O +
( O -
CbCln3+ O -
/ O -
+ O -
, O +
left O +
panel O -
) O +
and O +
heterozygous O +
( O -
CbCln3+ O -
/ O -
Δex7 O -
/ O -
8 O -
, O +
middle O +
panel O -
) O +
cells O -
, O +
dextran B-Chemical -
- O -
FITC B-Chemical +
label O +
was O +
observed O +
in O +
a O +
perinuclear O -
- O -
clustered O +
vesicular O +
pattern O +
with O +
scattered O +
labeled O +
vesicles O +
also O +
present O +
in O +
the O +
periphery O -
. O +

In O +
contrast O -
, O +
dextran B-Chemical -
- O -
FITC B-Chemical +
label O +
of O +
homozygous O +
mutant O +
( O -
CbCln3Δex7 O -
/ O -
8 O -
/ O -
Δex7 O -
/ O -
8 O -
, O +
right O +
panel O -
) O +
cells O +
was O +
reduced O +
overall O +
and O +
exhibited O +
smaller O +
stained O +
vesicles O +
with O +
less O +
perinuclear O +
clustering O -
. O +

Confocal O +
images O +
were O +
captured O +
with O +
identical O +
exposure O +
settings O -
. O +

40 O +
× O +
magnification O -
. O +

Finally O -
, O +
because O +
subunit O +
c O +
is O +
a O +
mitochondrial O +
protein O +
and O +
its O +
turnover O +
proceeds O +
through O +
autophagic O +
engulfment O +
of O +
mitochondria O +
[ O -
13 O -
] O -
, O +
we O +
analyzed O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cell O +
mitochondrial O +
morphology O +
and O +
function O -
. O +

Mitochondrial O +
distribution O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
was O +
indistinguishable O +
from O +
wild O -
- O -
type O +
and O +
heterozygous O +
cells O -
; O +
however O -
, O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
mitochondria O +
appeared O +
more O +
elongated O +
by O +
grp75 O +
marker O +
immunostaining O +
and O +
TEM O +
analysis O +
( O -
Fig. O +
8a O -
) O -
. O +

72 O -
% O +
of O +
homozygous O +
mutant O +
mitochondria O +
were O +
greater O +
than O +
0.6 O +
μm O +
in O +
length O +
( O -
range O +
= O +
0.26 O +
μm O +
to O +
2.75 O +
μm O -
) O -
, O +
while O +
fewer O +
wild O -
- O -
type O +
mitochondria O +
( O -
51 O -
% O -
) O +
reached O +
this O +
length O +
( O -
range O +
= O +
0.15 O +
μm O +
to O +
2.29 O +
μm O -
) O -
. O +

Mitochondrial O +
width O +
was O +
not O +
altered O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
( O -
data O +
not O +
shown O -
) O -
. O +

Moreover O -
, O +
compared O +
to O +
wild O -
- O -
type O +
or O +
heterozygous O +
cells O -
, O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
had O +
significantly O +
reduced O +
cellular O +
ATP O +
levels O +
( O -
1.3 O +
fold O +
less O -
, O +
Fig. O +
8b O -
) O +
and O +
exhibited O +
reduced O +
survival O +
following O +
hydrogen B-Chemical +
peroxide I-Chemical +
treatment O +
( O -
~50 O -
% O +
of O +
wild O -
- O -
type O +
survival O -
, O +
Fig. O +
8c O -
) O -
, O +
suggesting O +
impaired O +
energy O +
metabolism O +
and O +
oxidative O +
stress O +
response O -
. O +

Taken O +
together O -
, O +
these O +
data O +
support O +
impaired O +
mitochondrial O +
function O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
. O +

Figure O +
8 O +
Mitochondrial O +
morphology O +
and O +
function O +
in O +
wild O -
- O -
type O -
, O +
heterozygous O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
a. O +

Confocal O +
and O +
TEM O +
micrographs O +
of O +
wild O -
- O -
type O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
mitochondrial O +
morphology O +
are O +
shown O -
. O +

Immunostaining O +
with O +
the O +
inner O +
mitochondrial O +
membrane O +
marker O -
, O +
grp75 O +
( O -
top O +
panels O -
) O +
highlighted O +
elongated O +
mitochondria O +
in O +
homozygous O +
mutant O +
cells O +
( O -
CbCln3Δex7 O -
/ O -
8 O -
/ O -
Δex7 O -
/ O -
8 O -
) O -
, O +
relative O +
to O +
wild O -
- O -
type O +
mitochondria O +
( O -
CbCln3+ O -
/ O -
+ O -
) O +
( O -
insets O -
, O +
zoom O +
= O +
2.75x O -
) O -
. O +

Mitochondrial O +
distribution O +
was O +
not O +
altered O +
from O +
the O +
wild O -
- O -
type O +
pattern O -
. O +

Elongated O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
mitochondria O +
were O +
also O +
observed O +
by O +
TEM O +
analysis O -
. O +

60 O +
× O +
magnification O -
. O +

b. O +
Cellular O +
ATP O +
levels O +
in O +
wild O -
- O -
type O -
, O +
heterozygous O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
precursor O +
cells O +
are O +
shown O -
. O +

Wild O -
- O -
type O +
( O -
open O +
bar O -
) O +
and O +
heterozygous O +
( O -
gray O +
bar O -
) O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
contained O +
~39 O +
μM O +
ATP O -
, O +
while O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
( O -
black O +
bar O -
) O +
contained O +
~1.3 O +
fold O +
reduced O +
levels O +
of O +
ATP O +
( O -
~30 O +
μM O -
) O -
, O +
which O +
was O +
statistically O +
significant O +
in O +
a O +
t O -
- O -
test O +
( O -
p O +
< O +
0.0001 O -
) O -
. O +

Wild O -
- O -
type O +
and O +
heterozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cellular O +
ATP O +
levels O +
were O +
not O +
statistically O +
different O +
from O +
each O +
other O +
( O -
p O +
> O +
0.4 O -
) O -
. O +

A O +
representative O +
of O +
triplicate O +
experiments O +
is O +
shown O +
( O -
n O +
= O +
6 O +
in O +
each O +
experiment O -
) O -
. O +

c. O +
Cell O +
survival O +
following O +
24-hour O +
hydrogen B-Chemical +
peroxide I-Chemical +
treatment O +
is O +
shown O -
. O +

Homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
were O +
~2-fold O +
more O +
sensitive O +
to O +
oxidative O +
stress O +
by O +
hydrogen B-Chemical +
peroxide I-Chemical +
treatment O -
. O +

Wild O -
- O -
type O +
( O -
circle O -
) O +
and O +
heterozygous O +
( O -
triangle O -
) O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
exhibited O +
~50 O -
% O +
survival O +
rates O +
with O +
75–100 O +
μM O +
H2O2 B-Chemical -
, O +
whereas O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
( O -
squares O -
) O +
had O +
a O +
~50 O -
% O +
survival O +
rate O +
with O +
50 O +
μM O +
H2O2 B-Chemical -
. O +

A O +
representative O +
of O +
triplicate O +
experiments O +
is O +
shown O +
( O -
n O +
= O +
4 O +
in O +
each O +
experiment O -
) O -
. O +

Discussion O +
CbCln3Δex7 O -
/ O -
8 O +
cerebellar O +
precursor O +
cells O +
represent O +
the O +
first O +
genetically O +
accurate O +
neuron O -
- O -
derived O +
culture O +
model O +
of O +
JNCL O -
. O +

Homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
express O +
mutant O +
battenin O +
and O +
JNCL O -
- O -
hallmark O +
mitochondrial O +
ATPase O +
subunit O +
c O +
accumulation O -
, O +
upon O +
aging O +
of O +
cells O +
at O +
confluency O -
. O +

Moreover O -
, O +
this O +
is O +
the O +
first O +
study O +
to O +
indicate O +
recessive O +
endosomal O -
/ O -
lysosomal O +
membrane O +
trafficking O +
defects O +
and O +
mitochondrial O +
dysfunction O +
that O +
precedes O +
subunit O +
c O +
deposition O +
in O +
an O +
accurate O +
JNCL O +
model O -
. O +

Importantly O -
, O +
these O +
defects O +
are O +
likely O +
to O +
be O +
early O +
events O +
in O +
the O +
JNCL O +
disease O +
process O +
and O +
may O +
particularly O +
impact O +
neuronal O +
function O -
. O +

Abnormal O +
cathepsin O +
D O +
localization O +
and O +
processing O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
and O +
Cln3Δex7 O -
/ O -
8 O +
mice O +
likely O +
reflects O +
altered O +
vesicular O +
trafficking O +
and/or O +
lysosomal O +
pH O -
, O +
which O +
is O +
known O +
to O +
impact O +
cathepsin O +
D O +
processing O +
[ O -
14,16 O -
] O -
. O +

Indeed O -
, O +
CLN3 O +
overexpression O +
in O +
HEK-293 O +
cells O +
altered O +
lysosomal O +
pH O +
and O +
cathepsin O +
D O +
processing O +
[ O -
17 O -
] O -
, O +
and O +
lysosomal O +
pH O +
homeostasis O +
is O +
disrupted O +
in O +
JNCL O +
[ O -
10,15 O -
] O -
. O +

It O +
is O +
noteworthy O +
that O +
cathepsin O +
B O +
and O +
the O +
CLN2-encoded O +
enzyme O -
, O +
TPPI O -
, O +
are O +
also O +
altered O +
in O +
JNCL O +
[ O -
18 O -
- O -
20 O -
] O -
. O +

Nevertheless O -
, O +
despite O +
the O +
cathepsin O +
D O +
protein O +
alterations O +
that O +
are O +
observed O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
, O +
cathepsin O +
D O +
enzymatic O +
activity O +
does O +
not O +
appear O +
to O +
be O +
reduced O -
. O +

Thus O -
, O +
decreased O +
cathepsin O +
D O +
activity O +
is O +
unlikely O +
to O +
account O +
for O +
subunit O +
c O +
accumulation O +
in O +
JNCL O -
. O +

Aging O +
of O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
at O +
confluency O +
is O +
necessary O +
to O +
induce O +
significantly O +
accumulated O +
subunit O +
c O +
protein O -
. O +

However O -
, O +
membrane O +
organelle O +
disruptions O +
precede O +
subunit O +
c O +
accumulation O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O -
, O +
since O +
they O +
are O +
observed O +
without O +
aging O +
at O +
confluency O -
. O +

Lysosomal O +
and O +
endosomal O +
size O +
and O +
distribution O +
are O +
altered O -
, O +
and O +
mitochondria O +
are O +
abnormally O +
elongated O +
and O +
functionally O +
compromised O +
in O +
sub O -
- O -
confluent O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cultures O -
. O +

These O +
observations O +
argue O +
that O +
membrane O +
trafficking O +
defects O +
do O +
not O +
result O +
from O +
excessive O +
subunit O +
c O +
accumulation O +
compromising O +
the O +
lysosome O -
, O +
but O +
rather O +
are O +
early O +
events O +
in O +
the O +
disease O +
process O +
preceding O +
subunit O +
c O +
accumulation O -
. O +

Mitochondrial O +
abnormalities O -
, O +
which O +
have O +
also O +
been O +
reported O +
in O +
JNCL O +
patients O +
and O +
other O +
animal O +
models O +
[ O -
21 O -
- O -
23 O -
] O -
, O +
may O +
result O +
from O +
ineffective O +
turnover O +
by O +
autophagy O -
, O +
a O +
lysosomal O -
- O -
targeted O +
pathway O +
[ O -
24 O -
] O -
. O +

Alternatively O -
, O +
or O +
simultaneously O -
, O +
battenin O +
deficiency O +
may O +
impact O +
mitochondrial O +
function O +
upstream O +
of O +
turnover O -
, O +
affecting O +
mitochondrial O +
biogenesis O +
and/or O +
altered O +
transport O +
and O +
processing O +
of O +
mitochondrial O +
proteins O -
. O +

In O +
wild O -
- O -
type O +
CbCln3 O +
neuronal O +
precursor O +
cells O +
battenin O +
primarily O +
co O -
- O -
localizes O +
with O +
early O +
and O +
late O +
endosomes O -
. O +

Battenin O +
immunostaining O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
neuronal O +
precursors O +
is O +
significantly O +
reduced O +
in O +
abundance O -
, O +
but O +
mutant O +
signal O +
also O +
co O -
- O -
localizes O +
with O +
endosomal O +
markers O +
suggesting O +
mutant O +
battenin O +
protein O +
with O +
C O -
- O -
terminal O +
epitopes O +
is O +
trafficked O +
similar O +
to O +
wild O -
- O -
type O +
protein O -
. O +

In O +
other O +
studies O -
, O +
CLN3 O -
/ O -
battenin O +
protein O +
localization O +
has O +
been O +
reported O +
to O +
partially O +
overlap O +
with O +
late O +
endosomes O +
and O +
lysosomes O +
in O +
non O -
- O -
neuronal O +
cells O +
[ O -
7 O -
] O -
, O +
and O +
to O +
lysosomes O -
, O +
synaptosomes O +
[ O -
8 O -
] O +
and O +
endosomes O +
[ O -
9,25 O -
] O +
in O +
neurons O -
. O +

These O +
data O +
jointly O +
indicate O +
that O +
battenin O +
resides O +
in O +
a O +
subset O +
of O +
vesicular O +
compartments O +
linking O +
multiple O +
membrane O +
trafficking O +
pathways O -
, O +
perhaps O +
functioning O +
in O +
vesicular O +
transport O +
and/or O +
fusion O -
. O +

Endocytic O +
and O +
lysosomal O -
- O -
targeted O +
pathways O -
, O +
including O +
mitochondrial O +
autophagy O -
, O +
are O +
specifically O +
implicated O +
in O +
this O +
study O -
. O +

Conclusions O +
The O +
membrane O +
trafficking O +
and O +
mitochondrial O +
deficits O +
uncovered O +
in O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cells O +
are O +
likely O +
to O +
particularly O +
impact O +
neuronal O +
function O -
. O +

Neurotransmission O +
heavily O +
relies O +
on O +
membrane O +
vesicle O +
transport O -
, O +
and O +
a O +
high O -
- O -
energy O +
metabolism O +
may O +
further O +
sensitize O +
neurons O +
to O +
the O +
loss O +
of O +
battenin O +
activity O -
. O +

Thus O -
, O +
our O +
panel O +
of O +
wild O -
- O -
type O -
, O +
heterozygous O -
, O +
and O +
homozygous O +
CbCln3Δex7 O -
/ O -
8 O +
cerebellar O +
cells O +
provide O +
an O +
ideal O +
model O +
system O +
to O +
further O +
elucidate O +
battenin O +
function O +
and O +
JNCL O +
pathogenesis O -
. O +

Methods O +
Antibody O +
and O +
cell O +
staining O +
reagents B-Chemical +
Nestin O +
( O -
clone O +
Rat O +
401 O -
, O +
2 O +
μg O -
/ O -
ml O -
) O -
, O +
Lamp O +
1 O +
( O -
clone O +
1D4B O -
, O +
6 O +
μg O -
/ O -
ml O -
) O -
, O +
and O +
Lamp O +
2 O +
( O -
clone O +
Abl-93 O -
; O +
6 O +
μg O -
/ O -
ml O -
) O +
monoclonal O +
antibodies O +
were O +
obtained O +
from O +
the O +
Developmental O +
Studies O +
Hybridoma O +
Bank O -
, O +
maintained O +
by O +
The O +
University O +
of O +
Iowa O -
, O +
Department O +
of O +
Biological O +
Sciences O -
. O +

Batp1 O +
( O -
1 O +
μg O -
/ O -
ml O -
) O +
was O +
previously O +
described O +
[ O -
12 O -
] O -
. O +

Anti O -
- O -
subunit O +
c O +
antibody O +
( O -
0.7 O +
μg O -
/ O -
ml O -
) O +
was O +
kindly O +
provided O +
by O +
Dr. O +
Kominami O +
( O -
Juntendo O +
University O -
, O +
Tokyo O -
, O +
Japan O -
) O -
. O +

Additional O +
antibodies O +
were O +
as O +
follows O -
: O +
GFAP O -
, O +
1:2000 O +
( O -
DAKO O +
Corporation O -
) O -
; O +
calbindin O -
, O +
1:5000 O +
( O -
Sigma O -
) O -
; O +
NeuN O -
, O +
10 O +
μg O -
/ O -
ml O +
( O -
Chemicon O -
) O -
; O +
SV40 O +
T O +
antigen B-Chemical +
( O -
Pab O +
101 O -
) O -
, O +
2 O +
μg O -
/ O -
ml O +
( O -
Santa O +
Cruz O +
Biotechnology O -
) O -
; O +
cathepsin O +
D O +
( O -
C-20 O -
) O -
, O +
2 O +
μg O -
/ O -
ml O +
( O -
Santa O +
Cruz O +
Biotechnology O -
) O -
; O +
cytochrome B-Chemical +
c I-Chemical +
oxidase O +
subunit O +
IV O +
( O -
cox4 O -
) O -
, O +
1:1000 O +
( O -
BD O +
Biosciences O +
Clontech O -
) O -
; O +
PDI O +
( O -
H-160 O -
) O -
, O +
2 O +
μg O -
/ O -
ml O +
( O -
Santa O +
Cruz O +
Biotechnology O -
) O -
; O +
GM130 O -
, O +
1 O +
μg O -
/ O -
ml O +
( O -
BD O +
Transduction O +
Labs O -
) O -
; O +
α O -
- O -
tubulin O -
, O +
1:15,000 O +
( O -
Sigma O -
) O -
; O +
grp75 O -
, O +
1:200 O +
( O -
Stressgen O -
) O -
; O +
early O +
endosome O +
antigen-1 B-Chemical +
( O -
EEA1 O -
) O -
, O +
2 O +
μg O -
/ O -
ml O +
( O -
Santa O +
Cruz O +
Biotechnology O -
) O -
; O +
rab O +
7 O -
, O +
4 O +
μg O -
/ O -
ml O +
( O -
Santa O +
Cruz O +
Biotechnology O -
) O -
. O +

All O +
fluorescent O +
secondary O +
antibodies O +
were O +
obtained O +
from O +
Jackson O +
ImmunoResearch O +
Laboratories O +
and O +
HRP O -
- O -
conjugated O +
secondary O +
antibodies O +
were O +
obtained O +
from O +
Amersham O +
Biosciences O -
. O +

Additional O +
cell O +
markers O +
were O +
as O +
follows O -
: O +
VVL O -
- O -
biotin B-Chemical -
, O +
1:2000 O +
( O -
Vector O +
Laboratories O -
) O -
, O +
10,000 O +
MW O +
dextran B-Chemical -
- O -
FITC B-Chemical -
, O +
1 O +
mg O -
/ O -
ml O +
and O +
Lysotracker B-Chemical +
Red I-Chemical +
DND-99 I-Chemical -
, O +
500 O +
nM O +
( O -
Molecular O +
Probes O -
) O -
. O +

Generation O -
, O +
maintenance O +
and O +
differentiation O +
of O +
CbCln3 O +
cerebellar O +
neuronal O +
precursor O +
lines O +
Cln3Δex7 O -
/ O -
8 O +
knock O -
- O -
in O +
mice O +
have O +
been O +
previously O +
described O +
[ O -
12 O -
] O -
. O +

Littermate O +
pups O +
from O +
heterozygote O +
crosses O +
were O +
used O +
for O +
primary O +
culture O +
establishment O -
, O +
by O +
previously O +
described O +
methods O +
that O +
yield O +
cerebellar O +
granule O +
neuron O -
- O -
enriched O +
cultures O +
[ O -
26 O -
] O -
. O +

Postnatal O +
day O +
4 O +
( O -
P4 O -
) O +
cerebella O +
were O +
dissected O +
in O +
Hank O -
's O +
Balanced O +
Salt O +
Solution O +
( O -
HBSS O -
, O +
Sigma O -
) O -
, O +
supplemented O +
with O +
35 O +
mM O +
glucose B-Chemical -
. O +

Tail O +
biopsies O +
were O +
also O +
collected O +
for O +
genomic O +
DNA O +
isolation O +
and O +
genotypic O +
analysis O -
. O +

Trypsin O -
/ O -
EDTA O +
( O -
10 O +
mg O -
/ O -
ml O -
, O +
Sigma O -
) O +
and O +
DNase O +
I O +
( O -
100 O +
μg O -
/ O -
ml O -
, O +
Sigma O -
) O -
, O +
suspended O +
in O +
HBSS O -
, O +
helped O +
dissociate O +
cerebella O +
for O +
primary O +
culture O +
plating O +
onto O +
0.01 O -
% O +
poly O -
- O -
ornithine O +
( O -
Sigma O -
) O +
coated O +
100 O +
mm O +
dishes O -
. O +

Primary O +
cultures O +
from O +
individual O +
cerebella O +
were O +
cultured O +
overnight O +
at O +
37 O -
° O -
C O -
, O +
5 O -
% O +
CO2 B-Chemical -
, O +
in O +
granule O +
neuron O +
growth O +
media O +
( O -
Dulbecco O -
's O +
Modified O +
Eagle O +
Medium O +
[ O -
DMEM O -
, O +
Gibco O +
BRL O +
# O -
11995 O -
- O -
065 O -
] O -
, O +
10 O -
% O +
fetal O +
bovine O +
serum O +
[ O -
Sigma O +
# O -
F-2442 O -
] O -
, O +
supplemented O +
with O +
24 O +
mM O +
KCl B-Chemical -
) O -
. O +

Infection O +
was O +
performed O +
the O +
following O +
day O +
with O +
defective O +
retrovirus O +
transducing O +
the O +
temperature O -
- O -
sensitive O +
tsA58 O -
/ O -
U19 O +
large O +
T O +
antigen B-Chemical +
and O +
a O +
selection O +
neomycin B-Chemical -
- O -
resistance O +
cassette O +
[ O -
27 O -
] O -
, O +
as O +
previously O +
described O +
[ O -
28 O -
] O -
. O +

Following O +
infection O -
, O +
cultures O +
were O +
shifted O +
to O +
the O +
tsA58 O -
/ O -
U19 O +
permissive O +
growth O +
temperature O +
of O +
33 O -
° O -
C O +
and O +
selection O +
was O +
in O +
the O +
same O +
growth O +
media O +
as O +
above O -
, O +
with O +
200 O +
μg O -
/ O -
ml O +
G418 B-Chemical -
. O +

Conditionally O +
immortalized O +
colonies O +
were O +
isolated O +
3–9 O +
weeks O +
post O -
- O -
infection O +
and O +
expanded O +
for O +
frozen O +
stocks O +
and O +
further O +
sub O -
- O -
clone O +
isolation O -
. O +

Multiple O +
clonal O +
lines O +
were O +
obtained O +
for O +
each O +
genotype O +
and O +
all O +
phenotypes O +
were O +
confirmed O +
in O +
at O +
least O +
2 O +
independent O +
CbCln3 O +
cell O +
lines O -
. O +

CbCln3 O +
cell O +
lines O +
were O +
maintained O +
on O +
0.01 O -
% O +
poly O -
- O -
ornithine O +
coated O +
dishes O +
at O +
30–90 O -
% O +
confluency O -
, O +
in O +
33 O -
° O -
C O +
and O +
5 O -
% O +
CO2 B-Chemical +
atmosphere O -
. O +

Passage O +
number O +
was O +
recorded O +
( O -
up O +
to O +
~20 O +
passages O -
) O -
, O +
but O +
had O +
no O +
apparent O +
impact O +
on O +
phenotype O -
. O +

Neuronal O +
differentiation O +
was O +
as O +
previously O +
described O +
[ O -
29 O -
] O +
with O +
the O +
following O +
cocktail B-Chemical -
: O +
10 O +
ng O -
/ O -
ml O +
α O -
- O -
FGF O -
, O +
250 O +
μM O +
IBMX B-Chemical -
, O +
200 O +
nM O +
TPA B-Chemical -
, O +
50 O +
μM O +
forskolin B-Chemical -
, O +
5 O +
μM O +
dopamine B-Chemical +
( O -
Sigma O -
) O -
. O +

Genotyping O +
and O +
RT O -
- O -
PCR O +
Genomic O +
DNA O +
was O +
extracted O +
from O +
tail O +
biopsies O +
and O +
cell O +
pellets O +
as O +
described O +
( O -
Cotman O +
et O +
al. O -
, O +
2002 O -
) O -
. O +

Cln3Δex7 O -
/ O -
8 O +
knock O -
- O -
in O +
allele O +
PCR O +
genotyping O +
was O +
with O +
wild O -
- O -
type O +
primers O -
, O +
WtF O +
( O -
5'-CAGCATCTCCTCAGGGCTA-3 O -
' O -
) O +
and O +
WtR O +
( O -
5'-CCAACATAGAAAGTAGGGTGTGC-3 O -
' O -
) O +
to O +
yield O +
a O +
~250 O +
bp O +
band O +
and O +
knock O -
- O -
in O +
primers O -
, O +
552F O +
( O -
5'-GAGCTTTGTTCTGGTTGCCTTC-3 O -
' O -
) O +
and O +
Ex9RA O +
( O -
5'-GCAGTCTCTGCCTCGTTTTCT-3 O -
' O -
) O +
to O +
yield O +
a O +
~500 O +
bp O +
band O -
. O +

PCR O +
cycling O +
conditions O +
were O +
95 O -
° O -
C O +
for O +
30 O +
seconds O -
, O +
58 O -
° O -
C O +
for O +
30 O +
seconds O -
, O +
and O +
72 O -
° O -
C O +
for O +
35 O +
seconds O -
, O +
repeated O +
for O +
34 O +
cycles O -
. O +

Total O +
RNA O +
isolation O +
and O +
Cln3 O +
RT O -
- O -
PCR O +
primers O +
and O +
procedures O +
have O +
been O +
previously O +
described O +
[ O -
12 O -
] O -
. O +

Subunit O +
c O +
accumulation O +
assay O +
Cells O +
were O +
seeded O +
into O +
4-well O +
chamber O -
- O -
slides O +
( O -
Falcon O -
) O +
at O +
a O +
density O +
of O +
5 O +
× O +
104 O +
cells O +
per O +
well O +
for O +
microscopy O +
studies O -
, O +
or O +
into O +
100 O +
mm O +
dishes O +
( O -
Falcon O -
) O +
at O +
a O +
density O +
of O +
5 O +
× O +
105 O +
cells O +
per O +
dish O +
for O +
protein O +
extraction O -
. O +

Cells O +
were O +
typically O +
> O -
95 O -
% O +
confluent O +
one O +
day O +
post O -
- O -
plating O -
, O +
and O +
the O +
following O +
day O +
was O +
considered O +
1-day O +
post O -
- O -
confluency O -
. O +

At O +
the O +
indicated O +
times O -
, O +
cells O +
were O +
either O +
fixed O +
with O +
4 O -
% O +
formaldehyde B-Chemical +
in O +
phosphate O +
buffered O +
saline O +
( O -
PBS O -
) O -
, O +
pH O +
7.4 O -
, O +
for O +
20 O +
minutes O +
and O +
processed O +
for O +
autofluorescence O -
/ O -
subunit O +
c O +
immunostaining O -
, O +
or O +
cell O +
pellets O +
were O +
collected O +
for O +
total O +
protein O +
extraction O -
. O +

Alternatively O -
, O +
cells O +
were O +
fixed O +
with O +
2.5 O -
% O +
glutaraldehyde B-Chemical -
/ O -
2 O -
% O +
paraformaldehyde O +
in O +
0.1 O +
M O +
cacodylate B-Chemical +
buffer O -
, O +
pH O +
7.4 O +
for O +
1 O +
hour O +
and O +
subsequently O +
post O -
- O -
fixed O +
and O +
processed O +
for O +
TEM O +
analysis O +
as O +
described O +
[ O -
12 O -
] O -
. O +

In O +
confocal O +
microscopy O +
studies O -
, O +
autofluorescent O +
signal O +
was O +
observed O +
over O +
multiple O +
wavelengths O -
. O +

For O +
co O -
- O -
staining O -
, O +
settings O +
were O +
reduced O +
such O +
that O +
autofluorescent O +
signal O +
did O +
not O +
contribute O +
to O +
antibody O +
label O +
signal O -
. O +

Immunostaining O +
and O +
Immunoblot O +
analysis O +
For O +
immunostaining O -
, O +
cells O +
were O +
seeded O +
at O +
a O +
density O +
of O +
3–5 O +
× O +
104 O +
cells O +
per O +
well O +
in O +
4-well O +
chamber O -
- O -
slides O +
and O +
grown O +
overnight O +
at O +
33 O -
° O -
C O -
, O +
unless O +
indicated O +
otherwise O -
. O +

Fixation O +
was O +
with O +
ice O -
- O -
cold O +
4 O -
% O +
formaldehyde B-Chemical +
in O +
PBS O -
, O +
pH O +
7.4 O -
, O +
for O +
20 O +
minutes O -
, O +
or O +
with O +
ice O -
- O -
cold O +
methanol B-Chemical -
/ O -
acetone B-Chemical +
( O -
1:1 O -
) O +
for O +
10 O +
minutes O +
at O +
-20 O -
° O -
C O +
followed O +
by O +
air O -
- O -
drying O +
( O -
antibody O -
- O -
dependent O -
) O -
. O +

Cells O +
were O +
washed O +
with O +
PBS O +
at O +
least O +
2 O +
times O -
, O +
5 O +
minutes O +
per O +
wash O -
, O +
between O +
each O +
of O +
the O +
following O +
steps O +
of O +
the O +
staining O +
procedure O -
: O +
0.1 O +
M O +
glycine O +
in O +
PBS O +
for O +
5 O +
minutes O -
, O +
0.05 O -
% O +
or O +
0.1 O -
% O +
( O -
antibody O -
- O -
dependent O -
) O +
Triton B-Chemical +
X-100 I-Chemical +
( O -
Fisher O +
Scientific O -
) O +
in O +
PBS O +
for O +
5 O +
minutes O -
, O +
2 O -
% O +
bovine O +
serum O +
albumin O +
( O -
BSA O -
) O +
in O +
PBS O +
for O +
30 O +
minutes O -
, O +
primary O +
antibody O +
diluted O +
in O +
2 O -
% O +
BSA O -
/ O -
PBS O +
for O +
90 O +
minutes O -
, O +
secondary O +
antibody O +
diluted O +
in O +
2 O -
% O +
BSA O -
/ O -
PBS O +
for O +
60 O +
minutes O -
. O +

All O +
incubations O +
were O +
carried O +
out O +
at O +
room O +
temperature O -
. O +

Following O +
staining O +
procedures O -
, O +
slides O +
were O +
coverslipped O +
with O +
Vectashield O +
mounting O +
medium O +
( O -
Vector O +
Laboratories O -
) O +
and O +
analyzed O +
on O +
a O +
BioRad O +
Radiance O +
2100 O +
confocal O +
microscope O +
( O -
Biorad O -
) O -
, O +
with O +
identical O +
exposure O +
settings O +
for O +
wild O -
- O -
type O +
and O +
mutant O +
like O +
images O -
. O +

All O +
comparisons O +
of O +
wild O -
- O -
type O +
and O +
mutant O +
staining O +
were O +
performed O +
in O +
Adobe O +
Photoshop O +
with O +
identical O +
brightness O +
and O +
contrast O +
adjustments O -
. O +

Total O +
proteins O +
were O +
isolated O +
from O +
cell O +
pellets O +
by O +
extraction O +
with O +
ice O -
- O -
cold O +
20 O +
mM O +
Tris B-Chemical -
, O +
pH O +
7.4 O -
, O +
1 O -
% O +
Triton B-Chemical +
X-100 I-Chemical +
( O -
membrane O -
- O -
research O +
grade O -
, O +
Roche O -
) O -
, O +
plus O +
protease O +
inhibitors O +
( O -
Complete O +
mini O +
tablet O -
, O +
0.7 O +
μg O -
/ O -
ml O +
pepstatin B-Chemical +
A I-Chemical -
, O +
2 O +
μg O -
/ O -
ml O +
aprotinin O -
, O +
5 O +
μg O -
/ O -
ml O +
leupeptin B-Chemical +
[ O -
Roche O -
] O -
) O -
. O +

Following O +
homogenization O +
through O +
a O +
25-gauge O +
needle O +
( O -
~10 O +
passes O -
) O -
, O +
extracts O +
were O +
centrifuged O +
at O +
1000 O +
× O +
g O +
for O +
10 O +
minutes O -
, O +
at O +
4 O -
° O -
C O -
, O +
to O +
remove O +
debris O -
. O +

Typically O -
, O +
20–40 O +
μg O +
of O +
protein O +
( O -
determined O +
by O +
Bio O -
- O -
rad O +
Dc O +
Protein O +
Assay O -
) O +
was O +
separated O +
by O +
SDS B-Chemical -
- O -
PAGE O -
, O +
for O +
subsequent O +
immunoblotting O -
, O +
as O +
described O +
[ O -
12 O -
] O -
. O +

16.5 O -
% O +
tris B-Chemical -
- O -
tricine B-Chemical +
SDS B-Chemical -
- O -
PAGE O +
gels O +
were O +
used O +
for O +
subunit O +
c O +
immunoblotting O +
experiments O -
. O +

Cathepsin O +
D O +
activity O +
assay O +
100 O +
mm O +
tissue O +
culture O +
dishes O -
, O +
which O +
were O +
approximately O +
80–90 O -
% O +
confluent O -
, O +
were O +
washed O +
briefly O +
with O +
ice O -
- O -
cold O +
PBS O -
, O +
and O +
total O +
protein O +
extracts O +
were O +
isolated O +
by O +
scraping O +
cells O +
into O +
10 O +
mM O +
Tris B-Chemical -
, O +
pH O +
7.4 O -
, O +
0.1 O -
% O +
Triton B-Chemical +
X-100 I-Chemical +
followed O +
by O +
incubation O +
on O +
ice O -
, O +
for O +
20 O +
minutes O -
. O +

The O +
insoluble O +
material O +
was O +
centrifuged O +
at O +
14,000 O +
g O -
, O +
the O +
supernatant O +
was O +
isolated O -
, O +
and O +
protein O +
concentration O +
was O +
determined O +
using O +
the O +
Bio O -
- O -
rad O +
Dc O +
Protein O +
Assay O -
. O +

50–70 O +
μg O +
of O +
total O +
protein O +
extract O +
were O +
used O +
to O +
measure O +
cathepsin O +
D O +
activity O +
using O +
the O +
Fluorogenic B-Chemical +
Innozyme O -
™ O +
Cathepsin O +
D O +
Immunocapture O +
Activity O +
Assay O +
Kit O +
( O -
EMD O +
Biosciences O -
) O +
according O +
to O +
the O +
manufacturer O -
's O +
recommendations O -
. O +

Relative O +
fluorescence O +
was O +
measured O +
using O +
an O +
Analyst O +
AD O +
plate O +
reader O +
( O -
Molecular O +
Devices O -
) O +
with O +
the O +
following O +
filters O +
and O +
settings O -
: O +
excitation O +
filter O -
, O +
360 O -
- O -
35 O -
; O +
emission O +
filter O -
, O +
400 O -
- O -
20 O -
, O +
Flash O +
lamp O +
with O +
100 O +
readings O -
/ O -
well O -
, O +
100 O +
ms O +
between O +
readings O -
, O +
and O +
100,000 O +
μs O +
integration O +
time O -
. O +

Lysosomal O +
staining O +
and O +
endocytic O +
uptake O +
Cells O +
were O +
seeded O +
at O +
a O +
density O +
of O +
3–5 O +
× O +
104 O +
cells O +
per O +
well O +
in O +
4-well O +
chamber O -
- O -
slides O +
and O +
grown O +
overnight O +
at O +
33 O -
° O -
C O -
. O +

Growth O +
media O +
was O +
exchanged O +
for O +
fresh O -
, O +
pre O -
- O -
warmed O +
growth O +
media O +
containing O +
500 O +
nM O +
Lysotracker O +
or O +
1 O +
mg O -
/ O -
ml O +
dextran B-Chemical -
- O -
FITC B-Chemical -
, O +
and O +
cells O +
were O +
incubated O +
at O +
33 O -
° O -
C O +
for O +
45 O +
minutes O +
or O +
15 O +
minutes O -
, O +
respectively O -
. O +

Following O +
labeling O -
, O +
cells O +
were O +
immediately O +
placed O +
on O +
ice O +
and O +
washed O +
for O +
10 O +
minutes O +
in O +
ice O -
- O -
cold O +
dye B-Chemical -
- O -
free O +
media O -
, O +
and O +
fixed O +
with O +
4 O -
% O +
formaldehyde B-Chemical +
in O +
PBS O -
, O +
for O +
20 O +
minutes O +
on O +
ice O -
. O +

Chambers O +
were O +
removed O +
and O +
slides O +
were O +
coverslipped O +
with O +
Vectashield O +
mounting O +
media O +
for O +
confocal O +
microscopy O +
analysis O -
, O +
as O +
described O +
above O -
. O +

Morphometric O +
analysis O +
of O +
mitochondria O +
TEM O +
photomicrographs O +
( O -
10,000 O +
× O +
– O +
40,000 O +
× O +
magnification O -
) O +
were O +
taken O +
from O +
random O +
grid O +
fields O -
. O +

For O +
length O +
measurements O -
, O +
the O +
longest O +
side O +
of O +
each O +
mitochondria O +
was O +
measured O +
in O +
centimeters O -
, O +
and O +
along O +
the O +
length O +
of O +
the O +
mitochondria O -
, O +
width O +
measurements O +
were O +
taken O +
every O +
2.5–4 O +
mm O +
( O -
dependent O +
on O +
the O +
magnification O +
of O +
the O +
micrograph O +
image O -
) O -
. O +

Following O +
measurement O -
, O +
all O +
numbers O +
were O +
normalized O +
to O +
reflect O +
one O +
magnification O +
and O +
data O +
was O +
analyzed O +
using O +
Microsoft O +
Excel O +
software O -
. O +

To O +
ascertain O +
unmagnified O +
mitochondrial O +
size O -
, O +
final O +
measurement O +
data O -
, O +
in O +
centimeters O -
, O +
was O +
converted O +
to O +
nanometers O +
according O +
to O +
scale O +
bar O +
representation O -
. O +

ATP O +
measurement O +
ATP O +
was O +
measured O +
by O +
using O +
the O +
CellTiter O -
- O -
GLO O -
® O +
Luminescent O +
Cell O +
Viability O +
kit O +
( O -
Promega O -
) O -
, O +
according O +
to O +
the O +
manufacturer O -
's O +
recommendations O -
. O +

Briefly O -
, O +
cells O +
were O +
plated O +
in O +
a O +
black O +
opaque O -
- O -
walled O +
96 O +
well O +
plate O +
( O -
Packard O +
Bioscience O -
) O +
at O +
a O +
density O +
of O +
20000 O -
/ O -
well O +
and O +
incubated O +
at O +
33 O -
° O -
C O +
overnight O -
. O +

The O +
following O +
day O -
, O +
CellTiter O -
- O -
GLO O -
® O +
Reagent B-Chemical +
was O +
added O +
to O +
each O +
well O +
and O +
cell O +
lysis O +
was O +
induced O +
by O +
mixing O +
2 O +
minutes O -
. O +

An O +
ATP O +
standard O +
curve O +
was O +
prepared O +
in O +
the O +
same O +
plate O -
. O +

Before O +
recording O +
luminescence O +
with O +
a O +
microplate O +
luminometer O +
( O -
MicroLumat O +
Plus O +
LB O +
96V O -
, O +
Berthold O +
Techonologies O -
) O -
, O +
the O +
plate O +
was O +
dark O +
adapted O +
for O +
10 O +
minutes O +
at O +
room O +
temperature O +
to O +
stabilize O +
the O +
luminescence O +
signal O -
. O +

Hydrogen B-Chemical +
peroxide I-Chemical +
treatment O +
assay O +
Cells O +
were O +
plated O +
at O +
a O +
density O +
of O +
10,000 O +
cells O -
/ O -
well O +
in O +
96-well O +
plates O +
and O +
incubated O +
at O +
33 O -
° O -
C O +
overnight O -
. O +

The O +
following O +
day O -
, O +
fresh O +
media O +
containing O +
varying O +
concentrations O +
of O +
hydrogen B-Chemical +
peroxide I-Chemical +
was O +
dispersed O +
to O +
each O +
well O -
. O +

Cells O +
were O +
incubated O +
in O +
the O +
presence O +
of O +
hydrogen B-Chemical +
peroxide I-Chemical +
for O +
24 O +
hours O -
, O +
at O +
33 O -
° O -
C O -
, O +
and O +
viability O +
was O +
measured O +
using O +
the O +
CellTiter-96 O -
® O +
AQueous O +
Non O -
- O -
Radioactive O +
Cell O +
Proliferation O +
Assay O +
( O -
Promega O -
) O -
, O +
according O +
to O +
the O +
manufacturer O -
's O +
specifications O -
. O +

Authors O -
' O +
contributions O +
EF O +
participated O +
in O +
establishment O +
and O +
characterization O +
of O +
cell O +
lines O +
and O +
performed O +
ATP O +
determinations O -
. O +

PW O +
participated O +
in O +
mitochondrial O +
analysis O +
and O +
immunocytochemistry O -
. O +

JE O -
, O +
TL O -
- O -
N O -
, O +
AMT O -
, O +
and O +
HG O +
participated O +
in O +
genotypic O +
and O +
additional O +
phenotypic O +
analysis O +
of O +
cell O +
lines O -
. O +

DR O +
and O +
EC O +
generated O +
virus O -
- O -
conditioned O +
medium O +
for O +
conditional O +
immortalization O +
of O +
cells O -
. O +

MEM O +
co O -
- O -
conceived O +
of O +
the O +
study O +
and O +
assisted O +
on O +
drafting O +
of O +
the O +
manuscript O -
. O +

SLC O +
co O -
- O -
conceived O +
of O +
the O +
study O -
, O +
participated O +
in O +
establishment O +
and O +
phenotypic O +
analysis O +
of O +
cell O +
lines O -
, O +
and O +
drafted O +
the O +
manuscript O -
. O +

All O +
authors O +
read O +
and O +
approved O +
the O +
final O +
manuscript O -
. O +

Acknowledgements O +
The O +
authors O +
thank O +
Dr. O +
E. O +
Kominami O +
for O +
antibody O +
to O +
subunit O +
c O +
of O +
mitochondrial O +
ATPase O -
, O +
L. O +
Trakimas O +
and O +
M. O +
Ericsson O +
of O +
the O +
Harvard O +
Medical O +
School O +
Electron B-Chemical +
Microscope O +
Facility O -
, O +
Dr. O +
David O +
Sulzer O +
for O +
assistance O +
with O +
TEM O +
analysis O -
, O +
Dr. O +
Sylvie O +
Breton O +
for O +
assistance O +
with O +
endocytosis O +
experiments O -
, O +
and O +
Dr. O +
Andre O +
Bernards O +
and O +
James O +
Follen O +
for O +
assistance O +
with O +
the O +
cathepsin O +
D O +
activity O +
assay O -
. O +

This O +
work O +
was O +
supported O +
by O +
NIH O -
/ O -
NINDS O +
grant O +
# O +
NS O +
33648 O -
. O +

Dr. O +
S.L. O +
Cotman O +
received O +
fellowship O +
funding O +
from O +
the O +
Batten O +
Disease O +
Support O +
and O +
Research O +
Association O +
( O -
BDSRA O -
) O -
. O +

PGC-1α O +
Deficiency O +
Causes O +
Multi O -
- O -
System O +
Energy O +
Metabolic O +
Derangements O -
: O +

Muscle O +
Dysfunction O -
, O +
Abnormal O +
Weight O +
Control O +
and O +
Hepatic O +
Steatosis O +
Abstract O +
The O +
gene O +
encoding O +
the O +
transcriptional O +
coactivator O +
peroxisome O +
proliferator O -
- O -
activated O +
receptor O -
- O -
γ O +
coactivator-1α O +
( O -
PGC-1α O -
) O +
was O +
targeted O +
in O +
mice O -
. O +

PGC-1α O +
null O +
( O -
PGC-1α− O -
/ O -
− O -
) O +
mice O +
were O +
viable O -
. O +

However O -
, O +
extensive O +
phenotyping O +
revealed O +
multi O -
- O -
system O +
abnormalities O +
indicative O +
of O +
an O +
abnormal O +
energy O +
metabolic O +
phenotype O -
. O +

The O +
postnatal O +
growth O +
of O +
heart O +
and O +
slow O -
- O -
twitch O +
skeletal O +
muscle O -
, O +
organs O +
with O +
high O +
mitochondrial O +
energy O +
demands O -
, O +
is O +
blunted O +
in O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

With O +
age O -
, O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
develop O +
abnormally O +
increased O +
body O +
fat O -
, O +
a O +
phenotype O +
that O +
is O +
more O +
severe O +
in O +
females O -
. O +

Mitochondrial O +
number O +
and O +
respiratory O +
capacity O +
is O +
diminished O +
in O +
slow O -
- O -
twitch O +
skeletal O +
muscle O +
of O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
leading O +
to O +
reduced O +
muscle O +
performance O +
and O +
exercise O +
capacity O -
. O +

PGC-1α− O -
/ O -
− O +
mice O +
exhibit O +
a O +
modest O +
diminution O +
in O +
cardiac O +
function O +
related O +
largely O +
to O +
abnormal O +
control O +
of O +
heart O +
rate O -
. O +

The O +
PGC-1α− O -
/ O -
− O +
mice O +
were O +
unable O +
to O +
maintain O +
core O +
body O +
temperature O +
following O +
exposure O +
to O +
cold O -
, O +
consistent O +
with O +
an O +
altered O +
thermogenic O +
response O -
. O +

Following O +
short O -
- O -
term O +
starvation O -
, O +
PGC-1α− O -
/ O -
− O +
mice O +
develop O +
hepatic O +
steatosis O +
due O +
to O +
a O +
combination O +
of O +
reduced O +
mitochondrial O +
respiratory O +
capacity O +
and O +
an O +
increased O +
expression O +
of O +
lipogenic O +
genes O -
. O +

Surprisingly O -
, O +
PGC-1α− O -
/ O -
− O +
mice O +
were O +
less O +
susceptible O +
to O +
diet O -
- O -
induced O +
insulin O +
resistance O +
than O +
wild O -
- O -
type O +
controls O -
. O +

Lastly O -
, O +
vacuolar O +
lesions O +
were O +
detected O +
in O +
the O +
central O +
nervous O +
system O +
of O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

These O +
results O +
demonstrate O +
that O +
PGC-1α O +
is O +
necessary O +
for O +
appropriate O +
adaptation O +
to O +
the O +
metabolic O +
and O +
physiologic O +
stressors O +
of O +
postnatal O +
life O -
. O +

Introduction O +
Mitochondrial O +
functional O +
capacity O +
is O +
dynamically O +
regulated O +
to O +
meet O +
the O +
diverse O +
energy O +
demands O +
imposed O +
on O +
the O +
mammalian O +
organism O +
following O +
birth O -
. O +

Postnatal O +
mitochondrial O +
biogenesis O +
involves O +
multiple O +
signaling O +
and O +
transcriptional O +
regulatory O +
pathways O +
that O +
control O +
the O +
coordinate O +
expression O +
of O +
nuclear O +
and O +
mitochondrial O +
genes O +
involved O +
in O +
mitochondrial O +
structure O -
, O +
metabolism O -
, O +
and O +
proliferation O +
[ O -
1 O -
] O -
. O +

Recent O +
evidence O +
points O +
toward O +
a O +
transcriptional O +
coactivator O -
, O +
peroxisome O +
proliferator O -
- O -
activated O +
receptor O -
- O -
γ O +
( O -
PPARγ O -
) O +
coactivator-1α O +
( O -
PGC-1α O -
) O -
, O +
as O +
an O +
integrator O +
of O +
the O +
molecular O +
regulatory O +
circuitry O +
involved O +
in O +
the O +
transcriptional O +
control O +
of O +
cellular O +
energy O +
metabolism O -
, O +
including O +
mitochondrial O +
function O +
and O +
biogenesis O +
[ O -
1,2 O -
] O -
. O +

PGC-1α O +
was O +
discovered O +
in O +
a O +
yeast O +
two O -
- O -
hybrid O +
screen O +
for O +
brown O +
adipose O -
- O -
specific O +
factors O +
that O +
interact O +
with O +
the O +
adipogenic O +
nuclear O +
receptor O +
PPARγ O +
[ O -
2 O -
] O -
. O +

Subsequently O -
, O +
two O +
additional O +
PGC-1 O +
family O +
members O +
were O +
identified O -
, O +
PGC-1 O +
related O +
coactivator O +
( O -
PRC O -
) O +
[ O -
3 O -
] O +
and O +
PGC-1β O +
[ O -
4,5 O -
] O -
. O +

PGC-1α O +
serves O +
as O +
a O +
direct O +
transcriptional O +
coactivator O +
of O +
nuclear O +
and O +
nonnuclear O +
receptor O +
transcription O +
factors O +
involved O +
in O +
cellular O +
energy O +
metabolism O +
[ O -
6 O -
] O -
. O +

PGC-1α O +
is O +
distinct O +
among O +
most O +
coactivators O +
in O +
that O +
it O +
exhibits O +
a O +
tissue O -
- O -
enriched O +
expression O +
pattern O +
and O +
is O +
highly O +
inducible O +
by O +
physiologic O +
conditions O +
known O +
to O +
increase O +
the O +
demand O +
for O +
mitochondrial O +
ATP O +
or O +
heat O +
production O +
[ O -
2,6,7 O -
] O -
. O +

PGC-1α O +
is O +
enriched O +
in O +
brown O +
adipose O +
tissue O +
( O -
BAT O -
) O -
, O +
heart O -
, O +
slow O -
- O -
twitch O +
skeletal O +
muscle O -
, O +
and O +
kidney O -
— O -
all O +
tissues O +
with O +
high O -
- O -
capacity O +
mitochondrial O +
systems O -
. O +

The O +
expression O +
of O +
the O +
gene O +
encoding O +
PGC-1α O +
is O +
rapidly O +
induced O +
by O +
cold O +
exposure O -
, O +
short O -
- O -
term O +
exercise O -
, O +
and O +
fasting O +
[ O -
2,8,9,10,11,12,13,14,15 O -
] O -
. O +

These O +
latter O +
observations O +
suggest O +
that O +
PGC-1α O +
is O +
involved O +
in O +
the O +
physiologic O +
control O +
of O +
energy O +
metabolism O -
. O +

Several O +
lines O +
of O +
evidence O -
, O +
based O +
on O +
the O +
results O +
of O +
overexpression O +
studies O -
, O +
indicate O +
that O +
PGC-1α O +
is O +
sufficient O +
to O +
promote O +
mitochondrial O +
biogenesis O +
and O +
regulate O +
mitochondrial O +
respiratory O +
capacity O -
. O +

First O -
, O +
PGC-1α O +
activates O +
the O +
transcription O +
of O +
mitochondrial O +
uncoupling O +
protein-1 O +
( O -
UCP-1 O -
) O +
in O +
BAT O +
through O +
interactions O +
with O +
the O +
nuclear O +
hormone O +
receptors O +
PPARγ O +
and O +
thyroid O +
receptor O +
[ O -
2 O -
] O -
. O +

Second O -
, O +
forced O +
expression O +
studies O +
in O +
adipogenic O +
and O +
myogenic O +
mammalian O +
cell O +
lines O +
demonstrated O +
that O +
PGC-1α O +
activates O +
mitochondrial O +
biogenesis O +
through O +
a O +
group O +
of O +
transcription O +
factor O +
targets O +
including O +
nuclear O +
respiratory O +
factors O +
1 O +
and O +
2 O +
( O -
NRF-1 O +
and O +
-2 O -
) O +
and O +
mitochondrial O +
transcription O +
factor O +
A O +
( O -
Tfam O -
) O -
, O +
key O +
transcriptional O +
regulators O +
of O +
mitochondrial O +
DNA O +
transcription O +
and O +
replication O +
[ O -
8 O -
] O -
. O +

Third O -
, O +
studies O +
in O +
primary O +
cardiac O +
myocytes O +
in O +
culture O +
and O +
in O +
the O +
hearts O +
of O +
transgenic O +
mice O +
have O +
demonstrated O +
that O +
overexpression O +
of O +
PGC-1α O +
promotes O +
mitochondrial O +
biogenesis O +
[ O -
10,16 O -
] O -
. O +

Lastly O -
, O +
forced O +
expression O +
of O +
PGC-1α O +
in O +
skeletal O +
muscle O +
of O +
transgenic O +
mice O +
triggers O +
mitochondrial O +
proliferation O +
and O +
the O +
formation O +
of O +
mitochondrial O -
- O -
rich O +
type O +
I O -
, O +
oxidative O +
( O -
" O -
slow O -
- O -
twitch O -
" O -
) O +
muscle O +
fibers O +
[ O -
17 O -
] O -
. O +

Collectively O -
, O +
these O +
results O +
indicate O +
that O +
PGC-1α O +
is O +
sufficient O +
to O +
drive O +
mitochondrial O +
biogenesis O -
. O +

Recent O +
evidence O +
also O +
implicates O +
PGC-1α O +
in O +
the O +
homeostatic O +
control O +
of O +
systemic O +
energy O +
metabolism O -
. O +

PGC-1α O +
has O +
been O +
shown O +
to O +
regulate O +
several O +
key O +
hepatic O +
gluconeogenic O +
genes O +
[ O -
18,19,20,21 O -
] O -
. O +

Recent O +
studies O +
have O +
also O +
shown O +
altered O +
expression O +
of O +
PGC-1α O +
and O +
downstream O +
mitochondrial O +
target O +
pathways O +
in O +
skeletal O +
muscle O +
of O +
humans O +
with O +
insulin O +
resistance O +
and O +
diabetes O +
[ O -
22,23,24 O -
] O -
. O +

In O +
addition O -
, O +
single O +
nucleotide O +
polymorphisms O +
within O +
the O +
human O +
PGC-1α O +
gene O +
have O +
been O +
shown O +
to O +
be O +
associated O +
with O +
obesity O -
, O +
hypertension O -
, O +
and O +
diabetes O +
[ O -
25,26,27,28,29,30 O -
] O -
. O +

The O +
gain O -
- O -
of O -
- O -
function O +
studies O +
described O +
to O +
date O +
provide O +
compelling O +
evidence O +
that O +
PGC-1α O +
is O +
capable O +
of O +
regulating O +
postnatal O +
energy O +
metabolism O -
. O +

However O -
, O +
the O +
necessity O +
of O +
PGC-1α O +
for O +
energy O +
metabolic O +
homeostasis O -
, O +
mitochondrial O +
biogenesis O -
, O +
development O -
, O +
and O +
growth O +
can O +
only O +
be O +
addressed O +
using O +
loss O -
- O -
of O -
- O -
function O +
strategies O -
. O +

To O +
this O +
end O -
, O +
we O +
have O +
established O +
and O +
characterized O +
mice O +
with O +
targeted O +
deletion O +
of O +
the O +
PGC-1α O +
gene O -
. O +

Our O +
studies O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
demonstrate O +
that O +
PGC-1α O +
is O +
not O +
absolutely O +
required O +
for O +
prenatal O +
viability O +
including O +
mitochondrial O +
biogenesis O -
. O +

However O -
, O +
our O +
findings O +
indicate O +
that O +
the O +
coactivator O +
PGC-1α O +
serves O +
a O +
critical O +
role O +
in O +
the O +
normal O +
metabolic O +
function O +
of O +
multiple O +
organs O +
and O +
for O +
appropriate O +
adaptation O +
to O +
physiologic O +
stress O +
during O +
postnatal O +
life O -
. O +

Results O +
Disruption O +
of O +
the O +
PGC-1α O +
Gene O +
in O +
Mice O +
A O +
neomycin O -
- O -
based O +
gene O +
targeting O +
vector O +
was O +
generated O +
to O +
delete O +
exons O +
4 O +
and O +
5 O +
of O +
the O +
murine O +
PGC-1α O +
gene O -
. O +

The O +
targeting O +
event O +
resulted O +
in O +
a O +
3′ O +
homologous O +
recombination O +
with O +
insertion O +
of O +
the O +
remainder O +
of O +
the O +
construct O +
( O -
Figure O +
1A O -
) O -
. O +

The O +
insertion O -
/ O -
recombination O +
event O +
was O +
confirmed O +
by O +
Southern O +
blotting O +
and O +
DNA O +
sequencing O -
. O +

The O +
insertion O +
caused O +
an O +
exon O +
3 O +
duplication O +
between O +
exons O +
5 O +
and O +
6 O +
that O +
creates O +
a O +
coding O +
region O +
frameshift O +
resulting O +
in O +
a O +
premature O +
termination O +
at O +
amino O +
acid O +
255 O -
. O +

Germline O +
transmission O +
of O +
the O +
mutant O +
allele O +
was O +
confirmed O +
using O +
Southern O +
blotting O +
( O -
Figure O +
1B O -
) O +
and O +
PCR O +
( O -
unpublished O +
data O -
) O -
. O +

The O +
PGC-1α O +
gene O +
disruption O +
resulted O +
in O +
an O +
unstable O +
transcript O +
that O +
could O +
not O +
be O +
detected O +
by O +
RNA O +
blot O +
analysis O +
in O +
heart O +
and O +
other O +
tissues O +
in O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
Figure O +
1C O +
and O +
unpublished O +
data O -
) O -
. O +

Quantitative O +
RT O -
- O -
PCR O +
was O +
utilized O +
to O +
further O +
evaluate O +
the O +
efficacy O +
of O +
the O +
gene O +
targeting O -
. O +

For O +
these O +
studies O -
, O +
PCR O +
primers O +
were O +
designed O +
to O +
amplify O +
a O +
region O +
of O +
the O +
PGC-1α O +
gene O +
transcript O +
containing O +
the O +
exon O +
5–6 O +
border O +
( O -
predicted O +
to O +
be O +
absent O +
in O +
PGC-1α− O -
/ O -
− O +
mice O -
) O +
or O +
the O +
exon O +
5–3 O +
border O +
( O -
predicted O +
to O +
be O +
present O +
only O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
) O -
. O +

The O +
exon O +
5–6 O +
amplicon O +
was O +
detected O +
in O +
heart O +
and O +
BAT O +
of O +
wild O -
- O -
type O +
( O -
WT O -
) O +
but O +
not O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
Figure O +
1D O -
) O -
. O +

Conversely O -
, O +
the O +
exon O +
5–3 O +
product O +
was O +
present O +
only O +
in O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
Figure O +
1D O -
) O -
. O +

An O +
exon O +
10–11 O +
border O +
amplicon O +
( O -
predicted O +
to O +
be O +
present O +
in O +
both O +
genotypes O -
) O +
was O +
detected O +
in O +
WT O +
and O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
but O +
was O +
greatly O +
diminished O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
indicating O +
that O +
the O +
mutant O +
transcript O +
is O +
unstable O -
. O +

PGC-1α O +
protein O +
was O +
not O +
detected O +
in O +
whole O +
cell O +
( O -
Figure O +
1E O -
) O +
or O +
nuclear O +
protein O +
extracts O +
( O -
unpublished O +
data O -
) O +
isolated O +
from O +
BAT O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
under O +
basal O +
conditions O +
or O +
in O +
response O +
to O +
cold O +
exposure O -
, O +
a O +
condition O +
known O +
to O +
markedly O +
induce O +
the O +
expression O +
of O +
PGC-1α O +
in O +
BAT O -
. O +

Smaller O +
mutant O +
PGC-1α O +
proteins O +
were O +
also O +
not O +
detected O +
by O +
Western O +
blot O +
analysis O +
( O -
unpublished O +
data O -
) O -
. O +

Lastly O -
, O +
expression O +
of O +
the O +
genes O +
encoding O +
the O +
other O +
known O +
PGC-1 O +
family O +
members O -
, O +
PGC-1β O +
and O +
PRC O -
, O +
was O +
not O +
significantly O +
altered O +
in O +
heart O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
Figure O +
1C O -
) O -
. O +

Taken O +
together O -
, O +
these O +
results O +
support O +
the O +
conclusion O +
that O +
the O +
gene O +
targeting O +
event O +
resulted O +
in O +
a O +
PGC-1α O +
null O +
allele O -
. O +

General O +
Characteristics O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
Mice O -
: O +
Age- O +
and O +
Sex O -
- O -
Dependent O +
Obesity O +
Heterozygous O +
( O -
PGC-1α+ O -
/ O -
− O -
) O +
mice O +
were O +
bred O +
to O +
generate O +
PGC-1α− O -
/ O -
− O +
offspring O -
. O +

The O +
observed O +
genotype O +
ratios O +
of O +
the O +
offspring O +
were O +
consistent O +
with O +
the O +
expected O +
Mendelian O +
ratios O +
( O -
unpublished O +
data O -
) O -
. O +

Unexpected O +
deaths O +
of O +
the O +
offspring O +
were O +
not O +
observed O -
, O +
and O +
PGC-1α+ O -
/ O -
− O +
and O +
PGC-1α− O -
/ O -
− O +
offspring O +
appeared O +
normal O -
. O +

Total O +
body O +
weights O +
obtained O +
1 O +
wk O +
after O +
birth O +
revealed O +
a O +
15%–20 O -
% O +
reduction O +
in O +
total O +
body O +
mass O +
for O +
male O +
and O +
female O +
PGC-1α− O -
/ O -
− O +
mice O +
relative O +
to O +
sex O -
- O -
matched O +
PGC-1α+ O -
/ O -
+ O +
littermates O +
( O -
Figure O +
2 O -
) O -
. O +

The O +
weight O +
decrement O +
between O +
PGC-1α− O -
/ O -
− O +
and O +
PGC-1α+ O -
/ O -
+ O +
littermates O +
disappeared O +
by O +
3 O +
wk O +
of O +
age O +
( O -
Figure O +
2A O -
) O -
. O +

At O +
18 O +
wk O +
of O +
age O -
, O +
body O +
weight O +
was O +
modestly O +
but O +
significantly O +
greater O +
in O +
male O +
and O +
female O +
PGC-1α− O -
/ O -
− O +
mice O +
compared O +
to O +
sex O -
- O -
matched O +
PGC-1α+ O -
/ O -
+ O +
controls O +
( O -
Figure O +
2A O -
) O -
. O +

This O +
weight O +
difference O +
was O +
also O +
significant O +
for O +
female O +
PGC-1α− O -
/ O -
− O +
mice O +
at O +
24 O +
wk O +
of O +
age O +
( O -
Figure O +
2A O -
) O -
. O +

The O +
abnormal O +
weight O +
gain O +
in O +
PGC-1α− O -
/ O -
− O +
mice O +
was O +
not O +
associated O +
with O +
differences O +
in O +
food B-Chemical +
intake O +
( O -
unpublished O +
data O -
) O +
or O +
alterations O +
in O +
general O +
activity O +
as O +
monitored O +
for O +
48 O +
h O +
( O -
Figure O +
S1 O -
) O -
. O +

Percent O +
body O +
fat O -
, O +
as O +
determined O +
by O +
dual O -
- O -
energy O +
X O -
- O -
ray O +
absorption O +
( O -
DEXA O -
) O -
, O +
was O +
greater O +
in O +
18- O +
and O +
24-wk O -
- O -
old O +
female O +
PGC-1α− O -
/ O -
− O +
mice O +
compared O +
to O +
age O -
- O -
matched O +
female O +
PGC-1α+ O -
/ O -
+ O +
counterparts O -
, O +
indicating O +
that O +
the O +
body O +
weight O +
difference O +
was O +
due O -
, O +
at O +
least O +
in O +
part O -
, O +
to O +
increased O +
body O +
fat O +
( O -
Figure O +
2A O -
) O -
. O +

Lean O +
mass O +
was O +
not O +
significantly O +
different O +
between O +
the O +
genotypes O +
( O -
unpublished O +
data O -
) O -
. O +

Although O +
DEXA O +
did O +
not O +
detect O +
excess O +
body O +
fat O +
in O +
male O +
PGC-1α− O -
/ O -
− O +
mice O +
at O +
18 O +
or O +
24 O +
wk O +
of O +
age O -
, O +
older O +
male O +
mutant O +
mice O +
( O -
over O +
7 O +
mo O +
of O +
age O -
) O +
accumulated O +
more O +
body O +
fat O +
than O +
male O +
WT O +
controls O +
( O -
Figure O +
2A O +
and O +
unpublished O +
data O -
) O -
. O +

Individual O +
organ O +
weights O +
were O +
assessed O -
, O +
given O +
the O +
importance O +
of O +
mitochondrial O +
energy O +
metabolism O +
for O +
postnatal O +
growth O +
in O +
certain O +
organs O -
. O +

The O +
weights O +
of O +
heart O +
and O +
slow O -
- O -
twitch O +
fiber O -
- O -
enriched O +
skeletal O +
muscles O -
, O +
including O +
gastrocnemius O +
and O +
soleus O -
, O +
but O +
not O +
the O +
less O +
oxidative O +
tibialis O +
anterior O -
, O +
were O +
significantly O +
lower O +
in O +
male O +
and O +
female O +
PGC-1α− O -
/ O -
− O +
mice O +
compared O +
with O +
age O +
and O +
sex O -
- O -
matched O +
PGC-1α+ O -
/ O -
+ O +
controls O +
at O +
3 O +
and O +
8 O +
wk O +
of O +
age O +
( O -
Figure O +
2B O +
and O +
unpublished O +
data O -
) O -
. O +

In O +
contrast O -
, O +
the O +
weights O +
of O +
brain O -
, O +
liver O -
, O +
kidney O -
, O +
and O +
BAT O +
were O +
not O +
significantly O +
different O +
between O +
the O +
genotypes O +
at O +
the O +
3-wk O +
time O +
point O +
( O -
Figure O +
2B O -
) O -
. O +

Thus O -
, O +
certain O +
tissues O +
with O +
high O +
mitochondrial O +
energy O +
requirements O -
, O +
such O +
as O +
heart O +
and O +
slow O -
- O -
twitch O +
skeletal O +
muscle O -
, O +
exhibit O +
modest O +
growth O +
defects O +
in O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

Abnormal O +
Muscle O +
Mitochondrial O +
Phenotype O +
in O +
PGC-1α− O -
/ O -
− O +
Mice O +
General O +
histologic O +
analyses O +
were O +
performed O +
to O +
begin O +
to O +
evaluate O +
the O +
mild O +
growth O +
defect O +
found O +
in O +
postnatal O +
heart O +
and O +
skeletal O +
muscle O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

There O +
were O +
no O +
obvious O +
abnormalities O +
in O +
cellularity O -
, O +
cell O +
size O -
, O +
or O +
extracellular O +
matrix O +
in O +
the O +
tissues O +
of O +
1–2-mo O -
- O -
old O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
unpublished O +
data O -
) O -
. O +

Given O +
the O +
important O +
role O +
of O +
PGC-1α O +
in O +
mitochondrial O +
function O +
and O +
biogenesis O -
, O +
we O +
examined O +
mitochondrial O +
ultrastructure O +
in O +
the O +
relevant O +
tissues O -
. O +

Electron B-Chemical +
microscopic O +
analysis O +
revealed O +
fewer O +
and O +
smaller O +
mitochondria O +
in O +
soleus O +
muscle O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
compared O +
to O +
sex- O +
and O +
age- O +
matched O +
PGC-1α+ O -
/ O -
+ O +
controls O +
( O -
Figure O +
3A O -
) O -
. O +

Quantitative O +
morphometry O +
of O +
the O +
electron B-Chemical +
micrographs O +
confirmed O +
that O +
the O +
cellular O +
volume O +
density O +
of O +
soleus O +
mitochondria O +
was O +
significantly O +
lower O +
in O +
PGC-1α− O -
/ O -
− O +
mice O +
compared O +
to O +
PGC-1α+ O -
/ O -
+ O +
controls O +
independent O +
of O +
changes O +
in O +
the O +
myofibrillar O +
component O +
( O -
Figure O +
3B O -
) O -
. O +

Consistent O +
with O +
a O +
defect O +
in O +
mitochondrial O +
biogenesis O -
, O +
we O +
found O +
a O +
reduction O +
in O +
the O +
expression O +
of O +
nuclear O +
genes O +
encoding O +
proteins O +
involved O +
in O +
mitochondrial O +
electron B-Chemical +
transport O +
( O -
cytochrome B-Chemical +
c I-Chemical +
and O +
cytochrome B-Chemical +
oxidase O +
IV O -
) O +
and O +
oxidative O +
phosphorylation O +
( O -
beta O +
subunit O +
of O +
ATP O +
synthase O -
) O +
in O +
soleus O +
muscle O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
compared O +
with O +
PGC-1α+ O -
/ O -
+ O +
controls O -
. O +

In O +
addition O -
, O +
the O +
expression O +
of O +
Tfam O -
, O +
a O +
known O +
PGC-1α O +
target O +
involved O +
in O +
mitochondrial O +
DNA O +
replication O -
/ O -
transcription O -
, O +
was O +
diminished O +
in O +
PGC-1α− O -
/ O -
− O +
soleus O -
, O +
providing O +
one O +
potential O +
mechanism O +
for O +
defective O +
mitochondrial O +
biogenesis O +
( O -
Figure O +
3C O -
) O -
. O +

In O +
contrast O +
to O +
the O +
results O +
with O +
soleus O -
, O +
no O +
significant O +
differences O +
in O +
mitochondrial O +
ultrastructure O +
or O +
volume O +
density O +
were O +
noted O +
in O +
heart O +
or O +
BAT O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
unpublished O +
data O -
) O -
. O +

To O +
determine O +
whether O +
mitochondrial O +
function O +
was O +
altered O +
in O +
the O +
skeletal O +
muscle O +
of O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
mitochondrial O +
respiration O +
rates O +
were O +
measured O +
using O +
tissue O +
strips O +
prepared O +
from O +
soleus O +
muscle O -
. O +

In O +
soleus O +
of O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
a O +
significant O +
defect O +
in O +
state O +
3 O +
( O -
ADP O -
- O -
stimulated O -
) O +
respiration O -
, O +
but O +
not O +
state O +
2 O +
( O -
basal O -
) O -
, O +
was O +
detected O +
using O +
succinate O +
as O +
the O +
substrate O +
( O -
Figure O +
3D O -
) O -
. O +

State O +
4 O +
respiration O +
rates O +
( O -
in O +
the O +
presence O +
of O +
oligomycin B-Chemical -
) O +
were O +
also O +
similar O +
between O +
the O +
genotypes O -
, O +
indicating O +
that O +
the O +
coupling O +
of O +
respiration O +
to O +
ATP O +
production O +
was O +
not O +
significantly O +
altered O +
in O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

These O +
results O +
are O +
consistent O +
with O +
the O +
modest O +
but O +
significant O +
reduction O +
in O +
mitochondrial O +
volume O +
density O -
. O +

Altered O +
Skeletal O +
Muscle O +
Function O +
in O +
PGC-1α− O -
/ O -
− O +
Mice O +
The O +
abnormality O +
in O +
mitochondrial O +
number O +
and O +
respiratory O +
function O +
in O +
skeletal O +
muscle O +
led O +
us O +
to O +
further O +
evaluate O +
the O +
skeletal O +
muscle O +
phenotype O -
. O +

As O +
an O +
initial O +
step O -
, O +
we O +
measured O +
locomotor O +
activity O +
levels O +
over O +
a O +
1-h O +
period O +
using O +
a O +
high O -
- O -
resolution O +
photobeam O +
system O -
. O +

PGC-1α− O -
/ O -
− O +
male O +
mice O +
exhibited O +
a O +
significantly O +
lower O +
mean O +
number O +
of O +
ambulations O +
and O +
rearings O +
during O +
the O +
hour O +
compared O +
to O +
the O +
PGC-1α+ O -
/ O -
+ O +
age O -
- O -
matched O +
controls O +
( O -
Figure O +
4 O -
) O -
. O +

However O -
, O +
an O +
analysis O +
of O +
exploratory O +
behavior O +
showed O +
that O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
were O +
reluctant O +
to O +
go O +
into O +
the O +
center O +
of O +
the O +
" O -
field O -
" O +
compared O +
to O +
controls O -
. O +

Specifically O -
, O +
PGC-1α− O -
/ O -
− O +
mice O +
made O +
significantly O +
fewer O +
entries O +
into O -
, O +
spent O +
significantly O +
less O +
time O +
in O -
, O +
and O +
traveled O +
a O +
significantly O +
shorter O +
distance O +
in O +
the O +
central O +
area O +
of O +
the O +
" O -
field O -
, O -
" O +
although O +
differences O +
in O +
distance O +
traveled O +
in O +
the O +
peripheral O +
zone O +
of O +
the O +
" O -
field O -
" O +
was O +
not O +
significantly O +
different O +
between O +
groups O +
( O -
Figure O +
S2 O -
) O -
. O +

These O +
data O +
suggest O +
that O +
the O +
general O +
activity O +
level O +
may O +
have O +
been O +
affected O +
by O +
the O +
reluctance O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
to O +
go O +
into O +
the O +
central O +
area O +
of O +
the O +
field O +
and O +
thus O +
remain O +
in O +
the O +
periphery O +
( O -
thigmotaxis O -
) O -
, O +
possibly O +
reflecting O +
altered O +
emotionality O +
such O +
as O +
increased O +
fear O -
. O +

A O +
battery O +
of O +
tests O +
was O +
performed O +
to O +
further O +
evaluate O +
the O +
general O +
sensorimotor O +
phenotype O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

No O +
differences O +
were O +
found O +
between O +
PGC-1α− O -
/ O -
− O +
mice O +
and O +
PGC-1α+ O -
/ O -
+ O +
controls O +
on O +
the O +
ledge O -
, O +
platform O -
, O +
walking O +
initiation O -
, O +
and O +
60 O -
° O +
and O +
90 O -
° O +
inclined O +
screen O +
tests O +
( O -
unpublished O +
data O -
) O -
, O +
suggesting O +
that O +
several O +
sensorimotor O +
functions O +
were O +
intact O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

However O -
, O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
were O +
unable O +
to O +
remain O +
on O +
an O +
inverted O +
screen O +
for O +
as O +
long O +
as O +
the O +
PGC-1α+ O -
/ O -
+ O +
controls O +
( O -
Figure O +
4A O -
) O -
. O +

Since O +
the O +
groups O +
did O +
not O +
differ O +
on O +
the O +
times O +
it O +
took O +
to O +
turn O +
around O +
and O +
climb O +
to O +
the O +
top O +
of O +
60 O -
° O +
and O +
90 O -
° O +
inclined O +
screens O -
, O +
the O +
differences O +
on O +
the O +
inverted O +
screen O +
test O +
suggest O +
that O +
impaired O +
strength O +
rather O +
than O +
deficits O +
in O +
coordination O +
were O +
responsible O +
for O +
these O +
differences O -
. O +

To O +
further O +
evaluate O +
the O +
skeletal O +
muscle O +
phenotype O -
, O +
exercise O +
capacity O +
was O +
assessed O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

To O +
this O +
end O -
, O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
were O +
exercised O +
on O +
a O +
motorized O +
treadmill O +
apparatus O +
using O +
a O +
run O -
- O -
to O -
- O -
exhaustion O +
format O -
. O +

PGC-1α− O -
/ O -
− O +
mice O +
( O -
6–8 O +
mo O +
of O +
age O -
) O +
exhibited O +
a O +
markedly O +
reduced O +
capacity O +
to O +
sustain O +
running O +
exercise O +
( O -
PGC-1α− O -
/ O -
− O +
mice O -
, O +
64 O +
± O +
6 O +
s O -
; O +
age O -
- O -
matched O +
PGC-1α+ O -
/ O -
+ O +
mice O -
, O +
586 O +
± O +
104 O +
s O -
; O +
Figure O +
4B O -
) O -
. O +

The O +
same O +
result O +
was O +
obtained O +
with O +
younger O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
i.e. O -
, O +
at O +
3.5 O +
mo O +
of O +
age O +
( O -
unpublished O +
data O -
) O -
. O +

To O +
quantify O +
aerobic O +
exercise O +
capacity O -
, O +
VO2max O +
( O -
maximum O +
oxygen O +
consumption O -
, O +
measured O +
in O +
milliliters O +
of O +
oxygen O +
per O +
kilogram O +
of O +
body O +
weight O +
per O +
minute O -
) O +
was O +
measured O +
with O +
the O +
treadmill O -
- O -
running O +
protocol O +
using O +
indirect O +
calorimetry O -
. O +

VO2max O +
was O +
significantly O +
lower O +
for O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
120.9 O +
± O +
2.0 O +
ml O +
O2 B-Chemical +
· O +
kg−1 O +
· O +
min−1 O -
) O +
compared O +
to O +
PGC-1α+ O -
/ O -
+ O +
controls O +
( O -
141.6 O +
± O +
2.1 O +
ml O +
O2 B-Chemical +
· O +
kg−1 O +
· O +
min−1 O -
) O +
( O -
Figure O +
4B O -
) O -
. O +

To O +
directly O +
evaluate O +
muscle O +
fatigability O -
, O +
the O +
force O +
response O +
to O +
repetitive O +
stimulation O +
of O +
isolated O +
soleus O +
muscle O +
was O +
determined O -
. O +

The O +
capacity O +
to O +
generate O +
force O +
following O +
a O +
series O +
of O +
tetani O +
is O +
dependent O +
upon O +
mitochondrial O +
ATP O +
production O -
. O +

During O +
the O +
initial O +
phase O +
of O +
the O +
stimulation O +
period O -
, O +
there O +
was O +
no O +
difference O +
in O +
force O +
generation O +
in O +
muscles O +
isolated O +
from O +
PGC-1α− O -
/ O -
− O +
mice O +
and O +
PGC-1α+ O -
/ O -
+ O +
controls O -
. O +

However O -
, O +
fatigue O +
resistance O +
index O -
, O +
defined O +
as O +
the O +
percent O +
of O +
initial O +
force O +
generated O +
following O +
a O +
2-min O +
series O +
of O +
fatiguing O +
contractions O -
, O +
was O +
significantly O +
lower O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
14.6 O +
± O +
1.5 O -
% O -
) O +
compared O +
to O +
PGC-1α+ O -
/ O -
+ O +
controls O +
( O -
24.8 O +
± O +
2.9 O -
% O -
) O +
( O -
Figure O +
4C O -
) O -
. O +

These O +
results O -
, O +
together O +
with O +
the O +
observed O +
abnormalities O +
in O +
skeletal O +
muscle O +
mitochondrial O +
structure O +
and O +
function O -
, O +
indicate O +
that O +
PGC-1α O +
is O +
necessary O +
for O +
functional O +
adaptation O +
of O +
skeletal O +
muscle O +
to O +
physiologic O +
demands O -
. O +

Functional O +
Abnormalities O +
in O +
Hearts O +
of O +
PGC-1α− O -
/ O -
− O +
Mice O +
PGC-1α O +
expression O +
is O +
enriched O +
in O +
heart O -
, O +
a O +
tissue O +
that O +
relies O +
heavily O +
on O +
mitochondrial O +
energy O +
metabolism O +
to O +
maintain O +
pump O +
function O +
throughout O +
the O +
postnatal O +
life O +
of O +
the O +
mammalian O +
organism O -
. O +

Echocardiographic O +
screening O +
studies O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
at O +
ages O +
4–6 O +
mo O +
did O +
not O +
reveal O +
any O +
significant O +
differences O +
in O +
chamber O +
sizes O +
or O +
ventricular O +
function O +
compared O +
to O +
WT O +
controls O +
( O -
unpublished O +
data O -
) O -
. O +

Cardiac O +
functional O +
and O +
metabolic O +
reserve O +
was O +
evaluated O +
using O +
exercise O +
echocardiographic O +
stress O +
testing O +
( O -
EST O -
) O -
. O +

Given O +
that O +
the O +
exercise O +
capacity O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
is O +
diminished O -
, O +
a O +
series O +
of O +
preliminary O +
treadmill O +
exercise O +
studies O +
were O +
performed O +
to O +
define O +
a O +
reasonable O +
exercise O +
duration O +
for O +
run O -
- O -
to O -
- O -
exhaustion O +
to O +
be O +
used O +
as O +
a O +
target O +
duration O +
for O +
the O +
EST O -
. O +

Based O +
on O +
the O +
results O +
of O +
these O +
studies O -
, O +
an O +
EST O +
regimen O +
was O +
performed O +
in O +
which O +
PGC-1α+ O -
/ O -
+ O +
control O +
animals O +
were O +
exercised O +
for O +
a O +
duration O +
of O +
60 O +
s O +
to O +
match O +
the O +
predicted O +
average O +
for O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
ages O +
6–8 O +
mo O -
) O -
. O +

Echocardiographic O +
images O +
were O +
obtained O +
immediately O +
following O +
60 O +
s O +
of O +
exercise O +
for O +
the O +
PGC-1α+ O -
/ O -
+ O +
controls O +
or O +
at O +
the O +
point O +
of O +
exhaustion O +
for O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
mean O +
60 O +
± O +
6.1 O +
s O -
, O +
range O +
45–90 O +
s O -
) O -
. O +

Echocardiographic O -
- O -
determined O +
left O +
ventricular O +
fractional O +
shortening O +
and O +
heart O +
rate O +
were O +
monitored O +
for O +
the O +
10-min O +
period O +
immediately O +
post O +
exercise O -
. O +

The O +
mean O +
heart O +
rate O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
exhibited O +
an O +
inappropriate O +
decline O +
during O +
the O +
post O +
exercise O +
period O +
( O -
Figure O +
5A O -
) O -
. O +

In O +
addition O -
, O +
echocardiographically O +
determined O +
left O +
ventricular O +
fractional O +
shortening O +
was O +
decreased O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
but O +
not O +
the O +
PGC-1α+ O -
/ O -
+ O +
mice O +
during O +
the O +
first O +
4 O +
min O +
of O +
the O +
post O +
exercise O +
period O +
( O -
Figure O +
5A O -
) O -
. O +

The O +
results O +
of O +
the O +
EST O +
did O +
not O +
distinguish O +
between O +
a O +
primary O +
cardiac O +
abnormality O +
versus O +
effects O +
secondary O +
to O +
the O +
exhaustion O +
caused O +
by O +
reduced O +
exercise O +
tolerance O +
related O +
to O +
skeletal O +
muscle O +
dysfunction O -
. O +

To O +
directly O +
assess O +
cardiac O +
function O -
, O +
the O +
hearts O +
of O +
PGC-1α− O -
/ O -
− O +
and O +
PGC-1α+ O -
/ O -
+ O +
mice O +
were O +
isolated O +
and O +
perfused O +
in O +
the O +
working O +
mode O -
. O +

Hearts O +
isolated O +
from O +
PGC-1α− O -
/ O -
− O +
mice O +
generated O +
lower O +
cardiac O +
work O +
( O -
cardiac O +
output O +
multiplied O +
by O +
peak O +
systolic O +
pressure O -
) O +
compared O +
to O +
PGC-1α+ O -
/ O -
+ O +
mice O +
at O +
identical O +
loading O +
conditions O +
( O -
Table O +
1 O -
) O -
. O +

This O +
reduction O +
in O +
cardiac O +
work O +
was O +
due O +
to O +
a O +
reduced O +
cardiac O +
output O +
( O -
Table O +
1 O -
) O -
. O +

The O +
relative O +
contribution O +
of O +
heart O +
rate O +
and O +
stroke O +
volume O +
to O +
diminished O +
cardiac O +
output O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
could O +
not O +
be O +
delineated O -
, O +
because O +
both O +
were O +
decreased O +
but O +
neither O +
to O +
a O +
significant O +
degree O +
( O -
Table O +
1 O -
) O -
. O +

To O +
further O +
distinguish O +
between O +
abnormalities O +
in O +
heart O +
rate O +
and O +
ventricular O +
function O -
, O +
in O +
vivo O +
hemodynamic O +
response O +
to O +
the O +
β1,α1-adrenergic O -
- O -
selective O +
agonist O +
dobutamine B-Chemical +
was O +
evaluated O +
using O +
a O +
miniaturized O +
Millar O +
catheter O -
. O +

The O +
ventricular O +
functional O +
response O +
to O +
dobutamine B-Chemical +
was O +
similar O +
in O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
Figure O +
5B O -
, O +
right O +
graph O -
) O -
. O +

However O -
, O +
PGC-1α− O -
/ O -
− O +
mice O +
exhibited O +
a O +
significantly O +
blunted O +
heart O +
rate O +
response O +
to O +
β O -
- O -
adrenergic O +
stimulation O +
( O -
Figure O +
5B O -
, O +
left O +
graph O -
) O -
. O +

Taken O +
together O +
with O +
the O +
EST O -
, O +
these O +
results O +
strongly O +
suggest O +
that O +
the O +
PGC-1α− O -
/ O -
− O +
hearts O +
are O +
unable O +
to O +
mount O +
an O +
appropriate O +
chronotropic O +
response O +
to O +
exercise O +
and O +
other O +
physiologic O +
stimuli O +
that O +
activate O +
β O -
- O -
adrenergic O +
input O +
to O +
the O +
heart O -
. O +

However O -
, O +
our O +
results O +
did O +
not O +
reveal O +
evidence O +
for O +
contractile O +
dysfunction O -
. O +

PGC-1α− O -
/ O -
− O +
Mice O +
Exhibit O +
an O +
Abnormal O +
Thermogenic O +
Response O +
PGC-1α O +
has O +
been O +
implicated O +
as O +
an O +
inducible O +
regulator O +
of O +
mitochondrial O +
respiratory O +
uncoupling O -
, O +
an O +
important O +
source O +
of O +
heat O +
production O +
in O +
BAT O +
[ O -
2 O -
] O -
. O +

To O +
determine O +
whether O +
PGC-1α O +
is O +
necessary O +
for O +
an O +
appropriate O +
thermogenic O +
response O -
, O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O +
were O +
subjected O +
to O +
cold O +
exposure O +
( O -
4 O +
° O -
C O -
) O +
for O +
a O +
5-h O +
period O +
while O +
core O +
body O +
temperature O +
was O +
monitored O -
. O +

PGC-1α− O -
/ O -
− O +
mice O +
exhibited O +
a O +
markedly O +
abnormal O +
drop O +
in O +
core O +
temperature O +
compared O +
to O +
the O +
WT O +
controls O +
( O -
Figure O +
6A O -
) O -
. O +

Specifically O -
, O +
the O +
mean O +
decline O +
in O +
core O +
temperature O +
was O +
greater O +
than O +
12 O +
° O -
C O +
at O +
the O +
5-h O +
time O +
point O +
in O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
compared O +
to O +
an O +
approximately O +
3 O +
° O -
C O +
decrement O +
in O +
PGC-1α+ O -
/ O -
+ O +
controls O -
. O +

Although O +
this O +
thermogenic O +
phenotype O +
was O +
consistently O +
present O +
in O +
mice O +
aged O +
28–37 O +
d O -
, O +
it O +
was O +
absent O +
in O +
older O +
mice O +
( O -
unpublished O +
data O -
) O -
. O +

The O +
histologic O +
appearance O +
and O +
neutral O +
lipid B-Chemical +
stores O +
of O +
BAT O +
were O +
assessed O +
as O +
an O +
initial O +
step O +
to O +
characterize O +
the O +
thermogenic O +
phenotype O +
exhibited O +
by O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

Histologic O +
and O +
lipid B-Chemical +
quantification O +
studies O +
were O +
performed O -
. O +

Electron B-Chemical +
microscopic O +
analyses O +
indicated O +
that O +
the O +
mitochondrial O +
ultrastructure O +
was O +
similar O +
in O +
BAT O +
isolated O +
from O +
PGC-1α− O -
/ O -
− O +
and O +
PGC-1α+ O -
/ O -
+ O +
mice O +
before O +
and O +
after O +
cold O +
exposure O +
( O -
unpublished O +
data O -
) O -
. O +

In O +
addition O -
, O +
levels O +
of O +
BAT O +
triglyceride B-Chemical +
were O +
similar O +
between O +
the O +
two O +
genotypes O +
( O -
unpublished O +
data O -
) O -
. O +

UCP-1 O +
is O +
a O +
cold O -
- O -
inducible O +
protein O +
involved O +
in O +
mitochondrial O +
respiratory O +
uncoupling O +
to O +
generate O +
heat O +
in O +
BAT O -
. O +

UCP-1 O +
gene O +
transcription O +
is O +
known O +
to O +
be O +
activated O +
by O +
PGC-1α O +
[ O -
2 O -
] O -
. O +

Surprisingly O -
, O +
basal O +
and O +
cold O -
- O -
induced O +
BAT O +
UCP-1 O +
mRNA O +
levels O +
were O +
similar O +
in O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
Figure O +
6B O -
) O -
. O +

These O +
results O +
suggest O +
that O +
PGC-1α O +
is O +
not O +
necessary O +
for O +
the O +
induction O +
of O +
the O +
expression O +
of O +
UCP-1 O +
with O +
cold O +
exposure O -
, O +
and O +
that O +
other O +
factors O -
, O +
such O +
as O +
reduced O +
capacity O +
for O +
mitochondrial O +
respiration O -
, O +
likely O +
contribute O +
to O +
the O +
abnormal O +
thermogenic O +
response O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

Thermogenesis O +
in O +
rodents O +
related O +
to O +
mitochondrial O +
uncoupling O +
is O +
under O +
the O +
control O +
of O +
β3-adrenergic O +
receptor O +
coupled O +
signaling O -
. O +

Accordingly O -
, O +
the O +
in O +
vivo O +
oxygen O +
consumption O +
response O +
to O +
β3-adrenergic O +
stimulation O +
was O +
examined O +
in O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

For O +
these O +
experiments O -
, O +
VO2 O +
( O -
oxygen O +
consumption O -
) O +
was O +
measured O +
following O +
administration O +
of O +
the O +
β3-agonist O +
BRL O +
37344 O +
using O +
indirect O +
calorimetry O -
. O +

VO2 O +
was O +
significantly O +
increased O +
in O +
response O +
to O +
BRL O +
3744 O +
in O +
PGC-1α+ O -
/ O -
+ O +
but O +
not O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
Figure O +
6C O -
) O -
. O +

These O +
results O +
indicate O +
that O +
the O +
metabolic O +
response O +
of O +
BAT O +
to O +
an O +
acute O +
stimulus O +
such O +
as O +
cold O +
and/or O +
β3-adrenergic O +
stimulation O +
is O +
altered O +
in O +
the O +
PGC-1α O +
null O +
mice O -
, O +
likely O +
related O +
to O +
reduced O +
capacity O +
for O +
mitochondrial O +
respiratory O +
uncoupling O -
. O +

Fasting O -
- O -
Induced O +
Hepatic O +
Steatosis O +
in O +
PGC-1α− O -
/ O -
− O +
Mice O +
Previous O +
studies O +
have O +
implicated O +
PGC-1α O +
in O +
several O +
hepatic O +
metabolic O +
functions O +
including O +
fatty B-Chemical +
acid I-Chemical +
oxidation O +
and O +
gluconeogenesis O +
[ O -
18,19,20,21 O -
] O -
. O +

Accordingly O -
, O +
the O +
hepatic O +
phenotype O +
was O +
evaluated O +
under O +
basal O +
conditions O +
and O +
following O +
a O +
24-h O +
fast O -
, O +
a O +
stimulus O +
known O +
to O +
induce O +
fatty B-Chemical +
acid I-Chemical +
oxidation O +
and O +
gluconeogenic O +
rates O +
in O +
liver O -
. O +

Under O +
basal O +
fed O +
conditions O -
, O +
the O +
livers O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
appeared O +
grossly O +
normal O +
and O +
did O +
not O +
exhibit O +
histologic O +
abnormalities O +
( O -
unpublished O +
data O -
) O -
. O +

However O -
, O +
following O +
a O +
24 O +
h O -
- O -
fast O -
, O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
exhibited O +
marked O +
hepatic O +
steatosis O +
as O +
determined O +
by O +
gross O +
inspection O -
, O +
oil O +
red O +
O O +
staining O -
, O +
electron B-Chemical +
microscopy O -
, O +
and O +
measurements O +
of O +
liver O +
triglyceride B-Chemical +
( O -
TAG B-Chemical -
) O +
levels O +
( O -
Figure O +
7 O -
) O -
. O +

There O +
were O +
no O +
differences O +
in O +
plasma O +
triglycerides B-Chemical +
or O +
free O +
fatty B-Chemical +
acids I-Chemical +
between O +
the O +
genotypes O +
in O +
fed O +
or O +
fasted O +
states O +
( O -
unpublished O +
data O -
) O -
. O +

To O +
further O +
investigate O +
the O +
mechanisms O +
involved O +
in O +
the O +
fasting O -
- O -
induced O +
hepatic O +
steatotic O +
response O -
, O +
hepatocytes O +
were O +
isolated O +
from O +
PGC-1α− O -
/ O -
− O +
mice O +
and O +
WT O +
controls O -
. O +

Oleate B-Chemical +
loading O +
experiments O +
revealed O +
that O +
the O +
PGC-1α− O -
/ O -
− O +
hepatocytes O +
accumulated O +
neutral O +
lipid B-Chemical +
to O +
a O +
significantly O +
greater O +
extent O +
than O +
the O +
WT O +
cells O +
( O -
Figure O +
8A O -
) O -
. O +

3H B-Chemical -
- O -
palmitate B-Chemical +
oxidation O +
rates O +
were O +
significantly O +
lower O +
in O +
PGC-1α− O -
/ O -
− O +
hepatocytes O +
compared O +
to O +
PGC-1α+ O -
/ O -
+ O +
hepatocytes O +
under O +
basal O +
conditions O +
and O +
following O +
exposure O +
to O +
oleate B-Chemical +
( O -
Figure O +
8B O -
) O -
. O +

Taken O +
together O -
, O +
these O +
latter O +
results O +
indicate O +
a O +
cell O -
- O -
autonomous O +
defect O +
in O +
PGC-1α− O -
/ O -
− O +
hepatocytes O +
that O +
results O +
in O +
an O +
inability O +
to O +
maintain O +
cellular O +
lipid B-Chemical +
balance O +
in O +
the O +
context O +
of O +
increased O +
delivery O +
of O +
lipid B-Chemical +
such O +
as O +
occurs O +
with O +
fasting O -
. O +

PPAR O -
, O +
a O +
known O +
regulator O +
of O +
hepatic O +
mitochondrial O +
fatty B-Chemical +
acid I-Chemical +
oxidation O +
enzyme O +
gene O +
expression O -
, O +
is O +
a O +
target O +
for O +
coactivation O +
by O +
PGC-1α O +
[ O -
31 O -
] O -
. O +

Therefore O -
, O +
we O +
sought O +
to O +
determine O +
whether O +
the O +
steatotic O +
phenotype O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
related O +
to O +
reduced O +
expression O +
of O +
PPAR O +
target O +
genes O -
. O +

To O +
this O +
end O -
, O +
a O +
survey O +
of O +
candidate O +
genes O +
and O +
gene O +
expression O +
profiling O +
experiments O +
were O +
performed O -
. O +

Surprisingly O -
, O +
the O +
hepatic O +
expression O +
of O +
PPAR O +
target O +
genes O +
involved O +
in O +
cellular O +
fatty B-Chemical +
acid I-Chemical +
and O +
oxidation O +
( O -
MCPT O +
and O +
MCAD O -
) O +
were O +
not O +
significantly O +
different O +
between O +
the O +
genotypes O +
under O +
fed O +
or O +
fasted O +
conditions O +
( O -
Table O +
2 O -
) O -
. O +

Next O -
, O +
we O +
performed O +
experiments O +
to O +
determine O +
whether O +
the O +
reduced O +
capacity O +
for O +
fat O +
oxidation O +
in O +
the O +
hepatocytes O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
was O +
related O +
to O +
altered O +
mitochondrial O +
respiratory O +
function O -
. O +

Compared O +
to O +
the O +
WT O +
controls O -
, O +
PGC-1α− O -
/ O -
− O +
hepatocytes O +
exhibited O +
a O +
modest O +
but O +
significant O +
reduction O +
in O +
both O +
state O +
2 O +
and O +
state O +
3 O +
respiration O +
rates O +
( O -
Figure O +
8C O -
) O -
. O +

These O +
results O +
identify O +
one O +
potential O +
mechanism O +
responsible O +
for O +
the O +
fasting O -
- O -
induced O +
hepatic O +
steatosis O -
: O +
reduced O +
capacity O +
for O +
fat O +
oxidation O +
due O +
to O +
mitochondrial O +
respiratory O +
dysfunction O -
. O +

Although O +
the O +
liver O +
gene O +
expression O +
profiling O +
studies O +
did O +
not O +
reveal O +
abnormalities O +
in O +
the O +
fatty B-Chemical +
acid I-Chemical +
oxidation O +
pathway O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
several O +
interesting O +
differences O +
in O +
the O +
activity O +
of O +
the O +
sterol B-Chemical +
regulatory O +
element O +
binding O +
protein-1c O +
( O -
SREBP-1c O -
) O +
pathway O +
were O +
noted O -
. O +

Specifically O -
, O +
the O +
fasting O -
- O -
mediated O +
down O -
- O -
regulation O +
of O +
SREBP-1c O +
and O +
its O +
target O +
gene O +
stearoyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
desaturase O +
( O -
SCD1 O -
) O -
, O +
was O +
abolished O +
in O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
Table O +
2 O -
) O -
. O +

Furthermore O -
, O +
expression O +
of O +
the O +
gene O +
encoding O +
diglyceride B-Chemical +
acyltransferase O +
( O -
DGAT O -
) O -
, O +
which O +
catalyzes O +
the O +
last O +
step O +
in O +
TAG B-Chemical +
synthesis O -
, O +
was O +
activated O +
at O +
baseline O +
and O +
induced O +
by O +
fasting O +
to O +
a O +
greater O +
level O +
in O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
Table O +
2 O -
) O -
. O +

These O +
results O +
suggest O +
that O -
, O +
in O +
addition O +
to O +
a O +
defect O +
in O +
oxidation O -
, O +
components O +
of O +
the O +
TAG B-Chemical +
synthesis O +
pathway O +
are O +
activated O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

To O +
evaluate O +
this O +
possibility O +
directly O -
, O +
rates O +
of O +
3H B-Chemical -
- O -
glycerol B-Chemical +
incorporation O +
into O +
TAG B-Chemical +
were O +
determined O +
in O +
isolated O +
hepatocytes O -
. O +

3H B-Chemical -
- O -
TAG B-Chemical +
incorporation O +
was O +
increased O +
nearly O +
50 O -
% O +
in O +
hepatocytes O +
isolated O +
from O +
PGC-1α− O -
/ O -
− O +
mice O +
compared O +
to O +
PGC-1α+ O -
/ O -
+ O +
controls O +
( O -
Figure O +
8D O -
) O -
, O +
confirming O +
that O +
TAG B-Chemical +
synthesis O +
rates O +
are O +
increased O +
in O +
PGC-1α O +
null O +
hepatocytes O -
, O +
identifying O +
a O +
second O +
potential O +
mechanism O +
contributing O +
to O +
the O +
fasting O -
- O -
induced O +
hepatic O +
steatosis O -
. O +

Despite O +
a O +
Mild O +
Obese O +
Phenotype O -
, O +
Female O +
PGC-1α− O -
/ O -
− O +
Mice O +
Do O +
Not O +
Exhibit O +
Insulin O +
Resistance O +
Recent O +
studies O +
have O +
suggested O +
that O +
specific O +
PGC-1α O +
single O +
nucleotide O +
polymorphisms O +
and O +
haplotypes O +
may O +
influence O +
the O +
development O +
of O +
insulin O +
resistance O +
and O +
diabetes O +
[ O -
27,30 O -
] O +
and O +
that O +
PGC-1 O +
activity O +
is O +
diminished O +
in O +
insulin O -
- O -
resistant O +
and O +
diabetic O +
muscle O +
[ O -
22,23 O -
] O -
. O +

Accordingly O -
, O +
peripheral O +
glucose B-Chemical +
disposal O +
and O +
insulin O +
responsiveness O +
were O +
examined O +
in O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

Glucose B-Chemical +
tolerance O +
testing O +
of O +
2-mo O -
- O -
old O +
male O +
and O +
female O +
mice O +
revealed O +
no O +
significant O +
difference O +
in O +
blood O +
glucose B-Chemical +
excursion O +
between O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
groups O +
( O -
unpublished O +
data O -
) O -
. O +

Given O +
that O +
older O +
female O +
PGC-1α− O -
/ O -
− O +
mice O +
develop O +
an O +
increase O +
in O +
body O +
fat O +
stores O -
, O +
glucose B-Chemical +
tolerance O +
and O +
insulin O +
responsiveness O +
were O +
further O +
evaluated O +
in O +
this O +
group O -
. O +

Glucose B-Chemical +
tolerance O +
testing O +
in O +
4.5-mo O -
- O -
old O +
female O +
PGC-1α− O -
/ O -
− O +
mice O +
revealed O +
that O -
, O +
despite O +
increased O +
body O +
weight O +
[ O -
mean O +
± O +
standard O +
error O +
of O +
the O +
mean O +
( O -
SEM O -
) O +
weight O +
of O +
PGC-1α+ O -
/ O -
+ O +
mice O +
= O +
22.4 O +
± O +
0.79 O +
g O -
; O +
PGC-1α− O -
/ O -
− O +
mice O +
= O +
25.2 O +
± O +
1.04 O +
g O -
) O -
, O +
PGC-1α− O -
/ O -
− O +
mice O +
exhibited O +
similar O +
levels O +
of O +
glucose B-Chemical +
tolerance O +
compared O +
to O +
WT O +
mice O +
on O +
standard O +
rodent O +
chow B-Chemical +
( O -
Figure O +
9 O -
) O -
. O +

To O +
examine O +
glucose B-Chemical +
homeostasis O +
in O +
response O +
to O +
high O -
- O -
fat O +
diet O -
, O +
female O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O +
were O +
placed O +
on O +
high O -
- O -
fat O +
chow B-Chemical +
( O -
43 O -
% O +
calories O +
from O +
fat O -
) O +
for O +
6 O +
wk O +
starting O +
at O +
8 O +
wk O +
of O +
age O -
. O +

The O +
weight O +
gained O +
on O +
the O +
high O -
- O -
fat O +
diet O +
was O +
similar O +
for O +
the O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
groups O +
( O -
Figure O +
S3 O -
) O -
. O +

Surprisingly O -
, O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
on O +
a O +
high O -
- O -
fat O +
diet O +
were O +
significantly O +
more O +
glucose B-Chemical -
- O -
tolerant O +
and O +
insulin O -
- O -
sensitive O +
compared O +
to O +
the O +
PGC-1α+ O -
/ O -
+ O +
mice O +
( O -
Figure O +
9B O -
) O -
. O +

Taken O +
together O -
, O +
these O +
results O +
indicate O +
that O -
, O +
despite O +
excess O +
body O +
fat O +
under O +
standard O +
conditions O -
, O +
the O +
female O +
PGC-1α− O -
/ O -
− O +
mice O +
do O +
not O +
exhibit O +
insulin O +
resistance O -
. O +

Moreover O -
, O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
are O +
more O +
glucose B-Chemical -
- O -
tolerant O +
and O +
insulin O -
- O -
sensitive O +
than O +
WT O +
mice O +
on O +
a O +
high O -
- O -
fat O +
diet O -
. O +

Structural O +
Abnormalities O +
of O +
the O +
Central O +
Nervous O +
System O +
in O +
PGC-1α− O -
/ O -
− O +
Mice O +
In O +
surveying O +
the O +
tissues O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
structural O +
abnormalities O +
of O +
the O +
brain O +
were O +
observed O -
. O +

Light O +
microscopic O +
examination O +
of O +
PGC-1α− O -
/ O -
− O +
brain O +
tissue O +
samples O +
demonstrated O +
a O +
well O -
- O -
preserved O +
cerebral O +
cortical O +
neuronal O +
complement O -
, O +
a O +
result O +
confirmed O +
by O +
measurement O +
of O +
neuron O +
density O +
in O +
sections O +
of O +
the O +
parietal O +
lobe O +
( O -
PGC-1α+ O -
/ O -
+ O -
, O +
1,261 O +
± O +
91 O +
neurons O -
/ O -
mm2 O +
versus O +
PGC-1α− O -
/ O -
− O -
, O +
1,299 O +
± O +
82 O +
neurons O -
/ O -
mm2 O -
; O +
not O +
significant O -
) O -
. O +

Patchy O +
areas O +
of O +
microvacuolation O +
involving O +
the O +
neuropil O +
and O +
individual O +
pyramidal O +
neurons O +
of O +
the O +
deep O +
layers O +
of O +
the O +
cerebral O +
cortex O +
were O +
noted O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
but O +
not O +
the O +
PGC-1α+ O -
/ O -
+ O +
mice O +
( O -
Figure O +
10A O -
) O -
. O +

Immunolocalization O +
of O +
an O +
astrocytic O +
marker O -
, O +
glial O +
fibrillary O +
acidic B-Chemical +
protein O -
, O +
failed O +
to O +
show O +
an O +
increase O +
in O +
numbers O +
of O +
astrocytic O +
processes O +
in O +
PGC-1α− O -
/ O -
− O +
mouse O +
cerebral O +
cortex O +
( O -
unpublished O +
data O -
) O -
. O +

The O +
hippocampus O +
also O +
showed O +
neuronal O +
microvacuolation O -
, O +
albeit O +
to O +
a O +
lesser O +
degree O +
than O +
the O +
parietal O +
cortex O -
. O +

Microvacuolation O +
of O +
the O +
neuropil O +
and O +
neurons O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
basal O +
ganglia O +
( O -
caudate O +
and O +
putamen O -
) O +
was O +
also O +
noted O +
in O +
association O +
with O +
a O +
patchy O +
increase O +
in O +
the O +
number O +
and O +
intensity O +
of O +
glial O +
fibrillary O +
acidic B-Chemical +
protein O -
- O -
immunoreactive O +
astrocytic O +
processes O +
( O -
unpublished O +
data O -
) O -
. O +

Areas O +
of O +
microvacuolation O +
also O +
involved O +
multiple O +
brainstem O +
regions O -
. O +

Only O +
rare O +
vacuolated O +
Purkinje O +
and O +
granule O +
cell O +
neurons O +
were O +
identified O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
cerebellar O +
cortex O -
. O +

Neither O +
microglial O +
proliferation O +
nor O +
perivascular O +
lymphocytic O +
inflammatory O +
infiltrates O +
were O +
noted O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
CNS O -
. O +

Ultrastructural O +
examination O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
parietal O +
cerebral O +
cortex O +
confirmed O +
the O +
presence O +
of O +
microvacuolated O +
neurons O +
and O +
neuropil O +
( O -
Figure O +
10B O -
) O -
. O +

Vacuoles O +
containing O +
aggregates O +
of O +
membranous O +
material O +
were O +
present O +
in O +
a O +
subset O +
of O +
cortical O +
neurons O -
. O +

Subcellular O +
localization O +
of O +
the O +
vacuoles O +
was O +
difficult O +
to O +
establish O -
; O +
some O +
may O +
represent O +
vacuolated O +
elements O +
of O +
the O +
neuropil O -
, O +
material O +
in O +
phagocytic O +
cells O -
, O +
presynaptic O +
nerve O +
terminals O +
compressing O +
the O +
soma O -
, O +
or O +
genuine O +
intraperikaryal O +
deposits O -
. O +

Discussion O +
Previous O +
studies O +
using O +
gain O -
- O -
of O -
- O -
function O +
strategies O +
have O +
shown O +
that O +
the O +
coactivator O +
PGC-1α O +
is O +
capable O +
of O +
coactivating O +
an O +
array O +
of O +
transcription O +
factors O +
involved O +
in O +
energy O +
metabolic O +
processes O +
including O +
fatty B-Chemical +
acid I-Chemical +
oxidation O -
, O +
electron B-Chemical +
transport O -
, O +
and O +
oxidative O +
phosphorylation O +
[ O -
6 O -
] O -
. O +

Forced O +
expression O +
of O +
PGC-1α O +
triggers O +
mitochondrial O +
biogenesis O +
by O +
activating O +
a O +
complex O +
circuitry O +
of O +
factors O +
including O +
NRF-1 O -
, O +
NRF-2 O -
, O +
and O +
the O +
orphan O +
nuclear O +
receptor O +
estrogen B-Chemical -
- O -
related O +
receptor O +
α O +
[ O -
23,32 O -
] O -
. O +

However O -
, O +
gain O -
- O -
of O -
- O -
function O +
strategies O +
can O -
not O +
determine O +
whether O +
PGC-1α O +
is O +
essential O +
for O +
critical O +
energy O +
metabolic O +
processes O +
including O +
mitochondrial O +
biogenesis O +
and O +
function O -
. O +

Using O +
targeted O +
gene O +
deletion O +
in O +
mice O -
, O +
we O +
show O +
here O +
that O +
PGC-1α O +
is O +
not O +
essential O +
for O +
normal O +
embryologic O +
development O +
or O +
the O +
fundamental O +
events O +
of O +
mitochondrial O +
biogenesis O -
. O +

However O -
, O +
several O +
lines O +
of O +
evidence O +
support O +
the O +
conclusion O +
that O +
PGC-1α O +
is O +
necessary O +
for O +
the O +
programs O +
that O +
regulate O +
postnatal O +
mitochondrial O +
function O +
and O +
cellular O +
energy O +
metabolism O -
, O +
processes O +
that O +
equip O +
the O +
organism O +
for O +
the O +
energy O +
metabolic O +
rigors O +
of O +
the O +
postnatal O +
environment O -
. O +

First O -
, O +
mitochondrial O +
volume O +
density O +
is O +
diminished O +
in O +
slow O -
- O -
twitch O +
skeletal O +
muscle O +
of O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

Second O -
, O +
mitochondrial O +
respiratory O +
capacity O +
is O +
modestly O +
but O +
significantly O +
altered O +
in O +
skeletal O +
muscle O +
and O +
liver O +
of O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

Third O -
, O +
the O +
growth O +
of O +
heart O +
and O +
soleus O +
muscle O -
, O +
tissues O +
with O +
high O +
reliance O +
on O +
mitochondrial O +
energy O +
production O -
, O +
is O +
blunted O -
. O +

Fourth O -
, O +
control O +
of O +
body O +
fat O +
mass O +
is O +
abnormal O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

Finally O -
, O +
PGC-1α− O -
/ O -
− O +
mice O +
do O +
not O +
respond O +
normally O +
to O +
a O +
variety O +
of O +
physiologic O +
and O +
dietary O +
stresses O +
known O +
to O +
increase O +
oxidative O +
energy O +
demands O -
. O +

Taken O +
together O -
, O +
these O +
results O +
strongly O +
suggest O +
that O +
PGC-1α O +
is O +
necessary O +
for O +
the O +
terminal O +
stages O +
of O +
mitochondrial O +
maturation O +
necessary O +
to O +
meet O +
the O +
energy O +
demands O +
of O +
the O +
postnatal O +
environment O -
. O +

Extensive O +
phenotypic O +
analyses O +
demonstrated O +
that O +
mice O +
lacking O +
PGC-1α O +
are O +
unable O +
to O +
cope O +
with O +
physiologic O +
stressors O +
relevant O +
to O +
postnatal O +
survival O -
. O +

For O +
example O -
, O +
a O +
skeletal O +
muscle O +
phenotype O +
was O +
unveiled O +
in O +
PGC-1α− O -
/ O -
− O +
mice O +
under O +
conditions O +
in O +
which O +
energy O +
supply O +
becomes O +
limiting O -
. O +

This O +
was O +
most O +
clearly O +
demonstrated O +
by O +
the O +
profound O +
abnormalities O +
exhibited O +
by O +
PGC-1α− O -
/ O -
− O +
mice O +
with O +
exercise O -
- O -
to O -
- O -
exhaustion O +
and O +
repetitive O +
muscle O +
stimulation O +
studies O -
. O +

Similarly O -
, O +
cardiac O +
performance O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
was O +
compromised O +
following O +
severe O +
exertion O -
. O +

This O +
effect O +
was O +
largely O +
due O +
to O +
an O +
abnormal O +
heart O +
rate O +
response O -
. O +

The O +
basis O +
for O +
the O +
observed O +
abnormalities O +
of O +
cardiac O +
heart O +
rate O -
, O +
including O +
a O +
blunted O +
response O +
to O +
β O -
- O -
adrenergic O +
stimulation O -
, O +
is O +
unknown O -
, O +
but O +
could O +
be O +
related O +
to O +
the O +
effects O +
of O +
late O -
- O -
stage O +
growth O +
arrest O +
and O +
corresponding O +
derangements O +
in O +
energy O +
metabolism O +
on O +
sinus O +
node O +
function O -
. O +

PGC-1α O +
was O +
first O +
identified O +
as O +
a O +
coactivator O +
in O +
BAT O +
[ O -
2 O -
] O -
. O +

Indeed O -
, O +
we O +
found O +
that O +
exposure O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
to O +
cold O -
, O +
another O +
relevant O +
physiologic O +
stress O -
, O +
resulted O +
in O +
an O +
untoward O +
drop O +
in O +
core O +
body O +
temperature O +
consistent O +
with O +
an O +
abnormality O +
in O +
thermogenesis O +
despite O +
normal O +
cold O +
induction O +
of O +
UCP-1 O +
mRNA O +
in O +
BAT O -
. O +

Studies O +
with O +
a O +
β3-adrenergic O +
agonist B-Chemical +
confirmed O +
that O +
the O +
peak O +
oxygen O +
consumption O +
rate O +
in O +
thermogenic O +
tissue O +
is O +
diminished O +
in O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

We O +
propose O +
that O +
the O +
thermogenic O +
phenotype O +
is O +
related O +
to O +
reduced O +
capacity O +
for O +
mitochondrial O +
respiration O +
in O +
BAT O -
. O +

Interestingly O -
, O +
this O +
phenotype O +
was O +
only O +
evident O +
during O +
a O +
rather O +
narrow O +
window O +
of O +
postnatal O +
life O -
. O +

Animals O +
at O +
an O +
older O +
age O +
did O +
not O +
exhibit O +
cold O +
intolerance O -
, O +
possibly O +
due O +
to O +
the O +
insulating O +
properties O +
of O +
increased O +
body O +
mass O -
. O +

Collectively O -
, O +
these O +
results O +
demonstrate O +
the O +
importance O +
of O +
PGC-1α O +
as O +
a O +
key O +
transducer O +
of O +
physiologic O +
stimuli O +
to O +
the O +
control O +
of O +
energy O +
metabolism O -
. O +

The O +
observation O +
of O +
fasting O -
- O -
induced O +
hepatic O +
steatosis O +
is O +
another O +
example O +
of O +
the O +
inability O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
to O +
respond O +
to O +
postnatal O +
environmental O +
metabolic O +
demands O -
. O +

Following O +
short O -
- O -
term O +
starvation O -
, O +
we O +
found O +
that O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
developed O +
marked O +
hepatocyte O +
triglyceride B-Chemical +
accumulation O -
. O +

Further O +
analysis O +
revealed O +
that O +
palmitate B-Chemical +
oxidation O +
rates O +
were O +
reduced O +
in O +
hepatocytes O +
isolated O +
from O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
which O +
would O +
predispose O +
to O +
lipid B-Chemical +
accumulation O -
. O +

Surprisingly O -
, O +
the O +
reduction O +
in O +
fatty B-Chemical +
acid I-Chemical +
oxidation O +
rates O +
in O +
PGC-1α O +
null O +
hepatocytes O +
was O +
not O +
due O +
to O +
altered O +
expression O +
of O +
PGC-1α O -
/ O -
PPAR O +
target O +
genes O +
involved O +
in O +
mitochondrial O +
fatty B-Chemical +
acid I-Chemical +
oxidation O -
. O +

However O -
, O +
mitochondrial O +
respiratory O +
rates O +
were O +
diminished O -
. O +

In O +
addition O -
, O +
we O +
found O +
that O +
triglyceride B-Chemical +
synthesis O +
was O +
abnormally O +
activated O -
, O +
and O +
the O +
expression O +
of O +
genes O +
encoding O +
SREBP-1c O +
and O +
SCD-1 O -
, O +
key O +
proteins O +
in O +
the O +
hepatic O +
lipogenic O +
pathway O -
, O +
failed O +
to O +
be O +
appropriately O +
down O -
- O -
regulated O +
in O +
fasted O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

The O +
mechanism O +
involved O +
in O +
this O +
latter O +
finding O +
is O +
unknown O -
. O +

Indeed O -
, O +
the O +
relative O +
contribution O +
of O +
increased O +
triglyceride B-Chemical +
synthesis O +
rates O +
to O +
the O +
steatotic O +
phenotype O +
can O -
not O +
be O +
fully O +
discerned O +
from O +
our O +
data O -
, O +
given O +
that O +
this O +
response O +
could O +
reflect O +
the O +
direct O +
effects O +
of O +
PGC-1α O +
deficiency O +
on O +
target O +
genes O +
or O +
a O +
secondary O +
compensatory O +
response O +
to O +
hepatocyte O +
fatty B-Chemical +
acid I-Chemical +
accumulation O -
. O +

Consistent O +
with O +
the O +
former O +
possibility O -
, O +
recent O +
evidence O +
indicates O +
that O +
PGC-1α O +
coactivates O +
the O +
nuclear O +
receptor O +
FXR O -
, O +
a O +
negative O +
regulator O +
of O +
SREBP-1c O +
expression O +
and O +
triglyceride B-Chemical +
synthesis O +
[ O -
33 O -
] O -
. O +

We O +
conclude O +
that O +
reduced O +
hepatocyte O +
mitochondrial O +
respiratory O +
capacity O -
, O +
and O +
possibly O +
activation O +
of O +
lipogenic O +
programs O -
, O +
result O +
in O +
hepatocyte O +
triglyceride B-Chemical +
accumulation O +
in O +
the O +
context O +
of O +
increased O +
hepatic O +
delivery O +
of O +
fatty B-Chemical +
acids I-Chemical +
such O +
as O +
occurs O +
with O +
fasting O -
. O +

We O +
found O +
that O +
after O +
18 O +
wk O +
of O +
age O -
, O +
female O +
PGC-1α− O -
/ O -
− O +
mice O +
exhibit O +
a O +
mild O +
but O +
significantly O +
abnormal O +
weight O +
increase O +
associated O +
with O +
increased O +
fat O +
stores O -
. O +

Lean O +
mass O +
was O +
unchanged O +
at O +
the O +
time O +
points O +
examined O -
. O +

With O +
further O +
aging O -
, O +
a O +
modest O +
but O +
significant O +
increase O +
in O +
body O +
fat O +
was O +
also O +
noted O +
in O +
male O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
unpublished O +
data O -
) O -
. O +

The O +
basis O +
for O +
the O +
observed O +
abnormalities O +
in O +
weight O +
control O +
is O +
unknown O -
. O +

We O +
did O +
not O +
find O +
differences O +
in O +
food B-Chemical +
intake O +
or O +
activity O +
levels O +
in O +
female O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

It O +
is O +
possible O +
that O +
a O +
reduction O +
in O +
systemic O +
energy O +
utilization O -
, O +
related O +
to O +
the O +
mitochondrial O +
dysfunction O -
, O +
leads O +
to O +
increased O +
fat O +
mass O +
and O +
weight O +
gain O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

Interestingly O -
, O +
an O +
association O +
between O +
PGC-1α O +
gene O +
polymorphisms O +
and O +
obesity O +
in O +
humans O +
has O +
been O +
recently O +
reported O +
[ O -
26 O -
] O -
. O +

Clearly O -
, O +
future O +
studies O +
of O +
male O +
and O +
female O +
PGC-1α− O -
/ O -
− O +
mice O +
in O +
pure O -
- O -
strain O +
backgrounds O +
over O +
a O +
range O +
of O +
ages O +
will O +
be O +
necessary O +
to O +
fully O +
investigate O +
the O +
observed O +
abnormalities O +
in O +
weight O +
control O +
and O +
fat O +
distribution O -
. O +

We O +
did O +
not O +
find O +
evidence O +
for O +
glucose B-Chemical +
intolerance O +
or O +
insulin O +
resistance O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
animals O +
on O +
standard O +
chow B-Chemical -
. O +

Moreover O -
, O +
female O +
PGC-1α− O -
/ O -
− O +
mice O +
were O +
more O +
glucose B-Chemical -
- O -
tolerant O +
and O +
insulin O -
- O -
sensitive O +
than O +
PGC-1α+ O -
/ O -
+ O +
controls O +
when O +
consuming O +
a O +
high O -
- O -
fat O +
diet O -
. O +

These O +
findings O +
are O +
surprising O -
, O +
given O +
the O +
results O +
of O +
several O +
recent O +
studies O +
demonstrating O +
reduced O +
expression O +
of O +
PGC-1α O +
in O +
human O +
diabetic O +
skeletal O +
muscle O +
[ O -
24,34 O -
] O -
. O +

It O +
is O +
certainly O +
possible O +
that O +
compensatory O +
metabolic O +
regulatory O +
mechanisms O +
have O +
been O +
activated O +
in O +
the O +
PGC-1α O -
- O -
deficient O +
mice O -
, O +
accounting O +
for O +
this O +
observation O -
. O +

Alternatively O -
, O +
PGC-1α O +
could O +
serve O +
as O +
a O +
coactivator O +
of O +
factors O +
that O +
mediate O +
diet O -
- O -
induced O +
insulin O +
resistance O -
. O +

Consistent O +
with O +
this O +
notion O -
, O +
we O +
and O +
others O +
have O +
shown O +
that O +
mice O +
lacking O +
the O +
PGC-1α O +
target O +
PPAR O +
exhibit O +
resistance O +
to O +
diet O -
- O -
induced O +
glucose B-Chemical +
intolerance O +
[ O -
21,35,36 O -
] O -
. O +

Histologic O +
surveys O +
of O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
revealed O +
ultrastructural O +
abnormalities O +
in O +
the O +
central O +
nervous O +
system O -
. O +

Inspection O +
of O +
sections O +
prepared O +
from O +
the O +
brains O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
revealed O +
patchy O +
areas O +
of O +
microvacuolation O +
in O +
the O +
pyramidal O +
neurons O +
of O +
the O +
cerebral O +
cortex O -
, O +
accompanied O +
by O +
a O +
mild O +
increase O +
in O +
the O +
number O +
of O +
astrocytes O +
in O +
the O +
basal O +
ganglia O -
. O +

The O +
basis O +
for O +
this O +
interesting O +
but O +
relatively O +
nonspecific O +
finding O +
is O +
unknown O -
. O +

It O +
is O +
possible O +
that O +
PGC-1α O +
plays O +
an O +
important O +
role O +
in O +
lipid B-Chemical +
metabolism O +
related O +
to O +
membrane O +
synthesis O -
. O +

Alternatively O -
, O +
the O +
normal O +
process O +
of O +
cellular O +
debris O +
turnover O +
could O +
be O +
altered O +
due O +
to O +
a O +
defect O +
in O +
the O +
energetics O +
of O +
the O +
microglial O +
component O +
of O +
the O +
central O +
nervous O +
system O -
. O +

Although O +
overt O +
neurologic O +
dysfunction O +
was O +
not O +
apparent O +
in O +
PGC-1α− O -
/ O -
− O +
mice O +
during O +
the O +
first O +
6 O +
mo O +
of O +
life O +
( O -
no O +
group O +
differences O +
were O +
found O +
on O +
five O +
of O +
six O +
sensorimotor O +
tests O -
) O -
, O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
showed O +
clear O +
deficits O +
on O +
the O +
inverted O +
screen O +
test O -
. O +

These O +
deficits O +
are O +
likely O +
due O +
to O +
impaired O +
muscle O +
strength O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
but O +
contributions O +
by O +
peripheral O +
or O +
central O +
nervous O +
system O +
determinants O +
( O -
or O +
both O -
) O +
could O +
be O +
contributory O -
. O +

Moreover O -
, O +
evidence O +
of O +
altered O +
emotionality O +
from O +
the O +
1-h O +
locomotor O +
activity O +
test O +
also O +
suggests O +
the O +
possibility O +
of O +
altered O +
brain O +
function O +
in O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

It O +
will O +
be O +
of O +
interest O +
to O +
determine O +
whether O +
the O +
neurologic O +
abnormalities O +
contribute O +
to O +
the O +
systemic O +
metabolic O +
abnormalities O +
of O +
the O +
PGC-1α O +
null O +
mice O -
. O +

During O +
the O +
preparation O +
of O +
this O +
manuscript O -
, O +
Lin O +
et O +
al. O +
reported O +
an O +
independent O +
mouse O +
line O +
in O +
which O +
the O +
PGC-1α O +
gene O +
was O +
targeted O +
[ O -
37 O -
] O -
. O +

Phenotypic O +
comparison O +
of O +
the O +
our O +
PGC-1α O -
- O -
deficient O +
line O +
with O +
that O +
of O +
Lin O +
et O +
al. O +
reveals O +
a O +
number O +
of O +
similarities O +
and O +
several O +
interesting O +
differences O -
. O +

Both O +
PGC-1α O -
- O -
deficient O +
lines O +
exhibit O +
cold O +
intolerance O -
, O +
reduced O +
hepatocyte O +
respiration O +
rates O -
, O +
and O +
neurologic O +
lesions O -
. O +

However O -
, O +
a O +
number O +
of O +
interesting O +
differences O +
are O +
notable O -
. O +

First O -
, O +
in O +
contrast O +
to O +
Lin O +
et O +
al. O -
, O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
described O +
here O +
do O +
not O +
exhibit O +
any O +
postnatal O +
mortality O -
. O +

Second O -
, O +
we O +
did O +
not O +
find O +
evidence O +
for O +
a O +
defect O +
in O +
gluconeogenesis O +
based O +
on O +
fasting O +
blood O +
glucose B-Chemical +
levels O +
( O -
unpublished O +
data O -
) O -
. O +

In O +
addition O -
, O +
whereas O +
Lin O +
et O +
al. O +
found O +
an O +
abnormal O +
expression O +
profile O +
forCCAAT O -
- O -
enhancer O -
- O -
binding O +
protein O +
β O +
and O +
δ O +
and O +
the O +
gluconeogenic O +
genes O +
encoding O +
phosphoenolpyruvate B-Chemical +
carboxykinase O +
and O +
glucose-6-phosphatase B-Chemical +
at O +
baseline O +
and O +
with O +
fasting O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O -
, O +
we O +
did O +
not O +
( O -
unpublished O +
data O -
) O -
. O +

Third O -
, O +
we O +
found O +
evidence O +
for O +
an O +
age O -
- O -
related O +
increase O +
in O +
body O +
fat O +
in O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
females O +
earlier O +
than O +
males O -
) O -
, O +
whereas O +
Lin O +
et O +
al. O +
identified O +
a O +
male O -
- O -
specific O +
resistance O +
to O +
diet O -
- O -
induced O +
obesity O +
and O +
insulin O +
resistance O -
. O +

We O +
have O +
also O +
found O +
that O +
male O +
PGC-1α O -
- O -
deficient O +
mice O +
are O +
somewhat O +
protected O +
against O +
diet O -
- O -
induced O +
obesity O +
( O -
Figure O +
S4 O -
) O -
. O +

However O -
, O +
we O +
observed O +
that O +
the O +
insulin O -
- O -
sensitive O +
phenotype O +
of O +
the O +
female O +
PGC-1α− O -
/ O -
− O +
mice O +
occurred O +
in O +
the O +
context O +
of O +
normal O +
weight O +
gain O +
with O +
high O -
- O -
fat O +
diet O -
. O +

These O +
latter O +
results O +
indicate O +
that O +
the O +
insulin O -
- O -
sensitive O +
phenotype O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
can O -
not O +
be O +
fully O +
explained O +
by O +
a O +
lean O +
phenotype O -
. O +

Of O +
interest O -
, O +
mice O +
lacking O +
the O +
nuclear O +
receptor O +
estrogen B-Chemical -
- O -
related O +
receptor O +
α O -
, O +
a O +
known O +
target O +
of O +
PGC-1α O -
, O +
exhibit O +
resistance O +
to O +
diet O -
- O -
induced O +
obesity O +
similar O +
to O +
that O +
of O +
male O +
PGC-1α O +
null O +
mice O +
[ O -
38 O -
] O -
. O +

Fourth O -
, O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
described O +
here O +
exhibit O +
a O +
dramatic O +
fasting O -
- O -
induced O +
hepatic O +
steatotic O +
phenotype O -
, O +
whereas O +
the O +
Lin O +
et O +
al. O +
mouse O +
does O +
not O -
. O +

Fifth O -
, O +
Lin O +
et O +
al. O +
found O +
a O +
neurologic O +
phenotype O +
in O +
males O +
characterized O +
by O +
hyperactivity O -
, O +
whereas O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
described O +
here O +
show O +
reduced O +
locomotor O +
activity O -
. O +

However O -
, O +
it O +
should O +
be O +
noted O +
that O +
we O +
did O +
not O +
study O +
activity O +
levels O +
over O +
an O +
extended O +
period O +
of O +
time O +
in O +
males O +
as O +
did O +
Lin O +
et O +
al. O -
, O +
so O +
it O +
is O +
possible O +
that O +
our O +
findings O +
reflect O +
an O +
emotional O +
disturbance O +
that O +
manifests O +
only O +
when O +
the O +
animals O +
are O +
placed O +
in O +
a O +
new O +
environment O -
. O +

Finally O -
, O +
we O +
report O +
significant O +
skeletal O +
muscle O +
and O +
cardiac O +
functional O +
abnormalities O +
( O -
although O +
the O +
report O +
by O +
Lin O +
et O +
al. O +
did O +
not O +
address O +
these O +
phenotypes O -
, O +
so O +
this O +
may O +
not O +
represent O +
a O +
true O +
difference O -
) O -
. O +

The O +
reasons O +
for O +
the O +
interesting O +
differences O +
between O +
the O +
two O +
PGC-1α O -
- O -
deficient O +
mouse O +
lines O +
are O +
not O +
clear O -
. O +

It O +
is O +
possible O +
that O +
distinct O +
genetic O +
backgrounds O +
related O +
to O +
hybrid O +
strains O +
confer O +
different O +
degrees O +
of O +
secondary O +
compensatory O +
responses O -
. O +

In O +
addition O -
, O +
the O +
incompletely O +
penetrant O +
postnatal O +
mortality O +
noted O +
in O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
reported O +
by O +
Lin O +
et O +
al. O +
could O +
have O +
resulted O +
in O +
a O +
selection O +
bias O +
toward O +
greater O +
levels O +
of O +
compensatory O +
responses O +
in O +
liver O +
and O +
other O +
tissues O +
in O +
the O +
surviving O +
group O -
. O +

It O +
is O +
also O +
possible O +
that O +
the O +
method O +
of O +
gene O +
targeting O +
led O +
to O +
different O +
phenotypes O -
. O +

Lin O +
et O +
al. O +
generated O +
PGC-1α− O -
/ O -
− O +
mice O +
by O +
Cre O +
recombinase O -
- O -
mediated O +
excision O +
of O +
exons O +
3–5 O +
in O +
oocytes O -
. O +

The O +
PGC-1α− O -
/ O -
− O +
mice O +
described O +
here O +
were O +
generated O +
by O +
a O +
targeting O +
event O +
that O +
involved O +
a O +
3′ O +
homologous O +
recombination O +
leading O +
to O +
an O +
insertion O +
of O +
the O +
targeting O +
vector O +
including O +
an O +
extra O +
exon O +
3 O +
between O +
exons O +
5 O +
and O +
6 O -
. O +

The O +
exon O +
3 O +
insertion O -
, O +
which O +
was O +
confirmed O +
by O +
RT O -
- O -
PCR O -
, O +
results O +
in O +
a O +
mutant O +
transcript O +
that O +
encodes O +
a O +
truncated O +
protein O -
. O +

We O +
were O +
unable O +
to O +
detect O +
normal O +
transcript O +
containing O +
an O +
exon O +
5–6 O +
border O -
, O +
indicating O +
that O +
the O +
targeting O +
was O +
accurate O +
and O +
complete O -
. O +

In O +
addition O -
, O +
we O +
could O +
not O +
detect O +
full O -
- O -
length O +
or O +
smaller O +
PGC-1α O +
proteins O +
by O +
Western O +
blotting O -
. O +

However O -
, O +
we O +
can O -
not O +
exclude O +
the O +
possibility O +
that O +
the O +
sensitivity O +
of O +
the O +
immunoblotting O +
was O +
not O +
high O +
enough O +
to O +
pick O +
up O +
a O +
small O +
amount O +
of O +
mutant O +
( O -
truncated O -
) O +
PGC-1α O +
protein O +
that O +
could O +
have O +
some O +
activity O -
, O +
given O +
that O +
it O +
would O +
contain O +
nuclear O +
receptor O -
- O -
interacting O +
domains O +
and O +
the O +
amino O -
- O -
terminal O +
activation O +
domain O -
. O +

If O +
small O +
amounts O +
of O +
PGC-1α O +
activity O +
are O +
present O +
in O +
the O +
mice O +
reported O +
here O -
, O +
it O +
could O +
explain O +
some O +
of O +
the O +
observed O +
differences O +
between O +
the O +
models O -
. O +

However O -
, O +
the O +
bulk O +
of O +
data O +
presented O +
here O +
support O +
the O +
conclusion O +
that O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
described O +
are O +
completely O +
deficient O +
in O +
PGC-1α O -
. O +

Future O +
direct O +
comparison O +
of O +
the O +
two O +
mouse O +
lines O +
in O +
pure O +
background O +
strains O +
will O +
be O +
of O +
interest O -
. O +

In O +
summary O -
, O +
this O +
body O +
of O +
work O +
provides O +
evidence O +
that O +
PGC O -
- O -
lα O +
is O +
critical O +
for O +
the O +
adaptive O +
responses O +
necessary O +
to O +
meet O +
postnatal O +
energy O +
demands O -
. O +

Our O +
results O +
also O +
suggest O +
a O +
broader O +
role O +
for O +
inducible O +
transcriptional O +
coactivators O +
such O +
as O +
PGC-1α O +
in O +
transducing O +
cellular O +
signals O +
triggered O +
by O +
physiologic O +
and O +
developmental O +
cues O +
to O +
the O +
transcriptional O +
control O +
of O +
energy O +
metabolism O +
and O +
other O +
dynamic O +
cellular O +
processes O -
. O +

In O +
this O +
regard O -
, O +
the O +
inducible O +
coactivator O +
PGC-1α O +
serves O +
as O +
a O +
transcriptional O +
" O -
booster O -
" O +
to O +
augment O +
the O +
capacity O +
of O +
downstream O +
metabolic O +
pathways O +
critical O +
for O +
metabolic O +
maturation O +
and O +
postnatal O +
growth O -
. O +

Indeed O -
, O +
although O +
PGC-1α O +
null O +
mice O +
survive O +
in O +
the O +
protected O +
environment O +
of O +
the O +
laboratory O -
, O +
our O +
results O +
indicate O +
that O +
in O +
the O +
rigors O +
of O +
a O +
typical O +
external O +
environment O -
, O +
PGC-1α O +
would O +
be O +
necessary O +
for O +
survival O -
. O +

Lastly O -
, O +
we O +
propose O +
that O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
should O +
serve O +
as O +
a O +
useful O +
murine O +
model O +
to O +
investigate O +
the O +
role O +
of O +
altered O +
energy O +
metabolism O +
in O +
obesity O -
, O +
diabetes O -
, O +
hepatic O +
steatosis O -
, O +
and O +
diseases O +
of O +
the O +
heart O -
, O +
skeletal O +
muscle O -
, O +
and O +
central O +
nervous O +
system O -
. O +

Materials O +
and O +
Methods O +
Targeting O +
the O +
PGC-1α O +
gene O +
in O +
mice O +
A O +
BAC O +
genomic O +
clone O +
containing O +
the O +
murine O +
PGC-1α O +
gene O -
, O +
isolated O +
from O +
an O +
Sv129 O +
genomic O +
library O -
, O +
was O +
obtained O +
from O +
Incyte O +
Genomics O +
( O -
Palo O +
Alto O -
, O +
California O -
, O +
United O +
States O -
) O -
. O +

A O +
3-kb O +
region O +
spanning O +
exon O +
3 O +
was O +
amplified O +
from O +
the O +
genomic O +
clone O -
. O +

A O +
5′ O +
primer O +
was O +
designed O +
to O +
amplify O +
a O +
fragment O +
with O +
the O +
5′ O +
end O +
beginning O +
732 O +
bp O +
upstream O +
of O +
exon O +
3 O +
just O +
upstream O +
of O +
an O +
endogenous O +
Kpn1 O +
restriction O +
site O +
( O -
5′-AGTTTCCTTAGCAACTTCATA-3′ O -
) O -
. O +

The O +
3′ O +
primer O +
contained O +
a O +
BamH1 O +
site O +
engineered O +
by O +
mutating O +
the O +
bases O +
shown O +
in O +
lowercase O +
( O -
5′-AAGGATTTTAgGATccCAGTAC-3′ O -
) O -
. O +

A O +
second O +
fragment O +
downstream O +
of O +
exon O +
5 O +
was O +
amplified O -
. O +

In O +
this O +
latter O +
amplicon O -
, O +
Not1 O +
and O +
Xho1 O +
sites O +
were O +
engineered O +
into O +
the O +
5′ O +
and O +
3′ O +
primers O -
, O +
respectively O +
( O -
5′-TGGAGTgcGGCCGCTGGGA-3′ O +
and O +
5′-AAAGAGTCTCgAgAATAGTTTCT-3′ O -
) O -
. O +

The O +
fragments O +
were O +
cloned O +
into O +
p1339-PGK O -
- O -
Neomycin O +
targeting O +
vector O -
. O +

The O +
construct O +
was O +
linearized O +
with O +
Xho1 O +
and O +
electroporated O +
into O +
RW4 O +
ES O +
cells O +
( O -
Sv129 O +
derived O -
) O +
using O +
G418 B-Chemical +
selection O -
. O +

The O +
electroporation O +
was O +
performed O +
by O +
the O +
Siteman O +
Cancer O +
Center O +
ES O +
Cell O +
Core O +
at O +
Washington O +
University O +
( O -
St. O +
Louis O -
, O +
Missouri O -
, O +
United O +
States O -
) O -
. O +

The O +
clones O +
were O +
screened O +
by O +
Southern O +
blot O +
using O +
an O +
Xba1 O +
digest O +
( O -
see O +
Figure O +
1A O +
and O +
1B O -
) O -
. O +

One O +
clone O +
out O +
of O +
approximately O +
400 O +
screened O +
was O +
positive O +
for O +
the O +
homologous O +
recombination O +
on O +
the O +
3′ O +
end O +
and O +
an O +
insertion O +
on O +
the O +
5′ O +
end O -
. O +

This O +
clone O +
was O +
injected O +
into O +
a O +
C57BL6 O -
/ O -
J O +
blastocyst O -
. O +

Chimeras O +
were O +
mated O +
to O +
C57BL6 O -
/ O -
J O +
mice O +
and O +
germline O +
transmission O +
was O +
confirmed O +
by O +
Southern O +
blotting O +
of O +
tail O +
DNA O +
( O -
see O +
Figure O +
1B O -
) O -
. O +

All O +
experiments O +
were O +
performed O +
using O +
sex- O +
and O +
age O -
- O -
matched O +
or O +
littermate O +
controls O +
as O +
noted O -
. O +

General O +
animal O +
studies O +
All O +
animal O +
experiments O +
and O +
euthanasia O +
protocols O +
were O +
conducted O +
in O +
strict O +
accordance O +
with O +
the O +
National O +
Institutes O +
of O +
Health O +
guidelines O +
for O +
humane O +
treatment O +
of O +
animals O +
and O +
were O +
reviewed O +
and O +
approved O +
by O +
the O +
Animal O +
Care O +
Committee O +
of O +
Washington O +
University O -
. O +

Animals O +
were O +
weighed O +
at O +
different O +
time O +
points O -
. O +

Male O +
and O +
female O +
3- O +
to O +
8-wk O -
- O -
old O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O +
were O +
euthanized O -
, O +
and O +
tissues O +
were O +
dissected O +
and O +
weighed O +
on O +
an O +
analytical O +
balance O -
. O +

Tissue O +
weights O +
were O +
corrected O +
for O +
total O +
body O +
weight O +
before O +
comparison O -
. O +

DEXA O +
studies O +
were O +
performed O +
as O +
previously O +
described O +
[ O -
39 O -
] O +
using O +
a O +
Lunar O +
PIXIMUS O +
DEXA O +
system O +
at O +
10 O -
, O +
18 O -
, O +
and O +
24 O +
wk O +
in O +
male O +
and O +
female O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

For O +
cold O +
exposure O +
experiments O -
, O +
male O +
and O +
female O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O +
were O +
singly O +
housed O +
and O +
placed O +
at O +
4 O +
° O -
C O +
for O +
5 O +
h O +
without O +
food B-Chemical -
. O +

Core O +
body O +
temperatures O +
were O +
monitored O +
by O +
rectal O +
probe O +
at O +
baseline O +
and O +
every O +
hour O +
thereafter O -
. O +

Mice O +
were O +
monitored O +
at O +
least O +
every O +
30 O +
min O +
to O +
check O +
for O +
lethargy O -
. O +

At O +
the O +
end O +
of O +
5 O +
h O -
, O +
mice O +
were O +
sacrificed O +
and O +
tissues O +
harvested O +
for O +
RNA O +
and O +
protein O +
extraction O -
. O +

For O +
fasting O +
studies O -
, O +
animals O +
were O +
singly O +
housed O +
and O +
given O +
water B-Chemical +
ad O +
libitum O -
. O +

Food B-Chemical +
was O +
removed O +
from O +
cages O +
in O +
the O +
morning O +
and O +
tissues O +
harvested O +
at O +
24 O +
h O +
for O +
RNA O +
and O +
histology O -
. O +

Photography O +
of O +
the O +
mice O +
was O +
performed O +
by O +
MedPic O +
at O +
Washington O +
University O +
School O +
of O +
Medicine O -
. O +

48-h O +
activity O +
monitoring O +
was O +
performed O +
by O +
JAX O +
Services O +
( O -
The O +
Jackson O +
Laboratory O -
, O +
West O +
Sacramento O -
, O +
California O -
, O +
United O +
States O -
) O +
using O +
a O +
Comprehensive O +
Laboratory O +
Animal O +
Monitoring O +
System O +
( O -
CLAMS O -
, O +
Columbus O +
Instruments O -
, O +
Columbus O -
, O +
Ohio O -
, O +
United O +
States O -
) O -
. O +

Briefly O -
, O +
3-mo O -
- O -
old O +
female O +
mice O +
were O +
acclimated O +
for O +
17 O +
h O +
before O +
data O +
collection O -
. O +

Data O +
were O +
collected O +
every O +
30 O +
min O -
. O +

Total O +
beam O +
breaks O +
in O +
the O +
XY O +
direction O +
were O +
tabulated O +
for O +
the O +
12-h O +
light O +
and O +
dark O +
cycles O +
and O +
compared O +
across O +
genotypes O -
. O +

RNA O -
, O +
DNA O -
, O +
and O +
protein O +
analyses O +
Total O +
RNA O +
was O +
isolated O +
by O +
the O +
RNAzol O +
method O +
( O -
Tel O -
- O -
Test O -
, O +
Friendswood O -
, O +
Texas O -
) O +
and O +
Northern O +
blotting O +
was O +
performed O +
as O +
previously O +
described O +
[ O -
40 O -
] O -
. O +

The O +
PGC-1β O +
and O +
PRC O +
cDNAs O +
were O +
generous O +
gifts O +
from O +
Bruce O +
Spiegelman O +
and O +
Richard O +
Scarpulla O -
, O +
respectively O -
. O +

The O +
UCP-1 O +
cDNA O +
was O +
a O +
gift O +
from O +
Daniel O +
Ricquier O -
. O +

RT O -
- O -
PCR O +
was O +
performed O +
as O +
described O +
[ O -
41 O -
] O -
. O +

In O +
brief O -
, O +
total O +
RNA O +
isolated O +
from O +
soleus O +
muscle O -
, O +
BAT O -
, O +
and O +
heart O +
of O +
1–2-mo O -
- O -
old O +
PGC-1α+ O -
/ O -
+ O +
or O +
PGCα− O -
/ O -
− O +
mice O +
was O +
reverse O +
transcribed O +
with O +
Taqman O +
reverse O +
transcription O +
reagents B-Chemical +
( O -
Applied O +
Biosystems O -
, O +
Foster O +
City O -
, O +
California O -
, O +
United O +
States O -
) O -
. O +

Reactions O +
were O +
performed O +
in O +
triplicate O +
in O +
96-well O +
format O +
using O +
Taqman O +
core O +
reagents B-Chemical +
and O +
a O +
Prism O +
7500 O +
Sequence O +
Detector O +
( O -
Applied O +
Biosystems O -
) O -
. O +

The O +
mouse O -
- O -
specific O +
primer O -
- O -
probe O +
sets O +
used O +
to O +
detect O +
specific O +
gene O +
expression O +
can O +
be O +
found O +
in O +
Table O +
S1 O -
. O +

The O +
primers O +
for O +
UCP-1 O +
have O +
been O +
previously O +
described O +
[ O -
42 O -
] O -
. O +

Actin O +
primer O -
- O -
probe O +
set O +
( O -
Applied O +
Biosystems O -
) O +
was O +
included O +
in O +
a O +
separate O +
well O +
and O +
used O +
to O +
normalize O +
the O +
soleus O -
, O +
BAT O -
, O +
and O +
heart O +
gene O +
expression O +
data O -
. O +

GAPDH O +
Rodent O +
primers O +
( O -
Applied O +
Biosystems O -
) O +
were O +
used O +
in O +
the O +
same O +
well O +
to O +
normalize O +
the O +
liver O +
gene O +
expression O +
data O -
. O +

For O +
Southern O +
blot O +
studies O -
, O +
5 O +
μg O +
of O +
genomic O +
DNA O +
was O +
digested O +
with O +
Pst1 O +
or O +
Xba1 O -
, O +
electrophoresed O +
on O +
a O +
0.8 O -
% O +
TAE O +
gel O +
and O +
transferred O +
to O +
a O +
Gene O +
Screen O +
( O -
Perkin O +
Elmer O -
, O +
Wellesley O -
, O +
California O -
, O +
United O +
States O -
) O +
membrane O +
for O +
hybridization O -
. O +

Western O +
blotting O +
was O +
performed O +
as O +
described O +
[ O -
43 O -
] O +
using O +
the O +
Enhanced O +
Chemiluminescence O +
detection O +
system O +
( O -
Amersham O +
Pharmacia O +
Biotech O -
, O +
Piscataway O -
, O +
New O +
Jersey O -
, O +
United O +
States O -
) O -
. O +

Ponceau O +
S O +
( O -
Sigma O -
, O +
St. O +
Louis O -
, O +
Missouri O -
, O +
United O +
States O -
) O +
staining O +
of O +
the O +
membrane O +
was O +
used O +
as O +
a O +
control O -
. O +

Mitochondrial O +
respiration O +
studies O +
Mitochondrial O +
respiration O +
was O +
assessed O +
in O +
saponin B-Chemical -
- O -
skinned O +
soleus O +
fibers O +
with O +
succinate O +
as O +
substrate O +
and O +
in O +
the O +
presence O +
of O +
rotenone B-Chemical +
as O +
previously O +
described O +
[ O -
44 O -
] O -
. O +

In O +
brief O -
, O +
3-mo O -
- O -
old O +
female O +
mice O +
were O +
anesthetized O +
with O +
chloral B-Chemical +
hydrate I-Chemical +
( O -
400 O +
mg O -
/ O -
kg O +
of O +
body O +
weight O -
) O -
. O +

Soleus O +
fibers O +
were O +
separated O +
and O +
then O +
transferred O +
to O +
a O +
buffer O +
( O -
2.77 O +
mM O +
K2Ca O -
- O -
EGTA O -
, O +
7.23 O +
mM O +
K2EGTA O -
, O +
6.56 O +
mM O +
MgCl2 B-Chemical -
, O +
20 O +
mM O +
imidazole B-Chemical -
, O +
53.3 O +
mM O +
K O -
- O -
MES B-Chemical -
, O +
20 O +
mM O +
taurine B-Chemical -
, O +
5.3 O +
mM O +
ATP O -
, O +
15 O +
mM O +
PCr B-Chemical -
, O +
3 O +
mM O +
KH2PO4 B-Chemical -
, O +
0.5 O +
mM O +
DTT B-Chemical +
[ O -
pH O +
7.1 O -
] O -
) O +
supplemented O +
with O +
50 O +
μg O -
/ O -
ml O +
saponin B-Chemical +
and O +
permeabilized O +
for O +
30 O +
min O +
at O +
4 O +
° O -
C O +
with O +
gentle O +
stirring O -
. O +

Fibers O +
were O +
then O +
washed O +
twice O +
for O +
10 O +
min O +
each O +
( O -
2.77 O +
mM O +
K2Ca O -
- O -
EGTA O -
, O +
7.23 O +
mM O +
K2EGTA O -
, O +
1.38 O +
mM O +
MgCl2 B-Chemical -
, O +
20 O +
mM O +
imidazole B-Chemical -
, O +
100 O +
mM O +
K O -
- O -
MES B-Chemical -
, O +
20 O +
mM O +
taurine B-Chemical -
, O +
3 O +
mM O +
KH2PO4 B-Chemical -
, O +
0.5 O +
mM O +
DTT B-Chemical -
, O +
2 O +
mg O -
/ O -
ml O +
BSA O +
[ O -
pH O +
7.1 O -
] O -
) O -
. O +

Respiration O +
was O +
measured O +
at O +
25 O +
° O -
C O +
using O +
an O +
optical O +
probe O +
( O -
Oxygen O +
FOXY O +
Probe O -
, O +
Ocean O +
Optics O -
, O +
Dunedin O -
, O +
Florida O -
, O +
United O +
States O -
) O -
. O +

Following O +
measurement O +
of O +
basal O +
state O +
2 O +
respiration O -
, O +
maximal O +
( O -
ADP O -
- O -
stimulated O -
) O +
state O +
3 O +
respiration O +
was O +
determined O +
by O +
exposing O +
fibers O +
to O +
1 O +
mM O +
ADP O -
. O +

The O +
integrity O +
of O +
the O +
outer O +
mitochondrial O +
membrane O +
was O +
assessed O +
by O +
adding O +
8 O +
μM O +
exogenous O +
cytochrome B-Chemical +
c I-Chemical +
to O +
ADP O -
- O -
stimulated O +
fibers O -
. O +

State O +
4 O +
respiration O +
( O -
uncoupled O -
) O +
was O +
evaluated O +
following O +
addition O +
of O +
oligomycin B-Chemical +
( O -
1 O +
μg O -
/ O -
ml O -
) O -
. O +

The O +
solubility O +
of O +
oxygen O +
in O +
the O +
respiration O +
buffer O +
at O +
25 O +
° O -
C O +
was O +
taken O +
as O +
246.87 O +
nmol O +
O2 B-Chemical +
· O +
ml−1 O -
. O +

Respiration O +
rates O +
were O +
expressed O +
as O +
nmol O +
O2 B-Chemical +
· O +
min−1 O +
· O +
mgdw−1 O -
. O +

Insulin O +
and O +
glucose B-Chemical +
tolerance O +
tests O +
Glucose B-Chemical +
and O +
Insulin O +
tolerance O +
tests O +
were O +
performed O +
as O +
described O +
[ O -
35 O -
] O -
. O +

Prior O +
to O +
studies O -
, O +
mice O +
were O +
fasted O +
overnight O +
( O -
GTT O -
) O +
or O +
6 O +
h O +
( O -
ITT O -
) O -
. O +

In O +
GTT O +
studies O -
, O +
mice O +
were O +
injected O +
with O +
a O +
10 O -
% O +
solution B-Chemical +
of O +
D B-Chemical -
- I-Chemical -
glucose I-Chemical +
( O -
1 O +
g O -
/ O -
kg O -
) O -
. O +

For O +
ITT O -
, O +
mice O +
received O +
an O +
IP O +
injection O +
of O +
human B-Chemical +
regular O +
insulin B-Chemical +
( O -
Eli O +
Lilly O -
, O +
Indianapolis O -
, O +
Indiana O -
, O +
United O +
States O -
) O +
at O +
a O +
dose O +
of O +
0.75 O +
units O -
/ O -
kg O +
of O +
body O +
weight O -
. O +

Tail O +
blood O +
glucose B-Chemical +
was O +
determined O +
at O +
0 O -
, O +
30 O -
, O +
60 O -
, O +
and O +
120 O +
min O +
after O +
challenge O +
using O +
a O +
B O -
- O -
GLUCOSE B-Chemical +
Analyzer O +
( O -
Hemacue O +
AB O -
, O +
Angelholm O -
, O +
Sweden O -
) O -
. O +

Indirect O +
calorimetry O +
Oxygen O +
consumption O +
rates O +
( O -
VO2 O -
) O +
of O +
5-wk O -
- O -
old O +
female O +
mice O +
were O +
measured O +
using O +
a O +
Columbus O +
Instruments O +
Oxymax O +
System O -
. O +

Resting O +
baseline O +
oxygen O +
consumption O +
rates O +
were O +
assessed O +
for O +
at O +
least O +
1.0 O +
h. O +
For O +
β3-adrenergic O +
stimulation O +
studies O -
, O +
BRL O +
37344 O +
( O -
Sigma O -
) O +
was O +
dissolved O +
in O +
sterile O +
saline O +
and O +
injected O +
IP O +
( O -
2 O +
μg O -
/ O -
g O +
of O +
body O +
weight O -
) O +
[ O -
45 O -
] O -
. O +

Postagonist O +
assessment O +
of O +
oxygen O +
consumption O +
was O +
recorded O +
for O +
an O +
additional O +
1.0 O +
h O -
, O +
with O +
data O +
collected O +
at O +
the O +
40-min O +
time O +
point O -
. O +

Histology O +
and O +
electron B-Chemical +
microscopy O +
Soleus O +
muscle O +
and O +
liver O +
were O +
dissected O +
and O +
fixed O +
overnight O +
in O +
2 O -
% O +
glutaraldehyde B-Chemical -
, O +
1 O -
% O +
paraformaldehyde O -
, O +
and O +
0.08 O -
% O +
sodium B-Chemical +
cacodylate I-Chemical +
buffer O -
. O +

The O +
tissues O +
were O +
postfixed O +
in O +
1 O -
% O +
osmium O +
tetroxide O -
, O +
dehydrated O +
in O +
graded O +
ethanol B-Chemical -
, O +
embedded O +
in O +
Poly O +
Bed O +
plastic O +
resin O -
, O +
and O +
sectioned O +
for O +
electron B-Chemical +
microscopy O -
. O +

Cardiac O +
and O +
skeletal O +
muscle O +
mitochondrial O +
and O +
myofibrillar O +
volume O +
densities O +
were O +
determined O +
from O +
electron B-Chemical +
micrographs O +
as O +
described O +
previously O +
[ O -
10 O -
] O -
. O +

For O +
each O +
animal O -
, O +
three O +
different O +
fields O +
at O +
the O +
magnification O +
of O +
7500 O -
× O +
were O +
quantified O +
in O +
blinded O +
fashion O -
. O +

Data O +
were O +
expressed O +
as O +
mean O +
volume O +
density O +
of O +
mitochondria O +
or O +
myofibrils O +
in O +
each O +
field O -
. O +

For O +
electron B-Chemical +
microscopic O +
analysis O +
of O +
the O +
brain O -
, O +
tissue O +
was O +
prepared O +
as O +
previously O +
described O +
[ O -
46 O -
] O -
. O +

Ultrathin O +
sections O +
of O +
cortex O +
were O +
cut O +
onto O +
formvar O -
- O -
coated O +
slot O +
grids O +
stained O +
with O +
uranyl O +
acetate O +
and O +
lead O +
citrate O +
and O +
examined O +
with O +
a O +
JEOL O +
1200 O +
electron B-Chemical +
microscope O -
. O +

For O +
H&E B-Chemical +
staining O -
, O +
sections O +
of O +
brain O -
, O +
including O +
cerebral O +
cortex O -
, O +
brainstem O -
, O +
and O +
cerebellum O -
, O +
were O +
dehydrated O +
in O +
graded O +
concentrations O +
of O +
alcohol B-Chemical +
and O +
embedded O +
in O +
paraffin O +
from O +
which O +
5-μm O +
sections O +
were O +
prepared O -
. O +

Primary O +
mouse O +
hepatocyte O +
studies O +
Primary O +
cultures O +
of O +
mouse O +
hepatocytes O +
were O +
prepared O +
from O +
male O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O +
essentially O +
as O +
described O +
[ O -
47 O -
] O -
. O +

Fatty B-Chemical +
acid I-Chemical +
oxidation O +
and O +
triglyceride B-Chemical +
synthesis O +
experiments O +
were O +
commenced O +
2–3 O +
h O +
after O +
the O +
cells O +
were O +
plated O -
. O +

Triglyceride B-Chemical +
synthesis O +
studies O -
, O +
were O +
performed O +
as O +
previously O +
described O +
[ O -
47 O -
] O -
. O +

Palmitate B-Chemical +
oxidation O +
rates O +
were O +
quantified O +
using O +
[ O -
9,10 O -
- O -
3H B-Chemical -
] O -
-palmitic O +
acid B-Chemical +
as O +
described O +
[ O -
48 O -
] O +
and O +
corrected O +
for O +
total O +
cellular O +
protein O +
content O -
. O +

For O +
respiration O +
studies O -
, O +
cells O +
were O +
spun O +
down O +
prior O +
to O +
plating O +
and O +
resuspended O +
in O +
a O +
permeabilization O +
buffer O +
( O -
described O +
above O -
) O +
containing O +
50 O +
μg O -
/ O -
ml O +
saponin B-Chemical -
. O +

Respiration O +
studies O +
were O +
performed O +
in O +
the O +
presence O +
of O +
5 O +
mM O +
succinate O +
in O +
the O +
presence O +
of O +
10 O +
μM O +
rotenone B-Chemical -
. O +

Respiration O +
rates O +
were O +
expressed O +
as O +
nmol O +
O2 B-Chemical +
· O +
min−1 O +
· O +
mg O +
of O +
protein−1 O -
. O +

Evaluation O +
of O +
locomotor O +
activity O -
, O +
sensorimotor O +
capabilities O -
, O +
and O +
muscle O +
function O +
To O +
evaluate O +
general O +
activity O +
levels O +
and O +
muscle O +
use O -
, O +
mice O +
were O +
evaluated O +
over O +
a O +
1-h O +
period O +
in O +
transparent O +
( O -
47.6 O +
cm O +
× O +
25.4 O +
cm O +
× O +
20.6 O +
cm O -
) O +
polystyrene O +
enclosures O +
as O +
previously O +
described O +
[ O -
49 O -
] O +
using O +
a O +
high O -
- O -
resolution O +
photobeam O +
system O +
( O -
Motor O +
Monitor O -
, O +
Hamilton O -
- O -
Kinder O -
, O +
Poway O -
, O +
California O -
, O +
United O +
States O -
) O -
. O +

Each O +
enclosure O +
was O +
surrounded O +
by O +
a O +
frame O +
containing O +
a O +
4 O +
× O +
8 O +
matrix O +
of O +
photocell O +
pairs O -
, O +
the O +
output O +
of O +
which O +
was O +
fed O +
to O +
an O +
on O -
- O -
line O +
computer O -
. O +

The O +
system O +
software O +
( O -
Hamilton O -
- O -
Kinder O -
) O +
was O +
used O +
to O +
define O +
a O +
33 O +
cm O +
× O +
11 O +
cm O +
central O +
zone O +
and O +
a O +
peripheral O +
or O +
surrounding O +
zone O +
that O +
was O +
5.5 O +
cm O +
wide O +
with O +
the O +
sides O +
of O +
the O +
cage O +
being O +
the O +
outermost O +
boundary O -
. O +

This O +
peripheral O +
area O +
extended O +
along O +
the O +
entire O +
perimeter O +
of O +
the O +
cage O -
. O +

Variables O +
that O +
were O +
analyzed O +
included O +
the O +
total O +
number O +
of O +
ambulations O -
, O +
as O +
well O +
as O +
the O +
number O +
of O +
entries O -
, O +
the O +
time O +
spent O -
, O +
and O +
the O +
distance O +
traveled O +
in O +
the O +
center O +
area O +
as O +
well O +
as O +
the O +
distance O +
traveled O +
in O +
the O +
periphery O +
surrounding O +
the O +
center O -
. O +

The O +
total O +
number O +
of O +
ambulations O +
and O +
rearings O +
were O +
recorded O -
. O +

For O +
the O +
inverted O +
screen O +
test O -
, O +
mice O +
were O +
placed O +
on O +
a O +
wire O +
mesh O +
grid O +
( O -
16 O +
squares O +
per O +
10 O +
cm O -
) O +
and O +
the O +
screen O +
was O +
inverted O +
to O +
180 O -
° O -
. O +

A O +
maximum O +
score O +
of O +
60 O +
s O +
was O +
given O +
if O +
an O +
animal O +
did O +
not O +
fall O -
. O +

The O +
tests O +
included O +
in O +
the O +
sensorimotor O +
battery O +
[ O -
50 O -
] O +
and O +
accompanying O +
protocols O +
were O +
designed O +
as O +
follows O -
. O +

( O -
1 O -
) O +
Inclined O +
screen O +
and O +
inverted O +
screen O +
tests O -
: O +

For O +
the O +
inclined O +
screen O +
tests O -
, O +
each O +
mouse O +
was O +
placed O +
on O +
top O +
of O +
an O +
elevated O +
( O -
47 O +
cm O +
above O +
the O +
floor O -
) O +
wire O +
mesh O +
grid O +
( O -
16 O +
squares O +
per O +
10 O +
cm O -
) O +
that O +
was O +
inclined O +
to O +
60 O -
° O +
or O +
90 O -
° O -
. O +

Each O +
animal O +
was O +
placed O +
in O +
the O +
middle O +
of O +
the O +
screen O +
with O +
its O +
head O +
oriented O +
down O +
and O +
was O +
timed O +
for O +
how O +
long O +
it O +
remained O +
on O +
the O +
screen O +
and O +
how O +
long O +
it O +
took O +
to O +
climb O +
to O +
the O +
top O +
of O +
the O +
screen O -
. O +

For O +
the O +
inverted O +
screen O +
test O -
, O +
mice O +
were O +
placed O +
as O +
above O +
and O +
then O +
the O +
screen O +
was O +
inverted O +
to O +
180 O -
° O -
. O +

A O +
maximum O +
score O +
of O +
60 O +
s O +
was O +
given O +
if O +
an O +
animal O +
did O +
not O +
fall O -
; O +
( O -
2 O -
) O +
Platform O +
test O -
: O +
Each O +
mouse O +
was O +
timed O +
for O +
how O +
long O +
it O +
remained O +
on O +
an O +
elevated O +
( O -
47 O +
cm O +
above O +
the O +
floor O -
) O +
circular O +
platform O +
( O -
1.0 O +
cm O +
thick O +
and O +
3.0 O +
cm O +
in O +
diameter O -
) O -
. O +

A O +
maximum O +
score O +
of O +
60 O +
s O +
was O +
assigned O +
if O +
the O +
mouse O +
remained O +
on O +
the O +
platform O +
for O +
the O +
maximum O +
amount O +
of O +
time O +
or O +
if O +
it O +
could O +
climb O +
down O +
on O +
a O +
very O +
thin O +
pole O +
that O +
supported O +
the O +
platform O -
, O +
without O +
falling O -
; O +
( O -
3 O -
) O +
Ledge O +
test O -
: O +
Each O +
mouse O +
was O +
timed O +
for O +
how O +
long O +
it O +
could O +
maintain O +
its O +
balance O +
on O +
a O +
0.75-cm O +
wide O +
Plexiglas O +
ledge O +
without O +
falling O +
( O -
60 O +
s O +
maximum O -
) O -
. O +

A O +
score O +
of O +
60 O +
s O +
was O +
also O +
assigned O +
if O +
the O +
mouse O +
traversed O +
the O +
entire O +
length O +
( O -
51 O +
cm O -
) O +
of O +
the O +
Plexiglas O +
ledge O +
and O +
returned O +
to O +
the O +
starting O +
place O +
in O +
less O +
than O +
60 O +
s O +
without O +
falling O -
; O +
( O -
4 O -
) O +
Walking O +
initiation O +
test O -
: O +
Each O +
mouse O +
was O +
placed O +
in O +
the O +
middle O +
of O +
a O +
square O +
outlined O +
by O +
white O +
cloth O +
tape O +
( O -
21 O +
cm O +
× O +
21 O +
cm O -
) O +
on O +
a O +
smooth O +
black O +
surface O +
of O +
a O +
large O +
tabletop O -
. O +

The O +
time O +
it O +
took O +
each O +
mouse O +
to O +
leave O +
the O +
square O +
( O -
place O +
all O +
four O +
paws O +
outside O +
of O +
the O +
tape O -
) O +
was O +
recorded O -
. O +

The O +
maximum O +
time O +
allowed O +
was O +
60 O +
s. O +
6–8-mo O -
- O -
old O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
4 O -
) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
8) O +
mice O +
were O +
run O +
to O +
exhaustion O +
employing O +
a O +
motorized O -
, O +
speed O +
controlled O -
, O +
modular O +
treadmill O +
system O +
( O -
Columbus O +
Instruments O -
) O -
. O +

The O +
treadmill O +
was O +
equipped O +
with O +
an O +
electric O +
shock O +
stimulus O +
and O +
an O +
adjustable O +
inclination O +
angle O -
. O +

Running O +
velocity O +
was O +
set O +
at O +
35 O +
m O -
/ O -
min O -
, O +
with O +
a O +
level O +
inclination O +
angle O -
. O +

VO2max O +
studies O +
VO2max O +
was O +
determined O +
while O +
the O +
mice O +
were O +
running O +
on O +
a O +
treadmill O +
using O +
an O +
open O +
flow O +
system O +
( O -
Columbus O +
Instruments O +
Oxymax O +
System O -
) O -
. O +

All O +
measurements O +
of O +
oxygen O +
consumption O +
took O +
place O +
at O +
an O +
elevation O +
of O +
150 O +
m O +
( O -
ambient O +
PBAR O +
= O +
745 O +
torr O -
) O -
. O +

Animals O +
were O +
placed O +
into O +
the O +
metabolic O +
chamber O +
for O +
3–5 O +
min O +
to O +
allow O +
the O +
system O +
to O +
equilibrate O -
. O +

Mice O +
were O +
then O +
induced O +
to O +
run O +
up O +
an O +
18 O -
° O +
incline O +
at O +
a O +
speed O +
of O +
40 O +
m O -
/ O -
min O +
using O +
a O +
shock O +
grid O +
in O +
the O +
rear O +
of O +
the O +
chamber O -
. O +

The O +
speed O +
was O +
increased O +
by O +
5 O +
m O -
/ O -
min O +
every O +
2 O +
min O +
until O +
the O +
animals O +
were O +
unable O +
to O +
continue O -
. O +

Maximal O +
effort O +
was O +
determined O +
when O +
oxygen O +
uptake O +
did O +
not O +
increase O +
with O +
power O +
output O +
and O +
subsequently O +
the O +
mouse O +
failed O +
to O +
maintain O +
effort O -
. O +

VO2max O +
was O +
calculated O +
using O +
the O +
averaged O +
values O +
over O +
1 O +
min O +
during O +
which O +
the O +
animal O -
's O +
O2 B-Chemical +
consumption O +
reached O +
a O +
plateau O -
. O +

Isolated O +
muscle O +
stimulation O +
studies O +
Animals O +
were O +
anesthetized O +
with O +
ketamine B-Chemical -
/ O -
xylazine O +
and O +
the O +
soleus O +
muscle O +
was O +
removed O +
from O +
one O +
leg O -
. O +

Upon O +
removal O -
, O +
the O +
muscle O +
was O +
suspended O +
in O +
a O +
Krebs O +
solution B-Chemical +
aerated O +
with O +
95 O -
% O +
O2 B-Chemical +
and O +
5 O -
% O +
CO2 B-Chemical -
. O +

The O +
muscle O +
and O +
Krebs O +
solution B-Chemical +
were O +
suspended O +
within O +
a O +
water B-Chemical +
bath O +
maintained O +
at O +
37 O +
° O -
C O -
, O +
and O +
the O +
muscle O +
was O +
anchored O +
to O +
a O +
Grass O +
( O -
West O +
Warwick O -
, O +
Rhode O +
Island O -
, O +
United O +
States O -
) O +
isometric O +
force O +
transducer O +
( O -
model O +
FTO3C O -
) O -
. O +

Muscles O +
were O +
stimulated O +
to O +
contract O +
with O +
a O +
Grass O +
stimulator O +
( O -
model O +
S88 O -
) O +
generating O +
a O +
field O +
stimulus O +
through O +
electrodes O +
located O +
at O +
both O +
ends O +
of O +
the O +
muscle O -
. O +

Force O -
- O -
voltage O +
( O -
maximal O +
force O +
at O +
about O +
100 O +
V O -
) O +
and O +
length O -
- O -
tension O +
relationships O +
were O +
determined O +
using O +
single O +
twitch O +
stimuli O -
. O +

The O +
stimulator O +
then O +
delivered O +
repeating O +
trains O +
of O +
stimuli O +
at O +
one O +
per O +
second O +
at O +
40 O +
Hz O +
for O +
2 O +
min O -
. O +

Each O +
train O +
lasted O +
330 O +
ms O -
, O +
and O +
were O +
digitally O +
recorded O +
using O +
MacLab O +
( O -
AD O +
Instruments O -
, O +
Colorado O +
Springs O -
, O +
Colorado O -
, O +
United O +
States O -
) O -
. O +

Fatigue O +
resistance O +
was O +
calculated O +
as O +
the O +
ratio O +
of O +
the O +
force O +
generated O +
by O +
the O +
last O +
tetanus O +
divided O +
by O +
the O +
highest O +
force O +
generated O +
multiplied O +
by O +
100 O +
to O +
give O +
the O +
percent O +
of O +
force O +
generation O +
that O +
remained O +
after O +
the O +
fatigue O +
protocol O -
. O +

Exercise O +
echocardiography O +
Adult O +
female O +
mice O +
( O -
6–8 O +
mo O +
old O -
) O +
were O +
exercised O +
on O +
the O +
motorized O +
treadmill O +
using O +
the O +
run O -
- O -
to O -
- O -
exhaustion O +
settings O +
described O +
above O +
for O +
60 O +
s O +
or O +
until O +
exhaustion O -
, O +
whichever O +
came O +
first O -
. O +

Immediately O +
following O +
its O +
treadmill O +
run O -
, O +
the O +
mouse O +
was O +
subjected O +
to O +
serial O +
echocardiography O +
using O +
an O +
Acuson O +
Sequoia O +
Echocardiography O +
System O +
performed O +
as O +
previously O +
described O +
[ O -
51 O -
] O -
. O +

In O +
vivo O +
cardiac O +
hemodynamic O +
studies O +
Hemodynamic O +
studies O +
were O +
performed O +
as O +
previously O +
described O +
with O +
some O +
modifications O +
[ O -
52 O -
] O -
. O +

In O +
brief O -
, O +
adult O +
mice O +
( O -
10–12 O +
wk O -
) O +
were O +
anesthetized O +
intraperitoneally O +
( O -
IP O -
) O +
with O +
thiopental B-Chemical +
sodium I-Chemical +
( O -
60 O +
mg O -
/ O -
kg O -
) O -
. O +

The O +
mice O +
were O +
intubated O +
and O +
ventilated O +
with O +
a O +
Harvard O +
ventilator O -
. O +

The O +
right O +
carotid O +
artery O +
was O +
isolated O +
in O +
the O +
region O +
of O +
the O +
trachea O +
and O +
cannulated O +
with O +
a O +
1.4-French O +
high O -
- O -
fidelity O +
micromanometer O +
catheter O +
( O -
Millar O +
Instruments O -
, O +
Houston O -
, O +
Texas O -
, O +
United O +
States O -
) O -
, O +
which O +
was O +
inserted O +
into O +
the O +
left O +
ventricle O +
retrograde O +
across O +
the O +
aortic O +
valve O -
. O +

Hemodynamic O +
measurements O +
were O +
recorded O +
at O +
baseline O +
and O +
3 O +
min O +
following O +
continuous O +
infusion O +
of O +
incremental O +
doses O +
of O +
dobutamine B-Chemical +
( O -
β1 O -
, O +
β2 O -
, O +
and O +
α1-adrenergic O +
agonist B-Chemical -
) O +
up O +
to O +
32 O +
ng O +
· O +
gBW−1 O -
· O +
min−1 O +
[ O -
53 O -
] O -
. O +

Continuous O +
pressure O -
- O -
volume O +
data O +
were O +
acquired O +
and O +
digitized O +
with O +
the O +
BioBench O +
computer O +
software O +
data O +
acquisition O +
system O +
( O -
National O +
Instruments O -
, O +
Austin O -
, O +
Texas O -
, O +
United O +
States O -
) O -
. O +

Isolated O +
working O +
mouse O +
heart O +
perfusion O +
Isolated O +
working O +
mouse O +
heart O +
perfusion O +
was O +
based O +
on O +
a O +
previously O +
described O +
procedure O +
[ O -
54 O -
] O -
. O +

Adult O +
mice O +
( O -
4–7 O +
mo O +
old O -
) O +
were O +
heparinized O +
( O -
100 O +
units O +
IP O -
) O +
10 O +
min O +
prior O +
to O +
anesthesia O -
. O +

Animals O +
were O +
then O +
deeply O +
anesthetized O +
with O +
5–10 O +
mg O +
of O +
sodium B-Chemical +
pentobarbital I-Chemical +
IP O -
. O +

Hearts O +
were O +
excised O +
and O +
placed O +
in O +
an O +
ice O -
- O -
cold O +
Krebs O -
- O -
Henseleit O +
bicarbonate B-Chemical +
( O -
KHB O -
) O +
solution B-Chemical +
[ O -
118 O +
mM O +
NaCl B-Chemical -
, O +
25 O +
mM O +
NaHCO3 B-Chemical -
, O +
4.7 O +
mM O +
KCl B-Chemical -
, O +
1.2 O +
mM O +
KH2PO4 B-Chemical -
, O +
2.5 O +
mM O +
CaCl2 B-Chemical -
, O +
5.0 O +
mM O +
glucose B-Chemical -
, O +
and O +
100 O +
units O -
/ O -
L O +
insulin O +
( O -
pH O +
7.4 O -
) O -
] O -
. O +

Hearts O +
were O +
cannulated O +
first O +
via O +
the O +
aorta O +
and O +
perfused O +
retrogradely O +
by O +
the O +
Langendorff O +
method O -
. O +

Following O +
left O +
atrial O +
cannulation O -
, O +
perfusion O +
was O +
switched O +
to O +
the O +
working O +
mode O +
with O +
KHB O +
solution B-Chemical +
containing O +
1.2 O +
mM O +
palmitate B-Chemical +
bound O +
to O +
3 O -
% O +
fatty B-Chemical +
acid I-Chemical -
- O -
free O +
BSA O +
with O +
a O +
preload O +
pressure O +
of O +
11.5 O +
mm O +
Hg O +
and O +
an O +
afterload O +
pressure O +
of O +
50 O +
mm O +
Hg O +
for O +
60 O +
min O +
with O +
oxygenated O +
buffer O +
solution B-Chemical -
. O +

Functional O +
measurements O -
, O +
namely O +
cardiac O +
output O -
, O +
aortic O +
flows O -
, O +
peak O +
systolic O +
pressure O -
, O +
and O +
heart O +
rate O +
were O +
acquired O +
every O +
10 O +
min O +
using O +
inline O +
flow O +
probes O +
( O -
Transonic O +
Systems O -
, O +
Ithaca O -
, O +
New O +
York O -
, O +
United O +
States O -
) O -
, O +
a O +
pressure O +
transducer O +
( O -
TSD O +
104A O -
, O +
BIOPAC O +
Systems O -
, O +
Santa O +
Barbara O -
, O +
California O -
, O +
United O +
States O -
) O +
and O +
data O +
acquired O +
with O +
the O +
MP100 O +
system O +
from O +
AcqKnowledge O +
( O -
BIOPAC O +
Systems O -
) O -
. O +

Cardiac O +
work O +
was O +
calculated O +
as O +
the O +
product O +
of O +
peak O +
systolic O +
pressure O +
and O +
cardiac O +
output O -
. O +

Statistics O +
Data O +
were O +
analyzed O +
using O +
T O -
- O -
tests O +
or O +
ANOVAs O +
( O -
measures O +
of O +
general O +
activity O +
and O +
sensorimotor O +
battery O -
) O -
. O +

The O +
level O +
of O +
significance O +
was O +
set O +
at O +
p O +
< O +
0.05 O +
in O +
all O +
cases O -
. O +

Data O +
are O +
reported O +
as O +
mean O +
values O +
± O +
SEM O -
, O +
unless O +
otherwise O +
noted O -
. O +

The O +
ANOVA O +
model O +
used O +
to O +
analyze O +
each O +
sensorimotor O +
test O +
included O +
one O +
between O -
- O -
subjects O +
variable O +
( O -
genotype O -
) O -
, O +
and O +
one O +
within O -
- O -
subjects O +
variable O +
( O -
trials O -
) O -
. O +

When O +
ANOVAs O +
with O +
repeated O +
measures O +
were O +
conducted O -
, O +
the O +
Huynh O -
- O -
Feldt O +
( O -
H O -
- O -
F O -
) O +
adjustment O +
of O +
alpha O +
levels O +
was O +
used O +
for O +
all O +
within O -
- O -
subjects O +
effects O +
containing O +
more O +
than O +
two O +
levels O -
, O +
in O +
order O +
to O +
protect O +
against O +
violations O +
of O +
the O +
sphericity O -
/ O -
compound O +
symmetry O +
assumptions O +
underlying O +
this O +
ANOVA O +
model O -
. O +

In O +
addition O -
, O +
Bonferroni O +
correction O +
was O +
used O +
when O +
appropriate O +
to O +
help O +
maintain O +
prescribed O +
alpha O +
levels O +
( O -
e.g. O -
, O +
p O +
< O +
0.05 O -
) O +
when O +
multiple O +
comparisons O +
were O +
conducted O -
. O +

Supporting O +
Information O +
Figure O +
S1 O +
Activity O +
Levels O +
in O +
Female O +
PGC-1α− O -
/ O -
− O +
Mice O +

Is O +
Unchanged O +
Using O +
a O +
CLAMS O +
system O -
, O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
4 O -
) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
3 O -
) O +
female O +
mice O +
were O +
monitored O +
for O +
48 O +
h O +
after O +
a O +
17-h O +
period O +
of O +
acclimation O -
. O +

XY O +
beam O +
breaks O +
were O +
tabulated O +
over O +
the O +
12-h O +
light O +
and O +
dark O +
cycles O +
as O +
denoted O +
on O +
the O +
bottom O -
. O +

The O +
bars O +
represent O +
mean O +
( O -
± O +
SEM O -
) O +
beam O +
breaks O +
per O +
each O +
12-h O +
cycle O -
. O +

( O -
342 O +
KB O +
EPS O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S2 O +
Altered O +
Emotionality O +
in O +
PGC-1α− O -
/ O -
− O +
Mice O +
An O +
analysis O +
of O +
exploratory O +
behavior O +
included O +
the O +
number O +
of O +
entries O +
into O +
the O +
center O +
of O +
the O +
cage O +
( O -
upper O +
left O -
) O -
, O +
the O +
time O +
spent O +
in O +
the O +
center O +
of O +
the O +
cage O +
in O +
seconds O +
( O -
sec O -
) O +
( O -
upper O +
right O -
) O -
, O +
the O +
distance O +
traveled O +
in O +
the O +
center O +
of O +
the O +
cage O +
in O +
meters O +
( O -
m O -
) O +
( O -
lower O +
left O -
) O +
as O +
well O +
as O +
the O +
distance O +
traveled O +
in O +
the O +
periphery O +
( O -
lower O +
right O -
) O -
. O +

* O +
p O +
< O +
0.05 O +
compared O +
to O +
the O +
PGC-1α+ O -
/ O -
+ O +
mice O -
. O +

( O -
620 O +
KB O +
EPS O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S3 O +
No O +
Difference O +
in O +
Weight O +
Gain O +
on O +
a O +
High O -
- O -
Fat O +
Diet O +
in O +
Female O +
PGC-1α− O -
/ O -
− O +
Mice O +
Compared O +
to O +
WT O +
Controls O +
8-wk O -
- O -
old O +
female O +
mice O +
were O +
fed O +
a O +
diet O +
high O +
in O +
fat O +
( O -
43 O -
% O +
calories O +
from O +
fat O -
) O +
for O +
6 O +
wk O -
. O +

The O +
change O +
in O +
body O +
weight O +
( O -
grams O -
) O +
after O +
6 O +
wk O +
on O +
a O +
high O -
- O -
fat O +
diet O +
is O +
shown O +
for O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
8) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
11 O -
) O +
mice O -
. O +

NS O -
, O +
not O +
significant O -
. O +

( O -
264 O +
KB O +
EPS O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S4 O +
Male O +
PGC-1α− O -
/ O -
− O +
Mice O +
Are O +
Somewhat O +
Resistant O +
to O +
Diet O -
- O -
Induced O +
Obesity O +
Male O +
and O +
female O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
≥ O +
6 O -
) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
≥ O +
6 O -
) O +
mice O +
were O +
fed O +
a O +
high O -
- O -
fat O +
diet O +
( O -
43 O -
% O +
calories O +
from O +
fat O -
) O +
beginning O +
at O +
4 O +
wk O +
of O +
age O -
. O +

Body O +
weight O +
was O +
monitored O +
weekly O +
as O +
shown O +
on O +
the O +
graph O +
on O +
the O +
left O -
. O +

The O +
mean O +
( O -
± O +
SEM O -
) O +
change O +
in O +
body O +
weight O +
is O +
shown O +
in O +
the O +
bar O +
graph O +
on O +
the O +
right O -
. O +

* O -
, O +
significant O +
difference O +
compared O +
to O +
the O +
PGC-1α+ O -
/ O -
+ O +
controls O -
, O +
p O +
< O +
0.05 O -
. O +

( O -
794 O +
KB O +
EPS O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S1 O +
Probes O +
and O +
Primers O +
Sequences O +
of O +
mouse O -
- O -
specific O +
probes O +
and O +
primers O +
used O +
for O +
real O -
- O -
time O +
RT O -
- O -
PCR O -
. O +

( O -
25 O +
KB O +
DOC O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Accession O +
Numbers O +
The O +
GenBank O +
( O -
http://www.ncbi.nlm.nih.gov/ O -
) O +
accession O +
numbers O +
of O +
the O +
vector O +
discussed O +
in O +
this O +
paper O +
is O +
p1339-PGK O -
- O -
Neomycin O +
targeting O +
vector O +
( O -
AF335420 O -
) O -
. O +

Acknowledgements O +
We O +
would O +
like O +
to O +
thank O +
Deanna O +
Young O +
and O +
Karen O +
Hemker O +
for O +
help O +
with O +
mouse O +
husbandry O -
, O +
Carolyn O +
Mansfield O +
for O +
ES O +
cell O +
and O +
mouse O +
genotyping O -
, O +
Anthony O +
Nardi O +
for O +
assistance O +
with O +
the O +
studies O +
to O +
assess O +
general O +
activity O +
and O +
muscle O +
strength O -
, O +
Bill O +
Kraft O +
for O +
expert O +
technical O +
assistance O +
with O +
electron B-Chemical +
microscopy O -
, O +
Carla O +
Weinheimer O +
for O +
performing O +
cardiac O +
catheterizations O -
, O +
Trey O +
Coleman O +
for O +
performing O +
the O +
TAG B-Chemical +
assays O -
, O +
Krista O +
Olson O +
for O +
expert O +
technical O +
assistance O +
with O +
the O +
Langendorff O +
method O -
, O +
and O +
Mary O +
Wingate O +
for O +
assistance O +
with O +
manuscript O +
preparation O -
. O +

This O +
work O +
was O +
supported O +
by O +
National O +
Institutes O +
of O +
Health O +
grants O +
RO1 O +
DK45416 O -
, O +
RO1 O +
HL58427 O -
, O +
PO1 O +
HL57278 O -
, O +
Digestive O +
Diseases O +
Research O +
Core O +
Center O +
( O -
P30 O +
DK52574 O -
) O -
, O +
Clinical O +
Nutrition O +
Research O +
Unit O +
Core O +
Center O +
( O -
P30 O +
DK56341 O -
) O -
, O +
and O +
K08 O +
AG24844 O -
. O +

SB O +
is O +
supported O +
by O +
a O +
postdoctoral O +
fellowship O +
from O +
the O +
Juvenile O +
Diabetes O +
Foundation O -
. O +

EDA O +
is O +
supported O +
by O +
the O +
American O +
Heart O +
Association O +
( O -
Established O +
Investigator O -
) O +
and O +
RO1 O +
HL70070 O -
. O +

Competing O +
interests O -
. O +

The O +
authors O +
have O +
declared O +
that O +
no O +
competing O +
interests O +
exist O -
. O +

Abbreviations O +
BAT O +
- O +
brown O +
adipose O +
tissue O +
DEXA O +
- O +
dual O -
- O -
energy O +
X O -
- O -
ray O +
absorption O +
EST O +
- O +
echocardiographic O +
stress O +
testing O +
IP O +
- O +
intraperitoneal O -
( O -
ly O -
) O +
NRF O +
- O +
nuclear O +
respiratory O +
factor O +
PGC O +
- O +
PPARγ O +
coactivator O +
PPAR O +
- O +
peroxisome O +
proliferator O -
- O -
activated O +
receptor O +
PRC O +
- O +
PGC-1 O +
related O +
coactivator O +
SCD O +
- O +
steroyl B-Chemical +
CoA I-Chemical +
desaturase O +
SREBP O +
- O +
sterol B-Chemical +
regulatory O +
element O +
binding O +
protein O +
SEM O +
- O +
standard O +
error O +
of O +
the O +
mean O +
TAG B-Chemical +
- O +
triglyceride B-Chemical +
Tfam O +
- O +
mitochondrial O +
transcription O +
factor O +
A O +
UCP O +
- O +
uncoupling O +
protein O +
WT O +
- O +
wild O -
- O -
type O +
Figures O +
and O +
Tables O +
Figure O +
1 O +
Deletion O +
of O +
the O +
PGC-1α O +
Gene O +
( O -
A O -
) O +
Schematic O +
of O +
the O +
gene O +
targeting O +
strategy O -
. O +

A O +
region O +
of O +
the O +
murine O +
PGC-1α O +
gene O +
containing O +
exons O +
3–6 O +
is O +
shown O +
schematically O +
at O +
the O +
top O -
. O +

Relevant O +
restriction O +
endonuclease O +
sites O +
are O +
also O +
shown O -
. O +

The O +
targeting O +
construct O +
containing O +
a O +
neomycin O +
( O -
Neo O -
) O +
cassette O +
is O +
shown O +
below O +
the O +
PGC-1α O +
gene O +
with O +
dashed O +
lines O +
indicating O +
the O +
regions O +
targeted O +
for O +
homologous O +
recombination O -
. O +

Homologous O +
recombination O +
between O +
the O +
3′ O +
end O +
of O +
the O +
targeting O +
vector O +
and O +
the O +
PGC-1α O +
gene O +
is O +
indicated O +
by O +
the O +
solid O +
lines O -
. O +

The O +
targeting O +
construct O +
inserted O +
into O +
the O +
PGC-1α O +
gene O +
resulting O +
in O +
a O +
duplication O +
of O +
exon O +
3 O +
and O +
incorporation O +
of O +
the O +
targeting O +
construct O +
DNA O +
into O +
the O +
final O +
recombinant O +
as O +
shown O -
. O +

Probes O +
used O +
for O +
the O +
Southern O +
blot O +
studies O +
and O +
relevant O +
restriction O +
fragments O +
predicted O +
by O +
digestion O +
of O +
the O +
recombinant O +
are O +
also O +
shown O -
. O +

( O -
B O -
) O +
Southern O +
blot O +
analysis O +
of O +
embryonic O +
stem O +
cells O +
( O -
ESC O -
) O +
( O -
digested O +
with O +
Xba1 O -
) O +
and O +
tail O +
DNA O +
( O -
digested O +
with O +
Pst1 O -
) O +
is O +
shown O -
. O +

The O +
blots O +
were O +
hybridized O +
with O +
the O +
probes O +
shown O +
in O +
Figure O +
1A O -
. O +

Results O +
for O +
PGC-1α+ O -
/ O -
+ O +
( O -
+ O -
/+ O -
) O -
, O +
PGC-1α+ O -
/ O -
− O +
( O -
+ O -
/− O -
) O -
, O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
− O -
/ O -
− O -
) O +
genotypes O +
are O +
shown O +
as O +
denoted O +
at O +
the O +
bottom O -
. O +

( O -
C O -
) O +
Northern O +
blot O +
analysis O +
using O +
RNA O +
isolated O +
from O +
the O +
hearts O +
of O +
the O +
three O +
relevant O +
PGC-1α O +
genotypes O +
( O -
as O +
in O +
Figure O +
1B O -
) O +
is O +
shown O +
using O +
PGC-1α O +
cDNA O +
as O +
a O +
probe O -
. O +

In O +
addition O -
, O +
PGC-1β O +
and O +
PRC O +
cDNA O +
probes O +
were O +
used O +
as O +
shown O -
. O +

Ethidium B-Chemical +
bromide I-Chemical +
staining O +
of O +
18S O +
ribosomal O +
RNA O +
is O +
shown O +
at O +
the O +
bottom O -
. O +

( O -
D O -
) O +
Quantitative O +
real O +
time O +
RT O -
- O -
PCR O +
( O -
Sybr B-Chemical +
green I-Chemical -
) O +
was O +
used O +
to O +
detect O +
PGC-1α O +
transcripts O +
using O +
primer O +
sets O +
crossing O +
different O +
exon O +
borders O +
as O +
denoted O -
. O +

The O +
exon O +
5–3 O +
primer O +
set O +
detects O +
only O +
the O +
mutant O +
transcript O +
( O -
− O -
/ O -
− O -
) O -
, O +
whereas O +
the O +
exon O +
5–6 O +
primer O +
set O +
detects O +
only O +
the O +
WT O +
transcript O -
. O +

The O +
values O +
represent O +
arbitrary O +
units O +
for O +
RNA O +
isolated O +
from O +
the O +
tissues O +
shown O +
for O +
the O +
three O +
amplicons O +
comparing O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
−. O +
N.D. O +
= O +
not O +
detectable O -
. O +

The O +
exon O +
10–11 O +
amplicon O +
was O +
evaluated O +
to O +
assess O +
levels O +
of O +
mutant O +
versus O +
WT O +
transcripts O -
. O +

The O +
values O +
represent O +
arbitrary O +
units O +
normalized O +
to O +
actin O +
control O -
. O +

( O -
E O -
) O +
Western O +
blot O +
analysis O +
using O +
whole O -
- O -
cell O +
protein O +
extracts O +
prepared O +
from O +
BAT O +
under O +
basal O +
conditions O +
and O +
following O +
exposure O +
to O +
4 O +
° O -
C O +
for O +
8 O +
h. O +
The O +
signal O +
shown O +
was O +
obtained O +
with O +
polyclonal O +
anti O -
- O -
PGC-1α O +
antibody O +
[ O -
10 O -
] O -
. O +

An O +
epitope O -
- O -
tagged O +
PGC-1α O -
, O +
overexpressed O +
in O +
neonatal O +
cardiac O +
myocytes O +
using O +
an O +
adenoviral O +
vector O +
( O -
Ad O -
- O -
PGC-1α O -
) O -
, O +
is O +
shown O +
as O +
a O +
positive O +
control O -
. O +

The O +
Ponceau O +
S O +
stain O +
of O +
the O +
protein O +
gel O +
is O +
shown O +
at O +
the O +
bottom O -
. O +

Figure O +
2 O +
Evidence O +
for O +
Tissue O -
- O -
Specific O +
Growth O +
Abnormalities O +
and O +
Mild O +
Sex O -
- O -
Limited O -
, O +
Age O -
- O -
Dependent O +
Obesity O +
in O +
PGC-1α− O -
/ O -
− O +
Mice O +
( O -
A O -
) O +
The O +
bars O +
represent O +
total O +
body O +
weight O +
for O +
the O +
ages O +
indicated O +
for O +
male O +
( O -
left O +
graph O -
) O +
and O +
female O +
( O -
center O +
graph O -
) O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

The O +
body O +
weight O +
( O -
BW O -
) O +
of O +
the O +
1-wk O -
- O -
old O +
PGC-1α− O -
/ O -
− O +
mice O +
was O +
normalized O +
to O +
that O +
of O +
PGC-1α+ O -
/ O -
+ O +
littermates O -
, O +
which O +
was O +
assigned O +
a O +
value O +
of O +
100 O +
( O -
left O +
axis O -
) O -
. O +

For O +
the O +
3- O -
, O +
18- O -
, O +
and O +
24-wk O +
time O +
points O -
, O +
absolute O +
weights O +
of O +
PGC-1α− O -
/ O -
− O +
mice O +
were O +
compared O +
to O +
age O -
- O -
matched O +
controls O +
( O -
right O +
axis O -
) O -
. O +

Percent O +
fat O +
as O +
determined O +
by O +
DEXA O +
scanning O +
for O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
right O +
graph O -
) O -
. O +

The O +
results O +
represent O +
n O +
= O +
4 O +
( O -
males O -
) O +
and O +
n O +
≥ O +
11 O +
( O -
females O -
) O +
for O +
each O +
genotype O +
at O +
24 O +
wk O -
. O +

* O +
p O +
< O +
0.05 O +
compared O +
to O +
corresponding O +
PGC-1α+ O -
/ O -
+ O +
mice O -
. O +

( O -
B O -
) O +
The O +
bars O +
represent O +
organ O +
weights O +
corrected O +
to O +
body O +
weight O +
for O +
3-wk O -
- O -
old O +
male O +
and O +
female O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

The O +
error O +
bars O +
represent O +
± O +
SEM O -
. O +

Results O +
represent O +
n O +
≥ O +
14 O +
for O +
each O +
group O -
. O +

* O +
p O +
< O +
0.05 O +
compared O +
to O +
corresponding O +
PGC-1α+ O -
/ O -
+ O +
mice O -
. O +

Figure O +
3 O +
Abnormal O +
Mitochondrial O +
Phenotype O +
in O +
Slow O -
- O -
Twitch O +
Skeletal O +
Muscle O +
of O +
PGC-1α− O -
/ O -
− O +
Mice O +
( O -
A O -
) O +
Representative O +
electron B-Chemical +
micrograph O +
of O +
soleus O +
muscle O +
from O +
1-mo O -
- O -
old O +
female O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O -
. O +

( O -
B O -
) O +
Quantitative O +
morphometric O +
measurements O +
of O +
the O +
cellular O +
volume O +
density O +
for O +
the O +
mitochondrial O +
( O -
Mito O -
) O +
and O +
myofibrillar O +
( O -
Myo O -
) O +
fractions O +
based O +
on O +
analysis O +
of O +
electron B-Chemical +
micrographs O +
( O -
three O +
sections O +
from O +
three O +
animals O +
per O +
group O -
) O -
. O +

The O +
bars O +
represent O +
mean O +
± O +
SEM O -
. O +

* O +
p O +
< O +
0.05 O +
compared O +
to O +
corresponding O +
PGC-1α+ O -
/ O -
+ O +
values O -
. O +

( O -
C O -
) O +
Gene O +
expression O +
data O -
. O +

The O +
results O +
of O +
real O -
- O -
time O +
PCR O +
analysis O +
of O +
nuclear O +
and O +
mitochondrial O +
genes O +
involved O +
in O +
various O +
components O +
of O +
mitochondrial O +
metabolism O +
and O +
mitochondrial O +
biogenesis O -
: O +
cytochrome B-Chemical +
C I-Chemical +
( O -
Cyto B-Chemical +
c I-Chemical -
) O -
, O +
ATP O +
synthase O +
β O -
, O +
Tfam O -
, O +
and O +
cytochrome B-Chemical +
oxidase O +
IV O +
( O -
COX O +
IV O -
) O -
. O +

Eight O +
littermate O +
pairs O +
were O +
used O +
for O +
analysis O +
at O +
1–2 O +
mo O +
of O +
age O +
and O +
normalized O +
to O +
the O +
WT O +
value O -
, O +
which O +
was O +
assigned O +
a O +
value O +
of O +
100 O -
, O +
in O +
each O +
case O -
. O +

* O +
p O +
< O +
0.05 O +
compared O +
to O +
corresponding O +
PGC-1α+ O -
/ O -
+ O +
values O -
. O +

( O -
D O -
) O +
Mitochondrial O +
respiration O +
rates O +
as O +
determined O +
by O +
oxygen O +
consumption O +
( O -
VO2 O -
) O +
performed O +
on O +
saponin B-Chemical -
- O -
permeabilized O +
muscle O +
strips O +
prepared O +
from O +
soleus O +
of O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O +
( O -
as O +
described O +
in O +
Materials O +
and O +
Methods O -
) O -
. O +

The O +
results O +
are O +
based O +
on O +
six O +
female O +
animals O +
in O +
each O +
group O -
, O +
using O +
succinate O +
as O +
a O +
substrate O +
in O +
the O +
presence O +
of O +
rotenone B-Chemical -
. O +

Mean O +
values O +
( O -
± O +
SEM O -
) O +
are O +
shown O +
for O +
state O +
2 O +
( O -
basal O -
) O -
, O +
state O +
3 O +
( O -
ADP O -
- O -
stimulated O -
) O -
, O +
and O +
state O +
4 O +
respiration O +
( O -
presence O +
of O +
oligomycin B-Chemical -
) O -
. O +

Figure O +
4 O +
PGC-1α− O -
/ O -
− O +
Mice O +
Exhibit O +
an O +
Abnormal O +
Skeletal O +
Muscle O +
Functional O +
Phenotype O +
( O -
A O -
) O +
Measures O +
of O +
general O +
activity O +
and O +
muscle O +
strength O -
. O +

General O +
activity O +
levels O +
were O +
measured O +
in O +
3.5-mo O -
- O -
old O +
male O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
8) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
11 O -
) O +
mice O +
using O +
a O +
photobeam O +
system O +
as O +
described O +
in O +
Materials O +
and O +
Methods O -
. O +

Total O +
ambulations O +
( O -
left O +
graph O -
) O -
, O +
and O +
rearings O +
( O -
center O +
graph O -
) O +
provide O +
a O +
general O +
measure O +
of O +
locomotor O +
activity O -
. O +

Time O +
spent O +
on O +
an O +
inverted O +
screen O +
( O -
right O +
graph O -
) O +
represents O +
a O +
general O +
measure O +
of O +
extremity O +
muscle O +
strength O -
. O +

The O +
results O +
from O +
two O +
trials O +
are O +
shown O -
. O +

* O +
p O +
< O +
0.05 O +
compared O +
to O +
corresponding O +
PGC-1α+ O -
/ O -
+ O -
. O +

( O -
B O -
) O +
Exercise O +
studies O -
. O +

Male O +
6–8-mo O -
- O -
old O +
PGC-1α− O -
/ O -
− O +
and O +
PGC-1α+ O -
/ O -
+ O +
mice O +
were O +
subjected O +
to O +
a O +
run O -
- O -
to O -
- O -
exhaustion O +
protocol O +
on O +
a O +
motorized O +
treadmill O +
( O -
left O +
graph O -
) O +
as O +
described O +
in O +
Materials O +
and O +
Methods O -
. O +

* O +
p O +
< O +
0.001 O +
compared O +
to O +
corresponding O +
PGC-1α+ O -
/ O -
+ O +
values O -
. O +

VO2max O +
measurements O +
were O +
determined O +
for O +
2-mo O -
- O -
old O +
male O +
mice O +
for O +
each O +
genotype O +
using O +
a O +
motorized O +
treadmill O +
at O +
an O +
elevation O +
of O +
150 O +
m O +
and O +
indirect O +
calorimetry O +
set O -
- O -
up O +
( O -
right O +
graph O -
) O +
as O +
described O +
in O +
Materials O +
and O +
Methods O -
. O +

* O +
p O +
< O +
0.05 O +
compared O +
to O +
corresponding O +
PGC-1α+ O -
/ O -
+ O +
values O -
. O +

( O -
C O -
) O +
Time O +
course O +
of O +
fatigue O +
following O +
repeated O +
stimulation O +
of O +
soleus O +
muscle O +
is O +
shown O +
for O +
4-mo O -
- O -
old O +
male O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
5 O -
) O +
and O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
5 O -
) O +
mice O +
( O -
left O +
graph O -
) O -
. O +

The O +
mean O +
percent O +
force O +
remaining O +
at O +
2 O +
min O +
( O -
Fatigue O +
Resistance O +
Index O -
) O +
is O +
shown O +
( O -
right O +
graph O -
) O -
. O +

* O +
p O +
< O +
0.05 O +
compared O +
to O +
corresponding O +
PGC-1α+ O -
/ O -
+ O +
values O -
. O +

Figure O +
5 O +
Abnormal O +
Cardiac O +
Response O +
to O +
Physiologic O +
Stress O +
in O +
PGC-1α− O -
/ O -
− O +
Mice O +
( O -
A O -
) O +
Exercise O +
echocardiographic O +
studies O -
. O +

PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
4 O -
) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
8) O +
female O +
mice O +
aged O +
6–8 O +
mo O +
were O +
subjected O +
to O +
an O +
exercise O +
protocol O +
on O +
a O +
motorized O +
treadmill O -
. O +

This O +
protocol O +
was O +
designed O +
such O +
that O +
the O +
PGC-1α− O -
/ O -
− O +
mice O +
ran O +
to O +
exhaustion O +
based O +
on O +
the O +
results O +
of O +
the O +
exercise O +
studies O +
shown O +
in O +
Figure O +
4 O -
. O +

Accordingly O -
, O +
an O +
exercise O +
regimen O +
of O +
60 O +
s O +
was O +
used O +
for O +
both O +
groups O -
. O +

The O +
graphs O +
depict O +
the O +
heart O +
rate O +
( O -
left O +
graph O -
) O +
and O +
echocardiographically O -
- O -
determined O +
ventricular O +
fractional O +
shortening O +
( O -
FS O -
) O +
as O +
a O +
percent O +
( O -
right O +
graph O -
) O -
. O +

Responses O +
were O +
monitored O +
for O +
10 O +
min O +
immediately O +
post O +
exercise O -
. O +

( O -
B O -
) O +
In O +
vivo O +
hemodynamic O +
response O +
to O +
the O +
β1,α1-adrenergic O +
agonist B-Chemical +
dobutamine B-Chemical -
. O +

Male O +
and O +
female O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
6 O -
) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
6 O -
) O +
mice O +
at O +
10–12 O +
wk O +
of O +
age O +
were O +
anesthetized O +
and O +
a O +
1.4-French O +
Millar O +
catheter O +
was O +
placed O +
through O +
the O +
carotid O +
artery O +
into O +
the O +
left O +
ventricle O +
as O +
described O +
in O +
Materials O +
and O +
Methods O -
. O +

Heart O +
rate O +
( O -
left O +
graph O -
) O +
and O +
a O +
measurement O +
of O +
ventricular O +
systolic O +
performance O -
, O +
dP O -
/ O -
dt O +
( O -
right O +
graph O -
) O -
, O +
were O +
measured O +
following O +
infusion O +
of O +
dobutamine B-Chemical -
. O +

* O +
p O +
< O +
0.05 O -
. O +

Figure O +
6 O +
PGC-1α− O -
/ O -
− O +
Mice O +
Exhibit O +
an O +
Abnormal O +
Thermogenic O +
Response O +
( O -
A O -
) O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
15 O -
) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
21 O -
) O +
mice O +
aged O +
28–37 O +
d O +
were O +
subjected O +
to O +
cold O +
( O -
4 O +
° O -
C O -
) O -
. O +

Core O +
rectal O +
temperature O +
was O +
monitored O +
over O +
a O +
5-h O +
period O -
. O +

The O +
change O +
in O +
core O +
temperature O +
± O +
SEM O +
is O +
shown O +
in O +
the O +
graph O +
( O -
left O -
) O +
as O +
a O +
function O +
of O +
time O -
. O +

* O +
p O +
< O +
0.05 O -
. O +

( O -
B O -
) O +
Representative O +
Northern O +
blot O +
analysis O +
( O -
blot O +
and O +
gel O +
at O +
top O -
) O +
performed O +
with O +
RNA O +
isolated O +
from O +
BAT O +
to O +
detect O +
UCP-1 O +
transcript O +
at O +
baseline O +
( O -
RT O -
) O +
and O +
after O +
5 O +
h O +
of O +
exposure O +
to O +
cold O +
( O -
4 O +
° O -
C O -
) O +
( O -
UCP1 O -
) O -
. O +

Ethidium B-Chemical +
bromide I-Chemical +
( O -
Eth B-Chemical +
Br I-Chemical -
) O +
staining O +
of O +
ribosomal O +
RNA O +
is O +
shown O +
as O +
a O +
control O -
. O +

Quantitative O +
real O -
- O -
time O +
RT O -
- O -
PCR O +
for O +
UCP-1 O +
transcript O +
is O +
shown O +
on O +
the O +
graph O +
at O +
the O +
bottom O -
. O +

The O +
values O +
represent O +
mean O +
arbitrary O +
units O +
normalized O +
to O +
a O +
36B4 O +
transcript O +
( O -
control O -
) O -
. O +

( O -
C O -
) O +
Altered O +
response O +
to O +
β3-adrenergic O +
agonist B-Chemical -
. O +

To O +
evaluate O +
the O +
oxygen O +
consumption O +
( O -
VO2 O -
) O +
in O +
response O +
to O +
the O +
stimulation O +
of O +
BAT O +
uncoupled O +
respiration O -
, O +
the O +
β3-adrenergic O +
agonist B-Chemical +
BRL O +
37344 O +
was O +
administered O +
to O +
littermate O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
5 O -
) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
5 O -
) O +
female O +
mice O +
followed O +
by O +
measurement O +
of O +
VO2 O +
by O +
indirect O +
calorimetry O -
. O +

Mean O +
± O +
SEM O +
VO2 O +
is O +
shown O -
. O +

* O +
p O +
< O +
0.05 O -
. O +

Figure O +
7 O +
Fasting O -
- O -
Induced O +
Hepatic O +
Steatosis O +
Develops O +
in O +
PGC-1α− O -
/ O -
− O +
Mice O +
( O -
A O -
) O +

The O +
photograph O +
depicts O +
the O +
development O +
of O +
a O +
pale O +
liver O +
in O +
PGC-1α− O -
/ O -
− O +
mice O +
subjected O +
to O +
a O +
24-h O +
fast O -
. O +

( O -
B O -
) O +
Oil O +
red O +
O O +
staining O +
of O +
histologic O +
sections O +
of O +
liver O +
taken O +
from O +
PGC-1α− O -
/ O -
− O +
mice O +
under O +
fed O +
and O +
24 O +
h O +
fasted O +
conditions O -
. O +

The O +
red O +
staining O +
indicates O +
neutral O +
lipid B-Chemical -
. O +

( O -
C O -
) O +
Representative O +
electron B-Chemical +
micrographs O +
of O +
the O +
liver O +
from O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O +
following O +
a O +
24-h O +
fast O -
. O +

The O +
droplets O +
are O +
indicative O +
of O +
neutral O +
lipid B-Chemical +
accumulation O -
. O +

( O -
D O -
) O +
Mean O +
liver O +
TAG B-Chemical +
levels O +
in O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
5 O -
) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
5 O -
) O +
mice O +
under O +
fed O +
and O +
24-h O +
fasted O +
conditions O -
. O +

* O +
p O +
< O +
0.05 O -
. O +

Figure O +
8 O +
Hepatocytes O +
Isolated O +
from O +
PGC-1α− O -
/ O -
− O +
Mice O +
Exhibit O +
Reduced O +
Oxidative O +
Capacity O +
( O -
A O -
) O +
Oil O +
red O +
O O +
staining O +
of O +
isolated O +
hepatocytes O +
exposed O +
to O +
BSA O +
alone O +
( O -
BSA O -
) O +
or O +
50 O +
μM O +
oleate B-Chemical +
complexed O +
to O +
BSA O +
( O -
oleate B-Chemical -
) O -
. O +

( O -
B O -
) O +
3H B-Chemical -
- O -
palmitate B-Chemical +
oxidation O +
rates O -
. O +

3H B-Chemical -
- O -
palmitate B-Chemical +
oxidation O +
rates O +
determined O +
in O +
hepatocytes O +
isolated O +
from O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
mice O +
under O +
cell O +
culture O +
conditions O +
containing O +
BSA O +
or O +
BSA O +
+ O +
50 O +
μM O +
oleate B-Chemical +
( O -
2:1 O +
oleate B-Chemical -
/ O -
BSA O +
ratio O -
) O -
. O +

Values O +
were O +
derived O +
from O +
ten O +
sets O +
of O +
triplicates O +
for O +
each O +
group O +
using O +
hepatocytes O +
from O +
5 O +
mice O +
of O +
each O +
genotype O -
. O +

The O +
bars O +
represent O +
mean O +
oxidation O +
rates O +
( O -
n O +
= O +
100 O -
) O +
normalized O +
to O +
the O +
condition O +
of O +
PGC-1α+ O -
/ O -
+ O +
in O +
BSA O +
alone O -
. O +

* O +
p O +
< O +
0.05 O +
compared O +
to O +
the O +
corresponding O +
PGC-1α+ O -
/ O -
+ O +
mice O -
. O +

† O +
p O +
< O +
0.05 O +
compared O +
to O +
PGC-1α+ O -
/ O -
+ O +
with O +
BSA O +
treatment O -
. O +

( O -
C O -
) O +
State O +
2 O +
and O +
3 O +
respiration O +
rates O +
determined O +
for O +
hepatocytes O +
isolated O +
from O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
3 O -
) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
3 O -
) O +
mice O +
using O +
succinate O -
/ O -
rotenone B-Chemical +
as O +
a O +
substrate O -
. O +

* O +
p O +
< O +
0.05 O +
compared O +
to O +
corresponding O +
PGC-1α+ O -
/ O -
+ O -
. O +

( O -
D O -
) O +
TAG B-Chemical +
synthesis O +
rates O +
in O +
isolated O +
hepatocytes O -
. O +

The O +
bars O +
represent O +
mean O +
TAG B-Chemical +
synthesis O +
rates O +
( O -
glycerol B-Chemical +
incorporation O -
, O +
see O +
Materials O +
and O +
Methods O -
) O +
for O +
hepatocytes O +
isolated O +
from O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
6 O -
) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
6 O -
) O +
mice O -
. O +

* O +
p O +
< O +
0.05 O +
compared O +
to O +
the O +
corresponding O +
PGC-1α+ O -
/ O -
+ O +
condition O -
. O +

Figure O +
9 O +
Female O +
PGC-1α− O -
/ O -
− O +
Mice O +
Are O +
More O +
Glucose B-Chemical +
Tolerant O +
and O +
Insulin O +
Sensitive O +
Compared O +
to O +
PGC-1α+ O -
/ O -
+ O +
on O +
High O -
- O -
Fat O +
Diet O +
( O -
A O -
) O +
At O +
4.5 O +
mo O +
of O +
age O -
, O +
glucose B-Chemical +
tolerance O +
testing O +
( O -
GTT O -
) O +
was O +
performed O +
on O +
female O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
6 O -
) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
6 O -
) O +
mice O +
maintained O +
on O +
standard O +
chow B-Chemical -
. O +

( O -
B O -
) O +
At O +
8 O +
wk O +
of O +
age O -
, O +
PGC-1α+ O -
/ O -
+ O +
( O -
n O +
= O +
8) O +
and O +
PGC-1α− O -
/ O -
− O +
( O -
n O +
= O +
11 O -
) O +
mice O +
were O +
provided O +
a O +
diet O +
containing O +
43 O -
% O +
of O +
its O +
calories O +
from O +
fat O +
( O -
HF O +
chow B-Chemical -
) O -
. O +

The O +
graphs O +
depict O +
blood O +
glucose B-Chemical +
levels O +
± O +
SEM O +
in O +
PGC-1α− O -
/ O -
− O +
mice O +
during O +
GTT O +
( O -
left O +
graph O -
) O +
and O +
ITT O +
( O -
right O +
graph O -
) O +
studies O -
. O +

Studies O +
were O +
performed O +
5 O +
wk O +
( O -
GTT O -
) O +
and O +
6 O +
wk O +
( O -
ITT O -
) O +
after O +
the O +
initiation O +
of O +
the O +
high O -
- O -
fat O +
diet O -
. O +

* O +
p O +
< O +
0.05 O +
compared O +
to O +
PGC-1α+ O -
/ O -
+ O +
mice O +
at O +
the O +
same O +
time O +
point O -
. O +

Figure O +
10 O +
Neuropathology O +
of O +
the O +
Central O +
Nervous O +
System O +
of O +
PGC-1α− O -
/ O -
− O +
Mice O +
( O -
A O -
) O +
Light O +
microscopic O +
appearance O +
of O +
representative O +
cerebral O +
cortex O +
of O +
2-mo O -
- O -
old O +
PGC-1α− O -
/ O -
− O +
mice O +
demonstrates O +
marked O +
vacuolation O +
of O +
the O +
neuropil O +
( O -
arrows O -
) O +
and O +
scattered O +
neuronal O +
perikarya O -
, O +
which O +
are O +
absent O +
in O +
PGC-1α+ O -
/ O -
+ O +
mice O +
( O -
hematoxylin B-Chemical +
and O +
eosin O -
) O -
. O +

The O +
scale O +
bar O +
shown O +
is O +
applicable O +
to O +
all O +
sections O -
. O +

( O -
B O -
) O +
Ultrastructural O +
appearance O +
of O +
typical O +
vacuoles O +
containing O +
membranous O +
debris O -
, O +
denoted O +
by O +
the O +
arrow O -
, O +
in O +
the O +
cerebral O +
cortex O +
of O +
a O +
representative O +
PGC-1α− O -
/ O -
− O +
mouse O +
in O +
comparison O +
to O +
PGC-1α+ O -
/ O -
+ O +
( O -
magnification O +
4000 O -
× O -
) O -
. O +

Table O +
1 O +
Cardiac O +
Hemodynamics O +
Measured O +
in O +
Isolated O +
Working O +
Hearts O +
of O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
Mice O +
Values O +
represent O +
mean O +
± O +
SEM O +
a O +
p O +
< O +
0.05 O +
Table O +
2 O +
Metabolic O +
Gene O +
Expression O +
in O +
Liver O +
of O +
Fed O +
and O +
Fasted O +
PGC-1α+ O -
/ O -
+ O +
and O +
PGC-1α− O -
/ O -
− O +
Mice O +
Values O +
represent O +
mean O +
( O -
± O +
SEM O -
) O +
( O -
n O +
≥ O +
6 O +
for O +
each O +
group O -
) O +
mRNA O +
levels O +
as O +
determined O +
by O +
real O -
- O -
time O +
RT O -
- O -
PCR O +
corrected O +
for O +
GAPDH O +
signal O +
intensity O +
and O +
normalized O +
( O -
to O +
1.0 O -
) O +
to O +
the O +
value O +
of O +
fed O +
PGC-1α+ O -
/ O -
+ O +
mice O +
a O +
p O +
< O +
0.05 O +
versus O +
fed O +
mice O +
of O +
the O +
same O +
genotype O +
b O +
p O +
< O +
0.05 O +
versus O +
PGC-1α+ O -
/ O -
+ O +
mice O +
of O +
the O +
same O +
dietary O +
treatment O +
L O -
- O -
CPT O +
I O -
, O +
liver O -
- O -
type O +
carnitine B-Chemical +
palmitoyltransferase O -
; O +
MCAD O -
, O +
medium B-Chemical -
- I-Chemical -
chain I-Chemical +
acyl I-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenase O -
; O +
SREBP O -
, O +
sterol B-Chemical +
regulatory O +
element O +
binding O +
protein O -
; O +
SCD O -
, O +
steroyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
desaturase O -
; O +
FAS O -
, O +
fatty B-Chemical +
acid I-Chemical +
synthase O -
; O +
GPAT O -
, O +
glycerol-3-phosphate O +
acyltransferase O -
; O +
DGAT O -
, O +
diacylglycerol B-Chemical +
acyltransferase O +
Footnotes O +
Author O +
contributions O -
. O +

TCL O -
, O +
JJL O -
, O +
BNF O -
, O +
PJS O -
, O +
and O +
DPK O +
conceived O +
and O +
designed O +
the O +
experiments O -
. O +

TCL O -
, O +
JJL O -
, O +
BNF O -
, O +
PJS O -
, O +
ARW O -
, O +
SB O -
, O +
MC O -
, O +
DFW O -
, O +
NS O -
, O +
CBM O -
, O +
ZC O -
, O +
DMM O -
, O +
RES O -
, O +
and O +
EDA O +
performed O +
the O +
experiments O -
. O +

TCL O -
, O +
JJL O -
, O +
BNF O -
, O +
PJS O -
, O +
ARW O -
, O +
SB O -
, O +
MC O -
, O +
DFW O -
, O +
NS O -
, O +
CBM O -
, O +
ZC O -
, O +
JOH O -
, O +
DMM O -
, O +
RES O -
, O +
JES O -
, O +
EDA O -
, O +
CFS O -
, O +
and O +
DPK O +
analyzed O +
the O +
data O -
. O +

TCL O -
, O +
BNF O -
, O +
and O +
DPK O +
wrote O +
the O +
paper O -
. O +

Citation O -
: O +

Leone O +
TC O -
, O +
Lehman O +
JJ O -
, O +
Finck O +
BN O -
, O +
Schaeffer O +
PJ O -
, O +
Wende O +
AR O -
, O +
et O +
al. O +
( O -
2005 O -
) O +
PGC-1α O -
- O -
deficiency O +
causes O +
multi O -
- O -
system O +
energy O +
metabolic O +
derangements O -
: O +
Muscle O +
dysfunction O -
, O +
abnormal O +
weight O +
control O +
and O +
hepatic O +
steatosis O -
. O +

PLoS O +
Biol O +
3 O -
( O -
4 O -
) O -
: O +
e101 O -
. O +

A O +
Hybrid O +
Photoreceptor O +
Expressing O +
Both O +
Rod O +
and O +
Cone O +
Genes O +
in O +
a O +
Mouse O +
Model O +
of O +
Enhanced O +
S O -
- O -
Cone O +
Syndrome O +
Abstract O +
Rod O +
and O +
cone O +
photoreceptors O +
subserve O +
vision O +
under O +
dim O +
and O +
bright O +
light O +
conditions O -
, O +
respectively O -
. O +

The O +
differences O +
in O +
their O +
function O +
are O +
thought O +
to O +
stem O +
from O +
their O +
different O +
gene O +
expression O +
patterns O -
, O +
morphologies O -
, O +
and O +
synaptic O +
connectivities O -
. O +

In O +
this O +
study O -
, O +
we O +
have O +
examined O +
the O +
photoreceptor O +
cells O +
of O +
the O +
retinal O +
degeneration O +
7 O +
( O -
rd7 O -
) O +
mutant O +
mouse O -
, O +
a O +
model O +
for O +
the O +
human O +
enhanced O +
S O -
- O -
cone O +
syndrome O +
( O -
ESCS O -
) O -
. O +

This O +
mutant O +
carries O +
a O +
spontaneous O +
deletion O +
in O +
the O +
mouse O +
ortholog O +
of O +
NR2E3 O -
, O +
an O +
orphan O +
nuclear O +
receptor O +
transcription O +
factor O +
mutated O +
in O +
ESCS O -
. O +

Employing O +
microarray O +
and O +
in O +
situ O +
hybridization O +
analysis O +
we O +
have O +
found O +
that O +
the O +
rd7 O +
retina O +
contains O +
a O +
modestly O +
increased O +
number O +
of O +
S O -
- O -
opsin O -
– O -
expressing O +
cells O +
that O +
ultrastructurally O +
appear O +
to O +
be O +
normal O +
cones O -
. O +

Strikingly O -
, O +
the O +
majority O +
of O +
the O +
photoreceptors O +
in O +
the O +
rd7 O +
retina O +
represent O +
a O +
morphologically O +
hybrid O +
cell O +
type O +
that O +
expresses O +
both O +
rod- O +
and O +
cone O -
- O -
specific O +
genes O -
. O +

In O +
addition O -
, O +
in O +
situ O +
hybridization O +
screening O +
of O +
genes O +
shown O +
to O +
be O +
up O -
- O -
regulated O +
in O +
the O +
rd7 O +
mutant O +
retina O +
by O +
microarray O +
identified O +
ten O +
new O +
cone O -
- O -
specific O +
or O +
cone O -
- O -
enriched O +
genes O +
with O +
a O +
wide O +
range O +
of O +
biochemical O +
functions O -
, O +
including O +
two O +
genes O +
specifically O +
involved O +
in O +
glucose B-Chemical -
/ O -
glycogen B-Chemical +
metabolism O -
. O +

We O +
suggest O +
that O +
the O +
abnormal O +
electroretinograms O -
, O +
slow O +
retinal O +
degeneration O -
, O +
and O +
retinal O +
dysmorphology O +
seen O +
in O +
humans O +
with O +
ESCS O +
may O -
, O +
in O +
part O -
, O +
be O +
attributable O +
to O +
the O +
aberrant O +
function O +
of O +
a O +
hybrid O +
photoreceptor O +
cell O +
type O +
similar O +
to O +
that O +
identified O +
in O +
this O +
study O -
. O +

The O +
functional O +
diversity O +
of O +
the O +
novel O +
cone O -
- O -
specific O +
genes O +
identified O +
here O +
indicates O +
molecular O +
differences O +
between O +
rods O +
and O +
cones O +
extending O +
far O +
beyond O +
those O +
previously O +
discovered O -
. O +

Synopsis O +
Vision O +
begins O +
with O +
light O +
entering O +
the O +
eye O -
. O +

This O +
light O +
is O +
projected O +
onto O +
the O +
retina O -
, O +
a O +
thin O +
neural O +
structure O +
lining O +
the O +
inside O +
of O +
the O +
eye O -
. O +

Photoreceptors O -
, O +
among O +
the O +
most O +
important O +
cell O +
types O +
in O +
the O +
retina O -
, O +
are O +
the O +
first O +
to O +
receive O +
the O +
incoming O +
rays O +
of O +
light O -
. O +

In O +
mammals O -
, O +
there O +
are O +
two O +
types O +
of O +
photoreceptors O -
: O +
rods O +
and O +
cones O -
. O +

Rods O +
are O +
specialized O +
for O +
nighttime O +
vision O -
, O +
and O +
cones O +
for O +
daytime O +
and O +
color O +
vision O -
. O +

In O +
this O +
study O -
, O +
the O +
authors O +
examined O +
the O +
photoreceptors O +
of O +
a O +
mouse O +
with O +
a O +
gene O +
mutation O +
that O +
causes O +
photoreceptors O +
to O +
develop O +
abnormally O -
. O +

Humans O +
with O +
a O +
similar O +
mutation O +
have O +
a O +
form O +
of O +
blindness O +
called O +
enhanced O +
S O -
- O -
cone O +
syndrome O +
( O -
ESCS O -
) O -
. O +

Surprisingly O -
, O +
the O +
majority O +
of O +
photoreceptors O +
in O +
this O +
mutant O +
mouse O +
were O +
found O +
to O +
have O +
features O +
of O +
both O +
normal O +
rods O +
and O +
cones O -
. O +

It O +
is O +
possible O +
that O +
the O +
abnormal O +
features O +
of O +
these O +
photoreceptors O +
predispose O +
them O +
to O +
undergo O +
premature O +
death O -
. O +

If O +
this O +
model O +
accurately O +
reflects O +
the O +
situation O +
in O +
human O +
patients O +
with O +
ESCS O -
, O +
it O +
may O +
provide O +
an O +
explanation O +
for O +
the O +
loss O +
of O +
vision O +
seen O +
in O +
this O +
disease O -
. O +

This O +
study O +
also O +
elucidated O +
previously O +
unknown O +
molecular O +
differences O +
between O +
normal O +
rods O +
and O +
cones O -
. O +

This O +
new O +
knowledge O +
may O +
contribute O +
to O +
a O +
better O +
overall O +
understanding O +
of O +
the O +
mechanisms O +
underlying O +
night O -
, O +
day O -
, O +
and O +
color O +
vision O -
. O +

Introduction O +
Enhanced O +
S O -
- O -
cone O +
syndrome O +
( O -
ESCS O -
) O +
is O +
an O +
unusual O +
disease O +
of O +
photoreceptors O +
that O +
includes O +
night O +
blindness O +
( O -
suggestive O +
of O +
rod O +
dysfunction O -
) O -
, O +
an O +
abnormal O +
electroretinogram O +
( O -
ERG O -
) O +
with O +
a O +
waveform O +
that O +
is O +
nearly O +
identical O +
under O +
both O +
light O +
and O +
dark O +
adaptation O -
, O +
and O +
an O +
increased O +
sensitivity O +
of O +
the O +
ERG O +
to O +
short O -
- O -
wavelength O +
light O +
[ O -
1,2 O -
] O -
. O +

The O +
disease O +
is O +
caused O +
by O +
mutations O +
in O +
the O +
orphan O +
nuclear O +
receptor O +
transcription O +
factor O +
NR2E3 O +
( O -
also O +
known O +
as O +
photoreceptor O +
nuclear O +
receptor O -
) O -
, O +
which O +
is O +
expressed O +
exclusively O +
in O +
rods O +
[ O -
3,4 O -
] O -
. O +

Recent O +
human O +
genetic O +
studies O +
have O +
also O +
demonstrated O +
mutations O +
in O +
this O +
gene O +
in O +
Goldmann O -
- O -
Favre O +
syndrome O +
and O +
many O +
cases O +
of O +
clumped O +
pigmentary B-Chemical +
retinal O +
degeneration O +
[ O -
5 O -
] O -
. O +

The O +
initial O +
reports O +
of O +
patients O +
with O +
ESCS O +
attributed O +
the O +
unusual O +
ERG O +
to O +
an O +
abnormally O +
functioning O +
rod O +
photoreceptor O +
system O +
with O +
persistent O +
activity O +
under O +
light O +
adaptation O +
[ O -
6–8 O -
] O -
. O +

Subsequent O +
studies O -
, O +
however O -
, O +
concluded O +
that O +
the O +
ERG O +
was O +
due O +
to O +
supernumerary O +
short O -
- O -
wavelength O +
( O -
" O -
blue O -
" O -
) O +
cone O +
photoreceptors O +
( O -
S O -
- O -
cones O -
) O +
in O +
these O +
patients O +
[ O -
1,2,9–11 O -
] O -
. O +

Histopathologic O +
analysis O +
of O +
a O +
retina O +
from O +
a O +
human O +
patient O +
with O +
ESCS O +
and O +
extensive O +
retinal O +
degeneration O +
demonstrated O +
an O +
absence O +
of O +
rhodopsin O -
- O -
positive O +
cells O +
and O +
an O +
increase O +
in O +
the O +
number O +
of O +
S O -
- O -
cone O +
opsin O -
- O -
expressing O +
cells O -
. O +

Nevertheless O -
, O +
the O +
overall O +
density O +
of O +
cones O +
was O +
only O +
modestly O +
increased O +
in O +
this O +
patient O +
( O -
approximately O +
2-fold O -
) O -
, O +
suggesting O +
that O +
there O +
might O +
be O +
additional O +
factors O +
that O +
contribute O +
to O +
the O +
very O +
large O -
, O +
light O -
- O -
adapted O +
ERG O +
seen O +
in O +
this O +
disease O -
. O +

In O +
addition O +
to O +
the O +
ERG O +
findings O -
, O +
patients O +
with O +
ESCS O +
have O +
dysmorphic O +
retinas O +
with O +
rosette O +
formation O +
in O +
the O +
outer O +
nuclear O +
layer O +
( O -
ONL O -
) O +
where O +
photoreceptor O +
cell O +
bodies O +
reside O -
, O +
and O +
a O +
slow O +
retinal O +
degeneration O +
that O +
can O +
ultimately O +
lead O +
to O +
complete O +
blindness O +
[ O -
12–14 O -
] O -
. O +

Mutations O +
in O +
the O +
mouse O +
ortholog O +
of O +
NR2E3 O +
have O +
been O +
identified O +
in O +
the O +
spontaneous O +
mutant O +
retinal O +
degeneration O +
7 O +
( O -
rd7 O -
) O +
[ O -
15 O -
] O -
. O +

This O +
mutant O +
demonstrates O +
slow O +
retinal O +
degeneration O +
and O +
abnormal O +
lamination O +
of O +
the O +
ONL O +
with O +
rosette O +
formation O +
[ O -
15,16 O -
] O -
. O +

Curiously O -
, O +
the O +
ERG O +
of O +
the O +
mouse O +
under O +
both O +
light O +
and O +
dark O +
adaptation O +
has O +
been O +
reported O +
to O +
be O +
normal O -
, O +
showing O +
progressive O +
attenuation O +
with O +
time O -
, O +
presumably O +
due O +
to O +
degenerative O +
cell O +
loss O +
[ O -
15 O -
] O -
. O +

A O +
prior O +
study O +
showed O +
a O +
2- O +
to O +
3-fold O +
increase O +
in O +
the O +
number O +
S O -
- O -
opsin O -
– O -
positive O +
cells O +
in O +
the O +
rd7 O +
retina O +
compared O +
to O +
wild O +
type O +
[ O -
17 O -
] O -
. O +

In O +
addition O -
, O +
two O +
groups O +
recently O +
reported O +
derepression O +
of O +
additional O +
cone O +
genes O +
in O +
the O +
rd7 O +
mutant O +
[ O -
18,19 O -
] O -
. O +

In O +
order O +
to O +
better O +
understand O +
the O +
mechanistic O +
basis O +
of O +
ESCS O -
, O +
we O +
undertook O +
a O +
molecular O +
and O +
ultrastructural O +
analysis O +
of O +
the O +
photoreceptors O +
of O +
the O +
rd7 O +
mutant O +
mouse O -
. O +

Microarray O +
and O +
in O +
situ O +
hybridization O +
analyses O +
revealed O +
a O +
modest O +
increase O +
in O +
the O +
number O +
of O +
S O -
- O -
opsin O -
– O -
positive O +
cells O +
and O +
widespread O +
derepression O +
of O +
many O +
cone O -
- O -
specific O +
genes O +
within O +
rod O +
photoreceptor O +
cells O -
. O +

Ultrastructural O +
studies O +
demonstrated O +
that O +
the O +
cells O +
that O +
coexpress O +
rod O +
and O +
cone O +
genes O +
in O +
the O +
rd7 O +
retina O +
represent O +
a O +
morphologically O +
hybrid O +
cell O +
type O -
, O +
intermediate O +
between O +
normal O +
rods O +
and O +
cones O -
. O +

Results O +
Widespread O +
Up O -
- O -
Regulation O +
of O +
Cone O +
Genes O +
in O +
the O +
rd7 O +
Mutant O +
Retina O +
In O +
an O +
initial O +
analysis O +
of O +
the O +
rd7 O +
mutant O -
, O +
homozygous O +
mutant O +
retinas O +
were O +
compared O +
with O +
wild O -
- O -
type O +
controls O +
at O +
multiple O +
postnatal O +
time O +
points O +
using O +
both O +
cDNA O +
and O +
Affymetrix O +
microarrays O -
. O +

The O +
cDNA O +
microarray O +
used O +
in O +
this O +
study O +
contains O +
approximately O +
12,000 O +
different O +
cDNAs O +
largely O +
derived O +
from O +
the O +
retina O +
and O +
nervous O +
system O -
, O +
and O +
the O +
Affymetrix O +
microarray O +
contains O +
over O +
34,000 O +
genes O -
. O +

Experiments O +
at O +
all O +
timepoints O +
were O +
carried O +
out O +
in O +
triplicate O -
, O +
and O +
stringent O +
criteria O +
were O +
applied O +
in O +
deciding O +
whether O +
a O +
given O +
gene O +
was O +
up- O +
or O +
down O -
- O -
regulated O +
in O +
the O +
mutant O +
( O -
see O +
Materials O +
and O +
Methods O +
for O +
details O -
) O -
. O +

These O +
experiments O +
demonstrated O +
widespread O +
up O -
- O -
regulation O +
of O +
cone O -
- O -
specific O +
and O +
cone O -
- O -
enriched O +
genes O +
in O +
the O +
rd7 O +
retina O -
, O +
especially O +
by O +
postnatal O +
day O +
14 O +
( O -
P14 O -
) O +
and O +
P21 O +
( O -
Figure O +
1 O -
) O -
. O +

Most O +
known O +
cone O -
- O -
specific O +
or O +
cone O -
- O -
enriched O +
genes O +
were O +
found O +
to O +
be O +
up O -
- O -
regulated O +
in O +
the O +
mutant O +
( O -
Figure O +
1 O -
, O +
genes O +
G1–G15 O -
) O -
. O +

The O +
majority O +
of O +
these O +
genes O +
represent O +
components O +
of O +
the O +
phototransduction O +
cascade O +
( O -
e.g. O -
, O +
opsins O -
, O +
transducins O -
, O +
and O +
phosphodiesterase O +
subunits O -
) O -
. O +

In O +
addition O +
to O +
these O +
genes O -
, O +
several O +
novel O +
cone O -
- O -
specific O +
genes O +
of O +
unknown O +
function O +
recently O +
identified O +
in O +
our O +
lab O +
were O +
also O +
up O -
- O -
regulated O +
( O -
Figure O +
1 O -
, O +
genes O +
G16 O -
, O +
G17 O -
, O +
G21 O -
, O +
and O +
G24 O -
; O +
unpublished O +
data O -
) O -
. O +

Finally O -
, O +
a O +
wide O +
range O +
of O +
other O +
genes O -
, O +
most O +
with O +
no O +
previously O +
recognized O +
role O +
in O +
the O +
retina O -
, O +
were O +
found O +
to O +
be O +
up O -
- O -
regulated O +
in O +
the O +
rd7 O +
mutant O +
( O -
Figure O +
1 O -
, O +
G26–G53 O -
; O +
Tables O +
S1 O +
and O +
S2 O -
; O +
Figures O +
S1–S7 O -
) O -
. O +

Nr2e3 O +
expression O +
is O +
first O +
detectable O +
by O +
in O +
situ O +
hybridization O +
around O +
embryonic O +
day O +
18 O +
( O -
E18 O -
) O -
; O +
it O +
then O +
peaks O +
around O +
P6 O +
and O +
subsequently O +
decreases O +
to O +
adult O +
levels O +
by O +
P21 O +
( O -
unpublished O +
data O -
) O -
. O +

In O +
accordance O +
with O +
this O +
time O +
course O +
of O +
expression O -
, O +
almost O +
no O +
gene O +
expression O +
changes O +
were O +
found O +
at O +
P0 O -
, O +
with O +
progressively O +
more O +
changes O +
at O +
later O +
timepoints O +
( O -
Figure O +
1 O -
) O -
. O +

One O +
exception O +
to O +
this O +
statement O +
is O +
the O +
gene O +
RIKEN O +
cDNA O +
4933409K07 O +
( O -
Figure O +
1 O -
, O +
gene O +
G47 O -
) O -
, O +
which O +
was O +
the O +
only O +
gene O +
shown O +
to O +
be O +
up O -
- O -
regulated O +
at O +
all O +
timepoints O +
examined O -
. O +

Additional O +
discussion O +
of O +
this O +
gene O +
and O +
its O +
unusual O +
expression O +
pattern O +
will O +
be O +
presented O +
below O -
. O +

Two O +
Distinct O +
Patterns O +
of O +
Cone O +
Gene O +
Derepression O +
in O +
rd7 O +
In O +
order O +
to O +
confirm O +
these O +
microarray O +
results O -
, O +
an O +
in O +
situ O +
hybridization O +
analysis O +
of O +
the O +
putative O +
up O -
- O -
regulated O +
cone O +
genes O +
was O +
carried O +
out O +
in O +
which O +
the O +
rd7 O +
mutant O +
retina O +
was O +
compared O +
with O +
age O -
- O -
matched O -
, O +
wild O -
- O -
type O +
controls O -
. O +

We O +
found O +
that O +
the O +
majority O +
of O +
the O +
cone O -
- O -
specific O +
genes O +
that O +
were O +
up O -
- O -
regulated O +
in O +
microarray O +
experiments O +
were O +
derepressed O +
when O +
assessed O +
by O +
in O +
situ O +
hybridization O +
( O -
Figure O +
2 O -
) O -
. O +

There O +
were O +
two O +
major O +
patterns O +
of O +
cone O +
gene O +
derepression O -
. O +

The O +
more O +
common O +
pattern O +
( O -
type O +
I O -
) O +
manifested O +
itself O +
as O +
ectopic O +
gene O +
expression O +
throughout O +
the O +
ONL O -
, O +
consistent O +
with O +
gene O +
expression O +
in O +
all O +
photoreceptors O +
( O -
Figure O +
2 O -
; O +
upper O +
left O +
photomicrographs O -
) O -
. O +

Typical O +
examples O +
of O +
this O +
pattern O +
of O +
derepression O +
are O +
shown O +
in O +
Figure O +
2 O -
, O +
and O +
many O +
more O +
are O +
available O +
in O +
Table O +
S1 O -
. O +

This O +
pattern O +
of O +
expression O +
contrasts O +
sharply O +
with O +
the O +
usual O +
pattern O +
of O +
cone O +
gene O +
expression O -
, O +
which O +
consists O +
of O +
scattered O +
cells O +
localized O +
to O +
the O +
scleral O +
edge O +
of O +
the O +
ONL O +
( O -
Figure O +
2 O -
) O -
. O +

The O +
second O +
category O +
of O +
cone O +
gene O +
derepression O +
( O -
type O +
II O -
) O +
consisted O +
of O +
a O +
patchy O -
, O +
salt B-Chemical -
- O -
and O -
- O -
pepper O +
pattern O +
of O +
ectopic O +
expression O +
in O +
which O +
individual O +
positive O +
cells O +
were O +
scattered O +
throughout O +
the O +
ONL O +
( O -
Figure O +
2 O -
, O +
upper O +
right O +
photomicrographs O -
; O +
Table O +
S1 O -
) O -
. O +

Although O +
numerous O +
positive O +
cells O +
were O +
present O +
in O +
the O +
rd7 O +
retina O +
( O -
particularly O +
in O +
the O +
ventral O +
portion O -
) O -
, O +
there O +
were O +
clearly O +
many O +
interspersed O +
cells O +
that O +
showed O +
a O +
complete O +
absence O +
of O +
expression O -
. O +

In O +
order O +
to O +
rule O +
out O +
the O +
possibility O +
that O +
these O +
scattered O +
positive O +
cells O +
were O +
simply O +
the O +
normal O +
complement O +
of O +
cones O +
that O +
had O +
failed O +
to O +
localize O +
their O +
cell O +
bodies O +
to O +
the O +
scleral O +
edge O +
of O +
the O +
ONL O -
, O +
the O +
number O +
of O +
positive O +
cells O +
in O +
the O +
rd7 O +
retina O +
was O +
quantitated O +
by O +
dissociated O +
cell O +
in O +
situ O +
hybridization O -
. O +

Dissociated O +
cell O +
in O +
situ O +
hybridization O +
was O +
performed O +
using O +
a O +
probe O +
for O +
the O +
S O -
- O -
cone O +
opsin O +
gene O +
( O -
Opn1sw O -
) O -
, O +
which O +
shows O +
type O +
II O +
derepression O +
( O -
Figures O +
2 O +
and O +
3A–3C O -
) O -
. O +

S O -
- O -
opsin O +
was O +
expressed O +
in O +
3.2 O -
% O +
of O +
retinal O +
cells O +
in O +
the O +
rd7 O +
mutant O +
( O -
66 O +
S O -
- O -
opsin O -
– O -
positive O +
cells O +
out O +
of O +
2,056 O +
6-diamidino-2-phenylindole B-Chemical +
[ O -
DAPI B-Chemical -
] O -
-positive O +
cells O -
) O -
. O +

This O +
value O +
is O +
approximately O +
2-fold O +
greater O +
than O +
the O +
percentage O +
of O +
S O -
- O -
opsin O -
– O -
positive O +
cells O +
identified O +
in O +
wild O -
- O -
type O +
control O +
retinas O -
, O +
1.65 O -
% O +
( O -
54 O +
S O -
- O -
opsin O -
- O -
positive O +
cells O +
out O +
of O +
3,271 O +
DAPI B-Chemical -
- O -
positive O +
cells O -
) O -
, O +
and O +
accords O +
well O +
with O +
the O +
previously O +
reported O +
value O +
of O +
2- O +
to O +
3-fold O +
more O +
S O -
- O -
opsin O -
– O -
positive O +
cells O +
in O +
rd7 O +
compared O +
to O +
wild O +
type O +
arrived O +
at O +
by O +
antibody O +
staining O +
of O +
tissue O +
sections O +
[ O -
17 O -
] O -
. O +

Previous O +
studies O +
have O +
estimated O +
that O +
the O +
total O +
number O +
of O +
cones O +
in O +
the O +
mouse O +
retina O +
is O +
2 O -
% O +
of O +
all O +
retinal O +
cells O +
[ O -
20 O -
] O -
, O +
and O +
that O +
S O -
- O -
opsin O +
is O +
largely O +
repressed O +
in O +
cones O +
in O +
the O +
dorsal O +
third O +
of O +
the O +
retina O +
[ O -
21 O -
] O -
. O +

The O +
estimate O +
of O +
1.65 O -
% O +
S O -
- O -
opsin O -
– O -
positive O +
cells O +
in O +
the O +
wild O -
- O -
type O +
retina O +
is O +
in O +
agreement O +
with O +
these O +
data O -
. O +

The O +
fact O +
that O +
only O +
3.2 O -
% O +
of O +
all O +
retinal O +
cells O +
are O +
S O -
- O -
opsin O -
– O -
positive O +
in O +
the O +
rd7 O +
mutant O +
also O +
confirms O +
that O +
the O +
majority O +
of O +
the O +
photoreceptors O +
( O -
which O +
make O +
up O +
just O +
over O +
70 O -
% O +
of O +
the O +
cells O +
in O +
the O +
adult O +
mouse O +
retina O -
) O +
do O +
not O +
express O +
this O +
gene O -
. O +

In O +
order O +
to O +
assess O +
whether O +
these O +
supernumerary O +
S O -
- O -
opsin O -
– O -
expressing O +
cells O +
coexpressed O +
rod O -
- O -
specific O +
markers O -
, O +
a O +
double O +
antibody O +
staining O +
for O +
S O -
- O -
opsin O +
and O +
rhodopsin O +
was O +
performed O -
. O +

This O +
study O +
showed O +
mutually O +
exclusive O +
domains O +
of O +
expression O +
of O +
S O -
- O -
opsin O +
and O +
rhodopsin O +
in O +
the O +
photoreceptor O +
outer O +
segments O +
( O -
Figure O +
3D–3F O -
) O -
. O +

This O +
finding O +
suggests O +
that O +
the O +
supernumerary O +
S O -
- O -
opsin O -
– O -
expressing O +
cells O +
in O +
the O +
rd7 O +
retina O +
may O +
represent O +
normal O +
" O -
blue O -
" O +
cones O -
. O +

Novel O +
Cone O -
- O -
Specific O +
Genes O +
Are O +
Derepressed O +
in O +
rd7 O +
Given O +
that O +
the O +
majority O +
of O +
known O +
cone O -
- O -
specific O +
genes O +
showed O +
marked O +
derepression O +
in O +
the O +
rd7 O +
mutant O -
, O +
additional O +
candidate O +
genes O +
up O -
- O -
regulated O +
on O +
microarray O +
analysis O +
were O +
evaluated O +
for O +
cone O -
- O -
specific O +
expression O -
. O +

In O +
situ O +
hybridization O +
was O +
performed O +
on O +
an O +
additional O +
45 O +
up O -
- O -
regulated O +
genes O -
, O +
confirming O +
that O +
21 O +
of O +
them O +
were O +
derepressed O -
. O +

Of O +
these O -
, O +
at O +
least O +
ten O +
showed O +
a O +
definite O +
cone O -
- O -
specific O +
or O +
cone O -
- O -
enriched O +
pattern O +
of O +
expression O +
in O +
the O +
wild O -
- O -
type O +
retina O +
( O -
Figure O +
1 O -
, O +
genes O +
G26–G35 O -
) O -
. O +

Several O +
examples O +
are O +
given O +
in O +
Figure O +
4 O -
. O +

Note O +
that O +
in O +
the O +
wild O -
- O -
type O +
retina O -
, O +
there O +
is O +
a O +
relatively O +
weak O +
pattern O +
of O +
scattered O +
positive O +
cells O +
at O +
the O +
scleral O +
edge O +
of O +
the O +
ONL O -
, O +
consistent O +
with O +
a O +
cone O -
- O -
specific O +
pattern O +
of O +
expression O -
. O +

All O +
of O +
these O +
genes O +
show O +
marked O +
derepression O +
in O +
the O +
rd7 O +
retina O -
. O +

A O +
number O +
of O +
these O +
novel O +
cone O -
- O -
specific O +
genes O +
showed O +
a O +
striking O +
localization O +
of O +
their O +
transcripts O +
to O +
the O +
photoreceptor O +
inner O +
segment O +
( O -
e.g. O -
, O +
Bub1b O +
and O +
Tcta O -
) O -
. O +

This O +
localization O +
manifests O +
in O +
a O +
section O +
in O +
situ O +
hybridization O +
as O +
a O +
dark O +
band O +
of O +
staining O +
just O +
beyond O +
the O +
outer O +
edge O +
of O +
the O +
ONL O +
immediately O +
underlying O +
the O +
outer O +
segment O +
layer O -
. O +

Although O +
such O +
a O +
pattern O +
of O +
transcript O +
localization O +
is O +
commonly O +
seen O +
in O +
many O +
rod O -
- O -
specific O +
genes O +
( O -
e.g. O -
, O +
Rho O +
in O +
Figure O +
2 O -
; O +
Pcdh21 O -
, O +
Rbp3 O -
, O +
and O +
Cnga1 O +
in O +
Table O +
S2 O -
) O -
, O +
it O +
is O +
not O +
easily O +
appreciated O +
in O +
cone O -
- O -
specific O +
genes O -
, O +
possibly O +
due O +
to O +
the O +
relative O +
scarcity O +
of O +
cones O +
in O +
the O +
mouse O -
. O +

In O +
the O +
rd7 O +
mutant O +
retina O +
in O +
which O +
such O +
genes O +
are O +
widely O +
derepressed O -
, O +
such O +
a O +
pattern O +
of O +
transcript O +
localization O +
often O +
becomes O +
apparent O -
. O +

In O +
addition O +
to O +
the O +
ten O +
genes O +
that O +
showed O +
cone O -
- O -
specific O +
expression O +
in O +
the O +
wild O -
- O -
type O +
retina O -
, O +
another O +
11 O +
novel O +
genes O +
were O +
derepressed O +
in O +
the O +
rd7 O +
retina O +
by O +
in O +
situ O +
hybridization O +
( O -
Figure O +
1 O -
, O +
genes O +
G36–G46 O -
) O -
. O +

Some O +
of O +
these O +
genes O +
showed O +
faint O +
expression O +
in O +
a O +
cone O -
- O -
like O +
distribution O +
( O -
see O +
Table O +
S1 O -
, O +
genes O +
G36 O -
, O +
G40 O -
, O +
and O +
G44 O -
) O -
, O +
and O +
one O +
appeared O +
to O +
be O +
expressed O +
throughout O +
the O +
ONL O +
but O +
at O +
greater O +
levels O +
in O +
cones O +
than O +
in O +
rods O +
( O -
Table O +
S1 O -
, O +
gene O +
G37 O -
) O -
. O +

The O +
remainder O +
of O +
the O +
up O -
- O -
regulated O +
genes O +
did O +
not O +
have O +
detectable O +
cone O +
staining O +
in O +
the O +
wild O -
- O -
type O +
retina O -
. O +

Despite O +
this O +
apparent O +
absence O +
of O +
cone O +
staining O -
, O +
the O +
pattern O +
of O +
derepression O +
in O +
rd7 O +
suggests O +
that O +
these O +
genes O +
may O +
also O +
be O +
novel O +
cone O -
- O -
specific O +
genes O -
, O +
albeit O +
expressed O +
at O +
levels O +
below O +
the O +
sensitivity O +
threshold O +
of O +
our O +
in O +
situ O +
hybridization O +
assay O -
. O +

In O +
most O +
cases O -
, O +
the O +
novel O +
cone O +
genes O +
identified O +
in O +
this O +
study O +
appear O +
to O +
have O +
a O +
type O +
I O +
pattern O +
of O +
derepression O -
. O +

However O -
, O +
due O +
to O +
the O +
weakness O +
of O +
the O +
signal O +
in O +
some O +
cases O -
, O +
or O +
transcript O +
localization O +
to O +
the O +
inner O +
segment O +
in O +
others O -
, O +
it O +
was O +
not O +
always O +
possible O +
to O +
determine O +
with O +
confidence O +
which O +
of O +
the O +
two O +
patterns O +
of O +
derepression O +
( O -
if O +
either O -
) O +
each O +
of O +
these O +
genes O +
displayed O -
. O +

In O +
terms O +
of O +
functional O +
categorization O -
, O +
the O +
novel O +
cone O +
genes O +
cover O +
a O +
broad O +
range O +
including O +
glucose B-Chemical +
metabolism O +
( O -
Pygm O +
and O +
Glo1 O -
) O -
, O +
fatty B-Chemical +
acid I-Chemical +
metabolism O +
( O -
Elovl2 O -
) O -
, O +
DNA O +
repair O +
( O -
Smug1 O -
) O -
, O +
cell O +
cycle O -
/ O -
chromosome O +
segregation O +
( O -
Bub1b O -
) O -
, O +
carcinogenesis O +
( O -
Tcta O -
) O -
, O +
endothelial O +
biology O +
( O -
Ece1 O -
) O -
, O +
cytoskeletal O +
function O +
( O -
Ebp4.1l1 O -
) O -
, O +
and O +
even O +
otolith O +
formation O +
( O -
Otop3 O -
) O -
. O +

A O +
relatively O +
frequent O +
finding O +
among O +
both O +
previously O +
identified O +
cone O -
- O -
specific O +
genes O -
, O +
as O +
well O +
as O +
in O +
some O +
of O +
those O +
identified O +
in O +
the O +
present O +
study O -
, O +
is O +
the O +
occurrence O +
of O +
gene O +
expression O +
in O +
an O +
early O +
photoreceptor O +
precursor O +
pattern O +
( O -
Figure O +
5 O -
) O -
. O +

This O +
pattern O +
of O +
expression O +
consists O +
of O +
positive O +
staining O +
by O +
in O +
situ O +
hybridization O +
specifically O +
at O +
the O +
scleral O +
border O +
of O +
the O +
retina O +
during O +
prenatal O +
timepoints O +
( O -
in O +
the O +
range O +
of O +
E13–E18 O -
) O -
. O +

Gnb3 O +
and O +
Thrb2 O +
are O +
two O +
examples O +
of O +
known O +
cone O +
genes O +
with O +
this O +
early O +
pattern O +
of O +
expression O +
( O -
Figure O +
5 O -
) O -
. O +

Two O +
of O +
the O +
11 O +
novel O +
cone O +
genes O +
identified O +
in O +
this O +
study O +
also O +
have O +
this O +
early O +
photoreceptor O +
pattern O +
of O +
expression O +
( O -
Ece1 O +
and O +
Otop3 O -
) O -
. O +

Intriguingly O -
, O +
three O +
genes O +
shown O +
to O +
be O +
up O -
- O -
regulated O +
in O +
rd7 O +
on O +
microarray O -
, O +
but O +
that O +
had O +
either O +
no O +
detectable O +
signal O +
by O +
in O +
situ O +
hybridization O +
at O +
adult O +
stages O +
or O +
no O +
apparent O +
change O +
in O +
expression O +
by O +
in O +
situ O +
hybridization O +
between O +
wild O +
type O +
and O +
rd7 O -
, O +
also O +
showed O +
this O +
early O +
photoreceptor O +
pattern O +
( O -
Figure O +
1 O -
, O +
genes O +
G48–G50 O -
) O -
. O +

The O +
embryonic O +
expression O +
pattern O +
of O +
two O +
of O +
these O +
genes O +
is O +
shown O +
in O +
Figure O +
5 O +
( O -
the O +
embryonic O +
in O +
situ O +
hybridization O +
for O +
the O +
third O -
, O +
G50 O -
, O +
can O +
be O +
found O +
in O +
Table O +
S1 O -
) O -
. O +

Although O +
the O +
significance O +
of O +
such O +
early O +
photoreceptor O +
expression O +
is O +
not O +
known O -
, O +
it O +
is O +
possible O +
that O +
these O +
genes O +
may O +
also O +
be O +
cone O -
- O -
specific O +
but O +
are O +
expressed O +
at O +
undetectably O +
low O +
levels O +
in O +
the O +
adult O -
. O +

M O -
- O -
Opsin O +
and O +
Thyroid B-Chemical +
Hormone I-Chemical +
Receptor O +
β2 O +
Are O +
Unchanged O +
in O +
the O +
rd7 O +
Mutant O +
Only O +
two O +
cone O -
- O -
specific O +
genes O +
failed O +
to O +
show O +
any O +
change O +
in O +
expression O +
by O +
either O +
microarray O +
or O +
in O +
situ O +
hybridization O +
in O +
the O +
rd7 O +
mutant O -
: O +
M O -
- O -
opsin O +
( O -
Opn1mw O -
) O +
and O +
thyroid B-Chemical +
hormone I-Chemical +
receptor O +
β2 O +
( O -
Thrb2 O -
) O +
( O -
Figure O +
S8 O -
) O -
. O +

This O +
result O +
is O +
particularly O +
notable O +
because O +
Thrb2 O +
is O +
absolutely O +
required O +
for O +
the O +
expression O +
of O +
M O -
- O -
opsin O +
[ O -
22 O -
] O -
. O +

Furthermore O -
, O +
the O +
repression O +
of O +
S O -
- O -
opsin O +
expression O +
in O +
the O +
dorsal O +
third O +
of O +
the O +
mouse O +
retina O +
is O +
thought O +
to O +
depend O -
, O +
at O +
least O +
in O +
part O -
, O +
on O +
Thrb2 O +
since O +
S O -
- O -
opsin O +
shows O +
dorsal O +
derepression O +
in O +
the O +
Thrb2 O +
mutant O +
[ O -
22 O -
] O -
. O +

Despite O +
the O +
derepression O +
of O +
S O -
- O -
opsin O +
seen O +
in O +
the O +
ventral O +
portion O +
of O +
the O +
rd7 O +
retina O -
, O +
the O +
normal O +
dorsal O +
repression O +
of O +
this O +
gene O +
is O +
still O +
present O +
in O +
this O +
mutant O +
( O -
unpublished O +
data O -
) O -
. O +

This O +
finding O +
is O +
consistent O +
with O +
the O +
normal O +
expression O +
pattern O +
and O +
function O +
of O +
Thrb2 O +
in O +
the O +
rd7 O +
mutant O -
. O +

One O +
further O +
finding O +
to O +
note O +
is O +
that O +
the O +
cell O +
bodies O +
of O +
the O +
M O -
- O -
opsin O -
– O -
positive O +
cells O +
appear O +
to O +
be O +
scattered O +
throughout O +
the O +
ONL O +
in O +
the O +
rd7 O +
mutant O +
at O +
P14 O +
( O -
Figure O +
S8 O -
) O -
. O +

Despite O +
this O +
fact O -
, O +
their O +
overall O +
number O +
does O +
not O +
appear O +
to O +
be O +
increased O +
relative O +
to O +
wild O -
- O -
type O -
. O +

In O +
addition O -
, O +
by O +
P28 O -
, O +
the O +
M O -
- O -
opsin O -
- O -
positive O +
cell O +
bodies O +
in O +
rd7 O +
appear O +
to O +
have O +
relocated O +
to O +
their O +
normal O +
position O +
at O +
the O +
scleral O +
edge O +
of O +
the O +
ONL O +
( O -
Figure O +
S8 O -
) O -
. O +

It O +
is O +
known O +
that O +
until O +
P11 O -
, O +
the O +
cell O +
bodies O +
of O +
cone O +
photoreceptors O +
in O +
the O +
mouse O +
are O +
normally O +
dispersed O +
throughout O +
the O +
ONL O -
, O +
only O +
to O +
relocate O +
subsequently O +
to O +
the O +
scleral O +
edge O +
of O +
the O +
ONL O +
around O +
P12 O +
[ O -
23 O -
] O -
. O +

It O +
is O +
possible O +
that O +
in O +
the O +
rd7 O +
mutant O +
retina O -
, O +
there O +
is O +
a O +
short O +
delay O +
in O +
the O +
relocation O +
of O +
the O +
M O -
- O -
opsin O -
– O -
expressing O +
cone O +
cell O +
bodies O +
to O +
the O +
scleral O +
edge O +
of O +
the O +
ONL O -
. O +

Rod O +
Genes O +
Are O +
Only O +
Modestly O +
and O +
Temporarily O +
Affected O +
in O +
rd7 O +
In O +
sharp O +
contrast O +
to O +
changes O +
in O +
cone O +
gene O +
expression O -
, O +
rod O -
- O -
specific O +
genes O +
were O +
much O +
less O +
severely O +
affected O +
in O +
the O +
rd7 O +
mutant O -
. O +

Microarray O +
and O +
in O +
situ O +
hybridization O +
analysis O +
of O +
numerous O +
rod O +
genes O +
failed O +
to O +
reveal O +
marked O +
changes O +
in O +
expression O +
levels O +
at O +
P14 O +
and O +
P21 O +
( O -
see O +
Figure O +
2 O -
, O +
lower O +
left O +
photomicrographs O -
; O +
Table O +
S2 O -
) O -
. O +

In O +
addition O +
to O +
the O +
three O +
rod O +
genes O +
depicted O +
in O +
Figure O +
2 O -
, O +
in O +
situ O +
hybridization O +
analysis O +
on O +
an O +
additional O +
19 O +
rod O -
- O -
specific O +
and O +
pan O -
- O -
photoreceptor O +
genes O +
demonstrated O +
only O +
a O +
very O +
mild O +
diminution O +
of O +
expression O +
in O +
two O +
of O +
these O +
genes O -
, O +
gucy2e O +
and O +
Rgs9 O -
, O +
at O +
P14 O -
, O +
and O +
an O +
increase O +
in O +
expression O +
in O +
two O -
, O +
Nr2e3 O -
, O +
and O +
Cnga1 O +
( O -
Table O +
S2 O -
) O -
. O +

Despite O +
the O +
minimal O +
changes O +
in O +
rod O +
gene O +
expression O +
at O +
later O +
postnatal O +
timepoints O -
, O +
there O +
was O +
evidence O +
of O +
a O +
significant O +
delay O +
in O +
the O +
onset O +
of O +
rhodopsin O +
( O -
Rho O -
) O +
expression O +
in O +
rd7 O +
mutants O +
relative O +
to O +
wild O -
- O -
type O -
. O +

Microarray O +
analysis O +
at O +
P6 O +
demonstrated O +
five O +
cDNA O +
spots O +
that O +
were O +
down O -
- O -
regulated O +
in O +
three O +
out O +
of O +
three O +
experiments O -
. O +

Of O +
these O +
spots O -
, O +
three O +
corresponded O +
to O +
rhodopsin O +
( O -
Table O +
S3 O -
) O -
. O +

In O +
situ O +
hybridization O +
analysis O +
of O +
several O +
rod O -
- O -
specific O +
genes O +
at O +
P6 O +
revealed O +
that O +
rhodopsin O +
alone O +
showed O +
a O +
markedly O +
lower O +
level O +
of O +
expression O +
compared O +
to O +
wild O +
type O +
( O -
Figure O +
6 O -
; O +
unpublished O +
data O -
) O -
. O +

Despite O +
this O +
modest O +
delay O +
in O +
the O +
onset O +
of O +
rhodopsin O +
expression O -
, O +
by O +
P14 O +
the O +
gene O +
had O +
attained O +
nearly O +
normal O +
levels O +
in O +
the O +
rd7 O +
mutant O +
( O -
see O +
Figure O +
2 O -
, O +
lower O +
left O +
photomicrographs O -
) O -
. O +

This O +
latter O +
finding O +
suggests O +
that O +
all O +
the O +
rod- O +
and O +
many O +
cone O -
- O -
specific O +
genes O +
are O +
coexpressed O +
in O +
the O +
majority O +
of O +
photoreceptors O +
in O +
the O +
rd7 O +
mutant O -
. O +

Changes O +
in O +
Retinal O +
Transcription O +
Factor O +
and O +
Müller O +
Glial O +
Gene O +
Expression O +
in O +
rd7 O +
Analysis O +
of O +
several O +
photoreceptor O +
transcription O +
factors O +
in O +
the O +
rd7 O +
mutant O +
indicated O +
that O +
the O +
levels O +
of O +
Crx O +
and O +
Nrl O +
are O +
unaffected O +
in O +
the O +
mutant O +
at O +
P14 O +
( O -
see O +
Figure O +
2 O -
, O +
lower O +
right O +
photomicrographs O -
) O -
. O +

Nrl O +
is O +
a O +
rod O -
- O -
specific O -
, O +
basic B-Chemical +
leucine O +
zipper O +
transcription O +
factor O +
required O +
for O +
the O +
activation O +
of O +
many O +
rod O -
- O -
specific O +
genes O +
and O +
the O +
repression O +
of O +
most O +
cone O -
- O -
specific O +
genes O +
in O +
rods O +
[ O -
24 O -
] O -
. O +

Nrl O +
is O +
known O +
to O +
be O +
genetically O +
upstream O +
of O +
Nr2e3 O +
and O +
is O +
required O +
for O +
its O +
expression O +
[ O -
24 O -
] O -
. O +

Crx O +
is O +
a O +
homeobox O +
transcription O +
factor O +
expressed O +
in O +
both O +
rods O +
and O +
cones O +
and O +
is O +
required O +
for O +
the O +
expression O +
of O +
a O +
variety O +
of O +
rod- O +
and O +
cone O -
- O -
specific O +
genes O +
[ O -
25 O -
] O -
. O +

In O +
contrast O +
to O +
what O +
is O +
seen O +
in O +
the O +
Nrl O +
mutant O -
, O +
Nr2e3 O +
expression O +
is O +
unchanged O +
in O +
Crx O +
mutant O +
homozygotes O +
( O -
unpublished O +
data O -
) O -
. O +

Strikingly O -
, O +
Nr2e3 O +
itself O +
was O +
markedly O +
up O -
- O -
regulated O +
in O +
the O +
rd7 O +
mutant O +
both O +
by O +
microarray O +
and O +
in O +
situ O +
hybridization O +
( O -
see O +
Figure O +
2 O -
, O +
lower O +
right O +
photomicrographs O -
; O +
Table O +
S2 O -
) O -
. O +

The O +
rd7 O +
mutant O +
carries O +
a O +
deletion O +
in O +
Nr2e3 O +
that O +
removes O +
portions O +
of O +
both O +
the O +
DNA O -
- O -
binding O +
and O +
ligand O -
- O -
binding O +
domains O +
[ O -
15 O -
] O -
. O +

Although O +
this O +
deletion O +
most O +
likely O +
creates O +
a O +
null O +
allele O -
, O +
a O +
residual O +
transcript O +
is O +
clearly O +
present O +
and O +
up O -
- O -
regulated O +
in O +
the O +
rd7 O +
mutant O -
. O +

This O +
finding O +
suggests O +
that O +
Nr2e3 O +
is O +
required O +
for O +
repression O +
of O +
its O +
own O +
transcription O -
. O +

One O +
gene O -
, O +
RIKEN O +
cDNA O +
4933409K07 O +
( O -
Figure O +
1 O -
, O +
gene O +
G47 O -
) O -
, O +
was O +
found O +
to O +
be O +
up O -
- O -
regulated O +
on O +
microarray O +
at O +
all O +
four O +
timepoints O +
examined O -
. O +

This O +
gene O +
showed O +
a O +
unique O +
pattern O +
of O +
expression O +
in O +
the O +
adult O +
rd7 O +
mutant O +
retina O -
. O +

Whereas O +
there O +
was O +
only O +
a O +
barely O +
detectable O +
hint O +
of O +
expression O +
in O +
the O +
inner O +
nuclear O +
layer O +
( O -
INL O -
) O +
in O +
the O +
wild O -
- O -
type O +
retina O -
, O +
this O +
gene O +
showed O +
strong O +
expression O +
in O +
the O +
middle O +
and O +
vitreal O +
thirds O +
of O +
the O +
INL O +
as O +
well O +
as O +
patchy O +
expression O +
in O +
the O +
ganglion O +
cell O +
layer O +
( O -
GCL O -
) O +
and O +
at O +
the O +
scleral O +
edge O +
of O +
the O +
ONL O +
in O +
rd7 O +
( O -
see O +
Table O +
S1 O -
) O -
. O +

This O +
in O +
situ O +
hybridization O +
pattern O +
is O +
consistent O +
with O +
staining O +
in O +
Müller O +
glia O -
, O +
the O +
principal O +
glial O +
cell O +
type O +
of O +
the O +
mouse O +
retina O -
. O +

One O +
possible O +
interpretation O +
of O +
this O +
unusual O +
expression O +
pattern O +
is O +
that O +
it O +
represents O +
an O +
early O +
reaction O +
of O +
Müller O +
glia O +
to O +
injury O +
in O +
this O +
mutant O -
. O +

The O +
Majority O +
of O +
the O +
Photoreceptors O +
in O +
the O +
rd7 O +
Retina O +
Represent O +
a O +
Morphologically O +
Hybrid O +
Cell O +
Type O +
In O +
order O +
to O +
assess O +
the O +
morphologic O +
effects O +
of O +
the O +
above O +
gene O +
expression O +
changes O -
, O +
the O +
ultrastructure O +
of O +
the O +
photoreceptor O +
cell O +
bodies O +
in O +
the O +
rd7 O +
mutant O +
was O +
examined O -
. O +

The O +
cell O +
bodies O +
were O +
chosen O +
for O +
evaluation O +
rather O +
than O +
the O +
outer O +
segments O -
, O +
since O +
in O +
the O +
mouse O -
, O +
the O +
ultrastructural O +
differences O +
between O +
rod O +
and O +
cone O +
somata O +
are O +
much O +
greater O +
than O +
are O +
the O +
differences O +
between O +
the O +
outer O +
segments O +
[ O -
26 O -
] O -
. O +

In O +
the O +
wild O -
- O -
type O +
mouse O -
, O +
cone O +
cell O +
bodies O +
are O +
aligned O +
along O +
the O +
scleral O +
border O +
of O +
the O +
ONL O -
, O +
and O +
they O +
are O +
larger O +
than O +
those O +
of O +
rods O -
. O +

They O +
have O +
a O +
smaller O -
, O +
more O +
irregular O +
mass O +
of O +
nuclear O +
heterochromatin O +
that O +
is O +
often O +
broken O +
up O +
into O +
multiple O +
discrete O +
clumps O +
connected O +
by O +
thin O +
threads O -
. O +

They O +
also O +
have O +
more O +
abundant O +
electron B-Chemical -
- O -
lucent O +
euchromatin O +
than O +
rods O -
. O +

Lastly O -
, O +
they O +
frequently O +
have O +
a O +
patch O +
of O +
organelle O -
- O -
rich O +
cytoplasm O +
next O +
to O +
their O +
nuclei O -
, O +
usually O +
containing O +
large O +
mitochondria O +
[ O -
26 O -
] O -
. O +

Analysis O +
of O +
toluidine O +
blue O -
- O -
stained O +
semi O -
- O -
thin O +
sections O +
revealed O +
that O +
such O +
cone O -
- O -
like O +
cells O +
were O +
present O +
in O +
greater O +
abundance O +
in O +
the O +
rd7 O +
retina O +
than O +
in O +
wild O -
- O -
type O -
, O +
and O +
that O +
their O +
somata O +
were O +
scattered O +
throughout O +
the O +
ONL O +
( O -
Figure O +
7 O -
) O -
. O +

A O +
comparison O +
between O +
the O +
distribution O +
of O +
these O +
cells O +
and O +
those O +
expressing O +
S O -
- O -
cone O +
opsin O +
strongly O +
suggests O +
that O +
they O +
represent O +
the O +
same O +
cell O +
population O +
( O -
compare O +
Figure O +
7D O +
and O +
7F O -
) O -
. O +

Analysis O +
of O +
the O +
nuclear O +
morphology O +
of O +
dissociated O +
retinal O +
cells O +
stained O +
for O +
S O -
- O -
cone O +
opsin O +
by O +
dissociated O +
cell O +
in O +
situ O +
hybridization O +
confirmed O +
that O +
this O +
is O +
the O +
case O +
( O -
unpublished O +
data O -
) O -
. O +

These O +
findings O -
, O +
along O +
with O +
the O +
absence O +
of O +
rhodopsin O +
staining O +
in O +
these O +
cells O +
( O -
see O +
Figure O +
3D–3F O -
) O -
, O +
suggest O +
that O +
these O +
" O -
cone O -
- O -
like O -
" O +
cells O +
in O +
the O +
rd7 O +
mutant O +
retina O +
may O +
represent O +
supernumerary O +
normal O +
cones O +
with O +
an O +
abnormal O +
localization O +
of O +
their O +
cell O +
bodies O -
. O +

In O +
contrast O +
to O +
the O +
cone O +
cell O +
body O -
, O +
the O +
wild O -
- O -
type O +
rod O +
soma O +
is O +
small O +
and O +
nearly O +
round O -
. O +

It O +
has O +
a O +
single O -
, O +
large O +
clump O +
of O +
dense O +
heterochromatin O -
, O +
a O +
thin O +
rim O +
of O +
moderately O +
electron B-Chemical -
- O -
dense O +
euchromatin O -
, O +
and O +
very O +
scant O +
juxtanuclear O +
cytoplasm O +
without O +
organelles O +
[ O -
26,27 O -
] O -
. O +

The O +
second O +
cell O +
population O +
in O +
the O +
ONL O +
of O +
the O +
rd7 O +
retina O +
has O +
some O +
of O +
the O +
nuclear O +
features O +
of O +
normal O +
rods O -
, O +
such O +
as O +
a O +
single O -
, O +
dense O +
mass O +
of O +
heterochromatin O +
and O +
moderately O +
electron B-Chemical -
- O -
dense O +
euchromatin O +
( O -
Figure O +
7H O -
) O -
; O +
yet O +
these O +
cells O +
also O +
show O +
features O +
of O +
cones O -
. O +

First O -
, O +
the O +
euchromatin O +
is O -
, O +
on O +
average O -
, O +
more O +
abundant O +
in O +
these O +
cells O +
than O +
in O +
wild O -
- O -
type O +
rods O +
( O -
compare O +
Figure O +
7 O -
G O +
and O +
7H O -
) O -
. O +

In O +
addition O -
, O +
comparison O +
of O +
the O +
diagrammatic O +
representation O +
of O +
the O +
wild O -
- O -
type O +
and O +
rd7 O +
ONLs O +
suggests O +
that O +
the O +
average O +
area O +
of O +
the O +
S O -
- O -
opsin O -
– O -
negative O +
cells O +
in O +
rd7 O +
is O +
greater O +
than O +
in O +
the O +
wild O -
- O -
type O +
( O -
Figure O +
7C O +
and O +
7D O -
) O -
. O +

In O +
order O +
to O +
confirm O +
this O +
impression O -
, O +
we O +
quantitated O +
the O +
area O +
of O +
50 O +
wild O -
- O -
type O +
and O +
50 O +
mutant O +
rod O -
- O -
like O +
cell O +
bodies O +
( O -
see O +
Materials O +
and O +
Methods O +
for O +
details O -
) O -
. O +

This O +
experiment O +
confirmed O +
that O +
the O +
average O +
area O +
of O +
the O +
rod O -
- O -
like O +
somata O +
in O +
rd7 O +
is O +
approximately O +
30 O -
% O +
larger O +
than O +
that O +
of O +
wild O -
- O -
type O +
rod O +
somata O +
( O -
mean O +
area O +
in O +
rd7 O +
was O +
9.75 O +
± O +
1.36 O +
( O -
standard O +
deviation O -
) O +
μm2 O -
, O +
compared O +
to O +
wild O -
- O -
type O +
rods O -
, O +
with O +
7.53 O +
± O +
0.72 O +
μm2 O +
; O +
n O +
= O +
50 O -
; O +
p O +
= O +
7.6 O +
× O +
10–16 O -
, O +
Student O -
's O +
t O -
- O -
test O -
) O -
. O +

It O +
is O +
also O +
notable O +
that O +
the O +
standard O +
deviation O +
of O +
the O +
somal O +
area O +
is O +
nearly O +
twice O +
as O +
great O +
in O +
rd7 O +
than O +
in O +
wild O -
- O -
type O -
, O +
confirming O +
the O +
subjective O +
impression O +
of O +
greater O +
variability O +
in O +
somal O +
size O +
and O +
shape O +
in O +
the O +
mutant O +
compared O +
to O +
the O +
wild O -
- O -
type O +
( O -
compare O +
Figure O +
7C O +
and O +
7D O -
) O -
. O +

Lastly O -
, O +
38 O -
% O +
( O -
19 O -
/ O -
50 O -
) O +
of O +
the O +
rd7 O +
photoreceptors O +
selected O +
for O +
somal O +
area O +
quantitation O +
had O +
prominent O +
juxtanuclear O +
mitochondria O +
( O -
red O +
arrow O +
in O +
Figure O +
7H O -
; O +
unpublished O +
data O -
) O -
. O +

Such O +
juxtanuclear O +
organelles O +
are O +
only O +
very O +
rarely O +
seen O +
in O +
normal O +
rods O +
( O -
1.5 O -
% O -
; O +
six O +
out O +
of O +
399 O +
cells O +
counted O -
) O -
, O +
but O +
are O +
common O +
in O +
cones O +
( O -
yellow O +
arrow O +
in O +
Figure O +
7H O -
) O -
. O +

In O +
conclusion O -
, O +
it O +
is O +
clear O +
that O +
this O +
second O +
cell O +
population O +
in O +
the O +
rd7 O +
retina O +
has O +
morphological O +
features O +
of O +
both O +
normal O +
rods O +
and O +
cones O +
consistent O +
with O +
the O +
coexpression O +
of O +
many O +
rod- O +
and O +
cone O -
- O -
specific O +
genes O +
in O +
these O +
cells O -
. O +

Discussion O +
In O +
this O +
paper O +
we O +
have O +
determined O +
that O +
the O +
primary O +
role O +
of O +
the O +
rod O -
- O -
specific O +
transcription O +
factor O -
, O +
Nr2e3 O -
, O +
is O +
to O +
maintain O +
cone O +
genes O +
transcriptionally O +
silent O +
within O +
rods O -
. O +

We O +
have O +
identified O +
two O +
patterns O +
of O +
cone O +
gene O +
derepression O +
in O +
the O +
rd7 O +
mutant O +
retina O -
, O +
in O +
agreement O +
with O +
a O +
previous O +
report O +
by O +
Chen O +
et O +
al. O +
[ O -
18 O -
] O -
. O +

The O +
first O +
pattern O +
of O +
derepression O +
identified O +
( O -
type O +
I O -
) O +
consists O +
of O +
ectopic O +
expression O +
of O +
cone O +
genes O +
in O +
the O +
vast O +
majority O +
of O +
cells O +
in O +
the O +
ONL O -
. O +

These O +
cells O +
were O +
also O +
shown O +
to O +
coexpress O +
all O +
rod O +
genes O +
tested O -
. O +

Consistent O +
with O +
the O +
hybrid O +
pattern O +
of O +
gene O +
expression O +
in O +
these O +
cells O -
, O +
electron B-Chemical +
microscopic O +
analysis O +
revealed O +
them O +
to O +
be O +
morphologically O +
intermediate O +
between O +
normal O +
rods O +
and O +
cones O -
. O +

Although O +
genes O +
showing O +
type O +
I O +
derepression O +
demonstrated O +
staining O +
in O +
the O +
majority O +
of O +
cells O +
in O +
the O +
ONL O -
, O +
two O +
lines O +
of O +
evidence O +
suggest O +
that O +
these O +
genes O +
are O +
not O +
completely O +
derepressed O +
in O +
these O +
cells O +
when O +
compared O +
to O +
their O +
expression O +
in O +
S O -
- O -
opsin O -
– O -
expressing O +
cones O -
. O +

First O -
, O +
close O +
evaluation O +
of O +
the O +
staining O +
pattern O +
of O +
a O +
number O +
of O +
type O +
I O +
genes O +
in O +
the O +
rd7 O +
mutant O +
retina O +
( O -
e.g. O -
, O +
see O +
Table O +
S1 O -
, O +
genes O +
G9 O -
, O +
G19 O -
, O +
and O +
G24 O -
) O -
, O +
reveals O +
that O -
, O +
in O +
addition O +
to O +
the O +
background O +
staining O +
throughout O +
the O +
ONL O -
, O +
there O +
is O +
a O +
more O +
darkly O +
staining O +
subpopulation O +
of O +
cells O +
scattered O +
throughout O +
this O +
layer O +
in O +
a O +
distribution O +
corresponding O +
to O +
that O +
of O +
the O +
supernumerary O +
S O -
- O -
cone O +
opsin O -
- O -
expressing O +
cells O -
. O +

This O +
pattern O +
of O +
staining O +
suggests O +
that O +
these O +
genes O +
are O +
more O +
highly O +
expressed O +
in O +
S O -
- O -
opsin O +
expressing O +
cells O +
than O +
in O +
the O +
hybrid O +
cells O +
of O +
the O +
rd7 O +
retina O -
. O +

The O +
second O +
line O +
of O +
evidence O +
derives O +
from O +
a O +
comparison O +
of O +
the O +
expression O +
pattern O +
of O +
many O +
type O +
I O +
genes O +
in O +
rd7 O +
and O +
Nrl− O -
/ O -
− O +
mutant O +
backgrounds O -
. O +

As O +
mentioned O +
above O -
, O +
Nrl O +
is O +
a O +
retinal O +
transcription O +
factor O +
that O -
, O +
when O +
mutated O -
, O +
results O +
in O +
en O +
masse O +
conversion O +
of O +
rods O +
into O +
S O -
- O -
opsin O -
– O -
expressing O +
cones O +
[ O -
24 O -
] O -
. O +

It O +
can O +
be O +
inferred O +
from O +
this O +
fact O +
that O +
Nrl O +
is O +
absolutely O +
required O +
for O +
the O +
normal O +
silencing O +
of O +
cone O -
- O -
specific O +
genes O +
in O +
rods O -
. O +

In O +
the O +
Nrl O +
homozygous O +
mutant O -
, O +
there O +
is O +
a O +
stronger O +
and O +
more O +
uniform O +
derepression O +
of O +
many O +
cone O -
- O -
specific O +
genes O +
throughout O +
the O +
ONL O +
than O +
is O +
seen O +
in O +
the O +
rd7 O +
retina O +
( O -
unpublished O +
data O -
) O -
. O +

This O +
finding O +
further O +
suggests O +
that O -
, O +
in O +
addition O +
to O +
its O +
repression O +
of O +
cone O +
gene O +
expression O +
via O +
induction O +
of O +
Nr2e3 O +
expression O -
, O +
Nrl O +
exerts O +
an O +
additional O +
level O +
of O +
negative O +
control O +
over O +
cone O +
genes O +
either O +
directly O +
or O +
via O +
a O +
second O -
, O +
as O +
yet O +
uncharacterized O -
, O +
repressor O -
. O +

The O +
second O +
pattern O +
of O +
derepression O +
seen O +
in O +
the O +
rd7 O +
retina O +
( O -
type O +
II O -
) O -
, O +
is O +
represented O +
by O +
a O +
scattered O +
population O +
of O +
cells O +
throughout O +
the O +
ONL O +
that O +
shows O +
derepression O +
of O +
several O +
cone O -
- O -
specific O +
genes O -
, O +
including O +
S O -
- O -
cone O +
opsin O -
. O +

By O +
ultrastructural O +
criteria O -
, O +
these O +
cells O +
appear O +
to O +
be O +
normal O +
cones O -
, O +
albeit O +
with O +
displaced O +
cell O +
bodies O -
. O +

Quantitation O +
of O +
these O +
supernumerary O +
S O -
- O -
cone O +
opsin O -
- O -
positive O +
cells O +
indicates O +
that O +
they O +
are O +
approximately O +
2-fold O +
more O +
abundant O +
than O +
in O +
normal O +
retina O -
, O +
consistent O +
with O +
previous O +
antibody O +
studies O +
[ O -
17 O -
] O -
. O +

Two O +
recent O +
studies O +
have O +
presented O +
data O +
that O +
are O +
consistent O +
with O +
many O +
of O +
the O +
findings O +
in O +
our O +
study O +
[ O -
18,19 O -
] O -
. O +

Both O +
studies O +
showed O +
that O +
cone O +
genes O +
in O +
addition O +
to O +
S O -
- O -
cone O +
opsin O +
are O +
derepressed O +
in O +
the O +
mouse O +
rd7 O +
mutant O -
. O +

In O +
addition O -
, O +
Peng O +
et O +
al. O +
[ O -
19 O -
] O +
found O +
by O +
RT O -
- O -
PCR O +
that O +
the O +
levels O +
of O +
several O +
rod O -
- O -
specific O +
genes O -
, O +
including O +
rhodopsin O -
, O +
were O +
modestly O +
reduced O +
in O +
rd7 O +
at O +
P28 O -
. O +

Our O +
in O +
situ O +
hybridization O +
data O +
suggest O +
that O +
rhodopsin O +
expression O +
is O +
markedly O +
reduced O +
at O +
P6 O -
, O +
but O +
that O +
it O +
attains O +
levels O +
indistinguishable O +
from O +
wild O -
- O -
type O +
by O +
P14 O -
. O +

Since O +
the O +
change O +
in O +
rhodopsin O +
levels O +
identified O +
by O +
Peng O +
et O +
al. O +
were O +
relatively O +
small O +
( O -
an O +
approximately O +
15 O -
% O +
reduction O -
) O -
, O +
it O +
is O +
not O +
surprising O +
that O +
such O +
a O +
difference O +
was O +
not O +
detected O +
by O +
in O +
situ O +
hybridization O -
. O +

The O +
overall O +
finding O +
of O +
modest O +
reductions O +
in O +
rod O -
- O -
specific O +
gene O +
expression O +
is O +
entirely O +
in O +
keeping O +
with O +
the O +
results O +
of O +
the O +
present O +
study O -
. O +

In O +
addition O +
to O +
demonstrating O +
derepression O +
of O +
a O +
range O +
of O +
known O +
cone O -
- O -
specific O +
genes O +
in O +
rd7 O +
mutants O -
, O +
Chen O +
et O +
al. O +
[ O -
18 O -
] O +
showed O +
up O -
- O -
regulation O +
by O +
Northern O +
blot O +
of O +
two O +
additional O +
genes O +
in O +
the O +
rd7 O +
mutant O -
, O +
Elovl2 O +
and O +
Fabp7 O -
. O +

These O +
two O +
genes O +
were O +
also O +
found O +
to O +
be O +
up O -
- O -
regulated O +
in O +
rd7 O +
in O +
the O +
present O +
study O +
( O -
see O +
Figure O +
1 O -
; O +
Table O +
S1 O -
) O -
. O +

Although O +
we O +
found O +
Elovl2 O +
to O +
have O +
a O +
cone O -
- O -
enriched O +
pattern O +
of O +
expression O +
( O -
see O +
Figure O +
1 O -
) O -
, O +
in O +
situ O +
hybridization O +
analysis O +
of O +
Fabp7 O +
failed O +
to O +
show O +
a O +
signal O +
in O +
wild O -
- O -
type O +
or O +
mutant O +
retina O +
( O -
unpublished O +
data O -
) O -
. O +

Nevertheless O -
, O +
previous O +
studies O +
have O +
suggested O +
that O +
Fabp7 O +
is O +
expressed O +
in O +
radial O +
glia O +
and O +
immature O +
astrocytes O +
in O +
the O +
brain O +
[ O -
28–30 O -
] O -
. O +

Given O +
the O +
expression O +
pattern O +
elsewhere O +
in O +
the O +
nervous O +
system O -
, O +
it O +
is O +
possible O +
that O +
Fabp7 O +
is O +
up O -
- O -
regulated O +
in O +
Müller O +
glia O +
in O +
the O +
rd7 O +
retina O +
in O +
response O +
to O +
injury O +
in O +
a O +
manner O +
akin O +
to O +
the O +
novel O +
Müller O +
glial O +
gene O +
identified O +
in O +
this O +
study O -
, O +
RIKEN O +
cDNA O +
4933409K07 O +
( O -
Figure O +
1 O -
, O +
gene O +
G47 O -
) O -
. O +

Indirect O +
support O +
for O +
this O +
idea O +
is O +
provided O +
by O +
the O +
observation O +
that O +
Fabp7 O +
is O +
up O -
- O -
regulated O +
by O +
microarray O +
analysis O +
in O +
Nrl O +
and O +
Crx O +
mutant O +
retinas O +
as O +
well O +
( O -
unpublished O +
data O -
) O -
, O +
suggesting O +
that O +
this O +
change O +
may O +
represent O +
a O +
generalized O +
response O +
to O +
injury O +
in O +
the O +
retina O +
rather O +
than O +
derepression O +
of O +
a O +
cone O -
- O -
enriched O +
gene O -
. O +

The O +
study O +
by O +
Chen O +
et O +
al. O +
[ O -
18 O -
] O +
made O +
two O +
further O +
observations O +
worthy O +
of O +
note O -
. O +

First O -
, O +
they O +
identified O +
a O +
zebrafish O +
homolog O +
of O +
Nr2e3 O +
and O +
showed O +
it O +
to O +
be O +
expressed O +
in O +
photoreceptors O -
. O +

Interestingly O -
, O +
they O +
showed O +
that O +
this O +
homolog O +
appears O +
to O +
have O +
a O +
pan O -
- O -
photoreceptor O +
pattern O +
of O +
expression O +
early O +
in O +
development O +
that O +
later O +
resolves O +
into O +
a O +
rod O -
- O -
specific O +
pattern O +
of O +
expression O -
. O +

This O +
early O +
expression O +
in O +
cones O +
may O +
represent O +
a O +
mechanism O +
whereby O +
the O +
expression O +
of O +
cone O -
- O -
specific O +
gene O +
products O +
is O +
temporarily O +
repressed O -
. O +

It O +
will O +
be O +
important O +
to O +
determine O +
the O +
extent O +
to O +
which O +
the O +
function O +
of O +
Nr2e3 O +
has O +
been O +
conserved O +
in O +
the O +
retina O +
of O +
such O +
a O +
distantly O +
related O +
organism O -
. O +

Secondly O -
, O +
Chen O +
et O +
al. O +
[ O -
18 O -
] O +
used O +
an O +
in O +
vitro O +
oligonucleotide O +
selection O +
protocol O +
to O +
determine O +
the O +
preferred O +
binding O +
site O +
for O +
Nr2e3 O -
. O +

This O +
information O +
will O +
be O +
very O +
useful O +
for O +
future O +
bioinformatic O +
analyses O +
of O +
Nr2e3 O +
target O +
genes O -
. O +

The O +
gene O +
expression O +
changes O +
identified O +
in O +
the O +
rd7 O +
mutant O +
retina O +
in O +
the O +
present O +
study O +
suggest O +
the O +
scheme O +
of O +
gene O +
regulation O +
in O +
mouse O +
rods O +
depicted O +
in O +
Figure O +
8 O -
. O +

As O +
this O +
diagram O +
implies O -
, O +
there O +
appear O +
to O +
be O +
at O +
least O +
two O +
different O +
repressors O +
of O +
cone O +
genes O +
within O +
rods O -
, O +
Nr2e3 O +
and O +
either O +
Nrl O +
itself O +
or O +
an O +
additional O +
unknown O +
transcription O +
factor O +
downstream O +
of O +
Nrl O -
, O +
here O +
termed O +
" O -
transcription O +
factor O +
X. O -
" O +
In O +
fact O -
, O +
it O +
appears O +
that O +
the O +
differences O +
between O +
type O +
I O +
and O +
type O +
II O +
cone O +
genes O +
may O +
simply O +
depend O +
on O +
which O +
repressor O -
— O -
Nr2e3 O +
or O +
transcription O +
factor O +
X O -
— O -
is O +
primarily O +
responsible O +
for O +
the O +
regulation O +
of O +
the O +
gene O +
in O +
question O -
. O +

In O +
the O +
case O +
of O +
type O +
I O +
genes O -
, O +
Nr2e3 O +
is O +
the O +
primary O +
repressor O +
and O +
transcription O +
factor O +
X O +
is O +
of O +
secondary O +
importance O -
. O +

In O +
the O +
case O +
of O +
type O +
II O +
genes O -
, O +
transcription O +
factor O +
X O +
exerts O +
the O +
major O +
repressive O +
effect O +
on O +
transcription O -
, O +
and O +
Nr2e3 O +
plays O +
a O +
lesser O -
, O +
but O +
still O +
important O +
role O -
. O +

In O +
contrast O +
to O +
the O +
marked O +
derepression O +
of O +
the O +
vast O +
majority O +
of O +
cone O -
- O -
specific O +
genes O +
in O +
the O +
rd7 O +
mutant O -
, O +
two O +
genes O +
stand O +
out O +
as O +
being O +
unaffected O +
by O +
the O +
mutation O -
: O +
the O +
gene O +
encoding O +
M O -
- O -
opsin O +
and O +
Thrb2 O -
. O +

As O +
Thrb2 O +
is O +
known O +
to O +
be O +
required O +
for O +
the O +
expression O +
of O +
M O -
- O -
opsin O +
[ O -
22 O -
] O -
, O +
the O +
absence O +
of O +
supernumerary O +
M O -
- O -
opsin O -
– O -
positive O +
cells O +
may O +
simply O +
be O +
a O +
consequence O +
of O +
the O +
fact O +
that O +
Thrb2 O +
expression O +
is O +
unchanged O +
in O +
the O +
rd7 O +
mutant O -
. O +

Further O +
support O +
for O +
this O +
idea O +
has O +
been O +
provided O +
by O +
recent O +
work O +
in O +
our O +
lab O +
showing O +
widespread O +
derepression O +
of O +
cone O +
genes O +
in O +
the O +
Notch1− O -
/ O -
− O +
retina O +
( O -
unpublished O +
data O -
) O -
. O +

In O +
contrast O +
to O +
the O +
rd7 O +
mutant O -
, O +
Notch1− O -
/ O -
− O +
retinas O +
show O +
marked O +
derepression O +
of O +
Thrb2 O +
and O +
a O +
corresponding O +
derepression O +
of O +
the O +
gene O +
that O +
encodes O +
M O -
- O -
opsin O -
. O +

An O +
additional O +
observation O +
suggesting O +
that O +
M O -
- O -
opsin O +
and O +
S O -
- O -
opsin O +
are O +
controlled O +
by O +
different O +
mechanisms O +
comes O +
from O +
in O +
vitro O +
experiments O +
[ O -
31,32 O -
] O -
. O +

While O +
explanted O +
P3 O +
retinas O +
express O +
S O -
- O -
opsin O +
and O +
M O -
- O -
opsin O +
with O +
normal O +
kinetics O -
, O +
explanted O +
P0 O +
retinas O +
express O +
only O +
S O -
- O -
opsin O +
[ O -
32 O -
] O -
. O +

The O +
factor O -
( O -
s O -
) O +
controlling O +
these O +
differences O +
are O +
unknown O -
, O +
but O +
may O +
be O +
intrinsic O -
, O +
as O +
cocultures O +
of O +
older O +
and O +
younger O +
retinas O -
, O +
conditioned O +
media O +
from O +
older O +
retinas O -
, O +
and O +
addition O +
of O +
a O +
variety O +
of O +
small O +
molecules B-Chemical +
were O +
unable O +
to O +
promote O +
the O +
expression O +
of O +
M O -
- O -
opsin O +
in O +
the O +
P0-initiated O +
cultures O +
[ O -
32 O -
] O -
. O +

In O +
contrast O +
to O +
our O +
findings O -
, O +
Peng O +
et O +
al. O +
[ O -
19 O -
] O +
reported O +
that O +
M O -
- O -
opsin O +
expression O +
is O +
mildly O +
increased O +
in O +
the O +
rd7 O +
mutant O +
retina O -
. O +

It O +
is O +
possible O +
that O +
a O +
subtle O +
increase O +
in O +
M O -
- O -
opsin O +
transcript O +
levels O +
does O +
occur O +
in O +
the O +
rd7 O +
retina O -
, O +
and O +
that O +
this O +
difference O +
could O +
not O +
be O +
detected O +
by O +
in O +
situ O +
hybridization O -
. O +

Since O +
virtually O +
all O +
M O -
- O -
opsin O -
– O -
expressing O +
cells O +
are O +
localized O +
at O +
the O +
outer O +
edge O +
of O +
the O +
ONL O +
by O +
P28 O +
in O +
the O +
rd7 O +
mutant O +
( O -
Figure O +
S8 O -
) O -
, O +
any O +
increase O +
in O +
M O -
- O -
opsin O +
transcript O +
in O +
the O +
mutant O +
must O +
have O +
occurred O +
in O +
cells O +
in O +
that O +
location O -
. O +

A O +
variety O +
of O +
novel O +
cone O -
- O -
specific O +
or O +
cone O -
- O -
enriched O +
genes O +
were O +
characterized O +
in O +
this O +
study O -
. O +

One O +
of O +
these O +
genes O -
, O +
Pygm O -
, O +
is O +
involved O +
in O +
glycogen B-Chemical -
/ O -
glucose B-Chemical +
metabolism O -
, O +
and O +
a O +
second O -
, O +
Glo1 O -
, O +
is O +
required O +
for O +
detoxification O +
of O +
methylglyoxal B-Chemical -
, O +
a O +
byproduct O +
of O +
glycolysis O +
[ O -
33 O -
] O -
. O +

A O +
third O +
gene O +
involved O +
in O +
glucose B-Chemical +
metabolism O -
, O +
hexokinase O +
2 O +
( O -
Hk2 O -
) O -
, O +
is O +
also O +
derepressed O +
in O +
the O +
rd7 O +
mutant O +
and O +
shows O +
a O +
pattern O +
of O +
expression O +
in O +
the O +
wild O -
- O -
type O +
retina O -
, O +
suggesting O +
greater O +
expression O +
in O +
cones O +
than O +
in O +
rods O +
( O -
see O +
Figure O +
1 O -
; O +
Table O +
S1 O -
) O -
. O +

A O +
fourth O +
gene O +
involved O +
in O +
glucose B-Chemical +
metabolism O -
, O +
glucokinase O +
regulatory O +
protein O +
( O -
Gckr O -
) O -
, O +
was O +
found O +
to O +
be O +
increased O +
in O +
three O +
out O +
of O +
three O +
microarrays O +
at O +
P21 O +
but O +
was O +
not O +
tested O +
by O +
in O +
situ O +
hybridization O +
( O -
Table O +
S4 O -
) O -
. O +

The O +
increased O +
expression O +
of O +
Gckr O +
in O +
rd7 O +
mutant O +
retina O +
suggests O +
that O +
it O +
too O +
may O +
be O +
a O +
cone O -
- O -
enriched O +
gene O -
. O +

A O +
previous O +
study O +
found O +
that O +
two O +
of O +
these O +
genes O -
, O +
Pygm O +
and O +
Hk2 O -
, O +
have O +
markedly O +
elevated O +
tag O +
levels O +
in O +
an O +
ONL O -
- O -
specific O +
serial O +
analysis O +
of O +
gene O +
expression O +
library O +
consistent O +
with O +
their O +
being O +
highly O +
enriched O +
in O +
wild O -
- O -
type O +
photoreceptors O +
[ O -
34 O -
] O -
. O +

Furthermore O -
, O +
prior O +
studies O +
have O +
suggested O +
differences O +
in O +
glycogen B-Chemical +
and O +
glucose B-Chemical +
metabolism O +
between O +
primate O +
rods O +
and O +
cones O +
[ O -
35 O -
] O -
. O +

Our O +
findings O +
lend O +
further O +
support O +
to O +
this O +
concept O -
. O +

Interestingly O -
, O +
Pygm O +
has O +
been O +
implicated O +
in O +
human O +
disease O -
. O +

Mutations O +
in O +
this O +
gene O +
underlie O +
McArdle O -
's O +
disease O +
( O -
glycogen B-Chemical +
storage O +
disease O +
type O +
V O -
) O -
, O +
the O +
symptoms O +
of O +
which O +
include O +
exercise O +
intolerance O -
, O +
muscle O +
cramps O -
, O +
and O +
myoglobinuria O +
[ O -
36 O -
] O -
. O +

To O +
our O +
knowledge O -
, O +
no O +
abnormalities O +
of O +
retinal O +
function O +
have O +
been O +
reported O -
. O +

One O +
of O +
the O +
most O +
curious O +
findings O +
in O +
the O +
rd7 O +
mutant O +
retina O +
was O +
the O +
occurrence O +
of O +
two O +
different O +
types O +
of O +
changes O -
: O +
an O +
increase O +
in O +
the O +
number O +
of O +
S O -
- O -
opsin O -
– O -
expressing O +
cones O +
and O +
a O +
transformation O +
of O +
rods O +
into O +
hybrid O +
photoreceptors O -
. O +

It O +
is O +
known O +
that O +
Nr2e3 O +
is O +
expressed O +
only O +
in O +
rods O -
, O +
and O +
the O +
transcript O +
is O +
first O +
detectable O +
in O +
postmitotic O +
cells O +
( O -
J. O +
Trimarchi O +
and O +
CLC O -
, O +
unpublished O +
data O -
) O -
. O +

Assuming O +
that O +
Nr2e3 O +
acts O +
cell O +
autonomously O -
, O +
we O +
can O +
conclude O +
that O +
the O +
supernumerary O +
S O -
- O -
cone O -
– O -
positive O +
cells O +
and O +
the O +
hybrid O +
photoreceptors O +
identified O +
in O +
the O +
rd7 O +
retina O +
were O +
redirected O +
to O +
these O +
fates O +
from O +
postmitotic O +
cells O +
that O +
were O +
destined O +
to O +
become O +
rods O -
. O +

This O +
conclusion O +
raises O +
this O +
question O -
: O +
Why O +
does O +
loss O +
of O +
a O +
single O +
transcription O +
factor O +
within O +
rod O +
precursors O +
lead O +
to O +
two O +
alternative O +
fates O -
— O -
a O +
hybrid O +
cell O +
type O +
on O +
the O +
one O +
hand O +
and O +
apparently O +
normal O +
S O -
- O -
cones O +
on O +
the O +
other O -
? O +

There O +
are O +
at O +
least O +
two O +
possible O +
explanations O +
for O +
these O +
differences O -
. O +

First O -
, O +
it O +
is O +
possible O +
that O +
there O +
are O +
two O +
distinct O +
types O +
of O +
rod O +
precursor O -
; O +
loss O +
of O +
Nr2e3 O +
in O +
one O +
leads O +
to O +
S O -
- O -
cone O +
fate O +
and O +
in O +
the O +
other O +
results O +
in O +
a O +
hybrid O +
cell O +
type O -
. O +

In O +
fact O -
, O +
there O +
is O +
experimental O +
evidence O +
from O +
the O +
rat O +
to O +
support O +
the O +
conclusion O +
that O +
early O -
- O -
born O +
and O +
late O -
- O -
born O +
rods O +
are O +
intrinsically O +
different O +
[ O -
37 O -
] O -
. O +

One O +
test O +
of O +
the O +
hypothesis O +
that O +
there O +
are O +
two O +
temporally O +
distinct O +
rod O +
precursor O +
populations O +
would O +
be O +
to O +
carry O +
out O +
birthdating O +
experiments O +
to O +
determine O +
whether O +
the O +
supernumerary O +
S O -
- O -
opsin O -
– O -
positive O +
cells O +
in O +
the O +
rd7 O +
retina O +
derived O +
exclusively O +
from O +
an O +
early- O +
or O +
late O -
- O -
born O +
population O -
. O +

Of O +
course O -
, O +
if O +
this O +
were O +
not O +
the O +
case O -
, O +
this O +
experiment O +
could O +
not O +
rule O +
out O +
the O +
possibility O +
that O +
molecularly O +
distinct O +
populations O +
of O +
rod O +
precursors O +
are O +
present O +
simultaneously O +
in O +
the O +
developing O +
retina O -
. O +

An O +
alternative O +
explanation O +
would O +
be O +
that O +
there O +
is O +
only O +
a O +
single O -
, O +
homogeneous O +
population O +
of O +
postmitotic O +
rod O +
precursors O +
in O +
the O +
mouse O -
, O +
and O +
a O +
stochastic O +
event O +
triggers O +
assumption O +
of O +
the O +
S O -
- O -
cone O +
fate O +
in O +
a O +
small O +
subpopulation O +
of O +
these O +
cells O +
in O +
the O +
rd7 O +
mutant O -
. O +

Recent O +
studies O +
in O +
a O +
variety O +
of O +
experiment O +
systems O +
suggest O +
that O +
such O +
a O +
stochastic O -
, O +
all O -
- O -
or O -
- O -
none O +
mechanism O +
of O +
gene O +
activation O +
is O +
commonplace O +
[ O -
38–44 O -
] O -
. O +

In O +
this O +
scenario O -
, O +
the O +
absence O +
of O +
Nr2e3 O +
would O +
alter O +
the O +
probability O +
that O +
an O +
unknown O +
master O +
control O +
gene O +
is O +
expressed O +
in O +
rod O +
precursors O -
. O +

Once O +
this O +
event O +
takes O +
place O -
, O +
it O +
would O +
initiate O +
an O +
irreversible O +
program O +
of O +
differentiation O +
toward O +
S O -
- O -
cone O +
fate O -
, O +
albeit O +
at O +
a O +
relatively O +
low O +
frequency O -
. O +

In O +
this O +
way O -
, O +
a O +
subset O +
of O +
cells O +
from O +
an O +
initially O +
homogeneous O +
population O +
would O +
select O +
the O +
S O -
- O -
cone O +
fate O +
in O +
an O +
entirely O +
probabilistic O +
manner O -
. O +

Human O +
patients O +
with O +
ESCS O +
display O +
three O +
types O +
of O +
abnormality O +
attributable O +
to O +
the O +
retina O -
: O +
( O -
1 O -
) O +
an O +
atypical O +
ERG O +
waveform O +
that O +
is O +
preferentially O +
sensitive O +
to O +
short O -
- O -
wavelength O +
light O -
, O +
( O -
2 O -
) O +
slowly O +
progressive O +
retinal O +
degeneration O -
, O +
and O +
( O -
3 O -
) O +
abnormal O +
retinal O +
lamination O +
with O +
rosette O +
formation O +
[ O -
1,12,13 O -
] O -
. O +

The O +
rd7 O +
mutant O +
mice O +
also O +
demonstrate O +
the O +
latter O +
two O +
defects O -
, O +
but O +
have O +
a O +
normal O +
ERG O +
[ O -
15,45 O -
] O -
. O +

These O +
similarities O +
and O +
differences O +
between O +
the O +
two O +
species O +
help O +
to O +
explain O +
the O +
possible O +
mechanistic O +
basis O +
of O +
the O +
ESCS O -
. O +

The O +
fact O +
that O +
the O +
rd7 O +
mouse O +
has O +
a O +
normal O +
ERG O +
strongly O +
suggests O +
that O +
the O +
aberrant O +
ERG O +
in O +
ESCS O +
is O +
not O +
attributable O +
to O +
the O +
activity O +
of O +
a O +
hybrid O +
photoreceptor O +
identical O +
to O +
that O +
found O +
in O +
this O +
study O -
. O +

Namely O -
, O +
the O +
signal O +
is O +
unlikely O +
to O +
derive O +
from O +
a O +
population O +
of O +
cells O +
coexpressing O +
both O +
rod O +
and O +
cone O +
genes O +
but O +
whose O +
photopigment O +
is O +
rhodopsin O +
and O +
not O +
S O -
- O -
cone O +
opsin O -
. O +

This O +
conclusion O +
is O +
consistent O +
with O +
the O +
evidence O +
from O +
human O +
ESCS O +
patients O +
indicating O +
a O +
markedly O +
reduced O +
rod O +
system O +
and O +
a O +
lack O +
of O +
measurable O +
rhodopsin O +
by O +
reflection O +
densitometry O +
[ O -
1,2,10,11 O -
] O -
. O +

It O +
is O +
also O +
unlikely O +
that O +
we O +
would O +
fail O +
to O +
detect O +
an O +
ESCS O -
- O -
like O +
ERG O +
signal O +
in O +
mice O +
if O +
it O +
were O +
present O -
, O +
as O +
such O +
a O +
signal O +
has O +
been O +
demonstrated O +
in O +
the O +
Nrl O +
mutant O +
mouse O -
, O +
which O +
has O +
a O +
near O +
total O +
transformation O +
of O +
all O +
its O +
rods O +
into O +
blue O +
cones O +
[ O -
24 O -
] O -
. O +

These O +
findings O -
, O +
however O -
, O +
do O +
not O +
rule O +
out O +
the O +
possibility O +
that O +
the O +
abnormal O +
human O +
ERG O +
derives O +
from O +
a O +
hybrid O +
photoreceptor O +
cell O +
type O +
that O +
also O +
expresses O +
S O -
- O -
opsin O -
. O +

It O +
is O +
possible O +
that O +
there O +
are O +
gene O +
regulatory O +
differences O +
between O +
mice O +
and O +
humans O +
such O +
that O +
in O +
human O +
NR2E3 O +
mutants O -
, O +
S O -
- O -
opsin O +
shows O +
a O +
type O +
I O +
pattern O +
of O +
derepression O +
rather O +
than O +
a O +
type O +
II O +
as O +
in O +
seen O +
in O +
the O +
rd7 O +
mouse O -
, O +
and O +
is O +
therefore O +
expressed O +
in O +
all O +
of O +
the O +
hybrid O +
photoreceptor O +
cells O -
. O +

Alternatively O -
, O +
the O +
ratio O +
of O +
supernumerary O +
S O -
- O -
cones O +
to O +
hybrid O +
photoreceptors O +
produced O +
in O +
the O +
retina O +
of O +
ESCS O +
patients O +
might O +
be O +
such O +
that O +
a O +
higher O +
percentage O +
of O +
the O +
presumptive O +
rods O +
in O +
ESCS O +
patients O +
become O +
S O -
- O -
cones O +
rather O +
than O +
hybrid O +
photoreceptors O -
. O +

As O +
discussed O +
above O -
, O +
this O +
ratio O +
could O +
depend O +
either O +
on O +
the O +
relative O +
percentages O +
of O +
two O +
distinct O +
rod O +
precursor O +
populations O +
or O +
on O +
stochastic O +
effects O +
on O +
regulatory O +
gene O +
expression O -
. O +

In O +
contrast O +
to O +
the O +
ERG O +
differences O +
between O +
mouse O +
rd7 O +
and O +
human O +
NR2E3 O +
mutants O -
, O +
both O +
species O +
demonstrate O +
slow O +
retinal O +
degeneration O -
. O +

It O +
is O +
possible O +
that O +
this O +
degeneration O +
is O +
attributable O +
to O +
the O +
abnormal O +
function O +
of O +
the O +
hybrid O +
photoreceptor O +
cell O +
type O +
characterized O +
in O +
the O +
present O +
study O -
. O +

The O +
coexpression O +
of O +
both O +
rod O +
and O +
cone O +
genes O +
in O +
the O +
same O +
cell O +
could O +
predispose O +
the O +
cell O +
to O +
apoptosis O -
. O +

The O +
final O +
common O +
feature O +
between O +
mouse O +
rd7 O +
and O +
human O +
NR2E3 O +
mutants O +
is O +
the O +
presence O +
of O +
an O +
abnormally O +
laminated O +
retina O +
with O +
waviness O +
and O +
rosette O +
formation O +
in O +
the O +
ONL O +
[ O -
12–15 O -
] O -
. O +

The O +
cause O +
of O +
this O +
abnormality O +
is O +
not O +
known O -
, O +
but O +
it O +
is O +
possibly O +
related O +
to O +
defects O +
in O +
photoreceptor O +
cell O +
polarity O +
in O +
the O +
rd7 O +
mutant O -
. O +

Rosette O +
formation O +
and O +
abnormally O +
wavy O +
epithelia O +
are O +
common O +
sequelae O +
of O +
defects O +
in O +
pathways O +
controlling O +
cell O +
polarity O +
[ O -
46,47 O -
] O -
. O +

In O +
particular O -
, O +
loss O -
- O -
of O -
- O -
function O +
mutations O +
in O +
the O +
polarity O +
gene O +
crumbs O +
( O -
CRB1 O -
) O +
have O +
been O +
shown O +
to O +
cause O +
morphological O +
abnormalities O +
of O +
the O +
ONL O +
in O +
both O +
humans O +
and O +
mice O -
, O +
including O +
rosette O +
formation O +
in O +
mice O +
very O +
similar O +
to O +
that O +
seen O +
in O +
the O +
rd7 O +
mutant O +
[ O -
48,49 O -
] O -
. O +

Interestingly O -
, O +
Sharon O +
et O +
al. O +
[ O -
5 O -
] O +
have O +
recently O +
pointed O +
out O +
additional O +
features O +
shared O +
by O +
patients O +
with O +
CRB1 O +
mutations O +
and O +
mutations O +
in O +
NR2E3 O -
, O +
including O +
hyperopic O +
refractive O +
errors O +
and O +
a O +
distinctive O +
pattern O +
of O +
clumped O +
pigmentation O +
in O +
the O +
retina O -
. O +

In O +
the O +
present O +
study O +
we O +
found O +
the O +
mouse O +
crumbs O +
ortholog O +
to O +
be O +
up O -
- O -
regulated O +
in O +
the O +
rd7 O +
mutant O +
retina O +
by O +
microarray O -
, O +
consistent O +
with O +
its O +
higher O +
expression O +
level O +
in O +
cones O +
than O +
in O +
rods O +
[ O -
50 O -
] O -
. O +

Although O +
we O +
were O +
unable O +
to O +
confirm O +
this O +
finding O +
by O +
in O +
situ O +
hybridization O +
due O +
to O +
the O +
weakness O +
of O +
the O +
signal O -
, O +
it O +
is O +
possible O +
that O +
the O +
up O -
- O -
regulation O +
of O +
crumbs O +
in O +
the O +
retina O +
is O +
the O +
cause O +
of O +
the O +
lamination O +
defects O +
seen O +
in O +
the O +
rd7 O +
mutant O -
. O +

Overexpression O +
of O +
wild O -
- O -
type O +
crumbs O +
in O +
Drosophila O +
has O +
been O +
shown O +
to O +
cause O +
polarity O +
defects O +
leading O +
to O +
waviness O +
of O +
epithelia O +
and O +
even O +
to O +
misalignment O +
of O +
nuclei O +
within O +
photoreceptors O +
analogous O +
to O +
what O +
is O +
seen O +
in O +
the O +
rd7 O +
retina O +
[ O -
47,51 O -
] O -
. O +

Future O +
experiments O +
will O +
address O +
this O +
question O +
by O +
overexpressing O +
full O -
- O -
length O +
Crb1 O +
in O +
a O +
wild O -
- O -
type O +
background O -
. O +

One O +
further O +
point O +
worthy O +
of O +
note O +
is O +
the O +
striking O +
similarity O +
between O +
the O +
hybrid O +
photoreceptor O +
identified O +
in O +
this O +
study O +
and O +
a O +
naturally O +
occurring O +
photoreceptor O +
found O +
in O +
ground O +
squirrels O -
. O +

The O +
" O -
rods O -
" O +
of O +
this O +
species O +
have O +
electrophysiologic O -
, O +
molecular O -
, O +
and O +
ultrastructural O +
features O +
of O +
both O +
rods O +
and O +
cones O +
[ O -
52–58 O -
] O -
. O +

Although O +
these O +
unusual O +
findings O +
have O +
been O +
difficult O +
to O +
interpret O +
under O +
the O +
usual O +
assumptions O +
of O +
" O -
duplicity O +
theory O -
" O +
[ O -
56 O -
] O -
, O +
we O +
would O +
like O +
to O +
suggest O +
that O +
ground O +
squirrels O +
may O +
have O +
experienced O +
a O +
naturally O +
occurring O +
down O -
- O -
regulation O +
or O +
loss O +
of O +
Nr2e3 O +
expression O +
in O +
their O +
" O -
rods O -
" O +
that O +
transformed O +
them O +
into O +
a O +
hybrid O +
photoreceptor O +
cell O +
type O -
. O +

The O +
adaptive O +
significance O +
of O +
such O +
a O +
change O -
, O +
if O +
any O -
, O +
is O +
unknown O -
, O +
and O +
it O +
may O +
simply O +
be O +
due O +
to O +
relaxation O +
of O +
selective O +
pressure O +
for O +
night O +
vision O +
in O +
this O +
strictly O +
diurnal O +
species O -
. O +

Materials O +
and O +
Methods O +
Mutant O +
mice O -
. O +

Nr2e3rd7 O +
mutant O +
mice O +
were O +
obtained O +
from O +
Jackson O +
Laboratories O +
( O -
Bar O +
Harbor O -
, O +
Maine O -
, O +
United O +
States O -
; O +
stock O +
# O -
004643 O -
) O +
and O +
maintained O +
on O +
a O +
C57BL O -
/ O -
6 O +
background O -
. O +

All O +
control O +
mice O +
were O +
C57BL O -
/ O -
6 O -
. O +

Microarray O +
analysis O -
. O +

Total O +
retinal O +
RNA O +
samples O +
were O +
isolated O +
from O +
P0 O -
, O +
P6 O -
, O +
P14 O -
, O +
and O +
P21 O +
Nr2e3 O +
mutant O +
mice O +
using O +
the O +
Trizol O +
reagent B-Chemical +
( O -
Gibco O -
, O +
San O +
Diego O -
, O +
California O -
. O +

United O +
States O -
) O -
. O +

Total O +
retinal O +
RNA O +
samples O +
from O +
age O -
- O -
matched O +
wild O -
- O -
type O +
C57BL O -
/ O -
6 O +
mice O +
were O +
used O +
as O +
controls O -
. O +

Individual O +
total O +
RNA O +
samples O +
were O +
derived O +
from O +
four O +
retinas O +
( O -
pooled O +
from O +
two O +
animals O -
) O -
. O +

All O +
microarray O +
experiments O +
were O +
performed O +
in O +
triplicate O -
, O +
in O +
each O +
case O +
with O +
separate O +
RNA O +
preparations O -
. O +

Microarray O +
experiments O +
with O +
cDNAs O +
were O +
performed O +
with O +
the O +
P0 O -
, O +
P6 O -
, O +
and O +
P14 O +
derived O +
samples O -
. O +

Probes O +
were O +
labeled O +
with O +
either O +
Cy3 B-Chemical +
or O +
Cy5 B-Chemical +
using O +
the O +
Array O +
900 O +
kit O +
from O +
Genisphere O +
( O -
Hatfield O -
, O +
Pennsylvania O -
, O +
United O +
States O -
) O +
starting O +
with O +
5 O +
μg O +
of O +
total O +
RNA O +
according O +
to O +
the O +
manufacturer O -
's O +
instructions O -
. O +

Wild O -
- O -
type O +
control O +
probes O +
were O +
compared O +
to O +
mutant O +
on O +
the O +
same O +
microarray O -
. O +

In O +
two O +
of O +
the O +
three O +
replicates O -
, O +
the O +
mutant O +
probe O +
was O +
labeled O +
with O +
Cy3 B-Chemical +
and O +
the O +
wild O +
type O +
with O +
Cy5 B-Chemical -
, O +
and O +
in O +
the O +
third O +
replicate O +
the O +
dyes B-Chemical +
were O +
swapped O -
. O +

Labeled O +
probe O +
was O +
hybridized O +
to O +
microarray O +
slides O +
spotted O +
with O +
approximately O +
11,500 O +
cDNA O +
clones O +
from O +
the O +
brain O +
molecular O +
anatomy O +
project O +
library O +
( O -
kind O +
gift O +
of O +
B. O +
Soares O -
, O +
University O +
of O +
Iowa O -
; O +
see O +
http://trans.nih.gov/bmap/index.htm O +
for O +
details O -
) O +
and O +
500 O +
cDNA O +
clones O +
from O +
our O +
lab O +
collection O -
. O +

Slides O +
were O +
printed O +
and O +
hybridized O +
as O +
described O +
[ O -
59,60 O -
] O -
. O +

After O +
hybridization O +
and O +
washing O +
of O +
slides O +
according O +
to O +
the O +
manufacturer O -
's O +
instructions O +
( O -
Genisphere O -
) O -
, O +
the O +
slides O +
were O +
scanned O +
on O +
an O +
Axon O +
Instruments O +
( O -
Union O +
City O -
, O +
California O -
, O +
United O +
States O -
) O +
GenePix O +
4000 O +
scanner O +
and O +
images O +
were O +
analyzed O +
using O +
the O +
accompanying O +
GenePix O +
Pro O +
software O +
package O -
. O +

The O +
complete O +
raw O +
cDNA O +
microarray O +
data O +
set O +
are O +
available O +
in O +
Tables O +
S6–S14 O -
. O +

Two O +
types O +
of O +
normalization O +
were O +
performed O +
on O +
the O +
raw O +
intensity O +
scores O +
derived O +
from O +
the O +
GenePix O +
Pro O +
analysis O -
. O +

First O -
, O +
for O +
a O +
given O +
experiment O -
, O +
the O +
average O +
intensity O +
of O +
all O +
the O +
spots O +
in O +
the O +
weaker O +
of O +
the O +
two O +
channels O +
( O -
Cy3 B-Chemical +
or O +
Cy5 B-Chemical -
) O +
was O +
normalized O +
to O +
those O +
in O +
the O +
stronger O +
channel O -
. O +

Second O -
, O +
in O +
a O +
given O +
set O +
of O +
experiments O +
done O +
in O +
triplicate O +
at O +
a O +
particular O +
time O +
point O -
, O +
the O +
two O +
experiments O +
with O +
the O +
weaker O +
average O +
signal O +
intensity O +
over O +
all O +
spots O +
were O +
normalized O +
to O +
those O +
in O +
the O +
third O +
microarray O +
with O +
the O +
strongest O +
average O +
signal O +
intensity O -
. O +

All O +
spots O +
with O +
signal O +
levels O +
equal O +
to O +
or O +
below O +
background O +
were O +
removed O +
from O +
the O +
analysis O -
. O +

The O +
resulting O +
files O +
contained O +
on O +
average O +
about O +
6,000 O +
spots O -
. O +

These O +
files O +
were O +
then O +
sorted O +
according O +
to O +
Cy3 B-Chemical -
/ O -
Cy5 B-Chemical +
signal O +
intensity O -
, O +
and O +
those O +
spots O +
with O +
the O +
10 O -
% O +
highest O +
and O +
10 O -
% O +
lowest O +
intensity O +
ratios O +
( O -
approximately O +
600 O +
spots O -
/ O -
experiment O -
) O +
were O +
compared O +
across O +
the O +
three O +
experiments O +
at O +
a O +
given O +
time O +
point O +
using O +
custom O +
Perl O +
scripts O +
( O -
available O +
upon O +
request O +
from O +
JCC O -
) O -
. O +

All O +
spots O +
which O +
were O +
present O +
in O +
the O +
top O +
10 O -
% O +
most O +
up- O +
or O +
down O -
- O -
regulated O +
genes O +
in O +
two O +
out O +
of O +
three O +
or O +
three O +
out O +
of O +
three O +
experiments O +
were O +
recorded O +
( O -
the O +
latter O +
are O +
listed O +
in O +
Table O +
S3 O -
) O -
. O +

Microarray O +
analysis O +
of O +
the O +
P21 O +
retinas O +
was O +
performed O +
on O +
Affymetrix O +
mouse O +
genome O +
430 O +
2.0 O +
GeneChip O +
array O +
( O -
Affymetrix O -
, O +
Santa O +
Clara O -
, O +
California O -
, O +
United O +
States O -
) O -
. O +

A O +
total O +
of O +
six O +
microarray O +
hybridizations O +
were O +
performed O -
: O +
three O +
with O +
probes O +
derived O +
from O +
mutant O +
RNA O +
and O +
three O +
from O +
wild O -
- O -
type O -
. O +

Probes O +
were O +
synthesized O +
starting O +
with O +
10 O +
μg O +
of O +
total O +
RNA O +
for O +
each O +
sample O +
according O +
to O +
manufacturer O -
's O +
instructions O +
( O -
Affymetrix O -
) O -
. O +

Hybridization O -
, O +
washing O -
, O +
and O +
scanning O +
of O +
the O +
microarrays O +
were O +
all O +
performed O +
at O +
the O +
Bauer O +
Center O +
for O +
Genomics O +
Research O +
at O +
Harvard O +
University O +
according O +
to O +
manufacturer O -
's O +
instructions O +
( O -
Affymetrix O -
) O -
. O +

Initial O +
data O +
analysis O +
was O +
carried O +
out O +
using O +
the O +
GeneChip O +
Operating O +
System O +
( O -
GCOS O -
) O +
software O +
from O +
Affymetrix O -
. O +

Pairwise O +
comparisons O +
were O +
made O +
between O +
individual O +
mutant O +
microarray O +
results O +
and O +
controls O -
. O +

All O +
genes O +
were O +
removed O +
from O +
the O +
analysis O +
for O +
which O +
" O -
absent O -
" O +
calls O +
were O +
made O +
by O +
the O +
software O +
for O +
both O +
the O +
wild O -
- O -
type O +
and O +
mutant O +
samples O +
being O +
compared O -
. O +

The O +
remaining O +
gene O +
lists O +
contained O +
approximately O +
26,000 O +
transcripts O -
. O +

These O +
lists O +
were O +
then O +
sorted O +
according O +
to O +
the O +
mutant O -
- O -
to O -
- O -
wild O -
- O -
type O +
" O -
signal O +
log O +
ratio O -
" O +
in O +
order O +
to O +
identify O +
the O +
most O +
markedly O +
up- O +
and O +
down O -
- O -
regulated O +
genes O -
. O +

The O +
top O +
500 O +
most O +
up- O +
and O +
down O -
- O -
regulated O +
transcripts O +
( O -
approximately O +
2 O -
% O +
of O +
all O +
genes O +
in O +
each O +
case O -
) O +
from O +
each O +
of O +
the O +
three O +
pairwise O +
comparisons O +
between O +
mutant O +
and O +
wild O -
- O -
type O +
were O +
compared O +
using O +
custom O +
Perl O +
scripts O +
( O -
available O +
upon O +
request O +
from O +
JCC O -
) O +
to O +
identify O +
those O +
genes O +
that O +
were O +
present O +
in O +
two O +
or O +
three O +
out O +
of O +
three O +
lists O -
. O +

Those O +
genes O +
that O +
were O +
up- O +
or O +
down O -
- O -
regulated O +
in O +
three O +
out O +
of O +
three O +
experiments O +
were O +
recorded O +
( O -
Tables O +
S4 O +
and O +
S5 O -
) O -
. O +

The O +
complete O +
pairwise O +
Affymetrix O +
microarray O +
datasets O +
are O +
available O +
in O +
Tables O +
S15–S17 O -
. O +

In O +
Situ O +
hybridization O -
. O +

Section O +
in O +
situ O +
hybridization O +
was O +
performed O +
as O +
previously O +
described O +
[ O -
61 O -
] O +
using O +
20-μm O +
cryosections O +
from O +
OCT O -
- O -
embedded O +
tissue O +
or O +
4-μm O +
paraffin O +
sections O -
. O +

All O +
in O +
situ O +
hybridizations O +
were O +
performed O +
with O +
the O +
mutant O +
and O +
wild O -
- O -
type O +
control O +
sections O +
on O +
the O +
same O +
glass O +
slide O -
. O +

Riboprobes O +
labeled O +
with O +
digoxygenin B-Chemical -
- O -
tagged O +
UTP O +
( O -
Roche O -
, O +
Basel O -
, O +
Switzerland O -
) O +
were O +
detected O +
with O +
NBT B-Chemical -
/ O -
BCIP B-Chemical +
( O -
Sigma O -
, O +
St. O +
Louis O -
, O +
Missouri O -
, O +
United O +
States O -
) O -
. O +

The O +
sources O +
of O +
the O +
individual O +
riboprobes O +
used O +
in O +
this O +
study O +
are O +
described O +
in O +
Tables O +
S1 O +
and O +
S2 O -
. O +

Dissociated O +
cell O +
in O +
situ O +
hybridization O +
was O +
performed O +
as O +
described O +
previously O +
[ O -
62 O -
] O +
using O +
the O +
same O +
S O -
- O -
opsin O +
digoxygenin B-Chemical -
- O -
labeled O +
probe O +
used O +
for O +
section O +
in O +
situ O +
hybridization O -
. O +

All O +
images O +
were O +
captured O +
on O +
a O +
compound O +
microscope O +
( O -
Eclipse O +
e1000 O -
; O +
Nikon O -
, O +
Tokyo O -
, O +
Japan O -
) O +
using O +
a O +
CCD O +
camera O +
( O -
DXM1200F O -
, O +
Nikon O -
) O -
. O +

S O -
- O -
opsin O +
positive O +
cells O +
were O +
quantitated O +
on O +
dissociated O +
cell O +
in O +
situ O +
hybridization O +
as O +
previously O +
described O +
[ O -
62 O -
] O -
. O +

Twenty O +
fields O +
were O +
quantitated O +
in O +
this O +
manner O +
at O +
200 O -
× O +
magnification O +
for O +
both O +
rd7 O +
and O +
wild O -
- O -
type O +
retinas O -
. O +

Immunohistochemistry O -
. O +

For O +
antibody O +
staining O -
, O +
cryosections O +
were O +
prepared O +
and O +
stained O +
as O +
described O +
previously O +
[ O -
63 O -
] O -
. O +

Primary O +
antibodies O +
used O +
were O +
a O +
polyclonal O +
anti O -
- O -
blue O +
opsin O +
raised O +
in O +
rabbit O +
( O -
1:300 O -
; O +
Chemicon O +
International O -
, O +
Temecula O -
, O +
California O -
, O +
United O +
States O -
; O +
AB5407 O -
) O +
and O +
a O +
mouse O +
monoclonal O +
anti O -
- O -
rhodopsin O +
( O -
1:200 O -
; O +
rho4D2 O -
) O -
. O +

Secondary O +
antibodies O +
used O +
were O +
Cy2- B-Chemical +
or O +
Cy3-conjugated B-Chemical +
goat O +
anti O -
- O -
rabbit O +
and O +
anti O -
- O -
mouse O +
( O -
1:500 O -
; O +
Jackson O +
Immunologicals O -
, O +
West O +
Grove O -
, O +
Pennsylvania O -
, O +
United O +
States O -
) O -
. O +

Following O +
antibody O +
staining O -
, O +
4′-DAPI B-Chemical +
was O +
applied O +
to O +
stain O +
nuclei O +
( O -
Sigma O -
) O -
, O +
and O +
the O +
sections O +
were O +
coverslipped O +
and O +
mounted O +
in O +
Gel O -
/ O -
Mount O +
( O -
Biomeda O -
, O +
Foster O +
City O -
, O +
California O -
, O +
United O +
States O -
) O -
. O +

Electron B-Chemical +
microscopy O -
. O +

This O +
protocol O +
was O +
adapted O +
from O +
one O +
used O +
by O +
Raviola O +
[ O -
64 O -
] O +
with O +
some O +
modifications O +
derived O +
from O +
Carter O -
- O -
Dawson O +
and O +
Lavail O +
[ O -
26 O -
] O -
. O +

Four O +
adult O +
wild O -
- O -
type O +
and O +
four O +
mutant O +
animals O +
were O +
deeply O +
anesthetized O +
by O +
intraperitoneal O +
injection O +
of O +
Avertin O +
and O +
the O +
eyes O +
were O +
then O +
removed O -
. O +

The O +
cornea O +
was O +
gently O +
punctured O +
with O +
sharp O +
forceps O +
and O +
excised O +
with O +
iridectomy O +
scissors O -
. O +

The O +
eye O +
was O +
then O +
transferred O +
to O +
a O +
solution B-Chemical +
of O +
2 O -
% O +
paraformaldehyde O -
/ O -
2 O -
% O +
glutaraldehyde B-Chemical +
in O +
cacodylate B-Chemical +
buffer O +
( O -
0.1 O +
M O +
cacodylic B-Chemical +
acid I-Chemical -
; O +
0.1 O -
% O +
calcium B-Chemical +
chloride I-Chemical -
) O -
. O +

The O +
lens O +
was O +
gently O +
removed O +
and O +
the O +
eyecup O +
allowed O +
to O +
fix O +
for O +
2 O +
h O +
at O +
room O +
temperature O -
. O +

The O +
fixed O +
eye O +
was O +
then O +
placed O +
on O +
dental O +
wax B-Chemical +
and O +
sectioned O +
in O +
the O +
midline O +
with O +
a O +
fresh O +
razor O +
blade O +
( O -
half O +
of O +
the O +
retinas O +
were O +
sectioned O +
along O +
the O +
D O -
- O -
V O +
axis O +
and O +
half O +
along O +
the O +
nasal O -
- O -
temporal O +
axis O -
) O -
. O +

The O +
retinas O +
( O -
and O +
attached O +
retinal O +
pigment B-Chemical +
epithelium O -
) O +
were O +
carefully O +
dissected O +
away O +
from O +
the O +
sclera O -
, O +
which O +
was O +
discarded O -
. O +

The O +
retinas O +
were O +
then O +
rinsed O +
four O +
times O +
for O +
15 O +
min O +
each O +
with O +
Sorenson O -
's O +
buffer O +
( O -
pH O +
7.4 O -
) O -
. O +

They O +
were O +
then O +
stained O +
for O +
2 O +
h O +
at O +
4 O +
° O -
C O +
with O +
1 O -
% O +
osmium O +
tetroxide O +
in O +
1.5 O -
% O +
potassium B-Chemical +
ferrocyanide I-Chemical -
. O +

Next O -
, O +
the O +
retinas O +
were O +
rinsed O +
four O +
times O +
for O +
15 O +
min O +
in O +
maleate O +
buffer O +
( O -
pH O +
5.1 O -
) O +
and O +
then O +
stained O +
for O +
2 O +
h O +
at O +
room O +
temperature O +
with O +
1 O -
% O +
uranyl O +
acetate O +
in O +
maleate O +
buffer O +
( O -
pH O +
6.2 O -
) O -
. O +

They O +
were O +
then O +
washed O +
four O +
times O +
for O +
15 O +
min O +
with O +
maleate O +
buffer O +
( O -
pH O +
5.1 O -
) O -
; O +
once O +
for O +
10 O +
min O +
with O +
70 O -
% O +
ethanol B-Chemical -
; O +
once O +
for O +
10 O +
min O +
with O +
95 O -
% O +
ethanol B-Chemical -
; O +
and O +
four O +
times O +
for O +
30 O +
min O +
with O +
100 O -
% O +
ethanol B-Chemical -
. O +

Next O -
, O +
the O +
retinas O +
were O +
washed O +
three O +
times O +
over O +
one O +
hour O +
with O +
propylene B-Chemical +
oxide I-Chemical +
and O +
then O +
embedded O +
in O +
TAAB O +
812 O +
Resin O +
( O -
Marivac O -
, O +
Quebec O -
, O +
Canada O -
) O +
for O +
1–2 O +
d O +
in O +
a O +
60 O +
° O -
C O +
oven O -
. O +

Semi O -
- O -
thin O +
sections O +
were O +
cut O +
at O +
a O +
thickness O +
of O +
0.5 O +
μm O +
and O +
stained O +
with O +
1 O -
% O +
toluidine O +
blue O +
in O +
1 O -
% O +
sodium B-Chemical +
borate I-Chemical +
buffer O -
. O +

Images O +
of O +
semi O -
- O -
thin O +
sections O +
from O +
the O +
mutant O +
retina O +
were O +
taken O +
within O +
the O +
ventral O +
two O -
- O -
thirds O +
of O +
the O +
retina O +
where O +
the O +
majority O +
of O +
the O +
supernumerary O +
S O -
- O -
opsin O -
– O -
expressing O +
cells O +
reside O -
. O +

Wild O -
- O -
type O +
images O +
were O +
taken O +
in O +
comparable O +
regions O -
. O +

Sections O +
for O +
electron B-Chemical +
microscopy O +
were O +
cut O +
at O +
a O +
thickness O +
of O +
95 O +
nm O -
, O +
placed O +
on O +
grids O -
, O +
and O +
poststained O +
with O +
2 O -
% O +
uranyl O +
acetate O +
followed O +
by O +
0.2 O -
% O +
lead O +
citrate O -
. O +

All O +
sections O +
were O +
cut O +
in O +
a O +
plane O +
perpendicular O +
to O +
the O +
plane O +
of O +
the O +
photoreceptor O +
layer O -
. O +

They O +
were O +
then O +
visualized O +
on O +
a O +
Jeol O +
1200EX O +
electron B-Chemical +
microscope O +
( O -
Jeol O -
, O +
Tokyo O -
, O +
Japan O -
) O -
. O +

The O +
electron B-Chemical +
microscopic O +
images O +
in O +
Figure O +
7 O +
derive O +
from O +
the O +
ventral O +
two O -
- O -
thirds O +
of O +
the O +
wild O -
- O -
type O +
and O +
mutant O +
retinas O -
. O +

The O +
area O +
of O +
the O +
cell O +
bodies O +
of O +
the O +
rods O +
and O +
" O -
rod O -
- O -
like O -
" O +
cells O +
in O +
the O +
wild O -
- O -
type O +
and O +
mutant O +
ONLs O -
, O +
respectively O -
, O +
were O +
quantitated O +
in O +
the O +
following O +
manner O -
. O +

First O -
, O +
ten O +
fields O +
within O +
the O +
ONL O +
were O +
chosen O +
at O +
random O +
at O +
1,000 O -
× O +
magnification O +
and O +
then O +
photographed O +
at O +
4,000 O -
× O +
magnification O +
for O +
each O +
of O +
the O +
two O +
genotypes O -
. O +

Such O +
images O +
typically O +
contained O +
35–45 O +
cell O +
bodies O -
. O +

In O +
order O +
to O +
quantitate O +
only O +
the O +
area O +
of O +
those O +
cell O +
bodies O +
that O +
were O +
cut O +
as O +
near O +
to O +
the O +
midline O +
of O +
the O +
cell O +
as O +
possible O +
( O -
i.e. O -
, O +
in O +
order O +
to O +
obtain O +
the O +
maximal O +
cross O -
- O -
sectional O +
area O -
) O +
the O +
five O +
cells O +
with O +
the O +
largest O +
apparent O +
area O +
in O +
each O +
photograph O +
were O +
chosen O +
by O +
eye O +
and O +
the O +
outline O +
of O +
the O +
cell O +
membranes O +
were O +
traced O +
onto O +
white O +
paper O -
. O +

These O +
tracings O +
were O +
scanned O +
along O +
with O +
the O +
size O +
bar O +
from O +
the O +
electron B-Chemical +
micrographs O -
, O +
and O +
the O +
areas O +
of O +
the O +
resulting O +
digital O +
images O +
were O +
quantitated O +
using O +
Scion O +
Image O +
software O +
( O -
NIH O +
Image O -
, O +
http://rsb.info.nih.gov/nih-image O -
) O -
. O +

A O +
total O +
of O +
50 O +
cells O +
of O +
each O +
genotype O +
were O +
quantitated O +
in O +
this O +
manner O -
. O +

In O +
addition O -
, O +
in O +
order O +
to O +
evaluate O +
the O +
percentage O +
of O +
rods O +
in O +
the O +
wild O -
- O -
type O +
retina O +
that O +
had O +
any O +
juxtanuclear O +
mitochondria O -
, O +
all O +
rods O +
within O +
all O +
ten O +
images O +
were O +
counted O +
as O +
were O +
the O +
number O +
of O +
cells O +
showing O +
juxtanuclear O +
organelles O -
. O +

A O +
total O +
of O +
six O +
out O +
of O +
399 O +
wild O -
- O -
type O +
rods O +
( O -
1.5 O -
% O -
) O +
possessed O +
a O +
juxtanuclear O +
organelle O -
. O +

This O +
analysis O +
permitted O +
us O +
to O +
evaluate O +
the O +
wild O -
- O -
type O +
rods O +
for O +
juxtanuclear O +
mitochondria O +
at O +
multiple O +
planes O +
of O +
section O -
; O +
however O -
, O +
serial O +
sections O +
of O +
individual O +
cell O +
bodies O +
were O +
not O +
performed O -
. O +

Supporting O +
Information O +
Figures O +
S1–S7 O +
show O +
the O +
in O +
situ O +
hybridization O +
images O +
of O +
all O +
genes O +
discussed O +
in O +
the O +
paper O +
( O -
see O +
Tables O +
S1 O +
and O +
S2 O -
) O -
. O +

All O +
paired O +
images O +
( O -
which O +
show O +
the O +
wild O -
- O -
type O +
control O +
on O +
the O +
left O +
and O +
the O +
rd7 O +
mutant O +
retina O +
on O +
the O +
right O -
) O +
are O +
labeled O +
in O +
the O +
lower O +
left O -
- O -
hand O +
corner O +
with O +
the O +
gene O +
symbol O +
followed O +
by O +
the O +
age O +
of O +
the O +
retinas O +
in O +
question O +
( O -
P6 O -
, O +
P14 O -
, O +
P28 O -
, O +
or O +
adult O -
) O -
. O +

Unpaired O +
images O +
represent O +
prenatal O +
time O +
points O +
and O +
are O +
labeled O +
with O +
the O +
gene O +
symbol O +
of O +
the O +
gene O +
in O +
question O +
( O -
" O -
wt O -
" O +
indicates O +
that O +
the O +
retina O +
is O +
from O +
a O +
wild O -
- O -
type O +
animal O -
) O +
and O +
a O +
designation O +
of O +
the O +
embryonic O +
day O +
from O +
which O +
the O +
retina O +
derives O +
( O -
e.g. O -
, O +
e17.5 O +
= O +
embryonic O +
day O +
17.5 O -
) O -
. O +

Figure O +
S1 O +
In O +
Situ O +
Hybridization O +
Images O +
for O +
G1–G13 O +
in O +
Table O +
S1 O +
( O -
3.1 O +
MB O +
JPG O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S2 O +
In O +
Situ O +
Hybridization O +
Images O +
for O +
G14–G25 O +
in O +
Table O +
S1 O +
( O -
2.4 O +
MB O +
JPG O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S3 O +
In O +
Situ O +
Hybridization O +
Images O +
for O +
G26–G35 O +
in O +
Table O +
S1 O +
( O -
2.1 O +
MB O +
JPG O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S4 O +
In O +
Situ O +
Hybridization O +
Images O +
for O +
G36–G46 O +
in O +
Table O +
S1 O +
( O -
2.0 O +
MB O +
JPG O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S5 O +
In O +
Situ O +
Hybridization O +
Images O +
for O +
G47–G53 O +
in O +
Table O +
S1 O +
( O -
1.7 O +
MB O +
JPG O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S6 O +
In O +
Situ O +
Hybridization O +
Images O +
for O +
Genes O +
1–11 O +
in O +
Table O +
S2 O +
( O -
2.9 O +
MB O +
JPG O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S7 O +
In O +
Situ O +
Hybridization O +
Images O +
for O +
Genes O +
12–22 O +
in O +
Table O +
S2 O +
( O -
3.2 O +
MB O +
JPG O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S8 O +
In O +
Situ O +
Hybridization O +
Results O +
for O +
M O -
- O -
Opsin O +
and O +
Thrb2 O +
Note O +
that O +
the O +
M O -
- O -
opsin O -
– O -
positive O +
cells O +
are O +
scattered O +
throughout O +
the O +
ONL O +
at O +
P14 O -
, O +
but O +
appear O +
to O +
have O +
migrated O +
to O +
the O +
scleral O +
edge O +
of O +
the O +
ONL O +
by O +
P28 O -
. O +

There O +
is O +
no O +
change O +
in O +
the O +
number O +
of O +
M O -
- O -
opsin– O +
or O +
Thrb2-positive O +
cells O +
in O +
the O +
rd7 O +
mutant O -
. O +

( O -
2.1 O +
MB O +
PDF O -
) O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S1 O +
Cone O -
- O -
Specific O +
and O +
Cone O -
- O -
Enriched O +
Genes O +
Evaluated O +
in O +
the O +
rd7 O +
Mutant O +
by O +
Microarray O +
and O +
In O +
Situ O +
Hybridization O +

This O +
table O +
is O +
a O +
supplemental O +
version O +
of O +
Figure O +
1 O -
. O +
" O +

Figure O +
Number O -
" O +
indicates O +
which O +
figure O +
( O -
Figure O +
S1–S5 O -
) O +
contains O +
the O +
in O +
situ O +
hybridization O +
images O +
corresponding O +
to O +
the O +
gene O +
in O +
question O -
. O +
" O +

Lab O +
Clone O +
Information O -
" O +
indicates O +
the O +
region O +
of O +
the O +
gene O +
in O +
question O +
from O +
which O +
the O +
probe O +
used O +
for O +
in O +
situ O +
hybridization O +
was O +
derived O -
. O +

All O +
abbreviations O +
are O +
as O +
indicated O +
in O +
Figure O +
1 O -
. O +

( O -
26 O +
KB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S2 O +
Rod O +
Genes O +
Evaluated O +
in O +
the O +
rd7 O +
Mutant O +
by O +
In O +
Situ O +
Hybridization O +
This O +
table O +
contains O +
details O +
about O +
the O +
in O +
situ O +
hybridization O +
patterns O +
of O +
22 O +
genes O +
( O -
many O +
of O +
which O +
are O +
rod O -
- O -
specific O -
) O +
evaluated O +
in O +
the O +
rd7 O +
mutant O +
retina O -
. O +
" O +

Figure O +
Number O -
" O +
indicates O +
which O +
figure O +
( O -
Figure O +
S6 O +
or O +
S7 O -
) O +
contains O +
the O +
in O +
situ O +
hybridization O +
images O +
corresponding O +
to O +
the O +
gene O +
in O +
question O -
. O +
" O +

Lab O +
Clone O +
Information O -
" O +
indicates O +
the O +
region O +
of O +
the O +
gene O +
in O +
question O +
from O +
which O +
the O +
probe O +
used O +
for O +
in O +
situ O +
hybridization O +
was O +
derived O -
. O +

The O +
color O +
coding O +
of O +
the O +
in O +
situ O +
hybridization O +
results O +
under O +
" O -
In O +
Situ O +
Pattern O -
" O +
is O +
as O +
follows O -
: O +
dark O +
green O -
, O +
markedly O +
down O -
- O -
regulated O -
; O +
light O +
green O -
, O +
mildly O +
down O -
- O -
regulated O -
; O +
red O -
, O +
markedly O +
up O -
- O -
regulated O -
; O +
orange O -
, O +
mildly O +
up O -
- O -
regulated O -
. O +

( O -
20 O +
KB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S3 O +
Summary O +
of O +
cDNA O +
Microarray O +
Results O +
from O +
P0 O -
, O +
P6 O -
, O +
and O +
P14 O +
The O +
spots O +
listed O +
in O +
this O +
table O +
represent O +
those O +
that O +
were O +
either O +
up- O +
or O +
down O -
- O -
regulated O +
in O +
three O +
out O +
of O +
three O +
microarray O +
experiments O +
as O +
described O +
in O +
Materials O +
and O +
Methods O -
. O +

The O +
Cy3 B-Chemical -
/ O -
Cy5 B-Chemical +
signal O +
ratios O +
are O +
indicated O +
for O +
all O +
three O +
microarray O +
experiments O +
at O +
each O +
time O +
point O -
. O +

Note O +
that O +
the O +
Cy3 B-Chemical -
/ O -
Cy5 B-Chemical +
ratios O +
for O +
" O -
Microarray O +
# O -
3 O -
" O +
are O +
reversed O +
relative O +
to O +
the O +
other O +
two O -
, O +
since O +
the O +
fluorescent O +
tag O +
used O +
to O +
label O +
wild O -
- O -
type O +
and O +
mutant O +
RNA O +
was O +
swapped O +
as O +
described O +
in O +
Materials O +
and O +
Methods O -
. O +

( O -
22 O +
KB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S4 O +
Summary O +
of O +
Genes O +
Up O -
- O -
Regulated O +
in O +
rd7 O +
Mutant O +
Retina O +
at O +
P21 O +
by O +
Affymetrix O +
Microarray O +
Only O +
genes O +
that O +
were O +
found O +
to O +
be O +
up O -
- O -
regulated O +
in O +
three O +
out O +
of O +
three O +
microarray O +
experiments O +
( O -
as O +
described O +
in O +
Materials O +
and O +
Methods O -
) O +
are O +
listed O -
. O +
" O -
Nr2e3 O +
signal O -
" O +
and O +
" O -
C57BL O -
/ O -
6 O +
signal O -
" O +
represent O +
the O +
average O +
signal O +
for O +
that O +
transcript O +
in O +
all O +
three O +
microarray O +
experiments O -
. O +

( O -
92 O +
KB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S5 O +
Summary O +
of O +
Genes O +
Down O -
- O -
Regulated O +
in O +
rd7 O +
Mutant O +
Retina O +
at O +
P21 O +
by O +
Affymetrix O +
Microarray O +
Only O +
genes O +
that O +
were O +
found O +
to O +
be O +
down O -
- O -
regulated O +
in O +
three O +
out O +
of O +
three O +
microarray O +
experiments O +
( O -
as O +
described O +
in O +
Materials O +
and O +
Methods O -
) O +
are O +
listed O -
. O +
" O -
Nr2e3 O +
signal O -
" O +
and O +
" O -
C57BL O -
/ O -
6 O +
signal O -
" O +
represent O +
the O +
average O +
signal O +
for O +
that O +
transcript O +
in O +
all O +
three O +
microarray O +
experiments O -
. O +

( O -
58 O +
KB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S6 O +
Raw O +
cDNA O +
Microarray O +
Data O +
for O +
rd7 O +
versus O +
Wild O -
- O -
Type O +
Comparison O +
at O +
P0 O +
( O -
I O -
) O +
( O -
5.6 O +
MB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S7 O +
Raw O +
cDNA O +
Microarray O +
Data O +
for O +
rd7 O +
versus O +
Wild O -
- O -
Type O +
Comparison O +
at O +
P0 O +
( O -
II O -
) O +
( O -
5.6 O +
MB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S8 O +
Raw O +
cDNA O +
Microarray O +
Data O +
for O +
rd7 O +
versus O +
Wild O -
- O -
Type O +
Comparison O +
at O +
P0 O +
( O -
III O -
) O +
( O -
5.6 O +
MB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S9 O +
Raw O +
cDNA O +
Microarray O +
Data O +
for O +
rd7 O +
versus O +
Wild O -
- O -
Type O +
Comparison O +
at O +
P6 O +
( O -
I O -
) O +
( O -
5.6 O +
MB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S10 O +
Raw O +
cDNA O +
Microarray O +
Data O +
for O +
rd7 O +
versus O +
Wild O -
- O -
Type O +
Comparison O +
at O +
P6 O +
( O -
II O -
) O +
( O -
5.6 O +
MB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S11 O +
Raw O +
cDNA O +
Microarray O +
Data O +
for O +
rd7 O +
versus O +
Wild O -
- O -
Type O +
Comparison O +
at O +
P6 O +
( O -
III O -
) O +
( O -
5.6 O +
MB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S12 O +
Raw O +
cDNA O +
Microarray O +
Data O +
for O +
rd7 O +
versus O +
Wild O -
- O -
Type O +
Comparison O +
at O +
P14 O +
( O -
I O -
) O +
( O -
5.5 O +
MB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S13 O +
Raw O +
cDNA O +
Microarray O +
Data O +
for O +
rd7 O +
versus O +
Wild O -
- O -
Type O +
Comparison O +
at O +
P14 O +
( O -
II O -
) O +
( O -
5.6 O +
MB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S14 O +
Raw O +
cDNA O +
Microarray O +
Data O +
for O +
rd7 O +
versus O +
Wild O -
- O -
Type O +
Comparison O +
at O +
P14 O +
( O -
III O -
) O +
( O -
5.6 O +
MB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S15 O +
Raw O +
Affymetrix O +
Microarray O +
Data O +
for O +
rd7 O +
versus O +
Wild O -
- O -
Type O +
Comparison O +
at O +
P21 O +
( O -
I O -
) O +
( O -
18 O +
MB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S16 O +
Raw O +
Affymetrix O +
Microarray O +
Data O +
for O +
rd7 O +
versus O +
Wild O -
- O -
Type O +
Comparison O +
at O +
P21 O +
( O -
II O -
) O +
( O -
18 O +
MB O +
XLS O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S17 O +
Raw O +
Affymetrix O +
Microarray O +
Data O +
for O +
rd7 O +
versus O +
Wild O -
- O -
Type O +
Comparison O +
at O +
P21 O +
( O -
III O -
) O +
( O -
18 O +
MB O +
XLS O +

) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Acknowledgements O +
We O +
are O +
grateful O +
to O +
E. O +
Raviola O +
and O +
T. O +
Reese O +
for O +
help O +
with O +
electron B-Chemical +
microscopy O +
and O +
to O +
A. O +
Jadhav O +
and O +
J. O +
Trimarchi O +
for O +
access O +
to O +
unpublished O +
data O +
and O +
reagents B-Chemical -
. O +

Thanks O +
to O +
A. O +
Jadhav O -
, O +
J. O +
Trimarchi O -
, O +
D. O +
Kim O -
, O +
and O +
T. O +
Cherry O +
for O +
helpful O +
comments O +
on O +
the O +
manuscript O -
. O +

This O +
work O +
was O +
supported O +
by O +
the O +
Howard O +
Hughes O +
Medical O +
Institute O +
and O +
grants O +
from O +
the O +
National O +
Institutes O +
of O +
Health O +
( O -
EY014822 O +
to O +
JCC O +
and O +
EY009676 O +
to O +
CLC O -
) O -
. O +

Thanks O +
to O +
A. O +
Swaroop O +
for O +
providing O +
us O +
with O +
Nrl O +
mutant O +
mice O -
. O +

Abbreviations O +
DAPI B-Chemical +
- O +
6-diamidino-2-phenylindole B-Chemical +
E O -
[ O -
number O -
] O +
- O +
embryonic O +
day O +
[ O -
number O -
] O +
ERG O +
- O +
electroretinogram O +
ESCS O +
- O +
enhanced O +
S O -
- O -
cone O +
syndrome O +
GCL O +
- O +
ganglion O +
cell O +
layer O +
INL O +
- O +
inner O +
nuclear O +
layer O +
ONL O +
- O +
outer O +
nuclear O +
layer O +
P O -
[ O -
number O -
] O +
- O +
postnatal O +
day O +
[ O -
number O -
] O +
Figures O +

Figure O +
1 O +
Cone O -
- O -
Specific O +
and O +
Cone O -
- O -
Enriched O +
Genes O +
Evaluated O +
in O +
the O +
rd7 O +
Mutant O +
by O +
Microarray O +
and O +
In O +
Situ O +
Hybridization O +
The O +
color O +
coding O +
of O +
text O +
in O +
the O +
column O +
" O -
Gene O +
Name O -
" O +
is O +
as O +
follows O -
: O +
light O +
blue O +
( O -
G1–G15 O -
) O -
, O +
genes O +
previously O +
reported O +
in O +
the O +
literature O +
to O +
have O +
cone O -
- O -
specific O +
or O +
cone O -
- O -
enriched O +
patterns O +
of O +
expression O -
; O +
yellow O +
( O -
G16–G25 O -
) O -
, O +
novel O +
cone O +
genes O +
identified O +
in O +
an O +
unrelated O +
study O +
( O -
unpublished O +
data O -
) O -
; O +
dark O +
green O +
( O -
G26–G36 O -
) O -
, O +
novel O +
cone O +
genes O +
identified O +
in O +
the O +
present O +
study O +
that O +
were O +
up O -
- O -
regulated O +
in O +
rd7 O -
; O +
light O +
green O +
( O -
G37–G46 O -
) O -
, O +
additional O +
genes O +
found O +
to O +
be O +
up O -
- O -
regulated O +
in O +
rd7 O +
by O +
microarray O +
in O +
the O +
present O +
study O +
but O +
that O +
had O +
either O +
weak O +
or O +
inapparent O +
cone O -
- O -
specific O +
signal O +
on O +
in O +
situ O +
hybridization O -
; O +
white O +
( O -
G47–G53 O -
) O -
, O +
additional O +
genes O +
up O -
- O -
regulated O +
by O +
microarray O +
at O +
two O +
different O +
timepoints O +
but O +
with O +
either O +
unusual O +
expression O +
patterns O +
or O +
nonconfirmatory O +
in O +
situ O +
hybridizations O -
. O +

The O +
column O +
" O -
ID O -
" O +
contains O +
identifiers O +
used O +
in O +
the O +
present O +
paper O +
to O +
refer O +
to O +
specific O +
genes O -
. O +

" O -
GenBank O +
ID O -
" O +
contains O +
the O +
GenBank O +
accession O +
number O +
of O +
the O +
clone O +
used O +
to O +
make O +
the O +
probe O +
for O +
in O +
situ O +
hybridization O -
. O +

Within O +
this O +
column O -
, O +
" O -
lab O +
clone O -
" O +
indicates O +
that O +
the O +
probe O +
used O +
for O +
in O +
situ O +
hybridization O +
derived O +
from O +
a O +
clone O +
in O +
our O +
laboratory O -
. O +

The O +
region O +
of O +
the O +
gene O +
to O +
which O +
it O +
corresponds O +
is O +
indicated O +
in O +
Table O +
S1 O -
. O +

Columns O +
" O -
P0 O -
" O +
through O +
" O -
P21 O -
" O +
contain O +
the O +
results O +
of O +
microarray O +
experiments O +
at O +
the O +
given O +
postnatal O +
dates O -
. O +

P0 O -
, O +
P6 O -
, O +
and O +
P14 O +
time O +
points O +
represent O +
analyses O +
on O +
cDNA O +
microarrays O -
; O +
the O +
P21 O +
time O +
point O +
represents O +
data O +
from O +
an O +
Affymetrix O +
microarray O +
( O -
mouse O +
genome O +
432 O +
2.0 O -
) O -
. O +

A O +
red O +
cell O +
with O +
a O +
single O +
up O +
arrow O +
indicates O +
that O +
the O +
gene O +
in O +
question O +
was O +
up O -
- O -
regulated O +
in O +
three O +
out O +
of O +
three O +
microarrays O +
at O +
that O +
time O +
point O +
( O -
as O +
described O +
in O +
Materials O +
and O +
Methods O -
) O -
. O +

Those O +
cells O +
labeled O +
orange O +
with O +
a O +
single O +
up O +
arrow O +
and O +
asterisk O +
indicate O +
that O +
the O +
gene O +
in O +
question O +
was O +
up O -
- O -
regulated O +
in O +
two O +
out O +
of O +
three O +
microarrays O +
at O +
that O +
time O +
point O -
. O +

The O +
column O +
" O -
In O +
Situ O -
" O +
lists O +
the O +
type O +
of O +
derepression O +
seen O +
for O +
the O +
gene O +
in O +
question O +
in O +
the O +
rd7 O +
mutant O +
retina O +
( O -
type O +
I O +
and O +
type O +
II O +
are O +
described O +
in O +
the O +
main O +
text O -
) O -
. O +

Genes O +
designated O +
" O -
unclassified O -
" O +
represent O +
patterns O +
of O +
derepression O +
that O +
were O +
difficult O +
to O +
classify O +
as O +
either O +
type O +
I O +
or O +
type O +
II O +
( O -
see O +
main O +
text O +
for O +
more O +
details O -
) O -
. O +
" O +

Wild O +
type O -
" O +
in O +
this O +
column O +
indicates O +
that O +
the O +
in O +
situ O +
hybridization O +
pattern O +
in O +
the O +
rd7 O +
mutant O +
retina O +
was O +
not O +
different O +
from O +
the O +
wild O -
- O -
type O +
pattern O -
; O +
and O +
" O -
special O -
" O +
indicates O +
a O +
special O +
pattern O +
of O +
expression O +
discussed O +
more O +
fully O +
in O +
the O +
main O +
text O -
. O +

The O +
column O +
" O -
Expression O +
Pattern O -
" O +
contains O +
a O +
concise O +
description O +
of O +
the O +
wild O -
- O -
type O +
expression O +
pattern O +
of O +
the O +
gene O +
in O +
question O -
. O +

In O +
the O +
case O +
of O +
genes O +
for O +
which O +
no O +
signal O +
was O +
obtained O +
on O +
in O +
situ O +
hybridization O +
in O +
the O +
present O +
study O -
, O +
the O +
specified O +
expression O +
pattern O +
derives O +
from O +
reports O +
in O +
the O +
literature O -
. O +

Within O +
this O +
column O -
, O +
" O -
cone O +
> O +
rod O -
" O +
indicates O +
that O +
the O +
gene O +
is O +
expressed O +
in O +
all O +
photoreceptors O -
, O +
but O +
at O +
higher O +
levels O +
in O +
cones O +
than O +
rods O -
; O +
" O -
cone O -
? O -
" O +
indicates O +
very O +
weak O +
staining O +
in O +
a O +
cone O -
- O -
like O +
distribution O -
. O +

BP O -
, O +
bipolar O +
cells O -
; O +
EP O -
, O +
early O +
photoreceptor O +
expression O +
pattern O -
; O +
IS O -
, O +
inner O +
core O +
segment O +
localization O -
; O +
MG O -
, O +
Müller O +
glia O -
; O +
N O -
/ O -
A O -
, O +
not O +
available O +
on O +
the O +
microarray O -
; O +
NS O -
, O +
no O +
signal O +
detected O +
on O +
in O +
situ O +
hybridization O -
; O +
RPE O -
, O +
retinal O +
pigment B-Chemical +
epithelium O -
. O +

Figure O +
2 O +
Cone O +
and O +
Rod O +
Gene O +
Expression O +
in O +
the O +
rd7 O +
Mutant O +
at O +
P14 O +
The O +
upper O +
sets O +
of O +
photomicrographs O +
demonstrate O +
examples O +
of O +
type O +
I O +
and O +
type O +
II O +
cone O +
gene O +
derepression O +
in O +
the O +
rd7 O +
mutant O +
retina O +
as O +
explained O +
in O +
the O +
main O +
text O -
. O +

The O +
bottom O +
left O +
images O +
show O +
several O +
rod O -
- O -
specific O +
genes O +
that O +
are O +
essentially O +
unchanged O +
in O +
the O +
rd7 O +
background O +
at O +
P14 O -
. O +

The O +
bottom O +
right O +
images O +
show O +
the O +
expression O +
pattern O +
of O +
three O +
photoreceptor O +
transcription O +
factors O +
in O +
the O +
rd7 O +
mutant O -
. O +

Abbreviations O +
in O +
the O +
lower O +
left O +
hand O +
corner O +
of O +
each O +
pair O +
of O +
panels O +
represent O +
the O +
gene O +
symbols O +
summarized O +
in O +
Figure O +
1 O -
. O +

Figure O +
3 O +
S O -
- O -
Opsin O +
Dissociated O +
Cell O +
In O +
Situ O +
Hybridization O +
and O +
S O -
- O -
Opsin O -
/ O -
Rhodopsin O +
Antibody O +
Staining O +
on O +
rd7 O +
Mutant O +
Retina O +
( O -
A O -
– O -
C O -
) O +
A O +
dissociated O +
cell O +
in O +
situ O +
hybridization O +
with O +
an O +
S O -
- O -
opsin O +
probe O +
( O -
red O -
) O +
on O +
dissociated O +
rd7 O +
mutant O +
retinal O +
cells O +
stained O +
with O +
DAPI B-Chemical +
( O -
blue O -
) O -
. O +

( O -
C O -
) O +
shows O +
the O +
merged O +
images O -
. O +

( O -
D O -
– O -
F O -
) O +

The O +
outer O +
nuclear O +
layer O +
of O +
an O +
rd7 O +
mutant O +
retina O +
stained O +
by O +
antibody O +
for O +
S O -
- O -
opsin O +
( O -
red O -
) O +
and O +
rhodopsin O +
( O -
green O -
) O -
. O +

The O +
scleral O +
edge O +
of O +
the O +
outer O +
nuclear O +
layer O +
is O +
up O -
. O +

DAPI B-Chemical +
staining O +
is O +
in O +
blue O -
. O +

( O -
F O -
) O +
shows O +
the O +
merged O +
images O -
. O +

Insets O +
are O +
higher O -
- O -
power O +
images O +
of O +
the O +
outer O +
segments O +
showing O +
non O -
- O -
overlap O +
of O +
S O -
- O -
opsin O +
and O +
rhodopsin O +
staining O +
in O +
the O +
mutant O -
. O +

Figure O +
4 O +
Expression O +
Patterns O +
of O +
Several O +
Novel O +
Cone O +
Genes O +
Up O -
- O -
Regulated O +
in O +
rd7 O +
In O +
the O +
wild O -
- O -
type O +
images O +
( O -
wt O -
) O -
, O +
note O +
the O +
scattered O -
, O +
weakly O +
positive O +
cells O +
at O +
the O +
scleral O +
edge O +
of O +
the O +
outer O +
nuclear O +
layer O +
in O +
a O +
cone O +
distribution O -
. O +

All O +
of O +
the O +
genes O +
show O +
marked O +
up O -
- O -
regulation O +
in O +
the O +
rd7 O +
mutant O -
. O +

Bub1b O +
and O +
Tcta O +
show O +
transcript O +
localization O +
predominantly O +
to O +
the O +
inner O +
segment O +
of O +
the O +
photoreceptors O -
. O +

Retinas O +
are O +
oriented O +
such O +
that O +
the O +
scleral O +
edge O +
is O +
up O -
. O +

Figure O +
5 O +
Some O +
of O +
the O +
Genes O +
Up O -
- O -
Regulated O +
in O +
rd7 O +
Show O +
an O +
Early O +
Photoreceptor O +
Pattern O +
of O +
Expression O +
Gnb3 O +
and O +
Thrb2 O +
are O +
both O +
previously O +
characterized O +
cone O +
genes O +
that O +
show O +
staining O +
at O +
the O +
scleral O +
edge O +
of O +
the O +
embryonic O +
mouse O +
retina O +
in O +
cells O +
that O +
will O +
differentiate O +
into O +
photoreceptors O -
. O +

Ece1 O +
and O +
Otop3 O +
are O +
two O +
novel O +
cone O +
genes O +
identified O +
in O +
this O +
study O +
that O +
were O +
up O -
- O -
regulated O +
in O +
rd7 O +
and O +
also O +
showed O +
an O +
early O +
photoreceptor O +
pattern O +
of O +
expression O -
. O +

Prdm1 O +
and O +
RIKEN O +
cDNA O +
1300018I05 O +
( O -
Figure O +
1 O -
, O +
genes O +
G48 O +
and O +
G49 O -
, O +
respectively O -
) O +
are O +
two O +
other O +
genes O +
that O +
had O +
either O +
undetectable O +
signal O +
( O -
Prdm1 O -
) O +
or O +
no O +
apparent O +
change O +
in O +
expression O +
pattern O +
in O +
adult O +
rd7 O +
mutants O +
( O -
RIKEN O +
cDNA O +
1300018I05 O -
) O -
, O +
but O +
which O +
also O +
showed O +
staining O +
in O +
the O +
embryonic O +
retina O +
in O +
a O +
presumptive O +
photoreceptor O +
pattern O -
. O +

All O +
images O +
are O +
from O +
E17.5 O +
retina O +
except O +
Gnb3 O -
, O +
which O +
was O +
from O +
E16 O -
. O +

Figure O +
6 O +
The O +
Onset O +
of O +
rhodopsin O +
Expression O +
Is O +
Delayed O +
in O +
the O +
rd7 O +
Mutant O +
Retina O +
Note O +
the O +
nearly O +
undetectable O +
staining O +
for O +
rhodopsin O +
in O +
this O +
P6 O +
mutant O +
retina O +
( O -
top O +
right O -
) O -
. O +

The O +
majority O +
of O +
rod O -
- O -
specific O +
genes O +
did O +
not O +
show O +
this O +
delay O +
in O +
expression O +
onset O -
, O +
as O +
indicated O +
by O +
the O +
normal O +
amount O +
of O +
staining O +
for O +
Pde6a O +
in O +
the O +
mutant O +
at O +
P6 O +
( O -
bottom O +
images O -
) O -
. O +

Figure O +
7 O +
The O +
rd7 O +
Mutant O +
Retina O +
Contains O +
a O +
Morphologically O +
Hybrid O +
Photoreceptor O +
Cell O +
Type O +
in O +
Addition O +
to O +
Supernumerary O +
S O -
- O -
Opsin O -
– O -
Positive O +
Cones O +
( O -
A O +
and O +
B O -
) O +
Toluidine O +
blue O -
- O -
stained O +
semi O -
- O -
thin O +
sections O +
of O +
the O +
outer O +
nuclear O +
layer O +
( O -
scleral O +
edge O +
oriented O +
up O -
) O -
. O +

( O -
C O +
and O +
D O -
) O +
Hand O -
- O -
drawn O +
diagrams O +
of O +
the O +
cells O +
in O +
( O -
A O -
) O +
and O +
( O -
B O -
) O -
, O +
respectively O -
. O +

Cells O +
with O +
the O +
nuclear O +
features O +
of O +
cones O +
are O +
highlighted O +
in O +
blue O -
. O +

Note O +
that O +
the O +
number O +
of O +
such O +
cells O +
is O +
greater O +
in O +
the O +
mutant O -
, O +
and O +
their O +
cell O +
bodies O +
are O +
scattered O +
throughout O +
the O +
outer O +
nuclear O +
layer O -
. O +

In O +
addition O -
, O +
the O +
overall O +
columnar O +
architecture O +
of O +
the O +
outer O +
nuclear O +
layer O +
seen O +
in O +
the O +
wild O +
type O +
is O +
disrupted O +
in O +
this O +
portion O +
of O +
the O +
mutant O +
retina O -
. O +

Other O +
portions O +
of O +
the O +
mutant O +
retina O +
with O +
fewer O +
supernumerary O +
cone O +
cells O -
, O +
however O -
, O +
retain O +
the O +
normal O +
columnar O +
appearance O +
( O -
unpublished O +
data O -
) O -
. O +

( O -
E O +
and O +
F O -
) O +
Images O +
of O +
the O +
outer O +
nuclear O +
layer O +
( O -
scleral O +
edge O +
up O -
) O +
stained O +
by O +
in O +
situ O +
hybridization O +
for O +
S O -
- O -
opsin O -
. O +

Note O +
the O +
typical O +
pattern O +
of O +
staining O +
at O +
the O +
scleral O +
edge O +
of O +
the O +
outer O +
nuclear O +
layer O +
in O +
the O +
wild O +
type O -
. O +

The O +
rd7 O +
mutant O +
retina O +
shows O +
supernumerary O +
S O -
- O -
opsin O -
– O -
positive O +
cells O +
scattered O +
throughout O +
the O +
outer O +
nuclear O +
layer O +
in O +
a O +
distribution O +
very O +
similar O +
to O +
the O +
supernumerary O +
cone O +
cells O +
seen O +
in O +
( O -
B O -
) O -
. O +

Since O +
images O +
( O -
E O -
) O +
and O +
( O -
F O -
) O +
derive O +
from O +
different O +
retinas O +
than O +
those O +
depicted O +
in O +
( O -
A O -
) O +
and O +
( O -
B O -
) O -
, O +
the O +
location O +
of O +
the O +
individual O +
cells O +
do O +
not O +
correspond O -
. O +

( O -
G O +
and O +
H O -
) O +

Electron B-Chemical +
micrographs O +
of O +
the O +
outer O +
nuclear O +
layer O +
( O -
10,000 O -
× O +
magnification O -
) O -
. O +

Note O +
the O +
uniform O +
distribution O +
of O +
rod O +
cell O +
bodies O +
in O +
the O +
wild O +
type O +
( O -
G O -
) O -
. O +

The O +
cell O +
bodies O +
are O +
nearly O +
round O +
and O +
consist O +
almost O +
exclusively O +
of O +
a O +
nucleus O +
with O +
a O +
single O -
, O +
dense O +
mass O +
of O +
heterochromatin O -
. O +

In O +
the O +
rd7 O +
mutant O +
( O -
H O -
) O -
, O +
two O +
types O +
of O +
cell O +
are O +
shown O -
. O +

The O +
ovoid O +
one O +
with O +
a O +
lesser O +
quantity O +
of O +
heterochromatin O -
, O +
paler O +
euchromatin O -
, O +
and O +
two O +
juxtanuclear O +
mitochondria O +
( O -
yellow O +
arrow O -
) O +
represents O +
a O +
typical O +
cone O +
cell O +
body O -
. O +

The O +
adjacent O +
cell O +
with O +
a O +
more O +
" O -
rod O -
- O -
like O -
" O +
mass O +
of O +
heterochromatin O +
and O +
a O +
single O +
juxtanuclear O +
mitochondrion O +
( O -
red O +
arrow O -
) O +
represents O +
one O +
of O +
the O +
hybrid O +
photoreceptors O +
discussed O +
more O +
fully O +
in O +
the O +
main O +
text O -
. O +

Figure O +
8 O +
A O +
Partial O +
View O +
of O +
the O +
Rod O +
Photoreceptor O +
Transcriptional O +
Regulatory O +
Network O +
Note O +
that O +
green O +
lines O +
indicate O +
activation O -
, O +
and O +
yellow O +
and O +
red O +
lines O +
indicate O +
weak O +
and O +
strong O +
repression O -
, O +
respectively O -
. O +

The O +
dotted O +
lines O +
associated O +
with O +
a O +
question O +
mark O +
indicate O +
that O +
it O +
is O +
not O +
known O +
whether O +
Nrl O +
directly O +
represses O +
the O +
target O +
genes O +
in O +
question O +
or O +
whether O +
its O +
repression O +
is O +
mediated O +
by O +
a O +
downstream O +
transcription O +
factor O +
( O -
" O -
X O -
" O -
) O -
. O +

Note O +
that O +
Nr2e3 O +
appears O +
to O +
negatively O +
regulate O +
its O +
own O +
transcription O -
. O +

The O +
regulatory O +
linkages O +
depicted O +
in O +
this O +
diagram O +
are O +
not O +
necessarily O +
direct O -
. O +

The O +
weak O +
activation O +
of O +
some O +
rod O -
- O -
specific O +
genes O +
by O +
Nr2e3 O +
is O +
omitted O +
from O +
this O +
diagram O +
for O +
clarity O -
. O +

Also O +
not O +
shown O +
is O +
the O +
role O +
of O +
other O +
photoreceptor O +
transcription O +
factors O -
, O +
such O +
as O +
Crx O -
. O +

Footnotes O +
Competing O +
interests O -
. O +

The O +
authors O +
have O +
declared O +
that O +
no O +
competing O +
interests O +
exist O -
. O +

Author O +
contributions O -
. O +

JCC O +
and O +
CLC O +
conceived O +
and O +
designed O +
the O +
experiments O -
. O +

JCC O +
performed O +
the O +
experiments O -
. O +

JCC O +
and O +
CLC O +
analyzed O +
the O +
data O -
. O +

JCC O +
contributed O +
reagents B-Chemical -
/ O -
materials O -
/ O -
analysis O +
tools O -
. O +

JCC O +
and O +
CLC O +
wrote O +
the O +
paper O -
. O +

Citation O -
: O +

Corbo O +
JC O -
, O +
Cepko O +
CL O +
( O -
2005 O -
) O +
A O +
hybrid O +
photoreceptor O +
expressing O +
both O +
rod O +
and O +
cone O +
genes O +
in O +
a O +
mouse O +
model O +
of O +
enhanced O +
s O -
- O -
cone O +
syndrome O -
. O +

PLoS O +
Genet O +
1 O -
( O -
2 O -
) O -
: O +
e11 O -
. O +

Medium B-Chemical -
- I-Chemical -
Chain I-Chemical +
Acyl I-Chemical -
- I-Chemical -
CoA I-Chemical +
Dehydrogenase O +
Deficiency O +
in O +
Gene O -
- O -
Targeted O +
Mice O +
Abstract O +
Medium B-Chemical -
- I-Chemical -
chain I-Chemical +
acyl I-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenase O +
( O -
MCAD O -
) O +
deficiency O +
is O +
the O +
most O +
common O +
inherited O +
disorder O +
of O +
mitochondrial O +
fatty B-Chemical +
acid I-Chemical +
β O -
- O -
oxidation O +
in O +
humans O -
. O +

To O +
better O +
understand O +
the O +
pathogenesis O +
of O +
this O +
disease O -
, O +
we O +
developed O +
a O +
mouse O +
model O +
for O +
MCAD O +
deficiency O +
( O -
MCAD− O -
/ O -
− O -
) O +
by O +
gene O +
targeting O +
in O +
embryonic O +
stem O +
( O -
ES O -
) O +
cells O -
. O +

The O +
MCAD− O -
/ O -
− O +
mice O +
developed O +
an O +
organic O +
aciduria O +
and O +
fatty O +
liver O -
, O +
and O +
showed O +
profound O +
cold O +
intolerance O +
at O +
4 O +
° O -
C O +
with O +
prior O +
fasting O -
. O +

The O +
sporadic O +
cardiac O +
lesions O +
seen O +
in O +
MCAD− O -
/ O -
− O +
mice O +
have O +
not O +
been O +
reported O +
in O +
human O +
MCAD O +
patients O -
. O +

There O +
was O +
significant O +
neonatal O +
mortality O +
of O +
MCAD− O -
/ O -
− O +
pups O +
demonstrating O +
similarities O +
to O +
patterns O +
of O +
clinical O +
episodes O +
and O +
mortality O +
in O +
MCAD O -
- O -
deficient O +
patients O -
. O +

The O +
MCAD O -
- O -
deficient O +
mouse O +
reproduced O +
important O +
aspects O +
of O +
human O +
MCAD O +
deficiency O +
and O +
is O +
a O +
valuable O +
model O +
for O +
further O +
analysis O +
of O +
the O +
roles O +
of O +
fatty B-Chemical +
acid I-Chemical +
oxidation O +
and O +
pathogenesis O +
of O +
human O +
diseases O +
involving O +
fatty B-Chemical +
acid I-Chemical +
oxidation O -
. O +

Synopsis O +
Medium B-Chemical -
- I-Chemical -
chain I-Chemical +
acyl I-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenase O +
( O -
MCAD O -
) O +
deficiency O +
is O +
one O +
of O +
the O +
most O +
common O +
inherited O +
disorders O +
of O +
metabolism O -
. O +

This O +
defect O +
in O +
fatty B-Chemical +
acid I-Chemical +
oxidation O +
can O +
lead O +
to O +
severe O +
and O +
sometimes O +
fatal O +
disease O -
, O +
especially O +
in O +
young O +
children O +
because O +
they O +
are O +
unable O +
to O +
tolerate O +
a O +
fasting O +
episode O -
. O +

Metabolic O +
complications O +
include O +
very O +
low O +
blood O +
glucose B-Chemical +
concentrations O +
and O +
generation O +
of O +
toxic O +
by O -
- O -
products O -
. O +

This O +
disorder O +
can O +
result O +
in O +
sudden O +
infant O +
death O -
. O +

Using O +
a O +
process O +
known O +
as O +
gene O +
targeting O +
in O +
mouse O +
embryonic O +
stem O +
cells O -
, O +
the O +
authors O +
have O +
developed O +
a O +
mouse O +
model O +
with O +
the O +
same O +
enzyme O +
deficiency O -
. O +

This O +
mouse O +
model O +
of O +
MCAD O +
deficiency O +
develops O +
many O +
of O +
the O +
same O +
disease O +
characteristics O +
found O +
in O +
affected O +
children O -
. O +

The O +
MCAD O -
- O -
deficient O +
mouse O +
model O +
shows O +
a O +
high O +
rate O +
of O +
newborn O +
loss O -
, O +
intolerance O +
to O +
cold O -
, O +
and O +
the O +
characteristic O +
biochemical O +
changes O +
in O +
the O +
blood O -
, O +
tissues O -
, O +
and O +
urine O +
that O +
are O +
very O +
similar O +
to O +
those O +
found O +
in O +
the O +
human O +
disease O +
counterpart O -
. O +

The O +
MCAD O -
- O -
deficient O +
mouse O +
model O +
will O +
allow O +
researchers O +
to O +
better O +
understand O +
disease O +
mechanisms O +
so O +
that O +
new O +
preventive O +
measures O +
or O +
therapies O +
can O +
be O +
developed O -
. O +

Introduction O +
Mitochondrial O +
β O -
- O -
oxidation O +
of O +
fatty B-Chemical +
acids I-Chemical +
provides O +
energy O -
, O +
especially O +
during O +
fasting O +
conditions O -
. O +

Fatty B-Chemical +
acid I-Chemical +
oxidation O +
occurs O +
in O +
mitochondria O +
and O +
consists O +
of O +
a O +
repeating O +
circuit O +
of O +
four O +
sequential O +
steps O -
. O +

There O +
are O +
four O +
straight O -
- O -
chain O +
acyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenases O +
involved O +
in O +
the O +
initial O +
step O -
. O +

Medium B-Chemical -
- I-Chemical -
chain I-Chemical +
acyl I-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenase O +
( O -
MCAD O -
) O +
( O -
the O +
mouse O +
gene O +
is O +
Acadm O -
, O +
whereas O +
the O +
protein O +
is O +
MCAD O -
) O -
, O +
specifically O -
, O +
is O +
responsible O +
for O +
catalyzing O +
the O +
dehydrogenation O +
of O +
medium B-Chemical -
- I-Chemical -
chain I-Chemical +
length I-Chemical +
( O -
C6–C12 O -
) O +
fatty B-Chemical +
acid I-Chemical +
thioesters B-Chemical +
[ O -
1 O -
] O -
. O +

Acadm O +
is O +
transcribed O +
in O +
the O +
nucleus O -
, O +
translated O +
in O +
the O +
cytosol O -
, O +
and O +
translocated O +
into O +
the O +
mitochondrial O +
matrix O +
[ O -
2–4 O -
] O -
. O +

Once O +
inside O +
the O +
mitochondrial O +
matrix O -
, O +
the O +
MCAD O +
monomers O +
are O +
assembled O +
into O +
homotetramers O +
to O +
gain O +
enzymatic O +
activity O +
[ O -
4 O -
] O -
. O +

MCAD O +
activity O +
is O +
essential O +
for O +
complete O +
fatty B-Chemical +
acid I-Chemical +
oxidation O -
. O +

Inherited O +
MCAD O +
deficiency O +
exists O +
in O +
humans O +
as O +
an O +
autosomal O +
recessive O +
disorder O -
. O +

MCAD O +
deficiency O +
was O +
first O +
described O +
in O +
1982—1983 O +
[ O -
5–7 O -
] O +
and O +
has O +
been O +
described O +
in O +
numerous O +
patients O +
[ O -
1,8–11 O -
] O -
. O +

The O +
carrier O +
frequency O +
in O +
the O +
Caucasian O +
population O +
has O +
been O +
estimated O +
to O +
be O +
between O +
1 O +
in O +
50 O +
to O +
80 O +
with O +
an O +
incidence O +
of O +
clinical O +
disease O +
expected O +
at O +
around O +
1 O +
in O +
15,000 O +
[ O -
1,9,12 O -
] O -
. O +

MCAD O -
- O -
deficient O +
patients O +
exhibit O +
clinical O +
episodes O +
often O +
associated O +
with O +
fasting O -
. O +

Patients O +
manifest O +
disease O +
usually O +
during O +
the O +
first O +
two O +
years O +
of O +
life O -
. O +

Symptoms O +
include O +
hypoketotic O +
hypoglycemia O +
and O +
Reye O -
- O -
like O +
episodes O +
[ O -
1 O -
] O -
. O +

It O +
is O +
estimated O +
that O +
approximately O +
59 O -
% O +
of O +
patients O +
presenting O +
clinically O +
between O +
15 O +
to O +
26 O +
mo O +
of O +
age O +
die O +
during O +
their O +
first O +
clinical O +
episode O +
[ O -
1 O -
] O -
. O +

The O +
pathogenesis O +
of O +
the O +
wide O +
range O +
of O +
metabolic O +
disturbances O +
in O +
MCAD O +
deficiency O +
is O +
poorly O +
understood O +
and O +
certain O +
aspects O +
of O +
patient O +
management O +
are O +
controversial O -
. O +

An O +
animal O +
model O +
for O +
MCAD O +
deficiency O +
is O +
essential O +
to O +
better O +
understand O +
the O +
pathogenesis O +
of O +
MCAD O +
deficiency O +
and O +
to O +
develop O +
better O +
management O +
regimens O +
for O +
human O +
patients O -
. O +

To O +
gain O +
further O +
insight O +
into O +
the O +
mechanisms O +
of O +
this O +
disease O -
, O +
we O +
developed O +
a O +
mouse O +
model O +
of O +
MCAD O +
deficiency O +
by O +
gene O +
targeting O +
in O +
embryonic O +
stem O +
( O -
ES O -
) O +
cells O +
( O -
for O +
reviews O +
[ O -
13,14 O -
] O -
) O -
. O +

The O +
mutant O +
mice O +
had O +
many O +
relevant O +
features O +
characteristic O +
of O +
the O +
disease O +
found O +
in O +
human O +
MCAD O -
- O -
deficient O +
patients O -
, O +
along O +
with O +
some O +
unexpected O +
findings O -
. O +

Results O +
Gene O +
Targeting O +
and O +
Generation O +
of O +
MCAD O -
- O -
Deficient O +
Mice O +
MCAD O +
insertion O +
vector O +
( O -
MCAD O +
IV2 O -
) O +
was O +
designed O +
to O +
undergo O +
gap O +
repair O +
of O +
the O +
1.3-kb O +
deleted O +
region O +
upon O +
homologous O +
recombination O +
in O +
129P2 O +
( O -
129P2 O -
/ O -
OlaHsd O -
) O +
ES O +
cells O +
E14–1 O -
. O +

Correct O +
targeting O +
of O +
the O +
MCAD O +
locus O +
resulted O +
in O +
a O +
duplication O +
of O +
exons O +
8 O -
, O +
9 O -
, O +
and O +
10 O +
and O +
integration O +
of O +
flanking O +
plasmid O +
and O +
Neo O +
sequences O +
( O -
Figure O +
1A O -
) O -
. O +

The O +
insertion O +
vector O +
was O +
designed O +
to O +
duplicate O +
exon O +
8 O -
, O +
9 O -
, O +
and O +
10 O +
at O +
the O +
MCAD O +
locus O -
. O +

Translation O +
of O +
the O +
duplicated O +
exon O +
8 O +
region O +
results O +
in O +
the O +
formation O +
of O +
premature O +
stop O +
codons O +
resulting O +
in O +
truncation O +
of O +
the O +
MCAD O +
monomer O -
. O +

Specifically O -
, O +
the O +
first O +
premature O +
stop O +
codon O +
arises O +
after O +
translation O +
of O +
only O +
seven O +
amino O +
acids O +
from O +
the O +
duplicated O +
exon O +
8 O -
. O +

The O +
resulting O +
MCAD O +
monomer O +
is O +
missing O +
the O +
C O -
- O -
terminal O +
domain O +
α O -
- O -
helixes O +
that O +
are O +
responsible O +
for O +
making O +
intersubunit O +
contacts O +
to O +
generate O +
the O +
functional O +
MCAD O +
homotetramer O -
. O +

Figure O +
1 O +
Strategy O +
for O +
Disruption O +
of O +
the O +
Mouse O +
Acadm O +
Gene O +
( O -
A O -
) O +
The O +
MCAD O +
IV2 O +
insertion O +
targeting O +
vector O +
with O +
a O +
deleted O +
1.3-kb O +
region O +
encompassing O +
exon O +
10 O +
and O +
flanking O +
sequences O -
. O +

MCAD O +
IV2 O +
undergoes O +
gap O +
repair O +
upon O +
homologous O +
recombination O +
at O +
the O +
endogenous O +
Acadm O +
locus O +
resulting O +
in O +
a O +
duplication O +
of O +
exons O +
8 O -
, O +
9 O -
, O +
and O +
10 O +
at O +
the O +
disrupted O +
allele O -
. O +

( O -
B O -
) O +
Southern O +
blot O +
analysis O +
of O +
EcoRI O -
- O -
digested O +
genomic O +
DNA O +
from O +
ES O +
cells O +
screened O +
by O +
PCR O -
. O +

Probe O +
A O -
, O +
a O +
DNA O +
fragment O +
consisting O +
of O +
a O +
portion O +
of O +
exon O +
10 O +
that O +
is O +
not O +
present O +
in O +
the O +
targeting O +
vector O -
, O +
hybridizes O +
to O +
an O +
endogenous O +
3.1-kb O +
fragment O +
and O -
, O +
upon O +
homologous O +
recombination O -
, O +
to O +
a O +
13.2-kb O +
fragment O -
. O +

Lane O +
1 O +
represents O +
a O +
wild O -
- O -
type O +
ES O +
cell O +
line O -
, O +
and O +
Lane O +
2 O +
and O +
3 O +
represent O +
targeted O +
ES O +
cell O +
lines O -
. O +

ES O +
cell O +
clones O +
were O +
screened O +
by O +
PCR O +
( O -
data O +
not O +
shown O -
) O +
and O +
confirmed O +
by O +
Southern O +
blot O +
analysis O -
. O +

Southern O +
blot O +
analysis O +
used O +
an O +
exon O +
10 O +
probe O +
( O -
probe O +
A O -
) O -
, O +
not O +
present O +
in O +
the O +
targeting O +
vector O -
, O +
hybridized O +
to O +
a O +
13.2-kb O +
band O +
in O +
addition O +
to O +
the O +
3.1-kb O +
endogenous O +
band O +
indicating O +
targeted O +
insertion O +
of O +
the O +
vector O +
at O +
the O +
Acadm O +
locus O +
( O -
Figure O +
1B O -
) O -
. O +

Correctly O +
targeted O +
ES O +
cell O +
clones O +
were O +
microinjected O +
into O +
B6 O +
( O -
C57BL O -
/ O -
6NTac O -
) O +
blastocysts O +
to O +
generate O +
chimeric O +
mice O -
. O +

Chimeric O +
mice O +
were O +
backcrossed O +
to O +
both O +
129P2 O +
and O +
B6 O +
inbred O +
mice O +
to O +
produce O +
MCAD+ O -
/ O -
− O +
and O +
eventually O +
MCAD− O -
/ O -
− O +
mice O +
on O +
a O +
B6 O -
/ O -
129 O +
mixed O +
background O -
. O +

The O +
studies O +
described O +
here O +
were O +
conducted O +
exclusively O +
on O +
the O +
B6 O -
/ O -
129 O +
mixed O +
background O +
compared O +
with O +
littermate O +
controls O +
or O +
B6 O -
/ O -
129 O +
control O +
groups O +
maintained O +
by O +
intercrosses O +
as O +
were O +
the O +
mutants O -
. O +

Perpetuating O +
this O +
mutation O +
as O +
a O +
congenic O +
mutant O +
line O +
on O +
the O +
129P2 O +
background O +
proved O +
impractical O -
. O +

The O +
129P2 O +
mice O +
were O +
poor O +
breeders O +
as O +
wild O -
- O -
types O -
, O +
and O +
when O +
introduced O -
, O +
the O +
Acadm O +
mutation O +
was O +
nearly O +
lost O +
on O +
this O +
background O +
because O +
of O +
the O +
high O +
rate O +
of O +
neonatal O +
death O -
. O +

Because O +
of O +
the O +
molecular O +
structure O +
of O +
the O +
targeted O +
allele O -
, O +
it O +
proved O +
virtually O +
impossible O +
to O +
distinguish O +
all O +
three O +
potential O +
genotypes O -
. O +

We O +
could O +
clearly O +
detect O +
the O +
presence O +
or O +
absence O +
of O +
the O +
targeted O +
allele O -
, O +
however O -
, O +
whether O +
a O +
particular O +
mouse O +
was O +
MCAD− O -
/ O -
− O +
or O +
MCAD+ O -
/ O -
− O +
could O +
not O +
be O +
determined O +
by O +
Southern O +
blot O +
or O +
PCR O +
of O +
genomic O +
DNA O -
. O +

Ultimately O +
MCAD− O -
/ O -
− O +
mice O +
were O +
ascertained O +
by O +
immunoblot O +
analysis O +
of O +
offspring O +
with O +
subsequent O +
perpetuation O +
of O +
MCAD− O -
/ O -
− O +
and O +
MCAD+ O -
/ O -
+ O +
mice O +
as O +
separate O +
groups O -
. O +

RNA O +
Analysis O +
RT O -
- O -
PCR O +
amplification O +
from O +
exon O +
7 O +
to O +
11 O +
from O +
total O +
heart O +
RNA O +
amplified O +
the O +
expected O +
600-base O +
pair O +
( O -
bp O -
) O +
fragment O +
in O +
MCAD+ O -
/ O -
+ O +
and O +
MCAD+ O -
/ O -
− O +
mice O -
, O +
and O +
a O +
1.5-kb O +
fragment O +
in O +
MCAD− O -
/ O -
− O +
mice O +
( O -
data O +
not O +
shown O -
) O -
. O +

Sequence O +
analysis O +
of O +
the O +
1.5-kb O +
fragment O +
revealed O +
that O +
the O +
amplified O +
fragment O +
consisted O +
of O +
exon O +
7 O +
to O +
exon O +
10 O +
with O +
280 O +
bp O +
of O +
pGEM O +
plasmid O +
sequence O +
followed O +
by O +
exons O +
8–11 O -
. O +

Some O +
of O +
the O +
plasmid O +
sequences O -
, O +
along O +
with O +
the O +
pPGKNEOpA O +
sequence O -
, O +
were O +
deleted O +
from O +
this O +
spliced O +
mRNA O -
. O +

Northern O +
blot O +
analysis O +
revealed O +
Acadm O +
was O +
normally O +
expressed O +
in O +
all O +
tissues O +
analyzed O +
from O +
MCAD+ O -
/ O -
+ O +
mice O +
with O +
the O +
most O +
robust O +
expression O +
occurring O +
in O +
brown O +
fat O -
, O +
kidney O -
, O +
heart O -
, O +
skeletal O +
muscle O -
, O +
and O +
liver O +
with O +
minimal O +
expression O +
in O +
the O +
brain O -
, O +
white O +
fat O -
, O +
and O +
testes O +
( O -
Figure O +
2 O -
) O -
. O +

Interestingly O -
, O +
although O +
RT O -
- O -
PCR O +
amplified O +
an O +
incorrectly O +
spliced O +
Acadm O +
transcript O -
, O +
no O +
Acadm O +
transcripts O +
were O +
detected O +
by O +
northern O +
blot O +
analysis O +
from O +
MCAD− O -
/ O -
− O +
mice O -
. O +

These O +
results O +
strongly O +
suggest O +
that O +
the O +
mutant O +
RNA O +
is O +
unstable O +
and O +
degraded O +
rapidly O +
or O -
, O +
alternatively O -
, O +
undergoes O +
nonsense O +
mediated O +
RNA O +
decay O -
. O +

Figure O +
2 O +
Northern O +
Blot O +
Analysis O +
from O +
MCAD− O -
/ O -
− O +
( O -
n O +
= O +
2 O -
) O +
and O +
MCAD+ O -
/ O -
+ O +
( O -
n O +
= O +
2 O -
) O +
Mice O +
Acadm O +
message B-Chemical +
was O +
detected O +
from O +
the O +
heart O -
, O +
liver O -
, O +
brown O +
fat O -
, O +
brain O -
, O +
kidney O -
, O +
and O +
muscle O +
( O -
and O +
white O +
fat O +
and O +
testes O -
, O +
data O +
not O +
shown O -
) O +
of O +
only O +
MCAD+ O -
/ O -
+ O +
mice O -
. O +

Most O +
robust O +
expression O +
occurred O +
in O +
brown O +
fat O -
, O +
kidney O -
, O +
heart O -
, O +
and O +
skeletal O +
muscle O -
. O +

MCAD− O -
/ O -
− O +
mice O +
had O +
no O +
detectable O +
message B-Chemical +
in O +
all O +
tissues O +
examined O -
. O +

Liver O +
Enzyme O +
Analyses O +
Immunoblot O +
analyses O +
of O +
liver O +
homogenates O +
with O +
anti O -
- O -
MCAD O +
antisera O +
demonstrated O +
that O +
the O +
42 O +
kDa O +
MCAD O +
monomer O +
was O +
present O +
in O +
MCAD+ O -
/ O -
+ O +
mice O -
, O +
but O +
not O +
in O +
MCAD− O -
/ O -
− O +
mice O +
( O -
Figure O +
3 O -
) O -
. O +

As O +
a O +
control O +
analysis O -
, O +
anti O -
– O -
short B-Chemical -
- I-Chemical -
chain I-Chemical +
acyl I-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenase O +
( O -
SCAD O -
) O +
antisera O +
revealed O +
no O +
differences O +
in O +
levels O +
of O +
expression O +
of O +
SCAD O +
protein O +
between O +
MCAD+ O -
/ O -
+ O +
and O +
MCAD− O -
/ O -
− O +
mice O +
( O -
Figure O +
3 O -
) O -
. O +

Figure O +
3 O +
Immunoblots O +
of O +
Liver O +
Homogenates O +
from O +
MCAD+ O -
/ O -
+ O +
and O +
MCAD− O -
/ O -
− O +
Mice O +
These O +
were O +
probed O +
with O +
anti O -
- O -
MCAD O +
antibody O +
or O +
anti O -
- O -
SCAD O +
antibody O -
. O +

Homozygous O +
MCAD− O -
/ O -
− O +
mice O +
had O +
no O +
detectable O +
MCAD O +
protein O -
. O +

MCAD O +
protein O +
is O +
only O +
detectable O +
under O +
the O +
MCAD O +
protein O -
– O -
spiked O +
( O -
positive O +
control O -
) O +
lane O -
. O +

As O +
a O +
control O +
analysis O -
, O +
liver O +
homogenates O +
probed O +
with O +
anti O -
- O -
SCAD O +
antibody O +
revealed O +
that O +
SCAD O +
protein O +
was O +
present O +
in O +
both O +
MCAD+ O -
/ O -
+ O +
and O +
MCAD− O -
/ O -
− O +
mice O -
. O +

No O +
MCAD O +
positive O -
- O -
control O +
protein O +
is O +
detected O +
by O +
anti O -
- O -
SCAD O +
antibodies O +
( O -
MCAD O +
lane O -
) O -
. O +

mw O -
, O +
molecular O +
weight O +
standards O -
. O +

Enzyme O +
activity O +
was O +
analyzed O +
in O +
mouse O +
liver O +
homogenates O +
using O +
the O +
electron B-Chemical +
transport O +
flavoprotein B-Chemical +
( O -
ETF O -
) O +
reduction O +
assay O +
with O +
octanoyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
( O -
C8:0 O -
) O +
and O +
palmitoyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
( O -
C16:0 O -
) O +
as O +
substrates O -
. O +

MCAD− O -
/ O -
− O +
mice O +
had O +
a O +
significant O +
reduction O +
in O +
ability O +
to O +
dehydrogenate O +
octanoyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
and O +
a O +
modest O +
reduction O +
in O +
activity O +
toward O +
palmitoyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
compared O +
to O +
MCAD+ O -
/ O -
+ O +
mice O +
( O -
Table O +
1 O -
) O -
. O +

Specifically O -
, O +
the O +
dehydrogenation O +
of O +
octanoyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
and O +
palmitoyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
substrates O +
were O +
reduced O +
by O +
75 O -
% O +
and O +
by O +
30 O -
% O -
, O +
respectively O -
, O +
in O +
MCAD− O -
/ O -
− O +
mice O +
as O +
compared O +
to O +
MCAD+ O -
/ O -
+ O +
controls O -
. O +

Table O +
1 O +
Characteristics O +
of O +
MCAD O -
- O -
Deficient O +
Mice O +
Values O +
given O +
are O +
mean O +
± O +
SD O -
. O +

aMCAD+ O -
/ O -
+ O +
n O +
= O +
5 O +
and O +
MCAD− O -
/ O -
− O +
n O +
= O +
5 O -
. O +

bMCAD+ O -
/ O -
+ O +
n O +
= O +
8 O +
litters O +
and O +
MCAD− O -
/ O -
− O +
n O +
= O +
10 O +
litters O -
. O +

cMCAD+ O -
/ O -
+ O +
n O +
= O +
5 O +
and O +
MCAD− O -
/ O -
− O +
n O +
= O +
6 O -
. O +

dMCAD+ O -
/ O -
+ O +
n O +
= O +
4 O +
and O +
MCAD− O -
/ O -
− O +
n O +
= O +
5 O -
. O +

eExpressed O +
as O +
a O +
ratio O +
relative O +
to O +
the O +
internal O +
standard O -
. O +

Neonatal O +
Deaths O +
Significant O +
neonatal O +
mortality O +
was O +
noted O +
in O +
MCAD− O -
/ O -
− O +
pups O -
. O +

Although O +
equal O +
numbers O +
of O +
pups O +
were O +
born O +
from O +
MCAD+ O -
/ O -
+ O +
and O +
MCAD− O -
/ O -
− O +
mice O -
, O +
only O +
41 O -
% O +
of O +
MCAD− O -
/ O -
− O +
mice O +
survived O +
to O +
weaning O +
as O +
compared O +
to O +
98 O -
% O +
of O +
MCAD+ O -
/ O -
+ O +
mice O +
( O -
Table O +
1 O -
) O -
. O +

The O +
mechanism O +
of O +
neonatal O +
loss O +
remains O +
undetermined O -
. O +

The O +
MCAD− O -
/ O -
− O +
pups O +
are O +
abandoned O +
more O +
frequently O +
than O +
MCAD+ O -
/ O -
+ O +
pups O +
for O +
unknown O +
reasons O -
. O +

They O +
are O +
likely O +
more O +
prone O +
to O +
hypothermia O +
than O +
MCAD+ O -
/ O -
+ O -
. O +

Because O +
of O +
the O +
difficulty O +
of O +
distinguishing O +
the O +
MCAD− O -
/ O -
− O +
mutants O +
from O +
the O +
MCAD+ O -
/ O -
− O +
heterozygous O +
pups O +
by O +
molecular O +
analysis O +
due O +
to O +
the O +
insertion O +
mutation O -
, O +
we O +
could O +
only O +
compare O +
MCAD+ O -
/ O -
+ O +
× O +
MCAD+ O -
/ O -
+ O +
matings O +
with O +
MCAD− O -
/ O -
− O +
× O +
MCAD− O -
/ O -
− O +
matings O -
. O +

Thus O -
, O +
we O +
were O +
unable O +
to O +
evaluate O +
the O +
pedigrees O +
from O +
heterozygous O +
matings O -
. O +

Fasting O +
and O +
Cold O +
Intolerance O +
In O +
order O +
to O +
examine O +
the O +
stress O +
effects O +
of O +
fasting O +
on O +
MCAD O -
- O -
deficient O +
mice O -
, O +
they O +
were O +
fasted O +
for O +
24 O +
h O +
prior O +
to O +
analysis O -
. O +

MCAD− O -
/ O -
− O +
mice O +
displayed O +
lower O +
serum O +
glucose B-Chemical +
and O +
elevated O +
serum O +
free O +
fatty B-Chemical +
acid I-Chemical +
levels O +
although O +
neither O +
result O +
was O +
significant O -
, O +
as O +
compared O +
to O +
MCAD+ O -
/ O -
+ O +
mice O +
( O -
Table O +
1 O -
) O -
. O +

To O +
determine O +
the O +
effects O +
of O +
cold O +
stress O -
, O +
mice O +
were O +
fasted O +
for O +
18 O +
h O +
and O +
placed O +
in O +
4 O +
° O -
C O +
environment O +
for O +
a O +
3-h O +
period O -
. O +

The O +
MCAD− O -
/ O -
− O +
mice O +
were O +
significantly O +
compromised O +
within O +
this O +
short O +
period O +
of O +
cold O +
stress O -
, O +
some O +
severe O +
enough O +
to O +
result O +
in O +
fatalities O -
. O +

After O +
1 O +
h O +
of O +
the O +
cold O +
challenge O -
, O +
the O +
average O +
rectal O +
temperature O +
of O +
MCAD− O -
/ O -
− O +
mice O +
( O -
n O +
= O +
5 O -
) O +
was O +
23.4 O +
° O -
C O +
as O +
compared O +
with O +
35 O +
° O -
C O +
for O +
MCAD+ O -
/ O -
+ O +
mice O +
( O -
n O +
= O +
4 O -
) O -
. O +

Rectal O +
temperatures O +
declined O +
to O +
unrecoverable O +
temperatures O +
of O +
16.7–19.2 O +
° O -
C O +
in O +
three O +
of O +
the O +
five O +
MCAD− O -
/ O -
− O +
mice O -
. O +

By O +
the O +
end O +
of O +
the O +
1.5-h O +
mark O -
, O +
the O +
two O +
surviving O +
MCAD− O -
/ O -
− O +
mice O +
averaged O +
22.7 O +
° O -
C O -
. O +

In O +
contrast O -
, O +
all O +
four O +
MCAD+ O -
/ O -
+ O +
mice O +
survived O +
the O +
3-h O +
cold O +
stress O -
, O +
ending O +
with O +
an O +
average O +
rectal O +
temperature O +
of O +
33.6 O +
° O -
C O -
. O +

Organic B-Chemical +
Acid I-Chemical +
and O +
Acylcarnitine B-Chemical +
Analysis O +
Urine O +
organic B-Chemical +
acid I-Chemical +
analysis O +
revealed O +
that O +
MCAD− O -
/ O -
− O +
mice O +
developed O +
an O +
organic B-Chemical +
acid I-Chemical +
profile O +
similar O +
to O +
MCAD O -
- O -
deficient O +
human O +
patients O -
. O +

Specifically O -
, O +
when O +
fasted O +
for O +
18 O +
h O -
, O +
MCAD− O -
/ O -
− O +
mice O +
developed O +
significantly O +
elevated O +
concentrations O +
of O +
adipic B-Chemical -
, O +
suberic B-Chemical -
, O +
and O +
sebacic B-Chemical +
acids I-Chemical +
and O +
hexanoylglycine B-Chemical +
as O +
compared O +
to O +
MCAD+ O -
/ O -
+ O +
controls O -
, O +
which O +
showed O +
trace O +
to O +
no O +
detectable O +
amounts O +
of O +
the O +
same O +
organic B-Chemical +
acids I-Chemical +
( O -
Table O +
1 O -
) O -
. O +

Adipic B-Chemical +
acid I-Chemical +
is O +
not O +
specific O +
to O +
MCAD O +
deficiency O -
. O +

We O +
also O +
evaluated O +
β B-Chemical -
- I-Chemical -
hydroxybutyric I-Chemical +
and O +
acetoacetic B-Chemical +
concentrations O +
and O +
found O +
no O +
significant O +
differences O +
between O +
MCAD O +
genotypes O +
( O -
data O +
not O +
shown O -
) O -
. O +

Comparison O +
of O +
MCAD+ O -
/ O -
+ O +
and O +
MCAD− O -
/ O -
− O +
mice O +
revealed O +
no O +
significant O +
differences O +
in O +
total O +
serum O +
carnitine B-Chemical +
concentrations O +
between O +
MCAD+ O -
/ O -
+ O +
and O +
MCAD− O -
/ O -
− O +
mice O -
, O +
but O +
MCAD− O -
/ O -
− O +
mice O +
had O +
a O +
5- O +
to O +
6-fold O +
elevation O +
of O +
serum O +
decenoylcarnitine B-Chemical +
evident O +
in O +
the O +
acylcarnitine B-Chemical +
profile O +
( O -
Figure O +
4A O -
) O -
. O +

Bile O +
acylcarnitine B-Chemical +
analysis O +
revealed O +
a O +
similar O +
acylcarnitine B-Chemical +
pattern O +
as O +
in O +
serum O +
( O -
Figure O +
4B O -
) O -
. O +

However O -
, O +
the O +
acylcarnitine B-Chemical +
profiles O +
of O +
the O +
MCAD− O -
/ O -
− O +
mice O +
are O +
different O +
from O +
those O +
of O +
human O +
MCAD O -
- O -
deficient O +
patients O +
( O -
Figure O +
4C O -
) O -
. O +

Human O +
patients O +
present O +
with O +
elevated O +
levels O +
of O +
C6 O -
, O +
C8 O -
, O +
and O +
C10:1 O +
acylcarnitines B-Chemical -
, O +
as O +
did O +
the O +
mutant O +
mice O -
; O +
however O -
, O +
the O +
predominant O +
peak O +
was O +
C8 O +
acylcarnitine B-Chemical +
in O +
humans O -
, O +
whereas O +
in O +
the O +
mouse O +
it O +
was O +
C10:1 O +
acylcarnitine B-Chemical -
. O +

Figure O +
4 O +
Acylcarnitine B-Chemical +
Analyses O +
( O -
A O -
) O +
Serum O +
acylcarnitine B-Chemical +
analysis O +
of O +
MCAD+ O -
/ O -
+ O +
( O -
n O +
= O +
4 O -
) O +
and O +
MCAD− O -
/ O -
− O +
mice O +
( O -
n O +
= O +
4 O -
) O +
There O +
are O +
significant O +
elevations O +
in O +
acylcarnitine B-Chemical +
species O +
as O +
indicated O +
in O +
MCAD− O -
/ O -
− O +
mice O -
. O +

Values O +
shown O +
are O +
mean O +
values O +
± O +
standard O +
deviation O +
( O -
SD O -
) O -
. O +

Asterisk O +
indicates O +
p O +
< O +
0.002 O +
and O +
‡ O +
indicates O +
p O +
< O +
0.01 O -
. O +

( O -
B O -
) O +
There O +
are O +
significant O +
elevations O +
in O +
bile O +
acylcarnitines B-Chemical +
of O +
the O +
same O +
mice O +
shown O +
in O +
( O -
A O -
) O +
as O +
indicated O -
. O +

Values O +
shown O +
are O +
mean O +
values O +
± O +
SD O -
. O +

Asterisk O +
indicates O +
p O +
< O +
0.001 O -
. O +

( O -
C O -
) O +
Bile O +
acylcarnitine B-Chemical +
profile O +
of O +
an O +
MCAD− O -
/ O -
− O +
mouse O +
compared O +
to O +
a O +
human O +
patient O +
with O +
MCAD O +
deficiency O -
. O +

Internal O +
standards O +
are O +
indicated O +
by O +
an O +
asterisk O -
. O +

Histopathology O +
Complete O +
histopathologic O +
examination O +
of O +
one O +
group O +
of O +
mutant O +
and O +
MCAD+ O -
/ O -
+ O +
control O +
mice O +
after O +
a O +
24-h O +
fast O +
demonstrated O +
diffuse O +
microvesicular O +
and O +
macrovesicular O +
hepatic O +
steatosis O +
in O +
6–8-wk O -
- O -
old O +
MCAD− O -
/ O -
− O +
mice O +
whereas O +
MCAD+ O -
/ O -
+ O +
mice O +
had O +
no O +
histologic O +
changes O +
( O -
Figure O +
5A O +
and O +
5B O -
) O -
. O +

In O +
another O +
group O +
of O +
4-wk O -
- O -
old O +
MCAD+ O -
/ O -
+ O +
and O +
MCAD− O -
/ O -
− O +
mice O +
fasted O +
for O +
24-h O -
, O +
there O +
were O +
minimal O +
to O +
no O +
abnormalities O +
in O +
all O +
organs O +
evaluated O -
. O +

Only O +
the O +
older O +
MCAD− O -
/ O -
− O +
mice O -
, O +
therefore O -
, O +
demonstrated O +
hepatic O +
steatosis O -
. O +

In O +
addition O -
, O +
we O +
found O +
sporadic O +
cardiac O +
lesions O +
in O +
multiple O +
MCAD− O -
/ O -
− O +
mice O -
. O +

Figure O +
5 O +
Histopathology O +
of O +
MCAD+ O -
/ O -
+ O +
and O +
MCAD− O -
/ O -
− O +
Mice O +
( O -
A O -
) O +
MCAD+ O -
/ O -
+ O +
mice O +
had O +
no O +
evidence O +
of O +
hepatic O +
steatosis O +
following O +
a O +
24-h O +
fast O -
. O +

Liver O +
section O +
with O +
Oil O -
- O -
Red O +
O O +
stain O -
. O +

( O -
B O -
) O +
Hepatosteatosis O +
in O +
MCAD− O -
/ O -
− O +
mouse O +
following O +
a O +
24-h O +
fast O -
. O +

Oil O -
- O -
Red O +
O O +
stained O +
liver O +
sections O +
revealed O +
severe O +
and O +
diffuse O +
microvesicular O +
and O +
macrovesicular O +
hepatic O +
steatosis O +
in O +
MCAD− O -
/ O -
− O +
mice O -
. O +

( O -
C O +
and O +
D O -
) O +
Diffuse O +
cardiomyopathy O +
with O +
chronic O +
active O +
multifocal O +
myocyte O +
degeneration O +
and O +
necrosis O +
in O +
MCAD− O -
/ O -
− O +
mice O -
. O +

In O +
one O +
example O -
, O +
an O +
MCAD− O -
/ O -
− O +
mouse O +
had O +
diffuse O +
cardiomyopathy O +
with O +
chronic O +
active O +
multifocal O +
myocyte O +
degeneration O +
and O +
necrosis O +
( O -
Figure O +
5C O +
and O +
5D O -
) O -
. O +

Changes O +
in O +
degenerating O +
myocytes O +
included O +
swelling O -
, O +
pale O +
staining O -
, O +
and O -
, O +
in O +
portions O +
of O +
the O +
sarcoplasm O -
, O +
replacement O +
of O +
myofibrils O +
with O +
finely O +
granular O +
eosinophilic O +
material O -
. O +

Nuclei O +
of O +
affected O +
myocytes O +
were O +
large O -
, O +
pale O -
, O +
and O +
vesicular O +
and O +
had O +
prominent O +
nucleoli O -
. O +

In O +
the O +
most O +
severely O +
affected O +
areas O -
, O +
there O +
was O +
loss O +
of O +
myocytes O +
accompanied O +
by O +
fibrosis O -
. O +

In O +
the O +
wall O +
of O +
the O +
aorta O +
at O +
the O +
base O +
of O +
the O +
heart O +
there O +
was O +
multifocal O +
degeneration O +
of O +
the O +
elastic O +
tissue O -
, O +
accompanied O +
by O +
multifocal O +
collections O +
of O +
globular O +
translucent O +
yellow O -
- O -
brown O +
pigment B-Chemical +
interpreted O +
to O +
be O +
ceroid O -
/ O -
lipofuscin O -
. O +

Similar O +
deposits O +
were O +
scattered O +
within O +
adjacent O +
adipose O +
tissue O -
. O +

Discussion O +
Successfully O +
targeting O +
Acadm O +
produced O +
a O +
mouse O +
model O +
for O +
MCAD O +
deficiency O +
with O +
features O +
that O +
mimic O +
the O +
clinical O -
, O +
biochemical O -
, O +
and O +
pathologic O +
phenotype O +
found O +
in O +
human O +
patients O -
. O +

MCAD O -
- O -
deficient O +
patients O +
have O +
abnormal O +
plasma O +
and O +
urine O +
metabolites B-Chemical +
associated O +
with O +
the O +
medium O +
chain O -
– O -
length O +
enzyme O +
specificity O -
. O +

MCAD O -
- O -
deficient O +
patients O +
[ O -
15 O -
] O +
often O +
display O +
a O +
characteristic O +
urinary O +
hexanoylglycine B-Chemical +
peak O -
, O +
as O +
was O +
seen O +
in O +
MCAD− O -
/ O -
− O +
mice O -
. O +

Acylcarnitine B-Chemical +
analysis O +
indicated O -
, O +
however O -
, O +
mouse O +
MCAD O +
is O +
more O +
active O +
toward O +
longer O +
chain O +
substrates O +
than O +
the O +
human O +
MCAD O +
enzyme O -
. O +

This O +
finding O +
is O +
similar O +
to O +
that O +
seen O +
with O +
very B-Chemical +
long I-Chemical -
- I-Chemical -
chain I-Chemical +
acyl I-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenase O +
( O -
VLCAD O -
) O +
where O +
mouse O +
VLCAD O +
is O +
most O +
active O +
toward O +
C16 O +
acyl B-Chemical -
- O -
substrates O +
as O +
compared O +
to O +
human O +
VLCAD O +
with O +
the O +
most O +
enzymatic O +
activity O +
toward O +
C14 O +
acyl B-Chemical -
- O -
substrates O +
[ O -
16 O -
] O -
. O +

ETF O +
reduction O +
assays O +
of O +
liver O +
homogenates O +
were O +
performed O +
to O +
characterize O +
the O +
MCAD− O -
/ O -
− O +
mice O +
at O +
the O +
enzymatic O +
level O -
. O +

MCAD− O -
/ O -
− O +
mice O +
had O +
a O +
significantly O +
reduced O +
ability O +
to O +
dehydrogenate O +
C8-CoA O -
, O +
as O +
is O +
the O +
case O +
in O +
human O +
patients O +
where O +
MCAD O +
activity O +
is O +
reduced O +
to O +
near O +
zero O +
with O +
C8-CoA O +
. O +

This O +
was O +
less O +
so O +
with O +
palmitoyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
( O -
C16:0 O -
) O -
. O +

Because O +
there O +
was O +
clearly O +
no O +
MCAD O +
antigen B-Chemical +
detected O +
in O +
MCAD− O -
/ O -
− O +
mice O -
, O +
the O +
residual O +
dehydrogenase O +
activity O +
measured O +
with O +
these O +
two O +
substrates O +
must O +
represent O +
the O +
activity O +
of O +
other O +
chain O +
length O -
– O -
specific O +
acyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenases O -
. O +

A O +
high O +
degree O +
of O +
neonatal O +
mortality O +
in O +
MCAD− O -
/ O -
− O +
mice O +
was O +
a O +
striking O +
observation O +
and O +
appears O +
to O +
be O +
analogous O +
to O +
the O +
patterns O +
of O +
clinical O +
episodes O +
and O +
mortality O +
in O +
MCAD O -
- O -
deficient O +
patients O -
. O +

MCAD− O -
/ O -
− O +
mice O +
exhibited O +
significant O +
neonatal O +
mortality O +
with O +
approximately O +
60 O -
% O +
of O +
the O +
MCAD− O -
/ O -
− O +
pups O +
dying O +
prior O +
to O +
weaning O +
at O +
3 O +
wk O +
of O +
age O -
. O +

Human O +
patients O +
present O +
with O +
hypoglycemia O -
, O +
hypoketonemia O -
, O +
and O +
nonketotic O +
organic O +
aciduria O +
precipitated O +
by O +
fasting O -
, O +
most O +
frequently O +
during O +
the O +
first O +
24 O +
mo O +
in O +
life O +
[ O -
1 O -
] O -
. O +

It O +
is O +
likely O +
that O +
neonatal O +
MCAD− O -
/ O -
− O +
pups O +
are O +
manifesting O +
sensitivity O +
to O +
fasting O +
with O +
decompensation O +
in O +
a O +
short O +
period O +
of O +
time O +
if O +
maternal O +
milk O +
is O +
not O +
ingested O -
. O +

In O +
contrast O -
, O +
no O +
mortality O +
was O +
noted O +
in O +
adult O +
MCAD− O -
/ O -
− O +
mice O +
unless O +
challenged O +
with O +
cold O +
stress O +
and O +
fasting O -
. O +

Under O +
cold O +
challenge O +
conditions O -
, O +
however O -
, O +
MCAD− O -
/ O -
− O +
mice O +
were O +
unable O +
to O +
maintain O +
body O +
temperature O -
. O +

Brown O +
fat O +
is O +
predominantly O +
responsible O +
for O +
thermogenesis O +
and O +
normally O +
expresses O +
high O +
levels O +
of O +
Acadm O +
mRNA O -
. O +

The O +
microvesicular O +
and O +
macrovesicular O +
hepatic O +
steatosis O +
seen O +
in O +
fasted O +
MCAD− O -
/ O -
− O +
mice O +
is O +
consistent O +
with O +
the O +
primary O +
pathological O +
finding O +
seen O +
in O +
human O +
MCAD O +
patients O +
with O +
fasting O +
stress O -
. O +

Sporadic O +
cardiac O +
lesions O +
in O +
MCAD− O -
/ O -
− O +
mice O -
, O +
however O -
, O +
were O +
an O +
interesting O +
and O +
unexpected O +
finding O -
. O +

The O +
diffuse O +
cardiomyopathy O +
with O +
multifocal O +
myocyte O +
degeneration O +
and O +
necrosis O +
observed O +
in O +
MCAD− O -
/ O -
− O +
mice O +
has O +
not O +
been O +
reported O +
in O +
human O +
MCAD O +
patients O -
, O +
however O -
, O +
cardiac O +
arrhythmias O +
and O +
dysfunction O +
have O +
been O +
reported O +
in O +
MCAD O -
- O -
deficient O +
patients O +
[ O -
17 O -
, O +
18 O -
] O -
. O +

Interestingly O -
, O +
cardiomyopathy O +
has O +
been O +
observed O +
in O +
VLCAD O +
deficiency O +
[ O -
19 O -
] O +
and O +
other O +
disorders O +
of O +
long B-Chemical +
chain I-Chemical +
fat I-Chemical +
metabolism O +
such O +
as O +
severe O +
CPT-1 O +
and O +
-2 O +
deficiencies O +
[ O -
1 O -
] O -
. O +

Thus O +
it O +
is O +
tempting O +
to O +
relate O +
the O +
cardiac O +
problems O +
in O +
the O +
mouse O +
to O +
the O +
apparent O +
broader O +
range O +
of O +
substrate O +
utilization O +
of O +
mouse O +
MCAD O -
. O +

The O +
inconsistent O +
liver O +
and O +
cardiac O +
lesions O +
in O +
these O +
mice O +
is O +
analogous O +
with O +
the O +
significant O +
inter- O +
and O +
intrafamilial O +
phenotypic O +
heterogeneity O +
seen O +
in O +
MCAD O +
deficiency O +
in O +
humans O +
[ O -
1,20 O -
] O -
. O +

In O +
comparisons O +
with O +
our O +
experiences O +
with O +
the O +
other O +
mouse O +
models O +
for O +
acyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenase O +
deficiencies O -
, O +
the O +
overall O +
phenotype O +
of O +
MCAD− O -
/ O -
− O +
mice O +
is O +
less O +
severe O +
than O +
that O +
found O +
in O +
LCAD− O -
/ O -
− O +
mice O -
, O +
yet O +
more O +
pronounced O +
than O +
the O +
VLCAD− O -
/ O -
− O +
or O +
SCAD− O -
/ O -
− O +
mouse O +
models O +
[ O -
16,21,22 O -
] O -
. O +

All O +
of O +
these O +
mutants O +
are O +
cold O +
intolerant O +
and O +
display O +
varying O +
degrees O +
of O +
fatty O +
changes O +
in O +
liver O -
, O +
heart O -
, O +
and O +
kidney O -
. O +

LCAD− O -
/ O -
− O +
mice O +
show O +
more O +
spontaneous O +
deaths O +
and O +
gestational O +
losses O +
than O +
the O +
other O +
deficiencies O +
[ O -
21 O -
] O -
. O +

The O +
significant O +
neonatal O +
mortality O +
in O +
MCAD− O -
/ O -
− O +
mice O +
is O +
distinctive O +
from O +
these O +
other O +
mouse O +
models O +
suggesting O +
a O +
greater O +
degree O +
of O +
sensitivity O +
to O +
fasting O +
intolerance O -
. O +

The O +
phenotypes O +
of O +
both O +
the O +
VLCAD− O -
/ O -
− O +
and O +
SCAD− O -
/ O -
− O +
mice O +
are O +
relatively O +
mild O +
if O +
the O +
animals O +
are O +
not O +
cold O +
stressed O +
[ O -
16,22 O -
] O -
. O +

The O +
MCAD O -
- O -
deficient O +
mouse O +
offers O +
new O +
insights O +
into O +
the O +
pathogenesis O +
of O +
mitochondrial O +
β O -
- O -
oxidation O +
deficiencies O +
and O +
will O +
provide O +
a O +
robust O +
tool O +
to O +
better O +
understand O +
the O +
role O +
of O +
fatty B-Chemical +
acids I-Chemical +
in O +
other O +
relevant O +
diseases O -
. O +

Materials O +
and O +
Methods O +
Construction O +
of O +
MCAD O +
targeting O +
vector O -
. O +

A O +
neomycin B-Chemical +
resistance O +
gene O +
cassette O +
[ O -
23 O -
] O +
was O +
subcloned O +
into O +
the O +
SalI O +
site O +
of O +
pGEM11Zf O -
( O -
+ O -
) O -
. O +

The O +
plasmid O +
was O +
digested O +
with O +
EcoRI O +
and O +
the O +
overhangs O +
were O +
filled O +
with O +
Klenow O +
enzyme O -
. O +

Subsequent O +
ligation O +
of O +
the O +
blunt O +
ends O +
recircularized O +
the O +
vector O +
and O +
destroyed O +
the O +
EcoRI O +
site O +
within O +
the O +
polylinker O +
of O +
the O +
pGEMl1Zf O -
( O -
+ O -
) O +
plasmid O -
. O +

Next O -
, O +
an O +
8-kb O +
Acadm O +
genomic O +
fragment O +
spanning O +
exons O +
8 O -
, O +
9 O -
, O +
and O +
10 O +
and O +
flanking O +
intron O +
sequences O -
, O +
originally O +
obtained O +
from O +
a O +
Lambda O +
FIXII O +
129Sv O +
mouse O +
genomic O +
library O +
[ O -
24,25 O -
] O -
, O +
was O +
directionally O +
cloned O +
into O +
the O +
NotI O +
and O +
XhoI O +
sites O +
of O +
pGEM11Zf O -
( O -
+ O -
) O -
. O +

The O +
vector O +
was O +
digested O +
with O +
BamHI O +
and O +
EcoRI O +
to O +
remove O +
a O +
1.3-kb O +
BamHI O -
/ O -
EcoRI O +
genomic O +
fragment O +
containing O +
exon O +
10 O +
and O +
flanking O +
intron O +
sequences O -
. O +

The O +
digested O +
vector O -
, O +
without O +
the O +
1.3-kb O +
BamHI O -
/ O -
EcoRI O +
genomic O +
fragment O -
, O +
was O +
purified O +
by O +
gel O +
purification O +
and O +
recircularized O +
by O +
ligation O +
using O +
three O +
oligonucleotides O -
: O +
5′-AATTGTCGACA-3′ O -
; O +
5′GATCGTCGACA-3′ O -
; O +
and O +
5′-TCGATGTCGAC-3′. O +
The O +
recircularized O +
vector O -
, O +
resulting O +
from O +
the O +
ligation O +
of O +
the O +
long O +
arm O +
to O +
the O +
short O +
arm O +
of O +
homology O -
, O +
contained O +
a O +
unique O +
SalI O +
site O +
where O +
the O +
1.3-kb O +
exon O +
10 O +
region O +
was O +
deleted O -
. O +

Generation O +
of O +
MCAD O -
- O -
deficient O +
mice O -
. O +

The O +
Acadm O +
insertion O +
vector O +
was O +
linearized O +
by O +
SalI O +
digestion O -
, O +
the O +
site O +
of O +
the O +
1.3-kb O +
genomic O +
fragment O +
deletion O -
, O +
and O +
electroporated O +
into O +
E14–1 O +
ES O +
cells O +
( O -
a O +
kind O +
gift O +
from O +
R. O +
Kuhn O -
) O -
, O +
derived O +
from O +
129P2 O +
mice O -
. O +

Correctly O +
targeted O +
Acadm O +
insertion O +
vector O +
was O +
designed O +
to O +
undergo O +
gap O +
repair O +
of O +
the O +
1.3-kb O +
deletion O +
upon O +
double O +
stranded O -
– O -
break O +
repair O +
[ O -
26 O -
] O +
during O +
homologous O +
recombination O -
. O +

Southern O +
blot O +
analysis O +
was O +
conducted O +
to O +
confirm O +
homologous O +
recombination O -
. O +

Genomic O +
DNA O +
from O +
G418 B-Chemical +
resistant O +
ES O +
colonies O +
was O +
digested O +
with O +
EcoRI O -
, O +
electrophoresed O -
, O +
blotted O -
, O +
and O +
probed O +
with O +
an O +
850-bp O +
probe O +
( O -
probe O +
A O -
) O +
generated O +
by O +
PCR O +
from O +
Acadm O +
exon O +
10 O +
to O +
intron O +
10 O -
. O +

This O +
DNA O +
fragment O +
is O +
not O +
present O +
within O +
Acadm O +
insertion O +
vector O +
and O +
was O +
expected O +
to O +
hybridize O +
to O +
a O +
13.2-kb O +
genomic O +
DNA O +
fragment O +
upon O +
homologous O +
recombination O -
. O +

Correctly O +
targeted O +
ES O +
cell O +
clones O +
were O +
microinjected O +
into O +
B6 O +
blastocysts O +
to O +
generate O +
chimeric O +
mice O -
. O +

Chimeric O +
mice O +
were O +
subsequently O +
backcrossed O +
to O +
B6 O +
and O +
129P2 O +
mice O +
to O +
produce O +
gene O -
- O -
targeted O +
mice O +
AcadmtmUab1 O -
/ O -
+ O +
( O -
MCAD+ O -
/ O -
− O -
) O +
and O +
eventually O +
AcadmtmUab1 O -
/ O -
tm1Uab O +
MCAD− O -
/ O -
− O +
( O -
B6;129 O -
) O +
mice O -
. O +

Mice O +
were O +
negative O +
for O +
mouse O +
pathogens O +
based O +
on O +
serological O +
assays O +
for O +
ten O +
different O +
viruses O -
, O +
aerobic O +
bacterial O +
cultures O +
of O +
nasopharynx O +
and O +
cecum O -
, O +
examinations O +
for O +
endo- O +
and O +
ectoparasites O -
, O +
and O +
histopathology O +
of O +
all O +
major O +
organs O -
. O +

RNA O +
analysis O -
. O +

Total O +
RNA O +
was O +
isolated O +
from O +
the O +
heart O +
of O +
30 O +
day O +
old O +
MCAD+ O -
/ O -
+ O -
, O +
MCAD+ O -
/ O -
− O -
, O +
and O +
MCAD− O -
/ O -
− O +
mice O +
by O +
standard O +
techniques O +
using O +
guanidinium B-Chemical +
thiocyanate B-Chemical +
method O +
[ O -
27 O -
] O -
. O +

Reverse O +
transcription O +
was O +
performed O +
using O +
random O +
oligonucleotides O +
as O +
recommended O +
by O +
the O +
manufacturer O +
( O -
Clontech O -
, O +
Mountain O +
View O -
, O +
California O -
, O +
United O +
States O -
) O -
. O +

PCR O +
was O +
subsequently O +
performed O +
using O +
oligonucleotides O +
specific O +
to O +
exon O +
7 O +
and O +
exon O +
11 O +
of O +
Acadm O -
. O +

PCR O +
amplifications O +
were O +
performed O +
as O +
described O +
above O -
. O +

PCR O +
fragments O +
were O +
subsequently O +
sequenced O +
after O +
subcloning O +
into O +
pGEM O -
- O -
T O +
Easy O +
vector O +
( O -
Promega O -
, O +
Madison O -
, O +
Wisconsin O -
, O +
United O +
States O -
) O -
. O +

In O +
order O +
to O +
determine O +
the O +
extent O +
of O +
Acadm O +
mRNA O +
expressed O +
from O +
the O +
MCAD− O -
/ O -
− O +
mice O -
, O +
northern O +
blot O +
analysis O +
was O +
performed O -
. O +

Total O +
RNA O +
was O +
isolated O +
from O +
heart O -
, O +
liver O -
, O +
brown O +
fat O -
, O +
brain O -
, O +
kidney O -
, O +
skeletal O +
muscle O -
, O +
white O +
fat O -
, O +
and O +
testes O +
of O +
3-mo O -
- O -
old O +
MCAD+ O -
/ O -
+ O +
and O +
MCAD− O -
/ O -
− O +
mice O +
using O +
the O +
Ultraspec O +
RNA O +
Isolation O +
Kit O +
( O -
BIOTEX O +
Laboratories O -
, O +
Inc. O -
, O +
Houston O -
, O +
Texas O -
, O +
United O +
States O -
) O +
as O +
per O +
manufacturer O -
's O +
protocol O -
. O +

Ten O +
μg O +
of O +
total O +
RNA O +
from O +
each O +
sample O +
was O +
loaded O +
onto O +
a O +
0.8 O -
% O +
agarose B-Chemical -
- O -
formaldehyde B-Chemical +
gel O -
, O +
transferred O +
to O +
nitrocellulose B-Chemical +
filter O +
( O -
Hybond O +
N O -
; O +
GE O +
Healthcare O +
Amersham O +
Biosciences O +
Corp. O -
, O +
Piscataway O -
, O +
New O +
Jersey O -
, O +
United O +
States O -
) O -
, O +
and O +
hybridized O +
with O +
32P B-Chemical -
- O -
radiolabeled O +
full O -
- O -
length O +
mouse O +
Acadm O +
cDNA O +
probe O +
using O +
standard O +
procedures O +
[ O -
28 O -
] O -
. O +

Hybridizations O +
were O +
performed O +
under O +
highly O +
stringent O +
conditions O +
( O -
42 O +
° O -
C O +
in O +
2 O -
× O +
SSC O -
, O +
50 O -
% O +
formamide B-Chemical -
, O +
10 O -
% O +
dextran B-Chemical +
sulfate I-Chemical -
, O +
5 O -
× O +
Denhardt O -
's O +
reagent B-Chemical -
, O +
1 O -
% O +
SDS B-Chemical -
, O +
and O +
salmon O +
sperm O +
DNA O -
) O +
for O +
18 O +
h. O +
The O +
hybridized O +
filter O +
was O +
washed O +
two O +
times O +
in O +
4 O -
× O +
SSC O -
, O +
0.1 O -
% O +
SDS B-Chemical +
and O +
two O +
times O +
in O +
2 O -
× O +
SSC O -
; O +
0.1 O -
% O +
SDS B-Chemical +
at O +
55 O +
° O -
C O +
for O +
1 O +
h. O +
The O +
filter O +
was O +
exposed O +
to O +
autoradiographic O +
film O +
( O -
Hyperfilm O +
MP O -
; O +
GE O +
Healthcare O +
Amersham O +
Biosciences O -
, O +
Piscataway O -
, O +
New O +
Jersey O -
, O +
United O +
States O -
) O -
. O +

Replicate O +
agarose B-Chemical -
- O -
formaldehyde B-Chemical +
gels O +
were O +
stained O +
by O +
ethidium B-Chemical +
bromide I-Chemical +
to O +
verify O +
equal O +
RNA O +
loading O -
. O +

Immunoblot O +
analysis O +
of O +
MCAD O +
protein O -
. O +

To O +
evaluate O +
the O +
quantity O +
of O +
MCAD O +
protein O +
in O +
mouse O +
tissue O -
, O +
liver O +
samples O +
from O +
6–8-wk O -
- O -
old O +
MCAD+ O -
/ O -
+ O +
( O -
n O +
= O +
1 O -
) O +
and O +
MCAD− O -
/ O -
− O +
( O -
n O +
= O +
3 O -
) O +
mice O +
were O +
immediately O +
frozen O +
in O +
liquid O +
nitrogen O +
and O +
stored O +
at O +
−80 O +
° O -
C O -
. O +

For O +
analysis O -
, O +
tissue O +
was O +
homogenized O +
and O +
lysed O +
in O +
RIPA O +
buffer O +
( O -
1 O -
× O +
PBS O -
, O +
1 O -
% O +
Nonidet B-Chemical +
P-40 I-Chemical -
, O +
0.5 O -
% O +
sodium B-Chemical +
deoxycholate I-Chemical -
, O +
and O +
1 O -
% O +
SDS B-Chemical -
) O +
with O +
10 O -
% O +
glycerol B-Chemical +
and O +
Complete O +
Protease O +
Inhibitor O -
, O +
( O -
Roche O +
Diagnostics O +
Corporation O -
, O +
Indianapolis O -
, O +
Indiana O -
, O +
United O +
States O -
) O -
, O +
1 O +
mM O +
of O +
phenylmethylsulfonylfluoride B-Chemical -
, O +
and O +
1 O +
mM O +
of O +
sodium B-Chemical +
orthovanadate I-Chemical -
. O +

Lysates O +
were O +
quantified O +
by O +
Bradford O +
BCA O +
protein O +
assay O +
( O -
Bio O -
- O -
Rad O -
, O +
Hercules O -
, O +
California O -
, O +
United O +
States O -
) O -
. O +

Protein O +
lysates O +
were O +
denatured O -
, O +
separated O +
in O +
8 O -
% O +
SDS B-Chemical -
- O -
PAGE O -
, O +
and O +
transferred O +
overnight O +
onto O +
a O +
0.45 O +
μm O +
nitrocellulose B-Chemical +
membrane O +
( O -
Schleicher O +
and O +
Schuell O -
, O +
Keene O -
, O +
New O +
Hampshire O -
, O +
United O +
States O -
) O -
. O +

After O +
blocking O +
with O +
5 O -
% O +
nonfat O +
milk O +
in O +
phosphate O -
- O -
buffered O +
saline O +
with O +
0.1 O -
% O +
Tween-20 B-Chemical -
, O +
the O +
membrane O +
was O +
immunoblotted O +
overnight O +
at O +
4 O +
° O -
C O +
with O +
1:500 O +
dilution O +
of O +
an O +
anti O -
- O -
MCAD O +
antibody O -
. O +

Blots O +
were O +
incubated O +
in O +
anti O -
- O -
mouse O +
IgG O +
HRP O -
- O -
conjugated O +
secondary O +
antibody O +
for O +
2–4 O +
h O +
at O +
room O +
temperature O +
using O +
standard O +
procedures O +
and O +
developed O +
by O +
chemiluminiscence O +
( O -
Renaissance O -
, O +
NEN O +
Lifesciences O +
Products O -
, O +
Boston O -
, O +
Massachusetts O -
, O +
United O +
States O -
) O -
. O +

Liver O +
enzyme O +
activity O -
. O +

In O +
order O +
to O +
evaluate O +
MCAD O +
activity O +
in O +
mice O -
, O +
liver O +
homogenates O +
were O +
prepared O +
from O +
MCAD+ O -
/ O -
+ O +
( O -
n O +
= O +
5 O -
) O +
and O +
MCAD− O -
/ O -
− O +
mice O +
( O -
n O +
= O +
5 O -
) O -
. O +

The O +
sensitive O +
and O +
highly O +
specific O +
anaerobic O +
ETF O +
reduction O +
assay O +
was O +
used O +
on O +
tissue O +
extracts O +
with O +
octanoyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
( O -
C8 O -
) O +
and O +
palmitoyl B-Chemical -
- I-Chemical -
CoA I-Chemical +
( O -
C16 O -
) O +
as O +
substrate O +
as O +
previously O +
described O +
[ O -
29 O -
] O -
. O +

Fasting O +
and O +
cold O +
challenge O -
. O +

Eight O -
- O -
wk O -
- O -
old O +
MCAD+ O -
/ O -
+ O +
and O +
MCAD− O -
/ O -
− O +
mice O +
were O +
fasted O +
for O +
18 O +
h O +
( O -
cold O +
tolerance O +
experiments O -
) O +
or O +
24 O +
h O +
( O -
serum O +
glucose B-Chemical -
, O +
free O +
fatty B-Chemical +
acid I-Chemical -
, O +
organic B-Chemical +
acid I-Chemical -
, O +
and O +
carnitine B-Chemical +
experiments O -
) O +
prior O +
to O +
analysis O -
. O +

Glucose B-Chemical +
concentration O +
was O +
measured O +
in O +
10 O +
μl O +
sera O +
using O +
an O +
Ektachem O +
DT O +
II O +
system O +
( O -
Johnson O +
and O +
Johnson O +
Clinical O +
Diagnostics O -
, O +
Rochester O -
, O +
New O +
York O -
, O +
United O +
States O -
) O -
. O +

Total O +
non O -
- O -
esterified O +
fatty B-Chemical +
acids I-Chemical +
( O -
NEFA O -
) O +
were O +
measured O +
by O +
an O +
enzymatic O -
, O +
colorimetric O +
method O +
( O -
" O -
NEFA O -
- O -
C O -
" O +
reagents B-Chemical -
, O +
Wako O +
Diagnostics O -
, O +
Richmond O -
, O +
Virginia O -
, O +
United O +
States O -
) O -
. O +

The O +
assay O +
was O +
modified O +
to O +
accommodate O +
a O +
reduced O +
sample O +
size O +
( O -
10 O +
μl O -
) O +
and O +
use O +
of O +
a O +
microplate O +
reader O +
for O +
measurement O +
of O +
optical O +
density O +
at O +
550 O +
nm O -
. O +

Urine O +
organic B-Chemical +
acid I-Chemical +
analyses O +
were O +
performed O +
using O +
gas O +
chromatography O -
- O -
mass O +
spectroscopy O +
as O +
previously O +
described O +
[ O -
22,30 O -
] O -
, O +
except O +
tetracosane B-Chemical +
( O -
C24 O -
; O +
Sigma O -
, O +
St. O +
Louis O -
, O +
Missouri O -
, O +
United O +
States O -
) O +
was O +
used O +
as O +
the O +
internal O +
standard O -
, O +
and O +
quantitative O +
determinations O +
were O +
made O +
based O +
on O +
comparison O +
with O +
synthetic O +
calibration O +
standards O -
. O +

Acylcarnitine B-Chemical +
analyses O +
in O +
serum O +
and O +
bile O +
were O +
conducted O +
using O +
electrospray O +
tandem O +
mass O +
spectrometry O +
[ O -
31,32 O -
] O -
. O +

Histopathology O -
. O +

Twelve O +
mice O +
were O +
examined O +
for O +
gross O +
and O +
histologic O +
abnormalities O -
, O +
including O +
one O +
male O +
and O +
one O +
female O +
MCAD− O -
/ O -
− O +
mouse O +
18-mo O -
- O -
old O -
, O +
one O +
male O +
and O +
one O +
female O +
MCAD+ O -
/ O -
+ O +
mouse O +
6-mo O -
- O -
old O -
, O +
two O +
male O +
and O +
two O +
female O +
MCAD− O -
/ O -
− O +
mice O +
4-wk O -
- O -
old O -
, O +
and O +
two O +
male O +
and O +
two O +
female O +
MCAD+ O -
/ O -
+ O +
mice O +
4-wk O -
- O -
old O -
. O +

Kidney O -
, O +
spleen O -
, O +
pancreas O -
, O +
liver O -
, O +
brain O -
, O +
heart O -
, O +
testicles O -
, O +
ovaries O -
, O +
and O +
skeletal O +
muscle O +
were O +
fixed O +
by O +
immersion O +
in O +
buffered O +
10 O -
% O +
formalin B-Chemical -
, O +
processed O +
routinely O +
for O +
paraffin O +
sectioning O -
, O +
sectioned O +
at O +
5 O +
μm O -
, O +
and O +
stained O +
with O +
hematoxylin B-Chemical +
and O +
eosin O -
. O +

Frozen O +
liver O +
sections O +
were O +
prepared O +
using O +
standard O +
methods O +
and O +
sections O +
were O +
stained O +
with O +
Oil O -
- O -
red O -
- O -
O. O +
Slides O +
were O +
examined O +
without O +
knowledge O +
of O +
genotype O +
or O +
age O -
. O +

Other O +
mice O +
were O +
examined O +
because O +
of O +
sporadic O +
clinical O +
disease O -
. O +

Those O +
with O +
visible O +
cardiac O +
enlargement O +
were O +
evaluated O +
for O +
cardiac O +
lesions O -
. O +

Statistical O +
analyses O -
. O +

Results O +
between O +
groups O +
were O +
tested O +
for O +
statistical O +
significance O +
using O +
Student O -
's O +
t O -
- O -
test O -
. O +

A O +
p O +
< O +
0.05 O +
was O +
set O +
as O +
significant O -
. O +

Supporting O +
Information O +
Accession O +
Number O +

The O +
GenBank O +
( O -
http://www.ncbi.nlm.nih.gov/Genbank O -
) O +
accession O +
number O +
for O +
the O +
mouse O +
gene O +
Acadm O +
is O +
U07159 O -
. O +

Acknowledgements O +

We O +
thank O +
Sushama O +
Varma O +
for O +
technical O +
assistance O -
. O +

This O +
research O +
was O +
supported O +
by O +
the O +
University O +
of O +
Alabama O +
at O +
Birmingham O +
( O -
UAB O -
) O +
Comprehensive O +
Cancer O +
Center O +
( O -
Oligonucleotide O +
and O +
Transgenic O +
Animal O +
Shared O +
Facilities O -
) O +
grant O +
P30-CA13148 O -
, O +
UAB O +
Musculoskeletal O +
Disease O +
and O +
Arthritis O +
Center O +
( O -
Gene O +
Targeting O +
Core O +
Facility O -
) O +
grant O +
P60-AR20614 O -
, O +
UAB O +
Clinical O +
Nutrition O +
Research O +
Center O +
grant O +
P30-DK-56336 O -
, O +
and O +
by O +
National O +
Institutes O +
of O +
Health O +
grants O +
R01-RR02599 O +
( O -
PAW O -
) O -
, O +
T32-RR-07003 O +
( O -
RJT O -
) O -
, O +
K01-RR00129 O +
( O -
RJT O -
) O -
, O +
RO1-DK45482 O +
( O -
JV O -
) O -
, O +
and O +
DK54936 O +
( O -
JV O -
) O -
. O +

Abbreviations O +
bp O +
- O +
base O +
pair O +
ES O +
- O +
embryonic O +
stem O +
ETF O +
- O +
electron B-Chemical +
transport O +
flavoprotein B-Chemical +
MCAD O +
- O +
medium B-Chemical -
- I-Chemical -
chain I-Chemical +
acyl I-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenase O +
SCAD O +
- O +
short B-Chemical -
- I-Chemical -
chain I-Chemical +
acyl I-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenase O +
SD O +
- O +
standard O +
deviation O +
VLCAD O +
- O +
very B-Chemical +
long I-Chemical -
- I-Chemical -
chain I-Chemical +
acyl I-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenase O +
Footnotes O +
Competing O +
interests O -
. O +

The O +
authors O +
have O +
declared O +
that O +
no O +
competing O +
interests O +
exist O -
. O +

Author O +
contributions O -
. O +

RJT O -
, O +
JV O -
, O +
PR O -
, O +
DM O -
, O +
and O +
PAW O +
conceived O +
and O +
designed O +
the O +
experiments O -
. O +

RJT O -
, O +
DAH O -
, O +
LT O -
, O +
JV O -
, O +
PR O -
, O +
DM O -
, O +
JDS O -
, O +
and O +
PAW O +
performed O +
the O +
experiments O -
. O +

RJT O -
, O +
DAH O -
, O +
LT O -
, O +
JV O -
, O +
JDS O -
, O +
PR O -
, O +
DM O -
, O +
TRS O -
, O +
and O +
PAW O +
analyzed O +
the O +
data O +
and O +
contributed O +
reagents B-Chemical -
/ O -
materials O -
/ O -
analysis O +
tools O -
. O +

RJT O -
, O +
JV O -
, O +
PR O -
, O +
DM O -
, O +
TRS O -
, O +
JDS O -
, O +
and O +
PAW O +
wrote O +
the O +
paper O -
. O +

Citation O -
: O +

Tolwani O +
RJ O -
, O +
Hamm O +
DA O -
, O +
Tian O +
L O -
, O +
Sharer O +
JD O -
, O +
Vockley O +
J O -
, O +
et O +
al. O +
( O -
2005 O -
) O +
Medium B-Chemical -
- I-Chemical -
chain I-Chemical +
acyl I-Chemical -
- I-Chemical -
CoA I-Chemical +
dehydrogenase O +
deficiency O +
in O +
gene O -
- O -
targeted O +
mice O -
. O +

PLoS O +
Genet O +
1 O -
( O -
2 O -
) O -
: O +
e23 O -
. O +

Two O +
major O +
branches O +
of O +
anti O -
- O -
cadmium O +
defense O +
in O +
the O +
mouse O -
: O +
MTF-1 O -
/ O -
metallothioneins O +
and O +
glutathione B-Chemical +
Abstract O +
Metal O -
- O -
responsive O +
transcription O +
factor O +
1 O +
( O -
MTF-1 O -
) O +
regulates O +
expression O +
of O +
its O +
target O +
genes O +
in O +
response O +
to O +
various O +
stress O +
conditions O -
, O +
notably O +
heavy O +
metal O +
load O -
, O +
via O +
binding O +
to O +
metal O +
response O +
elements O +
( O -
MREs O -
) O +
in O +
the O +
respective O +
enhancer O -
/ O -
promoter O +
regions O -
. O +

Furthermore O -
, O +
it O +
serves O +
a O +
vital O +
function O +
in O +
embryonic O +
liver O +
development O -
. O +

However O -
, O +
targeted O +
deletion O +
of O +
Mtf1 O +
in O +
the O +
liver O +
after O +
birth O +
is O +
no O +
longer O +
lethal O -
. O +

For O +
this O +
study O -
, O +
Mtf1 O +
conditional O +
knockout O +
mice O +
and O +
control O +
littermates O +
were O +
both O +
mock- O +
or O +
cadmium O -
- O -
treated O +
and O +
liver O -
- O -
specific O +
transcription O +
was O +
analyzed O -
. O +

Besides O +
the O +
well O -
- O -
characterized O +
metallothionein O +
genes O -
, O +
several O +
new O +
MTF-1 O +
target O +
genes O +
with O +
MRE O +
motifs O +
in O +
the O +
promoter O +
region O +
emerged O -
. O +

MTF-1 O +
is O +
required O +
for O +
the O +
basal O +
expression O +
of O +
selenoprotein O +
W O -
, O +
muscle O +
1 O +
gene O +
( O -
Sepw1 O -
) O +
that O +
encodes O +
a O +
glutathione B-Chemical -
- O -
binding O +
and O +
putative O +
antioxidant O +
protein O -
, O +
supporting O +
a O +
role O +
of O +
MTF-1 O +
in O +
the O +
oxidative O +
stress O +
response O -
. O +

Furthermore O -
, O +
MTF-1 O +
mediates O +
the O +
cadmium O -
- O -
induced O +
expression O +
of O +
N O -
- O -
myc O +
downstream O +
regulated O +
gene O +
1 O +
( O -
Ndrg1 O -
) O -
, O +
which O +
is O +
induced O +
by O +
several O +
stress O +
conditions O +
and O +
is O +
overexpressed O +
in O +
many O +
cancers O -
. O +

MTF-1 O +
is O +
also O +
involved O +
in O +
the O +
cadmium O +
response O +
of O +
cysteine- O +
and O +
glycine O -
- O -
rich O +
protein O +
1 O +
gene O +
( O -
Csrp1 O -
) O -
, O +
which O +
is O +
implicated O +
in O +
cytoskeletal O +
organization O -
. O +

In O +
contrast O -
, O +
MTF-1 O +
represses O +
the O +
basal O +
expression O +
of O +
Slc39a10 O -
, O +
a O +
putative O +
zinc O +
transporter O -
. O +

In O +
a O +
pathway O +
independent O +
of O +
MTF-1 O -
, O +
cadmium O +
also O +
induced O +
the O +
transcription O +
of O +
genes O +
involved O +
in O +
the O +
synthesis O +
and O +
regeneration O +
of O +
glutathione B-Chemical -
, O +
a O +
cadmium O -
- O -
binding O +
antioxidant O -
. O +

These O +
data O +
provide O +
strong O +
evidence O +
for O +
two O +
major O +
branches O +
of O +
cellular O +
anti O -
- O -
cadmium O +
defense O -
, O +
one O +
via O +
MTF-1 O +
and O +
its O +
target O +
genes O -
, O +
notably O +
metallothioneins O -
, O +
the O +
other O +
via O +
glutathione B-Chemical -
, O +
with O +
an O +
apparent O +
overlap O +
in O +
selenoprotein O +
W. O +
INTRODUCTION O +
All O +
organisms O +
have O +
evolved O +
mechanisms O +
to O +
cope O +
with O +
a O +
variety O +
of O +
stress O +
situations O -
. O +

One O +
type O +
of O +
stress O +
response O +
is O +
triggered O +
by O +
heavy O +
metals O -
, O +
such O +
as O +
zinc O -
, O +
copper O +
and O +
cadmium O +
( O -
for O +
convenience O -
, O +
the O +
terms O +
zinc O -
, O +
copper O +
and O +
cadmium O +
are O +
also O +
used O +
here O +
to O +
denote O +
Zn2 B-Chemical -
+ I-Chemical -
, O +
Cu2 B-Chemical -
+ I-Chemical +
and O +
Cd2 B-Chemical -
+ I-Chemical -
, O +
respectively O -
) O -
. O +

Metallothioneins O +
( O -
MTs O -
) O -
, O +
small O -
, O +
cysteine O -
- O -
rich O +
proteins O -
, O +
play O +
an O +
important O +
role O +
in O +
metal O +
homeostasis O +
and O +
detoxification O +
due O +
to O +
their O +
ability O +
to O +
bind O +
different O +
heavy O +
metal O +
ions B-Chemical +
( O -
1–3 O -
) O -
. O +

In O +
the O +
mouse O -
, O +
there O +
are O +
four O +
metallothionein O +
genes O -
, O +
designated O +
as O +
Mt1 O +
to O +
Mt4 O -
. O +

Basal O -
, O +
as O +
well O +
as O +
heavy O +
metal O -
- O -
induced O -
, O +
expression O +
of O +
Mt1 O +
and O +
Mt2 O +
is O +
mediated O +
by O +
metal O -
- O -
responsive O +
transcription O +
factor O +
1 O +
( O -
MTF-1 O -
) O +
( O -
4–7 O -
) O -
. O +

This O +
zinc O +
finger O +
protein O +
recognizes O +
short O +
cis O -
- O -
acting O +
DNA O +
sequences O -
, O +
termed O +
metal O +
response O +
elements O +
( O -
MREs O -
; O +
core O +
consensus O +
sequence O +
TGCRCNC O -
) O -
, O +
which O +
are O +
present O +
in O +
the O +
promoters O +
of O +
target O +
genes O +
( O -
8,9 O -
) O -
. O +

MTF-1 O +
is O +
conserved O +
in O +
evolution O -
, O +
and O +
homologs O +
have O +
been O +
characterized O +
in O +
the O +
mouse O +
( O -
10 O -
) O -
, O +
humans O +
( O -
11 O -
) O -
, O +
Drosophila O +
( O -
12–14 O -
) O +
and O +
fish O +
( O -
15,16 O -
) O -
. O +

The O +
role O +
of O +
MTF-1 O +
has O +
been O +
studied O +
most O +
extensively O +
in O +
the O +
mouse O -
. O +

Besides O +
coping O +
with O +
heavy O +
metal O +
load O -
, O +
MTF-1 O +
can O +
also O +
mediate O +
the O +
induction O +
of O +
Mt O +
genes O +
in O +
response O +
to O +
other O +
stress O +
situations O -
, O +
such O +
as O +
oxidative O +
stress O +
( O -
5,17 O -
) O +
and O +
hypoxia O +
( O -
18 O -
) O -
. O +

In O +
addition O -
, O +
it O +
is O +
required O +
for O +
the O +
metalloregulation O +
of O +
Znt1 O -
, O +
encoding O +
the O +
major O +
plasma O +
membrane O -
- O -
localized O +
zinc O +
efflux O +
transporter O +
( O -
19 O -
) O -
, O +
the O +
hypoxic O -
/ O -
anoxic O +
induction O +
of O +
the O +
gene O +
for O +
placental O +
growth O +
factor O +
( O -
Plgf O -
) O -
, O +
an O +
angiogenic O +
protein O +
of O +
the O +
vascular O +
endothelial O +
growth O +
factor O +
( O -
VEGF O -
) O +
family O +
( O -
20 O -
) O -
, O +
and O +
has O +
recently O +
been O +
invoked O +
in O +
tumor O +
development O +
( O -
21,22 O -
) O -
. O +

Furthermore O -
, O +
MTF-1 O +
has O +
an O +
essential O +
function O +
during O +
embryogenesis O -
: O +
targeted O +
disruption O +
of O +
Mtf1 O +
results O +
in O +
embryonic O +
lethality O +
around O +
14 O +
days O +
post O +
coitum O +
due O +
to O +
hepatocyte O +
necrosis O +
( O -
23 O -
) O -
. O +

In O +
contrast O -
, O +
mice O +
with O +
null O +
mutations O +
for O +
the O +
stress O -
- O -
inducible O +
metallothionein O +
genes O +
( O -
Mt1 O +
and O +
Mt2 O -
) O +
are O +
viable O -
, O +
though O +
sensitive O +
to O +
cadmium O +
( O -
24,25 O -
) O -
, O +
indicating O +
that O +
additional O +
important O +
MTF-1 O +
target O +
genes O +
are O +
involved O +
in O +
the O +
lethal O +
phenotype O -
. O +

With O +
the O +
Cre O -
- O -
loxP O +
conditional O +
knockout O +
technique O -
, O +
it O +
is O +
possible O +
to O +
circumvent O +
the O +
embryonic O +
lethal O +
phenotype O +
of O +
conventional O +
Mtf1 O +
knockout O +
mice O -
. O +

Previous O +
experiments O +
with O +
this O +
technique O +
revealed O +
that O +
deletion O +
of O +
Mtf1 O +
from O +
the O +
liver O +
after O +
birth O +
is O +
no O +
longer O +
lethal O +
under O +
non O -
- O -
stress O +
conditions O +
( O -
26 O -
) O -
. O +

For O +
this O +
study O -
, O +
an O +
inducible O -
, O +
liver O -
- O -
specific O +
Mtf1 O +
knockout O +
mouse O +
line O +
was O +
generated O +
to O +
perform O +
a O +
search O +
for O +
MTF-1 O +
target O +
genes O +
and O +
cadmium O -
- O -
inducible O +
genes O +
in O +
the O +
adult O +
liver O -
. O +

A O +
number O +
of O +
target O +
gene O +
candidates O +
emerged O +
upon O +
a O +
transcriptome O +
analysis O +
of O +
mock- O +
and O +
cadmium O -
- O -
treated O +
Mtf1 O +
conditional O +
knockout O +
mice O +
and O +
control O +
littermates O +
and O +
several O +
of O +
these O +
were O +
confirmed O +
by O +
semiquantitative O +
RT O -
– O -
PCR O -
. O +

Besides O +
the O +
stress O -
- O -
inducible O +
metallothionein O +
genes O +
that O +
were O +
already O +
known O +
as O +
target O +
genes O +
of O +
MTF-1 O -
, O +
we O +
find O +
that O +
MTF-1 O +
is O +
important O +
for O +
basal O +
liver O +
expression O +
of O +
the O +
gene O +
for O +
selenoprotein O +
W O -
, O +
muscle O +
1 O +
( O -
Sepw1 O -
) O +
as O +
well O +
as O +
for O +
cadmium O -
- O -
induced O +
expression O +
of O +
N O -
- O -
myc O +
downstream O +
regulated O +
gene O +
1 O +
( O -
Ndrg1 O -
) O +
and O +
the O +
gene O +
encoding O +
cysteine- O +
and O +
glycine O -
- O -
rich O +
protein O +
1 O +
( O -
Csrp1 O -
) O -
. O +

In O +
addition O -
, O +
MTF-1 O +
appears O +
to O +
repress O +
the O +
expression O +
of O +
solute O +
carrier O +
family O +
39 O -
, O +
member O +
10 O +
gene O +
( O -
Slc39a10 O -
) O -
, O +
which O +
encodes O +
a O +
putative O +
metal O +
ion B-Chemical +
transporter O -
. O +

In O +
an O +
MTF-1-independent O +
transcriptome O +
response O -
, O +
several O +
genes O +
involved O +
in O +
glutathione B-Chemical +
metabolism O +
are O +
induced O -
. O +

Further O +
studies O +
confirmed O +
a O +
dual O +
anti O -
- O -
cadmium O +
defense O -
, O +
one O +
via O +
glutathione B-Chemical +
and O +
another O +
one O +
via O +
MTF-1 O +
and O +
its O +
target O +
genes O -
, O +
including O +
metallothioneins O -
. O +

MATERIALS O +
AND O +
METHODS O +
Generation O +
of O +
Mtf1 O +
conditional O +
knockout O +
mice O +
and O +
liver O -
- O -
specific O +
deletion O +
Mtf1 O +
conditional O +
knockout O +
mice O +
were O +
generated O +
in O +
collaboration O +
with O +
Dr O +
Michael O +
Leviten O +
( O -
San O +
Carlos O -
, O +
CA O -
) O -
. O +

Two O +
genomic O +
clones O +
containing O +
exons O +
3 O +
to O +
6 O +
of O +
Mtf1 O +
were O +
used O +
to O +
construct O +
a O +
gene O +
targeting O +
vector O +
for O +
homologous O +
recombination O +
( O -
Supplementary O +
Data O -
) O -
. O +

A O +
neomycin B-Chemical +
resistance O +
cassette O +
( O -
PGK O -
- O -
neo O -
) O +
flanked O +
by O +
two O +
loxP O +
sites O +
was O +
cloned O +
into O +
the O +
SacI O +
site O +
5′ O +
of O +
exon O +
3 O +
of O +
Mtf1 O -
, O +
the O +
third O +
loxP O +
site O +
was O +
cloned O +
into O +
the O +
ScaI O +
site O +
3′ O +
of O +
exon O +
4 O -
. O +

A O +
thymidine O +
kinase O +
( O -
TK O -
) O +
cassette O +
was O +
inserted O +
in O +
the O +
HpaI O +
site O +
3′ O +
of O +
exon O +
6 O -
. O +

129 O +
ES O +
cells O +
were O +
electroporated O +
with O +
the O +
linearized O +
targeting O +
vector O -
, O +
selected O +
in O +
the O +
presence O +
of O +
G418 B-Chemical +
and O +
FIAU O -
, O +
and O +
screened O +
for O +
correct O +
integration O +
events O +
by O +
PCR O +
and O +
Southern O +
blot O +
analysis O -
. O +

Transient O +
expression O +
of O +
Cre O +
recombinase O +
led O +
to O +
removal O +
of O +
the O +
PGK O -
- O -
neo O +
cassette O -
, O +
and O +
mice O +
carrying O +
the O +
modified O +
Mtf1loxP O +
allele O +
were O +
generated O +
by O +
injection O +
of O +
positive O +
clones O +
into O +
C57Bl O -
/ O -
6 O +
blastocysts O +
and O +
subsequent O +
crosses O -
. O +

Homozygous O +
conditional O +
knockout O +
animals O +
( O -
Mtf1loxP O -
/ O -
loxP O -
) O +
were O +
crossed O +
with O +
the O +
Cre O +
recombinase O +
transgenic O +
line O +
Mx O -
- O -
cre O +
( O -
a O +
gift O +
from O +
Prof. O +
Michel O +
Aguet O -
) O +
to O +
obtain O +
an O +
inducible O -
, O +
liver O -
- O -
specific O +
Mtf1 O +
knockout O +
line O -
. O +

The O +
mice O +
were O +
genotyped O +
by O +
PCR O +
using O +
the O +
following O +
primers O +
( O -
Microsynth O -
) O -
: O +
Cre O +
recombinase O -
: O +
5′-CTATCCAGCAACATTTGGGCCAGC-3′ O -
; O +
5′-CCAGGTTACGGATATAGTTCATGAC-3′ O -
, O +
Mtf1loxP O +
or O +
wild O -
- O -
type O +
allele O -
: O +
5′-CACACCCAGTTTGTGTATGTCTTC-3′ O -
; O +
5′-CAGTCACAAGCAAATTACCAAACACTGCC-3′. O +
Animal O +
treatment O +
At O +
8 O +
weeks O +
of O +
age O -
, O +
male O +
Mtf1loxP O -
/ O -
loxP O +
mice O +
harboring O +
the O +
Mx O -
- O -
cre O +
transgene O +
( O -
Mtf1loxP O -
/ O -
loxP O +
Mx O -
- O -
cre O -
, O +
abbr O -
. O +

: O +
Mtf1Mx O -
- O -
cre O -
) O +
and O +
control O +
littermates O +
without O +
transgene O +
( O -
Mtf1loxP O -
/ O -
loxP O -
, O +
abbr O -
. O -
: O +
Mtf1loxP O -
) O +
received O +
four O +
intraperitoneal O +
injections O +
each O +
of O +
300 O +
µg O +
synthetic O +
double O -
- O -
stranded O +
RNA O +
polyinosinic B-Chemical -
– O -
polycytidylic O +
acid B-Chemical +
[ O -
pI B-Chemical -
– O -
pC O -
; O +
Sigma O -
; O +
in O +
a O +
volume O +
of O +
60 O +
µl O +
phosphate O -
- O -
buffered O +
saline O +
( O -
PBS O -
) O -
] O +
at O +
3 O +
day O +
intervals O -
. O +

Only O +
in O +
the O +
case O +
of O +
DNA O -
- O -
binding O +
studies O +
with O +
MRE O +
sequences O +
from O +
MTF-1 O +
target O +
gene O +
candidates O -
, O +
the O +
control O +
mice O +
received O +
no O +
pI B-Chemical -
– O -
pC O +
injections O -
. O +

For O +
experiments O +
with O +
metal O +
treatment O -
, O +
mice O +
received O +
2 O +
days O +
after O +
the O +
last O +
pI B-Chemical -
– O -
pC O +
treatment O +
a O +
subcutaneous O +
( O -
s.c O -
. O -
) O +
injection O +
of O +
either O +
20 O +
µmol O -
/ O -
kg O +
body O +
weight O +
CdSO4 B-Chemical +
( O -
2 O +
mM O +
CdSO4 B-Chemical +
in O +
H2O B-Chemical -
; O +
cadmium O +
treatment O -
) O +
or O +
10 O +
ml O -
/ O -
kg O +
body O +
weight O +
H2O B-Chemical +
( O -
mock O +
treatment O -
) O +
6 O +
h O +
before O +
sacrificing O +
them O -
. O +

Microarray O +
analysis O +
and O +
data O +
processing O +
Total O +
RNA O +
was O +
isolated O +
from O +
liver O +
tissue O +
of O +
pI B-Chemical -
– O -
pC O -
- O -
induced O -
, O +
mock- O +
or O +
cadmium O -
- O -
treated O +
Mtf1Mx O -
- O -
cre O +
and O +
Mtf1loxP O +
mice O +
( O -
n O +
= O +
3 O +
per O +
genotype O +
and O +
respective O +
treatment O -
; O +
all O +
male O -
) O +
essentially O +
as O +
described O +
by O +
Chomczynski O +
and O +
Sacchi O +
( O -
27 O -
) O -
. O +

Gene O +
expression O +
analysis O +
was O +
performed O +
in O +
the O +
Functional O +
Genomics O +
Center O +
Zurich O +
using O +
GeneChip O -
® O +
Mouse O +
Genome O +
430 O +
2.0 O +
Arrays O +
( O -
Affymetrix O -
) O +
according O +
to O +
the O +
manufacturer O -
's O +
instructions O +
and O +
the O +
following O +
reagents B-Chemical +
and O +
conditions O -
. O +

cDNA O +
was O +
synthesized O +
with O +
SuperScript O -
™ O +
Double O -
- O -
Stranded O +
cDNA O +
Synthesis O +
Kit O +
( O -
Invitrogen O -
) O -
, O +
using O +
15 O +
µg O +
total O +
RNA O -
. O +

In O +
vitro O +
transcription O +
was O +
performed O +
with O +
BioArray O -
™ O +
High O +
Yield O -
™ O +
RNA O +
Transcript O +
Labeling O +
Kit O +
( O -
Enzo O -
) O +
and O +
3.5 O +
to O +
6 O +
µg O +
of O +
each O +
cDNA O -
. O +

Clean O -
- O -
up O +
of O +
both O +
cDNA O +
and O +
cRNA O +
samples O +
was O +
done O +
using O +
GeneChip O -
® O +
Sample O +
Clean O -
- O -
up O +
Module O +
( O -
Affymetrix O -
) O -
. O +

For O +
the O +
automated O +
washing O +
and O +
staining O +
in O +
the O +
Affymetrix O +
fluidics O +
station O +
450 O -
, O +
the O +
protocol O +
EukGE O -
- O -
Ws2v4_450 O +
was O +
used O -
. O +

The O +
probe O +
arrays O +
were O +
scanned O +
with O +
the O +
Affymetrix O +
GS O +
3000 O +
scanner O -
. O +

Raw O +
data O +
are O +
available O +
at O +
ArrayExpress O +
( O -
, O +
accession O +
number O +
E O -
- O -
MEXP-438 O -
) O -
. O +

Data O +
analysis O +
was O +
performed O +
with O +
GeneSpring O +
6.1 O +
software O +
( O -
Silicon O +
Genetics O -
) O -
, O +
applying O +
a O +
significance O +
level O +
P O +
≤ O +
0.05 O -
. O +

Furthermore O -
, O +
multiple O +
testing O +
correction O +
was O +
used O +
in O +
addition O +
to O +
obtain O +
cadmium O -
- O -
responsive O -
, O +
MTF-1-independent O +
genes O -
. O +

Genes O +
were O +
considered O +
to O +
be O +
differentially O +
expressed O +
if O +
there O +
was O +
at O +
least O +
a O +
2-fold O +
difference O +
in O +
expression O +
levels O +
of O +
the O +
compared O +
experimental O +
groups O +
( O -
genotype O +
and O +
respective O +
treatment O -
) O -
. O +

The O +
result O +
was O +
considered O +
reliable O +
if O +
signal O +
values O +
for O +
the O +
respective O +
gene O +
were O +
scored O +
' O -
present O -
' O +
at O +
least O +
for O +
all O +
mice O +
in O +
one O +
experimental O +
group O +
or O +
for O +
two O +
mice O +
in O +
each O +
of O +
two O +
groups O -
. O +

To O +
screen O +
for O +
the O +
presence O +
of O +
the O +
MRE O +
core O +
consensus O +
sequence O +
TGCRCNC O +
in O +
the O +
promoter O +
region O -
, O +
the O +
upstream O +
sequences O +
of O +
the O +
respective O +
genes O +
were O +
obtained O +
from O +
the O +
University O +
of O +
California O +
Santa O +
Cruz O +
( O -
UCSC O -
) O +
Genome O +
Browser O +
Database O +
(; O +
October O -
/ O -
November O +
2004 O -
) O +
( O -
28 O -
) O -
. O +

RT O -
– O -
PCR O +
All O +
RT O -
– O -
PCRs O +
were O +
performed O +
with O +
QIAGEN O -
® O +
OneStep O +
RT O -
– O -
PCR O +
Kit O +
( O -
QIAGEN O -
) O +
according O +
to O +
the O +
manufacturer O -
's O +
instructions O -
, O +
using O +
150–200 O +
ng O +
DNase O +
I O -
- O -
digested O +
total O +
RNA O +
( O -
RNA O +
isolation O +
see O +
microarray O +
analysis O -
) O -
. O +

The O +
reactions O +
were O +
carried O +
out O +
using O +
the O +
following O +
primers O -
: O +
Csrp1 O -
: O +
5′-TTCCGATGTGCCAAGTGTGGC-3′ O -
; O +
5′-AGTAGAGAGTGGACATTCAGC-3′ O -
, O +
hypoxanthin B-Chemical -
- O -
guanin O -
- O -
phosphoribosyltransferase O +
( O -
Hprt O -
) O -
: O +
5′-GCTGGTGAAAAGGACCTCTCG-3′ O -
; O +
5′-CCACAGGACTAGGACACCTGC-3′ O -
, O +
Mtf1 O -
: O +
5′-GTGACTTTTGAGACTGTACTGAGTG-3′ O -
; O +
5′-CATGCCAAGAAACATTGAAGGTG-3′ O -
, O +
Ndrg1 O -
: O +
5′-AGATACACAACAACGTGGAGG-3′ O -
; O +
5′-TGTGCGAGCGGCTTCGGGGGC-3′ O -
, O +
Sepw1 O -
: O +
5′-TAGAGGCAGGGTCCTGAAAGC-3′ O -
; O +
5′-ACACCTGGAAACATGGCTGCC-3′ O -
, O +
Slc39a10 O -
: O +
5′-GCTGTGGCTGGTAGTAAAAGC-3′ O -
; O +
5′-GTGGCATGGGATGTAAACAGC-3′. O +
S1 O +
nuclease O +
mapping O +
of O +
transcripts O +
( O -
S1 O +
analysis O -
) O +
S1 O +
analysis O +
was O +
performed O +
as O +
previously O +
described O +
( O -
29 O -
) O -
, O +
using O +
100 O +
µg O +
DNase O +
I O -
- O -
digested O +
total O +
RNA O +
( O -
RNA O +
isolation O +
see O +
microarray O +
analysis O -
) O -
. O +

The O +
gels O +
were O +
developed O +
using O +
PhosphorImager O +
( O -
Molecular O +
Dynamics O -
) O -
. O +

S1 O +
analysis O +
was O +
done O +
with O +
the O +
following O +
32P B-Chemical -
- O -
labeled O +
oligonucleotides O -
: O +
Hprt O +
S1 O -
: O +
5′-TCTTCAGTCTGATAAAATCTACAGTCATAGGAATGGATCTATCACTATTTCTATTCAGTGATTACATTAAAG-3′ O -
, O +
Sepw1 O +
S1 O -
: O +
5′-TTCAACCGGGAACACCTGGAAACATGGCTGCCTGTCTTCTTGAAGTCTTGAGGTGGAAAGGGAAAGCAAAGCAGGAGGGTTTTCCCACCC-3′. O +
Electrophoretic O +
mobility O +
shift O +
assay O +
( O -
EMSA O -
) O +
Protein O +
was O +
extracted O +
from O +
liver O +
tissue O +
with O +
T O -
- O -
PER O -
™ O +
Tissue O +
Protein O +
Extraction O +
Reagent B-Chemical +
( O -
Pierce O -
) O +
according O +
to O +
the O +
manufacturer O -
's O +
instructions O -
, O +
using O +
a O +
1:10 O +
ratio O +
of O +
mouse O +
tissue O +
( O -
mg O -
) O +
to O +
T O -
- O -
PER O +
reagent B-Chemical +
( O -
µl O -
) O -
. O +

EMSA O +
was O +
essentially O +
performed O +
as O +
previously O +
described O +
( O -
10 O -
) O -
. O +

All O +
binding O +
reactions O +
were O +
carried O +
out O +
by O +
incubating O +
2–5 O +
fmol O +
32P B-Chemical -
- O -
end O -
- O -
labeled O +
double O -
- O -
stranded O +
oligonucleotides O +
with O +
100 O +
to O +
130 O +
µg O +
liver O +
protein O +
extract O -
. O +

For O +
competition O +
experiments O -
, O +
5 O +
pmol O +
of O +
unlabeled O +
competitor O +
oligonucleotide O +
was O +
added O +
to O +
the O +
binding O +
reaction O +
before O +
addition O +
of O +
the O +
extract O -
. O +

All O +
EMSA O +
gels O +
were O +
developed O +
using O +
PhosphorImager O +
( O -
Molecular O +
Dynamics O -
) O -
. O +

The O +
following O +
oligonucleotides O +
were O +
annealed O +
and O +
used O +
for O +
the O +
reactions O -
: O +
Csrp1 O +
MRE1 O -
: O +
5′-GGAAACAAAACGGCGCGCACTCCGGCGC-3′ O -
; O +
5′-GGCTGCGC O +
CGGAGTGCGCGCCGTTTTGT-3′ O -
, O +
Csrp1 O +
MRE2 O -
: O +
5′-TGTTGTGGTGCAGTGTGCAAAGCCTAC-3′ O -
; O +
5′-ACCAGTAGGCTTTGCACACTGCACCAC-3′ O -
, O +
Csrp1 O +
MRE3 O -
: O +
5′-GAGATCGCCATAGGGTGCAAAGAGAAG-3′ O -
; O +
5′-GTGACTTCTCTTTGCACCCTATGGCGA-3′ O -
, O +
Csrp1 O +
MRE4 O -
: O +
5′-TGTCTTATTCTGGAGTGCAAGTTAGTC-3′ O -
; O +
5′-AGGGGACTAACTTGCACTCCAGAATAA-3′ O -
, O +
Gal4 O -
: O +
5′-TCCGGAGGACTGTCCTCCGG-3′ O -
; O +
5′-GCCGGAGGACAGTCCTCCGG-3′ O -
, O +
MREd O +
[ O -
MRE O +
derived O +
from O +
mouse O +
Mt1 O +
promoter O +
( O -
10 O -
) O -
] O -
: O +
5′-CGAGGGAGCTCTGCACTCCGCCCGAAAAGTG-3′ O -
; O +
5′-TCGACACTTTTCGGGCGGAGTGCAGAGCTCCCTCGAGCT-3′ O -
, O +
MRE O -
- O -
s O +
[ O -
synthetic O +
MRE O +
consensus O +
sequence O +
( O -
10 O -
) O -
] O -
: O +
5′-CGAGGGAGCTCTGCACACGGCCCGAAAAGTG-3′ O -
; O +
5′-TCGACACTTTTCGGGCCGTGTGCAGAGCTCCCTCGAGCT-3′ O -
, O +
Ndrg1 O +
MRE1 O -
: O +
5′-CAGCCCAGGCAGGGTGCAGCACGAG-3′ O -
; O +
5′-CCGCCTCGTGCTGCACCCTGCCTGG-3′ O -
, O +
Ndrg1 O +
MRE2 O -
: O +
5′-CACACGTTCGCTGCACACGCCGCGG-3′ O -
; O +
5′-GGGACCGCGGCGTGTGCAGCGAACG-3′ O -
, O +
Ndrg1 O +
MRE3,4 O -
: O +
5′-GGAGTCCTTATGCACACGCGCACGAGCGCGCACGGGCAC-3′ O -
; O +
5′-TGGTGTGCCCGTGCGCGCTCGTGCGCGTGTGCATAAGGAC-3′ O -
, O +
Sepw1 O +
MRE1 O -
: O +
5′-GAGGCAGTCGGCTGTGCGCACGGCCCCACGCTC-3′ O -
; O +
5′-CTCTGAGCGTGGGGCCGTGCGCACAGCCGACTGC-3′ O -
, O +
Sepw1 O +
MRE2 O -
: O +
5′-ATGGTTTTGGGGGTGCGCAGGGGGTCTG-3′ O -
; O +
5′-CGACAGACCCCCTGCGCACCCCCAAAAC-3′ O -
, O +
Slc39a10 O +
MRE1 O -
: O +
5′-GAATACACGACTGGGTGCAGCCGGGGTTTGG-3′ O -
; O +
5′-GGTACCAAACCCCGGCTGCACCCAGTCGTGTA-3′ O -
, O +
Slc39a10 O +
MRE2 O -
: O +
5′-GCGGAGAGGAGATGCACACGGCACTCG-3′ O -
; O +
5′-CACTCGAGTGCCGTGTGCATCTCCTCT-3′ O -
, O +
Specificity O +
protein O +
1 O +
( O -
Sp1 O -
) O +
binding O +
sequence O +
( O -
10 O -
) O -
: O +
5′-CGAGGCCCCGCCCAG-3′ O -
; O +
5′-TCGACTGGGCGGGGCCTCGAGct-3′. O +
Cell O +
culture O +
Primary O +
embryonic O +
fibroblasts O +
were O +
isolated O +
from O +
a O +
12.5 O +
day O +
old O +
Mtf1loxP O +
mouse O +
embryo O +
and O +
grown O +
in O +
DMEM O +
supplemented O +
with O +
10 O -
% O +
fetal O +
bovine O +
serum O +
( O -
ICN O -
) O -
, O +
100 O +
U O -
/ O -
ml O +
penicillin B-Chemical -
– O -
streptomycin B-Chemical +
( O -
Gibco O +
BRL O -
) O +
and O +
2 O +
mM O +
l O -
- O -
glutamine O +
( O -
Gibco O +
BRL O -
) O -
. O +

100 O +
mm O +
plates O +
with O +
primary O +
cells O +
were O +
transfected O +
with O +
10 O +
µg O +
of O +
an O +
expression O +
plasmid O +
coding O +
for O +
simian O +
virus O +
40 O +
( O -
SV40 O -
) O +
large O +
T O +
antigen B-Chemical +
driven O +
by O +
the O +
cytomegalovirus O +
( O -
CMV O -
) O +
promoter O -
, O +
using O +
lipofectamine O -
™ O +
reagent B-Chemical +
( O -
Invitrogen O -
) O +
according O +
to O +
the O +
manufacturer O -
's O +
instructions O -
. O +

Cell O +
foci O +
were O +
isolated O +
and O +
the O +
immortalized O +
mouse O +
embryonic O +
fibroblast O +
cell O +
line O +
ckoC O +
was O +
derived O +
from O +
one O +
of O +
them O -
. O +

The O +
Mtf1loxP O +
genotype O +
of O +
this O +
line O +
as O +
well O +
as O +
the O +
genomic O +
integration O +
of O +
the O +
T O +
antigen B-Chemical +
were O +
confirmed O +
by O +
PCR O -
. O +

100 O +
mm O +
plates O +
with O +
these O +
cells O +
were O +
further O +
transfected O +
by O +
the O +
calcium B-Chemical +
phosphate I-Chemical +
method O +
( O -
30 O -
) O +
with O +
19.6 O +
µg O +
of O +
an O +
expression O +
plasmid O +
for O +
Cre O +
recombinase O +
driven O +
by O +
the O +
CMV O +
promoter O +
and O +
0.4 O +
µg O +
of O +
an O +
expression O +
plasmid O +
for O +
the O +
neomycin B-Chemical +
resistance O +
gene O +
under O +
the O +
control O +
of O +
the O +
TK O +
promoter O -
. O +

Stably O +
transfected O +
cells O +
were O +
selected O +
in O +
the O +
presence O +
of O +
0.4 O +
µg O -
/ O -
µl O +
G418 B-Chemical +
( O -
Calbiochem O -
) O -
, O +
isolated O +
clones O +
of O +
resistant O +
cells O +
were O +
harvested O +
and O +
grown O +
independently O -
, O +
and O +
the O +
expression O +
of O +
Cre O +
recombinase O +
and O +
excision O +
of O +
exons O +
3 O +
and O +
4 O +
of O +
Mtf1 O +
were O +
analyzed O +
by O +
RT O -
– O -
PCR O -
. O +

The O +
cell O +
lines O +
delC19 O -
, O +
delC21 O +
and O +
delC23 O +
with O +
a O +
deletion O +
of O +
Mtf1 O +
were O +
chosen O +
for O +
further O +
experiments O -
. O +

Cytotoxicity O +
assay O +
Samples O +
of O +
1 O +
× O +
104 O +
cells O -
/ O -
well O +
were O +
plated O +
in O +
96-well O +
tissue O +
culture O +
plates O +
and O +
allowed O +
to O +
adhere O +
for O +
24 O +
h. O +
The O +
cells O +
were O +
then O +
pre O -
- O -
incubated O +
for O +
24 O +
h O +
in O +
medium O +
containing O +
0 O -
, O +
5 O -
, O +
10 O -
, O +
25 O +
or O +
50 O +
µM O +
l B-Chemical -
- I-Chemical -
buthionine- I-Chemical -
[ I-Chemical -
S I-Chemical -
, I-Chemical -
R I-Chemical -
] I-Chemical -
-sulfoximine I-Chemical +
( O -
BSO B-Chemical -
) O +
( O -
Sigma O -
) O -
, O +
a O +
drug B-Chemical +
that O +
inhibits O +
glutathione B-Chemical +
synthesis O +
( O -
31 O -
) O -
. O +

Later O -
, O +
cells O +
were O +
exposed O +
to O +
0 O -
, O +
5 O -
, O +
10 O +
or O +
20 O +
µM O +
CdCl2 B-Chemical +
in O +
the O +
specified O +
pre O -
- O -
incubation O +
medium O +
for O +
an O +
additional O +
24 O +
h. O +
Cytotoxicity O +
was O +
determined O +
by O +
the O +
MTT B-Chemical +
( O -
3- B-Chemical -
[ I-Chemical -
4,5-dimethylthiazol-2-yl I-Chemical -
] I-Chemical -
-2,5-diphenyl I-Chemical +
tetrazolium I-Chemical +
bromid I-Chemical -
) O -
-based O +
Cell O +
Proliferation O +
Kit O +
I O +
( O -
Roche O -
) O +
according O +
to O +
the O +
manufacturer O -
's O +
instructions O -
. O +

RESULTS O +
Generation O +
of O +
an O +
inducible O -
, O +
liver O -
- O -
specific O +
Mtf1 O +
knockout O +
mouse O +
line O +
Using O +
a O +
homologous O +
recombination O +
strategy O -
, O +
mice O +
were O +
obtained O +
with O +
a O +
modified O +
Mtf1 O +
allele O +
Mtf1loxP O +
where O +
exons O +
3 O +
and O +
4 O -
, O +
encoding O +
four O +
of O +
the O +
six O +
zinc O +
fingers O +
of O +
the O +
DNA O -
- O -
binding O +
domain O -
, O +
are O +
flanked O +
by O +
loxP O +
sites O +
( O -
Figure O +
1a O -
) O -
. O +

Mice O +
homozygous O +
for O +
the O +
Mtf1loxP O +
allele O +
were O +
further O +
crossed O +
with O +
animals O +
of O +
the O +
Cre O +
recombinase O +
transgenic O +
line O +
Mx O -
- O -
cre O -
. O +

Cre O +
recombinase O +
is O +
expressed O +
in O +
this O +
line O +
under O +
the O +
control O +
of O +
the O +
mouse O +
Mx1 O +
gene O +
promoter O -
, O +
which O +
is O +
inducible O +
by O +
administration O +
of O +
interferon O +
alpha O +
or O +
beta O -
, O +
or O +
synthetic O +
double O -
- O -
stranded O +
RNA O +
pI B-Chemical -
– O -
pC O +
( O -
32 O -
) O -
. O +

Cre O -
- O -
mediated O +
deletion O +
was O +
reported O +
to O +
be O +
complete O +
in O +
the O +
liver O -
, O +
while O +
varying O +
in O +
other O +
tissues O -
, O +
ranging O +
from O +
94 O -
% O +
in O +
spleen O +
to O +
8 O -
% O +
in O +
brain O +
( O -
32 O -
) O -
. O +

After O +
Cre O -
- O -
mediated O +
deletion O +
of O +
exons O +
3 O +
and O +
4 O -
, O +
which O +
results O +
in O +
a O +
frameshift O +
and O +
premature O +
translation O +
stop O -
, O +
no O +
functional O +
MTF-1 O +
protein O +
can O +
be O +
produced O -
. O +

For O +
induction O +
of O +
Cre O +
recombinase O -
, O +
Mtf1 O +
conditional O +
knockout O +
mice O +
harboring O +
the O +
Mx O -
- O -
cre O +
transgene O +
( O -
Mtf1Mx O -
- O -
cre O -
) O +
received O +
four O +
intraperitoneal O +
pI B-Chemical -
– O -
pC O +
injections O +
at O +
3 O +
day O +
intervals O +
( O -
pI B-Chemical -
– O -
pC O +
induction O -
) O -
; O +
control O +
littermates O +
without O +
transgene O +
( O -
Mtf1loxP O -
) O +
received O +
similar O +
injections O -
. O +

Using O +
RT O -
– O -
PCRs O +
( O -
Figure O +
1b O -
) O -
, O +
a O +
shortened O +
product O +
was O +
obtained O +
with O +
RNA O +
from O +
Mtf1Mx O -
- O -
cre O +
livers O -
, O +
indicating O +
a O +
successful O +
excision O +
of O +
exons O +
3 O +
and O +
4 O +
of O +
Mtf1 O +
in O +
these O +
animals O -
. O +

On O +
close O +
examination O -
, O +
a O +
very O +
faint O +
band O +
similar O +
in O +
size O +
to O +
full O -
- O -
length O +
signal O +
was O +
also O +
observed O +
in O +
those O +
mice O -
, O +
probably O +
due O +
to O +
a O +
low O +
amount O +
of O +
residual O +
full O -
- O -
length O +
Mtf1 O +
mRNA O -
. O +

The O +
level O +
of O +
functional O +
MTF-1 O +
protein O +
was O +
examined O +
by O +
EMSA O +
( O -
Figure O +
1c O -
) O -
: O +
MTF-1 O +
protein O -
– O -
DNA O +
complex O +
was O +
detectable O +
with O +
liver O +
protein O +
extract O +
from O +
an O +
Mtf1loxP O +
control O +
mouse O -
, O +
but O +
no O +
functional O +
MRE O -
- O -
binding O +
protein O +
was O +
observed O +
with O +
an O +
Mtf1Mx O -
- O -
cre O +
sample O -
. O +

Thus O -
, O +
deletion O +
of O +
exons O +
3 O +
and O +
4 O +
of O +
Mtf1 O +
in O +
the O +
liver O +
of O +
Mtf1Mx O -
- O -
cre O +
mice O +
was O +
virtually O +
complete O -
. O +

All O +
examined O +
liver O -
- O -
specific O +
knockout O +
mice O +
were O +
viable O +
under O +
laboratory O +
conditions O +
and O +
appeared O +
normal O -
. O +

MTF-1 O +
target O +
gene O +
search O +
For O +
the O +
identification O +
of O +
MTF-1 O +
target O +
genes O -
, O +
we O +
compared O +
the O +
liver O +
transcript O +
profiles O +
of O +
mice O +
with O +
and O +
without O +
functional O +
Mtf1 O +
gene O +
that O +
had O +
been O +
mock O -
- O -
treated O +
or O +
exposed O +
to O +
cadmium O +
( O -
n O +
= O +
3 O +
per O +
genotype O +
and O +
respective O +
treatment O -
) O -
. O +

In O +
a O +
first O +
screen O -
, O +
the O +
transcripts O +
were O +
analyzed O +
with O +
a O +
differential O +
display O -
- O -
based O +
method O -
, O +
called O +
amplification O +
of O +
double O -
- O -
stranded O +
cDNA O +
end O +
restriction O +
fragments O +
( O -
ADDER O -
) O +
( O -
33 O -
) O -
. O +

Thereby O +
an O +
overwhelming O +
number O +
of O +
signals O +
was O +
obtained O +
for O +
the O +
two O +
stress O -
- O -
inducible O +
metallothioneins O +
( O -
Mt1 O +
and O +
Mt2 O -
) O -
, O +
due O +
to O +
the O +
abundance O +
of O +
their O +
transcripts O +
both O +
in O +
mock O -
- O -
treated O +
and O +
especially O +
in O +
cadmium O -
- O -
treated O +
livers O +
that O +
harbored O +
a O +
functional O +
MTF-1 O +
gene O +
( O -
data O +
not O +
shown O -
) O -
. O +

This O +
result O +
confirmed O +
the O +
importance O +
of O +
MTF-1 O +
for O +
both O +
basal O +
and O +
metal O -
- O -
induced O +
expression O +
of O +
metallothionein O +
genes O -
. O +

In O +
a O +
second O +
approach O -
, O +
the O +
gene O +
expression O +
profile O +
in O +
livers O +
of O +
the O +
above O +
mentioned O +
mice O +
was O +
compared O +
by O +
Affymetrix O +
GeneChip O -
® O +
Mouse O +
Genome O +
430 O +
2.0 O +
Arrays O +
( O -
Table O +
1 O -
) O -
. O +

When O +
analyzing O +
the O +
probe O +
array O +
data O +
of O +
livers O +
from O +
mock O -
- O -
treated O +
Mtf1Mx O -
- O -
cre O +
and O +
Mtf1loxP O +
mice O -
, O +
an O +
at O +
least O +
2-fold O -
, O +
reliable O +
downregulation O +
of O +
expression O +
was O +
detected O +
in O +
Mtf1Mx O -
- O -
cre O +
livers O +
for O +
13 O +
Affymetrix O +
GeneChip O -
® O +
probe O +
sets O +
corresponding O +
to O +
11 O +
characterized O +
genes O +
( O -
Table O +
1 O -
, O +
a O -
) O -
. O +

Seven O +
of O +
these O +
genes O +
contain O +
one O +
or O +
more O +
MRE O +
core O +
consensus O +
sequence O +
TGCRCNC O +
within O +
a O +
segment O +
of O +
1000 O +
bp O +
upstream O +
of O +
the O +
transcription O +
start O -
. O +

For O +
26 O +
probe O +
sets O +
corresponding O +
to O +
24 O +
different O +
characterized O +
genes O -
, O +
a O +
2-fold O +
or O +
higher O -
, O +
reliable O +
upregulation O +
was O +
detected O +
in O +
Mtf1Mx O -
- O -
cre O +
livers O +
( O -
Table O +
1 O -
, O +
b O -
) O -
; O +
17 O +
of O +
these O +
24 O +
genes O +
contain O +
MRE O +
core O +
consensus O +
sequences O +
in O +
the O +
upstream O +
region O -
. O +

The O +
data O +
set O +
for O +
livers O +
of O +
cadmium O -
- O -
treated O +
Mtf1Mx O -
- O -
cre O +
and O +
Mtf1loxP O +
mice O +
revealed O +
an O +
at O +
least O +
2-fold O -
, O +
reliable O +
downregulation O +
in O +
Mtf1Mx O -
- O -
cre O +
livers O +
for O +
21 O +
probe O +
sets O +
corresponding O +
to O +
16 O +
different O +
characterized O +
genes O +
( O -
Table O +
1 O -
, O +
c O -
) O -
; O +
10 O +
of O +
these O +
contain O +
MRE O +
core O +
consensus O +
sequences O +
in O +
their O +
upstream O +
region O -
. O +

For O +
9 O +
probe O +
sets O +
corresponding O +
to O +
9 O +
different O +
characterized O +
genes O -
, O +
an O +
at O +
least O +
2-fold O -
, O +
reliable O +
upregulation O +
was O +
detected O +
( O -
Table O +
1 O -
, O +
d O -
) O -
; O +
five O +
of O +
them O +
contain O +
MRE O +
motifs O -
. O +

In O +
addition O +
to O +
characterized O +
genes O -
, O +
ESTs O +
and O +
RIKEN O +
cDNA O +
sequences O +
were O +
also O +
found O +
in O +
the O +
comparison O +
of O +
Mtf1Mx O -
- O -
cre O +
and O +
Mtf1loxP O +
livers O +
to O +
be O +
differentially O +
expressed O +
( O -
Supplementary O +
Table O +
1 O -
) O -
. O +

Downregulation O +
of O +
Mt1 O +
and O +
Mt2 O +
was O +
detected O +
in O +
Mtf1Mx O -
- O -
cre O +
livers O +
for O +
both O +
conditions O +
( O -
though O +
the O +
level O +
of O +
significance O +
for O +
the O +
downregulation O +
of O +
Mt1 O +
in O +
mock O -
- O -
treated O +
animals O +
was O +
above O +
0.05 O -
; O +
data O +
not O +
shown O -
) O -
. O +

For O +
all O +
MTF-1 O +
target O +
genes O +
characterized O +
so O +
far O -
, O +
such O +
as O +
Mt1 O -
, O +
Mt2 O +
and O +
Znt1 O -
, O +
MTF-1 O +
exerts O +
its O +
transcriptional O +
activation O +
activity O +
via O +
standard O +
MRE O +
sequences O +
located O +
proximal O +
to O +
the O +
transcription O +
start O +
( O -
4,5,8,18,19 O -
) O -
. O +

Even O +
a O +
specific O +
search O +
for O +
MTF-1 O +
binding O +
sites O +
by O +
selection O +
from O +
a O +
pool O +
of O +
double O -
- O -
stranded O +
oligonucleotides O +
with O +
random O +
sequences O +
yielded O +
no O +
new O +
binding O +
motif O +
for O +
MTF-1 O +
in O +
addition O +
to O +
the O +
known O +
MREs O +
( O -
34 O -
) O -
. O +

Thus O -
, O +
an O +
MRE O +
sequence O +
is O +
to O +
date O +
the O +
only O +
indication O +
for O +
a O +
direct O +
MTF-1 O +
target O +
gene O -
, O +
and O +
four O +
MRE O -
- O -
containing O +
target O +
gene O +
candidates O +
were O +
further O +
analyzed O -
. O +

Basal O +
expression O +
of O +
Sepw1 O +
depends O +
on O +
MTF-1 O +
Sepw1 O +
was O +
found O +
in O +
microarray O +
analysis O +
to O +
be O +
significantly O +
downregulated O +
in O +
livers O +
from O +
cadmium- O +
and O +
mock O -
- O -
treated O +
Mtf1Mx O -
- O -
cre O +
mice O +
( O -
Table O +
1 O -
, O +
a O +
and O +
c O -
) O -
. O +

SEPW1 O +
is O +
a O +
selenocysteine O -
- O -
containing O +
protein O +
that O +
binds O +
glutathione B-Chemical +
( O -
35 O -
) O +
and O +
is O +
thought O +
to O +
act O +
as O +
an O +
antioxidant O +
in O +
vivo O +
( O -
36 O -
) O -
. O +

Sepw1 O +
expression O +
in O +
livers O +
of O +
pI B-Chemical -
– O -
pC O -
- O -
induced O -
, O +
mock- O +
or O +
cadmium O -
- O -
treated O +
Mtf1Mx O -
- O -
cre O +
and O +
Mtf1loxP O +
mice O +
was O +
further O +
analyzed O +
by O +
semiquantitative O +
RT O -
– O -
PCRs O +
and O +
S1 O +
analysis O +
( O -
Figure O +
2a O +
and O +
b O -
) O -
. O +

In O +
accordance O +
with O +
microarray O +
data O +
a O +
slight O -
, O +
if O +
any O -
, O +
upregulation O +
of O +
Sepw1 O +
transcription O +
was O +
observed O +
in O +
livers O +
from O +
Mtf1loxP O +
mice O +
upon O +
cadmium O +
treatment O -
. O +

The O +
basal O +
level O +
was O +
reduced O +
in O +
livers O +
from O +
mock- O +
and O +
cadmium O -
- O -
treated O +
Mtf1Mx O -
- O -
cre O +
mice O -
, O +
indicating O +
that O +
MTF-1 O +
is O +
important O +
for O +
the O +
basal O +
expression O +
of O +
Sepw1 O -
. O +

Three O +
MRE O +
core O +
consensus O +
sequences O +
were O +
found O +
in O +
the O +
region O +
upstream O +
of O +
the O +
mouse O +
Sepw1 O +
transcription O +
start O +
( O -
Figure O +
2c O -
) O -
. O +

Two O +
of O +
them O +
in O +
opposite O +
orientation O +
overlap O +
almost O +
completely O +
proximal O +
to O +
the O +
transcription O +
start O +
( O -
MRE1 O -
, O +
−40 O +
bp O -
) O -
, O +
the O +
third O +
one O +
is O +
located O +
further O +
upstream O +
( O -
MRE2 O -
, O +
−527 O +
bp O -
) O -
. O +

Specific O +
binding O +
of O +
MTF-1 O +
to O +
Sepw1 O +
MRE1 O +
but O +
not O +
MRE2 O +
oligonucleotide O +
was O +
observed O +
in O +
EMSA O +
with O +
liver O +
protein O +
extract O +
from O +
an O +
Mtf1loxP O +
control O +
mouse O +
( O -
Figure O +
2d O -
) O -
. O +

As O +
a O +
control O -
, O +
no O +
binding O +
to O +
MRE1 O +
was O +
detected O +
with O +
extract O +
from O +
a O +
pI B-Chemical -
– O -
pC O -
- O -
induced O +
Mtf1Mx O -
- O -
cre O +
mouse O -
, O +
confirming O +
that O +
the O +
bandshift O +
was O +
indeed O +
dependent O +
on O +
the O +
presence O +
of O +
MTF-1 O -
. O +

Cadmium O +
response O +
of O +
Ndrg1 O +
depends O +
on O +
MTF-1 O +
Ndrg1 O +
was O +
significantly O +
downregulated O +
in O +
microarrays O +
of O +
liver O +
transcripts O +
from O +
cadmium O -
- O -
treated O +
Mtf1Mx O -
- O -
cre O +
mice O +
compared O +
to O +
similarly O +
treated O +
Mtf1loxP O +
control O +
mice O +
( O -
Table O +
1 O -
, O +
c O -
) O -
. O +

Ndrg1 O +
probably O +
has O +
some O +
role O +
in O +
stress O +
response O +
since O +
various O +
stimuli O -
, O +
including O +
hypoxia O +
and O +
nickel O +
compounds B-Chemical -
, O +
activate O +
expression O +
of O +
rodent O +
Ndrg1 O +
and/or O +
its O +
human O +
ortholog O +
( O -
37–40 O -
) O -
. O +

The O +
Ndrg1 O +
microarray O +
results O +
were O +
confirmed O +
with O +
semiquantitative O +
RT O -
– O -
PCRs O +
( O -
Figure O +
3a O -
) O -
: O +
for O +
Mtf1loxP O +
control O +
livers O -
, O +
a O +
clear O +
increase O +
of O +
Ndrg1 O +
expression O +
was O +
observed O +
after O +
cadmium O +
exposure O -
; O +
in O +
livers O +
from O +
Mtf1Mx O -
- O -
cre O +
mice O -
, O +
this O +
cadmium O +
response O +
was O +
not O +
detectable O -
, O +
while O +
basal O +
expression O +
was O +
similar O +
to O +
controls O -
. O +

This O +
indicates O +
that O +
cadmium O -
- O -
induced O +
expression O +
of O +
Ndrg1 O +
depends O +
on O +
MTF-1 O -
. O +

Five O +
MRE O +
core O +
consensus O +
sequences O +
are O +
located O +
upstream O +
of O +
the O +
mouse O +
Ndrg1 O +
transcription O +
start O +
( O -
Figure O +
3b O -
) O -
. O +

Four O +
of O +
them O +
are O +
clustered O +
( O -
MRE1 O +
to O +
MRE4 O -
, O +
−138 O +
to O +
−332 O +
bp O -
) O -
, O +
the O +
fifth O +
one O +
is O +
located O +
farther O +
upstream O +
( O -
MRE5 O -
, O +
−883 O +
bp O -
) O -
. O +

EMSA O +
was O +
performed O +
to O +
test O +
whether O +
MTF-1 O +
is O +
interacting O +
with O +
some O +
or O +
all O +
of O +
the O +
four O +
proximal O +
MRE O +
sequences O +
( O -
Figure O +
3c O -
) O -
. O +

Separate O +
oligonucleotides O +
were O +
tested O +
for O +
MRE1 O +
and O +
MRE2 O -
, O +
whereas O +
one O +
oligonucleotide O +
spanning O +
both O +
sequences O +
was O +
used O +
for O +
MRE3 O +
and O +
MRE4 O +
( O -
MRE3,4 O -
) O -
. O +

No O +
complex O +
was O +
seen O +
with O +
MRE1 O -
, O +
but O +
specific O +
MTF-1 O +
complexes O +
were O +
observed O +
for O +
both O +
the O +
MRE2 O +
and O +
MRE3,4 O +
oligonucleotides O +
with O +
liver O +
protein O +
extract O +
from O +
an O +
Mtf1loxP O +
mouse O -
. O +

As O +
expected O -
, O +
no O +
bandshift O +
was O +
observed O +
with O +
protein O +
extract O +
from O +
a O +
mouse O +
lacking O +
MTF-1 O +
( O -
Mtf1Mx O -
- O -
cre O -
) O -
. O +

Cadmium O +
response O +
of O +
Csrp1 O +
depends O +
on O +
MTF-1 O +
Csrp1 O +
was O +
found O +
in O +
microarray O +
analyses O +
to O +
be O +
significantly O +
downregulated O +
in O +
cadmium O -
- O -
treated O +
Mtf1Mx O -
- O -
cre O +
mice O +
compared O +
to O +
Mtf1loxP O +
mice O +
( O -
Table O +
1 O -
, O +
c O -
) O -
. O +

CSRP1 O +
is O +
a O +
member O +
of O +
the O +
evolutionary O +
conserved O +
CRP O +
family O +
of O +
proteins O +
that O +
have O +
been O +
implicated O +
in O +
myogenesis O +
and O +
cytoskeletal O +
remodeling O +
( O -
41,42 O -
) O -
. O +

Semiquantitative O +
RT O -
– O -
PCRs O +
confirmed O +
the O +
microarray O +
results O -
, O +
namely O -
, O +
that O +
Csrp1 O +
expression O +
is O +
elevated O +
in O +
Mtf1loxP O +
livers O +
upon O +
cadmium O +
exposure O +
( O -
Figure O +
4a O -
) O -
. O +

In O +
contrast O -
, O +
no O +
cadmium O +
response O +
was O +
detectable O +
in O +
livers O +
from O +
Mtf1Mx O -
- O -
cre O +
mice O -
, O +
suggesting O +
that O +
MTF-1 O +
is O +
required O +
for O +
cadmium O +
induction O +
of O +
Csrp1 O -
. O +

Three O +
MRE O +
core O +
consensus O +
sequences O +
were O +
found O +
upstream O +
of O +
the O +
Csrp1 O +
transcription O +
start O +
( O -
MRE2 O +
to O +
MRE4 O -
, O +
−56 O +
to O +
−366 O +
bp O -
) O -
, O +
one O +
was O +
found O +
immediately O +
downstream O +
( O -
MRE1 O -
, O +
+ O -
7 O +
bp O -
; O +
Figure O +
4b O -
) O -
. O +

Specific O +
binding O +
of O +
MTF-1 O +
was O +
observed O +
with O +
EMSA O +
for O +
MRE2 O +
oligonucleotide O +
and O +
protein O +
extract O +
from O +
an O +
Mtf1loxP O +
liver O -
, O +
but O +
not O +
an O +
Mtf1Mx O -
- O -
cre O +
liver O +
extract O +
lacking O +
MTF-1 O -
, O +
confirming O +
the O +
participation O +
of O +
MTF-1 O +
in O +
the O +
complex O +
( O -
Figure O +
4c O -
) O -
. O +

MTF-1 O +
inhibits O +
expression O +
of O +
Slc39a10 O +
Slc39a10 O +
was O +
detected O +
in O +
microarray O +
analysis O +
to O +
be O +
significantly O +
upregulated O +
in O +
livers O +
from O +
both O +
mock- O +
and O +
cadmium O -
- O -
treated O +
Mtf1Mx O -
- O -
cre O +
mice O +
compared O +
to O +
control O +
animals O +
( O -
Table O +
1 O -
, O +
b O +
and O +
d O -
) O -
. O +

SLC39 O +
proteins O +
are O +
members O +
of O +
the O +
Zrt- O +
and O +
Irt O -
- O -
like O +
protein O +
( O -
ZIP O -
) O +
family O +
of O +
metal O +
ion B-Chemical +
transporters O +
that O +
transport O -
, O +
with O +
no O +
known O +
exception O -
, O +
metal O +
ion B-Chemical +
substrates O +
across O +
cellular O +
membranes O +
into O +
the O +
cytoplasm O +
( O -
43,44 O -
) O -
. O +

In O +
accordance O +
with O +
microarray O +
data O -
, O +
semiquantitative O +
RT O -
– O -
PCRs O +
showed O +
a O +
downregulation O +
of O +
Slc39a10 O +
expression O +
in O +
livers O +
of O +
Mtf1loxP O +
mice O +
upon O +
cadmium O +
exposure O -
. O +

In O +
samples O +
from O +
Mtf1Mx O -
- O -
cre O +
mice O -
, O +
the O +
basal O +
expression O +
was O +
significantly O +
increased O -
; O +
cadmium O +
treatment O +
still O +
resulted O +
in O +
a O +
decrease O +
of O +
Slc39a10 O +
expression O +
( O -
Figure O +
5a O -
) O -
. O +

It O +
can O -
not O +
be O +
judged O +
by O +
this O +
experiment O +
whether O +
the O +
degree O +
of O +
cadmium O -
- O -
induced O +
reduction O +
of O +
Slc39a10 O +
transcription O +
was O +
identical O +
for O +
Mtf1Mx O -
- O -
cre O +
and O +
Mtf1loxP O +
mice O +
or O +
lower O +
in O +
the O +
absence O +
of O +
MTF-1 O -
. O +

In O +
microarray O +
analysis O -
, O +
the O +
degree O +
of O +
the O +
downregulation O +
was O +
either O +
comparable O +
to O +
the O +
one O +
in O +
control O +
livers O +
or O +
lower O -
, O +
depending O +
on O +
the O +
considered O +
Affymetrix O +
GeneChip O -
® O +
probe O +
set O +
( O -
data O +
not O +
shown O -
) O -
. O +

The O +
results O +
indicate O +
that O +
MTF-1 O +
is O +
involved O +
in O +
repression O +
of O +
the O +
basal O +
expression O +
of O +
Slc39a10 O -
. O +

It O +
might O +
also O +
participate O +
in O +
the O +
cadmium O +
response O +
of O +
this O +
gene O -
, O +
but O +
it O +
is O +
apparently O +
not O +
exclusively O +
responsible O -
. O +

One O +
MRE O +
core O +
consensus O +
sequence O +
was O +
found O +
just O +
upstream O +
of O +
the O +
mouse O +
Slc39a10 O +
transcription O +
start O +
( O -
MRE1 O -
, O +
−21 O +
bp O -
) O -
, O +
another O +
one O +
directly O +
downstream O +
( O -
MRE2 O -
, O +
+ O -
17 O +
bp O -
; O +
Figure O +
5b O -
) O -
. O +

Specific O +
binding O +
of O +
MTF-1 O +
was O +
observed O +
in O +
EMSA O +
analysis O +
for O +
MRE2 O +
with O +
liver O +
protein O +
extract O +
from O +
an O +
Mtf1loxP O +
but O +
not O +
from O +
an O +
Mtf1Mx O -
- O -
cre O +
mouse O -
, O +
while O +
no O +
binding O +
was O +
detected O +
with O +
MRE1 O +
( O -
Figure O +
5c O -
) O -
. O +

Cadmium O -
- O -
responsive O -
, O +
MTF-1-independent O +
genes O +
Finally O -
, O +
we O +
also O +
identified O +
a O +
number O +
of O +
cadmium O -
- O -
responsive O +
genes O +
that O +
were O +
independent O +
of O +
MTF-1 O +
presence O -
, O +
by O +
comparing O +
the O +
probe O +
array O +
data O +
of O +
all O +
cadmium O -
- O -
treated O +
mice O +
with O +
the O +
data O +
of O +
all O +
mock O -
- O -
treated O +
mice O -
, O +
irrespective O +
of O +
the O +
genotype O +
( O -
Table O +
2 O -
) O -
. O +

An O +
at O +
least O +
2-fold O -
, O +
reliable O +
upregulation O +
was O +
observed O +
after O +
cadmium O +
exposure O +
for O +
31 O +
probe O +
sets O +
corresponding O +
to O +
21 O +
different O +
characterized O +
genes O +
( O -
Table O +
2 O -
, O +
a O -
) O -
. O +

For O +
2 O +
probe O +
sets O +
corresponding O +
to O +
2 O +
characterized O +
genes O -
, O +
an O +
at O +
least O +
2-fold O +
downregulation O +
was O +
detected O +
( O -
Table O +
2 O -
, O +
b O -
) O -
. O +

Several O +
genes O +
involved O +
in O +
the O +
metabolism O +
of O +
the O +
antioxidant O +
glutathione B-Chemical +
were O +
found O +
to O +
be O +
upregulated O +
by O +
cadmium O +
exposure O -
, O +
namely O +
the O +
genes O +
encoding O +
the O +
catalytic O +
subunit O +
of O +
glutamate O -
- O -
cysteine O +
ligase O +
( O -
Gclc O -
) O +
that O +
is O +
the O +
rate O +
limiting O +
enzyme O +
in O +
de O +
novo O +
synthesis O +
of O +
glutathione B-Chemical +
( O -
45 O -
) O -
; O +
glutathione B-Chemical +
reductase O +
1 O +
( O -
Gsr O -
) O -
, O +
the O +
reducing O +
enzyme O +
for O +
oxidized B-Chemical +
glutathione I-Chemical +
( O -
45 O -
) O -
; O +
and O +
glutathione B-Chemical -
- O -
S O -
- O -
transferase O -
, O +
mu O +
4 O +
( O -
Gstm4 O -
) O -
, O +
which O +
is O +
a O +
member O +
of O +
the O +
glutathione B-Chemical -
- O -
S O -
- O -
transferase O +
supergene O +
family O +
of O +
detoxification O +
enzymes O +
( O -
45 O -
) O -
. O +

In O +
all O +
of O +
these O +
cases O -
, O +
induction O +
was O +
confirmed O +
by O +
semiquantitative O +
RT O -
– O -
PCRs O +
( O -
data O +
not O +
shown O -
) O -
. O +

Gclc O -
, O +
also O +
referred O +
to O +
as O +
heavy O +
chain O +
subunit O +
of O +
gamma B-Chemical -
- I-Chemical -
glutamylcysteine I-Chemical +
synthetase O +
( O -
Ggcs O -
- O -
hc O -
) O -
, O +
had O +
been O +
discussed O +
previously O +
as O +
a O +
target O +
gene O +
of O +
MTF-1 O +
( O -
6 O -
) O -
. O +

Our O +
expression O +
data O +
indicate O +
that O +
Gclc O +
is O +
induced O +
by O +
cadmium O +
but O -
, O +
at O +
least O +
in O +
the O +
adult O +
mouse O +
liver O -
, O +
not O +
dependent O +
on O +
MTF-1 O -
. O +

To O +
analyze O +
the O +
role O +
of O +
the O +
glutathione B-Chemical +
system O +
in O +
the O +
cellular O +
cadmium O +
response O -
, O +
mouse O +
embryonic O +
fibroblasts O +
with O +
and O +
without O +
functional O +
Mtf1 O +
were O +
treated O +
with O +
cadmium O +
in O +
combination O +
with O +
BSO B-Chemical -
, O +
a O +
specific O +
inhibitor B-Chemical +
of I-Chemical +
glutamate I-Chemical -
- I-Chemical -
cysteine I-Chemical +
ligase I-Chemical +
( O -
31 O -
) O -
, O +
and O +
cell O +
viability O +
was O +
assessed O +
by O +
a O +
colorimetric O +
assay O +
based O +
on O +
the O +
tetrazolium B-Chemical +
salt B-Chemical +
MTT B-Chemical +
( O -
Figure O +
6 O -
) O -
. O +

Increasing O +
concentrations O +
of O +
BSO B-Chemical +
or O +
cadmium O +
alone O +
were O +
to O +
some O +
extent O +
cytotoxic O +
for O +
the O +
examined O +
cell O +
lines O -
. O +

Treatment O +
with O +
both O +
BSO B-Chemical +
and O +
cadmium O +
resulted O +
in O +
an O +
enhanced O +
lethality O +
particularly O +
for O +
the O +
cells O +
without O +
functional O +
Mtf1 O -
, O +
indicating O +
that O +
a O +
depletion O +
of O +
glutathione B-Chemical +
together O +
with O +
a O +
lack O +
of O +
Mtf1 O +
impair O +
an O +
efficient O +
anti O -
- O -
cadmium O +
defense O -
. O +

Thus O -
, O +
adequate O +
glutathione B-Chemical +
supply O +
as O +
well O +
as O +
MTF-1 O +
and O +
its O +
target O +
genes O +
are O +
essential O +
for O +
the O +
survival O +
of O +
the O +
cell O +
under O +
cadmium O +
stress O -
. O +

Besides O +
genes O +
related O +
to O +
the O +
glutathione B-Chemical +
pathway O -
, O +
several O +
other O +
stress O -
- O -
related O +
genes O +
were O +
upregulated O +
upon O +
cadmium O +
exposure O -
, O +
including O +
genes O +
for O +
thioredoxin O +
reductase O +
1 O +
( O -
Txnrd1 O -
) O -
, O +
one O +
of O +
the O +
reducing O +
enzymes O +
of O +
the O +
antioxidant O +
thioredoxin O +
( O -
46 O -
) O -
; O +
KDEL O +
endoplasmic O +
reticulum O +
protein O +
retention O +
receptor O +
2 O +
( O -
Kdelr2 O -
) O +
participating O +
in O +
ER O +
stress O +
response O +
( O -
47 O -
) O -
; O +
and O +
the O +
anti O -
- O -
apoptotic O +
Bcl2-associated O +
athanogene O +
3 O +
( O -
Bag3 O -
) O +
involved O +
in O +
stress O -
- O -
induced O +
apoptosis O +
( O -
48 O -
) O -
. O +

DISCUSSION O +
In O +
this O +
study O -
, O +
a O +
virtually O +
complete O +
deletion O +
of O +
Mtf1 O +
in O +
the O +
liver O +
of O +
adult O -
, O +
pI B-Chemical -
– O -
pC O -
- O -
induced O +
Mtf1Mx O -
- O -
cre O +
mice O +
did O +
not O +
detectably O +
affect O +
the O +
phenotype O +
of O +
the O +
respective O +
mice O +
under O +
non O -
- O -
stress O +
conditions O -
, O +
confirming O +
that O +
MTF-1 O +
is O +
dispensable O +
in O +
the O +
adult O +
liver O +
( O -
26 O -
) O -
, O +
in O +
contrast O +
to O +
its O +
essential O +
role O +
in O +
embryonic O +
liver O +
development O +
( O -
23 O -
) O -
. O +

The O +
comparison O +
of O +
gene O +
expression O +
in O +
livers O +
of O +
mock- O +
or O +
cadmium O -
- O -
treated O +
Mtf1Mx O -
- O -
cre O +
and O +
Mtf1loxP O +
mice O +
revealed O +
several O +
MTF-1 O +
target O +
gene O +
candidates O -
. O +

Transcripts O +
of O +
the O +
two O +
stress O -
- O -
responsive O +
metallothionein O +
genes O +
Mt1 O +
and O +
Mt2 O +
were O +
severely O +
reduced O -
, O +
in O +
support O +
of O +
a O +
crucial O +
role O +
of O +
MTF-1 O +
for O +
both O +
basal O +
and O +
metal O -
- O -
induced O +
expression O +
of O +
metallothioneins O +
( O -
4,6 O -
) O -
. O +

One O +
of O +
the O +
newly O +
found O +
target O +
genes O +
is O +
Sepw1 O -
. O +

The O +
exact O +
molecular O +
function O +
of O +
SEPW1 O +
protein O +
is O +
unknown O +
to O +
date O -
, O +
but O +
a O +
role O +
as O +
antioxidant O +
has O +
been O +
proposed O +
due O +
to O +
its O +
ability O +
to O +
bind O +
glutathione B-Chemical +
( O -
35 O -
) O -
. O +

In O +
accordance O +
with O +
this O -
, O +
ectopic O +
expression O +
of O +
mouse O +
Sepw1 O +
renders O +
cells O +
resistant O +
to O +
hydrogen B-Chemical +
peroxide I-Chemical -
, O +
and O +
this O +
resistance O +
is O +
dependent O +
on O +
it O +
binding O +
glutathione B-Chemical +
( O -
36 O -
) O -
. O +

Furthermore O -
, O +
Amantana O +
et O +
al. O +
( O -
49 O -
) O +
showed O +
that O +
expression O +
of O +
a O +
reporter O +
gene O +
fused O +
to O +
a O +
rat O +
Sepw1 O +
promoter O +
fragment O +
can O +
be O +
induced O +
in O +
rat O +
glial O +
cells O +
by O +
copper O +
and O +
zinc O -
, O +
but O +
not O +
cadmium O -
. O +

This O +
response O +
was O +
dependent O +
on O +
an O +
overlapping O -
- O -
inverted O +
MRE O +
sequence O +
located O +
proximal O +
to O +
the O +
rat O +
Sepw1 O +
transcription O +
start O +
( O -
49 O -
) O -
, O +
even O +
though O +
initial O +
studies O +
failed O +
to O +
demonstrate O +
MTF-1 O +
binding O +
to O +
that O +
sequence O +
( O -
50 O -
) O -
. O +

Our O +
expression O +
and O +
DNA O -
- O -
binding O +
studies O +
strongly O +
suggest O +
that O +
MTF-1 O +
is O +
important O +
for O +
the O +
basal O +
expression O +
of O +
mouse O +
Sepw1 O +
by O +
binding O +
to O +
the O +
corresponding O +
overlapping O -
- O -
inverted O +
MRE O +
sequence O -
. O +

Ndrg1 O -
, O +
another O +
interesting O +
MTF-1 O +
target O +
gene O +
was O +
named O +
N O -
- O -
myc O +
downstream O +
regulated O +
gene O +
1 O +
following O +
the O +
discovery O +
that O +
the O +
transcription O +
factor O +
N O -
- O -
myc O +
represses O +
the O +
expression O +
of O +
mouse O +
Ndrg1 O +
( O -
51 O -
) O -
. O +

Transcription O +
of O +
Ndrg1 O +
and/or O +
its O +
human O +
ortholog O +
is O +
induced O +
by O +
different O +
physiological O +
and O +
cell O +
stress O +
conditions O -
, O +
such O +
as O +
androgens B-Chemical -
, O +
nickel O +
compounds B-Chemical -
, O +
DNA O +
damage O +
and O +
hypoxia O +
( O -
37–40,52,53 O -
) O -
. O +

In O +
addition O -
, O +
the O +
protein O +
is O +
overexpressed O +
in O +
human O +
cancers O +
of O +
many O +
tissues O -
, O +
such O +
as O +
lung O -
, O +
liver O -
, O +
brain O -
, O +
breast O -
, O +
kidney O +
and O +
skin O +
( O -
40 O -
) O -
. O +

Although O +
Ndrg1 O +
and O +
especially O +
its O +
human O +
ortholog O +
have O +
been O +
quite O +
intensely O +
studied O -
, O +
its O +
function O +
remains O +
unclear O -
; O +
however O -
, O +
the O +
induction O +
by O +
stimuli O +
like O +
nickel O +
and O +
hypoxia O +
suggests O +
an O +
involvement O +
in O +
the O +
cell O +
stress O +
response O -
. O +

Such O +
a O +
role O +
is O +
strongly O +
endorsed O +
by O +
our O +
finding O +
that O +
Ndrg1 O +
gene O +
expression O +
is O +
also O +
induced O +
by O +
cadmium O -
, O +
and O +
that O +
MTF-1 O +
plays O +
a O +
crucial O +
role O +
in O +
this O +
induction O -
. O +

In O +
the O +
case O +
of O +
Csrp1 O -
, O +
expression O +
analyses O +
and O +
DNA O -
- O -
binding O +
studies O +
indicate O +
that O +
MTF-1 O +
is O +
required O +
for O +
cadmium O +
induction O +
by O +
binding O +
to O +
an O +
MRE O +
upstream O +
of O +
the O +
transcription O +
start O -
. O +

Studies O +
with O +
human O -
, O +
avian O +
and O +
chicken O +
CSRP1 O +
have O +
shown O +
that O +
this O +
protein O +
is O +
localized O +
at O +
adhesion O +
plaques O +
and O +
in O +
association O +
with O +
filamentous O +
actin O -
, O +
and O +
interacts O +
with O +
the O +
adhesion O +
plaque O +
protein O +
zyxin O -
, O +
as O +
well O +
as O +
the O +
actin O -
- O -
cross O -
- O -
linking O +
protein O +
alpha O -
- O -
actinin O +
( O -
54–57 O -
) O -
. O +

The O +
ability O +
to O +
bind O +
these O +
partners O +
suggests O +
a O +
role O +
in O +
cytoskeletal O +
organization O +
( O -
58 O -
) O -
. O +

Exposure O +
of O +
cultured O +
cells O +
to O +
cadmium O +
causes O +
a O +
decrease O +
in O -
, O +
and O +
destruction O +
of O -
, O +
cellular O +
contact O +
proteins O +
and O +
the O +
actin O +
cytoskeleton O +
( O -
59 O -
) O -
. O +

In O +
the O +
proximal O +
tubule O +
cells O +
of O +
the O +
rat O +
kidney O -
, O +
a O +
partial O +
loss O +
of O +
actin O +
and O +
the O +
actin O -
- O -
bundling O +
protein O +
villin O +
is O +
observed O +
upon O +
cadmium O +
treatment O -
, O +
as O +
well O +
as O +
the O +
derangement O +
and O +
depolymerization O +
of O +
microtubules O +
( O -
60 O -
) O -
. O +

Assuming O +
that O +
CSRP1 O +
is O +
important O +
for O +
the O +
organization O +
of O +
cytoskeletal O +
elements O +
in O +
the O +
mouse O -
, O +
its O +
upregulation O +
by O +
cadmium O +
might O +
protect O +
the O +
organism O +
from O +
damage O +
of O +
the O +
cytoskeleton O -
. O +

Such O +
a O +
mechanism O +
would O +
expand O +
the O +
role O +
of O +
MTF-1 O +
in O +
stress O +
response O -
. O +

Our O +
expression O +
studies O +
also O +
suggest O +
that O +
MTF-1 O +
represses O +
basal O +
transcription O +
of O +
Slc39a10 O -
, O +
in O +
contrast O +
to O +
its O +
role O +
as O +
activator O +
for O +
the O +
expression O +
of O +
other O +
target O +
genes O +
like O +
Mt1 O -
, O +
Mt2 O -
, O +
and O +
Znt1 O +
( O -
4,19 O -
) O -
. O +

SLC39A10 O +
is O +
one O +
of O +
14 O +
mouse O +
SLC39 O +
members O -
, O +
which O +
belong O +
to O +
the O +
ZIP O +
family O +
of O +
metal O +
ion B-Chemical +
transporters O +
( O -
43,44 O -
) O -
. O +

All O +
members O +
of O +
the O +
ZIP O +
family O +
characterized O +
so O +
far O +
increase O +
intracellular O +
cytoplasmic O +
metal O +
ion B-Chemical +
concentrations O +
by O +
promoting O +
extracellular O +
and O +
vesicular O +
ion B-Chemical +
transport O +
into O +
the O +
cytoplasm O -
. O +

ZIP O +
proteins O +
have O +
been O +
reported O +
to O +
be O +
transporters O +
of O +
zinc O -
, O +
iron O -
, O +
manganese O +
and/or O +
cadmium O +
( O -
44,61–63 O -
) O -
. O +

Although O +
SLC39A10 O +
is O +
largely O +
uncharacterized O +
( O -
44 O -
) O -
, O +
it O +
is O +
referred O +
to O +
in O +
several O +
databases O +
as O +
putative O +
zinc O +
transporter O -
. O +

It O +
has O +
been O +
previously O +
shown O +
that O +
MTF-1 O +
is O +
important O +
for O +
both O +
basal O +
expression O +
and O +
metal O +
induction O +
of O +
the O +
mouse O +
Znt1 O +
gene O +
( O -
19 O -
) O -
. O +

ZnT O +
proteins O +
represent O +
a O +
different O +
family O +
of O +
transporters O +
that O +
reduce O +
intracellular O +
cytoplasmic O +
zinc O +
by O +
promoting O +
zinc O +
efflux O +
from O +
cells O +
or O +
into O +
intracellular O +
vesicles O -
. O +

Thus O -
, O +
members O +
of O +
the O +
ZnT O +
and O +
ZIP O +
family O +
with O +
zinc O +
as O +
predominant O +
substrate O +
have O +
opposite O +
roles O +
in O +
cellular O +
zinc O +
homeostasis O +
( O -
43 O -
) O -
. O +

Assuming O +
that O +
SLC39A10 O +
is O +
indeed O +
a O +
zinc O +
transporter O -
, O +
MTF-1 O +
would O +
control O +
expression O +
of O +
two O +
zinc O +
transporters O +
with O +
antagonistic O +
functions O -
, O +
namely O -
, O +
Znt1 O +
and O +
Slc39a10 O -
. O +

Specific O +
binding O +
of O +
MTF-1 O +
was O +
observed O +
for O +
an O +
MRE O +
located O +
just O +
downstream O +
of O +
the O +
Slc39a10 O +
transcription O +
start O -
. O +

In O +
a O +
simple O +
model O -
, O +
such O +
a O +
binding O +
could O +
interfere O +
with O +
the O +
accessibility O +
of O +
the O +
transcriptional O +
start O +
site O +
for O +
RNA O +
polymerase O +
II O +
and/or O +
general O +
transcription O +
factors O -
, O +
thus O +
preventing O +
transcription O +
initiation O +
of O +
the O +
gene O -
. O +

Indeed O -
, O +
such O +
a O +
mechanism O +
has O +
been O +
described O +
in O +
yeast O +
for O +
the O +
zinc O -
- O -
responsive O +
activator O +
protein O +
1 O +
( O -
Zap1 O -
) O +
and O +
its O +
target O +
gene O -
, O +
zinc O -
- O -
regulated O +
transporter O +
2 O +
( O -
ZRT2 O -
) O +
( O -
64 O -
) O -
. O +

However O -
, O +
the O +
inhibition O +
of O +
Slc39a10 O +
expression O +
by O +
MTF-1 O +
may O +
well O +
be O +
more O +
complex O +
than O +
a O +
competition O +
for O +
promoter O +
binding O -
. O +

Independent O +
of O +
MTF-1 O -
, O +
cadmium O +
treatment O +
also O +
leads O +
to O +
downregulation O +
of O +
Slc39a10 O +
transcripts O -
, O +
suggesting O +
that O +
some O +
other O +
factor O +
is O +
mediating O +
this O +
response O -
. O +

A O +
previous O +
target O +
gene O +
search O +
for O +
MTF-1 O +
with O +
mouse O +
embryos O +
of O +
conventional O +
Mtf1 O +
knockout O +
phenotype O +
revealed O -
, O +
besides O +
metallothionein O +
genes O -
, O +
the O +
multifunctional O +
alpha O -
- O -
fetoprotein O +
( O -
Afp O -
) O +
and O +
the O +
liver O -
- O -
enriched O +
transcription O +
factor O +
CCAAT O -
/ O -
enhancer O +
binding O +
protein O +
alpha O +
( O -
Cebpa O -
) O +
as O +
prime O +
candidates O +
( O -
65 O -
) O -
. O +

After O +
an O +
early O +
onset O +
during O +
hepatogenesis O -
, O +
Afp O +
expression O +
is O +
repressed O +
postnatally O +
and O +
replaced O +
by O +
albumin O +
( O -
66 O -
) O -
. O +

Thus O -
, O +
our O +
adult O +
Mtf1Mx O -
- O -
cre O +
mice O +
lacking O +
MTF-1 O +
were O +
not O +
suitable O +
to O +
analyze O +
Afp O +
expression O -
. O +

Cebpa O +
is O +
expressed O +
in O +
the O +
adult O +
liver O +
as O +
well O +
as O +
in O +
other O +
tissues O +
( O -
67 O -
) O -
, O +
but O +
the O +
present O +
microarray O +
data O +
revealed O +
no O +
significant O +
expression O +
differences O +
in O +
livers O +
from O +
adult O +
Mtf1loxP O +
and O +
Mtf1Mx O -
- O -
cre O +
mice O +
( O -
data O +
not O +
shown O -
) O -
. O +

Therefore O -
, O +
MTF-1 O +
may O +
affect O +
Cebpa O +
expression O +
only O +
during O +
embryonal O +
development O -
, O +
perhaps O +
in O +
combination O +
with O +
as O +
yet O +
unidentified O +
factors O -
. O +

The O +
present O +
study O +
confirms O +
and O +
extends O +
the O +
role O +
of O +
MTF-1 O +
as O +
an O +
important O +
stress O +
response O +
regulator O -
. O +

We O +
have O +
identified O +
and O +
preliminarily O +
characterized O +
four O +
target O +
genes O +
of O +
MTF-1 O +
in O +
the O +
adult O +
mouse O +
liver O -
: O +
in O +
the O +
case O +
of O +
Sepw1 O -
, O +
MTF-1 O +
is O +
required O +
to O +
maintain O +
basal O +
expression O -
, O +
supporting O +
a O +
role O +
of O +
mouse O +
MTF-1 O +
in O +
oxidative O +
stress O +
response O -
. O +

In O +
addition O -
, O +
MTF-1 O +
contributes O +
to O +
the O +
cadmium O -
- O -
induced O +
expression O +
of O +
Ndrg1 O +
and O +
Csrp1 O -
. O +

Furthermore O -
, O +
MTF-1 O +
helps O +
to O +
repress O +
the O +
basal O +
expression O +
of O +
Slc39a10 O -
, O +
in O +
contrast O +
to O +
its O +
role O +
as O +
transcriptional O +
activator O +
for O +
genes O +
like O +
Mt1 O -
, O +
Mt2 O +
or O +
Znt1 O -
. O +

Thus O +
the O +
same O +
transcription O +
factor O +
apparently O +
serves O +
as O +
an O +
activator O +
or O +
repressor O -
, O +
depending O +
on O +
the O +
target O +
gene O -
. O +

The O +
comparison O +
of O +
liver O +
gene O +
expression O +
of O +
cadmium- O +
and O +
mock O -
- O -
treated O +
mice O +
also O +
revealed O +
a O +
number O +
of O +
genes O +
that O +
were O +
responsive O +
to O +
cadmium O +
exposure O -
, O +
independent O +
of O +
the O +
presence O +
or O +
absence O +
of O +
MTF-1 O -
. O +

Evidence O +
suggests O +
that O +
the O +
production O +
of O +
reactive B-Chemical +
oxygen I-Chemical +
species I-Chemical +
is O +
a O +
major O +
effect O +
of O +
acute O +
cadmium O +
toxicity O +
( O -
68,69 O -
) O -
, O +
and O +
exposure O +
of O +
cultured O +
cells O +
or O +
animals O +
to O +
cadmium O +
is O +
associated O +
with O +
depletion O +
of O +
reduced B-Chemical +
glutathione I-Chemical -
, O +
lipid B-Chemical +
peroxidation O +
and O +
DNA O +
damage O +
( O -
70–73 O -
) O -
. O +

Oxidative O +
stress O +
and O +
the O +
subsequent O +
restoration O +
of O +
cellular O +
homeostasis O +
have O +
been O +
shown O +
to O +
induce O +
the O +
expression O +
of O +
genes O +
encoding O +
acute O -
- O -
phase O +
proteins O +
and O +
antioxidant O +
enzymes O +
( O -
74 O -
) O -
. O +

In O +
mammals O -
, O +
cadmium O +
tends O +
to O +
accumulate O +
in O +
the O +
kidney O +
and O +
liver O +
as O +
a O +
cadmium O -
- O -
metallothionein O +
complex O +
that O +
has O +
an O +
extremely O +
slow O +
turnover O +
( O -
75,76 O -
) O -
. O +

Furthermore O -
, O +
metallothioneins O +
provide O +
protection O +
against O +
oxidative O +
stress O +
( O -
1,17 O -
) O -
. O +

In O +
addition O +
to O +
metallothioneins O -
, O +
glutathione B-Chemical +
was O +
postulated O +
as O +
a O +
first O +
line O +
of O +
defense O +
against O +
cadmium O +
toxicity O +
( O -
77 O -
) O -
. O +

Glutathione B-Chemical +
efficiently O +
complexes O +
cadmium O +
( O -
78 O -
) O +
and O +
scavenges O +
free B-Chemical +
radicals I-Chemical +
and O +
other O +
reactive B-Chemical +
oxygen I-Chemical +
species I-Chemical +
directly O -
, O +
and O +
indirectly O +
via O +
enzymatic O +
reactions O +
( O -
45 O -
) O -
. O +

In O +
such O +
reactions O -
, O +
glutathione B-Chemical +
is O +
oxidized O +
and O +
has O +
to O +
be O +
regenerated O +
by O +
glutathione B-Chemical +
reductase O -
. O +

Also O -
, O +
glutathione B-Chemical -
- O -
S O -
- O -
transferases O +
mediate O +
the O +
conjugation O +
of O +
various O +
electrophiles O +
to O +
glutathione B-Chemical -
. O +

The O +
observed O +
cadmium O -
- O -
induced O +
upregulation O +
of O +
Gclc O -
, O +
Gsr O +
and O +
Gstm4 O +
supports O +
the O +
importance O +
of O +
glutathione B-Chemical +
in O +
the O +
cellular O +
cadmium O +
response O -
. O +

The O +
enhanced O +
sensitivity O +
to O +
cadmium O +
toxicity O +
that O +
we O +
found O +
for O +
mouse O +
embryonic O +
fibroblasts O +
upon O +
a O +
combination O +
of O +
Mtf1 O +
deletion O +
and O +
depletion O +
of O +
glutathione B-Chemical +
further O +
corroborates O +
the O +
importance O +
of O +
MTF-1 O +
and O +
its O +
target O +
genes O +
as O +
well O +
as O +
reduced B-Chemical +
glutathione I-Chemical +
for O +
an O +
efficient O +
anti O -
- O -
cadmium O +
defense O -
. O +

Our O +
data O +
provide O +
strong O +
evidence O +
for O +
at O +
least O +
two O +
branches O +
of O +
cellular O +
anti O -
- O -
cadmium O +
defense O -
, O +
one O +
via O +
MTF-1 O +
and O +
its O +
target O +
genes O -
, O +
notably O +
metallothioneins O -
, O +
the O +
other O +
via O +
glutathione B-Chemical -
, O +
with O +
an O +
apparent O +
overlap O +
in O +
Sepw1 O -
. O +

SUPPLEMENTARY O +
DATA O +
Supplementary O +
data O +
are O +
available O +
at O +
NAR O +
online O -
. O +

Supplementary O +
Material O +
[ O -
Supplementary O +
Material O -
] O +

Acknowledgements O +
We O +
are O +
indebted O +
to O +
the O +
Functional O +
Genomics O +
Center O +
Zurich O +
( O -
Zurich O -
, O +
CH O -
) O +
for O +
financial O +
as O +
well O +
as O +
technical O +
support O +
( O -
thanks O +
especially O +
to O +
Andrea O +
Patrignani O -
, O +
Dr O +
Ulrich O +
Wagner O -
, O +
and O +
Dr O +
Hubert O +
Rehrauer O +
for O +
their O +
assistance O +
in O +
data O +
generation O +
and O +
evaluation O -
) O -
, O +
and O +
to O +
Dr O +
Michael O +
Leviten O +
( O -
San O +
Carlos O -
, O +
CA O -
) O +
for O +
the O +
help O +
in O +
generating O +
Mtf1 O +
conditional O +
knockout O +
mice O -
. O +

We O +
also O +
thank O +
Prof. O +
Ueli O +
Schibler O +
( O -
Geneva O -
, O +
CH O -
) O +
for O +
his O +
advice O +
on O +
the O +
ADDER O +
technique O -
, O +
Prof. O +
Michel O +
Aguet O +
( O -
Epalinges O -
- O -
Lausanne O -
, O +
CH O -
) O +
for O +
the O +
gift O +
of O +
Mx O -
- O -
Cre O +
mice O -
, O +
Dr O +
George O +
Hausmann O +
and O +
Dr O +
Michael O +
Fetchko O +
for O +
critical O +
reading O +
of O +
the O +
manuscript O -
, O +
and O +
Fritz O +
Ochsenbein O +
for O +
preparing O +
the O +
figures O -
. O +

Funding O +
to O +
pay O +
the O +
Open O +
Access O +
publication O +
charges O +
for O +
this O +
article O +
was O +
provided O +
by O +
the O +
Kanton O +
Zurich O -
. O +

Conflict O +
of O +
interest O +
statement O -
. O +

None O +
declared O -
. O +

Figures O +
and O +
Tables O +
Figure O +
1 O +
Deletion O +
of O +
Mtf1 O +
in O +
adult O +
mouse O +
liver O -
. O +

( O -
a O -
) O +
Generation O +
of O +
Mtf1 O +
conditional O +
knockout O +
mice O -
. O +

The O +
targeted O +
allele O +
was O +
obtained O +
by O +
homologous O +
recombination O +
of O +
wild O -
- O -
type O +
( O -
wt O -
) O +
allele O +
and O +
targeting O +
vector O +
in O +
ES O +
cells O -
. O +

Removal O +
of O +
the O +
neomycin B-Chemical +
cassette O +
( O -
NEO O -
) O +
by O +
Cre O +
recombinase O +
led O +
to O +
the O +
conditional O +
knockout O +
allele O +
Mtf1loxP. O +
Conditional O +
Cre O -
- O -
mediated O +
deletion O +
of O +
exons O +
3 O +
and O +
4 O +
( O -
Mtf1Δ O -
) O +
results O +
in O +
loss O +
of O +
function O +
via O +
loss O +
of O +
an O +
essential O +
part O +
of O +
the O +
DNA O -
- O -
binding O +
domain O +
and O +
the O +
generation O +
of O +
a O +
new O +
stop O +
codon O +
right O +
after O +
exon O +
2 O -
. O +

Exons O +
3 O +
to O +
7 O +
of O +
Mtf1 O +
are O +
indicated O +
by O +
grey O +
boxes O -
, O +
loxP O +
sites O +
by O +
black O +
triangles O -
. O +

TK O -
, O +
thymidine O +
kinase O +
cassette O -
. O +

Restriction O +
enzymes O -
: O +
San O -
, O +
SanDI O -
; O +
B O -
, O +
BbvCI O -
; O +
S O -
, O +
SrfI O -
; O +
H O -
, O +
HpaI. O +
The O +
HpaI O +
site O +
indicated O +
by O +
the O +
crossed O +
H O +
was O +
lost O +
during O +
the O +
cloning O +
procedure O +
for O +
the O +
targeting O +
vector O -
. O +

( O -
b O -
) O +
RT O -
– O -
PCRs O +
with O +
total O +
liver O +
RNA O +
from O +
pI B-Chemical -
– O -
pC O -
- O -
induced O +
male O +
Mtf1Mx O -
- O -
cre O +
or O +
Mtf1loxP O +
mice O -
. O +

The O +
used O +
primer O +
pair O +
results O +
in O +
products O +
of O +
589 O +
bp O +
and O +
218 O +
bp O +
with O +
full O -
- O -
length O +
mRNA O +
and O +
mRNA O +
without O +
exons O +
3 O +
and O +
4 O -
, O +
respectively O -
. O +

( O -
c O -
) O +
EMSA O +
with O +
liver O +
protein O +
extract O +
of O +
a O +
pI B-Chemical -
– O -
pC O -
- O -
induced O +
male O +
Mtf1Mx O -
- O -
cre O +
or O +
Mtf1loxP O +
mouse O -
. O +

MTF-1 O +
protein O -
– O -
DNA O +
complex O +
formation O +
was O +
tested O +
with O +
32P B-Chemical -
- O -
labeled O +
MRE O +
consensus O +
oligonucleotide O +
MRE O -
- O -
s O -
. O +

Specificity O +
of O +
binding O +
was O +
verified O +
with O +
excess O +
of O +
unlabeled O +
competitor O +
MREd O +
or O +
unrelated O +
Gal4 O +
oligonucleotide O -
; O +
Sp1 O +
bandshifts O +
with O +
32P B-Chemical -
- O -
labeled O +
Sp1 O +
consensus O +
oligonucleotide O +
were O +
included O +
as O +
a O +
loading O +
control O -
. O +

Figure O +
2 O +
Sepw1 O +
basal O +
expression O +
depends O +
on O +
MTF-1 O -
. O +

( O -
a O -
) O +
Semiquantitative O +
RT O -
– O -
PCRs O +
for O +
Sepw1 O +
mRNA O +
using O +
total O +
liver O +
RNA O +
from O +
pI B-Chemical -
– O -
pC O -
- O -
induced O +
male O +
Mtf1Mx O -
- O -
cre O +
or O +
Mtf1loxP O +
mice O -
. O +

The O +
animals O +
had O +
obtained O +
either O +
mock O +
s.c O -
. O +

injections O +
( O -
−Cd O -
) O +
or O +
s.c O -
. O +

injections O +
with O +
20 O +
µmol O -
/ O -
kg O +
body O +
weight O +
CdSO4 B-Chemical +
( O -
+ O -
Cd O -
) O +
6 O +
h O +
before O +
sacrificing O +
them O -
. O +

RT O -
– O -
PCRs O +
for O +
Hprt O +
mRNA O +
were O +
used O +
as O +
internal O +
control O +
to O +
adjust O +
the O +
amount O +
of O +
total O +
RNA O +
used O -
. O +

( O -
b O -
) O +
S1 O +
analysis O +
for O +
Sepw1 O +
mRNA O +
with O +
RNA O +
described O +
in O +
( O -
a O -
) O -
, O +
using O +
a O +
32P B-Chemical -
- O -
labeled O +
Sepw1 O +
S1 O +
probe O -
. O +

A O +
32P B-Chemical -
- O -
labeled O +
S1 O +
probe O +
for O +
Hprt O +
mRNA O +
was O +
used O +
to O +
adjust O +
the O +
amount O +
of O +
RNA O +
used O -
. O +

( O -
c O -
) O +
MRE O +
core O +
consensus O +
sequences O +
TGCRCNC O +
( O -
bold O +
letters O -
) O +
and O +
flanking O +
sequences O +
found O +
in O +
a O +
region O +
of O +
1000 O +
bp O +
upstream O +
from O +
Sepw1 O +
transcription O +
start O -
; O +
the O +
position O +
of O +
each O +
core O +
sequence O +
is O +
indicated O -
. O +

( O -
d O -
) O +
EMSA O +
with O +
liver O +
protein O +
extracts O +
of O +
a O +
male O +
Mtf1loxP O +
or O +
a O +
pI B-Chemical -
– O -
pC O -
- O -
induced O -
, O +
male O +
Mtf1Mx O -
- O -
cre O +
mouse O -
, O +
both O +
mock O -
- O -
treated O -
. O +

MTF-1 O +
protein O -
– O -
DNA O +
complex O +
formation O +
was O +
tested O +
with O +
32P B-Chemical -
- O -
labeled O +
Sepw1 O +
MRE1 O +
or O +
MRE2 O +
oligonucleotide O -
, O +
respectively O -
. O +

Specificity O +
of O +
binding O +
was O +
verified O +
with O +
excess O +
of O +
unlabeled O +
competitor O +
MREd O +
or O +
unrelated O +
Gal4 O +
oligonucleotide O -
. O +

32P B-Chemical -
- O -
labeled O +
MRE O -
- O -
s O +
was O +
included O +
to O +
indicate O +
the O +
position O +
of O +
an O +
MTF-1-DNA O +
complex O -
; O +
bandshifts O +
for O +
the O +
common O +
transcription O +
factor O +
Sp1 O +
with O +
32P B-Chemical -
- O -
labeled O +
Sp1 O +
consensus O +
oligonucleotide O +
were O +
obtained O +
as O +
protein O +
loading O +
control O -
. O +

Figure O +
3 O +
Cadmium O +
response O +
of O +
Ndrg1 O +
depends O +
on O +
MTF-1 O -
. O +

( O -
a O -
) O +
Semiquantitative O +
RT O -
– O -
PCRs O +
for O +
Ndrg1 O +
mRNA O +
using O +
total O +
liver O +
RNA O +
from O +
pI B-Chemical -
– O -
pC O -
- O -
induced O +
male O +
Mtf1Mx O -
- O -
cre O +
or O +
Mtf1loxP O +
mice O -
. O +

The O +
animals O +
had O +
obtained O +
either O +
mock O +
s.c O -
. O +

injections O +
( O -
−Cd O -
) O +
or O +
s.c O -
. O +

injections O +
with O +
20 O +
µmol O -
/ O -
kg O +
body O +
weight O +
CdSO4 B-Chemical +
( O -
+ O -
Cd O -
) O +
6 O +
h O +
before O +
sacrificing O +
them O -
. O +

RT O -
– O -
PCRs O +
for O +
Hprt O +
mRNA O +
were O +
used O +
as O +
internal O +
control O +
to O +
adjust O +
the O +
amount O +
of O +
total O +
RNA O +
used O -
. O +

( O -
b O -
) O +
MRE O +
core O +
consensus O +
sequences O +
TGCRCNC O +
( O -
bold O +
letters O -
) O +
and O +
flanking O +
sequences O +
found O +
in O +
a O +
region O +
of O +
1000 O +
bp O +
upstream O +
from O +
Ndrg1 O +
transcription O +
start O -
; O +
the O +
position O +
of O +
each O +
core O +
sequence O +
is O +
indicated O -
. O +

( O -
c O -
) O +
EMSA O +
with O +
liver O +
protein O +
extracts O +
of O +
a O +
male O +
Mtf1loxP O +
or O +
a O +
pI B-Chemical -
– O -
pC O -
- O -
induced O -
, O +
male O +
Mtf1Mx O -
- O -
cre O +
mouse O -
, O +
both O +
mock O -
- O -
treated O -
. O +

MTF-1 O +
protein O -
– O -
DNA O +
complex O +
formation O +
was O +
tested O +
with O +
32P B-Chemical -
- O -
labeled O +
Ndrg1 O +
MRE1 O +
or O +
MRE2 O +
oligonucleotide O -
, O +
or O +
a O +
32P B-Chemical -
- O -
labeled O +
oligonucleotide O +
including O +
both O +
MRE3 O +
and O +
MRE4 O +
( O -
MRE3,4 O -
) O -
. O +

Specificity O +
of O +
binding O +
was O +
verified O +
with O +
excess O +
of O +
unlabeled O +
competitor O +
MREd O +
or O +
unrelated O +
Gal4 O +
oligonucleotide O -
. O +

32P B-Chemical -
- O -
labeled O +
MRE O -
- O -
s O +
was O +
included O +
to O +
indicate O +
the O +
position O +
of O +
an O +
MTF-1-DNA O +
complex O -
; O +
Sp1 O +
bandshifts O +
with O +
32P B-Chemical -
- O -
labeled O +
Sp1 O +
consensus O +
oligonucleotide O +
were O +
obtained O +
as O +
protein O +
loading O +
control O -
. O +

Figure O +
4 O +
Cadmium O +
response O +
of O +
Csrp1 O +
depends O +
on O +
MTF-1 O -
. O +

( O -
a O -
) O +
Semiquantitative O +
RT O -
– O -
PCRs O +
for O +
Csrp1 O +
mRNA O +
using O +
total O +
liver O +
RNA O +
from O +
pI B-Chemical -
– O -
pC O -
- O -
induced O +
male O +
Mtf1Mx O -
- O -
cre O +
or O +
Mtf1loxP O +
mice O -
. O +

The O +
animals O +
had O +
obtained O +
either O +
mock O +
s.c O -
. O +

injections O +
( O -
−Cd O -
) O +
or O +
s.c O -
. O +

injections O +
with O +
20 O +
µmol O -
/ O -
kg O +
body O +
weight O +
CdSO4 B-Chemical +
( O -
+ O -
Cd O -
) O +
6 O +
h O +
before O +
sacrificing O +
them O -
. O +

RT O -
– O -
PCRs O +
for O +
Hprt O +
mRNA O +
were O +
used O +
as O +
internal O +
control O +
to O +
adjust O +
the O +
amount O +
of O +
total O +
RNA O +
used O -
. O +

( O -
b O -
) O +
MRE O +
core O +
consensus O +
sequences O +
TGCRCNC O +
( O -
bold O +
letters O -
) O +
and O +
flanking O +
sequences O +
found O +
in O +
a O +
region O +
of O +
1000 O +
bp O +
upstream O +
from O +
Csrp1 O +
transcription O +
start O -
; O +
the O +
position O +
of O +
each O +
core O +
sequence O +
is O +
indicated O -
. O +

( O -
c O -
) O +
EMSA O +
with O +
liver O +
protein O +
extracts O +
of O +
a O +
male O +
Mtf1loxP O +
or O +
a O +
pI B-Chemical -
– O -
pC O -
- O -
induced O -
, O +
male O +
Mtf1Mx O -
- O -
cre O +
mouse O -
, O +
both O +
mock O -
- O -
treated O -
. O +

MTF-1 O +
protein O -
– O -
DNA O +
complex O +
formation O +
was O +
tested O +
with O +
32P B-Chemical -
- O -
labeled O +
Csrp1 O +
MRE1 O -
, O +
MRE2 O -
, O +
MRE3 O +
or O +
MRE4 O +
oligonucleotide O -
, O +
respectively O -
. O +

Specificity O +
of O +
binding O +
was O +
verified O +
with O +
excess O +
of O +
unlabeled O +
competitor O +
MREd O +
or O +
unrelated O +
Gal4 O +
oligonucleotide O -
. O +

32P B-Chemical -
- O -
labeled O +
MRE O -
- O -
s O +
was O +
included O +
to O +
indicate O +
the O +
position O +
of O +
an O +
MTF-1–DNA O +
complex O -
; O +
Sp1 O +
bandshifts O +
with O +
32P B-Chemical -
- O -
labeled O +
Sp1 O +
consensus O +
oligonucleotide O +
were O +
obtained O +
as O +
protein O +
loading O +
control O -
. O +

Figure O +
5 O +
MTF-1 O +
represses O +
basal O +
expression O +
of O +
Slc39a10 O -
. O +

( O -
a O -
) O +
Semiquantitative O +
RT O -
– O -
PCRs O +
for O +
Slc39a10 O +
mRNA O +
using O +
total O +
liver O +
RNA O +
from O +
pI B-Chemical -
– O -
pC O -
- O -
induced O +
male O +
Mtf1Mx O -
- O -
cre O +
or O +
Mtf1loxP O +
mice O -
. O +

The O +
animals O +
had O +
obtained O +
either O +
mock O +
s.c O -
. O +

injections O +
( O -
−Cd O -
) O +
or O +
s.c O -
. O +

injections O +
with O +
20 O +
µmol O -
/ O -
kg O +
body O +
weight O +
CdSO4 B-Chemical +
( O -
+ O -
Cd O -
) O +
6 O +
h O +
before O +
sacrificing O +
them O -
. O +

RT O -
– O -
PCRs O +
for O +
Hprt O +
mRNA O +
were O +
used O +
as O +
internal O +
control O +
to O +
adjust O +
the O +
amount O +
of O +
total O +
RNA O +
used O -
. O +

( O -
b O -
) O +
MRE O +
core O +
consensus O +
sequences O +
TGCRCNC O +
( O -
bold O +
letters O -
) O +
and O +
flanking O +
sequences O +
found O +
in O +
a O +
region O +
of O +
1000 O +
bp O +
upstream O +
from O +
Slc39a10 O +
transcription O +
start O -
; O +
the O +
position O +
of O +
each O +
core O +
sequence O +
is O +
indicated O -
. O +

( O -
c O -
) O +
EMSA O +
with O +
liver O +
protein O +
extracts O +
of O +
a O +
male O +
Mtf1loxP O +
or O +
a O +
pI B-Chemical -
– O -
pC O -
- O -
induced O -
, O +
male O +
Mtf1Mx O -
- O -
cre O +
mouse O -
, O +
both O +
mock O -
- O -
treated O -
. O +

MTF-1 O +
protein O -
– O -
DNA O +
complex O +
formation O +
was O +
tested O +
with O +
32P B-Chemical -
- O -
labeled O +
Slc39a10 O +
MRE1 O +
or O +
MRE2 O +
oligonucleotide O -
, O +
respectively O -
. O +

Specificity O +
of O +
binding O +
was O +
verified O +
with O +
excess O +
of O +
unlabeled O +
competitor O +
MREd O +
or O +
unrelated O +
Gal4 O +
oligonucleotide O -
. O +

32P B-Chemical -
- O -
labeled O +
MRE O -
- O -
s O +
was O +
included O +
to O +
indicate O +
the O +
position O +
of O +
an O +
MTF-1–DNA O +
complex O -
; O +
Sp1 O +
bandshifts O +
with O +
32P B-Chemical -
- O -
labeled O +
Sp1 O +
consensus O +
oligonucleotide O +
were O +
obtained O +
as O +
protein O +
loading O +
control O -
. O +

Figure O +
6 O +
Cells O +
with O +
reduced B-Chemical +
glutathione I-Chemical +
level O +
that O +
also O +
lack O +
MTF-1 O +
are O +
hypersensitive O +
to O +
cadmium O -
. O +

The O +
viability O +
of O +
cells O +
was O +
assessed O +
with O +
the O +
so O -
- O -
called O +
MTT B-Chemical +
assay O -
. O +

Mouse O +
embryonic O +
fibroblasts O +
with O +
( O -
ckoC O -
) O +
and O +
without O +
( O -
delC19 O -
, O +
delC21 O +
and O +
delC23 O -
) O +
functional O +
Mtf1 O +
were O +
compared O -
. O +

Cells O +
were O +
pre O -
- O -
incubated O +
in O +
medium O +
containing O +
0 O -
, O +
5 O -
, O +
10 O -
, O +
25 O +
or O +
50 O +
µM O +
BSO B-Chemical +
for O +
24 O +
h O +
and O +
further O +
exposed O +
to O +
0 O -
, O +
5 O -
, O +
10 O +
or O +
20 O +
µM O +
CdCl2 B-Chemical +
( O -
Cd O -
) O +
in O +
the O +
specified O +
pre O -
- O -
incubation O +
medium O +
for O +
an O +
additional O +
24 O +
h. O +
Results O +
are O +
expressed O +
as O +
mean O +
values O +
± O +
SD O +
( O -
n O +
= O +
3 O -
) O +
normalized O +
to O +
the O +
respective O +
value O +
of O +
untreated O +
cells O -
. O +

Table O +
1 O +
Comparison O +
of O +
liver O +
gene O +
expression O +
for O +
pI B-Chemical -
– O -
pC O -
- O -
induced O +
Mtf1Mx O -
- O -
cre O +
and O +
Mtf1loxP O +
mice O +
( O -
up- O +
or O +
downregulation O +
at O +
least O +
2-fold O -
, O +
P O +
≤ O +
0.05 O -
) O +
The O +
animals O +
had O +
obtained O +
either O +
mock O +
s.c O -
. O +

injections O +
( O -
−Cd O -
) O +
or O +
s.c O -
. O +

injections O +
with O +
20 O +
µmol O -
/ O -
kg O +
body O +
weight O +
CdSO4 B-Chemical +
( O -
+ O -
Cd O -
) O +
6 O +
h O +
before O +
sacrificing O +
them O -
. O +

The O +
expression O +
values O +
for O +
each O +
gene O +
are O +
given O +
as O +
mean O +
value O +
of O +
three O +
animals O +
per O +
group O -
, O +
normalized O +
to O +
the O +
mean O +
value O +
of O +
group O +
Mtf1loxP O +
−Cd O +
( O -
relative O +
activity O -
) O -
. O +

Grey O +
shading O +
indicates O +
the O +
two O +
groups O +
of O +
animals O +
compared O -
, O +
relative O +
activities O +
for O +
the O +
other O +
two O +
groups O +
are O +
shown O +
for O +
a O +
complete O +
overview O -
. O +

The O +
number O +
of O +
MRE O +
core O +
consensus O +
sequences O +
TGCRCNC O +
in O +
a O +
region O +
of O +
1000 O +
bp O +
upstream O +
from O +
the O +
annotated O +
transcription O +
start O +
is O +
indicated O -
. O +

aOnly O +
incomplete O +
region O +
up O +
to O +
−1000 O +
bp O +
from O +
transcription O +
start O +
is O +
available O +
in O +
database O -
. O +

bMean O +
values O +
of O +
two O +
independent O +
Affymetrix O +
probe O +
sets O -
. O +

cMean O +
value O +
of O +
four O +
independent O +
Affymetrix O +
probe O +
sets O -
. O +

Table O +
2 O +
Comparison O +
of O +
liver O +
gene O +
expression O +
for O +
cadmium- O +
and O +
mock O -
- O -
treated O +
mice O +
( O -
up- O +
or O +
downregulation O +
at O +
least O +
2-fold O -
, O +
P O +
≤ O +
0.05 O -
) O +
The O +
animals O +
had O +
obtained O +
either O +
mock O +
s.c O -
. O +

injections O +
( O -
−Cd O -
) O +
or O +
s.c O -
. O +

injections O +
with O +
20 O +
µmol O -
/ O -
kg O +
body O +
weight O +
CdSO4 B-Chemical +
( O -
+ O -
Cd O -
) O +
6 O +
h O +
before O +
sacrificing O +
them O -
. O +

The O +
expression O +
values O +
for O +
each O +
gene O +
are O +
given O +
as O +
mean O +
value O +
of O +
three O +
animals O +
per O +
group O -
, O +
normalized O +
to O +
the O +
mean O +
value O +
of O +
group O +
Mtf1loxP O +
−Cd O +
( O -
relative O +
activity O -
) O -
. O +

aMean O +
values O +
of O +
three O +
independent O +
Affymetrix O +
probe O +
sets O -
. O +

bMean O +
value O +
of O +
six O +
independent O +
Affymetrix O +
probe O +
sets O -
. O +

cMean O +
value O +
of O +
two O +
independent O +
Affymetrix O +
probe O +
sets O -
. O +

CEBPG O +
transcription O +
factor O +
correlates O +
with O +
antioxidant O +
and O +
DNA O +
repair O +
genes O +
in O +
normal O +
bronchial O +
epithelial O +
cells O +
but O +
not O +
in O +
individuals O +
with O +
bronchogenic O +
carcinoma O +
Abstract O +
Background O +
Cigarette O +
smoking O +
is O +
the O +
primary O +
cause O +
of O +
bronchogenic O +
carcinoma O +
( O -
BC O -
) O -
, O +
yet O +
only O +
10–15 O -
% O +
of O +
heavy O +
smokers O +
develop O +
BC O +
and O +
it O +
is O +
likely O +
that O +
this O +
variation O +
in O +
risk O +
is O -
, O +
in O +
part O -
, O +
genetically O +
determined O -
. O +

We O +
previously O +
reported O +
a O +
set O +
of O +
antioxidant O +
genes O +
for O +
which O +
transcript O +
abundance O +
was O +
lower O +
in O +
normal O +
bronchial O +
epithelial O +
cells O +
( O -
NBEC O -
) O +
of O +
BC O +
individuals O +
compared O +
to O +
non O -
- O -
BC O +
individuals O -
. O +

In O +
unpublished O +
studies O +
of O +
the O +
same O +
NBEC O +
samples O -
, O +
transcript O +
abundance O +
values O +
for O +
several O +
DNA O +
repair O +
genes O +
were O +
correlated O +
with O +
these O +
antioxidant O +
genes O -
. O +

From O +
these O +
data O -
, O +
we O +
hypothesized O +
that O +
antioxidant O +
and O +
DNA O +
repair O +
genes O +
are O +
co O -
- O -
regulated O +
by O +
one O +
or O +
more O +
transcription O +
factors O +
and O +
that O +
inter O -
- O -
individual O +
variation O +
in O +
expression O +
and/or O +
function O +
of O +
one O +
or O +
more O +
of O +
these O +
transcription O +
factors O +
is O +
responsible O +
for O +
inter O -
- O -
individual O +
variation O +
in O +
risk O +
for O +
BC O -
. O +

Methods O +
The O +
putative O +
transcription O +
factor O +
recognition O +
sites O +
common O +
to O +
six O +
of O +
the O +
antioxidant O +
genes O +
were O +
identified O +
through O +
in O +
silico O +
DNA O +
sequence O +
analysis O -
. O +

The O +
transcript O +
abundance O +
values O +
of O +
these O +
transcription O +
factors O +
( O -
n O +
= O +
6 O -
) O +
and O +
an O +
expanded O +
group O +
of O +
antioxidant O +
and O +
DNA O +
repair O +
genes O +
( O -
n O +
= O +
16 O -
) O +
were O +
measured O +
simultaneously O +
by O +
quantitative O +
PCR O +
in O +
NBEC O +
of O +
24 O +
non O -
- O -
BC O +
and O +
25 O +
BC O +
individuals O -
. O +

Results O +
CEBPG O +
transcription O +
factor O +
was O +
significantly O +
( O -
p O +
< O +
0.01 O -
) O +
correlated O +
with O +
eight O +
of O +
the O +
antioxidant O +
or O +
DNA O +
repair O +
genes O +
in O +
non O -
- O -
BC O +
individuals O +
but O +
not O +
in O +
BC O +
individuals O -
. O +

In O +
BC O +
individuals O +
the O +
correlation O +
with O +
CEBPG O +
was O +
significantly O +
( O -
p O +
< O +
0.01 O -
) O +
lower O +
than O +
that O +
of O +
non O -
- O -
BC O +
individuals O +
for O +
four O +
of O +
the O +
genes O +
( O -
XRCC1 O -
, O +
ERCC5 O -
, O +
GSTP1 O -
, O +
and O +
SOD1 O -
) O +
and O +
the O +
difference O +
was O +
nearly O +
significant O +
for O +
GPX1 O -
. O +

The O +
only O +
other O +
transcription O +
factor O +
correlated O +
with O +
any O +
of O +
these O +
five O +
target O +
genes O +
in O +
non O -
- O -
BC O +
individuals O +
was O +
E2F1 O -
. O +

E2F1 O +
was O +
correlated O +
with O +
GSTP1 O +
among O +
non O -
- O -
BC O +
individuals O -
, O +
but O +
in O +
contrast O +
to O +
CEBPG O -
, O +
there O +
was O +
no O +
significant O +
difference O +
in O +
this O +
correlation O +
in O +
non O -
- O -
BC O +
individuals O +
compared O +
to O +
BC O +
individuals O -
. O +

Conclusion O +
We O +
conclude O +
that O +
CEBPG O +
is O +
the O +
transcription O +
factor O +
primarily O +
responsible O +
for O +
regulating O +
transcription O +
of O +
key O +
antioxidant O +
and O +
DNA O +
repair O +
genes O +
in O +
non O -
- O -
BC O +
individuals O -
. O +

Further O -
, O +
we O +
conclude O +
that O +
the O +
heavy O +
smokers O +
selected O +
for O +
development O +
of O +
BC O +
are O +
those O +
who O +
have O +
sub O -
- O -
optimal O +
regulation O +
of O +
antioxidant O +
and O +
DNA O +
repair O +
genes O +
by O +
CEBPG O -
. O +

Background O +
BC O +
is O +
currently O +
the O +
leading O +
cause O +
of O +
cancer O -
- O -
related O +
death O +
in O +
the O +
United O +
States O -
, O +
causing O +
28 O -
% O +
of O +
all O +
cancer O +
deaths O +
[ O -
1 O -
] O -
. O +

Although O +
cigarette O +
smoking O +
is O +
the O +
primary O +
risk O +
factor O -
, O +
only O +
10–15 O -
% O +
of O +
heavy O +
smokers O +
( O -
greater O +
than O +
20 O +
pack O +
years O -
) O +
develop O +
BC O +
[ O -
1 O -
- O -
3 O -
] O -
. O +

Antioxidant O +
and O +
DNA O +
repair O +
enzymes O +
that O +
provide O +
protection O +
from O +
the O +
effects O +
of O +
cigarette O +
smoke O +
are O +
expressed O +
in O +
the O +
progenitor O +
cells O +
for O +
BC O -
, O +
normal O +
bronchial O +
epithelial O +
cells O +
( O -
NBEC O -
) O +
[ O -
1 O -
] O -
. O +

Inherited O +
inter O -
- O -
individual O +
variation O +
in O +
the O +
function O +
of O +
these O +
genes O +
plays O +
a O +
role O +
in O +
determining O +
risk O +
for O +
BC O +
[ O -
4 O -
- O -
6 O -
] O -
. O +

Antioxidant O +
enzymes O +
protect O +
NBEC O +
from O +
reactive B-Chemical +
oxygen I-Chemical +
species I-Chemical +
produced O +
by O +
interaction O +
with O +
and O +
metabolism O +
of O +
xenobiotics B-Chemical +
such O +
as O +
pollution O +
and O +
cigarette O +
smoke O +
[ O -
4 O -
- O -
7 O -
] O +
as O +
well O +
as O +
those O +
produced O +
by O +
normal O +
cellular O +
metabolism O -
. O +

Reactive B-Chemical +
oxygen I-Chemical +
species I-Chemical +
cause O +
many O +
damaging O +
reactions O +
including O +
denaturation O +
of O +
proteins O -
, O +
cross O -
- O -
linking O +
of O +
lipids B-Chemical +
and O +
proteins O +
and O +
modification O +
of O +
nucleic O +
acid O +
bases O -
, O +
which O +
can O +
lead O +
to O +
cancer O +
[ O -
7 O -
] O -
. O +

DNA O +
repair O +
enzymes O +
repair O +
the O +
frequent O +
damage O +
to O +
DNA O +
caused O +
by O +
oxidant O +
stress O +
as O +
well O +
as O +
other O +
stresses O -
, O +
including O +
bulky O +
adducts O +
derived O +
from O +
carcinogens B-Chemical +
in O +
cigarette O +
smoke O +
[ O -
8 O -
] O -
. O +

We O +
previously O +
reported O +
that O +
an O +
interactive O +
transcript O +
abundance O +
index O +
comprising O +
antioxidant O +
genes O +
was O +
lower O +
in O +
NBEC O +
of O +
BC O +
individuals O +
compared O +
to O +
non O -
- O -
BC O +
individuals O -
, O +
suggesting O +
that O +
BC O +
individuals O +
are O +
selected O +
on O +
the O +
basis O +
of O +
poor O +
antioxidant O +
protection O +
[ O -
9 O -
] O -
. O +

In O +
that O +
study O -
, O +
there O +
was O +
a O +
tendency O +
towards O +
correlation O +
in O +
transcript O +
abundance O +
between O +
several O +
pairs O +
of O +
antioxidant O +
or O +
DNA O +
repair O +
genes O +
in O +
non O -
- O -
BC O +
individuals O -
, O +
but O +
not O +
in O +
BC O +
individuals O -
. O +

Gene O +
pairs O +
included O +
in O +
that O +
observation O +
were O +
GSTP1 O -
/ O -
GPX1 O -
, O +
CAT O -
/ O -
GPX3 O -
, O +
and O +
GPX3 O -
/ O -
SOD1 O -
. O +

Correlation O +
is O +
one O +
typical O +
characteristic O +
of O +
co O -
- O -
regulated O +
genes O -
. O +

Another O +
is O +
shared O +
transcription O +
factor O +
recognition O +
sites O +
in O +
the O +
regulatory O +
regions O +
of O +
those O +
genes O +
[ O -
10 O -
] O -
. O +

Based O +
on O +
the O +
above O +
findings O -
, O +
it O +
was O +
hypothesized O +
first O -
, O +
that O +
there O +
is O +
inter O -
- O -
individual O +
variation O +
in O +
regulation O +
of O +
key O +
antioxidant O +
and O +
DNA O +
repair O +
genes O +
by O +
one O +
or O +
more O +
transcription O +
factors O +
and O +
second O -
, O +
that O +
individuals O +
with O +
sub O -
- O -
optimal O +
regulation O +
are O +
selected O +
for O +
development O +
of O +
BC O +
if O +
they O +
smoke O +
cigarettes O -
. O +

To O +
test O +
these O +
hypotheses O -
, O +
transcription O +
factor O +
recognition O +
sites O +
common O +
to O +
the O +
regulatory O +
regions O +
of O +
the O +
above O +
correlated O +
gene O +
pairs O +
were O +
identified O +
through O +
in O +
silico O +
DNA O +
sequence O +
analysis O -
, O +
and O +
their O +
transcript O +
abundance O +
measured O +
simultaneously O +
with O +
an O +
expanded O +
group O +
of O +
ten O +
antioxidant O +
and O +
six O +
DNA O +
repair O +
genes O -
. O +

Methods O +
NBEC O +
sample O +
procurement O +
Brush O +
biopsy O +
samples O +
of O +
normal O +
bronchial O +
epithelium O +
were O +
obtained O +
for O +
research O +
studies O +
at O +
the O +
time O +
of O +
diagnostic O +
bronchoscopy O +
according O +
to O +
previously O +
described O +
methods O +
[ O -
9,11 O -
] O -
. O +

Normal O +
bronchial O +
epithelium O +
in O +
the O +
lung O +
not O +
involved O +
with O +
cancer O +
was O +
brushed O +
prior O +
to O +
biopsy O +
of O +
the O +
suspected O +
cancerous O +
area O -
. O +

Samples O +
were O +
collected O +
in O +
a O +
manner O +
satisfying O +
all O +
requirements O +
of O +
the O +
Institutional O +
Review O +
Board O +
for O +
the O +
Medical O +
University O +
of O +
Ohio O -
. O +

Each O +
BC O +
diagnosis O +
and O +
subtype O +
identification O +
was O +
determined O +
by O +
histopathological O +
examination O +
in O +
the O +
Department O +
of O +
Pathology O +
at O +
the O +
Medical O +
University O +
of O +
Ohio O -
. O +

NBEC O +
samples O +
from O +
a O +
total O +
of O +
49 O +
individuals O -
, O +
including O +
24 O +
non O -
- O -
BC O +
individuals O +
and O +
25 O +
BC O +
individuals O -
, O +
were O +
evaluated O +
in O +
this O +
study O -
. O +

The O +
biographical O +
characteristics O +
of O +
these O +
individuals O +
are O +
presented O +
in O +
Table O +
1 O -
. O +

Transcript O +
abundance O +
measurement O +
Total O +
RNA O +
samples O +
extracted O +
from O +
NBEC O +
were O +
reverse O +
transcribed O +
using O +
M O -
- O -
MLV O +
reverse O +
transcriptase O +
and O +
oligo O +
dT O +
primers O +
as O +
previously O +
described O +
[ O -
9,11 O -
] O -
. O +

Standardized O +
RT O +
( O -
StaRT O -
) O -
-PCR O +
was O +
used O +
for O +
transcript O +
abundance O +
measurement O +
in O +
these O +
studies O -
. O +

With O +
StaRT O -
- O -
PCR O -
, O +
an O +
internal O +
standard O +
for O +
each O +
gene O +
within O +
a O +
standardized O +
mixture O +
of O +
internal O +
standards O +
( O -
SMIS O -
) O +
is O +
included O +
in O +
each O +
PCR O +
reaction O -
. O +

After O +
amplification O -
, O +
products O +
were O +
electrophoresed O +
on O +
an O +
Agilent O +
2100 O +
Bioanalyzer O +
using O +
DNA O +
Chips O +
with O +
DNA O +
1000 O +
Kit O +
reagents B-Chemical +
for O +
visualization O +
according O +
to O +
the O +
manufacturer O -
's O +
protocol O +
( O -
Agilent O +
Technologies O +
Deutschland O +
GmbH O -
, O +
Waldbronn O -
, O +
Germany O -
) O -
. O +

The O +
StaRT O -
- O -
PCR O +
technology O +
is O +
licensed O +
to O +
Gene O +
Express O -
, O +
Inc. O +
( O -
Toledo O -
, O +
OH O -
) O -
. O +

Many O +
of O +
the O +
reagents B-Chemical +
are O +
available O +
commercially O +
and O +
were O +
obtained O +
through O +
Gene O +
Express O -
, O +
Inc. O +
for O +
this O +
study O -
. O +

StaRT O -
- O -
PCR O +
reagents B-Chemical +
for O +
each O +
of O +
the O +
measured O +
genes O +
that O +
were O +
not O +
commercially O +
available O -
, O +
including O +
primers O +
and O +
SMIS O -
, O +
were O +
prepared O +
according O +
to O +
previously O +
described O +
methods O +
[ O -
11,12 O -
] O -
. O +

Sequence O +
information O +
for O +
the O +
primers O +
is O +
provided O +
in O +
Table O +
2 O -
. O +

Including O +
an O +
internal O +
standard O +
within O +
a O +
SMIS O +
in O +
each O +
measurement O +
controls O +
for O +
all O +
known O +
sources O +
of O +
variation O +
during O +
PCR O -
, O +
including O +
inhibitors B-Chemical +
in O +
samples O -
, O +
and O +
generates O +
virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
data O +
that O +
are O +
directly O +
comparable O +
across O +
multiple O +
experiments O +
and O +
institutions O +
[ O -
13 O -
] O -
. O +

The O +
performance O +
characteristics O +
of O +
StaRT O -
- O -
PCR O +
are O +
superior O +
to O +
other O +
forms O +
of O +
commercially O +
available O +
quantitative O +
PCR O +
technology O +
in O +
the O +
areas O +
critical O +
to O +
this O +
study O -
. O +

With O +
respect O +
to O +
these O +
studies O -
, O +
the O +
key O +
property O +
of O +
a O +
quantitative O +
PCR O +
method O +
is O +
not O +
whether O +
the O +
PCR O +
products O +
are O +
measured O +
kinetically O +
or O +
at O +
endpoint O -
, O +
but O +
rather O +
whether O +
there O +
are O +
internal O +
standards O +
in O +
each O +
measurement O +
or O +
not O -
. O +

The O +
overall O +
performance O +
characteristics O +
of O +
StaRT O -
- O -
PCR O -
, O +
including O +
extensive O +
validation O +
of O +
the O +
method O +
in O +
independent O +
laboratories O +
have O +
been O +
presented O +
in O +
several O +
recent O +
articles O +
and O +
chapters O +
[ O -
13 O -
- O -
15 O -
] O -
. O +

With O +
respect O +
to O +
the O +
genes O +
measured O +
in O +
this O +
study O -
, O +
for O +
each O +
gene O +
the O +
StaRT O -
- O -
PCR O +
reagents B-Chemical +
had O +
lower O +
detection O +
threshold O +
of O +
less O +
than O +
10 O +
molecules B-Chemical -
, O +
linear O +
dynamic O +
range O +
of O +
more O +
than O +
six O +
orders O +
of O +
magnitude O +
( O -
less O +
than O +
10 O +
to O +
over O +
107 O +
molecules B-Chemical -
) O -
, O +
and O +
signal O -
- O -
to O -
- O -
analyte O +
response O +
of O +
100 O -
% O -
. O +

In O +
addition O -
, O +
the O +
presence O +
of O +
an O +
internal O +
standard O +
controls O +
for O +
inter O -
- O -
sample O +
variation O +
in O +
presence O +
of O +
PCR O +
inhibitors B-Chemical +
( O -
which O +
often O +
are O +
gene O -
- O -
specific O -
) O +
and O +
ensures O +
no O +
false O +
negatives O +
( O -
if O +
the O +
PCR O +
fails O +
the O +
internal O +
standard O +
PCR O +
product O +
is O +
not O +
observed O +
and O +
there O +
are O +
no O +
data O +
to O +
report O -
) O -
. O +

False O +
positives O +
are O +
eliminated O +
through O +
use O +
of O +
a O +
control O +
PCR O +
reaction O +
with O +
no O +
cDNA O +
in O +
it O -
. O +

Statistical O +
analysis O +
More O +
than O +
6,000 O +
transcript O +
abundance O +
measurements O +
were O +
conducted O +
in O +
multiple O +
experiments O +
over O +
two O +
years O +
to O +
assess O +
the O +
six O +
transcription O +
factors O +
and O +
sixteen O +
antioxidant O +
and O +
DNA O +
repair O +
genes O +
in O +
NBEC O +
samples O +
from O +
49 O +
individuals O +
( O -
24 O +
non O -
- O -
BC O +
individuals O +
and O +
25 O +
BC O +
individuals O -
) O -
. O +

Correlation O +
of O +
each O +
of O +
the O +
six O +
transcription O +
factors O +
with O +
each O +
of O +
the O +
antioxidant O +
or O +
DNA O +
repair O +
genes O +
was O +
determined O +
by O +
Pearson O -
's O +
correlation O +
following O +
logarithmic O +
transformation O -
. O +

The O +
transformation O +
was O +
necessary O +
due O +
to O +
the O +
wide O +
biological O +
variation O +
in O +
expression O +
of O +
each O +
gene O +
among O +
the O +
individuals O -
. O +

Significance O +
level O +
was O +
defined O +
as O +
p O +
< O +
0.01 O +
following O +
Bonferroni O +
adjustment O +
for O +
multiple O +
comparison O -
, O +
specifically O +
comparison O +
of O +
each O +
of O +
six O +
transcription O +
factors O +
to O +
each O +
of O +
the O +
antioxidant O +
or O +
DNA O +
repair O +
genes O -
. O +

Comparison O +
for O +
significant O +
differences O +
between O +
pairs O +
of O +
correlation O +
coefficients O +
was O +
done O +
by O +
Fisher O -
's O +
Z O -
- O -
transformation O +
test O +
[ O -
16 O -
] O -
. O +

Analysis O +
of O +
the O +
relationship O +
between O +
virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
data O +
for O +
each O +
gene O +
with O +
age O +
was O +
assessed O +
by O +
Pearson O -
's O +
correlation O -
, O +
with O +
gender O +
by O +
t O -
- O -
test O -
, O +
and O +
with O +
smoking O +
history O +
by O +
ANOVA O +
followed O +
by O +
Duncan O -
's O +
test O -
. O +

Transcription O +
factor O +
recognition O +
site O +
analysis O +
The O +
El O +
Dorado O +
( O -
Build O +
35 O -
) O +
program O +
from O +
the O +
Genomatix O +
software O +
package O +
was O +
used O +
to O +
locate O +
the O +
correlated O +
genes O +
within O +
the O +
genome O +
and O +
define O +
1101 O +
base O +
pairs O +
of O +
the O +
promoter O +
regions O +
( O -
1000 O +
base O +
pairs O +
upstream O +
of O +
and O +
100 O +
base O +
pairs O +
into O +
the O +
transcription O +
start O +
site O -
) O +
for O +
each O +
gene O +
( O -
Genomatix O +
Software O +
GmbH O -
, O +
Munich O -
, O +
Germany O -
, O +
[ O -
17 O -
] O -
) O -
. O +

The O +
1101 O +
base O +
pair O +
sequences O +
obtained O +
from O +
the O +
El O +
Dorado O +
program O +
then O +
were O +
used O +
as O +
the O +
target O +
sequences O +
for O +
putative O +
transcription O +
factor O +
recognition O +
site O +
identification O +
using O +
the O +
MatInspector O +
Version O +
4.2 O +
program O -
, O +
which O +
yielded O +
sites O +
for O +
11 O +
transcription O +
factors O +
( O -
Genomatix O +
Software O +
GmbH O -
, O +
Munich O -
, O +
Germany O -
, O +
[ O -
17 O -
] O -
) O -
. O +

The O +
parameters O +
used O +
were O +
the O +
standard O +
( O -
0.75 O -
) O +
core O +
similarity O +
and O +
the O +
optimized O +
matrix O +
similarity O +
[ O -
18 O -
] O -
. O +

StaRT O -
- O -
PCR O +
reagents B-Chemical +
were O +
optimized O +
for O +
ten O +
of O +
these O +
transcription O +
factors O -
, O +
including O +
CEBPB O -
, O +
CEBPE O -
, O +
CEBPG O -
, O +
E2F1 O -
, O +
E2F3 O -
, O +
E2F4 O -
, O +
E2F5 O -
, O +
E2F6 O -
, O +
EVI1 O -
, O +
and O +
PAX5 O -
. O +

Four O +
transcription O +
factors O +
were O +
expressed O +
at O +
low O +
and O +
invariant O +
levels O +
among O +
multiple O +
NBEC O +
samples O +
and O +
were O +
therefore O +
excluded O +
from O +
the O +
study O -
. O +

The O +
remaining O +
six O -
, O +
CEBPB O -
, O +
CEBPG O -
, O +
E2F1 O -
, O +
E2F3 O -
, O +
E2F6 O -
, O +
and O +
EVI O -
, O +
were O +
evaluated O +
for O +
correlation O +
with O +
an O +
expanded O +
group O +
of O +
ten O +
antioxidant O +
and O +
six O +
DNA O +
repair O +
genes O -
. O +

Results O +
Virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
data O +
were O +
obtained O +
for O +
each O +
gene O +
in O +
each O +
of O +
the O +
49 O +
samples O -
, O +
except O +
for O +
E2F1 O +
measurement O +
in O +
sample O +
147 O +
( O -
Table O +
3 O -
) O -
. O +

A O +
gene O -
- O -
specific O +
inhibitor B-Chemical +
in O +
sample O +
147 O +
prevented O +
amplification O +
of O +
E2F1 O -
. O +

Neither O +
the O +
internal O +
standard O -
, O +
nor O +
the O +
native O +
cDNA O +
PCR O +
product O +
was O +
observed O -
. O +

The O +
presence O +
of O +
gene O -
- O -
specific O +
PCR O +
inhibition O +
was O +
observable O +
in O +
some O +
other O +
samples O +
as O +
reduction O +
in O +
peak O +
heights O +
in O +
internal O +
standard O +
PCR O +
products O +
relative O +
to O +
that O +
expected O +
for O +
the O +
number O +
of O +
internal O +
standard O +
molecules B-Chemical +
present O +
at O +
the O +
beginning O +
of O +
the O +
PCR O +
reaction O -
. O +

However O -
, O +
in O +
each O +
such O +
case O -
, O +
the O +
PCR O +
amplification O +
was O +
efficient O +
enough O +
to O +
enable O +
quantification O -
. O +

Bivariate O +
analysis O +
In O +
non O -
- O -
BC O +
individuals O +
there O +
was O +
significant O +
( O -
p O +
< O +
0.01 O -
) O +
correlation O +
between O +
CEBPG O +
and O +
eight O +
of O +
the O +
16 O +
antioxidant O +
or O +
DNA O +
repair O +
genes O -
, O +
specifically O +
XRCC1 O -
, O +
ERCC5 O -
, O +
GSTP1 O -
, O +
SOD1 O -
, O +
GPX1 O -
, O +
ERCC1 O -
, O +
CAT O +
and O +
ERCC2 O +
( O -
Table O +
4 O -
) O -
. O +

In O +
contrast O -
, O +
in O +
BC O +
individuals O +
samples O +
CEBPG O +
was O +
not O +
correlated O +
with O +
any O +
of O +
the O +
antioxidant O +
or O +
DNA O +
repair O +
genes O -
. O +

These O +
relationships O +
were O +
not O +
observed O +
with O +
any O +
of O +
the O +
other O +
transcription O +
factors O +
studied O -
. O +

For O +
XRCC1 O -
, O +
ERCC5 O -
, O +
GSTP1 O -
, O +
and O +
SOD1 O +
the O +
correlation O +
with O +
CEBPG O +
was O +
significantly O +
lower O +
in O +
BC O +
individuals O +
compared O +
to O +
non O -
- O -
BC O +
individuals O +
and O +
the O +
difference O +
was O +
nearly O +
significant O +
for O +
GPX1 O +
( O -
Fig. O +
1b O -
) O -
. O +

Scatter O +
plots O +
of O +
the O +
relationship O +
between O +
CEBPG O +
and O +
XRCC1 O +
in O +
non O -
- O -
BC O +
individuals O +
or O +
BC O +
individuals O +
( O -
Fig. O +
2a O -
, O -
b O -
) O +
are O +
representative O +
of O +
the O +
other O +
four O +
genes O -
. O +

Neither O +
CEBPG O -
, O +
nor O +
XRCC1 O -
, O +
ERCC5 O -
, O +
GSTP1 O -
, O +
SOD1 O +
or O +
GPX1 O +
was O +
significantly O +
correlated O +
with O +
age O -
, O +
gender O -
, O +
or O +
smoking O +
history O +
in O +
non O -
- O -
BC O +
individuals O -
, O +
BC O +
individuals O -
, O +
or O +
the O +
combined O +
group O -
. O +

In O +
non O -
- O -
BC O +
individuals O -
, O +
based O +
on O +
the O +
r2 O +
values O +
from O +
Pearson O -
's O +
correlation O +
analysis O -
, O +
CEBPG O +
accounts O +
for O +
much O +
of O +
the O +
variance O +
in O +
expression O +
of O +
XRCC1 O +
( O -
69 O -
% O -
) O -
, O +
ERCC5 O +
( O -
62 O -
% O -
) O -
, O +
GSTP1 O +
( O -
55 O -
% O -
) O -
, O +
SOD1 O +
( O -
44 O -
% O -
) O -
, O +
and O +
GPX1 O +
( O -
52 O -
% O -
) O -
. O +

E2F1 O +
accounts O +
for O +
some O +
of O +
the O +
remaining O +
variance O -
. O +

For O +
example O -
, O +
when O +
samples O +
from O +
all O +
49 O +
non O -
- O -
BC O +
individuals O +
and O +
BC O +
individuals O +
were O +
assessed O +
as O +
a O +
single O +
group O -
, O +
E2F1 O +
was O +
significantly O +
correlated O +
with O +
ERCC5 O -
, O +
GSTP1 O +
and O +
SOD1 O +
( O -
Table O +
4 O -
) O -
. O +

Further O -
, O +
in O +
non O -
- O -
BC O +
individuals O -
, O +
E2F1 O +
was O +
correlated O +
with O +
GSTP1 O +
( O -
Fig. O +
1c O -
) O +
and O +
the O +
correlation O +
was O +
lower O +
in O +
BC O +
individuals O -
. O +

However O -
, O +
the O +
difference O +
in O +
correlation O +
between O +
non O -
- O -
BC O +
individuals O +
and O +
BC O +
individuals O +
was O +
not O +
significant O -
. O +

None O +
of O +
the O +
other O +
transcription O +
factors O +
were O +
correlated O +
with O +
XRCC1 O -
, O +
ERCC5 O -
, O +
GSTP1 O -
, O +
SOD1 O -
, O +
or O +
GPX1 O +
( O -
Fig. O +
1a O -
, O -
d O -
, O -
e O -
, O -
f O -
) O -
. O +

Comparison O +
of O +
gene O +
expression O +
with O +
demographic O +
characteristics O +
E2F1 O +
and O +
GSTZ1 O +
each O +
were O +
positively O +
correlated O +
with O +
age O -
. O +

GSTM1 O -
- O -
5 O +
was O +
the O +
only O +
gene O +
with O +
a O +
difference O +
in O +
expression O +
by O +
gender O -
. O +

There O +
was O +
a O +
difference O +
in O +
ERCC2 O +
expression O +
between O +
former O +
and O +
never O +
smokers O -
. O +

Discussion O +
In O +
this O +
study O -
, O +
we O +
tested O +
two O +
hypotheses O -
. O +

First O -
, O +
that O +
there O +
is O +
inter O -
- O -
individual O +
variation O +
in O +
regulation O +
of O +
key O +
antioxidant O +
and O +
DNA O +
repair O +
genes O +
by O +
one O +
or O +
more O +
transcription O +
factors O -
. O +

Second O -
, O +
that O +
individuals O +
with O +
sub O -
- O -
optimal O +
regulation O +
are O +
selected O +
for O +
development O +
of O +
BC O +
if O +
they O +
smoke O +
cigarettes O -
. O +

These O +
hypotheses O +
are O +
supported O +
by O +
the O +
findings O +
that O +
a O -
) O +
there O +
was O +
large O +
inter O -
- O -
individual O +
variation O +
in O +
transcript O +
levels O +
of O +
CEBPG O +
and O +
each O +
of O +
the O +
target O +
genes O +
and O +
in O +
non O -
- O -
BC O +
individuals O -
, O +
b O -
) O +
CEBPG O +
transcript O +
abundance O +
values O +
were O +
significantly O +
correlated O +
by O +
bivariate O +
analysis O +
with O +
the O +
transcript O +
abundance O +
values O +
of O +
four O +
key O +
antioxidant O +
and O +
DNA O +
repair O +
genes O +
in O +
non O -
- O -
BC O +
individuals O -
, O +
and O +
c O -
) O +
that O +
there O +
was O +
no O +
correlation O +
between O +
CEBPG O +
and O +
these O +
genes O +
in O +
BC O +
individuals O -
. O +

These O +
results O +
support O +
the O +
hypothesis O +
that O +
each O +
of O +
the O +
antioxidant O +
or O +
DNA O +
repair O +
genes O +
correlated O +
with O +
CEBPG O +
in O +
non O -
- O -
BC O +
individuals O +
is O +
regulated O +
by O +
CEBPG O -
. O +

This O +
is O +
supported O +
by O +
the O +
specificity O +
of O +
the O +
CEBPG O +
correlation O -
. O +

That O +
is O -
, O +
there O +
was O +
lack O +
of O +
correlation O +
between O +
any O +
of O +
the O +
other O +
five O +
transcription O +
factors O +
assessed O +
and O +
these O +
target O +
genes O -
. O +

Of O +
particular O +
note O +
is O +
the O +
lack O +
of O +
correlation O +
of O +
the O +
target O +
genes O +
with O +
CEBPB O -
, O +
which O +
binds O +
to O +
the O +
same O +
recognition O +
site O +
as O +
CEBPG O -
, O +
and O +
shares O +
its O +
recognition O +
site O +
within O +
each O +
of O +
the O +
antioxidant O +
or O +
DNA O +
repair O +
genes O -
. O +

However O -
, O +
there O +
are O +
alternative O +
explanations O +
for O +
the O +
observed O +
correlation O +
of O +
CEBPG O +
with O +
antioxidant O +
and O +
DNA O +
repair O +
genes O +
in O +
non O -
- O -
BC O +
individuals O -
. O +

One O +
possibility O +
is O +
that O +
CEBPG O +
and O +
each O +
of O +
the O +
correlated O +
antioxidant O +
or O +
DNA O +
repair O +
genes O +
is O +
regulated O +
by O +
a O +
transcription O +
factor O +
that O +
is O +
as O +
yet O +
undiscovered O -
, O +
and/or O +
has O +
a O +
recognition O +
site O +
that O +
is O +
not O +
yet O +
known O +
and O +
was O +
not O +
in O +
the O +
Genomatix O +
software O +
database O -
. O +

There O +
also O +
is O +
more O +
than O +
one O +
possible O +
explanation O +
for O +
the O +
observed O +
lack O +
of O +
correlation O +
between O +
CEBPG O +
and O +
antioxidant O +
or O +
DNA O +
repair O +
genes O +
in O +
BC O +
individuals O -
. O +

For O +
example O -
, O +
the O +
non O -
- O -
BC O +
individual O +
and O +
BC O +
individual O +
groups O +
are O +
not O +
perfectly O +
matched O +
with O +
respect O +
to O +
age O -
, O +
gender O +
or O +
smoking O +
history O +
( O -
Table O +
1 O -
) O +
and O +
each O +
of O +
these O +
factors O +
could O +
contribute O +
to O +
the O +
observed O +
difference O +
in O +
correlation O +
between O +
groups O -
. O +

However O -
, O +
the O +
lack O +
of O +
association O +
of O +
transcript O +
abundance O +
level O +
for O +
CEBPG O -
, O +
XRCC1 O -
, O +
ERCC5 O -
, O +
GSTP1 O -
, O +
SOD1 O -
, O +
or O +
GPX1 O +
with O +
age O -
, O +
gender O +
or O +
smoking O +
history O +
argues O +
against O +
such O +
an O +
explanation O -
. O +

One O +
way O +
to O +
examine O +
this O +
possibility O +
is O +
through O +
additional O -
, O +
larger O -
, O +
more O +
closely O +
matched O +
studies O -
. O +

Another O +
possible O +
explanation O +
is O +
that O +
any O +
differences O +
in O +
NBEC O +
from O +
BC O +
individuals O +
compared O +
to O +
non O -
- O -
BC O +
individuals O +
resulted O +
from O +
development O +
of O +
BC O -
, O +
instead O +
of O +
being O +
a O +
hereditary O +
cause O +
of O +
increased O +
risk O +
for O +
cancer O -
. O +

The O +
best O +
way O +
to O +
determine O +
this O +
will O +
be O +
to O +
conduct O +
a O +
prospective O +
study O -
. O +

In O +
such O +
a O +
study O -
, O +
individuals O +
matched O +
for O +
smoking O +
history O +
will O +
be O +
monitored O +
for O +
development O +
of O +
BC O +
over O +
time O -
. O +

The O +
correlation O +
of O +
transcript O +
abundance O +
values O +
for O +
CEBPG O +
relative O +
to O +
transcript O +
abundance O +
values O +
for O +
each O +
of O +
the O +
antioxidant O +
or O +
DNA O +
repair O +
genes O +
will O +
be O +
assessed O -
. O +

It O +
is O +
expected O +
that O +
the O +
greatest O +
incidence O +
of O +
BC O +
will O +
be O +
among O +
the O +
heaviest O +
smokers O -
. O +

Among O +
the O +
matched O +
heaviest O +
smokers O -
, O +
it O +
is O +
expected O +
that O +
CEBPG O +
will O +
be O +
significantly O +
correlated O +
with O +
each O +
of O +
the O +
antioxidant O +
or O +
DNA O +
repair O +
genes O +
among O +
the O +
non O -
- O -
BC O +
individuals O +
but O +
not O +
correlated O +
in O +
BC O +
individuals O -
. O +

Thus O -
, O +
there O +
are O +
multiple O +
possible O +
explanations O +
for O +
the O +
observed O +
findings O -
. O +

However O -
, O +
based O +
on O +
the O +
preponderance O +
of O +
data O +
thus O +
far O +
available O -
, O +
we O +
conclude O +
that O +
CEBPG O +
is O +
responsible O +
for O +
optimal O +
transcriptional O +
regulation O +
of O +
key O +
antioxidant O +
or O +
DNA O +
repair O +
genes O +
in O +
NBEC O +
and O +
that O +
there O +
is O +
inter O -
- O -
individual O +
variation O +
in O +
the O +
regulation O +
of O +
each O +
of O +
these O +
genes O +
by O +
CEBPG O -
. O +

If O +
this O +
conclusion O +
is O +
correct O -
, O +
the O +
individuals O +
at O +
greatest O +
risk O +
for O +
BC O +
will O +
be O +
those O +
with O +
the O +
most O +
extreme O +
smoking O +
history O +
combined O +
with O +
sub O -
- O -
optimal O +
regulation O +
of O +
the O +
largest O +
number O +
of O +
antioxidant O +
and O +
DNA O +
repair O +
genes O -
. O +

This O -
, O +
in O +
turn O -
, O +
leads O +
to O +
increased O +
representation O +
among O +
BC O +
individuals O +
of O +
individuals O +
with O +
lack O +
of O +
correlation O +
between O +
CEBPG O +
and O +
each O +
of O +
the O +
affected O +
antioxidant O +
and/or O +
DNA O +
repair O +
genes O -
. O +

CEBPG O +
is O +
a O +
truncated O +
CEBP O +
transcription O +
factor O +
[ O -
19 O -
] O +
and O +
possesses O +
the O +
sequences O +
necessary O +
for O +
DNA O +
binding O +
and O +
heterodimer O +
formation O -
, O +
but O +
lacks O +
the O +
sequences O +
necessary O +
for O +
transactivation O +
[ O -
20 O -
] O -
. O +

CEBPG O +
forms O +
heterodimers O +
with O +
other O +
CEBP O +
family O +
members O +
and O +
in O +
other O +
tissues O +
this O +
leads O +
to O +
increased O +
[ O -
21 O -
] O +
or O +
decreased O +
[ O -
20 O -
] O +
transcription O +
of O +
the O +
regulated O +
gene O -
. O +

CEBPG O +
is O +
known O +
to O +
have O +
stimulatory O +
effect O +
on O +
the O +
IL-6 O +
and O +
IL-8 O +
promoters O +
in O +
B O +
cell O +
lines O +
[ O -
21 O -
] O -
, O +
and O +
can O +
also O +
act O +
as O +
a O +
dominant O +
negative O +
regulator O +
of O +
CEBPA O +
and O +
CEBPB O +
in O +
fibroblast O +
and O +
B O +
cell O +
lines O +
[ O -
20 O -
] O -
. O +

The O +
data O +
from O +
CEBPG O +
knockout O +
mice O +
support O +
a O +
role O +
for O +
CEBPG O +
in O +
protecting O +
lungs O +
from O +
oxidant O +
damage O -
. O +

CEBPG- O -
/ O -
- O +
knockout O +
mice O +
are O +
healthy O +
at O +
birth O +
but O +
begin O +
to O +
die O +
within O +
24 O +
hours O -
, O +
and O +
histological O +
examination O +
reveals O +
emphysematous O +
lungs O +
[ O -
22 O -
] O -
. O +

In O +
humans O -
, O +
risk O +
for O +
emphysema O +
is O +
associated O +
with O +
antioxidant O +
capacity O +
[ O -
23 O -
] O -
, O +
and O +
there O +
is O +
a O +
strong O +
correlation O +
between O +
risk O +
for O +
emphysema O +
and O +
risk O +
for O +
BC O -
. O +

However O -
, O +
it O +
will O +
be O +
important O +
to O +
obtain O +
direct O +
experimental O +
evidence O +
in O +
NBECs O +
for O +
the O +
role O +
of O +
CEBPG O +
in O +
regulating O +
the O +
antioxidant O +
and O +
DNA O +
repair O +
genes O +
included O +
in O +
this O +
study O -
. O +

Correlation O +
between O +
CEBPG O +
and O +
target O +
gene O +
transcript O +
levels O +
may O +
not O +
be O +
associated O +
with O +
correlation O +
at O +
the O +
protein O +
level O -
. O +

In O +
this O +
study O -
, O +
E2F1 O +
correlation O +
with O +
DNA O +
repair O +
and O +
antioxidant O +
genes O +
was O +
less O +
than O +
the O +
correlation O +
observed O +
with O +
CEBPG O -
, O +
and O +
the O +
E2F1 O +
correlation O +
was O +
observed O +
in O +
both O +
non O -
- O -
BC O +
individuals O +
as O +
well O +
as O +
BC O +
individuals O -
. O +

The O +
maintained O +
correlation O +
of O +
E2F1 O +
with O +
DNA O +
repair O +
and O +
antioxidant O +
genes O +
in O +
BC O +
individuals O +
suggests O +
that O +
this O +
function O +
is O +
more O +
tightly O +
controlled O +
in O +
the O +
population O +
and O +
does O +
not O +
play O +
a O +
role O +
in O +
determination O +
of O +
risk O +
for O +
BC O -
. O +

E2F1 O +
has O +
previously O +
been O +
reported O +
to O +
regulate O +
transcription O +
of O +
DNA O +
repair O +
enzyme O +
genes O +
in O +
other O +
cell O +
types O -
, O +
including O +
primary O +
human O +
fibroblasts O +
and O +
mouse O +
epidermal O +
cells O +
[ O -
24,25 O -
] O -
. O +

Clearly O +
this O +
would O +
have O +
survival O +
value O +
since O +
DNA O +
repair O +
gene O +
up O -
- O -
regulation O +
in O +
response O +
to O +
E2F1 O +
provides O +
additional O +
DNA O +
repair O +
when O +
the O +
DNA O +
is O +
replicating O +
and O +
is O +
particularly O +
vulnerable O +
to O +
damage O -
. O +

Epidemiologic O +
assessment O +
of O +
the O +
correlation O +
between O +
a O +
particular O +
variation O +
in O +
DNA O +
sequence O -
, O +
or O +
polymorphism O -
, O +
and O +
risk O +
for O +
BC O +
has O +
been O +
a O +
dominant O +
paradigm O +
for O +
many O +
years O -
. O +

Thus O +
far O -
, O +
these O +
efforts O +
have O +
met O +
with O +
scant O +
success O +
[ O -
26 O -
] O -
. O +

A O +
common O +
limitation O +
in O +
design O +
of O +
such O +
studies O +
is O +
that O +
they O +
involve O +
assessment O +
of O +
a O +
single O +
polymorphism O +
or O +
occasionally O -
, O +
a O +
few O +
polymorphisms O -
. O +

Further O -
, O +
although O +
the O +
polymorphism O +
assessed O +
typically O +
resides O +
within O +
a O +
gene O +
known O +
to O +
protect O +
bronchial O +
epithelium O +
from O +
carcinogens B-Chemical -
, O +
oxidants B-Chemical -
, O +
or O +
DNA O +
damage O -
, O +
the O +
selection O +
of O +
the O +
particular O +
polymorphism O +
for O +
study O +
is O +
largely O +
empiric O -
, O +
and O +
not O +
based O +
on O +
known O +
functional O +
properties O -
. O +

These O +
are O +
problems O +
because O +
multiple O +
infrequent O +
polymorphisms O +
at O +
different O +
sites O +
may O +
all O +
contribute O +
to O +
risk O +
and O +
unless O +
the O +
key O +
polymorphisms O +
can O +
be O +
identified O +
through O +
a O +
functional O +
test O -
, O +
a O +
statistically O +
valid O +
assessment O +
would O +
require O +
much O +
larger O +
study O +
populations O +
[ O -
27 O -
] O -
. O +

The O +
findings O +
of O +
this O +
study O +
support O +
a O +
novel O +
approach O +
to O +
identifying O +
clinically O +
useful O +
biomarkers O -
. O +

According O +
to O +
the O +
paradigm O +
used O +
in O +
this O +
study O -
, O +
a O -
) O +
a O +
normal O +
phenotype O +
results O +
from O +
regulated O +
transcription O +
of O +
a O +
group O +
of O +
genes O +
by O +
one O +
or O +
more O +
transcription O +
factors O -
, O +
b O -
) O +
the O +
corresponding O +
risk O -
- O -
conferring O +
or O +
disease O +
phenotype O +
results O +
from O +
sub O -
- O -
optimal O +
interaction O +
among O +
those O +
same O +
genes O -
, O +
and O +
c O -
) O +
each O +
phenotype O +
is O +
identifiable O +
and O +
distinguishable O +
through O +
virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
analysis O -
. O +

The O +
data O +
presented O +
here O +
support O +
the O +
utility O +
of O +
this O +
paradigm O +
in O +
identifying O +
genes O +
associated O +
with O +
risk O +
for O +
BC O -
. O +

The O +
next O +
step O +
will O +
be O +
to O +
identify O +
polymorphisms O +
that O +
affect O +
regulation O +
of O +
XRCC1 O -
, O +
ERCC5 O -
, O +
GSTP1 O -
, O +
SOD1 O -
, O +
and O +
GPX1 O +
by O +
CEBPG O -
. O +

Such O +
polymorphisms O +
should O +
yield O +
biomarkers O +
suitable O +
for O +
more O +
readily O +
accessible O +
samples O -
, O +
such O +
as O +
peripheral O +
blood O +
or O +
buccal O +
smears O -
. O +

A O +
biomarker O +
combining O +
polymorphisms O +
that O +
affect O +
regulation O +
with O +
those O +
that O +
affect O +
function O +
of O +
antioxidant O +
and O +
DNA O +
repair O +
genes O +
is O +
likely O +
to O +
be O +
the O +
most O +
accurate O +
for O +
identifying O +
individuals O +
at O +
risk O +
for O +
BC O -
. O +

Biomarkers O +
that O +
accurately O +
identify O +
individuals O +
at O +
risk O +
for O +
BC O +
will O +
improve O +
efficacy O +
of O +
chemoprevention O +
and O +
early O +
detection O +
clinical O +
trials O -
. O +

The O +
observed O +
inter O -
- O -
sample O +
variation O +
in O +
the O +
presence O +
of O +
gene O -
- O -
specific O +
inhibitors B-Chemical +
of O +
PCR O +
provides O +
evidence O +
supporting O +
the O +
need O +
for O +
inclusion O +
of O +
an O +
internal O +
standard O +
in O +
each O +
quantitative O +
PCR O +
transcript O +
abundance O +
measurement O -
. O +

Including O +
such O +
internal O +
standards O +
in O +
the O +
form O +
of O +
standardized O +
mixtures O +
of O +
internal O +
standards O +
improves O +
the O +
reproducibility O +
of O +
transcript O +
abundance O +
measurement O +
and O +
enables O +
development O +
of O +
a O +
standardized O +
database O +
comprising O +
virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
data O -
. O +

Virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
data O +
are O +
highly O +
suited O +
to O +
identification O +
of O +
genes O +
that O +
have O +
correlated O +
transcript O +
abundance O +
values O -
. O +

Correlation O +
at O +
the O +
transcript O +
abundance O +
level O +
is O +
an O +
important O +
property O +
of O +
genes O +
that O +
are O +
co O -
- O -
regulated O +
at O +
the O +
transcription O +
level O -
. O +

Conclusion O +
We O +
conclude O +
that O +
in O +
non O -
- O -
BC O +
individuals O -
, O +
CEBPG O +
regulates O +
transcription O +
of O +
key O +
antioxidant O +
or O +
DNA O +
repair O +
genes O +
in O +
NBEC O +
and O +
that O +
in O +
smokers O +
who O +
develop O +
BC O -
, O +
CEBPG O +
regulation O +
is O +
sub O -
- O -
optimal O +
for O +
a O +
sufficient O +
number O +
of O +
antioxidant O +
and/or O +
DNA O +
repair O +
genes O +
to O +
cause O +
increased O +
risk O -
. O +

Competing O +
interests O +
JCW O +
and O +
ELC O +
each O +
have O +
significant O +
equity O +
interest O +
in O +
Gene O +
Express O -
, O +
Inc. O -
, O +
which O +
produces O +
and O +
markets O +
StaRT O -
- O -
PCR O -
™ O +
reagents B-Chemical +
used O +
in O +
this O +
study O -
. O +

Authors O -
' O +
contributions O +
DNM O +
participated O +
in O +
the O +
design O +
of O +
the O +
study O -
, O +
performed O +
the O +
TF O +
identification O -
, O +
carried O +
out O +
TA O +
measurements O -
, O +
coordinated O +
and O +
participated O +
in O +
the O +
statistical O +
analysis O +
and O +
drafted O +
the O +
manuscript O -
. O +

ELC O +
contributed O +
the O +
preliminary O +
data O -
, O +
participated O +
in O +
the O +
design O +
of O +
the O +
study O +
and O +
carried O +
out O +
TA O +
measurements O -
. O +

SAK O +
performed O +
the O +
statistical O +
analysis O +
for O +
interpretation O +
of O +
data O -
. O +

DAH O +
and O +
YY O +
consented O +
patients O +
and O +
obtained O +
the O +
primary O +
samples O +
necessary O +
for O +
the O +
study O +
according O +
to O +
IRB O +
regulations O -
. O +

JCW O +
conceived O +
of O +
the O +
study O -
, O +
participated O +
in O +
its O +
design O +
and O +
coordination O -
, O +
and O +
helped O +
to O +
draft O +
the O +
manuscript O -
. O +

All O +
authors O +
read O +
and O +
approved O +
the O +
final O +
manuscript O -
. O +

Pre O -
- O -
publication O +
history O +
The O +
pre O -
- O -
publication O +
history O +
for O +
this O +
paper O +
can O +
be O +
accessed O +
here O -
: O +
Acknowledgements O +
These O +
studies O +
and O +
manuscript O +
preparation O +
were O +
supported O +
by O +
grants O +
from O +
the O +
National O +
Cancer O +
Institute O +
( O -
NCI O -
) O -
, O +
including O +
CA85147 O +
and O +
CA O +
95806 O -
, O +
and O +
the O +
George O +
Isaac O +
Cancer O +
Research O +
Fund O -
. O +

StaRT O -
- O -
PCR O +
reagents B-Chemical +
for O +
measurement O +
of O +
some O +
of O +
the O +
genes O +
were O +
provided O +
at O +
no O +
cost O +
by O +
Gene O +
Express O -
, O +
Inc. O +
Neither O +
the O +
NCI O +
nor O +
Gene O +
Express O -
, O +
Inc. O +
had O +
any O +
role O +
in O +
study O +
design O -
, O +
collection O -
, O +
analysis O -
, O +
or O +
interpretation O +
of O +
data O -
, O +
writing O +
of O +
the O +
manuscript O -
, O +
or O +
in O +
the O +
decision O +
to O +
submit O +
the O +
manuscript O +
for O +
publication O -
. O +

Figures O +
and O +
Tables O +
Figure O +
1 O +
Correlation O +
of O +
each O +
transcription O +
factor O +
with O +
XRCC1 O -
, O +
ERCC5 O -
, O +
GSTP1 O -
, O +
SOD1 O -
, O +
or O +
GPX1 O -
. O +

( O -
a O -
- O -
f O -
) O +

Each O +
panel O +
presents O +
the O +
correlation O +
coefficients O +
( O -
r O +
values O -
) O +
for O +
one O +
transcription O +
factor O +
in O +
relation O +
to O +
each O +
of O +
the O +
five O +
genes O -
: O +
( O -
a O -
) O +
CEBPB O -
, O +
( O -
b O -
) O +
CEBPG O -
, O +
( O -
c O -
) O +
E2F1 O -
, O +
( O -
d O -
) O +
E2F3 O -
, O +
( O -
e O -
) O +
E2F6 O -
, O +
( O -
f O -
) O +
EVI1 O -
. O +

The O +
p O +
value O +
for O +
each O +
significant O +
correlation O +
is O +
provided O +
above O +
the O +
bar O -
. O +

For O +
CEBPG O -
, O +
presented O +
in O +
panel O +
b O -
, O +
the O +
difference O +
in O +
r O +
value O +
between O +
non O -
- O -
BC O +
individuals O +
and O +
BC O +
individuals O +
was O +
significant O +
or O +
nearly O +
significant O +
for O +
each O +
correlated O +
gene O -
, O +
and O +
the O +
p O +
value O +
for O +
each O +
comparison O +
is O +
provided O +
below O +
the O +
corresponding O +
pair O +
of O +
bars O -
. O +

Figure O +
2 O +
Scatter O +
plot O +
representation O +
of O +
bivariate O +
correlation O +
of O +
CEBPG O +
with O +
XRCC1 O -
. O +

( O -
a O -
, O +
b O -
) O +
CEBPG O -
/ O -
XRCC1 O +
data O +
from O +
Figure O +
1b O +
presented O +
as O +
scatter O +
plots O -
: O +
( O -
a O -
) O +
non O -
- O -
BC O +
individuals O -
, O +
( O -
b O -
) O +
BC O +
individuals O -
. O +

Table O +
1 O +
Demographic O +
data O +
of O +
patients O +
from O +
whom O +
the O +
NBEC O +
samples O +
were O +
obtained O -
. O +

1Pack O +
years O -
; O +
2Non O -
- O -
bronchogenic O +
carcinoma O +
individual O -
; O +
3White O -
; O +
4African O -
- O -
American O -
; O +
5Non O -
- O -
smoker O -
; O +
6Not O +
available O -
; O +
7Hispanic O -
; O +
8Bronchogenic O +
carcinoma O +
individual O -
; O +
9Non O -
- O -
small O +
cell O +
lung O +
cancer O -
; O +
10Squamous O +
carcinoma O -
; O +
11Small O +
cell O +
lung O +
cancer O -
; O +
12Carcinoma O -
- O -
in O -
- O -
situ O -
; O +
13Adenocarcinoma;14Bronchogenic O +
Cancer O -
, O +
histology O +
not O +
specified O -
; O +
15Poorly O +
differentiated O +
carcinoma O -
. O +

Table O +
2 O +
Sequence O +
for O +
each O +
primer O +
used O +
for O +
StaRT O -
- O -
PCR O +
virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
measurement O +
or O +
for O +
internal O +
standard O +
preparation O +
( O -
CT O -
) O +
[ O -
15 O -
] O -
. O +

Table O +
3 O +
Virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
data O -
. O +

Virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
data O +
for O +
each O +
gene O +
( O -
in O +
the O +
form O +
of O +
molecules B-Chemical -
/ O -
106 O +
β O -
- O -
actin O +
molecules B-Chemical -
) O +
from O +
all O +
experiments O +
were O +
included O +
in O +
the O +
same O +
Standardized O +
Expression O +
Database O +
( O -
SED O -
) O -
. O +

These O +
data O +
are O +
now O +
directly O +
comparable O +
to O +
previously O +
published O +
virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
data O +
from O +
this O +
laboratory O +
[ O -
15 O -
] O -
, O +
or O +
to O +
Virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
data O +
collected O +
by O +
others O +
who O +
use O +
the O +
NCI O -
- O -
funded O +
( O -
R24 O +
CA O +
95806 O -
) O +
Standardized O +
Expression O +
Measurement O +
( O -
SEM O -
) O +
Center O -
. O +

The O +
data O +
presented O +
here O +
represent O +
more O +
than O +
6,000 O +
Virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
measurements O +
conducted O +
in O +
multiple O +
experiments O -
. O +

The O +
sixteen O +
antioxidant O +
or O +
DNA O +
repair O +
genes O +
and O +
each O +
of O +
the O +
six O +
transcription O +
factors O +
except O +
for O +
E2F1 O +
were O +
measured O +
in O +
each O +
NBEC O +
sample O +
from O +
49 O +
individuals O +
( O -
24 O +
non O -
- O -
BC O +
individuals O +
and O +
25 O +
BC O +
individuals O -
) O -
. O +

1ND O -
, O +
Not O +
detectable O +
( O -
When O +
60 O +
molecules B-Chemical +
of O +
Competitive O +
Template O +
( O -
CT O -
) O +
were O +
added O +
to O +
the O +
reaction O -
, O +
CT O +
was O +
detected O +
but O +
native O +
template O +
was O +
not O -
. O -
) O +
2NA O -
, O +
Not O +
available O -
. O +

E2F1 O +
was O +
measured O +
in O +
all O +
of O +
the O +
samples O +
except O +
for O +
one O +
BC O +
individual O +
( O -
24 O +
non O -
- O -
BC O +
individuals O +
and O +
24 O +
BC O +
individuals O -
) O -
. O +

Table O +
4 O +
Bivariate O +
analysis O +
of O +
virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
data O +
values O +
for O +
each O +
antioxidant O +
or O +
DNA O +
repair O +
gene O +
versus O +
each O +
transcription O +
factor O -
. O +

The O +
correlation O +
of O +
logarithmically O +
transformed O +
virtually O -
- O -
multiplexed O +
transcript O +
abundance O +
data O +
( O -
Table O +
3 O -
) O +
from O +
each O +
of O +
the O +
six O +
transcription O +
factors O +
with O +
each O +
of O +
the O +
sixteen O +
antioxidant O +
or O +
DNA O +
repair O +
genes O +
was O +
determined O -
. O +

The O +
transformation O +
was O +
necessary O +
due O +
to O +
the O +
wide O +
range O +
of O +
expression O +
of O +
each O +
gene O +
among O +
the O +
samples O -
. O +

The O +
correlation O +
coefficient O +
( O -
r O +
value O -
) O +
and O +
level O +
of O +
significance O +
( O -
p O +
value O -
) O +
for O +
each O +
correlation O +
are O +
presented O -
. O +

Significance O +
( O -
p O +
< O +
0.01 O -
) O +
was O +
determined O +
using O +
a O +
two O -
- O -
tailed O +
test O +
following O +
Bonferroni O +
adjustment O +
for O +
six O +
multiple O +
comparisons O +
( O -
comparison O +
of O +
each O +
of O +
six O +
transcription O +
factors O +
to O +
each O +
of O +
the O +
antioxidant O +
or O +
DNA O +
repair O +
genes O -
) O -
. O +

* O -
values O +
for O +
E2F1 O +
obtained O +
in O +
all O +
but O +
one O +
BC O +
individuals O -
. O +

Production O +
and O +
characterization O +
of O +
murine O +
models O +
of O +
classic O +
and O +
intermediate O +
maple O +
syrup O +
urine O +
disease O +
Abstract O +
Background O +
Maple O +
Syrup O +
Urine O +
Disease O +
( O -
MSUD O -
) O +
is O +
an O +
inborn O +
error O +
of O +
metabolism O +
caused O +
by O +
a O +
deficiency O +
of O +
branched O -
- O -
chain O +
keto B-Chemical +
acid I-Chemical +
dehydrogenase O -
. O +

MSUD O +
has O +
several O +
clinical O +
phenotypes O +
depending O +
on O +
the O +
degree O +
of O +
enzyme O +
deficiency O -
. O +

Current O +
treatments O +
are O +
not O +
satisfactory O +
and O +
require O +
new O +
approaches O +
to O +
combat O +
this O +
disease O -
. O +

A O +
major O +
hurdle O +
in O +
developing O +
new O +
treatments O +
has O +
been O +
the O +
lack O +
of O +
a O +
suitable O +
animal O +
model O -
. O +

Methods O +
To O +
create O +
a O +
murine O +
model O +
of O +
classic O +
MSUD O -
, O +
we O +
used O +
gene O +
targeting O +
and O +
embryonic O +
stem O +
cell O +
technologies O +
to O +
create O +
a O +
mouse O +
line O +
that O +
lacked O +
a O +
functional O +
E2 O +
subunit O +
gene O +
of O +
branched O -
- O -
chain O +
keto B-Chemical +
acid I-Chemical +
dehydrogenase O -
. O +

To O +
create O +
a O +
murine O +
model O +
of O +
intermediate O +
MSUD O -
, O +
we O +
used O +
transgenic O +
technology O +
to O +
express O +
a O +
human O +
E2 O +
cDNA O +
on O +
the O +
knockout O +
background O -
. O +

Mice O +
of O +
both O +
models O +
were O +
characterized O +
at O +
the O +
molecular O -
, O +
biochemical O -
, O +
and O +
whole O +
animal O +
levels O -
. O +

Results O +
By O +
disrupting O +
the O +
E2 O +
subunit O +
gene O +
of O +
branched O -
- O -
chain O +
keto B-Chemical +
acid I-Chemical +
dehydrogenase O -
, O +
we O +
created O +
a O +
gene O +
knockout O +
mouse O +
model O +
of O +
classic O +
MSUD O -
. O +

The O +
homozygous O +
knockout O +
mice O +
lacked O +
branched O -
- O -
chain O +
keto B-Chemical +
acid I-Chemical +
dehydrogenase O +
activity O -
, O +
E2 O +
immunoreactivity O -
, O +
and O +
had O +
a O +
3-fold O +
increase O +
in O +
circulating O +
branched B-Chemical -
- I-Chemical -
chain I-Chemical +
amino I-Chemical +
acids I-Chemical -
. O +

These O +
metabolic O +
derangements O +
resulted O +
in O +
neonatal O +
lethality O -
. O +

Transgenic O +
expression O +
of O +
a O +
human O +
E2 O +
cDNA O +
in O +
the O +
liver O +
of O +
the O +
E2 O +
knockout O +
animals O +
produced O +
a O +
model O +
of O +
intermediate O +
MSUD O -
. O +

Branched O -
- O -
chain O +
keto B-Chemical +
acid I-Chemical +
dehydrogenase O +
activity O +
was O +
5–6 O -
% O +
of O +
normal O +
and O +
was O +
sufficient O +
to O +
allow O +
survival O -
, O +
but O +
was O +
insufficient O +
to O +
normalize O +
circulating O +
branched B-Chemical -
- I-Chemical -
chain I-Chemical +
amino I-Chemical +
acids I-Chemical +
levels O -
, O +
which O +
were O +
intermediate O +
between O +
wildtype O +
and O +
the O +
classic O +
MSUD O +
mouse O +
model O -
. O +

Conclusion O +
These O +
mice O +
represent O +
important O +
animal O +
models O +
that O +
closely O +
approximate O +
the O +
phenotype O +
of O +
humans O +
with O +
the O +
classic O +
and O +
intermediate O +
forms O +
of O +
MSUD O -
. O +

These O +
animals O +
provide O +
useful O +
models O +
to O +
further O +
characterize O +
the O +
pathogenesis O +
of O +
MSUD O -
, O +
as O +
well O +
as O +
models O +
to O +
test O +
novel O +
therapeutic O +
strategies O -
, O +
such O +
as O +
gene O +
and O +
cellular O +
therapies O -
, O +
to O +
treat O +
this O +
devastating O +
metabolic O +
disease O -
. O +

Background O +
Maple O +
Syrup O +
Urine O +
Disease O +
( O -
MSUD O -
) O +
is O +
a O +
genetic O +
disorder O +
caused O +
by O +
a O +
deficiency O +
of O +
branched O -
- O -
chain O +
keto B-Chemical +
acid I-Chemical +
dehydrogenase O +
( O -
BCKDH O -
) O -
, O +
a O +
mitochondrial O +
multienzyme O +
complex O +
responsible O +
for O +
the O +
oxidative O +
decarboxylation O +
of O +
branched O -
- O -
chain O +
keto B-Chemical +
acids I-Chemical +
derived O +
from O +
branched B-Chemical -
- I-Chemical -
chain I-Chemical +
amino I-Chemical +
acids I-Chemical +
( O -
BCAA B-Chemical -
) O -
, O +
leucine O -
, O +
isoleucine O +
and O +
valine O +
( O -
for O +
review O -
, O +
see O -
: O +
[ O -
1 O -
] O -
) O -
. O +

Patients O +
with O +
MSUD O -
, O +
depending O +
on O +
the O +
mutation O -
, O +
show O +
variable O +
degrees O +
of O +
enzyme O +
deficiency O +
leading O +
to O +
several O +
different O +
clinical O +
phenotypes O +
[ O -
1 O -
] O -
. O +

Approximately O +
75 O -
% O +
of O +
MSUD O +
patients O +
have O +
the O +
classic O +
form O +
of O +
the O +
disease O +
with O +
BCKDH O +
activity O +
in O +
the O +
range O +
of O +
0–2 O -
% O +
of O +
normal O +
[ O -
1 O -
] O -
. O +

These O +
patients O +
show O +
markedly O +
elevated O +
levels O +
of O +
BCAA B-Chemical +
in O +
blood O +
and O +
other O +
body O +
fluids O +
[ O -
1 O -
] O -
. O +

Besides O +
the O +
classic O +
form O -
, O +
there O +
are O +
other O +
variants O +
of O +
the O +
disease O -
. O +

Patients O +
with O +
the O +
intermediate O +
form O +
of O +
the O +
disease O +
show O +
BCKDH O +
activity O +
in O +
the O +
range O +
of O +
3–30 O -
% O +
of O +
normal O -
. O +

In O +
such O +
patients O +
the O +
onset O +
of O +
the O +
disease O +
is O +
delayed O -
, O +
but O +
there O +
are O +
persistently O +
elevated O +
levels O +
of O +
BCAA B-Chemical +
[ O -
1 O -
] O -
. O +

Patients O +
with O +
the O +
intermittent O +
form O +
of O +
MSUD O +
show O +
BCKDH O +
activity O +
in O +
the O +
range O +
of O +
5–20 O -
% O +
and O +
during O +
the O +
asymptomatic O +
phase O +
the O +
blood O +
BCAA B-Chemical +
levels O +
are O +
normal O +
[ O -
1 O -
] O -
. O +

The O +
overall O +
incidence O +
of O +
MSUD O +
in O +
the O +
general O +
population O +
is O +
1:185,000 O +
[ O -
1 O -
] O -
, O +
and O +
in O +
certain O +
population O +
groups O -
, O +
such O +
as O +
Mennonites O +
of O +
Pennsylvania O -
, O +
the O +
incidence O +
is O +
estimated O +
to O +
be O +
as O +
high O +
as O +
1:176 O +
[ O -
2 O -
] O -
. O +

The O +
BCKDH O +
complex O -
, O +
the O +
deficient O +
enzyme O +
in O +
MSUD O -
, O +
consists O +
of O +
three O +
catalytic O +
proteins O -
, O +
a O +
decarboxylase O +
( O -
E1 O -
) O -
, O +
a O +
dihydrolipoyl B-Chemical +
transacylase O +
( O -
E2 O -
) O -
, O +
and O +
a O +
dihydrolipoyl B-Chemical +
dehydrogenase O +
( O -
E3 O -
) O -
. O +

The O +
E1 O +
component O +
is O +
a O +
heterotetramer O +
composed O +
of O +
two O +
α O +
and O +
two O +
β O +
subunits O +
[ O -
3 O -
] O -
. O +

The O +
E1 O +
and O +
E2 O +
components O +
are O +
specific O +
to O +
BCKDH O -
, O +
whereas O +
E3 O +
is O +
also O +
used O +
by O +
pyruvate B-Chemical +
and O +
α O -
- O -
ketoglutarate O +
dehydrogenase O +
complexes O +
[ O -
3 O -
] O +
and O +
the O +
glycine O +
cleavage O +
system O +
[ O -
4 O -
] O -
. O +

BCKDH O +
is O +
also O +
associated O +
with O +
two O +
regulatory O +
proteins O -
, O +
a O +
specific O +
kinase O +
and O +
a O +
phosphatase O +
which O +
regulate O +
the O +
activity O +
of O +
this O +
enzyme O +
through O +
a O +
phosphorylation O +
( O -
inactivation O -
) O +
and O +
dephosphorylation O +
( O -
activation O -
) O +
cycle O +
of O +
the O +
E1 O +
α O +
subunit O +
[ O -
5,6 O -
] O -
. O +

Mutations O +
in O +
the O +
genes O +
of O +
the O +
E1 O +
and O +
E2 O +
subunits O +
of O +
BCKDH O +
have O +
been O +
described O -
, O +
however O -
, O +
the O +
majority O +
of O +
MSUD O +
mutations O +
identified O +
thus O +
far O +
are O +
in O +
the O +
E2 O +
subunit O +
[ O -
1,7 O -
] O -
. O +

To O +
date O -
, O +
cases O +
of O +
MSUD O +
have O +
not O +
been O +
associated O +
with O +
defects O +
in O +
the O +
regulatory O +
kinase O +
and O +
phosphatase O +
[ O -
1 O -
] O -
. O +

Current O +
management O +
of O +
MSUD O +
patients O +
relies O +
on O +
a O +
strict O +
lifelong O +
dietary O +
restriction O +
of O +
protein O +
or O +
BCAA B-Chemical +
[ O -
1,8 O -
] O -
. O +

Such O +
a O +
dietary O +
management O +
of O +
the O +
disease O -
, O +
however O -
, O +
is O +
not O +
entirely O +
satisfactory O +
especially O +
in O +
times O +
of O +
metabolic O +
decompensation O +
due O +
to O +
infection O -
, O +
injuries O +
and O +
other O +
stressors O -
. O +

In O +
spite O +
of O +
dietary O +
intervention O -
, O +
there O +
is O +
significant O +
mortality O +
associated O +
with O +
MSUD O +
and O +
there O +
is O +
a O +
high O +
incidence O +
of O +
mental O +
retardation O +
in O +
survivors O +
[ O -
9 O -
] O -
. O +

Because O +
of O +
the O +
central O +
role O +
of O +
the O +
liver O +
in O +
amino O +
acid O +
metabolism O +
and O +
moderate O -
/ O -
high O +
levels O +
of O +
BCKDH O +
activity O +
in O +
human O +
liver O +
[ O -
10 O -
- O -
12 O -
] O -
, O +
a O +
few O +
cases O +
of O +
MSUD O +
have O +
recently O +
been O +
treated O +
by O +
liver O +
transplantation O +
[ O -
13 O -
- O -
16 O -
] O -
. O +

While O +
the O +
short O -
- O -
term O +
outcome O +
of O +
liver O +
transplantation O +
is O +
encouraging O -
, O +
long O -
- O -
term O +
effects O +
of O +
this O +
approach O +
are O +
not O +
known O -
. O +

However O -
, O +
these O +
patients O +
are O +
now O +
required O +
to O +
take O +
immunosuppressant B-Chemical +
drugs B-Chemical +
for O +
the O +
rest O +
of O +
their O +
lives O -
, O +
often O +
with O +
undesirable O +
side O +
effects O -
. O +

Moreover O -
, O +
the O +
cost O +
associated O +
with O +
liver O +
transplantation O +
and O +
the O +
availability O +
of O +
donor O +
livers O +
are O +
additional O +
limiting O +
factors O +
for O +
the O +
practicality O +
of O +
treatment O +
of O +
this O +
disease O -
. O +

Because O +
of O +
the O +
current O +
unsatisfactory O +
options O +
for O +
the O +
treatment O +
of O +
MSUD O -
, O +
there O +
is O +
a O +
need O +
for O +
improved O +
therapies O +
to O +
combat O +
this O +
disease O -
. O +

An O +
obstacle O +
to O +
developing O +
novel O +
treatments O +
for O +
MSUD O +
has O +
been O +
the O +
lack O +
of O +
a O +
suitable O +
animal O +
model O +
to O +
perform O +
necessary O +
preclinical O +
studies O -
. O +

Although O +
a O +
Hereford O +
calf O +
model O +
with O +
MSUD O +
has O +
been O +
described O +
[ O -
17 O -
- O -
19 O -
] O -
, O +
this O +
model O +
is O +
neither O +
readily O +
available O +
nor O +
practical O +
to O +
perform O +
preclinical O +
studies O -
. O +

Furthermore O -
, O +
comparison O +
of O +
this O +
animal O +
model O +
with O +
human O +
MSUD O +
has O +
shown O +
some O +
differences O +
in O +
the O +
pathology O +
of O +
the O +
disease O +
[ O -
1 O -
] O -
, O +
making O +
this O +
animal O +
a O +
less O +
desirable O +
model O +
for O +
the O +
human O +
disease O -
. O +

Recently O -
, O +
a O +
N B-Chemical -
- I-Chemical -
ethyl I-Chemical -
- I-Chemical -
N I-Chemical -
- I-Chemical -
nitrosourea I-Chemical +
( O -
ENU B-Chemical -
) O -
-induced O +
mutant O +
mouse O +
that O +
phenotypically O +
resembles O +
human O +
MSUD O +
has O +
been O +
described O +
[ O -
20 O -
] O -
. O +

However O -
, O +
the O +
mutation O +
in O +
this O +
model O +
disrupts O +
a O +
splice O +
site O +
in O +
the O +
mitochondrial O +
branched O -
- O -
chain O +
aminotransferase O +
( O -
BCAT O -
) O +
gene O -
, O +
not O +
in O +
BCKDH O -
, O +
the O +
deficient O +
enzyme O +
in O +
MSUD O -
. O +

Because O +
the O +
mutation O +
is O +
not O +
in O +
BCKDH O -
, O +
the O +
validity O +
of O +
this O +
mutant O +
mouse O +
line O +
for O +
modeling O +
human O +
MSUD O +
is O +
questionable O -
. O +

The O +
objective O +
of O +
the O +
present O +
study O +
was O +
to O +
create O +
genetically O +
engineered O +
murine O +
models O +
of O +
MSUD O +
that O +
mimic O +
the O +
pathology O +
of O +
the O +
classic O +
and O +
intermediate O +
variant O +
forms O +
of O +
the O +
human O +
disease O -
. O +

The O +
classic O +
model O +
was O +
created O +
by O +
targeted O +
inactivation O +
of O +
the O +
E2 O +
subunit O +
of O +
BCKDH O +
by O +
homologous O +
recombination O +
in O +
embryonic O +
stem O +
( O -
ES O -
) O +
cells O -
. O +

The O +
model O +
of O +
intermediate O +
MSUD O +
was O +
created O +
by O +
partial O +
transgenic O +
rescue O +
of O +
the O +
E2 O +
gene O +
knockout O -
. O +

This O +
report O +
describes O +
the O +
generation O +
and O +
characterization O +
of O +
these O +
murine O +
models O +
of O +
MSUD O -
. O +

These O +
models O +
will O +
allow O +
for O +
the O +
development O +
of O +
novel O +
treatment O +
approaches O -
, O +
such O +
as O +
gene O +
or O +
stem O +
cell O +
therapies O -
, O +
to O +
ultimately O +
cure O +
MSUD O -
. O +

Methods O +
All O +
studies O +
involving O +
animals O +
were O +
reviewed O +
and O +
approved O +
by O +
the O +
University O +
of O +
Pittsburgh O -
's O +
Institutional O +
Animal O +
Care O +
and O +
Use O +
Committee O -
. O +

Gene O +
knockout O +
production O +
A O +
genomic O +
DNA O +
subclone O +
of O +
Strain O +
129 O -
/ O -
SvJ O +
DNA O +
that O +
contained O +
a O +
portion O +
of O +
Exons O +
4 O +
and O +
5 O +
of O +
the O +
E2 O +
gene O +
and O +
flanking O +
DNA O +
was O +
obtained O +
from O +
a O +
P1 O +
phage O +
library O +
from O +
Genome O +
Systems O -
, O +
Inc. O -
, O +
( O -
St. O +
Louis O -
, O +
MO O -
; O +
' O -
3-Hit O +
Mouse O +
ES O +
Library O -
' O -
) O -
. O +

A O +
positive O -
/ O -
negative O +
replacement O +
type O +
gene O +
targeting O +
vector O +
[ O -
21 O -
] O +
was O +
created O +
by O +
replacing O +
a O +
1.67 O +
kb O +
EcoRV O -
- O -
Smal O +
fragment O +
that O +
included O +
a O +
portion O +
of O +
Exon O +
4 O +
and O +
all O +
of O +
Exon O +
5 O +
with O +
the O +
PGKneo O +
marker O +
gene O +
( O -
See O +
Fig. O +
1A O -
) O +
from O +
the O +
pPNT O +
vector O +
[ O -
22 O -
] O -
. O +

The O +
targeting O +
construct O +
was O +
linearized O +
with O +
NotI O +
and O +
electroporated O +
into O +
R1 O +
ES O +
cells O +
[ O -
23 O -
] O +
under O +
conditions O +
described O +
previously O +
[ O -
24 O -
] O -
. O +

ES O +
cells O +
were O +
selected O +
with O +
G418 B-Chemical +
( O -
300 O +
μg O -
/ O -
ml O -
; O +
Life O +
Technologies O +
Inc. O -
, O +
Gaithersburg O -
, O +
MD O -
) O +
and O +
gancyclovir B-Chemical +
( O -
2 O +
μM O -
; O +
gift O +
of O +
Syntex O -
, O +
Palo O +
Alto O -
, O +
CA O -
) O -
. O +

Doubly O +
resistant O +
clones O +
were O +
screened O +
for O +
gene O +
targeting O +
by O +
Southern O +
blot O +
analysis O +
of O +
BglI O +
digested O +
genomic O +
DNA O -
. O +

Blots O +
were O +
hybridized O +
with O +
an O +
Exon O +
6 O +
specific O +
probe O +
that O +
was O +
external O +
to O +
the O +
gene O +
targeting O +
construct O -
. O +

Correctly O +
targeted O +
ES O +
cells O +
were O +
injected O +
into O +
C57BL O -
/ O -
6J O +
blastocysts O +
to O +
produce O +
chimeric O +
mice O +
using O +
standard O +
procedures O -
. O +

Heterozygous O +
offspring O +
from O +
germline O +
competent O +
chimeras O +
were O +
intercrossed O +
to O +
produce O +
wild O +
type O +
( O -
+ O -
/+ O -
) O -
, O +
heterozygous O +
( O -
+ O -
/- O -
) O +
and O +
homozygous O +
knockout O +
( O -
- O -
/ O -
- O -
) O +
mice O -
. O +

At O +
all O +
generations O -
, O +
+ O -
/- O +
breeding O +
pairs O +
were O +
used O -
. O +

Results O +
presented O +
here O +
are O +
from O +
mice O +
derived O +
from O +
the O +
F2 O -
+ O +
generations O -
. O +

All O +
animals O +
were O +
of O +
a O +
mixed O +
C57BL O -
/ O -
6J O +
× O +
Strain O +
129Sv O -
/ O -
SvJ O +
genetic O +
background O -
. O +

Figure O +
1 O +
E2 O +
gene O +
knockout O +
mouse O +
production O -
. O +

A O -
, O +
Gene O +
targeting O +
strategy O +
used O +
for O +
targeting O +
the O +
E2 O +
locus O +
in O +
mouse O +
ES O +
cells O -
. O +

The O +
targeting O +
construct O +
was O +
designed O +
to O +
delete O +
1.67 O +
kb O +
of O +
sequence O +
between O +
an O +
EcoRV O +
site O +
in O +
Exon O +
4 O +
and O +
a O +
Smal O +
site O +
in O +
intron O +
5 O -
. O +

The O +
wild O +
type O +
E2 O +
gene O +
contains O +
an O +
~16 O +
kb O +
BglI O +
restriction O +
fragment O +
that O +
hybridizes O +
to O +
the O +
Exon O +
6 O +
specific O +
probe O -
. O +

A O +
correctly O +
targeted O +
E2 O +
locus O +
harbors O +
an O +
~11 O +
kb O +
BglI O +
restriction O +
fragment O +
that O +
hybridizes O +
to O +
the O +
same O +
probe O -
. O +

Note O +
that O +
the O +
probe O +
will O +
not O +
detect O +
random O +
integration O +
of O +
the O +
targeting O +
vector O +
because O +
it O +
is O +
external O +
to O +
the O +
targeting O +
vector O -
. O +

B O -
, O +
Southern O +
blot O +
analysis O +
of O +
Bgll O +
digested O +
genomic O +
DNA O +
derived O +
from O +
the O +
parental O +
wild O +
type O +
ES O +
cell O +
line O +
( O -
R1 O -
) O -
, O +
a O +
heterozygous O +
targeted O +
ES O +
cell O +
line O +
( O -
362 O -
) O -
, O +
and O +
from O +
wild O +
type O +
( O -
+ O -
/+ O -
) O -
, O +
heterozygous O +
( O -
+ O -
/- O -
) O +
and O +
homozygous O +
knockout O +
( O -
- O -
/ O -
- O -
) O +
mice O -
. O +

The O +
blot O +
was O +
hybridized O +
with O +
an O +
Exon O +
6 O +
specific O +
probe O -
. O +

C O -
, O +
Immunohistochemical O +
analysis O +
of O +
fresh O +
frozen O +
liver O +
sections O +
from O +
control O +
( O -
+ O -
/+ O -
) O +
and O +
E2 O +
knockout O +
( O -
- O -
/ O -
- O -
) O +
postnatal O +
day O +
1 O +
mouse O +
pups O -
. O +

Sections O +
were O +
stained O +
for O +
E2 O +
using O +
an O +
E2 O +
specific O +
antibody O +
( O -
green O -
) O +
and O +
a O +
nuclear O +
stain O +
( O -
blue O -
) O -
. O +

Note O +
the O +
complete O +
absence O +
of O +
E2 O +
immunoreactivity O +
in O +
the O +
section O +
from O +
the O +
knockout O +
mouse O -
. O +

D O -
, O +
Similar O +
results O +
were O +
observed O +
upon O +
immunohistochemical O +
analysis O +
of O +
primary O +
mouse O +
embryonic O +
fibroblasts O +
( O -
MEFs O -
) O -
. O +

Note O +
that O +
the O +
readily O +
detectable O +
signal O +
for O +
E2 O +
in O +
the O +
control O +
cells O +
was O +
present O +
in O +
a O +
pattern O +
characteristic O +
of O +
mitochondria O -
, O +
the O +
subcellular O +
location O +
of O +
BCKDH O -
. O +

Production O +
of O +
transgenic O +
mice O +
Standard O +
molecular O +
techniques O +
were O +
used O +
to O +
assemble O +
the O +
transgenic O +
construct O -
, O +
pTRE O -
- O -
E2 O -
. O +

This O +
transgene O +
contains O +
the O +
tetracycline B-Chemical +
responsive O +
hCMV*-1 O +
promoter O +
[ O -
consisting O +
of O +
the O +
tetracycline B-Chemical +
responsive O +
element O +
( O -
TRE O -
) O +
and O +
a O +
minimal O +
hCMV O +
promoter O -
] O +
[ O -
25 O -
] O +
from O +
pTRE2 O +
( O -
Clontech O +
Inc. O -
, O +
Mt. O +
View O -
, O +
CA O -
) O -
, O +
a O +
chimeric O +
intron O +
from O +
pCI O +
( O -
Promega O -
) O +
to O +
increase O +
message B-Chemical +
stability O +
and O +
expression O +
[ O -
26,27 O -
] O -
, O +
a O +
Kozak O +
consensus O +
sequence O +
at O +
the O +
initiation O +
codon O +
to O +
optimize O +
translation O +
[ O -
28 O -
] O -
, O +
the O +
human O +
E2 O +
cDNA O +
which O +
has O +
been O +
modified O +
to O +
contain O +
a O +
4 O -
× O +
alanine O +
linker O +
followed O +
by O +
a O +
c O -
- O -
myc O +
epitope O +
tag O +
at O +
the O +
carboxy O +
terminus O +
to O +
facilitate O +
detection O -
, O +
and O +
an O +
SV40 O +
late O +
polyadenylation O +
sequence O +
from O +
pCI O +
for O +
enhanced O +
mRNA O +
stability O +
and O +
translation O -
. O +

The O +
2.48 O +
kb O +
TRE O -
- O -
E2 O +
transgene O +
was O +
purified O +
from O +
vector O +
sequences O +
following O +
digestion O +
with O +
XhoI O +
and O +
BamHI O +
and O +
injected O +
into O +
C57BL O -
/ O -
6J O +
or O +
C57BL O -
/ O -
6J O +
× O +
Strain O +
129SvEv O +
mouse O +
embryos O +
at O +
the O +
transgenic O +
core O +
facilities O +
of O +
the O +
University O +
of O +
Pittsburgh O +
and O +
the O +
University O +
of O +
Cincinnati O -
, O +
respectively O -
. O +

Genomic O +
DNA O +
from O +
the O +
tail O +
of O +
mice O +
was O +
screened O +
by O +
Southern O +
blot O +
analysis O +
following O +
digestion O +
with O +
EcoRI O +
and O +
hybridization O +
to O +
an O +
~400 O +
bp O +
probe O +
derived O +
from O +
the O +
SV40 O +
portion O +
of O +
the O +
TRE O -
- O -
E2 O +
transgene O -
. O +

Production O +
of O +
intermediate O +
MSUD O +
murine O +
model O +
The O +
various O +
TRE O -
- O -
E2 O +
transgenic O +
lines O +
produced O +
were O +
mated O +
independently O +
to O +
mice O +
that O +
were O +
heterozygous O +
for O +
both O +
the O +
E2 O +
knockout O +
and O +
the O +
LAP O -
- O -
tTA O +
transgene O +
[ O -
Tg O -
( O -
tTALap O -
) O -
Bjd O -
/ O -
J O -
; O +
Stock O +
3272 O -
; O +
The O +
Jackson O +
Laboratory O -
, O +
Bar O +
Harbor O -
, O +
ME O -
; O +
NMRI O +
× O +
FVB O +
× O +
C57BL O -
/ O -
6J O +
background O -
] O -
. O +

Interbreeding O +
of O +
animals O +
that O +
were O +
heterozygous O +
for O +
both O +
transgenes O +
and O +
the O +
knockout O +
resulted O +
in O +
the O +
production O +
of O +
mice O +
with O +
a O +
variety O +
of O +
genotypes O +
including O +
some O +
animals O +
that O +
were O +
homozygous O +
for O +
the O +
knockout O +
and O +
were O +
positive O +
for O +
both O +
transgenes O +
( O -
we O +
refer O +
to O +
this O +
genotype O +
as O +
the O +
" O -
rescue O -
" O +
genotype O -
) O -
. O +

If O +
our O +
strategy O +
for O +
rescuing O +
the O +
neonatal O +
lethal O +
phenotype O +
of O +
the O +
knockout O +
were O +
successful O -
, O +
then O +
those O +
homozygous O +
knockout O +
animals O +
that O +
had O +
both O +
transgenes O +
would O +
survive O +
beyond O +
the O +
neonatal O +
period O -
. O +

Genotyping O +
All O +
mice O +
were O +
genotyped O +
by O +
Southern O +
blot O +
analysis O -
. O +

Genomic O +
DNAs O +
prepared O +
from O +
tail O +
snips O +
were O +
digested O +
with O +
an O +
appropriate O +
restriction O +
enzyme O -
, O +
size O +
fractionated O +
by O +
agarose B-Chemical +
gel O +
electrophoresis O -
, O +
blotted O +
to O +
nylon B-Chemical -
, O +
and O +
probed O +
using O +
standard O +
procedures O -
. O +

Immunohistochemistry O +
Primary O +
mouse O +
embryonic O +
fibroblasts O +
were O +
prepared O +
from O +
embryonic O +
day O +
~16.5–18.5 O +
fetuses O +
as O +
described O +
[ O -
29 O -
] O -
. O +

Fibroblasts O +
were O +
passed O +
onto O +
glass O -
, O +
fixed O +
in O +
2 O -
% O +
paraformaldehyde O +
in O +
PBS O +
for O +
10 O +
minutes O -
, O +
permeabilized O +
in O +
2 O -
% O +
paraformaldehyde O +
containing O +
0.1 O -
% O +
Triton B-Chemical +
X100 I-Chemical +
for O +
10 O +
minutes O +
and O +
washed O +
three O +
times O +
in O +
PBS O +
containing O +
0.5 O -
% O +
BSA O +
and O +
0.15 O -
% O +
glycine O -
, O +
pH O +
7.4 O +
( O -
Buffer O +
A O -
) O -
. O +

Following O +
a O +
30 O +
min O +
incubation O +
with O +
purified O +
goat O +
IgG O +
( O -
50 O +
( O -
μg O -
/ O -
ml O -
) O +
at O +
25 O -
° O -
C O +
and O +
three O +
additional O +
washes O +
with O +
Buffer O +
A O -
, O +
cells O +
were O +
incubated O +
for O +
60 O +
min O +
with O +
E2-specific O +
antiserum O +
[ O -
30 O -
] O +
at O +
1 O +
μg O -
/ O -
ml O +
followed O +
by O +
three O +
washes O +
in O +
Buffer O +
A O +
and O +
60 O +
minute O +
incubation O +
in O +
fluorescently O +
labeled O +
second O +
antibody O +
( O -
1–2 O +
μg O -
/ O -
ml O -
) O -
. O +

The O +
cells O +
were O +
then O +
washed O +
six O +
times O +
( O -
5 O +
min O -
/ O -
wash O -
) O +
in O +
Buffer O +
A O +
and O +
then O +
mounted O +
in O +
gelvatol O +
( O -
Monsanto O -
, O +
St O +
Louis O -
) O -
. O +

When O +
livers O +
from O +
newborn O +
pups O +
were O +
examined O -
, O +
fixation O +
was O +
by O +
immersion O +
in O +
2 O -
% O +
paraformaldehyde O +
followed O +
by O +
cryoprotection O +
and O +
shock O +
freezing O +
in O +
liquid O +
nitrogen O +
cooled O +
isopentane B-Chemical +
and O +
sectioning O +
( O -
5 O +
microns O -
) O -
. O +

Otherwise O +
processing O +
was O +
as O +
for O +
the O +
cells O +
above O +
( O -
without O +
the O +
fixation O +
and O +
permabilization O +
steps O -
) O -
. O +

Amino O +
acid O +
analysis O +
Blood O +
was O +
collected O +
from O +
the O +
retroorbital O +
sinus O +
or O +
tail O +
vein O +
of O +
mice O +
and O +
spotted O +
on O +
a O +
filter O +
paper O +
routinely O +
used O +
for O +
blood O +
amino O +
acid O +
analysis O +
for O +
prenatal O +
screening O -
. O +

Concentrations O +
of O +
BCAA B-Chemical +
and O +
other O +
amino O +
acids O +
in O +
blood O +
were O +
determined O +
by O +
tandem O +
mass O +
spectrometry O +
( O -
Pediatrix O +
Screening O -
, O +
Bridgeville O -
, O +
PA O -
) O -
. O +

Assay O +
of O +
BCKDH O +
activity O +
Livers O +
were O +
removed O -
, O +
frozen O +
in O +
liquid O +
nitrogen O -
, O +
and O +
stored O +
at O +
-80 O -
° O -
C O -
. O +

At O +
the O +
time O +
of O +
enzyme O +
assay O -
, O +
livers O +
were O +
thawed O -
, O +
and O +
homogenized O +
( O -
1:9 O -
, O +
w O -
/ O -
v O -
) O +
in O +
0.25 O +
M O +
sucrose B-Chemical -
, O +
10 O +
mM O +
Tris B-Chemical -
- O -
HC1 B-Chemical -
, O +
pH O +
7.4 O -
. O +

Liver O +
homogenates O +
were O +
centrifuged O +
at O +
600 O +
× O +
g O +
for O +
10 O +
min O +
at O +
4 O -
° O -
C O +
and O +
the O +
supernatant O +
fraction O +
was O +
saved O +
to O +
determine O +
the O +
BCKDH O +
activity O -
. O +

The O +
use O +
of O +
tissue O +
homogenates O +
was O +
necessitated O +
by O +
the O +
limited O +
availability O +
of O +
liver O +
tissue O -
, O +
particularly O +
from O +
newborn O +
pups O -
. O +

BCKDH O +
activity O +
was O +
determined O +
by O +
measuring O +
the O +
release O +
of O +
14CO2 O +
from O +
α B-Chemical -
- I-Chemical -
keto I-Chemical +
[ O -
1 O -
- O -
14C B-Chemical -
] O +
isocaproate B-Chemical +
as O +
described O +
previously O +
[ O -
31 O -
] O -
. O +

The O +
complete O +
reaction O +
mixture B-Chemical +
contained O +
( O -
final O +
volume O +
1 O +
ml O -
) O +
30 O +
mM O +
potassium O +
phosphate O +
buffer O -
, O +
pH O +
7.4 O -
, O +
0.20 O +
mM O +
α B-Chemical -
- I-Chemical -
ketoisocaproate I-Chemical -
, O +
0.40 O +
mM O +
CoASH B-Chemical -
, O +
0.40 O +
mM O +
thiamin B-Chemical +
pyrophosphate I-Chemical -
, O +
2 O +
mM O +
NAD+ B-Chemical -
, O +
2 O +
mM O +
dithiothreitol B-Chemical -
, O +
5 O +
mM O +
Mg2 B-Chemical -
+ I-Chemical -
, O +
approximately O +
250,000 O +
DPM O +
of O +
α B-Chemical -
- I-Chemical -
keto I-Chemical +
[ O -
1 O -
- O -
14C B-Chemical -
] O +
isocaproate B-Chemical -
, O +
and O +
0.10 O +
ml O +
of O +
liver O +
homogenate O +
( O -
2–3 O +
mg O +
protein O -
) O -
. O +

Assays O +
were O +
carried O +
out O +
for O +
15 O +
min O +
at O +
37 O -
° O -
C O -
, O +
14CO2 O +
was O +
trapped O +
in O +
hydroxide B-Chemical +
of O +
Hyamine B-Chemical -
, O +
and O +
radioactivity O +
was O +
determined O +
by O +
liquid O +
scintillation O +
spectrometry O -
. O +

Western O +
blot O +
analysis O +
Protein O +
extracts O +
were O +
isolated O +
from O +
homogenized O +
liver O +
( O -
freshly O +
harvested O +
and O +
flash O +
frozen O -
) O +
of O +
wildtype O -
, O +
Line O +
525A O -
, O +
and O +
Line O +
A O +
transgenic O +
mice O -
. O +

Protein O +
( O -
25 O +
μg O +
per O +
sample O -
) O +
was O +
analyzed O +
by O +
electrophoresis O +
on O +
a O +
10 O -
% O +
SDS B-Chemical -
- O -
PAGE O +
Ready O +
Gel O +
( O -
Bio O -
- O -
Rad O -
, O +
Hercules O -
, O +
CA O -
) O +
and O +
transferred O +
to O +
PVDF B-Chemical +
membrane O +
( O -
Sequi O -
- O -
Blot O -
; O +
Bio O -
- O -
Rad O -
) O +
via O +
electroblotting O -
. O +

All O +
blots O +
were O +
probed O +
for O +
E2 O +
protein O +
using O +
polyclonal O +
rabbit O +
E2 O +
antisera O +
( O -
1:5,000 O -
) O -
, O +
which O +
detects O +
both O +
mouse O +
( O -
~47 O +
kD O -
) O +
and O +
human O +
( O -
~54 O +
kD O -
) O +
E2 O +
subunits O +
( O -
[ O -
30 O -
] O -
; O +
gift O +
from O +
Dr. O +
Susan O +
Hutson O -
, O +
Wake O +
Forest O +
University O -
) O -
. O +

Blots O +
were O +
re O -
- O -
probed O +
with O +
a O +
rabbit O +
anti O -
- O -
c O -
- O -
myc O +
tag O +
antibody O +
( O -
1:10,000 O -
; O +
abCam O -
, O +
Cambridge O -
, O +
MA O -
; O +
cat O -
. O +

# O +
ab9106 O -
- O -
100 O -
) O -
. O +

Blots O +
were O +
also O +
re O -
- O -
probed O +
with O +
an O +
antibody O +
for O +
β O -
- O -
actin O +
( O -
43 O +
kD O -
; O +
1:10,000 O -
; O +
abCam O -
; O +
cat O -
. O +

# O +
ab8227 O -
- O -
50 O -
) O +
to O +
allow O +
for O +
loading O +
comparisons O -
. O +

A O +
goat O +
anti O -
- O -
rabbit O +
secondary O +
antibody O +
conjugated O +
to O +
horseradish O +
peroxidase O +
( O -
1:10,000 O -
; O +
Novus O -
, O +
Littleton O -
, O +
CO O -
; O +
cat O -
. O +

# O +
NB730-H O -
) O +
was O +
used O +
for O +
detection O +
using O +
the O +
Western O +
Lightning O +
chemiluminescence O +
reagent B-Chemical +
( O -
Perkin O +
Elmer O -
, O +
Boston O -
, O +
MA O -
) O +
and O +
exposed O +
to O +
X O -
- O -
ray O +
film O -
. O +

Statistical O +
analyses O +
All O +
BCAA B-Chemical +
and O +
BCKDH O +
enzyme O +
activity O +
data O +
are O +
presented O +
as O +
the O +
mean O +
+ O -
/- O +

the O +
standard O +
error O +
of O +
the O +
mean O +
( O -
S.E.M. O -
) O -
. O +

Differences O +
between O +
genotypes O +
were O +
compared O +
by O +
Student O -
's O +
t O +
test O -
[ O -
32 O -
] O -
. O +

Results O +
Production O +
of O +
E2 O +
gene O +
knockout O +
mice O +
To O +
create O +
E2 O +
knockout O +
mice O -
, O +
we O +
used O +
gene O +
targeting O +
in O +
mouse O +
ES O +
cells O +
to O +
disrupt O +
the O +
E2 O +
gene O -
. O +

The O +
overall O +
strategy O +
for O +
disrupting O +
the O +
E2 O +
gene O +
is O +
illustrated O +
in O +
Fig. O +
1A O -
. O +

The O +
gene O +
targeting O +
construct O +
was O +
designed O +
to O +
replace O +
a O +
1.67 O +
kb O +
EcoRV O -
/ O -
Smal O +
genomic O +
DNA O +
fragment O +
encompassing O +
part O +
of O +
Exon O +
4 O +
and O +
all O +
of O +
Exon O +
5 O +
with O +
the O +
PGKneo O +
selectable O +
marker O +
cassette O -
. O +

Of O +
522 O +
ES O +
cell O +
clones O +
screened O +
for O +
targeting O +
by O +
Southern O +
blot O +
analysis O -
, O +
29 O +
( O -
5 O -
% O -
) O +
displayed O +
the O +
predicted O +
restriction O +
fragment O +
length O +
polymorphisms O +
indicative O +
of O +
gene O +
targeting O +
at O +
the O +
E2 O +
locus O -
. O +

As O +
illustrated O +
in O +
Fig. O +
1A O +
and O +
1B O -
, O +
an O +
E2 O +
Exon O +
6 O +
specific O +
probe O -
, O +
which O +
is O +
external O +
to O +
the O +
targeting O +
construct O -
, O +
hybridizes O +
to O +
only O +
a O +
~16 O +
kb O +
BglI O +
restriction O +
fragment O +
from O +
the O +
wild O +
type O +
allele O +
in O +
the O +
parental O +
R1 O +
ES O +
cell O +
line O -
. O +

In O +
correctly O +
targeted O +
ES O +
cells O -
, O +
this O +
probe O +
also O +
hybridizes O +
to O +
a O +
~11 O +
kb O +
BglI O +
restriction O +
fragment O -
. O +

Targeting O +
was O +
confirmed O +
with O +
several O +
additional O +
restriction O +
enzymes O +
and O +
probes O +
( O -
data O +
not O +
shown O -
) O -
. O +

Correctly O +
targeted O +
ES O +
cells O +
were O +
microinjected O +
into O +
blastocysts O +
to O +
produce O +
chimeric O +
mice O -
. O +

Chimerics O +
were O +
bred O +
to O +
C57BL O -
/ O -
6J O +
mice O -
. O +

Following O +
germline O +
transmission O +
of O +
the O +
targeted O +
allele O -
, O +
heterozygous O +
mice O +
were O +
interbred O +
to O +
produce O +
wild O +
type O +
( O -
+ O -
/+ O -
) O -
, O +
heterozygous O +
( O -
+ O -
/- O -
) O +
and O +
homozygous O +
( O -
- O -
/ O -
- O -
) O +
animals O -
. O +

Mice O +
were O +
genotyped O +
by O +
Southern O +
blot O +
analysis O -
. O +

The O +
Exon O +
6 O +
specific O +
probe O +
hybridized O +
to O +
only O +
a O +
~16 O +
kb O +
BglI O +
restriction O +
fragment O +
in O +
+ O -
/+ O +
mice O -
, O +
a O +
~11 O +
kb O +
BglI O +
fragment O +
in O +
- O -
/ O -
- O +
mice O -
, O +
and O +
to O +
both O +
of O +
these O +
fragments O +
in O +
+ O -
/- O +

mice O +
( O -
Fig. O +
1B O -
) O -
. O +

Mice O +
homozygous O +
for O +
the O +
E2 O +
mutation O +
were O +
born O +
at O +
the O +
expected O +
frequency O -
. O +

Genotype O +
analysis O +
of O +
pups O +
derived O +
from O +
+ O -
/- O +

by O +
+ O -
/- O +

matings O +
revealed O +
that O +
+ O -
/+ O -
, O +
+ O -
/- O -
, O +
and O +
- O -
/ O -
- O +
mice O +
were O +
present O +
at O +
nearly O +
the O +
expected O +
1:2:1 O +
frequency O -
. O +

Of O +
the O +
initial O +
60 O +
animals O +
genotyped O -
, O +
19 O +
( O -
32 O -
% O -
) O +
were O +
+ O -
/+ O -
, O +
27 O +
( O -
45 O -
% O -
) O +
were O +
+ O -
/- O -
, O +
and O +
14 O +
( O -
23 O -
% O -
) O +
were O +
- O -
/ O -
- O -
. O +

Thus O -
, O +
the O +
E2 O +
gene O +
was O +
dispensable O +
for O +
normal O +
embryonic O +
development O -
. O +

However O -
, O +
as O +
expected O -
, O +
nearly O +
all O +
homozygous O +
mice O +
died O +
in O +
the O +
perinatal O +
period O -
. O +

Immediately O +
following O +
birth O -
, O +
homozygous O +
pups O +
were O +
indistinguishable O +
from O +
their O +
+ O -
/+ O +
and O +
+ O -
/- O +

littermates O -
; O +
they O +
were O +
vigorous O -
, O +
active O +
and O +
able O +
to O +
suckle O -
. O +

By O +
mid O +
to O +
late O +
day O +
on O +
postnatal O +
day O +
one O -
, O +
most O +
- O -
/ O -
- O +
pups O +
became O +
moribund O +
and O +
were O +
readily O +
identifiable O +
as O +
they O +
were O +
lethargic O -
, O +
pale O -
, O +
and O +
exhibited O +
gasping O +
respiratory O +
movements O -
. O +

With O +
few O +
exceptions O -
, O +
- O -
/ O -
- O +
pups O +
died O +
within O +
72 O +
hours O +
of O +
birth O -
. O +

We O +
have O +
observed O +
one O +
rare O +
- O -
/ O -
- O +
pup O +
that O +
survived O +
to O +
postnatal O +
day O +
13 O -
. O +

The O +
reason O +
for O +
the O +
prolonged O +
survival O +
of O +
this O +
pup O +
is O +
unknown O -
. O +

E2 O +
deficient O +
mice O +
accurately O +
model O +
classic O +
MSUD O +
To O +
demonstrate O +
that O +
the O +
gene O +
targeting O +
event O +
created O +
a O +
true O +
E2 O +
null O +
allele O -
, O +
we O +
determined O +
BCKDH O +
activity O +
in O +
liver O +
homogenates O +
of O +
postnatal O +
day O +
1 O +
mouse O +
pups O +
derived O +
from O +
+ O -
/- O +

by O +
+ O -
/- O +

mating O +
pairs O -
. O +

As O +
shown O +
in O +
Figure O +
2A O -
, O +
the O +
BCKDH O +
activity O +
in O +
+ O -
/+ O +
mice O +
was O +
readily O +
detectable O -
. O +

In O +
marked O +
contrast O -
, O +
BCKDH O +
activity O +
was O +
completely O +
absent O +
in O +
- O -
/ O -
- O +
mouse O +
livers O -
. O +

As O +
expected O -
, O +
homogenates O +
from O +
+ O -
/- O +

mice O +
had O +
approximately O +
half O +
the O +
activity O +
of O +
their O +
+ O -
/+ O +
littermates O +
( O -
Figure O +
2A O -
) O -
. O +

The O +
results O +
from O +
- O -
/ O -
- O +
mice O +
are O +
similar O +
to O +
that O +
observed O +
in O +
humans O +
with O +
classic O +
MSUD O +
[ O -
1 O -
] O -
. O +

Figure O +
2 O +
Biochemical O +
characterization O +
of O +
the O +
classic O +
MSUD O +
murine O +
model O -
. O +

A O -
, O +
BCKDH O +
enzyme O +
activity O +
in O +
liver O +
of O +
newborn O +
wild O +
type O +
control O +
( O -
+ O -
/+ O -
) O -
, O +
heterozygous O +
( O -
+ O -
/- O -
) O -
, O +
and O +
homozygous O +
( O -
- O -
/ O -
- O -
) O +
knockout O +
mice O -
. O +

Enzyme O +
activity O +
was O +
significantly O +
reduced O +
in O +
+ O -
/- O +

liver O +
compared O +
to O +
+ O -
/+ O -
, O +
and O +
was O +
below O +
the O +
level O +
of O +
detection O +
in O +
- O -
/ O -
- O +
liver O -
. O +

B O -
, O +
Total O +
BCAA B-Chemical +
concentrations O +
in O +
blood O +
of O +
mice O -
. O +

Total O +
BCAA B-Chemical +
represent O +
the O +
sum O +
of O +
leucine O -
, O +
isoleucine O -
, O +
and O +
valine O -
. O +

Total O +
BCAA B-Chemical +
concentrations O +
in O +
blood O +
from O +
- O -
/ O -
- O +
mice O +
were O +
significantly O +
elevated O +
compared O +
to O +
+ O -
/+ O +
and O +
+ O -
/- O -
. O +

C O -
, O +
Ratio O +
of O +
total O +
BCAA B-Chemical +
to O +
alanine O +
in O +
blood O +
of O +
mice O -
. O +

This O +
ratio O +
was O +
significantly O +
elevated O +
in O +
- O -
/ O -
- O +
mice O +
compared O +
to O +
+ O -
/+ O +
and O +
+ O -
/- O +

mice O -
. O +

The O +
numbers O +
on O +
the O +
bars O +
indicates O +
the O +
number O +
of O +
mice O +
analyzed O -
. O +

* O -
, O +
Significantly O +
different O +
from O +
+ O -
/+ O +
( O -
P O +
< O +
0.001 O -
) O -
; O +

* O -
* O -
, O +
significantly O +
different O +
from O +
+ O -
/+ O +
and O +
+ O -
/- O +

( O -
P O +
< O +
0.001 O -
) O -
. O +

Immunohistochemistry O +
with O +
an O +
E2 O +
specific O +
antibody O +
was O +
used O +
to O +
examine O +
E2 O +
protein O +
in O +
the O +
mice O -
. O +

As O +
shown O +
in O +
Figure O +
1C O +
and O +
1D O -
, O +
immunoreactive O +
E2 O +
protein O +
was O +
abundant O +
in O +
liver O +
and O +
embryonic O +
fibroblasts O +
of+ O -
/ O -
+ O +
mice O -
. O +

In O +
marked O +
contrast O -
, O +
immunoreactive O +
E2 O +
protein O +
was O +
absent O +
in O +
these O +
same O +
tissues O +
of O +
- O -
/ O -
- O +
mice O -
. O +

Homozygous O +
E2 O +
knockout O +
mice O +
had O +
a O +
nearly O +
3-fold O +
increase O +
in O +
blood O +
( O -
Figure O +
2B O -
) O +
and O +
urine O +
( O -
data O +
not O +
shown O -
) O +
levels O +
of O +
BCAA B-Chemical +
( O -
sum O +
of O +
leucine O -
, O +
isoleucine O -
, O +
and O +
valine O -
) O +
as O +
compared O +
to O +
their O +
+ O -
/+ O +
littermates O -
. O +

Because O +
amino O +
acids O +
were O +
analyzed O +
by O +
tandem O +
mass O +
spectrometry O -
, O +
the O +
sum O +
of O +
BCAA B-Chemical +
shown O +
in O +
Figure O +
2B O +
also O +
may O +
include O +
alloisoleucine O +
that O +
may O +
have O +
been O +
produced O +
in O +
- O -
/ O -
- O +
MSUD O +
mice O -
. O +

The O +
metabolism O +
of O +
BCAA B-Chemical +
is O +
linked O +
with O +
the O +
synthesis O +
of O +
alanine O -
, O +
glutamate O -
, O +
and O +
glutamine O +
[ O -
33 O -
] O -
. O +

Because O +
of O +
impaired O +
metabolism O +
of O +
BCAA B-Chemical +
in O +
MSUD O +
mice O -
, O +
and O +
to O +
further O +
characterize O +
the O +
abnormal O +
biochemistry O +
in O +
this O +
model O -
, O +
we O +
analyzed O +
the O +
blood O +
levels O +
of O +
the O +
alanine O -
, O +
glutamate O -
, O +
and O +
glutamine O -
. O +

As O +
shown O +
in O +
Table O +
1 O -
, O +
the O +
levels O +
of O +
all O +
three O +
amino O +
acids O +
in O +
homozygous O +
mice O +
were O +
markedly O +
lower O +
than O +
the O +
levels O +
in O +
+ O -
/+ O +
or O +
+ O -
/- O +

mice O -
. O +

The O +
levels O +
of O +
these O +
amino O +
acids O +
in O +
the O +
+ O -
/- O +

mice O +
were O +
comparable O +
to O +
those O +
in O +
+ O -
/+ O +
mice O +
( O -
Table O +
1 O -
) O -
. O +

Because O +
of O +
the O +
abnormal O +
decrease O +
in O +
the O +
blood O +
alanine O +
level O +
and O +
marked O +
rise O +
in O +
blood O +
BCAA B-Chemical +
levels O +
that O +
are O +
characteristic O +
of O +
MSUD O -
, O +
a O +
recent O +
report O +
on O +
MSUD O +
patients O +
has O +
suggested O +
that O +
the O +
ratio O +
of O +
BCAA B-Chemical -
/ O -
alanine O +
provides O +
a O +
more O +
sensitive O +
measure O +
of O +
the O +
abnormal O +
biochemistry O +
of O +
MSUD O +
than O +
BCAA B-Chemical +
level O +
alone O +
[ O -
8 O -
] O -
. O +

Therefore O -
, O +
we O +
also O +
expressed O +
the O +
amino O +
acid O +
results O +
as O +
BCAA B-Chemical -
/ O -
alanine O +
ratio O -
. O +

As O +
shown O +
in O +
Figure O +
2C O -
, O +
this O +
ratio O +
in O +
- O -
/ O -
- O +
pups O +
was O +
more O +
than O +
6-fold O +
higher O +
than O +
+ O -
/+ O +
or O +
+ O -
/- O +

littermates O -
. O +

These O +
blood O +
amino O +
acid O +
results O +
are O +
consistent O +
with O +
the O +
concentrations O +
seen O +
in O +
patients O +
with O +
MSUD O +
[ O -
1,8,15 O -
] O -
. O +

Table O +
1 O +
Summary O +
of O +
additional O +
blood O +
amino O +
acid O +
levels O +
in O +
the O +
classic O +
MSUD O +
model O +
and O +
control O +
littermates O +
as O +
determined O +
by O +
tandem O +
mass O +
spectrometry O -
. O +

All O +
samples O +
were O +
collected O +
on O +
the O +
day O +
of O +
birth O -
. O +

All O +
values O +
are O +
mean O +
+ O -
/- O +

SEM O -
. O +

* O -
: O +
Significantly O +
different O +
from O +
+ O -
/+ O +
and O +
+ O -
/- O +

( O -
P O +
< O +
0.001 O -
) O -
. O +

In O +
summary O -
, O +
E2 O +
knockout O +
mice O +
lack O +
BCKDH O +
enzymatic O +
activity O -
, O +
E2 O +
immunoreactivity O -
, O +
and O +
have O +
markedly O +
elevated O +
levels O +
of O +
BCAA B-Chemical +
in O +
the O +
blood O +
and O +
urine O -
. O +

These O +
metabolic O +
derangements O +
ultimately O +
result O +
in O +
neonatal O +
lethality O -
. O +

These O +
phenotypes O +
are O +
remarkably O +
similar O +
to O +
that O +
observed O +
in O +
humans O +
with O +
the O +
classic O +
form O +
of O +
MSUD O -
. O +

Thus O -
, O +
E2 O +
knockout O +
mice O +
closely O +
model O +
classic O +
MSUD O -
. O +

Knockout O +
mice O +
expressing O +
a O +
human O +
E2 O +
transgene O +
model O +
a O +
variant O +
form O +
of O +
MSUD O +
that O +
mimics O +
intermediate O +
MSUD O +
To O +
create O +
a O +
murine O +
model O +
of O +
the O +
intermediate O +
variant O +
form O +
of O +
MSUD O -
, O +
we O +
used O +
a O +
transgenic O +
strategy O +
to O +
rescue O +
the O +
severe O +
elevation O +
of O +
BCAA B-Chemical +
and O +
neonatal O +
lethality O +
that O +
occurs O +
in O +
the O +
classic O +
MSUD O +
mouse O +
model O -
. O +

Our O +
strategy O +
was O +
composed O +
of O +
a O +
two O +
part O +
transgenic O +
system O +
to O +
express O +
human O +
E2 O +
in O +
liver O +
on O +
the O +
E2 O +
knockout O +
background O -
. O +

This O +
bi O -
- O -
transgenic O +
system O +
consisted O +
of O +
a O +
LAP O -
- O -
tTA O +
transgene O +
and O +
a O +
TRE O -
- O -
E2 O +
transgene O +
( O -
Fig. O +
3A O -
) O -
. O +

The O +
LAP O -
- O -
tTA O +
transgene O +
[ O -
34 O -
] O +
directs O +
high O +
levels O +
of O +
liver O +
specific O +
expression O +
of O +
the O +
tetracycline B-Chemical -
- O -
controlled O +
transactivator O +
( O -
tTA O -
) O -
, O +
a O +
transcription O +
factor O +
that O +
stimulates O +
expression O +
of O +
promoters O +
that O +
harbor O +
a O +
transactivator O +
response O +
element O +
( O -
TRE O -
) O -
. O +

The O +
TRE O -
- O -
E2 O +
transgene O +
was O +
designed O +
to O +
express O +
a O +
human O +
E2 O +
cDNA O +
from O +
a O +
TRE O +
containing O +
minimal O +
promoter O +
upon O +
stimulation O +
by O +
tTA O -
. O +

Figure O +
3 O +
Transgenic O +
mouse O +
production O +
and O +
characterization O -
. O +

A O -
, O +
Transgenic O +
strategy O +
used O +
to O +
produce O +
mice O +
that O +
express O +
human O +
E2 O -
. O +

LAP O -
- O -
tTA O +
transgenic O +
mice O +
have O +
been O +
previously O +
described O +
[ O -
34 O -
] O -
. O +

These O +
mice O +
express O +
the O +
tetracycline B-Chemical -
- O -
controlled O +
transactivator O +
( O -
tTA O -
) O +
from O +
the O +
liver O +
specific O +
LAP O +
promoter O -
. O +

The O +
TRE O -
- O -
E2 O +
transgene O +
contains O +
the O +
tetracycline B-Chemical +
response O +
element O +
( O -
TRE O -
) O +
as O +
part O +
of O +
the O +
promoter O -
, O +
a O +
synthetic O +
intron O +
( O -
thin O +
line O -
) O -
, O +
the O +
human O +
E2 O +
cDNA O -
, O +
an O +
alanine O +
spacer O -
, O +
a O +
c O -
- O -
myc O +
epitope O +
tag O -
, O +
and O +
SV40 O +
derived O +
polyadenylation O +
sequence O -
. O +

This O +
construct O +
was O +
used O +
to O +
create O +
several O +
lines O +
of O +
transgenic O +
mice O -
. O +

B O -
, O +
Western O +
blot O +
analysis O +
of O +
E2 O +
protein O +
in O +
liver O +
of O +
control O +
and O +
intermediate O +
MSUD O +
mice O -
. O +

Note O +
that O +
the O +
amount O +
of O +
human O +
E2 O +
protein O +
( O -
predicted O +
MW O +
~54 O +
Kd O -
) O +
in O +
mice O +
from O +
Lines O +
A O +
and O +
525 O +
A O +
was O +
variable O +
but O +
in O +
many O +
of O +
the O +
animals O +
the O +
amount O +
was O +
similar O +
to O +
the O +
amount O +
of O +
mouse O +
E2 O +
( O -
MW=~47 O +
Kd O -
) O +
in O +
control O +
animals O -
. O +

Re O -
- O -
probing O +
with O +
a O +
c O -
- O -
myc O +
tag O +
antibody O +
confirmed O +
the O +
presence O +
of O +
the O +
transgene O +
derived O -
, O +
c O -
- O -
myc O +
tagged O -
, O +
human O +
E2 O +
in O +
transgenic O +
mice O +
but O +
not O +
in O +
controls O -
. O +

Western O +
blot O +
analysis O +
of O +
brain O +
( O -
C O -
) O -
, O +
kidney O +
( O -
D O -
) O -
, O +
and O +
muscle O +
( O -
E O -
) O +
revealed O +
negligible O +
amounts O +
of O +
transgene O +
derived O +
E2 O +
in O +
those O +
tissues O -
. O +

All O +
blots O +
were O +
re O -
- O -
probed O +
with O +
an O +
actin O +
antibody O +
to O +
allow O +
amount O +
of O +
protein O +
loaded O +
in O +
each O +
lane O +
to O +
be O +
compared O -
. O +

LAP O -
- O -
tTA O +
mice O +
were O +
previously O +
produced O +
and O +
characterized O +
by O +
the O +
Bujard O +
laboratory O +
[ O -
34 O -
] O -
. O +

Pronuclear O +
microinjection O +
was O +
used O +
to O +
produce O +
transgenic O +
mice O +
that O +
harbored O +
the O +
TRE O -
- O -
E2 O +
transgene O -
. O +

From O +
injections O +
at O +
the O +
University O +
of O +
Pittsburgh O -
, O +
2 O +
transgene O +
positive O +
founders O +
were O +
identified O +
that O +
led O +
to O +
the O +
generation O +
of O +
3 O +
different O +
transgenic O +
lines O +
( O -
Lines O +
A O -
, O +
B O -
, O +
& O +
D O -
) O -
. O +

From O +
the O +
injections O +
at O +
the O +
University O +
of O +
Cincinnati O -
, O +
we O +
obtained O +
8 O +
transgene O +
positive O +
founders O -
. O +

Subsequent O +
breeding O +
of O +
these O +
founders O +
revealed O +
that O +
many O +
of O +
the O +
animals O +
had O +
multiple O +
transgene O +
insertion O +
sites O +
that O +
segregated O -
. O +

We O +
established O +
a O +
total O +
of O +
15 O +
different O +
transgenic O +
lines O +
from O +
these O +
founders O -
. O +

Limited O +
resources O +
allowed O +
us O +
to O +
only O +
focus O +
on O +
a O +
total O +
of O +
9 O +
of O +
these O +
lines O -
. O +

These O +
lines O +
differed O +
substantially O +
in O +
transgene O +
copy O +
number O +
as O +
compared O +
by O +
Southern O +
blot O +
analysis O +
of O +
tail O +
DNA O +
( O -
data O +
not O +
shown O -
) O -
. O +

Transgenic O +
TRE O -
- O -
E2 O +
mice O +
from O +
each O +
line O +
( O -
either O +
founders O +
or O +
F1 O +
offspring O -
) O +
were O +
crossed O +
to O +
mice O +
that O +
were O +
positive O +
for O +
the O +
LAP O -
- O -
tTA O +
transgene O +
and O +
were O +
heterozygous O +
for O +
the O +
E2 O +
knockout O -
. O +

Ultimately O -
, O +
breeding O +
pairs O +
were O +
used O +
in O +
which O +
the O +
mice O +
were O +
heterozygous O +
for O +
the O +
LAP O -
- O -
tTA O +
transgene O -
, O +
the O +
TRE O -
- O -
E2 O +
transgene O -
, O +
and O +
the O +
E2 O +
knockout O -
. O +

To O +
efficiently O +
screen O +
for O +
the O +
ability O +
of O +
the O +
transgenes O +
to O +
rescue O +
the O +
knockout O +
from O +
neonatal O +
lethality O -
, O +
we O +
genotyped O +
litters O +
at O +
weaning O -
. O +

This O +
breeding O +
strategy O +
is O +
expected O +
to O +
result O +
in O +
a O +
theoretical O +
maximum O +
of O +
animals O +
with O +
the O +
rescue O +
genotype O +
( O -
i.e. O -
, O +
homozygous O +
E2 O +
knockout O +
and O +
positive O +
for O +
both O +
transgenes O -
) O +
of O +
14 O -
% O -
. O +

Fig. O +
4A O +
shows O +
the O +
percentage O +
of O +
mice O +
alive O +
at O +
weaning O +
with O +
the O +
rescue O +
genotype O +
from O +
each O +
transgenic O +
line O +
tested O -
. O +

Considerable O +
variability O +
was O +
observed O +
between O +
lines O -
. O +

The O +
line O +
with O +
the O +
highest O +
percentage O +
of O +
rescue O +
mice O +
at O +
weaning O +
was O +
line O +
525 O +
A. O +
Approximately O +
10 O -
% O +
of O +
weaned O -
, O +
surviving O +
pups O +
from O +
this O +
line O +
had O +
the O +
rescue O +
genotype O -
. O +

Thus O -
, O +
the O +
525A O +
transgene O +
appears O +
to O +
be O +
highly O +
effective O +
at O +
rescuing O +
the O +
neonatal O +
lethal O +
phenotype O +
of O +
the O +
E2 O +
knockout O -
. O +

In O +
contrast O -
, O +
line O +
520B O +
completely O +
failed O +
to O +
rescue O +
the O +
neonatal O +
lethal O +
phenotype O -
. O +

All O +
other O +
lines O +
tested O +
produced O +
surviving O +
rescue O +
animals O +
at O +
a O +
frequency O +
between O +
1 O +
and O +
5 O -
% O +
of O +
weaned O +
pups O -
. O +

Figure O +
4 O +
Characterization O +
of O +
the O +
intermediate O +
MSUD O +
murine O +
model O -
. O +

A O -
, O +
Survival O +
analysis O +
of O +
transgenic O +
rescue O +
lines O -
. O +

Presented O +
are O +
percentages O +
of O +
mice O +
alive O +
at O +
weaning O +
from O +
each O +
transgenic O +
line O +
tested O +
that O +
had O +
the O +
rescue O +
genotype O +
( O -
i.e. O -
, O +
homozygous O +
for O +
knockout O +
of O +
endogenous O +
E2 O +
and O +
positive O +
for O +
both O +
the O +
LAP O -
- O -
tTA O +
and O +
TRE O -
- O -
E2 O +
transgenes O -
) O -
. O +

Also O +
plotted O +
is O +
the O +
theoretical O +
maximum O +
frequency O +
at O +
which O +
this O +
genotype O +
is O +
expected O +
in O +
this O +
population O +
of O +
animals O -
. O +

The O +
numbers O +
on O +
the O +
bars O +
indicates O +
the O +
numbers O +
of O +
observations O +
for O +
each O +
line O -
. O +

B O -
, O +
Ratio O +
of O +
total O +
BCAA B-Chemical +
to O +
alanine O +
in O +
blood O +
of O +
mice O +
from O +
controls O +
and O +
Lines O +
A O +
and O +
525A O -
. O +

Total O +
BCAA B-Chemical +
represent O +
the O +
sum O +
of O +
leucine O -
, O +
isoleucine O -
, O +
and O +
valine O -
. O +

BCAA B-Chemical -
/ O -
alanine O +
values O +
were O +
significantly O +
greater O +
for O +
Lines O +
A O +
and O +
525A O +
compared O +
to O +
controls O +
at O +
all O +
ages O +
tested O -
. O +

The O +
numbers O +
on O +
the O +
bars O +
indicates O +
the O +
numbers O +
of O +
samples O +
analyzed O -
. O +

* O -
, O +
P O +
≤ O +
0.01 O -
; O +

* O -
* O -
, O +
P O +
< O +
0.005 O -
. O +

C O -
, O +
BCKDH O +
enzyme O +
activity O +
in O +
liver O +
of O +
control O +
and O +
Lines O +
A O +
and O +
525A O +
mice O -
. O +

* O -
, O +
P O +
≤ O +
0.001 O -
; O +

* O -
* O -
, O +
P O +
≤ O +
0.0001 O -
. O +

D O -
, O +
Survival O +
curves O +
for O +
mice O +
from O +
Lines O +
A O +
and O +
525A O -
. O +

Rescue O +
mice O +
alive O +
at O +
weaning O +
were O +
monitored O +
until O +
they O +
were O +
moribund O +
and O +
subsequently O +
sacrificed O +
or O +
were O +
found O +
dead O +
in O +
their O +
cages O -
. O +

Lines O +
A O +
and O +
525A O +
were O +
selected O +
for O +
detailed O +
characterization O -
. O +

Fig. O +
4B O +
shows O +
the O +
results O +
of O +
blood O +
amino O +
acid O +
analysis O +
presented O +
as O +
a O +
ratio O +
of O +
total O +
BCAA B-Chemical +
to O +
alanine O -
. O +

The O +
BCAA B-Chemical -
/ O -
alanine O +
values O +
for O +
mice O +
from O +
both O +
lines O +
were O +
significantly O +
elevated O +
compared O +
to O +
controls O +
for O +
all O +
of O +
the O +
time O +
points O +
analyzed O -
. O +

Note O +
that O +
the O +
BCAA B-Chemical -
/ O -
alanine O +
values O +
for O +
the O +
transgenic O +
mice O +
are O +
intermediate O +
between O +
controls O +
and O +
knockouts O +
( O -
see O +
Figure O +
2C O -
) O -
. O +

Blood O +
levels O +
of O +
alanine O -
, O +
glutamate O -
, O +
and O +
glutamine O +
were O +
reduced O +
in O +
Line O +
A O +
mice O -
, O +
as O +
was O +
glutamate O +
in O +
Line O +
525A O +
mice O -
, O +
compared O +
to O +
controls O +
( O -
Table O +
2 O -
) O -
. O +

Table O +
2 O +
Summary O +
of O +
additional O +
blood O +
amino O +
acid O +
levels O +
in O +
the O +
intermediate O +
MSUD O +
model O +
and O +
littermate O +
controls O +
as O +
determined O +
by O +
tandem O +
mass O +
spectrometry O -
. O +

Samples O +
were O +
collected O +
from O +
mice O +
that O +
were O +
4–6 O +
weeks O +
of O +
age O -
. O +

All O +
values O +
are O +
mean O +
+ O -
/- O +

SEM O -
. O +

* O -
: O +
Significantly O +
different O +
from O +
control O +
( O -
P O +
< O +
0.05 O -
) O -
. O +

* O +

* O -
: O +
Significantly O +
different O +
from O +
control O +
( O -
P O +
< O +
0.01 O -
) O -
. O +

* O +

* O +

* O -
: O +
Significantly O +
different O +
from O +
Line O +
525A O +
( O -
P O +
< O +
0.05 O -
) O -
. O +

Because O +
the O +
LAP O -
- O -
tTA O +
mice O +
that O +
were O +
used O +
to O +
drive O +
expression O +
of O +
transgenic O +
human O +
E2 O +
have O +
been O +
demonstrated O +
to O +
produce O +
liver O +
specific O +
expression O +
[ O -
34 O -
] O -
, O +
BCKDH O +
enzyme O +
activity O +
and O +
production O +
of O +
human O +
E2 O +
protein O +
in O +
liver O +
of O +
Lines O +
A O +
and O +
525A O +
was O +
examined O -
. O +

BCKDH O +
enzymatic O +
activity O +
in O +
liver O +
from O +
Lines O +
A O +
and O +
525A O +
was O +
~6 O +
and O +
5 O -
% O -
, O +
respectively O -
, O +
of O +
the O +
enzymatic O +
activity O +
present O +
in O +
control O +
liver O +
( O -
Fig. O +
4C O -
) O -
. O +

As O +
shown O +
in O +
Fig. O +
3B O -
, O +
the O +
amount O +
of O +
human O +
E2 O +
( O -
predicted O +
MW~54 O +
Kd O -
) O +
in O +
these O +
transgenic O +
mice O +
was O +
quite O +
variable O +
between O +
mice O -
. O +

In O +
some O +
of O +
these O +
transgenic O +
mice O -
, O +
the O +
level O +
of O +
human O +
E2 O +
was O +
approximately O +
equal O +
to O +
the O +
amount O +
of O +
mouse O +
E2 O +
( O -
~47 O +
Kd O -
) O +
produced O +
in O +
liver O +
of O +
nontransgenic O +
control O +
mice O -
. O +

The O +
observations O +
that O +
these O +
near O +
normal O +
amounts O +
of O +
E2 O +
protein O +
result O +
in O +
only O +
~5–6 O -
% O +
of O +
normal O +
BCKDH O +
enzyme O +
activity O +
suggest O +
that O +
transgene O +
derived O +
E2 O +
is O +
functioning O +
at O +
a O +
suboptimal O +
level O -
. O +

It O +
is O +
probable O +
that O +
the O +
c O -
- O -
myc O +
tag O +
at O +
the O +
carboxy O +
terminus O +
of O +
the O +
transgene O +
derived O +
human O +
E2 O +
interfered O +
with O +
enzymatic O +
activity O -
. O +

This O +
interpretation O +
is O +
consistent O +
with O +
previous O +
studies O +
which O +
have O +
revealed O +
that O +
the O +
carboxy O +
terminus O +
of O +
an O +
analogous O +
subunit O +
of O +
the O +
pyruvate B-Chemical +
dehydrogenase O +
complex O +
is O +
essential O +
for O +
subunit O +
interactions O +
[ O -
35 O -
] O +
and O +
insertion O +
of O +
a O +
Hisx6 O +
tag O +
on O +
the O +
carboxy O +
terminus O +
of O +
an O +
analogous O +
E. O +
coli O +
subunit O +
interfered O +
with O +
normal O +
subunit O +
assembly O +
[ O -
36 O -
] O -
. O +

It O +
is O +
also O +
possible O +
that O +
human O +
E2 O +
was O +
not O +
fully O +
functional O +
when O +
complexed O +
with O +
mouse O +
E1 O +
and O +
E3 O +
subunits O -
. O +

Human O +
E2 O +
shares O +
~88 O -
% O +
identity O +
to O +
mouse O +
E2 O +
at O +
the O +
amino O +
acid O +
level O -
. O +

We O +
also O +
used O +
western O +
blot O +
analysis O +
to O +
analyze O +
expression O +
of O +
the O +
E2 O +
transgene O +
in O +
brain O -
, O +
kidney O +
and O +
muscle O -
. O +

As O +
shown O +
in O +
Figure O +
3C O -
, O +
D O +
and O +
3E O +
respectively O -
, O +
expression O +
of O +
E2 O +
is O +
negligible O +
in O +
those O +
tissues O -
. O +

Long O -
- O -
term O +
survival O +
of O +
the O +
mice O +
from O +
these O +
two O +
transgenic O +
lines O +
that O +
survived O +
beyond O +
weaning O +
is O +
plotted O +
in O +
Fig. O +
4D O -
. O +

Although O +
survival O +
data O +
for O +
control O +
animals O +
was O +
not O +
collected O -
, O +
it O +
is O +
readily O +
apparent O +
that O +
survival O +
of O +
the O +
rescue O +
mice O +
was O +
compromised O -
. O +

By O +
16 O +
weeks O -
, O +
all O +
mice O +
of O +
Line O +
A O +
were O +
moribund O +
and O +
humanely O +
sacrificed O -
, O +
or O +
were O +
found O +
dead O +
in O +
their O +
cage O -
. O +

Survival O +
of O +
Line O +
525A O +
appeared O +
to O +
be O +
somewhat O +
better O -
. O +

At O +
20 O +
weeks O +
of O +
age O -
, O +
~12 O -
% O +
of O +
mice O +
( O -
2 O +
of O +
16 O -
) O +
were O +
still O +
alive O -
. O +

These O +
two O +
rare O +
survivors O +
died O +
at O +
40 O +
and O +
60 O +
weeks O +
of O +
age O -
. O +

In O +
summary O -
, O +
these O +
surviving O +
mice O +
had O +
BCAA B-Chemical -
/ O -
alanine O +
ratios O +
that O +
were O +
intermediate O +
between O +
controls O +
and O +
knockouts O +
and O +
they O +
expressed O +
~5–6 O -
% O +
of O +
normal O +
BCKDH O +
enzyme O +
activity O +
in O +
the O +
liver O -
. O +

These O +
phenotypic O +
observations O +
are O +
remarkably O +
similar O +
to O +
the O +
clinical O +
phenotype O +
observed O +
in O +
MSUD O +
patients O +
with O +
the O +
intermediate O +
form O +
of O +
the O +
disease O +
[ O -
1 O -
] O -
. O +

Thus O -
, O +
these O +
rescue O +
mice O +
represent O +
a O +
very O +
useful O +
model O +
of O +
the O +
intermediate O +
MSUD O +
phenotype O -
. O +

Discussion O +
A O +
major O +
hurdle O +
in O +
developing O +
new O +
treatments O +
for O +
MSUD O +
has O +
been O +
the O +
lack O +
of O +
a O +
practical O -
, O +
accurate O +
animal O +
model O +
of O +
the O +
disease O -
. O +

This O +
hurdle O +
has O +
now O +
been O +
overcome O -
. O +

In O +
this O +
report O -
, O +
we O +
describe O +
the O +
development O +
and O +
characterization O +
of O +
two O +
genetically O +
engineered O +
mouse O +
models O +
that O +
are O +
phenotypically O +
very O +
similar O +
to O +
MSUD O +
patients O +
with O +
the O +
classic O +
and O +
intermediate O +
forms O +
of O +
the O +
disease O -
. O +

Our O +
model O +
of O +
classic O +
MSUD O +
was O +
created O +
by O +
gene O +
knockout O +
of O +
the O +
E2 O +
subunit O +
of O +
BCKDH O -
. O +

The O +
phenotype O +
of O +
these O +
knockout O +
animals O +
is O +
strikingly O +
similar O +
to O +
humans O +
with O +
classic O +
MSUD O -
. O +

Knockout O +
mice O +
were O +
born O +
at O +
the O +
expected O +
frequency O +
and O +
appeared O +
normal O +
at O +
birth O -
. O +

Within O +
a O +
day O +
of O +
birth O +
and O +
following O +
suckling O -
, O +
blood O +
levels O +
of O +
BCAA B-Chemical +
were O +
markedly O +
elevated O -
. O +

Concomitantly O -
, O +
levels O +
of O +
the O +
amino O +
acids O +
alanine O -
, O +
glutamate O -
, O +
and O +
glutamine O -
, O +
whose O +
synthesis O +
is O +
linked O +
with O +
normal O +
metabolism O +
of O +
BCAA B-Chemical -
, O +
were O +
decreased O +
( O -
Table O +
1 O -
) O -
. O +

The O +
activity O +
of O +
BCKDH O +
in O +
livers O +
of O +
homozygous O +
knockout O +
mouse O +
pups O +
was O +
undetectable O -
, O +
accounting O +
for O +
the O +
accumulation O +
of O +
unmetabolized O +
BCAA B-Chemical -
. O +

Immunoreactive O +
E2 O +
protein O +
was O +
absent O +
in O +
liver O +
and O +
fibroblasts O +
of O +
homozygous O +
pups O -
. O +

The O +
phenotypic O +
behavior O +
of O +
homozygous O +
mouse O +
pups O +
resembles O +
symptoms O +
seen O +
in O +
newborn O +
classic O +
MSUD O +
patients O -
. O +

These O +
include O +
signs O +
of O +
neurologic O +
dysfunction O +
such O +
as O +
seizures O -
, O +
stupor O -
, O +
lethargy O -
, O +
loss O +
of O +
motor O +
activity O -
, O +
and O +
respiratory O +
difficulties O +
[ O -
1 O -
] O -
. O +

These O +
neurologic O +
symptoms O +
may O +
result O +
from O +
reduced O +
levels O +
of O +
glutamate O -
, O +
glutamine O -
, O +
alanine O -
, O +
and O +
other O +
similar O +
neuroactive O +
amino O +
acids O -
, O +
which O +
are O +
considered O +
the O +
culprit O +
for O +
MSUD O +
encephalopathies O +
in O +
patients O +
[ O -
1,37 O -
] O -
. O +

Finally O -
, O +
nearly O +
all O +
of O +
the O +
homozygous O +
pups O +
died O +
within O +
72 O +
hours O +
of O +
birth O -
. O +

This O +
neonatal O +
lethality O +
is O +
likely O +
due O +
to O +
the O +
accumulation O +
of O +
BCAA B-Chemical +
to O +
neurotoxic O +
levels O -
, O +
ketoacidosis O -
, O +
brain O +
edema O -
, O +
dehydration O -
, O +
and O +
malnutrition O +
as O +
observed O +
in O +
the O +
MSUD O +
calf O +
[ O -
17 O -
] O +
and O +
in O +
classic O +
MSUD O +
patients O +
[ O -
1 O -
] O -
. O +

Heterozygous O +
knockouts O +
were O +
normal O +
and O +
had O +
normal O +
levels O +
of O +
BCAA B-Chemical +
despite O +
having O +
approximately O +
half O +
of O +
BCKDH O +
enzymatic O +
activity O -
. O +

From O +
the O +
characterization O +
studies O +
completed O +
thus O +
far O -
, O +
the O +
null O +
mutation O +
mouse O +
accurately O +
represents O +
a O +
model O +
of O +
classic O +
MSUD O +
and O +
appears O +
to O +
be O +
a O +
faithful O +
model O +
of O +
the O +
human O +
disease O +
with O +
respect O +
to O +
several O +
biochemical O +
phenotypes O +
[ O -
1 O -
] O -
. O +

To O +
create O +
a O +
model O +
of O +
intermediate O +
MSUD O -
, O +
we O +
used O +
a O +
transgenic O +
strategy O +
to O +
express O +
human O +
E2 O +
in O +
the O +
liver O +
of O +
E2 O +
knockout O +
mice O -
. O +

As O +
mentioned O +
above O -
, O +
E2 O +
knockouts O +
without O +
transgene O +
derived O +
E2 O +
die O +
during O +
the O +
early O +
neonatal O +
period O -
. O +

We O +
show O +
that O +
expression O +
of O +
a O +
human O +
E2 O +
transgene O +
in O +
the O +
liver O +
of O +
these O +
knockout O +
mice O +
is O +
able O +
to O +
rescue O +
the O +
neonatal O +
lethality O -
. O +

Many O +
of O +
the O +
rescue O +
mice O +
survived O +
to O +
adulthood O -
. O +

It O +
is O +
interesting O +
to O +
note O +
that O +
in O +
these O +
mouse O +
lines O +
only O +
~5–6 O -
% O +
of O +
normal O +
BCKDH O +
activity O +
in O +
the O +
liver O +
was O +
sufficient O +
to O +
allow O +
survival O -
. O +

We O +
also O +
demonstrated O +
that O +
BCAA B-Chemical +
levels O +
in O +
blood O +
of O +
these O +
rescue O +
mice O +
were O +
intermediate O +
between O +
controls O +
and O +
knockouts O -
. O +

The O +
hallmarks O +
of O +
intermediate O +
MSUD O +
human O +
patients O +
are O +
persistently O +
increased O +
levels O +
of O +
BCAA B-Chemical +
and O +
BCKDH O +
activity O +
in O +
the O +
range O +
of O +
3–30 O -
% O +
of O +
normal O +
[ O -
1 O -
] O -
. O +

Because O +
of O +
the O +
phenotypic O +
similarities O +
of O +
the O +
rescue O +
mice O +
to O +
the O +
human O +
patients O -
, O +
these O +
genetically O +
engineered O +
mice O +
represent O +
a O +
useful O +
small O +
animal O +
model O +
of O +
the O +
intermediate O +
form O +
of O +
MSUD O -
. O +

The O +
transgenic O +
approach O +
that O +
was O +
used O +
to O +
create O +
the O +
intermediate O +
MSUD O +
model O +
was O +
based O +
on O +
the O +
tetracycline B-Chemical +
regulated O +
gene O +
switch O +
system O +
that O +
has O +
been O +
used O +
with O +
great O +
success O +
in O +
other O +
studies O -
, O +
for O +
example O +
[ O -
34 O -
] O -
. O +

The O +
strategy O +
behind O +
our O +
approach O +
was O +
to O +
create O +
mice O +
with O +
an O +
intermediate O +
MSUD O +
phenotype O +
that O +
could O +
be O +
converted O +
to O +
the O +
classic O +
phenotype O +
at O +
the O +
investigator O -
's O +
discretion O +
by O +
turning O +
off O +
the O +
rescuing O +
transgene O -
. O +

However O -
, O +
we O +
were O +
unable O +
to O +
consistently O +
turn O +
off O +
the O +
human O +
E2 O +
expression O +
cassette O +
by O +
the O +
potent O +
tetracycline B-Chemical +
analogue O -
, O +
doxycycline B-Chemical +
in O +
either O +
of O +
the O +
two O +
transgenic O +
lines O +
tested O +
( O -
data O +
not O +
shown O -
) O -
. O +

The O +
reason O +
these O +
two O +
lines O +
were O +
unresponsive O +
to O +
doxycycline B-Chemical +
is O +
unknown O -
. O +

It O +
is O +
conceivable O +
that O +
the O +
integration O +
site O +
of O +
the O +
transgenes O +
was O +
not O +
permissive O +
for O +
regulated O +
expression O -
. O +

Screening O +
of O +
additional O +
lines O +
may O +
be O +
needed O +
to O +
find O +
lines O +
that O +
allow O +
for O +
survival O +
and O +
can O +
also O +
be O +
regulated O -
. O +

The O +
models O +
described O +
in O +
this O +
communication O +
are O +
important O +
advances O +
over O +
the O +
previously O +
described O +
models O -
. O +

An O +
ENU B-Chemical +
mouse O +
resembling O +
human O +
MSUD O +
was O +
previously O +
created O +
by O +
disrupting O +
the O +
mitochondrial O +
BCAT O +
gene O +
[ O -
20 O -
] O -
. O +

The O +
BCKDH O +
activity O +
in O +
the O +
liver O +
and O +
muscle O +
of O +
this O +
mouse O +
was O +
normal O +
even O +
though O +
the O +
blood O +
BCAA B-Chemical +
levels O +
were O +
markedly O +
elevated O -
. O +

While O +
this O +
is O +
an O +
interesting O +
model O -
, O +
it O +
is O +
not O +
a O +
true O +
model O +
of O +
MSUD O +
because O +
the O +
mutation O +
is O +
not O +
in O +
BCKDH O +
and O +
the O +
levels O +
of O +
BCKDH O +
are O +
normal O -
. O +

Furthermore O -
, O +
no O +
case O +
of O +
MSUD O +
has O +
been O +
described O +
attributing O +
this O +
disease O +
to O +
BCAT O +
deficiency O -
. O +

In O +
addition O +
to O +
this O +
mouse O +
model O -
, O +
a O +
cow O +
model O +
of O +
MSUD O +
has O +
also O +
been O +
previously O +
described O +
[ O -
17 O -
- O -
19 O -
] O -
. O +

However O -
, O +
due O +
to O +
practical O +
constraints O +
imposed O +
by O +
such O +
a O +
large O +
animal O +
model O +
and O +
due O +
to O +
the O +
observation O +
of O +
differences O +
between O +
the O +
MSUD O +
cow O +
model O +
and O +
MSUD O +
humans O +
[ O -
1 O -
] O -
, O +
this O +
model O +
is O +
also O +
of O +
limited O +
utility O -
. O +

In O +
contrast O -
, O +
the O +
murine O +
models O +
described O +
in O +
this O +
report O +
are O +
more O +
valid O +
and O +
appropriate O +
for O +
modeling O +
human O +
MSUD O -
. O +

The O +
most O +
significant O +
opportunity O +
presented O +
by O +
the O +
MSUD O +
mouse O +
models O +
is O +
to O +
test O +
novel O +
treatments O +
such O +
as O +
gene O +
[ O -
38 O -
- O -
41 O -
] O +
and O +
cell O +
based O +
therapies O +
( O -
e.g. O -
, O +
hepatocytes O +
[ O -
42,43 O -
] O +
or O +
embryonic O +
stem O +
cells O +
[ O -
44 O -
] O -
) O -
. O +

Relevant O +
to O +
gene O +
therapy O -
, O +
recent O +
problems O +
with O +
gene O +
therapy O +
in O +
humans O +
highlight O +
the O +
importance O +
and O +
critical O +
need O +
of O +
animal O +
models O +
of O +
genetic O +
diseases O +
for O +
preclinical O +
studies O -
. O +

The O +
testing O +
of O +
gene O +
and O +
cell O +
based O +
therapies O +
on O +
appropriate O +
animal O +
model O +
systems O +
provides O +
a O +
preliminary O +
method O +
of O +
establishing O +
not O +
only O +
the O +
efficacy O -
, O +
but O +
also O +
short- O +
and O +
long O -
- O -
term O +
safety O -
. O +

Success O +
with O +
animal O +
studies O +
is O +
expected O +
to O +
advance O +
such O +
therapeutic O +
approaches O +
and O +
could O +
pave O +
the O +
way O +
for O +
studies O +
in O +
humans O -
. O +

In O +
addition O +
to O +
testing O +
various O +
treatments O -
, O +
these O +
models O +
should O +
also O +
be O +
very O +
useful O +
for O +
investigating O +
the O +
underlying O +
pathophysiologic O +
consequences O +
of O +
the O +
disease O -
. O +

Such O +
studies O +
are O +
very O +
difficult O -
/ O -
impossible O +
to O +
do O +
in O +
human O +
patients O +
for O +
obvious O +
ethical O +
reasons O -
, O +
and O +
often O +
must O +
rely O +
on O +
autopsy O +
tissue O -
. O +

Additionally O -
, O +
the O +
intermediate O +
MSUD O +
model O +
may O +
also O +
be O +
useful O +
for O +
studies O +
to O +
test O +
the O +
effect O +
of O +
thiamin B-Chemical -
. O +

A O +
thiamin B-Chemical -
- O -
responsive O +
form O +
of O +
MSUD O +
has O +
been O +
described O +
[ O -
1 O -
] O -
. O +

The O +
phenotype O +
of O +
these O +
patients O +
is O +
heterogeneous O +
and O +
treatment O +
with O +
a O +
wide O +
range O +
of O +
thiamin B-Chemical +
doses O +
has O +
produced O +
limited O +
success O +
[ O -
1 O -
] O -
. O +

Recent O +
cell O +
culture O +
studies O +
with O +
MSUD O +
cells O +
have O +
suggested O +
that O +
the O +
thiamin B-Chemical -
- O -
responsive O +
phenotype O +
is O +
dependent O +
upon O +
the O +
presence O +
of O +
at O +
least O +
one O +
E2 O +
expressing O +
allele O +
[ O -
45,46 O -
] O -
. O +

In O +
light O +
of O +
these O +
newer O +
findings O -
, O +
our O +
intermediate O +
MSUD O +
mouse O +
provides O +
a O +
model O +
to O +
test O +
the O +
effect O +
of O +
thiamin B-Chemical +
with O +
respect O +
to O +
BCKDH O +
activity O +
and O +
blood O +
amino O +
acid O +
levels O +
at O +
the O +
level O +
of O +
the O +
whole O +
animal O -
. O +

Because O +
of O +
recent O +
interest O +
in O +
structural O +
analysis O +
of O +
multienzyme O +
complexes O +
[ O -
35,36,45,46 O -
] O -
, O +
the O +
intermediate O +
MSUD O +
model O +
may O +
provide O +
a O +
valuable O +
resource O +
for O +
studies O +
of O +
structural O +
biology O -
. O +

Lastly O -
, O +
the O +
information O +
and O +
knowledge O +
gained O +
from O +
studies O +
with O +
the O +
MSUD O +
models O +
described O +
here O +
will O +
also O +
be O +
applicable O +
and O +
transferable O +
to O +
other O +
mitochondrial O +
disorders O +
due O +
to O +
defects O +
in O +
multisubunit O +
enzymes O -
. O +

Conclusion O +
In O +
summary O -
, O +
this O +
report O +
describes O +
the O +
development O +
and O +
characterization O +
of O +
genetically O +
engineered O +
mouse O +
models O +
of O +
classic O +
as O +
well O +
as O +
intermediate O +
MSUD O -
. O +

These O +
animals O +
provide O +
useful O +
models O +
to O +
further O +
characterize O +
the O +
pathogenesis O +
of O +
MSUD O -
, O +
as O +
well O +
as O +
models O +
to O +
test O +
novel O +
therapeutic O +
strategies O -
, O +
such O +
as O +
gene O +
and O +
cellular O +
therapies O -
, O +
to O +
treat O +
this O +
devastating O +
metabolic O +
disease O -
. O +

Abbreviations O +
The O +
abbreviations O +
used O +
are O -
: O +
MSUD O -
, O +
Maple O +
Syrup O +
Urine O +
Disease O -
; O +
BCKDH O -
, O +
branched O +
chain O +
ketoacid B-Chemical +
dehydrogenase O -
; O +
BCAA B-Chemical -
, O +
branched B-Chemical +
chain I-Chemical +
amino I-Chemical +
acids I-Chemical -
; O +
ENU B-Chemical -
, O +
N B-Chemical -
- I-Chemical -
ethyl I-Chemical -
- I-Chemical -
N I-Chemical -
- I-Chemical -
nitrosourea I-Chemical -
; O +
BCAT O -
, O +
branched O +
chain O +
aminotransferase O -
; O +
ES O +
cell O -
, O +
embryonic O +
stem O +
cell O -
; O +
TRE O -
, O +
tetracycline B-Chemical +
responsive O +
element O -
; O +
MEF O -
, O +
mouse O +
embryonic O +
fibroblast O -
. O +

Competing O +
interests O +
The O +
author O -
( O -
s O -
) O +
declare O +
that O +
they O +
have O +
no O +
competing O +
interests O -
. O +

Authors O -
' O +
contributions O +
GEH O +
designed O +
and O +
produced O +
the O +
mouse O +
models O -
, O +
coordinated O +
experiments O -
, O +
interpreted O +
data O -
, O +
and O +
helped O +
draft O +
the O +
manuscript O -
. O +

KS O +
conducted O +
much O +
of O +
the O +
characterization O +
of O +
the O +
intermediate O +
MSUD O +
model O -
. O +

CF O +
assisted O +
with O +
production O +
of O +
the O +
mouse O +
models O -
, O +
data O +
collection O -
, O +
analysis O -
, O +
and O +
interpretation O -
. O +

SW O +
directed O +
the O +
immunohistochemistry O +
experiments O -
. O +

HSP O +
conceived O +
of O +
the O +
knockout O +
model O -
, O +
interpreted O +
data O +
and O +
drafted O +
the O +
manuscript O -
. O +

All O +
authors O +
contributed O +
to O +
composing O +
and O +
editing O +
the O +
manuscript O +
and O +
have O +
read O +
and O +
approved O +
the O +
final O +
version O -
. O +

Pre O -
- O -
publication O +
history O +
The O +
pre O -
- O -
publication O +
history O +
for O +
this O +
paper O +
can O +
be O +
accessed O +
here O -
: O +

Acknowledgements O +

The O +
authors O +
would O +
like O +
to O +
thank O +
Frank O +
Kist O -
, O +
Jodi O +
Dagget O -
, O +
Edward O +
Mallick O -
, O +
Brian O +
Sloat O -
, O +
and O +
Judith O +
Rodda O +
for O +
expert O +
technical O +
assistance O -
, O +
and O +
Dr. O +
Susan O +
Hutson O +
for O +
the O +
gift O +
of O +
E2 O +
antiserum O -
. O +

This O +
work O +
was O +
supported O +
by O +
National O +
Institutes O +
of O +
Health O +
Grants O +
DK51960 O -
, O +
DK57386 O -
, O +
DK57956 O -
, O +
AA10422 O -
, O +
the O +
Scott O +
C. O +
Foster O +
Metabolic O +
Disease O +
Fund O -
, O +
and O +
the O +
MSUD O +
Family O +
Support O +
Group O -
. O +

Genome O -
- O -
wide O +
isolation O +
of O +
growth O +
and O +
obesity O +
QTL O +
using O +
mouse O +
speed O +
congenic O +
strains O +
Abstract O +
Background O +
High O +
growth O +
( O -
hg O -
) O +
modifier O +
and O +
background O +
independent O +
quantitative O +
trait O +
loci O +
( O -
QTL O -
) O +
affecting O +
growth O -
, O +
adiposity O +
and O +
carcass O +
composition O +
were O +
previously O +
identified O +
on O +
mouse O +
chromosomes O +
( O -
MMU O -
) O +
1 O -
, O +
2 O -
, O +
5 O -
, O +
8 O -
, O +
9 O -
, O +
11 O +
and O +
17 O -
. O +

To O +
confirm O +
and O +
further O +
characterize O +
each O +
QTL O -
, O +
two O +
panels O +
of O +
speed O +
congenic O +
strains O +
were O +
developed O +
by O +
introgressing O +
CAST O -
/ O -
EiJ O +
( O -
CAST O -
) O +
QTL O +
alleles O +
onto O +
either O +
mutant O +
C57Bl O -
/ O -
6J O -
- O -
hg O -
/ O -
hg O +
( O -
HG O -
) O +
or O +
wild O +
type O +
C57Bl O -
/ O -
6J O +
( O -
B6 O -
) O +
genetic O +
backgrounds O -
. O +

Results O +
The O +
first O +
speed O +
congenic O +
panel O +
was O +
developed O +
by O +
introgressing O +
four O +
overlapping O +
donor O +
regions O +
spanning O +
MMU2 O +
in O +
its O +
entirety O +
onto O +
both O +
HG O +
and O +
B6 O +
backgrounds O -
, O +
for O +
a O +
total O +
of O +
eight O +
strains O -
. O +

Phenotypic O +
characterization O +
of O +
the O +
MMU2 O +
panel O +
confirmed O +
the O +
segregation O +
of O +
multiple O +
growth O +
and O +
obesity O +
QTL O +
and O +
strongly O +
suggested O +
that O +
a O +
subset O +
of O +
these O +
loci O +
modify O +
the O +
effects O +
of O +
the O +
hg O +
deletion O -
. O +

The O +
second O +
panel O +
consisted O +
of O +
individual O +
donor O +
regions O +
on O +
an O +
HG O +
background O +
for O +
each O +
QTL O +
on O +
MMU1 O -
, O +
5 O -
, O +
8 O -
, O +
9 O -
, O +
11 O +
and O +
17 O -
. O +

Of O +
the O +
six O +
developed O +
strains O -
, O +
five O +
were O +
successfully O +
characterized O +
and O +
displayed O +
significant O +
differences O +
in O +
growth O +
and/or O +
obesity O +
as O +
compared O +
to O +
controls O -
. O +

All O +
five O +
displayed O +
phenotypes O +
similar O +
to O +
those O +
originally O +
attributed O +
to O +
each O +
QTL O -
, O +
however O -
, O +
novel O +
phenotypes O +
were O +
unmasked O +
in O +
several O +
of O +
the O +
strains O +
including O +
sex O -
- O -
specific O +
effects O -
. O +

Conclusion O +
The O +
speed O +
congenic O +
strains O +
developed O +
herein O +
constitute O +
an O +
invaluable O +
genomic O +
resource O +
and O +
provide O +
the O +
foundation O +
to O +
identify O +
the O +
specific O +
nature O +
of O +
genetic O +
variation O +
influencing O +
growth O +
and O +
obesity O -
. O +

Background O +
The O +
use O +
of O +
mouse O +
models O +
has O +
provided O +
valuable O +
insight O +
into O +
the O +
etiology O +
of O +
monogenic O +
syndromes O +
caused O +
by O +
single O +
gene O +
mutations O -
. O +

However O -
, O +
such O +
models O +
do O +
not O +
mimic O +
the O +
genetic O +
complexity O +
of O +
disease O +
traits O +
commonly O +
seen O +
in O +
the O +
human O +
population O -
. O +

Complex O +
traits O -
, O +
such O +
as O +
polygenic O +
growth O +
and O +
obesity O +
are O +
influenced O +
by O +
the O +
small O +
to O +
moderate O +
direct O +
effects O +
of O +
quantitative O +
trait O +
loci O +
( O -
QTL O -
) O -
, O +
epistasis O +
between O +
QTL O +
alleles O -
, O +
environmental O +
perturbations O +
and O +
QTL O -
- O -
environment O +
interactions O -
. O +

To O +
date O +
numerous O +
mouse O +
growth O +
and O +
obesity O +
QTL O +
have O +
been O +
localized O +
[ O -
1,2 O -
] O -
, O +
however O -
, O +
little O +
progress O +
has O +
been O +
made O +
in O +
determining O +
the O +
specific O +
nature O +
of O +
the O +
underlying O +
genetic O +
variants O -
. O +

One O +
resource O +
used O +
to O +
fine O +
map O +
QTL O +
are O +
congenic O +
strains O +
which O +
are O +
designed O +
to O +
convert O +
a O +
complex O +
polygenic O +
trait O +
into O +
one O +
that O +
is O +
mono- O +
or O +
oligogenic O -
. O +

This O +
is O +
accomplished O +
by O +
eliminating O +
segregating O +
genetic O +
variation O +
outside O +
the O +
locus O +
of O +
interest O +
and O +
reducing O +
the O +
environmental O +
variation O +
influencing O +
a O +
trait O +
by O +
characterizing O +
large O +
numbers O +
of O +
genetically O +
identical O +
mice O -
. O +

The O +
Complex O +
Trait O +
Consortium O +
( O -
CTC O -
) O +
considers O +
congenic O +
analysis O +
an O +
excellent O +
method O +
to O +
confirm O +
and O +
subsequently O +
fine O +
map O +
QTL O +
[ O -
3 O -
] O -
. O +

Traditionally O -
, O +
congenic O +
strains O +
are O +
developed O +
by O +
introgressing O +
QTL O +
alleles O +
from O +
a O +
donor O +
strain O -
, O +
whose O +
boundaries O +
are O +
defined O +
by O +
genetic O +
markers O -
, O +
on O +
the O +
genetic O +
background O +
of O +
a O +
recipient O +
strain O +
via O +
10 O +
backcrosses O +
[ O -
4 O -
] O -
. O +

While O +
technically O +
straightforward O +
this O +
is O +
a O +
time O +
consuming O +
endeavor O +
taking O +
over O +
three O +
years O +
to O +
construct O +
a O +
single O +
strain O -
. O +

The O +
speed O +
congenic O +
approach O +
is O +
an O +
alternative O +
to O +
this O +
lengthy O +
process O +
and O +
can O +
reduce O +
the O +
number O +
of O +
required O +
backcrosses O +
from O +
10 O +
to O +
five O +
[ O -
5,6 O -
] O -
. O +

This O +
strategy O +
uses O +
marker O -
- O -
assisted O +
selection O +
to O +
identify O +
male O +
mice O +
inheriting O +
fewer O +
donor O +
alleles O -
, O +
than O +
expected O +
on O +
average O -
, O +
during O +
each O +
backcross O -
. O +

Numerous O +
traditionally O +
developed O +
and O +
speed O +
congenics O +
have O +
been O +
used O +
to O +
successfully O +
isolate O +
mouse O +
QTL O +
for O +
a O +
wide O +
array O +
of O +
traits O -
, O +
including O +
growth O +
and O +
obesity O +
[ O -
7 O -
- O -
13 O -
] O -
. O +

The O +
C57Bl O -
/ O -
6J O -
- O -
hg O -
/ O -
hg O +
( O -
HG O -
) O +
mouse O +
is O +
a O +
model O +
of O +
systemic O +
overgrowth O +
resulting O +
from O +
a O +
spontaneous O +
deletion O +
on O +
MMU10 O -
, O +
which O +
eliminates O +
expression O +
of O +
the O +
Socs2 O +
( O -
suppressor O +
of O +
cytokine O +
signaling O +
2 O -
) O +
gene O +
[ O -
14 O -
- O -
16 O -
] O -
. O +

The O +
role O +
of O +
Socs2 O +
in O +
the O +
HG O +
phenotype O +
was O +
confirmed O +
by O +
an O +
independently O +
engineered O +
Socs2- O -
/ O -
- O +
knockout O +
mouse O +
which O +
shared O +
a O +
number O +
of O +
phenotypes O +
in O +
common O +
with O +
HG O -
, O +
including O +
gigantism O +
[ O -
17 O -
] O -
. O +

QTL O +
which O +
alter O +
the O +
phenotypic O +
effects O +
of O +
another O +
locus O +
are O +
referred O +
to O +
as O +
modifier O +
QTL O +
[ O -
18 O -
] O -
. O +

Modifier O +
QTL O +
have O +
been O +
mapped O +
for O +
numerous O +
traits O +
and O +
in O +
these O +
studies O +
the O +
modified O +
locus O +
is O +
typically O +
a O +
known O +
gene O +
containing O +
a O +
spontaneously O +
arisen O +
or O +
engineered O +
mutation O +
with O +
major O +
phenotypic O +
effects O -
, O +
such O +
as O +
hg O +
[ O -
11,19 O -
- O -
21 O -
] O -
. O +

Epistasis O +
forms O +
the O +
basis O +
of O +
these O +
interactions O -
, O +
implying O +
that O +
the O +
known O +
gene O +
and O +
its O +
modifiers O +
are O +
members O +
of O +
the O +
same O +
biochemical O +
or O +
metabolic O +
pathway O -
. O +

Different O +
genetic O +
backgrounds O +
have O +
been O +
shown O +
to O +
modify O +
the O +
growth O -
- O -
enhancing O +
effects O +
of O +
hg O +
[ O -
15,22 O -
] O -
. O +

Since O +
the O +
primary O +
function O +
of O +
Socs2 O +
is O +
to O +
negatively O +
regulate O +
growth O +
hormone O +
( O -
Gh O -
) O +
[ O -
23 O -
] O -
, O +
it O +
is O +
likely O +
these O +
background O +
effects O +
are O +
the O +
result O +
of O +
polymorphism O +
influencing O +
interactions O +
between O +
members O +
of O +
the O +
Gh O +
signaling O +
pathway O -
. O +

Thus O -
, O +
identification O +
of O +
hg O +
modifiers O +
has O +
the O +
potential O +
to O +
uncover O +
novel O +
members O +
of O +
metabolically O +
important O +
pathways O +
or O +
previously O +
unknown O +
convergences O +
between O +
pathways O -
. O +

As O +
an O +
initial O +
step O -
, O +
growth O +
and O +
carcass O +
composition O +
QTL O +
were O +
identified O +
in O +
a O +
cross O +
between O +
CAST O -
/ O -
EiJ O +
( O -
CAST O -
) O +
and O +
HG O +
[ O -
24 O -
] O -
. O +

In O +
the O +
F2 O -
, O +
mice O +
homozygous O +
for O +
the O +
hg O +
deletion O +
( O -
hg O -
/ O -
hg O -
) O +
and O +
wild O +
type O +
( O -
+ O -
/+ O -
) O +
were O +
assayed O +
and O +
hg O +
modifier O +
QTL O +
were O +
defined O +
as O +
those O +
either O +
absent O +
in O +
+ O -
/+ O +
mice O +
and O +
segregating O +
in O +
hg O -
/ O -
hg O +
or O +
loci O +
with O +
altered O +
gene O +
action O +
dependent O +
on O +
background O -
. O +

Four O +
hg O +
modifier O +
QTL O +
( O -
Wg2 O +
on O +
MMU2 O -
, O +
Carfhg2 O +
on O +
MMU9 O -
, O +
Carp2 O +
on O +
MMU11 O +
and O +
Feml3 O +
on O +
MMU17 O -
) O +
were O +
identified O -
, O +
along O +
with O +
12 O +
additional O +
QTL O +
( O -
Q1Ucd1 O +
on O +
MMU1 O +
( O -
which O +
only O +
reached O +
a O +
suggestive O +
level O +
of O +
statistical O +
significance O -
) O -
, O +
Wg1 O -
, O +
Carp1 O -
, O +
Cara1 O +
and O +
Feml1 O +
on O +
MMU2 O -
, O +
Carfhg1 O +
on O +
MMU5 O -
, O +
Wg3 O +
on O +
MMU8 O -
, O +
Feml2 O +
on O +
MMU9 O -
, O +
Wg4 O +
and O +
Cara2 O +
on O +
MMU11 O +
and O +
Carp3 O +
and O +
Cara3 O +
on O +
MMU17 O -
) O +
whose O +
expression O +
was O +
independent O +
of O +
the O +
hg O +
locus O -
. O +

In O +
the O +
current O +
study O +
we O +
have O +
developed O +
speed O +
congenic O +
strains O +
to O +
isolate O +
all O +
the O +
aforementioned O +
QTL O -
. O +

Single O +
strains O +
on O +
an O +
HG O +
background O +
were O +
created O +
for O +
each O +
chromosomal O +
region O +
outside O +
of O +
MMU2 O -
, O +
while O +
a O +
comprehensive O +
panel O +
of O +
overlapping O +
strains O +
with O +
identical O +
donor O +
regions O +
on O +
both O +
B6 O +
and O +
HG O +
backgrounds O +
were O +
developed O +
for O +
MMU2 O -
. O +

The O +
MMU2 O +
panel O +
was O +
developed O +
to O +
confirm O +
the O +
presence O +
of O +
multiple O +
QTL O +
and O +
test O +
for O +
QTL O -
- O -
hg O +
interactions O -
. O +

Additionally O -
, O +
based O +
on O +
the O +
knowledge O +
of O +
potential O +
QTL O -
- O -
hg O +
interactions O -
, O +
genes O +
involved O +
in O +
Gh O +
signaling O -
, O +
whose O +
genomic O +
location O +
overlapped O +
hg O +
modifier O +
QTL O +
on O +
MMU2 O -
, O +
9 O -
, O +
11 O +
and O +
17 O -
, O +
were O +
sequenced O -
. O +

Results O +
Speed O +
congenic O +
strain O +
development O +
Two O +
speed O +
congenic O +
panels O +
were O +
created O -
, O +
the O +
first O +
comprehensively O +
dissected O +
MMU2 O +
while O +
the O +
second O +
isolated O +
QTL O +
on O +
MMU1 O -
, O +
5 O -
, O +
8 O -
, O +
9 O -
, O +
11 O +
and O +
17 O +
( O -
Table O +
1 O -
) O -
. O +

The O +
MMU2 O +
panel O +
consisted O +
of O +
eight O +
congenic O +
strains O +
developed O +
by O +
introgressing O +
four O +
overlapping O +
donor O +
regions O +
onto O +
both O +
B6 O +
and O +
HG O +
genetic O +
backgrounds O +
( O -
Table O +
1 O -
) O -
. O +

Single O +
donor O +
regions O +
bred O +
onto O +
an O +
HG O +
background O +
were O +
created O +
to O +
isolate O +
the O +
remaining O +
QTL O +
on O +
MMU1 O -
, O +
5 O -
, O +
8 O -
, O +
9 O -
, O +
11 O +
and O +
17 O -
. O +

Implementation O +
of O +
a O +
speed O +
congenic O +
approach O +
using O +
marker O -
- O -
assisted O +
breeding O +
with O +
79 O +
genome O -
- O -
wide O +
microsatellite O +
markers O +
accelerated O +
production O +
of O +
all O +
strains O +
[ O -
5,6 O -
] O +
( O -
Additional O +
File O +
1 O +
and O +
Figure O +
1 O -
) O -
. O +

Strain O +
abbreviations O +
and O +
genomic O +
region O +
isolated O +
by O +
each O +
strain O +
are O +
listed O +
in O +
Table O +
1 O -
. O +

In O +
addition O +
to O +
both O +
congenic O +
panels O -
, O +
two O +
control O +
strains O +
homozygous O +
B6 O +
( O -
B6.CASTC O -
; O +
B6C O -
) O +
or O +
HG O +
( O -
HG.CASTC O -
; O +
HGC O -
) O +
for O +
all O +
genome O -
- O -
wide O +
markers O +
genotyped O +
were O +
developed O +
from O +
the O +
same O +
cross O +
( O -
see O +
Methods O -
) O +
and O +
served O +
as O +
the O +
basis O +
for O +
strain O +
comparisons O -
. O +

After O +
stabilizing O +
each O +
congenic O -
, O +
12 O +
of O +
14 O +
were O +
phenotypically O +
characterized O +
for O +
growth O +
and O +
adiposity O -
. O +

The O +
HG2D O +
and O +
HG5 O +
strains O +
were O +
not O +
characterized O +
due O +
to O +
reproductive O +
problems O -
. O +

The O +
recombinant O +
end O +
points O +
for O +
all O +
strains O +
were O +
refined O +
using O +
microsatellite O +
markers O +
flanking O +
each O +
donor O +
region O +
( O -
Additional O +
File O +
2 O -
) O -
. O +

MMU2 O +
speed O +
congenic O +
strain O +
characterization O +
Due O +
to O +
the O +
overlapping O +
nature O +
of O +
the O +
MMU2 O +
congenics O -
, O +
five O +
distinct O +
chromosomal O +
regions O +
( O -
Regions O +
I O -
– O -
V O -
) O +
were O +
queried O +
for O +
the O +
presence O +
of O +
QTL O +
( O -
Figure O +
2 O -
) O -
. O +

As O +
a O +
separate O +
analysis O +
we O +
also O +
tested O +
for O +
interactions O +
between O +
each O +
donor O +
region O +
and O +
the O +
two O +
distinct O +
genetic O +
backgrounds O -
. O +

The O +
following O +
sections O +
describe O +
the O +
phenotypes O +
for O +
each O +
B6.CAST O +
and O +
HG.CAST O +
speed O +
congenic O +
strain O +
as O +
well O +
as O +
the O +
results O +
of O +
the O +
interaction O +
analysis O -
. O +

B6.CAST O +
MMU2 O +
speed O +
congenic O +
strains O +
The O +
B62D O +
strain O +
exhibited O +
the O +
largest O +
( O -
P O +
< O +
0.0001 O -
) O +
decreases O +
in O +
body O +
weight O +
of O +
any O +
B6.CAST O +
congenic O +
( O -
Additional O +
File O +
3 O -
) O -
. O +

Both O +
sexes O +
had O +
reductions O +
in O +
weight O +
at O +
2 O +
( O -
2WK O -
) O -
, O +
3 O +
( O -
3WK O -
) O -
, O +
6 O +
( O -
6WK O -
) O +
and O +
9 O +
( O -
9WK O -
) O +
weeks O +
of O +
age O +
compared O +
to O +
control O +
B6C O +
mice O +
( O -
Figure O +
3 O -
) O -
. O +

Despite O +
large O +
decreases O +
in O +
body O +
weight O -
, O +
no O +
differences O +
in O +
growth O +
rates O +
( O -
G26 O -
, O +
weight O +
gain O +
from O +
2 O +
to O +
6 O +
weeks O +
and O +
G29 O -
, O +
weight O +
gain O +
from O +
2 O +
to O +
9 O +
weeks O -
) O +
were O +
observed O +
( O -
Additional O +
File O +
3 O -
) O -
. O +

Therefore O -
, O +
the O +
B62D O +
unique O +
region O +
( O -
Region O +
V O -
) O +
harbors O +
either O +
an O +
early O -
- O -
growth O +
QTL O +
or O +
maternal O +
genotype O +
effect O +
which O +
produces O +
a O +
distinct O +
decrease O +
in O +
body O +
weight O +
prior O +
to O +
2WK O -
. O +

These O +
effects O +
are O +
evident O +
in O +
the O +
growth O +
curves O +
for O +
both O +
sexes O +
of O +
each O +
strain O +
( O -
Figure O +
3 O -
) O -
. O +

Additionally O -
, O +
B62D O +
mice O +
displayed O +
significantly O +
shorter O +
tail O +
lengths O +
despite O +
no O +
difference O +
in O +
naso O -
- O -
anal O +
length O +
( O -
NA O -
) O +
( O -
Table O +
2 O -
) O -
. O +

In O +
contrast O -
, O +
B62 O -
M O +
mice O +
displayed O +
small O +
decreases O +
in O +
body O +
weights O +
and O +
growth O +
( O -
male O +
9WK O +
was O +
significant O -
, O +
female O +
6WK O +
and O +
9WK O +
were O +
suggestive O +
at O +
P O +
< O +
0.05 O -
) O +
and O +
significant O +
decreases O +
in O +
NA O +
( O -
male O +
P O +
= O +
0.0152 O -
) O +
and O +
tail O +
length O +
( O -
Additional O +
File O +
3 O +
and O +
Table O +
2 O -
) O -
. O +

The O +
decrease O +
in O +
NA O +
in O +
B62 O -
M O +
mice O +
is O +
surprising O +
since O +
the O +
2 O -
M O +
donor O +
region O +
is O +
entirely O +
nested O +
within O +
the O +
2D O +
donor O +
region O +
and O +
B62D O +
mice O +
showed O +
no O +
difference O +
in O +
NA O +
( O -
Figure O +
2 O -
) O -
. O +

These O +
data O +
indicate O +
the O +
presence O +
of O +
three O +
QTL O +
with O +
the O +
2D O +
unique O +
region O -
. O +

Two O +
of O +
which O +
are O +
disjoined O +
by O +
the O +
B62 O -
M O +
and O +
B62D O +
strains O +
and O +
additively O +
decrease O +
body O +
weight O +
and O +
tail O +
length O -
, O +
but O +
not O +
NA O -
. O +

The O +
third O +
QTL O -
, O +
located O +
within O +
the O +
B62D O +
unique O +
region O +
( O -
Region O +
V O -
) O -
, O +
increases O +
NA O +
canceling O +
the O +
effects O +
of O +
the O +
B62 O -
M O +
QTL O +
( O -
Region O +
IV O -
) O +
decreasing O +
NA O -
. O +

B62PM O +
females O +
had O +
decreases O +
in O +
all O +
growth O -
- O -
related O +
traits O +
except O +
2WK O +
and O +
3WK O -
, O +
while O +
no O +
differences O +
were O +
seen O +
in O +
males O +
( O -
Additional O +
File O +
3 O -
) O -
. O +

Similarly O -
, O +
only O +
B62P O +
females O +
and O +
not O +
males O +
showed O +
significant O +
decreases O +
in O +
9WK O -
, O +
G26 O +
and O +
G29 O +
( O -
Additional O +
File O +
3 O -
) O -
, O +
indicating O +
these O +
two O +
strains O +
share O +
a O +
female O +
specific O +
growth O +
QTL O +
( O -
Region O +
II O -
) O -
. O +

In O +
the O +
original O +
genome O +
scan O +
body O +
fat O +
percentage O +
as O +
determined O +
by O +
chemical O +
compositional O +
analysis O +
was O +
not O +
linked O +
to O +
markers O +
on O +
MMU2 O +
[ O -
24 O -
] O -
. O +

However O -
, O +
since O +
numerous O +
obesity O +
QTL O +
have O +
been O +
found O +
on O +
MMU2 O +
[ O -
2 O -
] O -
, O +
some O +
of O +
which O +
were O +
discovered O +
in O +
B6 O +
by O +
CAST O +
crosses O +
[ O -
9,25 O -
] O -
, O +
we O +
chose O +
to O +
measure O +
dissected O +
fat O +
pad O +
weights O +
as O +
a O +
more O +
sensitive O +
measure O +
of O +
adiposity O -
. O +

Table O +
2 O +
lists O +
the O +
weights O +
of O +
gonadal O +
( O -
GFP O -
) O -
, O +
femoral O +
( O -
FFP O -
) O -
, O +
mesenteric O +
( O -
MFP O -
) O +
and O +
retroperitoneal O +
( O -
RFP O -
) O +
fat O +
pads O -
, O +
along O +
with O +
total O +
fat O +
pad O +
weight O +
( O -
sum O +
of O +
the O +
four O +
fat O +
pads O -
) O -
, O +
adiposity O +
index O +
( O -
AI O +
= O +
TF O -
/ O -
weight O +
at O +
sacrifice O +
( O -
WSAC O -
) O -
) O +
and O +
body O +
mass O +
index O +
( O -
BMI O +
= O +
WSAC O -
/ O -
NA2 O +
* O -
100 O -
) O +
for O +
each O +
MMU2 O +
congenic O +
strain O -
. O +

Similar O +
to O +
large O +
differences O +
in O +
body O +
weight O +
the O +
B62D O +
strain O +
displayed O +
highly O +
significant O +
decreases O +
in O +
adiposity O -
. O +

B62D O +
was O +
the O +
only O +
strain O +
where O +
both O +
sexes O +
had O +
significant O +
decreases O +
in O +
TF O -
, O +
AI O +
and O +
BMI O -
. O +

Interestingly O -
, O +
no O +
difference O +
in O +
adiposity O +
was O +
seen O +
in O +
B62 O -
M O +
mice O -
. O +

This O +
discordance O +
indicates O +
the O +
leanness O +
promoting O +
QTL O +
is O +
located O +
in O +
the O +
B62D O +
unique O +
region O +
( O -
Region O +
V O -
) O -
. O +

Only O +
minor O +
differences O +
in O +
various O +
fat O +
pad O +
weights O +
were O +
observed O +
for O +
the O +
B62P O +
and O +
B62PM O +
strains O +
( O -
Table O +
2 O -
) O -
. O +

HG.CAST O +
MMU2 O +
speed O +
congenic O +
panel O +
HG2P O +
and O +
HG2PM O +
mice O +
of O +
both O +
sexes O +
displayed O +
significant O +
decreases O +
in O +
post O -
- O -
weaning O +
body O +
weights O +
and O +
growth O +
rates O +
( O -
Additional O +
Table O +
3 O -
) O -
. O +

In O +
addition O -
, O +
the O +
HG2 O -
M O +
strain O +
displayed O +
highly O +
significant O +
decreases O +
in O +
length O -
, O +
similar O +
to O +
B62 O -
M O +
mice O +
( O -
Table O +
2 O -
) O -
. O +

These O +
results O +
indicate O +
QTL O +
within O +
Region O +
II O +
shared O +
between O +
the O +
HG2P O +
and O +
HG2PM O +
strains O +
decrease O +
body O +
size O -
, O +
weight O +
gain O +
and O +
NA O +
( O -
only O +
in O +
females O -
) O -
, O +
while O +
a O +
QTL O +
in O +
the O +
HG2 O -
M O +
region O +
significantly O +
decreases O +
tail O +
length O -
. O +

Similar O +
to O +
growth O +
traits O +
a O +
general O +
decrease O +
in O +
GFP O -
, O +
MFP O -
, O +
RFP O -
, O +
TF O +
and O +
AI O +
were O +
seen O +
in O +
HG2P O +
and O +
HG2PM O +
mice O +
( O -
Region O +
II O -
) O +
( O -
Table O +
2 O -
) O -
. O +

These O +
differences O +
in O +
adiposity O +
are O +
likely O +
pleiotropic O +
effects O +
of O +
the O +
growth O +
QTL O +
shared O +
between O +
these O +
two O +
strains O -
. O +

Surprisingly O -
, O +
HG2 O -
M O +
mice O +
displayed O +
striking O +
sex O +
differences O +
in O +
adiposity O -
. O +

Males O +
exhibited O +
an O +
increase O +
in O +
AI O +
( O -
P O +
= O +
0.0256 O -
) O +
with O +
a O +
decrease O +
in O +
BMI O +
( O -
P O +
= O +
0.0462 O -
) O +
and O +
the O +
exact O +
opposite O +
was O +
seen O +
in O +
females O +
( O -
AI O -
, O +
P O +
< O +
0.0001 O -
; O +
BMI O -
, O +
P O +
= O +
0.0425 O -
) O +
( O -
Table O +
2 O -
) O -
. O +

Therefore O -
, O +
the O +
obesity O +
QTL O +
in O +
the O +
HG2 O -
M O +
unique O +
region O +
( O -
Region O +
IV O -
) O +
is O +
profoundly O +
impacted O +
by O +
the O +
presence O +
of O +
hg O -
. O +

Confirmation O +
of O +
QTL O -
- O -
hg O +
interactions O +
An O +
important O +
feature O +
of O +
our O +
experimental O +
design O +
was O +
the O +
ability O +
to O +
test O +
for O +
interactions O +
between O +
QTL O +
in O +
each O +
MMU2 O +
donor O +
region O +
and O +
genotype O +
at O +
the O +
HG O +
locus O -
, O +
since O +
identical O +
donor O +
regions O +
were O +
introgressed O +
on O +
two O +
genetic O +
backgrounds O -
, O +
B6 O +
( O -
+ O -
/+ O -
) O +
and O +
HG O +
( O -
hg O -
/ O -
hg O -
) O -
. O +

Significant O +
interactions O +
between O +
donor O +
region O +
and O +
HG O +
genotype O +
were O +
viewed O +
as O +
strong O +
evidence O +
that O +
hg O +
modifier O +
QTL O +
reside O +
within O +
that O +
unique O +
genomic O +
region O -
. O +

In O +
the O +
original O +
linkage O +
analysis O +
the O +
mode O +
of O +
gene O +
action O +
and O +
peak O +
location O +
of O +
Wg2 O +
were O +
dependent O +
on O +
the O +
presence O +
of O +
hg O +
[ O -
24 O -
] O +
( O -
Table O +
1 O -
) O -
. O +

In O +
the O +
present O +
study O -
, O +
only O +
homozygous O +
congenic O +
mice O +
were O +
characterized O -
, O +
thus O -
, O +
the O +
overdominant O +
effects O +
of O +
Wg2 O +
were O +
not O +
tested O -
. O +

However O -
, O +
since O +
its O +
original O +
peak O +
location O +
differed O +
dependent O +
on O +
background O +
we O +
hypothesized O +
that O +
Wg2 O +
represents O +
a O +
set O +
of O +
linked O +
QTL O +
between O +
74.9 O +
and O +
181.8 O +
Mbp O +
within O +
the O +
2 O -
M O +
and O +
2D O +
donor O +
regions O +
( O -
Region O +
III O -
– O -
V O -
) O -
, O +
some O +
of O +
which O +
interact O +
with O +
hg O -
. O +

Following O +
this O +
logic O +
we O +
expected O +
one O +
or O +
both O +
of O +
these O +
strains O +
would O +
exhibit O +
donor O +
region O +
by O +
HG O +
genotype O +
interactions O -
. O +

Unfortunately O -
, O +
we O +
were O +
unable O +
to O +
characterize O +
HG2D O +
mice O -
. O +

However O -
, O +
as O +
noted O +
above O -
, O +
strong O +
sex O -
- O -
specific O +
effects O +
were O +
seen O +
in O +
HG2 O -
M O +
mice O -
. O +

Significant O +
2 O -
M O +
donor O +
region O +
by O +
HG O +
genotype O +
by O +
sex O +
three O -
- O -
way O +
interactions O +
for O +
AI O +
( O -
P O +
= O +
0.0004 O -
; O +
Figure O +
4 O -
) O +
and O +
TF O +
were O +
identified O +
( O -
Table O +
3 O -
) O -
. O +

The O +
basis O +
of O +
these O +
interactions O +
was O +
a O +
decrease O +
in O +
HG2 O -
M O +
female O +
and O +
an O +
increase O +
in O +
HG2 O -
M O +
male O +
adiposity O -
, O +
with O +
no O +
differences O +
in O +
fat O +
accumulation O +
across O +
B62 O -
M O +
sexes O -
. O +

Significant O +
2PM O +
donor O +
region O +
by O +
HG O +
genotype O +
two O -
- O -
way O +
and O +
2PM O +
donor O +
region O +
by O +
HG O +
genotype O +
by O +
sex O +
three O -
- O -
way O +
interactions O +
were O +
also O +
seen O +
for O +
TF O +
and O +
AI O +
( O -
Table O +
3 O -
) O -
. O +

In O +
addition O -
, O +
significant O +
2P O +
donor O +
region O +
× O +
HG O +
genotype O +
interactions O +
were O +
observed O +
for O +
all O +
traits O +
listed O -
, O +
although O +
some O +
traits O +
did O +
reached O +
significance O +
at O +
the O +
critical O +
P O +
< O +
0.0071 O +
( O -
Table O +
3 O -
) O -
. O +

The O +
basis O +
for O +
each O +
interaction O +
was O +
a O +
decrease O +
in O +
phenotype O +
in O +
HG2P O +
compared O +
to O +
HGC O +
and O +
no O +
difference O +
between O +
B62P O +
and O +
B6C O -
. O +

Together O +
these O +
data O +
confirm O +
that O +
MMU2 O +
QTL O +
modify O +
the O +
effects O +
of O +
the O +
hg O +
deletion O -
. O +

Speed O +
congenic O +
strains O +
for O +
QTL O +
on O +
MMU1 O -
, O +
8 O -
, O +
9 O -
, O +
11 O +
and O +
17 O +
HG1 O +
Q1Ucd1 O +
affecting O +
G26 O +
was O +
the O +
least O +
significant O +
of O +
any O +
QTL O +
identified O +
in O +
the O +
original O +
intercross O +
and O +
only O +
reached O +
a O +
suggestive O +
level O +
of O +
significance O +
( O -
LOD O +
= O +
2.46 O -
, O +
P O +
< O +
0.05 O -
) O +
[ O -
26 O -
] O -
. O +

In O +
accordance O -
, O +
HG1 O +
mice O +
had O +
small O +
differences O +
in O +
all O +
growth O +
and O +
length O +
traits O -
. O +

NA O +
in O +
both O +
sexes O +
and O +
2WK O -
, O +
3WK O -
, O +
6WK O +
and O +
tail O +
length O +
in O +
females O +
was O +
significant O +
at O +
a O +
critical O +
P O +
< O +
0.005 O +
( O -
Table O +
4 O -
) O -
. O +

The O +
only O +
difference O +
in O +
adiposity O +
was O +
a O +
significant O +
decrease O +
in O +
male O +
MFP O +
( O -
Table O +
5 O -
) O -
. O +

The O +
successful O +
capture O +
and O +
confirmation O +
of O +
the O +
small O +
effect O +
Q1Ucd1-w26 O +
QTL O +
adds O +
support O +
to O +
pursuing O +
QTL O +
identified O +
at O +
suggestive O +
levels O +
of O +
statistical O +
confidence O +
from O +
genome O +
scans O -
. O +

HG8 O +
Markers O +
on O +
MMU8 O +
were O +
linked O +
with O +
G29 O +
in O +
the O +
original O +
intercross O +
[ O -
24 O -
] O -
. O +

This O +
QTL O +
was O +
small O -
, O +
only O +
accounting O +
for O +
4.3 O -
% O +
of O +
the O +
phenotypic O +
variance O -
. O +

Interestingly O -
, O +
in O +
HG8 O +
mice O +
no O +
differences O +
in O +
growth O +
were O +
detected O -
; O +
however O -
, O +
they O +
were O +
significantly O +
leaner O +
than O +
controls O +
( O -
Table O +
5 O -
) O -
. O +

In O +
males O +
a O +
general O +
decrease O +
in O +
fat O +
pad O +
mass O -
, O +
TF O +
and O +
AI O +
was O +
detected O -
; O +
however O -
, O +
only O +
MFP O +
was O +
significant O +
at O +
a O +
critical O +
P O +
< O +
0.005 O -
. O +

Male O +
AI O +
was O +
nearly O +
significant O +
at O +
a O +
nominal O +
P O +
= O +
0.0082 O -
. O +

Larger O +
decreases O +
in O +
fat O +
mass O +
were O +
seen O +
in O +
HG8 O +
females O -
, O +
with O +
significant O +
decreases O +
detected O +
for O +
GFP O -
, O +
MFP O +
and O +
AI O -
. O +

Additionally O -
, O +
RFP O +
and O +
TF O +
were O +
nearly O +
significant O +
with O +
nominal O +
P O +
values O +
of O +
0.0208 O +
and O +
0.0153 O -
, O +
respectively O -
. O +

HG8 O +
mice O +
represent O +
a O +
lean O +
congenic O +
model O +
in O +
which O +
CAST O +
alleles O +
protect O +
against O +
fat O +
accumulation O -
. O +

HG9 O +
CAST O +
alleles O +
in O +
the O +
proximal O +
region O +
of O +
MMU9 O +
were O +
previously O +
found O +
to O +
be O +
linked O +
with O +
an O +
increase O +
in O +
body O +
fat O +
percentage O +
and O +
a O +
decrease O +
in O +
femur O +
length O +
[ O -
24 O -
] O -
. O +

The O +
effects O +
appeared O +
to O +
be O +
the O +
result O +
of O +
two O +
linked O +
QTL O -
, O +
Carfhg2 O +
at O +
10 O +
cM O +
and O +
Feml2 O +
at O +
20 O +
cM O -
, O +
instead O +
of O +
one O +
pleiotropically O +
impacting O +
both O +
traits O +
( O -
Table O +
1 O -
) O -
. O +

In O +
support O +
of O +
this O -
, O +
the O +
increase O +
in O +
fat O +
was O +
dependent O +
on O +
hg O -
; O +
however O -
, O +
differences O +
in O +
femur O +
length O +
were O +
not O +
[ O -
24 O -
] O -
. O +

In O +
confirmation O +
of O +
Carfhg2 O +
all O +
measures O +
of O +
adiposity O +
in O +
HG9 O +
mice O +
were O +
increased O +
relative O +
to O +
control O +
mice O -
; O +
except O +
MFP O +
in O +
both O +
sexes O +
and O +
BMI O +
in O +
males O +
( O -
Table O +
5 O -
) O -
. O +

In O +
males O -
, O +
GFP O -
, O +
RFP O -
, O +
FFP O +
and O +
AI O +
were O +
increased O +
by O +
29.0 O -
% O -
, O +
51.2 O -
% O -
, O +
42.9 O -
% O +
and O +
30.0 O -
% O -
, O +
respectively O -
. O +

In O +
females O +
these O +
increases O +
were O +
much O +
larger O -
. O +

The O +
same O +
measurements O +
were O +
increased O +
by O +
68.8 O -
% O -
, O +
99.4 O -
% O -
, O +
69.7 O -
% O +
and O +
57.3 O -
% O -
, O +
relative O +
to O +
HGC O +
females O -
. O +

A O +
2.9 O -
% O +
and O +
3.6 O -
% O +
reduction O +
in O +
male O +
and O +
female O +
NA O -
, O +
respectively O -
, O +
was O +
also O +
detected O -
. O +

This O +
was O +
expected O +
since O +
NA O +
was O +
previously O +
found O +
to O +
be O +
an O +
excellent O +
indicator O +
of O +
femur O +
length O +
( O -
R2 O +
= O +
0.88 O -
) O +
in O +
HG O +
mice O +
[ O -
27 O -
] O +
and O +
as O +
noted O +
above O +
this O +
region O +
contains O +
the O +
Feml2 O +
QTL O +
[ O -
24 O -
] O -
. O +

These O +
data O +
confirm O +
the O +
effects O +
of O +
Carfhg2 O +
on O +
adiposity O +
and O +
Feml2 O +
on O +
length O +
and O +
indicate O +
the O +
isolated O +
effects O +
of O +
Carfhg2 O +
are O +
more O +
significant O +
than O +
originally O +
observed O -
. O +

HG11 O +
In O +
the O +
original O +
intercross O +
CAST O +
alleles O +
near O +
50 O +
cM O +
on O +
MMU11 O +
were O +
linked O +
with O +
a O +
reduction O +
in O +
G29 O -
, O +
carcass O +
ash O +
( O -
ASH O -
) O +
and O +
carcass O +
protein O +
( O -
PROT O -
) O +
[ O -
24 O -
] O -
. O +

Therefore O -
, O +
we O +
measured O +
each O +
carcass O +
component O +
using O +
chemical O +
compositional O +
analysis O +
in O +
the O +
HGC O -
, O +
HG11 O +
and O +
HG17 O +
strains O -
. O +

Originally O -
, O +
Carp2 O +
was O +
dependent O +
on O +
the O +
presence O +
of O +
hg O +
and O +
no O +
significant O +
sex O +
effects O +
were O +
detected O +
[ O -
24 O -
] O -
. O +

In O +
contrast O +
to O +
those O +
results O -
, O +
HG11 O +
mice O +
displayed O +
significant O +
differences O +
in O +
growth O +
and O +
obesity O +
between O +
the O +
sexes O -
. O +

In O +
general O -
, O +
males O +
demonstrated O +
a O +
5 O -
% O +
increase O +
and O +
females O +
a O +
5 O -
% O +
decrease O +
in O +
all O +
growth O -
- O -
related O +
traits O +
( O -
Table O +
4 O -
) O -
. O +

Most O +
of O +
these O +
differences O -
, O +
however O -
, O +
were O +
not O +
significant O +
at O +
a O +
critical O +
P O +
< O +
0.005 O -
, O +
although O +
almost O +
all O +
were O +
at O +
a O +
nominal O +
P O +
< O +
0.05 O -
. O +

Following O +
the O +
same O +
trend O -
, O +
males O +
displayed O +
an O +
increase O +
in O +
tail O +
length O +
and O +
a O +
small O +
suggestive O +
increase O +
in O +
NA O +
( O -
P O +
= O +
0.06 O -
) O -
, O +
while O +
females O +
displayed O +
significant O +
decreases O +
in O +
NA O -
. O +

In O +
support O +
of O +
the O +
sex O -
- O -
specific O +
QTL O +
effects O +
strain O +
by O +
sex O +
interactions O +
( O -
P O +
< O +
0.04 O -
) O +
were O +
seen O +
for O +
the O +
following O +
growth O +
traits O -
: O +
3WK O -
, O +
6WK O -
, O +
9WK O -
, O +
G26 O -
, O +
G29 O +
and O +
NA O +
( O -
data O +
not O +
shown O -
) O -
. O +

The O +
basis O +
of O +
each O +
interaction O +
was O +
an O +
increase O +
in O +
the O +
males O +
and O +
a O +
decrease O +
in O +
females O -
. O +

In O +
our O +
analysis O +
of O +
the O +
HGC O -
, O +
HG11 O +
and O +
HG17 O +
strains O -
, O +
concordant O +
results O +
were O +
observed O +
measuring O +
adiposity O +
using O +
chemical O +
lipid B-Chemical +
extraction O +
and O +
weighing O +
fat O +
pad O +
mass O -
. O +

The O +
phenotypic O +
correlation O +
between O +
carcass O +
fat O +
( O -
FAT O -
) O +
as O +
a O +
percent O +
of O +
the O +
empty O +
carcass O +
weight O +
( O -
ECW O -
; O +
weight O +
of O +
total O +
body O +
( O -
including O +
organs O -
) O +
minus O +
the O +
head O +
and O +
gastrointestinal O +
tract O -
) O +
( O -
% O -
FAT O -
) O +
determined O +
by O +
chemical O +
analysis O +
and O +
AI O -
, O +
using O +
data O +
from O +
all O +
three O +
lines O +
( O -
HGC O -
, O +
HG11 O +
and O +
HG17 O -
) O -
, O +
was O +
0.92 O -
. O +

These O +
data O +
suggest O +
that O +
individual O +
fat O +
pad O +
dissection O +
is O +
an O +
excellent O +
proxy O +
for O +
measuring O +
whole O +
body O +
adiposity O +
and O +
provides O +
a O +
much O +
more O +
sensitive O +
technique O +
to O +
measure O +
fat O +
accumulation O +
in O +
specific O +
body O +
regions O -
. O +

HG11 O +
females O +
displayed O +
slight O +
increases O +
in O +
all O +
fat O +
pads O +
( O -
except O +
MFP O -
) O +
and O +
AI O -
, O +
although O -
, O +
only O +
the O +
16.5 O -
% O +
increase O +
in O +
AI O +
was O +
significant O +
( O -
Table O +
5 O -
) O -
. O +

In O +
contrast O -
, O +
HG11 O +
males O +
did O +
not O +
show O +
a O +
difference O +
in O +
fat O +
mass O +
leading O +
to O +
a O +
significant O +
strain O +
by O +
sex O +
interaction O +
( O -
P O +
= O +
0.008 O -
) O +
for O +
AI O +
( O -
data O +
not O +
shown O -
) O -
. O +

Identical O +
to O +
the O +
results O +
obtained O +
using O +
fat O +
pad O +
weights O -
; O +
female O +
HG11 O +
carcasses O +
displayed O +
an O +
increase O +
in O +
% O -
FAT O +
( O -
Table O +
6 O -
) O -
. O +

HG11 O +
male O +
carcasses O +
had O +
higher O +
levels O +
carcass O +
ash O +
( O -
ASH O -
) O +
as O +
a O +
percent O +
of O +
ECW O +
( O -
% O -
ASH O -
) O +
and O +
female O +
carcasses O +
displayed O +
lower O +
levels O +
of O +
H2O B-Chemical +
and O +
ASH O +
( O -
Table O +
6 O -
) O -
. O +

Strains O +
by O +
sex O +
interactions O +
( O -
P O +
< O +
0.005 O -
) O +
were O +
identified O +
for O +
H2O B-Chemical -
, O +
% O -
H2O B-Chemical -
, O +
% O -
FAT O -
, O +
ASH O +
and O +
PROT O +
( O -
data O +
not O +
shown O -
) O -
. O +

If O +
the O +
aggregate O +
phenotype O +
in O +
HG11 O +
is O +
due O +
to O +
a O +
single O +
locus O -
, O +
its O +
function O +
may O +
be O +
to O +
disrupt O +
energy O +
partitioning O +
by O +
decreasing O +
the O +
deposition O +
of O +
lean O +
tissue O +
and O +
increasing O +
lipid B-Chemical +
accumulation O +
in O +
females O -
, O +
while O +
having O +
the O +
opposite O +
action O +
in O +
males O -
. O +

However O -
, O +
it O +
may O +
also O +
be O +
due O +
to O +
distinct O +
sex O -
- O -
specific O +
QTL O +
with O +
opposing O +
action O -
. O +

HG17 O +
In O +
the O +
original O +
intercross O +
CAST O +
alleles O +
at O +
MMU17 O +
markers O +
were O +
associated O +
with O +
decreases O +
in O +
femur O +
length O -
, O +
ASH O +
and O +
PROT O +
[ O -
24 O -
] O +
and O +
similar O +
results O +
were O +
seen O +
in O +
HG17 O +
mice O -
. O +

Interestingly O -
, O +
both O +
sexes O +
were O +
heavier O +
at O +
2WK O +
( O -
males O -
, O +
P O +
= O +
0.0045 O -
; O +
females O -
, O +
P O +
= O +
0.0342 O -
) O -
, O +
but O +
lighter O +
at O +
9WK O -
, O +
leading O +
to O +
substantially O +
lower O +
G26 O +
and O +
G29 O +
( O -
Table O +
4 O -
) O -
. O +

In O +
general O +
growth O +
differences O +
ranged O +
between O +
5 O -
% O +
and O +
15 O -
% O +
lower O +
in O +
congenic O +
mice O -
. O +

Both O +
sexes O +
had O +
significant O +
reductions O +
in O +
length O +
traits O +
relative O +
to O +
control O +
mice O -
. O +

NA O +
was O +
reduced O +
by O +
2.7 O -
% O +
( O -
P O +
= O +
0.0186 O -
) O +
and O +
3.4 O -
% O +
in O +
males O +
and O +
females O -
, O +
respectively O +
( O -
Table O +
4 O -
) O -
. O +

In O +
addition O -
, O +
tail O +
was O +
reduced O +
by O +
approximately O +
6 O -
% O +
in O +
both O +
sexes O +
( O -
Table O +
4 O -
) O -
. O +

In O +
general O -
, O +
HG17 O +
mice O +
displayed O +
increases O +
in O +
all O +
fat O +
pads O +
( O -
except O +
MFP O -
) O -
, O +
TF O +
and O +
AI O +
( O -
Table O +
5 O -
) O -
. O +

However O -
, O +
none O +
of O +
these O +
differences O +
were O +
significant O +
at O +
critical O +
P O +
< O +
0.005 O -
. O +

In O +
addition O -
, O +
HG17 O +
male O +
carcasses O +
possessed O +
lower O +
levels O +
of O +
H2O B-Chemical +
and O +
ASH O -
, O +
while O +
female O +
carcasses O +
contained O +
lower O +
levels O +
of O +
% O +
H2O B-Chemical -
, O +
ASH O -
, O +
% O -
ASH O +
and O +
% O -
PROT O +
( O -
Table O +
6 O -
) O -
. O +

MMU2 O -
, O +
9 O -
, O +
11 O +
and O +
17 O +
hg O +
modifier O +
candidate O +
gene O +
sequencing O +
The O +
HG O +
phenotype O +
is O +
due O +
to O +
the O +
deletion O +
of O +
Socs2 O -
, O +
therefore O +
we O +
reasoned O +
that O +
QTL O +
on O +
MMU2 O -
, O +
9 O -
, O +
11 O +
and O +
17 O +
interacting O +
with O +
hg O +
possibly O +
represent O +
variation O +
within O +
genes O +
participating O +
in O +
various O +
aspects O +
of O +
Gh O +
function O -
. O +

To O +
select O +
candidate O +
genes O +
for O +
sequencing O +
we O +
identified O +
genes O +
known O +
to O +
be O +
or O +
potentially O +
involved O +
in O +
Gh O +
signaling O -
, O +
are O +
responsive O +
to O +
Gh O +
or O +
that O +
propagate O +
downstream O +
Gh O +
functions O -
. O +

Forty O -
- O -
four O +
hg O +
modifier O +
candidate O +
genes O +
were O +
identified O +
from O +
primary O +
literature O -
, O +
reviews O +
and O +
book O +
chapters O +
and O +
coordinated O +
using O +
the O +
GenMAPP O +
( O -
Gene O +
MicroArray O +
Pathway O +
Profiler O -
) O +
pathway O +
building O +
software O +
( O -
Figure O +
5 O -
) O -
. O +

The O +
coding O +
region O +
of O +
each O +
gene O +
was O +
sequenced O +
from O +
the O +
CAST O +
strain O +
and O +
compared O +
to O +
the O +
publicly O +
available O +
B6 O +
sequence O +
to O +
identify O +
polymorphisms O +
( O -
Additional O +
File O +
4 O -
) O -
. O +

A O +
total O +
of O +
94.492 O +
kbp O +
was O +
sequenced O +
( O -
75.378 O +
kbp O +
CDS O +
and O +
19.114 O +
Kbp O +
5 O -
' O +
and O +
3 O -
' O +
untranslated O +
region O +
( O -
UTR O -
) O -
) O -
, O +
representing O +
25,083 O +
amino O +
acids O -
. O +

Comparison O +
with O +
the O +
public O +
B6 O +
assembly O +
( O -
May O +
2004 O +
University O +
of O +
California O -
, O +
Santa O +
Cruz O +
( O -
UCSC O +
[ O -
28 O -
] O -
) O +
mm5 O +
genome O +
assembly O -
, O +
National O +
Center O +
for O +
Biotechnology O +
Information O +
( O -
NCBI O -
) O +
Build O +
33 O -
) O +
identified O +
307 O +
polymorphisms O +
between O +
CAST O +
and O +
B6 O -
. O +

Of O +
these O -
, O +
295 O +
were O +
single O +
nucleotide O +
polymorphisms O +
( O -
SNP O -
) O +
and O +
12 O +
were O +
insertions O +
or O +
deletions O +
in O +
CAST O +
( O -
Additional O +
File O +
4 O -
) O -
. O +

All O +
12 O +
insertions O +
or O +
deletions O +
were O +
located O +
within O +
5 O -
' O +
and O +
3 O -
' O +
UTRs O -
. O +

Fifty O -
- O -
six O +
nonsynonomous O +
SNP O +
( O -
nsSNP O -
) O +
were O +
identified O +
in O +
14 O +
different O +
genes O +
( O -
Additional O +
File O +
4 O -
) O -
. O +

PolyPhen O +
[ O -
29 O -
] O +
and O +
SIFT O +
[ O -
30 O -
] O +
are O +
software O +
programs O +
designed O +
to O +
identify O +
nsSNP O +
which O +
potentially O +
alter O +
protein O +
function O +
by O +
evaluating O +
evolutionary O +
conservation O +
at O +
specific O +
amino O +
acid O +
residues O +
using O +
a O +
multiple O +
sequence O +
alignment O +
of O +
protein O +
sequences O +
homologous O +
to O +
the O +
query O -
. O +

When O +
applied O +
to O +
our O +
data O +
set O +
PolyPhen O -
, O +
SIFT O +
or O +
both O +
programs O +
predicted O +
that O +
15 O +
of O +
the O +
56 O +
nsSNP O +
in O +
9 O +
different O +
genes O +
would O +
possibly O +
alter O +
protein O +
function O +
( O -
Table O +
7 O -
) O -
. O +

Discussion O +
Speed O +
congenic O +
strains O +
provide O +
a O +
powerful O +
approach O +
to O +
confirm O +
and O +
physically O +
confine O +
QTL O +
within O +
intervals O +
defined O +
by O +
molecular O +
markers O -
. O +

In O +
the O +
current O +
study O -
, O +
approximately O +
20 O -
% O +
of O +
the O +
CAST O +
genome O +
harboring O +
all O +
previously O +
detected O +
growth O +
and O +
carcass O +
composition O +
QTL O +
was O +
isolated O +
on O +
an O +
HG O +
or O +
B6 O +
background O +
through O +
the O +
development O +
of O +
14 O +
speed O +
congenic O +
strains O -
. O +

Two O +
distinct O +
speed O +
congenic O +
panels O +
were O +
developed O -
, O +
the O +
first O +
provided O +
a O +
comprehensive O +
isolation O +
of O +
all O +
MMU2 O +
QTL O +
between O +
the O +
B6 O -
, O +
HG O +
and O +
CAST O +
strains O +
and O +
the O +
second O +
targeted O +
all O +
QTL O +
outside O +
of O +
MMU2 O -
. O +

Each O +
successfully O +
characterized O +
strain O +
exhibited O +
phenotypic O +
differences O +
relative O +
to O +
control O +
mice O -
. O +

These O +
strains O +
represent O +
important O +
resources O +
and O +
provide O +
the O +
genetic O +
resource O +
to O +
positionally O +
clone O +
numerous O +
quantitative O +
trait O +
genes O -
. O +

One O +
criticism O +
of O +
the O +
speed O +
congenic O +
approach O +
is O +
the O +
potential O +
for O +
QTL O +
to O +
reside O +
among O +
unwanted O +
donor O +
alleles O +
not O +
eliminated O +
during O +
backcrossing O -
. O +

In O +
this O +
case O +
differences O +
between O +
the O +
congenic O +
and O +
control O +
strains O +
would O +
be O +
due O +
in O +
part O +
or O +
whole O +
to O +
these O +
contaminating O +
alleles O -
. O +

We O +
took O +
several O +
precautions O +
to O +
reduce O +
the O +
probability O +
of O +
this O +
occurrence O -
. O +

First O -
, O +
our O +
control O +
strains O +
were O +
developed O +
from O +
mice O +
undergoing O +
the O +
same O +
selection O +
as O +
all O +
of O +
the O +
other O +
congenics O -
. O +

Therefore O -
, O +
it O +
is O +
possible O +
that O +
any O +
unwanted O +
QTL O +
or O +
mutations O +
arising O +
during O +
congenic O +
construction O +
are O +
shared O +
between O +
all O +
strains O -
. O +

More O +
importantly O -
, O +
we O +
have O +
knowledge O +
of O +
all O +
large O +
previously O +
detected O +
growth O +
and O +
obesity O +
QTL O +
in O +
the O +
current O +
cross O +
[ O -
24 O -
] O -
. O +

Using O +
this O +
information O +
we O +
increased O +
the O +
density O +
of O +
markers O +
in O +
each O +
QTL O +
region O +
( O -
MMU1 O -
, O +
2 O -
, O +
5 O -
, O +
8 O -
, O +
9 O -
, O +
11 O +
and O +
17 O -
; O +
Table O +
1 O +
and O +
Additional O +
File O +
1 O -
) O -
, O +
ensuring O +
the O +
absence O +
of O +
CAST O +
alleles O +
at O +
each O +
of O +
these O +
QTL O -
. O +

This O +
approach O -
, O +
termed O +
" O -
QTL O -
- O -
Marker O -
- O -
Assisted O +
Counter O +
Selection O -
" O +
or O +
QMACS O -
, O +
has O +
been O +
previously O +
used O +
to O +
characterize O +
QTL O +
for O +
hypnotic O +
sensitivity O +
to O +
ethanol B-Chemical +
[ O -
31 O -
] O -
. O +

In O +
that O +
study O -
, O +
only O +
markers O +
flanking O +
QTL O +
were O +
typed O -
, O +
not O +
genome O -
- O -
wide O +
markers O -
. O +

In O +
contrast O -
, O +
we O +
selected O +
not O +
only O +
against O +
known O +
QTL O -
, O +
we O +
also O +
screened O +
for O +
genome O +
wide O +
heterozygosity O +
increasing O +
the O +
probability O +
that O +
effects O +
observed O +
are O +
due O +
to O +
genetic O +
variation O +
within O +
each O +
donor O +
region O -
. O +

Although O +
great O +
effort O +
was O +
put O +
forth O +
to O +
eliminate O +
non O -
- O -
donor O +
region O +
direct O +
genetic O +
effects O -
, O +
other O +
factors O +
such O +
as O +
maternal O +
genotype O +
( O -
maternal O +
genotype O +
for O +
each O +
congenic O +
versus O +
control O +
dams O +
differed O -
) O +
and O +
environmental O +
effects O +
could O +
confound O +
our O +
results O -
. O +

Maternal O +
genotype O +
effects O +
on O +
growth O +
and O +
obesity O +
have O +
been O +
observed O +
in O +
a O +
number O +
of O +
mouse O +
crosses O +
[ O -
8,32 O -
- O -
35 O -
] O +
and O +
their O +
existence O +
in O +
the O +
current O +
cross O +
can O -
not O +
be O +
discounted O -
. O +

However O -
, O +
our O +
congenics O +
provide O +
the O +
ideal O +
foundation O +
genomic O +
resource O +
to O +
test O +
for O +
the O +
influence O +
of O +
any O +
of O +
these O +
possible O +
effects O -
. O +

Future O +
fine O +
mapping O +
experiments O +
can O +
be O +
designed O +
to O +
randomize O +
the O +
influences O +
of O +
any O +
contaminating O +
donor O +
alleles O +
and O +
environmental O +
differences O -
, O +
as O +
well O +
as O +
test O +
for O +
maternal O +
genotype O +
effects O -
. O +

MMU2 O +
is O +
a O +
hotspot O +
for O +
growth O +
and O +
obesity O +
QTL O -
. O +

Over O +
30 O +
QTL O +
have O +
been O +
identified O +
in O +
various O +
experiments O +
[ O -
1,2 O -
] O -
. O +

Several O +
previously O +
reported O +
or O +
novel O +
MMU2 O +
QTL O +
have O +
been O +
isolated O +
and O +
characterized O +
using O +
congenic O +
strains O +
[ O -
7,9 O -
- O -
11,36 O -
] O -
. O +

Our O +
findings O +
are O +
no O +
different O +
and O +
indicate O +
that O +
MMU2 O +
is O +
highly O +
complex O +
with O +
regards O +
to O +
genes O +
affecting O +
growth O +
and O +
obesity O -
. O +

The O +
overlapping O +
nature O +
of O +
our O +
MMU2 O +
strains O +
allowed O +
us O +
to O +
parse O +
the O +
chromosome O +
into O +
five O +
regions O +
( O -
Regions O +
I O -
– O -
V O -
) O +
( O -
Figure O +
2 O -
) O -
. O +

The O +
data O +
support O +
the O +
presence O +
of O +
at O +
least O +
one O +
QTL O +
in O +
each O +
of O +
the O +
five O +
regions O +
( O -
Figure O +
2 O -
) O -
. O +

Each O +
of O +
the O +
five O +
pleiotropically O +
impact O +
both O +
growth O +
and O +
obesity O -
, O +
although O +
to O +
varying O +
degrees O -
. O +

In O +
addition O +
to O +
the O +
large O +
number O +
of O +
MMU2 O +
QTL O -
, O +
the O +
presence O +
of O +
hg O +
adds O +
complexity O +
by O +
either O +
eliciting O +
interactions O +
with O +
the O +
same O +
QTL O +
or O +
by O +
inducing O +
the O +
expression O +
of O +
novel O +
QTL O -
. O +

The O +
2P O +
unique O +
region O +
( O -
Region O +
I O -
) O +
contains O +
an O +
hg O +
modifier O +
with O +
large O +
effects O +
on O +
growth O +
and O +
smaller O +
effects O +
on O +
obesity O +
( O -
Table O +
3 O -
) O -
. O +

In O +
contrast O -
, O +
interactions O +
between O +
2PM O -
/ O -
2 O -
M O +
QTL O +
and O +
hg O +
primarily O +
affect O +
fat O +
deposition O +
( O -
Table O +
3 O -
) O -
. O +

As O +
illustrated O +
in O +
Figure O +
4 O +
the O +
2 O -
M O +
donor O +
region O +
exhibits O +
strong O +
sex O +
effects O +
on O +
the O +
rate O +
of O +
lipid B-Chemical +
storage O -
, O +
dependent O +
on O +
background O -
. O +

In O +
control O +
mice O -
, O +
HGC O +
females O +
have O +
a O +
higher O +
AI O +
than O +
males O -
, O +
while O +
the O +
opposite O +
is O +
seen O +
in O +
B6C O +
mice O -
. O +

Interestingly O -
, O +
the O +
2 O -
M O +
hg O +
modifier O +
QTL O +
abolished O +
the O +
hg O +
induced O +
sexual O +
dimorphism O +
in O +
adiposity O +
( O -
Figure O +
4 O -
) O -
. O +

Although O +
these O +
results O +
provide O +
insight O +
into O +
the O +
nature O +
of O +
hg O +
modifier O +
QTL O -
, O +
it O +
should O +
be O +
noted O -
, O +
that O +
the O +
actual O +
number O +
and O +
precise O +
location O +
of O +
loci O +
is O +
still O +
unclear O -
. O +

In O +
addition O +
to O +
MMU2 O -
, O +
three O +
other O +
congenics O +
( O -
HG9 O -
, O +
HG11 O +
and O +
HG17 O -
) O +
captured O +
hg O +
modifier O +
QTL O -
. O +

In O +
classical O +
terms O -
, O +
they O +
are O +
QTL O +
which O +
modify O +
the O +
expressivity O +
of O +
growth O +
and O +
obesity O +
in O +
HG O +
mice O +
[ O -
18 O -
] O -
. O +

These O +
QTL O +
are O +
novel O +
since O +
they O +
represent O +
epistasis O +
between O +
hg O +
and O +
the O +
modifier O +
gene O -
. O +

QTL O -
- O -
hg O +
epistasis O +
implies O +
that O +
Socs2 O +
and O +
the O +
hg O +
modifiers O +
are O +
in O +
the O +
same O +
biological O +
pathway O -
. O +

Therefore O -
, O +
these O +
QTL O +
are O +
likely O +
due O +
to O +
polymorphism O +
in O +
genes O +
interacting O +
with O +
Gh O -
, O +
responsive O +
to O +
Gh O +
or O +
which O +
in O +
some O +
way O +
modulate O +
Gh O +
function O -
. O +

This O +
information O +
will O +
significantly O +
aid O +
QTL O +
cloning O +
by O +
providing O +
another O +
filter O +
to O +
screen O +
candidates O -
. O +

Cloning O +
these O +
QTL O +
has O +
major O +
implications O +
to O +
improve O +
our O +
understanding O +
of O +
Gh O +
and O +
its O +
regulation O +
of O +
growth O +
and O +
adiposity O +
and O +
in O +
the O +
administration O +
of O +
human O +
Gh O +
therapeutics O -
. O +

HG1 O +
mice O +
displayed O +
differences O +
only O +
in O +
growth O +
traits O -
. O +

Originally O -
, O +
Q1Ucd1 O +
had O +
small O +
effects O +
and O +
these O +
results O +
illustrate O +
the O +
power O +
of O +
congenic O +
strain O +
analysis O +
to O +
isolate O +
small O +
effect O +
QTL O -
, O +
although O +
it O +
is O +
likely O +
this O +
QTL O +
represents O +
the O +
lower O +
boundary O +
of O +
detection O +
using O +
only O +
20–30 O +
congenic O +
mice O -
. O +

The O +
most O +
notable O +
candidate O +
genes O +
located O +
within O +
the O +
HG1 O +
interval O +
are O +
the O +
signal O +
transducer O +
and O +
activator O +
of O +
transcription O +
1 O +
( O -
Stat1 O -
) O +
and O +
Stat4 O -
. O +

Two O +
of O +
the O +
congenics O +
had O +
major O +
alterations O +
in O +
the O +
deposition O +
of O +
adipose O +
tissue O -
, O +
HG8 O +
and O +
HG9 O -
. O +

The O +
HG8 O +
donor O +
region O +
promotes O +
leanness O -
. O +

Congenic O +
females O +
displayed O +
a O +
reduction O +
of O +
over O +
25 O -
% O +
in O +
AI O -
. O +

In O +
contrast O -
, O +
the O +
HG9 O +
strain O +
is O +
an O +
obese O +
mouse O +
model O -
. O +

The O +
strain O +
is O +
quite O +
novel O +
for O +
two O +
reasons O -
. O +

First O -
, O +
the O +
effect O +
size O +
is O +
large O -
; O +
AI O +
was O +
57 O -
% O +
higher O +
in O +
HG9 O +
females O +
and O +
30 O -
% O +
higher O +
in O +
males O -
. O +

Secondly O -
, O +
it O +
is O +
dependent O +
on O +
hg O +
for O +
its O +
expression O -
. O +

The O +
HG9 O +
strain O +
represents O +
a O +
major O +
epistasis O -
- O -
based O +
obese O +
mouse O +
model O +
and O +
promises O +
to O +
aid O +
in O +
the O +
understanding O +
of O +
obesity O +
and O +
specifically O +
the O +
modulation O +
of O +
adipose O +
tissue O +
deposition O +
by O +
Gh O -
. O +

Studies O +
are O +
currently O +
underway O +
to O +
identify O +
the O +
causative O +
mutation O +
and O +
to O +
characterize O +
the O +
effects O +
of O +
age O +
and O +
diet O +
on O +
obesity O +
in O +
this O +
strain O +
as O +
well O +
as O +
testing O +
for O +
other O +
physiological O +
consequences O +
such O +
as O +
alterations O +
in O +
food B-Chemical +
intake O +
and O +
insulin O +
sensitivity O -
. O +

The O +
HG11 O +
strain O +
is O +
of O +
particular O +
interest O +
for O +
a O +
number O +
of O +
reasons O -
. O +

First O -
, O +
HG11 O +
congenic O +
mice O +
demonstrated O +
significant O +
strain O +
by O +
sex O +
interactions O +
for O +
a O +
number O +
of O +
traits O -
. O +

Males O +
were O +
generally O +
larger O -
, O +
faster O +
growing O +
and O +
longer O +
and O +
the O +
converse O +
was O +
seen O +
in O +
females O -
. O +

The O +
confounding O +
effects O +
of O +
sex O +
are O +
likely O +
the O +
reason O +
for O +
the O +
discrepancies O +
between O +
the O +
congenic O +
and O +
genome O +
scan O +
results O -
, O +
where O +
both O +
sexes O +
were O +
analyzed O +
together O -
. O +

Secondly O -
, O +
Carp2 O +
was O +
found O +
to O +
interact O +
with O +
hg O +
and O +
MMU11 O +
is O +
saturated O +
with O +
genes O +
involved O +
in O +
the O +
central O +
Gh O +
intracellular O +
signaling O +
pathway O -
, O +
such O +
as O +
Gh O -
, O +
Stat5b O +
and O +
Stat5a O -
. O +

Thirdly O -
, O +
MMU11 O +
growth O +
QTL O +
overlapping O +
HG11 O +
have O +
been O +
identified O +
in O +
a O +
number O +
of O +
crosses O +
using O +
different O +
mouse O +
strains O +
[ O -
37 O -
- O -
41 O -
] O -
. O +

Given O +
the O +
well O +
documented O +
sexually O +
dimorphic O +
nature O +
of O +
Gh O +
secretion O +
and O +
Gh O +
induced O +
gene O +
expression O +
[ O -
42,43 O -
] O -
, O +
it O +
is O +
probable O +
that O +
the O +
underlying O +
mutation O +
in O +
the O +
HG11 O +
congenic O +
may O +
reside O +
in O +
a O +
gene O +
enhancing O +
Gh O +
induced O +
sex O -
- O -
specific O +
effects O -
. O +

The O +
structural O +
Gh O +
gene O +
itself O +
and O +
Stat5b O +
are O +
excellent O +
candidates O -
. O +

The O +
potential O +
role O +
of O +
Gh O +
would O +
include O +
polymorphism O +
that O +
alters O +
protein O +
function O +
in O +
the O +
absence O +
of O +
Socs2 O +
or O +
that O +
causes O +
transcriptional O +
deregulation O +
of O +
Gh O -
. O +

Additionally O -
, O +
functional O +
variation O +
in O +
Stat5b O +
may O +
explain O +
the O +
sex O -
- O -
specific O +
phenotypes O +
in O +
HG11 O +
mice O +
since O +
it O +
is O +
the O +
primary O +
transcription O +
factor O +
responsible O +
for O +
Gh O +
induced O +
sex O -
- O -
specific O +
liver O +
gene O +
expression O +
[ O -
44 O -
] O -
. O +

Future O +
studies O +
aimed O +
at O +
identifying O +
the O +
HG11 O +
QTG O -
, O +
will O +
certainly O +
include O +
a O +
thorough O +
characterization O +
of O +
Gh O +
and O +
Stat5b O +
sequence O +
and O +
expression O +
patterns O +
in O +
congenic O +
mice O -
. O +

The O +
hg O +
modifier O +
QTL O +
located O +
within O +
the O +
HG17 O +
strain O +
had O +
large O +
effects O +
on O +
growth O -
, O +
body O +
length O +
and O +
carcass O +
components O -
. O +

The O +
most O +
intriguing O +
candidate O +
gene O +
located O +
in O +
the O +
congenic O +
is O +
Sstr5 O -
. O +

Somatostatin O +
is O +
a O +
potent O +
inhibitor B-Chemical +
of O +
Gh O +
and O +
Sstr5 O +
is O +
one O +
of O +
five O +
receptors O +
which O +
mediate O +
these O +
effects O +
[ O -
45,46 O -
] O -
. O +

Ubiquitous O +
and O +
pancreatic O +
beta O +
cell O +
specific O +
knockout O +
of O +
Sstr5 O +
leads O +
to O +
alterations O +
in O +
insulin O +
secretion O +
and O +
glucose B-Chemical +
homeostasis O +
[ O -
47,48 O -
] O -
. O +

We O +
sequenced O +
candidate O +
hg O +
modifier O +
genes O +
to O +
complement O +
the O +
characterization O +
of O +
the O +
speed O +
congenics O +
on O +
MMU2 O -
, O +
9 O -
, O +
11 O +
and O +
17 O -
. O +

A O +
limited O +
number O +
of O +
studies O +
have O +
identified O +
variation O +
within O +
CAST O +
coding O +
sequence O -
; O +
so O +
sequencing O +
candidates O +
gave O +
us O +
the O +
opportunity O +
to O +
estimate O +
the O +
SNP O +
frequency O +
in O +
coding O +
sequence O +
relative O +
to O +
B6 O -
. O +

This O +
information O +
will O +
be O +
vital O +
to O +
future O +
fine O +
mapping O +
studies O -
, O +
which O +
will O +
include O +
gene O +
expression O +
analysis O -
. O +

The O +
high O +
SNP O +
frequency O +
( O -
0.312 O -
% O -
; O +
295 O +
SNP O +
in O +
94.492 O +
kbp O -
) O +
in O +
CAST O +
genes O +
may O +
lead O +
to O +
a O +
higher O +
rate O +
of O +
false O +
positives O +
using O +
DNA O +
microarrays O +
or O +
quantitative O +
real O -
- O -
time O +
PCR O +
assays O -
, O +
most O +
of O +
which O +
are O +
based O +
on O +
B6 O +
sequence O -
. O +

Therefore O -
, O +
these O +
sequence O +
data O +
can O +
be O +
used O +
to O +
guide O +
the O +
development O +
of O +
gene O +
expression O +
assays O +
to O +
confirm O +
differential O +
expression O +
for O +
candidates O +
and O +
suggests O +
that O +
genes O +
identified O +
by O +
downstream O +
experiments O +
should O +
also O +
be O +
sequenced O -
. O +

More O +
importantly O -
, O +
sequencing O +
hg O +
modifier O +
candidates O +
allowed O +
us O +
to O +
identify O +
nonsynonomous O +
polymorphism O -
, O +
which O +
may O +
underlie O +
QTL O -
. O +

SIFT O +
and/or O +
PolyPhen O +
predicted O +
alterations O +
in O +
protein O +
function O +
for O +
15 O +
of O +
the O +
56 O +
total O +
nsSNP O +
( O -
27 O -
% O -
) O +
in O +
nine O +
of O +
the O +
44 O +
total O +
genes O +
( O -
20 O -
% O -
) O +
( O -
Table O +
7 O -
) O -
. O +

It O +
has O +
been O +
shown O +
that O +
predicting O +
function O +
based O +
on O +
evolutionary O +
conservation O +
using O +
programs O +
such O +
as O +
SIFT O +
and O +
PolyPhen O +
is O +
very O +
accurate O +
[ O -
49 O -
] O -
. O +

Four O +
of O +
the O +
nine O +
genes O +
( O -
Ubr1 O -
, O +
Ptpns1 O -
, O +
Ubce7ip5 O +
and O +
Mmp9 O -
; O +
all O +
of O +
which O +
are O +
on O +
MMU2 O -
) O +
are O +
of O +
particular O +
interest O -
. O +

It O +
has O +
been O +
suggested O +
the O +
Socs2 O +
may O +
rely O +
on O +
ubiquitination O +
dependent O +
proteasomal O +
degradation O +
to O +
inhibit O +
Gh O +
signaling O +
[ O -
23 O -
] O -
. O +

Ubr1 O +
and O +
Ubce7ip5 O +
are O +
both O +
involved O +
in O +
protein O +
ubiquitination O +
and O +
Ubr1 O +
knockout O +
mice O +
show O +
an O +
20 O -
% O +
decrease O +
in O +
body O +
weight O +
partly O +
due O +
to O +
a O +
reduction O +
in O +
adipose O +
tissue O +
[ O -
50,51 O -
] O -
. O +

Ptpns1 O +
knockout O +
mice O +
displayed O +
a O +
10 O -
% O +
reduction O +
in O +
body O +
weight O +
[ O -
52 O -
] O +
and O +
Mmp9 O +
knockout O +
mice O +
show O +
a O +
reduction O +
in O +
size O +
and O +
drastically O +
reduced O +
bone O +
length O +
[ O -
53 O -
] O -
. O +

All O +
of O +
these O +
genes O +
are O +
excellent O +
functional O +
and O +
positional O +
hg O +
modifier O +
candidate O +
genes O +
and O +
this O +
information O +
can O +
be O +
incorporated O +
into O +
future O +
fine O +
mapping O +
studies O -
. O +

Conclusion O +
The O +
speed O +
congenic O +
strains O +
developed O +
herein O +
confirm O +
previously O +
identified O +
genome O -
- O -
wide O +
QTL O +
affecting O +
growth O -
, O +
obesity O +
and O +
carcass O +
composition O -
. O +

Our O +
novel O +
congenic O +
development O +
approach O +
on O +
MMU2 O +
provided O +
confirmation O +
of O +
QTL O -
- O -
hg O +
interactions O -
, O +
which O +
will O +
significantly O +
aid O +
in O +
future O +
fine O +
mapping O +
experiments O -
. O +

The O +
identification O +
of O +
the O +
molecular O +
mediators O +
of O +
QTL O -
- O -
hg O +
epistasis O +
as O +
well O +
as O +
the O +
QTG O +
for O +
the O +
remaining O +
congenics O +
will O +
provide O +
essential O +
information O +
on O +
the O +
molecular O +
genetic O +
architecture O +
of O +
growth O +
and O +
obesity O -
. O +

Methods O +
Mouse O +
strains O +
and O +
husbandry O +
CAST O -
/ O -
EiJ O +
( O -
stock O +
# O -
000928 O -
) O +
mice O +
were O +
purchased O +
from O +
the O +
Jackson O +
Laboratory O -
. O +

The O +
hg O +
mutation O +
was O +
originally O +
identified O +
in O +
a O +
selected O +
outcross O +
line O +
[ O -
22 O -
] O +
and O +
has O +
been O +
introgressed O +
onto O +
a O +
B6 O +
background O +
via O +
nine O +
backcrosses O +
to O +
create O +
the O +
HG O +
strain O -
. O +

HG O +
mice O +
used O +
in O +
this O +
experiment O +
were O +
from O +
the O +
17th O +
or O +
later O +
generation O +
of O +
inbreeding O -
. O +

Mice O +
were O +
housed O +
in O +
polycarbonate O +
cages O +
under O +
controlled O +
conditions O +
of O +
temperature O +
( O -
21 O -
° O -
C O +
± O +
2 O -
° O -
C O -
) O -
, O +
humidity O +
( O -
40–70 O -
% O -
) O +
and O +
lighting O +
( O -
14 O +
h O +
light O -
, O +
10 O +
h O +
dark O -
, O +
lights O +
on O +
at O +
7 O +
AM O -
) O -
, O +
and O +
managed O +
according O +
to O +
the O +
guidelines O +
of O +
the O +
American O +
Association O +
for O +
Accreditation O +
of O +
Laboratory O +
Animal O +
Care O +
( O -
AAALAC O -
) O -
. O +

Genotyping O +
DNA O +
for O +
genotyping O +
was O +
isolated O +
from O +
1.0–2.0 O +
mm O +
tail O +
clips O +
by O +
digesting O +
with O +
Proteinase O +
K O +
( O -
Fisher O -
) O +
at O +
55 O -
° O -
C O +
in O +
a O +
buffer O +
composed O +
of O +
0.45 O -
% O +
NP40 B-Chemical +
( O -
Sigma O -
) O -
, O +
0.45 O -
% O +
Tween B-Chemical +
20 I-Chemical +
( O -
Fisher O -
) O +
and O +
1X O +
PCR O +
buffer O +
( O -
Promega O -
) O -
. O +

The O +
product O +
of O +
this O +
digestion O +
was O +
diluted O +
( O -
1:10 O -
) O +
in O +
sterile O +
H2O B-Chemical +
and O +
used O +
for O +
genotyping O +
without O +
further O +
purification O -
. O +

Microsatellite O +
genotyping O +
was O +
performed O +
using O +
standard O +
PCR O +
and O +
gel O +
electrophoresis O +
protocols O -
. O +

Reaction O +
conditions O +
for O +
each O +
marker O +
are O +
listed O +
in O +
Additional O +
File O +
1 O +
and O +
2 O -
. O +

MMU2 O +
congenic O +
mice O +
were O +
genotyped O +
for O +
hg O +
using O +
a O +
two O +
primer O +
genotyping O +
assay O -
. O +

One O +
primer O +
set O +
( O -
HG O -
- O -
F O -
, O +
ctcctgtctgggctgtgag O +
and O +
HG O -
- O -
R O -
, O +
caaaggcagaagtggggtaa O -
) O +
spanned O +
the O +
hg O +
deletion O +
producing O +
a O +
447 O +
bp O +
product O +
in O +
hg O -
/ O -
hg O +
and O +
+ O -
/hg O +
mice O -
. O +

The O +
other O +
set O +
( O -
CRADD3a O -
. O +

F O -
, O +
gtccatcagcattcctgaaa O +
and O +
CRADD3.R O -
, O +
tgtccagcaacagcattgtc O -
) O +
amplified O +
a O +
232 O +
bp O +
Cradd O +
amplicon O +
( O -
located O +
within O +
the O +
hg O +
deletion O -
) O +
in O +
+ O -
/+ O +
and O +
+ O -
/hg O +
mice O +
[ O -
54 O -
] O -
. O +

The O +
PCR O +
annealing O +
temperature O +
was O +
55 O -
° O -
C O +
and O +
the O +
MgCl2 B-Chemical +
concentration O +
was O +
1.5 O +
mM. O +
Development O +
of O +
B6.CAST O +
and O +
HG.CAST O +
MMU2 O +
speed O +
congenic O +
strains O +
All O +
speed O +
congenic O +
strains O +
were O +
developed O +
starting O +
with O +
an O +
initial O +
cross O +
between O +
a O +
CAST O +
male O +
and O +
HG O +
females O +
( O -
Figure O +
1 O -
) O +
[ O -
5,6 O -
] O -
. O +

Male O +
F1 O +
mice O +
were O +
then O +
backcrossed O +
to O +
HG O +
females O -
. O +

All O +
agouti O +
( O -
the O +
dominant O +
nonagouti O +
( O -
a O -
) O +
locus O +
is O +
located O +
at O +
154.8 O +
Mbp O +
on O +
MMU2 O -
) O +
N2 O +
males O +
were O +
genotyped O +
for O +
79 O +
microsatellite O +
markers O +
( O -
Additional O +
File O +
1 O -
) O -
. O +

These O +
markers O +
were O +
evenly O +
spaced O +
across O +
the O +
genome O -
, O +
except O +
in O +
regions O +
previously O +
identified O +
as O +
harboring O +
QTL O +
[ O -
1 O -
] O -
, O +
which O +
were O +
more O +
densely O +
screened O -
. O +

The O +
" O -
best O -
" O +
N2 O +
agouti O +
male O +
with O +
the O +
lowest O +
level O +
of O +
genome O -
- O -
wide O +
unwanted O +
heterozygosity O +
while O +
maintaining O +
CAST O +
alleles O +
for O +
all O +
MMU2 O +
markers O +
was O +
selected O +
for O +
breeding O -
. O +

This O +
selection O +
scheme O +
was O +
used O +
at O +
each O +
generation O +
until O +
a O +
N4 O +
male O +
was O +
identified O +
as O +
homozygous O +
HG O +
for O +
all O +
markers O +
typed O +
outside O +
MMU2 O -
. O +

After O +
an O +
additional O +
backcross O +
to O +
HG O +
females O -
, O +
recombinant O +
males O +
were O +
identified O +
providing O +
the O +
foundation O +
for O +
the O +
four O +
overlapping O +
donor O +
regions O -
. O +

Selected O +
recombinant O +
males O +
were O +
then O +
backcrossed O +
to O +
both O +
B6 O +
and O +
HG O +
females O +
to O +
create O +
strains O -
, O +
which O +
were O +
B6 O +
( O -
+ O -
/+ O -
) O +
or O +
HG O +
( O -
hg O -
/ O -
hg O -
) O +
and O +
heterozygous O +
congenic O -
. O +

These O +
mice O +
were O +
intermated O +
to O +
produce O +
homozygous O +
founders O +
for O +
each O +
strain O -
. O +

This O +
novel O +
breeding O +
scheme O +
created O +
four O +
identical O +
founder O +
congenics O +
on O +
two O +
backgrounds O +
B6 O +
( O -
+ O -
/+ O -
) O +
and O +
HG O +
( O -
hg O -
/ O -
hg O -
) O -
, O +
which O +
formed O +
the O +
basis O +
for O +
our O +
examination O +
of O +
interactions O +
caused O +
by O +
the O +
presence O +
of O +
the O +
hg O +
deletion O -
. O +

MMU2 O +
speed O +
congenic O +
strains O +
were O +
maintained O +
through O +
brother O -
- O -
sister O +
mating O -
. O +

Once O +
each O +
congenic O +
was O +
stabilized O -
, O +
20 O +
additional O +
microsatellite O +
markers O +
were O +
used O +
to O +
refine O +
the O +
position O +
of O +
each O +
congenic O +
recombinant O +
end O +
point O +
( O -
Additional O +
File O +
2 O -
) O -
. O +

Development O +
of O +
HG.CAST O +
speed O +
congenic O +
strains O +
for O +
MMU1 O -
, O +
5 O -
, O +
8 O -
, O +
9 O -
, O +
11 O +
and O +
17 O +
All O +
black O +
N2 O +
males O +
from O +
the O +
first O +
two O +
crosses O +
described O +
above O +
were O +
genotyped O +
for O +
12 O +
markers O +
( O -
D1Mit432 O -
, O +
-480 O -
, O +
D5Mit353 O -
, O +
-311 O -
, O +
D9Mit60 O -
, O +
-262 O -
, O +
D11Mit5 O -
, O +
-67 O -
, O +
D8Mit234 O -
, O +
-211 O +
and O +
D17Mit28 O +
and O +
-142 O -
) O -
, O +
two O +
spanning O +
each O +
of O +
the O +
six O +
QTL O +
harboring O +
regions O +
( O -
MMU1 O -
, O +
5 O -
, O +
8 O -
, O +
9 O -
, O +
11 O +
and O +
17 O -
; O +
Table O +
1 O +
and O +
Additional O +
File O +
1 O -
) O -
. O +

Markers O +
were O +
selected O +
to O +
capture O -
, O +
at O +
a O +
minimum O -
, O +
the O +
2-LOD O +
support O +
interval O -
. O +

Two O +
N2 O +
males O +
were O +
selected O +
to O +
propagate O +
the O +
N3 O +
generation O -
; O +
one O +
heterozygous O +
for O +
QTL O +
on O +
MMU1 O +
and O +
9 O +
and O +
the O +
other O +
heterozygous O +
for O +
QTL O +
on O +
MMU5 O -
, O +
8 O -
, O +
11 O +
and O +
17 O +
( O -
Figure O +
1 O -
) O -
. O +

Both O +
males O +
were O +
homozygous O +
for O +
HG O +
alleles O +
at O +
all O +
other O +
known O +
QTL O -
. O +

These O +
males O +
were O +
backcrossed O +
to O +
HG O +
females O +
and O +
two O +
of O +
the O +
resulting O +
N3 O +
males O +
inheriting O +
the O +
same O +
sets O +
of O +
QTL O +
as O +
their O +
sire O +
were O +
selected O +
for O +
breeding O -
. O +

These O +
males O +
were O +
subsequently O +
backcrossed O +
to O +
HG O +
females O +
and O +
three O +
N4 O +
males O +
were O +
identified O +
heterozygous O +
for O +
the O +
following O +
regions O -
: O +
1 O -
) O +
MMU1 O +
and O +
9 O -
; O +
2 O -
) O +
MMU5 O +
and O +
11 O -
; O +
3 O -
) O +
MMU8 O -
, O +
11 O +
and O +
17 O +
( O -
Figure O +
1 O -
) O -
. O +

Starting O +
at O +
N4 O +
and O +
continuing O +
through O +
N6 O -
, O +
the O +
" O -
best O -
" O +
male O +
with O +
the O +
lowest O +
percent O +
of O +
unwanted O +
donor O +
alleles O +
was O +
selected O +
after O +
performing O +
a O +
genome O +
scan O +
using O +
the O +
remaining O +
67 O +
genome O -
- O -
wide O +
markers O +
( O -
79 O +
total O +
markers O +
minus O +
the O +
12 O +
markers O +
genotyped O +
in O +
the O +
first O +
two O +
backcrosses O +
spanning O +
the O +
know O +
QTL O +
intervals O -
) O -
. O +

At O +
N5 O +
a O +
distinct O +
strain O +
was O +
created O +
for O +
each O +
of O +
the O +
six O +
individual O +
donor O +
regions O +
and O +
heterozygous O +
mice O +
were O +
intermated O +
( O -
Figure O +
1 O -
) O -
. O +

Homozygous O +
HG.CAST O +
speed O +
congenic O +
strains O +
were O +
maintained O +
through O +
brother O -
- O -
sister O +
mating O -
. O +

Once O +
each O +
congenic O +
was O +
stabilized O -
, O +
19 O +
additional O +
microsatellite O +
markers O +
were O +
used O +
to O +
refine O +
the O +
position O +
of O +
each O +
congenic O +
recombinant O +
end O +
point O +
( O -
Additional O +
File O +
2 O -
) O -
. O +

Development O +
of O +
B6.CASTC O +
and O +
HG.CASTC O +
control O +
strains O +
HG O +
is O +
a O +
strain O +
in O +
which O +
the O +
hg O +
deletion O +
has O +
been O +
introgressed O +
onto O +
a O +
B6 O +
background O -
, O +
therefore O +
the O +
only O +
genetic O +
differences O +
between O +
the O +
strains O +
would O +
be O +
the O +
hg O +
locus O -
, O +
tightly O +
linked O +
alleles O +
from O +
the O +
outbred O +
strain O +
on O +
which O +
hg O +
arose O +
and O +
contaminating O +
alleles O +
remaining O +
after O +
the O +
nine O +
backcrosses O +
and O +
fixed O +
during O +
inbreeding O -
. O +

Instead O +
of O +
using O +
parental O +
B6 O +
and O +
HG O +
strains O +
as O +
controls O +
for O +
phenotypic O +
comparisons O +
with O +
each O +
speed O +
congenic O -
, O +
we O +
choose O +
to O +
develop O +
independent O +
control O +
strains O +
originating O +
from O +
the O +
same O +
cross O +
as O +
the O +
congenic O +
panels O -
. O +

Separate O +
B6.CAST O +
control O +
( O -
B6C O -
) O +
and O +
HG.CAST O +
control O +
( O -
HGC O -
) O +
strains O +
were O +
developed O +
using O +
mice O +
from O +
the O +
MMU2 O +
experiment O -
. O +

Mice O +
from O +
the O +
last O +
backcross O +
inheriting O +
only O +
B6 O +
or O +
HG O +
MMU2 O +
alleles O +
at O +
markers O +
spanning O +
MMU2 O +
were O +
intermated O +
to O +
serve O +
as O +
the O +
basis O +
for O +
each O +
control O -
. O +

Both O +
control O +
strains O +
were O +
subsequently O +
maintained O +
through O +
brother O -
- O -
sister O +
mating O -
. O +

The O +
control O +
strains O +
were O +
coisogenic O +
with O +
the O +
parental O +
B6 O +
or O +
HG O +
strain O +
with O +
the O +
exception O +
of O +
mutations O +
that O +
arose O +
during O +
congenic O +
construction O +
and O +
a O +
small O +
percentage O +
of O +
contaminating O +
donor O +
alleles O +
missed O +
after O +
6 O +
backcrosses O -
. O +

Therefore O -
, O +
since O +
the O +
congenics O +
and O +
controls O +
were O +
developed O +
through O +
the O +
same O +
selection O +
scheme O +
and O +
possibly O +
share O +
common O +
contaminating O +
regions O -
, O +
the O +
B6C O +
and O +
HGC O +
strains O +
are O +
the O +
most O +
ideal O +
control O +
to O +
compare O +
each O +
congenic O -
. O +

Phenotypic O +
characterization O +
Trait O +
data O +
were O +
collected O +
on O +
approximately O +
40 O +
mice O +
( O -
20 O +
of O +
each O +
sex O -
) O +
from O +
each O +
congenic O +
and O +
control O +
strain O -
. O +

To O +
eliminate O +
parity O +
and O +
reduce O +
litter O +
size O +
effects O +
only O +
progeny O +
from O +
uniparous O +
dams O +
were O +
characterized O +
and O +
all O +
litters O +
were O +
standardized O +
to O +
5–7 O +
pups O -
/ O -
litter O -
. O +

Mice O +
were O +
weaned O +
at O +
3 O +
weeks O +
of O +
age O -
. O +

Feed B-Chemical +
( O -
Purina O +
5008 O -
; O +
23.5 O -
% O +
protein O -
, O +
6.5 O -
% O +
fat O -
, O +
3.3 O +
Kcal O -
/ O -
g O -
) O +
and O +
water B-Chemical +
were O +
offered O +
ad O +
libitum O -
. O +

Mice O +
were O +
weighed O +
to O +
the O +
nearest O +
0.1 O +
g O +
at O +
2WK O -
, O +
3WK O -
, O +
6WK O -
, O +
and O +
9WK O +
of O +
age O -
. O +

At O +
9WK O +
( O +
± O +
5 O +
days O -
) O +
mice O +
were O +
anesthetized O +
under O +
isoflurane B-Chemical +
and O +
nasal O -
- O -
anal O +
length O +
( O -
NA O -
) O +
and O +
nasal O -
- O -
tail O +
( O -
NT O -
) O +
were O +
measured O +
to O +
the O +
nearest O +
mm O -
. O +

Tail O +
length O +
was O +
calculated O +
as O +
NA O +
minus O +
NT O -
. O +

Anesthetized O +
mice O +
were O +
then O +
sacrificed O +
by O +
decapitation O +
and O +
exsanguinated O -
. O +

Femoral O +
fat O +
pad O +
( O -
FFP O -
) O -
, O +
gonadal O +
fat O +
pad O +
( O -
GFP O -
) O -
, O +
mesenteric O +
fat O +
pad O +
( O -
MFP O -
) O +
and O +
retroperitoneal O +
fat O +
pad O +
( O -
RFP O -
) O +
were O +
removed O +
and O +
weighed O +
to O +
the O +
nearest O +
mg O -
. O +

Chemical O +
compositional O +
analysis O +
was O +
performed O +
for O +
HGC O -
, O +
HG11 O +
and O +
HG17 O +
carcasses O +
as O +
previously O +
described O +
with O +
slight O +
modifications O +
[ O -
24 O -
] O -
. O +

Briefly O -
, O +
after O +
weighing O +
each O +
fat O +
pad O +
was O +
returned O +
to O +
the O +
carcass O -
. O +

The O +
entire O +
gastrointestinal O +
( O -
GI O -
) O +
tract O +
was O +
subsequently O +
removed O +
and O +
carcasses O +
were O +
again O +
weighed O -
. O +

This O +
represented O +
the O +
empty O +
carcass O +
weight O +
( O -
ECW O -
) O -
. O +

Carcasses O +
were O +
labeled O +
and O +
secured O +
in O +
two O +
layers O +
of O +
cheesecloth O +
( O -
Fisher O -
) O +
and O +
frozen O +
at O +
-20 O -
° O -
C O +
until O +
analysis O -
. O +

At O +
this O +
time O -
, O +
carcasses O +
were O +
freeze O -
- O -
dried O +
for O +
seven O +
days O +
and O +
water B-Chemical +
content O +
was O +
determined O +
by O +
subtracting O +
the O +
freeze O -
- O -
dried O +
weight O +
from O +
ECW O -
. O +

FAT O +
was O +
then O +
extracted O +
with O +
ether B-Chemical +
for O +
7 O +
days O -
, O +
followed O +
by O +
acetone B-Chemical +
for O +
an O +
additional O +
7 O +
days O +
in O +
a O +
Soxhlet O +
apparatus O -
. O +

Carcass O +
ash O +
( O -
ASH O -
) O +
was O +
determined O +
measuring O +
the O +
remains O +
after O +
a O +
16 O +
hour O +
incineration O +
at O +
575 O -
° O -
C O -
. O +

Carcass O +
protein O +
( O -
PROT O -
) O +
was O +
calculated O +
as O +
the O +
remaining O +
portion O +
after O +
carcass O +
fat O +
( O -
FAT O -
) O +
and O +
ASH O +
were O +
subtracted O +
from O +
ECW O -
. O +

Statistical O +
analysis O +
The O +
MEANS O +
and O +
UNIVARIATE O +
procedures O +
of O +
SAS O +
were O +
used O +
to O +
generate O +
descriptive O +
statistics O +
and O +
test O +
normality O +
assumptions O +
for O +
each O +
trait O +
[ O -
55 O -
] O -
. O +

All O +
data O +
were O +
then O +
analyzed O +
using O +
the O +
GLM O +
procedure O +
of O +
SAS O +
[ O -
55 O -
] O +
with O +
a O +
linear O +
model O +
that O +
included O +
the O +
fixed O +
effects O +
of O +
strain O -
, O +
sex O +
and O +
strain O +
by O +
sex O +
interaction O -
; O +
dam O -
's O +
weight O +
at O +
breeding O +
by O +
strain O +
was O +
used O +
as O +
a O +
covariate O -
. O +

A O +
second O +
linear O +
model O +
was O +
used O +
to O +
test O +
for O +
strain O +
by O +
hg O +
genotype O +
( O -
+ O -
/+ O +
or O +
hg O -
/ O -
hg O -
) O +
interactions O -
. O +

This O +
model O +
included O +
the O +
fixed O +
effects O +
of O +
donor O +
region O -
, O +
sex O +
and O +
HG O +
genotype O +
and O +
all O +
possible O +
two O +
and O +
three O -
- O -
way O +
interactions O -
. O +

Choosing O +
a O +
nominal O +
P O +
value O +
of O +
0.05 O +
and O +
applying O +
the O +
Bonferroni O +
correction O +
for O +
multiple O +
comparisons O +
established O +
significant O +
differences O +
in O +
the O +
ANOVA O -
's O -
. O +

The O +
critical O +
P O +
values O +
used O +
are O +
indicated O +
in O +
each O +
table O -
. O +

Identification O +
of O +
candidate O +
genes O +
Genes O +
were O +
identified O +
by O +
manual O +
data O +
mining O +
of O +
primary O +
literature O -
, O +
reviews O +
and O +
book O +
chapters O -
. O +

To O +
organize O +
and O +
collate O +
genomic O +
and O +
functional O +
information O +
for O +
each O +
gene O +
we O +
created O +
a O +
custom O +
Gh O +
signaling O +
Gene O +
Map O +
Annotator O +
and O +
Pathway O +
Profiler O +
( O -
GenMAPP O -
) O +
pathway O +
[ O -
56 O -
] O +
( O -
Figure O +
5 O -
) O -
. O +

Visualization O +
and O +
color O -
- O -
coding O +
of O +
genes O +
using O +
GenMAPP O +
aided O +
the O +
selection O +
of O +
candidate O +
genes O +
mapping O +
within O +
QTL O +
regions O +
on O +
MMU2 O -
, O +
9 O -
, O +
11 O +
and O +
17 O -
. O +

Candidate O +
gene O +
sequencing O +
PCR O +
amplicons O +
covering O +
the O +
coding O +
sequence O +
and O +
partial O +
5 O -
' O +
and O +
3 O -
' O +
untranslated O +
regions O +
for O +
each O +
selected O +
candidate O +
gene O +
were O +
amplified O -
, O +
purified O +
and O +
sequenced O +
from O +
the O +
CAST O +
strain O +
using O +
protocols O +
outlined O +
in O +
[ O -
57 O -
] O +
with O +
slight O +
modifications O -
. O +

Total O +
RNA O +
from O +
brain O -
, O +
liver O -
, O +
spleen O -
, O +
lung O +
and O +
testis O +
was O +
isolated O +
from O +
an O +
adult O +
CAST O +
male O +
mouse O +
using O +
Trizol O +
( O -
Ambion O -
) O -
. O +

cDNA O +
was O +
produced O +
from O +
total O +
RNA O +
using O +
standard O +
procedures O -
. O +

PCR O +
primer O +
sets O +
for O +
each O +
gene O +
were O +
designed O +
using O +
Primer3 O +
[ O -
58 O -
] O +
( O -
Additional O +
File O +
5 O -
) O -
. O +

The O +
initial O +
amplification O +
was O +
performed O +
in O +
10 O +
μl O +
PCR O +
reactions O +
using O +
the O +
Invitrogen O +
Platinum O +
TaqPCRx O +
amplification O +
system O +
( O -
Invitrogen O -
) O -
. O +

The O +
reactions O +
contained O +
1X O +
PCR O +
buffer O -
, O +
1X O +
Enhancer O +
solution B-Chemical -
, O +
1.5 O +
mM O +
MgSO4 B-Chemical -
, O +
0.17 O +
mM O +
dNTPs O -
, O +
1 O +
μM O +
each O +
primer O -
, O +
0.1 O +
unit O +
of O +
Platinum O +
Taq O +
( O -
Invitrogen O -
) O +
and O +
approximately O +
25 O +
ng O +
of O +
cDNA O -
. O +

Reactions O +
were O +
incubated O +
for O +
5 O +
min O +
at O +
95 O -
° O -
C O -
, O +
then O +
cycled O +
for O +
45 O +
s O +
at O +
95 O -
° O -
C O -
, O +
45 O +
s O +
at O +
55 O -
° O -
C O -
, O +
1 O +
min O +
at O +
72 O -
° O -
C O +
for O +
35 O +
cycles O +
with O +
a O +
final O +
72 O -
° O -
C O +
extension O +
for O +
10 O +
min O +
on O +
a O +
MJ O +
Research O +
PTC-200 O -
. O +

The O +
products O +
were O +
visualized O +
on O +
1.5 O -
% O +
agarose B-Chemical +
gels O +
containing O +
0.06 O +
μg O -
/ O -
ml O +
EtBr B-Chemical -
. O +

Bands O +
of O +
the O +
correct O +
size O +
were O +
excised O +
and O +
incubated O +
in O +
100 O +
μl O +
of O +
sterile O +
H2O B-Chemical +
at O +
80 O -
° O -
C O +
for O +
10 O +
min O +
to O +
elute O +
DNA O -
. O +

Reamplification O +
reactions O +
consisted O +
of O +
1X O +
PCR O +
buffer O -
, O +
1.5 O +
mM O +
MgCl2 B-Chemical -
, O +
0.17 O +
mM O +
dNTPs O -
, O +
1 O +
μM O +
each O +
primer O -
, O +
0.1 O +
unit O +
of O +
Taq O +
( O -
Promega O -
) O +
and O +
10 O +
μl O +
of O +
eluate O +
in O +
a O +
total O +
volume O +
of O +
50 O +
μl O -
. O +

The O +
same O +
cycling O +
parameters O +
were O +
used O +
for O +
reamplification O +
reactions O -
. O +

Products O +
were O +
visualized O +
on O +
1 O -
% O +
0.5X O +
TBE O +
agarose B-Chemical +
gels O +
containing O +
0.06 O +
μg O -
/ O -
ml O +
EtBr B-Chemical -
, O +
excised O +
and O +
purfied O +
using O +
PCR O +
purification O +
columns O +
( O -
Promega O -
) O -
. O +

To O +
quantity O +
each O +
fragment O +
1 O +
μl O +
of O +
each O +
purified O +
product O +
was O +
run O +
on O +
a O +
1.0 O -
% O +
agarose B-Chemical +
gel O +
containing O +
0.06 O +
μg O -
/ O -
ml O +
EtBr B-Chemical -
, O +
along O +
with O +
a O +
DNA O +
mass O +
ladder O +
( O -
Invitrogen O -
) O -
. O +

In O +
a O +
96 O +
well O +
plate O -
, O +
15 O +
ng O +
of O +
each O +
PCR O +
product O +
was O +
added O +
to O +
5 O +
pM O +
of O +
primer O +
for O +
sequencing O -
. O +

The O +
College O +
of O +
Agriculture O +
and O +
Environmental O +
Sciences O +
( O -
CAES O -
) O +
Genomics O +
Facility O +
at O +
the O +
University O +
of O +
California O -
, O +
Davis O -
, O +
performed O +
bidirectional O +
sequencing O +
of O +
each O +
amplicon O -
. O +

Sequence O +
analysis O +
B6 O +
mRNA O +
sequences O +
for O +
each O +
gene O +
were O +
downloaded O +
from O +
the O +
May O +
2004 O +
( O -
mm5 O -
) O +
UCSC O +
( O -
NCBI O +
Build O +
33 O -
) O +
genome O +
assembly O +
[ O -
28 O -
] O -
. O +

These O +
sequences O +
were O +
imported O +
along O +
with O +
all O +
CAST O +
sequence O +
traces O +
into O +
the O +
SeqMan O +
sequence O +
assembly O +
program O +
( O -
DNASTAR O -
) O +
and O +
manually O +
curated O +
for O +
quality O -
. O +

Poor O +
quality O +
reads O +
were O +
resequenced O -
. O +

Individual O +
contigs O +
were O +
created O +
for O +
each O +
gene O +
and O +
polymorphisms O +
were O +
detected O +
and O +
curated O +
by O +
manual O +
inspection O -
. O +

Authors O -
' O +
contributions O +
CRF O +
and O +
JFM O +
conceived O +
the O +
study O -
. O +

CRF O +
developed O +
and O +
characterized O +
each O +
speed O +
congenic O +
strain O -
, O +
assisted O +
with O +
phenotypic O +
data O +
analysis O +
and O +
drafted O +
the O +
manuscript O -
. O +

PMC O +
assisted O +
with O +
experimental O +
design O +
and O +
phenotypic O +
data O +
analysis O -
. O +

JFM O +
assisted O +
in O +
the O +
evaluation O +
of O +
experimental O +
results O +
and O +
the O +
manuscript O +
and O +
provided O +
coordination O +
of O +
the O +
project O -
. O +

All O +
authors O +
read O +
and O +
approved O +
the O +
final O +
manuscript O -
. O +

Supplementary O +
Material O +
Additional O +
File O +
1 O +
Table O +
of O +
microsatellite O +
markers O +
used O +
in O +
the O +
construction O +
of O +
B6.CAST O +
and O +
HG.CAST O +
speed O +
congenic O +
strains O +
Click O +
here O +
for O +
file O +
Additional O +
File O +
2 O +
Table O +
of O +
microsatellite O +
markers O +
used O +
to O +
position O +
the O +
recombinant O +
ends O +
of O +
each O +
speed O +
congenic O +
strain O +
Click O +
here O +
for O +
file O +
Additional O +
File O +
3 O +
Table O +
of O +
body O +
weight O +
and O +
growth O +
rate O +
phenotypes O +
of O +
B6.CAST O +
and O +
HG.CAST O +
MMU2 O +
speed O +
congenic O +
strains O +
Click O +
here O +
for O +
file O +
Additional O +
File O +
4 O +
Table O +
of O +
results O +
of O +
sequence O +
comparisons O +
between O +
CAST O +
and O +
B6 O +
for O +
MMU2 O +
hg O +
modifier O +
candidate O +
genes O +
Click O +
here O +
for O +
file O +
Additional O +
File O +
5 O +
Table O +
of O +
PCR O +
primers O +
used O +
to O +
sequence O +
MMU2 O -
, O +
9 O -
, O +
11 O +
and O +
17 O +
hg O +
modifier O +
candidate O +
genes O +
Click O +
here O +
for O +
file O +
Acknowledgements O +

We O +
thank O +
Vince O +
De O +
Vera O +
for O +
mouse O +
care O +
and O +
Alma O +
Islas O -
- O -
Trejo O -
, O +
Kerri O +
Morimoto O -
, O +
Gonzalo O +
Rincon O -
, O +
Ricardo O +
Verdugo O -
, O +
Karina O +
Guevara O -
, O +
James O +
Chitwood O -
, O +
Lee O +
Nguyen O -
, O +
Galen O +
Williams O +
and O +
Emily O +
Farber O +
for O +
assistance O +
with O +
mouse O +
phenotyping O -
. O +

We O +
also O +
thank O +
Scott O +
Taylor O +
and O +
Dr. O +
Ed O +
DePeters O +
for O +
assistance O +
and O +
use O +
of O +
the O +
UCD O +
Animal O +
Science O +
Nutrition O +
Laboratory O +
for O +
carcass O +
composition O +
analysis O -
. O +

This O +
work O +
was O +
supported O +
by O +
the O +
National O +
Research O +
Initiative O +
of O +
the O +
USDA O +
Cooperative O +
State O +
Research O -
, O +
Education O +
and O +
Extension O +
Service O -
, O +
grant O +
number O +
2005–35205–15453 O -
. O +

CRF O +
was O +
supported O +
by O +
the O +
Austin O +
Eugene O +
Lyons O +
fellowship O -
. O +

Figures O +
and O +
Tables O +
Figure O +
1 O +
Outline O +
of O +
the O +
speed O +
congenic O +
approach O +
used O +
to O +
capture O +
genome O -
- O -
wide O +
growth O +
and O +
obesity O +
QTL O -
. O +

Details O +
of O +
the O +
congenic O +
matings O +
are O +
outlined O +
in O +
" O -
Methods O -
" O -
. O +

The O +
matings O +
used O +
to O +
construct O +
the O +
MMU2 O +
speed O +
congenic O +
panel O +
are O +
listed O +
on O +
the O +
left O +
of O +
the O +
figure O -
, O +
along O +
with O +
the O +
expected O +
and O +
observed O +
% O +
heterozygosity O +
at O +
each O +
generation O -
. O +

% O +
heterozygosity O +
is O +
defined O +
as O +
the O +
number O +
of O +
markers O +
heterozygous O +
B6 O +
( O -
or O +
HG O -
) O -
/ O -
CAST O +
as O +
a O +
percent O +
of O +
the O +
total O +
number O +
of O +
markers O +
typed O +
( O -
N O +
= O +
79 O -
) O -
. O +

The O +
right O +
side O +
of O +
the O +
illustration O +
lists O +
the O +
matings O +
used O +
to O +
construct O +
the O +
MMU1 O -
, O +
5 O -
, O +
8 O -
, O +
9 O -
, O +
11 O +
and O +
17 O +
speed O +
congenic O +
strains O -
, O +
along O +
with O +
the O +
expected O +
and O +
observed O +
% O +
heterozygosity O +
at O +
each O +
generation O -
. O +

Figure O +
2 O +
Genome O -
- O -
wide O +
speed O +
congenic O +
strains O +
and O +
summary O +
of O +
QTL O +
effects O -
. O +

White O +
bars O +
indicate O +
the O +
boundaries O +
of O +
CAST O +
donor O +
regions O +
and O +
hatched O +
bars O +
indicate O +
intervals O +
of O +
unknown O +
genotype O -
. O +

The O +
minimum O +
physical O +
intervals O +
( O -
Mbp O -
) O +
of O +
each O +
donor O +
region O +
are O +
listed O +
in O +
Table O +
1 O -
. O +

To O +
provide O +
a O +
general O +
summary O +
of O +
the O +
results O -
, O +
MMU2 O +
is O +
divided O +
into O +
five O +
chromosomal O +
regions O +
( O -
I O -
, O +
II O -
, O +
III O -
, O +
IV O +
and O +
V O -
) O -
. O +

Phenotypic O +
differences O +
for O +
male O +
and O +
female O +
( O -
+ O -
/+ O +
and O +
hg O -
/ O -
hg O -
) O +
mice O +
relative O +
to O +
the O +
appropriate O +
controls O +
are O +
listed O -
. O +

For O +
congenics O +
outside O +
of O +
MMU2 O -
, O +
a O +
general O +
summary O +
of O +
QTL O +
effects O +
is O +
listed O +
to O +
the O +
right O +
of O +
each O +
donor O +
region O -
. O +

Abbreviations O -
: O +
WT O -
, O +
body O +
weight O -
; O +
GR O -
, O +
growth O +
rate O -
; O +
T O -
, O +
tail O +
length O -
; O +
NA O -
, O +
nasal O -
- O -
anal O +
body O +
length O -
; O +
TF O -
, O +
total O +
weight O +
of O +
four O +
fat O +
pads O -
; O +
AI O -
, O +
adiposity O +
index O +
and O +
BMI O -
, O +
body O +
mass O +
index O -
. O +

Figure O +
3 O +
Growth O +
curves O +
for O +
MMU2 O +
B6.CAST O +
and O +
HG.CAST O +
speed O +
congenic O +
strains O -
. O +

Body O +
weight O +
LSMEANS O +
± O +
SEM O +
are O +
plotted O +
as O +
a O +
function O +
of O +
time O +
( O -
weeks O -
) O -
. O +

Top O +
plot O -
, O +
growth O +
curves O +
in O +
male O +
B6 O +
( O -
+ O -
/+ O -
) O +
and O +
HG O +
( O -
hg O -
/ O -
hg O -
) O +
speed O +
congenic O +
strains O -
; O +
bottom O +
plot O -
, O +
growth O +
curves O +
in O +
female O +
B6 O +
( O -
+ O -
/+ O -
) O +
and O +
HG O +
( O -
hg O -
/ O -
hg O -
) O +
speed O +
congenic O +
strains O -
. O +

Figure O +
4 O +
Significant O +
three O -
- O -
way O +
donor O +
region O +
by O +
HG O +
genotype O +
by O +
sex O +
interaction O +
for O +
AI O +
in O +
the O +
2 O -
M O +
donor O +
region O -
. O +

AI O +
plot O +
illustrates O +
the O +
effect O +
of O +
the O +
hg O +
deletion O +
on O +
altering O +
fat O +
deposition O +
between O +
the O +
sexes O -
. O +

The O +
interaction O +
is O +
significant O +
at O +
P O +
= O +
0.0004 O -
. O +

Figure O +
5 O +
GenMAPP O +
growth O +
hormone O +
( O -
Gh O -
) O +
signaling O +
pathway O -
. O +

Genes O +
known O +
to O +
be O +
or O +
potentially O +
involved O +
in O +
Gh O +
signaling O +
were O +
mined O +
from O +
primary O +
literature O -
, O +
reviews O +
and O +
book O +
chapters O -
. O +

Genes O +
are O +
organized O +
broadly O +
based O +
on O +
functionality O -
. O +

MMU O +
genomic O +
position O +
for O +
each O +
gene O +
is O +
to O +
the O +
right O +
of O +
each O +
symbol O +
and O +
genes O +
located O +
on O +
MMU2 O -
, O +
9 O -
, O +
11 O +
and O +
17 O +
are O +
highlighted O +
in O +
yellow O -
, O +
purple O -
, O +
orange O +
and O +
green O -
, O +
respectively O -
. O +

Genes O +
located O +
on O +
MMUX O +
are O +
labeled O +
in O +
white O -
. O +

Forty O -
- O -
four O +
of O +
the O +
genes O +
overlapping O +
QTL O +
intervals O +
were O +
selected O +
for O +
sequencing O +
in O +
the O +
CAST O +
strain O -
. O +

Table O +
1 O +
B6.CAST O +
and O +
HG.CAST O +
speed O +
congenic O +
strains O +
developed O +
to O +
isolate O +
and O +
characterize O +
genome O -
- O -
wide O +
QTL O +
affecting O +
growth O +
and O +
obesity O +
QTL O -
, O +
quantitative O +
trait O +
locus O -
; O +
MMU O -
, O +
mouse O +
chromosome O -
; O +
LOD O -
, O +
log O +
of O +
the O +
odds O +
a O +
QTL O +
MGI O +
[ O -
59 O -
] O +
nomenclature O -
. O +

Q1Ucd1-w26 O +
never O +
received O +
an O +
official O +
MGI O +
name O -
, O +
because O +
it O +
only O +
reached O +
a O +
suggestive O +
level O +
of O +
significance O -
; O +
hg O +
modifier O +
QTL O +
are O +
in O +
bold O +
[ O -
24 O -
] O -
. O +

b O +
Mbp O +
position O +
according O +
to O +
the O +
August O +
2005 O +
mm7 O +
UCSC O +
[ O -
28 O -
] O +
genome O +
assembly O +
( O -
NCBI O +
Build O +
35 O -
) O -
, O +
peak O +
LOD O +
from O +
[ O -
24 O -
] O -
. O +

c O +
In O +
the O +
linkage O +
analysis O +
performed O +
in O +
[ O -
24 O -
] O -
, O +
the O +
peak O +
location O +
for O +
Wg2 O -
, O +
Carp1 O -
, O +
Cara1 O +
and O +
Feml1 O +
was O +
59–63 O +
cM O +
( O -
115–120 O +
Mbp O -
) O +
in O +
hg O -
/ O -
hg O +
F2 O +
mice O +
and O +
78–83 O +
cM O +
( O -
135–150 O +
Mbp O -
) O +
in O +
+ O -
/+ O +
F2 O +
mice O -
. O +

d O +
Full O +
congenic O +
name O +
consists O +
of O +
three O +
parts O -
: O +
1 O -
. O +
B6.CAST O -
, O +
indicates O +
the O +
recipient O +
strain O +
is O +
B6 O +
and O +
the O +
donor O +
strain O +
is O +
CAST O -
; O +
HG.CAST O -
, O +
indicates O +
the O +
recipient O +
strain O +
is O +
HG O +
and O +
the O +
donor O +
strain O +
is O +
CAST O -
; O +
2 O -
. O +

markers O +
defining O +
the O +
minimal O +
congenic O +
interval O -
; O +
3 O -
. O +

the O +
number O +
of O +
backcrosses O +
used O +
for O +
speed O +
congenic O +
development O -
. O +

e O +
Represents O +
the O +
minimum O +
genomic O +
region O +
spanned O +
by O +
CAST O +
donor O +
alleles O -
. O +

Table O +
2 O +
Body O +
length O +
and O +
adiposity O +
phenotypes O +
of O +
B6.CAST O +
and O +
HG.CAST O +
MMU2 O +
speed O +
congenic O +
strains O +
NA O -
, O +
nasal O -
- O -
anal O +
body O +
length O -
; O +
Tail O -
, O +
tail O +
length O -
; O +
GFP O -
, O +
gonadal O +
fat O +
pad O -
; O +
FFP O -
, O +
femoral O +
fat O +
pad O -
; O +
MFP O -
, O +
mesenteric O +
fat O +
pad O -
; O +
RFP O -
, O +
retroperitoneal O +
fat O +
pad O -
; O +
TF O -
, O +
summed O +
weight O +
of O +
four O +
fat O +
pads O -
; O +
AI O -
, O +
adiposity O +
index O +
( O -
TF O -
/ O -
body O +
weight*100 O -
) O +
and O +
BMI O -
, O +
body O +
mass O +
index O +
( O -
body O +
weight O +
at O +
sacrifice O -
/ O -
NA2 O +
* O -
100 O -
) O -
. O +

Values O +
are O +
expressed O +
as O +
LSMEANS O +
± O +
SEM O -
. O +

LSMEANS O +
in O +
bold O +
are O +
significantly O +
different O +
than O +
the O +
respective O +
control O +
after O +
Bonferroni O +
correction O +
( O -
B6 O +
( O -
critical O +
P O +
< O +
0.00625 O -
) O +
or O +
HG O +
( O -
P O +
< O +
0.00833 O -
) O -
) O +
within O +
each O +
sex O -
. O +

Table O +
3 O +
Significance O +
levels O +
for O +
the O +
main O +
effects O -
, O +
two O -
- O -
way O +
and O +
three O +
way O +
interactions O +
of O +
MMU2 O +
speed O +
congenic O +
donor O +
region O +
( O -
DR O -
) O -
, O +
HG O +
genotype O +
( O -
HG O -
) O +
( O -
+ O -
/+ O +
or O +
hg O -
/ O -
hg O -
) O +
and O +
sex O +
for O +
selected O +
traits O +
6WK O -
, O +
weight O +
at O +
6 O +
weeks O +
of O +
age O -
; O +
9WK O -
, O +
weight O +
at O +
9 O +
weeks O +
of O +
age O -
; O +
G26 O -
, O +
weight O +
gain O +
from O +
2 O +
to O +
6 O +
weeks O +
of O +
age O -
; O +
G29 O -
, O +
weight O +
gain O +
from O +
2 O +
to O +
9 O +
weeks O +
of O +
age O -
; O +
NA O -
, O +
nasal O -
- O -
anal O +
body O +
length O -
; O +
TF O -
, O +
total O +
fat O +
pad O +
weight O +
and O +
AI O -
, O +
adiposity O +
index O -
. O +

Significant O +
effects O +
after O +
a O +
Bonferroni O +
correction O +
( O -
critical O +
P O +
< O +
0.0071 O -
) O +
are O +
in O +
bold O -
. O +

a O +
The O +
distal O +
( O -
2D O -
) O +
donor O +
region O +
was O +
not O +
analyzed O -
. O +

Table O +
4 O +
Body O +
size O -
, O +
growth O +
rate O +
and O +
length O +
phenotypes O +
of O +
HG.CAST O +
speed O +
congenic O +
strains O +
2WK O -
, O +
weight O +
at O +
2 O +
weeks O +
of O +
age O -
; O +
3WK O -
, O +
weight O +
at O +
3 O +
weeks O +
of O +
age O -
; O +
6WK O -
, O +
weight O +
at O +
6 O +
weeks O +
of O +
age O -
; O +
9WK O -
, O +
weight O +
at O +
9 O +
weeks O +
of O +
age O -
; O +
G26 O -
, O +
weight O +
gain O +
from O +
2 O +
to O +
6 O +
weeks O +
of O +
age O -
; O +
G29 O -
, O +
weight O +
gain O +
from O +
2 O +
to O +
9 O +
weeks O +
of O +
age O -
; O +
NA O -
, O +
nasal O -
- O -
anal O +
body O +
length O -
; O +
Tail O -
, O +
tail O +
length O -
. O +

Values O +
are O +
expressed O +
as O +
least O +
square O +
means O +
( O -
LSMEANS O -
) O +
± O +
SEM O -
. O +

LSMEANS O +
in O +
bold O +
are O +
significantly O +
different O +
than O +
the O +
control O +
( O -
HGC O -
) O +
( O -
critical O +
P O +
< O +
0.005 O -
) O +
after O +
Bonferroni O +
correction O +
within O +
each O +
sex O -
. O +

Table O +
5 O +
Adiposity O +
phenotypes O +
of O +
HG.CAST O +
speed O +
congenic O +
strains O +
GFP O -
, O +
gonadal O +
fat O +
pad O -
; O +
FFP O -
, O +
femoral O +
fat O +
pad O -
; O +
MFP O -
, O +
mesenteric O +
fat O +
pad O -
; O +
RFP O -
, O +
retroperitoneal O +
fat O +
pad O -
; O +
TF O -
, O +
summed O +
weight O +
of O +
four O +
fat O +
pads O -
; O +
AI O -
, O +
adiposity O +
index O +
( O -
TF O -
/ O -
body O +
weight*100 O -
) O +
and O +
BMI O -
, O +
body O +
mass O +
index O +
( O -
body O +
weight O +
at O +
sacrifice O -
/ O -
NA2 O +
* O -
100 O -
) O -
. O +

Values O +
are O +
expressed O +
as O +
least O +
square O +
means O +
( O -
LSMEANS O -
) O +
± O +
SEM O -
. O +

LSMEANS O +
in O +
bold O +
are O +
significantly O +
different O +
than O +
the O +
control O +
( O -
HGC O -
) O +
( O -
critical O +
P O +
< O +
0.005 O -
) O +
after O +
Bonferroni O +
correction O +
within O +
each O +
sex O -
. O +

Table O +
6 O +
Carcass O +
composition O +
phenotypes O +
of O +
HG.CAST O +
speed O +
congenic O +
strains O +
H2O B-Chemical -
, O +
carcass O +
water B-Chemical -
; O +
% O -
H2O B-Chemical -
, O +
water B-Chemical +
as O +
a O +
percent O +
of O +
carcass O +
weight O -
; O +
FAT O -
, O +
carcass O +
fat O -
; O +
% O -
FAT O -
, O +
fat O +
as O +
a O +
percent O +
of O +
carcass O +
weight O -
; O +
ASH O -
, O +
carcass O +
ash O -
; O +
% O -
ASH O -
, O +
ash O +
as O +
a O +
percent O +
of O +
carcass O +
weight O -
; O +
PROT O -
, O +
carcass O +
protein O -
, O +
% O -
PROT O -
, O +
protein O +
as O +
a O +
percent O +
of O +
carcass O +
weight O -
. O +

Values O +
are O +
expressed O +
as O +
least O +
square O +
means O +
( O -
LSMEANS O -
) O +
± O +
SEM O -
. O +

LSMEANS O +
in O +
bold O +
are O +
significantly O +
different O +
than O +
the O +
control O +
( O -
HGC O -
) O +
( O -
critical O +
P O +
< O +
0.0125 O -
) O +
after O +
Bonferroni O +
correction O +
within O +
each O +
sex O -
. O +

Table O +
7 O +
Nonsynonymous O +
SNP O +
in O +
MMU2 O -
, O +
9 O +
and O +
17 O +
hg O +
modifier O +
candidate O +
genes O +
predicted O +
by O +
SIFT O +
and O +
Polyphen O +
to O +
alter O +
protein O +
function O +
MMU O -
, O +
mouse O +
chromosome O -
; O +
AA O -
, O +
amino O +
acid O -
; O +
PBD O -
, O +
probably O +
damaging O -
, O +
PSD O -
, O +
possibly O +
damaging O -
; O +
B O -
, O +
Benign O -
; O +
T O -
, O +
tolerated O +
and O +
D O -
, O +
deleterious O -
. O +

a O +
Amino O +
acid O +
change O -
, O +
first O +
residue O +
listed O +
corresponds O +
to O +
the O +
CAST O +
allele O +
and O +
second O +
corresponds O +
to O +
the O +
B6 O +
allele O -
. O +

b O +
Indicates O +
which O +
allele O +
was O +
designated O +
as O +
" O -
mutant O -
" O -
, O +
i.e. O +
B6 O -
/ O -
CAST O -
, O +
B6 O +
allele O +
is O +
mutant O +
and O +
CAST O +
is O +
wild O +
type O -
. O +

Fgf9 O +
and O +
Wnt4 O +
Act O +
as O +
Antagonistic O +
Signals O +
to O +
Regulate O +
Mammalian O +
Sex O +
Determination O +
Abstract O +
The O +
genes O +
encoding O +
members O +
of O +
the O +
wingless O -
- O -
related O +
MMTV O +
integration O +
site O +
( O -
WNT O -
) O +
and O +
fibroblast O +
growth O +
factor O +
( O -
FGF O -
) O +
families O +
coordinate O +
growth O -
, O +
morphogenesis O -
, O +
and O +
differentiation O +
in O +
many O +
fields O +
of O +
cells O +
during O +
development O -
. O +

In O +
the O +
mouse O -
, O +
Fgf9 O +
and O +
Wnt4 O +
are O +
expressed O +
in O +
gonads O +
of O +
both O +
sexes O +
prior O +
to O +
sex O +
determination O -
. O +

Loss O +
of O +
Fgf9 O +
leads O +
to O +
XY O +
sex O +
reversal O -
, O +
whereas O +
loss O +
of O +
Wnt4 O +
results O +
in O +
partial O +
testis O +
development O +
in O +
XX O +
gonads O -
. O +

However O -
, O +
the O +
relationship O +
between O +
these O +
signals O +
and O +
the O +
male O +
sex O -
- O -
determining O +
gene O -
, O +
Sry O -
, O +
was O +
unknown O -
. O +

We O +
show O +
through O +
gain- O +
and O +
loss O -
- O -
of O -
- O -
function O +
experiments O +
that O +
fibroblast O +
growth O +
factor O +
9 O +
( O -
FGF9 O -
) O +
and O +
WNT4 O +
act O +
as O +
opposing O +
signals O +
to O +
regulate O +
sex O +
determination O -
. O +

In O +
the O +
mouse O +
XY O +
gonad O -
, O +
Sry O +
normally O +
initiates O +
a O +
feed O -
- O -
forward O +
loop O +
between O +
Sox9 O +
and O +
Fgf9 O -
, O +
which O +
up O -
- O -
regulates O +
Fgf9 O +
and O +
represses O +
Wnt4 O +
to O +
establish O +
the O +
testis O +
pathway O -
. O +

Surprisingly O -
, O +
loss O +
of O +
Wnt4 O +
in O +
XX O +
gonads O +
is O +
sufficient O +
to O +
up O -
- O -
regulate O +
Fgf9 O +
and O +
Sox9 O +
in O +
the O +
absence O +
of O +
Sry O -
. O +

These O +
data O +
suggest O +
that O +
the O +
fate O +
of O +
the O +
gonad O +
is O +
controlled O +
by O +
antagonism O +
between O +
Fgf9 O +
and O +
Wnt4 O -
. O +

The O +
role O +
of O +
the O +
male O +
sex O -
- O -
determining O +
switch O -
— O -
Sry O +
in O +
the O +
case O +
of O +
mammals O -
— O -
is O +
to O +
tip O +
the O +
balance O +
between O +
these O +
underlying O +
patterning O +
signals O -
. O +

In O +
principle O -
, O +
sex O +
determination O +
in O +
other O +
vertebrates O +
may O +
operate O +
through O +
any O +
switch O +
that O +
introduces O +
an O +
imbalance O +
between O +
these O +
two O +
signaling O +
pathways O -
. O +

Introduction O +
The O +
development O +
of O +
sexually O +
dimorphic O +
reproductive O +
organs O +
is O +
a O +
common O +
feature O +
among O +
animal O +
species O -
. O +

The O +
testis O +
and O +
ovary O +
represent O +
two O +
divergent O +
pathways O +
of O +
development O +
from O +
the O +
bipotential O +
embryonic O +
gonad O -
. O +

The O +
switch O +
that O +
initiates O +
divergent O +
development O +
of O +
the O +
gonad O +
is O +
highly O +
diverse O +
among O +
species O -
; O +
however O -
, O +
the O +
underlying O +
mechanisms O +
that O +
lead O +
to O +
the O +
establishment O +
of O +
ovary O +
or O +
testis O +
pathways O +
are O +
likely O +
to O +
be O +
conserved O -
. O +

In O +
all O +
species O -
, O +
the O +
embryonic O +
gonad O +
is O +
made O +
up O +
of O +
a O +
mixed O +
population O +
of O +
germ O +
cells O +
and O +
somatic O +
cells O -
. O +

This O +
tissue O +
is O +
remarkable O +
in O +
that O +
all O +
of O +
its O +
cells O +
are O +
believed O +
to O +
be O +
bipotential O -
, O +
and O +
can O +
differentiate O +
into O +
ovarian O +
or O +
testicular O +
lineages O +
[ O -
1,2 O -
] O -
. O +

Consistent O +
with O +
the O +
idea O +
that O +
cells O +
in O +
this O +
primordium O +
are O +
poised O +
between O +
two O +
developmental O +
pathways O -
, O +
some O +
of O +
the O +
genes O +
that O +
are O +
involved O +
in O +
establishing O +
sexual O +
dimorphism O -
, O +
including O +
Dax1 O +
( O -
dosage O -
- O -
sensitive O +
sex O +
reversal O -
- O -
congenital O +
adrenal O +
hypoplasia O +
critical O +
region O +
on O +
the O +
X O +
chromosome O +
protein O +
1 O -
) O -
, O +
Sox9 O +
( O -
Sry O -
- O -
like O +
HMG O +
box O +
9 O -
) O -
, O +
Fgf9 O +
( O -
fibroblast O +
growth O +
factor O +
9 O -
) O -
, O +
and O +
Wnt4 O +
( O -
wingless O -
- O -
related O +
MMTV O +
integration O +
site O +
4 O -
) O -
, O +
are O +
initially O +
expressed O +
in O +
similar O +
patterns O +
in O +
XX O +
and O +
XY O +
gonads O +
[ O -
3–8 O -
] O -
. O +

The O +
conventional O +
view O +
of O +
mammalian O +
sex O +
determination O +
is O +
that O +
the O +
basic O +
pathway O +
of O +
organ O +
development O +
is O +
ovarian O -
, O +
and O +
that O +
the O +
testis O -
- O -
determining O +
gene O +
operates O +
by O +
diverting O +
this O +
program O +
toward O +
testis O +
development O +
by O +
simultaneously O +
influencing O +
the O +
fate O +
of O +
the O +
key O +
supporting O +
cell O +
lineage O +
and O +
initiating O +
a O +
male O -
- O -
specific O +
morphogenetic O +
program O -
. O +

All O +
of O +
the O +
experimental O +
evidence O +
suggests O +
that O +
these O +
two O +
processes O +
are O +
closely O +
interwoven O -
. O +

For O +
example O -
, O +
both O +
proliferation O +
[ O -
9 O -
] O +
and O +
migration O +
of O +
cells O +
to O +
trigger O +
testis O +
cord O +
formation O +
[ O -
10,11 O -
] O +
appear O +
to O +
be O +
closely O +
integrated O +
with O +
Sertoli O +
cell O +
differentiation O -
. O +

Sry O -
, O +
a O +
Y O +
chromosome O -
- O -
linked O +
gene O -
, O +
is O +
the O +
primary O +
sex O -
- O -
determining O +
gene O +
in O +
mammals O +
[ O -
12–14 O -
] O -
. O +

In O +
the O +
absence O +
of O +
Sry O +
expression O -
— O -
in O +
XX O +
embryos O -
, O +
or O +
in O +
XY O +
embryos O +
carrying O +
a O +
deletion O +
of O +
Sry O -
— O -
cells O +
in O +
the O +
gonad O +
follow O +
an O +
ovarian O +
differentiation O +
pathway O -
. O +

Genetic O +
evidence O +
from O +
chimeric O +
mice O +
[ O -
15 O -
] O -
, O +
and O +
expression O +
studies O +
using O +
reporter O +
transgenes O +
[ O -
2,16 O -
] O -
, O +
indicate O +
that O +
Sry O +
expression O +
is O +
required O +
only O +
in O +
precursors O +
of O +
the O +
somatic O +
supporting O +
cell O +
lineage O -
. O +

Expression O +
of O +
Sry O +
in O +
these O +
bipotential O +
cells O +
leads O +
to O +
their O +
differentiation O +
as O +
testis O -
- O -
specific O +
Sertoli O +
cells O +
rather O +
than O +
as O +
follicle O +
cells O -
, O +
the O +
parallel O +
cell O +
type O +
of O +
the O +
ovary O +
[ O -
2 O -
] O -
. O +

It O +
is O +
believed O +
that O +
the O +
Sertoli O +
cell O +
is O +
the O +
first O +
cell O +
type O +
to O +
differentiate O +
in O +
the O +
gonad O +
[ O -
17 O -
] O -
. O +

There O +
is O +
substantial O +
evidence O +
that O +
a O +
critical O +
threshold O +
number O +
of O +
Sertoli O +
cells O +
is O +
required O +
to O +
establish O +
testis O +
differentiation O +
[ O -
9,15,18–20 O -
] O -
. O +

In O +
cases O +
where O +
this O +
threshold O +
is O +
not O +
reached O -
, O +
ovary O +
differentiation O +
ensues O -
. O +

Once O +
Sry O +
expression O +
begins O -
, O +
expression O +
patterns O +
of O +
other O +
genes O +
in O +
the O +
gonad O +
begin O +
to O +
diverge O -
. O +

The O +
first O +
gene O +
downstream O +
of O +
Sry O +
known O +
to O +
show O +
male O -
- O -
specific O +
up O -
- O -
regulation O +
in O +
Sertoli O +
cell O +
precursors O +
is O +
a O +
related O +
gene O +
expressed O +
in O +
many O +
tissues O +
in O +
the O +
developing O +
embryo O -
, O +
Sox9 O -
. O +

Disruption O +
of O +
Sox9 O +
expression O +
in O +
the O +
XY O +
gonad O +
causes O +
male O -
- O -
to O -
- O -
female O +
sex O +
reversal O +
[ O -
21,22 O -
] O -
, O +
whereas O +
increasing O +
the O +
dose O +
of O +
Sox9 O +
in O +
the O +
XX O +
gonad O +
leads O +
to O +
testis O +
development O +
[ O -
23–25 O -
] O -
. O +

These O +
studies O +
indicate O +
that O +
Sox9 O +
plays O +
a O +
central O +
role O +
in O +
sex O +
determination O -
. O +

Unlike O +
Sry O -
, O +
which O +
is O +
specific O +
to O +
mammals O -
, O +
expression O +
of O +
Sox9 O +
is O +
known O +
to O +
be O +
conserved O +
in O +
the O +
gonad O +
of O +
many O +
species O -
. O +

In O +
mammals O -
, O +
Sox9 O +
is O +
up O -
- O -
regulated O +
immediately O +
after O +
Sry O +
expression O +
initiates O -
. O +

Experiments O +
tracing O +
Sry O -
- O -
expressing O +
cells O +
using O +
a O +
stable O +
reporter O +
demonstrated O +
that O +
once O +
testis O +
differentiation O +
is O +
established O -
, O +
all O +
Sertoli O +
cells O +
that O +
express O +
Sox9 O +
are O +
descendants O +
of O +
cells O +
that O +
have O +
expressed O +
Sry O +
[ O -
16 O -
] O -
, O +
suggesting O +
that O +
activation O +
of O +
Sox9 O +
is O +
a O +
cell O -
- O -
autonomous O +
effect O +
of O +
Sry O -
. O +

However O -
, O +
mutations O +
in O +
several O +
signaling O +
pathways O +
including O +
Fgf9 O +
and O +
Igf1r O -
/ O -
Irr O -
/ O -
Ir O +
( O -
insulin O -
- O -
like O +
growth O +
factor O +
1 O +
receptor O -
/ O -
insulin O +
receptor O -
- O -
related O +
receptor O -
/ O -
insulin O +
receptor O -
) O +
resulted O +
in O +
loss O +
of O +
Sox9 O +
expression O +
and O +
partial O +
or O +
complete O +
sex O +
reversal O +
[ O -
26,27 O -
] O -
, O +
suggesting O +
that O +
extracellular O +
signaling O +
pathways O +
play O +
a O +
significant O +
role O +
during O +
primary O +
sex O +
determination O -
. O +

Mice O +
homozygous O +
for O +
a O +
null O +
mutation O +
in O +
Fgf9 O +
display O +
male O -
- O -
to O -
- O -
female O +
sex O +
reversal O +
caused O +
by O +
disruption O +
of O +
all O +
testis O -
- O -
specific O +
cellular O +
events O -
, O +
including O +
cell O +
proliferation O -
, O +
mesonephric O +
cell O +
migration O -
, O +
testis O +
cord O +
formation O -
, O +
and O +
the O +
differentiation O +
of O +
Sertoli O +
cells O +
[ O -
26,27 O -
] O -
. O +

Fgf9 O -
, O +
like O +
many O +
of O +
the O +
founding O +
signals O +
in O +
the O +
gonads O -
, O +
is O +
initially O +
expressed O +
in O +
gonads O +
of O +
both O +
sexes O -
, O +
but O +
becomes O +
male O -
- O -
specific O +
after O +
Sry O +
is O +
expressed O -
. O +

In O +
a O +
reciprocal O +
manner O -
, O +
expression O +
of O +
Wnt4 O -
, O +
which O +
is O +
also O +
initially O +
common O +
to O +
gonads O +
of O +
both O +
sexes O -
, O +
becomes O +
female O -
- O -
specific O +
[ O -
8 O -
] O -
. O +

XX O +
gonads O +
with O +
a O +
null O +
mutation O +
in O +
Wnt4 O +
display O +
some O +
obvious O +
aspects O +
of O +
testicular O +
differentiation O +
[ O -
28 O -
] O -
. O +

Based O +
on O +
the O +
theory O +
that O +
Sertoli O +
cells O +
initiate O +
all O +
downstream O +
testicular O +
differentiation O -
, O +
this O +
might O +
imply O +
that O +
Sertoli O +
differentiation O +
had O +
been O +
initiated O +
in O +
Wnt4− O -
/ O -
− O +
XX O +
gonads O -
. O +

However O -
, O +
expression O +
of O +
Sertoli O +
cell O +
markers O +
was O +
not O +
previously O +
detected O +
in O +
these O +
mutants O +
during O +
fetal O +
stages O +
[ O -
8,29 O -
] O -
, O +
leading O +
to O +
the O +
conclusion O +
that O +
Wnt4 O +
was O +
not O +
involved O +
in O +
primary O +
sex O +
determination O +
in O +
the O +
gonad O -
. O +

To O +
integrate O +
these O +
findings O -
, O +
we O +
investigated O +
the O +
genetic O +
relationship O +
of O +
Sry O -
, O +
Sox9 O -
, O +
Fgf9 O -
, O +
and O +
Wnt4 O +
in O +
the O +
regulatory O +
network O +
that O +
governs O +
the O +
gonadal O +
field O -
. O +

We O +
show O +
that O +
the O +
loss O +
of O +
Fgf9 O +
in O +
homozygous O +
mutant O +
XY O +
gonads O +
does O +
not O +
affect O +
the O +
expression O +
of O +
SRY O +
or O +
the O +
initial O +
up O -
- O -
regulation O +
of O +
SOX9 O -
; O +
however O -
, O +
SOX9 O +
expression O +
is O +
not O +
maintained O +
in O +
the O +
Fgf9− O -
/ O -
− O +
mutant O +
gonads O -
, O +
and O +
testis O +
differentiation O +
is O +
aborted O -
. O +

We O +
also O +
demonstrate O +
that O +
FGF9 O +
represses O +
the O +
ovary O -
- O -
promoting O +
gene O -
, O +
Wnt4 O -
. O +

We O +
hypothesize O +
that O +
FGF9 O +
functions O +
in O +
a O +
feed O -
- O -
forward O +
loop O +
to O +
expand O +
Sertoli O +
precursor O +
cells O -
, O +
which O +
secrete O +
FGF9 O -
, O +
to O +
a O +
critical O +
threshold O +
number O +
sufficient O +
to O +
suppress O +
Wnt4 O -
. O +

This O +
directly O +
or O +
indirectly O +
stabilizes O +
SOX9 O +
expression O +
and O +
secures O +
the O +
male O +
fate O +
of O +
the O +
gonad O -
. O +

WNT4 O +
seems O +
to O +
oppose O +
the O +
male O +
pathway O +
by O +
repressing O +
expression O +
of O +
SOX9 O +
and O +
FGF9 O -
. O +

Surprisingly O -
, O +
both O +
male O +
pathway O +
genes O +
are O +
transiently O +
activated O +
in O +
Wnt4− O -
/ O -
− O +
XX O +
gonads O +
in O +
the O +
absence O +
of O +
the O +
Y O -
- O -
linked O +
gene O +
Sry O -
. O +

Based O +
on O +
this O +
genetic O +
and O +
in O +
vitro O +
data O -
, O +
we O +
suggest O +
that O +
the O +
plasticity O +
of O +
the O +
bipotential O +
gonad O +
is O +
controlled O +
by O +
mutually O +
antagonistic O +
signals O +
between O +
FGF9 O +
and O +
WNT4 O +
in O +
the O +
gonadal O +
field O -
. O +

These O +
signals O +
coordinate O +
sexually O +
dimorphic O +
patterns O +
of O +
growth O -
, O +
morphogenesis O -
, O +
and O +
cellular O +
differentiation O -
. O +

Results O +
Early O +
Bipotential O +
Expression O +
of O +
FGF9 O +
Resolves O +
to O +
an O +
XY O -
- O -
Specific O +
Pattern O +
by O +
12.5 O +
dpc O +
Using O +
an O +
antibody O +
specific O +
to O +
FGF9 O -
, O +
we O +
examined O +
expression O +
during O +
normal O +
gonad O +
development O -
. O +

FGF9 O +
protein O +
was O +
distributed O +
throughout O +
the O +
11.5 O +
dpc O +
gonad O +
in O +
both O +
sexes O +
( O -
Figure O +
1A O +
and O +
1B O -
) O -
. O +

However O -
, O +
by O +
12.5 O +
dpc O -
, O +
FGF9 O +
was O +
detected O +
only O +
in O +
XY O +
gonads O +
in O +
two O +
domains O -
: O +
in O +
cells O +
near O +
the O +
surface O +
of O +
gonads O +
and O +
in O +
cells O +
located O +
within O +
testis O +
cords O -
. O +

This O +
sex O -
- O -
specific O +
expression O +
pattern O +
was O +
maintained O +
in O +
gonads O +
at O +
13.5 O +
dpc O +
( O -
Figure O +
1C–1F O -
) O -
. O +

FGF9 O +
expression O +
within O +
testis O +
cords O +
was O +
localized O +
to O +
Sertoli O +
cells O +
and O +
excluded O +
from O +
germ O +
cells O +
based O +
on O +
the O +
germ O +
cell O +
membrane O +
marker O +
platelet O -
/ O -
endothelial O +
cell O +
adhesion O +
molecule B-Chemical +
( O -
PECAM O -
) O +
( O -
Figure O +
1D O +
and O +
1F O -
) O -
. O +

To O +
confirm O +
this O +
result O -
, O +
we O +
examined O +
agametic O +
gonads O +
from O +
KitW O -
/ O -
Wv O +
compound O +
heterozygous O +
embryos O -
, O +
which O +
develop O +
testis O +
cords O +
containing O +
Sertoli O +
cells O +
only O -
. O +

FGF9 O +
was O +
detectable O +
at O +
normal O +
levels O +
in O +
testis O +
cords O +
in O +
XY O +
KitW O -
/ O -
Wv O +
gonads O -
, O +
where O +
alkaline O +
phosphatase O +
staining O +
verified O +
the O +
absence O +
of O +
germ O +
cells O +
( O -
Figure O +
1G–1J O -
) O -
, O +
indicating O +
that O +
FGF9 O +
is O +
expressed O +
by O +
Sertoli O +
cells O -
, O +
and O +
that O +
its O +
expression O +
is O +
not O +
dependent O +
on O +
the O +
presence O +
of O +
germ O +
cells O -
. O +

In O +
summary O -
, O +
FGF9 O +
expression O +
was O +
present O +
in O +
both O +
XX O +
and O +
XY O +
gonads O +
at O +
bipotential O +
stages O -
, O +
and O +
became O +
restricted O +
to O +
XY O +
gonads O +
as O +
testis O +
differentiation O +
proceeded O -
. O +

Sry O +
Expression O +
Is O +
Normal O +
in O +
Homozygous O +
Null O +
Fgf9 O +
XY O +
Gonads O +
The O +
early O +
expression O +
of O +
Fgf9 O +
in O +
bipotential O +
gonads O +
raised O +
the O +
question O +
of O +
whether O +
Fgf9 O +
is O +
an O +
upstream O +
regulator O +
of O +
Sry O -
. O +

To O +
investigate O +
this O +
possibility O -
, O +
we O +
mated O +
Fgf9+ O -
/ O -
− O +
mice O +
with O +
a O +
transgenic O +
reporter O +
line O +
that O +
carries O +
an O +
enhanced O +
green O +
fluorescent O +
protein O +
( O -
EGFP O -
) O +
transgene O +
driven O +
by O +
the O +
Sry O +
promoter O +
Sry O -
- O -
EGFP O -
. O +

At O +
early O +
stages O -
, O +
this O +
transgene O +
represents O +
the O +
pattern O +
of O +
endogenous O +
Sry O +
expression O +
[ O -
2 O -
] O -
. O +

The O +
expression O +
of O +
the O +
EGFP O +
reporter O +
was O +
detected O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
comparable O +
to O +
Fgf9+ O -
/ O -
− O +
littermate O +
controls O +
( O -
Figure O +
2A O +
and O +
2B O -
) O -
, O +
suggesting O +
that O +
transcriptional O +
regulation O +
of O +
Sry O +
is O +
independent O +
of O +
Fgf9 O -
. O +

Sex O +
reversal O +
is O +
caused O +
not O +
only O +
by O +
the O +
loss O +
of O +
normal O +
levels O +
of O +
Sry O +
expression O +
[ O -
30,31 O -
] O -
, O +
but O +
also O +
by O +
mutations O +
disrupting O +
SRY O +
import O +
into O +
the O +
nucleus O +
[ O -
32 O -
] O -
. O +

The O +
transgene O -
, O +
Sry O -
- O -
EGFP O -
, O +
does O +
not O +
reflect O +
the O +
intracellular O +
distribution O +
of O +
the O +
SRY O +
protein O -
. O +

To O +
investigate O +
this O +
aspect O +
of O +
SRY O +
regulation O -
, O +
we O +
bred O +
Fgf9+ O -
/ O -
− O +
mice O +
with O +
another O +
Sry O +
reporter O +
mouse O +
line O +
carrying O +
a O +
Myc O -
- O -
tagged O +
Sry O +
transgene O -
, O +
SryMyc O -
, O +
which O +
recapitulates O +
the O +
endogenous O +
intracellular O +
SRY O +
expression O +
pattern O +
[ O -
16 O -
] O -
. O +

Using O +
an O +
antibody O +
against O +
c O -
- O -
MYC O -
, O +
the O +
expression O +
and O +
nuclear O +
localization O +
of O +
SRYMYC O +
in O +
SryMyc O -
; O +
Fgf9− O -
/ O -
− O +
gonads O +
was O +
indistinguishable O +
from O +
littermate O +
controls O +
( O -
Figure O +
2C O +
and O +
2D O -
) O -
. O +

These O +
data O +
using O +
two O +
different O +
Sry O +
transgenic O +
reporter O +
lines O +
provide O +
evidence O +
that O +
Sry O +
expression O +
is O +
not O +
dependent O +
on O +
Fgf9 O -
. O +

Therefore O -
, O +
Fgf9 O +
signaling O +
must O +
act O +
in O +
parallel O +
and/or O +
downstream O +
of O +
Sry O +
to O +
regulate O +
testis O +
development O -
. O +

FGF9 O +
Can O +
Up O -
- O -
Regulate O +
SOX9 O +
Expression O +
In O +
our O +
previous O +
study O +
we O +
did O +
not O +
observe O +
SOX9 O +
expression O +
at O +
12.5 O +
dpc O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
that O +
fail O +
to O +
develop O +
into O +
normal O +
testes O +
[ O -
26 O -
] O -
. O +

However O -
, O +
the O +
loss O +
of O +
SOX9 O +
expression O +
at O +
12.5 O +
dpc O +
could O +
be O +
a O +
consequence O +
of O +
the O +
loss O +
of O +
Sertoli O +
differentiation O +
rather O +
than O +
a O +
reflection O +
of O +
the O +
genetic O +
interaction O +
between O +
FGF9 O +
and O +
SOX9 O -
. O +

Normally O -
, O +
Sox9 O +
is O +
weakly O +
expressed O +
in O +
wild O -
- O -
type O +
genital O +
ridges O +
of O +
both O +
XX O +
and O +
XY O +
embryos O +
at O +
10.5 O +
dpc O +
and O -
, O +
after O +
the O +
onset O +
of O +
Sry O +
expression O -
, O +
is O +
up O -
- O -
regulated O +
in O +
XY O +
gonads O +
[ O -
5,33,16 O -
] O -
. O +

As O +
results O +
indicated O +
that O +
Fgf9 O +
functioned O +
downstream O +
of O -
, O +
or O +
in O +
parallel O +
with O +
Sry O -
, O +
we O +
investigated O +
whether O +
Fgf9 O +
was O +
involved O +
in O +
the O +
up O -
- O -
regulation O +
of O +
Sox9 O +
expression O -
. O +

Primary O +
cell O +
culture O +
and O +
gonad O +
culture O +
systems O +
were O +
used O +
to O +
assess O +
Sox9 O +
activation O +
by O +
exogenous O +
FGF9 O -
. O +

For O +
in O +
vitro O +
cell O +
culture O -
, O +
cells O +
were O +
isolated O +
from O +
11.5 O +
dpc O +
gonads O +
free O +
of O +
mesonephroi O -
, O +
and O +
cultured O +
on O +
extracellular O +
matrix O -
- O -
coated O +
coverslips O +
with O +
or O +
without O +
addition O +
of O +
purified O +
FGF9 O +
in O +
culture O +
media O -
. O +

After O +
culture O +
for O +
24 O +
h O -
, O +
SOX9 O +
expression O +
was O +
monitored O +
by O +
an O +
antibody O +
specific O +
to O +
SOX9 O +
in O +
XX O +
cells O +
and O +
control O +
XY O +
cells O -
. O +

Exogenous O +
FGF9 O +
increased O +
cell O +
number O +
in O +
XX O +
and O +
XY O +
cell O +
cultures O +
compared O +
with O +
cells O +
in O +
a O +
duplicate O +
culture O +
without O +
FGF9 O +
treatment O +
( O -
unpublished O +
data O -
) O -
, O +
and O +
caused O +
the O +
up O -
- O -
regulation O +
of O +
SOX9 O +
in O +
XX O +
cells O +
( O -
Figure O +
2E–2H O -
) O -
. O +

Up O -
- O -
regulation O +
of O +
SOX9 O +
had O +
not O +
previously O +
been O +
seen O +
in O +
whole O +
XX O +
gonads O +
cultured O +
with O +
exogenous O +
FGF9 O +
[ O -
9 O -
] O -
. O +

To O +
explain O +
the O +
difference O +
between O +
experimental O +
results O +
from O +
dissociated O +
XX O +
gonadal O +
cells O +
and O +
XX O +
gonads O -
, O +
we O +
reasoned O +
that O +
the O +
local O +
concentrations O +
of O +
FGF9 O +
might O +
not O +
be O +
high O +
enough O +
to O +
override O +
blocking O +
signals O +
in O +
the O +
intact O +
XX O +
gonad O -
, O +
or O +
that O +
active O +
FGF9 O +
was O +
not O +
efficiently O +
localized O +
or O +
presented O +
in O +
the O +
extracellular O +
matrix O +
of O +
the O +
XX O +
gonad O -
. O +

To O +
test O +
the O +
local O +
effect O +
of O +
FGF9 O -
, O +
we O +
modified O +
the O +
XX O +
gonad O +
culture O +
by O +
stably O +
immobilizing O +
FGF9 O -
, O +
or O +
BSA O +
as O +
a O +
control O -
, O +
on O +
beads O +
( O -
Figure O +
2I–2 O -
K O -
) O -
. O +

Under O +
these O +
conditions O -
, O +
SOX9 O +
expression O +
was O +
up O -
- O -
regulated O +
locally O +
in O +
cells O +
near O +
the O +
surface O +
of O +
the O +
XX O +
gonad O +
in O +
contact O +
with O +
the O +
FGF9 O +
bead O +
( O -
Figure O +
2 O -
K O -
) O -
. O +

Taken O +
together O -
, O +
these O +
in O +
vitro O +
data O +
demonstrate O +
that O +
ectopic O +
FGF9 O +
signaling O +
can O +
induce O +
SOX9 O +
expression O +
in O +
XX O +
gonadal O +
cells O -
, O +
suggesting O +
a O +
positive O +
interaction O +
between O +
Fgf9 O +
and O +
Sox9 O -
. O +

Fgf9 O +
Is O +
Required O +
for O +
Maintaining O +
SOX9 O +
Expression O +
in O +
XY O +
Gonads O +
To O +
investigate O +
whether O +
Fgf9 O +
is O +
essential O +
for O +
the O +
up O -
- O -
regulation O +
of O +
Sox9 O +
in O +
vivo O -
, O +
we O +
assessed O +
SOX9 O +
expression O +
in O +
loss O -
- O -
of O -
- O -
function O +
Fgf9+ O -
/ O -
− O +
and O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
at O +
11.5–12.5 O +
dpc O +
( O -
Figure O +
3A–3F O -
) O -
. O +

In O +
wild O -
- O -
type O +
and O +
heterozygous O +
mutant O +
XY O +
gonads O +
at O +
11.5 O +
dpc O -
, O +
SOX9 O +
was O +
detected O +
in O +
a O +
small O +
number O +
of O +
cells O +
in O +
the O +
gonad O +
( O -
Figure O +
3A O -
) O -
. O +

Over O +
the O +
next O +
6 O +
h O +
of O +
development O -
, O +
nuclear O +
SOX9 O +
accumulated O +
rapidly O +
in O +
cells O +
toward O +
the O +
cortex O +
and O +
the O +
anterior O +
and O +
posterior O +
poles O +
of O +
the O +
gonad O -
, O +
replicating O +
patterns O +
previously O +
reported O +
for O +
both O +
Sry O +
and O +
Sox9 O +
expression O +
[ O -
2,16,34–36 O -
] O -
. O +

This O +
unique O +
pattern O +
was O +
also O +
observed O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
( O -
Figure O +
3D O +
and O +
3E O -
) O -
. O +

Somatic O +
cells O +
within O +
Fgf9− O -
/ O -
− O +
gonads O +
were O +
positive O +
for O +
SOX9 O +
at O +
11.5 O +
dpc O -
, O +
the O +
earliest O +
stages O +
examined O -
, O +
demonstrating O +
that O +
initial O +
expression O +
and O +
up O -
- O -
regulation O +
of O +
SOX9 O +
were O +
not O +
disrupted O +
in O +
Fgf9− O -
/ O -
− O +
mutant O +
XY O +
gonads O +
prior O +
to O +
12.0 O +
dpc O -
. O +

Notably O -
, O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O -
, O +
SOX9 O +
was O +
no O +
longer O +
detectable O +
by O +
12.5 O +
dpc O -
, O +
and O +
Sertoli O +
precursor O +
cells O +
never O +
began O +
to O +
organize O +
into O +
normal O +
testis O +
cord O +
structures O +
( O -
Figure O +
3F O -
) O -
. O +

These O +
data O +
indicate O +
that O +
although O +
Fgf9 O +
is O +
not O +
required O +
for O +
the O +
up O -
- O -
regulation O +
of O +
Sox9 O +
in O +
vivo O -
, O +
it O +
is O +
indispensable O +
to O +
maintain O +
Sox9 O +
expression O +
in O +
Sertoli O +
precursor O +
cells O -
. O +

Sox9 O +
Is O +
Required O +
for O +
Fgf9 O +
Up O -
- O -
Regulation O +
in O +
XY O +
Gonads O +
We O +
hypothesized O +
that O +
if O +
the O +
linear O +
relationship O +
among O +
the O +
three O +
genes O +
were O +
Sry O +
→ O +
Fgf9 O +
→ O +
Sox9 O -
, O +
expression O +
of O +
Fgf9 O +
would O +
be O +
normal O +
in O +
XY O +
gonads O +
in O +
the O +
absence O +
of O +
Sox9 O -
. O +

Alternatively O -
, O +
if O +
the O +
relationship O +
were O +
Sry O +
→ O +
Sox9 O +
→ O +
Fgf9 O -
, O +
expression O +
of O +
Fgf9 O +
should O +
be O +
reduced O +
or O +
absent O +
in O +
XY O +
gonads O +
in O +
the O +
absence O +
of O +
Sox9 O -
. O +

We O +
examined O +
Fgf9 O +
expression O +
in O +
Sox9 O +
homozygous O +
mutant O +
( O -
Sox9Δ O -
/ O -
Δ O -
) O +
XY O +
gonads O +
generated O +
by O +
crossing O +
mice O +
homozygous O +
for O +
a O +
conditional O +
null O +
( O -
flox O -
) O +
allele O +
of O +
Sox9 O +
( O -
Sox9flox O -
/ O -
flox O -
) O +
with O +
mice O +
carrying O +
germline O -
- O -
specific O +
Cre O +
transgenes O -
, O +
Prm1-Cre O +
in O +
male O +
and O +
Zp3-Cre O +
in O +
female O +
[ O -
22,37 O -
] O -
. O +

The O +
Sox9 O +
null O +
mutant O +
embryos O +
die O +
after O +
11.5 O +
dpc O +
because O +
of O +
cardiovascular O +
defects O +
[ O -
37 O -
] O -
. O +

Chaboissier O +
et O +
al. O +
[ O -
22 O -
] O +
successfully O +
cultured O +
11.5 O +
dpc O +
Sox9 O +
null O +
mutant O +
gonads O +
in O +
vitro O +
and O +
detected O +
male O +
and O +
female O +
markers O +
after O +
2–3 O +
d O +
of O +
culture O -
, O +
suggesting O +
that O +
Sox9 O +
mutant O +
gonads O +
are O +
viable O +
and O +
developmentally O +
competent O +
at O +
11.5 O +
dpc O -
— O -
the O +
time O +
point O +
at O +
which O +
we O +
collected O +
samples O +
to O +
perform O +
mRNA O +
in O +
situ O +
hybridization O +
( O -
Figure O +
3G–3J O -
) O -
. O +

The O +
expression O +
of O +
Fgf9 O +
was O +
significantly O +
decreased O +
or O +
absent O +
in O +
XY O +
Sox9Δ O -
/ O -
Δ O +
gonads O +
at O +
11.5 O +
dpc O +
( O -
Figure O +
3J O -
) O -
, O +
while O +
Sry O +
expression O +
was O +
similar O +
to O +
wild O -
- O -
type O +
( O -
Figure O +
3 O -
G O +
and O +
3H O -
) O -
, O +
as O +
previously O +
reported O +
[ O -
20 O -
] O -
, O +
suggesting O +
that O +
Fgf9 O +
expression O +
in O +
wild O -
- O -
type O +
XY O +
gonads O +
is O +
dependent O +
on O +
the O +
expression O +
of O +
Sox9 O -
. O +

These O +
findings O +
also O +
indicate O +
that O +
expression O +
of O +
Sry O +
is O +
not O +
sufficient O +
to O +
regulate O +
Fgf9 O +
in O +
the O +
absence O +
of O +
Sox9 O -
. O +

Therefore O -
, O +
we O +
conclude O +
that O +
Sox9 O +
is O +
essential O +
for O +
Fgf9 O +
expression O -
, O +
and O +
Fgf9 O -
, O +
in O +
return O -
, O +
maintains O +
Sox9 O +
expression O -
, O +
generating O +
a O +
positive O +
feed O -
- O -
forward O +
loop O +
between O +
these O +
two O +
genes O +
in O +
XY O +
gonads O -
. O +

Like O +
Fgf9 O +
Mutant O +
Gonads O -
, O +
Sox9Δ O -
/ O -
Δ O +
XY O +
Gonads O +
Show O +
Defects O +
in O +
Cell O +
Proliferation O +
We O +
previously O +
reported O +
that O +
XY O -
- O -
specific O +
cell O +
proliferation O +
is O +
defective O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
[ O -
7 O -
] O -
. O +

Because O +
Sox9 O +
acts O +
as O +
a O +
positive O +
regulator O +
of O +
Fgf9 O +
expression O -
, O +
we O +
questioned O +
whether O +
cell O +
proliferation O +
in O +
XY O +
gonads O +
was O +
also O +
compromised O +
by O +
the O +
loss O +
of O +
Sox9 O -
. O +

We O +
examined O +
proliferation O +
in O +
Sox9Δ O -
/ O -
Δ O +
gonads O +
at O +
11.5 O +
dpc O +
using O +
a O +
mitotic O +
cell O +
marker O -
, O +
phosphorylated O +
histone B-Chemical +
H3 O -
. O +

Proliferating O +
cells O +
were O +
more O +
abundant O +
and O +
concentrated O +
in O +
a O +
domain O +
near O +
the O +
surface O +
of O +
wild O -
- O -
type O +
XY O +
gonads O -
, O +
and O +
this O +
XY O -
- O -
specific O +
cell O +
proliferation O +
was O +
evident O +
in O +
XY O +
Sox9flox O -
/ O -
Δ O +
littermate O +
controls O +
( O -
Figure O +
3 O -
K O -
) O -
. O +

However O -
, O +
in O +
Sox9Δ O -
/ O -
Δ O +
XY O +
gonads O +
proliferation O +
was O +
reduced O +
and O +
similar O +
to O +
XX O +
gonads O +
( O -
Figure O +
3L–3O O -
) O -
. O +

This O +
result O +
supports O +
the O +
idea O +
that O +
there O +
is O +
a O +
mutual O +
interdependence O +
between O +
Sox9 O +
and O +
Fgf9 O +
generating O +
a O +
positive O +
feed O -
- O -
forward O +
loop O -
, O +
and O +
that O +
both O +
genes O +
are O +
required O +
for O +
the O +
expansion O +
of O +
somatic O +
cells O -
, O +
including O +
Sertoli O +
cell O +
precursors O -
, O +
in O +
XY O +
gonads O -
. O +

The O +
Male O +
Pathway O +
Is O +
Aborted O +
in O +
Fgf9− O -
/ O -
− O +
Sertoli O +
Precursors O +
Based O +
on O +
the O +
fact O +
that O +
Sox9 O +
is O +
initially O +
expressed O +
in O +
Fgf9− O -
/ O -
− O +
gonads O -
, O +
we O +
investigated O +
whether O +
other O +
genes O +
in O +
the O +
male O +
pathway O +
are O +
activated O -
. O +

We O +
examined O +
two O +
markers O +
for O +
Sertoli O +
cell O +
differentiation O -
, O +
anti O -
- O -
Mullerian O +
hormone O +
( O -
Amh O -
) O +
[ O -
38 O -
] O +
and O +
Desert O +
hedgehog O +
( O -
Dhh O -
) O +
[ O -
39 O -
] O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
using O +
whole O -
- O -
mount O +
in O +
situ O +
hybridization O -
. O +

Dhh O -
, O +
which O +
is O +
expressed O +
in O +
XY O +
wild O -
- O -
type O +
and O +
heterozygous O +
gonads O +
beginning O +
at O +
11.5 O +
dpc O -
, O +
was O +
absent O +
from O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O -
, O +
although O +
mesonephric O +
expression O +
was O +
still O +
detected O +
( O -
Figure O +
4A O +
and O +
4B O -
) O -
. O +

Amh O -
, O +
which O +
is O +
a O +
direct O +
transcriptional O +
target O +
of O +
SOX9 O +
activated O +
after O +
11.5 O +
dpc O +
[ O -
38,40 O -
] O -
, O +
was O +
detected O +
at O +
reduced O +
levels O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
at O +
12.5 O +
dpc O +
( O -
Figure O +
4C–4F O -
) O -
. O +

The O +
residual O +
level O +
of O +
Amh O +
suggested O +
that O +
the O +
transient O +
expression O +
of O +
SOX9 O +
in O +
Fgf9− O -
/ O -
− O +
gonads O +
at O +
11.5 O +
dpc O +
was O +
sufficient O +
to O +
activate O +
Amh O -
, O +
a O +
direct O +
downstream O +
target O -
. O +

However O -
, O +
the O +
absence O +
of O +
Dhh O +
indicated O +
that O +
not O +
all O +
Sertoli O +
pathways O +
are O +
initiated O -
. O +

The O +
initial O +
specification O +
of O +
Sertoli O +
cell O +
precursors O +
was O +
not O +
affected O +
by O +
the O +
loss O +
of O +
Fgf9 O -
, O +
as O +
evidenced O +
by O +
normal O +
Sry O +
and O +
Sox9 O +
expression O +
in O +
Fgf9− O -
/ O -
− O +
gonads O +
at O +
11.5 O +
dpc O +
( O -
Figures O +
2 O +
and O +
3D O -
) O -
. O +

However O -
, O +
SOX9 O +
expression O +
in O +
XY O +
Fgf9− O -
/ O -
− O +
gonads O +
rapidly O +
disappeared O +
( O -
Figure O +
3E O +
and O +
3F O -
) O -
, O +
and O +
other O +
Sertoli O +
markers O +
were O +
absent O +
or O +
severely O +
reduced O +
( O -
Figure O +
4A–4F O -
) O -
. O +

To O +
investigate O +
the O +
possibility O +
that O +
this O +
loss O +
was O +
due O +
to O +
cell O +
death O -
, O +
we O +
immunostained O +
XY O +
Fgf9− O -
/ O -
− O +
gonads O +
at O +
12.0 O +
dpc O -
— O -
a O +
time O +
point O +
at O +
which O +
SOX9-expressing O +
cells O +
were O +
declining O +
in O +
numbers O +
( O -
Figure O +
3E O -
) O -
—for O +
active O +
caspase-3 O -
, O +
an O +
apoptotic O +
cell O +
marker O -
. O +

Apoptotic O +
cells O +
were O +
not O +
observed O +
in O +
Fgf9− O -
/ O -
− O +
gonads O +
or O +
in O +
littermate O +
controls O +
at O +
12.0 O +
dpc O -
, O +
although O +
Fgf9− O -
/ O -
− O +
samples O +
showed O +
somewhat O +
increased O +
cell O +
death O +
in O +
mesonephric O +
tubules O +
and O +
ducts O -
, O +
another O +
site O +
of O +
Fgf9 O +
expression O +
( O -
Figure O +
4 O -
G O +
and O +
4H O -
) O -
. O +

These O +
data O +
suggested O +
that O +
the O +
loss O +
of O +
SOX9 O +
expression O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
was O +
not O +
caused O +
by O +
cell O +
death O +
but O +
by O +
the O +
disruption O +
of O +
FGF9 O -
/ O -
SOX9 O +
feed O -
- O -
forward O +
regulation O -
. O +

To O +
determine O +
whether O +
the O +
aborting O +
of O +
the O +
male O +
pathway O +
in O +
Fgf9− O -
/ O -
− O +
Sertoli O +
precursors O +
was O +
associated O +
with O +
the O +
transition O +
of O +
supporting O +
cells O +
from O +
male O +
to O +
female O +
differentiation O -
, O +
we O +
investigated O +
expression O +
of O +
Wnt4 O -
, O +
an O +
ovary O -
- O -
promoting O +
gene O -
. O +

At O +
12.5 O +
dpc O +
Wnt4 O +
was O +
up O -
- O -
regulated O +
in O +
XY O +
Fgf9− O -
/ O -
− O +
but O +
not O +
in O +
XY O +
Fgf9+ O -
/ O -
− O +
gonad O +
controls O +
( O -
Figure O +
4I–4 O -
K O -
) O -
. O +

This O +
result O +
suggests O +
that O +
Fgf9 O +
is O +
necessary O +
for O +
the O +
down O -
- O -
regulation O +
of O +
Wnt4 O +
in O +
differentiating O +
XY O +
gonads O +
at O -
/ O -
after O +
bipotential O +
stages O -
. O +

Fgf9 O +
and O +
Wnt4 O +
Antagonize O +
Each O +
Other O +
Our O +
finding O +
that O +
high O +
levels O +
of O +
Wnt4 O +
persist O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
implies O +
a O +
genetic O +
antagonism O +
specifically O +
between O +
Fgf9 O +
and O +
Wnt4 O -
, O +
as O +
both O +
SRY O +
and O +
SOX9 O +
are O +
initially O +
expressed O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
at O +
11.5 O +
dpc O -
, O +
yet O +
this O +
is O +
not O +
sufficient O +
to O +
down O -
- O -
regulate O +
Wnt4 O -
. O +

To O +
test O +
whether O +
exogenous O +
FGF9 O +
could O +
down O -
- O -
regulate O +
expression O +
of O +
Wnt4 O -
, O +
we O +
cultured O +
the O +
XX O +
gonad O -
/ O -
mesonephros O +
complex O +
with O +
or O +
without O +
FGF9 O +
protein O -
, O +
and O +
examined O +
Wnt4 O +
expression O +
by O +
whole O -
- O -
mount O +
in O +
situ O +
hybridization O -
. O +

Treatment O +
of O +
XX O +
gonads O +
with O +
exogenous O +
FGF9 O +
suppressed O +
the O +
normal O +
expression O +
of O +
Wnt4 O +
( O -
Figure O +
5A–5C O -
) O -
, O +
supporting O +
the O +
hypothesis O +
that O +
Fgf9 O -
, O +
rather O +
than O +
Sry O +
or O +
Sox9 O -
, O +
functions O +
to O +
down O -
- O -
regulate O +
Wnt4 O +
in O +
wild O -
- O -
type O +
XY O +
gonads O -
. O +

We O +
reasoned O +
that O +
if O +
FGF9 O +
and O +
WNT4 O +
do O +
act O +
as O +
opposing O +
signals O -
, O +
then O +
reduction O +
in O +
the O +
dose O +
of O +
Wnt4 O +
might O +
render O +
the O +
XX O +
gonad O +
more O +
susceptible O +
to O +
the O +
male O -
- O -
promoting O +
effects O +
of O +
exogenous O +
FGF9 O -
. O +

To O +
test O +
this O +
possibility O -
, O +
XX O +
Wnt4+ O -
/ O -
− O +
and O +
Wnt4+ O -
/ O -
+ O +
gonads O +
were O +
cultured O +
in O +
medium O +
with O +
or O +
without O +
FGF9 O -
, O +
and O +
were O +
examined O +
for O +
SOX9 O +
expression O +
( O -
Figure O +
5D–5 O -
G O -
) O -
. O +

We O +
found O +
that O +
FGF9 O +
induced O +
SOX9 O +
up O -
- O -
regulation O +
in O +
XX O +
Wnt4+ O -
/ O -
− O +
gonads O -
, O +
but O +
not O +
in O +
Wnt4+ O -
/ O -
+ O +
XX O +
gonads O +
( O -
Figure O +
5F O +
and O +
5 O -
G O -
) O -
. O +

These O +
results O +
demonstrate O +
antagonism O +
between O +
WNT4 O +
and O +
FGF9 O +
under O +
in O +
vitro O +
gain O -
- O -
of O -
- O -
function O +
conditions O -
. O +

To O +
test O +
antagonism O +
between O +
these O +
factors O +
under O +
loss O -
- O -
of O -
- O -
function O +
conditions O +
in O +
vivo O -
, O +
we O +
investigated O +
whether O +
Fgf9 O +
is O +
derepressed O +
in O +
the O +
absence O +
of O +
Wnt4 O +
( O -
Figure O +
6A–6C O -
) O -
. O +

Using O +
an O +
antibody O +
against O +
FGF9 O -
, O +
we O +
found O +
that O +
FGF9 O +
was O +
expressed O +
in O +
Wnt4− O -
/ O -
− O +
XX O +
gonads O +
but O +
not O +
in O +
Wnt4+ O -
/ O -
− O +
XX O +
controls O +
( O -
Figure O +
6B O +
and O +
6C O -
) O -
. O +

This O +
result O +
suggested O +
that O +
FGF9 O +
is O +
normally O +
down O -
- O -
regulated O +
by O +
WNT4 O +
in O +
XX O +
gonads O -
. O +

Given O +
our O +
finding O +
that O +
FGF9 O -
, O +
a O +
positive O +
regulator O +
of O +
Sox9 O -
, O +
is O +
derepressed O +
in O +
XX O +
Wnt4− O -
/ O -
− O +
gonads O -
, O +
we O +
asked O +
whether O +
expression O +
of O +
SOX9 O +
might O +
also O +
occur O +
in O +
XX O +
Wnt4− O -
/ O -
− O +
gonads O +
( O -
Figure O +
6D–6L O -
) O -
. O +

An O +
antibody O +
against O +
SOX9 O +
revealed O +
that O +
expression O +
was O +
initially O +
up O -
- O -
regulated O +
in O +
Wnt4− O -
/ O -
− O +
XX O +
gonads O +
at O +
11.5 O +
dpc O +
( O -
Figure O +
6F O +
and O +
6I O -
) O -
, O +
although O +
it O +
was O +
rapidly O +
down O -
- O -
regulated O +
by O +
12.0 O +
dpc O +
and O +
absent O +
at O +
12.5 O +
dpc O +
( O -
Figure O +
6I O +
and O +
6L O -
) O -
. O +

This O +
finding O +
was O +
confirmed O +
by O +
mRNA O +
in O +
situ O +
hybridization O -
, O +
which O +
also O +
detected O +
Sox9 O +
transcripts O +
in O +
11.5 O +
dpc O +
Wnt4− O -
/ O -
− O +
XX O +
gonads O +
( O -
Figure O +
S1 O -
) O -
. O +

Wnt4− O -
/ O -
− O +

XX O +
gonads O +
do O +
not O +
increase O +
in O +
size O +
comparable O +
to O +
normal O +
XY O +
gonads O +
( O -
Figure O +
6C O -
, O +
6F O -
, O +
6I O -
, O +
and O +
6L O -
) O -
, O +
and O +
Sertoli O +
cell O +
differentiation O +
and O +
testis O +
cord O +
formation O +
do O +
not O +
occur O -
. O +

Nevertheless O -
, O +
it O +
is O +
noteworthy O +
that O +
up O -
- O -
regulation O +
of O +
SOX9 O +
occurs O +
in O +
this O +
case O +
in O +
the O +
absence O +
of O +
Sry O -
, O +
by O +
eliminating O +
the O +
antagonistic O +
effect O +
of O +
Wnt4 O +
and O +
up O -
- O -
regulating O +
FGF9 O -
, O +
supporting O +
our O +
hypothesis O +
that O +
sex O +
determination O +
occurs O +
by O +
tipping O +
the O +
balance O +
between O +
these O +
two O +
opposing O +
signals O -
. O +

Discussion O +
Many O +
studies O +
support O +
the O +
view O +
that O +
cells O +
in O +
the O +
undifferentiated O +
gonad O +
are O +
bipotential O -
; O +
the O +
supporting O +
cell O +
precursor O +
lineage O +
can O +
develop O +
into O +
follicle O +
cells O +
or O +
Sertoli O +
cells O -
. O +

In O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O -
, O +
cells O +
initially O +
embark O +
on O +
the O +
Sertoli O +
pathway O -
, O +
but O +
in O +
the O +
absence O +
of O +
Fgf9 O +
can O +
neither O +
maintain O +
Sox9 O +
expression O +
nor O +
establish O +
downstream O +
male O +
pathways O -
. O +

The O +
loss O +
of O +
Sertoli O +
cells O +
in O +
XY O +
Fgf9− O -
/ O -
− O +
gonads O +
is O +
not O +
due O +
to O +
cell O +
death O -
, O +
but O +
instead O +
to O +
a O +
transition O +
of O +
supporting O +
cell O +
fate O +
as O +
SOX9 O +
expression O +
is O +
lost O -
. O +

We O +
suggest O +
that O +
in O +
the O +
absence O +
of O +
the O +
antagonizing O +
activity O +
of O +
FGF9 O -
, O +
WNT4 O +
signals O +
predominate O +
and O +
govern O +
somatic O +
cell O +
fate O +
in O +
the O +
gonadal O +
field O -
. O +

The O +
Drosophila O +
genital O +
disk O +
is O +
also O +
a O +
field O +
of O +
cells O +
that O +
normally O +
follows O +
one O +
of O +
two O +
sexually O +
dimorphic O +
fates O -
. O +

For O +
many O +
years O +
it O +
was O +
believed O +
that O +
the O +
fate O +
of O +
each O +
cell O +
in O +
the O +
genital O +
disk O +
was O +
under O +
the O +
cell O -
- O -
autonomous O +
control O +
of O +
double O +
sex O +
( O -
dsx O -
) O -
, O +
the O +
key O +
regulator O +
of O +
the O +
sex O +
determination O +
pathway O -
. O +

However O -
, O +
mosaic O +
studies O +
have O +
shown O +
that O +
the O +
genetic O +
sex O +
of O +
the O +
cells O +
in O +
the O +
anterior O -
/ O -
posterior O +
organizers O +
of O +
the O +
disk O -
, O +
not O +
the O +
sex O +
of O +
the O +
majority O +
of O +
cells O +
in O +
the O +
disk O -
, O +
regulate O +
the O +
sexually O +
dimorphic O +
fate O +
of O +
the O +
disk O -
. O +

This O +
occurs O +
through O +
the O +
sex O -
- O -
specific O +
regulation O +
of O +
WNT O -
, O +
FGF O -
, O +
and O +
transforming O +
growth O +
factor O +
beta O +
signaling O -
, O +
which O +
in O +
turn O +
regulate O +
the O +
growth O -
, O +
cell O +
differentiation O -
, O +
and O +
morphogenesis O +
of O +
the O +
disk O +
[ O -
41,42 O -
] O -
. O +

Sex O -
- O -
specific O +
regulation O +
of O +
gonad O +
organogenesis O +
in O +
vertebrates O +
may O +
occur O +
in O +
a O +
similar O +
manner O -
, O +
where O +
some O +
cells O +
are O +
cell O -
- O -
autonomously O +
responsive O +
to O +
the O +
sex O -
- O -
determining O +
switch O -
; O +
however O -
, O +
the O +
establishment O +
of O +
the O +
male O +
or O +
female O +
program O +
occurs O +
through O +
the O +
non O -
- O -
cell O -
- O -
autonomous O +
activity O +
of O +
classic O +
signaling O +
pathways O +
that O +
act O +
in O +
an O +
antagonistic O +
manner O +
and O +
coordinate O +
growth O -
, O +
cell O +
differentiation O +
and O +
morphogenesis O +
in O +
the O +
gonad O -
. O +

The O +
interplay O +
between O +
cell O -
- O -
autonomous O +
and O +
non O -
- O -
cell O -
- O -
autonomous O +
pathways O +
in O +
the O +
mammalian O +
gonad O +
is O +
not O +
well O +
understood O -
. O +

In O +
XX↔XY O +
chimera O +
experiments O -
, O +
XX O +
cells O +
can O +
be O +
recruited O +
to O +
the O +
Sertoli O +
lineage O -
, O +
indicating O +
that O +
non O -
- O -
cell O -
- O -
autonomous O +
signaling O +
mechanisms O +
operate O +
under O +
these O +
conditions O +
[ O -
15 O -
] O -
. O +

Other O +
more O +
recent O +
studies O +
have O +
suggested O +
that O +
paracrine O +
signals O +
could O +
be O +
involved O +
in O +
the O +
establishment O +
of O +
Sertoli O +
cells O +
[ O -
43–46 O -
] O -
. O +

The O +
current O +
study O +
reveals O +
that O +
ectopic O +
FGF9 O +
can O +
induce O +
SOX9 O +
under O +
conditions O +
in O +
which O +
XX O +
cells O +
are O +
dissociated O +
( O -
Figure O +
2F O -
) O -
, O +
when O +
an O +
FGF9-coated O +
bead O +
is O +
directly O +
applied O +
to O +
the O +
XX O +
gonad O +
( O -
Figure O +
2 O -
K O -
) O -
, O +
or O +
when O +
the O +
dose O +
of O +
Wnt4 O +
is O +
reduced O +
( O -
Figure O +
5 O -
G O -
) O -
. O +

Whether O +
FGF9 O +
normally O +
acts O +
non O -
- O -
cell O -
- O -
autonomously O +
in O +
vivo O +
to O +
recruit O +
XY O +
cells O +
to O +
the O +
Sertoli O +
lineage O +
by O +
up O -
- O -
regulating O +
SOX9 O +
is O +
not O +
clear O -
. O +

We O +
show O +
that O +
Sry O +
can O +
initially O +
up O -
- O -
regulate O +
SOX9 O +
in O +
the O +
absence O +
of O +
Fgf9 O -
, O +
suggesting O +
that O +
FGF9 O +
is O +
not O +
necessary O +
for O +
this O +
step O -
. O +

However O -
, O +
FGF9 O +
may O +
act O +
to O +
trigger O +
cell O +
proliferation O -
, O +
increasing O +
the O +
number O +
of O +
Sertoli O +
precursors O +
above O +
a O +
threshold O +
needed O +
to O +
stabilize O +
the O +
male O +
pathway O -
, O +
consistent O +
with O +
threshold O +
requirements O +
deduced O +
from O +
earlier O +
studies O +
using O +
XX↔XY O +
chimeric O +
gonads O +
[ O -
15 O -
] O -
. O +

Since O +
Sertoli O +
cells O +
produce O +
FGF9 O -
, O +
loss O +
of O +
proliferation O +
of O +
Sertoli O +
precursors O +
may O +
result O +
in O +
a O +
reduction O +
of O +
the O +
overall O +
level O +
of O +
FGF9 O -
, O +
and/or O +
other O +
male O +
paracrine O +
signals O -
, O +
below O +
a O +
critical O +
threshold O +
level O +
required O +
to O +
antagonize O +
the O +
influence O +
of O +
WNT4 O -
. O +

This O +
model O +
is O +
appealing O -
, O +
because O +
it O +
links O +
cell O +
proliferation O -
, O +
believed O +
to O +
be O +
required O +
for O +
establishment O +
of O +
the O +
male O +
pathway O +
[ O -
9 O -
] O -
, O +
with O +
Sertoli O +
fate O +
determination O -
. O +

A O +
recent O +
study O +
by O +
Yoshioka O +
et O +
al. O +
[ O -
47 O -
] O +
showed O +
that O +
misexpression O +
of O +
Fgf9 O +
in O +
chick O +
nephrogenous O +
mesenchyme O +
led O +
to O +
the O +
expansion O +
of O +
gonadal O +
marker O +
gene O +
expression O -
, O +
implicating O +
Fgf9 O +
in O +
gonadal O +
cell O +
proliferation O +
across O +
species O -
. O +

It O +
has O +
been O +
suggested O +
that O +
SOX9 O +
represses O +
WNT4 O +
based O +
on O +
misexpression O +
studies O +
[ O -
48 O -
] O -
. O +

Here O +
we O +
show O +
that O +
the O +
addition O +
of O +
FGF9 O +
protein O +
to O +
XX O +
gonad O +
explant O +
cultures O +
repressed O +
the O +
expression O +
of O +
Wnt4 O -
. O +

Down O -
- O -
regulation O +
of O +
Wnt4 O +
is O +
unlikely O +
to O +
occur O +
through O +
SOX9 O -
, O +
as O +
SOX9 O +
is O +
not O +
up O -
- O -
regulated O +
in O +
this O +
situation O +
[ O -
7 O -
] O -
. O +

Furthermore O -
, O +
although O +
both O +
SRY O +
and O +
SOX9 O +
are O +
initially O +
expressed O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O -
, O +
Wnt4 O +
is O +
not O +
down O -
- O -
regulated O +
in O +
the O +
absence O +
of O +
Fgf9 O +
( O -
Figure O +
4 O -
K O -
) O -
. O +

These O +
findings O +
support O +
the O +
idea O +
that O +
FGF9 O +
acts O +
as O +
the O +
antagonist O +
of O +
Wnt4 O -
. O +

Antagonism O +
of O +
WNT O +
signals O +
may O +
be O +
a O +
multistep O +
process O +
involving O +
both O +
the O +
transcriptional O +
down O -
- O -
regulation O +
of O +
Wnt4 O +
observed O +
in O +
this O +
study O +
and O +
the O +
destabilization O +
of O +
downstream O +
Wnt O +
intracellular O +
pathways O +
that O +
antagonize O +
SOX9 O +
expression O -
, O +
as O +
shown O +
in O +
chondrocyte O +
differentiation O +
[ O -
49 O -
] O -
, O +
or O +
that O +
compete O +
for O +
intracellular O +
signal O +
transducers O +
as O +
has O +
been O +
reported O +
in O +
other O +
systems O +
[ O -
50,51 O -
] O -
. O +

Future O +
work O +
will O +
address O +
these O +
possibilities O -
. O +

In O +
support O +
of O +
the O +
idea O +
that O +
Wnt4 O +
antagonizes O +
the O +
male O +
pathway O -
, O +
we O +
found O +
that O +
the O +
loss O +
of O +
Wnt4 O +
caused O +
the O +
up O -
- O -
regulation O +
of O +
both O +
SOX9 O +
and O +
FGF9 O +
in O +
XX O +
gonads O +
where O +
Sry O +
is O +
absent O -
. O +

It O +
appears O +
that O +
the O +
male O +
pathway O +
can O +
be O +
initiated O +
by O +
disrupting O +
the O +
balance O +
between O +
Wnt4 O +
and O +
Fgf9 O -
, O +
a O +
finding O +
that O +
has O +
strong O +
implications O +
for O +
other O +
vertebrate O +
sex O -
- O -
determination O +
systems O +
in O +
which O +
Sry O +
is O +
not O +
the O +
sex O +
determining O +
factor O -
. O +

However O -
, O +
up O -
- O -
regulation O +
of O +
Sox9 O +
is O +
not O +
sufficient O +
to O +
establish O +
testis O +
development O +
in O +
this O +
mutant O -
, O +
as O +
occurs O +
in O +
Odsex O +
and O +
other O +
gain O -
- O -
of O -
- O -
function O +
mutants O +
where O +
Sox9 O +
is O +
misexpressed O +
in O +
the O +
XX O +
gonad O +
[ O -
24,25 O -
] O -
. O +

In O +
those O +
two O +
misexpression O +
cases O -
, O +
Sox9 O +
expression O +
may O +
have O +
been O +
artificially O +
sustained O +
by O +
exogenous O +
regulatory O +
sequences O +
that O +
bypass O +
the O +
fine O +
dosage O +
balance O +
in O +
this O +
signaling O +
network O -
. O +

In O +
Wnt4 O +
mutants O -
, O +
SOX9 O +
expression O +
is O +
not O +
maintained O -
. O +

In O +
light O +
of O +
the O +
observation O +
that O +
the O +
Wnt4− O -
/ O -
− O +
XX O +
gonad O +
does O +
not O +
increase O +
significantly O +
in O +
size O +
( O -
Figure O +
6 O -
) O -
, O +
it O +
is O +
possible O +
that O +
the O +
FGF9 O -
/ O -
SOX9-expressing O +
population O +
did O +
not O +
reach O +
a O +
critical O +
threshold O -
. O +

Alternatively O +
( O -
or O +
in O +
addition O -
) O -
, O +
another O +
male O -
- O -
specific O +
factor O +
normally O +
dependent O +
on O +
Sry O +
may O +
be O +
required O +
to O +
sustain O +
SOX9 O +
expression O -
, O +
possibly O +
FGF O -
- O -
binding O +
proteins O +
in O +
the O +
extracellular O +
matrix O +
or O +
FGF O +
receptors O -
. O +

It O +
is O +
equally O +
plausible O +
that O +
there O +
are O +
other O +
female O -
- O -
specific O +
factors O +
that O +
antagonize O +
the O +
establishment O +
of O +
SOX9 O +
expression O -
. O +

It O +
has O +
been O +
observed O +
that O +
several O +
other O +
WNTs O +
are O +
expressed O +
in O +
the O +
XX O +
gonad O +
[ O -
52 O -
] O -
, O +
and O +
these O +
or O +
other O +
factors O +
may O +
partially O +
compensate O +
for O +
the O +
loss O +
of O +
Wnt4 O -
. O +

These O +
findings O +
suggest O +
that O +
WNT4 O +
signaling O +
normally O +
acts O +
as O +
a O +
repressor O +
of O +
the O +
male O +
pathway O +
by O +
interfering O +
with O +
the O +
up O -
- O -
regulation O +
of O +
SOX9 O +
expression O -
. O +

One O +
report O +
of O +
a O +
duplication O +
of O +
the O +
region O +
of O +
human O +
Chromosome O +
1 O -
, O +
which O +
includes O +
WNT4 O -
, O +
led O +
to O +
an O +
intersex O +
phenotype O +
[ O -
53 O -
] O -
. O +

However O -
, O +
the O +
report O +
constitutes O +
only O +
circumstantial O +
evidence O -
. O +

Such O +
a O +
role O +
is O +
not O +
supported O +
by O +
efforts O +
to O +
misexpress O +
Wnt4 O +
in O +
XY O +
gonads O -
, O +
which O +
have O +
led O +
to O +
very O +
mild O +
phenotypes O +
with O +
no O +
evidence O +
for O +
defects O +
in O +
Sertoli O +
cell O +
differentiation O +
[ O -
54 O -
] O -
. O +

It O +
is O +
possible O +
that O +
WNT4 O +
protein O +
did O +
not O +
function O +
as O +
an O +
active O +
signal O +
in O +
these O +
transgenic O +
mice O -
, O +
either O +
because O +
it O +
was O +
not O +
expressed O +
in O +
the O +
right O +
cells O -
, O +
at O +
the O +
right O +
time O -
, O +
or O +
at O +
the O +
right O +
level O -
. O +

Consistent O +
with O +
our O +
data O +
and O +
the O +
partially O +
sex O -
- O -
reversed O +
phenotype O +
of O +
Wnt4− O -
/ O -
− O +
XX O +
mutants O -
, O +
other O +
WNTs O +
or O +
additional O +
female O +
factors O +
may O +
be O +
required O -
. O +

The O +
switch O +
that O +
controls O +
sex O +
determination O +
is O +
biologically O +
diverse O -
. O +

Sry O +
is O +
not O +
present O +
in O +
nonmammalian O +
systems O -
; O +
however O -
, O +
antagonistic O +
signaling O +
between O +
FGFs O +
and O +
WNTs O +
may O +
be O +
the O +
conserved O +
mechanism O +
that O +
balances O +
the O +
gonad O +
between O +
testicular O +
and O +
ovarian O +
fates O +
in O +
vertebrates O -
. O +

In O +
theory O -
, O +
any O +
genetic O +
or O +
environmental O +
switch O +
may O +
tip O +
the O +
balance O +
toward O +
the O +
male O +
pathway O -
. O +

Based O +
on O +
our O +
findings O +
we O +
propose O +
that O +
cells O +
in O +
the O +
mammalian O +
gonad O +
are O +
balanced O +
between O +
two O +
competing O +
cell O +
fates O +
by O +
counterbalanced O +
signaling O +
pathways O -
, O +
Fgf9 O -
, O +
expressed O +
near O +
the O +
coelomic O +
surface O -
, O +
and O +
Wnt4 O -
, O +
expressed O +
near O +
the O +
mesonephric O +
border O +
( O -
Figure O +
7 O -
) O -
. O +

In O +
mammalian O +
XY O +
gonads O -
, O +
the O +
onset O +
of O +
Sry O +
expression O +
initiates O +
the O +
male O +
pathway O +
by O +
up O -
- O -
regulating O +
Sox9 O -
. O +

SOX9 O +
up O -
- O -
regulates O +
Fgf9 O -
, O +
which O +
initiates O +
a O +
Sox9 O -
/ O -
Fgf9 O +
feed O -
- O -
forward O +
loop O +
that O +
accelerates O +
commitment O +
to O +
the O +
male O +
pathway O -
. O +

In O +
XX O +
gonads O +
or O +
XY O +
mutant O +
gonads O +
lacking O +
Sry O -
, O +
Sox9 O -
, O +
or O +
Fgf9 O -
, O +
the O +
SOX9 O -
/ O -
FGF9 O +
feed O -
- O -
forward O +
loop O +
is O +
not O +
established O -
, O +
and O +
WNT4 O +
gains O +
control O +
of O +
the O +
gonadal O +
field O -
. O +

This O +
results O +
in O +
the O +
down O -
- O -
regulation O +
of O +
Sox9 O +
and O +
Fgf9 O -
, O +
tilting O +
the O +
balance O +
toward O +
commitment O +
to O +
the O +
female O +
pathway O -
. O +

Further O +
experiments O +
will O +
be O +
required O +
to O +
define O +
the O +
molecular O +
mechanism O +
of O +
FGF9 O +
and O +
WNT4 O +
action O -
. O +

However O -
, O +
our O +
in O +
vivo O +
and O +
in O +
vitro O +
data O +
strongly O +
support O +
the O +
antagonistic O +
relationship O +
of O +
these O +
two O +
signaling O +
pathways O +
in O +
regulating O +
expression O +
of O +
the O +
testis O -
- O -
determining O +
factor O +
SOX9 O -
. O +

Materials O +
and O +
Methods O +
Animals O +
and O +
genotyping O -
. O +

The O +
Fgf9 O +
mutation O +
was O +
maintained O +
on O +
a O +
C57BL O -
/ O -
6 O +
( O -
B6 O -
) O +
background O +
that O +
leads O +
to O +
sex O +
reversal O +
in O +
100 O -
% O +
of O +
XY O +
Fgf9− O -
/ O -
− O +
offspring O -
. O +

Sry O -
- O -
EGFP O +
mice O -
, O +
a O +
kind O +
gift O +
from O +
K. O +
Albrecht O +
and O +
E. O +
Eicher O -
, O +
were O +
initially O +
on O +
a O +
mixed O +
B6 O -
/ O -
129 O +
and O +
were O +
backcrossed O +
to O +
B6 O +
for O +
five O +
generations O -
. O +

Offspring O +
were O +
then O +
crossed O +
to O +
Fgf9+ O -
/ O -
− O +
and O +
intercrossed O +
and O +
backcrossed O +
to O +
B6 O +
in O +
alternating O +
generations O -
. O +

All O +
XY O +
Fgf9− O -
/ O -
− O +
offspring O +
showed O +
complete O +
sex O +
reversal O -
. O +

SryMyc O +
mice O +
were O +
maintained O +
on O +
a O +
CBA O +
background O -
, O +
and O +
Wnt4 O +
on O +
a O +
mixed O +
129 O -
/ O -
SVJ O +
background O -
. O +

Mutant O +
embryos O +
were O +
sexed O +
by O +
PCR O +
using O +
Y O +
chromosome O -
- O -
specific O +
primers O +
and O +
were O +
genotyped O +
as O +
described O +
[ O -
2,16,26,55 O -
] O -
. O +

Mice O +
homozygous O +
for O +
the O +
Sox9 O +
deletion O +
were O +
generated O +
using O +
a O +
germline O -
- O -
specific O +
gene O +
deletion O +
system O +
as O +
described O +
[ O -
20 O -
] O -
. O +

In O +
situ O +
hybridization O +
and O +
immunocytochemistry O -
. O +

In O +
situ O +
hybridization O +
was O +
performed O +
on O +
paraformaldehyde O -
- O -
fixed O -
/ O -
OCT O +
embedded O +
cryosections O -
, O +
as O +
described O +
[ O -
56 O -
] O -
. O +

Whole O -
- O -
mount O +
in O +
situ O +
hybridization O +
was O +
performed O +
as O +
previously O +
described O +
[ O -
57 O -
] O -
. O +

Probes O +
used O +
for O +
in O +
situ O +
hybridization O +
were O -
: O +
Amh O +
[ O -
58 O -
] O -
, O +
Dhh O +
[ O -
20 O -
] O -
, O +
Wnt4 O +
[ O -
8 O -
] O -
, O +
and O +
Fgf9 O +
[ O -
59 O -
] O -
. O +

Digoxigenin B-Chemical -
- O -
labeled O +
probes O +
were O +
prepared O +
according O +
to O +
the O +
Boehringer O -
- O -
Mannheim O -
- O -
Roche O +
protocol O -
. O +

Antibodies O +
used O +
in O +
whole O -
- O -
mount O +
immunocytochemistry O +
were O -
: O +
mouse O +
monoclonal O +
anti O -
- O -
N O -
- O -
MYC O +
( O -
Cell O +
Signaling O +
Technology O -
, O +
Beverly O -
, O +
Massachusetts O -
, O +
United O +
States O -
; O +
1:100 O -
) O -
, O +
rabbit O +
anti O -
- O -
SOX9 O +
( O -
gift O +
of O +
F. O +
Poulat O -
; O +
1:1,000 O -
) O -
, O +
rat O +
anti O -
- O -
PECAM O +
( O -
Pharmingen O -
, O +
San O +
Diego O -
, O +
California O -
, O +
United O +
States O -
; O +
1:500 O -
) O -
, O +
rabbit O +
anti O -
- O -
caspase-3 O +
fragment O +
( O -
BD O +
Bioscience O -
, O +
San O +
Diego O -
, O +
California O -
, O +
United O +
States O -
; O +
1:100 O -
) O -
, O +
and O +
rabbit O +
anti O -
- O -
phosphorylated O +
histone B-Chemical +
H3 O +
( O -
Cell O +
Signaling O -
; O +
1:250 O -
) O -
. O +

Antibody O +
binding O +
was O +
detected O +
using O +
fluorophore B-Chemical -
- O -
conjugated O +
secondary O +
antibodies O +
( O -
Jackson O +
ImmunoResearch O -
, O +
West O +
Grove O -
, O +
Pennsylvania O -
, O +
United O +
States O -
) O +
as O +
recommended O -
. O +

For O +
FGF9 O +
immunostaining O -
, O +
gonads O +
were O +
prepared O +
as O +
frozen O +
sections O -
, O +
and O +
rabbit O +
anti O -
- O -
mouse O +
FGF9 O +
( O -
Cell O +
Science O -
; O +
1:50 O -
) O +
and O +
anti O -
- O -
rabbit O +
IgG O +
conjugated O +
with O +
peroxidase O +
secondary O +
antibody O +
were O +
used O -
, O +
followed O +
by O +
amplification O +
with O +
tyramide O -
- O -
Cy3 B-Chemical +
fluorophore B-Chemical +
( O -
Molecular O +
Probes O -
, O +
Eugene O -
, O +
Oregon O -
, O +
United O +
States O -
) O -
. O +

This O +
antibody O +
did O +
not O +
detect O +
FGF9 O +
in O +
12.5 O +
dpc O +
ovary O +
or O +
Fgf9− O -
/ O -
− O +
null O +
mutant O +
gonads O -
. O +

Immunostained O +
samples O +
were O +
mounted O +
in O +
DABCO O +
and O +
imaged O +
on O +
a O +
Zeiss O +
LSM420 O +
confocal O +
microscope O -
. O +

Primary O +
gonadal O +
cell O +
culture O -
. O +

11.5 O +
dpc O +
embryos O +
were O +
collected O +
from O +
CD1 O +
mice O -
, O +
and O +
sex O +
was O +
determined O +
by O +
staining O +
amnions O +
as O +
described O +
[ O -
15 O -
] O -
. O +

Whole O +
genital O +
ridges O +
were O +
dissected O +
and O +
gonads O +
were O +
separated O +
from O +
mesonephroi O -
. O +

The O +
gonads O +
were O +
treated O +
with O +
collagenase O +
( O -
0.025 O -
% O -
) O +
and O +
trypsin O +
( O -
0.025 O -
% O -
) O +
in O +
HAT O +
buffer O +
at O +
37 O +
° O -
C O +
for O +
10 O +
min O -
. O +

After O +
the O +
digestion O -
, O +
cells O +
were O +
mechanically O +
dissociated O +
by O +
pipetting O -
, O +
washed O +
in O +
DMEM O -
, O +
plated O +
on O +
10-mm O +
diameter O +
coverslips O +
coated O +
with O +
extracellular O +
matrix O +
( O -
Sigma O -
) O -
, O +
and O +
were O +
cultured O +
in O +
DMEM O +
containing O +
5 O -
% O +
fetal O +
bovine O +
serum O +
and O +
1 O -
× O +
antibiotics B-Chemical -
/ O -
antimycotics B-Chemical +
at O +
37 O +
° O -
C O -
, O +
5 O -
% O +
CO2 B-Chemical -
. O +

In O +
one O +
of O +
duplicate O +
cultures O -
, O +
FGF9 O +
( O -
R&D O +
Systems O -
, O +
Minneapolis O -
, O +
Minnesota O -
, O +
United O +
States O -
) O +
was O +
added O +
to O +
the O +
final O +
concentration O +
of O +
50 O +
ng O -
/ O -
ml O +
in O +
the O +
culture O +
medium O -
. O +

After O +
36 O +
h O +
of O +
culture O -
, O +
cells O +
were O +
fixed O +
and O +
immunostained O +
for O +
SOX9 O -
. O +

Syto13 O +
( O -
Molecular O +
Probes O -
) O +
was O +
used O +
for O +
nuclear O +
counterstaining O -
, O +
according O +
to O +
the O +
manufacturer O -
's O +
instruction O -
. O +

Gonad O +
explant O +
culture O -
. O +

Gonad O -
/ O -
mesonephros O +
complexes O +
were O +
dissected O +
at O +
11.5 O +
dpc O +
and O +
cultured O +
on O +
agar O +
blocks O +
for O +
36 O +
h O +
at O +
37 O +
° O -
C O -
, O +
5 O -
% O +
CO2 B-Chemical +
as O +
described O +
[ O -
60 O -
] O -
. O +

For O +
FGF9 O +
treatment O -
, O +
50 O +
ng O -
/ O -
ml O +
FGF9 O +
( O -
R&D O +
Systems O -
) O +
was O +
added O +
directly O +
to O +
the O +
culture O +
medium O -
, O +
or O +
an O +
FGF9-loaded O +
bead O +
was O +
placed O +
on O +
the O +
surface O +
of O +
gonad O -
. O +

To O +
coat O +
beads O -
, O +
heparin B-Chemical -
- O -
agarose B-Chemical +
beads O +
( O -
Sigma O -
, O +
St. O +
Louis O -
, O +
Missouri O -
, O +
United O +
States O -
) O +
were O +
incubated O +
in O +
50 O +
μg O -
/ O -
ml O +
FGF9 O +
for O +
2 O +
h O -
, O +
and O +
washed O +
five O +
times O +
in O +
culture O +
medium O -
. O +

Supporting O +
Information O +
Figure O +
S1 O +
Confirmation O +
that O +
Transcription O +
of O +
Sox9 O +
Is O +
Up O -
- O -
Regulated O +
in O +
Wnt4− O -
/ O -
− O +
XX O +
Gonads O +
Whole O -
- O -
mount O +
in O +
situ O +
hybridization O +
for O +
Sox9 O +
detected O +
Sox9 O +
expression O +
in O +
11.5 O +
dpc O +
Wnt4+ O -
/ O -
− O +
XY O +
controls O +
and O +
Wnt4− O -
/ O -
− O +
XX O +
gonads O -
. O +

( O -
428 O +
KB O +
PPT O -
) O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Acknowledgements O +
The O +
Sry O -
- O -
EGFP O +
transgenics O +
were O +
a O +
kind O +
gift O +
from O +
Eva O +
M. O +
Eicher O -
. O +

We O +
thank O +
Serge O +
Nef O +
for O +
freely O +
providing O +
information O +
from O +
his O +
microarray O +
screen O -
, O +
Hao O +
Chang O +
for O +
generating O +
some O +
of O +
the O +
Sox9 O +
mutant O +
and O +
control O +
urogenital O +
ridges O -
, O +
members O +
of O +
the O +
Capel O +
lab O +
for O +
discussion O -
, O +
and O +
Iordan O +
Batchvarov O +
for O +
help O +
with O +
animals O -
. O +

Competing O +
interests O -
. O +

The O +
authors O +
have O +
declared O +
that O +
no O +
competing O +
interests O +
exist O -
. O +

Abbreviations O +
dpc O +
- O +
day O +
post O +
coitum O +
EGFP O +
- O +
enhanced O +
green O +
fluorescent O +
protein O +
FGF O +
- O +
fibroblast O +
growth O +
factor O +
PECAM O +
- O +
platelet O -
/ O -
endothelial O +
cell O +
adhesion O +
molecule B-Chemical +
SOX O +
- O +
SRY O -
- O -
like O +
HMG O +
box O +
SRY O +
- O +
sex O -
- O -
determining O +
region O +
of O +
the O +
Y O +
WNT O +
- O +
wingless O -
- O -
related O +
MMTV O +
integration O +
site O +
Figures O +
and O +
Tables O +
Figure O +
1 O +
Stage- O +
and O +
Cell O -
- O -
Specific O +
Expression O +
of O +
FGF9 O +
in O +
Embryonic O +
Gonads O +
( O -
A O -
– O -
F O -
) O +
Detection O +
of O +
FGF9 O +
protein O +
( O -
red O -
) O +
at O +
different O +
stages O +
of O +
gonad O +
development O -
. O +

FGF9 O +
is O +
up O -
- O -
regulated O +
in O +
XY O +
gonads O +
at O +
11.5 O +
( O -
B O -
) O -
, O +
12.5 O +
( O -
D O -
) O -
, O +
and O +
13.5 O +
dpc O +
( O -
F O -
) O +
while O +
it O +
is O +
down O -
- O -
regulated O +
in O +
XX O +
after O +
11.5 O +
dpc O +
( O -
A O -
, O +
C O -
, O +
and O +
E O -
) O -
. O +

No O +
signal O +
was O +
detected O +
in O +
XY O +
Fgf9− O -
/ O -
− O +
gonads O +
( O -
unpublished O +
data O -
) O -
. O +

( O -
G O -
– O -
J O -
) O +
Serial O +
sections O +
of O +
wild O -
- O -
type O +
XX O +
and O +
compound O +
heterozygous O +
KitW O -
/ O -
Wv O +
XY O +
gonads O +
stained O +
for O +
alkaline O +
phosphatase O +
( O -
purple O -
; O +
G O +
and O +
I O -
) O +
and O +
FGF9 O +
( O -
red O -
; O +
H O +
and O +
J O -
) O -
. O +

Testis O +
cords O +
are O +
formed O +
in O +
the O +
absence O +
of O +
germ O +
cells O +
in O +
XY O +
KitW O -
/ O -
Wv O +
mutant O +
gonads O +
at O +
12.5 O +
dpc O +
( O -
arrowhead O +
in O +
J O -
) O -
. O +

Expression O +
of O +
FGF9 O +
is O +
present O +
in O +
the O +
mutant O +
gonads O +
where O +
Sertoli O +
cells O +
are O +
the O +
only O +
remaining O +
cell O +
type O +
in O +
the O +
cords O +
( O -
J O -
) O -
. O +

Semitransparent O +
dotted O +
line O +
indicates O +
the O +
boundary O +
between O +
gonad O +
and O +
mesonephroi O -
. O +

PECAM O +
( O -
green O -
) O +
marks O +
germ O +
cells O +
and O +
vascular O +
endothelial O +
cells O +
( O -
C O -
– O -
F O -
, O +
H O -
, O +
and O +
J O -
) O -
. O +

The O +
scale O +
bars O +
represent O +
25 O +
μm O -
. O +

g O -
, O +
gonad O -
; O +
m O -
, O +
mesonephroi O -
. O +

Figure O +
2 O +
Epistatic O +
Relationship O +
of O +
Sry O -
, O +
Fgf9 O -
, O +
and O +
Sox9 O +
( O -
A O -
– O -
D O -
) O +
Sry O +
expression O +
is O +
not O +
dependent O +
on O +
Fgf9 O -
. O +

Fgf9+ O -
/ O -
− O +
( O -
A O -
) O +
and O +
Fgf9− O -
/ O -
− O +
( O -
B O -
) O +
XY O +
gonads O +
at O +
11.5 O +
dpc O +
expressing O +
GFP O +
( O -
green O -
) O +
from O +
the O +
Sry O +
promoter O +
( O -
polygonal O +
cells O -
, O +
arrows O -
) O -
. O +

Blood O +
cells O +
show O +
background O +
fluorescence O +
( O -
doughnut O -
- O -
shaped O +
cells O -
) O -
. O +

Fgf9+ O -
/ O -
− O +
( O -
C O -
) O +
and O +
Fgf9− O -
/ O -
− O +
( O -
D O -
) O +
XY O +
gonads O +
at O +
11.5 O +
dpc O +
expressing O +
SRYMYC O +
protein O +
( O -
red O -
, O +
arrowheads O -
) O -
. O +

Inset O +
shows O +
nuclear O +
counterstain O +
( O -
green O -
, O +
Syto13 O -
) O +
colocalizing O +
with O +
SRYMYC O -
. O +

PECAM O +
( O -
blue O -
) O +
marks O +
endothelial O +
and O +
germ O +
cells O -
. O +

Scale O +
bars O +
represent O +
25 O +
μm O -
. O +

( O -
E O -
– O -
K O -
) O +
Exogenous O +
FGF9 O +
can O +
up O -
- O -
regulate O +
SOX9 O +
expression O +
in O +
XX O +
gonads O -
. O +

Immunostaining O +
of O +
SOX9 O +
( O -
green O -
) O +
in O +
primary O +
cultures O +
of O +
gonadal O +
cells O -
. O +

XX O +
cells O +
( O -
E O -
) O +
and O +
XY O +
cells O +
( O -
G O -
) O +
cultured O +
with O +
exogenous O +
FGF9 O +
show O +
induction O +
of O +
SOX9 O +
expression O +
( O -
F O +
and O +
H O -
, O +
respectively O -
) O -
. O +

Cells O +
were O +
counterstained O +
using O +
the O +
nuclear O +
marker O -
, O +
Syto13 O +
( O -
red O -
) O -
. O +

Immunostaining O +
of O +
SOX9 O +
( O -
red O -
) O +
in O +
gonad O +
explants O +
cultured O +
with O +
BSA- O +
or O +
FGF9-coated O +
beads O -
. O +

SOX9 O +
is O +
expressed O +
in O +
XY O +
gonads O +
and O +
cells O +
contacting O +
FGF9-coated O +
beads O +
( O -
dotted O +
circle O +
labeled O +
" O -
F O -
" O -
) O +
in O +
XX O +
gonads O +
( O -
I O +
and O +
K O -
) O +
but O +
not O +
in O +
XX O +
cells O +
contacting O +
BSA O -
- O -
coated O +
control O +
beads O +
( O -
" O -
B O -
" O -
) O +
( O -
J O -
) O -
. O +

PECAM O +
( O -
blue O -
) O +
marks O +
endothelial O +
and O +
germ O +
cells O -
. O +

Scale O +
bars O +
( O -
I O -
– O -
K O -
) O +
represent O +
50 O +
μm O -
. O +

Figure O +
3 O +
Interdependent O +
Relationship O +
between O +
Fgf9 O +
and O +
Sox9 O +
( O -
A O -
– O -
F O -
) O +
Immunostaining O +
of O +
SOX9 O +
( O -
red O -
) O +
in O +
Fgf9+ O -
/ O -
− O +
and O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
shows O +
that O +
Fgf9 O +
is O +
required O +
for O +
maintenance O +
of O +
SOX9 O -
. O +

The O +
up O -
- O -
regulation O +
of O +
SOX9 O +
in O +
Sertoli O +
precursor O +
cells O +
appears O +
normal O +
in O +
Fgf9− O -
/ O -
− O +
gonads O +
at O +
11.5 O +
dpc O +
( O -
D O -
) O +
compared O +
with O +
heterozygous O +
littermate O +
controls O +
( O -
A O -
) O -
. O +

However O -
, O +
SOX9 O +
is O +
detected O +
in O +
fewer O +
cells O +
in O +
mutant O +
gonads O +
at O +
12.0 O +
dpc O +
( O -
B O +
and O +
E O -
) O -
, O +
and O +
is O +
lost O +
by O +
12.5 O +
dpc O +
( O -
C O +
and O +
F O -
) O -
. O +

( O -
G O -
– O -
J O -
) O +
mRNA O +
whole O -
- O -
mount O +
in O +
situ O +
hybridization O +
for O +
Sry O +
and O +
Fgf9 O +
in O +
Sox9flox O -
/ O -
Δ O +
and O +
Sox9Δ O -
/ O -
Δ O +
XY O +
gonads O +
shows O +
that O +
Sox9 O +
is O +
required O +
for O +
Fgf9 O +
expression O -
. O +

Sry O +
expression O +
is O +
detected O +
in O +
both O +
Sox9flox O -
/ O -
Δ O +
and O +
Sox9Δ O -
/ O -
Δ O +
gonads O +
at O +
11.5 O +
dpc O +
( O -
G O +
and O +
H O -
) O -
, O +
whereas O +
Fgf9 O +
expression O +
is O +
markedly O +
decreased O +
or O +
absent O +
in O +
Sox9Δ O -
/ O -
Δ O +
gonads O +
at O +
11.5 O +
dpc O +
( O -
I O +
and O +
J O -
) O -
. O +

( O -
K O -
– O -
O O -
) O +
Comparison O +
of O +
cell O +
proliferation O +
in O +
Sox9Δ O -
/ O -
Δ O +
versus O +
Sox9flox O -
/ O -
Δ O +
gonads O +
at O +
11.5 O +
dpc O +
using O +
immunostaining O +
for O +
phosphorylated O +
histone B-Chemical +
H3 O -
. O +

XY O -
- O -
specific O +
proliferation O +
at O +
the O +
gonad O +
surface O +
( O -
K O -
) O +
is O +
reduced O +
in O +
the O +
absence O +
of O +
Sox9 O +
( O -
L O -
) O -
. O +

Bar O +
graph O +
( O -
O O -
) O +
shows O +
quantitation O +
of O +
proliferation O +
obtained O +
by O +
counting O +
positive O +
cells O +
in O +
the O +
cortical O +
region O +
of O +
each O +
gonad O +
( O -
right O +
brace O -
) O +
and O +
normalizing O +
to O +
the O +
number O +
obtained O +
from O +
XY O +
Sox9flox O -
/ O -
Δ O +
gonads O -
. O +

n O +
= O +
30 O -
, O +
with O +
five O +
sections O +
of O +
each O +
gonad O +
and O +
three O +
pairs O +
of O +
gonads O +
for O +
each O +
genotype O -
. O +

PECAM O -
, O +
green O +
( O -
A O -
– O -
F O +
and O +
K O -
– O -
N O -
) O -
. O +

The O +
scale O +
bars O +
represent O +
25 O +
μm O -
. O +

Figure O +
4 O +
Sertoli O +
Cell O +
Precursors O +
Switch O +
from O +
Expression O +
of O +
Male O +
to O +
Female O +
Pathway O +
Genes O +
( O -
A O -
– O -
F O -
) O +
Whole O -
- O -
mount O +
in O +
situ O +
hybridization O +
for O +
genes O +
in O +
the O +
male O +
pathway O +
downstream O +
of O +
Sox9 O -
, O +
Dhh O -
, O +
and O +
Amh O -
. O +

Dhh O +
expression O +
is O +
disrupted O +
in O +
XY O +
Fgf9− O -
/ O -
− O +
gonads O +
( O -
g O -
) O +
at O +
11.5 O +
dpc O +
( O -
A O +
and O +
B O -
) O -
. O +

Amh O +
expression O +
is O +
severely O +
reduced O +
in O +
XY O +
Fgf9− O -
/ O -
− O +
gonads O +
at O +
12.5 O +
dpc O +
( O -
E O +
and O +
F O -
) O -
. O +

( O -
G O +
and O +
H O -
) O +
Analysis O +
of O +
cell O +
death O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
using O +
an O +
apoptotic O +
marker O -
, O +
active O +
caspase-3 O +
( O -
red O -
) O -
. O +

No O +
increased O +
apoptosis O +
is O +
observed O +
in O +
XY O +
Fgf9− O -
/ O -
− O +
gonads O +
( O -
g O -
) O +
compared O +
with O +
control O +
XY O +
gonads O -
, O +
although O +
apoptotic O +
cells O +
are O +
increased O +
around O +
mesonephric O +
tubules O +
( O -
m O -
) O +
of O +
the O +
mutant O +
gonads O +
( O -
arrow O +
in O +
H O -
) O -
. O +

Semitransparent O +
dotted O +
line O +
indicates O +
boundary O +
between O +
mesonephros O +
and O +
gonad O -
. O +

( O -
PECAM O -
, O +
green O -
) O -
. O +

( O -
I O -
– O -
K O -
) O +
Whole O -
- O -
mount O +
in O +
situ O +
hybridization O +
for O +
Wnt4 O -
, O +
an O +
ovary O +
marker O -
. O +

Wnt4 O +
is O +
expressed O +
in O +
Fgf9− O -
/ O -
− O +
XY O +
gonads O +
at O +
12.5 O +
dpc O +
( O -
K O -
) O +
similar O +
to O +
the O +
level O +
in O +
XX O +
Fgf9+ O -
/ O -
− O +
controls O +
( O -
I O -
) O +
but O +
not O +
in O +
XY O +
controls O +
( O -
J O -
) O -
. O +

The O +
scale O +
bars O +
represent O +
50 O +
μm O -
. O +

g O -
, O +
gonad O -
; O +
m O -
, O +
mesonephros O -
. O +

Figure O +
5 O +
Mutual O +
Antagonism O +
between O +
Fgf9 O +
and O +
Wnt4 O +
( O -
A O -
– O -
C O -
) O +
Wnt4 O +
whole O -
- O -
mount O +
in O +
situ O +
hybridization O +
on O +
gonad O +
cultures O -
. O +

Adding O +
exogenous O +
FGF9 O +
in O +
gonad O +
cultures O +
results O +
in O +
the O +
down O -
- O -
regulation O +
of O +
Wnt4 O +
expression O +
in O +
cultured O +
XX O +
gonads O +
( O -
C O -
) O -
. O +

Controls O +
( O -
A O +
and O +
B O -
) O +
were O +
cultured O +
without O +
FGF9 O +
peptide O -
. O +

( O -
D O -
– O -
G O -
) O +
Reduction O +
in O +
the O +
dose O +
of O +
Wnt4 O +
allows O +
FGF9 O +
to O +
induce O +
SOX9 O +
in O +
XX O +
gonads O -
. O +

Immunostaining O +
of O +
SOX9 O +
( O -
red O -
) O +
shows O +
that O +
addition O +
of O +
FGF9 O +
up O -
- O -
regulates O +
SOX9 O +
expression O +
in O +
heterozygous O +
Wnt4+ O -
/ O -
− O +
XX O +
gonads O +
( O -
G O -
) O -
, O +
but O +
not O +
in O +
Wnt4+ O -
/ O -
+ O +
XX O +
gonads O +
( O -
F O -
) O -
. O +

PECAM O -
, O +
green O -
. O +

The O +
scale O +
bars O +
represent O +
50 O +
μm O -
. O +

Figure O +
6 O +
Ectopic O +
Expression O +
of O +
Male O +
Factors O -
, O +
SOX9 O +
and O +
FGF9 O -
, O +
in O +
XX O +
Wnt4− O -
/ O -
− O +
Gonads O +
( O -
A O -
– O -
C O -
) O +
FGF9 O +
( O -
red O -
) O +
immunostaining O +
shows O +
that O +
FGF9 O +
is O +
expressed O +
in O +
XX O +
Wnt4− O -
/ O -
− O +
gonads O +
at O +
12.5 O +
dpc O +
( O -
C O -
) O +
relative O +
to O +
littermate O +
controls O +
( O -
A O +
and O +
B O -
) O -
. O +

( O -
D O -
– O -
L O -
) O +
SOX9 O +
( O -
red O -
) O +
immunostaining O +
shows O +
that O +
SOX9 O +
is O +
transiently O +
up O -
- O -
regulated O +
in O +
XX O +
Wnt4− O -
/ O -
− O +
gonads O -
. O +

SOX9 O +
expression O +
is O +
detected O +
in O +
Wnt4− O -
/ O -
− O +
XX O +
gonads O +
at O +
11.5–12.0 O +
dpc O +
( O -
F O +
and O +
I O -
) O -
, O +
albeit O +
at O +
reduced O +
levels O +
compared O +
with O +
XY O +
gonad O +
controls O +
( O -
E O -
- O -
H O -
) O -
. O +

SOX9 O +
is O +
not O +
detected O +
in O +
control O +
XX O +
Wnt4+ O -
/ O -
− O +
gonads O +
( O -
D O -
- O -
J O -
) O +
or O +
Wnt4− O -
/ O -
− O +
XX O +
gonads O +
at O +
12.5 O +
dpc O +
( O -
L O -
) O -
. O +

The O +
ectopic O +
coelomic O +
vessel O +
in O +
XX O +
Wnt4− O -
/ O -
− O +
gonads O +
[ O -
28 O -
] O +
is O +
indicated O +
by O +
arrowheads O -
. O +

PECAM O -
, O +
green O -
. O +

The O +
scale O +
bars O +
represent O +
50 O +
μm O -
. O +

Figure O +
7 O +
Opposing O +
Signals O +
Regulate O +
Sex O +
Determination O +
in O +
the O +
Bipotential O +
Gonad O +

In O +
both O +
XX O +
and O +
XY O +
gonads O +
at O +
11.25 O +
dpc O +
( O -
15 O +
tail O -
- O -
somite O +
stage O -
) O -
, O +
Fgf9 O +
transcripts O +
( O -
white O +
arrows O -
) O +
are O +
detected O +
near O +
the O +
gonad O +
surface O +
( O -
A O +
and O +
B O -
) O -
, O +
whereas O +
Wnt4 O +
transcripts O +
are O +
detected O +
near O +
the O +
gonad O +
mesonephric O +
boundary O +
( O -
C O +
and O +
D O -
) O -
. O +

We O +
propose O +
a O +
model O +
in O +
which O +
the O +
fate O +
of O +
the O +
gonad O +
is O +
balanced O +
between O +
these O +
competing O +
signals O -
. O +

A O +
genetic O +
or O +
environmental O +
switch O +
initiates O +
the O +
male O +
pathway O +
by O +
creating O +
an O +
imbalance O +
between O +
these O +
signals O -
. O +

In O +
mammals O -
, O +
this O +
imbalance O +
occurs O +
through O +
the O +
up O -
- O -
regulation O +
of O +
Sox9 O -
. O +

Sox9 O +
up O -
- O -
regulates O +
Fgf9 O -
, O +
and O +
Fgf9 O +
maintains O +
Sox9 O -
, O +
forming O +
a O +
positive O +
feed O -
- O -
forward O +
loop O +
in O +
XY O +
gonads O -
. O +

In O +
this O +
situation O -
, O +
the O +
balance O +
between O +
FGF9 O +
and O +
WNT4 O +
signals O +
is O +
shifted O +
in O +
favor O +
of O +
FGF9 O -
, O +
and O +
the O +
dominance O +
of O +
the O +
male O +
pathway O +
is O +
established O -
. O +

In O +
the O +
absence O +
of O +
a O +
feed O -
- O -
forward O +
loop O +
between O +
SOX9 O +
and O +
FGF9 O +
( O -
e.g. O -
, O +
in O +
XX O +
gonads O -
) O -
, O +
WNT4 O +
blocks O +
Fgf9 O -
, O +
initiating O +
the O +
female O +
pathway O -
. O +

Footnotes O +
Author O +
contributions O -
. O +

YK O -
, O +
AK O -
, O +
and O +
BC O +
conceived O +
and O +
designed O +
the O +
experiments O -
. O +

YK O -
, O +
AK O -
, O +
LD O -
, O +
and O +
JB O +
performed O +
the O +
experiments O -
. O +

YK O -
, O +
RLB O -
, O +
and O +
BC O +
analyzed O +
the O +
data O -
. O +

YK O -
, O +
RS O -
, O +
MCC O -
, O +
FP O -
, O +
RRB O -
, O +
RLB O -
, O +
and O +
BC O +
contributed O +
reagents B-Chemical -
/ O -
materials O -
/ O -
analysis O +
tools O -
. O +

YK O +
and O +
BC O +
wrote O +
the O +
paper O +
with O +
significant O +
input O +
from O +
RLB O -
. O +

Citation O -
: O +
Kim O +
Y O -
, O +
Kobayashi O +
A O -
, O +
Sekido O +
R O -
, O +
DiNapoli O +
L O -
, O +
Brennan O +
J O -
, O +
et O +
al. O +
( O -
2006 O -
) O +
Fgf9 O +
and O +
Wnt4 O +
act O +
as O +
antagonistic O +
signals O +
to O +
regulate O +
mammalian O +
sex O +
determination O -
. O +

PLoS O +
Biol O +
4 O -
( O -
6 O -
) O -
: O +
e187 O -
. O +

DOI O -
: O +
10.1371 O -
/ O -
journal.pbio.0040187 O +
Funding O -
. O +

This O +
work O +
was O +
funded O +
by O +
grants O +
from O +
the O +
National O +
Institutes O +
of O +
Health O +
to O +
BC O +
( O -
HD39963 O -
) O -
, O +
and O +
to O +
RRB O +
( O -
HD30284 O -
) O -
. O +

Defective O +
ALK5 O +
signaling O +
in O +
the O +
neural O +
crest O +
leads O +
to O +
increased O +
postmigratory O +
neural O +
crest O +
cell O +
apoptosis O +
and O +
severe O +
outflow O +
tract O +
defects O +
Abstract O +
Background O +
Congenital O +
cardiovascular O +
diseases O +
are O +
the O +
most O +
common O +
form O +
of O +
birth O +
defects O +
in O +
humans O -
. O +

A O +
substantial O +
portion O +
of O +
these O +
defects O +
has O +
been O +
associated O +
with O +
inappropriate O +
induction O -
, O +
migration O -
, O +
differentiation O +
and O +
patterning O +
of O +
pluripotent O +
cardiac O +
neural O +
crest O +
stem O +
cells O -
. O +

While O +
TGF O -
- O -
β O -
- O -
superfamily O +
signaling O +
has O +
been O +
strongly O +
implicated O +
in O +
neural O +
crest O +
cell O +
development O -
, O +
the O +
detailed O +
molecular O +
signaling O +
mechanisms O +
in O +
vivo O +
are O +
still O +
poorly O +
understood O -
. O +

Results O +
We O +
deleted O +
the O +
TGF O -
- O -
β O +
type O +
I O +
receptor O +
Alk5 O +
specifically O +
in O +
the O +
mouse O +
neural O +
crest O +
cell O +
lineage O -
. O +

Failure O +
in O +
signaling O +
via O +
ALK5 O +
leads O +
to O +
severe O +
cardiovascular O +
and O +
pharyngeal O +
defects O -
, O +
including O +
inappropriate O +
remodeling O +
of O +
pharyngeal O +
arch O +
arteries O -
, O +
abnormal O +
aortic O +
sac O +
development O -
, O +
failure O +
in O +
pharyngeal O +
organ O +
migration O +
and O +
persistent O +
truncus O +
arteriosus O -
. O +

While O +
ALK5 O +
is O +
not O +
required O +
for O +
neural O +
crest O +
cell O +
migration O -
, O +
our O +
results O +
demonstrate O +
that O +
it O +
plays O +
an O +
important O +
role O +
in O +
the O +
survival O +
of O +
post O -
- O -
migratory O +
cardiac O +
neural O +
crest O +
cells O -
. O +

Conclusion O +
Our O +
results O +
demonstrate O +
that O +
ALK5-mediated O +
signaling O +
in O +
neural O +
crest O +
cells O +
plays O +
an O +
essential O +
cell O -
- O -
autonomous O +
role O +
in O +
the O +
pharyngeal O +
and O +
cardiac O +
outflow O +
tract O +
development O -
. O +

Background O +
A O +
considerable O +
percentage O +
of O +
cardiac O +
birth O +
defects O +
is O +
caused O +
by O +
a O +
failure O +
in O +
normal O +
migration O -
, O +
differentiation O +
or O +
patterning O +
of O +
the O +
cardiac O +
neural O +
crest O +
( O -
CNC O -
) O -
. O +

This O +
subset O +
of O +
pluripotent O +
neural O +
crest O +
stem O +
cells O +
forms O +
in O +
the O +
dorsal O +
aspect O +
of O +
the O +
neural O +
tube O +
at O +
the O +
level O +
of O +
the O +
mid O -
- O -
otic O +
placode O +
to O +
the O +
third O +
somite O +
[ O -
1 O -
] O -
. O +

Subsequently O +
cardiac O +
neural O +
crest O +
cells O +
( O -
CNCCs O -
) O +
delaminate O -
, O +
undergo O +
a O +
phenotypic O +
transformation O +
from O +
an O +
epithelial O +
to O +
mesenchymal O +
cell O +
type O -
, O +
and O +
migrate O +
latero O -
- O -
ventrally O +
into O +
the O +
3rd O -
, O +
4th O +
and O +
6th O +
pharyngeal O +
arch O +
arteries O +
( O -
PAAs O -
) O -
, O +
where O +
they O +
contribute O +
to O +
the O +
formation O +
of O +
the O +
smooth O +
muscle O +
cell O +
layer O +
of O +
endothelial O +
structures O +
derived O +
from O +
the O +
aortic O +
arch O +
arteries O +
[ O -
1 O -
- O -
3 O -
] O -
. O +

A O +
subset O +
of O +
CNCCs O +
continues O +
to O +
migrate O +
deeper O +
into O +
the O +
aortic O +
sac O +
to O +
form O +
the O +
aortico O -
- O -
pulmonary O +
septum O -
; O +
a O +
vital O +
structure O -
, O +
which O +
separates O +
the O +
pulmonary O +
trunk O +
from O +
the O +
aorta O +
[ O -
4 O -
] O -
. O +

An O +
indispensable O +
role O +
of O +
CNCCs O +
in O +
the O +
development O +
of O +
the O +
cardiac O +
outflow O +
tract O +
was O +
originally O +
demonstrated O +
by O +
pioneering O +
studies O +
of O +
Kirby O +
and O +
coworkers O +
[ O -
1 O -
] O -
, O +
who O +
showed O +
that O +
ablation O +
of O +
the O +
CNC O +
in O +
the O +
chick O +
led O +
to O +
severe O +
outflow O +
tract O +
( O -
OFT O -
) O +
defects O +
including O +
persistent O +
truncus O +
arteriosus O +
( O -
PTA O -
) O -
, O +
mispatterning O +
of O +
the O +
great O +
vessels O +
and O +
outflow O +
tract O +
mal O -
- O -
alignments O +
[ O -
5 O -
] O -
. O +

Early O +
migratory O +
CNCCs O +
have O +
been O +
shown O +
to O +
retain O +
a O +
considerable O +
degree O +
of O +
plasticity O +
and O +
their O +
fate O +
is O +
largely O +
controlled O +
by O +
instructional O +
signals O +
from O +
local O +
environments O +
into O +
which O +
NCCs O +
migrate O +
[ O -
6 O -
] O -
. O +

Several O +
recent O +
studies O +
have O +
indicated O +
that O +
members O +
of O +
the O +
TGF O -
- O -
β O +
superfamily O -
, O +
i.e. O -
, O +
TGF O -
- O -
βs O +
and O +
BMPs O +
are O +
likely O +
candidates O +
to O +
provide O +
some O +
of O +
these O +
signals O -
. O +

Mice O +
deficient O +
in O +
TGF O -
- O -
β2 O +
display O +
fourth O +
aortic O +
arch O +
artery O +
defects O +
[ O -
7 O -
] O -
, O +
while O +
neural O +
crest O +
cell O +
specific O +
abrogation O +
of O +
TGF O -
- O -
β O +
type O +
II O +
receptor O +
( O -
Tgfbr2 O -
) O +
results O +
in O +
interruption O +
of O +
the O +
aortic O +
arch O +
and O +
PTA O +
[ O -
8,9 O -
] O -
. O +

BMPs O +
6 O +
and O +
-7 O +
are O +
required O +
for O +
proper O +
formation O +
of O +
the O +
outflow O +
tract O +
cushions O +
[ O -
10 O -
] O -
, O +
while O +
BMP O +
type O +
II O +
receptor O +
is O +
needed O +
for O +
proper O +
development O +
of O +
the O +
conotruncal O +
ridges O +
[ O -
11 O -
] O -
. O +

Moreover O -
, O +
neural O +
crest O -
- O -
specific O +
deletion O +
of O +
the O +
BMP O +
type O +
I O +
receptors O +
Alk2 O +
and O +
Alk3 O +
has O +
been O +
shown O +
to O +
lead O +
to O +
defective O +
aortico O -
- O -
pulmonary O +
septation O -
, O +
among O +
other O +
cardiac O +
defects O +
[ O -
12,13 O -
] O -
. O +

TGF O -
- O -
β O +
subfamily O +
ligands O +
signal O +
via O +
a O +
receptor O +
complex O +
composed O +
of O +
two O +
type O +
II O +
receptors O +
and O +
two O +
type O +
I O +
receptors O +
[ O -
14,15 O -
] O -
. O +

Ligand O +
binding O +
leads O +
to O +
phosphorylation O +
and O +
activation O +
of O +
type O +
I O +
receptors O -
, O +
which O -
, O +
in O +
turn O -
, O +
phosphorylate O +
and O +
activate O +
a O +
specific O +
set O +
of O +
downstream O +
signaling B-Chemical +
molecules I-Chemical +
called O +
Smads O -
. O +

In O +
general O +
terms O -
, O +
TGF O -
- O -
βs O +
bind O +
to O +
the O +
TGF O -
- O -
β O +
type O +
II O +
receptor O +
( O -
TGFβRII O -
) O +
and O +
TGF O -
- O -
β O +
type O +
I O +
receptor O +
( O -
ALK5 O -
) O +
activating O +
TGF O -
- O -
β O +
Smads O +
( O -
2 O +
and O +
3 O -
) O -
, O +
while O +
BMPs O +
bind O +
to O +
the O +
BMP O +
type O +
II O +
receptor O +
and O +
type O +
I O +
receptors O +
ALK2 O -
, O +
-3 O -
, O +
or O +
6 O -
, O +
activating O +
BMP O +
Smads O +
( O -
1 O -
, O +
5 O +
and O +
8) O -
. O +

However O -
, O +
it O +
is O +
likely O +
that O +
these O +
signaling O +
interactions O +
are O +
more O +
complex O +
in O +
vivo O -
, O +
possibly O +
allowing O +
formation O +
of O +
heterotetrameric O +
complexes O +
composed O +
of O +
different O +
type O +
II O +
and O +
type O +
I O +
receptors O +
[ O -
16 O -
] O -
. O +

In O +
addition O -
, O +
recent O +
studies O +
have O +
identified O +
novel O +
TGF O -
- O -
β O -
- O -
related O +
ligands O -
, O +
which O +
can O +
bind O +
to O +
entire O +
different O +
combinations O +
of O +
receptors O -
. O +

For O +
instance O -
, O +
growth O +
and O +
differentiation O +
factors O +
( O -
GDFs O -
) O +
8 O +
and O +
9 O +
can O +
bind O +
to O +
Activin O +
type O +
II O +
receptor O +
and O +
ALK5 O +
to O +
activate O +
TGF O -
- O -
β O +
Smads O +
[ O -
17,18 O -
] O -
. O +

Therefore O -
, O +
we O +
hypothesized O +
that O +
deletion O +
of O +
Alk5 O +
in O +
a O +
specific O +
cell O +
lineage O +
should O +
reveal O +
phenotypes O +
which O +
can O -
not O +
be O +
seen O +
in O +
comparable O +
mutants O +
lacking O +
Tgfbr2 O -
. O +

Indeed O -
, O +
we O +
recently O +
showed O +
that O +
neural O +
crest O +
cell O +
specific O +
Alk5 O +
mutants O +
display O +
a O +
unique O +
spectrum O +
of O +
craniofacial O +
developmental O +
defects O -
, O +
e.g. O -
, O +
cleft O +
snout O +
and O +
severe O +
mandibular O +
hypoplasia O +
[ O -
19 O -
] O -
; O +
these O +
phenotypes O +
were O +
not O +
seen O +
in O +
corresponding O +
Tgfbr2 O +
mutants O +
[ O -
20 O -
] O -
. O +

To O +
determine O -
, O +
whether O +
ALK5 O +
would O +
also O +
mediate O +
unique O +
non O -
- O -
redundant O +
signaling O +
events O +
in O +
cardiac O +
neural O +
crest O +
cells O -
, O +
we O +
focused O +
on O +
cardiac O +
and O +
pharyngeal O +
phenotypes O +
of O +
mouse O +
embryos O +
lacking O +
Alk5 O +
specifically O +
in O +
neural O +
crest O +
cells O -
. O +

We O +
discovered O +
that O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
, O +
pharyngeal O +
organs O +
( O -
thymus O +
and O +
parathyroid O -
) O +
fail O +
to O +
migrate O +
appropriately O -
. O +

Moreover O -
, O +
the O +
mutant O +
embryos O +
display O +
severe O +
aortic O +
sac O +
and O +
pharyngeal O +
arch O +
artery O +
defects O -
, O +
and O +
failed O +
aortico O -
- O -
pulmonary O +
septation O +
leading O +
to O +
PTA O -
. O +

Our O +
data O +
further O +
suggest O +
that O +
at O +
least O +
some O +
of O +
these O +
abnormal O +
detected O +
phenotypes O +
result O +
from O +
a O +
dramatic O +
increase O +
in O +
apoptosis O +
of O +
postmigratory O +
cardiac O +
neural O +
crest O +
cells O -
. O +

These O +
phenotypes O +
differ O +
remarkably O +
from O +
those O +
seen O +
in O +
corresponding O +
Tgfbr2 O +
mutants O -
, O +
suggesting O +
that O +
ALK5 O +
mediates O +
a O +
wider O +
spectrum O +
of O +
signaling O +
events O +
than O +
its O +
classical O +
binding O +
partner O +
TGFβRII O +
in O +
cardiac O +
neural O +
crest O +
cells O +
during O +
cardiac O +
and O +
pharyngeal O +
development O -
. O +

Results O +
Persistent O +
truncus O +
arteriosus O +
and O +
abnormal O +
large O +
vessels O +
in O +
mice O +
lacking O +
Alk5 O +
in O +
cardiac O +
NCCs O +
To O +
inactivate O +
Alk5 O +
in O +
cardiac O +
NCCs O -
, O +
mice O +
homozygous O +
for O +
the O +
floxed O +
Alk5 O +
allele O +
( O -
Alk5Flox O -
/ O -
Flox O -
) O +
[ O -
21 O -
] O +
were O +
crossed O +
with O +
transgenic O +
Wnt1-Cre O +
mice O +
[ O -
22 O -
] O -
, O +
which O +
were O +
also O +
heterozygous O +
for O +
the O +
Alk5 O +
knockout O +
allele O +
( O -
Alk5KO O -
) O +
allele O -
. O +

The O +
resulting O +
mice O +
heterozygous O +
for O +
the O +
Alk5Flox O +
and O +
Alk5KO O +
alleles O -
, O +
which O +
also O +
carried O +
the O +
Wnt1-Cre O +
transgene O -
, O +
had O +
the O +
Alk5 O +
gene O +
specifically O +
inactivated O +
in O +
NCCs O +
( O -
herein O +
termed O +
Alk5 O -
/ O -
Wnt1-Cre O -
) O -
, O +
while O +
the O +
littermates O +
with O +
remaining O +
allelic O +
combinations O +
were O +
phenotypically O +
normal O +
and O +
served O +
as O +
controls O +
( O -
Alk5Flox O -
/ O -
+ O -
, O +
Alk5KO O -
/ O -
+ O -
; O +
Wnt1-Cre O -
) O -
. O +

When O +
embryos O +
were O +
harvested O +
during O +
the O +
last O +
day O +
of O +
gestation O -
, O +
an O +
expected O +
number O +
( O -
25 O -
% O -
) O +
of O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
were O +
recovered O -
. O +

However O -
, O +
all O +
mutant O +
offspring O +
died O +
either O +
during O +
the O +
birth O +
or O +
during O +
the O +
first O +
post O -
- O -
natal O +
hours O -
. O +

To O +
determine O -
, O +
if O +
ALK5-mediated O +
TGF O -
- O -
β O -
- O -
signaling O +
had O +
a O +
role O +
in O +
development O +
of O +
the O +
OFT O +
and O +
large O +
vessels O +
of O +
the O +
aortic O +
arch O -
, O +
we O +
performed O +
casting O +
dye B-Chemical +
experiments O +
on O +
E17 O +
embryos O +
( O -
Fig. O +
1A O -
– O -
D O -
) O -
. O +

In O +
wild O -
- O -
type O +
embryos O +
( O -
Fig. O +
1A O -
) O -
, O +
the O +
aorta O +
was O +
clearly O +
separated O +
from O +
the O +
pulmonary O +
trunk O -
, O +
and O +
the O +
right O +
brachiocephalic O -
, O +
left O +
carotid O +
and O +
left O +
subclavian O +
arteries O +
branched O +
directly O +
off O +
the O +
aortic O +
arch O -
. O +

In O +
contrast O -
, O +
Alk5 O -
/ O -
Wnt1Cre O +
mutant O +
embryos O +
consistently O +
displayed O +
a O +
single O +
prominent O +
arterial O +
trunk O +
( O -
Fig. O +
1C O -
– O -
D O -
) O -
, O +
while O +
corresponding O +
Tgfbr2 O +
mutant O +
embryos O +
( O -
Fig. O +
1B O -
) O +
displayed O +
interrupted O +
aortic O +
arch O -
, O +
as O +
reported O +
earlier O +
[ O -
8 O -
] O -
. O +

Approximately O +
40 O -
% O +
of O +
the O +
Alk5 O +
mutants O +
had O +
a O +
right O -
- O -
sided O +
outflow O +
tract O -
, O +
with O +
the O +
retroesophageal O +
arch O +
connecting O +
to O +
the O +
descending O +
aorta O +
and O +
to O +
the O +
left O +
subclavian O +
artery O -
. O +

The O +
carotid O +
arteries O +
originated O +
either O +
from O +
a O +
common O +
bud O +
located O +
in O +
the O +
ventral O +
side O +
of O +
the O +
ascending O +
arch O -
, O +
or O +
from O +
separate O +
adjacent O +
sites O -
, O +
as O +
verified O +
by O +
serial O +
sectioning O +
( O -
Fig. O +
1M O -
– O -
P O -
) O -
. O +

The O +
remaining O +
mutants O +
displayed O +
a O +
left O -
- O -
sided O +
aortic O +
arch O -
, O +
where O +
the O +
right O +
carotid O +
arteries O +
originated O +
from O +
the O +
right O +
lateral O +
aspect O +
of O +
the O +
ascending O +
trunk O -
, O +
while O +
the O +
left O +
carotid O +
arteries O +
budded O +
from O +
the O +
ventral O +
or O +
right O +
ventral O +
aspects O +
of O +
the O +
trunk O +
( O -
Fig. O +
1I O -
– O -
L O -
) O -
. O +

Both O +
right O +
and O +
left O +
subclavian O +
arteries O +
consistently O +
originated O +
from O +
the O +
descending O +
part O +
of O +
the O +
aortic O +
arch O -
. O +

Similarly O -
, O +
in O +
all O +
mutants O +
both O +
left O +
and O +
right O +
pulmonary O +
arteries O +
always O +
branched O +
out O +
from O +
the O +
common O +
arterial O +
trunk O -
. O +

To O +
conclude O -
, O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
consistently O +
displayed O +
PTA O -
, O +
which O +
differed O +
significantly O +
from O +
the O +
characteristic O +
interrupted O +
aortic O +
arch O +
phenotype O +
seen O +
in O +
Tgfbr2 O -
/ O -
Wnt1-Cre O +
mutants O +
[ O -
8,9 O -
] O -
. O +

Figure O +
1 O +
Abrogation O +
of O +
Alk5 O +
in O +
neural O +
crest O +
cells O +
leads O +
to O +
persistent O +
truncus O +
arteriosus O +
type O +
A2 O -
. O +

A O -
- O -
D O -
, O +
Casting O -
- O -
dye B-Chemical +
analysis O +
of O +
OFT O +
morphogenesis O +
at O +
E17.0 O -
. O +

Control O +
( O -
A O -
) O -
, O +
Tgfbr2 O -
/ O -
Wnt1-Cre O +
mutant O +
[ O -
8 O -
] O +
( O -
B O -
) O +
demonstrating O +
the O +
PTA O +
type O +
A4 O +
(= O +
truncus O +
arteriosus O +
with O +
interrupted O +
aortic O +
arch O +
[ O -
30 O -
] O -
) O +
and O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
demonstrating O +
the O +
right O -
- O -
sided O +
( O -
C O -
) O +
and O +
left O -
- O -
sided O +
( O -
D O -
) O +
arches O +
of O +
the O +
truncus O -
. O +

E O -
- O -
P O -
, O +
Histological O +
cross O -
- O -
sections O +
on O +
four O +
different O +
levels O +
( O -
rostral O +
to O +
caudal O -
) O +
at O +
E17.0 O -
. O +

In O +
a O +
control O +
( O -
E O -
- O -
H O -
) O -
, O +
the O +
ascending O +
aorta O +
( O -
Ao O -
) O +
and O +
pulmonary O +
trunk O +
( O -
PT O -
) O +
are O +
separated O +
by O +
the O +
conotruncal O +
septum O -
. O +

In O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
( O -
I O -
- O -
P O -
) O +
the O +
conotruncal O +
septum O +
fails O +
to O +
form O -
, O +
and O +
either O +
left O -
- O -
sided O +
( O -
I O -
- O -
L O -
) O +
or O +
right O -
- O -
sided O +
( O -
M O -
- O -
P O -
) O +
aortic O +
arch O +
can O +
be O +
seen O -
. O +

Aberrant O +
branching O +
of O +
carotid O +
arteries O +
from O +
the O +
truncus O +
has O +
been O +
illustrated O +
by O +
black O +
arrows O +
( O -
J O +
and O +
M O -
) O -
. O +

Ao O -
, O +
aorta O -
; O +
PT O -
, O +
pulmonary O +
trunk O -
; O +
RSA O -
, O +
right O +
subclavian O +
artery O -
; O +
RCA O -
, O +
right O +
carotid O +
artery O -
; O +
LCA O -
; O +
left O +
carotid O +
artery O -
; O +
LSA O -
, O +
left O +
subclavian O +
artery O -
; O +
IAA O -
, O +
interrupted O +
aortic O +
arch O -
; O +
PTA O -
, O +
persistent O +
truncus O +
arteriosus O -
. O +

Abnormal O +
patterning O +
of O +
the O +
pharyngeal O +
arch O +
arteries O +
and O +
aortic O +
sac O +
in O +
Alk5 O -
/ O -
Wnt1Cre O +
mutants O +
During O +
cardiovascular O +
development O -
, O +
the O +
PAAs O +
undergo O +
a O +
complex O +
set O +
of O +
sequential O +
asymmetric O +
remodeling O +
steps O +
resulting O +
in O +
the O +
left O -
- O -
sided O +
aortic O +
arch O -
. O +

To O +
determine O -
, O +
whether O +
ALK5-mediated O +
signaling O +
was O +
involved O +
in O +
remodeling O +
of O +
PAAs O -
, O +
we O +
performed O +
intracardiac O +
India O +
ink O +
injections O +
at O +
different O +
developmental O +
stages O -
. O +

While O +
at O +
E10 O -
, O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
did O +
not O +
show O +
obvious O +
differences O +
in O +
the O +
PAAs O -
, O +
abnormal O +
remodeling O +
became O +
obvious O +
in O +
mutants O +
a O +
day O +
later O +
at O +
E11 O +
( O -
Fig. O +
2 O -
) O -
. O +

The O +
controls O +
displayed O +
the O +
well O -
- O -
formed O +
3rd O -
, O +
4th O +
and O +
6th O +
PAAs O -
. O +

Moreover O -
, O +
the O +
carotid O +
duct O +
( O -
the O +
dorsal O +
aorta O +
between O +
the O +
3rd O +
and O +
4th O +
PAAs O -
) O +
was O +
already O +
regressing O +
as O +
demonstrated O +
by O +
the O +
reduced O +
size O +
( O -
Fig. O +
2A O -
) O -
. O +

In O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
, O +
the O +
3rd O +
and O +
4th O +
pairs O +
of O +
PAAs O +
were O +
bilaterally O +
hypoplastic O -
, O +
whereas O +
the O +
6th O +
pair O +
of O +
PAAs O +
was O +
notably O +
hyperplastic O +
( O -
Fig. O +
2B O -
) O -
. O +

Furthermore O -
, O +
the O +
carotid O +
duct O +
was O +
remarkably O +
large O -
, O +
when O +
compared O +
to O +
controls O -
. O +

While O +
the O +
controls O +
displayed O +
an O +
interruption O +
of O +
the O +
carotid O +
duct O +
at O +
E12 O +
and O +
E13 O +
as O +
expected O +
( O -
Fig. O +
2C O -
) O -
, O +
the O +
mutants O +
demonstrated O +
an O +
uncharacteristic O +
break O +
of O +
the O +
dorsal O +
aorta O +
between O +
the O +
4th O +
and O +
6th O +
pairs O +
of O +
PAAs O +
( O -
Fig. O +
2D O -
) O -
. O +

Figure O +
2 O +
Abnormal O +
patterning O +
of O +
the O +
PAAs O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
. O +

Left O +
lateral O +
view O +
after O +
intracardiac O +
ink O +
injections O +
to O +
visualize O +
the O +
developing O +
PAAs O +
at O +
E11.0 O +
( O -
A O -
, O -
B O -
) O -
, O +
E12.0 O +
( O -
C O -
, O +
D O -
) O +
and O +
E13.0 O +
( O -
E O -
, O +
F O -
) O +
in O +
controls O +
( O -
A O -
, O +
C O -
, O +
E O -
) O +
and O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
( O -
B O -
, O +
D O -
, O +
F O -
) O -
. O +

Arrow O +
in O +
A O +
points O +
to O +
the O +
regressing O +
carotid O +
duct O -
. O +

Asterisk O +
in O +
B O +
depicts O +
the O +
corresponding O +
structure O +
in O +
the O +
mutant O +
with O +
no O +
signs O +
of O +
regression O -
. O +

Asterisk O +
in O +
D O +
illustrates O +
the O +
aberrant O +
regression O +
of O +
the O +
dorsal O +
aorta O +
between O +
the O +
4th O +
and O +
6th O +
PAAs O -
. O +

PT O -
, O +
pulmonary O +
trunk O -
; O +
Ao O -
, O +
Aorta O -
; O +
TA O -
, O +
truncus O +
arteriosus O -
. O +

Around O +
E11.5 O -
, O +
the O +
aortic O +
sac O +
normally O +
forms O +
a O +
distinctive O +
T O -
- O -
shaped O +
structure O -
, O +
as O +
seen O +
in O +
frontal O +
sections O +
of O +
the O +
control O +
sample O +
in O +
Fig. O +
3 O -
( O -
A O -
, O -
C O -
) O -
. O +

Subsequently O -
, O +
the O +
right O +
horn O +
of O +
this O +
structure O +
transforms O +
into O +
the O +
prospective O +
brachiocephalic O +
artery O -
, O +
while O +
the O +
left O +
horn O +
together O +
with O +
the O +
left O +
4th O +
PAA O +
gives O +
rise O +
to O +
the O +
definitive O +
aortic O +
arch O +
[ O -
23 O -
] O -
. O +

In O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
, O +
the O +
T O -
- O -
shaped O +
aortic O +
sac O +
failed O +
to O +
form O +
( O -
Fig. O +
3B O -
, O -
D O -
) O -
. O +

Instead O -
, O +
the O +
truncus O +
bifurcated O +
to O +
a O +
left O +
and O +
right O +
arm O -
, O +
which O +
further O +
branched O +
to O +
the O +
PAAs O -
, O +
particularly O +
to O +
the O +
predominant O +
pair O +
of O +
6th O +
PAAs O +
( O -
Fig. O +
3B O -
, O -
D O -
) O -
. O +

The O +
observed O +
phenotype O +
is O +
consistent O +
with O +
the O +
absence O +
or O +
severe O +
hypoplasia O +
of O +
structures O +
derived O +
from O +
the O +
aortic O +
sac O +
in O +
late O +
stage O +
embryos O +
( O -
E17 O -
) O -
, O +
e.g. O -
, O +
the O +
missing O +
brachiocephalic O +
artery O +
and O +
severe O +
shortening O +
of O +
the O +
ascending O +
truncus O +
as O +
shown O +
in O +
the O +
Figure O +
1 O -
. O +

Figure O +
3 O +
Abnormal O +
Aortic O +
Sac O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
. O +

Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
( O -
B O -
, O +
D O -
) O +
fail O +
to O +
form O +
the O +
typical O +
T O -
- O -
shaped O +
structure O +
of O +
the O +
aortic O +
sac O +
seen O +
in O +
controls O +
at O +
E11.5 O -
. O +

( O -
A O -
, O +
C O -
) O -
. O +

A O -
- O -
B O -
, O +
frontal O +
image O +
of O +
ink O -
- O -
injected O +
embryos O -
; O +
C O -
- O -
D O -
, O +
frontal O +
sections O +
( O -
H&E B-Chemical +
staining O -
) O -
. O +

Arrows O +
in O +
A O +
and O +
B O +
point O +
to O +
the O +
level O +
of O +
section O +
shown O +
in O +
C O +
and O +
D O +
( O -
red O +
arrows O +
in O +
C O +
and O +
D O +
point O +
to O +
the O +
aortic O +
sac O +
of O +
the O +
control O +
and O +
mutant O -
, O +
respectively O -
) O -
. O +

Cardiac O +
NCCs O +
deficient O +
in O +
Alk5 O +
can O +
populate O +
the O +
outflow O +
tract O +
Next O +
we O +
used O +
the O +
R26R O +
lineage O -
- O -
tracing O +
assay O +
to O +
determine O +
whether O +
CNCCs O +
could O +
appropriately O +
populate O +
the O +
outflow O +
tract O +
region O -
. O +

Briefly O -
, O +
Alk5Flox O -
/ O -
Flox O +
mice O +
were O +
crossed O +
with O +
the O +
ROSA26 O +
Cre O +
reporter O +
mice O -
, O +
and O +
subsequently O +
Alk5Flox O -
/ O -
Flox;R26R O -
( O -
+ O -
/ O -
+ O -
) O +
females O +
were O +
crossed O +
with O +
Alk5KO O -
/ O -
WT;Wnt1-Cre O +
males O -
. O +

The O +
resulting O +
embryos O +
had O +
the O +
NC O -
- O -
lineage O +
permanently O +
labeled O +
with O +
β O -
- O -
galactosidase O +
expression O -
, O +
and O +
displayed O +
identical O +
phenotypes O +
to O +
those O +
obtained O +
without O +
the O +
R26R O +
reporter O -
. O +

Staining O +
of O +
embryos O +
for O +
β O -
- O -
galactosidase O +
at O +
E8-E11 O +
did O +
not O +
reveal O +
detectable O +
differences O +
in O +
NCC O +
migration O +
between O +
mutants O +
and O +
controls O +
( O -
data O +
not O +
shown O -
) O -
. O +

Similarly O -
, O +
serial O +
transverse O +
sectioning O +
of O +
whole O +
mount O +
embryos O +
( O -
E10-E12 O -
) O +
and O +
subsequent O +
analysis O +
of O +
positively O +
stained O +
cells O +
in O +
the O +
OFT O +
region O +
demonstrated O +
that O +
CNCCs O +
deficient O +
in O +
Alk5 O +
were O +
capable O +
of O +
populating O +
the O +
PAAs O -
, O +
aortic O +
sac O +
and O +
conotruncal O +
ridges O +
at O +
a O +
level O +
comparable O +
to O +
that O +
of O +
controls O +
( O -
Fig O +
4 O -
) O -
. O +

To O +
conclude O -
, O +
the O +
observed O +
phenotypes O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
were O +
certainly O +
not O +
due O +
to O +
defective O +
migration O +
of O +
CNCCs O +
to O +
the O +
pharyngeal O +
and O +
outflow O +
tract O +
regions O -
. O +

Figure O +
4 O +
Normal O +
cardiac O +
NCC O +
migration O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
. O +

The O +
OFT O +
of O +
controls O +
( O -
A O -
, O +
C O -
, O +
E O -
) O +
and O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
( O -
B O -
, O +
D O -
, O +
F O -
) O +
display O +
similar O +
staining O +
patterns O +
when O +
analyzed O +
using O +
the O +
R26R O +
lineage O +
tracing O +
assay O +
at O +
E11.0 O -
. O +

A O -
- O -
B O -
, O +
whole O +
mount O +
staining O +
( O -
left O +
lateral O +
image O -
) O -
; O +
C O -
- O -
F O -
, O +
transverse O +
sections O +
on O +
the O +
level O +
of O +
the O +
4th O +
( O -
C O -
, O +
D O -
) O +
and O +
6th O +
( O -
E O -
, O +
F O -
) O +
PAAs O -
. O +

Arrows O +
( O -
A O -
- O -
F O -
) O +
point O +
to O +
the O +
most O +
proximal O +
location O +
staining O +
positive O +
for O +
the O +
β O -
- O -
galactosidase O +
activity O -
. O +

Aortic O +
sac O +
and O +
aortico O -
- O -
pulmonary O +
septal O +
defects O +
in O +
Alk5 O -
/ O -
Wnt1Cre O +
mutant O +
embryos O +
Septation O +
of O +
the O +
outflow O +
tract O +
lumen O +
begins O +
in O +
a O +
cranial O -
- O -
to O -
- O -
caudal O +
direction O -
, O +
starting O +
distally O +
in O +
the O +
aortic O +
sac O +
and O +
proceeding O +
toward O +
the O +
heart O +
[ O -
24 O -
] O -
. O +

Initially O -
, O +
the O +
condensed O +
mesenchyme O +
derived O +
from O +
the O +
NC O +
forms O +
in O +
the O +
base O +
of O +
the O +
aortic O +
sac O +
between O +
the O +
origins O +
of O +
4th O +
and O +
6th O +
PAAs O -
. O +

Subsequently O -
, O +
two O +
prongs O +
of O +
the O +
developing O +
aortico O -
- O -
pulmonary O +
( O -
AP O -
) O +
septum O +
extend O +
into O +
the O +
truncal O +
cushions O +
and O +
the O +
aortico O -
- O -
pulmonary O +
septation O +
complex O +
crosses O +
the O +
aortic O +
sac O +
cranially O -
. O +

In O +
ink O -
- O -
injected O +
control O +
embryos O +
at O +
E11.5 O -
, O +
a O +
characteristic O +
conotruncal O +
transition O +
separating O +
the O +
truncus O +
and O +
conus O +
could O +
be O +
seen O +
as O +
a O +
twisted O +
configuration O -
, O +
resulting O +
from O +
a O +
change O +
in O +
orientation O +
of O +
the O +
truncal O +
and O +
conal O +
cushions O +
( O -
Fig. O +
5 O -
) O -
. O +

In O +
contrast O -
, O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
the O +
outflow O +
tract O +
appeared O +
unusually O +
straight O -
, O +
failing O +
to O +
demonstrate O +
the O +
distinct O +
conotruncal O +
transition O +
( O -
Fig. O +
5B O -
, O -
D O -
) O -
. O +

This O +
assay O +
also O +
clearly O +
showed O +
a O +
dramatic O +
reduction O +
in O +
the O +
size O +
of O +
the O +
aortic O +
sac O -
. O +

Histological O +
analysis O +
of O +
control O +
samples O +
displayed O +
the O +
characteristic O +
rotation O +
of O +
the O +
aortic O +
sac O +
and O +
truncal O +
OFT O +
at O +
the O +
level O +
where O +
the O +
AP O +
septation O +
takes O +
place O +
and O +
verified O +
the O +
presence O +
of O +
the O +
distinctive O +
condensed O +
AP O -
- O -
septal O +
mesenchyme O -
, O +
which O +
gradually O +
divided O +
the O +
OFT O +
to O +
the O +
aorta O +
and O +
the O +
pulmonary O +
trunk O +
( O -
asterisks O +
in O +
Fig. O +
6A O -
) O -
. O +

R26R O +
lineage O +
tracing O +
showed O +
that O +
this O +
tissue O +
is O +
derived O +
from O +
the O +
NC O -
, O +
while O +
immunostaining O +
for O +
α O -
- O -
SMA O +
showed O +
differentiation O +
into O +
smooth O +
muscle O +
( O -
Fig O +
6B O -
) O -
. O +

In O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
the O +
characteristic O +
rotation O +
of O +
the O +
aortic O +
sac O +
and O +
truncal O +
OFT O +
fails O +
to O +
take O +
place O +
( O -
Fig. O +
6G O -
– O -
L O -
) O -
, O +
and O +
a O +
properly O +
formed O +
AP O -
- O -
septum O +
was O +
not O +
detectable O +
( O -
Fig. O +
6G O -
, O -
H O -
) O -
. O +

R26R O +
lineage O +
tracing O +
demonstrated O +
that O +
the O +
defects O +
were O +
not O +
due O +
to O +
failure O +
of O +
NCCs O +
to O +
reach O +
the O +
OFT O +
region O -
. O +

NC O -
- O -
derived O +
cells O +
around O +
the O +
abnomally O +
bifurcated O +
aortic O +
sac O -
, O +
the O +
abnormally O +
large O +
sixth O +
PAAs O +
and O +
the O +
truncus O +
demonstrated O +
strong O +
αSMA O +
staining O +
( O -
Fig. O +
6H O -
, O -
J O -
, O -
L O -
) O -
. O +

Recently O -
, O +
we O +
showed O +
that O +
the O +
NC O -
- O -
specific O +
mutants O +
of O +
the O +
related O +
type O +
I O +
receptor O -
, O +
Alk2 O -
, O +
display O +
PTA O +
as O +
well O +
[ O -
12 O -
] O -
. O +

In O +
Alk2 O -
/ O -
Wnt1-Cre O +
mutants O -
, O +
the O +
rotation O +
of O +
the O +
aortic O +
sac O +
and O +
truncal O +
OFT O +
failed O +
to O +
occur O +
( O -
Fig. O +
6M O -
– O -
R O -
) O +
as O +
seen O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
. O +

However O -
, O +
in O +
Alk2 O +
mutants O +
the O +
6th O +
pair O +
of O +
the O +
PAAs O +
was O +
grossly O +
hypoplastic O -
, O +
and O +
while O +
the O +
Alk2 O -
/ O -
Wnt1-Cre O +
mutants O +
displayed O +
a O +
noticeable O +
amount O +
of O +
septal O +
tissue O +
between O +
the O +
4th O +
and O +
6th O +
PAAs O +
( O -
Fig. O +
6M O -
, O -
N O -
) O -
, O +
the O +
condensed O +
septal O +
mesenchyme O +
lacking O +
Alk2 O +
failed O +
to O +
extend O +
the O +
prongs O +
into O +
the O +
truncal O +
cushions O +
and O +
to O +
form O +
the O +
AP O +
septum O -
. O +

Concurrently O -
, O +
the O +
6th O +
PAAs O +
were O +
losing O +
their O +
patency O -
, O +
which O +
may O +
have O +
further O +
contributed O +
to O +
the O +
failed O +
AP O +
septation O +
( O -
Fig. O +
6M O -
, O -
O O -
, O -
Q O -
) O -
. O +

While O +
CNCCs O +
managed O +
to O +
migrate O +
to O +
the O +
aortic O +
sac O +
and O +
the O +
truncal O +
cushion O +
level O +
( O -
Fig. O +
6N O -
, O -
P O -
, O -
R O -
) O -
, O +
immunostaining O +
for O +
αSMA O +
appeared O +
much O +
weaker O +
when O +
compared O +
to O +
controls O +
and O +
Alk5 O +
mutants O -
, O +
implying O +
that O +
ALK2-mediated O +
signaling O +
is O +
involved O +
in O +
smooth O +
muscle O +
cell O +
differentiation O +
as O +
previously O +
suggested O +
[ O -
12 O -
] O -
. O +

To O +
conclude O -
, O +
while O +
both O +
Alk2 O +
and O +
Alk5 O +
mutants O +
demonstrate O +
a O +
failure O +
in O +
both O +
the O +
rotation O +
of O +
the O +
aortic O +
sac O +
and O +
the O +
truncal O +
OFT O -
, O +
and O +
in O +
the O +
formation O +
of O +
the O +
AP O +
septum O -
, O +
the O +
pathogenetic O +
mechanisms O +
behind O +
these O +
defects O +
appear O +
remarkably O +
different O -
. O +

Figure O +
5 O +
The O +
truncal O +
OFT O +
fails O +
to O +
rotate O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
. O +

Left O +
( O -
A O -
, O +
C O -
) O +
and O +
right O +
( O -
B O -
, O +
D O -
) O +
lateral O +
images O +
of O +
ink O -
- O -
injected O +
control O +
( O -
A O -
- O -
B O -
) O +
and O +
mutant O +
( O -
C O -
- O -
D O -
) O +
embryos O +
at O +
E11.5 O +
demonstrate O +
the O +
abnormally O +
straight O +
OFT O +
in O +
mutants O +
lacking O +
the O +
typical O +
conotruncal O +
transition O +
( O -
black O +
arrow O +
in O +
A O +
vs. O +
black O +
arrowhead O +
in O +
C O -
) O +
seen O +
in O +
control O -
. O +

Red O +
arrowhead O +
( O -
C O -
) O +
points O +
to O +
the O +
abnormally O +
shaped O +
aortic O +
sac O -
. O +

Red O +
" O -
s O -
" O -
, O +
aortic O +
sac O -
; O +
t O -
, O +
truncus O -
; O +
c O -
, O +
conus O -
. O +

Figure O +
6 O +
Signaling O +
via O +
ALK5 O +
and O +
ALK2 O +
controls O +
different O +
aspects O +
of O +
aortico O -
- O -
pulmonary O +
septation O -
. O +

Frontal O +
sections O +
from O +
distal O +
( O -
top O +
row O -
) O +
to O +
proximal O +
( O -
bottom O +
row O -
) O +
of O +
the O +
control O +
( O -
A O -
- O -
F O -
) O -
, O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutant O +
( O -
G O -
- O -
L O -
) O +
and O +
Alk2 O -
/ O -
Wnt1-Cre O +
mutant O +
( O -
M O -
- O -
R O -
) O +
samples O +
( O -
E11.5 O -
) O -
. O +

A O -
, O +
C O -
, O +
E O -
, O +
G O -
, O +
I O -
, O +
K O -
, O +
M O -
, O +
O O -
, O +
Q O -
, O +
H&E B-Chemical +
staining O -
; O +
B O -
, O +
D O -
, O +
F O -
, O +
H O -
, O +
J O -
, O +
L O -
, O +
N O -
, O +
P O -
, O +
R O -
, O +
double O +
staining O +
for O +
αSMA O +
( O -
brown O -
) O +
and O +
β O -
- O -
galactosidase O +
( O -
green O -
; O +
R26R O +
reporter O +
assay O -
) O -
. O +

6 O -
, O +
the O +
6th O +
PAA O -
; O +
AS O -
, O +
aortic O +
sac O -
; O +
TA O -
, O +
truncus O +
arteriosus O -
; O +
Ao O -
, O +
Aorta O -
; O +
PT O -
, O +
pulmonary O +
trunk O -
; O +
Asterisks O +
in O +
A O -
, O +
B O -
, O +
M O +
and O +
N O +
depict O +
the O +
AP O +
septal O +
mesenchyme O -
. O +

Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
display O +
increased O +
apoptosis O +
of O +
post O -
- O -
migratory O +
neural O +
crest O +
cells O +
As O +
described O +
above O -
, O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
displayed O +
an O +
inadequate O +
amount O +
of O +
AP O -
- O -
septal O +
tissue O +
in O +
the O +
base O +
of O +
the O +
aortic O +
sac O +
between O +
the O +
origins O +
of O +
4th O +
and O +
6th O +
PAAs O -
. O +

To O +
analyze O +
whether O +
this O +
phenotype O +
resulted O +
either O +
from O +
defective O +
CNCC O +
proliferation O +
or O +
inappropriate O +
apoptosis O -
, O +
we O +
used O +
BrdU B-Chemical +
and O +
TUNEL O +
staining O -
, O +
respectively O -
. O +

While O +
CNCC O +
proliferation O +
was O +
not O +
affected O +
in O +
Alk5 O +
mutants O +
( O -
data O +
not O +
shown O -
) O -
, O +
we O +
could O +
detect O +
a O +
dramatic O +
increase O +
in O +
the O +
number O +
of O +
TUNEL O +
positive O +
cells O +
in O +
tissues O +
surrounding O +
the O +
aortic O +
sac O +
including O +
the O +
site O +
where O +
the O +
AP O -
- O -
septum O +
forms O +
( O -
Fig. O +
7A O -
– O -
C O -
) O -
. O +

Dual O +
staining O +
for O +
lacZ O +
and O +
TUNEL O +
positive O +
cells O +
demonstrated O +
that O +
these O +
cells O +
were O +
postmigratory O +
CNCCs O -
; O +
this O +
phenotype O +
was O +
already O +
clearly O +
detectable O +
at O +
E10.5 O -
. O +

These O +
results O +
were O +
confirmed O +
by O +
using O +
immunostaining O +
for O +
cleaved O +
caspase-3 O -
, O +
another O +
marker O +
for O +
apoptosis O +
( O -
Fig. O +
7I O -
, O -
J O -
) O -
. O +

In O +
the O +
chick O -
, O +
apoptotic O +
neural O +
crest O -
- O -
derived O +
cells O +
have O +
also O +
been O +
found O +
at O +
the O +
sites O -
, O +
where O +
the O +
prongs O +
of O +
the O +
AP O +
septum O +
penetrate O +
into O +
the O +
OFT O +
cushion O +
mesenchyme O +
[ O -
25,26 O -
] O -
. O +

Thus O -
, O +
we O +
compared O +
apoptosis O +
patterns O +
also O +
on O +
the O +
more O +
proximal O +
level O -
, O +
but O +
found O +
no O +
detectable O +
differences O +
at O +
E11.0 O +
between O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
and O +
controls O +
( O -
Fig. O +
7D O -
, O -
E O -
) O -
. O +

Unlike O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutant O +
embryos O -
, O +
increased O +
apoptosis O +
of O +
NC O -
- O -
derived O +
cells O +
is O +
not O +
responsible O +
for O +
the O +
observed O +
defects O +
in O +
the O +
OFT O +
septation O +
in O +
corresponding O +
Alk2 O +
mutants O +
( O -
Fig. O +
7C O -
, O -
E O -
) O -
. O +

Figure O +
7 O +
Aberrant O +
apoptosis O +
of O +
NCCs O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
. O +

TUNEL O +
( O -
A O -
- O -
H O -
) O +
and O +
Cleaved O +
Caspase-3 O +
( O -
I O -
, O +
J O -
) O +
staining O +
at O +
E11.0 O +
demonstrates O +
a O +
notable O +
increase O +
in O +
apoptosis O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
( O -
B O -
, O +
H O -
, O +
J O -
) O +
on O +
the O +
aortic O +
sac O +
level O +
when O +
compared O +
to O +
controls O +
( O -
A O -
, O +
G O -
, O +
I O -
) O +
or O +
Alk2 O -
/ O -
Wnt1-Cre O +
mutants O +
( O -
C O -
) O +
( O -
frontal O +
sections O -
) O -
, O +
while O +
sections O +
on O +
the O +
OFT O +
level O +
do O +
not O +
demonstrate O +
differences O +
between O +
controls O +
( O -
D O -
) O +
and O +
Alk5 O +
( O -
E O -
) O +
or O +
Alk2 O +
( O -
F O -
) O +
mutants O -
. O +

G O -
, O -
H O -
, O +
TUNEL O +
staining O +
of O +
lacZ O -
- O -
stained O +
embryos O +
demonstrates O +
that O +
apoptotic O +
cells O +
are O +
of O +
neural O +
crest O +
origin O -
. O +

G O -
, O +
control O -
; O +
H O -
, O +
mutant O -
. O +

AS O -
, O +
aortic O +
sac O -
, O +
arrows O +
point O +
to O +
clusters O +
of O +
apoptotic O +
cells O +
surrounding O +
the O +
aortic O +
sac O -
. O +

To O +
conclude O -
, O +
our O +
results O +
suggest O +
that O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
a O +
noticeable O +
increase O +
in O +
apoptosis O +
coincides O +
with O +
the O +
abnormal O +
patterning O +
of O +
the O +
PAAs O +
and O +
the O +
aortic O +
sac O -
, O +
and O +
with O +
the O +
failed O +
AP O -
- O -
septation O -
. O +

These O +
data O +
support O +
a O +
specific O +
role O +
for O +
ALK5 O +
signaling O -
, O +
either O +
directly O +
or O +
indirectly O -
, O +
in O +
CNCC O +
survival O -
, O +
since O +
a O +
similar O +
apoptosis O +
of O +
NC O -
- O -
derived O +
cells O +
is O +
not O +
seen O +
in O +
Tgfbr2 O -
/ O -
Wnt1-Cre O +
mutants O +
[ O -
8,9 O -
] O -
. O +

Pharyngeal O +
organs O +
fail O +
to O +
migrate O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
In O +
addition O +
to O +
the O +
cardiac O +
OFT O -
, O +
development O +
of O +
pharyngeal O +
organs O -
, O +
i.e. O -
, O +
the O +
parathyroid O +
glands O +
and O +
the O +
thymus O +
was O +
also O +
abnormal O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
( O -
see O +
Figs. O +
1 O +
and O +
8) O -
. O +

Normally O +
the O +
thymus O +
develops O +
from O +
the O +
third O +
pharyngeal O +
pouch O +
endoderm O +
and O +
migrates O +
caudally O +
to O +
its O +
final O +
location O +
in O +
the O +
superior O +
mediastinum O +
as O +
seen O +
in O +
controls O +
at O +
E14 O +
( O -
Fig. O +
8A O -
, O -
B O -
) O -
. O +

In O +
contrast O -
, O +
the O +
thymic O +
primordia O +
of O +
the O +
Alk5 O +
mutant O +
littermates O +
failed O +
to O +
descend O +
caudally O -
, O +
and O +
were O +
located O +
bilaterally O +
in O +
the O +
neck O +
region O -
, O +
where O +
they O +
were O +
surrounded O +
by O +
neural O +
crest O -
- O -
derived O +
mesenchyme O +
( O -
Fig. O +
8D O -
, O -
E O -
) O -
. O +

The O +
fate O +
determination O +
assay O +
demonstrated O +
that O +
the O +
thymic O +
primordia O +
were O +
equally O +
populated O +
by O +
NCCs O +
both O +
in O +
controls O +
and O +
Alk5 O +
mutants O +
( O -
Fig. O +
8B O -
, O -
E O -
) O -
. O +

Likewise O +
the O +
parathyroid O +
glands O +
failed O +
to O +
migrate O +
normally O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
. O +

During O +
normal O +
development O -
, O +
the O +
parathyroids O +
first O +
migrate O +
in O +
association O +
with O +
the O +
thymic O +
primordia O -
, O +
until O +
they O +
reach O +
the O +
thyroids O +
in O +
the O +
neck O +
region O +
as O +
seen O +
in O +
Fig O +
8C O -
. O +

In O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
, O +
the O +
parathyroids O +
remained O +
associated O +
with O +
the O +
thymic O +
primordia O -
, O +
and O +
despite O +
this O +
abnormal O +
rostral O +
location O -
, O +
expression O +
of O +
parathyroid O +
hormone O +
was O +
indistinguishable O +
between O +
Alk5 O +
mutants O +
and O +
controls O +
at O +
E14 O +
( O -
Fig. O +
8C O -
, O -
F O -
) O -
. O +

To O +
conclude O -
, O +
the O +
observed O +
pharyngeal O +
organ O +
phenotypes O +
were O +
also O +
in O +
striking O +
contrast O +
to O +
those O +
seen O +
in O +
Tgfbr2 O -
/ O -
Wnt1-Cre O +
mutants O +
[ O -
8,9 O -
] O -
. O +

Figure O +
8 O +
Pharyngeal O +
organs O +
fail O +
to O +
migrate O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
. O +

At O +
E14.0 O -
, O +
the O +
thymus O +
was O +
not O +
detectable O +
in O +
the O +
superior O +
mediastinum O +
( O -
asterisks O -
) O +
in O +
Alk5 O +
mutants O +
( O -
D O -
) O -
, O +
when O +
compared O +
to O +
controls O +
( O -
A O -
) O -
. O +

Serial O +
sectioning O +
revealed O +
that O +
the O +
thymic O +
primordia O +
had O +
failed O +
to O +
descend O +
and O +
were O +
seen O +
bilaterally O +
in O +
the O +
upper O +
pharyngeal O +
region O +
( O -
E O -
, O +
F O -
) O +
surrounded O +
by O +
neural O +
crest O +
derived O +
mesenchyme O +
( O -
blue O +
staining O +
cells O +
in O +
E O -
) O -
. O +

In O +
controls O -
, O +
the O +
parathyroid O +
glands O +
were O +
properly O +
associated O +
with O +
the O +
thyroid O +
glands O +
( O -
arrows O +
in O +
C O -
) O -
, O +
while O +
in O +
Alk5 O +
mutants O +
the O +
parathyroid O +
glands O +
were O +
associated O +
with O +
the O +
thymic O +
primordia O +
( O -
arrows O +
in O +
F O -
) O -
. O +

However O -
, O +
both O +
controls O +
and O +
mutants O +
expressed O +
parathyroid O +
hormone O +
( O -
PTH O -
) O +
at O +
comparable O +
levels O +
( O -
blue O +
staining O +
in O +
C O +
and O +
F O -
) O -
. O +

A O +
and O +
D O -
, O +
hematoxyllin B-Chemical +
and O +
eosin O +
staining O -
; O +
B O +
and O +
E O -
, O +
R26 O +
R O +
lineage O +
tracing O +
assay O +
– O +
counterstaining O +
with O +
eosin O -
; O +
C O +
and O +
F O -
, O +
section O +
in O +
situ O +
hybridization O +
for O +
PTH O +
– O +
counterstaining O +
with O +
eosin O -
. O +

T O -
, O +
thymus O -
; O +
Th O -
, O +
thyroid O -
; O +
asterisks O +
in O +
D O +
depict O +
the O +
absence O +
of O +
the O +
thymic O +
primordia O -
; O +
asterisks O +
in O +
E O +
and O +
F O +
depict O +
the O +
tongue O -
. O +

Discussion O +
During O +
the O +
last O +
few O +
years O +
the O +
Wnt1-Cre O +
transgenic O +
driver O +
line O +
has O +
proven O +
to O +
be O +
a O +
powerful O +
tool O +
for O +
tissue O -
- O -
specific O +
gene O +
deletion O +
in O +
NCCs O +
[ O -
12,13,27,28 O -
] O -
. O +

Using O +
this O +
approach O -
, O +
several O +
studies O +
have O +
independently O +
shown O +
that O +
the O +
NC O -
- O -
specific O +
deletion O +
of O +
the O +
Tgfbr2 O +
gene O +
leads O +
to O +
a O +
distinct O +
set O +
of O +
calvarial O -
, O +
facial O +
and O +
cardiac O +
defects O +
[ O -
8,9,20,29 O -
] O -
. O +

Interestingly O -
, O +
these O +
defects O +
appear O +
quite O +
different O +
both O +
in O +
the O +
craniofacial O +
and O +
pharyngeal O +
regions O -
, O +
including O +
the O +
heart O -
, O +
when O +
compared O +
to O +
the O +
corresponding O +
mutants O +
of O +
Alk5 O -
, O +
which O +
encodes O +
the O +
TGF O -
- O -
β O +
type O +
I O +
receptor O -
, O +
a O +
prototypical O +
binding O +
partner O +
of O +
TGF O -
- O -
βRII O +
[ O -
19 O -
] O +
and O +
the O +
present O +
study O -
) O -
. O +

While O +
Tgfbr2 O -
/ O -
Wnt1-Cre O +
mutants O +
as O +
well O +
as O +
mice O +
deficient O +
in O +
Tgf O -
- O -
β2 O +
display O +
the O +
PTA O +
type O +
A4 O +
( O -
truncus O +
arteriosus O +
with O +
interrupted O +
aortic O +
arch O +
[ O -
30 O -
] O -
) O -
, O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
reported O +
here O +
demonstrate O +
earlier O +
patterning O +
defects O +
of O +
the O +
PAAs O -
, O +
which O +
is O +
particularly O +
obvious O +
in O +
the O +
3rd O +
pair O +
of O +
the O +
PAAs O -
. O +

Moreover O -
, O +
the O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
display O +
an O +
abnormal O +
patterning O +
of O +
the O +
aortic O +
sac O +
and O +
defective O +
AP O +
septation O +
leading O +
to O +
PTA O -
, O +
reminiscent O +
of O +
type O +
A2 O +
(= O +
truncus O +
artriosus O +
with O +
no O +
main O +
pulmonary O +
artery O +
segment O +
present O +
[ O -
30 O -
] O -
) O -
. O +

However O -
, O +
our O +
results O +
also O +
demonstrate O +
that O +
significant O +
hypoplasia O +
of O +
the O +
aortic O +
sac O +
leads O +
to O +
a O +
severe O +
shortening O +
of O +
the O +
ascending O +
truncal O +
arch O -
, O +
which O +
masks O +
possible O +
defects O +
in O +
derivatives O +
of O +
the O +
4th O +
PAAs O -
, O +
i.e. O -
, O +
interruption O +
of O +
the O +
aortic O +
arch O -
. O +

These O +
observed O +
differences O +
are O +
likely O +
due O +
to O +
substantial O +
apoptosis O +
of O +
Alk5-deficient O +
post O -
- O -
migratory O +
neural O +
crest O +
cells O -
, O +
which O +
is O +
clearly O +
detectable O +
at O +
E10.5 O -
, O +
whereas O +
similar O +
intense O +
cell O +
death O +
has O +
not O +
been O +
reported O +
in O +
Tgfbr2 O -
/ O -
Wnt1-Cre O +
mutants O -
[ O -
9 O -
] O -
. O +

Our O +
present O +
results O +
suggest O +
that O +
while O +
TGF O -
- O -
β O +
signaling O +
in O +
cardiac O +
NCCs O +
is O +
predominantly O +
mediated O +
via O +
the O +
ALK5 O -
/ O -
TGF O -
- O -
βRII O +
receptor O +
complex O -
, O +
ALK5 O +
also O +
mediates O +
signaling O +
of O +
other O +
related O +
ligands O -
, O +
which O +
are O +
either O +
directly O +
or O +
indirectly O +
required O +
for O +
appropriate O +
NCC O +
survival O -
. O +

In O +
fact O -
, O +
it O +
has O +
been O +
shown O +
that O -
, O +
besides O +
TGF O -
- O -
βRII O -
, O +
ALK5 O +
can O +
also O +
form O +
a O +
complex O +
with O +
the O +
Activin O +
type O +
IIB O +
receptor O +
to O +
activate O +
downstream O +
Smads O +
2 O -
/ O -
3 O +
[ O -
18,31 O -
] O -
. O +

Furthermore O -
, O +
a O +
subset O +
of O +
TGF O -
- O -
β O -
- O -
related O +
growth O +
and O +
differentiation O +
factors O +
( O -
GDFs O -
) O -
, O +
e.g. O -
, O +
GDF8 O -
, O +
GDF9 O -
, O +
GDF11 O +
and O +
GDF15 O +
could O +
induce O +
these O +
events O +
[ O -
17,18,32,33 O -
] O -
. O +

Although O +
relevant O +
Gdfs O +
8 O -
, O +
9 O +
11 O +
and O +
15 O +
are O +
not O +
expressed O +
in O +
the O +
developing O +
heart O -
, O +
nor O +
do O +
the O +
mice O +
deficient O +
in O +
these O +
Gdfs O +
display O +
developmental O +
cardiac O +
defects O -
, O +
we O +
can O -
not O +
exclude O +
the O +
possibility O +
that O +
circulating O +
GDFs O -
, O +
perhaps O +
in O +
concert O +
with O +
TGF O -
- O -
βs O +
may O +
contribute O +
to O +
NCC O +
survival O +
during O +
cardiac O +
and O +
pharyngeal O +
morphogenesis O -
. O +

We O +
specifically O +
studied O +
apoptosis O +
at O +
the O +
level O +
of O +
the O +
aortic O +
sac O -
, O +
where O +
the O +
AP O -
- O -
septum O +
forms O +
between O +
the O +
origins O +
of O +
4th O +
and O +
6th O +
PAAs O -
. O +

Already O +
at O +
E10.5 O -
, O +
we O +
could O +
see O +
intense O +
apoptosis O +
among O +
the O +
postmigratory O +
NCCs O +
in O +
the O +
mesenchyme O +
surrounding O +
the O +
aortic O +
sac O +
at O +
the O +
site O +
where O +
the O +
prospective O +
AP O +
septum O +
forms O -
, O +
i.e. O -
, O +
this O +
cell O +
death O +
precedes O +
the O +
AP O +
septal O +
defect O +
seen O +
in O +
mutants O -
. O +

Although O +
some O +
NC O -
- O -
derived O +
cells O +
appeared O +
to O +
be O +
differentiating O +
to O +
smooth O +
muscle O +
cells O +
in O +
the O +
OFT O +
( O -
Fig. O +
6 O -
) O -
, O +
we O +
could O +
never O +
detect O +
the O +
AP O +
septum O +
forming O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
between O +
E10.5 O +
and O +
E11.5 O -
. O +

These O +
findings O +
suggest O +
that O +
the O +
pool O +
of O +
cells O +
forming O +
the O +
AP O +
septum O +
is O +
severely O +
affected O +
by O +
the O +
cell O +
death O -
. O +

Moreover O -
, O +
it O +
is O +
likely O +
that O +
these O +
cells O +
forming O +
the O +
AP O -
- O -
septum O +
die O +
the O +
before O +
majority O +
of O +
them O +
can O +
differentiate O +
to O +
smooth O +
muscle O +
cells O -
. O +

Several O +
in O +
vitro O +
studies O +
have O +
suggested O +
an O +
indispensable O +
role O +
for O +
TGF O -
- O -
β O -
- O -
signaling O +
in O +
differentiation O +
of O +
NCCs O +
into O +
smooth O +
muscle O +
cells O -
. O +

Moreover O -
, O +
a O +
recent O +
in O +
vivo O +
study O +
suggested O +
that O +
mice O +
lacking O +
Tgfbr2 O +
in O +
CNCCs O +
display O +
defective O +
NCC O +
differentiation O +
into O +
αSMA O -
- O -
positive O +
cells O +
in O +
the O +
AP O +
septum O +
[ O -
9 O -
] O -
, O +
although O +
this O +
result O +
was O +
later O +
disputed O +
by O +
another O +
study O +
[ O -
8 O -
] O -
. O +

Our O +
immunohistochemical O +
staining O +
of O +
αSMA O +
in O +
the O +
OFT O +
unequivocally O +
demonstrated O +
that O +
signaling O +
via O +
ALK5 O +
is O +
not O +
required O +
for O +
smooth O +
muscle O +
differentiation O +
in O +
vivo O -
. O +

Moreover O -
, O +
it O +
has O +
been O +
suggested O +
that O +
deletion O +
of O +
Tgfbr2 O +
in O +
NCCs O +
leads O +
to O +
other O +
phenotypic O +
features O +
reminiscent O +
of O +
those O +
seen O +
in O +
the O +
velocardiofacial O -
/ O -
DiGeorge O +
syndrome O +
( O -
VCF O -
/ O -
DGS O -
) O +
[ O -
9 O -
] O +
caused O +
by O +
a O +
deletion O +
of O +
the O +
so O +
called O +
DiGeorge O +
critical O +
region O +
( O -
DGCR O -
) O +
on O +
chromosome O +
22q11 O +
[ O -
34,35 O -
] O -
. O +

Our O +
present O +
results O +
suggest O +
that O +
although O +
many O +
of O +
the O +
observed O +
phenotypes O +
seen O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
superficially O +
resemble O +
those O +
seen O +
in O +
VCF O -
/ O -
DGS O -
, O +
a O +
detailed O +
examination O +
shows O +
that O +
the O +
NC O -
- O -
specific O +
abrogation O +
of O +
Alk5 O +
does O +
not O +
lead O +
to O +
VCF O -
/ O -
DGS O -
- O -
like O +
phenotypes O -
. O +

Firstly O -
, O +
while O +
the O +
pharyngeal O +
organ O +
migration O +
fails O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O -
, O +
perhaps O +
as O +
a O +
result O +
of O +
increased O +
mesenchymal O +
cell O +
death O +
in O +
the O +
pharyngeal O +
region O -
, O +
both O +
the O +
thymus O -
, O +
thyroid O +
and O +
parathyroid O +
seem O +
to O +
develop O +
relatively O +
normally O +
on O +
the O +
histological O +
level O +
in O +
these O +
mutants O -
. O +

Secondly O -
, O +
the O +
NCC O +
death O +
seen O +
in O +
Alk5 O +
mutants O +
affects O +
a O +
predominantly O +
postmigratory O +
population O +
of O +
NCCs O -
, O +
while O +
genes O +
located O +
in O +
the O +
DGCR O -
, O +
i.e. O -
, O +
Tbx1 O +
and O +
CrkL O -
, O +
control O +
NCC O +
survival O +
earlier O +
at O +
E8.5-E10 O +
by O +
regulating O +
proliferation O +
of O +
the O +
secondary O +
heart O +
field O +
( O -
SHF O -
) O -
, O +
and O +
endoderm O +
expansion O -
, O +
which O +
in O +
turn O +
provides O +
survival O +
signal O +
for O +
NCCs O +
allowing O +
them O +
to O +
populate O +
the O +
pharyngeal O +
region O +
[ O -
36 O -
- O -
39 O -
] O -
. O +

NCC O +
ablation O +
in O +
the O +
chick O +
has O +
been O +
shown O +
to O +
lead O +
to O +
PTA O +
and O +
to O +
a O +
failure O +
of O +
addition O +
of O +
myocardium O +
from O +
the O +
secondary O +
heart O +
field O +
[ O -
40 O -
] O -
. O +

It O +
was O +
suggested O +
that O +
the O +
defective O +
migration O +
of O +
cells O +
from O +
the O +
secondary O +
heart O +
field O +
to O +
the O +
OFT O +
in O +
turn O +
resulted O +
in O +
shortening O +
and O +
inappropriate O +
rotation O +
of O +
the O +
OFT O -
, O +
leading O +
to O +
mal O -
- O -
alignment O +
of O +
the O +
arterial O +
pole O +
with O +
the O +
ventricles O +
[ O -
41 O -
] O -
. O +

While O +
the O +
detected O +
OFT O +
phenotype O +
in O +
Alk5 O -
/ O -
Wnt1-Cre O +
mutants O +
shared O +
many O +
similarities O +
with O +
that O +
seen O +
in O +
the O +
chick O +
NC O +
ablation O +
models O -
, O +
e.g. O -
, O +
PTA O +
and O +
the O +
hypoplastic O +
aortic O +
sac O -
, O +
our O +
current O +
results O +
suggest O +
that O +
the O +
secondary O +
heart O +
field O +
is O +
not O +
severely O +
affected O +
in O +
Alk5 O +
mutants O +
( O -
data O +
not O +
shown O -
) O -
. O +

Since O +
we O +
could O +
not O +
detect O +
appropriate O +
rotation O +
of O +
the O +
OFT O +
in O +
neural O +
crest O -
- O -
specific O +
mutants O +
of O +
Alk5 O +
or O +
Alk2 O -
, O +
it O +
appears O +
that O +
cells O +
derived O +
from O +
the O +
NC O -
, O +
as O +
well O +
as O +
those O +
from O +
the O +
SHF O -
, O +
are O +
mutually O +
required O +
for O +
proper O +
OFT O +
rotation O +
in O +
mice O -
. O +

However O -
, O +
it O +
appears O +
that O +
these O +
two O +
TGF O -
- O -
β O -
/ O -
BMP O +
type O +
I O +
receptors O +
contribute O +
to O +
OFT O +
rotation O +
through O +
different O +
mechanisms O -
. O +

In O +
Alk5 O +
mutants O +
there O +
is O +
very O +
little O -
, O +
if O +
any O -
, O +
detectable O +
septal O +
mesenchyme O +
present O -
, O +
and O +
thus O +
it O +
could O +
be O +
argued O +
that O +
in O +
these O +
mutants O +
OFT O +
rotation O +
fails O +
due O +
to O +
a O +
lack O +
of O +
penetration O +
of O +
septal O +
prongs O +
into O +
the O +
cushion O +
mesenchyme O -
. O +

In O +
contrast O -
, O +
in O +
Alk2 O -
/ O -
Wnt1-Cre O +
mutants O +
a O +
sizeable O +
septal O +
mesenchyme O +
could O +
be O +
seen O -
, O +
still O +
without O +
any O +
obvious O +
looping O +
of O +
the O +
aortic O +
sac O +
and O +
truncal O +
OFT O -
, O +
suggesting O +
that O +
the O +
mere O +
presence O +
of O +
the O +
septal O +
mesenchyme O -
, O +
without O +
correct O +
smooth O +
muscle O +
cell O +
differentiation O -
, O +
is O +
not O +
sufficient O +
for O +
OFT O +
rotation O -
. O +

Conclusion O +
In O +
this O +
study O -
, O +
we O +
have O +
deleted O +
the O +
TGF O -
- O -
β O +
type O +
I O +
receptor O +
( O -
Alk5 O -
) O +
gene O +
specifically O +
in O +
the O +
mouse O +
neural O +
crest O +
( O -
NC O -
) O +
cell O +
lineage O -
. O +

Our O +
data O +
suggest O +
that O +
ALK5 O +
is O +
required O +
cell O +
autonomously O +
in O +
the O +
NC O +
to O +
mediate O +
non O -
- O -
redundant O +
signaling O +
events O +
that O +
are O +
essential O +
for O +
appropriate O +
patterning O +
of O +
the O +
pharyngeal O +
organs O +
and O +
cardiac O +
OFT O -
. O +

The O +
cardiac O +
and O +
pharyngeal O +
defects O +
observed O +
in O +
the O +
NC O -
- O -
specific O +
Alk5 O +
mutants O +
differ O +
significantly O +
from O +
those O +
seen O +
in O +
corresponding O +
mutants O +
lacking O +
the O +
TGF O -
- O -
β O +
type O +
II O +
receptor O -
, O +
suggesting O +
that O +
signaling O +
mediated O +
by O +
ALK5 O +
is O +
not O +
limited O +
to O +
the O +
classical O +
TGF O -
- O -
β O +
ligands O +
during O +
cardiac O -
/ O -
pharyngeal O +
development O -
. O +

Methods O +
Alk5 O -
/ O -
Wnt1Cre O +
mice O +
Alk5 O +
( O -
and O +
Alk2 O -
) O +
mutant O +
and O +
control O +
embryos O +
were O +
generated O +
by O +
mating O +
Alk5ko O -
/ O -
+ O -
( O -
Alk2ko O -
/ O -
+ O -
) O -
/ O -
Wnt1-Cre O +
male O +
mice O +
with O +
females O +
homozygous O +
for O +
the O +
Alk5flox O +
( O -
Alk2flox O -
) O +
allele O +
and O +
the O +
R26R O +
reporter O -
[ O -
12,19 O -
] O -
. O +

Genotyping O +
was O +
performed O +
by O +
PCR O +
as O +
described O +
earlier O +
[ O -
21,42 O -
] O -
. O +

Wnt1-Cre O +
mice O +
were O +
kindly O +
provided O +
by O +
A. O +
McMahon O +
( O -
Harvard O +
University O -
) O +
and O +
R26R O +
reporter O +
mice O +
were O +
obtained O +
from O +
the O +
Jackson O +
laboratories O -
. O +

All O +
studies O +
were O +
carried O +
out O +
at O +
the O +
Animal O +
Care O +
Facility O +
of O +
the O +
Saban O +
Research O +
Institute O +
of O +
Childrens O +
Hospital O +
Los O +
Angeles O +
in O +
accordance O +
with O +
institutional O +
guidelines O -
. O +

Timed O +
mataings O +
Mice O +
were O +
mated O +
during O +
the O +
dark O +
period O +
of O +
the O +
controlled O +
light O +
cycle O -
; O +
presence O +
of O +
vaginal O +
plugs O +
was O +
designated O +
as O +
day O +
0 O +
hour O +
0 O -
. O +

Females O +
were O +
euthanized O +
by O +
CO2 B-Chemical -
, O +
and O +
embryos O +
were O +
collected O +
in O +
Hanks O -
' O +
balanced O +
salt O +
solution O +
on O +
ice O -
. O +

Histological O +
analyses O +
Embryos O +
( O -
E17 O -
) O +
were O +
fixed O +
with O +
4 O -
% O +
paraformaldehyhe O +
for O +
14 O +
hours O -
, O +
dehydrated O +
and O +
embedded O +
in O +
paraffin O +
wax B-Chemical -
. O +

Sections O +
( O -
7–8 O +
um O -
) O +
were O +
stained O +
with O +
Hematoxylin B-Chemical +
and O +
Eosin O +
( O -
n≥3 O +
for O +
each O +
genotype O -
) O -
. O +

For O +
lineage O +
tracing O +
analyses O -
, O +
embryos O +
were O +
stained O +
for O +
β O -
- O -
galactosidase O +
activity O +
as O +
described O +
[ O -
43 O -
] O -
. O +

Briefly O -
, O +
the O +
specimens O +
( O -
E11.0 O +
– O +
E11.5 O -
) O +
were O +
fixed O +
in O +
4 O -
% O +
paraformaldehyde O +
for O +
30 O +
minutes O +
at O +
room O +
temperature O -
, O +
washed O +
3 O +
times O +
for O +
10 O +
minutes O +
in O +
the O +
detergent B-Chemical +
wash O +
and O +
developed O +
for O +
2–12 O +
hours O +
in O +
X B-Chemical -
- I-Chemical -
gal I-Chemical +
solution B-Chemical +
( O -
n≥3 O +
for O +
each O +
genotype O -
) O -
. O +

For O +
immunohistochemistry O -
, O +
fixed O +
sections O +
from O +
tissues O +
harvested O +
at O +
E10.5 O +
– O +
E11.5 O +
were O +
stained O +
with O +
monoclonal O +
α O -
- O -
smooth O +
muscle O +
actin O +
( O -
DAKO O -
) O -
, O +
cleaved O +
caspase-3 O +
( O -
Cell O +
Signaling O -
) O +
or O +
phophohistone O -
- O -
H3 O +
( O -
Cell O +
Signaling O -
) O +
antibodies O -
. O +

TUNEL O +
assays O +
were O +
performed O +
using O +
the O +
DeadEnd O +
fluorometric O +
TUNEL O +
system O +
( O -
Promega O -
) O -
. O +

In O +
each O +
assay O +
3 O +
or O +
more O +
embryos O +
were O +
analyzed O +
for O +
each O +
genotype O -
. O +

Ink O +
and O +
casting O +
dye B-Chemical +
injections O +
Embryos O +
( O -
E10.0 O +
– O +
E13.0 O -
) O +
were O +
dissected O +
and O +
placed O +
in O +
ice O +
cold O +
PBS O +
( O -
n≥3 O +
per O +
genotype O +
in O +
each O +
time O +
point O -
) O -
. O +

Using O +
a O +
pulled O +
glass O +
pipette O -
, O +
India O +
ink O +
or O +
Yellow O +
casting O +
dye B-Chemical +
( O -
Connecticut O +
Valley O +
Biological O +
Supply O -
) O +
was O +
injected O +
into O +
the O +
ventricles O +
until O +
ink O -
/ O -
dye B-Chemical +
penetrated O +
small O +
vessels O -
. O +

Embryos O +
were O +
postfixed O +
in O +
10 O -
% O +
buffered O +
formalin B-Chemical +
for O +
12 O +
hours O -
, O +
dehydrated O +
and O +
cleared O +
in O +
benzylbenzoate B-Chemical -
: O +
benzyl B-Chemical +
alcohol I-Chemical +
( O -
2:1v O -
/ O -
v O -
) O -
. O +

Expression O +
analyses O +
To O +
visualize O +
parathyroid O +
hormone O +
expression O +
we O +
used O +
in O +
situ O +
hybridization O +
and O +
an O +
antisense O +
probe O +
corresponding O +
to O +
nucleotides O +
97–534 O +
( O -
kindly O +
provided O +
by O +
Nancy O +
Manley O -
) O +
as O +
described O +
[ O -
44 O -
] O -
. O +

Authors O -
' O +
contributions O +
J.W. O +
did O +
most O +
of O +
the O +
mouse O +
dissections O +
and O +
analyses O -
, O +
A.N. O +
did O +
some O +
of O +
the O +
histological O +
analyses O -
, O +
J.L. O +
generated O +
the O +
Alk5FXFXmice O -
, O +
M.D. O +
did O +
some O +
of O +
the O +
expression O +
analyses O -
, O +
H.M.S. O +
participated O +
in O +
design O +
and O +
provided O +
the O +
Tgfbr2 O +
mutant O +
embryos O +
and O +
V.K. O +
generated O +
the O +
Alk2FXFX O +
mice O -
, O +
designed O +
and O +
supervised O +
the O +
experiments O +
and O +
wrote O +
the O +
manuscript O -
. O +

All O +
authors O +
have O +
read O +
and O +
approved O +
the O +
final O +
manuscript O -
. O +

Acknowledgements O +
We O +
thank O +
A. O +
McMahon O +
for O +
providing O +
the O +
Wnt1-Cre O +
mouse O +
line O -
, O +
N. O +
Manley O +
for O +
the O +
PTH O +
probe O +
and O +
B. O +
Choudhary O +
for O +
Tgfbr2 O -
/ O -
Wnt1-Cre O +
embryos O -
. O +

H.M.S. O +
was O +
supported O +
by O +
grants O +
from O +
the O +
NIH O -
, O +
and O +
V.K. O +
by O +
grants O +
from O +
the O +
Robert O +
E. O +
Schneider O +
Foundation O +
and O +
the O +
NIH O +
( O -
HL074862 O +
and O +
DE013085 O -
) O -
. O +

Genetic O +
Analysis O +
of O +
the O +
Roles O +
of O +
BMP2 O -
, O +
BMP4 O -
, O +
and O +
BMP7 O +
in O +
Limb O +
Patterning O +
and O +
Skeletogenesis O +
Abstract O +
Bone O +
morphogenetic O +
protein O +
( O -
BMP O -
) O +
family O +
members O -
, O +
including O +
BMP2 O -
, O +
BMP4 O -
, O +
and O +
BMP7 O -
, O +
are O +
expressed O +
throughout O +
limb O +
development O -
. O +

BMPs O +
have O +
been O +
implicated O +
in O +
early O +
limb O +
patterning O +
as O +
well O +
as O +
in O +
the O +
process O +
of O +
skeletogenesis O -
. O +

However O -
, O +
due O +
to O +
complications O +
associated O +
with O +
early O +
embryonic O +
lethality O -
, O +
particularly O +
for O +
Bmp2 O +
and O +
Bmp4 O -
, O +
and O +
with O +
functional O +
redundancy O +
among O +
BMP O +
molecules B-Chemical -
, O +
it O +
has O +
been O +
difficult O +
to O +
decipher O +
the O +
specific O +
roles O +
of O +
these O +
BMP O +
molecules B-Chemical +
during O +
different O +
stages O +
of O +
limb O +
development O -
. O +

To O +
circumvent O +
these O +
issues O -
, O +
we O +
have O +
constructed O +
a O +
series O +
of O +
mouse O +
strains O +
lacking O +
one O +
or O +
more O +
of O +
these O +
BMPs O -
, O +
using O +
conditional O +
alleles O +
in O +
the O +
case O +
of O +
Bmp2 O +
and O +
Bmp4 O +
to O +
remove O +
them O +
specifically O +
from O +
the O +
limb O +
bud O +
mesenchyme O -
. O +

Contrary O +
to O +
earlier O +
suggestions O -
, O +
our O +
results O +
indicate O +
that O +
BMPs O +
neither O +
act O +
as O +
secondary O +
signals O +
downstream O +
of O +
Sonic O +
Hedghog O +
( O -
SHH O -
) O +
in O +
patterning O +
the O +
anteroposterior O +
axis O +
nor O +
as O +
signals O +
from O +
the O +
interdigital O +
mesenchyme O +
in O +
specifying O +
digit O +
identity O -
. O +

We O +
do O +
find O +
that O +
a O +
threshold O +
level O +
of O +
BMP O +
signaling O +
is O +
required O +
for O +
the O +
onset O +
of O +
chondrogenesis O -
, O +
and O +
hence O +
some O +
chondrogenic O +
condensations O +
fail O +
to O +
form O +
in O +
limbs O +
deficient O +
in O +
both O +
BMP2 O +
and O +
BMP4 O -
. O +

However O -
, O +
in O +
the O +
condensations O +
that O +
do O +
form O -
, O +
subsequent O +
chondrogenic O +
differentiation O +
proceeds O +
normally O +
even O +
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP7 O +
or O +
BMP2 O +
and O +
BMP4 O -
. O +

In O +
contrast O -
, O +
we O +
find O +
that O +
the O +
loss O +
of O +
both O +
BMP2 O +
and O +
BMP4 O +
results O +
in O +
a O +
severe O +
impairment O +
of O +
osteogenesis O -
. O +

Synopsis O +
A O +
group O +
of O +
related O +
signaling B-Chemical +
molecules I-Chemical +
called O +
bone O +
morphogenetic O +
proteins O +
( O -
BMPs O -
) O +
are O +
known O +
to O +
play O +
important O +
roles O +
in O +
the O +
formation O +
of O +
the O +
structures O +
such O +
as O +
the O +
limbs O -
. O +

However O -
, O +
because O +
different O +
members O +
of O +
this O +
group O +
often O +
have O +
similar O +
effects O +
on O +
target O +
cells O +
and O +
are O +
produced O +
in O +
overlapping O +
regions O +
of O +
the O +
embryo O +
and O +
hence O +
can O +
be O +
redundant O +
with O +
one O +
another O -
, O +
removal O +
of O +
any O +
single O +
member O +
of O +
the O +
BMP O +
family O +
may O +
not O +
reveal O +
the O +
full O +
extent O +
of O +
the O +
roles O +
they O +
play O +
during O +
development O -
. O +

We O +
have O +
therefore O +
improved O +
on O +
this O +
type O +
of O +
analysis O +
by O +
removing O +
pairs O +
of O +
these O +
factors O +
( O -
BMP2 O +
and O +
BMP4 O +
or O +
BMP2 O +
and O +
BMP7 O -
) O +
specifically O +
from O +
the O +
developing O +
limb O -
. O +

Although O +
some O +
have O +
speculated O +
that O +
these O +
signals O +
play O +
an O +
early O +
role O +
in O +
organizing O +
or O +
" O -
patterning O -
" O +
the O +
different O +
tissues O +
of O +
the O +
limb O -
, O +
we O +
find O +
no O +
evidence O +
for O +
such O +
a O +
role O -
. O +

We O +
do O +
find O -
, O +
however O -
, O +
that O +
a O +
minimal O +
amount O +
of O +
BMP O +
signal O +
is O +
required O +
to O +
form O +
cartilage O -
, O +
and O +
hence O +
some O +
cartilaginous O +
elements O +
fail O +
to O +
form O +
in O +
limbs O +
deficient O +
in O +
both O +
BMP2 O +
and O +
BMP4 O -
. O +

Moreover O -
, O +
in O +
the O +
absence O +
of O +
these O +
two O +
BMP O +
family O +
members O -
, O +
there O +
is O +
a O +
severe O +
impairment O +
in O +
the O +
development O +
of O +
bone O +
tissue O -
, O +
resulting O +
in O +
severely O +
deformed O +
limbs O -
. O +

This O +
study O +
gives O +
important O +
new O +
insight O +
into O +
the O +
roles O +
of O +
these O +
BMP O +
signals O +
in O +
making O +
skeletal O +
tissues O +
in O +
the O +
embryo O -
. O +

Introduction O +
Bone O +
morphogenetic O +
proteins O +
( O -
BMPs O -
) O +
are O +
secreted O +
signaling B-Chemical +
molecules I-Chemical +
belonging O +
to O +
the O +
transforming O +
growth O +
factor O +
β O +
superfamily O -
, O +
originally O +
identified O +
on O +
the O +
basis O +
of O +
their O +
ability O +
to O +
induce O +
ectopic O +
bone O +
formation O +
when O +
implanted O +
within O +
soft O +
tissue O +
in O +
vivo O +
[ O -
1–3 O -
] O -
. O +

BMP O +
family O +
members O +
are O +
now O +
known O +
to O +
play O +
an O +
extremely O +
diverse O +
set O +
of O +
roles O +
in O +
a O +
wide O +
variety O +
of O +
developmental O +
processes O +
[ O -
4 O -
] O -
. O +

Even O +
in O +
the O +
context O +
of O +
the O +
morphogenesis O +
of O +
a O +
single O +
structure O -
, O +
these O +
molecules B-Chemical +
can O +
play O +
a O +
series O +
of O +
quite O +
divergent O +
roles O -
. O +

For O +
example O -
, O +
during O +
limb O +
development O -
, O +
BMPs O +
have O +
been O +
postulated O +
to O +
act O +
sequentially O +
in O +
multiple O +
distinct O +
aspects O +
of O +
patterning O -
, O +
cell O +
type O +
specification O -
, O +
and O +
differentiation O +
of O +
various O +
tissues O -
, O +
particularly O +
of O +
the O +
skeleton O -
. O +

The O +
earliest O +
step O +
of O +
limb O +
development O +
in O +
which O +
BMP O +
signaling O +
has O +
been O +
implicated O +
is O +
the O +
establishment O +
of O +
the O +
anterior O -
- O -
posterior O +
limb O +
axis O -
. O +

Differences O +
in O +
anterior O -
- O -
posterior O +
pattern O +
are O +
instructed O +
as O +
a O +
graded O +
response O +
to O +
Sonic O +
Hedghog O +
( O -
SHH O -
) O +
signaling O +
emanating O +
from O +
the O +
posterior O +
margin O +
of O +
the O +
limb O +
bud O +
[ O -
5 O -
] O -
. O +

It O +
has O +
remained O +
controversial O -
, O +
however O -
, O +
whether O +
this O +
response O +
is O +
direct O +
or O +
indirect O -
. O +

If O +
indeed O +
the O +
long O -
- O -
range O +
effects O +
of O +
SHH O +
are O +
indirectly O +
mediated O +
by O +
local O +
production O +
of O +
secondary O +
signals O -
, O +
the O +
leading O +
candidates O +
have O +
been O +
two O +
members O +
of O +
the O +
BMP O +
family O -
, O +
BMP2 O +
and O +
BMP7 O -
. O +

Both O +
are O +
expressed O +
in O +
a O +
broader O +
domain O +
than O +
SHH O +
in O +
the O +
early O +
posterior O +
limb O +
bud O +
mesenchyme O +
[ O -
6,7 O -
] O -
, O +
although O +
BMP7 O +
also O +
has O +
a O +
second O -
, O +
weaker O +
domain O +
of O +
expression O +
in O +
the O +
anterior O +
limb O +
bud O +
mesenchyme O -
. O +

BMP2 O +
[ O -
8 O -
] O +
and O +
BMP7 O +
[ O -
7 O -
] O +
can O +
be O +
induced O +
by O +
ectopic O +
SHH O +
and O +
their O +
expression O +
is O +
greatly O +
diminished O +
in O +
the O +
absence O +
of O +
SHH O +
activity O +
[ O -
9 O -
] O -
. O +

BMP2 O +
and O +
BMP7 O +
are O +
thus O +
secondary O +
signals O +
produced O +
in O +
response O +
to O +
SHH O +
activity O -
. O +

Moreover O -
, O +
BMP O +
signaling O +
has O +
a O +
weak O +
ability O +
to O +
posteriorly O +
polarize O +
the O +
limb O +
in O +
ectopic O +
grafting O +
experiments O +
[ O -
10 O -
] O -
, O +
an O +
activity O +
enhanced O +
by O +
prior O +
low O -
- O -
level O +
exposure O +
to O +
SHH O +
[ O -
11 O -
] O -
. O +

It O +
remains O +
unclear O -
, O +
however O -
, O +
whether O +
BMP2 O +
and O +
BMP7 O +
activity O +
is O +
required O +
endogenously O +
for O +
anterior O -
- O -
posterior O +
limb O +
patterning O +
by O +
SHH O -
. O +

Bmp2 O +
mutant O +
embryos O +
die O +
too O +
early O +
to O +
assess O +
their O +
limb O +
phenotypes O -
. O +

A O +
targeted O +
deletion O +
of O +
Bmp7 O +
has O +
been O +
made O -
, O +
and O +
Bmp7-deficient O +
embryos O +
display O +
hindlimb O +
polydactyly O +
with O +
incomplete O +
penetrance O +
but O +
otherwise O +
phenotypically O +
normal O +
limbs O +
[ O -
12,13 O -
] O -
. O +

Nonetheless O -
, O +
Bmp7 O +
knockout O +
mice O +
do O +
not O +
show O +
any O +
defect O +
in O +
limb O +
polarity O -
. O +

However O -
, O +
a O +
redundant O +
function O +
in O +
anterior O -
- O -
posterior O +
patterning O +
with O +
BMP2 O +
remains O +
a O +
possibility O -
. O +

In O +
addition O +
to O +
BMP2 O +
and O +
BMP7 O -
, O +
a O +
third O +
member O +
of O +
this O +
family O +
that O +
is O +
closely O +
related O +
to O +
BMP2 O -
, O +
BMP4 O -
, O +
is O +
also O +
expressed O +
in O +
the O +
early O +
limb O +
bud O -
. O +

Like O +
BMP7 O -
, O +
it O +
is O +
expressed O +
in O +
both O +
the O +
anterior O +
and O +
posterior O +
margins O +
of O +
the O +
limb O +
bud O +
mesenchyme O +
[ O -
4,14 O -
] O -
; O +
however O -
, O +
it O +
does O +
not O +
appear O +
to O +
be O +
induced O +
by O +
SHH O +
signaling O -
, O +
nor O +
does O +
its O +
expression O +
change O +
in O +
SHH O -
- O -
deficient O +
limb O +
buds O -
. O +

Thus O -
, O +
BMP4 O +
is O +
not O +
a O +
candidate O +
for O +
a O +
secondary O +
signal O +
downstream O +
of O +
SHH O +
in O +
early O +
patterning O -
. O +

However O -
, O +
all O +
three O +
of O +
these O +
molecules B-Chemical -
, O +
BMP2 O -
, O +
BMP4 O -
, O +
and O +
BMP7 O -
, O +
have O +
been O +
suggested O +
to O +
act O +
in O +
a O +
second O +
distinct O +
phase O +
of O +
limb O +
patterning O -
, O +
when O +
digit O +
identities O +
are O +
established O +
downstream O +
of O +
earlier O +
patterning O +
events O -
. O +

In O +
the O +
vertebrate O +
limb O -
, O +
each O +
digit O +
can O +
be O +
uniquely O +
identified O +
based O +
on O +
its O +
size O -
, O +
length O -
, O +
number O +
of O +
phalanges O -
, O +
and O +
location O +
within O +
the O +
autopod O -
. O +

As O +
a O +
consequence O +
of O +
the O +
initial O +
establishment O +
of O +
anterior O -
- O -
posterior O +
positioned O +
information O +
within O +
the O +
limb O +
by O +
SHH O +
and/or O +
BMP O +
signaling O -
, O +
the O +
interdigital O +
mesenchyme O +
of O +
the O +
hand O +
plate O +
becomes O +
specified O +
in O +
a O +
graded O +
manner O -
. O +

Grafting O +
and O +
extirpation O +
experiments O +
have O +
shown O +
that O +
it O +
is O +
this O +
polarized O +
interdigital O +
tissue O +
which O +
directs O +
digit O +
morphology O +
[ O -
15 O -
] O -
. O +

BMP2 O -
, O +
BMP4 O -
, O +
and O +
BMP7 O +
are O +
all O +
expressed O +
in O +
the O +
interdigital O +
mesenchyme O +
[ O -
4,14 O -
] O -
, O +
and O +
experiments O +
inhibiting O +
BMP O +
signaling O +
in O +
this O +
tissue O +
suggested O +
that O +
differential O +
levels O +
of O +
BMPs O +
in O +
the O +
interdigital O +
mesenchyme O +
might O +
be O +
the O +
relevant O +
factor O +
directing O +
digit O +
morphology O +
[ O -
15 O -
] O -
. O +

As O +
noted O +
above O -
, O +
BMP7-deficient O +
embryos O +
produce O +
mostly O +
normal O +
limbs O -
, O +
and O +
mice O +
harboring O +
a O +
conditional O +
deletion O +
of O +
Bmp4 O +
in O +
the O +
limb O +
bud O +
mesenchyme O +
also O +
do O +
not O +
show O +
evidence O +
of O +
anterior O +
digit O +
transformation O +
[ O -
16 O -
] O -
, O +
as O +
would O +
have O +
been O +
predicted O +
if O +
BMP4 O +
acted O +
as O +
an O +
interdigital O +
regulator O +
of O +
digit O +
morphology O -
. O +

In O +
the O +
light O +
of O +
these O +
observations O -
, O +
it O +
would O +
seem O +
unlikely O +
that O +
quantitative O +
differences O +
in O +
levels O +
of O +
interdigital O +
BMP O +
signal O +
are O +
responsible O +
for O +
establishing O +
digit O +
identity O -
, O +
although O +
redundancy O +
between O +
BMP2 O -
, O +
BMP4 O -
, O +
and O +
BMP7 O +
in O +
this O +
role O +
remains O +
a O +
possibility O -
. O +

A O +
third O +
aspect O +
of O +
limb O +
patterning O +
in O +
which O +
BMP2 O -
, O +
BMP4 O -
, O +
and O +
BMP7 O +
have O +
been O +
implicated O +
is O +
in O +
the O +
apoptotic O +
death O +
of O +
the O +
interdigital O +
tissue O -
. O +

For O +
example O -
, O +
ectopic O +
application O +
of O +
BMP O +
antagonists O +
demonstrates O +
that O +
BMP O +
signaling O +
is O +
necessary O +
for O +
this O +
process O -
, O +
and O +
in O +
its O +
absence O -
, O +
webbing O +
occurs O +
[ O -
17–19 O -
] O -
) O -
. O +

BMP O +
activity O +
also O +
plays O +
an O +
indirect O +
role O +
in O +
limb O +
patterning O +
as O +
a O +
key O +
component O +
of O +
a O +
feedback O +
loop O +
between O +
SHH O +
production O +
in O +
the O +
posterior O +
limb O +
bud O +
and O +
fibroblast O +
growth O +
factor O +
production O +
in O +
the O +
overlying O +
apical O +
ectodermal O +
ridge O +
( O -
AER O -
) O -
. O +

SHH O +
activity O +
leads O +
to O +
the O +
upregulation O +
of O +
the O +
BMP O +
antagonist O +
Gremlin O +
in O +
the O +
mesenchyme O +
[ O -
20,21 O -
] O -
. O +

This O -
, O +
in O +
turn O -
, O +
prevents O +
BMPs O +
from O +
downregulating O +
fibroblast O +
growth O +
factor O +
( O -
FGF O -
) O +
production O +
in O +
the O +
AER O +
[ O -
17,22 O -
] O +
and O +
maintains O +
the O +
integrity O +
of O +
the O +
AER O +
itself O +
[ O -
23 O -
] O -
. O +

FGF O +
signaling O +
feeds O +
back O +
to O +
maintain O +
SHH O +
production O +
in O +
the O +
posterior O +
mesenchyme O +
[ O -
8,24 O -
] O -
. O +

Thus O -
, O +
conditional O +
removal O +
of O +
BMP4 O +
activity O +
from O +
the O +
posterior O +
limb O +
mesenchyme O +
results O +
in O +
a O +
persistence O +
of O +
the O +
AER O -
, O +
expanded O +
SHH O +
signaling O -
, O +
and O +
consequent O +
preaxial O +
and O +
postaxial O +
polydactyly O +
[ O -
16 O -
] O -
. O +

At O +
later O +
stages O +
of O +
limb O +
development O -
, O +
BMP O +
activity O +
is O +
also O +
believed O +
to O +
play O +
critical O +
roles O +
in O +
skeletogenesis O -
. O +

Activation O +
and O +
dominant O -
- O -
negative O +
experiments O +
in O +
the O +
chick O +
have O +
shown O +
that O +
signaling O +
through O +
the O +
BMPR O -
- O -
IB O +
receptor O +
is O +
necessary O +
and O +
sufficient O +
for O +
cartilage O +
condensation O +
in O +
chick O +
[ O -
25 O -
] O -
. O +

Likewise O -
, O +
conditional O +
knockout O +
of O +
BmpR1A O +
and O +
BmpR1B O +
blocks O +
all O +
chondrogenic O +
differentiation O +
in O +
the O +
mouse O +
limb O +
bud O +
[ O -
26 O -
] O -
. O +

Similarly O -
, O +
when O +
noggin O -
, O +
a O +
potent O +
BMP O +
inhibitor B-Chemical -
, O +
is O +
introduced O +
in O +
early O +
stage O +
chick O +
limb O +
buds O +
prior O +
to O +
skeletogenesis O -
, O +
mesenchymal O +
condensation O +
does O +
not O +
take O +
place O +
[ O -
27,28 O -
] O -
. O +

Taken O +
together O -
, O +
these O +
studies O +
strongly O +
implicate O +
BMP O +
signaling O +
as O +
necessary O +
for O +
mesenchymal O +
condensations O +
and O +
the O +
initiation O +
of O +
chondrogenesis O -
. O +

However O -
, O +
the O +
phenotypes O +
in O +
these O +
experiments O +
are O +
severe O -
, O +
causing O +
either O +
global O +
chondrogenesis O +
or O +
absence O +
of O +
chondrogenesis O -
, O +
in O +
the O +
gain- O +
and O +
loss O -
- O -
of O -
- O -
function O +
experiments O -
, O +
respectively O -
. O +

These O +
severe O +
defects O +
during O +
the O +
early O +
stages O +
of O +
skeletogenesis O +
preclude O +
investigation O +
of O +
any O +
specific O +
roles O +
for O +
BMPs O +
in O +
later O +
events O +
in O +
cartilage O +
differentiation O -
, O +
bone O +
formation O -
, O +
and O +
bone O +
metabolism O +
[ O -
29 O -
] O -
. O +

Conversely O -
, O +
removal O +
of O +
individual O +
ligands O +
such O +
as O +
BMP4 O +
[ O -
16 O -
] O +
or O +
BMP7 O +
[ O -
12,13 O -
] O +
has O +
not O +
displayed O +
defects O +
in O +
skeletal O +
differentiation O -
, O +
presumably O +
due O +
to O +
functional O +
redundancy O -
. O +

To O +
gain O +
further O +
insights O +
into O +
the O +
potential O +
roles O +
of O +
BMP O +
signaling O +
in O +
vertebrate O +
limb O +
patterning O +
and O +
skeletogenesis O -
, O +
we O +
have O +
produced O +
mice O +
simultaneously O +
lacking O +
BMP2 O +
and O +
BMP4 O +
activity O +
or O +
BMP2 O +
and O +
BMP7 O +
activity O +
in O +
the O +
limb O +
mesechyme O +
during O +
limb O +
development O -
. O +

Since O +
Bmp2 O +
and O +
Bmp4 O +
mutants O +
are O +
both O +
lethal O +
early O +
in O +
embryogenesis O +
[ O -
30,31 O -
] O -
, O +
we O +
used O +
conditional O +
alleles O +
of O +
both O +
these O +
genes O -
. O +

The O +
conditional O +
alleles O +
were O +
deleted O +
early O +
in O +
limb O +
development O +
through O +
the O +
action O +
of O +
a O +
cre O -
- O -
recombinase O +
transgene O +
expressed O +
under O +
the O +
control O +
of O +
the O +
Prx1 O +
enhancer O +
[ O -
32 O -
] O -
. O +

Neither O +
limbs O +
deficient O +
in O +
BMP2 O +
and O +
BMP7 O +
nor O +
those O +
deficient O +
in O +
BMP2 O +
and O +
BMP4 O +
had O +
defects O +
suggestive O +
of O +
loss O +
of O +
anterior O -
- O -
posterior O +
patterning O +
information O -
, O +
arguing O +
against O +
these O +
factors O +
acting O +
as O +
secondary O +
signals O +
downstream O +
of O +
SHH O +
or O +
acting O +
as O +
interdigital O +
determinants O +
of O +
digit O +
identity O -
. O +

The O +
Bmp2 O -
/ O -
Bmp4 O +
double O +
mutants O +
did O +
display O +
a O +
loss O +
of O +
posterior O +
digits O +
with O +
a O +
broad O +
posterior O +
hand O +
plate O -
, O +
suggestive O +
of O +
a O +
block O +
in O +
the O +
chondrogenic O +
condensation O +
of O +
the O +
posterior O +
digit O +
rays O -
, O +
rather O +
than O +
a O +
change O +
in O +
anterior O -
- O -
posterior O +
digit O +
identity O -
. O +

At O +
later O +
stages O -
, O +
the O +
combined O +
activity O +
of O +
neither O +
BMP2 O +
and O +
BMP4 O +
nor O +
of O +
BMP2 O +
and O +
BMP7 O +
is O +
required O +
for O +
chondrogenesis O -
. O +

Osteogenesis O +
is O +
also O +
initiated O +
properly O +
in O +
the O +
absence O +
of O +
these O +
pairs O +
of O +
factors O -
. O +

However O -
, O +
at O +
later O +
stages O -
, O +
the O +
combined O +
loss O +
of O +
BMP2 O +
and O +
BMP4 O +
evidently O +
becomes O +
limiting O -
, O +
and O +
osteogenesis O +
ceases O -
. O +

As O +
all O +
prior O +
reported O +
manipulations O +
of O +
the O +
BMP O +
pathway O +
during O +
skeletal O +
development O +
either O +
result O +
in O +
a O +
block O +
at O +
the O +
first O +
stage O +
of O +
chondrogenesis O +
or O +
allow O +
complete O +
skeletal O +
formation O -
, O +
this O +
is O +
the O +
first O +
demonstration O +
of O +
a O +
requirement O +
for O +
BMP O +
activity O +
in O +
osteogenic O +
differentiation O -
. O +

Results O +
To O +
investigate O +
the O +
roles O +
of O +
BMP O +
signaling O +
at O +
various O +
stages O +
of O +
limb O +
patterning O +
and O +
skeletogenesis O -
, O +
we O +
constructed O +
a O +
series O +
of O +
mice O +
deficient O +
singly O +
or O +
in O +
combination O +
in O +
the O +
ability O +
to O +
produce O +
BMP2 O -
, O +
BMP4 O -
, O +
and O +
BMP7 O -
. O +

BMP7-deficient O +
mice O +
( O -
kindly O +
provided O +
by O +
Dr. O +
Liz O +
Robertson O -
) O +
survive O +
until O +
birth O -
. O +

However O -
, O +
BMP2 O +
and O +
BMP4 O +
are O +
both O +
required O +
for O +
viability O +
early O +
in O +
embryonic O +
development O +
[ O -
30,31 O -
] O -
. O +

We O +
therefore O +
constructed O +
a O +
conditional O +
allele O +
of O +
Bmp2 O -
, O +
introducing O +
loxP O +
sites O +
flanking O +
exon O +
3 O -
. O +

We O +
obtained O +
a O +
conditional O +
allele O +
of O +
Bmp4 O -
, O +
in O +
which O +
exon O +
4 O +
is O +
flanked O +
by O +
loxP O +
sites O -
, O +
from O +
Dr. O +
Holger O +
Kulessa O +
and O +
Dr. O +
Brigid O +
Hogan O +
[ O -
16 O -
] O -
. O +

Both O +
of O +
these O +
alleles O +
would O +
be O +
expected O +
to O +
result O +
in O +
null O +
alleles O +
following O +
recombination O +
( O -
see O +
Materials O +
and O +
Methods O +
for O +
details O -
) O -
. O +

To O +
conditionally O +
inactivate O +
Bmp2 O +
and O +
Bmp4 O +
in O +
the O +
limb O -
, O +
we O +
used O +
a O +
well O -
- O -
characterized O +
transgene O +
in O +
which O +
cre O -
- O -
recombinase O +
is O +
expressed O +
under O +
the O +
control O +
of O +
the O +
Prx1 O +
limb O +
enhancer O +
[ O -
32 O -
] O -
. O +

This O +
transgene O +
expresses O +
cre O +
very O +
early O +
in O +
limb O +
development O -
, O +
resulting O +
in O +
complete O +
recombination O +
of O +
floxed O +
alleles O +
at O +
early O +
limb O +
bud O +
stages O -
. O +

We O +
verified O +
the O +
ability O +
of O +
Prx1::cre O +
to O +
recombine O +
the O +
conditional O +
Bmp2 O +
and O +
Bmp4 O +
alleles O +
at O +
earliest O +
limb O +
bud O +
stages O +
using O +
in O +
situ O +
hybridization O -
. O +

Bmp2 O +
is O +
first O +
expressed O +
in O +
the O +
limb O +
mesenchyme O +
at O +
embryonic O +
day O +
( O -
E O -
) O -
10.5 O +
in O +
the O +
mouse O +
( O -
Figure O +
1A O -
, O +
asterisk O -
) O -
. O +

By O +
the O +
time O +
its O +
expression O +
is O +
first O +
detectable O -
, O +
the O +
floxed O +
Bmp2 O +
allele O +
appears O +
to O +
be O +
completely O +
recombined O +
in O +
the O +
limb O +
mesenchyme O -
, O +
as O +
whole O +
mount O +
in O +
situ O +
hybridization O +
does O +
not O +
detect O +
any O +
mesenchymal O +
Bmp2 O +
transcription O +
( O -
Figure O +
1B O -
) O -
. O +

At O +
E10.5 O +
Bmp4 O +
is O +
expressed O +
in O +
the O +
mouse O +
limb O +
mesenchyme O +
in O +
two O +
stripes O +
at O +
the O +
anterior O +
and O +
posterior O +
margins O +
( O -
Figure O +
1C O -
, O +
red O +
arrows O -
) O -
. O +

These O +
expression O +
domains O +
are O +
completely O +
lost O +
by O +
E10.5 O +
in O +
the O +
presence O +
of O +
the O +
Prx1::cre O +
transgene O +
( O -
Figure O +
1D O -
) O -
. O +

Bmp2 O +
and O +
Bmp4 O +
are O +
also O +
expressed O +
in O +
the O +
AER O -
, O +
where O +
Prx1::cre O +
is O +
inactive O -
, O +
and O +
these O +
domains O +
of O +
expression O +
are O +
not O +
affected O +
( O -
Figure O +
1A–1D O -
, O +
black O +
arrows O -
) O -
. O +

An O +
Allelic O -
/ O -
Nonallelic O +
Series O +
of O +
BMP O -
- O -
Deficient O +
Limbs O +
Mice O +
were O +
generated O +
with O +
limbs O +
deficient O +
in O +
BMP2 O -
, O +
BMP4 O -
, O +
or O +
BMP7 O -
, O +
both O +
BMP2 O +
and O +
BMP4 O -
, O +
or O +
both O +
BMP2 O +
and O +
BMP7 O -
. O +

To O +
obtain O +
an O +
initial O +
indication O +
of O +
the O +
range O +
of O +
phenotypes O +
produced O +
in O +
these O +
animals O -
, O +
we O +
first O +
examined O +
the O +
limb O +
skeletons O +
of O +
newborn O +
animals O -
. O +

BMP2-deficient O +
limbs O +
appeared O +
remarkably O +
normal O -
, O +
both O +
in O +
skeletal O +
pattern O +
and O +
in O +
gross O +
aspects O +
of O +
chondrogenesis O +
and O +
osteogenesis O +
indicated O +
by O +
Alcian O +
blue O -
/ O -
Alizarin B-Chemical +
red I-Chemical +
staining O -
. O +

The O +
one O +
notable O +
defect O +
in O +
the O +
appendicular O +
skeleton O +
of O +
these O +
animals O +
is O +
a O +
characteristic O +
malformation O +
of O +
the O +
scapula O +
( O -
Figure O +
1 O -
, O +
red O +
arrow O -
) O -
. O +

BMP2-deficient O +
limbs O +
also O +
exhibit O +
3 O -
/ O -
4 O +
soft O -
- O -
tissue O +
syndactyly O +
with O +
variable O +
penetrance O +
( O -
Figure O +
2 O -
) O -
. O +

Mice O +
with O +
limbs O +
deficient O +
in O +
BMP4 O +
activity O +
and O +
the O +
limbs O +
of O +
Bmp7 O +
mutant O +
mice O +
have O +
both O +
been O +
previously O +
described O -
. O +

As O +
reported O +
[ O -
16 O -
] O -
, O +
in O +
the O +
absence O +
of O +
BMP4 O +
activity O -
, O +
limbs O +
display O +
a O +
variable O +
penetrance O +
of O +
preaxial O +
and O +
postaxial O +
polydactyly O -
, O +
but O +
otherwise O -
, O +
normal O +
digit O +
patterns O +
and O +
apparently O +
normal O +
skeletal O +
differentiation O +
( O -
Figure O +
1 O -
G O +
and O +
1O O -
) O +
take O +
place O -
. O +

As O +
previously O +
described O -
, O +
mice O +
homozygous O +
for O +
a O +
null O +
mutation O +
in O +
Bmp7 O +
[ O -
12 O -
] O +
have O +
no O +
defects O +
in O +
the O +
formation O +
of O +
the O +
normal O +
appendicular O +
skeletal O +
elements O +
( O -
Figure O +
1H O +
and O +
1P O -
) O -
. O +

We O +
do O +
occasionally O +
observe O +
preaxial O +
polydactyly O +
in O +
these O +
mutants O -
. O +

Compound O +
heterozygous O +
mice O -
, O +
with O +
one O +
functional O +
copy O +
each O +
of O +
Bmp2 O +
and O +
Bmp4 O +
in O +
the O +
limb O +
( O -
Bmp2+ O -
/ O -
C O -
; O +
Bmp4+ O -
/ O -
C O -
; O +
Prx1::cre O -
) O -
, O +
show O +
no O +
effect O +
on O +
either O +
limb O +
patterning O +
or O +
skeletogenesis O +
( O -
unpublished O +
data O -
) O -
. O +

Similarly O -
, O +
limb O +
skeletons O +
of O +
mice O +
in O +
which O +
both O +
copies O +
of O +
the O +
Bmp4 O +
gene O +
and O +
one O +
copy O +
of O +
the O +
Bmp2 O +
gene O +
have O +
been O +
conditionally O +
removed O +
in O +
the O +
limb O +
( O -
Bmp2+ O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O -
) O +
are O +
phenotypically O +
normal O +
other O +
than O +
exhibiting O +
the O +
variable O +
penetrance O +
preaxial O +
and O +
postaxial O +
polydactyly O +
seen O +
in O +
mice O +
deficient O +
in O +
BMP4 O +
activity O +
alone O +
( O -
Figure O +
1J O +
and O +
1R O -
) O -
. O +

In O +
contrast O -
, O +
mice O +
in O +
which O +
both O +
copies O +
of O +
Bmp2 O +
and O +
one O +
copy O +
of O +
Bmp4 O +
had O +
been O +
removed O +
( O -
Bmp2C O -
/ O -
C O -
; O +
Bmp4+ O -
/ O -
C O -
; O +
Prx1::cre O -
) O +
showed O +
more O +
severe O +
skeletal O +
defects O -
, O +
including O +
significantly O +
thinner O +
skeletal O +
elements O -
. O +

However O -
, O +
the O +
digit O +
patterns O +
of O +
those O +
animals O +
are O +
completely O +
normal O +
( O -
Figure O +
1I O +
and O +
1Q O -
) O -
. O +

Animals O +
in O +
which O +
both O +
copies O +
of O +
Bmp2 O +
and O +
Bmp4 O +
were O +
removed O +
( O -
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O -
) O +
had O +
extremely O +
malformed O +
limbs O +
( O -
Figure O +
1 O -
K O +
and O +
1S O -
) O -
. O +

They O +
displayed O +
severely O +
short O +
and O +
malformed O +
stylopods O -
; O +
one O +
of O +
the O +
zeugopod O +
elements O +
was O +
almost O +
always O +
missing O -
, O +
and O +
the O +
remaining O +
one O +
was O +
so O +
deformed O +
that O +
it O +
was O +
difficult O +
to O +
identify O +
the O +
element O +
correctly O -
. O +

Moreover O -
, O +
the O +
joint O +
articulations O +
are O +
defective O +
such O +
that O +
zeugopod O +
and O +
stylopod O +
elements O +
are O +
fused O +
( O -
see O +
below O +
and O +
Figure O +
S1A O -
– O -
S1C O -
) O -
. O +

Interestingly O -
, O +
the O +
autopods O +
are O +
less O +
affected O +
than O +
the O +
proximal O +
elements O -
. O +

Nonetheless O -
, O +
the O +
autopod O +
elements O +
are O +
significantly O +
reduced O +
in O +
size O -
, O +
and O +
strikingly O +
the O +
two O +
posterior O -
- O -
most O +
digits O +
are O +
missing O +
in O +
the O +
forelimbs O +
of O +
these O +
animals O -
. O +

Simultaneous O +
removal O +
of O +
BMP2 O +
and O +
BMP7 O +
had O +
far O +
less O +
of O +
an O +
effect O +
than O +
did O +
removal O +
of O +
BMP2 O +
and O +
BMP4 O +
activity O -
. O +

Compound O +
heterozygous O +
removal O +
of O +
BMP2 O +
and O +
BMP7 O +
( O -
Bmp2+ O -
/ O -
C O -
, O +
Bmp7+ O -
/ O -
− O -
; O +
Prx1::cre O -
) O +
and O +
heterozygous O +
removal O +
of O +
BMP2 O +
with O +
complete O +
removal O +
of O +
BMP7 O +
( O -
Bmp2+ O -
/ O -
C O -
, O +
Bmp7− O -
/ O -
− O -
; O +
Prx1::cre O -
) O +
were O +
both O +
completely O +
wild O -
- O -
type O +
in O +
skeletal O +
pattern O +
and O +
differentiation O +
( O -
unpublished O +
data O -
) O -
. O +

Mice O +
homozygous O +
for O +
removal O +
of O +
Bmp2 O +
and O +
heterozygous O +
for O +
Bmp7 O +
( O -
Bmp2C O -
/ O -
C O -
, O +
Bmp7+ O -
/ O -
− O -
; O +
Prx1::cre O -
) O +
displayed O +
the O +
same O +
subtle O +
scapular O +
defect O +
seen O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Prx1::cre O +
mutants O +
alone O +
( O -
unpublished O +
data O -
) O -
. O +

In O +
limbs O +
developing O +
in O +
the O +
complete O +
absence O +
of O +
both O +
BMP7 O +
and O +
BMP2 O +
activity O +
( O -
Bmp2C O -
/ O -
C O -
, O +
Bmp7− O -
/ O -
− O -
; O +
Prx1::cre O -
) O -
, O +
the O +
last O +
phalanx O +
was O +
missing O +
from O +
digit O +
III O +
in O +
the O +
forelimb O -
, O +
and O +
these O +
limbs O +
displayed O +
the O +
same O +
phenotype O +
in O +
the O +
hindlimb O +
with O +
variable O +
penetrance O +
( O -
Figure O +
1L O +
and O +
1 O -
T O -
, O +
black O +
arrow O -
) O -
. O +

Additionally O -
, O +
the O +
fibulae O +
of O +
these O +
hindlimbs O +
are O +
malformed O +
and O +
do O +
not O +
articulate O +
with O +
the O +
femur O +
at O +
the O +
knee O +
( O -
Figure O +
1 O -
T O -
, O +
thick O +
red O +
arrow O -
) O -
. O +

They O +
also O +
display O +
the O +
same O +
scapular O +
defects O +
seen O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Prx1::cre O +
mice O -
, O +
and O +
the O +
overall O +
size O +
of O +
the O +
appendicular O +
skeleton O +
is O +
slightly O +
diminished O -
. O +

However O -
, O +
skeletal O +
differentiation O +
appears O +
normal O +
in O +
the O +
limbs O +
of O +
these O +
animals O -
. O +

Soft O +
Tissue O +
Syndactyly O +
Observed O +
in O +
Limbs O +
of O +
Mice O +
Devoid O +
of O +
BMP2 O +
and O +
BMP4 O +
Activity O +
As O +
noted O +
above O -
, O +
Bmp2-deficient O +
animals O +
display O +
a O +
variably O +
penetrant O +
3 O -
/ O -
4 O +
soft O +
tissue O +
syndactyly O +
phenotype O +
( O -
Figure O +
2B O -
) O -
. O +

In O +
contrast O -
, O +
Bmp4-deficient O +
mice O +
show O +
no O +
evidence O +
of O +
syndactyly O +
( O -
unpublished O +
data O -
) O -
. O +

However O -
, O +
one O +
of O +
the O +
striking O +
defects O +
observed O +
in O +
the O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mice O +
is O +
that O +
in O +
the O +
newborn O +
animals O -
, O +
the O +
digits O +
of O +
both O +
forelimb O +
( O -
unpublished O +
data O -
) O +
and O +
hindlimb O +
show O +
complete O +
syndactyly O +
( O -
Figure O +
2D O -
; O +
compare O +
to O +
wild O -
- O -
type O -
, O +
Figure O +
2C O -
) O -
. O +

To O +
determine O +
the O +
origin O +
of O +
this O +
defect O -
, O +
we O +
examined O +
embryonic O +
limbs O +
at O +
E15.5 O -
, O +
the O +
stage O +
when O +
interdigital O +
separation O +
is O +
normally O +
taking O +
place O +
( O -
Figure O +
2E O -
) O -
. O +

In O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
limbs O -
, O +
only O +
the O +
very O +
distal O +
tips O +
of O +
each O +
digit O +
were O +
separated O -
, O +
with O +
the O +
autopod O +
adopting O +
the O +
shape O +
of O +
a O +
notched O +
pallet O +
( O -
Figure O +
2F O -
) O -
. O +

In O +
wild O -
- O -
type O +
development O -
, O +
the O +
individual O +
digits O +
become O +
free O +
from O +
one O +
another O +
through O +
a O +
process O +
of O +
interdigital O +
apoptosis O -
, O +
observable O +
by O +
staining O +
with O +
acridine B-Chemical +
orange I-Chemical +
( O -
Figure O +
2E O +
and O +
2 O -
G O -
, O +
arrow O -
) O -
. O +

Interdigital O +
apoptosis O +
is O +
dramatically O +
reduced O +
in O +
the O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
limbs O +
( O -
Figure O +
2F O +
and O +
2H O -
, O +
arrow O -
) O -
. O +

( O -
Note O +
that O +
the O +
strong O +
acridine B-Chemical +
orange I-Chemical +
staining O +
in O +
Figure O +
2H O +
is O +
not O +
in O +
the O +
interdigital O +
mesenchyme O +
but O +
rather O +
is O +
in O +
the O +
remnant O +
of O +
the O +
cells O +
of O +
the O +
AER O +
[ O -
red O +
asterisk O -
] O -
. O -
) O +

Another O +
region O +
of O +
very O +
prominent O +
apoptosis O +
in O +
the O +
wild O -
- O -
type O +
limb O +
bud O +
is O +
within O +
the O +
AER O -
. O +

The O +
AER O +
is O +
a O +
specialized O +
ridge O +
of O +
ectoderm O +
running O +
along O +
the O +
anterior O -
- O -
posterior O +
axis O +
at O +
the O +
distal O +
margin O +
of O +
the O +
early O +
limb O +
bud O -
. O +

One O +
of O +
the O +
phenotypes O +
characterizing O +
the O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mutant O +
is O +
expansion O +
of O +
the O +
AER O +
( O -
see O +
below O -
) O -
. O +

Moreover O -
, O +
in O +
the O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
animals O -
, O +
the O +
AER O +
is O +
maintained O +
as O +
late O +
as O +
E15.5 O -
, O +
long O +
after O +
it O +
has O +
started O +
to O +
degrade O +
in O +
wild O -
- O -
type O +
limbs O -
. O +

This O +
can O +
be O +
seen O +
morphologically O +
( O -
unpublished O +
data O -
) O +
or O +
by O +
staining O +
for O +
expression O +
of O +
AER O -
- O -
specific O +
marker O +
such O +
as O +
Fgf8 O +
( O -
Figure O +
2I O +
and O +
2J O -
) O -
. O +

The O +
AER O +
displays O +
intense O +
staining O +
with O +
acridine B-Chemical +
orange I-Chemical -
, O +
TUNEL O -
, O +
or O +
other O +
markers O +
for O +
apoptosis O +
at O +
every O +
stage O +
when O +
it O +
is O +
present O -
, O +
reflecting O +
the O +
rapid O +
turnover O +
of O +
cells O +
in O +
this O +
structure O +
[ O -
33–35 O -
] O -
. O +

The O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mutant O +
limbs O +
at O +
E15.5 O +
show O +
strong O +
acridine B-Chemical +
orange I-Chemical +
staining O +
in O +
the O +
remnants O +
of O +
AER O +
( O -
Figure O +
2H O -
, O +
asterisk O -
) O -
, O +
in O +
domains O +
of O +
the O +
distal O +
tip O +
where O +
the O +
AER O +
remains O +
the O +
longest O +
( O -
compare O +
staining O +
in O +
Figure O +
2F O +
and O +
2J O -
) O -
. O +

No O +
significant O +
difference O +
was O +
observed O +
in O +
the O +
extent O +
of O +
apoptosis O +
in O +
the O +
cells O +
of O +
the O +
AER O +
in O +
earlier O +
stage O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mutant O +
embryonic O +
limbs O +
( O -
Figure O +
S1D O -
– O -
S1 O -
G O -
) O -
. O +

Patterning O +
Defects O +
in O +
Limb O +
Developing O +
with O +
Reduced O +
Levels O +
of O +
BMP O +
Signaling O +
BMP O +
signaling O +
has O +
been O +
proposed O +
to O +
play O +
several O +
distinct O +
roles O +
in O +
limb O +
patterning O -
. O +

The O +
first O +
of O +
these O +
is O +
in O +
establishing O +
differences O +
along O +
the O +
anterior O -
- O -
posterior O +
axis O +
of O +
the O +
limb O +
downstream O +
of O +
sonic O +
hedgehog O +
( O -
Shh O -
) O -
. O +

SHH O +
signaling O +
itself O +
extends O +
over O +
a O +
long O +
range O +
in O +
the O +
developing O +
limb O +
bud O -
, O +
based O +
on O +
both O +
activation O +
of O +
target O +
genes O +
[ O -
36 O -
] O +
and O +
protein O +
distribution O +
[ O -
37 O -
] O -
. O +

Nonetheless O -
, O +
some O +
models O +
have O +
suggested O +
that O +
the O +
patterning O +
effect O +
of O +
this O +
morphogenic O +
signal O +
is O +
mediated O +
entirely O +
[ O -
10 O -
] O +
or O +
in O +
part O +
[ O -
11 O -
] O +
by O +
BMP2 O +
and O +
BMP7 O +
produced O +
as O +
secondary O +
signals O +
in O +
response O +
to O +
SHH O -
. O +

We O +
have O +
removed O +
both O +
BMP2 O +
and O +
BMP7 O +
activities O +
in O +
the O +
early O +
limb O +
bud O +
( O -
Figure O +
1 O -
) O -
, O +
and O +
moreover O -
, O +
there O +
is O +
no O +
apparent O +
upregulation O +
of O +
BMP4 O +
expression O +
in O +
the O +
posterior O +
of O +
these O +
limbs O +
( O -
Figure O +
3A–3D O -
) O -
. O +

The O +
skeletal O +
phenotypes O +
of O +
mouse O +
limbs O +
formed O +
in O +
the O +
absence O +
of O +
BMP2 O -
, O +
BMP7 O -
, O +
and O +
both O +
BMP2 O +
and O +
BMP7 O +
are O +
illuminating O -
, O +
as O +
none O +
of O +
these O +
exhibit O +
significant O +
digit O +
pattern O +
defects O +
( O -
Figure O +
1 O -
) O -
. O +

While O +
a O +
distal O +
phalanx O +
is O +
missing O +
in O +
the O +
middle O +
digits O +
of O +
the O +
double O +
mutants O +
( O -
Bmp2C O -
/ O -
C O -
, O +
Bmp7− O -
/ O -
− O -
; O +
Prx1::cre O -
) O -
, O +
this O +
is O +
not O +
a O +
phenotype O +
consistent O +
with O +
a O +
decrease O +
or O +
loss O +
of O +
a O +
posteriorly O +
derived O +
polarizing O +
activity O -
. O +

Indeed O -
, O +
the O +
terminal O +
phalanx O +
forms O +
at O +
the O +
distal O +
tip O +
of O +
each O +
digit O +
by O +
a O +
distinct O +
mechanism O -
, O +
not O +
dependent O +
upon O +
anterior O -
- O -
posterior O +
patterning O +
[ O -
38 O -
] O -
. O +

These O +
data O +
strongly O +
indicate O +
that O +
BMP2 O +
and O +
BMP7 O +
are O +
not O +
required O +
secondary O +
signals O +
for O +
SHH O -
- O -
mediated O +
polarization O +
of O +
the O +
digits O +
along O +
the O +
anterior O -
- O -
posterior O +
axis O -
. O +

The O +
lack O +
of O +
transformations O +
in O +
digit O +
identity O +
in O +
the O +
limb O +
skeletons O +
formed O +
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP7 O +
activity O +
also O +
argues O +
against O +
BMP O +
signaling O +
being O +
the O +
critical O +
instructive O +
signal O +
from O +
the O +
interdigital O +
mesenchyme O +
to O +
the O +
forming O +
digits O -
. O +

While O +
a O +
distal O +
phalanx O +
was O +
lost O +
from O +
the O +
middle O +
digit O +
of O +
the O +
forelimbs O +
of O +
these O +
animals O -
, O +
these O +
digits O +
do O +
not O +
otherwise O +
have O +
a O +
morphology O +
consistent O +
with O +
their O +
being O +
transformed O +
anteriorly O +
into O +
digit O +
1 O +
( O -
thumb O -
) O -
. O +

Indeed O -
, O +
in O +
the O +
hindlimbs O -
, O +
where O +
the O +
penetrance O +
of O +
the O +
phenotype O +
is O +
variable O -
, O +
the O +
mutant O +
middle O +
digits O +
are O +
otherwise O +
indistinguishable O +
from O +
wild O -
- O -
type O -
, O +
other O +
than O +
the O +
presence O +
or O +
absence O +
of O +
this O +
variable O +
skeletal O +
element O -
. O +

In O +
contrast O +
to O +
the O +
proposed O +
roles O +
for O +
BMPs O +
in O +
anterior O -
- O -
posterior O +
digit O +
patterning O -
, O +
we O +
obtained O +
further O +
support O +
for O +
the O +
well O -
- O -
accepted O +
idea O +
that O +
a O +
threshold O +
level O +
of O +
BMP O +
signaling O +
is O +
necessary O +
interdigitally O +
for O +
programmed O +
cell O +
death O +
to O +
occur O -
. O +

We O +
observed O +
syndactyly O +
with O +
variable O +
penetrance O +
in O +
limbs O +
developing O +
without O +
BMP2 O +
activity O +
( O -
Figure O +
2B O -
) O -
, O +
and O +
nearly O +
complete O +
soft O +
tissue O +
syndactyly O +
of O +
all O +
digits O +
in O +
limbs O +
deficient O +
in O +
both O +
BMP2 O +
and O +
BMP4 O +
( O -
compare O +
Figure O +
2C O +
and O +
Figure O +
2D O -
) O -
. O +

The O +
one O +
dramatic O +
patterning O +
defect O +
we O +
observed O +
in O +
our O +
BMP O +
deficiency O +
series O +
was O +
the O +
loss O +
of O +
posterior O +
digits O +
in O +
forelimbs O +
deficient O +
in O +
both O +
BMP2 O +
and O +
BMP4 O +
( O -
Figure O +
1 O -
K O -
) O -
, O +
also O +
observed O +
in O +
earlier O +
limb O +
buds O +
stained O +
to O +
show O +
no O +
expression O +
of O +
the O +
condensation O +
marker O +
Sox9 O +
( O -
Figure O +
3 O -
) O -
. O +

To O +
understand O +
this O +
phenotype O -
, O +
we O +
analyzed O +
limb O +
buds O +
at O +
various O +
stages O +
using O +
a O +
series O +
of O +
molecular O +
markers O -
. O +

By O +
E11.5 O -
, O +
the O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
limb O +
buds O +
are O +
noticeably O +
broader O -
, O +
expanded O +
in O +
the O +
posterior O +
relative O +
to O +
wild O -
- O -
type O -
. O +

This O +
correlates O +
with O +
an O +
anterior O +
expansion O +
in O +
Shh O +
expression O +
( O -
Figure O +
3E O +
and O +
3F O -
, O +
red O +
bracket O -
) O +
and O +
a O +
concomitant O +
expansion O +
of O +
the O +
AER O +
as O +
visualized O +
by O +
Fgf8 O +
expression O +
( O -
Figure O +
3 O -
G O +
and O +
3H O -
, O +
red O +
bracket O -
) O -
. O +

The O +
expansion O +
in O +
Shh O +
expression O +
can O +
first O +
be O +
detected O +
at O +
E10.5 O +
and O +
persists O +
at O +
least O +
until O +
E12.5 O -
, O +
well O +
after O +
the O +
time O +
normal O +
Shh O +
expression O +
disappears O +
at O +
E11.75 O +
( O -
Figure O +
3L O +
and O +
3P O -
) O -
. O +

The O +
expansion O +
of O +
the O +
AER O +
in O +
the O +
absence O +
of O +
BMP O +
signaling O +
may O +
be O +
understood O +
on O +
the O +
basis O +
of O +
the O +
feedback O +
loop O +
between O +
the O +
zone O +
of O +
polarizing O +
activity O +
( O -
ZPA O -
) O +
and O +
the O +
AER O -
. O +

Expression O +
of O +
several O +
Fgf O +
genes O +
[ O -
20,21 O -
] O +
and O +
maintenance O +
of O +
the O +
AER O +
itself O +
[ O -
23 O -
] O +
normally O +
depend O +
on O +
BMP O +
antagonism O +
induced O +
by O +
SHH O -
. O +

Thus O -
, O +
a O +
decrease O +
in O +
BMP O +
signaling O +
expands O +
and O +
maintains O +
the O +
AER O -
. O +

Because O +
Shh O +
expression O +
is O -
, O +
reciprocally O -
, O +
supported O +
by O +
FGF O +
signaling O +
from O +
the O +
AER O +
[ O -
8,24 O -
] O -
, O +
this O -
, O +
in O +
turn O -
, O +
feeds O +
back O +
on O +
the O +
ZPA O -
, O +
expanding O +
Shh O +
expression O -
. O +

While O +
this O +
explains O +
the O +
broader O +
hand O +
plate O +
of O +
the O +
BMP2 O -
, O +
BMP4–deficient O +
limb O +
buds O -
, O +
it O +
is O +
somewhat O +
paradoxical O +
in O +
terms O +
of O +
the O +
skeletal O +
phenotype O -
, O +
as O +
a O +
broadened O +
autopod O +
would O +
normally O +
be O +
expected O +
to O +
result O +
in O +
the O +
formation O +
of O +
extra O +
digits O +
( O -
polydactyly O -
) O +
( O -
e.g. O -
, O +
Figure O +
1 O -
G O +
and O +
1O O +
of O +
this O +
paper O +
and O +
[ O -
16 O -
] O -
) O -
, O +
not O +
the O +
loss O +
of O +
digits O -
, O +
as O +
observed O +
in O +
the O +
double O +
mutant O +
forelimbs O -
. O +

To O +
examine O +
the O +
loss O +
of O +
digits O +
more O +
closely O -
, O +
BMP2 O -
, O +
BMP4–deficient O +
limb O +
buds O +
were O +
examined O +
during O +
cartilage O +
condensation O +
phase O +
of O +
the O +
digit O +
rays O +
at O +
E12.5 O -
. O +

In O +
wild O -
- O -
type O +
limb O +
buds O +
the O +
condensation O +
of O +
all O +
five O +
digits O +
can O +
be O +
visualized O +
at O +
this O +
stage O +
by O +
in O +
situ O +
hybridization O +
with O +
a O +
probe O +
directed O +
against O +
Sox9 O -
, O +
the O +
earliest O +
known O +
chondrogenic O +
marker O +
( O -
Figure O +
3I O -
) O -
. O +

However O -
, O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
limb O +
buds O +
at O +
E12.5 O -
, O +
Sox9 O +
only O +
detects O +
primordia O +
of O +
the O +
anterior O +
three O +
digits O +
of O +
the O +
forelimb O -
, O +
indicating O +
a O +
failure O +
in O +
the O +
formation O +
of O +
posterior O +
digits O +
at O +
this O +
earliest O +
stage O +
( O -
Figure O +
3J O -
) O -
. O +

Genes O +
such O +
as O +
Msx2 O +
( O -
Figure O +
3N O -
) O +
continue O +
to O +
be O +
expressed O +
throughout O +
the O +
posterior O +
forelimb O +
mesenchyme O -
, O +
indicating O +
that O +
the O +
posterior O +
forelimb O +
tissue O +
is O +
viable O +
at O +
E12.5 O +
in O +
the O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
animals O -
. O +

Msx2 O +
is O +
normally O +
expressed O +
in O +
the O +
non O -
- O -
chondrogenic O +
interdigital O +
mesenchyme O +
at O +
this O +
stage O +
( O -
Figure O +
3 O -
M O -
) O -
, O +
a O +
continuation O +
of O +
an O +
earlier O +
expression O +
domain O +
throughout O +
the O +
distal O +
mesenchyme O -
. O +

This O +
expression O +
of O +
Msx2 O +
in O +
the O +
posterior O +
of O +
the O +
BMP2 O -
, O +
BMP4–deficient O +
forelimbs O +
reflects O +
a O +
failure O +
of O +
chondrogenesis O +
in O +
this O +
region O -
. O +

The O +
loss O +
of O +
the O +
posterior O +
forelimb O +
digits O +
in O +
these O +
mice O +
thus O +
does O +
not O +
appear O +
to O +
represent O +
a O +
decrease O +
in O +
polarizing O +
activity O +
leading O +
to O +
a O +
change O +
in O +
digit O +
identity O +
rather O +
a O +
consequence O +
of O +
the O +
overall O +
level O +
of O +
BMP O +
signaling O +
falling O +
below O +
a O +
threshold O +
for O +
initiating O +
chondrogenesis O +
in O +
the O +
posterior O +
of O +
these O +
forelimbs O -
. O +

The O +
posterior O +
of O +
the O +
hindlimb O +
in O +
the O +
mutant O -
, O +
in O +
contrast O -
, O +
appears O +
to O +
remain O +
above O +
this O +
threshold O -
, O +
and O +
more O +
than O +
five O +
digit O +
condensations O +
form O +
in O +
the O +
hindlimb O +
bud O +
( O -
Figures O +
3 O -
K O +
and O +
1S O -
) O +
and O +
no O +
ectopic O +
expression O +
of O +
Msx2 O +
is O +
observed O +
in O +
the O +
posterior O +
( O -
Figure O +
3O O -
) O -
. O +

Skeletal O +
Differentiation O +
in O +
Limbs O +
Developing O +
with O +
Reduced O +
Levels O +
of O +
BMP O +
Signaling O +
BMPs O +
were O +
first O +
discovered O +
in O +
the O +
context O +
of O +
their O +
skeletogenic O +
activity O -
. O +

We O +
therefore O +
wanted O +
to O +
determine O +
whether O +
the O +
loss O +
of O +
the O +
specific O +
BMP O +
molecules B-Chemical +
under O +
investigation O +
here O +
would O +
perturb O +
the O +
skeletal O +
differentiation O +
pathways O -
. O +

Accordingly O -
, O +
skeletal O +
preparations O +
from O +
each O +
of O +
the O +
various O +
mutant O +
alleles O +
were O +
subjected O +
to O +
histological O +
and O +
molecular O +
analyses O -
. O +

The O +
skeletal O +
elements O +
that O +
formed O +
in O +
the O +
absence O +
of O +
BMP2 O -
, O +
BMP4 O -
, O +
or O +
BMP7 O +
or O +
BMP2 O +
and O +
BMP7 O +
all O +
underwent O +
normal O +
chondrogenesis O +
and O +
osteogenesis O +
by O +
a O +
series O +
of O +
criteria O -
. O +

All O +
showed O +
normal O +
staining O +
with O +
Alcian O +
blue O +
( O -
for O +
cartilage O -
) O +
and O +
Alizarin B-Chemical +
red I-Chemical +
( O -
for O +
mineralized O +
tissue O -
, O +
see O +
Figure O +
1 O -
) O -
. O +

Most O +
were O +
also O +
analyzed O +
in O +
histological O +
sections O +
stained O +
with O +
toluidine O +
blue O +
and O +
showed O +
osteoid O +
formation O +
and O +
bone O +
matrix O +
deposition O +
( O -
compare O +
Figure O +
S2A O +
and O +
S2E O -
; O +
and O +
unpublished O +
data O -
) O -
. O +

The O +
skeletal O +
elements O +
in O +
these O +
various O +
BMP O -
- O -
deficient O +
animals O +
contained O +
normal O +
prehypertrophic O +
chondrocytes O +
expressing O +
type O +
II O +
collagen O -
, O +
hypertrophic O +
chondrocytes O +
expressing O +
type O +
X O +
collagen O -
, O +
as O +
well O +
as O +
the O +
osteoblasts O +
expressing O +
type O +
I O +
collagen O -
, O +
like O +
their O +
wild O -
- O -
type O +
counterparts O +
( O -
Figure O +
S2 O -
; O +
compare O +
Figure O +
S2F O -
– O -
S2H O +
with O +
Figure O +
S2B O -
– O -
S2D O -
; O +
and O +
unpublished O +
data O -
) O -
. O +

In O +
contrast O -
, O +
however O -
, O +
limbs O +
completely O +
deficient O +
in O +
both O +
BMP2 O +
and O +
BMP4 O +
activity O +
showed O +
severe O +
defects O +
in O +
skeletal O +
differentiation O -
. O +

BMP2 O +
and O +
BMP4 O +
Are O +
Not O +
Critical O +
for O +
Chondrogenic O +
Differentiation O +
As O +
noted O +
above O -
, O +
at O +
E12.5 O -
, O +
chondrogenic O +
condensation O +
of O +
the O +
digits O +
could O +
be O +
visualized O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
limb O +
buds O +
by O +
in O +
situ O +
hybridization O +
with O +
a O +
Sox9 O +
probe O -
. O +

Similar O +
analysis O +
at O +
E10.5 O +
and O +
E11.5 O +
demonstrated O +
a O +
relatively O +
normal O +
process O +
of O +
condensation O +
of O +
the O +
proximal O +
skeletal O +
elements O +
( O -
Figure O +
S1H O -
– O -
S1 O -
M O -
) O -
, O +
despite O +
the O +
absence O +
of O +
detectable O +
Bmp2 O +
and O +
Bmp4 O +
transcripts O -
. O +

As O +
shown O +
in O +
Figure O +
S1N O +
and O +
S1O O -
, O +
expression O +
of O +
Col O +
II O -
, O +
a O +
chondrocyte O +
marker O -
, O +
is O +
observed O +
in O +
the O +
BMP2 O -
, O +
BMP4–deficient O +
cartilage O +
( O -
Figure O +
S1O O -
) O +
as O +
early O +
as O +
E12.5 O -
, O +
similar O +
to O +
a O +
wild O -
- O -
type O +
control O +
( O -
Figure O +
S1N O -
) O -
. O +

Similarly O -
, O +
at O +
E13.5 O -
, O +
the O +
entire O +
limb O +
skeleton O +
could O +
be O +
visualized O +
undergoing O +
chondrogenesis O +
by O +
Alcian O +
blue O +
staining O -
, O +
albeit O +
in O +
a O +
defective O +
pattern O -
, O +
in O +
the O +
BMP2 O -
, O +
BMP4–deficient O +
limb O +
buds O +
( O -
Figure O +
4A O +
and O +
4B O +
and O +
unpublished O +
data O -
) O -
. O +

As O +
the O +
cartilage O +
elements O +
grow O -
, O +
a O +
wave O +
of O +
hypertrophic O +
differentiation O +
occurs O +
from O +
the O +
center O +
toward O +
the O +
distal O +
ends O +
( O -
reviewed O +
in O +
[ O -
39–41 O -
] O -
) O -
. O +

Histological O +
examination O +
of O +
the O +
humeri O +
at O +
E13.5 O +
showed O +
that O +
while O +
chondrogenic O +
differentiation O +
had O +
taken O +
place O +
in O +
the O +
BMP2 O -
, O +
BMP4–deficient O +
humerus O -
, O +
hypertrophic O +
differentiation O +
was O +
delayed O +
( O -
Figure O +
4C O +
and O +
4D O -
) O -
. O +

However O -
, O +
by O +
E15.5 O -
, O +
hypertrophy O +
was O +
evident O +
in O +
these O +
elements O +
as O +
seen O +
by O +
type O +
X O +
collagen O +
expression O +
( O -
Figure O +
4E O +
and O +
4F O -
) O -
. O +

The O +
hypertrophic O +
cells O +
in O +
BMP2 O -
, O +
BMP4–deficient O +
limb O +
also O +
express O +
late O +
hypertrophic O +
markers O -
, O +
such O +
as O +
osteopontin O +
[ O -
42 O -
] O +
( O -
unpublished O +
data O -
) O -
. O +

To O +
examine O +
whether O +
the O +
successful O +
execution O +
of O +
chondrogenesis O +
in O +
the O +
BMP2 O -
, O +
BMP4–deficient O +
limbs O +
is O +
a O +
result O +
of O +
compensatory O +
upregulation O +
of O +
other O +
ostegenic O +
BMPs O -
, O +
we O +
carried O +
out O +
in O +
situ O +
hybridization O +
for O +
Bmp6 O +
and O +
Bmp7 O +
in O +
these O +
limbs O -
. O +

At O +
E13.5 O -
, O +
we O +
observed O +
no O +
increase O +
in O +
expression O +
of O +
Bmp6 O +
( O -
Figure O +
S1P O -
– O -
S1S O -
) O +
or O +
Bmp7 O +
( O -
compare O +
Figure O +
4H O +
with O +
Figure O +
4 O -
G O -
) O +
mRNA O +
in O +
the O +
mutant O +
tissues O +
compared O +
to O +
their O +
wild O -
- O -
type O +
counterparts O +
Osteogenesis O +
Is O +
Initiated O +
Normally O +
in O +
BMP2 O -
, O +
BMP4–Deficient O +
Limb O +
Buds O +
Bone O +
formation O +
first O +
occurs O +
at O +
the O +
interface O +
between O +
the O +
late O +
hypertrophic O +
chondrocytes O +
and O +
the O +
surrounding O +
perichondrium O -
, O +
a O +
region O +
identified O +
as O +
the O +
bone O +
collar O -
. O +

We O +
examined O +
whether O +
the O +
osteogenesis O +
program O +
is O +
initiated O +
in O +
the O +
BMP2 O -
, O +
BMP4–deficient O +
limbs O +
using O +
several O +
histological O +
and O +
molecular O +
criteria O -
, O +
as O +
described O +
below O +
( O -
Figure O +
5 O -
) O -
. O +

Adjacent O +
to O +
the O +
hypertrophic O +
cells O -
, O +
a O +
bone O +
collar O +
is O +
laid O +
down O +
normally O +
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP4 O +
( O -
Figure O +
5A O +
and O +
5B O -
, O +
red O +
star O -
) O -
. O +

As O +
can O +
be O +
seen O +
in O +
sagittal O +
sections O +
through O +
an O +
E15.5 O +
humerus O -
, O +
the O +
cells O +
embedded O +
in O +
the O +
mineralized O +
matrix O +
express O +
the O +
osteoblast O +
marker O +
Col O +
I O +
as O +
normal O +
( O -
Figure O +
5C O +
and O +
5D O -
) O -
. O +

By O +
E17.5 O -
, O +
the O +
mineralized O +
cartilage O +
that O +
makes O +
up O +
the O +
late O +
hypertrophic O +
zone O +
of O +
the O +
growth O +
plate O +
normally O +
undergoes O +
removal O +
by O +
osteoclasts O +
( O -
Figure O +
5 O -
G O -
, O +
brown O -
- O -
stained O +
cells O -
, O +
red O +
arrows O -
) O -
, O +
resulting O +
in O +
the O +
formation O +
of O +
a O +
bone O +
marrow O +
cavity O +
( O -
red O +
arrow O +
in O +
Figure O +
5E O +
and O +
5I O -
, O +
see O +
also O +
Figure O +
6 O -
) O -
. O +

Osteoprogenitor O +
cells O +
from O +
bone O +
collar O +
region O +
now O +
populate O +
this O +
site O +
and O +
deposit O +
osteoid O -
, O +
forming O +
the O +
trabecular O +
bone O +
in O +
the O +
bone O +
marrow O +
cavity O +
( O -
Figure O +
6E O -
, O +
red O +
arrow O -
) O +
and O +
cortical O +
bone O +
at O +
birth O +
( O -
Figure O +
5I O -
, O +
asterisk O -
) O -
. O +

In O +
contrast O -
, O +
in O +
E17.5 O +
limbs O +
deficient O +
in O +
BMP2 O +
and O +
BMP4 O -
, O +
there O +
is O +
an O +
overall O +
delay O +
in O +
the O +
normal O +
endochondral O +
process O +
( O -
Figure O +
5F O -
) O -
. O +

While O +
vascularization O +
occurs O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
forelimbs O -
, O +
few O +
osteoclasts O +
are O +
recruited O +
to O +
the O +
mineralized O +
cartilage O +
( O -
compare O +
Figure O +
5 O -
G O +
and O +
Figure O +
5H O -
, O +
red O +
arrows O -
) O -
, O +
resulting O +
in O +
a O +
delay O +
in O +
bone O +
marrow O +
cavity O +
formation O +
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP4 O -
. O +

In O +
fact O -
, O +
bone O +
marrow O +
formation O +
and O +
trabecular O +
bone O +
formation O +
have O +
not O +
yet O +
started O +
at O +
birth O +
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP4 O +
( O -
Figure O +
5J O -
) O -
, O +
and O +
the O +
morphology O +
of O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
bones O +
at O +
birth O +
is O +
most O +
similar O +
to O +
control O +
embryos O +
at O +
E17.5 O +
( O -
Figure O +
5E O -
) O -
. O +

To O +
differentiate O +
between O +
a O +
simple O +
delay O +
in O +
bone O +
formation O +
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP4 O +
and O +
the O +
inability O +
to O +
form O +
bone O +
without O +
these O +
BMPs O -
, O +
we O +
performed O +
histological O +
analyses O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mice O +
up O +
to O +
3 O +
wks O +
of O +
age O -
. O +

As O +
shown O +
in O +
Figure O +
6A O +
through O +
6E O -
, O +
in O +
the O +
control O +
mice O -
, O +
a O +
bone O +
collar O +
is O +
found O +
adjacent O +
to O +
the O +
zone O +
of O +
late O +
hypertrophic O +
chondrocytes O +
at O +
1 O +
wk O +
( O -
Figure O +
6A O +
and O +
6B O -
) O -
. O +

Many O +
osteoblasts O +
line O +
the O +
newly O +
formed O +
cortical O +
bone O +
in O +
the O +
diaphyseal O +
region O +
( O -
Figure O +
6C O -
, O +
blue O +
arrow O -
) O -
, O +
and O +
formation O +
of O +
a O +
secondary O +
ossification O +
center O +
has O +
begun O +
( O -
Figure O +
6A O -
, O +
red O +
star O -
) O -
. O +

At O +
3 O +
wks O +
of O +
age O -
, O +
formation O +
of O +
the O +
secondary O +
ossification O +
center O +
is O +
complete O +
( O -
Figure O +
6D O -
, O +
red O +
star O -
) O -
, O +
along O +
with O +
robust O +
bone O +
marrow O +
formation O +
( O -
Figure O +
6D O -
, O +
bm O -
) O +
and O +
deposition O +
of O +
trabecular O +
bone O +
( O -
Figure O +
6E O -
, O +
pale O +
blue O +
tissue O +
marked O +
by O +
red O +
arrow O -
) O -
. O +

In O +
stark O +
contrast O -
, O +
bone O +
formation O +
is O +
not O +
observed O +
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP4 O +
at O +
1 O +
or O +
3 O +
wks O +
after O +
birth O +
( O -
Figure O +
6F–6J O -
) O -
. O +

The O +
appearance O +
of O +
the O +
skeletal O +
elements O +
in O +
the O +
double O +
mutants O +
remains O +
similar O +
to O +
E17.5 O +
structures O +
seen O +
in O +
wild O -
- O -
type O +
limbs O +
( O -
Figure O +
5E O -
) O -
, O +
and O +
although O +
there O +
is O +
a O +
bone O +
collar O +
at O +
the O +
site O +
of O +
hypertrophic O +
cartilage O +
( O -
Figure O +
6 O -
G O -
) O -
, O +
no O +
bone O +
marrow O +
cavity O -
, O +
trabecular O +
bone O -
, O +
or O +
cortical O +
bone O +
is O +
present O +
( O -
Figure O +
6F O -
) O -
. O +

Many O +
osteoclasts O +
have O +
been O +
recruited O +
to O +
the O +
remaining O +
mineralized O +
cartilage O +
and O +
are O +
actively O +
resorbing O +
this O +
tissue O +
( O -
red O +
asterisks O -
, O +
Figure O +
6I O -
) O -
, O +
so O +
that O +
by O +
3 O +
wks O -
, O +
all O +
the O +
mineralized O +
cartilage O +
in O +
the O +
diaphyseal O +
region O +
has O +
disappeared O -
, O +
leaving O +
a O +
void O +
where O +
bone O +
formation O +
should O +
have O +
occurred O +
( O -
Figure O +
6J O -
, O +
also O +
see O +
Figures O +
6L O +
and O +
S3 O -
) O -
. O +

This O +
void O +
is O +
eventually O +
invaded O +
by O +
soft O +
tissues O +
and O +
the O +
adjacent O +
muscle O +
( O -
marked O +
s O +
and O +
m O -
, O +
respectively O -
, O +
in O +
Figure O +
6J O -
) O -
. O +

The O +
resorption O +
of O +
bone O +
at O +
3 O +
wks O +
of O +
age O +
is O +
clearly O +
visible O +
in O +
the O +
proximal O +
femur O +
of O +
mutant O +
animals O +
where O +
a O +
portion O +
of O +
that O +
bone O +
is O +
missing O +
( O -
Figure O +
6L O -
, O +
black O +
arrow O -
) O -
. O +

The O +
inability O +
to O +
complete O +
osteoblast O +
differentiation O +
in O +
the O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mice O +
results O +
in O +
strikingly O +
defective O +
limb O +
morphology O +
at O +
1 O +
wk O +
of O +
age O +
( O -
compare O +
Figure O +
S3 O -
G O +
and O +
S3H O -
) O -
. O +

To O +
determine O +
if O +
any O +
osteoblast O +
differentiation O +
occurs O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
forelimbs O -
, O +
we O +
examined O +
osteoblast O -
- O -
related O +
gene O +
expression O +
( O -
Figure O +
7 O -
) O -
. O +

In O +
the O +
control O +
mice O -
, O +
osteoblasts O +
lining O +
the O +
surface O +
of O +
trabecular O +
and O +
cortical O +
bone O +
express O +
type O +
I O +
collagen O -
, O +
runx2 O -
, O +
and O +
osterix O +
genes O +
at O +
both O +
1 O +
wk O +
and O +
3 O +
wks O +
after O +
birth O +
( O -
Figure O +
7A–7D O +
and O +
7I–7L O -
) O -
. O +

In O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP4 O -
, O +
cells O +
which O +
are O +
fibroblastic O +
in O +
appearance O +
( O -
Figure O +
6H O -
) O +
are O +
found O +
adjacent O +
to O +
the O +
mineralized O +
cartilage O +
surfaces O -
. O +

These O +
cells O +
express O +
amounts O +
of O +
type O +
I O +
collagen O +
and O +
runx2 O +
comparable O +
to O +
control O +
osteoblasts O -
, O +
but O +
their O +
expression O +
of O +
osterix O -
, O +
while O +
noticeable O +
at O +
1 O +
wk O -
, O +
becomes O +
almost O +
undetectable O +
at O +
3 O +
wks O +
( O -
Figure O +
7E–7H O +
and O +
7M–7P O -
) O -
. O +

These O +
results O +
allow O +
us O +
to O +
conclude O +
that O +
the O +
fibroblast O -
- O -
like O +
cells O +
resident O +
in O +
the O +
bone O +
shaft O +
( O -
Figure O +
6H O -
) O +
may O +
be O +
osteoprogenitor O +
cells O +
unable O +
to O +
differentiate O +
into O +
mature O +
osteoblasts O +
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP4 O -
. O +

Discussion O +
Using O +
a O +
genetic O +
approach O +
to O +
remove O +
activity O +
of O +
different O +
Bmp O +
genes O +
during O +
limb O +
development O -
, O +
we O +
have O +
found O +
that O +
BMP2 O -
, O +
BMP4 O -
, O +
and O +
BMP7 O +
either O +
individually O +
or O +
in O +
combination O +
are O +
not O +
required O +
for O +
specification O +
of O +
normal O +
digit O +
identities O -
. O +

However O -
, O +
BMP2 O +
and O +
BMP4 O +
are O +
required O +
in O +
concert O +
to O +
promote O +
condensation O +
of O +
the O +
posterior O +
digit O +
anlagen O -
. O +

We O +
have O +
also O +
shown O +
that O +
chondrogenesis O +
can O +
be O +
initiated O +
and O +
chondrogenic O +
differentiation O +
will O +
take O +
place O +
even O +
in O +
the O +
absence O +
of O +
both O +
BMP2 O +
and O +
BMP4 O +
or O +
BMP2 O +
and O +
BMP7 O -
. O +

On O +
the O +
other O +
hand O -
, O +
BMP2 O +
and O +
BMP4 O +
together O +
are O +
required O +
for O +
completion O +
of O +
osteogenesis O -
. O +

BMP O +
Signaling O +
and O +
Pattern O +
Formation O +
It O +
has O +
been O +
proposed O +
that O +
BMP O +
signaling O +
may O +
be O +
involved O +
in O +
digit O +
patterning O +
as O +
a O +
secondary O +
signal O +
originating O +
in O +
the O +
ZPA O +
[ O -
7,11,43 O -
] O +
or O +
as O +
a O +
later O +
mediator O +
of O +
interdigital O +
patterning O +
information O +
[ O -
15 O -
] O -
. O +

In O +
particular O -
, O +
BMP2 O -
, O +
a O +
secreted O +
factor O +
that O +
is O +
induced O +
by O +
SHH O +
[ O -
8 O -
] O +
in O +
the O +
posterior O +
limb O +
bud O -
, O +
has O +
been O +
suggested O +
to O +
act O +
as O +
a O +
true O +
morphogen O +
secondary O +
to O +
SHH O +
signaling O +
to O +
properly O +
pattern O +
the O +
limb O +
digits O -
. O +

However O -
, O +
inactivation O +
of O +
Bmp2 O +
during O +
early O +
limb O +
bud O +
development O +
clearly O +
does O +
not O +
cause O +
any O +
digit O +
patterning O +
defects O -
. O +

BMPs O +
are O +
known O -
, O +
in O +
many O +
cases O -
, O +
to O +
function O +
redundantly O +
[ O -
44 O -
] O -
. O +

In O +
considering O +
potential O +
secondary O +
signals O +
mediating O +
ZPA O +
activity O -
, O +
the O +
most O +
relevant O +
family O +
member O +
to O +
consider O +
is O +
BMP7 O +
as O -
, O +
like O +
BMP2 O +
( O -
and O +
unlike O +
BMP4 O -
) O -
, O +
it O +
is O +
positively O +
regulated O +
by O +
SHH O +
signaling O +
[ O -
7 O -
] O -
. O +

However O -
, O +
Bmp7 O +
expression O +
does O +
not O +
overlap O +
with O +
Bmp2 O +
in O +
the O +
early O +
mouse O +
limb O +
bud O +
[ O -
45 O -
] O -
, O +
and O +
in O +
any O +
case O -
, O +
mice O +
in O +
which O +
we O +
conditionally O +
knocked O +
out O +
Bmp2 O +
in O +
the O +
Bmp7− O -
/ O -
− O +
background O +
do O +
not O +
show O +
any O +
obvious O +
digit O +
patterning O +
defect O +
other O +
than O +
the O +
missing O +
final O +
phalanx O +
in O +
digit O +
III O -
. O +

Although O +
still O +
poorly O +
understood O -
, O +
the O +
final O +
phalanges O +
form O +
at O +
the O +
tip O +
of O +
every O +
digit O +
through O +
a O +
process O +
distinct O +
from O +
the O +
more O +
proximal O +
phalanges O +
[ O -
38 O -
] O -
. O +

Our O +
data O +
implicate O +
BMP O +
signaling O +
in O +
this O +
process O -
. O +

At O +
later O +
stages O -
, O +
BMP O +
signaling O +
has O +
been O +
suggested O +
to O +
play O +
a O +
role O +
in O +
mediating O +
the O +
transfer O +
of O +
positional O +
information O +
from O +
the O +
interdigital O +
mesenchyme O +
to O +
specify O +
the O +
identity O +
of O +
the O +
adjacent O +
digits O +
[ O -
15 O -
] O -
. O +

Application O +
of O +
the O +
BMP O +
antagonist O +
noggin O +
to O +
the O +
interdigital O +
tissue O +
at O +
the O +
time O +
of O +
digit O +
condensation O +
results O +
in O +
loss O +
of O +
phalanges O +
and O +
a O +
resultant O +
pattern O +
that O +
can O +
be O +
interpreted O +
as O +
an O +
anterior O +
homeotic O +
transformation O +
in O +
digit O +
identity O -
. O +

However O -
, O +
increasing O +
BMP O +
concentrations O +
interdigitally O +
with O +
exogenous O +
protein O +
does O +
not O +
result O +
in O +
the O +
reciprocal O +
posterior O +
transformations O -
, O +
and O +
the O +
noggin O +
experiments O +
can O +
also O +
be O +
interpreted O +
simply O +
as O +
a O +
block O +
in O +
the O +
condensation O +
of O +
the O +
primordia O +
of O +
distal O +
phalanges O +
when O +
BMP O +
activity O +
is O +
completely O +
abolished O +
[ O -
38 O -
] O -
. O +

Decreasing O +
the O +
level O +
of O +
interdigital O +
BMP O +
signaling O -
, O +
without O +
abolishing O +
it O -
, O +
provides O +
an O +
opportunity O +
for O +
differentiating O +
between O +
these O +
models O -
. O +

If O +
BMP O +
signaling O +
were O +
only O +
required O +
as O +
a O +
permissive O +
factor O +
for O +
chondrogenesis O -
, O +
partial O +
reduction O +
in O +
the O +
level O +
of O +
signaling O +
might O +
have O +
no O +
effect O -
. O +

However O -
, O +
if O +
levels O +
of O +
BMP O +
signaling O +
were O +
instructive O +
in O +
terms O +
of O +
digit O +
identities O -
, O +
then O +
a O +
substantial O +
decrease O +
in O +
the O +
amount O +
of O +
BMP O +
ligand O +
present O +
should O +
cause O +
transformations O +
in O +
digit O +
identity O -
. O +

This O +
is O +
not O +
what O +
is O +
observed O -
, O +
either O +
in O +
limbs O +
deficient O +
in O +
both O +
BMP2 O +
and O +
BMP4 O +
or O +
in O +
those O +
deficient O +
in O +
BMP2 O +
and O +
BMP7 O -
. O +

It O +
should O +
be O +
noted O +
that O +
the O +
interdigital O +
expression O +
domains O +
form O +
several O +
days O +
after O +
recombination O +
of O +
the O +
floxed O +
BMP O +
alleles O +
is O +
complete O -
. O +

Moreover O -
, O +
there O +
is O +
no O +
detectable O +
compensatory O +
upregulation O +
of O +
BMP7 O +
in O +
the O +
interdigital O +
mesenchyme O +
of O +
the O +
BMP2 O -
, O +
BMP4–deficient O +
limbs O +
( O -
compare O +
Figure O +
4 O -
G O +
and O +
Figure O +
4H O -
) O -
. O +

Thus O -
, O +
we O +
conclude O +
that O +
BMP O +
signaling O +
is O +
not O +
likely O +
to O +
be O +
responsible O +
in O +
a O +
quantitative O +
fashion O +
for O +
the O +
instructive O +
role O +
of O +
interdigital O +
mesenchyme O +
in O +
establishing O +
digit O +
identities O -
. O +

However O -
, O +
in O +
the O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
forelimbs O -
, O +
there O +
is O +
a O +
complete O +
loss O +
of O +
posterior O +
digit O +
ray O +
condensations O -
, O +
presumably O +
because O +
the O +
total O +
level O +
of O +
BMP O +
signaling O +
falls O +
below O +
the O +
threshold O +
for O +
initiation O +
of O +
condensation O -
, O +
as O +
previously O +
seen O +
in O +
cases O +
where O +
BMP O +
antagonists O +
have O +
been O +
used O +
[ O -
27,28 O -
] O -
. O +

It O +
is O +
worth O +
noting O +
that O +
the O +
defects O +
in O +
chondrogenesis O +
seen O +
in O +
the O +
BMP2 O -
, O +
BMP4–deficient O +
limbs O +
are O +
much O +
more O +
severe O +
proximally O +
than O +
distally O -
. O +

This O +
is O +
particularly O +
significant O +
because O +
proximal O +
elements O +
condense O +
and O +
differentiate O +
before O +
distal O +
ones O -
. O +

Thus O -
, O +
if O +
the O +
conditional O +
alleles O +
were O +
partially O +
recombined O +
at O +
early O +
stages O +
and O +
only O +
completely O +
recombined O +
at O +
later O +
stages O -
, O +
it O +
is O +
the O +
distal O +
elements O -
, O +
formed O +
after O +
greater O +
recombination O +
has O +
taken O +
place O -
, O +
that O +
should O +
be O +
more O +
severely O +
affected O -
. O +

Since O +
it O +
is O +
the O +
proximal O +
elements O +
which O +
are O +
more O +
severely O +
affected O -
, O +
the O +
explanation O +
for O +
the O +
difference O +
in O +
severity O +
must O +
lie O +
elsewhere O -
. O +

This O +
is O +
most O +
likely O +
explained O +
by O +
compensation O +
in O +
the O +
distal O +
limb O +
bud O +
by O +
BMP2 O -
, O +
BMP4 O -
, O +
and O +
BMP7 O +
produced O +
in O +
the O +
AER O -
. O +

Compensation O +
by O +
BMPs O +
in O +
the O +
AER O +
also O +
likely O +
explains O +
a O +
difference O +
seen O +
between O +
the O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mice O +
in O +
our O +
experiments O +
and O +
a O +
recently O +
published O +
analysis O +
[ O -
16 O -
] O -
, O +
which O +
used O +
the O +
identical O +
Bmp4 O +
conditional O +
allele O +
and O +
Prx1::cre O +
driver O -
. O +

The O +
earlier O +
report O -
, O +
like O +
ours O -
, O +
described O +
preaxial O +
and O +
postaxial O +
polydactyly O -
. O +

However O -
, O +
they O +
observed O +
these O +
phenotypes O +
with O +
less O +
variability O +
and O -
, O +
moreover O -
, O +
described O +
multiple O +
preaxial O +
and O +
postaxial O +
ectopic O +
digits O -
, O +
while O +
we O +
saw O -
, O +
at O +
most O -
, O +
a O +
single O +
preaxial O +
and O +
postaxial O +
digit O -
. O +

The O +
difference O +
is O +
that O +
the O +
mice O +
analyzed O +
in O +
the O +
previous O +
report O +
had O +
one O +
null O +
allele O +
and O +
one O +
conditional O +
allele O -
, O +
while O +
ours O +
had O +
two O +
conditional O +
alleles O -
. O +

Their O +
mice O -
, O +
therefore O -
, O +
lost O +
a O +
half O -
- O -
dose O +
of O +
BMP4 O +
from O +
the O +
AER O +
in O +
addition O +
to O +
complete O +
loss O +
in O +
the O +
mesenchyme O -
, O +
while O +
our O +
conditional O +
alleles O +
were O +
only O +
recombined O +
in O +
the O +
mesenchyme O +
by O +
the O +
Prx1::cre O +
driver O -
. O +

It O +
is O +
also O +
possible O +
that O +
the O +
difference O +
in O +
severity O +
relates O +
to O +
the O +
time O +
required O +
to O +
recombine O +
one O +
as O +
opposed O +
to O +
two O +
floxed O +
alleles O -
; O +
however O -
, O +
we O +
do O +
not O +
favor O +
this O +
explanation O +
as O +
all O +
detectable O +
BMP4 O +
expression O +
is O +
lost O +
prior O +
to O +
any O +
morphological O +
differences O +
between O +
the O +
mutant O +
and O +
wild O -
- O -
type O +
limb O +
buds O -
. O +

Finally O -
, O +
differences O +
in O +
genetic O +
background O +
could O +
contribute O +
to O +
the O +
differences O +
as O +
the O +
Prx1::cre O +
line O +
is O +
outbred O -
. O +

A O +
final O +
aspect O +
of O +
patterning O +
previously O +
associated O +
with O +
BMP O +
signaling O +
is O +
interdigital O +
apoptosis O -
. O +

Consistent O +
with O +
this O -
, O +
we O +
see O +
some O +
syndactyly O +
in O +
the O +
BMP2-deficient O +
limbs O -
. O +

The O +
fact O +
that O +
this O +
is O +
variable O -
, O +
and O +
limited O +
to O +
the O +
3 O -
/ O -
4 O +
interdigit O -
, O +
implies O +
that O +
the O +
threshold O +
for O +
induction O +
of O +
apoptosis O +
is O +
low O +
enough O +
that O +
loss O +
of O +
BMP2 O -
, O +
BMP4 O +
or O +
BMP7 O +
or O +
BMP2 O +
and O +
BMP7 O +
still O +
leaves O +
sufficient O +
BMP O +
signaling O +
for O +
most O +
interdigital O +
cell O +
death O +
to O +
occur O +
normally O -
. O +

However O -
, O +
loss O +
of O +
both O +
BMP2 O +
and O +
BMP4 O +
results O +
in O +
complete O +
soft O +
tissue O +
syndactyly O -
, O +
i.e. O -
, O +
webbing O +
between O +
all O +
the O +
digits O -
. O +

Although O +
BMP O +
activity O +
has O +
been O +
previously O +
implicated O +
in O +
regulating O +
interdigital O +
apoptosis O -
, O +
this O +
is O +
the O +
first O +
genetic O +
verification O +
of O +
their O +
requirement O +
for O +
this O +
process O -
. O +

BMP O +
Signaling O +
and O +
Skeletal O +
Development O +
As O +
discussed O +
above O -
, O +
our O +
data O +
indicate O +
that O +
threshold O +
levels O +
of O +
BMP O +
signaling O +
are O +
required O +
for O +
initiating O +
chondrogenic O +
condensation O -
, O +
consistent O +
with O +
prior O +
results O +
[ O -
26–28 O -
] O -
. O +

However O -
, O +
once O +
chondrogenesis O +
begins O -
, O +
cartilage O +
differentiation O +
can O +
be O +
sustained O -
, O +
albeit O +
with O +
some O +
detectable O +
delay O -
, O +
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP4 O +
or O +
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP7 O -
. O +

Thus O -
, O +
the O +
expression O +
of O +
either O +
BMP5 O -
, O +
BMP6 O -
, O +
and O +
BMP7 O +
( O -
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP4 O -
) O +
or O +
the O +
expression O +
of O +
BMP4 O -
, O +
BMP5 O -
, O +
and O +
BMP6 O +
( O -
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP7 O -
) O +
is O +
sufficient O +
to O +
support O +
mesenchymal O +
condensation O +
and O +
chondrocyte O +
differentiation O +
in O +
the O +
developing O +
limb O -
. O +

In O +
one O +
set O +
of O +
previous O +
studies O +
implicating O +
BMP O +
signaling O +
in O +
chondrogenesis O -
, O +
Yoon O +
et O +
al. O +
[ O -
26 O -
] O +
showed O +
that O +
if O +
mice O +
lose O +
both O +
Alk3 O +
( O -
BmprIa O -
) O +
and O +
Alk6 O +
( O -
BmpIb O -
) O -
, O +
two O +
of O +
the O +
three O +
type O +
I O +
receptors O +
used O +
in O +
BMP O +
signal O +
transduction O -
, O +
there O +
is O +
a O +
dramatic O +
decrease O +
in O +
the O +
size O +
of O +
skeletal O +
primordial O +
due O +
to O +
a O +
reduction O +
of O +
proliferation O +
and O +
increase O +
in O +
apoptosis O -
. O +

The O +
size O +
of O +
the O +
skeletal O +
elements O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
limbs O +
are O +
also O +
decreased O +
compared O +
to O +
those O +
of O +
control O +
mice O -
, O +
although O +
not O +
to O +
the O +
extent O +
seen O +
in O +
the O +
double O +
receptor O +
mutant O -
. O +

We O +
do O +
not O +
know O +
if O +
reduced O +
size O +
of O +
the O +
skeletal O +
elements O +
in O +
our O +
study O +
is O +
similarly O +
due O +
to O +
reduced O +
proliferation O +
and O +
increase O +
in O +
apoptosis O -
, O +
lack O +
of O +
replacement O +
by O +
bone O -
, O +
or O +
a O +
combination O +
of O +
these O -
. O +

It O +
is O +
possible O +
that O +
a O +
triple O +
mutant O +
removing O +
BMP2 O -
, O +
BMP4 O -
, O +
and O +
BMP7 O +
activities O +
would O +
have O +
a O +
similar O +
phenotype O +
as O +
the O +
BmprIa O -
, O +
BmprIb O +
double O +
mutant O -
, O +
although O +
these O +
could O +
also O +
be O +
compensated O +
from O +
other O +
BMPs O -
. O +

We O +
do O +
know O -
, O +
however O -
, O +
that O +
osteogenesis O +
is O +
defective O +
in O +
these O +
mice O -
, O +
although O +
bone O +
formation O +
proceeds O +
normally O +
in O +
siblings O +
retaining O +
one O +
functional O +
copy O +
of O +
either O +
the O +
Bmp2 O +
or O +
Bmp4 O +
gene O +
( O -
Figure O +
S4 O -
) O -
, O +
as O +
it O +
does O +
in O +
mice O +
completely O +
deficient O +
in O +
BMP2 O +
and O +
BMP7 O +
( O -
Figures O +
1 O +
and O +
S2 O -
) O -
. O +

The O +
phenotype O +
we O +
observe O +
in O +
limbs O +
of O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mice O +
is O +
similar O +
to O +
the O +
phenotype O +
reported O +
for O +
osterix O +
knockout O +
mice O +
[ O -
46 O -
] O -
, O +
which O +
exhibited O +
severe O +
defects O +
in O +
osteoblastic O +
differentiation O -
. O +

Since O +
we O +
observe O +
fibroblastic O +
cells O +
adjacent O +
to O +
mineralized O +
cartilage O +
that O +
have O +
characteristics O +
of O +
osteoprogenitor O +
cells O +
but O +
fail O +
to O +
express O +
osterix O +
in O +
the O +
absence O +
of O +
both O +
BMP2 O +
and O +
BMP4 O -
, O +
one O +
important O +
role O +
of O +
BMP2 O +
and O +
BMP4 O +
during O +
endochondral O +
ossification O +
may O +
be O +
to O +
induce O +
osterix O +
gene O +
expression O +
in O +
osteoprogenitors O -
. O +

Strikingly O -
, O +
however O -
, O +
we O +
do O +
observe O +
osterix O +
expression O +
in O +
the O +
bone O +
collar O +
of O +
E16.5 O +
mice O +
missing O +
functional O +
copies O +
of O +
both O +
the O +
Bmp2 O +
and O +
Bmp4 O +
genes O +
( O -
K. O +
Tsuji O +
and O +
A. O +
Bandyopadhyay O -
, O +
unpublished O +
data O -
) O -
. O +

This O +
suggests O +
that O +
varying O +
levels O +
of O +
expression O +
from O +
different O +
BMP O +
genes O +
during O +
preaxial O +
and O +
postaxial O +
development O +
result O +
in O +
fluctuations O +
in O +
total O +
levels O +
of O +
BMP O +
signaling O -
, O +
which O +
at O +
distinct O +
times O +
are O +
above O +
or O +
below O +
the O +
threshold O +
for O +
supporting O +
osteogenesis O -
. O +

While O +
many O +
osteogenic O +
BMP O +
molecules B-Chemical -
, O +
apart O +
from O +
BMP2 O +
and O +
BMP4 O -
, O +
such O +
as O +
BMP5 O -
, O +
BMP6 O -
, O +
and O +
BMP7 O -
, O +
are O +
expressed O +
during O +
the O +
endochondral O +
process O -
, O +
our O +
data O +
suggest O +
that O +
these O +
BMP O +
molecules B-Chemical +
can O -
not O +
compensate O +
for O +
the O +
combined O +
loss O +
of O +
BMP2 O +
and O +
BMP4 O +
in O +
bone O +
formation O -
. O +

Recent O +
biochemical O +
and O +
genetic O +
experiments O +
have O +
suggested O +
that O +
individual O +
BMPs O +
have O +
identical O +
functions O -
. O +

BMP2 O -
, O +
BMP4 O -
, O +
BMP5 O -
, O +
BMP6 O -
, O +
and O +
BMP7 O +
can O +
utilize O +
the O +
same O +
type O +
I O +
( O -
Alk2 O -
, O +
Alk3 O -
, O +
and O +
Alk6 O -
) O +
and O +
type O +
II O +
receptors O +
( O -
BMP O +
RII O -
, O +
ActRII O -
, O +
and O +
ActRIIb O -
) O +
[ O -
47 O -
] O -
. O +

Once O +
the O +
complex O +
between O +
ligand O +
and O +
receptors O +
is O +
formed O -
, O +
BMP2 O -
, O +
BMP4 O -
, O +
BMP5 O -
, O +
BMP6 O -
, O +
and O +
BMP7 O +
direct O +
the O +
phosphorylation O +
of O +
the O +
same O +
set O +
of O +
BMP O +
receptor O -
– O -
specific O +
Smads O +
( O -
1 O -
, O +
5 O -
, O +
or O +
8) O -
, O +
and O +
the O +
signal O +
that O +
is O +
transduced O +
by O +
each O +
BMP O +
appears O +
to O +
be O +
identical O +
in O +
the O +
skeletal O +
target O +
cells O +
[ O -
48–51 O -
] O -
. O +

BMPs O +
have O +
also O +
been O +
shown O +
to O +
activate O +
MAPK O +
and O +
AKT O +
pathways O +
and O -
, O +
based O +
on O +
current O +
published O +
information O -
, O +
each O +
of O +
the O +
osteogenic O +
BMPs O +
appears O +
to O +
have O +
the O +
same O +
capacity O +
to O +
activate O +
these O +
signaling O +
pathways O +
[ O -
52–54 O -
] O -
. O +

When O +
this O +
information O +
is O +
considered O +
along O +
with O +
our O +
observation O +
that O +
one O +
allele O +
of O +
either O +
Bmp2 O +
or O +
Bmp4 O +
can O +
rescue O +
the O +
osteoblast O +
differentiation O +
phenotype O +
observed O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mice O +
( O -
see O +
Figures O +
1I O -
, O +
1J O -
, O +
1Q O -
, O +
and O +
1R O +
and O +
S4 O -
) O -
, O +
we O +
favor O +
the O +
hypothesis O +
that O +
bone O +
formation O +
requires O +
a O +
threshold O +
amount O +
of O +
BMP O +
signaling O +
which O +
is O +
not O +
met O +
when O +
both O +
BMP2 O +
and O +
BMP4 O +
are O +
completely O +
absent O -
. O +

We O +
can O -
not O -
, O +
however O -
, O +
exclude O +
the O +
possibility O +
that O +
BMP2 O +
and O +
BMP4 O +
have O +
distinct O +
functions O +
in O +
osteoblastogenesis O -
. O +

Our O +
analysis O +
of O +
skeletogenesis O +
indicates O +
that O +
BMP2 O +
and O +
BMP4 O +
are O +
prerequisite O +
for O +
osteoblastogenesis O +
while O +
less O +
important O +
for O +
chondrogenesis O -
. O +

These O +
studies O +
provide O +
the O +
first O +
evidence O +
linking O +
BMP2 O +
and O +
BMP4 O +
with O +
bone O +
formation O +
in O +
an O +
in O +
vivo O +
setting O +
where O +
the O +
preceding O +
events O +
of O +
chondrogenesis O +
are O +
not O +
compromised O -
. O +

Materials O +
and O +
Methods O +
Reagents B-Chemical -
. O +

Xylene B-Chemical -
, O +
formamide B-Chemical -
, O +
and O +
acetic B-Chemical +
anhydride I-Chemical +
were O +
purchased O +
from O +
Fisher O +
Scientific O +
( O -
http://www.fishersci.com O -
) O -
. O +

Alizarin B-Chemical +
red I-Chemical +
S O -
, O +
toluidine O +
blue O -
, O +
paraformaldehyde O -
, O +
polyvinylpyrrolidone B-Chemical -
, O +
proteinase O +
K O -
, O +
RNase O +
A O -
, O +
tRNA O -
, O +
and O +
dithiothreitol B-Chemical +
were O +
purchased O +
from O +
Sigma O +
( O -
http://www.sigmaaldrich.com O -
) O -
. O +

Alcian O +
blue O +
8GX O +
was O +
purchased O +
from O +
Electron B-Chemical +
Microscopy O +
Science O +
( O -
http://www.emsdiasum.com O -
) O -
. O +

Dextran B-Chemical +
sulfate I-Chemical +
was O +
purchased O +
from O +
Pharmacia O +
( O -
http://www.pharmacia.com O -
) O -
. O +

Generation O +
of O +
Bmp2 O +
and O +
Bmp4 O +
conditional O +
null O +
allele O -
. O +

Mice O +
carrying O +
floxed O +
Bmp2 O +
allele O +
were O +
available O +
through O +
a O +
material O +
transfer O +
agreement O +
between O +
Harvard O +
University O +
and O +
Wyeth O +
Pharmaceuticals B-Chemical -
. O +

In O +
these O +
mice O -
, O +
LoxP O +
sites O +
were O +
integrated O +
to O +
excise O +
the O +
entire O +
protein O -
- O -
coding O +
region O +
in O +
exon O +
3 O +
of O +
the O +
Bmp2 O +
gene O -
. O +

Generation O +
of O +
Bmp4 O +
conditional O +
allele O +
has O +
been O +
described O +
[ O -
16,55 O -
] O -
. O +

The O +
Prx1::cre O +
transgene O +
has O +
been O +
described O +
[ O -
32 O -
] O -
. O +

Generation O +
of O +
Bmp2 O -
, O +
Bmp4 O +
double O +
conditional O +
mice O +
and O +
Bmp2 O +
conditional O -
, O +
Bmp7 O +
mutant O +
mice O -
. O +

Bmp2C O -
/ O -
C O +
animals O +
were O +
crossed O +
with O +
Bmp4C O -
/ O -
C O +
animals O +
to O +
generate O +
Bmp2C O -
/ O -
+ O -
; O +
Bmp4C O -
/ O -
+ O +
animals O -
. O +

These O +
animals O +
were O +
crossed O +
with O +
Bmp2C O -
/ O -
C O +
or O +
Bmp4C O -
/ O -
C O +
animals O +
to O +
generate O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
+ O +
or O +
Bmp2C O -
/ O -
+ O -
; O +
Bmp4C O -
/ O -
C O +
animals O -
, O +
respectively O -
. O +

Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
+ O +
or O +
Bmp2C O -
/ O -
+ O -
; O +
Bmp4C O -
/ O -
C O +
animals O +
were O +
crossed O +
with O +
each O +
other O +
to O +
generate O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O +
animals O -
. O +

Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O +
females O +
were O +
crossed O +
with O +
males O +
bearing O +
Prx1::cre O +
transgene O +
to O +
generate O +
Bmp2C O -
/ O -
+ O -
; O +
Bmp4C O -
/ O -
+ O -
; O +
Prx1::cre O +
animals O -
. O +

Bmp2C O -
/ O -
+ O -
; O +
Bmp4C O -
/ O -
+ O -
; O +
Prx1::cre O +
males O +
were O +
crossed O +
with O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O +
females O +
to O +
generate O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
animals O -
. O +

Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O +
mice O +
carrying O +
floxed O +
alleles O +
of O +
the O +
Bmp O +
genes O +
without O +
Prx1::cre O +
are O +
wild O -
- O -
type O +
( O -
WT O -
) O -
. O +

Genotyping O +
of O +
animals O +
were O +
done O +
by O +
PCR O +
analyses O +
with O +
the O +
primers O +
( O -
5′–3′ O -
) O +
GTGTGGTCCACCGCATCAC O +
( O -
AHP2–9 O -
) O +
and O +
GGCAGACATTGTATCTCTAGG O +
( O -
AHP2–35 O -
) O +
for O +
Bmp2 O +
and O +
AGACTCTTTAGTGAGCATTTTCAAC O +
( O -
No. O +
79 O +
[ O -
order O +
of O +
primers O +
tried O -
] O -
) O +
and O +
AGCCCAATTTCCACAACTTC O +
( O -
No. O +
80 O -
) O +
for O +
Bmp4 O +
following O +
extraction O +
of O +
genomic O +
DNA O +
from O +
embryonic O +
or O +
adult O +
tail O -
. O +

For O +
Bmp2 O -
, O +
the O +
floxed O +
allele O +
amplifies O +
as O +
a O +
545-bp O +
product O -
, O +
while O +
the O +
wild O -
- O -
type O +
allele O +
amplifies O +
as O +
a O +
474-bp O +
product O -
. O +

For O +
Bmp4 O -
, O +
the O +
floxed O +
allele O +
amplifies O +
as O +
a O +
220-bp O +
product O -
, O +
while O +
the O +
wild O -
- O -
type O +
allele O +
amplifies O +
as O +
a O +
180-bp O +
product O -
. O +

Protocols O +
utilized O +
for O +
mouse O +
experiments O +
were O +
approved O +
by O +
the O +
Harvard O +
University O +
Institutional O +
Animal O +
Care O +
and O +
Use O +
Committee O +
( O -
Cliff O +
Tabin O +
# O -
02735 O -
) O -
. O +

The O +
strategy O +
for O +
generating O +
a O +
Bmp2 O +
conditional O +
null O +
in O +
the O +
BMP7− O -
/ O -
− O +
background O +
is O +
similar O +
to O +
the O +
strategy O +
used O +
for O +
generating O +
the O +
Bmp2 O -
, O +
Bmp4 O +
double O +
conditional O +
allele O +
with O +
three O +
important O +
differences O -
. O +

First O -
, O +
the O +
Bmp7− O -
/ O -
− O +
( O -
strain O +
kindly O +
donated O +
by O +
Dr. O +
Liz O +
Robertson O +
[ O -
12 O -
] O -
) O +
is O +
not O +
a O +
conditional O +
allele O +
but O +
a O +
null O +
mutation O -
. O +

Second O -
, O +
Bmp7− O -
/ O -
− O +
mice O +
do O +
not O +
survive O +
past O +
birth O +
due O +
to O +
kidney O +
failure O +
[ O -
12 O -
] O +
and O +
hence O +
can O -
not O +
be O +
maintained O +
as O +
homozygous O +
for O +
the O +
null O +
allele O -
. O +

Third O -
, O +
Bmp2 O +
and O +
Bmp7 O +
are O +
on O +
the O +
same O +
chromosome O +
( O -
Chromosome O +
2 O -
) O -
. O +

To O +
obtain O +
Bmp2C O -
/ O -
C O -
, O +
Bmp7− O -
/ O -
− O -
; O +
Prx1::cre O +
we O +
crossed O +
Bmp2C O -
/ O -
C O -
, O +
Bmp7− O -
/ O -
+ O +
females O +
with O +
Bmp2C O -
/ O -
+ O -
, O +
Bmp7− O -
/ O -
+ O -
; O +
Prx1::cre O +
males O -
. O +

Bmp2C O -
/ O -
C O -
, O +
Bmp7− O -
/ O -
− O -
; O +
Prx1::cre O +
progeny O +
were O +
obtained O +
at O +
a O +
rate O +
slightly O +
higher O +
than O +
1 O +
in O +
16 O -
. O +

For O +
genotyping O +
of O +
Bmp7 O +
locus O +
we O +
used O +
the O +
following O +
set O +
of O +
primers O -
: O +
Bmp7_ExI_5′ O +
( O -
5′–3′ O -
) O +
TCGCCTGCAGCAAGTGACCTCGGGTC O -
; O +
Bmp7_ExI_3′ O +
( O -
5′–3′ O -
) O +
TAGGGGTAGGAGAAGCCCTGTCCGTCC O +
and O +
Beta O -
- O -
geo O +
5′ O +
of O +
3′ O +
( O -
5′–3′ O -
) O +
CTGCATACGCTTGATCCGGCTACCTGC O -
. O +

From O +
a O +
wild O -
- O -
type O +
chromosome O +
Bmp7_ExI_5′ O +
and O +
Bmp7_ExI_3′ O +
amplifies O +
an O +
approximately O +
423-bp O +
PCR O +
product O -
, O +
while O +
from O +
the O +
lacZ O +
insertion O +
mutant O +
this O +
pair O +
fails O +
to O +
amplify O +
any O +
product O -
. O +

Bmp7_ExI_5′ O +
and O +
Beta O -
- O -
geo O +
5′ O +
of O +
3′ O +
( O -
this O +
primer O +
is O +
designed O +
from O +
the O +
Beta O -
- O -
geo O +
cassette O -
) O +
amplifies O +
an O +
approximately O +
1-kb O +
PCR O +
product O +
from O +
the O +
lacZ O +
inserted O +
chromosome O -
. O +

Skeletal O +
analysis O -
. O +

Our O +
protocol O +
is O +
an O +
adaptation O +
of O +
the O +
procedure O +
described O +
[ O -
56 O -
] O +
previously O -
. O +

Newborn O +
and O +
older O +
animals O +
were O +
killed O +
using O +
carbon B-Chemical +
dioxide I-Chemical -
. O +

Skin O -
, O +
viscera O -
, O +
and O +
adipose O +
tissues O +
were O +
removed O +
within O +
2 O +
h O +
after O +
death O -
, O +
and O +
samples O +
were O +
fixed O +
in O +
95 O -
% O +
ethanol B-Chemical +
for O +
5 O +
d. O +
Samples O +
were O +
then O +
placed O +
in O +
acetone B-Chemical +
to O +
remove O +
residual O +
fat O +
for O +
2 O +
d. O +
For O +
E13.5 O +
embryos O -
, O +
skin O +
was O +
not O +
removed O -
. O +

The O +
dehydrated O +
animals O +
were O +
stained O +
with O +
0.015 O -
% O +
w O -
/ O -
v O +
Alcian O +
blue O +
and O +
0.005 O -
% O +
w O -
/ O -
v O +
Alizarin B-Chemical +
red I-Chemical +
in O +
a O +
1:19 O +
mixture B-Chemical +
of O +
glacial O +
acetic B-Chemical +
acid I-Chemical +
and O +
70 O -
% O +
ethanol B-Chemical -
. O +

The O +
younger O +
animals O +
were O +
stained O +
for O +
5 O +
h O +
at O +
37 O +
° O -
C O +
and O +
then O +
overnight O +
at O +
room O +
temperature O -
, O +
while O +
the O +
newborns O +
were O +
stained O +
overnight O +
at O +
37 O +
° O -
C O +
followed O +
by O +
2 O +
d O +
at O +
room O +
temperature O -
. O +

The O +
stained O +
skeletons O +
were O +
kept O +
in O +
1 O -
% O +
KOH B-Chemical -
, O +
with O +
occasional O +
change O +
of O +
solution B-Chemical -
, O +
until O +
cleared O -
. O +

The O +
cleared O +
skeletons O +
were O +
transferred O +
into O +
100 O -
% O +
glycerol B-Chemical +
and O +
photographed O -
. O +

Acridine B-Chemical +
orange I-Chemical +
staining O +
for O +
apoptotic O +
cells O -
. O +

A O +
working O +
stock O +
of O +
5 O +
mg O -
/ O -
ml O +
acridine B-Chemical +
orange I-Chemical +
was O +
diluted O +
1:10,000 O +
in O +
PBS O -
. O +

Dissected O +
fresh O +
embryos O +
were O +
transferred O +
to O +
the O +
working O +
solution B-Chemical +
of O +
acridine B-Chemical +
orange I-Chemical +
and O +
incubated O +
for O +
30 O +
min O +
at O +
37 O +
° O -
C O +
in O +
the O +
dark O -
. O +

Embryos O +
were O +
then O +
washed O +
twice O +
in O +
PBS O +
for O +
5 O +
min O +
and O +
viewed O +
with O +
a O +
fluorescence O +
microscope O -
. O +

Whole O +
mount O +
in O +
situ O +
hybridization O -
. O +

In O +
situ O +
hybridization O +
staining O +
on O +
whole O +
embryos O +
was O +
performed O +
as O +
described O +
[ O -
57 O -
] O -
. O +

For O +
section O +
in O +
situ O +
hybridizations O -
, O +
please O +
see O +
below O -
. O +

Histology O -
, O +
section O +
in O +
situ O +
hybridizations O -
, O +
and O +
immunohistochemistry O -
. O +

For O +
histology O +
and O +
section O +
in O +
situ O +
hybridization O -
, O +
samples O +
were O +
fixed O +
in O +
4 O -
% O +
paraformaldehyde O +
in O +
PBS O +
at O +
4 O +
° O -
C O +
overnight O -
. O +

Newborn O +
and O +
older O +
animals O +
were O +
then O +
decalcified O +
in O +
Tris B-Chemical +
buffer O +
containing O +
10 O -
% O +
EDTA O +
and O +
7.5 O -
% O +
polyvinylpyrrolidone B-Chemical +
( O -
pH O +
7.5 O -
) O +
at O +
4 O +
° O -
C O +
for O +
3 O +
wks O -
. O +

Samples O +
were O +
then O +
dehydrated O +
through O +
a O +
graded O +
ethanol B-Chemical +
series O -
, O +
cleared O +
in O +
xylene B-Chemical -
, O +
and O +
embedded O +
in O +
paraffin O -
. O +

8μm O +
sections O +
were O +
collected O +
and O +
stained O +
with O +
hematoxylin B-Chemical +
and O +
eosin O +
( O -
H B-Chemical +
& O +
E O -
) O +
or O +
toluidine O +
blue O +
following O +
standard O +
procedure O -
. O +

Section O +
in O +
situ O +
hybridization O +
with O +
digoxigenin B-Chemical +
labeled O +
probes O +
was O +
performed O +
as O +
described O +
[ O -
57 O -
] O -
. O +

Section O +
in O +
situ O +
hybridization O +
with O +
radiolabeled O +
probes O +
was O +
performed O +
as O +
described O +
[ O -
58 O -
] O +
with O +
a O +
small O +
modification O -
. O +

Briefly O -
, O +
sections O +
were O +
deparaffinized O +
in O +
xylene B-Chemical +
and O +
rehydrated O +
through O +
a O +
graded O +
ethanol B-Chemical +
series O -
. O +

Sections O +
were O +
postfixed O +
in O +
4 O -
% O +
paraformaldehyde O +
in O +
PBS O +
at O +
room O +
temperature O +
for O +
15 O +
min O -
, O +
digested O +
with O +
10 O +
μg O -
/ O -
ml O +
proteinase O +
K O +
at O +
room O +
temperature O +
for O +
10 O +
min O -
, O +
and O +
again O +
fixed O +
in O +
4 O -
% O +
paraformaldehyde O +
at O +
room O +
temperature O +
for O +
10 O +
min O +
and O +
acetylated O +
in O +
the O +
solution B-Chemical +
containing O +
0.2 O -
% O +
hydrochloric B-Chemical +
acid I-Chemical -
, O +
0.1 O +
M O +
triethanol B-Chemical +
amine I-Chemical -
, O +
and O +
0.25 O -
% O +
acetic B-Chemical +
anhydride I-Chemical +
at O +
room O +
temperature O +
for O +
10 O +
min O -
. O +

Sections O +
were O +
then O +
dehydrated O +
in O +
increasing O +
concentrations O +
of O +
ethanol B-Chemical +
and O +
air O -
- O -
dried O -
. O +

Hybridization O +
was O +
performed O +
in O +
a O +
humidified O +
chamber O +
in O +
a O +
solution B-Chemical +
containing O +
50 O -
% O +
formamide B-Chemical -
, O +
10 O -
% O +
dextran B-Chemical +
sulfate I-Chemical -
, O +
1 O -
× O +
Denhardt O -
's O +
solution B-Chemical -
, O +
0.6 O +
M O +
sodium B-Chemical +
chloride I-Chemical -
, O +
0.01 O +
M O +
Tris B-Chemical +
buffer O +
( O -
pH O +
7.5 O -
) O -
, O +
0.001 O +
M O +
EDTA O -
, O +
0.05 O +
M O +
dithiothreitol B-Chemical -
, O +
0.25 O -
% O +
SDS B-Chemical -
, O +
200 O +
μg O +
tRNA O -
, O +
and O +
35S B-Chemical -
- O -
labeled O +
cRNA O +
probe O +
at O +
the O +
final O +
concentration O +
of O +
5 O +
× O +
106 O +
cpm O -
/ O -
ml O +
at O +
55 O +
° O -
C O +
for O +
16 O +
h. O +
After O +
hybridization O -
, O +
sections O +
were O +
washed O +
with O +
a O +
solution B-Chemical +
containing O +
5 O -
× O +
SSC O +
and O +
10 O +
mM O +
dithiothreitol B-Chemical +
at O +
50 O +
° O -
C O +
for O +
30 O +
min O -
, O +
incubated O +
in O +
a O +
solution B-Chemical +
containing O +
50 O -
% O +
formamide B-Chemical -
, O +
2 O -
× O +
SSC O -
, O +
and O +
10 O +
mM O +
dithiothreitol B-Chemical +
at O +
65 O +
° O -
C O +
for O +
30 O +
min O -
, O +
treated O +
in O +
a O +
solution B-Chemical +
containing O +
10 O +
μg O -
/ O -
ml O +
RNase O +
A O +
in O +
TNE O +
[ O -
0.01 O +
M O +
Tris B-Chemical +
buffer O +
( O -
pH O +
7.6 O -
) O -
, O +
0.5 O +
M O +
sodium B-Chemical +
chloride I-Chemical -
, O +
and O +
0.001 O +
M O +
EDTA O -
] O +
at O +
37 O +
° O -
C O +
for O +
30 O +
min O +
and O +
then O +
washed O +
with O +
50 O -
% O +
formamide B-Chemical -
, O +
2 O -
× O +
SSC O -
, O +
and O +
10 O +
mM O +
dithiothreitol B-Chemical +
at O +
65 O +
° O -
C O +
for O +
an O +
additional O +
30 O +
min O +
followed O +
by O +
two O +
washes O +
with O +
2 O -
× O +
SSC O -
/ O -
10 O +
mM O +
dithiothreitol B-Chemical +
at O +
65 O +
° O -
C O +
for O +
30 O +
min O -
, O +
and O +
0.1 O -
× O +
SSC O -
/ O -
10 O +
mM O +
dithiothreitol B-Chemical +
at O +
65 O +
° O -
C O +
for O +
30 O +
min O -
. O +

To O +
visualize O +
the O +
signal O -
, O +
sections O +
were O +
dipped O +
into O +
NTB-2 O +
emulsion O +
( O -
Kodak O -
, O +
http://www.Kodak.com O -
) O +
and O +
placed O +
at O +
4 O +
° O -
C O -
. O +

After O +
developing O -
, O +
sections O +
were O +
counterstained O +
with O +
H&E. B-Chemical +
The O +
35S B-Chemical -
- O -
labeled O +
cRNA O +
probes O +
were O +
transcribed O +
from O +
plasmids O +
encoding O +
type O +
I O +
collagen O +
[ O -
59 O -
] O -
, O +
runx2 O +
[ O -
60 O -
] O -
, O +
osteopontin O +
[ O -
61 O -
] O -
, O +
and O +
osterix O +
[ O -
46 O -
] O -
. O +

Sense O +
and O +
antisense O +
probes O +
were O +
synthesized O +
from O +
linearized O +
plasmids O +
using O +
a O +
Riboprobe O +
Combination O +
System O +
( O -
Promega O -
, O +
http://www.promega.com O -
) O -
. O +

Supporting O +
Information O +
Figure O +
S1 O +
Chondrogenic O +
Differentiation O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
Animals O +
( O -
A O -
– O -
C O -
) O +
In O +
BMP2 O -
, O +
BMP4–deficient O +
limbs O -
, O +
there O +
is O +
only O +
one O +
zeugopod O +
present O -
, O +
and O +
it O +
is O +
often O +
fused O +
with O +
the O +
stylopod O -
. O +

All O +
panels O +
are O +
from O +
E17.5 O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
embryos O -
. O +

( O -
A O -
) O +
Hematoxylin B-Chemical +
and O +
eosin O -
– O -
stained O +
section O +
of O +
the O +
forelimb O -
. O +

Alcian O +
blue– O +
and O +
Alizarin B-Chemical +
red I-Chemical -
– O -
stained O +
skeletons O +
shown O +
in O +
( O -
B O -
) O +
( O -
forelimb O -
) O +
and O +
( O -
C O -
) O +
( O -
hindlimb O -
) O -
. O +

Black O +
arrow O +
shows O +
the O +
fusion O +
of O +
the O +
zeugopod O +
and O +
stylopod O +
in O +
BMP2 O -
, O +
BMP4–deficient O +
limbs O -
. O +

( O -
D O +
and O +
E O -
) O +
Acridine B-Chemical +
orange I-Chemical -
– O -
stained O +
limbs O +
from O +
E11.5 O +
wild O -
- O -
type O +
( O -
D O -
) O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
embryos O +
( O -
E O -
) O -
. O +

( O -
F O +
and O +
G O -
) O +

Acridine B-Chemical +
orange I-Chemical -
– O -
stained O +
hindlimbs O +
from O +
E13.5 O +
wild O -
- O -
type O +
( O -
F O -
) O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
( O -
G O -
) O +
embryos O -
. O +

( O -
H O -
– O -
M O -
) O +
In O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP4 O -
, O +
condensation O +
begins O +
in O +
the O +
limb O +
normally O -
. O +

Whole O +
mount O +
in O +
situ O +
staining O +
of O +
Sox9 O +
mRNA O +
in O +
embryonic O +
limb O +
buds O +
from O +
E10.5 O +
( O -
H O +
and O +
I O -
) O +
and O +
E11.5 O +
( O -
J O -
– O -
M O -
) O +
embryos O -
. O +

( O -
H O -
, O +
J O -
, O +
and O +
L O -
) O +
From O +
wild O -
- O -
type O +
embryos O -
, O +
( O -
I O -
, O +
K O -
, O +
and O +
M O -
) O +
from O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
embryos O -
. O +

( O -
H O -
, O +
I O -
, O +
J O -
, O +
and O +
K O -
) O +

Forelimbs O -
, O +
( O -
L O +
and O +
M O -
) O +
hindlimbs O -
. O +

( O -
N O +
and O +
O O -
) O +
In O +
situ O +
hybridizations O +
with O +
Col O +
II O +
mRNA O +
probes O +
of O +
sections O +
derived O +
from O +
E12.5 O +
wild O -
- O -
type O +
( O -
N O -
) O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
( O -
O O -
) O +
embryos O -
. O +

( O -
P O -
– O -
S O -
) O +
Bmp6 O +
mRNA O +
expression O +
is O +
not O +
increased O +
in O +
E13.5 O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
cartilage O -
. O +

Bmp6 O +
in O +
situ O +
on O +
sagittal O +
sections O +
from O +
wild O -
- O -
type O +
( O -
Q O -
) O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
( O -
S O -
) O +
embryonic O +
forelimbs O -
. O +

( O -
P O +
and O +
R O -
) O +

Bright O +
field O +
images O +
of O +
( O -
Q O -
) O +
and O +
( O -
S O -
) O -
, O +
respectively O -
. O +

( O -
23 O +
MB O +
TIF O -
) O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S2 O +
Skeletal O +
Differentiation O +
Occurs O +
Normally O +
in O +
Absence O +
of O +
BMP2 O +
( O -
A O -
) O +
Toluidine O +
blue O -
– O -
stained O +
section O +
of O +
newborn O +
femurs O +
from O +
Bmp2C O -
/ O -
C O +
animals O -
. O +

( O -
B O -
– O -
D O -
) O +
Marker O +
analyses O -
. O +

Sections O +
of O +
femurs O +
from O +
Bmp2C O -
/ O -
C O +
animals O +
hybridized O +
with O +
Col O +
II O +
( O -
B O -
) O -
, O +
Col O +
X O +
( O -
C O -
) O -
, O +
and O +
Col O +
I O +
( O -
D O -
) O +
mRNA O +
probes O -
. O +

( O -
E O -
) O +
Toluidine O +
blue O -
– O -
stained O +
section O +
of O +
newborn O +
femurs O +
from O +
Bmp2C O -
/ O -
C O -
; O +
Prx1::cre O +
animals O -
. O +

( O -
F O -
– O -
H O -
) O +
Marker O +
analyses O -
. O +

Sections O +
of O +
femurs O +
from O +
Bmp2C O -
/ O -
C O -
; O +
Prx1::cre O +
animals O +
hybridized O +
with O +
Col O +
II O +
( O -
F O -
) O -
, O +
Col O +
X O +
( O -
G O -
) O -
, O +
and O +
Col O +
I O +
( O -
H O -
) O +
mRNA O +
probes O -
. O +

( O -
15 O +
MB O +
TIF O -
) O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S3 O +
BMP2 O -
, O +
BMP4–Deficient O +
Limb O +
Skeleton O +
Is O +
Resorbed O +
Alcian O +
blue– O +
and O +
Alizarin B-Chemical +
red I-Chemical -
– O -
stained O +
skeletons O +
of O +
forelimbs O +
( O -
A O -
– O -
D O -
) O +
and O +
hindlimbs O +
( O -
E O -
– O -
F O -
) O +
from O +
1-wk O -
- O -
old O +
( O -
A O -
, O +
B O -
, O +
E O -
, O +
and O +
F O -
) O +
and O +
3-wk O -
- O -
old O +
( O -
C O +
and O +
D O -
) O +
animals O -
. O +

( O -
A O -
, O +
C O -
, O +
and O +
E O -
) O +
Wild O -
- O -
type O +
animals O -
, O +
( O -
B O -
, O +
D O -
, O +
and O +
F O -
) O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
animals O -
. O +

The O +
limbs O +
of O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
( O -
H O -
) O +
animals O +
are O +
severely O +
defective O +
compared O +
to O +
a O +
wild O -
- O -
type O +
( O -
G O -
) O +
animal O +
at O +
1 O +
wk O +
of O +
age O -
. O +

Please O +
note O +
that O +
the O +
proximal O +
part O +
of O +
the O +
femur O +
is O +
present O +
at O +
1 O +
wk O +
of O +
age O +
but O +
missing O +
at O +
3 O +
wks O +
( O -
refer O +
to O +
Figure O +
6L O -
) O -
. O +

( O -
12 O +
MB O +
TIF O -
) O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S4 O +
Osteogenesis O +
Occurs O +
in O +
Mice O +
Lacking O +
Three O +
of O +
Four O +
Alleles O +
of O +
Bmp2 O +
and O +
Bmp4 O +
Combined O +
Toluidine O +
blue O -
– O -
stained O +
sections O +
of O +
femurs O +
from O +
adult O +
control O -
, O +
Bmp2C O -
/ O -
+ O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O -
, O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
+ O -
; O +
Prx1::cre O +
animals O -
. O +

( O -
11 O +
MB O +
TIF O -
) O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Acknowledgements O +
We O +
thank O +
Dr. O +
Andy O +
Dudley O +
for O +
his O +
help O +
in O +
designing O +
mouse O +
genotyping O +
strategies O -
. O +

We O +
also O +
thank O +
Jose O +
Rivera O -
- O -
Feliciano O +
and O +
Dr. O +
Douglas O +
Kim O +
for O +
helpful O +
discussions O -
. O +

We O +
are O +
immensely O +
grateful O +
to O +
Drs O -
. O +

Brigid O +
Hogan O +
and O +
Holger O +
Kulessa O +
for O +
their O +
kind O +
gift O +
of O +
the O +
Bmp4 O +
conditional O +
allele O +
and O +
Drs O -
. O +

Liz O +
Robertson O +
and O +
Andy O +
Dudley O +
for O +
the O +
Bmp7 O +
knockout O +
allele O -
. O +

We O +
would O +
like O +
to O +
acknowledge O +
the O +
help O +
of O +
Dr. O +
Ernestina O +
Schipani O +
and O +
Jan O +
Saxton O +
for O +
help O +
with O +
histology O -
. O +

This O +
manuscript O +
is O +
dedicated O +
to O +
the O +
memory O +
of O +
Dr. O +
Holger O +
Kulessa O -
, O +
whose O +
efforts O +
contributed O +
to O +
the O +
groundwork O +
for O +
this O +
study O +
and O +
whose O +
dedication O +
and O +
intense O +
commitment O +
to O +
excellence O +
in O +
science O +
are O +
greatly O +
missed O -
. O +

Abbreviations O +
AER O +
- O +
apical O +
ectodermal O +
ridge O +
BMP O +
- O +
bone O +
morphogenetic O +
protein O +
E O +
- O +
embryonic O +
day O +
FGF O +
- O +
fibroblast O +
growth O +
factor O +
SHH O +
- O +
Sonic O +
Hedgehog O +
Shh O +
- O +
sonic O +
hedgehog O +
ZPA O +
- O +
zone O +
of O +
polarizing O +
activity O +
Figures O +
and O +
Tables O +
Figure O +
1 O +

An O +
Allelic O -
/ O -
Nonallelic O +
Series O +
of O +
BMP O -
- O -
Deficient O +
Limbs O +
( O -
A O -
– O -
D O -
) O +
Prx1::cre O +
efficiently O +
recombines O +
Bmp2 O +
and O +
Bmp4 O +
conditional O +
alleles O +
in O +
the O +
limbs O -
. O +

Bmp2 O +
( O -
A O +
and O +
B O -
) O +
and O +
Bmp4 O +
( O -
C O +
and O +
D O -
) O +
whole O +
mount O +
mRNA O +
in O +
situ O +
hybridization O +
in O +
the O +
limb O -
. O +

Wild O -
- O -
type O +
( O -
A O -
) O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Prx1::cre O +
( O -
B O -
) O +
are O +
forelimbs O +
from O +
E10.5 O +
mouse O +
embryos O -
. O +

Mesenchymal O +
expression O +
[ O -
asterisk O +
( O -
A O -
) O -
] O +
of O +
Bmp2 O +
is O +
abolished O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Prx1::cre O +
embryo O +
while O +
the O +
AER O +
expression O +
[ O -
black O +
arrow O +
( O -
A O +
and O +
B O -
) O -
] O +
of O +
Bmp2 O +
persists O -
. O +

Note O +
that O +
pink O +
staining O +
in O +
the O +
central O +
region O +
of O +
the O +
limb O +
bud O +
in O +
( O -
B O -
) O +
is O +
nonspecific O +
background O -
. O +

Wild O -
- O -
type O +
( O -
C O -
) O +
and O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
( O -
D O -
) O +
are O +
forelimbs O +
from O +
E10.5 O +
mouse O +
embryos O -
. O +

Mesenchymal O +
expression O +
[ O -
red O +
arrow O +
( O -
C O -
) O -
] O +
of O +
Bmp4 O +
is O +
abolished O +
in O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
embryo O +
while O +
the O +
AER O +
expression O +
[ O -
black O +
arrow O +
( O -
C O +
and O +
D O -
) O -
] O +
of O +
Bmp4 O +
persists O -
. O +

( O -
E O -
– O -
T O -
) O +
Depletion O +
of O +
BMP2 O +
and O +
BMP4 O +
together O +
causes O +
severe O +
limb O +
skeletal O +
defects O -
. O +

( O -
E O -
– O -
T O -
) O +

Whole O +
mount O +
skeletons O +
from O +
newborn O +
animals O +
stained O +
with O +
Alcian O +
blue O +
and O +
Alizarin B-Chemical +
red I-Chemical -
. O +

( O -
E O -
– O -
L O -
) O +

Forelimbs O -
, O +
( O -
M O -
– O -
T O -
) O +
hindlimbs O -
. O +

( O -
E O +
and O +
M O -
) O +
Wild O -
- O -
type O -
, O +
( O -
F O +
and O +
N O -
) O +
Bmp2C O -
/ O -
C O -
; O +
Prx1::cre O -
, O +
( O -
G O +
and O +
O O -
) O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O -
, O +
( O -
H O +
and O +
P O -
) O +
Bmp7 O +
− O -
/ O -
− O -
, O +
( O -
I O +
and O +
Q O -
) O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4+ O -
/ O -
C O -
; O +
Prx1::cre O -
, O +
( O -
J O +
and O +
R O -
) O +
Bmp2+ O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O -
, O +
( O -
K O +
and O +
S O -
) O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O -
, O +
( O -
L O +
and O +
T O -
) O +
Bmp2C O -
/ O -
C O -
, O +
Bmp7 O +
− O -
/ O -
− O -
; O +
Prx1::cre O -
. O +

Thin O +
red O +
arrow O +
in O +
( O -
F O -
) O -
, O +
( O -
I O -
) O -
, O +
and O +
( O -
L O -
) O -
, O +
defective O +
scapula O -
; O +
thick O +
red O +
arrow O +
in O +
( O -
T O -
) O -
, O +
failure O +
of O +
fibula O +
to O +
articulate O +
with O +
knee O -
, O +
and O +
thick O +
black O +
arrow O +
in O +
( O -
L O -
) O +
and O +
( O -
T O -
) O -
, O +
missing O +
phalanx O +
in O +
digit O +
III O -
. O +

Figure O +
2 O +
Depletion O +
of O +
BMP O +
Signaling O +
Causes O +
Interdigital O +
Syndactyly O +
( O -
A O -
– O -
D O -
) O +
Forelimb O +
of O +
adult O +
wild O -
- O -
type O +
( O -
A O -
) O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Prx1::cre O +
mouse O +
( O -
B O -
) O +
and O +
hindlimbs O +
of O +
newborn O +
wild O -
- O -
type O +
( O -
C O -
) O +
mouse O +
and O +
newborn O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
( O -
D O -
) O +
mouse O -
. O +

The O +
black O +
arrow O +
in O +
( O -
B O -
) O +
shows O +
soft O +
tissue O +
syndactyly O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Prx1::cre O +
mouse O -
. O +

( O -
E O +
and O +
F O -
) O +
Wild O -
- O -
type O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O -
, O +
respectively O -
, O +
showing O +
acridine B-Chemical +
orange I-Chemical -
– O -
stained O +
hindlimbs O +
of O +
E15.5 O +
mouse O +
embryos O -
. O +

Acridine B-Chemical +
orange I-Chemical +
stain O +
is O +
in O +
yellow O -
. O +

( O -
G O +
and O +
H O -
) O +
Enlarged O +
views O +
of O +
selected O +
regions O +
from O +
( O -
E O -
) O +
and O +
( O -
F O -
) O -
, O +
respectively O -
. O +

Black O +
arrow O +
in O +
( O -
G O -
) O +
and O +
( O -
H O -
) O +
show O +
acridine B-Chemical +
orange I-Chemical -
– O -
stained O +
apoptotic O +
cells O +
in O +
the O +
interdigital O +
mesenchyme O -
, O +
and O +
asterisk O +
in O +
( O -
H O -
) O +
shows O +
the O +
remnant O +
of O +
the O +
AER O -
. O +

( O -
I O +
and O +
J O -
) O +
Fgf8 O +
mRNA O +
expression O +
in O +
the O +
hindlimbs O +
of O +
E13.5 O +
wild O -
- O -
type O +
( O -
I O -
) O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
( O -
J O -
) O +
embryos O -
. O +

The O +
thick O +
black O +
arrows O +
in O +
( O -
J O -
) O +
show O +
Fgf8 O +
mRNA O +
expression O -
. O +

Figure O +
3 O +
Patterning O +
Defects O +
in O +
Limbs O +
Deficient O +
of O +
Different O +
Combinations O +
of O +
BMP O +
Molecules B-Chemical +
( O -
A O -
– O -
D O -
) O +
Bmp4 O +
expression O +
in O +
limb O +
buds O +
from O +
E11.5 O +
wild O -
- O -
type O +
( O -
A O +
and O +
C O -
) O +
and O +
Bmp2C O -
/ O -
C O -
, O +
Bmp7 O +
− O -
/ O -
− O -
; O +
Prx1::cre O +
( O -
B O +
and O +
D O -
) O +
mouse O +
embryos O -
. O +

( O -
A O +
and O +
B O -
) O +

Forelimbs O -
, O +
( O -
C O +
and O +
D O -
) O +
hindlimbs O -
. O +
( O -
E O -
– O -
H O -
) O +
Shh O +
( O -
E O +
and O +
F O -
) O +
and O +
Fgf8 O +
( O -
G O +
and O +
H O -
) O +
expression O +
in O +
E11.5 O +
forelimbs O +
and O +
hindlimbs O -
, O +
respectively O -
. O +

( O -
E O +
and O +
G O -
) O +
Wild O -
- O -
type O +
embryos O -
, O +
( O -
F O +
and O +
H O -
) O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
embryos O -
. O +

( O -
I O -
– O -
P O -
) O +
Sox9 O +
( O -
I O -
– O -
K O -
) O +
and O +
Msx2 O +
( O -
M O -
– O -
O O -
) O +
expression O +
in O +
E12.5 O +
wild O -
- O -
type O +
( O -
I O +
and O +
M O -
) O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mouse O +
embryonic O +
forelimbs O +
( O -
J O +
and O +
N O -
) O +
and O +
hindlimbs O +
( O -
K O +
and O +
O O -
) O -
. O +

( O -
L O +
and O +
P O -
) O +
Shh O +
expression O +
in O +
E12.5 O +
wild O -
- O -
type O +
( O -
L O -
) O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
( O -
P O -
) O +
embryonic O +
hindlimbs O -
. O +

The O +
red O +
brackets O +
in O +
( O -
F O -
) O +
and O +
( O -
H O -
) O +
show O +
the O +
broadened O +
domains O +
of O +
expressions O +
of O +
Shh O +
and O +
Fgf8 O -
, O +
respectively O -
. O +

Figure O +
4 O +
Chondrogenesis O +
Starts O +
and O +
Proceeds O +
Normally O +
Even O +
in O +
the O +
Absence O +
of O +
BMP2 O +
and O +
BMP4 O +
( O -
A O +
and O +
B O -
) O +

Whole O +
mount O +
skeletons O +
from O +
E13.5 O +
embryos O +
that O +
are O +
stained O +
with O +
alcian O +
blue O -
. O +

( O -
A O -
) O +
Wild O -
- O -
type O +
embryo O -
, O +
( O -
B O -
) O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
embryo O -
. O +

Black O +
arrow O +
in O +
( O -
B O -
) O +
shows O +
the O +
fusion O +
of O +
the O +
zeugopod O +
and O +
stylopod O -
. O +

( O -
C O +
and O +
D O -
) O +
Hematoxylin B-Chemical +
and O +
eosin O -
– O -
stained O +
sagittal O +
sections O +
of O +
humeri O +
from O +
E13.5 O +
wild O -
- O -
type O +
( O -
C O -
) O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
( O -
D O -
) O +
embryos O -
. O +

Thick O +
red O +
arrow O +
in O +
( O -
C O -
) O +
shows O +
the O +
hypertrophic O +
region O -
. O +

( O -
E O +
and O +
F O -
) O +

Sagittal O +
sections O +
of O +
wild O -
- O -
type O +
( O -
E O -
) O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
( O -
F O -
) O +
humeri O +
from O +
E15.5 O +
embryos O +
were O +
hybridized O +
with O +
digoxigenin B-Chemical -
- O -
labeled O +
antisense O +
rioprobes O +
for O +
ColX. O +
( O -
G O +
and O +
H O -
) O +
Sagittal O +
sections O +
of O +
forelimbs O +
from O +
E13.5 O +
wild O -
- O -
type O +
and O +
BMP2 O -
, O +
BMP4–deficient O +
embryos O -
, O +
respectively O -
, O +
stained O +
with O +
radioactive O +
riboprobes O +
for O +
Bmp7 O +
mRNA O -
. O +

( O -
G′ O -
) O +
and O +
( O -
H′ O -
) O +
show O +
the O +
bright O +
field O +
views O +
of O +
( O -
G O -
) O +
and O +
( O -
H O -
) O -
, O +
respectively O -
. O +

Figure O +
5 O +
In O +
the O +
Absence O +
of O +
BMP2 O +
and O +
BMP4 O -
, O +
Osteogenesis O +
Begins O +

During O +
Early O +
Embryonic O +
Development O +
( O -
A O -
– O -
D O -
) O +
Sagittal O +
sections O +
of O +
forelimb O +
from O +
E15.5 O +
embryos O -
. O +

( O -
A O +
and O +
B O -
) O +
Stained O +
with O +
toluidine O +
blue O -
. O +

( O -
A O -
) O +
Distal O +
ulna O +
from O +
wild O -
- O -
type O +
embryo O -
, O +
( O -
B O -
) O +
distal O +
ulna O -
/ O -
radius O +
from O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
embryo O -
. O +

Mineralized O +
cartilage O +
is O +
shown O +
by O +
dark O +
purple O +
and O +
osteoid O +
is O +
shown O +
by O +
light O +
blue O +
( O -
red O +
asterisk O -
) O -
. O +

( O -
C O +
and O +
D O -
) O +
Humeri O +
sections O +
were O +
hybridized O +
with O +
digoxigenin B-Chemical +
labeled O +
riboprobe O +
for O +
ColI. O +
( O -
C O -
) O +
Section O +
of O +
wild O -
- O -
type O +
humerus O +
from O +
E15.5 O +
embryo O -
, O +
( O -
D O -
) O +
from O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
E15.5 O +
embryo O -
. O +

( O -
E O -
– O -
H O -
) O +

Sagittal O +
sections O +
of O +
zeugopod O +
from O +
E17.5 O +
embryos O -
. O +

( O -
E O +
and O +
F O -
) O +
Stained O +
with O +
toluidine O +
blue O +
while O +
G O +
and O +
H O +
are O +
stained O +
for O +
TRAP O +
( O -
brown O +
stain O -
, O +
red O +
arrow O -
) O -
. O +

( O -
E O +
and O +
G O -
) O +
E17.5 O +
proximal O +
radius O +
from O +
wild O -
- O -
type O +
embryo O -
, O +
( O -
F O +
and O +
H O -
) O +
E17.5 O +
proximal O +
ulna O -
/ O -
radius O +
from O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
embryo O -
. O +

Although O +
vascularization O +
occurs O +
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP4 O -
, O +
few O +
osteoclasts O +
are O +
observed O +
in O +
the O +
mineralized O +
cartilage O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mice O -
. O +

Please O +
note O +
all O +
the O +
panels O +
other O +
than O +
( O -
G O -
) O +
and O +
( O -
H O -
) O +
are O +
photographed O +
at O +
×20 O -
, O +
while O +
( O -
G O -
) O +
and O +
( O -
H O -
) O +
were O +
photographed O +
at O +
×40 O -
. O +

( O -
I O +
and O +
J O -
) O +
Sections O +
of O +
newborn O +
proximal O +
radius O +
( O -
I O -
) O +
from O +
control O +
animal O +
and O +
newborn O +
proximal O +
ulna O -
/ O -
radius O +
( O -
J O -
) O +
from O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
animal O +
were O +
stained O +
with O +
toluidine O +
blue O -
. O +

Red O +
arrow O +
shows O +
the O +
bone O +
marrow O +
cavity O +
in O +
( O -
E O -
) O +
and O +
( O -
I O -
) O -
. O +

Note O +
that O +
bone O +
collar O +
( O -
red O +
* O -
) O +
forms O +
at O +
the O +
right O +
time O +
and O +
place O +
in O +
the O +
absence O +
of O +
BMP2 O +
and O +
BMP4 O -
. O +

Also O +
note O +
that O +
since O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mice O +
occasionally O +
have O +
only O +
one O +
bone O +
in O +
zeugopod O +
and O +
the O +
elbow O +
joint O +
is O +
occasionally O +
fused O -
, O +
it O +
is O +
difficult O +
to O +
distinguish O +
between O +
the O +
ulna O +
and O +
the O +
radius O -
. O +

Figure O +
6 O +
Defects O +
in O +
Bone O +
Formation O +
in O +
the O +
Absence O +
of O +
BMP2 O +
and O +
BMP4 O +
Toluidine O +
blue O +
staining O +
of O +
sagittal O +
sections O +
of O +
distal O +
femurs O -
. O +

( O -
A O -
– O -
E O -
) O +
Control O +
femurs O +
at O +
1 O +
wk O +
( O -
A O -
) O +
and O +
3 O +
wks O +
( O -
D O -
) O +
of O +
age O -
. O +

Boxed O +
areas O +
in O +
( O -
A O -
) O +
are O +
enlarged O +
in O +
( O -
B O -
) O +
and O +
( O -
C O -
) O -
. O +

Boxed O +
area O +
in O +
( O -
D O -
) O +
is O +
enlarged O +
in O +
( O -
E O -
) O -
. O +

Blue O +
arrows O +
in O +
( O -
C O -
) O +
point O +
to O +
osteoblast O +
cells O +
lining O +
the O +
surface O +
of O +
cortical O +
bone O -
. O +

Pink O +
arrows O +
in O +
( O -
G O -
) O +
show O +
similar O +
cells O +
to O +
those O +
in O +
( O -
C O -
) O +
in O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
femurs O -
. O +

Red O +
star O +
in O +
( O -
A O -
) O +
and O +
( O -
D O -
) O +
marks O +
the O +
secondary O +
ossification O +
center O -
. O +

Pale O +
blue O -
– O -
stained O +
tissue O +
in O +
( O -
E O -
) O -
, O +
marked O +
by O +
red O +
arrows O -
, O +
is O +
trabecular O +
bone O -
. O +

bm O -
, O +
marks O +
the O +
bone O +
marrow O +
cavity O +
in O +
( O -
D O -
) O -
. O +

( O -
F O -
– O -
J O -
) O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
femurs O +
at O +
1 O +
wk O +
( O -
F O -
) O +
and O +
3 O +
wks O +
( O -
J O -
) O +
of O +
age O -
. O +

Boxed O +
areas O +
in O +
( O -
F O -
) O +
are O +
enlarged O +
in O +
( O -
G O -
) O -
, O +
( O -
H O -
) O -
, O +
and O +
( O -
I O -
) O -
. O +

( O -
A O -
) O -
, O +
( O -
D O -
) O -
, O +
( O -
F O -
) O -
, O +
and O +
( O -
J O -
) O +
are O +
shown O +
with O +
the O +
same O +
magnification O -
. O +

Note O +
that O +
there O +
are O +
defects O +
in O +
bone O +
formation O +
but O +
no O +
defect O +
in O +
osteoclast O +
mediated O +
bone O +
resorption O -
. O +

Mineralized O +
tissue O +
in O +
the O +
mid O +
shaft O +
of O +
femur O +
is O +
almost O +
resorbed O +
at O +
3 O +
wks O -
. O +

( O -
H O -
) O +
Fibroblast O -
- O -
like O +
cells O +
present O +
in O +
the O +
bone O +
shaft O +
of O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mouse O -
. O +

Red O +
star O +
in O +
( O -
I O -
) O +
shows O +
the O +
osteoclasts O +
invading O +
the O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
femurs O +
at O +
1 O +
wk O +
of O +
age O -
. O +

s O +
and O +
m O +
mark O +
soft O +
tissues O +
and O +
muscle O +
in O +
( O -
J O -
) O -
, O +
respectively O -
. O +

( O -
K O +
and O +
L O -
) O +
Three O -
- O -
wk O -
- O -
old O +
wild O -
- O -
type O +
( O -
K O -
) O +
and O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
( O -
L O -
) O +
hindlimb O +
skeletons O +
stained O +
with O +
Alcian O +
blue O +
and O +
Alizarin B-Chemical +
red I-Chemical -
. O +

The O +
black O +
arrow O +
shows O +
the O +
missing O +
part O +
of O +
proximal O +
femur O -
. O +

Figure O +
7 O +
Osteoblast O +
Maturation O +
Is O +
Inhibited O +
in O +
the O +
Absence O +
of O +
BMP2 O +
and O +
BMP4 O +
( O -
A O -
– O -
D O -
) O +
Distal O +
femurs O +
from O +
control O +
mice O +
at O +
1 O +
wk O +
of O +
age O -
. O +

( O -
E O -
– O -
H O -
) O +
Distal O +
femurs O +
from O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mice O +
at O +
1 O +
wk O +
of O +
age O -
. O +

( O -
I O -
– O -
L O -
) O +

Distal O +
femurs O +
from O +
control O +
mice O +
at O +
3 O +
wks O +
of O +
age O -
. O +

( O -
M O -
– O -
P O -
) O +
Distal O +
femurs O +
from O +
Bmp2C O -
/ O -
C O -
; O +
Bmp4C O -
/ O -
C O -
; O +
Prx1::cre O +
mice O +
at O +
3 O +
wks O +
of O +
age O -
. O +

In O +
situ O +
hybridization O +
of O +
early O +
osteoblast O +
differentiation O -
- O -
related O +
marker O +
genes O +
Col O +
I O +
( O -
B O -
, O +
F O -
, O +
J O -
, O +
and O +
N O -
) O -
, O +
runx2 O +
( O -
C O -
, O +
G O -
, O +
K O -
, O +
and O +
O O -
) O +
and O +
osterix O +
( O -
D O -
, O +
H O -
, O +
L O -
, O +
and O +
P O -
) O -
. O +

Footnotes O +
Competing O +
interests O -
. O +

The O +
authors O +
have O +
declared O +
that O +
no O +
competing O +
interests O +
exist O -
. O +

A O +
previous O +
version O +
of O +
this O +
article O +
appeared O +
as O +
an O +
Early O +
Online O +
Release O +
on O +
November O +
6 O -
, O +
2006 O +
( O -
doi:10.1371 O -
/ O -
journal.pgen.0020216.eor O -
) O -
. O +

Author O +
contributions O -
. O +

AB O -
, O +
KT O -
, O +
BDH O -
, O +
VR O -
, O +
and O +
CJT O +
conceived O +
and O +
designed O +
the O +
experiments O -
. O +

AB O -
, O +
KT O -
, O +
KC O -
, O +
and O +
BDH O +
performed O +
the O +
experiments O -
. O +

AB O -
, O +
KT O -
, O +
VR O -
, O +
and O +
CJT O +
analyzed O +
the O +
data O -
. O +

AB O +
and O +
KT O +
wrote O +
the O +
paper O -
. O +

Funding O -
. O +

This O +
work O +
was O +
supported O +
by O +
a O +
grant O +
from O +
the O +
National O +
Institutes O +
of O +
Health O +
( O -
P01 O +
DK56246 O +
to O +
CJT O -
) O +
and O +
by O +
funds O +
from O +
the O +
Forsyth O +
Institute O +
and O +
Harvard O +
School O +
of O +
Dental O +
Medicine O +
( O -
to O +
VR O -
) O -
. O +

Pygo1 O +
and O +
Pygo2 O +
roles O +
in O +
Wnt O +
signaling O +
in O +
mammalian O +
kidney O +
development O +
Abstract O +
Background O +
The O +
pygopus O +
gene O +
of O +
Drosophila O +
encodes O +
an O +
essential O +
component O +
of O +
the O +
Armadillo O +
( O -
β O -
- O -
catenin O -
) O +
transcription O +
factor O +
complex O +
of O +
canonical O +
Wnt O +
signaling O -
. O +

To O +
better O +
understand O +
the O +
functions O +
of O +
Pygopus O -
- O -
mediated O +
canonical O +
Wnt O +
signaling O +
in O +
kidney O +
development O -
, O +
targeted O +
mutations O +
were O +
made O +
in O +
the O +
two O +
mammalian O +
orthologs O -
, O +
Pygo1 O +
and O +
Pygo2 O -
. O +

Results O +
Each O +
mutation O +
deleted O +
> O -
80 O -
% O +
of O +
the O +
coding O +
sequence O -
, O +
including O +
the O +
critical O +
PHD O +
domain O -
, O +
and O +
almost O +
certainly O +
resulted O +
in O +
null O +
function O -
. O +

Pygo2 O +
homozygous O +
mutants O -
, O +
with O +
rare O +
exception O -
, O +
died O +
shortly O +
after O +
birth O -
, O +
with O +
a O +
phenotype O +
including O +
lens O +
agenesis O -
, O +
growth O +
retardation O -
, O +
altered O +
kidney O +
development O -
, O +
and O +
in O +
some O +
cases O +
exencephaly O +
and O +
cleft O +
palate O -
. O +

Pygo1 O +
homozygous O +
mutants O -
, O +
however O -
, O +
were O +
viable O +
and O +
fertile O -
, O +
with O +
no O +
detectable O +
developmental O +
defects O -
. O +

Double O +
Pygo1 O -
/ O -
Pygo2 O +
homozygous O +
mutants O +
showed O +
no O +
apparent O +
synergy O +
in O +
phenotype O +
severity O -
. O +

The O +
BAT O -
- O -
gal O +
transgene O +
reporter O +
of O +
canonical O +
Wnt O +
signaling O +
showed O +
reduced O +
levels O +
of O +
expression O +
in O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
mutants O -
, O +
with O +
tissue O -
- O -
specific O +
variation O +
in O +
degree O +
of O +
diminution O -
. O +

The O +
Pygo1 O +
and O +
Pygo2 O +
genes O +
both O +
showed O +
widespread O +
expression O +
in O +
the O +
developing O +
kidney O -
, O +
with O +
raised O +
levels O +
in O +
the O +
stromal O +
cell O +
compartment O -
. O +

Confocal O +
analysis O +
of O +
the O +
double O +
mutant O +
kidneys O +
showed O +
disturbance O +
of O +
both O +
the O +
ureteric O +
bud O +
and O +
metanephric O +
mesenchyme O -
- O -
derived O +
compartments O -
. O +

Branching O +
morphogenesis O +
of O +
the O +
ureteric O +
bud O +
was O +
altered O -
, O +
with O +
expanded O +
tips O +
and O +
reduced O +
tip O +
density O -
, O +
probably O +
contributing O +
to O +
the O +
smaller O +
size O +
of O +
the O +
mutant O +
kidney O -
. O +

In O +
addition O -
, O +
there O +
was O +
an O +
expansion O +
of O +
the O +
zone O +
of O +
condensed O +
mesenchyme O +
capping O +
the O +
ureteric O +
bud O -
. O +

Nephron O +
formation O -
, O +
however O -
, O +
proceeded O +
normally O -
. O +

Microarray O +
analysis O +
showed O +
changed O +
expression O +
of O +
several O +
genes O -
, O +
including O +
Cxcl13 O -
, O +
Slc5a2 O -
, O +
Klk5 O -
, O +
Ren2 O +
and O +
Timeless O -
, O +
which O +
represent O +
candidate O +
Wnt O +
targets O +
in O +
kidney O +
development O -
. O +

Conclusion O +
The O +
mammalian O +
Pygopus O +
genes O +
are O +
required O +
for O +
normal O +
branching O +
morphogenesis O +
of O +
the O +
ureteric O +
bud O +
during O +
kidney O +
development O -
. O +

Nevertheless O -
, O +
the O +
relatively O +
mild O +
phenotype O +
observed O +
in O +
the O +
kidney O -
, O +
as O +
well O +
as O +
other O +
organ O +
systems O -
, O +
indicates O +
a O +
striking O +
evolutionary O +
divergence O +
of O +
Pygopus O +
function O +
between O +
mammals O +
and O +
Drosophila O -
. O +

In O +
mammals O -
, O +
the O +
Pygo1 O -
/ O -
Pygo2 O +
genes O +
are O +
not O +
absolutely O +
required O +
for O +
canonical O +
Wnt O +
signaling O +
in O +
most O +
developing O +
systems O -
, O +
but O +
rather O +
function O +
as O +
quantitative O +
transducers O -
, O +
or O +
modulators O -
, O +
of O +
Wnt O +
signal O +
intensity O -
. O +

Background O +
Wnt O +
signaling O +
is O +
of O +
critical O +
importance O +
in O +
several O +
stages O +
of O +
kidney O +
development O -
. O +

Mutual O +
inductive O +
interactions O +
between O +
the O +
ureteric O +
bud O +
and O +
metanephric O +
mesenchyme O +
drive O +
nephrogenesis O +
[ O -
1 O -
] O -
. O +

The O +
ureteric O +
bud O +
synthesizes O +
Wnt9b O -
, O +
which O +
is O +
essential O +
for O +
induction O +
of O +
the O +
mesenchyme O +
to O +
form O +
nephrons O +
[ O -
2 O -
] O -
. O +

Wnt4 O +
is O +
made O +
by O +
the O +
induced O +
metanephric O +
mesenchyme O +
and O +
is O +
also O +
required O +
for O +
nephrogenesis O +
[ O -
3 O -
] O -
. O +

Furthermore O -
, O +
Wnt11 O -
, O +
secreted O +
by O +
the O +
ureteric O +
bud O +
tips O -
, O +
participates O +
in O +
a O +
positive O +
feedback O +
loop O +
promoting O +
glial O +
cell O +
line O -
- O -
derived O +
neurotrophic O +
factor O +
( O -
GDNF O -
) O +
expression O +
by O +
the O +
metanephric O +
mesenchyme O +
[ O -
4 O -
] O -
. O +

Mutations O +
in O +
Wnt9b O +
or O +
Wnt4 O +
result O +
in O +
a O +
dramatic O +
block O +
in O +
nephron O +
formation O -
, O +
while O +
Wnt11 O +
mutants O +
show O +
a O +
significant O +
reduction O +
in O +
nephron O +
number O -
. O +

It O +
is O +
interesting O +
to O +
note O +
that O +
Wnt4 O +
and O +
Wnt11 O +
have O +
been O +
shown O +
to O +
signal O -
, O +
at O +
least O +
in O +
some O +
cases O -
, O +
through O +
noncanonical O +
pathways O +
[ O -
5 O -
- O -
7 O -
] O -
, O +
while O +
there O +
is O +
evidence O +
indicating O +
that O +
Wnt9b O +
activates O +
canonical O +
Wnt O +
signaling O +
in O +
the O +
kidney O +
[ O -
2 O -
] O -
. O +

Genetic O +
studies O +
in O +
Drosophila O +
have O +
identified O +
the O +
Pygopus O +
( O -
Pygo O -
) O +
gene O +
as O +
a O +
critical O +
component O +
of O +
canonical O +
Wnt O +
signaling O +
[ O -
8 O -
- O -
11 O -
] O -
. O +

Pygo O +
and O +
Lgs O +
interact O +
with O +
β O -
- O -
catenin O +
during O +
the O +
formation O +
of O +
the O +
canonical O +
transcriptional O +
complex O +
and O +
are O +
required O +
for O +
accumulation O +
of O +
β O -
- O -
catenin O +
in O +
the O +
nucleus O +
[ O -
12 O -
] O -
. O +

Lgs O +
binds O +
the O +
central O +
armadillo O +
repeats O +
of O +
β O -
- O -
catenin O -
, O +
while O +
Pygo O +
interacts O +
with O +
Lgs O -
, O +
mediating O +
activation O +
of O +
Wnt O +
targets O +
[ O -
9,13 O -
] O -
. O +

The O +
N O -
- O -
terminal O +
domain O +
of O +
Pygo O +
is O +
required O +
for O +
Wnt O +
transcriptional O +
activation O -
, O +
while O +
the O +
PHD O +
motif O +
is O +
required O +
for O +
the O +
association O +
of O +
Pygo O +
with O +
Lgs O +
[ O -
9,13 O -
] O -
. O +

Additionally O -
, O +
a O +
putative O +
nuclear O +
localization O +
signal O +
( O -
NLS O -
) O +
was O +
identified O +
within O +
the O +
N O -
- O -
terminal O +
domain O +
of O +
Pygo O -
, O +
suggesting O +
a O +
possible O +
role O +
of O +
nuclear O +
importation O +
of O +
β O -
- O -
catenin O +
[ O -
8,11 O -
] O -
. O +

Analyses O +
of O +
multiple O +
aspects O +
of O +
the O +
pygopus O +
mutant O +
phenotype O +
indicate O +
that O +
this O +
gene O +
is O +
dedicated O +
to O -
, O +
and O +
required O +
for O -
, O +
canonical O +
Wnt O +
signaling O +
during O +
Drosophila O +
development O +
[ O -
9 O -
] O -
. O +

The O +
mammalian O +
genome O +
carries O +
two O -
, O +
and O +
only O +
two O -
, O +
orthologs O +
of O +
Drosophila O +
Pygo O -
, O +
Pygo1 O +
and O +
Pygo2 O +
[ O -
8,9,14 O -
] O -
. O +

In O +
this O +
report O -
, O +
we O +
generated O +
targeted O +
mutations O +
of O +
Pygo1 O +
and O +
Pygo2 O +
to O +
determine O +
their O +
functions O -
, O +
with O +
a O +
particular O +
interest O +
in O +
the O +
contributions O +
of O +
these O +
genes O +
to O +
canonical O +
Wnt O +
signaling O +
during O +
kidney O +
development O -
. O +

The O +
resulting O +
double O -
- O -
homozygous O +
mutant O +
embryos O +
showed O +
a O +
context O -
- O -
dependent O +
reduction O +
in O +
canonical O +
Wnt O +
signaling O +
as O +
measured O +
by O +
Wnt O +
reporter O +
transgene O +
expression O -
. O +

Development O +
remained O -
, O +
however O -
, O +
surprisingly O +
normal O -
, O +
with O +
survival O +
to O +
birth O +
and O +
few O +
apparent O +
defects O +
in O +
most O +
organ O +
systems O -
. O +

Our O +
phenotypic O +
analysis O +
focused O +
on O +
the O +
kidney O -
, O +
which O +
showed O +
altered O +
branching O +
morphogenesis O +
of O +
the O +
ureteric O +
bud O -
, O +
and O +
expansion O +
of O +
the O +
zone O +
of O +
condensed O +
mesenchyme O +
surrounding O +
the O +
ureteric O +
bud O -
, O +
yet O +
relatively O +
normal O +
nephron O +
formation O -
, O +
as O +
measured O +
by O +
histology O -
, O +
confocal O +
analysis O -
, O +
in O +
situ O +
hybridization O +
and O +
microarray O +
analysis O -
. O +

The O +
obvious O +
conclusion O +
is O +
that O +
in O +
mammals O -
, O +
unlike O +
Drosophila O -
, O +
Pygopus O -
- O -
mediated O +
canonical O +
Wnt O +
signaling O +
is O +
not O +
absolutely O +
necessary O +
in O +
most O +
developing O +
organ O +
systems O -
. O +

Results O +
Pygo1 O +
and O +
Pygo2 O +
targeted O +
mutations O +
We O +
targeted O +
both O +
the O +
Pygo1 O +
and O +
Pygo2 O +
genes O +
by O +
inserting O +
LoxP O +
sequences O +
to O +
flank O +
critical O +
coding O +
regions O +
including O +
the O +
PHD O +
domains O -
. O +

The O +
resulting O +
targeted O +
mice O +
were O +
mated O +
with O +
transgenic O +
CMV O -
- O -
Cre O +
mice O +
[ O -
15 O -
] O +
to O +
drive O +
germline O +
LoxP O +
recombination O -
, O +
resulting O +
in O +
the O +
null O +
mutant O +
alleles O +
that O +
were O +
used O +
for O +
this O +
study O -
. O +

PCR O +
confirmed O +
the O +
deletion O +
of O +
the O +
bulk O +
of O +
the O +
coding O +
sequences O +
for O +
both O +
genes O -
, O +
including O +
89 O -
% O +
of O +
coding O +
sequence O +
for O +
Pygo1 O +
and O +
87 O -
% O +
of O +
coding O +
sequence O +
for O +
Pygo2 O -
. O +

Previous O +
studies O +
in O +
Drosophila O +
have O +
shown O +
that O +
even O +
a O +
single O +
missense O +
mutation O +
in O +
the O +
PHD O +
domain O +
can O +
eliminate O +
Pygo O +
function O +
in O +
Wnt O +
signaling O +
[ O -
8 O -
] O -
. O +

Pygo1 O +
and O +
Pygo2 O +
mutant O +
phenotypes O +
Pygo1 O +
homozygous O +
null O +
mice O +
were O +
viable O +
and O +
fertile O +
with O +
no O +
developmental O +
defects O +
detectable O -
. O +

This O +
was O +
surprising O +
given O +
the O +
importance O +
of O +
the O +
pygopus O +
gene O +
in O +
Wnt O +
signaling O +
in O +
Drosophila O -
, O +
and O +
the O +
reported O +
expression O +
during O +
development O +
of O +
the O +
mouse O +
Pygo1 O +
gene O +
in O -
, O +
for O +
example O -
, O +
the O +
brain O -
, O +
limbs O -
, O +
kidney O +
and O +
branchial O +
arches O +
[ O -
14,16 O -
] O +
( O -
Yu O +
J O -
, O +
Valerius O +
MT O -
, O +
McMahon O +
AP O -
, O +
contribution O +
to O +
GUDMAP O -
, O +
) O -
. O +

The O +
Pygo2 O +
homozygous O +
null O +
mice O +
survived O +
to O +
birth O -
, O +
but O +
with O +
rare O +
exceptions O -
, O +
died O +
shortly O +
afterwards O -
. O +

The O +
gut O -
, O +
heart O +
and O +
limbs O +
developed O +
without O +
detectable O +
abnormality O +
( O -
data O +
not O +
shown O -
) O +
despite O +
known O +
requirements O +
for O +
Wnt O +
signaling O -
. O +

The O +
Pygo2 O +
mutants O +
did O -
, O +
however O -
, O +
show O +
growth O +
retardation O -
, O +
lens O +
agenesis O +
and O +
a O +
kidney O +
phenotype O +
with O +
high O +
penetrance O -
, O +
exencephaly O -
, O +
and O +
cleft O +
palate O +
with O +
incomplete O +
penetrance O -
. O +

Double O -
- O -
homozygous O +
mutant O +
Pygo1 O +
and O +
Pygo2 O +
mice O +
had O +
a O +
phenotype O +
similar O +
to O +
that O +
of O +
single O +
Pygo2 O +
nulls O +
( O -
Figure O +
1 O -
, O +
Table O +
1 O -
) O -
. O +

There O +
was O +
no O +
significant O +
synergism O +
of O +
developmental O +
abnormalities O +
in O +
the O +
double O +
mutants O -
. O +

Together O +
these O +
results O +
suggest O +
that O +
Pygo2 O +
is O +
required O +
for O +
the O +
proper O +
development O +
of O +
a O +
limited O +
number O +
of O +
structures O -
, O +
whereas O +
Pygo1 O +
is O +
not O +
necessary O +
for O +
normal O +
development O -
. O +

Figure O +
1 O +
Pygo1 O -
/ O -
Pygo2 O +
mutant O +
embryos O -
. O +

( O -
A O -
) O +
E18.5 O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
embryos O -
, O +
with O +
only O +
one O +
wild O -
- O -
type O +
Pygo2 O +
allele O -
, O +
appeared O +
normal O -
. O +

( O -
B O -
, O +
C O -
) O +
Double O +
homozygous O +
mutant O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
embryos O +
were O +
smaller O -
, O +
with O +
eye O +
defects O +
including O +
absent O +
or O +
rudimentary O +
lens O +
and O +
folded O +
pigmented B-Chemical +
retina O +
( O -
arrows O -
) O -
. O +

( O -
C O -
) O +
A O +
small O +
percentage O +
of O +
Pygo1 O -
/ O -
Pygo2 O +
null O +
embryos O +
also O +
displayed O +
exencephaly O -
. O +

Table O +
1 O +
Phenotypes O +
of O +
Pygo2 O +
wild O -
- O -
type O -
, O +
heterozyogous O -
, O +
and O +
null O +
E18.5 O +
embryos O +
on O +
a O +
Pygo1 O +
null O +
background O -
. O +

* O +
Denotes O +
a O +
significant O +
change O +
( O -
p O +
< O +
0.01 O -
) O +
of O +
the O +
average O +
weight O +
of O +
the O +
Pygo2 O +
null O +
group O +
compared O +
with O +
both O +
the O +
Pygo O +
wild O -
- O -
type O +
and O +
heterozygous O +
groups O -
. O +

Expression O +
of O +
Pygo1 O +
and O +
Pygo2 O +
in O +
the O +
developing O +
kidney O +
In O +
situ O +
hybridization O +
has O +
been O +
used O +
previously O +
to O +
characterize O +
expression O +
of O +
Pygo1 O +
[ O -
14,16 O -
] O -
( O -
Yu O +
J O -
, O +
Valerius O +
MT O -
, O +
McMahon O +
AP O -
, O +
contribution O +
to O +
GUDMAP O -
, O +
) O -
. O +

In O +
this O +
report O -
, O +
we O +
used O +
immunofluorescence O +
to O +
better O +
define O +
the O +
expression O +
patterns O +
of O +
the O +
Pygo1 O +
and O +
Pygo2 O +
genes O +
in O +
the O +
developing O +
kidney O -
. O +

Both O +
genes O +
were O +
widely O +
expressed O -
, O +
showing O +
nuclear O +
localization O +
of O +
encoded O +
proteins O +
in O +
the O +
ureteric O +
bud O -
, O +
capping O +
mesenchyme O -
, O +
and O +
stromal O +
cells O +
( O -
Figure O +
2 O -
) O -
. O +

Raised O +
expression O +
of O +
Pygo1 O -
, O +
and O +
to O +
a O +
lesser O +
degree O +
of O +
Pygo2 O -
, O +
was O +
seen O +
in O +
stromal O +
cells O -
, O +
and O +
significant O +
nuclear O +
staining O +
was O +
detected O +
in O +
essentially O +
all O +
cells O +
of O +
the O +
developing O +
kidney O +
for O +
both O +
proteins O -
. O +

Figure O +
2 O +
Pygo1 O +
and O +
Pygo2 O +
expression O +
in O +
the O +
E18.5 O +
developing O +
kidney O -
. O +

Immunofluorescence O +
was O +
used O +
to O +
determine O +
expression O +
patterns O +
of O +
the O +
Pygo1 O +
and O +
Pygo2 O +
proteins O +
in O +
the O +
cortex O +
of O +
the O +
E18.5 O +
kidney O -
. O +

Both O +
Pygo1 O +
and O +
Pygo2 O +
( O -
red O -
) O +
were O +
localized O +
in O +
the O +
nucleus O -
, O +
as O +
expected O -
. O +

Both O +
genes O +
showed O +
widespread O +
expression O -
, O +
with O +
signal O +
detected O +
in O +
all O +
components O +
of O +
the O +
developing O +
kidney O -
, O +
but O +
with O +
elevated O +
levels O +
in O +
the O +
stromal O +
cell O +
compartment O +
( O -
arrows O -
) O -
. O +

Epithelial O +
cells O -
, O +
primarily O +
ureteric O +
bud O +
in O +
these O +
sections O -
, O +
were O +
labeled O +
blue O +
using O +
E O -
- O -
cadherin O +
antibody O -
. O +

Original O +
magnification O +
× O +
200 O -
. O +

Confocal O +
analysis O +
of O +
Pygo1 O -
/ O -
Pygo2 O +
mutant O +
kidneys O +
Histological O +
examination O +
of O +
Pygo2 O +
null O +
and O +
Pygo1 O -
/ O -
Pygo2 O +
double O -
- O -
null O +
mutant O +
kidneys O +
did O +
not O +
reveal O +
any O +
abnormalities O +
in O +
nephrogenesis O +
( O -
data O +
not O +
shown O -
) O -
. O +

Confocal O +
analysis O +
was O +
therefore O +
performed O +
to O +
characterize O +
renal O +
development O +
in O +
E18.5 O +
Pygo1 O -
/ O -
Pygo2 O +
null O +
kidneys O +
more O +
precisely O +
( O -
Figure O +
3 O -
) O -
. O +

Wt1 O +
( O -
red O -
) O +
and O +
Cited1 O +
( O -
red O -
) O +
antibodies O +
both O +
stain O +
the O +
capping O +
metanephric O +
mesenchyme O +
around O +
the O +
ureteric O +
bud O +
tips O +
[ O -
17 O -
] O -
. O +

WT1 O +
antibody O +
also O +
stains O +
renal O +
vesicles O +
and O +
glomerular O +
anlage O -
. O +

Antibodies O +
to O +
Cdh1 O -
, O +
also O +
known O +
as O +
E O -
- O -
cadherin O +
( O -
blue O -
) O -
, O +
were O +
used O +
to O +
identify O +
epithelial O +
structures O -
, O +
including O +
the O +
branching O +
ureteric O +
bud O +
and O +
nascent O +
nephrons O +
of O +
the O +
developing O +
kidney O +
[ O -
18 O -
] O -
. O +

Dolichos O +
biflorus O +
( O -
DBA O -
) O +
lectin O +
[ O -
16 O -
] O +
was O +
used O +
to O +
selectively O +
stain O +
ureteric O +
bud O -
- O -
derived O +
structures O +
[ O -
19 O -
] O -
. O +

Figure O +
3 O +
Confocal O +
analysis O +
of O +
Pygo1 O -
/ O -
Pygo2 O +
mutant O +
E18.5 O +
kidneys O -
. O +

( O -
B O -
, O +
D O -
) O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
mutant O +
E18.5 O +
kidneys O +
and O +
( O -
A O -
, O +
C O -
) O +
kidneys O +
of O +
normal O +
littermates O +
were O +
stained O +
using O +
antibodies O +
to O +
( O -
C O -
, O +
D O -
) O +
Cited1 O +
or O +
( O -
A O -
, O +
B O -
) O +
Wt1 O -
, O +
both O +
expressed O +
in O +
the O +
condensing O +
metanephric O +
mesenchyme O -
, O +
and O +
colored O +
as O +
red O -
, O +
Cdh1 O -
, O +
a O +
general O +
marker O +
of O +
epithelia O +
( O -
blue O -
) O -
, O +
and O +
DBA O +
lectin O +
staining O +
the O +
ureteric O +
tree O +
[ O -
16 O -
] O -
. O +

Confocal O +
Z O -
- O -
sections O +
were O +
obtained O +
every O +
5 O +
μm O +
for O +
75–80 O +
μm O -
. O +

A O +
reduced O +
number O +
of O +
ureteric O +
tips O +
per O +
area O +
was O +
observed O +
in O +
( O -
B O -
, O +
D O -
) O +
the O +
Pygo1 O -
/ O -
Pygo2 O +
null O +
kidneys O +
compared O +
with O +
( O -
A O -
, O +
C O -
) O +
control O +
littermates O -
. O +

In O +
addition O -
, O +
ureteric O +
bud O +
tips O +
were O +
often O +
more O +
dilated O +
in O +
Pygo1 O -
/ O -
2 O +
null O +
mutants O +
compared O +
with O +
controls O -
. O +

The O +
condensed O +
mesenchyme O +
surrounding O +
the O +
ureteric O +
bud O +
was O +
also O +
significantly O +
expanded O +
in O +
the O +
mutants O -
. O +

Original O +
magnification O +
× O +
200 O -
. O +

Wt1 O +
and O +
Cited1 O +
( O -
red O -
) O +
staining O +
revealed O +
an O +
increase O +
of O +
approximately O +
30 O -
% O +
in O +
the O +
thickness O +
of O +
the O +
capping O +
mesenchyme O +
surrounding O +
the O +
mutant O +
ureteric O +
buds O +
( O -
Figure O +
3 O -
, O +
Table O +
2 O -
) O -
. O +

Nevertheless O -
, O +
the O +
mutant O +
metanephric O +
mesenchyme O +
underwent O +
relatively O +
normal O +
nephrogenesis O -
. O +

Cdh1-staining O +
nephrons O +
( O -
blue O -
) O +
were O +
identified O +
connecting O +
to O +
the O +
ureteric O +
bud O +
tips O +
[ O -
16 O -
] O +
and O +
extending O +
into O +
the O +
medulla O +
of O +
the O +
kidney O -
, O +
as O +
normal O -
. O +

Intermediate O +
structures O +
of O +
nephrogenesis O -
, O +
including O +
renal O +
vesicles O -
, O +
comma O -
- O -
shaped O +
bodies O -
, O +
and O +
S O -
- O -
shaped O +
bodies O +
appeared O +
normal O -
. O +

Table O +
2 O +
Confocal O +
analysis O +
of O +
Pygo2 O +
wild O -
- O -
type O -
, O +
heterozygous O -
, O +
and O +
null O +
E18.5 O +
kidneys O +
on O +
the O +
Pygo1 O +
null O +
background O -
. O +

* O -
Significant O +
change O +
( O -
P O +
< O +
0.01 O -
) O +
between O +
the O +
three O +
groups O -
. O +

SD O -
, O +
Standard O +
deviation O -
; O +
n O -
, O +
number O +
Confocal O +
analysis O +
also O +
showed O +
that O +
the O +
ureteric O +
bud O +
tips O +
[ O -
16 O -
] O +
of O +
Pygo1 O -
/ O -
Pygo2 O +
null O +
kidneys O +
were O +
dilated O +
and O +
misshaped O +
compared O +
with O +
those O +
of O +
littermates O +
with O +
at O +
least O +
one O +
wild O -
- O -
type O +
Pygo2 O +
allele O +
( O -
Figure O +
3 O -
) O -
. O +

In O +
addition O -
, O +
the O +
Pygo1 O -
/ O -
Pygo2 O +
double O -
- O -
homozygous O +
mutant O +
kidneys O +
also O +
had O +
a O +
decrease O +
of O +
approximately O +
25 O -
% O +
in O +
the O +
number O +
of O +
ureteric O +
bud O +
tips O +
per O +
area O +
compared O +
with O +
littermates O +
with O +
at O +
least O +
one O +
wild O -
- O -
type O +
copy O +
of O +
Pygo2 O +
( O -
Table O +
2 O -
) O -
. O +

No O +
significant O +
difference O +
in O +
ureteric O +
bud O -
- O -
tip O +
density O +
was O +
seen O +
between O +
Pygo2+ O -
/ O -
- O +
and O +
Pygo2+ O -
/ O -
+ O +
embryos O +
( O -
P O +
= O +
0.33 O -
) O -
. O +

In O +
situ O +
hybridization O +
We O +
examined O +
expression O +
of O +
three O +
Wnt O +
genes O +
in O +
Pygo O +
mutants O -
. O +

Wnt7b O +
is O +
expressed O +
in O +
the O +
stalks O +
[ O -
20 O -
] O -
, O +
Wnt11 O +
in O +
the O +
tips O +
[ O -
4 O -
] O -
, O +
and O +
Wnt9b O +
in O +
the O +
stalks O +
and O +
weakly O +
in O +
the O +
tips O +
of O +
the O +
branching O +
ureteric O +
bud O +
[ O -
2 O -
] O -
. O +

All O +
three O +
genes O +
showed O +
similar O +
expression O +
patterns O +
in O +
Pygo2+ O -
/ O -
+ O +
and O +
Pygo1 O -
/ O -
Pygo2 O +
double O -
- O -
mutant O +
kidneys O +
( O -
Figure O +
4 O -
) O -
. O +

In O +
addition O -
, O +
these O +
in O +
situ O +
hybridization O +
patterns O +
confirmed O +
the O +
confocal O +
microscopy O +
results O -
, O +
showing O +
a O +
reduced O +
number O +
of O +
tips O +
( O -
Wnt11-positive O -
) O +
per O +
surface O +
area O +
in O +
the O +
Pygo1 O -
/ O -
Pygo2 O +
double O -
- O -
homozygous O +
mutants O -
. O +

Figure O +
4 O +
Expression O +
of O +
Wnt7b O -
, O +
Wnt9b O -
, O +
and O +
Wnt11 O +
in O +
E18.5 O +
Pygo1 O -
/ O -
Pygo2 O +
compound O +
null O +
kidneys O -
. O +

Whole O -
- O -
mount O +
in O +
situ O +
of O +
hybridizations O +
of O +
( O -
A O -
- O -
C O -
) O +
E18.5 O +
wild O -
- O -
type O +
kidneys O +
and O +
( O -
D O -
- O -
F O -
) O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
mutant O +
kidneys O +
with O +
the O +
ureteric O +
bud O +
derivative O +
markers O -
: O +
( O -
A O -
, O +
D O -
) O +
Wnt7b O -
, O +
( O -
B O -
, O +
E O -
) O +
Wnt9b O -
, O +
and O +
( O -
C O -
, O +
F O -
) O +
Wnt11 O -
. O +

The O +
mutant O +
kidneys O +
showed O +
normal O +
expression O +
patterns O +
for O +
the O +
ureteric O +
stalk O +
markers O +
Wnt7b O +
and O +
Wnt9b O -
, O +
and O +
reduced O +
density O +
of O +
ureteric O +
tips O +
as O +
measured O +
by O +
Wnt11 O -
. O +

Original O +
magnification O +
× O +
32 O -
. O +

Reduced O +
canonical O +
Wnt O +
signaling O +
in O +
Pygo1 O -
/ O -
Pygo2 O +
mutant O +
mice O +
The O +
BAT O -
- O -
gal O +
transgene O +
reporter O +
of O +
canonical O +
Wnt O +
signaling O +
[ O -
21 O -
] O +
was O +
used O +
to O +
examine O +
changes O +
in O +
Wnt O +
signaling O +
in O +
the O +
mutant O +
mice O -
. O +

Both O +
Pygo2- O -
/ O -
- O +
and O +
Pygo1 O -
/ O -
Pygo2 O +
double O -
- O -
null O +
E10.5 O +
embryos O +
showed O +
a O +
decrease O +
in O +
canonical O +
Wnt O +
signaling O +
( O -
Figure O +
5 O -
) O -
. O +

There O +
was O -
, O +
however O -
, O +
tissue O -
- O -
specific O +
variability O +
in O +
the O +
degree O +
of O +
reduction O -
, O +
with O +
the O +
somites O -
, O +
for O +
example O -
, O +
showing O +
strong O +
reduction O -
, O +
while O +
the O +
mutant O +
telencephalon O +
still O +
showed O +
robust O +
Wnt O +
signaling O -
. O +

These O +
results O +
suggest O +
that O +
the O +
mammalian O +
Pygo O +
genes O +
are O +
significant O +
modulators O +
of O +
canonical O +
Wnt O +
signaling O +
in O +
some O -
, O +
but O +
not O +
in O +
all O +
developing O +
systems O -
. O +

Figure O +
5 O +
Reduced O +
canonical O +
Wnt O +
signaling O +
in O +
Pygo2 O +
and O +
Pygo1 O -
/ O -
Pygo2 O +
mutant O +
embryos O -
. O +

E10.5 O +
embryos O -
, O +
all O +
with O +
the O +
BAT O -
- O -
gal O +
transgene O +
reporter O +
of O +
canonical O +
Wnt O +
signaling O -
. O +

( O -
A O -
) O +
Pygo1+ O -
/ O -
+ O -
/ O -
Pygo2+ O -
/ O -
- O +
embryos O +
showed O +
normal O +
X B-Chemical -
- I-Chemical -
gal I-Chemical +
staining O +
in O +
the O +
developing O +
brain O -
, O +
pharyngeal O +
pouches O -
, O +
otic O +
vesicle O -
, O +
apical O +
ectodermal O +
ridges O +
of O +
the O +
fore O +
and O +
hind O +
limb O +
buds O -
, O +
and O +
in O +
somites O -
. O +

( O -
B O -
) O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
embryos O -
, O +
with O +
loss O +
of O +
both O +
Pygo2 O +
alleles O -
, O +
showed O +
reduced O +
but O +
not O +
absent O +
BAT O -
- O -
gal O +
reporter O +
expression O +
in O +
many O +
developing O +
structures O -
, O +
including O +
pharyngeal O +
pouches O -
, O +
otic O +
vesicle O -
, O +
and O +
somites O -
. O +

( O -
C O -
) O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
embryo O -
, O +
with O +
mutation O +
of O +
both O +
Pygo1 O +
alleles O -
, O +
but O +
one O +
wild O -
- O -
type O +
Pygo2 O +
allele O -
, O +
showed O +
normal O +
BAT O -
- O -
gal O +
expression O -
. O +

( O -
D O -
) O +
Double O -
- O -
homozygous O +
mutant O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
embryos O +
still O +
showed O +
some O +
remaining O +
BAT O -
- O -
gal O +
expression O -
, O +
suggesting O +
residual O +
canonical O +
Wnt O +
signaling O -
. O +

Embryos O +
in O +
panels O +
( O -
A O -
) O +
and O +
( O -
B O -
) O +
were O +
from O +
the O +
same O +
litter O +
and O +
were O +
processed O +
in O +
parallel O -
, O +
while O +
embryos O +
in O +
( O -
C O -
) O +
and O +
( O -
D O -
) O +
were O +
from O +
a O +
separate O +
litter O -
, O +
also O +
processed O +
in O +
parallel O -
, O +
and O +
were O +
slightly O +
more O +
developmentally O +
advanced O -
. O +

Original O +
magnification O +
( O -
A O -
, O +
B O -
) O +
× O +
20 O -
; O +
( O -
C O -
, O +
D O -
) O +
× O +
16 O -
. O +

We O +
also O +
examined O +
BAT O -
- O -
gal O +
reporter O +
expression O +
in O +
more O +
detail O +
in O +
the O +
developing O +
urogenital O +
system O +
of O +
Pygo O +
mutants O -
. O +

The O +
results O +
suggested O +
that O +
the O +
Pygo2 O +
gene O +
is O +
required O +
for O +
canonical O +
Wnt O +
signaling O +
in O +
the O +
nephric O +
duct O -
. O +

Both O +
Pygo2 O +
null O +
and O +
Pygo1 O -
/ O -
Pygo2 O +
double O -
- O -
null O +
E10.5 O +
embryos O +
showed O +
an O +
absence O +
of O +
reporter O +
expression O +
in O +
the O +
nephric O +
duct O -
, O +
while O +
control O +
littermates O +
showed O +
strong O +
expression O +
( O -
Figure O +
6A O -
– O -
C O -
) O -
. O +

In O +
Pygo1 O -
/ O -
Pygo2 O +
double O -
- O -
null O +
mutants O -
, O +
the O +
nephric O +
duct O +
did O +
form O -
, O +
however O -
, O +
and O +
give O +
rise O +
to O +
the O +
ureteric O +
bud O +
outgrowth O -
, O +
which O +
showed O +
reduced O +
but O +
not O +
absent O +
BAT O -
- O -
gal O +
reporter O +
expression O +
( O -
Figure O +
6A O -
– O -
C O -
) O -
. O +

Figure O +
6 O +
Pygo2 O +
is O +
required O +
for O +
BAT O -
- O -
gal O +
reporter O +
expression O +
in O +
ureteric O +
bud O -
- O -
derived O +
structures O +
of O +
the O +
developing O +
kidney O -
. O +

X B-Chemical -
- I-Chemical -
Gal I-Chemical +
staining O +
of O +
BAT O -
- O -
gal O +
transgenic O +
( O -
A O -
- O -
C O -
) O +
E10.5 O -
, O +
and O +
( O -
E O -
- O -
L O -
) O +
E13.5 O +
urogenital O +
tracts O -
, O +
and O +
( O -
M O -
- O -
O O -
) O +
E18.5 O +
kidneys O -
. O +

( O -
A O -
) O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
+ O +
( O -
left O -
) O +
and O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
( O -
right O -
) O -
. O +

Note O +
the O +
loss O +
of O +
reporter O +
activity O +
in O +
the O +
nephric O +
duct O +
( O -
black O +
arrowhead O -
) O +
and O +
reduction O +
of O +
staining O +
in O +
the O +
ureteric O +
bud O +
( O -
white O +
arrow O -
) O +
of O +
the O +
Pygo2 O +
null O +
embryo O +
( O -
Right O -
) O -
. O +

( O -
B O -
) O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
E10.5 O +
embryo O +
with O +
BAT O -
- O -
gal O +
reporter O +
activity O +
in O +
the O +
nephric O +
duct O +
( O -
black O +
arrowhead O -
) O +
and O +
ureteric O +
bud O +
( O -
white O +
arrow O -
) O -
. O +

( O -
C O -
) O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo- O -
/ O -
- O +
embryo O -
, O +
with O +
reporter O +
expression O +
lost O +
in O +
the O +
nephric O +
duct O +
and O +
reduced O +
in O +
the O +
ureteric O +
bud O +
( O -
white O +
arrow O -
) O -
. O +

( O -
D O -
) O +
Control O +
background O +
X B-Chemical -
- I-Chemical -
gal I-Chemical +
staining O +
of O +
a O +
urogenital O +
tract O +
from O +
an O +
E13.5 O +
embryo O +
without O +
the O +
BAT O -
- O -
gal O +
transgene O +
( O -
Non O -
- O -
Tg O -
) O -
, O +
showing O +
absence O +
of O +
endogenous O +
beta O -
- O -
galactosidase O +
activity O -
. O +

( O -
E O -
) O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
+ O -
, O +
with O +
BAT O -
- O -
gal O +
reporter O +
activity O +
in O +
the O +
ureteric O +
compartment O +
of O +
the O +
developing O +
kidney O -
, O +
including O +
the O +
ureteric O +
tips O -
, O +
ureteric O +
tree O -
, O +
and O +
ureter O -
. O +

( O -
F O -
) O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O -
, O +
with O +
marked O +
reduction O +
of O +
BAT O -
- O -
gal O +
reporter O +
activity O +
in O +
the O +
ureteric O +
compartment O -
. O +

( O -
G O -
) O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O -
, O +
with O +
reporter O +
expression O +
in O +
the O +
paramesonephric O +
duct O +
( O -
white O +
arrowhead O -
) O +
and O +
ureteric O +
tree O -
. O +

( O -
H O -
, O +
I O -
) O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O -
, O +
with O +
( O -
H O -
) O +
ventral O +
view O +
showing O +
reporter O +
expression O +
in O +
the O +
paramesonephric O +
duct O +
( O -
white O +
arrowhead O -
) O -
, O +
and O +
( O -
I O -
) O +
dorsal O +
view O +
showing O +
ureteric O +
tree O +
expression O +
in O +
the O +
kidney O -
. O +

( O -
J O -
) O -
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O -
, O +
a O +
control O +
processed O +
in O +
parallel O +
with O +
( O -
K O -
) O +
and O +
( O -
L O -
) O -
, O +
with O +
expression O +
in O +
ureteric O +
tree O +
and O +
paramesonephric O +
duct O -
. O +

( O -
K O -
, O +
L O -
) O -
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O -
, O +
reporter O +
activity O +
was O +
lost O +
in O +
the O +
paramesonephric O +
duct O +
( O -
white O +
arrowhead O -
) O -
, O +
and O +
in O +
the O +
ureter O +
and O +
ureteric O +
compartment O +
of O +
the O +
developing O +
kidneys O +
( O -
dashed O +
circles O -
) O -
, O +
except O +
for O +
( O -
K O -
) O +
a O +
few O +
faintly O +
staining O +
cells O -
. O +

( O -
M O -
, O +
N O -
) O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
( O -
left O -
) O +
and O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
( O -
right O -
) O +
E18.5 O +
kidneys O -
. O +

The O +
kidneys O +
in O +
( O -
N O -
) O +
were O +
bisected O -
. O +

BAT O -
- O -
gal O +
reporter O +
expression O +
was O +
seen O +
in O +
the O +
ureteric O +
tree O +
components O +
of O +
the O +
cortex O +
and O +
medulla O +
of O +
the O +
double O +
heterozygotes O +
but O +
was O +
almost O +
completely O +
lost O +
in O +
the O +
double O -
- O -
homozygous O +
mutants O -
. O +

( O -
O O -
) O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
+ O +
( O -
left O -
) O -
, O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
( O -
middle O -
) O -
, O +
and O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
( O -
right O -
) O +
E18.5 O +
kidneys O -
. O +

Reporter O +
activity O +
was O +
present O +
in O +
the O +
ureteric O +
compartments O +
of O +
the O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
+ O +
( O -
left O -
) O +
and O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
( O -
middle O -
) O +
kidneys O -
, O +
but O +
lost O +
in O +
the O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
( O -
right O -
) O +
kidney O -
. O +

Original O +
magnification O -
: O +
( O -
A O -
- O -
C O -
) O +
× O +
32 O -
, O +
( O -
D O -
- O -
F O -
) O +
× O +
63 O -
, O +
( O -
G O -
- O -
I O -
) O +
× O +
40 O -
, O +
( O -
J O -
- O -
L O -
) O +
× O +
50 O -
, O +
( O -
M O -
, O +
N O -
) O +
× O +
10 O -
, O +
and O +
( O -
O O -
) O +
× O +
12.5 O -
. O +

At O +
E13.5 O -
, O +
the O +
Pygo2 O +
gene O +
appeared O +
to O +
play O +
a O +
major O +
role O -
, O +
and O +
the O +
Pygo1 O +
gene O +
a O +
minor O +
role O -
, O +
in O +
canonical O +
Wnt O +
signaling O +
in O +
the O +
ureteric O +
tree O -
, O +
as O +
measured O +
by O +
BAT O -
- O -
gal O +
expression O -
. O +

A O +
negative O +
control O +
kidney O -
, O +
without O +
the O +
BAT O -
- O -
gal O +
transgene O -
, O +
showed O +
minimal O +
background O +
X B-Chemical -
- I-Chemical -
gal I-Chemical +
staining O +
( O -
Figure O +
6D O -
) O -
, O +
whereas O +
a O +
BAT O -
- O -
gal O +
transgenic O +
kidney O +
with O +
at O +
least O +
one O +
wild O -
- O -
type O +
Pygo2 O +
gene O +
showed O +
strong O +
X B-Chemical -
- I-Chemical -
gal I-Chemical +
staining O +
in O +
the O +
ureteric O +
tree O +
( O -
Figure O +
6E O -
) O -
. O +

In O +
contrast O -
, O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
E13.5 O +
kidneys O +
showed O +
very O +
weak O +
reporter O +
expression O +
( O -
Figure O +
6F O -
) O -
, O +
suggesting O +
a O +
significant O +
loss O +
of O +
canonical O +
Wnt O +
signaling O -
. O +

Homozygous O +
loss O +
of O +
the O +
Pygo1 O +
gene O +
alone O -
, O +
however O -
, O +
had O +
a O +
small O +
effect O +
on O +
reporter O +
expression O +
( O -
Figure O +
6G O -
– O -
H O -
) O -
. O +

Homozygous O +
mutation O +
of O +
both O +
the O +
Pygo1 O +
and O +
Pygo2 O +
genes O +
gave O +
a O +
more O +
dramatic O +
reduction O +
of O +
BAT O -
- O -
gal O +
expression O +
than O +
loss O +
of O +
Pygo2 O +
alone O +
( O -
Figure O +
6F O -
, O +
L O -
) O -
. O +

The O +
Pygo1 O +
and O +
Pygo2 O +
genes O +
were O +
also O +
required O +
for O +
BAT O -
- O -
gal O +
reporter O +
expression O +
in O +
the O +
paramesonephric O +
( O -
Mullerian O -
) O +
ducts O -
. O +

In O +
Pygo2- O -
/ O -
- O +
mice O -
, O +
there O +
was O +
a O +
significant O +
loss O +
of O +
reporter O +
expression O +
( O -
data O +
not O +
shown O -
) O -
, O +
and O +
double O -
- O -
homozygous O +
mutants O +
showed O +
loss O +
of O +
X B-Chemical -
- I-Chemical -
gal I-Chemical +
staining O +
in O +
the O +
paramesonephric O +
ducts O +
( O -
Figure O +
6 O -
K O -
) O -
, O +
whereas O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
and O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
mice O +
showed O +
normal O +
levels O +
of O +
BAT O -
- O -
gal O +
expression O +
( O -
Figure O +
6 O -
G O -
, O +
H O -
, O +
J O -
) O -
. O +

BAT O -
- O -
gal O +
reporter O +
analysis O +
of O +
the O +
Pygo O +
mutants O +
at O +
a O +
later O +
developmental O +
stage O -
, O +
E18.5 O -
, O +
also O +
identified O +
a O +
significant O +
decrease O +
in O +
canonical O +
Wnt O +
signaling O +
in O +
the O +
cortical O +
ureteric O +
branches O +
and O +
renal O +
pelvis O +
of O +
the O +
developing O +
kidney O +
( O -
Figure O +
6M O -
– O -
O O -
) O -
. O +

Cortical O +
X B-Chemical -
- I-Chemical -
gal I-Chemical +
staining O +
was O +
seen O +
in O +
the O +
ureteric O +
branches O +
of O +
a O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
kidney O +
( O -
Figure O +
6 O -
M O -
, O +
left O -
) O -
, O +
but O +
was O +
completely O +
absent O +
in O +
the O +
cortex O +
of O +
a O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
kidney O +
( O -
Figure O +
6 O -
M O -
, O +
right O -
) O -
. O +

Bisection O +
revealed O +
a O +
significant O +
loss O +
of O +
X B-Chemical -
- I-Chemical -
gal I-Chemical +
staining O +
cells O +
in O +
the O +
collecting O +
ducts O +
and O +
renal O +
pelvis O +
of O +
the O +
Pygo2 O +
null O +
kidney O +
compared O +
with O +
control O +
littermates O +
( O -
Figure O +
6N O -
) O -
. O +

Side O +
by O +
side O +
comparison O +
of O +
Pygo1+ O -
/ O -
+ O -
/ O -
Pygo2+ O -
/ O -
- O +
( O -
Figure O +
6O O -
, O +
left O -
) O -
, O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
( O -
Figure O +
6O O -
, O +
middle O -
) O -
, O +
and O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
( O -
Figure O +
6O O -
, O +
right O -
) O +
E18.5 O +
kidneys O +
suggested O +
a O +
significant O +
role O +
for O +
the O +
Pygo2 O +
gene O +
in O +
canonical O +
Wnt O +
signaling O +
in O +
the O +
ureteric O +
tree O +
and O +
its O +
derivatives O -
. O +

In O +
order O +
to O +
validate O +
and O +
quantify O +
the O +
BAT O -
- O -
gal O +
reporter O +
expression O +
changes O +
in O +
the O +
Pygo2 O +
null O +
and O +
Pygo1 O -
/ O -
Pygo2 O +
nulls O -
, O +
we O +
performed O +
ELISA O +
measurements O +
of O +
transgene O +
specific O +
β O -
- O -
galactosidase O +
levels O +
in O +
E18.5 O +
kidneys O +
( O -
Figure O +
7 O -
) O -
. O +

Loss O +
of O +
the O +
Pygo2 O +
gene O +
( O -
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
and O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O -
) O +
gave O +
greater O +
than O +
90 O -
% O +
reduction O +
in O +
BAT O -
- O -
gal O +
expression O -
. O +

Loss O +
of O +
Pygo1 O +
alone O +
( O -
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
+ O -
) O +
did O +
not O +
result O +
in O +
a O +
significant O +
change O -
. O +

Interestingly O -
, O +
however O -
, O +
the O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
showed O +
only O +
50 O -
% O +
of O +
wild O -
- O -
type O +
BAT O -
- O -
gal O +
expression O -
, O +
suggesting O +
a O +
minor O +
contribution O +
by O +
Pygo1 O +
in O +
canonical O +
Wnt O +
signaling O -
. O +

Although O +
BAT O -
- O -
gal O +
expression O +
was O +
decreased O +
in O +
the O +
E18.5 O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
kidney O -
, O +
confocal O +
analysis O +
of O +
kidneys O +
with O +
this O +
genotype O +
revealed O +
no O +
dilated O +
ureteric O +
tips O +
or O +
significant O +
changes O +
in O +
ureteric O +
tip O +
number O +
per O +
area O +
compared O +
with O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
+ O +
kidneys O +
( O -
data O +
not O +
shown O -
) O -
. O +

Collectively O -
, O +
these O +
BAT O -
- O -
gal O +
reporter O +
results O +
suggest O +
a O +
significant O +
role O +
for O +
the O +
Pygo1 O +
and O +
Pygo2 O +
genes O +
in O +
canonical O +
Wnt O +
signaling O +
during O +
development O +
of O +
the O +
ureteric O +
tree O +
of O +
the O +
kidney O -
. O +

Figure O +
7 O +
Quantitative O +
analysis O +
of O +
BAT O -
- O -
gal O +
reporter O +
expression O +
in O +
Pygo1 O -
/ O -
Pygo2 O +
E18.5 O +
kidney O +
extracts O -
. O +

Transgene O -
- O -
specific O +
beta O -
- O -
galactosidase O +
was O +
quantified O +
by O +
ELISA O +
analysis O -
. O +

Pygo1+ O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
+ O -
, O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
- O +
and O +
Pygo1+ O -
/ O -
- O -
/ O -
Pygo2+ O -
/ O -
+ O +
kidneys O +
all O +
showed O +
similar O +
levels O +
of O +
BAT O -
- O -
gal O +
expression O -
. O +

In O +
the O +
Pygo2 O +
hetereozygote O -
, O +
Pygo1 O +
homozygous O +
mutants O -
, O +
however O -
, O +
reporter O +
expression O +
was O +
reduced O +
by O +
about O +
50 O -
% O -
. O +

In O +
Pygo2 O +
homozygous O +
mutants O +
BAT O -
- O -
gal O +
expression O +
was O +
uniformly O +
low O -
, O +
with O +
or O +
without O +
wild O -
- O -
type O +
Pygo1 O +
alleles O -
. O +

Each O +
experimental O +
group O +
included O +
a O +
sample O +
size O +
of O +
at O +
least O +
four O -
. O +

Interestingly O -
, O +
however O -
, O +
even O +
in O +
wild O -
- O -
type O +
mice O +
the O +
BAT O -
- O -
gal O +
reporter O +
showed O +
no O +
expression O +
in O +
the O +
developing O +
metanephric O +
mesenchyme O -
, O +
or O +
metanephric O +
mesenchyme O -
- O -
derived O +
structures O -
, O +
such O +
as O +
renal O +
vesicles O -
, O +
S O -
- O -
shaped O +
bodies O -
, O +
tubules O -
, O +
and O +
glomeruli O -
. O +

This O +
has O +
been O +
reported O +
previously O -
, O +
and O +
was O +
interpreted O +
to O +
indicate O +
the O +
absence O +
of O +
canonical O +
Wnt O +
signaling O +
in O +
the O +
metanephric O +
mesenchyme O +
[ O -
21 O -
] O -
. O +

Results O +
from O +
other O +
studies O -
, O +
however O -
, O +
argue O +
for O +
the O +
presence O +
of O +
canonical O +
Wnt O +
signaling O +
in O +
the O +
metanephric O +
mesenchyme O -
. O +

For O +
example O -
, O +
ureteric O +
bud O +
expression O +
of O +
Wnt1 O -
, O +
thought O +
to O +
act O +
through O +
canonical O +
Wnt O +
signaling O -
, O +
can O +
rescue O +
Wnt9b O +
mutants O +
and O +
induce O +
nephrogenesis O +
of O +
the O +
metanephric O +
mesenchyme O +
[ O -
2 O -
] O -
. O +

This O +
suggests O +
that O +
the O +
BAT O -
- O -
gal O +
transgene O +
might O +
not O +
accurately O +
report O +
canonical O +
Wnt O +
signaling O +
in O +
the O +
metanephric O +
mesenchyme O -
. O +

To O +
address O +
this O +
question O -
, O +
we O +
incubated O +
E11.5 O +
metanephric O +
mesenchyme O +
in O +
lithium B-Chemical +
chloride I-Chemical +
( O -
LiCl B-Chemical -
) O -
, O +
which O +
activates O +
canonical O +
Wnt O +
signaling O +
through O +
inhibition O +
of O +
GSK3 O -
, O +
and O +
also O +
functions O +
as O +
an O +
inducer O +
of O +
nephrogenesis O +
in O +
kidney O +
organ O +
culture O +
[ O -
22 O -
] O -
. O +

We O +
observed O +
that O +
LiCl B-Chemical -
- O -
treated O +
metanephric O +
mesenchyme O +
did O +
undergo O +
nephrogenesis O -
, O +
as O +
expected O -
, O +
but O +
failed O +
to O +
show O +
BAT O -
- O -
gal O +
expression O +
( O -
data O +
not O +
shown O -
) O -
, O +
suggesting O +
that O +
this O +
transgene O +
is O +
not O +
an O +
accurate O +
reporter O +
of O +
canonical O +
Wnt O +
signaling O +
in O +
the O +
metanephric O +
mesenchyme O +
of O +
the O +
developing O +
kidney O -
. O +

Microarray O +
analysis O +
of O +
Pygo1 O -
/ O -
Pygo2 O +
null O +
kidneys O +
To O +
further O +
examine O +
possible O +
disturbance O +
of O +
gene O +
expression O +
in O +
the O +
Pygo1 O -
/ O -
Pygo2 O +
mutant O +
kidneys O -
, O +
we O +
used O +
microarrays O +
to O +
perform O +
a O +
global O +
analysis O +
of O +
gene O +
expression O +
changes O -
. O +

Whereas O +
the O +
BAT O -
- O -
gal O +
transgene O +
reporter O +
monitors O +
the O +
response O +
of O +
one O +
promoter O +
to O +
Wnt O +
signaling O -
, O +
microarrays O +
can O +
be O +
used O +
to O +
follow O +
expression O +
changes O +
of O +
all O +
genes O -
, O +
including O +
all O +
known O +
Wnt O +
targets O -
. O +

E18.5 O +
wild O -
- O -
type O +
and O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
kidneys O +
were O +
examined O +
in O +
biological O +
triplicate O -
. O +

In O +
total O -
, O +
45 O +
genes O +
were O +
identified O +
as O +
significantly O +
changed O -
, O +
using O +
a O +
relatively O +
low O +
stringency O +
screen O +
of O +
the O +
data O -
, O +
with O +
a O +
p O -
- O -
value O +
cutoff O +
of O +
< O -
0.05 O -
, O +
and O +
fold O +
change O +
> O -
2 O +
( O -
Table O +
3 O -
) O -
. O +

Notably O -
, O +
both O +
Pygo1 O +
and O +
Pygo2 O +
were O +
identified O +
as O +
downregulated O +
( O -
- O +
5.3-fold O +
and O +
- O +
3.9-fold O -
, O +
respectively O -
) O +
in O +
the O +
mutant O +
kidneys O -
. O +

Other O +
genes O +
with O +
significant O +
decreases O +
in O +
mutant O +
kidneys O +
included O +
Cxcl13 O +
( O -
- O +
2.3-fold O -
) O -
, O +
Slc5a2 O +
( O -
- O +
2.8-fold O -
) O -
, O +
and O +
Slco1a4 O +
( O -
- O +
2.1-fold O -
) O -
. O +

Slc5a2 O +
is O +
expressed O +
in O +
the O +
proximal O +
tubules O +
of O +
the O +
adult O +
nephron O +
and O +
has O +
been O +
implicated O +
in O +
autosomal O +
recessive O +
renal O +
glucosuria O -
, O +
characterized O +
by O +
loss O +
of O +
glucose B-Chemical +
uptake O +
by O +
the O +
nephron O +
[ O -
23 O -
] O -
. O +

The O +
organic B-Chemical +
anion I-Chemical +
transporter O -
, O +
Slco1a4 O -
, O +
is O +
also O +
strongly O +
expressed O +
in O +
the O +
tubules O +
of O +
the O +
adult O +
kidney O +
[ O -
24 O -
] O -
. O +

These O +
results O +
suggest O +
that O +
the O +
Pygo1 O -
/ O -
Pygo2 O +
genes O +
might O +
play O +
a O +
role O +
in O +
nephron O +
maturation O +
and O +
subsequent O +
function O -
. O +

Table O +
3 O +
Genes O +
differentially O +
expressed O +
( O -
p O +
< O +
0.05 O -
, O +
two O -
- O -
fold O +
change O +
or O +
greater O -
) O +
in O +
the O +
Pygo1 O -
/ O -
Pygo2 O +
null O +
E18.5 O +
kidney O +
normalized O +
to O +
wild O -
- O -
type O +
samples O -
. O +

Noteworthy O +
genes O +
upregulated O +
in O +
the O +
Pygo1 O -
/ O -
Pygo2 O +
null O +
kidney O +
included O +
Klk5 O +
( O -
2.8-fold O -
) O -
, O +
Klk6 O +
( O -
2.7-fold O -
) O -
, O +
Ren2 O +
( O -
2.2-fold O -
) O -
, O +
and O +
Timeless O +
( O -
2.4-fold O -
) O -
. O +

Klk5 O +
and O +
Klk6 O +
are O +
members O +
of O +
the O +
kallikrein O +
family O +
of O +
trypsin O -
- O -
like O +
serine O +
proteases O -
. O +

Kallikreins O +
have O +
diverse O +
functions O +
in O +
cancer O -
, O +
tissue O +
remodeling O -
, O +
and O +
regulation O +
of O +
blood O +
pressure O +
[ O -
25 O -
] O -
. O +

Ren2 O -
, O +
a O +
homolog O +
of O +
the O +
endopeptidase O +
Renin O +
1 O -
, O +
activates O +
the O +
renin O -
- O -
angiotensin O +
system O -
, O +
increasing O +
blood O +
pressure O +
[ O -
26 O -
] O -
. O +

Disruption O +
of O +
the O +
renin O -
- O -
angiotensin O +
system O +
during O +
development O +
results O +
in O +
congenital O +
abnormalities O +
of O +
the O +
ureter O +
and O +
collecting O -
- O -
duct O +
system O +
[ O -
27 O -
] O -
. O +

Timeless O -
, O +
a O +
transcription O +
factor O +
involved O +
in O +
the O +
regulation O +
of O +
circadian O +
rhythms O -
, O +
and O +
expressed O +
in O +
the O +
branching O +
ureteric O +
tips O -
, O +
has O +
also O +
been O +
shown O +
to O +
regulate O +
ureteric O +
branching O +
morphogenesis O +
[ O -
28 O -
] O -
. O +

We O +
were O +
interested O +
in O +
the O +
possible O +
altered O +
expression O +
of O +
previously O +
known O +
Wnt O +
targets O +
in O +
the O +
Pygo1- O -
/ O -
- O -
/ O -
Pygo2- O -
/ O -
- O +
mutant O +
kidneys O -
. O +

A O +
list O +
of O +
known O +
Wnt O +
targets O +
was O +
compiled O +
from O +
. O +

Both O +
Pygo1 O +
and O +
Pygo2 O +
probe O +
sets O +
were O +
included O +
as O +
references O +
to O +
illustrate O +
significant O +
down O +
regulation O -
. O +

Remarkably O -
, O +
the O +
known O +
Wnt O +
target O +
genes O +
showed O +
very O +
few O +
differences O +
in O +
expression O +
between O +
wild O -
- O -
type O +
and O +
mutant O +
kidneys O +
( O -
Figure O +
8) O -
. O +

Only O +
the O +
expression O +
of O +
Ccnd1 O +
encoding O +
cyclin O +
D1 O +
[ O -
29 O -
] O -
, O +
and O +
Wisp1 O +
[ O -
30 O -
] O +
were O +
significantly O +
changed O -
, O +
with O +
expression O +
level O +
changes O +
of O +
< O -
1.5-fold O +
in O +
Pygo1 O -
/ O -
Pygo2 O +
null O +
kidneys O -
. O +

These O +
results O +
indicate O +
an O +
absence O +
of O +
dramatic O +
changes O +
in O +
expression O +
of O +
previously O +
known O +
Wnt O +
signaling O +
target O +
genes O +
in O +
the O +
Pygo1 O -
/ O -
Pygo2 O +
mutant O +
kidneys O -
. O +

Figure O +
8 O +
Gene O +
expression O +
changes O +
of O +
common O +
Wnt O +
signaling O +
targets O +
in O +
the O +
E18.5 O +
Pygo1 O -
/ O -
Pygo2 O +
null O +
kidney O -
. O +

Microarray O +
analysis O +
was O +
performed O +
in O +
triplicate O +
on O +
wild O -
- O -
type O +
and O +
Pygo1 O -
/ O -
2 O +
compound O +
null O +
E18.5 O +
kidneys O -
. O +

Possible O +
Wnt O +
targets O +
were O +
selected O +
from O +
those O +
compiled O +
at O +
[ O -
39 O -
] O -
. O +

An O +
initial O +
gene O +
list O +
of O +
82 O +
Wnt O +
targets O +
was O +
created O +
and O +
then O +
reduced O +
to O +
a O +
total O +
of O +
40 O +
genes O +
using O +
an O +
expression O +
level O +
restriction O +
requiring O +
the O +
raw O +
expression O +
intensity O +
to O +
be O +
> O -
100 O +
in O +
at O +
least O +
3 O +
samples O -
. O +

Pygo1 O +
and O +
Pygo2 O +
probes O +
were O +
included O +
to O +
demonstrate O +
significant O +
changes O +
in O +
expression O +
levels O -
. O +

We O +
used O +
quantitative O +
real O -
- O -
time O +
PCR O -
, O +
with O +
independent O +
biological O +
samples O -
, O +
to O +
validate O +
the O +
microarray O +
results O -
. O +

Nine O +
genes O +
were O +
tested O -
, O +
and O +
for O +
seven O +
we O +
did O +
observe O +
a O +
significant O +
fold O +
change O +
in O +
the O +
same O +
direction O +
predicted O +
by O +
the O +
microarray O +
results O +
( O -
Table O +
4 O -
) O -
. O +

It O +
is O +
not O +
surprising O +
that O +
two O +
of O +
the O +
nine O +
genes O +
could O +
not O +
be O +
validated O -
, O +
considering O +
the O +
relatively O +
low O +
stringency O +
used O +
in O +
screening O +
the O +
microarray O +
data O -
. O +

Table O +
4 O +
Validation O +
of O +
gene O +
expression O +
changes O +
in O +
the O +
E18.5 O +
Pygo1 O -
/ O -
Pygo2 O +
null O +
kidneys O +
normalized O +
to O +
E18.5 O +
wild O -
- O -
type O +
kidneys O -
. O +

Discussion O +
In O +
Drosophila O -
, O +
the O +
Pygopus O +
gene O +
is O +
a O +
key O +
mediator O +
of O +
canonical O +
Wnt O +
signaling O -
. O +

In O +
one O +
study O -
, O +
12 O +
distinct O +
measures O +
of O +
Wnt O +
signaling O +
in O +
Pygo O +
mutants O +
were O +
performed O -
, O +
including O +
analysis O +
of O +
leg O -
, O +
wing O -
, O +
and O +
eye O +
imaginal O +
discs O -
. O +

In O +
2 O +
cases O +
there O +
was O +
a O +
significant O +
reduction O +
of O +
Wnt O +
signaling O +
and O +
in O +
10 O +
cases O +
a O +
complete O +
block O +
[ O -
10 O -
] O -
. O +

A O +
second O +
study O +
in O +
Drosophila O +
examined O +
the O +
effects O +
of O +
Pygo O +
mutation O +
on O +
cuticle O +
patterning O -
, O +
midgut O +
constriction O -
, O +
central O +
nervous O +
system O -
, O +
and O +
cardiac O +
development O -
, O +
and O +
concluded O +
that O +
" O -
Pygo O +
is O +
an O +
essential O +
component O +
in O +
the O +
Wg O +
signal O +
transduction O +
pathway O -
" O -
. O +

[ O -
8 O -
] O -
. O +

Given O +
these O +
results O +
in O +
Drosophila O -
, O +
the O +
relatively O +
mild O +
phenotypes O +
of O +
mice O +
with O +
targeted O +
Pygo1 O -
, O +
Pygo2 O -
, O +
or O +
double O +
Pygo1 O -
/ O -
Pygo2 O +
mutations O +
were O +
striking O -
. O +

Pygo2 O +
mutants O +
developed O +
to O +
birth O +
and O +
showed O +
limited O +
abnormalities O -
, O +
while O +
Pygo1 O +
homozygous O +
mutants O +
were O +
normal O +
and O +
fertile O -
. O +

Furthermore O -
, O +
there O +
was O +
no O +
detected O +
synergism O +
in O +
the O +
phenotype O +
of O +
the O +
double O +
Pygo1 O -
/ O -
Pygo2 O +
mutant O -
, O +
although O +
in O +
several O +
tissues O +
the O +
BAT O -
- O -
gal O +
Wnt O +
reporter O +
did O +
show O +
more O +
a O +
severe O +
reduction O +
in O +
expression O -
. O +

One O +
possible O +
explanation O +
of O +
these O +
unexpected O +
results O +
is O +
a O +
failure O +
of O +
the O +
gene O +
targeting O +
to O +
eliminate O +
functioning O +
of O +
the O +
Pygo1 O +
and O +
Pygo2 O +
genes O -
. O +

The O +
Pygopus O +
deletion O +
alleles O +
described O +
in O +
this O +
report O -
, O +
however O -
, O +
are O +
almost O +
certainly O +
functional O +
nulls O -
. O +

In O +
Drosophila O -
, O +
it O +
has O +
been O +
shown O +
that O +
the O +
PHD O +
domain O +
is O +
absolutely O +
necessary O +
for O +
Pygopus O +
function O +
in O +
Wg O +
signaling O -
. O +

The O +
PHD O +
domain O +
is O +
60 O +
amino O +
acids O +
with O +
seven O +
cysteines O +
and O +
a O +
histidine O -
, O +
predicted O +
to O +
chelate O +
two O +
zinc B-Chemical +
ions I-Chemical -
. O +

PHD O +
domains O +
are O +
found O +
in O +
diverse O +
proteins O -
, O +
including O +
transcription O +
factors O -
, O +
and O +
have O +
been O +
implicated O +
in O +
chromatin O +
remodeling O +
and O +
protein O -
- O -
protein O +
interactions O +
[ O -
8 O -
] O -
. O +

In O +
Drosophila O +
the O +
pygoF107 O +
allele O -
, O +
with O +
a O +
single O +
missense O +
mutation O +
converting O +
amino O +
acid O +
802 O +
in O +
the O +
PHD O +
domain O +
from O +
cysteine O +
to O +
tyrosine O -
, O +
loses O +
Wnt O +
signaling O +
function O +
in O +
both O +
embryogenesis O +
and O +
imaginal O +
disc O +
development O +
[ O -
8 O -
] O -
. O +

The O +
Pygo1 O -
/ O -
Pygo2 O +
mutant O +
alleles O +
made O +
in O +
this O +
report O +
carried O +
deletions O +
of O +
the O +
entire O +
PHD O +
domains O -
, O +
as O +
well O +
as O +
most O +
other O +
coding O +
sequences O -
. O +

For O +
the O +
Pygo1 O +
gene O -
, O +
the O +
coding O +
region O +
for O +
372 O +
of O +
417 O +
total O +
amino O +
acids O +
was O +
deleted O -
, O +
and O +
for O +
the O +
Pygo2 O +
gene O -
, O +
we O +
deleted O +
coding O +
for O +
354 O +
of O +
405 O +
amino O +
acids O -
. O +

It O +
is O +
therefore O +
very O +
unlikely O +
that O +
the O +
relatively O +
mild O +
phenotypes O +
observed O +
were O +
the O +
result O +
of O +
residual O +
function O +
of O +
the O +
targeted O +
alleles O -
. O +

We O +
focused O +
our O +
analysis O +
on O +
the O +
developing O +
kidney O -
, O +
in O +
which O +
Wnt O +
signaling O +
has O +
been O +
shown O +
to O +
be O +
of O +
critical O +
importance O +
in O +
several O +
stages O +
of O +
nephrogenesis O -
. O +

Wnt9b O +
is O +
made O +
by O +
the O +
ureteric O +
bud O +
and O +
induces O +
the O +
metanephric O +
mesenchyme O +
to O +
undergo O +
nephrogenesis O +
[ O -
2 O -
] O -
. O +

Downstream O +
of O +
Wnt9b O +
is O +
Wnt4 O +
[ O -
2 O -
] O -
, O +
which O +
is O +
made O +
by O +
the O +
metanephric O +
mesenchyme O -
, O +
and O +
is O +
also O +
required O +
for O +
nephrogenesis O +
[ O -
3 O -
] O -
. O +

In O +
addition O -
, O +
Wnt11 O +
is O +
produced O +
by O +
the O +
ureteric O +
bud O +
tips O +
and O +
induces O +
GDNF O +
expression O +
in O +
the O +
metanephric O +
mesenchyme O +
[ O -
4 O -
] O -
. O +

In O +
this O +
report O +
we O +
describe O +
a O +
novel O +
Wnt O +
function O +
in O +
kidney O +
development O -
. O +

The O +
BAT O -
- O -
gal O +
transgene O +
reporter O +
indicated O +
the O +
presence O +
of O +
canonical O +
Wnt O +
signaling O +
in O +
the O +
ureteric O +
bud O +
and O +
its O +
derivatives O +
in O +
the O +
developing O +
kidney O -
. O +

Further O -
, O +
in O +
the O +
Pygo2 O +
mutants O +
this O +
signal O +
was O +
lost O -
, O +
suggesting O +
significant O +
reduction O +
of O +
Wnt O +
signaling O -
. O +

In O +
addition O -
, O +
we O +
observed O +
a O +
resulting O +
decrease O +
in O +
ureteric O +
tip O +
density O -
, O +
reduced O +
kidney O +
size O +
and O +
altered O +
morphology O +
of O +
the O +
ureteric O +
tree O +
in O +
mutants O -
, O +
indicating O +
a O +
role O +
for O +
canonical O +
Wnt O +
signaling O +
in O +
branching O +
morphogenesis O +
of O +
the O +
ureteric O +
bud O -
. O +

While O +
the O +
simplest O +
interpretation O +
is O +
direct O +
Wnt O +
signaling O +
to O +
the O +
ureteric O +
bud O -
, O +
it O +
remains O +
possible O +
that O +
the O +
observed O +
abnormalities O +
are O +
the O +
result O +
of O +
indirect O +
effects O -
, O +
with O +
altered O +
Wnt O +
signaling O +
to O +
the O +
metanephric O +
mesenchyme O +
then O +
affecting O +
mesenchyme O +
to O +
ureteric O +
bud O +
signaling O -
. O +

The O +
Pygo1 O -
/ O -
Pygo2 O +
mutant O +
phenotype O +
of O +
reduced O +
branching O +
morphogenesis O +
of O +
the O +
ureteric O +
bud O +
is O +
surprisingly O +
similar O +
to O +
that O +
previously O +
reported O +
for O +
Wnt11 O +
mutants O +
[ O -
4 O -
] O -
. O +

The O +
underlying O +
mechanisms O -
, O +
however O -
, O +
are O +
likely O +
to O +
be O +
distinct O -
. O +

Wnt11 O +
is O +
generally O +
thought O +
to O +
act O +
through O +
a O +
noncanonical O +
pathway O -
, O +
( O -
although O +
exceptions O +
have O +
been O +
noted O +
[ O -
31 O -
] O -
) O -
, O +
whereas O +
the O +
Pygopus O +
genes O +
promote O +
canonical O +
Wnt O +
signaling O -
. O +

Further O -
, O +
the O +
Wnt11 O +
mutants O +
showed O +
an O +
altered O +
feedback O +
loop O +
between O +
Wnt O +
signaling O +
from O +
the O +
ureteric O +
bud O +
to O +
the O +
mesenchyme O +
and O +
GDNF O +
signaling O +
from O +
the O +
mesenchyme O +
to O +
the O +
bud O -
, O +
whereas O +
in O +
the O +
Pygo1 O -
/ O -
Pygo2 O +
mutants O -
, O +
we O +
observed O +
disrupted O +
Wnt O +
signaling O +
in O +
the O +
ureteric O +
bud O -
. O +

The O +
Pygo1 O -
/ O -
2 O +
mutants O +
also O +
showed O +
an O +
expansion O +
of O +
the O +
zone O +
of O +
thickened O +
mesenchyme O +
that O +
caps O +
the O +
ureteric O +
bud O -
. O +

Nevertheless O -
, O +
the O +
mutant O +
metanephric O +
mesenchyme O +
formed O +
nephrons O +
normally O -
. O +

This O +
was O +
particularly O +
interesting O -
, O +
as O +
Wnt9b O +
signaling O +
from O +
the O +
ureteric O +
bud O +
to O +
the O +
metanephric O +
mesenchyme O +
has O +
been O +
shown O +
to O +
induce O +
nephrogenesis O +
via O +
canonical O +
Wnt O +
signaling O +
[ O -
2 O -
] O -
. O +

The O +
results O +
in O +
this O +
report O +
indicate O +
a O +
striking O +
and O +
surprising O +
evolutionary O +
divergence O +
of O +
Pygopus O +
function O +
between O +
Drosophila O +
and O +
mammals O -
. O +

In O +
Drosophila O -
, O +
the O +
Pygopus O +
gene O +
is O +
often O +
required O +
for O +
canonical O +
Wnt O +
signaling O -
, O +
while O +
in O +
mammals O +
the O +
Pygo1 O -
/ O -
Pygo2 O +
genes O +
appear O +
to O +
play O +
a O +
smaller O +
role O +
in O +
canonical O +
Wnt O +
signaling O -
. O +

The O +
BAT O -
- O -
gal O +
transgene O +
reporter O +
of O +
canonical O +
Wnt O +
signaling O +
showed O +
reduced O +
but O +
generally O +
not O +
absent O +
signal O +
in O +
Pygo1 O -
/ O -
Pygo2 O +
mutant O +
embryos O -
, O +
with O +
tissue O -
- O -
specific O +
variation O +
in O +
level O +
of O +
diminution O -
. O +

In O +
addition O -
, O +
the O +
kidneys O +
were O +
not O +
unique O +
in O +
showing O +
surprisingly O +
normal O +
development O +
in O +
Pygo1 O -
/ O -
Pygo2 O +
mutants O -
. O +

Indeed O -
, O +
organogenesis O +
generally O +
proceeded O +
without O +
detectable O +
abnormality O -
, O +
with O +
few O +
exceptions O -
. O +

These O +
results O +
suggest O +
that O +
the O +
proteins O +
encoded O +
by O +
mammalian O +
Pygopus O +
genes O +
are O +
often O +
mere O +
modulators O +
of O +
canonical O +
Wnt O +
signaling O +
intensity O -
, O +
and O +
not O +
essential O +
components O -
. O +

The O +
microarray O +
results O +
further O +
support O +
this O +
conclusion O -
. O +

Whereas O +
the O +
BAT O -
- O -
gal O +
transgene O +
reporter O +
monitors O +
the O +
expression O +
level O +
of O +
only O +
one O +
Wnt O +
responsive O +
promoter O -
, O +
the O +
microarray O +
allows O +
the O +
analysis O +
of O +
the O +
activity O +
levels O +
of O +
promoters O +
of O +
all O +
genes O -
. O +

Interestingly O -
, O +
the O +
mutant O +
kidneys O +
showed O +
gene O -
- O -
expression O +
profiles O +
surprisingly O +
similar O +
to O +
wild O +
type O -
. O +

Some O +
genes O +
did O -
, O +
however O -
, O +
show O +
expression O +
differences O -
, O +
and O +
a O +
high O +
percentage O +
of O +
these O +
differences O +
could O +
be O +
validated O +
by O +
real O -
- O -
time O +
PCR O +
with O +
independent O +
biological O +
samples O -
. O +

Assuming O +
that O +
the O +
Pygopus O +
genes O +
in O +
mammals O +
are O +
dedicated O +
to O +
canonical O +
Wnt O +
signaling O -
, O +
as O +
has O +
been O +
previously O +
shown O +
in O +
Drosophila O -
, O +
the O +
genes O +
with O +
expression O +
differences O +
represent O +
candidate O +
Wnt O +
targets O +
( O -
direct O +
or O +
indirect O -
) O +
in O +
kidney O +
development O -
. O +

We O +
would O +
predict O +
these O +
genes O +
to O +
show O +
greater O +
changes O +
in O +
expression O +
level O +
in O +
a O +
developing O +
kidney O +
with O +
a O +
more O +
complete O +
removal O +
of O +
canonical O +
Wnt O +
signaling O -
. O +

Conclusion O +
In O +
conclusion O -
, O +
the O +
mammalian O +
Pygo2 O +
gene O +
is O +
required O +
for O +
normal O +
branching O +
morphogenesis O +
of O +
the O +
ureteric O +
bud O -
, O +
with O +
mutants O +
showing O +
dilated O +
tips O +
and O +
reduced O +
numbers O +
of O +
tips O -
. O +

In O +
addition O -
, O +
in O +
Pygo2 O +
mutants O +
there O +
was O +
an O +
expansion O +
of O +
the O +
zone O +
of O +
metanephric O +
mesenchyme O +
that O +
caps O +
the O +
ureteric O +
buds O -
. O +

Nevertheless O -
, O +
nephron O +
formation O +
proceeded O +
remarkably O +
normally O -
, O +
even O +
in O +
Pygo1 O -
/ O -
Pygo2 O +
double O -
- O -
homozygous O +
mutants O -
. O +

This O +
was O +
surprising O +
considering O +
the O +
importance O +
of O +
the O +
Pygopus O +
gene O +
in O +
canonical O +
Wnt O +
signaling O +
in O +
Drosophila O -
, O +
and O +
the O +
importance O +
of O +
canonical O +
Wnt O +
signaling O +
in O +
nephrogenesis O -
. O +

The O +
results O +
argue O +
that O +
the O +
mammalian O +
Pygopus O +
genes O +
are O -
, O +
in O +
most O +
developing O +
systems O -
, O +
only O +
quantitative O +
transducers O +
of O +
Wnt O +
signaling O -
. O +

Previous O +
cell O +
culture O +
studies O +
[ O -
32,33 O -
] O +
and O +
the O +
reduced O +
BAT O -
- O -
gal O +
transgene O +
reporter O +
expression O +
in O +
the O +
Pygo1 O -
/ O -
Pygo2 O +
knockout O +
mice O +
described O +
in O +
this O +
report O -
, O +
do O +
confirm O +
an O +
evolutionarily O +
conserved O +
function O +
in O +
canonical O +
Wnt O +
signaling O -
. O +

In O +
mammals O -
, O +
however O -
, O +
the O +
phenotypic O +
effects O +
of O +
Pygopus O +
mutation O +
are O +
much O +
milder O +
than O +
in O +
Drosophila O -
. O +

The O +
degree O +
of O +
importance O +
of O +
the O +
Pyg1 O -
/ O -
2 O +
genes O +
in O +
Wnt O +
signaling O +
was O +
context O -
- O -
dependent O -
, O +
but O +
in O +
general O -
, O +
mammalian O +
organogenesis O +
remained O +
intact O +
in O +
Pygopus O +
mutants O -
. O +

Perhaps O +
the O +
simplest O +
explanation O +
is O +
that O +
in O +
mammals O -
, O +
other O +
genes O +
show O +
partial O +
functional O +
redundancy O +
with O +
the O +
two O +
Pygopus O +
genes O -
. O +

The O +
β O -
- O -
catenin O +
transcription O -
- O -
factor O +
complex O +
includes O +
a O +
large O +
and O +
growing O +
number O +
of O +
proteins O +
, O +
some O +
of O +
which O +
may O +
share O +
the O +
nuclear O +
localization O +
and/or O +
transcription O +
activation O +
functions O +
of O +
Pygo1 O -
/ O -
Pygo2 O +
in O +
mammals O -
. O +

The O +
identities O +
and O +
roles O +
of O +
these O +
Pygopus O +
redundant O +
genes O +
remain O +
to O +
be O +
determined O -
. O +

Methods O +
Targeting O +
of O +
Pygo1 O +
and O +
Pygo2 O +
Pygo1 O +
and O +
Pygo2 O +
genes O +
were O +
each O +
targeted O +
by O +
flanking O +
the O +
critical O +
coding O +
regions O +
of O +
the O +
third O +
exon O +
containing O +
the O +
PHD O +
motif O +
with O +
LoxP O +
sequences O -
. O +

Targeting O +
constructs O +
were O +
made O +
using O +
the O +
Flp O -
/ O -
Cre O +
vector O +
previously O +
described O +
[ O -
34 O -
] O -
, O +
which O +
carries O +
a O +
neomycin B-Chemical -
- O -
resistance O +
gene O +
flanked O +
by O +
FRT O +
sequences O -
, O +
and O +
three O +
unique O +
restriction O +
sites O +
for O +
subcloning O +
the O +
two O +
blocks O +
of O +
homology O +
for O +
driving O +
recombination O -
, O +
and O +
the O +
critical O +
region O +
to O +
be O +
flanked O +
by O +
LoxP O +
sequences O -
. O +

For O +
each O +
construct O -
, O +
the O +
three O +
genomic O +
segments O +
required O +
for O +
subcloning O +
were O +
made O +
by O +
PCR O +
from O +
RI O +
ES O +
cell O +
DNA O -
. O +

The O +
resulting O +
targeting O +
constructs O +
were O +
confirmed O +
by O +
sequencing O -
. O +

For O +
Pygo1 O -
, O +
the O +
genomic O +
sequences O +
used O +
for O +
PCR O +
were O -
: O +
5 O -
' O +
forward O -
, O +
GTGAAGGAGAGATGGATAAGTATG O -
; O +
5 O -
' O +
back O -
, O +
TAGACCCTAACCACCTACAAG O -
; O +
exon O +
forward O -
, O +
GGTTAGGGTCTATGTGCTGG O -
; O +
exon O +
back O -
, O +
TCACCAAATCTCTGTTCTACAC O -
; O +
3 O -
' O +
forward O -
, O +
TGTGTAGAACAGAGATTTGGTG O -
; O +
3 O -
' O +
back O -
, O +
CAGTGAAGAAAGAGGGTCAG O -
. O +

For O +
Pygo2 O -
, O +
the O +
genomic O +
sequences O +
used O +
for O +
PCR O +
were O -
: O +
GCCTGGGTTGCTTGTCTTCTG O +
and O +
CCACCTTACTTGTGTGTGAGGATACATAC O -
, O +
CCAAGTCCCAGCATCTCTTAC O +
and O +
CCAGTCATACCAGCAACAAG O -
, O +
and O +
exon O +
sequences O +
TGGGTGCTGGGAACAGAAC O +
and O +
CAACAACAACAGAAGACAAGC O -
. O +

Linearized O +
constructs O +
were O +
electroporated O +
into O +
RI O +
ES O +
cells O -
, O +
and O +
resulting O +
targeted O +
ES O +
cells O +
used O +
for O +
C57 O -
/ O -
Bl6 O +
blastocyst O +
injections O +
according O +
to O +
standard O +
protocols O -
. O +

Resulting O +
chimeras O +
were O +
mated O +
with O +
Swiss O +
Black O +
mice O -
, O +
and O +
the O +
targeted O +
stocks O +
maintained O +
on O +
a O +
mixed O +
129 O -
/ O -
Swiss O +
Black O +
background O -
. O +

Germline O +
null O +
alleles O +
of O +
both O +
Pygo1 O +
and O +
Pygo2 O +
were O +
generated O +
by O +
mating O +
heterozygous O +
floxed O +
mice O +
with O +
the O +
CMV O -
- O -
Cre O +
mice O +
[ O -
15 O -
] O -
. O +

The O +
sequences O +
of O +
the O +
primers O +
used O +
for O +
genotyping O +
PCR O +
were O -
: O +
Pygo2 O +
null O +
allele O -
, O +
forward O +
( O -
F O -
) O +
CCTGGATTCTTGTTGCTGGTATG O -
; O +
reverse O +
( O -
R O -
) O +
AAGGTATTTGGTGCTCCGAGGG O -
; O +
Pygo2 O +
WT O +
or O +
floxed O +
allele O -
, O +
F O +
TGTCTTGATGACAGCGTTTAGCC O -
, O +
R O +
AGATTCAGTAAGCTGAGCCTGGTG O -
; O +
Pygo1 O +
null O +
allele O -
, O +
F O +
AGTTTGAAATAGCGACGAGTTTGAG O -
, O +
R O +
5'-CACTTCTGCCCCTCTCTTTGC O -
; O +
Pygo1 O +
WT O +
or O +
floxed O +
allele O -
, O +
F O +
AAGCGTGCCTCATCTCCATCCCTAAG O -
, O +
R O +
GCCCTCCCCGACGTTTATATTG O -
. O +

The O +
noon O +
of O +
the O +
day O +
that O +
vaginal O +
plugs O +
were O +
observed O +
was O +
designated O +
E0.5 O -
. O +

Confocal O +
microscopy O +
Kidneys O +
were O +
dissected O -
, O +
fixed O +
in O +
paraformaldehyde O -
, O +
treated O +
with O +
methanol B-Chemical -
, O +
and O +
washed O +
with O +
PBS O +
containing O +
Tween-20 B-Chemical +
( O -
PBS O -
- O -
T B-Chemical -
) O +
prior O +
to O +
treatment O +
with O +
lectins O +
and O +
antibodies O -
. O +

PBS O -
- O -
T B-Chemical +
was O +
used O +
for O +
incubations O +
of O +
the O +
tissues O +
with O +
fluoroscein B-Chemical -
- O -
conjugated O +
Dilichos O +
biflorus O +
aggutinin O +
( O -
DBA O -
, O +
Vector O -
; O +
Burlingame O -
, O +
USA O -
) O -
, O +
and O +
PBS O -
- O -
T O +
plus O +
2 O -
% O +
goat O +
serum O +
was O +
used O +
for O +
incubations O +
with O +
the O +
antibodies O -
. O +

The O +
primary O +
antibodies O +
were O +
anti O -
- O -
WT1 O +
( O -
c-19 O -
; O +
Santa O +
Cruz O +
Biotechnology O -
, O +
Santa O +
Cruz O -
, O +
CA O -
, O +
USA O -
) O -
, O +
anti O -
- O -
uvomorulin O +
( O -
e O -
- O -
cadherin O -
, O +
Cdh1 O -
, O +
Sigma O -
- O -
Aldrich O +
St. O +
Louis O -
, O +
MO O -
, O +
USA O -
) O -
, O +
and O +
anti O -
- O -
Cited1 O +
( O -
Neomarkers O -
- O -
Lab O +
Vision O +
Corporation O -
, O +
Fremont O -
, O +
CA O -
, O +
USA O -
) O -
. O +

The O +
secondary O +
antibodies O +
were O +
Alexa B-Chemical +
555-conjugated I-Chemical +
anti O -
- O -
rabbit O +
and O +
Alexa O +
633-conjugated O +
anti O -
- O -
rat O +
antibodies O +
( O -
Molecular O +
Probes O -
, O +
Eugene O -
, O +
OR O -
, O +
USA O -
) O -
. O +

The O +
tissues O +
were O +
imaged O +
with O +
a O +
laser O +
scanning O +
microscope O +
( O -
Carl O +
Zeiss O -
, O +
Thornwood O -
, O +
New O +
York O -
, O +
USA O -
) O +
equipped O +
with O +
an O +
argon O +
( O -
488 O +
nm O -
) O +
and O +
two O +
HeNe O +
lasers O +
( O -
543 O +
nm O +
and O +
633 O +
nm O -
) O -
. O +

Optical O +
sections O +
approximately O +
2 O +
μm O +
thick O +
were O +
obtained O +
every O +
5 O +
μm O +
to O +
a O +
depth O +
of O +
at O +
least O +
65 O +
μm O -
. O +

The O +
sections O +
began O +
at O +
the O +
surface O +
of O +
the O +
kidney O +
and O +
were O +
on O +
a O +
plane O +
tangential O +
to O +
it O -
. O +

Two O +
Z O -
- O -
stack O +
series O +
were O +
obtained O -
, O +
one O +
from O +
each O +
of O +
the O +
two O +
kidneys O +
of O +
each O +
embryo O -
. O +

Ureteric O +
bud O +
tips O +
identified O +
by O +
section O +
tracing O +
were O +
counted O +
within O +
a O +
defined O +
area O +
of O +
the O +
confocal O +
image O -
. O +

In O +
situ O +
hybridization O +
Whole O -
- O -
mount O +
in O +
situ O +
hybridization O +
was O +
performed O +
as O +
previously O +
described O +
[ O -
35 O -
] O -
. O +

Riboprobes O +
to O +
Wnt11 O +
and O +
Wnt7b O +
were O +
described O +
previously O +
[ O -
35 O -
] O -
. O +

The O +
Wnt9b O +
riboprobe O +
was O +
provided O +
by O +
T. O +
Carroll O +
[ O -
2 O -
] O -
. O +

Pygo1 O +
and O +
Pygo2 O +
antibody O +
production O +
To O +
generate O +
anti O -
- O -
human O +
Pygo2 O +
( O -
anti O -
- O -
hPygo2 O -
) O +
and O +
anti O -
- O -
mouse O +
Pygo1 O +
( O -
anti O -
- O -
mPygo1 O -
) O +
polyclonal O +
antibodies O -
, O +
we O +
subcloned O +
cDNA O +
by O +
PCR O +
corresponding O +
to O +
amino O -
- O -
acid O +
residues O +
80–327 O +
of O +
human O +
Pygo O +
2 O +
or O +
amino O -
- O -
acid O +
residues O +
76–263 O +
of O +
mouse O +
Pygo1 O +
into O +
pGEX4T1 O +
( O -
Amersham O +
Health O -
, O +
Piscataway O -
, O +
NJ O -
, O +
USA O -
) O -
. O +

The O +
PCR O +
fragments O +
of O +
hPygo O +
2 O +
and O +
mPygo O +
1 O +
lack O +
both O +
NHD O +
and O +
PHD O +
conserved O +
regions O +
of O +
hPygo2 O +
and O +
mPygo1 O -
. O +

GST O -
- O -
hPygo2 O +
and O +
GST O -
- O -
mPygo1 O +
proteins O +
were O +
expressed O +
in O +
bacteria O -
, O +
purified O -
, O +
and O +
injected O +
into O +
rabbits O +
for O +
antibody O +
production O +
by O +
( O -
Proteintech O +
Group O +
Inc. O -
, O +
Chicago O -
, O +
IL O -
, O +
USA O -
) O -
. O +

The O +
rabbit O +
antisera O +
of O +
anti O -
- O -
mPygo1 O +
and O +
anti O -
- O -
hPygo2 O +
were O +
initially O +
allowed O +
to O +
bind O +
to O +
the O +
GST O +
affinity O +
matrix O +
to O +
remove O +
any O +
antibodies O +
against O +
GST O -
. O +

The O +
anti O -
- O -
hPygo2 O +
and O +
anti O -
- O -
mPygo1 O +
antisera O +
were O +
then O +
separated O +
from O +
the O +
GST O +
affinity O +
matrix O +
and O +
allowed O +
to O +
bind O +
to O +
the O +
GST O -
- O -
hPygo2 O +
or O +
GST O -
- O -
mPygo1 O +
affinity O +
columns O -
, O +
respectively O -
. O +

The O +
bound O +
antibodes O +
were O +
eluted O +
with O +
elution O +
buffer O -
. O +

To O +
further O +
ensure O +
antibody O +
specficity O -
, O +
the O +
purified O +
antibodies O +
were O +
extensively O +
incubated O +
with O +
Pygo1 O -
/ O -
2 O +
double O -
- O -
homozygous O +
mutant O +
embryo O +
extract O +
before O +
use O -
. O +

BAT O -
- O -
gal O +
transgene O +
reporter O +
assay O +
of O +
canonical O +
Wnt O +
signaling O +
X B-Chemical -
- I-Chemical -
gal I-Chemical +
staining O +
of O +
both O +
embryos O +
and O +
developing O +
kidneys O +
was O +
performed O +
as O +
previously O +
described O +
[ O -
21 O -
] O -
. O +

Care O +
was O +
taken O +
to O +
reduce O +
endogenous O +
β O -
- O -
galactosidase O +
activity O +
within O +
the O +
developing O +
kidney O +
by O +
increasing O +
pH O +
of O +
the O +
X B-Chemical -
- I-Chemical -
gal I-Chemical +
staining O +
solution B-Chemical +
to O +
8.0 O -
. O +

Changes O +
in O +
transgene O +
β O -
- O -
Gal O +
expression O +
were O +
quantitated O +
using O +
a O +
β O -
- O -
Gal O +
ELISA O +
( O -
Enzyme O -
- O -
linked O +
immunoassay O -
) O +
kit O +
( O -
Roche O -
, O +
Indianapolis O -
, O +
IN O -
) O -
, O +
normalizing O +
according O +
to O +
total O +
protein O -
. O +

Each O +
genotype O +
was O +
represented O +
by O +
a O +
sample O +
size O +
of O +
4 O +
except O +
the O +
non O -
- O -
transgenic O +
( O -
n O +
= O +
5 O -
) O -
, O +
Pygo1+ O -
/ O -
- O +
; O +
Pygo2+ O -
/ O -
+ O +
( O -
n O +
= O +
6 O -
) O -
, O +
Pygo1- O -
/ O -
- O +
; O +
Pygo2+ O -
/ O -
- O +
( O -
n O +
= O +
8) O -
, O +
and O +
Pygo1- O -
/ O -
- O +
; O +
Pygo2- O -
/ O -
- O +
( O -
n O +
= O +
6 O -
) O +
groups O -
. O +

Microarray O +
analysis O +
Total O +
RNA O +
was O +
isolated O +
from O +
E18.5 O +
kidneys O +
dissected O +
from O +
normal O +
and O +
Pygo1 O -
/ O -
Pygo2 O +
compound O +
null O +
embryos O +
using O +
a O +
commercial O +
kit O +
( O -
Stratagene O +
Absolutely O +
RNA O +
Microprep O +
Kit O -
; O +
La O +
Jolla O -
, O +
CA O -
, O +
USA O -
) O -
. O +

An O +
aliquot O +
( O -
300 O +
ng O -
) O +
of O +
total O +
RNA O +
was O +
processed O +
and O +
labeled O +
using O +
a O +
commercial O +
kit O +
( O -
TargetAmp O +
1-Round O +
Aminoallyl O -
- O -
aRNA O +
Ki O -
; O +
Epicentre O -
, O +
Madison O -
, O +
WI O -
, O +
USA O -
) O -
. O +

Labeled O +
RNA O +
was O +
hybridized O +
to O +
microarrays O +
( O -
Sentrix O +
Mouse-6 O +
expression O +
Beadchip O -
; O +
Illumina O -
, O +
San O +
Diego O -
, O +
CA O -
) O +
providing O +
coverage O +
of O +
over O +
47000 O +
genes O +
and O +
expressed O +
sequence O +
tags O +
as O +
previously O +
described O +
[ O -
36 O -
] O -
. O +

Microarray O +
analysis O +
of O +
Pygo1 O -
/ O -
Pygo2 O +
null O +
and O +
normal O +
wild O -
- O -
type O +
kidneys O +
was O +
performed O +
in O +
biological O +
triplicate O -
. O +

Raw O +
signal O +
intensities O +
of O +
each O +
probe O +
were O +
obtained O +
from O +
data O +
analysis O +
software O +
( O -
Beadstudio O +
; O -
Illumina O -
) O +
and O +
imported O +
into O +
GeneSpring O +
GX O +
7.3 O +
( O -
Agilent O +
Technologies O -
, O +
Palo O +
Alto O -
, O +
CA O -
, O +
USA O -
) O -
. O +

Genes O +
were O +
selected O +
on O +
the O +
basis O +
of O +
greater O +
than O +
two O -
- O -
fold O +
average O +
fold O +
change O +
and O +
statistical O +
significance O +
( O -
p O -
- O -
value O +
< O +
0.05 O -
) O -
. O +

Previously O +
described O +
Wnt O +
target O +
genes O +
were O +
obtained O +
from O +
. O +

Quantitative O +
PCR O +
validation O +
of O +
microarray O +
results O +
Total O +
RNA O +
from O +
E18.5 O +
Pygo1 O -
/ O -
Pygo2 O +
null O +
and O +
control O +
kidneys O +
( O -
both O +
represented O +
in O +
duplicate O +
and O +
distinct O +
from O +
the O +
kidneys O +
used O +
for O +
microrray O +
analysis O -
) O +
was O +
purified O +
using O +
a O +
commercial O +
kit O +
( O -
Absolutely O +
RNA O +
Microprep O +
Kit O -
; O +
Stratagene O -
, O +
La O +
Jolla O -
, O +
CA O +
USA O -
) O +
including O +
DNAse1 O +
treatment O -
. O +

cDNA O +
was O +
generated O +
using O +
random O +
hexamers O +
according O +
to O +
conventional O +
protocols O +
( O -
Invitrogen O -
, O +
Carlsbad O -
, O +
CA O -
, O +
USA O -
) O -
. O +

The O +
following O +
primers O +
were O +
generated O +
to O +
include O +
the O +
sequence O +
obtained O +
from O +
the O +
Illumina O +
probe O -
: O +
Actb O +
( O -
TTGCTGACAGGATGCAGAAG O -
, O +
ACATCTGCTGGAAGGTGGAC O -
) O -
; O +
Aldh1a7 O +
( O -
CCAGAAAGTGGTGTTTTGCT O -
, O +
GAGTTACAGAGAGCTTGCACCTT O -
) O -
; O +
Col8a1 O +
( O -
GCAGACAGGCATCTTCACCT O -
, O +
TGTGTACATCATGGGCTCGT O -
) O -
; O +
Csrp1 O +
( O -
CAGCATAGCCCAGGGTAGAG O -
, O +
TGGGCAAGGTAGTGAAGGTT O -
) O -
; O +
Klk5 O +
( O -
GCAGCATTACACCCGTCATA O -
, O +
TTGCCTCCATCCATATCTCC O -
) O -
; O +
Picalm O +
( O -
GGGAGGGAACAGAAATCCTT O -
, O +
GCACCGATCAACAGTGCAG O -
) O -
; O +
Pygo2 O +
( O -
TTCTGGGAACTTGTGCACTG O -
, O +
AACTTCCTCCAGCCCATTTT O -
) O -
; O +
Ren2 O +
( O -
TTGTGAGCTGTAGCCAGGTG O -
, O +
TGTGCACAGCTTGTCTCTCC O -
) O +
and O +
Tia1 O +
( O -
TGATTGAAGGGCTACTAGAGTGGT O -
, O +
AGCCCCAGAGGACAATTTTT O -
) O +
using O +
Primer3 O +
software O +
[ O -
37 O -
] O -
. O +

Relative O +
quantitative O +
PCR O +
was O +
performed O +
according O +
to O +
the O +
conventional O +
SYBR B-Chemical +
Green I-Chemical +
protocol O +
( O -
Stratagene O -
) O +
using O +
a O +
quantitative O +
PCR O +
system O +
( O -
Mx3000p O -
; O +
Stratagene O -
) O -
. O +

Dissociation O +
curve O +
and O +
agarose B-Chemical -
- O -
gel O +
analysis O +
of O +
each O +
primer O +
set O +
were O +
used O +
to O +
insure O +
specificity O +
of O +
the O +
amplicon O -
. O +

All O +
data O +
were O +
normalized O +
to O +
an O +
internal O +
housekeeping O +
control O +
( O -
Actb O -
) O +
and O +
analyzed O +
using O +
the O +
2 O -
( O -
-Delta O +
Delta O +
C O -
( O -
T O -
) O -
) O +
method O +
[ O -
38 O -
] O -
. O +

Authors O -
' O +
contributions O +
SP O +
designed O +
and O +
did O +
most O +
of O +
the O +
work O +
for O +
targeting O +
the O +
Pygo O +
genes O -
, O +
provided O +
oversight O +
for O +
the O +
project O +
and O +
helped O +
write O +
the O +
paper O -
. O +

KS O +
did O +
most O +
of O +
the O +
experiments O -
, O +
including O +
confocal O +
analysis O +
with O +
LP O -
, O +
in O +
situ O +
hybridizations O +
with O +
HH O -
, O +
and O +
helped O +
write O +
the O +
paper O -
. O +

XL O +
made O +
and O +
tested O +
the O +
Pygo O +
antibodies O -
. O +

NS O +
and O +
RL O +
provided O +
useful O +
suggestions O +
and O +
helped O +
with O +
the O +
immunostaining O +
and O +
Bat O -
- O -
Gal O +
analyses O -
. O +

Acknowledgements O +
L. O +
McClain O +
provided O +
essential O +
technical O +
assistance O +
and O +
we O +
thank O +
P. O +
Groen O +
and O +
D. O +
Witte O +
for O +
initial O +
histology O +
and O +
embryological O +
analyses O -
. O +

D. O +
Ash O +
helped O +
make O +
targeting O +
constructs O -
. O +

We O +
thank O +
T. O +
Carroll O +
for O +
providing O +
a O +
Wnt9b O +
riboprobe O +
construct O -
. O +

We O +
thank O +
H. O +
Liang O +
for O +
generation O +
of O +
microarray O +
data O -
. O +

This O +
work O +
was O +
supported O +
by O +
grant O +
DK61916 O +
from O +
the O +
National O +
Institutes O +
of O +
Health O +
( O -
S.S.P. O -
) O -
. O +

Deletion O +
at O +
ITPR1 O +
Underlies O +
Ataxia O +
in O +
Mice O +
and O +
Spinocerebellar O +
Ataxia O +
15 O +
in O +
Humans O +
Abstract O +
We O +
observed O +
a O +
severe O +
autosomal O +
recessive O +
movement O +
disorder O +
in O +
mice O +
used O +
within O +
our O +
laboratory O -
. O +

We O +
pursued O +
a O +
series O +
of O +
experiments O +
to O +
define O +
the O +
genetic O +
lesion O +
underlying O +
this O +
disorder O +
and O +
to O +
identify O +
a O +
cognate O +
disease O +
in O +
humans O +
with O +
mutation O +
at O +
the O +
same O +
locus O -
. O +

Through O +
linkage O +
and O +
sequence O +
analysis O +
we O +
show O +
here O +
that O +
this O +
disorder O +
is O +
caused O +
by O +
a O +
homozygous O +
in O -
- O -
frame O +
18-bp O +
deletion O +
in O +
Itpr1 O +
( O -
Itpr1Δ18 O -
/ O -
Δ18 O -
) O -
, O +
encoding O +
inositol O +
1,4,5-triphosphate O +
receptor O +
1 O -
. O +

A O +
previously O +
reported O +
spontaneous O +
Itpr1 O +
mutation O +
in O +
mice O +
causes O +
a O +
phenotype O +
identical O +
to O +
that O +
observed O +
here O -
. O +

In O +
both O +
models O +
in O -
- O -
frame O +
deletion O +
within O +
Itpr1 O +
leads O +
to O +
a O +
decrease O +
in O +
the O +
normally O +
high O +
level O +
of O +
Itpr1 O +
expression O +
in O +
cerebellar O +
Purkinje O +
cells O -
. O +

Spinocerebellar O +
ataxia O +
15 O +
( O -
SCA15 O -
) O -
, O +
a O +
human O +
autosomal O +
dominant O +
disorder O -
, O +
maps O +
to O +
the O +
genomic O +
region O +
containing O +
ITPR1 O -
; O +
however O -
, O +
to O +
date O +
no O +
causal O +
mutations O +
had O +
been O +
identified O -
. O +

Because O +
ataxia O +
is O +
a O +
prominent O +
feature O +
in O +
Itpr1 O +
mutant O +
mice O -
, O +
we O +
performed O +
a O +
series O +
of O +
experiments O +
to O +
test O +
the O +
hypothesis O +
that O +
mutation O +
at O +
ITPR1 O +
may O +
be O +
the O +
cause O +
of O +
SCA15 O -
. O +

We O +
show O +
here O +
that O +
heterozygous O +
deletion O +
of O +
the O +
5′ O +
part O +
of O +
the O +
ITPR1 O +
gene O -
, O +
encompassing O +
exons O +
1–10 O -
, O +
1–40 O -
, O +
and O +
1–44 O +
in O +
three O +
studied O +
families O -
, O +
underlies O +
SCA15 O +
in O +
humans O -
. O +

Author O +
Summary O +
We O +
have O +
identified O +
a O +
spontaneous O +
in O -
- O -
frame O +
deletion O +
mutation O +
in O +
the O +
gene O +
Itpr1 O +
that O +
causes O +
a O +
recessive O +
movement O +
disorder O +
in O +
mice O -
. O +

In O +
an O +
attempt O +
to O +
define O +
whether O +
any O +
similar O +
disease O +
occurs O +
in O +
humans O +
we O +
performed O +
a O +
literature O +
search O +
for O +
diseases O +
linked O +
to O +
the O +
human O +
chromosomal O +
region O +
containing O +
ITPR1 O -
. O +

We O +
identified O +
the O +
disease O +
spinocerebellar O +
ataxia O +
15 O +
as O +
linked O +
to O +
this O +
region O -
. O +

High O -
- O -
density O +
genomic O +
analysis O +
of O +
affected O +
members O +
from O +
three O +
families O +
revealed O +
that O +
disease O +
in O +
these O +
patients O +
was O +
caused O +
by O +
deletion O +
of O +
a O +
large O +
portion O +
of O +
the O +
region O +
containing O +
ITPR1 O -
. O +

We O +
show O +
here O +
that O +
this O +
mutation O +
results O +
in O +
a O +
dramatic O +
reduction O +
in O +
ITPR1 O +
in O +
cells O +
from O +
these O +
patients O -
. O +

These O +
data O +
show O +
convincingly O +
that O +
ITPR1 O +
deletion O +
underlies O +
spinocerebellar O +
ataxia O +
15 O +
in O +
humans O -
. O +

Introduction O +
The O +
use O +
of O +
forward O +
genetics O +
to O +
define O +
novel O +
loci O +
of O +
interest O +
in O +
human O +
disease O +
has O +
become O +
increasingly O +
viable O +
with O +
the O +
implementation O +
of O +
large O -
- O -
scale O +
mutagenesis O +
programs O -
. O +

Prior O +
to O +
these O +
initiatives O +
this O +
work O +
was O +
carried O +
out O +
in O +
part O +
by O +
the O +
investigation O +
of O +
spontaneous O +
mutations O +
that O +
cause O +
disorders O +
in O +
mouse O +
breeding O +
colonies O -
. O +

Careful O +
observation O +
of O +
these O +
serendipitous O +
events O +
has O +
led O +
to O +
the O +
establishment O +
and O +
study O +
of O +
many O +
in O +
vivo O +
disease O +
models O +
[ O -
3 O -
] O -
. O +

During O +
the O +
generation O +
of O +
a O +
knockout O +
line O +
of O +
mice O +
we O +
noted O +
an O +
early O +
movement O +
disorder O +
that O +
was O +
inherited O +
independently O +
of O +
targeting O +
vector O +
transmission O -
. O +

We O +
embarked O +
on O +
a O +
series O +
of O +
experiments O +
to O +
identify O +
the O +
genetic O +
lesion O +
underlying O +
this O +
movement O +
disorder O +
and O +
to O +
identify O +
a O +
cognate O +
disease O +
and O +
corresponding O +
mutation O +
in O +
humans O -
. O +

Here O +
we O +
describe O +
this O +
effort O +
and O +
the O +
discovery O +
of O +
deletion O +
at O +
the O +
ITPR1 O +
locus O +
as O +
a O +
cause O +
of O +
this O +
disorder O +
in O +
mice O +
and O +
of O +
spinocerebellar O +
ataxia O +
15 O +
( O -
SCA15 O -
) O +
in O +
humans O -
. O +

Results O -
/ O -
Discussion O +
During O +
the O +
generation O +
of O +
a O +
line O +
of O +
mice O +
with O +
knockout O +
of O +
the O +
gene O +
Park7 O +
we O +
noted O +
an O +
early O +
movement O +
disorder O +
that O +
was O +
inherited O +
independently O +
of O +
targeting O +
vector O +
transmission O -
. O +

Our O +
initial O +
observations O +
suggested O +
the O +
affected O +
mice O +
suffered O +
from O +
an O +
apparently O +
paroxysmal O +
movement O +
disorder O -
, O +
often O +
induced O +
by O +
touch O -
. O +

The O +
abnormal O +
movements O +
occurred O +
predominantly O +
below O +
the O +
cervical O +
level O -
, O +
and O +
the O +
disorder O +
appeared O +
progressive O -
. O +

At O +
initial O +
examination O -
, O +
a O +
human O +
movement O +
disorder O +
specialist O +
( O -
K. O +
G O -
.- O -
H. O -
) O +
likened O +
the O +
disorder O +
to O +
episodic O +
intermittent O +
ataxia O +
or O +
kinesiogenic O +
paroxysmal O +
dystonia O +
and O +
predicted O +
the O +
involvement O +
of O +
an O +
ion B-Chemical +
channel O +
mutation O +
in O +
the O +
etiology O -
. O +

Affected O +
mice O +
presented O +
at O +
approximately O +
postnatal O +
day O +
14 O -
, O +
and O +
survival O +
time O +
without O +
weaning O +
was O +
on O +
average O +
4 O +
wk O +
after O +
onset O -
. O +

Breeding O +
experiments O +
suggested O +
that O +
the O +
observed O +
disorder O +
was O +
inherited O +
in O +
an O +
autosomal O +
recessive O +
manner O -
. O +

To O +
map O +
the O +
location O +
of O +
the O +
disease O -
- O -
causing O +
lesion O -
, O +
we O +
performed O +
genome O -
- O -
wide O +
linkage O +
analysis O +
using O +
strain O -
- O -
specific O +
single O +
nucleotide O +
polymorphisms O +
( O -
SNPs O -
) O +
at O +
120 O +
loci O +
across O +
the O +
mouse O +
genome O -
. O +

Analysis O +
of O +
these O +
data O +
showed O +
a O +
single O +
genomic O +
region O +
with O +
significant O +
linkage O +
to O +
disease O -
, O +
providing O +
a O +
two O -
- O -
point O +
LOD O +
score O +
of O +
5.13 O +
at O +
marker O +
20.MMHAP85FLG2 O +
on O +
Chromosome O +
6qE1 O -
. O +

The O +
linked O +
haplotype O +
suggested O +
the O +
mutation O +
had O +
occurred O +
on O +
the O +
129x1 O -
/ O -
SvJ O +
background O +
( O -
Figure O +
S1 O -
) O -
. O +

Literature O +
searches O +
revealed O +
that O +
among O +
disease O +
lines O +
mapped O +
to O +
6qE1 O -
, O +
the O +
spontaneous O +
mutant O +
opt O +
mouse O +
displays O +
a O +
strikingly O +
similar O +
presentation O +
to O +
that O +
described O +
here O +
[ O -
1 O -
] O -
. O +

The O +
underlying O +
genetic O +
lesion O +
causing O +
the O +
opt O +
phenotype O +
is O +
a O +
homozygous O +
in O -
- O -
frame O +
deletion O +
of O +
exons O +
43 O +
and O +
44 O +
of O +
the O +
gene O +
Itpr1 O +
( O -
Itpr1opt O -
/ O -
opt O -
) O -
, O +
encoding O +
inositol O +
1,4,5-triphosphate O +
receptor O +
1 O +
( O -
Itpr1 O -
) O -
. O +

Sequencing O +
of O +
all O +
exons O +
and O +
intron O -
– O -
exon O +
boundaries O +
of O +
Itpr1 O +
in O +
affected O +
mice O +
from O +
the O +
current O +
study O +
revealed O +
a O +
single O +
mutation O +
within O +
Itpr1 O -
: O +
a O +
novel O +
in O -
- O -
frame O +
deletion O +
of O +
18 O +
bp O +
within O +
exon O +
36 O +
( O -
Itpr1Δ18 O -
/ O -
Δ18 O -
) O -
. O +

To O +
confirm O +
the O +
pathogenicity O +
of O +
this O +
mutation O +
we O +
crossed O +
heterozygous O +
mice O +
from O +
the O +
current O +
study O +
( O -
Itpr1wt O -
/ O -
Δ18 O -
) O +
with O +
mice O +
heterozygous O +
for O +
the O +
opt O +
mutation O +
( O -
Itpr1wt O -
/ O -
opt O -
) O -
. O +

This O +
resulted O +
in O +
two O +
litters O +
of O +
mice O +
with O +
a O +
total O +
of O +
four O +
affected O +
Itpr1opt O -
/ O -
Δ18 O +
pups O +
( O -
from O +
a O +
total O +
of O +
15 O -
) O +
with O +
a O +
phenotype O +
indistinguishable O +
from O +
that O +
of O +
the O +
Itpr1Δ18 O -
/ O -
Δ18 O +
and O +
Itpr1opt O -
/ O -
opt O +
mice O +
[ O -
1 O -
] O -
. O +

Furthermore O -
, O +
this O +
phenotype O +
was O +
similar O -
, O +
although O +
less O +
severe O -
, O +
to O +
that O +
described O +
in O +
a O +
mouse O +
line O +
with O +
targeted O +
deletion O +
of O +
Itpr1 O -
, O +
where O +
ataxia O +
was O +
described O +
as O +
a O +
prominent O +
feature O +
[ O -
4 O -
] O -
. O +

As O +
with O +
the O +
Itpr1opt O -
/ O -
opt O +
mice O -
, O +
where O +
the O +
deletion O +
of O +
exons O +
43 O +
and O +
44 O +
is O +
also O +
predicted O +
to O +
leave O +
the O +
translational O +
reading O +
frame O +
unaffected O -
, O +
the O +
in O -
- O -
frame O +
Itpr1Δ18 O -
/ O -
Δ18 O +
deletion O +
mutation O +
results O +
in O +
markedly O +
decreased O +
levels O +
of O +
Itpr1 O +
in O +
cerebellar O +
Purkinje O +
cells O -
. O +

In O +
these O +
two O +
spontaneous O +
mutants O +
[ O -
1 O -
] O +
and O +
in O +
the O +
Itpr1-deficient O +
mouse O +
[ O -
4 O -
] O +
generated O +
by O +
gene O +
targeting O -
, O +
decreased O +
Itpr1 O +
expression O +
is O +
associated O +
with O +
the O +
same O +
autosomal O +
recessive O +
movement O +
disorder O +
( O -
Figure O +
1 O -
) O -
. O +

Given O +
our O +
interest O +
in O +
human O +
neurological O +
disease O +
we O +
sought O +
to O +
identify O +
any O +
cognate O +
human O +
disorders O +
where O +
linkage O +
had O +
been O +
established O +
to O +
the O +
syntenic O +
region O +
of O +
the O +
human O +
genome O -
, O +
but O +
where O +
no O +
causal O +
mutation O +
had O +
been O +
identified O -
. O +

SCA15 O -
, O +
an O +
adult O -
- O -
onset O +
autosomal O +
dominant O +
progressive O +
ataxia O +
is O +
linked O +
to O +
this O +
locus O +
[ O -
5 O -
] O -
. O +

Although O +
missense O +
mutation O +
of O +
ITPR1 O +
had O +
previously O +
been O +
ruled O +
out O +
[ O -
2 O -
] O +
and O +
the O +
mode O +
of O +
inheritance O +
was O +
inconsistent O +
with O +
that O +
seen O +
in O +
the O +
Itpr1Δ18 O +
and O +
Itpr1opt O +
mice O -
, O +
the O +
phenotypic O +
presence O +
of O +
ataxia O +
in O +
the O +
mice O +
led O +
us O +
to O +
reexamine O +
this O +
candidate O +
gene O +
as O +
a O +
possible O +
cause O +
of O +
SCA15 O -
. O +

We O +
obtained O +
genomic O +
DNA O +
from O +
three O +
affected O +
family O +
members O +
and O +
one O +
family O +
member O +
with O +
unknown O +
disease O +
status O +
from O +
the O +
kindred O +
originally O +
used O +
to O +
define O +
and O +
map O +
SCA15 O +
( O -
family O +
AUS1 O -
, O +
of O +
Australian O +
Anglo O -
- O -
Celtic O +
origin O -
) O +
[ O -
2 O -
] O -
. O +

We O +
performed O +
two O +
experiments O +
concurrently O +
in O +
three O +
affected O +
members O +
of O +
this O +
family O -
: O +
sequence O +
analysis O +
of O +
the O +
coding O +
exons O +
of O +
ITPR1 O +
and O +
high O -
- O -
density O +
genome O -
- O -
wide O +
SNP O +
genotyping O -
. O +

Sequence O +
analysis O +
failed O +
to O +
show O +
any O +
coding O +
alterations O +
segregating O +
with O +
disease O +
or O +
any O +
alterations O +
that O +
were O +
inconsistent O +
with O +
Mendelian O +
patterns O +
of O +
inheritance O +
within O +
the O +
family O -
. O +

However O -
, O +
visualization O +
of O +
log O +
R O +
ratio O +
and O +
B O +
allele O +
frequency O +
metrics O +
from O +
the O +
genome O -
- O -
wide O +
SNP O +
genotyping O +
experiments O +
clearly O +
showed O +
data O +
consistent O +
with O +
a O +
heterozygous O +
genomic O +
deletion O +
across O +
the O +
first O +
one O -
- O -
third O +
of O +
ITPR1 O +
and O +
across O +
the O +
first O +
half O +
of O +
a O +
neighboring O +
gene O -
, O +
SUMF1 O +
( O -
Figure O +
2 O -
) O -
. O +

This O +
deletion O +
was O +
apparent O +
in O +
all O +
three O +
affected O +
family O +
members O +
studied O +
and O +
absent O +
from O +
the O +
family O +
member O +
with O +
unknown O +
affection O +
status O +
( O -
Figure O +
3 O -
) O -
. O +

The O +
SNP O +
data O +
showed O +
a O +
deletion O +
of O +
between O +
188 O +
kb O +
and O +
210 O +
kb O +
in O +
size O -
; O +
examination O +
of O +
SNPs O +
at O +
the O +
flanking O +
unknown O +
regions O +
of O +
this O +
deletion O +
allowed O +
us O +
to O +
delimit O +
the O +
borders O +
of O +
the O +
deletion O +
to O +
7.5 O +
kb O +
on O +
the O +
telomeric O +
side O +
of O +
the O +
deletion O +
( O -
between O +
rs12634249 O +
and O +
rs793396 O -
) O +
and O +
~14.4 O +
kb O +
on O +
the O +
centromeric O +
side O +
of O +
the O +
deletion O +
( O -
between O +
rs4073665 O +
and O +
rs17709863 O -
) O -
. O +

In O +
an O +
attempt O +
to O +
define O +
whether O +
this O +
variation O +
was O +
a O +
benign O +
polymorphism O +
we O +
analyzed O +
genome O -
- O -
wide O +
SNP O +
data O +
at O +
this O +
locus O -
, O +
produced O +
using O +
the O +
same O +
genotyping O +
chip O -
, O +
from O +
577 O +
individuals O +
of O +
European O +
descent O +
who O +
were O +
either O +
controls O +
or O +
individuals O +
with O +
an O +
unrelated O +
neurological O +
disorder O -
. O +

We O +
failed O +
to O +
find O +
any O +
deletions O +
affecting O +
the O +
coding O +
sequence O +
of O +
either O +
gene O -
, O +
ITPR1 O +
or O +
SUMF1 O -
; O +
we O +
did O -
, O +
however O -
, O +
identify O +
a O +
single O +
individual O +
with O +
a O +
possible O +
heterozygous O +
deletion O +
approximately O +
6 O +
kb O +
in O +
size O +
within O +
intron O +
40–41 O +
of O +
ITPR1 O -
, O +
at O +
least O +
5 O +
kb O +
away O +
from O +
exon O +
40 O -
. O +

Given O +
the O +
location O +
of O +
this O +
alteration O +
it O +
is O +
unlikely O +
to O +
effect O +
the O +
expression O +
or O +
splicing O +
of O +
ITPR1 O -
. O +

In O +
an O +
attempt O +
to O +
fine O -
- O -
map O +
the O +
breakpoints O +
of O +
the O +
disease O -
- O -
causing O +
deletion O +
we O +
performed O +
a O +
series O +
of O +
experiments O +
designed O +
to O +
refine O +
the O +
unknown O +
intervals O +
at O +
the O +
edges O +
between O +
definite O +
deleted O +
and O +
definite O +
diploid O +
sequences O -
. O +

These O +
data O +
narrowed O +
the O +
unknown O +
borders O +
to O +
~4 O +
kb O +
on O +
the O +
telomeric O +
side O +
and O +
~7 O +
kb O +
on O +
the O +
centromeric O +
side O -
. O +

We O +
used O +
all O +
possible O +
combinations O +
of O +
forward O +
orientation O +
primers O +
designed O +
within O +
the O +
newly O +
defined O +
telomeric O +
boundary O +
and O +
of O +
reverse O +
orientation O +
primers O +
designed O +
within O +
the O +
newly O +
defined O +
centromeric O +
boundary O +
in O +
PCR O +
assays O +
in O +
an O +
attempt O +
to O +
amplify O +
across O +
the O +
deletion O +
in O +
affected O +
family O +
members O -
. O +

Using O +
PCR O +
primers O +
T3F O +
and O +
C11R O -
, O +
which O +
should O +
be O +
more O +
than O +
200 O +
kb O +
apart O -
, O +
we O +
were O +
able O +
to O +
amplify O +
a O +
fragment O +
953 O +
bp O +
in O +
size O +
using O +
DNA O +
from O +
each O +
of O +
the O +
three O +
affected O +
family O +
members O +
as O +
template O -
. O +

Sequencing O +
of O +
this O +
fragment O +
revealed O +
a O +
deletion O +
of O +
201,509 O +
bp O +
( O -
Figure O +
S3 O -
) O -
, O +
removing O +
the O +
first O +
three O +
of O +
the O +
nine O +
exons O +
of O +
SUMF1 O +
and O +
the O +
first O +
ten O +
of O +
the O +
58 O +
exons O +
of O +
ITPR1 O -
. O +

We O +
were O +
unable O +
to O +
amplify O +
the O +
deletion O -
- O -
specific O +
fragment O +
in O +
the O +
family O +
member O +
of O +
unknown O +
affection O +
status O -
, O +
or O +
in O +
275 O +
neurologically O +
normal O +
controls O -
. O +

To O +
further O +
establish O +
genetic O +
deletion O +
at O +
ITPR1 O +
as O +
the O +
cause O +
of O +
SCA15 O +
we O +
analyzed O +
two O +
additional O +
families O +
with O +
an O +
inherited O +
cerebellar O +
ataxia O +
similar O +
to O +
that O +
described O +
in O +
the O +
AUS1 O +
family O -
, O +
ascertained O +
through O +
neurology O +
clinics O +
in O +
London O -
, O +
United O +
Kingdom O -
. O +

DNA O +
extracted O +
from O +
probands O +
from O +
these O +
two O +
families O +
( O -
family O +
H33 O +
and O +
family O +
H27 O -
) O +
were O +
also O +
analyzed O +
using O +
Illumina O +
Infinium O +
HumanHap550 O +
genotyping O +
chips O -
. O +

These O +
experiments O +
showed O +
deletion O +
at O +
the O +
SCA15 O +
locus O +
in O +
all O +
affected O +
members O +
assayed O -
, O +
from O +
SUMF1 O +
through O +
ITPR1 O -
. O +

These O +
mutations O +
segregated O +
with O +
disease O +
in O +
these O +
two O +
families O +
( O -
Figure O +
S3 O -
) O -
. O +

A O +
strategy O +
similar O +
to O +
the O +
one O +
outlined O +
above O +
enabled O +
us O +
to O +
sequence O +
over O +
the O +
breakpoint O +
in O +
family O +
H27 O +
but O +
not O +
family O +
H33 O -
. O +

In O +
the O +
former O -
, O +
the O +
deletion O +
spans O +
344,408 O +
bp O -
, O +
removing O +
exons O +
1–3 O +
of O +
SUMF1 O +
and O +
1–44 O +
of O +
ITPR1 O -
; O +
in O +
the O +
latter O -
, O +
we O +
estimate O +
that O +
the O +
deletion O +
is O +
310 O +
kb O +
in O +
length O +
and O +
that O +
it O +
removes O +
exons O +
1–3 O +
of O +
SUMF1 O +
and O +
exons O +
1–40 O +
of O +
ITPR1 O -
. O +

The O +
site O +
of O +
mutation O +
is O +
of O +
interest O -
, O +
particularly O +
the O +
fact O +
that O +
in O +
each O +
of O +
the O +
three O +
families O +
the O +
telomeric O +
end O +
of O +
the O +
deletion O +
is O +
anchored O +
between O +
exons O +
3 O +
and O +
4 O +
of O +
SUMF1 O -
; O +
sequence O +
searches O +
failed O +
to O +
identify O +
any O +
repeat O +
sequences O +
that O +
might O +
explain O +
this O +
phenomenon O -
. O +

With O +
three O +
cerebellar O +
ataxia O +
families O +
segregating O +
a O +
SUMF1–ITPR1 O +
deletion O -
, O +
and O +
this O +
deletion O +
not O +
observed O +
in O +
a O +
control O +
population O -
, O +
we O +
may O +
reasonably O +
conclude O +
that O +
the O +
association O +
is O +
causal O -
, O +
and O +
that O +
the O +
deletion O +
is O +
indeed O +
the O +
genetic O +
basis O +
of O +
the O +
disease O -
, O +
with O +
SCA15 O +
the O +
diagnosis O +
in O +
the O +
two O +
British O +
families O +
as O +
well O +
as O +
the O +
original O +
Australian O +
family O -
. O +

It O +
is O +
improbable O +
that O +
heterozygosity O +
for O +
the O +
deletion O +
of O +
SUMF1 O -
, O +
encoding O +
sulfatase O +
modifying O +
factor O +
1 O -
, O +
of O +
itself O +
causes O +
or O +
contributes O +
to O +
SCA15 O -
. O +

Homozygous O +
mutation O +
of O +
SUMF1 O +
results O +
in O +
autosomal O +
recessive O +
multiple O +
sulfatase O +
deficiency O -
, O +
a O +
metabolic O +
disorder O +
characterized O +
by O +
hepatosplenomegaly O -
, O +
deafness O -
, O +
and O +
developmental O +
delay O +
[ O -
6,7 O -
] O -
. O +

No O +
co O -
- O -
occurrence O +
of O +
ataxia O +
has O +
been O +
described O +
in O +
( O -
heterozygous O -
) O +
parents O +
of O +
patients O +
with O +
multiple O +
sulfatase O +
deficiency O -
. O +

Conversely O -
, O +
mutation O +
of O +
ITPR1 O +
is O +
biologically O +
plausible O +
as O +
a O +
cause O +
of O +
ataxia O -
: O +
the O +
protein O +
is O +
highly O +
expressed O +
in O +
Purkinje O +
cells O -
; O +
as O +
we O +
have O +
shown O +
here O -
, O +
mice O +
with O +
mutation O +
at O +
this O +
locus O +
present O +
with O +
ataxia O -
; O +
and O +
perturbed O +
Ca2 B-Chemical -
+ I-Chemical +
signaling O +
has O +
previously O +
been O +
implicated O +
in O +
the O +
etiology O +
of O +
ataxia O -
, O +
notably O +
in O +
episodic O +
ataxia O +
type O +
2 O +
and O +
SCA6 O +
[ O -
8 O -
] O -
. O +

In O +
further O +
support O +
of O +
this O +
conclusion O -
, O +
analysis O +
of O +
protein O +
levels O +
of O +
ITPR1 O +
in O +
Epstein O -
- O -
Barr O +
virus O +
( O -
EBV O -
) O +
immortalized O +
lymphocytes O +
from O +
affected O +
and O +
unaffected O +
AUS1 O +
family O +
members O +
revealed O +
that O +
all O +
affected O +
members O +
showed O +
a O +
dramatic O +
decrease O +
in O +
ITPR1 O +
levels O +
when O +
compared O +
with O +
the O +
family O +
member O +
without O +
the O +
deletion O +
( O -
Figure O +
4 O -
) O -
. O +

Itpr1 O +
contains O +
three O +
domains O -
, O +
an O +
N O -
- O -
terminal O +
inositol B-Chemical +
triphosphate I-Chemical +
binding O +
domain O -
, O +
a O +
coupling O +
domain O -
, O +
and O +
a O +
C O -
- O -
terminal O +
transmembrane O +
domain O -
; O +
it O +
also O +
contains O +
two O +
protein O +
kinase O +
A O +
phosphorylation O +
sites O +
and O +
an O +
ATP O -
- O -
binding O +
site O -
. O +

Itpr1 O +
is O +
coupled O +
to O +
Ca2 B-Chemical -
+ I-Chemical +
channels O +
and O +
facilitates O +
Ca2 B-Chemical -
+ I-Chemical +
release O +
from O +
the O +
endoplasmic O +
reticulum O +
after O +
binding O +
by O +
the O +
intracellular O +
second O +
messenger B-Chemical +
inositol O +
1,4,5-triphosphate O +
[ O -
9 O -
] O -
. O +

Itpr1 O +
is O +
enriched O +
in O +
the O +
Purkinje O +
cells O +
of O +
the O +
cerebellum O +
[ O -
4 O -
] O -
. O +

ITPR1 O +
mutations O +
have O +
more O +
than O +
one O +
potential O +
pathogenic O +
mechanism O -
. O +

First O -
, O +
the O +
disease O +
may O +
be O +
a O +
result O +
of O +
haploinsufficiency O +
at O +
ITPR1 O -
; O +
this O +
concept O +
is O +
consistent O +
with O +
the O +
observation O +
that O +
heterozygous O +
deletion O +
leads O +
to O +
a O +
later O +
onset O +
disorder O +
in O +
humans O -
, O +
whereas O +
homozygous O +
deletion O +
in O +
mice O +
leads O +
to O +
an O +
early O +
onset O +
disorder O -
, O +
able O +
to O +
be O +
expressed O +
within O +
the O +
much O +
shorter O +
life O +
span O +
of O +
the O +
mouse O -
. O +

Second O -
, O +
we O +
can O -
not O +
rule O +
out O +
the O +
existence O +
of O +
an O +
alternate O +
start O +
site O +
for O +
ITPR1 O +
that O +
may O +
result O +
in O +
a O +
product O +
that O +
confers O +
a O +
pathogenic O +
gain O +
of O +
function O +
to O +
the O +
protein O -
; O +
however O -
, O +
Western O +
blot O +
analysis O +
of O +
cells O +
derived O +
from O +
affected O +
AUS1 O +
family O +
members O -
, O +
which O +
was O +
performed O +
using O +
an O +
antibody O +
raised O +
against O +
the O +
C O -
- O -
terminal O +
portion O +
of O +
ITPR1 O -
, O +
failed O +
to O +
identify O +
any O +
disease O -
- O -
specific O +
truncated O +
protein O +
products O -
. O +

Clearly O -
, O +
the O +
identification O +
of O +
distinct O +
ITPR1 O +
mutations O +
underlying O +
SCA15 O +
will O +
help O +
elucidate O +
the O +
pathogenic O +
mechanism O +
of O +
this O +
disorder O -
. O +

We O +
show O +
here O +
the O +
utility O +
of O +
investigating O +
spontaneous O +
mouse O +
mutations O +
in O +
understanding O +
human O +
disease O -
. O +

Currently O -
, O +
the O +
small O +
number O +
of O +
aged O +
Itpr1wt O -
/ O -
Δ18 O +
animals O +
precludes O +
us O +
from O +
examining O +
these O +
mice O +
for O +
subtle O +
signs O +
and O +
symptoms O +
similar O +
to O +
those O +
seen O +
in O +
SCA15 O +
patients O -
; O +
however O -
, O +
these O +
mice O +
are O +
clearly O +
of O +
interest O +
to O +
us O +
as O +
a O +
potential O +
model O +
of O +
SCA15 O -
. O +

These O +
data O +
also O +
demonstrate O +
that O +
genome O -
- O -
wide O +
SNP O +
assay O +
can O +
facilitate O +
rapid O +
detection O +
of O +
structural O +
genomic O +
mutations O +
that O +
may O +
underlie O +
disease O -
. O +

The O +
data O +
provided O +
by O +
these O +
approaches O +
provide O +
compelling O +
evidence O +
that O +
heterozygous O +
deletion O +
of O +
ITPR1 O +
causes O +
SCA15 O -
. O +

Clearly O -
, O +
sequence O +
analysis O +
of O +
ITPR1 O +
in O +
potential O +
SCA15 O +
cases O +
may O +
provide O +
additional O +
insight O +
into O +
the O +
disease O -
, O +
particularly O +
if O +
a O +
stop O +
mutation O +
were O +
to O +
be O +
identified O -
; O +
however O -
, O +
the O +
mutational O +
mechanism O +
noted O +
here O +
means O +
that O +
standard O +
sequencing O +
approaches O +
alone O +
are O +
insufficient O +
to O +
confidently O +
rule O +
out O +
ITPR1 O +
mutation O +
as O +
a O +
cause O +
of O +
disease O -
: O +
a O +
comprehensive O +
gene O +
dosage O +
approach O +
is O +
also O +
required O -
. O +

Given O +
that O +
SCA16 O +
and O +
autosomal O +
dominant O +
congenital O +
nonprogressive O +
ataxia O +
have O +
both O +
recently O +
been O +
mapped O +
to O +
regions O +
overlapping O +
with O +
the O +
SCA15 O +
locus O +
[ O -
10,11 O -
] O -
, O +
ITPR1 O +
is O +
a O +
gene O +
of O +
importance O +
for O +
screening O +
in O +
these O +
families O -
. O +

These O +
data O +
add O +
weight O +
to O +
a O +
role O +
for O +
aberrant O +
intracellular O +
Ca2 B-Chemical -
+ I-Chemical +
signaling O +
in O +
Purkinje O +
cells O +
in O +
the O +
pathogenesis O +
of O +
spinocerebellar O +
ataxia O -
. O +

Materials O +
and O +
Methods O +
Genome O -
- O -
wide O +
linkage O +
in O +
mice O -
. O +

One O +
hundred O +
and O +
twenty O +
DNA O +
fragments O +
were O +
amplified O +
across O +
the O +
genome O -
, O +
each O +
selected O +
to O +
contain O +
one O +
or O +
more O +
strain O -
- O -
specific O +
SNPs O +
that O +
would O +
differentiate O +
between O +
C57BL O -
/ O -
6J O +
and O +
129x1 O -
/ O -
SvJ O +
inbred O +
strains O +
[ O -
12 O -
] O -
. O +

Each O +
fragment O +
was O +
initially O +
amplified O +
in O +
11 O +
affected O +
mice O +
and O +
nine O +
unaffected O +
mice O -
; O +
genotype O +
calling O +
was O +
performed O +
by O +
dye B-Chemical -
- O -
terminator O +
sequencing O +
of O +
these O +
fragments O -
. O +

Linkage O +
analysis O +
using O +
these O +
data O +
was O +
performed O +
using O +
mlink O +
[ O -
13 O -
] O -
, O +
which O +
revealed O +
a O +
positive O +
linkage O +
at O +
Chromosome O +
6qE1 O -
, O +
on O +
the O +
129x1 O -
/ O -
SvJ O +
background O +
( O -
two O -
- O -
point O +
LOD O +
score O +
5.13 O +
at O +
marker O +
20.MMHAP85FLG2 O -
) O -
. O +

In O +
an O +
attempt O +
to O +
narrow O +
the O +
disease O +
interval O +
we O +
performed O +
backcross O +
experiments O +
that O +
resulted O +
in O +
the O +
generation O +
of O +
three O +
additional O +
affected O +
mice O -
. O +

Genotyping O +
of O +
all O +
affected O +
mice O +
across O +
the O +
disease O -
- O -
segregating O +
interval O +
revealed O +
flanking O +
recombinants O +
and O +
a O +
candidate O +
region O +
of O +
~5 O +
Mb O -
, O +
between O +
markers O +
D6Mit37 O +
and O +
44.MMHAP85FLG5 O +
( O -
Figure O +
S1 O -
) O -
. O +

This O +
region O +
contains O +
16 O +
genes O +
and O +
predicted O +
transcripts O -
. O +

Identification O +
of O +
the O +
underlying O +
genetic O +
lesion O +
in O +
mice O -
. O +

Identification O +
of O +
similar O +
phenotypes O +
in O +
mice O +
linked O +
to O +
the O +
6qE1 O +
interval O +
was O +
performed O +
by O +
literature O +
searches O -
. O +

This O +
revealed O +
the O +
Itpr1opt O -
/ O -
opt O +
mouse O -
, O +
in O +
which O +
disease O +
is O +
caused O +
by O +
homozygous O +
deletion O +
mutation O +
of O +
exons O +
43 O +
and O +
44 O +
of O +
Itpr1 O -
. O +

Primer O +
pairs O +
were O +
designed O +
to O +
sequence O +
each O +
of O +
the O +
coding O +
exons O +
and O +
at O +
least O +
50 O +
bp O +
of O +
each O +
flanking O +
intronic O +
sequence O +
of O +
Itpr1 O -
. O +

PCR O +
amplification O +
of O +
each O +
exon O +
was O +
performed O +
using O +
DNA O +
from O +
two O +
affected O +
mice O +
as O +
templates O -
. O +

The O +
Itpr1Δ18 O -
/ O -
Δ18 O +
mutation O +
was O +
confirmed O +
by O +
sequencing O +
in O +
all O +
affected O +
mice O +
( O -
Figure O +
S2 O -
) O -
. O +

Breeding O +
experiments O +
were O +
performed O +
between O +
two O +
female O +
mice O +
heterozygous O +
for O +
the O +
current O +
mutation O +
( O -
Itpr1wt O -
/ O -
Δ18 O -
) O +
and O +
a O +
male O +
mouse O +
heterozygous O +
for O +
the O +
Itpr1opt O +
mutation O +
( O -
Itpr1wt O -
/ O -
opt O -
) O -
. O +

This O +
resulted O +
in O +
two O +
litters O +
of O +
mice O +
with O +
a O +
total O +
of O +
four O +
affected O +
Itpr1opt O -
/ O -
Δ18 O +
pups O +
( O -
from O +
a O +
total O +
of O +
15 O -
; O +
two O +
of O +
seven O +
from O +
first O +
mating O -
; O +
two O +
of O +
eight O +
from O +
the O +
second O +
mating O -
) O +
with O +
a O +
phenotype O +
indistinguishable O +
from O +
that O +
of O +
the O +
Itpr1Δ18 O -
/ O -
Δ18 O +
and O +
Itpr1opt O -
/ O -
opt O +
mice O -
. O +

Analysis O +
of O +
Itpr1 O +
protein O +
in O +
mice O -
. O +

We O +
performed O +
Western O +
blot O +
analyses O +
using O +
standard O +
techniques O +
with O +
ECL O +
detection O +
kits O +
( O -
Amersham O -
, O +
http://www.amersham.com O -
) O -
. O +

Briefly O -
, O +
dissected O +
whole O +
brains O +
from O +
postnatal O +
day O +
21 O +
littermates O +
were O +
homogenized O +
in O +
a O +
buffer O +
containing O +
50 O +
mM O +
Tris B-Chemical -
- O -
HCl B-Chemical -
, O +
150 O +
mM O +
NaCl B-Chemical -
, O +
1 O +
mM O +
EDTA O -
, O +
1 O -
% O +
Triton B-Chemical +
X-100 I-Chemical -
, O +
1 O -
% O +
sodium B-Chemical +
deoxycholate I-Chemical -
, O +
0.1 O -
% O +
SDS B-Chemical -
, O +
and O +
a O +
cocktail B-Chemical +
of O +
protease O +
inhibitors O +
( O -
Roche O -
, O +
http://www.roche.com O -
) O -
. O +

Homogenates O +
were O +
diluted O +
appropriately O -
, O +
mixed O +
with O +
4 O -
× O +
reducing O +
sample O +
buffer O -
, O +
and O +
loaded O +
onto O +
4%–12 O -
% O +
precast O +
gradient O +
gels O +
( O -
Novex O -
, O +
http://www.invitrogen.com O -
) O +
for O +
SDS B-Chemical -
- O -
PAGE O +
and O +
immunoblotting O -
. O +

The O +
antibodies O +
to O +
Itpr1 O +
( O -
1:2,000 O -
) O +
and O +
Actb O +
( O -
1:5,000 O -
) O +
were O +
used O +
as O +
recommended O +
by O +
manufacturers O -
. O +

Immunohistochemistry O -
. O +

Brains O +
were O +
isolated O +
from O +
21-d O -
- O -
old O +
mice O -
, O +
perfused O +
with O +
4 O -
% O +
paraformaldehyde O +
in O +
PBS O -
, O +
and O +
post O -
- O -
fixed O +
overnight O +
in O +
the O +
same O +
fixative B-Chemical -
. O +

Brains O +
were O +
embedded O +
in O +
gelatin B-Chemical -
, O +
and O +
35-μm O +
sagittal O +
sections O +
were O +
cut O +
using O +
a O +
sliding O +
microtome O +
( O -
NeuroScience O +
Associates O -
, O +
http://www.neuroscienceassociates.com O -
) O -
. O +

Sections O +
from O +
wild O -
- O -
type O -
, O +
heterozygote O -
, O +
and O +
homozygous O +
brains O +
were O +
placed O +
in O +
the O +
MultiBrain O +
template O -
. O +

Sections O +
were O +
washed O +
in O +
1 O -
× O +
PBS O +
prior O +
to O +
1 O +
h O +
of O +
incubation O +
in O +
block O +
solution B-Chemical +
containing O +
1 O -
× O +
PBS O +
with O +
20 O -
% O +
normal O +
goat O +
serum O +
and O +
0.3 O -
% O +
Triton B-Chemical +
X-100 I-Chemical +
( O -
pH O +
7.4 O -
) O -
. O +

Sections O +
were O +
incubated O +
overnight O +
at O +
4 O +
° O -
C O +
in O +
primary O +
antibodies O -
: O +
affinity O +
purified O +
polyclonal O +
Itpr1 O +
antibody O +
( O -
1:2,000 O -
, O +
Chemicon O +
International O -
, O +
http://www.chemicon.com O -
) O +
and O +
monoclonal O +
anti O -
- O -
Calb1 O +
antibody O +
( O -
1:6,000 O -
, O +
Sigma O -
- O -
Aldrich O -
, O +
http://www.sigmaaldrich.com O -
) O +
diluted O +
in O +
carrier O +
solution B-Chemical -
. O +

Following O +
extensive O +
washes O +
( O -
in O +
6.0 O +
ml O +
of O +
PBS O -
, O +
three O +
times O -
) O -
, O +
sections O +
were O +
incubated O +
with O +
appropriate O +
secondary O +
antibodies O +
( O -
Alexa B-Chemical +
Fluor I-Chemical +
555 I-Chemical +
goat O +
anti O -
- O -
rabbit O +
IgG O +
and O +
Alexa B-Chemical +
Fluor I-Chemical +
488 I-Chemical +
goat O +
anti O -
- O -
mouse O +
IgG O +
[ O -
Invitrogen O -
, O +
http://www.invitrogen.com O -
] O -
) O +
for O +
1 O +
h O +
at O +
room O +
temperature O -
. O +

Sections O +
were O +
washed O +
and O +
mounted O +
on O +
glass O +
slides O +
in O +
a O +
buffered O +
medium O +
containing O +
Mowiol O +
( O -
Calbiochem O -
, O +
http://www.emdbiosciences.com O -
) O +
as O +
described O +
earlier O +
[ O -
14 O -
] O -
. O +

Sections O +
were O +
imaged O +
using O +
a O +
laser O +
scanning O +
confocal O +
microscope O +
( O -
LSM O +
510 O -
; O +
Zeiss O -
, O +
http://www.zeiss.com O -
) O -
. O +

Imaging O +
parameters O +
( O -
pinhole O -
, O +
detector O +
gain O -
, O +
laser O +
power O -
) O +
were O +
optimized O -
, O +
and O +
were O +
kept O +
constant O +
for O +
the O +
wild O -
- O -
type O -
, O +
heterozygous O -
, O +
and O +
homozygous O +
mutant O +
brains O -
. O +

Specificity O +
of O +
the O +
Itpr1 O +
antibodies O +
was O +
verified O +
by O +
preabsorption O +
control O +
experiments O -
. O +

Antibody O +
dilutions O +
were O +
incubated O +
for O +
24 O +
h O +
at O +
4 O +
° O -
C O +
with O +
the O +
immunizing O +
peptide O -
. O +

Tissue O +
sections O +
were O +
incubated O +
with O +
the O +
preabsorbed O +
antibodies O +
and O +
processed O +
as O +
described O +
above O -
. O +

Under O +
these O +
conditions O -
, O +
no O +
staining O +
above O +
autofluorescence O +
was O +
detected O -
. O +

Analysis O +
of O +
ITPR1 O +
in O +
SCA15 O +
patients O -
. O +

DNA O +
was O +
extracted O +
from O +
EBV O +
immortalized O +
lymphocytes O -
, O +
derived O +
from O +
family O +
members O -
. O +

The O +
coding O +
exons O +
and O +
at O +
least O +
50 O +
bp O +
of O +
flanking O +
introns O +
of O +
ITPR1 O +
were O +
PCR O +
amplified O +
and O +
sequenced O +
using O +
dye B-Chemical -
- O -
terminator O +
sequencing O +
( O -
BigDye O +
version O +
3.1 O -
; O +
Applied O +
Biosystems O -
, O +
http://www.appliedbiosystems.com O -
) O -
. O +

Sequence O +
reactions O +
were O +
run O +
on O +
an O +
ABI3730XP O +
automated O +
sequencer O +
as O +
per O +
the O +
manufacturer O -
's O +
instructions O +
( O -
Applied O +
Biosystems O -
) O -
. O +

This O +
analysis O +
was O +
performed O +
in O +
all O +
three O +
affected O +
family O +
members O +
for O +
whom O +
genomic O +
DNA O +
was O +
available O +
( O -
members O +
6 O -
, O +
7 O -
, O +
and O +
19 O -
) O -
. O +

Primer O +
sequences O +
and O +
conditions O +
are O +
available O +
upon O +
request O -
. O +

Sequence O +
data O +
were O +
analyzed O +
using O +
Sequencher O +
( O -
Gene O +
Codes O +
Corporation O -
, O +
http://www.genecodes.com O -
) O -
. O +

Genome O -
- O -
wide O +
SNP O +
genotyping O +
was O +
performed O +
using O +
Infinium O +
HumanHap550 O +
SNP O +
genotyping O +
chips O +
as O +
per O +
the O +
manufacturer O -
's O +
protocol O +
( O -
Illumina O -
, O +
http://www.illumina.com O -
) O -
. O +

This O +
product O +
assays O +
555,352 O +
unique O +
SNPs O -
. O +

Data O +
were O +
collected O +
using O +
the O +
Illumina O +
BeadStation O +
scanner O +
and O +
data O +
collection O +
software O -
. O +

Genotypes O +
were O +
produced O +
using O +
the O +
genotyping O +
module O +
of O +
BeadStudio O +
( O -
version O +
2.3.25 O -
; O +
Illumina O -
) O -
, O +
and O +
log O +
R O +
ratio O +
and O +
B O +
allele O +
frequency O +
were O +
visualized O +
using O +
the O +
genome O +
viewer O +
tool O +
within O +
this O +
package O -
. O +

In O +
order O +
to O +
rule O +
out O +
the O +
possibility O +
that O +
the O +
observed O +
deletion O +
within O +
ITPR1 O +
was O +
a O +
benign O +
copy O +
number O +
variant O +
we O +
examined O +
log O +
R O +
ratio O +
and O +
B O +
allele O +
frequency O +
metrics O +
of O +
HumanHap550 O +
genotyping O +
data O +
at O +
this O +
locus O +
from O +
577 O +
individuals O +
of O +
Northern O +
European O +
descent O +
from O +
North O +
America O +
and O +
Europe O -
, O +
produced O +
by O +
us O +
as O +
a O +
part O +
of O +
an O +
ongoing O +
study O -
. O +

In O +
an O +
attempt O +
to O +
narrow O +
the O +
unknown O +
intervals O +
flanking O +
the O +
deletion O +
observed O +
in O +
family O +
AUS1 O -
, O +
we O +
designed O +
primers O +
for O +
30 O +
PCR O +
amplifications O +
that O +
would O +
generate O +
overlapping O +
fragments O +
across O +
the O +
two O +
bordering O +
regions O +
( O -
primer O +
sequence O +
and O +
conditions O +
available O +
upon O +
request O -
) O -
. O +

There O +
were O +
ten O +
primer O +
pairs O +
in O +
the O +
telomeric O +
flanking O +
region O +
and O +
20 O +
pairs O +
in O +
the O +
centromeric O +
flanking O +
region O +
( O -
Figure O +
S3 O -
) O -
. O +

On O +
average O +
each O +
product O +
was O +
~750 O +
bp O +
in O +
size O -
, O +
and O +
amplifications O +
were O +
performed O +
using O +
genomic O +
DNA O +
from O +
each O +
of O +
the O +
three O +
affected O +
individuals O +
( O -
family O +
members O +
6 O -
, O +
7 O -
, O +
and O +
19 O -
) O -
. O +

Dye B-Chemical -
- O -
terminator O +
sequencing O +
of O +
each O +
product O +
was O +
performed O +
using O +
the O +
forward O +
and O +
reverse O +
primers O +
designed O +
for O +
amplification O -
; O +
running O +
and O +
analysis O +
of O +
each O +
fragment O +
was O +
performed O +
as O +
described O +
above O -
. O +

Amplification O +
of O +
a O +
fragment O +
from O +
a O +
normal O +
diploid O +
genome O +
was O +
denoted O +
by O +
the O +
presence O +
of O +
a O +
heterozygous O +
polymorphism O -
; O +
amplification O +
of O +
a O +
fragment O +
from O +
a O +
region O +
of O +
the O +
genome O +
harboring O +
a O +
heterozygous O +
genomic O +
deletion O +
was O +
inferred O +
when O +
homozygosity O +
for O +
the O +
major O +
allele O +
and O +
the O +
minor O +
allele O +
were O +
noted O +
among O +
the O +
three O +
affected O +
family O +
members O +
( O -
i.e. O -
, O +
this O +
is O +
inconsistent O +
with O +
Mendelian O +
inheritance O +
in O +
related O +
individuals O +
known O +
to O +
share O +
a O +
common O +
haplotype O -
) O -
. O +

Using O +
the O +
data O +
from O +
the O +
experiments O +
described O +
above O +
we O +
were O +
able O +
to O +
limit O +
the O +
size O +
of O +
unknown O +
regions O +
flanking O +
the O +
deletion O +
to O +
~4 O +
kb O +
on O +
the O +
telomeric O +
side O +
and O +
7 O +
kb O +
on O +
the O +
centromeric O +
side O -
. O +

All O +
combinations O +
of O +
forward O +
primers O +
from O +
the O +
newly O +
defined O +
region O +
flanking O +
the O +
deletion O +
on O +
the O +
telomeric O +
side O +
with O +
reverse O +
primers O +
from O +
the O +
newly O +
defined O +
region O +
flanking O +
the O +
deletion O +
on O +
the O +
centromeric O +
side O +
were O +
used O +
in O +
PCR O +
amplification O +
reactions O +
performed O +
with O +
DNA O +
from O +
the O +
three O +
affected O +
family O +
members O +
and O +
single O +
unaffected O +
family O +
members O -
. O +

This O +
experiment O +
was O +
performed O +
in O +
an O +
attempt O +
to O +
amplify O +
across O +
the O +
deleted O +
fragment O +
and O +
define O +
the O +
exact O +
breakpoint O -
. O +

A O +
single O +
fragment O +
was O +
obtained O +
from O +
the O +
third O +
forward O +
primer O +
from O +
the O +
telomeric O +
side O +
( O -
T3f O +
5′-TGAATGCTCAATTTTCCAGC-3′ O -
) O +
with O +
the O +
11th O +
reverse O +
primer O +
from O +
the O +
centromeric O +
side O +
( O -
C11r O +
5′-GGGAAAATGGATAGAGGGTG-3′ O -
) O -
. O +

The O +
fragment O -
, O +
which O +
is O +
953 O +
bp O +
in O +
size O -
, O +
was O +
sequenced O +
as O +
described O +
above O +
and O +
compared O +
to O +
the O +
current O +
build O +
of O +
the O +
human O +
genome O -
. O +

A O +
similar O +
series O +
of O +
experiments O +
was O +
performed O +
to O +
identify O +
the O +
deletion O +
breakpoints O +
in O +
families O +
H27 O +
and O +
H33 O -
; O +
we O +
were O +
able O +
to O +
amplify O +
a O +
369-bp O +
PCR O +
product O +
across O +
the O +
breakpoint O +
found O +
in O +
affected O +
members O +
of O +
family O +
H27 O +
using O +
primer O +
pair O +
H27 O -
- O -
11F O +
5′-GACCTCAAGAAGGCATGAATAC-3′ O +
and O +
H27 O -
- O -
3R O +
5′-ATGGTGGCCAGGTACACAAG-3′ O +
( O -
Figure O +
S4 O -
) O -
, O +
but O +
to O +
date O +
we O +
have O +
been O +
unable O +
to O +
identify O +
the O +
breakpoint O +
in O +
family O +
H33 O -
. O +

Western O +
blot O +
analysis O +
in O +
SCA15 O +
patients O -
. O +

EBV O +
immortalized O +
lymphoblasts O +
from O +
three O +
affected O +
family O +
members O +
who O +
carry O +
the O +
deletion O +
and O +
one O +
family O +
member O +
without O +
the O +
mutation O +
were O +
used O +
as O +
a O +
readily O +
accessible O +
source O +
of O +
protein O -
; O +
all O +
samples O +
came O +
from O +
members O +
of O +
family O +
AUS1 O -
. O +

Protein O +
extraction O +
was O +
performed O +
using O +
lysis O +
buffer O +
containing O +
1 O -
× O +
TBS O -
, O +
1 O -
% O +
Triton B-Chemical +
X-100 I-Chemical -
, O +
and O +
a O +
cocktail B-Chemical +
of O +
protease O +
inhibitors O +
( O -
Roche O -
) O +
with O +
overnight O +
lysis O +
at O +
−80 O +
° O -
C O -
. O +

Homogenates O +
were O +
diluted O +
appropriately O -
, O +
mixed O +
with O +
4 O -
× O +
reducing O +
sample O +
buffer O -
, O +
and O +
loaded O +
onto O +
4%–12 O -
% O +
precast O +
gradient O +
gels O +
( O -
NuPAGE O -
, O +
Invitrogen O -
) O +
for O +
SDS B-Chemical -
- O -
PAGE O +
and O +
immunoblotting O -
. O +

The O +
antibodies O +
to O +
ITPR1 O +
( O -
1:1,000 O -
) O +
and O +
ACTB O +
( O -
1:5,000 O -
) O +
were O +
used O +
as O +
recommended O +
by O +
manufacturers O -
. O +

Supporting O +
Information O +
Figure O +
S1 O +
Schematic O +
of O +
Genotyping O +
Results O +
across O +
Mouse O +
Chromosome O +
6 O +
in O +
Affected O +
Mice O +
Black O +
squares O +
are O +
indicative O +
of O +
a O +
C57BL O -
/ O -
6J O +
homozygous O +
genotype O -
; O +
light O +
grey O +
squares O -
, O +
a O +
129x1 O -
/ O -
SvJ O +
homozygous O +
genotype O -
; O +
grey O +
squares O -
, O +
a O +
C57BL O -
/ O -
6J O +
129x1 O -
/ O -
SvJ O +
heterozygous O +
genotype O -
; O +
white O +
squares O -
, O +
undetermined O +
genotype O -
. O +

The O +
black O +
box O +
bounds O +
a O +
region O +
of O +
homozygous O +
129x1 O -
/ O -
SvJ O +
genotypes O +
that O +
segregate O +
with O +
disease O -
; O +
thus O -
, O +
the O +
critical O +
region O +
was O +
determined O +
to O +
be O +
between O +
markers O +
D6Mit37 O +
and O +
44.MMHAP85FLG5 O -
. O +

( O -
10 O +
MB O +
TIF O -
) O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S2 O +
Sequence O +
of O +
Exon O +
36 O +
of O +
Itpr1 O +
from O +
Four O +
Mice O +
A O +
wild O -
- O -
type O +
homozygous O +
C57BL O -
/ O -
6J O +
mouse O +
( O -
A O -
) O -
, O +
a O +
wild O -
- O -
type O +
homozygous O +
129x1 O -
/ O -
SvJ O +
mouse O +
( O -
B O -
) O -
, O +
an O +
affected O +
129x1B6 O +
mice O +
homozygous O +
for O +
the O +
18-bp O +
deletion O +
mutation O +
( O -
C O -
) O -
, O +
and O +
an O +
unaffected O +
mouse O +
heterozygous O +
for O +
the O +
18-bp O +
deletion O +
mutation O +
( O -
D O -
) O -
. O +

The O +
deleted O +
nucleotides O +
are O +
bounded O +
by O +
a O +
green O +
box O -
. O +

( O -
5.1 O +
MB O +
TIF O -
) O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S3 O +
Additional O +
Families O +
Harboring O +
Deletion O +
at O +
the O +
SCA15 O +
Locus O +
( O -
A O -
) O +
Family O +
H33 O -
; O +
( O -
B O -
) O +
family O +
H27 O -
. O +

Upper O +
panel O +
shows O +
log O +
R O +
ratio O +
and O +
B O +
allele O +
frequency O +
metrics O +
generated O +
from O +
Infinium O +
HumanHap550 O +
arrays O +
for O +
an O +
affected O +
family O +
member O +
from O +
each O +
family O -
. O +

Log O +
R O +
ratio O +
is O +
the O +
ratio O +
of O +
normalized O -
, O +
observed O +
R O +
to O +
expected O +
R O +
for O +
each O +
SNP O +
( O -
each O +
SNP O +
is O +
a O +
blue O +
dot O -
) O +
and O +
thus O +
serves O +
as O +
a O +
surrogate O +
of O +
copy O +
number O +
at O +
each O +
locus O -
. O +

B O +
allele O +
frequency O +
is O +
a O +
measure O +
of O +
the O +
number O +
of O +
times O +
the O +
A O +
or O +
B O +
alleles O +
are O +
detected O +
at O +
each O +
locus O +
( O -
each O +
SNP O +
is O +
denoted O +
by O +
a O +
blue O +
dot O -
) O -
. O +

Thus O -
, O +
SNPs O +
with O +
a O +
B O +
allele O +
frequency O +
of O +
one O +
are O +
apparent O +
B O -
/ O -
B O +
homozygotes O -
, O +
SNPs O +
with O +
a O +
B O +
allele O +
frequency O +
of O +
0.5 O +
are O +
apparent O +
A O -
/ O -
B O +
heterozygotes O -
, O +
and O +
those O +
with O +
a O +
B O +
allele O +
frequency O +
of O +
zero O +
are O +
apparent O +
A O -
/ O -
A O +
homozygotes O -
. O +

These O +
plots O +
show O +
a O +
contiguous O +
region O +
~310 O +
kb O +
long O +
( O -
family O +
H33 O -
) O +
and O +
~350 O +
kb O +
long O +
( O -
family O +
H27 O -
) O +
with O +
decreased O +
copy O +
number O +
and O +
apparent O +
homozygosity O +
indicative O +
of O +
a O +
genomic O +
deletion O +
( O -
shaded O +
grey O -
) O -
. O +

The O +
pedigrees O +
below O +
show O +
the O +
available O +
family O +
members O +
assayed O +
for O +
these O +
deletions O -
, O +
all O +
of O +
whom O +
were O +
affected O +
and O +
all O +
of O +
whom O +
carried O +
a O +
deletion O +
at O +
this O +
locus O -
. O +

( O -
6.8 O +
MB O +
TIF O -
) O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S4 O +
Deleted O +
Regions O +
Identified O +
in O +
Families O +
AUS1 O +
and O +
H27 O +
( O -
Top O -
) O +
Family O +
AUS1 O -
; O +
sequence O +
from O +
the O +
PCR O +
product O +
generated O +
using O +
primers O +
T3f O +
and O +
C11r O +
from O +
genomic O +
DNA O +
from O +
an O +
affected O +
family O +
member O -
. O +

Red O +
arrowhead O +
denotes O +
the O +
deletion O +
breakpoint O -
; O +
the O +
deletion O +
is O +
201,510 O +
bp O +
in O +
length O -
. O +

( O -
Bottom O -
) O +
Family O +
H27 O -
; O +
sequence O +
flanking O +
deleted O +
region O -
. O +

Green O +
font O +
indicates O +
nucleotides O +
telomeric O +
to O +
the O +
deletion O -
; O +
blue O +
font O +
indicates O +
nucleotides O +
centromeric O +
to O +
the O +
deletion O -
. O +

The O +
deletion O +
is O +
344,408 O +
bp O +
in O +
length O -
. O +

Basepair O +
positions O +
are O +
based O +
on O +
NCBI O +
genome O +
build O +
36 O +
reference O +
assembly O -
. O +

( O -
876 O +
KB O +
MB O +
TIF O -
) O -
. O +

Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Accession O +
Numbers O +
The O +
OMIM O +
( O -
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM O -
) O +
accession O +
number O +
for O +
SUMF1 O +
is O +
607939 O -
. O +

Acknowledgements O +
We O +
thank O +
the O +
SCA15 O +
family O +
members O +
for O +
participating O +
in O +
this O +
study O -
. O +

Abbreviations O +
EBV O +
- O +
Epstein O -
- O -
Barr O +
virus O +
SCA O -
[ O -
number O -
] O +
- O +
spinocerebellar O +
ataxia O +
[ O -
number O -
] O +
SNP O +
- O +
single O +
nucleotide O +
polymorphism O +
Figures O +
and O +
Tables O +
Figure O +
1 O +
Immunohistochemistry O +
and O +
Western O +
Blot O +
Analysis O +
of O +
ITPR1 O +
Protein O +
Levels O +
in O +
Mouse O +
Cerebellum O +
( O -
A O -
– O -
F O -
) O +
Immunohistochemistry O +
of O +
cerebellum O +
from O +
a O +
wild O -
- O -
type O +
mouse O +
( O -
A O +
and O +
D O -
) O -
, O +
a O +
mouse O +
heterozygous O +
for O +
the O +
Itpr1 O +
18-bp O +
deletion O +
( O -
B O +
and O +
E O -
) O -
, O +
and O +
a O +
mouse O +
homozygous O +
for O +
the O +
18-bp O +
Itpr1 O +
deletion O +
( O -
C O +
and O +
F O -
) O -
. O +

( O -
A O -
– O -
C O -
) O +
Immunohistochemistry O +
using O +
polyclonal O +
Itpr1 O +
anti O -
- O -
rabbit O +
antibody O +
( O -
1:2,000 O -
; O +
Alexa B-Chemical +
Fluor I-Chemical +
555 I-Chemical -
) O -
; O +
( O -
D O -
– O -
F O -
) O +
immunohistochemistry O +
using O +
monoclonal O +
Calb1 O +
anti O -
- O -
mouse O +
antibody O +
( O -
1:6,000 O -
; O +
Alexa B-Chemical +
Fluor I-Chemical +
488 I-Chemical -
) O -
. O +

Scale O +
bars O +
denote O +
100 O +
μm O -
. O +

As O +
previously O +
described O -
, O +
Iptr1 O +
is O +
highly O +
expressed O +
in O +
the O +
Purkinje O +
cells O -
. O +

Notably O -
, O +
there O +
appears O +
to O +
be O +
decreased O +
immunoreactivity O +
to O +
Itpr1 O +
in O +
the O +
heterozygous O +
and O +
homozygous O +
mutant O +
mice O -
. O +

( O -
G O -
) O +
Western O +
blot O +
performed O +
to O +
examine O +
Itpr1 O +
levels O +
in O +
whole O +
brain O +
from O +
wild O -
- O -
type O -
, O +
Itpr1wt O -
/ O -
Δ18 O -
, O +
and O +
Itpr1Δ18 O -
/ O -
Δ18 O +
mice O -
; O +
this O +
clearly O +
shows O +
a O +
reduction O +
of O +
Itpr1 O +
in O +
brain O +
tissue O +
from O +
Itpr1wt O -
/ O -
Δ18 O +
mice O +
and O +
a O +
greater O +
reduction O +
of O +
Itpr1 O +
in O +
Itpr1Δ18 O -
/ O -
Δ18 O +
mice O -
. O +

Figure O +
2 O +
Metrics O +
Derived O +
from O +
Analysis O +
of O +
DNA O +
from O +
Affected O +
Family O +
Member O +
7 O +
Using O +
Illumina O +
Infinium O +
HumanHap550 O +
Genotyping O +
Chips O +
The O +
upper O +
and O +
lower O +
plots O +
are O +
log O +
R O +
ratio O +
and O +
B O +
allele O +
frequency O -
, O +
respectively O -
, O +
at O +
an O +
~800-kb O +
segment O +
on O +
the O +
p O +
arm O +
of O +
Chromosome O +
3 O -
. O +

Log O +
R O +
ratio O +
is O +
the O +
ratio O +
of O +
normalized O -
, O +
observed O +
R O +
to O +
expected O +
R O +
for O +
each O +
SNP O +
( O -
each O +
SNP O +
is O +
a O +
blue O +
dot O -
) O +
and O +
thus O +
serves O +
as O +
a O +
surrogate O +
of O +
copy O +
number O +
at O +
each O +
locus O -
. O +

B O +
allele O +
frequency O +
is O +
a O +
measure O +
of O +
the O +
number O +
of O +
times O +
the O +
A O +
or O +
B O +
alleles O +
are O +
detected O +
at O +
each O +
locus O +
( O -
each O +
SNP O +
is O +
denoted O +
by O +
a O +
blue O +
dot O -
) O -
. O +

Thus O -
, O +
SNPs O +
with O +
a O +
B O +
allele O +
frequency O +
of O +
one O +
are O +
apparent O +
B O -
/ O -
B O +
homozygotes O -
, O +
SNPs O +
with O +
a O +
B O +
allele O +
frequency O +
of O +
0.5 O +
are O +
apparent O +
A O -
/ O -
B O +
heterozygotes O -
, O +
and O +
those O +
with O +
a O +
B O +
allele O +
frequency O +
of O +
zero O +
are O +
apparent O +
A O -
/ O -
A O +
homozygotes O -
. O +

Clearly O -
, O +
these O +
plots O +
show O +
a O +
contiguous O +
region O +
~200 O +
kb O +
long O +
with O +
decreased O +
copy O +
number O +
and O +
apparent O +
homozygosity O +
( O -
bounded O +
by O +
a O +
red O +
box O -
) O -
. O +

As O +
we O +
have O +
demonstrated O +
previously O -
, O +
this O +
is O +
indicative O +
of O +
a O +
heterozygous O +
genomic O +
deletion O +
[ O -
15 O -
] O -
. O +

Below O +
these O +
plots O +
is O +
a O +
schematic O +
of O +
the O +
two O +
known O +
genes O +
affected O +
by O +
this O +
deletion O -
, O +
ITPR1 O +
and O +
SUMF1 O -
. O +

Figure O +
3 O +
Mutation O +
Analysis O +
in O +
the O +
Australian O +
SCA15 O +
Family O +
( O -
Top O -
) O +
Pedigree O +
of O +
kindred O -
. O +

Filled O +
symbols O +
denote O +
affected O +
individuals O -
; O +
open O +
symbols O -
, O +
unaffected O +
individuals O -
; O +
grey O +
symbol O +
denotes O +
unknown O +
disease O +
status O -
; O +
bulls O -
- O -
eye O +
symbol O +
denotes O +
obligate O +
carrier O -
. O +

w O -
/ O -
w O -
, O +
wild O -
- O -
type O +
at O +
ITPR1 O -
; O +
w O -
/ O -
m O -
, O +
heterozygous O +
carrier O +
of O +
the O +
ITPR1 O +
deletion O -
. O +

( O -
Middle O -
) O +
Schematic O +
of O +
primer O +
pairs O +
used O +
to O +
narrow O +
the O +
unknown O +
regions O +
between O +
known O +
deleted O +
sequence O +
and O +
known O +
diploid O +
sequence O +
at O +
the O +
SCA15 O +
locus O -
. O +

Nine O +
primer O +
pairs O +
( O -
T1–T9 O -
) O +
were O +
used O +
to O +
amplify O +
across O +
the O +
unknown O +
region O +
telomeric O +
to O +
the O +
known O +
deleted O +
region O -
; O +
19 O +
primer O +
pairs O +
( O -
C1–C19 O -
) O +
were O +
used O +
to O +
amplify O +
across O +
the O +
unknown O +
region O +
centromeric O +
to O +
the O +
known O +
deleted O +
region O -
. O +

All O +
PCRs O +
were O +
carried O +
out O +
in O +
the O +
three O +
affected O +
family O +
members O -
. O +

Analysis O +
of O +
these O +
data O +
narrowed O +
the O +
unknown O +
region O -
, O +
and O +
ultimately O +
we O +
were O +
able O +
to O +
use O +
primer O +
T3f O +
and O +
C11r O +
to O +
amplify O +
across O +
the O +
deletion O +
breakpoint O +
in O +
the O +
three O +
affected O +
family O +
members O -
, O +
producing O +
a O +
fragment O +
of O +
953 O +
bp O +
in O +
affected O +
individuals O -
. O +

( O -
Bottom O -
) O +
Gel O +
showing O +
amplification O +
product O +
using O +
primer O +
pair O +
T3f O +
and O +
C11r O +
from O +
affected O +
pedigree O +
members O +
6 O -
, O +
7 O -
, O +
and O +
19 O -
; O +
in O +
pedigree O +
member O +
23 O -
, O +
with O +
unknown O +
disease O +
affection O +
status O -
; O +
in O +
a O +
neurologically O +
normal O +
control O +
( O -
C O -
) O -
; O +
and O +
in O +
a O +
no O +
template O +
control O +
( O -
NC O -
) O -
. O +

Figure O +
4 O +
Western O +
Blot O +
Analysis O +
of O +
ITPR1 O +
Protein O +
Levels O +
in O +
EBV O +
Immortalized O +
Lymphoblasts O +
from O +
AUS1 O +
Family O +
Members O +
Western O +
blot O +
performed O +
to O +
examine O +
ITPR1 O +
levels O +
in O +
EBV O +
immortalized O +
lymphocytes O +
from O +
AUS1 O +
affected O +
family O +
members O +
carrying O +
the O +
ITPR1 O +
deletion O +
and O +
from O +
an O +
AUS1 O +
family O +
member O +
of O +
unknown O +
disease O +
status O +
who O +
does O +
not O +
carry O +
the O +
deletion O -
. O +

Notably O +
the O +
samples O +
from O +
patients O +
with O +
ITPR1 O +
deletion O +
show O +
a O +
dramatic O +
decrease O +
in O +
ITPR1 O +
levels O -
. O +

To O +
demonstrate O +
equal O +
loading O -
, O +
these O +
samples O +
were O +
diluted O +
one O +
in O +
five O -
, O +
and O +
the O +
Western O +
blot O +
was O +
repeated O +
using O +
an O +
antibody O +
against O +
ACTB O -
. O +

Footnotes O +
A O +
previous O +
version O +
of O +
this O +
article O +
appeared O +
as O +
an O +
Early O +
Online O +
Release O +
on O +
May O +
16 O -
, O +
2007 O +
( O -
doi:10.1371 O -
/ O -
journal.pgen.0030108.eor O -
) O -
. O +

Author O +
contributions O -
. O +

EMCF O -
, O +
JTR O -
, O +
and O +
ABS O +
conceived O +
and O +
designed O +
the O +
experiments O -
. O +

JvdL O -
, O +
JC O -
, O +
MAK O -
, O +
LAH O -
, O +
SS O -
, O +
MRC O -
, O +
HCF O -
, O +
XL O -
, O +
DH O -
, O +
JSS O -
, O +
IR O -
, O +
and O +
HC O +
performed O +
the O +
experiments O -
. O +

JvdL O -
, O +
JC O -
, O +
MAK O -
, O +
SS O -
, O +
MRC O -
, O +
KGH O -
, O +
HCF O -
, O +
JSS O -
, O +
JTR O -
, O +
and O +
ABS O +
analyzed O +
the O +
data O -
. O +

HH O -
, O +
NWW O -
, O +
PG O -
, O +
JH O -
, O +
ES O -
, O +
RJMG O -
, O +
SMF O -
, O +
HC O -
, O +
and O +
ABS O +
contributed O +
reagents B-Chemical -
/ O -
materials O -
/ O -
analysis O +
tools O -
. O +

RJMG O -
, O +
EMCF O -
, O +
and O +
ABS O +
wrote O +
the O +
paper O -
. O +

Funding O -
. O +

This O +
research O +
was O +
funded O +
in O +
part O +
by O +
the O +
intramural O +
programs O +
of O +
the O +
National O +
Institute O +
on O +
Aging O +
and O +
the O +
National O +
Institute O +
on O +
Neurological O +
Disorders O +
and O +
Stroke O +
( O -
NINDS O -
) O -
, O +
both O +
of O +
the O +
National O +
Institutes O +
of O +
Health O -
, O +
Department O +
of O +
Health O +
and O +
Human O +
Services O -
, O +
United O +
States O +
of O +
America O -
. O +

MAK O +
was O +
supported O +
by O +
a O +
NINDS O +
Competitive O +
Postdoctoral O +
Fellowship O -
. O +

HH O +
is O +
supported O +
by O +
the O +
Medical O +
Research O +
Council O -
, O +
United O +
Kingdom O -
. O +

Competing O +
interests O -
. O +

The O +
authors O +
have O +
declared O +
that O +
no O +
competing O +
interests O +
exist O -
. O +

Mouse O +
Pachytene O +
Checkpoint O +
2 O +
( O -
Trip13 O -
) O +
Is O +
Required O +
for O +
Completing O +
Meiotic O +
Recombination O +
but O +
Not O +
Synapsis O +
Abstract O +
In O +
mammalian O +
meiosis O -
, O +
homologous O +
chromosome O +
synapsis O +
is O +
coupled O +
with O +
recombination O -
. O +

As O +
in O +
most O +
eukaryotes O -
, O +
mammalian O +
meiocytes O +
have O +
checkpoints O +
that O +
monitor O +
the O +
fidelity O +
of O +
these O +
processes O -
. O +

We O +
report O +
that O +
the O +
mouse O +
ortholog O +
( O -
Trip13 O -
) O +
of O +
pachytene O +
checkpoint O +
2 O +
( O -
PCH2 O -
) O -
, O +
an O +
essential O +
component O +
of O +
the O +
synapsis O +
checkpoint O +
in O +
Saccharomyces O +
cerevisiae O +
and O +
Caenorhabditis O +
elegans O -
, O +
is O +
required O +
for O +
completion O +
of O +
meiosis O +
in O +
both O +
sexes O -
. O +

TRIP13-deficient O +
mice O +
exhibit O +
spermatocyte O +
death O +
in O +
pachynema O +
and O +
loss O +
of O +
oocytes O +
around O +
birth O -
. O +

The O +
chromosomes O +
of O +
mutant O +
spermatocytes O +
synapse O +
fully O -
, O +
yet O +
retain O +
several O +
markers O +
of O +
recombination O +
intermediates O -
, O +
including O +
RAD51 O -
, O +
BLM O -
, O +
and O +
RPA O -
. O +

These O +
chromosomes O +
also O +
exhibited O +
the O +
chiasmata O +
markers O +
MLH1 O +
and O +
MLH3 O -
, O +
and O +
okadaic B-Chemical +
acid I-Chemical +
treatment O +
of O +
mutant O +
spermatocytes O +
caused O +
progression O +
to O +
metaphase O +
I O +
with O +
bivalent O +
chromosomes O -
. O +

Double O +
mutant O +
analysis O +
demonstrated O +
that O +
the O +
recombination O +
and O +
synapsis O +
genes O +
Spo11 O -
, O +
Mei1 O -
, O +
Rec8 O -
, O +
and O +
Dmc1 O +
are O +
all O +
epistatic O +
to O +
Trip13 O -
, O +
suggesting O +
that O +
TRIP13 O +
does O +
not O +
have O +
meiotic O +
checkpoint O +
function O +
in O +
mice O -
. O +

Our O +
data O +
indicate O +
that O +
TRIP13 O +
is O +
required O +
after O +
strand O +
invasion O +
for O +
completing O +
a O +
subset O +
of O +
recombination O +
events O -
, O +
but O +
possibly O +
not O +
those O +
destined O +
to O +
be O +
crossovers O -
. O +

To O +
our O +
knowledge O -
, O +
this O +
is O +
the O +
first O +
model O +
to O +
separate O +
recombination O +
defects O +
from O +
asynapsis O +
in O +
mammalian O +
meiosis O -
, O +
and O +
provides O +
the O +
first O +
evidence O +
that O +
unrepaired O +
DNA O +
damage O +
alone O +
can O +
trigger O +
the O +
pachytene O +
checkpoint O +
response O +
in O +
mice O -
. O +

Author O +
Summary O +
It O +
is O +
critical O +
that O +
the O +
chromosomes O +
carried O +
by O +
sperm O +
and O +
eggs O +
contain O +
faithful O +
representations O +
of O +
the O +
genome O +
of O +
the O +
individual O +
that O +
produced O +
them O -
. O +

During O +
the O +
process O +
of O +
meiosis O -
, O +
the O +
maternal O +
and O +
paternal O +
copies O +
of O +
each O +
chromosome O +
" O -
synapse O -
" O +
with O +
each O +
other O +
( O -
become O +
tightly O +
associated O -
) O -
, O +
exchange O +
genetic O +
material O +
via O +
the O +
process O +
of O +
recombination O -
, O +
then O +
separate O +
into O +
daughter O +
cells O +
in O +
the O +
first O +
of O +
two O +
meiotic O +
cell O +
divisions O -
. O +

The O +
intricate O +
chromosome O +
behavior O +
is O +
subject O +
to O +
errors O -
, O +
so O +
most O +
organisms O +
have O +
evolved O +
meiotic O +
" O -
checkpoints O -
" O +
that O +
monitor O +
fidelity O +
of O +
chromosome O +
synapsis O +
and O +
repair O +
of O +
DNA O +
damage O -
. O +

These O +
checkpoints O +
cause O +
defective O +
cells O +
to O +
self O +
destruct O +
rather O +
than O +
generate O +
defective O +
sperm O +
or O +
eggs O -
. O +

We O +
studied O +
the O +
effects O +
of O +
deleting O +
mouse O +
Trip13 O -
, O +
a O +
gene O +
that O +
in O +
distant O +
organisms O +
plays O +
a O +
key O +
role O +
in O +
meiotic O +
checkpoint O +
control O -
. O +

These O +
experiments O +
revealed O +
that O +
instead O +
of O +
having O +
a O +
checkpoint O +
role O -
, O +
Trip13 O +
is O +
required O +
for O +
one O +
of O +
the O +
two O +
major O +
classes O +
of O +
recombination O +
in O +
meiosis O +
that O +
is O +
required O +
for O +
repairing O +
broken O +
DNA O +
molecules B-Chemical -
. O +

The O +
chromosomes O +
still O +
synapsed O +
normally O -
, O +
but O +
animals O +
were O +
sterile O +
due O +
to O +
massive O +
death O +
of O +
oocytes O +
and O +
spermatocytes O -
. O +

These O +
results O +
indicate O +
that O -
, O +
in O +
addition O +
to O +
a O +
checkpoint O +
that O +
responds O +
to O +
failed O +
synapsis O -
, O +
one O +
exists O +
to O +
specifically O +
detect O +
unrepaired O +
DNA O +
damage O +
that O +
is O +
due O +
to O +
failed O +
recombination O -
. O +

Introduction O +
The O +
genesis O +
of O +
gametes O +
containing O +
an O +
intact O -
, O +
haploid O +
genome O +
is O +
critical O +
for O +
the O +
prevention O +
of O +
birth O +
defects O -
, O +
and O +
is O +
highly O +
dependent O +
upon O +
the O +
fidelity O +
of O +
chromosome O +
dynamics O +
before O +
the O +
first O +
meiotic O +
division O -
. O +

Homologous O +
chromosomes O +
must O +
pair O -
, O +
synapse O -
, O +
undergo O +
recombination O -
, O +
and O +
segregate O +
properly O +
to O +
opposite O +
poles O -
. O +

Recombination O -
, O +
which O +
repairs O +
repair O +
double O +
strand O +
breaks O +
( O -
DSBs O -
) O +
that O +
are O +
genetically O +
induced O +
in O +
leptonema O -
, O +
is O +
coupled O +
with O +
synapsis O +
in O +
budding O +
yeast O +
and O +
mammals O -
. O +

While O +
our O +
knowledge O +
of O +
the O +
assembly O +
and O +
nature O +
of O +
recombination O +
machinery O +
is O +
extensive O -
, O +
little O +
is O +
known O +
about O +
the O +
disassembly O +
of O +
recombination O +
intermediates O -
, O +
recruitment O +
of O +
DNA O +
replication O +
machinery O +
during O +
recombinational O +
repair O -
, O +
and O +
how O +
the O +
choice O +
between O +
different O +
repair O +
pathways O +
is O +
made O -
. O +

Defects O +
in O +
recombination O +
can O +
preclude O +
homologous O +
chromosome O +
pairing O -
, O +
leave O +
unrepaired O +
chromosome O +
breaks O -
, O +
and O +
cause O +
aneuploidy O +
by O +
abrogating O +
crossing O +
over O -
. O +

To O +
avoid O +
such O +
deleterious O +
outcomes O -
, O +
surveillance O +
systems O +
( O -
" O -
checkpoints O -
" O -
) O +
exist O +
to O +
sense O +
meiotic O +
errors O +
and O +
eliminate O +
cells O +
containing O +
unresolved O +
defects O -
. O +

In O +
many O +
organisms O -
, O +
including O +
S. O +
cerevisiae O -
, O +
Drosophila O +
melanogaster O -
, O +
C. O +
elegans O -
, O +
and O +
mice O +
[ O -
1–4 O -
] O -
, O +
meiocytes O +
with O +
defects O +
in O +
recombination O +
and/or O +
chromosome O +
synapsis O +
trigger O +
meiotic O +
arrest O +
in O +
the O +
pachytene O +
stage O +
of O +
meiotic O +
prophase O +
I. O +
This O +
response O +
to O +
meiotic O +
defects O +
is O +
referred O +
to O +
as O +
the O +
" O -
pachytene O +
checkpoint O -
" O +
( O -
reviewed O +
in O +
[ O -
5 O -
] O -
) O -
. O +

Genetic O +
experiments O +
in O +
S. O +
cerevisiae O +
have O +
identified O +
elements O +
of O +
the O +
pachytene O +
checkpoint O +
machinery O +
( O -
reviewed O +
in O +
[ O -
5 O -
] O -
) O -
. O +

In O +
addition O +
to O +
meiosis O -
- O -
specific O +
proteins O -
, O +
these O +
include O +
factors O +
that O +
play O +
roles O +
in O +
DNA O +
damage O +
signaling O +
in O +
mitotic O +
cells O +
[ O -
6–10 O -
] O -
. O +

Arabidopsis O +
thaliana O +
does O +
not O +
appear O +
to O +
have O +
a O +
pachytene O +
checkpoint O +
akin O +
to O +
that O +
in O +
yeast O +
[ O -
11 O -
] O -
, O +
nor O +
do O +
male O +
Drosophila O -
. O +

The O +
pachytene O +
checkpoint O +
is O +
known O +
to O +
monitor O +
two O +
aspects O +
of O +
meiotic O +
chromosome O +
metabolism O +
in O +
S. O +
cerevisiae O +
and O +
C. O +
elegans O -
: O +
( O -
1 O -
) O +
DSB O +
repair O +
and O +
( O -
2 O -
) O +
chromosome O +
synapsis O +
[ O -
2,12 O -
] O -
. O +

In O +
mice O -
, O +
both O +
spermatocytes O +
and O +
oocytes O +
harboring O +
mutations O +
that O +
disrupt O +
DSB O +
repair O +
( O -
such O +
as O +
Dmc1 O -
, O +
Msh5 O -
, O +
and O +
Atm O -
) O +
are O +
efficiently O +
eliminated O +
in O +
pachynema O -
, O +
but O +
spermatocytes O +
are O +
much O +
more O +
sensitive O +
to O +
DSB O +
repair O -
– O -
independent O +
synapsis O +
defects O +
than O +
oocytes O +
[ O -
13–15 O -
] O -
. O +

However O -
, O +
because O +
recombination O +
is O +
required O +
for O +
synapsis O +
in O +
mice O +
( O -
mutations O +
in O +
recombination O +
genes O +
such O +
as O +
Dmc1 O +
cause O +
extensive O +
asynapsis O +
[ O -
16 O -
] O -
) O -
, O +
it O +
has O +
remained O +
formally O +
uncertain O +
whether O +
there O +
is O +
a O +
distinct O +
pachytene O +
checkpoint O +
that O +
responds O +
to O +
defects O +
in O +
meiotic O +
recombination O -
, O +
and O +
if O +
so O -
, O +
whether O +
it O +
would O +
be O +
identical O +
to O +
that O +
used O +
in O +
somatic O +
cells O -
. O +

The O +
mechanisms O +
of O +
putative O +
pachytene O +
checkpoint O +
control O +
remain O +
unknown O +
in O +
mammals O -
, O +
since O +
no O +
mutations O +
have O +
been O +
identified O +
that O +
abolish O +
it O -
. O +

PCH2 O -
, O +
encoding O +
a O +
nucleolar O -
- O -
localized O +
AAA O -
- O -
ATPase O +
that O +
was O +
originally O +
identified O +
in O +
an O +
S. O +
cerevisiae O +
genetic O +
screen O +
for O +
mutants O +
that O +
relieve O +
pachytene O +
arrest O +
of O +
asynaptic O +
zip1 O +
mutants O +
[ O -
8 O -
] O -
, O +
was O +
recently O +
determined O +
to O +
be O +
an O +
essential O +
component O +
of O +
the O +
pachytene O +
synapsis O +
( O -
but O +
not O +
DSB O +
repair O -
) O +
checkpoint O +
in O +
yeast O +
and O +
worms O +
[ O -
2,12 O -
] O -
. O +

PCH2 O +
orthologs O +
are O +
present O +
in O +
organisms O +
that O +
undergo O +
synaptic O +
meiosis O -
, O +
but O +
not O +
asynaptic O +
meiosis O -
, O +
prompting O +
the O +
suggestion O +
that O +
a O +
Pch2-dependent O +
checkpoint O +
evolved O +
to O +
monitor O +
synaptonemal O +
complex O +
( O -
SC O -
) O +
defects O +
from O +
yeast O +
to O +
humans O +
[ O -
12 O -
] O -
. O +

Here O -
, O +
we O +
generated O +
mice O +
deficient O +
for O +
the O +
Trip13 O -
, O +
the O +
ortholog O +
of O +
PCH2 O -
, O +
and O +
evaluated O +
whether O +
it O +
also O +
plays O +
a O +
role O +
in O +
the O +
pachytene O +
checkpoint O -
. O +

Surprisingly O -
, O +
while O +
we O +
found O +
no O +
evidence O +
for O +
checkpoint O +
function O -
, O +
we O +
did O +
uncover O +
a O +
potential O +
role O +
for O +
this O +
protein O +
in O +
noncrossover O +
( O -
NCO O -
) O +
repair O +
of O +
meiotic O +
DSBs O -
. O +

Results O +
Trip13 O +
Is O +
a O +
Widely O +
Expressed O +
Mammalian O +
Ortholog O +
of O +
PCH2 O +
with O +
Unusual O +
Phylogenetic O +
Relationships O +
The O +
mammalian O +
ortholog O +
of O +
PCH2 O -
, O +
Trip13 O +
( O -
thyroid B-Chemical +
hormone I-Chemical +
receptor O +
interacting O +
protein O +
13 O -
) O -
, O +
encodes O +
a O +
protein O +
with O +
extensive O +
amino O +
acid O +
homology O +
in O +
regions O +
alignable O +
to O +
the O +
yeast O +
and O +
worm O +
orthologs O +
( O -
Figure O +
S1 O -
) O +
[ O -
12 O -
] O -
) O -
. O +

Interestingly O -
, O +
phylogenetic O +
analysis O +
of O +
TRIP13 O -
/ O -
Pch2p O +
shows O +
that O +
the O +
mammalian O +
protein O +
clusters O +
more O +
closely O +
to O +
plants O +
than O +
it O +
does O +
to O +
the O +
evolutionarily O +
more O +
closely O +
related O +
worms O +
and O +
flies O +
( O -
Figure O +
1A O -
; O +
see O +
Discussion O -
) O -
. O +

Semi O -
- O -
quantitative O +
reverse O -
- O -
transcriptase O +
PCR O +
( O -
RT O -
- O -
PCR O -
) O +
analysis O +
showed O +
Trip13 O +
mRNA O +
to O +
be O +
expressed O +
in O +
a O +
variety O +
of O +
embryonic O +
and O +
adult O +
tissues O -
, O +
including O +
testis O +
( O -
Figure O +
1B O -
) O -
, O +
consistent O +
with O +
mouse O +
and O +
human O +
EST O +
data O +
summarized O +
in O +
Unigene O +
( O -
http://www.ncbi.nlm.nih.gov/UniGene O -
) O -
. O +

It O +
is O +
also O +
highly O +
expressed O +
in O +
human O +
and O +
mouse O +
oocytes O +
[ O -
17 O -
] O -
. O +

Figure O +
1 O +
The O +
Mouse O +
PCH2 O +
Ortholog O +
TRIP13 O +
and O +
Expression O +
in O +
Wild O +
Type O +
and O +
Mutant O +
( O -
A O -
) O +
Phylogenetic O +
tree O +
of O +
presumed O +
PCH2 O -
/ O -
TRIP13 O +
orthologs O -
. O +

The O +
database O +
sequence O +
accession O +
number O +
of O +
each O +
protein O +
is O +
presented O +
in O +
Table O +
S1 O -
. O +

Numbers O +
shown O +
are O +
bootstrap O +
values O +
( O -
see O +
Materials O +
and O +
Methods O -
) O -
. O +

The O +
clustering O +
was O +
the O +
same O +
regardless O +
of O +
whether O +
the O +
whole O +
entire O +
AA O +
sequence O +
or O +
trimmed O +
sequences O +
( O -
where O +
regions O +
showing O +
little O +
conservation O +
were O +
removed O -
) O +
were O +
used O +
for O +
the O +
analysis O -
. O +

Major O +
eukaryotic O +
groups O +
are O +
indicated O +
in O +
color O -
, O +
with O +
deuterostomia O +
in O +
blue O -
, O +
plants O +
in O +
green O -
, O +
protostomia O +
in O +
purple O -
, O +
and O +
fungi O +
in O +
maroon O -
. O +

( O -
B O -
) O +
Amplification O +
products O +
of O +
cDNA O +
from O +
the O +
following O +
tissues O -
: O +
1 O -
, O +
heart O -
; O +
2 O -
, O +
brain O -
; O +
3 O -
, O +
spleen O -
; O +
4 O -
, O +
lung O -
; O +
5 O -
, O +
liver O -
; O +
6 O -
, O +
skeletal O +
muscle O -
; O +
7 O -
, O +
kidney O -
; O +
8 O -
, O +
testis O -
; O +
9 O -
, O +
E7 O +
embryo O -
; O +
10 O -
, O +
E11 O +
embryo O -
; O +
11 O -
, O +
E15 O +
embryo O -
; O +
and O +
12 O -
, O +
E17 O +
embryo O -
. O +

( O -
C O -
) O +
Intron O -
– O -
exon O +
structure O +
of O +
TRIP13 O +
and O +
insertion O +
site O +
of O +
gene O -
- O -
trap O +
vector O -
. O +

See O +
Materials O +
and O +
Methods O +
for O +
details O +
on O +
how O +
the O +
precise O +
insertion O +
site O +
was O +
identified O -
. O +
( O -
D O -
) O +
RT O -
- O -
PCR O +
of O +
Trip13 O +
and O +
a O +
control O +
gene O +
Med31 O +
from O +
testis O +
RNA O -
. O +

The O +
Trip13 O +
primers O +
are O +
situated O +
in O +
the O +
first O +
and O +
last O +
exons O +
( O -
see O +
Materials O +
and O +
Methods O -
) O -
. O +

( O -
E O -
) O +
Western O +
blot O +
analysis O +
of O +
testis O +
protein O +
with O +
anti O -
- O -
TRIP13 O +
antibody O -
. O +

The O +
blot O +
was O +
later O +
probed O +
with O +
anti O -
- O -
alpha O +
tubulin O +
actin O +
as O +
a O +
loading O +
control O -
. O +

The O +
expected O +
TRIP13 O +
protein O +
is O +
∼48 O +
KDa O -
. O +

( O -
F O -
) O +
Localization O +
of O +
TRIP13 O +
in O +
testes O -
. O +

Wild O -
- O -
type O +
( O -
top O -
) O +
and O +
mutant O +
( O -
bottom O -
) O +
testis O +
sections O +
were O +
probed O +
with O +
chicken O +
anti O -
- O -
TRIP13 O -
, O +
and O +
detected O +
with O +
HRP O -
- O -
conjugated O +
anti O -
- O -
chicken O +
IgG O +
( O -
brown O -
/ O -
red O +
staining O -
) O -
. O +

Expression O +
in O +
WT O +
was O +
most O +
prominent O +
in O +
the O +
nuclei O +
of O +
Type O +
B O +
spermatogonia O +
( O -
Sg O -
) O -
, O +
leptotene O +
spermatocytes O +
( O -
LS O -
) O -
, O +
and O +
early O +
pachytene O +
spermatocytes O +
( O -
PS O -
) O -
, O +
but O +
not O +
late O +
pachytene O +
spermatocytes O +
( O -
LP O -
) O -
. O +

No O +
nuclear O +
staining O +
was O +
seen O +
in O +
mutant O +
testis O +
sections O -
, O +
although O +
reddish O +
cytoplasmic O +
background O +
is O +
present O -
. O +

Identification O +
of O +
cell O +
types O +
was O +
judged O +
in O +
part O +
by O +
estimating O +
the O +
epithelial O +
stage O +
of O +
the O +
tubules O +
as O +
described O +
[ O -
67 O -
] O -
. O +

( O -
G O -
) O +
TRIP13 O +
localization O +
in O +
surface O -
- O -
spread O +
spermatocytes O -
. O +

Preparations O +
were O +
immunolabeled O +
with O +
anti O -
- O -
SYCP3 O +
( O -
S O -
) O +
and O +
TRIP13 O +
( O -
T O -
) O -
. O +

Both O +
individual O +
and O +
merged O +
images O +
are O +
shown O +
for O +
leptotene O +
( O -
Lep O -
) O -
, O +
zygotene O +
( O -
Zyg O -
) O -
, O +
and O +
pachytene O +
( O -
Pac O -
) O +
spermatocytes O -
. O +

Nuclear O +
staining O +
was O +
absent O +
in O +
the O +
mutant O -
. O +

Generation O +
of O +
Trip13 O +
Mutant O +
Mice O +
To O +
explore O +
the O +
function O +
of O +
TRIP13 O +
in O +
mammals O -
, O +
we O +
generated O +
mice O +
with O +
a O +
gene O +
trap O -
- O -
disrupted O +
allele O -
, O +
Trip13RRB047 O +
( O -
Figure O +
1C O -
; O +
abbreviated O +
as O +
Trip13Gt O -
) O -
. O +

Heterozygotes O +
were O +
normal O +
in O +
all O +
respects O -
, O +
but O +
homozygotes O +
were O +
present O +
at O +
∼2 O -
/ O -
3 O +
the O +
expected O +
ratio O +
from O +
intercrosses O +
between O +
heterozygotes O +
( O -
91 O +
Trip13+ O -
/ O -
+ O -
, O +
183 O +
Trip13Gt O -
/ O -
+ O -
, O +
and O +
61 O +
Trip13Gt O -
/ O -
Gt O -
) O -
. O +

Since O +
> O -
90 O -
% O +
of O +
prewean O +
mice O +
that O +
died O +
were O +
mutant O +
homozygotes O -
, O +
this O +
discrepancy O +
is O +
apparently O +
due O +
to O +
a O +
partially O +
penetrant O +
lethality O -
. O +

Most O +
surviving O +
Trip13Gt O -
/ O -
Gt O +
animals O +
were O +
grossly O +
normal O -
. O +

However O -
, O +
homozygotes O +
that O +
were O +
semi O -
- O -
congenic O +
( O -
N4 O -
) O +
on O +
the O +
C57BL O -
/ O -
6J O +
strain O +
were O +
often O +
markedly O +
smaller O +
and/or O +
had O +
kinked O +
or O +
shorter O +
tails O +
( O -
Figure O +
2A O +
and O +
2B O -
) O -
. O +

Figure O +
2 O +
Developmental O +
Phenotypes O +
of O +
Trip13 O +
Mutant O +
Mice O +
( O -
A O -
) O +
Shown O +
are O +
21-d O -
- O -
old O +
littermates O -
. O +

Note O +
the O +
shortened O +
tail O +
in O +
the O +
mutant O -
, O +
but O +
overall O +
similar O +
body O +
size O -
. O +

( O -
B O -
) O +
Shown O +
are O +
23-d O -
- O -
old O +
littermates O -
. O +

The O +
mutant O +
is O +
smaller O +
in O +
this O +
case O -
, O +
but O +
the O +
tail O +
is O +
not O +
as O +
truncated O +
as O +
the O +
mouse O +
in O +
( O -
A O -
) O -
. O +

( O -
C O -
) O +
Wild O -
- O -
type O +
( O -
WT O -
) O +
and O +
homozygous O +
Trip13 O +
mutant O +
( O -
MUT O -
) O +
testes O -
. O +

( O -
D O -
) O +
and O +
( O -
E O -
) O +
are O +
cross O +
sections O +
through O +
17.5-d O -
- O -
old O +
heterozygous O +
( O -
" O -
WT O -
" O -
) O +
and O +
homozygous O +
mutant O +
Trip13 O +
testes O -
, O +
respectively O -
. O +

Whereas O +
the O +
tubules O +
in O +
WT O +
show O +
coordinated O +
spermatogenesis O +
with O +
pachytene O +
spermatocytes O +
present O +
in O +
all O +
tubules O +
( O -
proximal O +
to O +
the O +
lumen O -
) O -
, O +
developmental O +
progression O +
in O +
the O +
mutant O +
is O +
not O +
synchronized O +
between O +
tubules O -
. O +

Some O +
tubules O +
have O +
no O +
pachytene O +
spermatocyes O +
( O -
asterisks O -
) O -
, O +
while O +
in O +
others O -
, O +
development O +
is O +
somewhat O +
disorganized O +
( O -
# O -
) O -
. O +

RT O -
- O -
PCR O +
analysis O +
of O +
Trip13Gt O +
expression O +
( O -
Figure O +
1D O -
) O +
revealed O +
a O +
low O +
level O +
of O +
normally O +
spliced O +
transcripts O +
in O +
testes O +
of O +
homozygotes O +
that O +
is O +
presumably O +
a O +
consequence O +
of O +
incomplete O +
usage O +
of O +
the O +
gene O +
trap O -
's O +
splice O +
acceptor O -
. O +

Western O +
blot O +
analysis O -
, O +
using O +
a O +
polyclonal O +
antibody O +
raised O +
against O +
a O +
peptide O +
encoded O +
by O +
exon O +
3 O -
, O +
revealed O +
multiple O +
species O +
in O +
wild O -
- O -
type O +
and O +
heterozygous O +
testes O -
, O +
one O +
of O +
which O +
corresponds O +
to O +
the O +
expected O +
size O +
of O +
48 O +
kDa O +
( O -
Figure O +
1E O -
) O -
. O +

This O +
and O +
three O +
other O +
species O +
were O +
undetectable O +
in O +
homozygous O +
mutant O +
testes O -
, O +
but O +
a O +
reduced O +
amount O +
of O +
an O +
intense O +
∼38 O +
kDa O +
smaller O +
band O +
was O +
present O -
. O +

It O +
is O +
not O +
clear O +
if O +
this O +
corresponds O +
to O +
TRIP13 O -
. O +

The O +
greatly O +
decreased O +
Trip13 O +
mRNA O +
and O +
predicted O +
correct O -
- O -
length O +
protein O +
in O +
mutants O +
indicate O +
that O +
the O +
Trip13RRB047 O +
allele O +
is O +
severely O +
hypomorphic O -
. O +

To O +
determine O +
the O +
germ O +
cell O +
types O +
in O +
which O +
TRIP13 O +
is O +
expressed O -
, O +
and O +
to O +
assess O +
possible O +
expression O +
in O +
the O +
mutant O +
by O +
means O +
other O +
than O +
Western O +
analysis O -
, O +
testis O +
sections O +
were O +
immunolabeled O +
for O +
TRIP13 O +
using O +
a O +
polyclonal O +
chicken O +
antipeptide O +
antibody O +
( O -
see O +
Materials O +
and O +
Methods O -
) O -
. O +

The O +
most O +
intensely O +
labeled O +
cells O +
in O +
control O +
testes O +
were O +
Type O +
B O +
spermatogonia O +
and O +
leptotene O +
spermatocytes O +
( O -
Figure O +
1F O -
) O -
. O +

Zygotene O -
/ O -
pachytene O +
spermatocytes O +
stained O +
less O +
strongly O -
, O +
and O +
there O +
was O +
no O +
detectable O +
staining O +
in O +
late O +
pachytene O +
spermatocytes O -
. O +

TRIP13 O +
appeared O +
to O +
be O +
nuclear O +
localized O -
. O +

There O +
was O +
no O +
such O +
staining O +
of O +
nuclei O +
in O +
mutant O +
seminiferous O +
tubules O +
( O -
Figure O +
1F O -
) O -
. O +

To O +
further O +
assess O +
the O +
nuclear O +
localization O -
, O +
TRIP13 O +
was O +
used O +
to O +
probe O +
meiotic O +
chromosomes O +
prepared O +
by O +
surface O +
spreading O +
of O +
spermatocyte O +
nuclei O -
. O +

In O +
wild O +
type O -
, O +
there O +
was O +
diffuse O +
nuclear O +
staining O -
, O +
and O +
no O +
evidence O +
of O +
concentration O +
on O +
SC O +
cores O +
( O -
marked O +
by O +
the O +
axial O +
element O +
protein O +
SYCP3 O -
) O +
at O +
any O +
meiotic O +
substage O +
( O -
Figure O +
1 O -
G O -
) O -
. O +

TRIP13 O +
signal O +
was O +
noticeably O +
absent O +
in O +
mutant O +
meiotic O +
nuclei O -
. O +

Infertility O +
Due O +
to O +
Meiotic O +
Disruption O +
in O +
TRIP13-Deficient O +
Meiocytes O +
Homozygotes O +
of O +
both O +
sexes O +
had O +
small O +
gonads O +
( O -
Figure O +
2C O -
; O +
see O +
below O -
) O +
and O +
were O +
invariably O +
sterile O -
. O +

Ovaries O +
of O +
adult O +
Trip13Gt O -
/ O -
Gt O +
females O +
were O +
severely O +
dysmorphic O +
and O +
had O +
few O +
or O +
no O +
follicles O +
( O -
Figure O +
3A O +
and O +
3B O -
) O -
. O +

The O +
majority O +
of O +
oocyte O +
loss O +
occurred O +
in O +
late O +
embryogenesis O +
or O +
early O +
in O +
postnatal O +
development O -
, O +
since O +
2 O +
d O +
postpartum O +
ovaries O +
were O +
markedly O +
smaller O +
than O +
those O +
of O +
control O +
littermates O -
, O +
and O +
were O +
lacking O +
oocytes O +
or O +
newly O +
forming O +
follicles O +
( O -
Figure O +
3C O +
and O +
3D O -
) O -
. O +

Thus O -
, O +
oocytes O +
failed O +
to O +
progress O +
to O +
the O +
dictyate O +
( O -
resting O -
) O +
phase O -
. O +

Since O +
we O +
observed O +
oocytes O +
with O +
pachytene O +
stage O +
chromosomes O +
in O +
17.5 O +
d O +
Trip13Gt O -
/ O -
Gt O +
embryonic O +
ovaries O +
( O -
unpublished O +
data O -
) O -
, O +
this O +
indicates O +
that O +
oocytes O +
were O +
eliminated O +
somewhere O +
between O +
pachynema O +
and O +
dictyate O -
. O +

Figure O +
3 O +
Histology O +
of O +
Mutant O +
Gonads O +
All O +
are O +
hematoxylin B-Chemical -
/ O -
eosin O -
- O -
stained O +
paraffin O +
sections O -
. O +

Testes O +
are O +
from O +
6-wk O -
- O -
old O +
males O -
, O +
except O +
as O +
indicated O +
below O -
. O +

( O -
A O -
) O +
Wild O -
- O -
type O +
25-d O -
- O -
old O +
ovary O -
. O +

( O -
B O -
) O +
Trip13Gt O -
/ O -
Gt O +
25-d O -
- O -
old O +
ovary O -
, O +
showing O +
dysgenesis O +
from O +
an O +
absence O +
of O +
oocytes O -
. O +

( O -
C O -
) O +
Trip13Gt O -
/ O -
+ O +
2-d O -
- O -
old O +
control O +
ovary O -
. O +

Arrows O +
point O +
to O +
oocytes O +
in O +
newly O +
forming O +
follicles O -
. O +

( O -
D O -
) O +
Trip13Gt O -
/ O -
Gt O +
2-d O -
- O -
old O +
ovary O -
, O +
dysgenic O +
due O +
to O +
lack O +
of O +
oocytes O -
. O +

Magnification O +
is O +
the O +
same O +
as O +
its O +
littermate O +
in O +
" O -
C. O -
" O +
( O -
E O -
) O +
Wild O -
- O -
type O +
testis O -
. O +

( O -
F O -
) O +
Trip13Gt O -
/ O -
Gt O +
testis O +
with O +
uniform O +
pachytene O +
arrest O -
. O +

( O -
G O -
) O +
Trip13Gt O -
/ O -
Gt O +
3-mo O -
- O -
old O +
testis O +
with O +
some O +
postmeiotic O +
spermatids O +
( O -
arrows O -
) O -
. O +

( O -
H O -
) O +
Spo11− O -
/ O -
- O +
testis O -
. O +

A O +
tubule O +
with O +
spermatocytes O +
at O +
leptotene O -
/ O -
zygotene O +
transition O +
is O +
labeled O +
ZP O -
, O +
and O +
tubules O +
with O +
apoptotic O +
spermatocytes O +
are O +
marked O +
with O +
an O +
asterisk O -
. O +

The O +
specimen O +
was O +
taken O +
from O +
a O +
littermate O +
of O +
that O +
in O +
( O -
I O -
) O -
. O +

( O -
I O -
) O +
Spo11− O -
/ O -
− O +
Trip13Gt O -
/ O -
Gt O +
testis O -
. O +

Labeling O +
is O +
the O +
same O +
as O +
in O +
( O -
H O -
) O -
. O +

The O +
inset O +
contains O +
a O +
tubule O +
with O +
leptotene O -
- O -
zygotene O +
spermatocytes O -
. O +

( O -
J O -
) O +
Mei1− O -
/ O -
− O +
Trip13Gt O -
/ O -
+ O +
testis O -
. O +

The O +
specimen O +
was O +
taken O +
from O +
a O +
littermate O +
of O +
that O +
in O +
( O -
K O -
) O -
. O +

( O -
K O -
) O +
Mei1− O -
/ O -
− O +
Trip13Gt O -
/ O -
Gt O +
testis O -
. O +

( O -
L O -
) O +
Rec8Mei8 O -
/ O -
Rec8Mei8 O +
Trip13Gt O -
/ O -
+ O +
testis O -
. O +

The O +
Rec8Mei8 O +
allele O +
was O +
described O +
[ O -
39 O -
] O -
. O +

The O +
specimen O +
was O +
taken O +
from O +
a O +
littermate O +
of O +
that O +
in O +
( O -
M O -
) O -
. O +

( O -
M O -
) O +
Rec8Mei8 O -
/ O -
Rec8Mei8 O +
Trip13Gt O -
/ O -
Gt O +
testis O -
. O +

( O -
N O -
) O +
Dmc1− O -
/ O -
− O +
Trip13Gt O -
/ O -
Gt O +
testis O -
. O +

( O -
O O -
) O +
Spo11− O -
/ O -
− O +
Trip13Gt O -
/ O -
+ O +
25-d O -
- O -
old O +
ovary O -
. O +

The O +
specimen O +
was O +
taken O +
from O +
a O +
littermate O +
of O +
that O +
in O +
( O -
P O -
) O -
. O +

( O -
P O -
) O +
Spo11− O -
/ O -
− O +
Trip13Gt O -
/ O -
Gt O +
25-d O -
- O -
old O +
ovary O -
. O +

( O -
Q O -
) O +
Mei1− O -
/ O -
− O +
Trip13Gt O -
/ O -
+ O +
25-d O -
- O -
old O +
ovary O -
. O +

The O +
specimen O +
was O +
taken O +
from O +
a O +
littermate O +
of O +
that O +
in O +
( O -
R O -
) O -
. O +

( O -
R O -
) O +
Mei1− O -
/ O -
− O +
Trip13Gt O -
/ O -
Gt O +
25-d O -
- O -
old O +
ovary O -
. O +

( O -
S O -
) O +
Rec8Mei8 O -
/ O -
Rec8Mei8 O +
Trip13Gt O -
/ O -
+ O +
25-d O -
- O -
old O +
ovary O -
. O +

The O +
specimen O +
was O +
taken O +
from O +
a O +
littermate O +
of O +
that O +
in O +
( O -
T O -
) O -
. O +

( O -
T O -
) O +
Rec8Mei8 O -
/ O -
Rec8Mei8 O +
Trip13Gt O -
/ O -
Gt O +
25-d O -
- O -
old O +
ovary O -
. O +

Histological O +
sections O +
of O +
mutant O +
testes O +
revealed O +
a O +
lack O +
of O +
postmeiotic O +
cell O +
types O +
that O +
are O +
characteristic O +
of O +
wild O -
- O -
type O +
seminiferous O +
tubules O +
( O -
Figure O +
3E O -
) O -
. O +

The O +
most O +
developmentally O +
advanced O +
seminiferous O +
tubules O +
contained O +
adluminal O +
spermatocytes O +
with O +
condensed O +
chromatin O +
characteristic O +
of O +
pachynema O +
( O -
Figure O +
3F O -
) O -
. O +

The O +
absence O +
of O +
coordinated O +
spermatogenic O +
progression O +
beyond O +
this O +
stage O +
is O +
indicative O +
of O +
a O +
pachytene O +
arrest O -
. O +

This O +
was O +
revealed O +
more O +
clearly O +
by O +
chromosome O +
analysis O +
( O -
see O +
below O -
) O -
. O +

Some O +
sections O +
of O +
adult O +
seminiferous O +
tubules O +
contained O +
postmeiotic O +
spermatids O +
( O -
Figure O +
3 O -
G O -
) O -
, O +
although O +
we O +
saw O +
no O +
motile O +
epididymal O +
sperm O -
. O +

These O +
drastic O +
meiotic O +
defects O +
stand O +
in O +
contrast O +
to O +
yeast O +
and O +
C. O +
elegans O -
, O +
in O +
which O +
deletion O +
of O +
Pch2 O +
alone O +
has O +
minor O +
effects O +
on O +
spore O -
/ O -
gamete O +
development O +
[ O -
2,8 O -
] O -
. O +

TRIP13-Deficient O +
Meiocytes O +
Undergo O +
Homologous O +
Chromosome O +
Synapsis O +

Despite O +
the O +
Presence O +
of O +
Unrepaired O +
DSBs O +
in O +
Pachynema O +
To O +
better O +
characterize O +
the O +
degree O +
of O +
meiotic O +
progression O +
in O +
Trip13Gt O -
/ O -
Gt O +
spermatocytes O -
, O +
we O +
immunostained O +
chromosome O +
spreads O +
for O +
SYCP3 O +
and O +
SYCP1 O -
, O +
components O +
of O +
the O +
axial O -
/ O -
lateral O +
elements O +
and O +
transverse O +
filaments O -
, O +
respectively O -
, O +
of O +
the O +
synaptonemal O +
complex O +
( O -
SC O -
) O -
. O +

Pachytene O +
spermatocyte O +
nuclei O +
from O +
postpubertal O +
mutant O +
testes O +
could O +
assemble O +
normal O +
SC O +
cores O +
and O +
exhibited O +
full O +
synapsis O +
of O +
chromosomes O +
as O +
judged O +
by O +
colabeling O +
of O +
SYCP1 O +
and O +
SYCP3 O +
along O +
the O +
full O +
lengths O +
of O +
all O +
autosomes O +
( O -
Figure O +
4A O -
) O -
. O +

Additionally O -
, O +
the O +
X O +
and O +
Y O +
chromosomes O +
were O +
normally O +
synapsed O +
at O +
their O +
pseudoautosomal O +
region O -
. O +

More O +
prepubertal O +
( O -
17.5 O +
d O +
postpartum O -
) O +
mutant O +
spermatocytes O +
contained O +
asynaptic O +
or O +
terminally O +
asynapsed O +
chromosomes O +
than O +
age O -
- O -
matched O +
controls O +
( O -
62.5 O -
% O +
versus O +
25 O -
% O -
, O +
respectively O -
; O +
Figure O +
4B O -
) O -
. O +

We O +
attribute O +
this O +
to O +
a O +
delay O +
in O +
the O +
first O +
wave O +
of O +
postnatal O +
spermatogenesis O +
( O -
Figure O +
2D O +
and O +
2E O -
) O -
, O +
likely O +
related O +
to O +
systemic O +
developmental O +
retardation O +
( O -
Figure O +
2A O +
and O +
2B O -
) O -
. O +

Nevertheless O -
, O +
since O +
Trip13Gt O -
/ O -
Gt O +
spermatocytes O +
progress O +
to O +
pachynema O +
with O +
no O +
gross O +
SC O +
abnormalities O -
, O +
and O +
oocytes O +
were O +
eliminated O +
soon O +
after O +
birth O +
( O -
a O +
characteristic O +
of O +
DNA O +
repair O +
mutants O +
[ O -
13 O -
] O -
) O -
, O +
this O +
suggested O +
that O +
unrepaired O +
DSBs O +
are O +
responsible O +
for O +
eventual O +
meiotic O +
arrest O +
and O +
elimination O -
. O +

Figure O +
4 O +
Immunohistochemical O +
Analysis O +
of O +
Pachytene O +
Spermatocyte O +
Chromosomes O +
Surface O -
- O -
spread O +
chromosomes O +
were O +
immunolabeled O +
with O +
the O +
indicated O +
antibodies O +
and O +
fluorophores B-Chemical -
. O +

As O +
indicated O +
in O +
the O +
upper O +
right O +
of O +
each O +
panel O -
, O +
cells O +
were O +
from O +
wild O +
type O +
( O -
WT O -
, O +
either O +
+ O -
/+ O +
or O +
Trip13Gt O -
/ O -
+ O -
) O +
or O +
Trip13Gt O -
/ O -
Gt O +
( O -
Mut O -
) O -
. O +

There O +
were O +
no O +
differences O +
seen O +
between O +
heterozygotes O +
and O +
+ O -
/+ O +
spermatocytes O -
. O +

( O -
A O -
) O +
A O +
mutant O +
pachytene O +
nucleus O +
with O +
full O +
synapsis O -
. O +

Areas O +
of O +
SYCP1 O -
/ O -
SYCP3 O +
colabeling O +
are O +
yellow O -
. O +

( O -
B O -
– O -
E O -
) O +
Spermatocytes O +
nucleus O +
from O +
17.5 O +
d O +
postpartum O +
mutant O -
. O +

Asynapsed O +
chromosomes O +
or O +
regions O +
of O +
chromosomes O +
are O +
indicated O +
by O +
white O +
and O +
yellow O +
arrows O -
, O +
respectively O -
. O +

Unlike O +
the O +
normal O +
distribution O +
in O +
wild O -
- O -
type O +
pachytene O +
spermatocytes O +
( O -
C O -
) O -
, O +
BLM O +
foci O +
are O +
present O +
on O +
synapsed O +
pachytene O +
chromosomes O +
in O +
the O +
mutant O +
( O -
D O -
) O -
. O +

RAD51 O +
foci O -
, O +
which O +
are O +
abundant O +
earlier O +
in O +
prophase O -
, O +
disappear O +
from O +
autosomes O +
in O +
wild O -
- O -
type O +
pachytene O +
nuclei O +
( O -
E O -
) O +
and O +
the O +
bulk O +
of O +
staining O +
is O +
over O +
the O +
XY O +
body O +
( O -
arrow O -
) O -
. O +

( O -
F O -
) O +
RAD51 O +
persists O +
on O +
the O +
synapsed O +
mutant O +
chromosomes O +
( O -
arrows O -
) O -
. O +

( O -
G O -
) O +
H2AX O +
phosphorylation O +
is O +
restricted O +
to O +
the O +
XY O +
body O +
in O +
WT O -
. O +

( O -
H O -
) O +
In O +
addition O +
to O +
a O +
large O +
area O +
of O +
γH2AX O +
staining O +
( O -
arrow O -
) O +
over O +
the O +
XY O +
body O -
, O +
there O +
is O +
extensive O +
autosomal O +
H2AX O +
phosphorylation O +
( O -
arrows O -
) O -
. O +

( O -
I O -
, O +
J O -
) O +
Note O +
that O +
in O +
wild O -
- O -
type O +
pachytene O +
spermatocytes O -
, O +
TOPBP1 O +
is O +
present O +
only O +
over O +
the O +
XY O +
body O +
( O -
yellow O +
arrow O -
) O -
. O +

In O +
the O +
mutant O +
( O -
J O -
) O -
, O +
an O +
arrow O +
denotes O +
one O +
area O +
of O +
intensive O +
staining O +
that O +
may O +
be O +
over O +
the O +
sex O +
chromosomes O -
, O +
but O +
many O +
other O +
chromosome O +
cores O +
are O +
positively O +
stained O -
. O +

( O -
K O -
, O +
L O -
) O +
RPA O +
persists O +
along O +
synapsed O +
cores O +
in O +
the O +
mutant O -
, O +
not O +
WT O -
. O +

( O -
M O -
, O +
N O -
) O +
Arrows O +
indicate O +
examples O +
of O +
MLH3 O +
foci O +
on O +
SCs O -
. O +

( O -
O O -
) O +
In O +
WT O +
late O +
pachytene O +
spermatocytes O -
, O +
RAD51 O +
is O +
present O +
only O +
at O +
background O +
levels O -
. O +

( O -
P O -
) O +
As O +
in O +
( O -
F O -
) O -
, O +
extensive O +
RAD51 O +
staining O +
delineates O +
SCs O +
in O +
mutant O +
pachytene O +
nuclei O +
( O -
indicated O +
by O +
white O +
arcs O -
) O -
. O +

MLH1 O +
foci O +
colocalize O +
with O +
these O +
tracts O +
( O -
arrows O -
) O +
at O +
the O +
typical O +
1–2 O +
foci O +
per O +
chromosome O +
as O +
in O +
( O -
M O -
) O -
. O +

To O +
elucidate O +
the O +
cause O +
of O +
meiotic O +
arrest O -
, O +
we O +
analyzed O +
meiotic O +
chromosomes O +
with O +
a O +
variety O +
of O +
markers O +
that O +
are O +
diagnostic O +
of O +
recombination O +
and O +
synapsis O -
. O +

Recombination O +
in O +
Trip13Gt O -
/ O -
Gt O +
spermatocytes O +
appeared O +
to O +
initiate O +
normally O +
as O +
judged O +
by O +
the O +
presence O +
of O +
γH2AX O +
in O +
leptonema O +
( O -
Figure O +
S2A O +
and O +
S2B O -
) O -
, O +
which O +
reflects O +
the O +
presence O +
of O +
meiotically O +
induced O +
DSBs O +
[ O -
18 O -
] O -
. O +

RAD51 O +
and/or O +
DMC1 O -
, O +
components O +
of O +
early O +
recombination O +
nodules O +
( O -
ERNs O -
) O -
, O +
was O +
also O +
present O +
as O +
abundant O +
foci O +
in O +
Trip13Gt O -
/ O -
Gt O +
zygotene O +
spermatocytes O +
( O -
unpublished O +
data O -
; O +
the O +
anti O -
- O -
RAD51 O +
antibody O +
cross O -
- O -
reacts O +
with O +
DMC1 O -
) O -
, O +
indicating O +
that O +
recombinational O +
repair O +
of O +
DSBs O +
is O +
initiated O -
. O +

The O +
cohesin O +
complex O -
, O +
which O +
is O +
essential O +
for O +
completion O +
and/or O +
maintenance O +
of O +
synaptic O +
associations O -
, O +
appeared O +
to O +
assemble O +
normally O +
as O +
judged O +
by O +
immunolabeling O +
for O +
the O +
meiosis O -
- O -
specific O +
cohesins O +
STAG3 O +
( O -
Figure O +
S2C O +
and O +
S2D O -
) O +
and O +
REC8 O +
( O -
unpublished O +
data O -
) O -
. O +

Because O +
yeast O +
PCH2 O +
localizes O +
to O +
telomeres O +
in O +
a O +
Sir3p O -
- O -
dependent O +
manner O -
, O +
we O +
tested O +
for O +
possible O +
telomere O +
defects O +
by O +
immunolabeling O +
for O +
TRF2 O -
, O +
a O +
component O +
of O +
a O +
protein O +
complex O +
that O +
plays O +
an O +
essential O +
role O +
in O +
telomere O +
protection O +
[ O -
19 O -
] O -
. O +

It O +
was O +
localized O +
to O +
telomeres O +
of O +
both O +
fully O +
synapsed O +
and O +
telomerically O +
asynaptic O +
mutant O +
chromosomes O +
( O -
Figure O +
S2E O +
and O +
S2F O -
) O -
. O +

Defects O +
in O +
DSB O +
repair O +
became O +
apparent O +
in O +
pachynema O +
upon O +
probing O +
of O +
mutant O +
spermatocyte O +
nuclei O +
with O +
antibodies O +
against O +
molecules B-Chemical +
involved O +
in O +
various O +
stages O +
of O +
recombination O -
. O +

In O +
> O -
99 O -
% O +
of O +
Trip13Gt O -
/ O -
Gt O +
chromosome O +
spreads O -
, O +
BLM O +
helicase O +
( O -
Figure O +
4C O +
and O +
4D O -
) O -
, O +
RAD51 O -
/ O -
DMC1 O +
( O -
Figure O +
4E O +
and O +
4F O -
) O -
, O +
γH2AX O +
( O -
Figure O +
4 O -
G O +
and O +
4H O -
) O -
, O +
and O +
TOPBP1 O +
( O -
Figure O +
4I O +
and O +
4J O -
) O +
all O +
persisted O +
abnormally O +
on O +
synapsed O +
chromosomes O -
. O +

For O +
RAD51 O -
/ O -
DMC1 O -
, O +
mutant O +
pachytene O +
spermatocytes O +
contained O +
138 O +
± O +
6 O +
foci O +
( O -
compared O +
to O +
11 O +
± O +
3 O +
foci O +
in O +
wild O +
type O -
, O +
most O +
of O +
which O +
were O +
on O +
the O +
XY O +
body O -
) O -
, O +
down O +
from O +
218 O +
± O +
13 O +
in O +
zygonema O +
( O -
compared O +
to O +
220 O +
± O +
13 O +
foci O +
in O +
wild O +
type O -
) O -
. O +

TOPBP1 O +
is O +
a O +
DNA O +
damage O -
– O -
checkpoint O +
protein O +
involved O +
in O +
ATM O +
protein O -
– O -
dependent O +
activation O +
of O +
ATR O +
protein O +
[ O -
20,21 O -
] O -
. O +

It O +
binds O +
sites O +
of O +
DSBs O +
and O +
unsynapsed O +
regions O +
of O +
meiotic O +
chromosomes O +
[ O -
22,23 O -
] O -
. O +

BLM O +
has O +
been O +
reported O +
to O +
colocalize O +
with O +
markers O +
( O -
RPA O +
and O +
MSH4 O -
) O +
of O +
recombination O +
at O +
sites O +
distinct O +
from O +
those O +
that O +
become O +
resolved O +
as O +
crossovers O +
( O -
CO O -
) O +
[ O -
24 O -
] O -
. O +

We O +
therefore O +
assessed O +
the O +
distribution O +
of O +
RPA O -
, O +
the O +
ssDNA O +
binding O +
protein O -
, O +
which O +
is O +
normally O +
present O +
at O +
focal O +
sites O +
of O +
synapsing O +
meiotic O +
chromosomes O +
before O +
disappearing O +
in O +
mid O -
- O -
pachynema O +
[ O -
25 O -
] O -
. O +

It O +
is O +
thought O +
to O +
bind O +
D O -
- O -
loops O +
of O +
recombination O +
intermediates O +
[ O -
26 O -
] O -
. O +

RPA O +
also O +
persisted O +
on O +
pachytene O +
mutant O +
chromosomes O +
( O -
Figure O +
4 O -
K O +
and O +
4L O -
) O -
. O +

These O +
data O +
indicate O +
that O +
unrepaired O +
DSBs O -
, O +
or O +
unresolved O +
recombination O +
intermediates O -
, O +
remain O +
in O +
pachynema O +
and O +
activate O +
a O +
DNA O +
damage O +
checkpoint O +
system O -
. O +

It O +
should O +
be O +
noted O +
that O +
chromosomes O +
affected O +
by O +
meiotic O +
sex O +
chromosome O +
inactivation O +
( O -
MSCI O -
) O +
and O +
meiotic O +
silencing O +
of O +
unpaired O +
chromatin O +
( O -
MSUC O -
) O +
are O +
heavily O +
stained O +
by O +
antibodies O +
for O +
several O +
DSB O +
repair O -
- O -
associated O +
molecules B-Chemical -
, O +
including O +
γH2AX O -
. O +

H2AX O +
phosphorylation O +
due O +
to O +
MSCI O +
and O +
MSUC O +
is O +
conducted O +
by O +
ATR O -
, O +
not O +
ATM O +
[ O -
27–29 O -
] O -
. O +

Since O +
mutant O +
chromosomes O +
are O +
fully O +
synapsed O -
, O +
and O +
MSUC O +
is O +
known O +
to O +
occur O +
only O +
as O +
a O +
result O +
of O +
asynapsis O -
, O +
the O +
decoration O +
of O +
Trip13Gt O -
/ O -
Gt O +
chromosomes O +
with O +
DNA O +
repair O +
markers O +
is O +
probably O +
attributable O +
to O +
incomplete O +
DNA O +
repair O +
rather O +
than O +
transcriptional O +
silencing O -
. O +

Consistent O +
with O +
the O +
presence O +
of O +
rare O +
( O -
< O -
1 O -
% O -
) O +
Trip13Gt O -
/ O -
Gt O +
pachytene O +
spermatocytes O +
devoid O +
of O +
persistent O +
DNA O +
repair O +
markers O -
, O +
and O +
testis O +
histology O +
showing O +
some O +
degree O +
of O +
postmeiotic O +
progression O +
( O -
Figure O +
3 O -
G O -
) O -
, O +
we O +
observed O +
both O +
diplotene O +
nuclei O +
that O +
lacked O +
autosomal O +
RAD51 O -
/ O -
DMC1 O +
and O +
γH2AX O +
( O -
Figure O +
S3A O -
– O -
S3D O -
) O -
, O +
and O +
also O +
metaphase O +
I O +
spreads O +
with O +
20 O +
bivalents O +
( O -
Figure O +
S3E O -
– O -
S3F O -
) O -
. O +

Since O +
Trip13Gt O +
may O +
not O +
be O +
a O +
complete O +
null O -
, O +
these O +
diplotene O +
and O +
metaphase O +
I O +
spermatocytes O +
might O +
arise O +
by O +
virtue O +
of O +
having O +
sufficient O +
wild O -
- O -
type O +
TRIP13 O -
. O +

CO O -
- O -
Associated O +
Markers O +
Appear O +
Normally O +
in O +
the O +
Absence O +
of O +
TRIP13 O +
The O +
persistence O +
of O +
BLM O +
on O +
Trip13Gt O -
/ O -
Gt O +
spermatocyte O +
chromosomes O +
suggests O +
that O +
at O +
least O +
a O +
subset O +
of O +
the O +
unrepaired O +
DSBs O +
correspond O +
to O +
sites O +
of O +
defective O +
NCO O +
recombinational O +
repair O -
. O +

To O +
assess O +
whether O +
CO O +
recombination O +
occurs O +
in O +
the O +
mutant O -
, O +
we O +
examined O +
the O +
distribution O +
of O +
the O +
mismatch O +
repair O +
proteins O +
MLH1 O +
and O +
MLH3 O -
, O +
which O +
are O +
normally O +
detectable O +
as O +
foci O +
in O +
mid O -
- O -
late O +
pachynema O +
and O +
mark O +
the O +
locations O +
of O +
chiasmata O +
[ O -
30,31 O -
] O -
. O +

Remarkably O -
, O +
MLH1 O -
/ O -
3 O +
foci O +
were O +
formed O -
; O +
we O +
observed O +
1–2 O +
foci O -
/ O -
chromosome O +
as O +
in O +
wild O +
type O +
and O +
at O +
typical O +
overall O +
levels O +
( O -
MLH3 O +
= O +
23 O +
± O +
2 O -
, O +
N O +
= O +
10 O -
; O +
[ O -
30,32 O -
] O -
) O +
on O +
mid O -
- O -
late O +
pachytene O +
chromosomes O +
( O -
Figure O +
4 O -
M O +
and O +
4N O -
; O +
MLH1 O +
not O +
shown O -
) O -
. O +

Since O +
< O -
1 O -
% O +
of O +
Trip13Gt O -
/ O -
Gt O +
pachytene O +
nuclei O +
had O +
normal O +
repair O +
( O -
as O +
judged O +
by O +
absence O +
of O +
persistent O +
DSB O +
repair O +
markers O -
; O +
see O +
above O -
) O -
, O +
but O +
most O +
of O +
the O +
pachytene O +
nuclei O +
had O +
MLH1 O -
/ O -
3 O +
foci O -
, O +
it O +
was O +
unlikely O +
that O +
the O +
MLH1 O -
/ O -
3 O +
foci O +
formed O +
only O +
on O +
chromosomes O +
with O +
fully O +
repaired O +
DSBs O -
. O +

To O +
test O +
this O +
directly O -
, O +
we O +
conducted O +
double O +
staining O +
for O +
MLH1 O +
and O +
RAD51 O -
/ O -
DMC1 O -
. O +

MLH1 O +
foci O +
were O +
present O +
on O +
chromosomes O +
that O +
also O +
contained O +
numerous O +
RAD51 O -
/ O -
DMC1 O +
foci O +
( O -
Figure O +
4O O +
and O +
4P O -
) O -
. O +

To O +
assess O +
whether O +
these O +
MLH1 O -
/ O -
3 O +
foci O +
in O +
Trip13Gt O -
/ O -
Gt O +
pachytene O +
spermatocytes O +
represent O +
CO O +
events O +
completed O +
to O +
a O +
point O +
where O +
they O +
could O +
maintain O +
interhomolog O +
attachments O +
though O +
the O +
end O +
of O +
prophase O +
I O -
, O +
we O +
treated O +
testicular O +
cells O +
from O +
17.5–20.5-d O -
- O -
old O +
control O +
( O -
+ O -
/+ O -
) O -
, O +
Trip13Gt O -
/ O -
Gt O -
, O +
and O +
Dmc1− O -
/ O -
− O +
mice O +
with O +
the O +
protein O +
phosphatase O +
inhibitor B-Chemical +
okadaic B-Chemical +
acid I-Chemical +
( O -
OA B-Chemical -
) O -
, O +
a O +
chemical O +
that O +
induces O +
degradation O +
of O +
the O +
SC O -
, O +
chromosome O +
condensation O -
, O +
and O +
premature O +
progression O +
to O +
metaphase O +
I O +
[ O -
33 O -
] O -
. O +

Fifteen O +
metaphase O +
spreads O +
were O +
identified O +
for O +
each O +
genotype O -
. O +

Whereas O +
all O +
of O +
the O +
Dmc1− O -
/ O -
− O +
spreads O +
had O +
∼35 O +
or O +
more O +
condensed O +
chromosomes O -
, O +
all O +
of O +
the O +
+ O -
/+ O +
and O +
Trip13Gt O -
/ O -
Gt O +
spreads O +
had O +
20–25 O -
, O +
suggesting O +
that O +
the O +
MLH1 O -
/ O -
3 O +
foci O +
in O +
Trip13Gt O -
/ O -
Gt O +
pachytene O +
spermatocytes O +
represent O +
sites O +
of O +
completed O -
, O +
or O +
near O -
- O -
completed O -
, O +
COs O -
. O +

Because O +
the O +
preparations O +
were O +
made O +
from O +
whole O +
testes O -
, O +
it O +
is O +
possible O +
that O +
the O +
univalent O -
- O -
containing O +
metaphases O +
from O +
Dmc1− O -
/ O -
− O +
mice O +
were O +
from O +
spermatogonia O -
, O +
not O +
spermatocytes O -
. O +

TRIP13 O +
Deficiency O +
Does O +
Not O +
Alleviate O +
Meiotic O +
Arrest O +
Phenotypes O +
of O +
Mutants O +
Defective O +
in O +
Synapsis O +
To O +
determine O +
if O +
TRIP13 O +
deficiency O +
prevents O +
apoptosis O +
triggered O +
by O +
asynapsis O +
as O +
in O +
C. O +
elegans O -
, O +
we O +
analyzed O +
mice O +
that O +
were O +
doubly O +
mutant O +
for O +
Spo11 O +
and O +
Trip13 O -
. O +

SPO11 O +
is O +
a O +
transesterase O +
that O +
is O +
essential O +
for O +
the O +
creation O +
of O +
genetically O +
programmed O +
DSB O +
during O +
leptonema O +
of O +
many O +
organisms O -
, O +
including O +
mice O +
[ O -
18 O -
] O -
. O +

In O +
C. O +
elegans O -
, O +
spo-11 O +
mutant O +
gametes O +
have O +
extensive O +
asynapsis O -
, O +
which O +
triggers O +
PCH-2 O +
dependent O +
apoptosis O +
in O +
pachynema O +
[ O -
2 O -
] O -
. O +

In O +
mice O -
, O +
Spo11− O -
/ O -
− O +
spermatocytes O +
are O +
severely O +
defective O +
in O +
homologous O +
chromosome O +
synapsis O +
[ O -
34,35 O -
] O -
, O +
and O +
arrest O +
with O +
chromosomes O +
in O +
a O +
state O +
characteristic O +
of O +
the O +
zygotene O -
/ O -
pachytene O +
transition O +
( O -
Figure O +
3H O -
) O -
. O +

Spermatocytes O +
in O +
Trip13Gt O -
/ O -
Gt O +
Spo11− O -
/ O -
− O +
testes O +
progressed O +
maximally O +
to O +
that O +
point O +
before O +
undergoing O +
death O +
( O -
Figs O +
3I O -
) O -
, O +
well O +
before O +
the O +
spindle O +
checkpoint O +
that O +
eliminates O +
achiasmate O +
spermatocytes O +
[ O -
36 O -
] O -
. O +

There O +
was O +
no O +
evidence O +
of O +
metaphase O +
I O +
spermatocytes O +
or O +
postmeiotic O +
spermatids O +
in O +
these O +
testes O -
, O +
unlike O +
those O +
seen O +
in O +
Trip13 O +
single O +
mutants O +
( O -
Figure O +
3 O -
G O -
) O -
. O +

In O +
contrast O +
to O +
the O +
complete O +
synapsis O +
in O +
Trip13Gt O -
/ O -
Gt O +
pachytene O +
spermatocytes O +
( O -
Figure O +
5A O -
) O -
, O +
in O +
which O +
SPO11 O +
is O +
available O +
in O +
leptonema O +
to O +
initiate O +
( O -
via O +
DSB O +
induction O -
, O +
Figure O +
S2A O +
and O +
S2B O -
) O +
a O +
recombination O -
- O -
driven O +
homolog O +
search O -
, O +
chromosome O +
synapsis O +
in O +
doubly O +
mutant O +
spermatocytes O +
was O +
highly O +
disrupted O +
as O +
in O +
Spo11 O +
single O +
mutants O +
( O -
Figure O +
5B O +
and O +
5C O -
) O -
. O +

Identical O +
studies O +
were O +
performed O +
with O +
mice O +
deficient O +
for O +
Mei1 O -
, O +
a O +
vertebrate O -
- O -
specific O +
gene O +
also O +
required O +
for O +
DSB O +
formation O +
and O +
chromosome O +
synapsis O +
[ O -
37 O -
] O -
, O +
with O +
similar O +
results O +
( O -
Figure O +
3J O +
and O +
3 O -
K O -
; O +
immunocytology O +
not O +
shown O -
) O -
. O +

Figure O +
5 O +
Immunocytological O +
Analysis O +
of O +
Trip13 O +
Compound O +
Mutants O +
Surface O -
- O -
spread O +
chromosomes O +
were O +
immunolabeled O +
with O +
the O +
indicated O +
antibodies O +
and O +
fluorophores B-Chemical -
. O +

Genotypes O +
are O +
indicated O -
, O +
as O +
are O +
those O +
panels O +
in O +
which O +
dual O +
staining O +
patterns O +
are O +
merged O -
. O +

Note O +
that O +
( O -
H O -
) O +
and O +
( O -
I O -
) O +
are O +
at O +
lower O +
magnification O +
to O +
show O +
multiple O +
nuclei O -
. O +

In O +
yeast O -
, O +
deletion O +
of O +
PCH2 O +
alleviates O +
the O +
pachytene O +
arrest O +
caused O +
by O +
asynaptic O +
mutants O +
zip1 O +
and O +
zip2 O +
[ O -
8 O -
] O -
. O +

Although O +
mouse O +
SYCP1 O +
might O +
be O +
a O +
functional O +
equivalent O +
of O +
Zip1p O -
, O +
because O +
Sycp1 O +
mutant O +
spermatocytes O +
arrest O +
at O +
approximately O +
the O +
same O +
point O +
as O +
Trip13 O +
mutants O -
, O +
there O +
would O +
be O +
no O +
opportunity O +
to O +
observe O +
bypass O +
of O +
Sycp1− O -
/ O -
−. O +
Since O +
Zip2p O +
is O +
present O +
at O +
sites O +
of O +
axial O +
associations O -
, O +
even O +
in O +
zip1 O +
mutants O -
, O +
it O +
has O +
been O +
suggested O +
that O +
Zip2p O +
promotes O +
initiation O +
of O +
chromosome O +
synapsis O +
[ O -
38 O -
] O -
. O +

These O +
observations O +
raise O +
the O +
possibility O +
that O +
in O +
yeast O -
, O +
Pch2p O +
responds O +
to O +
synapsis O +
polymerization O +
rather O +
than O +
initiation O -
. O +

To O +
test O +
this O -
, O +
we O +
performed O +
epistasis O +
analysis O +
with O +
a O +
Rec8 O +
allele O +
( O -
Rec8Mei8 O -
, O +
abbreviated O +
as O +
Rec8− O -
) O -
. O +

Meiotic O +
chromosomes O +
of O +
Rec8 O +
mutant O +
spermatocytes O +
undergo O +
apparent O +
homolog O +
pairing O +
and O +
interhomolog O +
synaptic O +
initiation O -
, O +
but O +
are O +
defective O +
in O +
DSB O +
repair O +
and O +
fail O +
to O +
maintain O +
interhomolog O +
synapsis O +
[ O -
39,40 O -
] O -
. O +

Rather O -
, O +
sister O +
chromatids O +
appear O +
to O +
synapse O +
and O +
are O +
bound O +
by O +
SYCP1 O +
along O +
their O +
axes O -
. O +

Rec8 O +
mutants O +
do O +
not O +
progress O +
to O +
diplonema O +
or O +
metaphase O +
I. O +
Double O +
mutant O +
analysis O +
indicated O +
that O +
Rec8 O +
is O +
epistatic O +
to O +
Trip13 O -
. O +

As O +
in O +
the O +
Spo11 O +
and O +
Mei1 O +
experiments O -
, O +
histology O +
of O +
testes O +
deficient O +
for O +
both O +
REC8 O +
and O +
TRIP13 O +
resembled O +
the O +
Rec8 O +
mutant O -
, O +
with O +
no O +
evidence O +
of O +
progression O +
to O +
metaphase O +
I O +
that O +
occurs O +
in O +
Trip13Gt O -
/ O -
Gt O +
mice O +
( O -
Figure O +
3L O +
and O +
3 O -
M O -
) O -
. O +

Immunocytological O +
analysis O +
of O +
spread O +
chromosomes O +
showed O +
a O +
failure O +
of O +
homologous O +
chromosome O +
synapsis O +
in O +
both O +
the O +
Rec8− O -
/ O -
− O +
and O +
Rec8− O -
/ O -
− O +
Trip13Gt O -
/ O -
Gt O +
spermatocytes O -
, O +
as O +
previously O +
reported O +
for O +
Rec8 O +
mutants O +
( O -
Figure O +
5D O +
and O +
5E O -
) O +
[ O -
39,40 O -
] O -
. O +

Although O +
subsequent O +
reports O +
indicate O +
otherwise O +
[ O -
10,12 O -
] O -
, O +
deletion O +
of O +
PCH2 O +
in O +
yeast O +
was O +
originally O +
reported O +
to O +
alleviate O +
meiotic O +
arrest O +
caused O +
by O +
deficiency O +
for O +
the O +
meiosis O -
- O -
specific O +
RecA O +
homolog O +
DMC1 O +
[ O -
8 O -
] O -
. O +

To O +
investigate O +
this O +
relationship O +
in O +
mice O -
, O +
we O +
constructed O +
animals O +
doubly O +
mutant O +
for O +
Trip13 O +
and O +
Dmc1 O -
. O +

As O +
in O +
Dmc1− O -
/ O -
− O +
mice O -
, O +
in O +
which O +
spermatocytes O +
undergo O +
meiotic O +
arrest O +
from O +
defective O +
DSB O +
repair O +
and O +
failed O +
chromosome O +
synapsis O +
[ O -
16 O -
] O -
, O +
spermatogenesis O +
in O +
Dmc1− O -
/ O -
− O +
Trip13Gt O -
/ O -
Gt O +
testes O +
was O +
uniformly O +
arrested O +
at O +
the O +
point O +
where O +
spermatocytes O +
contained O +
chromatin O +
characteristic O +
of O +
zygonema O -
/ O -
pachynema O +
( O -
Figure O +
3N O -
) O -
. O +

Immunocytological O +
analysis O +
indicated O +
that O +
both O +
Dmc1− O -
/ O -
− O +
and O +
Dmc1− O -
/ O -
− O +
Trip13Gt O -
/ O -
Gt O +
chromosomes O +
had O +
extensive O +
asynapsis O +
compared O +
to O +
Trip13Gt O +
single O +
mutants O +
( O -
Figure O +
5F–5H O -
) O -
, O +
and O +
all O +
had O +
persistent O +
RAD51 O -
/ O -
DMC1 O +
foci O +
and O +
phosphorylated O +
H2AX O +
( O -
γH2AX O -
; O +
Figure O +
5I–5L O -
) O -
, O +
confirming O +
that O +
Dmc1 O +
is O +
epistatic O +
to O +
Trip13 O -
. O +

Doubly O +
mutant O +
females O +
had O +
residual O +
ovaries O -
, O +
phenocopying O +
Dmc1− O -
/ O -
− O +
and O +
Trip13Gt O -
/ O -
Gt O +
single O +
mutants O +
( O -
unpublished O +
data O -
) O -
. O +

Meiotic O +
Defects O +
in O +
Trip13Gt O -
/ O -
Gt O +
Oocytes O +
Are O +
DSB O -
- O -
Dependent O +
Epistasis O +
analysis O +
of O +
females O +
was O +
insightful O +
with O +
respect O +
to O +
the O +
cause O +
of O +
arrest O +
in O +
Trip13 O +
mutants O -
. O +

Both O +
Mei1− O -
/ O -
− O -
/ O -
Trip13Gt O -
/ O -
Gt O +
and O +
Spo11− O -
/ O -
− O -
/ O -
Trip13Gt O -
/ O -
Gt O +
females O +
had O +
ovaries O +
with O +
numerous O +
follicles O -
, O +
identical O +
to O +
Mei1 O +
and O +
Spo11 O +
single O +
mutants O +
( O -
Figure O +
3O–3R O -
) O -
. O +

Thus O -
, O +
Spo11 O +
and O +
Mei1 O +
are O +
epistatic O +
to O +
Trip13 O +
in O +
oogenesis O -
, O +
just O +
as O +
they O +
are O +
to O +
Dmc1 O +
[ O -
13,41 O -
] O -
. O +

This O +
demonstrates O +
that O +
oocyte O +
loss O +
in O +
Trip13Gt O -
/ O -
Gt O +
females O +
is O +
dependent O +
on O +
DSB O +
formation O -
. O +

In O +
conjunction O +
with O +
the O +
immunohistochemical O +
data O -
, O +
these O +
data O +
provide O +
strong O +
evidence O +
that O +
meiotic O +
arrest O +
in O +
Trip13 O +
mutant O +
mice O +
is O +
due O +
to O +
defects O +
in O +
DSB O +
repair O -
. O +

As O +
expected O -
, O +
ovaries O +
of O +
Rec8 O +
Trip13 O +
double O +
mutants O +
were O +
devoid O +
of O +
oocytes O +
as O +
were O +
those O +
from O +
either O +
single O +
mutant O +
( O -
Figure O +
3B O -
, O +
3S O -
, O +
and O +
3 O -
T O -
) O -
. O +

Discussion O +
Genetic O +
experiments O +
in O +
S. O +
cerevisiae O +
provided O +
evidence O +
that O +
the O +
pachytene O +
checkpoint O +
monitors O +
and O +
responds O +
to O +
recombinational O +
DSB O +
repair O +
and O +
synapsis O +
independently O -
. O +

Wu O +
and O +
Burgess O +
concluded O +
that O +
the O +
repair O +
checkpoint O +
is O +
RAD17-SAE2 O +
dependent O -
, O +
while O +
the O +
synapsis O +
checkpoint O +
is O +
PCH2-ZIP1 O +
dependent O +
[ O -
12 O -
] O -
. O +

Of O +
these O +
four O +
genes O -
, O +
SAE2 O +
and O +
ZIP1 O +
do O +
not O +
have O +
clear O +
mammalian O +
orthologs O +
( O -
although O +
SYCP1 O +
may O +
be O +
a O +
functional O +
ortholog O +
of O +
ZIP1 O -
) O -
, O +
and O +
mutation O +
of O +
the O +
mouse O +
RAD17 O +
ortholog O -
, O +
Rad1 O -
, O +
presumably O +
causes O +
embryonic O +
lethality O +
[ O -
42 O -
] O -
. O +

Thus O -
, O +
mutational O +
analysis O +
of O +
mouse O +
Pch2 O +
( O -
Trip13 O -
) O -
, O +
which O +
is O +
also O +
critical O +
for O +
the O +
synapsis O +
checkpoint O +
in O +
C. O +
elegans O +
[ O -
2 O -
] O -
, O +
was O +
the O +
best O +
remaining O +
option O +
to O +
evaluate O +
potential O +
functional O +
conservation O +
in O +
mammalian O +
meiotic O +
checkpoint O +
control O -
. O +

Our O +
results O +
demonstrate O +
that O +
in O +
mice O -
, O +
the O +
primary O +
meiotic O +
function O +
of O +
TRIP13 O +
is O +
in O +
recombination O +
itself O -
. O +

We O +
found O +
no O +
evidence O +
that O +
it O +
is O +
involved O +
in O +
pachytene O +
checkpoint O +
control O -
. O +

Our O +
data O +
suggest O +
that O +
while O +
recombination O +
events O +
destined O +
to O +
be O +
resolved O +
as O +
COs O +
can O +
proceed O +
normally O +
in O +
Trip13 O +
mutants O -
, O +
DSBs O +
that O +
enter O +
the O +
NCO O +
repair O +
pathway O +
are O +
incompletely O +
resolved O +
or O +
processed O +
inefficiently O -
. O +

This O +
hypothesis O +
is O +
compatible O +
with O +
current O +
knowledge O +
of O +
meiotic O +
recombination O +
pathways O -
. O +

In O +
S. O +
cerevisiae O -
, O +
CO O +
and O +
NCO O +
pathways O +
are O +
distinct O +
[ O -
43 O -
] O -
; O +
they O +
have O +
different O +
recombination O +
intermediates O -
, O +
and O +
are O +
dependent O +
upon O +
different O +
proteins O +
[ O -
44,45 O -
] O -
. O +

Mice O +
also O +
appear O +
to O +
have O +
independent O +
CO O +
versus O +
NCO O +
recombination O +
pathways O +
[ O -
46 O -
] O -
. O +

As O +
in O +
yeast O -
, O +
both O +
require O +
SPO11-induced O +
breaks O -
, O +
but O +
only O +
the O +
CO O +
pathway O +
requires O +
MLH1 O -
. O +

Both O +
types O +
of O +
recombinant O +
products O +
are O +
formed O +
by O +
mid O -
- O -
late O +
pachynema O -
. O +

Another O +
possibility O +
is O +
that O +
the O +
recombination O +
defects O +
are O +
a O +
result O +
of O +
defective O +
intersister O +
recombination O -
. O +

However O -
, O +
this O +
type O +
of O +
DSB O +
repair O +
is O +
suppressed O +
in O +
meiotic O +
cells O -
. O +

Ablation O +
of O +
RAD54 O -
, O +
which O +
mediates O +
intersister O +
recombination O +
in O +
yeast O -
, O +
does O +
not O +
significantly O +
disrupt O +
meiosis O +
in O +
either O +
yeast O +
or O +
mice O +
[ O -
47,48 O -
] O -
. O +

Interestingly O -
, O +
RAD54-deficient O +
spermatocytes O +
display O +
abnormal O +
persistence O +
of O +
RAD51 O +
foci O +
on O +
pachytene O +
chromosomes O -
, O +
similar O +
to O +
those O +
in O +
TRIP13 O +
mice O -
, O +
but O +
there O +
are O +
no O +
deleterious O +
effects O +
on O +
meiotic O +
progression O +
or O +
fertility O +
[ O -
49 O -
] O -
. O +

Data O +
from O +
budding O +
yeast O +
also O +
indicate O +
that O +
Pch2p O +
functions O +
in O +
recombination O -
. O +

Deletion O +
of O +
PCH2 O +
delays O +
meiotic O +
progression O +
by O +
∼2 O +
h O +
in O +
SK1 O +
yeast O -
, O +
and O +
causes O +
a O +
minor O +
decrease O +
in O +
ascus O +
formation O +
[ O -
50 O -
] O -
. O +

DSBs O +
persist O +
> O -
2 O +
h O +
longer O +
in O +
pch2Δ O +
yeast O +
than O +
in O +
wild O +
type O -
, O +
and O +
hyperresection O +
of O +
DSBs O +
in O +
dmc1Δ O +
pch2Δ O +
double O +
mutants O +
is O +
lower O +
than O +
in O +
dmc1Δ O +
cells O +
[ O -
10 O -
] O -
. O +

Additionally O -
, O +
it O +
was O +
reported O +
that O +
pch2Δ O +
yeast O +
had O +
a O +
meiosis O +
I O +
delay O +
dependent O +
on O +
the O +
RAD17–SAE2 O +
checkpoint O +
that O +
monitors O +
recombination O +
intermediates O +
[ O -
12 O -
] O -
. O +

However O -
, O +
the O +
exact O +
role O +
of O +
TRIP13 O +
( O -
or O +
Pch2 O -
) O +
in O +
recombination O +
is O +
unclear O -
. O +

Because O +
synapsis O +
occurs O +
in O +
TRIP13-deficient O +
spermatocytes O +
and O +
is O +
dependent O +
on O +
DSB O +
formation O +
( O -
activity O +
of O +
SPO11 O +
and O +
MEI1 O -
) O -
, O +
we O +
suggest O +
that O +
TRIP13 O +
functions O +
after O +
homology O +
recognition O +
and O +
strand O +
exchange O -
, O +
and O +
that O +
recombination O +
events O +
entering O +
the O +
CO O +
repair O +
pathway O +
are O +
either O +
completed O +
or O +
nearly O +
so O +
( O -
because O +
OA B-Chemical +
treated O +
resulted O +
in O +
bivalent O +
chromosomes O -
) O -
. O +

One O +
possibility O +
for O +
TRIP13′s O +
role O +
in O +
recombination O +
is O +
that O +
it O +
is O +
directly O +
involved O +
in O +
a O +
step O +
specific O +
to O +
resolution O +
of O +
NCO O +
recombination O +
intermediates O -
. O +

Another O +
possibility O +
is O +
that O +
TRIP13 O +
is O +
required O +
for O +
disassembly O +
of O +
NCO O +
recombinational O +
repair O +
complexes O +
[ O -
51 O -
] O +
containing O +
those O +
proteins O +
that O +
persist O +
abnormally O +
on O +
Trip13Gt O -
/ O -
Gt O +
pachytene O +
chromosomes O -
. O +

Notably O -
, O +
TRIP13 O +
has O +
two O +
putative O +
ATPase O +
domains O -
, O +
a O +
signature O +
of O +
AAA O -
- O -
ATPase O +
ClpA O -
/ O -
B O +
chaperones O +
that O +
perform O +
protein O +
or O +
protein O -
/ O -
DNA O +
complex O +
disassembly O +
[ O -
52 O -
] O -
. O +

These O +
potential O +
recombination O +
roles O +
might O +
not O +
be O +
limited O +
to O +
meiosis O -
, O +
since O +
Trip13 O +
is O +
widely O +
transcribed O +
and O +
the O +
mutant O +
animals O +
exhibited O +
developmental O +
defects O -
. O +

Finally O -
, O +
TRIP13 O +
might O +
play O +
an O +
indirect O +
role O -
, O +
such O +
as O +
providing O +
a O +
" O -
licensing O -
" O +
signal O +
for O +
the O +
resolution O +
of O +
NCO O +
intermediates O +
and O +
completion O +
of O +
meiosis O -
. O +

Regarding O +
the O +
cause O +
of O +
cell O +
death O +
in O +
Trip13 O +
mutants O -
, O +
our O +
data O +
indicate O +
that O +
this O +
is O +
triggered O +
by O +
defective O +
DSB O +
repair O +
rather O +
than O +
asynapsis O -
. O +

We O +
base O +
this O +
conclusion O +
on O +
two O +
observations O -
: O +
( O -
1 O -
) O +
oocyte O +
elimination O +
is O +
dependent O +
upon O +
DSB O +
formation O +
and O +
( O -
2 O -
) O +
synapsis O +
is O +
normal O +
in O +
spermatocytes O +
of O +
adult O +
testes O -
. O +

Indeed O -
, O +
this O +
mutant O +
is O +
unique O +
in O +
that O +
recombination O +
defects O +
occur O +
in O +
the O +
absence O +
of O +
asynapsis O +
( O -
e.g. O -
, O +
as O +
in O +
Dmc1 O +
knockouts O -
) O -
. O +

Thus O -
, O +
the O +
Trip13 O +
mutant O +
provides O +
the O +
first O +
evidence O +
that O +
unrepaired O +
DNA O +
damage O +
alone O +
can O +
trigger O +
the O +
mammalian O +
pachytene O +
checkpoint O +
response O -
. O +

Furthermore O -
, O +
our O +
results O +
allow O +
us O +
to O +
conclude O +
that O +
oocytes O +
and O +
spermatocytes O +
share O +
a O +
similar O -
, O +
if O +
not O +
identical O -
, O +
DNA O +
damage O +
pachytene O +
checkpoint O +
that O +
is O +
decoupled O +
from O +
a O +
synapsis O +
checkpoint O -
. O +

Interestingly O -
, O +
we O +
found O +
that O +
OA B-Chemical +
treatment O +
of O +
Trip13Gt O -
/ O -
Gt O +
spermatocytes O +
could O +
propel O +
them O +
into O +
MI O -
, O +
despite O +
a O +
report O +
that O +
the O +
same O +
did O +
not O +
occur O +
when O +
wild O -
- O -
type O +
pachytene O +
spermatocytes O +
were O +
treated O +
with O +
the O +
DSB O -
- O -
inducing O +
agents O +
gamma O +
radiation O +
or O +
etoposide B-Chemical +
[ O -
53 O -
] O -
. O +

It O +
is O +
possible O +
that O +
the O +
nascent O +
induction O +
of O +
DSBs O +
in O +
pachynema O +
evokes O +
a O +
checkpoint O +
response O +
that O +
can O -
not O +
be O +
bypassed O +
by O +
OA B-Chemical -
, O +
whereas O +
the O +
post O -
- O -
strand O +
invasion O +
lesions O +
in O +
TRIP13-deficient O +
spermatocytes O +
do O +
not O -
. O +

TRIP13 O +
was O +
originally O +
discovered O +
to O +
be O +
an O +
interactor O +
with O +
rat O +
thyroid O +
receptor O +
beta O +
( O -
THRB O -
; O +
[ O -
54 O -
] O -
) O -
, O +
but O +
the O +
relationship O +
between O +
THRB O +
and O +
TRIP13 O +
in O +
meiosis O +
is O +
unknown O -
. O +

Interestingly O -
, O +
we O +
observed O +
that O +
THRB O +
is O +
distributed O +
diffusely O +
throughout O +
wild O -
- O -
type O +
spermatocyte O +
nuclei O +
but O +
is O +
excluded O +
from O +
the O +
XY O +
( O -
sex O -
) O +
body O +
( O -
unpublished O +
observations O -
) O -
, O +
a O +
compartmentalized O +
nuclear O +
domain O +
beginning O +
in O +
pachynema O -
, O +
in O +
which O +
the O +
sex O +
chromosomes O +
become O +
heterochromatinized O +
and O +
transcriptionally O +
silenced O +
in O +
the O +
process O +
of O +
MSCI O +
[ O -
55 O -
] O -
. O +

However O -
, O +
the O +
XY O +
body O +
appeared O +
intact O +
in O +
most O +
mutant O +
spermatocytes O +
upon O +
probing O +
with O +
several O +
markers O +
of O +
XY O +
heterochromatinization O +
( O -
unpublished O +
observations O -
) O -
. O +

Considering O +
that O +
THRB O +
knockout O +
mice O +
are O +
viable O +
and O +
fertile O +
[ O -
56 O -
] O -
, O +
the O +
functional O +
relationship O +
between O +
TRIP13 O +
and O +
its O +
receptor O +
THRB O +
in O +
meiosis O +
is O +
unclear O -
. O +

Given O +
the O +
high O +
similarity O +
of O +
PCH2 O +
orthologs O +
throughout O +
the O +
eukaryotic O +
world O -
, O +
one O +
or O +
more O +
essential O +
functions O +
of O +
this O +
protein O +
must O +
be O +
conserved O -
. O +

Since O +
TRIP13 O +
does O +
not O +
exhibit O +
checkpoint O +
function O +
in O +
mice O -
, O +
we O +
surmise O +
that O +
the O +
TRIP13 O -
/ O -
PCH2 O +
ancestral O +
protein O +
had O +
a O +
function O +
in O +
recombination O +
that O +
persists O +
to O +
the O +
present O -
. O +

Notably O -
, O +
A. O +
thaliana O +
does O +
not O +
appear O +
to O +
have O +
a O +
meiotic O +
checkpoint O +
activity O +
that O +
eliminates O +
mutant O +
meiocytes O +
in O +
a O +
manner O +
analogous O +
to O +
organisms O +
such O +
as O +
mice O -
, O +
budding O +
yeast O -
, O +
and O +
female O +
Drosophila O +
[ O -
11,57 O -
] O -
, O +
and O +
mammalian O +
TRIP13 O +
is O +
more O +
similar O +
to O +
Arabidopsis O +
PCH2 O +
than O +
the O +
fly O +
or O +
worm O +
proteins O +
( O -
Figures O +
1A O +
and O +
S1 O -
) O -
. O +

The O +
unusual O +
relatedness O +
between O +
mammalian O +
and O +
plant O +
PCH2 O +
may O +
therefore O +
be O +
attributable O +
to O +
both O +
the O +
presence O +
of O +
a O +
common O +
conserved O +
function O +
( O -
namely O +
recombination O -
, O +
although O +
the O +
role O +
of O +
PCH2 O +
in O +
plants O +
has O +
yet O +
to O +
be O +
determined O -
) O -
, O +
and O +
the O +
absence O +
of O +
checkpoint O +
function O -
. O +

Nevertheless O -
, O +
the O +
evolutionary O +
relationships O +
between O +
animals O -
, O +
fungi O -
, O +
and O +
plants O +
( O -
which O +
are O +
discordant O +
with O +
PCH2 O +
sequence O +
phylogeny O -
) O +
do O +
not O +
allow O +
parsimonious O +
models O +
addressing O +
the O +
points O +
in O +
time O +
that O +
checkpoint O +
functions O +
in O +
PCH2 O +
were O +
gained O +
or O +
lost O -
. O +

It O +
is O +
possible O +
that O +
its O +
checkpoint O +
function O +
evolved O +
independently O +
in O +
worms O +
and O +
budding O +
yeast O -
. O +

The O +
picture O +
will O +
become O +
clearer O +
as O +
the O +
function O +
of O +
PCH2 O +
in O +
other O +
organisms O +
is O +
elucidated O -
. O +

The O +
nature O +
of O +
the O +
synapsis O +
checkpoint O +
in O +
male O +
mice O +
remains O +
unidentified O -
. O +

One O +
possible O +
candidate O +
is O +
Dot1 O +
( O -
PCH1 O +
in O +
yeast O -
) O -
, O +
a O +
histone B-Chemical +
methyltransferase O +
silencing O +
factor O +
that O +
is O +
required O +
for O +
pachytene O +
arrest O +
of O +
zip1 O +
and O +
dmc1 O +
mutants O +
in O +
yeast O +
[ O -
58 O -
] O -
, O +
and O +
for O +
preventing O +
RAD54-mediated O +
recombinational O +
DSB O +
repair O +
between O +
sister O +
chromatids O -
. O +

However O -
, O +
DOT1 O +
acts O +
upstream O +
of O +
PCH2 O -
. O +

Given O +
that O +
TRIP13 O +
does O -
n't O +
have O +
checkpoint O +
function O +
in O +
mice O -
, O +
a O +
potential O +
role O +
for O +
mammalian O +
DOT1 O +
in O +
the O +
pachytene O +
checkpoint O +
is O +
dubious O +
but O +
awaits O +
investigation O -
. O +

Recently O -
, O +
it O +
was O +
shown O +
that O +
the O +
TRP53 O +
homolog O +
TRP63 O +
is O +
required O +
for O +
DNA O +
damage O -
– O -
induced O +
death O +
of O +
dictyate O -
- O -
stage O +
primordial O +
oocytes O -
, O +
leading O +
to O +
the O +
suggestion O +
that O +
it O +
is O +
involved O +
in O +
monitoring O +
genome O +
integrity O +
[ O -
59 O -
] O -
. O +

However O -
, O +
this O +
activity O +
occurs O +
subsequent O +
to O +
a O +
pachytene O +
checkpoint O -
. O +

As O +
alluded O +
to O +
earlier O -
, O +
a O +
complicating O +
problem O +
for O +
studying O +
potential O +
meiotic O +
checkpoint O +
genes O +
in O +
mice O +
is O +
that O +
as O +
in O +
yeast O -
, O +
such O +
genes O +
often O +
have O +
mitotic O +
functions O +
( O -
such O +
as O +
RAD24 O +
[ O -
7 O -
] O -
) O -
, O +
and O +
their O +
ablation O +
can O +
cause O +
lethality O +
[ O -
42 O -
] O -
. O +

Unless O +
mammalian O +
pachytene O +
checkpoint O +
components O +
have O +
orthologs O +
with O +
similar O +
functions O +
in O +
organisms O +
such O +
as O +
yeast O -
, O +
their O +
identities O +
are O +
likely O +
to O +
remain O +
elusive O -
. O +

Materials O +
and O +
Methods O +
PCR O +
analysis O +
of O +
Trip13 O +
cDNA O -
. O +

Trip13 O +
was O +
amplified O +
from O +
samples O +
of O +
Clontech O -
's O +
Mouse O +
Multiple O +
Tissue O +
cDNA O +
Panel O +
I O +
( O -
http://www.clontech.com O -
) O -
, O +
using O +
the O +
following O +
primers O -
: O +
5′-GCACCATTGCACTTCACATC-3′ O +
( O -
TRP3 O -
- O -
6F O -
) O +
and O +
5′-TGACCATCAGACTGTCGAGC-3′ O +
( O -
TRP3 O -
- O -
6R O -
) O -
. O +

These O +
primers O +
correspond O +
to O +
exons O +
3 O +
and O +
6 O -
, O +
respectively O -
, O +
and O +
amplify O +
a O +
330-bp O +
cDNA O +
product O -
. O +

The O +
cDNAs O +
in O +
this O +
panel O +
are O +
equalized O +
to O +
allow O +
quantitative O +
analysis O +
by O +
RT O -
- O -
PCR O -
. O +

Generation O +
of O +
Trip13-deficient O +
mice O -
. O +

The O +
mouse O +
embryonic O +
stem O +
cell O +
line O +
RRB047 O +
( O -
strain O +
129 O -
/ O -
Ola O -
) O +
containing O +
a O +
gene O +
trap O +
insertion O +
in O +
Trip13 O +
was O +
obtained O +
from O +
BayGenomics O +
( O -
http://www.baygenomics.ucsf.edu/ O -
) O -
. O +

The O +
gene O -
- O -
trapping O +
vector O +
used O +
to O +
create O +
this O +
line O -
, O +
pGT1lxf O -
, O +
was O +
designed O +
to O +
create O +
an O +
in O -
- O -
frame O +
fusion O +
between O +
the O +
5′ O +
exons O +
of O +
the O +
trapped O +
gene O +
and O +
a O +
reporter O -
, O +
βgeo O +
( O -
a O +
fusion O +
of O +
β O -
- O -
galactosidase O +
and O +
neomycin B-Chemical +
phosphotransferase O +
II O -
) O -
. O +

The O +
gene O -
- O -
trapped O +
locus O +
creates O +
a O +
fusion O +
transcript O +
containing O +
exons O +
1–3 O +
of O +
Trip13 O +
and O +
βgeo O -
. O +

To O +
identify O +
the O +
exact O +
insertion O +
site O +
within O +
intron O +
3 O -
, O +
PCR O +
was O +
performed O +
using O +
one O +
primer O +
within O +
the O +
gene O +
trap O +
vector O -
, O +
and O +
the O +
other O +
primer O +
at O +
various O +
positions O +
in O +
intron O +
3 O +
pointing O +
towards O +
the O +
3′ O +
end O +
of O +
the O +
gene O -
. O +

Product O +
from O +
a O +
productive O +
reaction O +
was O +
sequenced O -
, O +
revealing O +
that O +
the O +
insertion O +
site O +
was O +
445 O +
bp O +
into O +
intron O +
3 O -
. O +

Genotyping O +
of O +
mice O -
. O +

Three O +
primers O +
were O +
used O +
to O +
distinguish O +
wild O -
- O -
type O +
and O +
mutant O +
alleles O +
of O +
Trip13 O -
: O +
primer O +
1 O -
, O +
5′-CGTCGCTCCATTGCTTTGTGC-3′ O -
; O +
primer O +
2 O -
, O +
5′-AGTAGTGGTACACTGTATTTTTGCTTTCATTGA-3′ O -
; O +
and O +
primer O +
3 O -
, O +
5′-GTAGATCCCGGCGCTCTTACCAA-3′. O +
Primers O +
1 O +
and O +
2 O +
are O +
located O +
upstream O +
and O +
downstream O -
, O +
respectively O -
, O +
of O +
the O +
gene O +
trap O +
insertion O +
within O +
the O +
intron O +
3 O -
. O +

Primer O +
3 O +
corresponds O +
to O +
pGTlxf O +
sequence O -
. O +

Primers O +
1 O +
and O +
2 O +
amplify O +
a O +
700-bp O +
band O +
from O +
a O +
wild O -
- O -
type O +
allele O -
; O +
primers O +
1 O +
and O +
3 O +
amplify O +
a O +
540-bp O +
fragment O +
from O +
a O +
mutant O +
allele O -
. O +

Separate O +
reactions O +
were O +
used O +
to O +
assay O +
the O +
presence O +
or O +
absence O +
of O +
each O +
amplicon O +
from O +
a O +
DNA O +
sample O -
. O +

The O +
cycling O +
conditions O +
were O -
: O +
94 O +
° O -
C O +
2 O +
min O -
; O +
35 O +
cycles O +
of O +
94 O +
° O -
C O +
30 O +
s O -
, O +
57 O +
° O -
C O +
45 O +
s O -
, O +
and O +
72 O -
° O -
C O +
50 O +
s O -
; O +
and O +
72 O +
° O -
C O +
2 O +
min O -
. O +

RT O -
- O -
PCR O -
. O +

Total O +
RNA O +
was O +
isolated O +
from O +
adult O +
testes O +
with O +
the O +
RNeasy O +
Mini O +
Kit O +
( O -
Qiagen O -
, O +
http://www.qiagen.com O -
) O -
, O +
and O +
4.0 O +
μg O +
was O +
oligo O +
dT O -
– O -
primed O +
and O +
reverse O -
- O -
transcribed O +
with O +
Superscript O +
II O +
( O -
Stratagene O -
, O +
http://www.stratagene.com O -
) O -
. O +

The O +
entire O +
Trip13 O +
protein O -
- O -
coding O +
sequence O +
was O +
amplified O +
with O +
primers O +
5′-ATGGACGAGGCGGTG-3′ O +
and O +
5′-TCAAACATAAGCTGAAAGTT-3′. O +
The O +
cycling O +
conditions O +
were O -
: O +
94 O +
° O -
C O +
2 O +
min O -
; O +
94 O +
° O -
C O +
30s O -
, O +
55 O +
° O -
C O +
45 O +
s O -
, O +
and O +
72 O +
° O -
C O +
80 O +
s O +
for O +
35 O +
cycles O -
; O +
and O +
72 O +
° O -
C O +
2 O +
min O -
. O +

The O +
primers O +
for O +
amplifying O +
the O +
Med31 O +
coding O +
sequence O +
as O +
control O +
were O +
: O +
5′-ATGGCCGCGGCCGTCGCTATGG-3′ O +
and O +
5′-TCATTTCCCTGCTGTGTTATTCTGCTGCTGCTGC-3′. O +
The O +
cycling O +
conditions O +
were O -
: O +
94 O +
° O -
C O +
2 O +
min O -
; O +
94 O +
° O -
C O +
30 O +
s O -
, O +
55 O +
° O -
C O +
30 O +
s O -
, O +
and O +
72 O +
° O -
C O +
35 O +
s O +
for O +
35 O +
cycles O -
; O +
and O +
72 O +
° O -
C O +
2 O +
min O -
. O +

Development O +
and O +
purification O +
of O +
chicken O +
antibodies O -
. O +

A O +
peptide O +
corresponding O +
to O +
amino O +
acids O +
25–40 O +
of O +
TRIP13 O -
, O +
VLQRSGSTAKKEDIK O -
, O +
was O +
conjugated O +
to O +
KLH O +
and O +
used O +
to O +
immunize O +
chickens O +
( O -
done O +
by O +
Sigma O +
Genosys O -
, O +
http://www.sigmaaldrich.com O -
) O -
. O +

Polyclonal O +
IgY O +
was O +
isolated O +
from O +
eggs O +
with O +
the O +
Eggcellent O +
Chicken O +
IgY O +
Purification O +
kit O +
( O -
Pierce O -
, O +
http://www.piercenet.com O -
) O -
. O +

IgY O +
antibodies O +
were O +
then O +
affinity O +
purified O +
using O +
the O +
immunizing O +
synthetic O +
peptide O -
. O +

Western O +
blotting O -
. O +

50 O +
μg O +
of O +
testis O +
extract O +
in O +
RIPA O +
buffer O +
was O +
separated O +
by O +
8 O -
% O +
SDS B-Chemical -
- O -
PAGE O +
and O +
electrotransferred O +
onto O +
a O +
Pure O +
Nitrocellulose B-Chemical +
membrane O +
( O -
Bio O -
- O -
Rad O -
, O +
http://www.biorad.com O -
) O -
. O +

The O +
membrane O +
was O +
incubated O +
with O +
a O +
polyclonal O +
rabbit O +
anti O -
- O -
human O +
TRIP13 O +
antibody O +
( O -
18 O -
- O -
003 O -
- O -
42687 O -
; O +
Genway O -
, O +
http://www.genwaybio.com O -
) O -
. O +

According O +
to O +
the O +
manufacturer O -
, O +
the O +
immunogen B-Chemical +
was O +
a O +
synthetic O +
peptide O +
embedded O +
in O +
sequence O +
we O +
deduced O +
to O +
correspond O +
to O +
exon O +
3 O -
. O +

Binding O +
was O +
detected O +
by O +
chemiluminescence O +
ECL O +
kit O +
( O -
Pierce O -
) O +
using O +
a O +
rabbit O +
anti O -
- O -
chicken O +
IgG O +
horseradish O +
peroxidase O +
conjugate B-Chemical +
( O -
Pierce O -
) O -
. O +

Histological O +
analyses O -
. O +

Testes O +
or O +
ovaries O +
were O +
fixed O +
in O +
Bouin O -
's O -
, O +
embedded O +
in O +
paraffin O -
, O +
sectioned O +
at O +
6 O +
μm O -
, O +
and O +
stained O +
by O +
hematoxylin B-Chemical +
and O +
eosin O -
. O +

Antigen B-Chemical +
retrieval O +
for O +
immunohistochemistry O +
of O +
testis O +
sections O +
was O +
as O +
described O +
[ O -
60 O -
] O -
. O +

Oocyte O +
and O +
follicle O +
numbers O +
were O +
counted O +
as O +
described O +
[ O -
61 O -
] O -
. O +

Only O +
follicles O +
containing O +
an O +
oocyte O +
with O +
a O +
clearly O +
visible O +
nucleus O +
were O +
scored O -
. O +

Immunocytochemistry O -
. O +

Immunolabeling O +
of O +
surface O -
- O -
spread O +
spermatocytes O +
and O +
oocytes O +
was O +
performed O +
as O +
described O +
[ O -
39,62 O -
] O -
. O +

To O +
reach O +
conclusions O +
on O +
the O +
pattern O +
of O +
staining O +
for O +
various O +
proteins O -
, O +
30 O +
( O -
unless O +
otherwise O +
indicated O -
) O +
well O -
- O -
spread O +
nuclei O +
of O +
particular O +
meiotic O +
stages O +
were O +
first O +
identified O +
under O +
the O +
fluorescent O +
microscope O +
on O +
the O +
basis O +
of O +
SYCP3 O +
or O +
STAG3 O +
staining O -
, O +
then O +
imaged O +
at O +
both O +
appropriate O +
wavelengths O +
to O +
determine O +
the O +
pattern O +
of O +
second O +
proteins O +
with O +
focal O +
patterns O +
such O +
as O +
RAD51 O +
or O +
RPA O -
. O +

Unless O +
otherwise O +
indicated O -
, O +
the O +
panels O +
shown O +
in O +
the O +
figures O +
were O +
the O +
exclusive O +
or O +
predominant O +
patterns O +
seen O -
. O +

The O +
exception O +
for O +
this O +
approach O +
was O +
in O +
the O +
case O +
of O +
staining O +
for O +
MLH1 O +
or O +
MLH3 O +
plus O +
RAD51 O +
( O -
in O +
which O +
case O +
SYCP3 O +
or O +
STAG3 O +
was O +
not O +
available O +
to O +
find O +
chromosome O +
cores O -
) O -
. O +

Nuclei O +
in O +
this O +
situation O +
were O +
identified O +
first O +
by O +
MLH1 O -
/ O -
3 O +
foci O +
clustering O -
, O +
then O +
imaged O +
for O +
both O +
fluorescent O +
wavelengths O -
. O +

Primary O +
antibodies O +
used O +
in O +
this O +
study O +
were O +
as O +
follows O -
: O +
mouse O +
anti O -
- O -
SCP3 O +
( O -
1:500 O -
; O +
Abcam O -
, O +
http://www.abcam.com O -
) O -
; O +
rabbit O +
anti O -
- O -
SYCP1 O +
( O -
1:1,000 O -
; O +
a O +
gift O +
from O +
C. O +
Heyting O -
) O +
[ O -
63 O -
] O -
; O +
rabbit O +
anti O -
- O -
REC8 O +
( O -
1:100 O -
; O +
a O +
gift O +
from O +
C. O +
Heyting O -
) O -
; O +
rabbit O +
anti O -
- O -
RAD51 O +
( O -
1:250 O -
, O +
this O +
polyclonal O +
antibody O +
recognizes O +
both O +
RAD51 O +
and O +
DMC1 O -
; O +
Oncogene O +
Research O +
Products O -
, O +
http://www.merckbiosciences.co.uk O -
) O -
; O +
rabbit O +
anti O -
- O -
γH2AX O +
( O -
1:500 O -
; O +
Upstate O +
Biotechnology O -
, O +
http://www.upstate.com/ O -
) O -
; O +
rabbit O +
anti O -
- O -
STAG3 O +
( O -
1:1,000 O -
; O +
a O +
gift O +
from O +
R. O +
Jessberger O -
) O -
; O +
rabbit O +
anti O -
- O -
MLH3 O +
( O -
1:400 O -
; O +
a O +
gift O +
from O +
P. O +
Cohen O -
) O -
; O +
mouse O -
- O -
anti O -
- O -
human O +
MLH1 O +
( O -
1:50 O -
; O +
BD O +
Biosciences O -
, O +
http://www.bdbiosciences.com O -
) O -
; O +
rabbit O -
- O -
anti O -
- O -
TopBP1 O +
( O -
1:100 O -
; O +
a O +
gift O +
from O +
J. O +
Chen O -
) O +
[ O -
22 O -
] O -
; O +
mouse O -
- O -
anti O -
- O -
ubiquityl O -
- O -
histone B-Chemical +
H2A O +
( O -
1:200 O -
; O +
Upstate O +
Biotechnology O -
) O -
; O +
rabbit O -
- O -
anti O -
- O -
TRF2 O +
( O -
1:500 O -
; O +
a O +
gift O +
from O +
T. O +
de O +
Lange O -
) O -
; O +
and O +
rabbit O -
- O -
anti O -
- O -
BLM O +
( O -
1:50 O -
; O +
a O +
gift O +
from O +
R. O +
Freire O -
) O -
. O +

All O +
secondary O +
antibodies O +
conjugated O +
with O +
either O +
Alexa B-Chemical +
Fluor I-Chemical +
488 B-Chemical +
or O +
594 B-Chemical +
( O -
Molecular O +
Probes O -
, O +
http://probes.invitrogen.com/ O -
) O +
were O +
used O +
at O +
a O +
dilution O +
of O +
1:1,000 O -
. O +

All O +
images O +
were O +
taken O +
with O +
a O +
100 O -
× O +
objective O +
lens O +
under O +
immersion O +
oil O -
. O +

Metaphase O +
I O +
spermatocyte O +
spreads O +
and O +
OA B-Chemical +
treatment O -
. O +

Metaphase O +
fixed O +
spermatocytes O +
from O +
8-mo O -
- O -
old O +
Trip13RRB047 O +
homozygotes O -
, O +
using O +
23-d O -
- O -
old O +
wild O -
- O -
type O +
mice O +
as O +
control O -
, O +
were O +
prepared O +
and O +
stained O +
with O +
Giemsa O +
as O +
described O +
[ O -
64 O -
] O -
. O +

For O +
OA B-Chemical +
treatment O -
, O +
cells O +
were O +
exposed O +
to O +
5 O +
μM O +
OA B-Chemical +
( O -
Calbiochem O -
, O +
http://www.emdbiosciences.com O -
) O +
for O +
6 O +
h O +
at O +
32 O +
° O -
C O +
in O +
a O +
humidified O +
environment O +
of O +
5 O -
% O +
CO2 B-Chemical +
before O +
spreading O +
[ O -
65 O -
] O -
. O +

These O +
preparations O +
were O +
stained O +
with O +
DAPI B-Chemical +
to O +
visualize O +
metaphase O +
nuclei O +
and O +
chromosomes O -
. O +

Phylogenetic O +
analyses O -
. O +

TRIP13 O +
orthologs O +
were O +
identified O +
by O +
BLASTP O +
searches O +
of O +
Genbank O +
and O +
other O +
sources O +
providing O +
gene O +
models O +
such O +
as O +
Ensembl O -
. O +

The O +
selected O +
orthologs O +
can O +
be O +
found O +
in O +
Table O +
S1 O -
. O +

Amino O +
acid O +
alignments O +
were O +
done O +
with O +
Clustal O +
W O -
, O +
using O +
the O +
default O +
settings O +
with O +
and O +
without O +
removing O +
the O +
regions O +
outside O +
of O +
the O +
AAA O -
- O -
ATPase O +
central O +
domain O -
. O +

The O +
trees O +
were O +
constructed O +
by O +
using O +
the O +
neighbor O -
- O -
joining O +
method O +
with O +
Poisson O +
correction O -
. O +

The O +
reliability O +
of O +
internal O +
branches O +
was O +
assessed O +
by O +
using O +
500 O +
bootstrap O +
replicates O -
, O +
and O +
sites O +
with O +
gaps O +
were O +
ignored O +
in O +
this O +
analysis O -
. O +

Neighbor O -
- O -
joining O +
searches O +
were O +
conducted O +
by O +
using O +
the O +
computer O +
program O +
MEGA3 O +
[ O -
66 O -
] O -
. O +

Supporting O +
Information O +
Figure O +
S1 O +
Depiction O +
of O +
Conserved O +
Regions O +
of O +
Mouse O +
TRIP13 O +
and O +
Its O +
PCH2 O +
Orthologs O +
( O -
75 O +
KB O +
PDF O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S2 O +
Surface O -
- O -
Spread O +
Chromosomes O +
Immunolabeled O +
with O +
the O +
Indicated O +
Antibodies O +
and O +
Fluorophores B-Chemical +
( O -
947 O +
KB O +
PDF O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Figure O +
S3 O +
Trip13 O +
Mutant O +
Spermatocytes O +
That O +
Progress O +
Beyond O +
Pachynema O +
Have O +
Repaired O +
DSBs O +
and O +
Form O +
Bivalents O +
at O +
Metaphase O +
I O +
( O -
1.5 O +
MB O +
PDF O +

) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Table O +
S1 O +
Sources O +
of O +
TRIP13 O +
Amino O +
Acid O +
Sequences O +
Used O +
to O +
Construct O +
the O +
Phylogenetic O +
Tree O +
in O +
Figure O +
1 O +
( O -
22 O +
KB O +
PDF O -
) O +
Click O +
here O +
for O +
additional O +
data O +
file O -
. O +

Acknowledgements O +
We O +
thank O +
P. O +
Burgoyne O -
, O +
P. O +
Cohen O -
, O +
E. O +
Alani O -
, O +
and O +
P. O +
Moens O +
for O +
helpful O +
discussions O -
, O +
R. O +
Viswanatha O +
for O +
helpful O +
comments O +
on O +
the O +
manuscript O -
, O +
W. O +
Pawlowski O +
and O +
T. O +
Pawlowska O +
for O +
input O +
on O +
the O +
evolutionary O +
tree O +
of O +
PCH2 O -
, O +
R. O +
Freire O +
and O +
J. O +
Chen O +
for O +
antibodies O -
, O +
M. O +
Jasin O +
for O +
Spo11− O +
embryonic O +
stem O +
cells O -
, O +
and O +
R. O +
Munroe O +
for O +
generating O +
chimeric O +
mice O -
. O +

We O +
also O +
thank O +
an O +
anonymous O +
reviewer O +
for O +
pointing O +
out O +
that O +
Pch2p O +
might O +
be O +
sensing O +
synaptic O +
polymerization O +
in O +
yeast O -
, O +
not O +
initiation O -
. O +

Abbreviations O +
CO O +
- O +
crossover O +
DSB O +
- O +
double O +
strand O +
break O +
MSCI O +
- O +
meiotic O +
sex O +
chromosome O +
inactivation O +
MSUC O +
- O +
meiotic O +
silencing O +
of O +
unpaired O +
chromatin O +
NCO O +
- O +
noncrossover O +
OA B-Chemical +
- O +
okadaic B-Chemical +
acid I-Chemical +
RT O -
- O -
PCR O +
- O +
reverse O -
- O -
transcriptase O +
PCR O +
SC O +
- O +
synaptonemal O +
complex O +
Footnotes O +
A O +
previous O +
version O +
of O +
this O +
article O +
appeared O +
as O +
an O +
Early O +
Online O +
Release O +
on O +
June O +
21 O -
, O +
2007 O +
( O -
doi:10.1371 O -
/ O -
journal.pgen.0030130.eor O -
) O -
. O +

Author O +
contributions O -
. O +

XL O +
and O +
JCS O +
conceived O +
and O +
designed O +
the O +
experiments O +
and O +
analyzed O +
the O +
data O -
. O +

XL O +
performed O +
the O +
experiments O -
. O +

JCS O +
wrote O +
the O +
paper O -
. O +

Funding O -
. O +

This O +
work O +
was O +
supported O +
by O +
NIH O +
grant O +
GM45415 O +
to O +
JS O -
. O +

Competing O +
interests O -
. O +

The O +
authors O +
have O +
declared O +
that O +
no O +
competing O +
interests O +
exist O -
. O +

